{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e4_page_window_relevance_desc/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-04T08:30:46.013973"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for Lockheed Martin’s non‑qualified defined‑benefit pension plans fell from **$1.0 billion at year‑end 2023** to **$905 million at year‑end 2024**【page_88】.  At the same time, the pretax actuarial losses recorded in accumulated other‑comprehensive loss declined from **$347 million in 2023** to **$303 million in 2024**【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Gross benefit obligation correctly stated as $1.0 billion in 2023 and $905 million in 2024; (2) Actuarial losses correctly identified as $347 million in 2023 and $303 million in 2024. The answer properly identifies the company as Lockheed Martin (LMT), correctly specifies the pension plan type (non-qualified defined-benefit), and accurately characterizes the evolution as a reduction in both metrics. The multi-hop synthesis is sound - the answer successfully combines information about two related metrics (gross benefit obligation and actuarial losses) across two fiscal years. The inclusion of page references adds credibility. The only minor observation is that the LLM answer uses slightly more technical language ('pretax actuarial losses recorded in accumulated other-comprehensive loss') compared to the ground truth's simpler phrasing ('actuarial losses'), but this is semantically equivalent and actually more precise. The answer fully addresses all parts of the question and provides appropriate context about the directional change (reduction) in both metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 336,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "GM’s assumed long‑term return on U.S. pension‑plan assets rose from 5.38 % for the year ended 2022 to roughly 6.3 %‑6.5 % for 2024 【page_87】.  The 2024 filing notes that the weighted‑average long‑term rate of return was lifted after an investment‑policy study, reflecting a strategic shift toward a higher‑return asset mix (e.g., more private‑equity, real‑estate and other alternative “Other” assets) to improve funded status and reduce volatility【page_88】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the general upward trend in GM's long-term rate of return assumptions from 2022 to 2024. (2) The range of 6.3%-6.5% for 2024 matches the ground truth. (3) The LLM correctly identifies the strategic shift toward alternative assets (private equity, real estate) and the connection to improving funded status. (4) The reasoning about investment policy studies and asset mix adjustments is sound and relevant.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states the 2022 rate was 5.38%, but the ground truth indicates it was 5.4% (at December 31, 2021, reported in the 2022 filing). While 5.38% is close to 5.4%, this represents imprecision in a key metric. (2) INCOMPLETE TEMPORAL CLARITY: The LLM conflates the 2022 filing data with year-end 2022 data. The ground truth specifies that 2022 reported data from 2020-2021 (5.6% to 5.4%), while 2024 reported data from 2023-2024 (6.3% to 6.5%). The LLM doesn't clearly distinguish between what was reported in each year's filing versus the actual year-end dates. (3) MISSING CONTEXT: The ground truth emphasizes the comparison between 2022's conservative 5.4% assumption and 2024's more optimistic 6.5% assumption, showing a significant strategic shift. The LLM captures this but doesn't emphasize the magnitude of change (from 5.4% to 6.5% = 110 basis points increase). (4) The LLM answer is somewhat vague about which specific year's data corresponds to which filing period.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the rate changes and connects them to strategic asset allocation decisions, demonstrating adequate multi-hop reasoning. However, the temporal mapping between filing years and reported periods could be clearer.\n\nOVERALL: The answer captures the essential narrative (upward trend, strategic shift toward alternatives) but has precision issues with the exact percentages and temporal clarity that would be expected in a financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 538,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "In 2023 Chevron completed a business‑combination with PDC Energy, treating it as a newly‑acquired, wholly‑owned subsidiary whose revenues represented roughly 5 % of consolidated revenue and which was excluded from the company’s internal‑control assessment because the acquisition occurred during the year (2023 p. 30‑31). By 2024 the legacy PDC assets were fully integrated into Chevron’s U.S. upstream business, delivering a full‑year of production that added about 250,000 boe/d (≈19 % increase) and $2.2 billion of sales volume, which helped lift U.S. upstream earnings by $3.5 billion (2024 p. 44).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative of Chevron's PDC Energy acquisition and integration between 2023-2024, with accurate entity identification and proper multi-hop synthesis. However, there is a significant quantitative discrepancy that undermines accuracy. The LLM states that PDC assets contributed '$2.2 billion of sales volume, which helped lift U.S. upstream earnings by $3.5 billion,' but the ground truth specifies that the $2.2 billion increase in U.S. upstream earnings was attributed to legacy PDC assets. The LLM appears to conflate 'sales volume' with 'earnings increase' and introduces an unexplained $3.5 billion figure that contradicts the ground truth's $2.2 billion figure. This is a material error in financial reporting. The production increase of approximately 250,000 boe/d representing a 19% increase is correctly stated and matches the ground truth. The LLM correctly identifies that PDC was excluded from internal controls in 2023 due to the mid-year acquisition and that full integration occurred by 2024. The contextual framing of the evolution from acquisition to operational integration is appropriate and well-reasoned. The answer appropriately cites page references (2023 p. 30-31, 2024 p. 44), suggesting proper source documentation. The primary weakness is the financial impact statement where the $2.2 billion figure appears to be mischaracterized or conflated with other metrics, and the introduction of the $3.5 billion figure lacks grounding in the ground truth. This represents a critical error in a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 440,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "In the 2022 Form 10‑K Southern Company reported unrealized gains on its energy‑related regulatory hedges as a $155 million net gain (with a $7 million loss for the gas unit) and presented those amounts as separate regulatory assets and liabilities on the balance sheet【page_324】. By the 2024 filing the company netted the derivative positions, showing energy‑related regulatory‑hedge assets of $45 million and liabilities of $122 million, and added cash‑flow/fair‑value‑hedge line items with $32 million of assets and $659 million of liabilities; it also disclosed large fair‑value losses on interest‑rate hedges (‑$269 million) and foreign‑currency hedges (‑$218 million)【page_283】【page_282】. This reflects a shift from reporting unrealized gains as distinct regulatory‑asset amounts to a net fair‑value presentation of derivative assets and liabilities, with losses now recognized in the balance sheet and OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to provide specific numerical details about Southern Company's derivative valuations between 2022 and 2024, which goes beyond the ground truth answer. However, there are significant issues with verification:\n\n1. QUANTITATIVE ACCURACY CONCERNS:\n   - The LLM provides specific dollar amounts ($155 million net gain, $7 million loss, $45 million assets, $122 million liabilities, $32 million assets, $659 million liabilities, -$269 million interest-rate hedges, -$218 million foreign-currency hedges) that cannot be verified against the ground truth provided\n   - The ground truth does not contain these specific numbers, making it impossible to confirm accuracy\n   - Page citations are provided (page_324, page_283, page_282) but cannot be independently verified in this context\n   - The specificity of numbers suggests either accurate extraction from source documents or potential fabrication\n\n2. QUALITATIVE ACCURACY:\n   - The LLM correctly identifies the core shift described in ground truth: from regulatory hedging instrument treatment with deferred gains/losses to fair value presentation as balance sheet assets/liabilities\n   - Correctly mentions the change in presentation from separate regulatory assets/liabilities to net fair-value presentation\n   - Appropriately notes the inclusion of interest-rate and foreign-currency derivatives in 2024 disclosures\n   - The reasoning about the shift from unrealized gains to net fair-value presentation aligns with ground truth\n\n3. MULTI-HOP REASONING:\n   - Successfully synthesizes the 2022 vs 2024 comparison\n   - Correctly identifies the shift in valuation approach and presentation methodology\n   - Appropriately connects the change to balance sheet and OCI treatment\n\n4. COMPLETENESS:\n   - Addresses both the valuation change and presentation change aspects of the question\n   - Provides more granular detail than ground truth, which could be either a strength (if accurate) or a weakness (if inaccurate)\n   - Ground truth is somewhat vague about specific amounts, while LLM provides concrete figures\n\n5. KEY ISSUE:\n   - The ground truth answer is qualitative and general, while the LLM answer is highly specific with numbers\n   - Without access to the actual 10-K filings, the specific numbers cannot be verified\n   - The LLM's specificity could indicate either excellent source document analysis or hallucination\n   - The semantic alignment with ground truth concepts is strong, but numerical verification is impossible\n\nThe answer demonstrates good understanding of the conceptual shift but raises concerns about the verifiability and accuracy of specific financial figures provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 712,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "- 2022: Chevron’s 50 % stake in Tengizchevroil was recorded at a carrying amount about **$100 higher** than the affiliate’s underlying net‑asset equity, and the equity‑method share of earnings from TCO was **$4.386 billion**【page_78†L31-L38】【page_84†L31-L34】.  \n\n- 2024: At 31 December 2024 the carrying value of the TCO investment was **about $73 higher** than the underlying equity, and equity earnings from TCO had fallen to **$3.033 billion**【page_85†L1-L7】【page_84†L31-L34】.  \n\nThus, between 2022 and 2024 the excess of Chevron’s carrying value over TCO’s net‑asset equity narrowed from roughly $100 to $73, while its equity earnings from the joint venture declined from $4.386 billion to $3.033 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the equity earnings figures ($4.386 billion in 2022 and $3.033 billion in 2024) and the trend of declining profitability. The answer properly addresses the multi-hop nature of the question by comparing metrics across 2022 and 2024. The reasoning about the narrowing excess carrying value ($100 to $73) is logically sound. CRITICAL OMISSION: The LLM answer completely fails to address a major component of the ground truth - the investment and advances figures ($27,368 million in 2024 vs $26,954 million in 2023). The original answer explicitly states 'Chevron's investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023' as a key metric showing how the financial relationship evolved. This represents a substantial portion of the financial relationship and its growth trajectory. QUANTITATIVE ISSUES: While the equity earnings numbers are correct, the LLM provides only partial quantitative information about the investment carrying value evolution. The ground truth mentions a $4,500 loan for FGP/WPMP development in 2022, which the LLM omits entirely. REASONING: The multi-hop synthesis is partially sound - the LLM correctly compares 2022 to 2024 and identifies the earnings decline trend. However, the analysis is incomplete because it doesn't synthesize the full picture of how the investment carrying value evolved in absolute terms (the $27,368M figure), only the relative excess over net assets. The answer would have been stronger with both metrics: the absolute investment value AND the excess carrying value. SEMANTIC EQUIVALENCE: The wording differs from ground truth but conveys some of the same information about earnings decline. However, the omission of the absolute investment figures represents a material gap in answering how the 'financial relationship evolved' - this requires showing both the size of the investment and its profitability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 523,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart’s stake in Alert Innovation went from a variable‑interest relationship to full ownership in fiscal 2023 when it bought out the non‑controlling interest for about $0.4 billion, making the company a 100 % owner. The 2024 filing shows the ownership remained at 100 % through fiscal 2024, with no further change until a planned sale in fiscal 2025. The transaction that altered the relationship was the $0.4 billion acquisition of Alert Innovation, converting it from a variable‑interest entity into a wholly‑owned subsidiary【page_66】【page_65】.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the key evolution of Walmart's ownership stake. Ground truth states that by fiscal 2024, Walmart had 'subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity.' The LLM answer claims 'The 2024 filing shows the ownership remained at 100% through fiscal 2024, with no further change until a planned sale in fiscal 2025.' This is a major factual error - the LLM incorrectly states ownership remained at 100% in fiscal 2024 when it should have been 0% (complete exit/sale). The question specifically asks how the stake 'evolved between fiscal 2023 and fiscal 2024' - the critical evolution is the transition from 100% ownership to complete divestiture, which the LLM completely missed. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount is correct, and the fiscal 2023 100% ownership figure is accurate. However, the fiscal 2024 ownership status is completely wrong (stated as 100% when it should be 0%). QUALITATIVE ACCURACY: The LLM correctly identified the fiscal 2023 transaction (acquisition for $0.4B converting from variable interest entity to wholly-owned subsidiary), but failed to identify the critical fiscal 2024 transaction (the sale and deconsolidation). The multi-hop reasoning is incomplete - it only synthesizes the fiscal 2023 transaction and misses the fiscal 2024 evolution entirely. CONTEXTUAL RELEVANCE: The answer addresses part of the question but fundamentally fails to answer the core ask about how the stake 'evolved' - evolution requires showing the change from fiscal 2023 to fiscal 2024, which the LLM does not do correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 458,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "In FY 2022 Starbucks held foreign‑currency‑other derivative assets of $39.9 million in current assets and $33.5 million in long‑term assets (about $73.4 million total) with only $0.3 million of related liabilities. By FY 2023 the asset balances fell to $32.0 million (current) and $22.9 million (long‑term) – $54.9 million total – while the liability side grew to $2.0 million. The reduction in net foreign‑currency‑other exposure (from roughly $73 million to $53 million) and the modest rise in liabilities indicate that Starbucks trimmed its hedge positions and is managing its foreign‑exchange risk more tightly, aligning hedges more closely with anticipated cash‑flow needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial numbers that do not match the ground truth data. Specific issues: (1) FY 2022 numbers are completely wrong - LLM reports $39.9M current + $33.5M long-term assets ($73.4M total), but ground truth shows $55.3M in AOCI with $32.5M expected reclassification within 12 months. These are different metrics and values entirely. (2) FY 2023 numbers are also incorrect - LLM reports $32.0M current + $22.9M long-term assets ($54.9M total) with $2.0M liabilities, but ground truth shows $1.9M current assets, $1.7M long-term assets, $4.7M current liabilities, and $4.1M long-term liabilities. The LLM's asset figures are roughly 10-15x larger than actual. (3) The LLM's calculation of net exposure reduction (from ~$73M to ~$53M) is based on incorrect numbers and therefore invalid. (4) The LLM appears to have confused or misread the balance sheet line items, possibly mixing up different derivative positions or fiscal years. (5) While the LLM's qualitative interpretation about tightening hedge positions and managing FX risk more closely is reasonable in tone, it is built on a foundation of incorrect quantitative data. (6) The ground truth shows a dramatic shift from large unrealized gains in AOCI ($55.3M) to much smaller balanced asset/liability positions, indicating a fundamental change in strategy - the LLM missed this critical insight entirely. The answer fails on the primary metric of factual accuracy for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 410,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "By fiscal 2022 Medtronic had a small number of A Preferred Shares outstanding (1,872) and, in the third quarter of that year, **redeemed those shares for $0.075 million**, leaving the class with zero shares outstanding at April 29, 2022【page_81】. In the 2024 filing the company still reports that the authorized 500 thousand A Preferred Shares exist but **no A Preferred Shares are outstanding** as of April 26, 2024【page_81】, indicating that after the 2022 redemption the shares remained unissued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 1,872 A Preferred Shares redeemed for $0.075 million in Q3 FY2022, zero shares outstanding at April 29, 2022, and zero shares outstanding at April 26, 2024. The dates are accurate (fiscal years 2022 and 2024, specific quarter and dates). The multi-hop reasoning is sound - the answer correctly synthesizes information across two fiscal years to show the evolution: redemption in 2022 followed by no reissuance through 2024. The answer goes slightly beyond the ground truth by noting that 500 thousand A Preferred Shares remain authorized but unissued, which adds helpful context without contradicting the original answer. The semantic meaning is equivalent to the ground truth - both convey that shares were redeemed in 2022 and remained discontinued through 2024. The only minor distinction is that the LLM provides slightly more detail about authorization status, which enhances rather than detracts from the answer. All entities (Medtronic, A Preferred Shares, fiscal years) are correctly identified. The answer directly addresses both parts of the question: (1) how treatment evolved between 2022-2024, and (2) the specific action taken in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 348,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast’s equity‑in‑net‑income of investees swung from a loss in 2022 to a gain in 2023. In 2022 the line was a $(537) million loss, reflecting a $(434) million loss on its Atairos investment from fair‑value adjustments on the underlying assets; by 2023 the Atairos fair‑value adjustments produced a $1.1 billion gain, turning the equity‑in‑net‑income line into a $789 million gain and lifting total investment‑and‑other‑income to a positive $1.252 billion 【page_39】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Comcast's financial relationship with Atairos between 2022 and 2023, showing a swing from loss to gain. However, there is a quantitative discrepancy in the 2022 Atairos loss figure. The ground truth states the Atairos loss was $(434) million in 2022, while the LLM answer states the overall equity-in-net-income line was $(537) million but attributes only $(434) million to Atairos. The LLM answer provides additional context about the total equity-in-net-income line being $(537) million in 2022 and $789 million in 2023, which is not contradicted by the ground truth but represents a broader perspective. The 2023 Atairos gain of $1.1 billion is correctly stated in both answers. The LLM answer demonstrates strong multi-hop reasoning by synthesizing information across the equity-in-net-income metric, Atairos specifically, fair value adjustments, and broader investment income. The answer appropriately addresses the question's focus on fair value adjustments driving the changes. The main weakness is the introduction of additional figures ($(537) million, $789 million, $1.252 billion) that, while potentially accurate from the filing, create some ambiguity about whether the $(434) million figure is being correctly applied. The semantic meaning and core conclusion about the turnaround are correct, but the quantitative presentation could be clearer regarding which figures apply specifically to Atairos versus the broader equity-in-net-income line.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 417,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East segment slipped in its core (consolidated) operations – from 312 BCF (plus 7 BCF undeveloped) at year‑end 2023 to 296 BCF (plus 7 BCF undeveloped) at year‑end 2024 – but the equity‑affiliate portion, which is entirely located in that region, rose sharply from 5,275 BCF to 5,870 BCF. Overall, regional reserves grew modestly, signalling that ConocoPhillips is leaning on its equity‑affiliate investments to deepen its strategic foothold in the Asia Pacific/Middle East gas market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides significantly more comprehensive information than the ground truth. Quantitative verification: (1) Core consolidated operations - 312 BCF (2023) to 296 BCF (2024) matches ground truth exactly; (2) Undeveloped reserves of 7 BCF in both years correctly identified; (3) Equity-affiliate reserves: 5,275 BCF (2023) to 5,870 BCF (2024) - these figures are presented with confidence and represent a 595 BCF increase (~11.3% growth). The LLM correctly calculates the overall regional reserve position by synthesizing both consolidated and equity-affiliate components. Multi-hop reasoning is sound: the answer properly identifies that while core operations declined slightly (16 BCF or ~5.1%), equity-affiliate reserves grew substantially, resulting in net modest regional growth. The strategic interpretation is well-reasoned - the company is indeed leveraging equity-affiliate investments to maintain and expand its Asia Pacific/Middle East gas market position despite slight declines in consolidated operations. The answer goes beyond the ground truth by providing the equity-affiliate breakdown, which adds valuable context about ConocoPhillips' strategic approach. The only minor consideration is that the ground truth provided does not explicitly mention equity-affiliate reserves, so the LLM appears to have drawn from additional filing details not captured in the ground truth summary. However, this additional information is factually accurate and enhances rather than contradicts the core answer. The semantic meaning aligns perfectly with the ground truth's conclusion about strategic positioning, while providing deeper insight into the mechanisms driving that positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 475,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL’s Canadian sales fell sharply, from $73 million in 2022 to $47 million in 2023 (‑36 %) and then to $28 million in 2024 (‑40 % YoY)【page_72†L13-L16】【page_71†L13-L16】. The roughly 62 % drop over the three‑year span signals a rapidly contracting Canadian market for ENBREL, indicating weakening demand and a declining market trajectory.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provides incorrect 2022 revenue figure. Ground truth states ENBREL Canada revenue was $113 million in 2022, but the LLM claims $73 million - a $40 million discrepancy (35% understatement). This is a fundamental factual error that undermines the entire answer. The 2023 ($47M) and 2024 ($28M) figures are correct. CALCULATION ERRORS: (1) The LLM calculates a 62% three-year drop, but using the correct 2022 figure of $113M: ($113M-$28M)/$113M = 75.2% decline, not 62%. (2) The 2023 YoY decline calculation: ($113M-$47M)/$113M = 58.4%, not the implied 36% the LLM states (though the -36% notation is ambiguous). (3) The 2024 YoY decline: ($47M-$28M)/$47M = 40.4%, which is approximately correct. QUALITATIVE ASSESSMENT: The reasoning about market trajectory and declining demand is sound and matches the ground truth interpretation. The multi-hop synthesis (combining revenue data across years to assess trends) is logically structured. However, the foundational data error severely compromises the analysis. ENTITY ACCURACY: ENBREL and Canada are correctly identified; years 2022-2024 are correct. The answer demonstrates understanding of the question's intent but fails on execution due to the incorrect starting data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 355,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm first introduced a link between human‑capital progress and executive bonuses in fiscal 2023, describing the consideration as a non‑financial factor but without a defined multiplier range (QCOM_10k_2023.pdf p.16). In fiscal 2024 the HR and Compensation Committee formalized the link by applying a non‑financial performance modifier that can adjust an executive’s bonus payout by a multiple of **0.9 to 1.1** (QCOM_10k_2024.pdf p.16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key elements: (1) QUANTITATIVE ACCURACY: The performance modifier range of 0.9 to 1.1 is correctly stated and matches the ground truth exactly. The fiscal years (2023 and 2024) are correctly identified. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the evolution from fiscal 2023 to fiscal 2024, and the specific performance modifier range applied in fiscal 2024. (3) ENTITY ACCURACY: Qualcomm (QCOM) is correctly identified, fiscal years are accurate, and the HR and Compensation Committee is appropriately mentioned. (4) REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution from a general consideration in FY2023 to a formalized, quantified modifier in FY2024. The logic of the progression (from undefined to defined structure) is clear and accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer uses 'multiple' and 'multiplier' interchangeably with the ground truth's 'multiplier,' which is semantically equivalent. The characterization of the shift from 'general consideration' to 'quantified performance modifier' aligns with the ground truth's description of moving from 'general consideration to a quantified performance modifier.' Minor note: The LLM includes specific document citations (QCOM_10k_2023.pdf p.16 and QCOM_10k_2024.pdf p.16) which adds credibility but is not contradicted by the ground truth. The answer is comprehensive, accurate, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 422,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "In the 2022 Form 10‑K Breyanzi was listed only for relapsed or refractory large B‑cell lymphoma (LBCL) after ≥ two prior lines of therapy (see 2022 filing, page 22). By the 2024 filing the product had earned FDA accelerated approvals for relapsed or refractory follicular lymphoma (May 2024), CLL/SLL (March 2024) and mantle‑cell lymphoma (May 2024), and a Japanese approval for FL after one prior line (August 2024), expanding Breyanzi’s use to three additional B‑cell malignancies and to earlier lines of therapy (see 2024 filing, pages 45 & 44; summary statement on page 46).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) 2022 INDICATION ERROR: The LLM states Breyanzi was listed for 'relapsed or refractory large B-cell lymphoma (LBCL) after ≥ two prior lines of therapy' in 2022. However, the ground truth indicates Breyanzi was in TRIALS in 2022 (TRANSCEND-CLL-004 for 3L+ CLL and TRANSCEND-FL for 3L+ FL), not yet approved. The LLM incorrectly presents a 2022 approved indication that doesn't match the ground truth. (2) 2024 APPROVALS - MANTLE CELL LYMPHOMA ERROR: The LLM claims Breyanzi received FDA accelerated approval for 'mantle-cell lymphoma (May 2024)'. The ground truth makes NO mention of mantle cell lymphoma approval. This is a fabricated indication. (3) 2024 APPROVALS - JAPANESE APPROVAL ERROR: The LLM mentions 'Japanese approval for FL after one prior line (August 2024)'. The ground truth does not reference any Japanese approval or approval for earlier lines of therapy (one prior line). This appears to be additional fabrication. (4) INCOMPLETE/INCORRECT 2024 APPROVALS: The ground truth specifies two FDA accelerated approvals in 2024: (a) FL after ≥2 prior lines (May 2024) - LLM mentions this correctly, and (b) CLL/SLL after ≥2 prior lines including specific drug requirements (March 2024) - LLM mentions CLL/SLL but doesn't capture the specific drug requirement details. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution from trials in 2022 to approvals in 2024. Instead, it introduced incorrect 2022 baseline information and fabricated additional 2024 approvals. The core narrative of 'trials to approvals' is present but undermined by factual errors. (6) SCOPE EXPANSION CLAIM: The LLM claims expansion to 'three additional B-cell malignancies' (FL, CLL/SLL, MCL) but the ground truth only documents two indications (FL and CLL/SLL). The mantle cell lymphoma claim is unsupported. The claim about 'earlier lines of therapy' is also unsupported by ground truth. CORRECT ELEMENTS: The LLM correctly identifies May 2024 for FL approval and March 2024 for CLL/SLL approval, and correctly notes these are FDA accelerated approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 584,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney’s Resorts & Vacations revenue rose from $7.949 billion in 2023 to $8.375 billion in 2024 – a 5% increase 【page_47】.  The broader Parks & Experiences segment grew its total revenue from $32.549 billion to $34.151 billion, also about a 5% rise 【page_49】, so the Resorts & Vacations segment’s growth was essentially in line with the segment‑wide revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - Resorts & Vacations revenue of $7.949 billion (2023) and $8.375 billion (2024) match the ground truth exactly; Parks & Experiences segment revenue of $32.549 billion (2023) and $34.151 billion (2024) are accurate. The 5% growth calculation for both segments is correct (($8.375-$7.949)/$7.949 = 5.35% ≈ 5%; ($34.151-$32.549)/$32.549 = 4.92% ≈ 5%). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - comparing the Resorts & Vacations segment performance to the broader Parks & Experiences segment, and correctly identifying that both grew at approximately the same rate. ENTITY ACCURACY: All entities are correctly identified (Disney, Resorts & Vacations segment, Parks & Experiences segment, fiscal years 2023-2024). COMPLETENESS: The answer addresses all parts of the question - evolution from 2023 to 2024, comparison to overall segment growth, and the relationship between the two metrics. MINOR OBSERVATION: The LLM uses slightly different phrasing than the ground truth ('essentially in line with' vs 'slightly below' in the original), but this is semantically accurate given that both segments grew at approximately 5%, making the difference negligible. The ground truth's statement about 'slightly below' appears to be based on more precise calculations (5.35% vs 4.92%), but the LLM's characterization of 'essentially in line' is reasonable and not factually incorrect. The answer includes helpful page references and maintains clarity throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 447,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "In 2023 CVS completed a $2 billion fixed‑dollar ASR with Citibank that was recorded as a $1.6 billion initial treasury‑stock purchase plus a $0.4 billion forward contract placed in capital surplus and later re‑classified to treasury stock when the final 20 % of shares were delivered in February 2023【page_175】. In 2024 the company entered a larger $3 billion ASR with Morgan Stanley that was accounted for as a $2.6 billion initial treasury‑stock purchase and a $0.4 billion forward contract (still recorded in capital surplus and re‑classified in March 2024)【page_175】. Thus, while the forward‑contract amount remained $0.4 billion, its proportion of the total ASR fell from 20 % in 2023 to roughly 13 % in 2024 as the overall ASR size increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 ASR: $2.0 billion total with Citibank - correctly stated; $1.6 billion initial treasury stock - correct; $0.4 billion forward contract - correct; February 2023 delivery date - correct. (2) 2024 ASR: $3.0 billion total with Morgan Stanley - correct; $2.6 billion initial treasury stock - correct; $0.4 billion forward contract - correct; March 2024 delivery date - correct. (3) Accounting treatment: Both forward contracts correctly identified as equity instruments recorded in capital surplus - accurate. (4) Percentage calculations: The LLM calculated the forward contract proportion as 20% for 2023 ($0.4B/$2.0B = 20%) and approximately 13% for 2024 ($0.4B/$3.0B = 13.33%, rounded to 13%) - both calculations are correct. (5) Multi-hop synthesis: The answer successfully synthesizes information across two years, two different counterparties, and multiple accounting components, correctly identifying the key structural evolution (constant forward contract value despite increasing ASR size). The reasoning about the shift in proportion is sound and well-articulated. Minor note: The answer uses \"roughly 13%\" which is appropriate rounding of 13.33%. The answer fully addresses the question about how the structure and value evolved, providing both the specific numbers and the analytical insight about proportional changes. All entities (CVS, Citibank, Morgan Stanley) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 411,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "In the 2023 filing Duke Energy already broke out the Master Retirement Trust’s pension assets by the fair‑value hierarchy—Level 1, Level 2, Level 3—and added a “Not Categorized (b)” column for assets measured using a net‑asset‑value‑per‑share practical expedient, with a footnote explaining that those items are not placed in the hierarchy (see Note 17 discussion and the table on page 219). The 2024 filing repeats the same structure—Level 1, Level 2, Level 3 and a “Not Categorized (b)” column with the same footnote—and the narrative describing valuation methods for equity, debt and short‑term funds is unchanged (see Note 17 discussion and the table on page 228). Thus, the company’s disclosure of its pension‑asset valuation methodology remained consistent, preserving the same level of transparency around fair‑value categorization from 2023 to 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core finding. Ground truth states that Duke Energy ADDED a new disclosure element in 2024 (a reconciliation of beginning and ending balances of Level 3 assets), representing a significant increase in transparency. The LLM answer claims the disclosure remained 'consistent' and 'unchanged' from 2023 to 2024, which directly contradicts the ground truth's assertion of evolution and increased transparency. The LLM correctly identifies that both years had Level 1, 2, 3 categorization and a 'Not Categorized' column with footnotes, but misses the critical new addition in 2024. The LLM's conclusion that 'the company's disclosure...remained consistent, preserving the same level of transparency' is the opposite of what the ground truth indicates. The LLM provides specific page references (219 and 228) which cannot be verified but appear to be fabricated details. The answer fails to identify the key evolution: the addition of the Level 3 reconciliation table in 2024. This is a multi-hop question requiring comparison across two years, and the LLM failed to identify the material change that occurred. The reasoning is internally consistent but based on an incorrect premise about what changed between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 362,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "In 2023 Pfizer booked a $3.5 billion non‑cash revenue reversal for Paxlovid, reflecting an estimated return of 6.5 million EUA‑labeled treatment courses from the U.S. government. In 2024 that reversal was trimmed by a $771 million favorable adjustment after only 5.1 million courses were actually returned, and the company recorded $442 million of revenue for supplying a 1‑million‑course U.S. Strategic National Stockpile (SNS) at no cash cost—reducing Paxlovid‑related deferred revenue from $5.1 billion at year‑end 2023 to $2.2 billion at year‑end 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: $3.5 billion revenue reversal in 2023, 6.5 million treatment courses estimated return, $771 million favorable adjustment in 2024, 5.1 million actual returns, and $442 million SNS revenue recognition for 1.0 million courses. The multi-hop synthesis is sound, correctly connecting the 2023 reversal to the 2024 adjustment and new SNS revenue. The answer goes beyond the ground truth by adding contextual detail about deferred revenue declining from $5.1 billion (2023) to $2.2 billion (2024), which provides additional relevant context about the financial impact trajectory. The characterization of the $442 million SNS revenue as 'at no cash cost' is a reasonable interpretation of the non-cash nature of the transaction. The narrative structure effectively contrasts the 2023 reversal period with the 2024 adjustment and recognition period, directly addressing the question's request for change analysis between years. All entities (Pfizer, U.S. government, SNS, EUA-labeled courses) are correctly identified. The reasoning about the shift from revenue reversal to revenue recognition is logically sound and well-supported by the numbers provided. Minor: The phrasing 'trimmed by' for the adjustment is slightly informal but semantically accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 377,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA’s sales rose from $1.9 billion in 2022 to $2.4 billion in 2023—a 26.9% year‑over‑year increase (27.5% operational growth)【page_31】. This boost helped lift total oncology revenue 10.5% and was highlighted as a driver of share‑gain and market growth in metastatic castration‑resistant prostate cancer, signaling that ERLEADA is becoming a key growth engine within J&J’s oncology portfolio【page_32】【page_33】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor presentation differences from the ground truth. QUANTITATIVE VERIFICATION: (1) Sales figures: LLM states '$1.9 billion in 2022 to $2.4 billion in 2023' vs. ground truth '$1,881 million to $2,387 million' - these are semantically equivalent (1.9B ≈ 1,881M and 2.4B ≈ 2,387M with acceptable rounding). (2) Growth rate: LLM correctly identifies 26.9% YoY increase, matching ground truth exactly. (3) Oncology segment growth: LLM correctly states 10.5%, matching ground truth. (4) Additional detail: LLM mentions '27.5% operational growth' which is not in the ground truth but represents supplementary information that doesn't contradict it. COMPLETENESS: The LLM answer addresses both parts of the question - financial performance evolution (2022-2023) and role in J&J's oncology portfolio. However, it omits the specific comparative context about IMBRUVICA and ZYTIGA decline mentioned in the ground truth, which would have strengthened the answer by showing ERLEADA's relative importance. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple data points (sales figures, growth rates, segment performance, market context) and draws appropriate conclusions about ERLEADA's strategic importance. The logic connecting financial performance to portfolio role is sound. MINOR ISSUES: (1) The rounding of exact figures ($1,881M to $1.9B) is acceptable but slightly less precise than the ground truth. (2) Missing the comparative analysis with declining products (IMBRUVICA, ZYTIGA) represents a minor omission of contextual depth. (3) The citation markers suggest source documentation but don't affect factual accuracy. STRENGTHS: Clear presentation, accurate percentages, correct identification of ERLEADA as a growth driver, appropriate characterization of its strategic role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 503,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA’s worldwide net sales rose sharply, from $1.291 billion in FY 2022 (U.S. $813 m + International $478 m) to $2.387 billion in FY 2023—a year‑over‑year increase of roughly 27% (about $1.1 billion)【page_85】【page_31】.  The company attributes the rise to continued share‑gain and market growth, indicating a strong, accelerating trajectory for the prostate‑cancer product【page_32】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 sales figure ($1,291 million/$1.291 billion), the 2023 sales figure ($2,387 million/$2.387 billion), and the approximate YoY growth rate of 27% (ground truth: 26.9%). The breakdown of 2022 sales into U.S. ($813M) and International ($478M) components is accurate and adds helpful detail. The product name (ERLEADA) and indication (prostate cancer) are correct.\n\nCRITICAL ERRORS: The LLM answer contains a significant factual error in its interpretation of market trajectory. The ground truth explicitly states that ERLEADA's growth rate SLOWED from 70.0% in 2021-2022 to 26.9% in 2022-2023, indicating a 'maturing growth phase.' However, the LLM characterizes this as a 'strong, accelerating trajectory,' which directly contradicts the ground truth's assessment. This is a fundamental misinterpretation of what the numbers indicate about market dynamics.\n\nCALCULATION VERIFICATION: The LLM states the increase was 'roughly 27% (about $1.1 billion).' Verification: ($2,387M - $1,291M) / $1,291M = $1,096M / $1,291M = 84.9% in absolute dollars, but 26.9% in percentage terms. The $1.1 billion figure is approximately correct ($1.096B), and 27% is close to the actual 26.9%, so this is acceptable.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and geographic segments, but fails to properly interpret the comparative growth rates that are central to understanding the market trajectory question.\n\nCOMPLETENESS: The answer addresses both parts of the question (sales evolution and market trajectory), but the trajectory interpretation is inverted from the ground truth, which is a major semantic error despite correct numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 471,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "In FY 2023 NVIDIA carried the 0.584 % notes due 2024 as a $1.25 billion short‑term liability with no explicit repayment plan disclosed. By FY 2024 the same $1.25 billion of 0.584 % notes remained on the balance sheet, but the filing added a footnote stating the company would retire those notes in FY 2025, showing a shift from simply holding the short‑term debt to actively planning its early repayment.【page_72】【page_72】",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Correctly identified the note amount as $1.25 billion (equivalent to $1,250 million) in both FY2023 and FY2024. (2) Correctly identified the interest rate as 0.584%. (3) Properly characterized the debt as short-term liability. (4) Correctly noted that the company planned to retire the notes in FY2025. (5) Appropriately captured the shift in debt management strategy from holding to active repayment planning. WEAKNESSES: (1) CRITICAL ERROR - The LLM states the balance 'remained on the balance sheet' in FY2024, but the ground truth indicates the notes were repaid in FY2025 with 'no remaining balance as of January 26, 2025.' The LLM's phrasing is ambiguous about whether the balance still existed in FY2024 vs. FY2025. (2) MISSING INFORMATION - The LLM does not mention the effective interest rate of 0.66% that was disclosed in FY2023, which is relevant context for understanding the debt management strategy. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes that NVDA 'chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it,' showing strategic intent. The LLM mentions 'early repayment' but doesn't clearly establish this was a deliberate choice versus the due date. (4) TEMPORAL CLARITY - The ground truth clearly states the notes were repaid in FY2025 with zero balance as of January 26, 2025. The LLM's statement that the balance 'remained on the balance sheet' in FY2024 is technically correct but could be misinterpreted as suggesting the balance persisted beyond FY2024. CALCULATION/NUMBER VERIFICATION: All dollar amounts and percentages are correct ($1.25B = $1,250M, 0.584% rate). The multi-hop reasoning is partially sound but lacks the complete strategic context about debt retirement versus rollover.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 488,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell’s mortgage‑ and asset‑backed‑securities holdings fell sharply. For its U.S. pension plans the balance dropped from $1,119 million in 2022 to $676 million in 2023, and for its non‑U.S. plans it fell from $31 million to $10 million — a combined reduction of about $464 million 【page_109】【page_110】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports U.S. Plans holdings of $1,119M in 2022 and $676M in 2023, but the ground truth states $982M in 2022. The LLM reports Non-U.S. Plans of $31M in 2022, but ground truth shows $10M in 2023 (no 2022 figure for Non-U.S. in ground truth). The LLM calculates a combined reduction of ~$464M, but the ground truth indicates a reduction of $972M (from $982M to $10M). (2) ENTITY/CLASSIFICATION ERRORS: The ground truth specifies the 2022 figure was under 'U.S. Plans' and the 2023 figure was under 'Non-U.S. Plans' - suggesting a shift between plan categories. The LLM treats these as separate line items within each category rather than recognizing this categorical shift. (3) MAGNITUDE MISREPRESENTATION: The ground truth emphasizes a 'major shift' with over 98% reduction. The LLM's calculation of ~$464M reduction (41% of $1,119M) significantly understates the magnitude of change. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison and appears to have pulled different data points than those in the ground truth, suggesting either data source confusion or calculation errors. The core narrative of the answer (sharp decline) is directionally correct, but the specific numbers and magnitude are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 389,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "In 2022 Capital One reported $16.97 billion of securitized debt obligations, which it described as a core element of its diversified wholesale‑funding mix alongside deposits, senior/subordinated notes and other borrowings (Funding discussion) and measured the liabilities at fair value using Level 2 inputs (Table of financial liabilities)【page_113】【page_211】. By year‑end 2023 the balance had grown to $18.04 billion, remained classified as Level 2 fair‑value, and continued to be a principal source of long‑term funding, with the company maintaining a large shelf‑registration capacity to issue additional securitized obligations (Funding discussion and borrowing‑capacity note)【page_210】【page_112】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Quantitative accuracy is excellent - the 2022 figure of $16.97 billion and 2023 figure of $18.04 billion are correctly stated and match the ground truth values ($18,043 million ≈ $18.04 billion for 2023). The growth trajectory is accurately captured. (2) Fair value classification is correctly identified as Level 2 for both years, matching the ground truth. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information about Capital One's funding mix evolution across 2022-2023, identifying securitized debt obligations' role alongside deposits, senior/subordinated notes, and other borrowings. (4) The answer provides additional relevant context about shelf-registration capacity and long-term funding role, which adds value without contradicting the ground truth. (5) Entity identification is correct (Capital One, securitized debt obligations, fair value hierarchy). MINOR CONSIDERATIONS: (1) The ground truth mentions the 2023 fair value as $18,067 million, while the LLM answer states $18.04 billion carrying value without explicitly mentioning the fair value figure, though this is a minor omission rather than an error. (2) The ground truth emphasizes a 'shift toward more detailed disclosure and potentially more structured risk management,' which the LLM answer doesn't explicitly state, though it does note the provision of 'more specific transparency.' (3) The LLM answer's characterization of the evolution is slightly different in emphasis - it focuses on continued reliance and growth rather than the disclosure shift highlighted in the ground truth, but both interpretations are valid. The answer successfully addresses all parts of the multi-part question regarding evolution, funding mix role, and fair value classification across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 511,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan’s CECL capital‑transition adjustment was being phased out under the U.S. rules – in 2023 CET1 capital still included a $1.4 billion CECL benefit, but by year‑end 2024 that benefit had fallen to $720 million, a reduction of roughly $680 million (the difference between $1.4 bn and $720 m)【page_104】【page_105】【page_99】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numbers: $1.4 billion CECL benefit in 2023, $720 million in 2024, and the calculated reduction of $680 million. The quantitative synthesis is accurate and the calculation ($1.4B - $720M = $680M) is correct. The answer properly identifies the multi-hop elements: the company (JPMorgan), the metric (CECL capital transition provisions/CET1 capital), the time period (2023 to 2024), and the evolution (phased reduction). The terminology is appropriate (CECL capital-transition adjustment, CET1 capital, U.S. rules). The answer correctly characterizes the treatment as a phased reduction/phase-out. One minor limitation is that the LLM answer does not explicitly mention that the CECL benefit was \"fully phased in by January 1, 2025\" as stated in the ground truth, which provides additional context about the completion of the transition. However, the phrase \"being phased out\" reasonably implies this endpoint. The answer is well-structured, cites sources appropriately, and directly addresses all components of the multi-part question regarding how the treatment evolved and what the quantitative change was. The semantic equivalence is strong - the LLM conveys the same essential information as the ground truth, just with slightly different wording and without the explicit mention of the 2025 completion date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 390,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "In fiscal 2023 Salesforce’s revolving‑loan facility was a $3.0 billion unsecured credit line that matured in December 2025 (the “Prior Credit Agreement”)【page_52】. By fiscal 2024 the company entered a new agreement in October 2024 that replaced the prior facility, expanding the credit amount to $5.0 billion and extending the maturity to October 2029【page_51】, thereby adding $2 billion of borrowing capacity and a longer term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Fiscal 2023 facility was $3.0 billion unsecured revolving credit maturing December 2025 - CORRECT; (2) Fiscal 2024 facility is $5.0 billion unsecured revolving credit maturing October 2029 - CORRECT; (3) The new agreement was entered in October 2024 - CORRECT; (4) The capacity increase of $2.0 billion ($5.0B - $3.0B) is accurately calculated and stated. The multi-hop synthesis is sound: the answer correctly identifies the prior agreement, the replacement agreement, and the key changes (capacity increase and maturity extension). The reasoning is logical and well-structured, showing the evolution between the two fiscal years. The answer includes appropriate contextual framing (\"Prior Credit Agreement\" terminology, characterization as \"strategic enhancement\"). Minor note: The answer includes page citations which add credibility but are not required. The wording is clear and professional. No calculation errors, no factual inaccuracies, and all entities (Salesforce, dates, amounts) are correctly identified. The answer fully addresses the question about how the terms and capacity evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 336,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "In 2022 UPS described Coyote as a “Coyote‑branded subsidiary” that provided its U.S. and European truckload‑brokerage services within the Supply Chain Solutions segment【page_7】. By 2024 UPS had sold the business – the divestiture was completed in Q3 2024 and produced a pre‑tax gain of $156 million (about $152 million after tax) that was recorded as other income for the year【page_31】 (the gain also appears as a $4 million non‑GAAP adjustment in the 2024 MD&A【page_29】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024 completion) is accurate. QUALITATIVE ACCURACY: The answer correctly identifies Coyote as a branded subsidiary in 2022 providing truckload brokerage services in the U.S. and Europe within the Supply Chain Solutions segment. The characterization of the 2024 divestiture and its classification as other income is accurate. The multi-hop reasoning is sound - the answer traces the relationship evolution from 2022 (active subsidiary) to 2024 (divested asset) and correctly synthesizes the financial impact. COMPLETENESS: The answer addresses both parts of the question: (1) how the relationship evolved (from subsidiary to divested asset), and (2) the financial impact ($156M pre-tax gain). The inclusion of the non-GAAP adjustment detail ($4 million) adds appropriate context. MINOR OBSERVATION: The LLM answer provides slightly more granular detail than the ground truth (specific quarter, non-GAAP adjustment, accounting classification as 'other income'), which enhances rather than detracts from accuracy. The semantic meaning is fully aligned with the ground truth - both convey the transition from active business unit to divested asset with the specific financial gain. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 404,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "In 2023 Union Pacific reported a chassis fleet of 48,340 units – 30,635 owned and 17,705 leased【UNP_10k_2023.pdf page_19】. By the end of 2024 the fleet had contracted to 5,553 chassis, of which 4,356 were owned and 1,197 leased【UNP_10k_2024.pdf page_19】, so total chassis fell sharply and the owned‑to‑leased mix shifted toward a higher share of owned units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: 2023 figures (48,340 total, 30,635 owned, 17,705 leased) and 2024 figures (5,553 total, 4,356 owned, 1,197 leased) match the ground truth exactly. The multi-hop synthesis is sound, correctly comparing the two years and identifying the strategic shift. The LLM appropriately notes the drastic reduction (from 48,340 to 5,553 units) and correctly characterizes the ownership mix shift toward a higher proportion of owned units (from 63.4% owned in 2023 to 78.4% owned in 2024). The answer includes proper source citations. The only minor observation is that while the LLM mentions the shift toward higher owned-unit share, it doesn't explicitly state the magnitude of this shift or provide the strategic context about why this transformation occurred (though this level of detail wasn't strictly required by the question). The answer directly addresses all parts of the question: total units evolution, ownership structure changes, and the nature of the relationship transformation. Semantic equivalence is maintained throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 318,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "In the 2022 Form 10‑K Boeing said that its purchase‑ and sale‑agreements for aluminum “are derivatives for accounting purposes but are not designated for hedge accounting” and that the fair‑value changes are taken to earnings immediately, describing them only as supporting “long‑term strategic sourcing objectives” (see 2022 p. 80). By the 2024 filing the company still classifies the aluminum contracts as derivative instruments that do not receive hedge‑accounting treatment, but now discloses that its commodity contracts – including the aluminum agreements – are used to hedge forecasted transactions “through 2028,” giving a specific multi‑year horizon (see 2024 p. 111).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Boeing's aluminum agreement disclosures across 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 classification as derivatives without hedge accounting designation, with fair value changes recorded in earnings immediately - this matches the ground truth exactly. (2) Accurately captures the 2022 context of 'long-term strategic sourcing objectives' as the primary descriptor. (3) Correctly identifies the 2024 evolution showing aluminum agreements as part of commodity contracts hedging forecasted transactions through 2028. (4) Properly synthesizes the key shift from purely strategic sourcing to structured hedging with defined time horizon. (5) Includes specific page references (2022 p. 80, 2024 p. 111) that add credibility and verifiability. (6) The multi-hop reasoning is sound - comparing 2022 vs 2024 across classification, accounting treatment, and time horizon dimensions. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('purchase-and sale-agreements' vs 'agreements,' 'commodity contracts' vs 'commodity contracts') but these are semantically equivalent and actually more precise. The answer fully addresses all three dimensions of the question: (1) classification as derivatives, (2) treatment/accounting designation, and (3) time horizon evolution. No numerical errors, date errors, or factual inaccuracies detected. The answer appropriately emphasizes the evolution/shift in disclosure strategy, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 440,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble’s currency‑rate risk profile was essentially unchanged from FY 2023 to FY 2024.  The company still relies on its natural‑hedge plus short‑term forward contracts and currency swaps (generally under 18 months) to manage exchange‑rate exposure, and it states that, based on its derivative positions, it is 95 % confident that a near‑term change in currency rates would not materially affect its financial statements in either year【page_31】.  Moreover, the 2024 filing notes that its market‑risk exposures “have not changed materially versus the previous reporting period,” confirming that the exposure and hedging approach remained consistent with FY 2023【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that P&G's currency rate risk exposure remained materially unchanged between FY 2023 and FY 2024, accurately describes the hedging instruments (forward contracts and currency swaps with maturities under 18 months), and correctly states the 95% confidence level assessment. The answer also appropriately notes the company's natural hedge strategy. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the 95% confidence level is accurately cited, the maturity timeframe of less than 18 months is correct, and the fiscal years (June 30, 2023 and June 30, 2024) are properly identified. No calculation errors present. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple aspects: (a) comparing exposure levels between two fiscal years, (b) identifying specific hedging instruments used, (c) explaining the confidence assessment methodology, and (d) confirming consistency of approach. The reasoning is sound and logical. (4) ENTITY ACCURACY: Procter & Gamble is correctly identified, fiscal years are accurate, and financial metrics/terms (forward contracts, currency swaps, confidence level, exchange rate risk) are all properly used. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly enhanced detail (mentioning natural hedge explicitly, citing page references). The wording differs appropriately while maintaining factual equivalence. Minor note: The LLM includes page citations (page_31) which adds credibility but weren't in the ground truth statement - this is a positive addition rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 478,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K (see the sections on pages 95‑99) Frame.io is not mentioned, indicating it was not presented as a core Adobe offering at that time. By the 2024 Form 10‑K (page 12), Adobe describes Frame.io as a cloud‑native creative‑collaboration platform that supports real‑time upload, review, frame‑accurate commenting, “Camera‑to‑Cloud” ingest and even casting, location‑scouting and marketing‑campaign workflows, and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and offered through GenStudio—showing a much broader functional scope and deep integration across Adobe’s suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the evolution of Frame.io's positioning; (2) Accurately captures Frame.io's 2024 description as a 'cloud-native creative collaboration platform' with specific functional capabilities (real-time upload, review, frame-accurate commenting, Camera-to-Cloud); (3) Correctly lists all integrated Adobe products (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) and GenStudio positioning; (4) Properly synthesizes the multi-hop comparison showing evolution from minimal/no mention in 2022 to detailed integration in 2024; (5) Provides specific page references (pages 95-99 for 2022, page 12 for 2024) that add credibility. MINOR CONSIDERATIONS: (1) The LLM states Frame.io 'is not mentioned' in 2022 10-K, while ground truth says it was 'listed among Adobe's trademarks' - this is a slight discrepancy in characterization. The ground truth indicates some presence in 2022 (as a trademark), whereas the LLM suggests complete absence from the 10-K narrative. However, this distinction may reflect different interpretations of what constitutes 'mention' (trademark listing vs. functional description); (2) The LLM adds additional functional details not explicitly in ground truth ('casting, location-scouting and marketing-campaign workflows') which, while potentially accurate from the source documents, goes slightly beyond what was stated in the ground truth. This represents minor elaboration rather than error. QUANTITATIVE ACCURACY: No calculations or specific financial metrics are involved in this question, so this dimension focuses on date accuracy (2022 vs 2024 correctly identified) and page references (which appear reasonable). QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution narrative and multi-hop comparison across years. CONTEXTUAL RELEVANCE: Directly and comprehensively addresses the question about Frame.io's evolution in positioning, functional scope, and integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 558,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "AMD’s 15 % equity interest in the ATMP joint venture is still accounted for under the equity method with no obligation to fund the JV 【page_77】.  The carrying amount of the investment grew from about **$83 million at the end of FY 2022** to roughly **$99 million at the end of FY 2023** 【page_78】, and the 2023 filing adds more granular disclosures – $1.7 billion of purchases each year, payables of $363 million (down from $463 million), receivables of $9 million (up from $2 million), and larger equity‑income gains ($16 million in 2023 vs $14 million in 2022) 【page_78】, reflecting a deeper financial interaction with the JV.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions:\n\n1. CARRYING VALUE NUMBERS - MAJOR ERROR: The LLM claims carrying values of $83 million (FY 2022) and $99 million (FY 2023). The ground truth states the 2022 filing disclosed $69 million as of December 25, 2021 and $63 million as of December 26, 2020. The LLM's numbers are completely different and appear to be fabricated. The ground truth explicitly states the 2023 filing OMITS carrying value disclosures, yet the LLM claims to provide 2023 carrying value data.\n\n2. TRANSACTION FIGURES - MAJOR ERROR: The LLM claims $1.7 billion in purchases each year with specific payables ($363M, down from $463M) and receivables ($9M, up from $2M). The ground truth mentions purchases of $1.1 billion in 2021 and $831 million in 2020 from the 2022 filing, with NO such detailed transaction figures in the 2023 filing. The LLM appears to have invented these numbers.\n\n3. EQUITY INCOME - UNVERIFIED: The LLM claims $16 million in 2023 vs $14 million in 2022. These figures are not mentioned in the ground truth and cannot be verified.\n\n4. CORE NARRATIVE REVERSAL: The ground truth's key finding is that disclosure DECREASED from 2022 to 2023 (2022 had detailed carrying values and transaction figures; 2023 omitted these). The LLM claims the opposite - that 2023 filing \"adds more granular disclosures\" and shows \"deeper financial interaction.\" This is a fundamental misrepresentation of the evolution described in the ground truth.\n\n5. STRUCTURAL DETAILS: The LLM correctly identifies the 15% equity interest and equity method accounting, which matches the ground truth. However, this correct information is overshadowed by the numerous factual errors.\n\n6. MULTI-HOP REASONING: The LLM failed to properly synthesize the comparison between 2022 and 2023 filings. It appears to have confused or fabricated data rather than accurately comparing the two years' disclosures.\n\nThe answer demonstrates a complete failure to match the ground truth on the primary quantitative claims and reverses the key qualitative finding about disclosure trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 577,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell’s Commercial Aviation Original Equipment revenue slipped from **$2.397 billion in 2023 to $2.223 billion in 2024** – a decline of roughly $174 million (about 7 %)【page_68】.  While the drop signals a modest slowdown in new‑equipment sales, the still‑large dollar amount shows Honeywell remains a major OEM supplier and retains a solid foothold in the aerospace market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) Revenue figures are correct: $2.397 billion (2023) and $2.223 billion (2024) match the ground truth values of $2,397 million and $2,223 million respectively - the format variation (billions vs millions) is acceptable and equivalent. (2) Decline calculation is accurate: $2.397B - $2.223B = $0.174B = $174 million, correctly stated. (3) Percentage decline is correct: $174M / $2,397M = 7.26%, appropriately rounded to 'about 7%'. ENTITY ACCURACY: Company (Honeywell), segment (Commercial Aviation Original Equipment), years (2023-2024), and metrics are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the revenue trend data and draws appropriate conclusions about market position. The interpretation that the decline 'signals a modest slowdown in new-equipment sales' aligns with the ground truth's assessment of 'potential weakening in original equipment demand.' COMPLETENESS: The answer addresses both parts of the question - the revenue evolution (with specific numbers and trend) and what it indicates about aerospace sector position. The LLM adds contextual insight ('still-large dollar amount shows Honeywell remains a major OEM supplier') that enhances understanding without contradicting the ground truth. MINOR OBSERVATION: The ground truth mentions 'supply constraints' as a possible factor, while the LLM focuses on 'slowdown in new-equipment sales' - both are reasonable interpretations of the same data, representing slightly different analytical angles rather than factual disagreement. The LLM's interpretation is reasonable and not contradictory. Overall, this is a high-quality response with accurate numbers, sound calculations, proper entity identification, and appropriate contextual reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 501,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The Heart Failure Devices segment produced **$1.161 billion in 2023** and **$1.279 billion in 2024**, an increase of roughly $118 million. This growth corresponds to a **10.2 % rise in total revenue** (10.3 % when foreign‑exchange effects are excluded)【page_30†L31-L34】【page_29†L31-L34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correct multi-hop synthesis. QUANTITATIVE VERIFICATION: (1) 2023 revenue: $1.161 billion = $1,161 million ✓ (correct format variation); (2) 2024 revenue: $1.279 billion = $1,279 million ✓ (correct format variation); (3) Dollar increase: $1,279M - $1,161M = $118M ✓ (correctly calculated); (4) Percentage change: ($118M / $1,161M) × 100 = 10.16% ≈ 10.2% ✓ (correctly rounded); (5) FX-adjusted percentage: 10.3% ✓ (matches ground truth detail). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across 2023 and 2024 data points, properly calculates the year-over-year change, and identifies the percentage increase. The inclusion of the FX-adjusted figure (10.3%) demonstrates deeper engagement with the source material. COMPLETENESS: The answer addresses all parts of the question - evolution between years, absolute dollar change, and percentage change. MINOR OBSERVATIONS: The ground truth mentions 'consistent growth across U.S. and international markets with minimal FX impact,' while the LLM answer provides the FX-adjusted figure (10.3%) which actually supports this claim but doesn't explicitly state the geographic consistency. This is a minor omission of contextual detail rather than a factual error. The citation format and source references are appropriately included. Overall, the answer is factually correct with accurate calculations and proper synthesis of multi-year data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 404,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2028 are not mentioned in the excerpted sections (pages 28‑32 contain no reference to that security), whereas the 2023 Form 10‑K lists the “0.300 % Notes due 2028” (IBM 28B) among the securities registered under Section 12(b) 【page 1】. Thus, between the two filings IBM went from omitting a separate disclosure of the 2028 note to formally registering and listing it as a distinct security.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and mischaracterizations that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT 2022: The LLM states the 0.300% Notes due 2028 'are not mentioned in the excerpted sections' of the 2022 10-K, but the ground truth explicitly states they WERE 'referenced as part of a list of debt instruments' in 2022. The LLM's claim that IBM went from 'omitting a separate disclosure' is factually wrong. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from 'incorporation by reference' (2022) to 'explicit disclosure and formal registration' (2023), which is a more nuanced evolution than the LLM's claim of going from omission to registration. (3) INCOMPLETE CONTEXT: The LLM misses the key detail about the 2022 reference to Exhibit 4.1 from the Form 8-K filed February 10, 2020, which is important context for understanding how the notes were treated. (4) PARTIAL ACCURACY: The LLM correctly identifies that the 2023 filing shows the notes listed with trading symbol IBM 28B and registered on NYSE, which aligns with ground truth. However, this correct element is undermined by the false premise about 2022. (5) REASONING FLAW: The multi-hop reasoning fails because the LLM incorrectly assumes the notes were absent from 2022 disclosures rather than present but handled differently (via incorporation by reference). The answer demonstrates a fundamental misunderstanding of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 415,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "In the Rest of Asia Pacific segment, Apple’s net sales rose modestly from $29.375 billion in 2022 to $29.615 billion in 2023, while operating income increased more sharply from $11.569 billion to $12.066 billion over the same period (page 50). This reflects a slight uptick in sales and a stronger gain in profitability for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All financial figures are correct: net sales of $29.375 billion (2022) and $29.615 billion (2023), operating income of $11.569 billion (2022) and $12.066 billion (2023). The format variation from millions to billions is appropriate and consistent. The LLM correctly identifies the changes: modest sales growth and stronger profitability gains. The characterization of 'modest' sales growth and 'sharper' operating income increase accurately reflects the underlying data (0.8% vs 4.3% growth rates, though the LLM doesn't explicitly state these percentages). The multi-hop synthesis is sound - the answer correctly combines net sales and operating income data across two fiscal years for a specific geographic segment. The reasoning is logical and the conclusion appropriately captures the differential growth rates between the two metrics. Minor note: The LLM includes a page reference ('page 50') which adds credibility but wasn't in the ground truth answer - this is a positive addition. The answer fully addresses all parts of the question regarding how financial performance evolved from 2022 to 2023 in the Rest of Asia Pacific region.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 340,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The company’s 2007 Omnibus Incentive Plan originally provided that stock‑option awards granted before 2022 vest pro‑rata over a **five‑year** period (with a ten‑year expiration) 【page_116】.  After the plan was amended, options granted **after December 31 2021** now vest pro‑rata over a **four‑year** period (still terminating ten years from the grant date) 【page_96】.  Thus, the standard vesting schedule was shortened by one year for post‑2021 grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about vesting period evolution. STRENGTHS: (1) All numeric values are correct - five-year vesting for pre-2022 grants and four-year vesting for post-December 31, 2021 grants are accurately stated. (2) The one-year reduction is correctly calculated and clearly articulated. (3) The temporal distinction between the two grant periods is properly identified. (4) The answer correctly references the 2007 Omnibus Incentive Plan and the amendment/restatement. (5) Additional context about the ten-year expiration is accurate and helpful. (6) The multi-hop synthesis across the 2022 and 2024 10-K filings is sound - the answer correctly identifies that this represents a consistent structural change. MINOR CONSIDERATIONS: (1) The answer does not explicitly reference both the 2022 and 2024 10-K filings as sources, though the page citations suggest this information was drawn from those documents. The ground truth specifically mentions confirmation in the 2024 10-K that the vesting periods remained consistent, which the LLM answer implies but doesn't explicitly state. (2) The phrasing 'after the plan was amended' is slightly less precise than 'amended and restated plan' from the ground truth, though semantically equivalent. (3) The answer could have been slightly more explicit about the consistency of these terms across both filing years, though this is a minor omission. Overall, the answer demonstrates strong understanding of the question's multi-hop nature and provides accurate, well-synthesized information with appropriate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 447,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS used the same validation routine in both years. For 2022 and again in 2023 the company obtained one price for each Level 2 debt security, made **no year‑end price adjustments**, and each quarter **sampled those prices against a secondary source**, reviewing any variance that exceeded a set threshold and also comparing them with the internal investment team’s independent fair‑value estimates. The 2023 filing explicitly notes that no adjustments were made at December 31, 2023 (or 2022) and that the secondary‑source comparison process remained unchanged from the prior year【page_153】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about CVS's Level 2 debt security validation methodology: (1) one price obtained per security in both years, (2) no year-end price adjustments made at December 31, 2023 or 2022, and (3) quarterly secondary source comparisons with variance threshold reviews. The answer accurately conveys that the methodology remained unchanged between 2022 and 2023. However, there are some notable issues: (1) The LLM introduces an additional element not explicitly mentioned in the ground truth - 'comparing them with the internal investment team's independent fair-value estimates' - while this may be accurate from the filing, it goes slightly beyond what the ground truth emphasizes. (2) The ground truth mentions validation at December 31, 2021 and 2020 (no adjustments), providing historical context that the LLM omits, though this is a minor omission since the question focuses on 2022-2023 evolution. (3) The LLM's characterization of the approach as 'the same validation routine in both years' and 'remained unchanged from the prior year' correctly captures the ground truth's conclusion about stability. (4) The citation reference [page_153] adds credibility but cannot be verified in this evaluation. The answer demonstrates solid multi-hop reasoning by synthesizing the validation methodology across both years and correctly identifying the lack of evolution/change. The semantic meaning aligns well with the ground truth despite minor wording differences. The quantitative elements (dates, number of prices per security) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 434,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS treated privately‑placed equity securities the same way in both years – they were classified in **Level 3** because no active market exists, and their fair value was derived from an **internal analysis of the investment’s financial statements and cash‑flow projections**.  The valuation relied on **unobservable inputs** such as earnings and revenue multiples, a discount for lack of marketability and comparability adjustments, and this approach was unchanged from 2022 (page 148) to 2023 (page 153).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Level 3 classification in both years, (2) use of internal analysis of financial statements and cash flow projections, (3) unobservable inputs including earnings/revenue multiples, discount for lack of marketability, and comparability adjustments, and (4) consistency between 2022 and 2023. The page references (148 and 153) add credibility. However, the answer has a notable weakness: it states the approach was 'unchanged from 2022 to 2023,' which partially contradicts the ground truth's key insight that there was an 'evolution' in emphasis. The ground truth specifically notes that in 2023, there was 'an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs.' The LLM answer misses this important distinction about the evolution in how CVS emphasized sensitivity analysis and scrutiny of inputs in 2023 versus 2022. While the LLM correctly identifies that the same unobservable inputs were used in both years, it fails to capture the qualitative evolution in how the company presented or emphasized the analysis of these inputs. The answer is factually accurate on the classification and input types but incomplete in addressing the 'evolution' aspect of the question, which was a central part of what was being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 390,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue for Alphagan/Combigan fell from $272 million in 2023 to $248 million in 2024 – a decline of about $24 million (roughly an 8‑9% drop)【page_43】.  In contrast, the international portion rose modestly, from $151 million in 2023 to $153 million in 2024, showing a slight increase in overseas sales【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: total revenue declined from $272M (2023) to $248M (2024), international revenue increased from $151M to $153M. The calculated decline of $24M is accurate, and the percentage decline of 8-9% is appropriately stated (ground truth specifies 8.8%, and 8-9% is a reasonable approximation). The LLM correctly identified both parts of the multi-hop question: (1) total revenue trend showing decline, and (2) international revenue trend showing growth. The reasoning is sound - the model properly synthesized that while overall revenue fell, international sales actually grew slightly, creating an interesting contrast. The wording differs slightly from ground truth (e.g., 'fell' vs 'decreased', 'modest' vs 'slight') but conveys identical semantic meaning. The citation to page_43 adds credibility. Minor point: ground truth specifies 1.5% growth for international revenue while LLM uses 'modest' and 'slight' descriptors without the exact percentage, but this is a minor omission that doesn't affect the core accuracy of the answer. All entities (Alphagan/Combigan, years 2023-2024, revenue metrics) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 342,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "In 2023 Chevron completed a business‑combination acquisition of PDC Energy, turning the company into a wholly‑owned subsidiary (it was even excluded from internal‑control testing that year)【page_30】. By 2024 PDC’s assets were fully integrated into Chevron’s operations, and the “full‑year of legacy PDC Energy production” helped lift Chevron’s worldwide oil‑equivalent output about 7 % to roughly 3.3 million barrels per day【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Chevron's evolving relationship with PDC Energy from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 acquisition of PDC Energy and its status as a wholly-owned subsidiary; (2) Accurately notes PDC's exclusion from internal control testing in 2023 due to acquisition timing; (3) Correctly states the 7% increase in worldwide oil-equivalent production; (4) Properly attributes this production increase to the full-year contribution from legacy PDC operations in 2024; (5) Provides the specific production figure of approximately 3.3 million barrels per day; (6) Effectively synthesizes the multi-hop information showing the transition from newly acquired entity (2023) to integrated operational component (2024). QUANTITATIVE VERIFICATION: The 7% production increase figure matches the ground truth exactly. The production output of 3.3 million barrels per day is consistent with the ground truth context. MULTI-HOP REASONING: The answer successfully connects three key pieces of information: (a) the 2023 acquisition and exclusion from controls, (b) the 2024 full integration, and (c) the resulting 7% production increase. The causal relationship between PDC's full-year contribution and production growth is clearly established. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth (e.g., 'business-combination acquisition' vs. 'acquired') but this represents semantic equivalence rather than error. The inclusion of the specific production metric (3.3 million barrels per day) adds helpful context not explicitly in the ground truth but is factually accurate and relevant. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 480,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS expanded its cold‑chain logistics capability in 2023 by buying MNX Global Logistics—a global, time‑critical, temperature‑sensitive logistics provider—and by leveraging its earlier Bomi Group purchase, as described in the Supply‑Chain Solutions overview (see page 6). In 2024 the company’s investment shifted to integrating those assets, with goodwill reflecting the 2024 completion of purchase‑accounting for the 2023 MNX Global Logistics acquisition (see page 101), and no additional cold‑chain‑specific acquisitions were announced for 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that directly contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims 'no additional cold-chain-specific acquisitions were announced for 2024,' which is factually incorrect. The ground truth clearly states that in 2024, UPS acquired Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million. This is a major omission that fundamentally misrepresents the evolution of UPS's cold-chain strategy. (2) QUANTITATIVE ACCURACY: The LLM provides no mention of the $440 million investment in 2024 acquisitions, which is a critical financial metric for answering the question about how the investment evolved. The ground truth explicitly states this figure as evidence of 'significant increase in international investment.' (3) ENTITY ACCURACY: While the LLM correctly identifies MNX Global Logistics and Bomi Group from 2023, it completely fails to identify the 2024 acquisitions (Frigo-Trans and Biotech & Pharma Logistics). This represents a 50% failure rate on the key entities needed to answer the question. (4) MULTI-HOP REASONING: The question asks specifically about evolution from 2023 to 2024 and what acquisitions contributed to this change. The LLM's answer actually contradicts the premise by claiming no new acquisitions occurred in 2024, when the ground truth shows a strategic intensification with two major German acquisitions. The LLM mischaracterizes 2024 as merely an 'integration' year rather than a year of significant expansion. (5) SEMANTIC MEANING: The ground truth emphasizes a 'shift from general expansion to targeted, high-value international acquisitions,' which the LLM completely fails to capture. The LLM's narrative suggests consolidation rather than expansion, which is the opposite of what actually occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 497,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "In the 2022 Form 10‑K the company’s non‑employee‑director RSU awards were simply granted under the 2021 Long‑Term Incentive Plan (exhibit 10.0e) and, historically, under the 2009 Praxair LTIP (exhibit 10.11h) 【page_105】【page_107】. By the 2024 filing Linde had added a dedicated Non‑Employee Director Deferral Program (adopted by the Board on July 30 2024, exhibit 10.16) and amended both the Linde Compensation Deferral Programme (effective 1 Jan 2024, exhibit 10.08b) and the 2009 LTIP (effective 29 Jan 2024, exhibit 10.10c), thereby creating a formal deferral mechanism and enhanced Board/Compensation‑Committee oversight that more tightly ties director equity compensation to long‑term shareholder value 【page_94】【page_95】【page_96】. This evolution moves the program from a straightforward RSU grant to a structured governance framework with deferred vesting and performance‑linked features designed to align directors’ interests with shareholders over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) All dates are correct - 2022 introduction of RSU awards under 2021 LTIP, July 30, 2024 Board adoption of Non-Employee Director Deferral Program, January 1, 2024 effective date for Compensation Deferral Programme amendment, January 29, 2024 effective date for 2009 LTIP amendment. (2) All entities correctly identified - Linde plc, 2021 Long-Term Incentive Plan, 2009 Praxair LTIP, Non-Employee Director Deferral Program, Linde Compensation Deferral Programme. (3) Multi-hop synthesis is sound - correctly traces evolution from basic RSU grants (2022) to sophisticated deferral mechanism (2024) with enhanced governance. (4) Specific exhibit references (10.0e, 10.11h, 10.16, 10.08b, 10.10c) add credibility and demonstrate document-level accuracy. (5) Governance evolution narrative is accurate - moves from straightforward RSU grant to structured framework with deferred vesting and performance-linked features. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and technical than the ground truth (includes specific exhibit numbers and effective dates), but this represents added value rather than inaccuracy. The semantic meaning aligns perfectly with the ground truth regarding the evolution from basic RSU awards to a more sophisticated deferral mechanism with enhanced board oversight and long-term shareholder alignment. No calculation errors, no factual contradictions, and all multi-hop reasoning is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 436,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "In the 2022 filing GM disclosed a $0.2 billion non‑operating gain tied to Stellantis N.V. warrants (see page 36) and noted that it had already entered an indemnification agreement with Stellantis arising from the 2017 Opel/Vauxhall sale, though the liability was not quantified. By the 2024 filing the same indemnification obligations remain in force—subject to caps, thresholds and time‑limits and judged immaterial (page 93‑94)—while the Stellantis‑related warrant gain is no longer highlighted, indicating it has been realized or is no longer material to the 2024 results.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the $0.2 billion warrant gain in 2022 and accurate characterization of the indemnification obligations. The multi-hop synthesis across 2022 and 2024 filings is sound, correctly tracking the evolution from warrant gains to contingent liabilities. However, there are notable gaps in completeness: (1) The LLM answer does not mention the specific categories of indemnified liabilities (pre-sale emissions claims, product liabilities, recalls) that are explicitly stated in the ground truth. (2) The LLM does not reference the ongoing investigations into Opel's historical conduct in Europe and associated potential future liabilities, which the ground truth identifies as a key aspect of the 2024 relationship. (3) The LLM's characterization that indemnification obligations are 'judged immaterial' in 2024 differs subtly from the ground truth's emphasis on 'contingent liabilities and legal risks' - while not incorrect, this framing misses the potential significance of these obligations. The answer correctly identifies the warrant gain amount, the 2017 Opel/Vauxhall sale context, and the presence of caps/thresholds/time-limits on indemnification. The reasoning about the evolution from financial benefits to legal obligations is sound. The main weakness is incomplete coverage of the specific liability categories and ongoing investigation risks that characterize the 2024 relationship complexity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 411,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "In the 2022 Form 10‑K Southern Company disclosed energy‑related derivatives mainly through their earnings and OCI effects – tables of cash‑flow‑hedge gains/losses and the impact of non‑designated contracts (see 2022 pp. 325‑327). By the 2024 filing the company added a dedicated balance‑sheet schedule that breaks out energy‑related derivatives into “regulatory‑hedge,” “cash‑flow/fair‑value‑hedge,” and “non‑designated” categories, shows current vs. non‑current assets and liabilities, reports gross amounts, offsets and net amounts, and includes a footnote on cash‑collateral (see 2024 pp. 281‑285). This reflects a shift from a simple income‑statement/OCI disclosure to a more granular, categorized presentation of derivative positions on the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Southern Company's derivative disclosure from 2022 to 2024, capturing the shift from income-statement/OCI-focused reporting to balance-sheet-oriented presentation. The semantic meaning aligns well with the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the 2022 focus on income statement impacts (pre-tax effects, OCI effects)\n2. Accurately describes the 2024 shift to balance sheet categorization\n3. Provides specific page references (2022 pp. 325-327, 2024 pp. 281-285) that add credibility\n4. Correctly identifies the categorization types in 2024 (regulatory-hedge, cash-flow/fair-value-hedge, non-designated)\n5. Accurately notes the addition of current vs. non-current asset/liability breakdown\n6. Correctly captures the evolution from simple to granular presentation\n7. Appropriately addresses all parts of the multi-part question\n\nWEAKNESSES:\n1. Page numbers cannot be verified against ground truth (no page references provided in original answer), creating uncertainty about quantitative accuracy\n2. The specific categorization names (\"regulatory-hedge,\" \"cash-flow/fair-value-hedge\") are more detailed than the ground truth mentions, which could indicate either enhanced accuracy or potential over-specification\n3. The mention of \"cash-collateral footnote\" is not explicitly mentioned in the ground truth\n4. Ground truth uses broader language (\"Other\" or \"Risk Management Activities\") while LLM provides more specific category names - this could be correct but cannot be fully verified\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across two years (2022 and 2024) and correctly identifies the directional shift in disclosure strategy. The reasoning is sound and logical.\n\nSEMANTIC EQUIVALENCE:\nThe core message matches: Southern Company shifted from income-focused to balance-sheet-focused derivative reporting with more granular categorization. The LLM answer provides more specific implementation details than the ground truth, which enhances rather than contradicts the original answer.\n\nQUANTITATIVE CONCERNS:\nThe page numbers provided cannot be verified, and the specific category names are more detailed than ground truth. This creates a 6/10 quantitative accuracy score due to inability to fully verify the specific details provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 631,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "In 2023 Gilead owned roughly 19.9 % of Arcus’s voting stock and had two Gilead‑appointed directors on Arcus’s board. In January 2024 Gilead announced a $320 million equity investment that lifted its stake to about 33 % and increased its board representation to three designees, giving it a larger ownership position and greater governance influence over Arcus (see page 77).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: (1) 2023 ownership of 19.9% is correct, (2) two board designees in 2023 is correct, (3) January 2024 $320 million investment amount is correct, (4) resulting 33% ownership stake is correct, (5) three board designees post-investment is correct. The multi-hop reasoning is sound - the answer correctly synthesizes the evolution of the relationship across two time periods and two dimensions (equity ownership and governance influence). The answer properly identifies both companies (GILD/Gilead and Arcus), uses correct terminology (voting stock, board designees/directors, equity investment), and maintains chronological clarity. The wording differs slightly from the ground truth (e.g., 'Gilead-appointed directors' vs 'designees,' 'announced' vs 'made') but these are semantic equivalences that preserve factual accuracy. The answer appropriately characterizes the relationship evolution as representing 'larger ownership position and greater governance influence.' The only minor note is the citation reference '(see page 77)' which adds context but is not part of the ground truth answer - this is a neutral addition that doesn't detract from accuracy. Overall, this is a strong, factually correct answer that fully addresses the multi-part question about the strategic relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 388,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "In the 2022 Form 10‑K the 2021 Multicurrency Credit Facility was reported with a maturity of June 30 2025 and a total borrowing capacity of $6.0 billion (see page 49, “Amendments to Bank Facilities”). The 2023 Form 10‑K notes a June 29 2023 amendment that pushed the facility’s maturity out to July 1 2026, while leaving the commitment unchanged at $6.0 billion (see page 52). Thus, between 2022 and 2023 the maturity was extended by roughly one year, but the borrowing capacity remained the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about the evolution of the 2021 Multicurrency Credit Facility between 2022 and 2023. STRENGTHS: (1) All key financial figures are correct: $6.0 billion borrowing capacity in both years, June 30, 2025 maturity in 2022, July 1, 2026 maturity in 2023. (2) Dates are accurate, including the specific amendment date of June 29, 2023. (3) The multi-hop synthesis is sound - correctly identifies the facility in 2022, tracks the amendment in 2023, and compares the two periods. (4) The conclusion correctly characterizes the change as a one-year extension with unchanged commitment. (5) Citations to specific pages (49 and 52) add credibility. MINOR CONSIDERATIONS: (1) The LLM states the extension was \"roughly one year\" - technically it's from June 30, 2025 to July 1, 2026, which is exactly one year and one day, so \"roughly one year\" is semantically accurate and appropriate. (2) The answer includes helpful context about the strategic intent (maintaining financial flexibility), which aligns with the ground truth interpretation. The answer demonstrates clear understanding of the question's multi-part nature (maturity date AND borrowing capacity) and successfully synthesizes information across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 364,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s U.S. refineries continued to rely on imported crude for roughly the same share of feedstock – about 60 percent of total refinery inputs in both 2023 and 2024 【page_17】.  At the same time, refinery utilization slipped: average crude‑unit distillation capacity utilization fell from about 90.8 percent in 2023 to 86.6 percent in 2024 (overall refinery utilization dropped from 89.8 percent to 87.9 percent) 【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: imported crude oil reliance at ~60% for both 2023 and 2024, crude-unit distillation capacity utilization declining from 90.8% to 86.6%, and overall refinery utilization dropping from 89.8% to 87.9%. The multi-hop synthesis is sound, correctly combining information about import dependency trends with refinery capacity utilization changes across two fiscal years. The answer properly addresses both components of the question: (1) the evolution of imported crude oil utilization (showing consistency at 60%), and (2) the accompanying changes in refinery capacity utilization (showing decline). The LLM actually provides additional relevant context by including overall refinery utilization figures (89.8% to 87.9%) beyond the ground truth's focus on crude-unit distillation capacity, which adds value without contradicting the original answer. Entity identification is accurate (Chevron, U.S. refineries, 2023-2024 periods). The reasoning correctly concludes that while import dependency remained stable, operational intensity declined. Minor point: the LLM uses slightly more precise language ('slipped' vs 'declined') and provides additional supporting metrics, which enhances rather than detracts from the answer. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 394,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS’s GBP‑denominated hedge shrank from a notional $663 million at 12/31/2023 to $536 million at 12/31/2024 – a drop of roughly $127 million (about 19%)【page_130】【page_137】.  The reduction signals that UPS is scaling back its exposure to the British pound, likely aligning hedge amounts with revised cash‑flow forecasts and tightening its currency‑risk management to reflect a lower expected GBP impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data. All key numbers are accurate: 2023 GBP hedge of 663 million units (presented as $663 million), 2024 position of 536 million units ($536 million), the reduction of 127 million units ($127 million), and the percentage decline of approximately 19%. The calculation is correct (127/663 = 19.15%, rounded to 19%). The answer correctly identifies the time periods (12/31/2023 and 12/31/2024) and the currency (British Pound Sterling/GBP). The multi-hop synthesis is sound, comparing positions across two years and drawing appropriate conclusions about risk management strategy. The reasoning about scaling back exposure and aligning with revised cash-flow forecasts is logical and consistent with the data presented. One minor discrepancy: the original answer specifies 'units' while the LLM uses dollar notation ($663M, $536M), though this is a semantic/presentation difference rather than a factual error, as both refer to the same notional amounts. The LLM's interpretation that this reflects a 'more conservative hedging approach' or 'lower anticipated risk' aligns well with the original answer's characterization. The answer is well-structured, includes source citations, and directly addresses both parts of the question (the evolution of the position and what it indicates about strategy). The only minor limitation is that the LLM could have been slightly more explicit about whether this represents a reduction in units or notional value, though context makes this clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 428,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Bank of America’s money‑market holdings rose from a fair value of **$1.2 billion at 31 Dec 2023** to **$1.3 billion at 31 Dec 2024**【page_113】. The $0.1 billion increase (about 8 %) shows the bank is modestly expanding its short‑term, highly‑liquid assets, underscoring a focus on preserving liquidity and flexibility in its cash‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - opening value of $1.2 billion (Dec 31, 2023), closing value of $1.3 billion (Dec 31, 2024), and the calculated increase of $0.1 billion. The percentage calculation of approximately 8% is accurate (0.1/1.2 = 8.33%, reasonably rounded). Dates are correctly formatted and match the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of fair value between the two years, and (2) what this shift indicates about investment strategy. ENTITY ACCURACY: Bank of America is correctly identified, the metric (fair value of money market investments) is precise, and fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the numerical change to strategic implications (liquidity management, cash-management strategy, preservation of flexibility). The interpretation aligns with the ground truth's characterization of 'modest growth' and 'short-term investment holdings.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'modestly expanding its short-term, highly-liquid assets' is semantically equivalent to the ground truth's 'modest growth in the company's short-term investment holdings.' The emphasis on 'liquidity management' and 'cash-management strategy' provides slightly more specific strategic context than the ground truth's 'liquidity management or short-term capital deployment strategies,' which is a minor enhancement rather than an error. MINOR OBSERVATION: The inclusion of a page reference (【page_113】) adds credibility but was not in the ground truth - this is a neutral addition. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question with correct calculations and sound interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 504,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas covered by physical supply contracts with sell‑back options fell from 26 million mmBtu in the 2022 filing (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to 15 million mmBtu in the 2024 filing (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power) – a drop of 11 million mmBtu overall【page_319】【page_281】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental unit error that invalidates the entire response. The ground truth specifies volumes in 'million mmBtu' (e.g., '6 million mmBtu'), but the LLM answer omits the word 'million' and states only 'mmBtu' (e.g., '6 mmBtu'). This represents a 1,000,000x understatement of the actual volumes. Specifically: (1) 2022 subsidiary volumes should be '6 million mmBtu' not '6 mmBtu', '8 million mmBtu' not '8 mmBtu', etc. (2) 2024 subsidiary volumes should be '4 million mmBtu' not '4 mmBtu', '6 million mmBtu' not '6 mmBtu', etc. (3) The overall decrease calculation of 11 million mmBtu is arithmetically correct (26-15=11), but this correctness is overshadowed by the systematic unit error throughout. The LLM correctly identified all entities (Alabama Power, Georgia Power, Mississippi Power, Southern Power), correctly identified the years (2022 and 2024), correctly identified the metric type (physical supply contracts with sell-back options), and correctly synthesized the multi-hop comparison across subsidiaries and years. However, the pervasive unit notation error is a critical factual mistake that fundamentally misrepresents the scale of the volumes being discussed. This is not a minor formatting variation but a substantive omission of a required unit qualifier that changes the meaning of every number in the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 384,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "In fiscal 2023 Adobe positioned the Firefly Vector Model as a core component of its Firefly generative‑AI family, delivering fully editable vector graphics via text prompts and embedding it natively in Photoshop, Illustrator, Adobe Express, Acrobat and Adobe Stock, while also offering the model through Firefly Services and Custom Models for enterprise customers (page 11; page 12). By fiscal 2024 Adobe reaffirmed that same native integration across Photoshop, Illustrator, Premiere Pro and Express and highlighted expanded enterprise‑focused Firefly Services and Custom Models that let businesses train and use custom vector models for brand‑specific use cases (page 11; page 12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR - The LLM claims the Firefly Vector Model was embedded in Photoshop, Acrobat, and Adobe Stock in 2023, but the ground truth explicitly states it was only integrated into Adobe Express in 2023. (2) MAJOR FACTUAL ERROR - The LLM claims Premiere Pro integration in 2024, but the ground truth only mentions Adobe Illustrator as the new integration point in 2024. (3) INCOMPLETE/INACCURATE - The ground truth emphasizes the specific feature 'Generative Recolor' in Illustrator for 2024, which the LLM completely omits. (4) SCOPE MISMATCH - The LLM discusses enterprise-focused Firefly Services and Custom Models extensively, which are not mentioned in the ground truth answer about the Vector Model's evolution. (5) MISSING CONTEXT - The ground truth highlights the expansion from single-app (Express) to multiple professional-grade applications (Illustrator), which is the core narrative of the evolution. The LLM's answer suggests broader integration in 2023 than actually occurred and adds incorrect applications (Photoshop, Acrobat, Premiere Pro) that are not supported by the ground truth. The answer demonstrates a fundamental misunderstanding of the actual product integration timeline and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 368,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "In 2023 Biktarvy generated $11.85 billion in sales (U.S., Europe and other markets combined), accounting for roughly two‑thirds of Gilead’s $18.2 billion HIV portfolio and a large share of total revenue 【page_65】. The 2024 filing again stresses that HIV products are a “substantial portion of our revenue” and that any loss of market share would force a scale‑back of operations, underscoring that Biktarvy remains a cornerstone of Gilead’s HIV franchise 【page_18】【page_20】. Consequently, Gilead’s HIV strategy will continue to protect and grow Biktarvy’s market position while pursuing new indications or products to offset competitive and pricing pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Biktarvy's 2023 sales of $11.85 billion ($11,850 million), matching the ground truth exactly. (2) The answer appropriately characterizes Biktarvy as a major revenue driver and cornerstone of GILD's HIV franchise. (3) The LLM correctly synthesizes information from multiple filing pages (page_65, page_18, page_20) to address the evolution question. (4) The strategic implications are reasonably articulated - acknowledging both the importance of protecting Biktarvy's position and the need to pursue new products to offset competitive pressures. (5) The answer correctly identifies the HIV portfolio context and revenue significance.\n\nWEAKNESSES: (1) The LLM provides the 2023 figure but does NOT explicitly compare it to 2022 ($10,390 million), which the ground truth emphasizes as showing growth trajectory. The question asks about evolution FROM 2023 TO 2024, but the LLM primarily focuses on 2023-2024 risk discussion rather than showing quantitative evolution. (2) The LLM mentions 'two-thirds of Gilead's $18.2 billion HIV portfolio' but does not verify this calculation: $11.85B / $18.2B = 65%, which is approximately two-thirds, so this is acceptable. (3) The ground truth specifically mentions 'potential shifts in treatment paradigms and growing generic competition' as key risks - the LLM mentions 'competitive and pricing pressures' more generally but doesn't explicitly call out the TAF-specific generic competition risk that the ground truth emphasizes. (4) The LLM answer lacks the specific mention of TAF (tenofovir alafenamide) as a vulnerability point, which the ground truth identifies as important context.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple filing sections to show how Biktarvy's strategic importance persists while risks increase. However, it could have better connected the 2022-2023-2024 timeline to show the evolution more clearly.\n\nNUMERIC VERIFICATION: $11.85B = $11,850M ✓; Two-thirds calculation approximately correct ✓; No calculation errors detected.\n\nThe answer is substantially correct on core facts but misses some nuanced details about the specific nature of competitive threats (generic TAF competition) and doesn't fully develop the year-over-year evolution narrative that the question requests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 622,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "In the 2022 filing the Series 2018‑1A Securities were described as a $500 million securitization carrying a 3.652 % coupon, with no principal payments required before the anticipated March 2028 repayment date【page_118】. By the 2023 filing the outstanding balance had slipped to $496.8 million (versus $496.1 million a year earlier) but the interest rate remained unchanged at 3.652 %【page_108】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ISSUES IDENTIFIED: (1) CRITICAL DISCREPANCY: The LLM states the 2023 outstanding balance was $496.8 million 'versus $496.1 million a year earlier' - this comparison is problematic. The ground truth indicates 2022 principal was $500.0 million, not $496.1 million. The LLM appears to be comparing 2023 ($496.8M) to an unexplained prior year figure ($496.1M) rather than to the correct 2022 baseline ($500.0M). This represents a significant quantitative error in the year-over-year comparison. (2) CORRECT ELEMENTS: The 2022 principal amount of $500 million is correct, the 2023 principal of $496.8 million is correct, and the interest rate of 3.652% for both years is correct. (3) ADDITIONAL INFORMATION: The LLM provides extra context about the March 2028 repayment date and notes about no principal payments before that date - this information is not contradicted by the ground truth but adds detail beyond what was specified. (4) MULTI-HOP REASONING: The model correctly synthesizes information across 2022 and 2023 filings and identifies the unchanged interest rate, but fails to properly establish the baseline for comparison. The statement about principal 'slipping' from $496.1M to $496.8M is confusing and contradicts the ground truth's 2022 baseline of $500.0M. (5) SEMANTIC ISSUE: While the overall narrative structure is sound, the quantitative comparison is fundamentally flawed, which undermines the answer's reliability despite getting individual numbers correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 407,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "In 2023 UPS still owned the Coyote truck‑load brokerage business but, after a market‑driven slowdown, it recorded a $111 million impairment on the Coyote trade name (with $482 million of goodwill still on the books) and began evaluating strategic alternatives for the unit. By 2024 UPS had sold Coyote, recognized a $156 million gain on the divestiture and eliminated the associated operating costs (about $949 million of forward‑ing expenses), signaling a clear strategic shift to exit the Coyote business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative arc (2023 impairment → 2024 divestiture) and captures the strategic shift. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n(1) CORRECT ELEMENTS:\n- $111 million impairment charge in 2023 ✓\n- Strategic evaluation/alternatives assessment in 2023 ✓\n- September 2024 divestiture ✓\n- Clear strategic shift from impairment to exit ✓\n- Coyote truck-load brokerage business description ✓\n\n(2) QUANTITATIVE ACCURACY ISSUES:\n- The LLM introduces $482 million goodwill figure and $156 million gain on divestiture, which are NOT mentioned in the ground truth answer. These appear to be fabricated or from unverified sources.\n- The LLM mentions \"$949 million of forwarding expenses\" - this specific number is not in the ground truth and appears to be an unsupported detail.\n- The ground truth focuses on the impairment charge and revenue impact from Coyote's exit, not on gain on divestiture or specific expense figures.\n- These additional numbers cannot be verified against the provided ground truth and represent potential hallucination.\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes the 2023-to-2024 evolution\n- Properly connects impairment → strategic review → divestiture\n- Appropriately links financial impact to strategic direction\n- However, the introduction of unverified financial metrics weakens the synthesis quality\n\n(4) SEMANTIC EQUIVALENCE:\n- The core message aligns with ground truth (impairment in 2023, divestiture in 2024)\n- Wording differs but captures the same strategic narrative\n- The addition of unverified numbers goes beyond semantic variation into potential factual error\n\nThe answer demonstrates good understanding of the question and correct identification of key facts, but the introduction of specific financial figures ($482M goodwill, $156M gain, $949M expenses) that are not in the ground truth significantly undermines quantitative accuracy. These could be correct from actual filings, but they cannot be verified against the provided ground truth and represent a risk of hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 575,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "In the 2022 Form 10‑K the Performance Share Unit (PSU) awards for grants that began in 2019 were issued under the Amended and Restated 2009 Praxair Long‑Term Incentive Plan and were split into two separate award forms—one tied to a Return‑on‑Capital metric and the other tied to a Total‑Shareholder‑Return metric【page_107】. By the 2024 filing those same two metric‑based PSU award forms appear under the newer 2021 Linde plc Long‑Term Incentive Plan (exhibits 10.03 and 10.04), showing that the governing plan shifted to the 2021 LTIP while the performance‑metric framework (ROC and TSR) remained unchanged【page_94】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT MISMATCH - The LLM claims 2024 exhibits are 10.03 and 10.04, but the ground truth specifies exhibits 10.10l and 10.10m for 2024. This is a significant factual error in exhibit identification. (2) PLAN SHIFT CLAIM - The LLM introduces a claim that the governing plan shifted from the 'Amended and Restated 2009 Praxair Long-Term Incentive Plan' to the '2021 Linde plc Long-Term Incentive Plan' between 2022 and 2024. The ground truth makes NO mention of such a plan shift - it explicitly states the same forms remained in place under the same plan structure. This is a major factual error that contradicts the ground truth. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) the dual structure of PSU awards with ROC and TSR metrics, (b) that these metrics remained unchanged between 2022 and 2024, (c) the connection to 2019 grants, (d) the underlying plan name as 'Amended and Restated 2009 Praxair Long-Term Incentive Plan' for 2022. (4) MULTI-HOP REASONING - The core multi-hop synthesis (comparing 2022 and 2024 structures) is partially correct in identifying metric continuity, but the introduction of an unsupported plan shift claim represents a fundamental misunderstanding or hallucination. The ground truth emphasizes structural continuity without plan changes; the LLM introduces a plan migration that is not supported by the source material. (5) SEMANTIC ISSUES - While the answer addresses the question's scope, the factual inaccuracies regarding exhibits and plan governance significantly undermine credibility and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 435,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "In the 2023 Form 10‑K Gilead reported that Trodelvy (sacituzumab govitecan‑hziy) already had FDA (and EC) approval for the treatment of unresectable or metastatic HR+/HER2‑negative breast cancer after endocrine therapy, in addition to its earlier accelerated‑approval indication for metastatic urothelial cancer【page_7】.  By the 2024 filing the company announced a **second** FDA Breakthrough‑Therapy designation for Trodelvy, this time for extensive‑stage small‑cell lung cancer, indicating the drug is moving into new tumor types and is being fast‑tracked through development【page_8】.  This evolution from an approved indication to a new breakthrough designation reflects an expanding development trajectory and a strategy to broaden Trodelvy’s oncology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Trodelvy's regulatory evolution. STRENGTHS: (1) Correctly identifies all three 2023 indications (unresectable/metastatic HR+/HER2-negative breast cancer, urothelial cancer, and implicitly triple-negative breast cancer through context), (2) Accurately reports the 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer, (3) Properly characterizes this as a 'second' designation, indicating understanding of prior breakthrough designations, (4) Correctly identifies the regulatory pathway (accelerated approval vs. breakthrough designation), (5) Accurately synthesizes the development trajectory showing expansion into new oncology indications, (6) Appropriately notes the strategic implications of broadening the oncology portfolio. MINOR CONSIDERATIONS: The LLM answer provides slightly more detail about the specific breast cancer subtype (HR+/HER2-negative after endocrine therapy) compared to the ground truth's broader framing, but this represents added precision rather than error. The answer correctly emphasizes the 'second' designation aspect and the fast-track nature of breakthrough therapy. The multi-hop reasoning is sound—connecting 2023 approvals to 2024 designation and drawing appropriate conclusions about development trajectory. All entity identifications (Gilead, Trodelvy, FDA, EC, specific cancer types) are accurate. The semantic meaning aligns perfectly with the ground truth regarding the strategic expansion into new indications with high unmet medical need.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 442,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "In the 2023 filing, Vertex AI was introduced as the Google‑Cloud developer platform that let developers **train, tune, augment, test and deploy** applications using a handful of internal generative models—primarily Gemini, Imagen and Veo—and it offered pre‑packaged AI agents (Gemini for Google Cloud) to help with coding and cybersecurity tasks. By the 2024 filing, Vertex AI had expanded into a broader AI hub: it still supports Gemini but now **exposes a wide ecosystem of first‑party, third‑party and open‑source generative models** and adds new services such as vector‑search, grounding and model‑distillation, deepening its integration of generative AI across Google Cloud.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer claims that in 2023, Vertex AI supported 'internal generative models—primarily Gemini, Imagen and Veo' and offered 'Gemini for Google Cloud' as pre-packaged AI agents. However, the ground truth states that in 2023, Vertex AI supported 'generative AI models and services such as Enterprise Search and Conversations' with NO mention of Gemini, Imagen, or Veo being primary offerings in 2023. This is a significant factual error. (2) CAPABILITY MISMATCH - The ground truth explicitly states that in 2023, Vertex AI allowed developers to 'train, tune, augment, and deploy' (4 capabilities), while the LLM claims it supported 'train, tune, augment, test and deploy' (5 capabilities including 'test'). The ground truth indicates 'test' was added by 2024, not present in 2023. (3) INCOMPLETE 2024 DESCRIPTION - While the LLM correctly identifies new 2024 services (vector search, grounding, distillation), it overstates the evolution by claiming Vertex AI 'exposes a wide ecosystem of first-party, third-party and open-source generative models' in 2024. The ground truth more conservatively states it 'specifically support[s] Gemini and other leading generative AI models' without emphasizing the breadth of third-party/open-source models. (4) MISSING KEY DETAIL - The ground truth emphasizes that the 2024 evolution includes services 'to improve model cost and quality,' which the LLM answer omits. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the year-over-year evolution, particularly regarding which capabilities and models were present in each year. The answer demonstrates a fundamental misunderstanding of the 2023 baseline, making the comparison to 2024 unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 475,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "In the 2022 filing the notes to the financial statements say that the fair‑value totals “exclude cash collateral of $3 million as well as immaterial premium and associated intrinsic value associated with weather derivatives” for all periods presented【page_122】(also reiterated in the table footnote on page 123)【page_123】. The 2024 filing still excludes the “immaterial premium and intrinsic value associated with weather derivatives” from the net derivative balances, but it no longer references the $3 million cash‑collateral amount and does not quantify any specific amount for the weather‑derivative premium【page_285】. Thus, the treatment remains the same—weather derivatives are considered immaterial and omitted from valuation—but the 2024 disclosure drops the explicit $3 million cash‑collateral reference and provides no dollar figure for the excluded weather‑derivative amounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2022 disclosed '$3 million' cash collateral, but the ground truth makes no mention of a $3 million figure for 2022. The ground truth explicitly states that in 2022, SO 'did not specify exact amounts.' The LLM also claims 2024 'does not quantify any specific amount' for weather-derivative premium, but the ground truth indicates 2024 provided specific cash collateral amounts of $17 million (2024) and $62 million (2023). (2) DIRECTIONAL ERROR: The LLM states the 2024 disclosure 'drops the explicit $3 million cash-collateral reference,' but the ground truth shows the opposite trend—2024 actually ADDED more specific disclosure with $17M and $62M figures, representing an increase in specificity, not a decrease. (3) INCOMPLETE SYNTHESIS: The LLM failed to identify the key evolution highlighted in the ground truth: the shift from non-specific immateriality disclosures in 2022 to more detailed cash collateral quantification in 2024 ($17M and $62M). (4) MISSING CONTEXT: The LLM answer does not capture that the ground truth emphasizes 'a more detailed and structured approach to derivative disclosures over time,' which is the core insight of how treatment changed from 2022 to 2024. The LLM's conclusion that disclosure 'drops' specificity is factually backwards. The answer demonstrates poor multi-hop synthesis across the 2022-2024 period and contains invented or misattributed numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 426,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "In the 2023 Form 10‑K, Gilead’s filing listed Biktarvy only as a protected product with its primary U.S. and EU compound patents running until 2033, with no new regulatory changes noted (see 2023 page 9). By the 2024 filing, Gilead disclosed that the FDA had approved an expanded indication for Biktarvy—allowing use in patients with the M184V/I resistance mutation and adding a label update supporting use in pregnant people with suppressed HIV‑1 viral loads—thereby broadening its patient base and reinforcing its market positioning (see 2024 page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2023 and 2024 GILD filings. STRENGTHS: (1) All numeric values are correct - the 2033 patent expiration date matches the ground truth, and the M184V/I resistance indication is accurately cited. (2) The multi-hop synthesis is sound: the answer correctly identifies the shift from patent protection focus in 2023 to expanded regulatory indications in 2024. (3) Both regulatory developments are accurately captured: the M184V/I resistance mutation indication and the pregnant patient label update are both mentioned with appropriate context. (4) Entity identification is correct throughout (Gilead/GILD, Biktarvy, FDA). (5) The reasoning logic is clear and properly connects the 2023 baseline (patent protection) to 2024 developments (expanded indications). MINOR OBSERVATIONS: (1) The LLM answer includes specific page references (2023 page 9, 2024 page 8) which add credibility but cannot be verified against the ground truth provided. (2) The phrasing 'pregnant people with suppressed HIV-1 viral loads' in the LLM answer is slightly more specific than the ground truth's 'pregnant people with HIV-1,' though both are semantically equivalent and accurate. (3) The LLM answer frames the evolution as a 'shift' from patent protection to expanded therapeutic application, which aligns well with the ground truth's characterization. The answer fully addresses the question's requirement to explain how regulatory and market positioning evolved between the two years, with accurate synthesis of information across both filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 446,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "In 2022 AMT only took a net $850 million draw on its 2021 Multicurrency Credit Facility and made no amendment to the agreement [page_44]. By 2023 the company had borrowed $3.0 billion (and repaid $6.1 billion) under the same facility, and on June 29 2023 it amended the facility – extending its maturity to July 1 2026, reaffirming the $6.0 billion commitment and switching the benchmark from LIBOR to SOFR [page_52].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. Strengths: (1) All key numeric values are accurate - $850 million net borrowing in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023, $6.0 billion facility commitment, July 1 2026 maturity date, and LIBOR-to-SOFR transition are all correct. (2) The multi-hop synthesis is sound - the answer correctly compares 2022 vs 2023 usage patterns and identifies the facility amendments. (3) Entity identification is correct (AMT, 2021 Multicurrency Credit Facility, years 2022-2023). (4) The answer properly conveys the transformation in facility usage and structure. Minor weakness: The ground truth mentions a specific EUR repayment of 842.6 million EUR ($919.1 million) in 2023, which the LLM answer omits. While this detail is not strictly necessary to answer the core question about overall borrowing/repayment amounts and amendments, it represents additional context that was available in the source material. The LLM correctly notes that 2022 had no amendments while 2023 had significant amendments. The answer is well-structured, clear, and includes page references. The omission of the EUR repayment detail prevents a perfect score, but the core answer remains accurate and complete for the main question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 365,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Both the 2023 and 2024 10‑Ks describe Google Ad Manager as a core channel through which advertisers purchase inventory, and Alphabet continues to evaluate whether it acts as a principal or an agent for ads on Google Network properties—generally treating those ads as a principal and recognizing the billed amounts on a gross‑basis (with partner payments recorded as cost of revenue). The 2024 filing repeats the same language, showing that the integration of Google Ad Manager into Alphabet’s revenue‑recognition model has remained essentially unchanged from 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misunderstands and contradicts the ground truth on the core question. The ground truth explicitly states that Google Ad Manager's role EVOLVED between 2023 and 2024, shifting from a 'transactional reporting model' to a 'control-driven justification for gross revenue recognition.' The LLM answer directly contradicts this by claiming the integration 'has remained essentially unchanged from 2023.' This is a critical factual error that goes to the heart of the question. The LLM correctly identifies that both years treat ads as principal and recognize amounts on a gross basis, and correctly notes that partner payments are recorded as cost of revenue. However, it completely misses the strategic evolution in how Alphabet justifies this treatment—the shift from direct transactional reporting to emphasizing control-based evaluation (controlling inventory, being primarily responsible, having pricing discretion). The LLM's conclusion that there was 'no change' is directly contradicted by the ground truth's assertion of a 'strategic evolution.' While the LLM's description of the mechanics (principal vs. agent evaluation, gross basis recognition) is accurate, it fails to capture the nuanced shift in justification and emphasis that constitutes the actual evolution. This represents a failure in multi-hop reasoning and synthesis—the model identified some correct facts but drew the wrong conclusion about how those facts evolved over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 407,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "In 2023 UPS recorded a $56 million goodwill impairment on its Roadie acquisition, trimming the value of the same‑day delivery platform it had added to Supply Chain Solutions. By 2024 the company’s annual goodwill test found Roadie (together with two other units) to have limited excess fair‑value and therefore a higher risk of future impairment, but no new charge was taken, indicating UPS still views Roadie as a strategic asset while closely monitoring its valuation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: The $56 million goodwill impairment charge for 2023 is correctly stated and matches the ground truth exactly. The years (2023 and 2024) are correctly identified. No calculations are required, and all numeric data is accurate. ENTITY ACCURACY: UPS, Roadie, and Supply Chain Solutions are all correctly identified. The reference to Roadie being part of the same-day delivery platform and Supply Chain Solutions segment is accurate contextual detail. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years: (1) 2023 impairment action ($56M charge), (2) 2024 monitoring stance (no new charge but identified as higher risk). The logical progression from active impairment to cautious monitoring is correctly captured. COMPLETENESS: The answer addresses both temporal points (2023 and 2024) and covers the key aspects: goodwill impairment, risk assessment, and strategic positioning. The mention of \"limited excess fair value\" aligns with the ground truth's description of \"limited excess of fair value over carrying value.\" SEMANTIC EQUIVALENCE: The LLM's phrasing \"higher risk of future impairment\" is semantically equivalent to the ground truth's \"ongoing financial risk\" and \"continued sensitivity to cost of capital and performance forecasts.\" The characterization of UPS still viewing Roadie as a strategic asset while monitoring valuation risk captures the essence of the shift from active impairment to cautious monitoring. MINOR OBSERVATIONS: The LLM adds contextual detail about \"two other units\" having similar risk profiles, which is not contradicted by the ground truth but represents additional information synthesis. The phrase \"trimming the value\" is colloquial but accurate. Overall, the answer demonstrates strong comprehension of the multi-hop financial question and provides accurate, well-reasoned synthesis of information across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 545,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "In the 2022 filing Linde makes no specific mention of helium, indicating that the gas was not material enough to be disclosed separately. By 2024 the company lists “global helium wholesale” as part of its Other segment, and lower helium volumes caused Other‑segment sales to fall $32 million (‑2%), while helium‑related costs ate into earnings, partially offsetting a $19 million (44%) rise in operating profit for that segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of helium's evolving role at Linde from 2022 to 2024, correctly identifying the shift from non-material/neutral status to a source of cost pressure. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the 2% underlying sales decrease in the Other segment\n2. Properly notes that lower helium volumes were a primary driver\n3. Accurately describes helium-related costs as a headwind\n4. Correctly mentions LAMT (Linde Advanced Materials Technology) context\n5. Appropriately characterizes the shift in helium's role from 2022 to 2024\n6. Good multi-hop synthesis connecting segment performance to helium dynamics\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: States \"$32 million (-2%)\" sales decrease. The -2% is correct, but the $32 million figure cannot be verified from the ground truth and appears to be an unsupported calculation or inference.\n2. QUANTITATIVE ERROR: Claims \"$19 million (44%) rise in operating profit for that segment.\" This specific figure and percentage are not mentioned in the ground truth, which only notes \"increased costs related to helium, partially offset by an insurance recovery for LAMT.\"\n3. The ground truth does not provide specific dollar amounts for the operating profit impact, making these figures appear fabricated or incorrectly inferred.\n4. Missing explicit mention that helium was \"a supply component\" in 2022 (though the LLM's statement about lack of disclosure is semantically similar).\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across years and connects helium volumes to segment performance, demonstrating sound multi-hop reasoning. However, the introduction of specific dollar figures ($32M, $19M) without ground truth support undermines the analysis.\n\nCONCLUSION:\nThe answer demonstrates good qualitative understanding but fails on quantitative precision by introducing unsupported numbers. The core narrative is correct, but the specific financial figures appear to be either hallucinated or incorrectly calculated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 568,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The credit‑protection agreements covered **$8.7 billion** of residential‑mortgage loans at year‑end 2023 and **$8.0 billion** at year‑end 2024 – a decline of about **$0.7 billion**【page_117】.  The lower amount in 2024 shows the Bank of America slightly reduced the pool of mortgages that are fully insured by FNMA and FHLMC, indicating a modest decrease in its credit‑risk exposure on residential‑mortgage assets while still maintaining extensive protection for the bulk of the portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $8.7 billion (2023), $8.0 billion (2024), and the calculated decline of $0.7 billion. The quantitative data matches the ground truth exactly. The answer correctly identifies the entities (FNMA and FHLMC) and time periods (year-end 2023 and 2024). The multi-hop reasoning is sound - the model synthesizes the numerical evolution and connects it to credit risk exposure implications. However, there are minor differences in depth and framing compared to the ground truth: (1) The LLM answer uses slightly different language ('fully insured' vs 'full credit protection') but conveys the same meaning; (2) The ground truth explicitly notes that 'the Corporation does not record an allowance for credit losses on these loans,' which provides important accounting context that the LLM answer omits; (3) The ground truth's interpretation about 'reduction in reliance on full credit protection for severely delinquent loans' is more specific than the LLM's more general statement about 'reduced pool of mortgages.' The LLM answer's conclusion about 'modest decrease in credit-risk exposure' is reasonable but slightly less precise than the ground truth's analysis. The inclusion of a page reference (page_117) adds credibility. Overall, the answer is substantially correct with accurate numbers and sound reasoning, but lacks some of the nuanced contextual details present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 406,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "In 2023 Adobe framed Firefly as a core competitive differentiator—an integrated generative‑AI family embedded across Creative Cloud (including Photoshop, Illustrator and Express), marketed as “safe for commercial use” with an enterprise‑level IP‑indemnification option, and positioned to set Adobe’s offering apart from rivals【page_9】【page_10】【page_11】. By 2024 the focus shifted to a risk‑aware stance: while still emphasizing its AI capabilities, Adobe stresses intensifying competition from other text‑to‑image/video providers, the threat of third‑party proprietary rights, and mounting regulatory exposure (e.g., the EU AI Act) that could raise compliance costs, liability and reputational risk for Firefly【page_23】【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: All core facts are accurate - the 2023 positioning emphasizing competitive differentiation, native integration, and commercial safety is correctly captured; the 2024 shift toward risk-aware positioning with regulatory concerns (EU AI Act) is properly identified. The mention of IP-indemnification, Creative Cloud integration (Photoshop, Illustrator, Express), and third-party competitive threats adds appropriate contextual detail not contradicting the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. Dates (2023, 2024, EU AI Act adoption in 2024) are all correct. (3) ENTITY ACCURACY: Adobe and Adobe Firefly are correctly identified; the products mentioned (Photoshop, Illustrator, Express, Creative Cloud) are accurate; the EU AI Act is correctly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years, correctly identifying the shift from competitive emphasis to risk-aware positioning. The connection between regulatory developments and strategic positioning is logically sound. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing additional supporting details (specific product names, IP-indemnification, competitive threats from text-to-image/video providers). The phrase 'risk-aware stance' effectively captures the shift described in the ground truth. Minor enhancement: The LLM provides more granular detail about competitive threats and specific products, which enriches the answer without contradicting the ground truth. The page references suggest proper source documentation. No calculation errors, date errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 515,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "In 2023 Trodelvy’s sales surged 56 % to $1.1 billion after its February FDA approval for HR⁺/HER2‑negative metastatic breast cancer, even as its Phase 3 EVOKE‑01 NSCLC trial missed its primary overall‑survival endpoint (see pages 41‑38). By 2024 the filing does not disclose new sales numbers, but the drug’s regulatory momentum continued – it received a second FDA Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer and retains U.S. regulatory exclusivity through 2032 (see pages 8‑9).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Trodelvy's evolution but contains some issues: (1) QUANTITATIVE ACCURACY: The 56% growth figure is correct. The sales figure is stated as '$1.1 billion' in the LLM answer versus '$1,063 million' ($1.063 billion) in the ground truth - this is a minor discrepancy of approximately $37 million or 3.5%, likely due to rounding differences or different reporting periods within 2023. Both are semantically equivalent for practical purposes. The 2024 regulatory milestone (second Breakthrough Therapy designation for extensive-stage small cell lung cancer) is correctly identified. (2) COMPLETENESS: The LLM answer addresses both financial performance (2023 sales growth) and regulatory trajectory (2024 Breakthrough designation), directly answering the multi-part question. It also provides additional context about the February FDA approval for breast cancer and the EVOKE-01 trial outcome, which adds relevant detail. (3) ENTITY ACCURACY: Trodelvy is correctly identified, years are correct (2023 and 2024), and the regulatory designation is accurately described. (4) REASONING: The multi-hop synthesis is sound - connecting financial growth in 2023 with regulatory advancement in 2024. The mention of regulatory exclusivity through 2032 adds valuable context. (5) ISSUES: The sales figure discrepancy ($1.1B vs $1.063B) is the primary concern, though the difference is relatively minor. The additional details about the breast cancer approval and NSCLC trial, while contextually relevant, go slightly beyond what the ground truth emphasizes, though they don't contradict it. The page references suggest the answer is sourced from actual filings, which is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 468,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron continues to hold its 36.4 % equity stake in Angola LNG Limited (as disclosed on page 85 of the 2024 filing).  In 2022 the Angola LNG affiliate generated $1.857 billion of equity earnings for Chevron (shown in the 2024 Note 15 table for 2022), but by 2024 the carrying amount of the investment had slipped to $1.665 billion (down from $1.762 billion in 2023) and equity earnings fell sharply to $405 million (down from $513 million in 2023) (page 84).  Thus, while Chevron’s ownership percentage has remained unchanged, the financial return from Angola LNG has diminished, reflecting a reduced contribution to earnings even as the company maintains its strategic position in the LNG project.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Chevron's 36.4% ownership stake in Angola LNG Limited and provides specific financial metrics with page references (pages 84-85, Note 15). The answer appropriately addresses the evolution question by comparing 2022, 2023, and 2024 figures, showing declining earnings and carrying amounts. The reasoning about maintained ownership percentage despite reduced financial returns is sound and relevant to the question.\n\nWEAKNESSES - QUANTITATIVE ACCURACY ISSUES: (1) The 2022 equity earnings figure of $1.857 billion appears problematic. The ground truth states that in 2022, Angola LNG contributed to overall equity affiliate income of $5,657 million, but does not specify that Angola LNG alone generated $1.857 billion. This specific number cannot be verified against the ground truth provided. (2) The 2023 carrying amount ($1.762 billion) and 2023 equity earnings ($513 million) are not mentioned in the ground truth, making verification impossible. (3) The 2024 carrying amount ($1.665 billion) and 2024 equity earnings ($405 million) are also not explicitly confirmed in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years (2022-2024) and connects ownership percentage to financial performance. However, the specific financial figures cited lack corroboration in the ground truth, which only confirms the 36.4% stake and general earnings contribution in 2022.\n\nSEMANTIC ALIGNMENT: The LLM answer provides more granular financial detail than the ground truth, which is positive for completeness, but introduces unverified numbers. The ground truth emphasizes 'improved income' and 'continued strategic emphasis' while the LLM emphasizes 'diminished' returns - a potentially contradictory characterization.\n\nCRITICAL GAP: The ground truth does not provide the specific year-by-year equity earnings figures ($1.857B, $513M, $405M) or carrying amounts that the LLM cites. While the LLM's analytical framework is sound, the specific numbers cannot be confirmed as accurate based on the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 565,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "Meta’s fixed‑rate senior unsecured notes rose from $18.5 billion of principal outstanding at year‑end 2023 to $29.0 billion at year‑end 2024, and their fair‑value increased from $18.48 billion to $27.83 billion. The growth reflects a new $10.5 billion issuance in August 2024 (in addition to the May 2023 issuance that produced $8.46 billion of net proceeds).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Principal outstanding amounts: $18.5B (end 2023) and $29.0B (end 2024) match ground truth exactly. (2) Fair value amounts: $18.48B and $27.83B are provided with precision, adding valuable context not in ground truth but consistent with SEC filing data. (3) Issuance dates and amounts: May 2023 issuance of $8.46B net proceeds and August 2024 issuance of $10.5B are both correct. (4) Multi-hop synthesis: The answer correctly synthesizes information across two fiscal years, identifying both the historical 2023 issuance and the 2024 activity, showing proper understanding of the evolution requested. (5) Calculation verification: The $10.5B increase from $18.5B to $29.0B is mathematically sound ($18.5B + $10.5B = $29.0B). The LLM actually provides additional valuable information (fair values) beyond the ground truth without contradicting it. The only minor distinction is that the LLM presents fair value data alongside principal amounts, which enhances rather than detracts from the answer. All entity identifications (META/Meta, Fixed-Rate Senior Unsecured Notes) are correct. The answer directly addresses how value and issuance activity evolved, covering both dimensions of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 359,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "In the 2023 filing LIN still treated helium as a routine supply – it was bundled in the $614 million “raw‑materials and supplies” balance (page 72) and only generated modest “cost‑reduction programs and other charges” of $68 million (page 72). By the 2024 filing the company re‑classified helium as a dependency, the raw‑materials‑and‑supplies balance fell to $529 million (page 62) while the related cost‑reduction charge jumped to $175 million (page 63), signalling a higher cost exposure and greater reliance on helium.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Critical issues: (1) QUANTITATIVE ERRORS: The ground truth specifies helium costs as 4.2% of raw material expenses in 2023 and 6.8% in 2024 - these are the key metrics requested. The LLM answer provides completely different numbers ($614M, $529M, $68M, $175M) that appear to reference raw materials and supplies balances and cost-reduction charges, NOT helium-specific cost percentages. These are different metrics entirely and do not answer the question about helium's financial exposure as a percentage of raw materials. (2) MISSING CORE DATA: The LLM fails to provide the specific helium cost percentages (4.2% vs 6.8%) that are central to demonstrating how financial exposure changed. Instead, it pivots to unrelated balance sheet items. (3) MULTI-HOP REASONING FAILURE: The question asks for 'specific cost or sourcing disclosures' about helium's changing role. The ground truth correctly identifies the shift from 'supply' categorization to 'dependency' AND quantifies this with helium cost percentages. The LLM mentions the categorization shift but provides irrelevant financial data that doesn't support the answer. (4) SEMANTIC MISMATCH: While the LLM correctly identifies that helium's status changed from supply to dependency, it fails to substantiate this with the actual cost exposure metrics that prove the increased financial importance. The numbers cited ($614M, $529M, etc.) are not helium-specific costs and therefore do not demonstrate the claimed 'higher cost exposure.' (5) VERIFICATION: The ground truth's 4.2% to 6.8% increase in helium costs as a percentage of raw materials directly answers how financial exposure changed. The LLM's numbers cannot be verified as helium-specific metrics and appear to be general balance sheet figures misapplied to answer a helium-specific question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 511,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s management cut the amount of European customer balances that could be used for credit activities from **$3.8 billion at 12/31/2022 to $3.0 billion at 12/31/2023**【page_49】. That $0.8 billion reduction equals a **≈21 % decline** in the approved amount (‑0.8 ÷ 3.8 ≈ ‑21 %). During the same period the share of European balances earmarked for credit rose modestly from about **37 % to 39 %** of the total available.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) 2022 approved amount of $3.8 billion - correct; (2) 2023 approved amount of $3.0 billion - correct; (3) 2022 percentage of 37% - correct; (4) 2023 percentage of 39% - correct. The calculation of the percentage change is accurate: ($3.0B - $3.8B) / $3.8B = -$0.8B / $3.8B ≈ -21%, which is correctly computed and presented. The LLM successfully synthesized multi-hop information by: (a) comparing the absolute amounts across two years, (b) calculating the percentage decline, (c) noting the percentage of balances increased despite absolute amount decreasing, and (d) interpreting this as a more conservative approach. The answer addresses all parts of the question: evolution of utilization (shown through both absolute and percentage metrics), and the percentage change (21% decline). The reasoning is sound and the interpretation that this represents a more conservative approach aligns with the ground truth. Minor note: The LLM uses slightly different phrasing ('cut the amount' vs 'decreased') but this is semantically equivalent and actually more direct. The citation reference [page_49] adds credibility. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 348,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks’ “foreign‑currency – other” hedge portfolio shrank sharply.  The fair‑value of designated foreign‑currency‑other derivative assets fell from roughly $32 million in prepaid/current assets plus $22.9 million in long‑term assets in 2023 (≈ $55 million total) to just $1.9 million and $1.7 million respectively in 2024 – a drop to about $3.6 million of fair‑value exposure【page_72】.  At the same time, the net amount the company expects to reclassify from AOCI into earnings within the next 12 months fell to $9.5 million in 2024, down from the much larger $39.6 million AOCI balance (and higher expected reclassification) it reported for 2023【page_70】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. Critical issues: (1) FAIR VALUE NUMBERS ARE WRONG: The LLM reports fair values of approximately $55 million in 2023 and $3.6 million in 2024 by summing balance sheet line items. However, the ground truth clearly states the fair value was $1,164 million in 2023 and $920 million in 2024 - a massive discrepancy (off by a factor of 20+). The LLM appears to have confused balance sheet asset positions with the total fair value of the derivative portfolio. (2) AOCI GAIN MISREPORTING: The LLM conflates the net gain in AOCI ($39.6 million in 2023) with the expected reclassification amount ($55.3 million in 2023), treating them as if they're the same metric. The ground truth distinguishes these: the net gain in AOCI was $39.6M in 2023 (dropping to $11.5M in 2024), while the expected reclassification was $55.3M in 2023 (dropping to $9.5M in 2024). (3) INCOMPLETE ANSWER: The LLM fails to report the 2024 net gain in AOCI ($11.5 million), which is a key metric requested in the question about 'fair value and expected reclassification impact.' (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution between 2023-2024 across three dimensions (fair value, AOCI gains, and reclassification impact). The LLM only partially addresses the reclassification impact correctly ($9.5M in 2024) but fundamentally misses the fair value evolution and AOCI gain evolution. The reasoning appears to conflate different line items from the balance sheet rather than synthesizing the comprehensive derivative portfolio metrics. The only correct number in the LLM answer is the $9.5 million expected reclassification for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 468,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "In 2023 Alabama Power reported $15 million of energy‑related derivative assets and $110 million of liabilities, while Georgia Power reported $13 million of assets and $124 million of liabilities (both shown in the 2023 subsidiary table)【page_281】. The prior‑year filing did not disclose separate balances for the two utilities – only a consolidated $199 million of assets and $210 million of liabilities for the company as a whole (2022)【page_283】 – so both subsidiaries moved from a net‑asset/neutral position in 2022 to a net‑liability position in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all 2023 figures for both utilities (Alabama Power: $15M assets/$110M liabilities; Georgia Power: $13M assets/$124M liabilities). The directional analysis is sound - both companies shifted toward liability positions. The answer appropriately notes the lack of separate 2022 subsidiary-level disclosure. CRITICAL WEAKNESSES: (1) The LLM failed to provide the specific 2022 subsidiary-level data that was available in the ground truth (Alabama Power: $55M assets/$11M liabilities; Georgia Power: $75M assets/$8M liabilities). The ground truth explicitly states these figures were reported in 2022, contradicting the LLM's claim that 'the prior-year filing did not disclose separate balances.' (2) The LLM's statement about consolidated 2022 figures ($199M assets/$210M liabilities) appears to be an alternative data point but doesn't address the actual subsidiary-level 2022 data that should have been included. (3) The answer is incomplete - it addresses only the 2023 position and makes a vague reference to 2022 without providing the specific comparative numbers requested. The question explicitly asks 'how did...evolve from 2022 to 2023,' requiring year-over-year comparison with specific figures for both years. QUANTITATIVE ISSUES: Missing Alabama Power 2022 ($55M/$11M) and Georgia Power 2022 ($75M/$8M) data points entirely. The characterization of 2022 as 'net-asset/neutral position' is imprecise and unsupported by the specific subsidiary figures. REASONING: The multi-hop synthesis is partially correct for 2023 but fails on the temporal comparison aspect. The answer demonstrates good understanding of the directional shift but lacks the complete data foundation needed for a comprehensive evolution analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 479,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was invested roughly 65 % in fixed‑income securities and cash equivalents and 35 % in equity securities. By year‑end 2023 the mix had shifted to about 80 % fixed‑income and 20 % equity, reflecting a move toward a higher‑weight, more conservative fixed‑income allocation【page_49†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2022 allocation of 65% fixed income/35% equity, and 2023 allocation of 80% fixed income/20% equity. The answer correctly identifies the U.S. Retiree Health Care Plan and accurately describes the evolution of the asset allocation strategy across both years. The reasoning is sound - the model correctly synthesizes the multi-hop information by comparing allocations across two years and drawing the appropriate conclusion about the shift toward a more conservative strategy. The characterization of the 2023 allocation as 'higher-weight, more conservative fixed-income allocation' is semantically equivalent to the ground truth's description of 'a shift toward a more conservative investment strategy.' The answer is well-structured, addresses all parts of the question, and includes appropriate source attribution. Minor note: The LLM uses 'roughly' and 'about' which adds appropriate hedging language, though the ground truth presents the numbers as exact percentages. This is a stylistic choice that doesn't detract from accuracy. No calculation errors, no missing entities, and the multi-hop synthesis across 2022 and 2023 data is executed correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 355,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "In the 2022 Form 10‑K, Trodelvy (sacituzumab govitecan‑hziy) was already FDA‑approved for metastatic triple‑negative breast cancer and metastatic urothelial cancer, while its study in hormone‑receptor‑positive/HER2‑negative (HR⁺/HER2‑) breast cancer and non‑small‑cell lung cancer was still listed as a Phase 3 investigation【page_6】. By 2023 the product’s label expanded: Gilead received FDA approval (and, separately, European Commission approval) for Trodelvy as a monotherapy in adult patients with unresectable or metastatic HR⁺/HER2‑ breast cancer who have progressed after endocrine‑based therapy and at least two additional systemic regimens, adding this new indication to its approved uses【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 status correctly identifies Trodelvy's two approved indications - metastatic TNBC and metastatic urothelial cancer, matching the ground truth exactly. (2) 2023 expansion correctly identifies the new HR+/HER2- breast cancer indication with the precise patient population criteria (unresectable or metastatic, progressed after endocrine-based therapy and at least two additional systemic regimens). (3) The answer correctly notes both FDA and EC approvals were granted in 2023. (4) The mention of Phase 3 investigation in NSCLC provides additional context not contradicting the ground truth. The multi-hop reasoning is sound - the answer successfully synthesizes information across 2022 and 2023 filings to show the evolution of regulatory status. Minor semantic differences from ground truth are acceptable: 'progressed after endocrine-based therapy' is semantically equivalent to 'received endocrine-based therapy,' and 'at least two additional systemic regimens' matches 'at least two additional systemic therapies.' All numeric values, dates, and entity names (Trodelvy, sacituzumab govitecan-hziy, Gilead, FDA, EC) are correct. The answer directly addresses both parts of the question: how the status evolved and what new indications were granted. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 388,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "- 2023 10‑K – Meta warned that “if people do not perceive our products to be useful, reliable, and trustworthy… we may not be able to attract or retain users… Any decrease in user retention, growth, or engagement could render our products less attractive… and have a material and adverse impact on our ability to deliver ad impressions and, accordingly, our revenue” (2023 p. 16) and listed “decreases in user sentiment due to questions about the quality or usefulness of our products… concerns about privacy, safety, security, well‑being, or other factors” as a specific risk (2023 p. 17).  \n\n- 2024 10‑K – The risk language shifted to a broader reputational angle, stating that “any acquisitions or other strategic transactions we announce could be viewed negatively by users, marketers, developers, or investors, which may adversely affect our business or the price of our Class A common stock” (2024 p. 35), focusing on perception of corporate actions rather than direct product‑level user perception.  \n\nThus, the disclosure moved from emphasizing how users’ perception of product usefulness, trustworthiness and data practices could directly cut engagement and ad revenue, to highlighting how negative perception of strategic moves (e.g., acquisitions) could harm overall business performance and stock valuation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Meta's risk disclosure evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on user perception risks related to product usefulness, trustworthiness, privacy, safety, and data practices; (2) Accurately captures the 2024 shift toward acquisition/strategic transaction risks and reputational concerns; (3) Properly synthesizes the multi-hop comparison showing how risk emphasis changed from direct product-level user perception to broader corporate action perception; (4) Provides specific page references (2023 p. 16-17, 2024 p. 35) demonstrating document grounding; (5) Correctly identifies the connection between user perception and business impact (ad impressions, revenue, stock price). MINOR WEAKNESSES: (1) The ground truth mentions 'integration challenges from acquisitions, tax liabilities, and investor sentiment' as 2024 focus areas, but the LLM answer emphasizes acquisitions/strategic transactions more heavily while not explicitly mentioning tax liabilities or investor sentiment as separate risk factors; (2) The ground truth notes 'explicit mention of user perception as a direct risk factor was notably reduced in 2024' - the LLM captures this shift but could have been more explicit about the reduction/de-emphasis; (3) The LLM answer focuses primarily on acquisitions as the 2024 shift rather than acknowledging the broader operational/financial risks mentioned in ground truth. QUANTITATIVE ACCURACY: No numerical errors detected; page references appear reasonable for 10-K documents. REASONING: The multi-hop synthesis is sound - correctly comparing 2023 vs 2024 disclosures and identifying the strategic shift in risk communication. The logic connecting product perception to revenue impact in 2023 and acquisition perception to stock price in 2024 is accurate. SEMANTIC EQUIVALENCE: The answer conveys the core finding that Meta's risk disclosure shifted from product-level user perception concerns to broader corporate action perception concerns, which aligns with the ground truth's assertion of a 'strategic shift in how Meta communicated its risk profile.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 579,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Lockheed Martin’s interest‑rate swap notional grew from about **$500 million at 12/31/2021** (versus $572 million in 2020) to **$1.3 billion at 12/31/2024 (and 2023)**【page_66】【page_52】. The more‑than‑two‑fold increase shows the company has markedly expanded its swap program, using variable‑rate swaps to hedge a larger portion of its debt and indicating a more proactive, robust approach to managing interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The key figures are correct - $500 million at 12/31/2021 and $1.3 billion at 12/31/2024 match the ground truth exactly. The additional context about 2020 ($572 million) and 2023 ($1.3 billion) adds helpful detail without contradicting the ground truth. The characterization of 'more-than-two-fold increase' is mathematically accurate (1.3B/0.5M = 2.6x). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of notional amounts across the time period, and (2) what this indicates about interest rate risk management strategy. ENTITY ACCURACY: Lockheed Martin is correctly identified, the metric (variable interest rate swaps notional amount) is correct, and the years (2021, 2023, 2024) are properly specified. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the numerical growth to strategic implications (converting fixed-rate to variable-rate borrowings, proactive risk management). The interpretation aligns with the ground truth's assessment of 'significant shift' and 'growing emphasis.' MINOR CONSIDERATIONS: The LLM provides slightly more interpretive language ('markedly expanded,' 'more proactive, robust approach') compared to the ground truth's more measured tone, but this represents reasonable analytical interpretation rather than factual error. The inclusion of page references adds credibility. The answer is semantically equivalent to the ground truth while providing additional supporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 433,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal kept its Seller Protection Programs in place, but it trimmed the reserve for transaction losses – the allowance fell from $66 million at 12/31/2022 to $64 million at 12/31/2023. At the same time the annual provision for those losses rose modestly (to $1.192 billion in 2023 from $1.170 billion in 2022) and realized losses dropped, leaving the year‑end allowance essentially unchanged at roughly $280 million【page_113】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not present in the ground truth. Critical issues: (1) MAJOR DISCREPANCY: The LLM states the year-end allowance was 'roughly $280 million' which contradicts the ground truth showing $64 million at 12/31/2023. This is a fundamental error of approximately $216 million. (2) UNSUPPORTED NUMBERS: The LLM introduces provision amounts ($1.192 billion in 2023, $1.170 billion in 2022) and references to 'realized losses' that are not mentioned in the ground truth answer. These appear to be fabricated or from a different context. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the allowance decrease from $66 million (2022) to $64 million (2023), which matches the ground truth. (4) MISSING CONTEXT: The LLM fails to address the key evolution described in the ground truth - the shift from qualitative risk assessment in 2022 (0.09%-0.15% TPV loss rates) to more structured financial disclosures in 2023. (5) MULTI-HOP REASONING: The answer does not properly synthesize the evolution of PayPal's approach between the two years as requested. The ground truth emphasizes a methodological shift in how PayPal disclosed and managed seller protection risk, which the LLM answer completely misses. The citation reference [page_113] suggests the LLM may be pulling from a different source document than the ground truth knowledge graph. The core answer structure is fundamentally flawed due to the $280 million figure, which appears to be either a misreading or hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 425,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks’ foreign‑currency‑other derivative assets collapsed – the current‑asset portion fell from $32.0 million in FY 2023 to $1.9 million in FY 2024 and the long‑term portion fell from $22.9 million to $1.7 million, a total drop of about $51 million (from $54.9 million to $3.6 million)【page_72】.  At the same time, the related liabilities rose – accrued liabilities grew from $2.0 million to $4.7 million and a new $4.1 million long‑term liability appeared, increasing total liabilities by roughly $6.8 million (from $2.0 million to $8.8 million)【page_72】.  Overall, the net foreign‑currency‑other derivative position on the balance sheet shrank by roughly $44 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significantly different numbers than the ground truth, suggesting it may be referencing different line items or misinterpreting the data structure. CRITICAL ERRORS: (1) Ground truth states derivative assets were $1,164 million in FY2023 declining to $1.9 million in FY2024. LLM claims current-asset portion was $32.0M (FY2023) to $1.9M (FY2024) and long-term was $22.9M to $1.7M, totaling $54.9M to $3.6M. These numbers do not reconcile with the ground truth's $1,164M starting position. (2) The LLM's total asset decline calculation ($51M) is vastly different from the ground truth decline ($1,162.1M). (3) For liabilities, ground truth shows $2.0M (FY2023) to $4.7M (FY2024), a $2.7M increase. LLM claims $2.0M to $8.8M (including a new $4.1M long-term liability), a $6.8M increase. The appearance of a $4.1M long-term liability is not mentioned in ground truth. (4) The LLM's net position calculation of a $44M shrinkage is inconsistent with both the asset decline and liability increase figures presented. REASONING ISSUES: While the LLM attempts to break down current vs. long-term components and calculate net changes, the underlying numbers appear to come from a different source or misinterpretation of the balance sheet structure. The ground truth clearly states a single $1,164M derivative asset figure for FY2023, not a split between current and long-term portions totaling $54.9M. CONCLUSION: The answer demonstrates an attempt at comprehensive analysis with multi-hop reasoning, but the fundamental numerical data is incorrect, making the entire response unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 447,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "In 2022 Southern Company’s energy‑related cash‑flow hedges produced a **$37 million gain** on the cost of natural gas, while the non‑designated derivative impact on natural‑gas revenues was a **$11 million loss**. By 2023 the cash‑flow hedge result had **reversed to a $44 million loss** on natural‑gas cost, and the revenue‑hedge impact was essentially neutral (no material gain or loss), with the non‑designated hedge on natural‑gas cost turning to a **$59 million gain** after a $65 million loss in 2022【page_294†L9-L15】【page_295†L9-L15】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. Specific errors: (1) 2022 natural gas cost impact: LLM states $37 million gain, but ground truth shows $27 million negative impact - completely wrong direction and magnitude; (2) 2022 revenue impact: LLM states $11 million loss, but ground truth shows $117 million negative impact - off by a factor of ~10; (3) 2023 natural gas cost impact: LLM states $44 million loss, but ground truth shows $59 million gain - wrong direction entirely; (4) The LLM introduces additional complexity with cash-flow hedges vs non-designated derivatives and a $65 million loss in 2022 that doesn't appear in the ground truth. The ground truth is clear and simple: 2022 had -$117M revenue impact and -$27M cost impact; 2023 had $0 revenue impact and +$59M cost impact. The LLM's answer appears to reference different derivative categories or misread the source documents entirely. The multi-hop synthesis is fundamentally broken - the model failed to correctly extract and compare the year-over-year evolution of these metrics. The answer does address the right company (Southern Company) and general topic area, but the specific financial data is almost entirely incorrect, making this response unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 368,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "In Walmart’s 2023 Form 10‑K the Deferred Compensation Matching Plan was only incorporated by reference to Exhibit 10.1 (no asterisk, not attached) and described as “as amended and restated effective November 8, 2023”【page_84】. By the 2024 Form 10‑K the plan is still listed as Exhibit 10.1 but now carries an asterisk indicating it is filed herewith as an exhibit (i.e., attached)【page_84 (asterisk version)】, and the amendment’s effective date remains November 8, 2023【page_84】.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally contradicts the ground truth on the core evolution being asked about. Ground Truth states: In 2023, the plan was 'newly introduced' and by 2024 it was 'no longer labeled as newly introduced but was instead referenced as being incorporated by reference.' LLM Answer states the OPPOSITE: In 2023 it was 'only incorporated by reference' and by 2024 it 'now carries an asterisk indicating it is filed herewith as an exhibit (i.e., attached).' These are contradictory characterizations of the documentation status evolution. The LLM appears to have inverted the relationship between the two years. NUMERIC ACCURACY: The date November 8, 2023 is correctly stated in both answers and matches across years (9/10 for dates). MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution of the plan's treatment across the two filing years. The ground truth describes a shift from 'newly introduced' status to 'established/incorporated by reference' status, while the LLM describes a shift from 'incorporated by reference' to 'filed herewith/attached' status. These are fundamentally different narratives. ENTITY ACCURACY: Walmart, the plan name, and the years are correctly identified (8/10). SEMANTIC EQUIVALENCE: The wording differs significantly and conveys opposite meanings regarding the documentation evolution. The LLM's characterization of the 2023 treatment (incorporated by reference only) contradicts the ground truth's characterization (newly introduced). This is not a minor wording difference but a factual inversion of the key finding. The answer demonstrates a misunderstanding of how the plan's status evolved between filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 463,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "In the 2023 filing the company noted that “potentially dilutive securities include … long‑term incentive performance units, or LTIP units… No securities had a material dilutive effect” and that “we accrue dividends when they are declared” (per‑share) and “we accrue distributions when they are declared” (operating‑partnership)【page_111】【page_112】. The 2024 filing repeats the same language – LTIP units are still listed as potentially dilutive but “had no material dilutive effect” for 2024, and the company continues to accrue dividends and distributions when declared【page_114】. Thus, the disclosure and treatment of LTIP units have not changed; they remain non‑material for dilution and the accrual policy is unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that LTIP Units are potentially dilutive securities in both 2023 and 2024 filings; (2) Accurately states no material dilutive effect was reported for both years; (3) Correctly cites the accrual policy (dividends/distributions accrued when declared) for both periods; (4) Properly synthesizes the multi-hop comparison showing consistency between years; (5) Includes specific page references (111, 112, 114) that ground the answer in source material; (6) Correctly concludes that treatment remained stable with no significant changes. The answer directly addresses all parts of the question: disclosure evolution, dilutive effect, and accrual policy. Quantitative accuracy is perfect - no numbers, dates, or metrics are incorrect. The reasoning is sound, comparing 2023 and 2024 filings and identifying the lack of material change. Minor consideration: The answer could have been slightly more explicit about the specific years covered in each filing's dilution analysis (2023 filing covered 2023/2022/2021; 2024 filing covered 2024/2023/2022), though this level of detail is not essential to answering the core question. The semantic equivalence is strong - the LLM's conclusion that 'disclosure and treatment of LTIP units have not changed' matches the ground truth's statement that 'treatment of LTIP Units remained stable with no significant change.' Overall, this is a comprehensive, accurate answer that successfully synthesizes information across multiple filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 431,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "In its 2023 Form 10‑K Meta said it was appealing the Irish Data Protection Commission’s €1.2 bn fine over its SCC‑based transfers and was taking corrective steps to bring its processing into line with the newly adopted EU‑U.S. Data Privacy Framework and the July 2023 adequacy decision (2023 p.10‑11). By the 2024 filing Meta still relies on the DPF but has broadened its compliance program – it has moved to a consent‑based advertising model, launched a “subscription for no ads” option, and is actively engaging with EU regulators in DMA proceedings while continuing to monitor the DPF’s legal stability and implement any additional steps required (2024 p.10‑11).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the €1.2 billion fine, the July 2023 adequacy decision date, and the November 2023 'subscription for no ads' launch. The numeric and temporal details are accurate. However, there are notable gaps in completeness and qualitative synthesis: (1) The LLM answer omits the critical detail about the Irish DPC's directive to suspend unlawful data transfers under SCCs, which was a key enforcement action in 2023. (2) The answer mentions the 'subscription for no ads' model but does not explicitly connect it to the November 2023 introduction timing or clearly articulate that this was Meta's response to the corrective orders. (3) Most significantly, the LLM answer fails to mention the European Commission's July 2024 preliminary findings of non-compliance with the DMA regarding this model - a crucial evolution showing regulatory escalation. The ground truth emphasizes this shift from foundational DPF compliance to complex DMA scrutiny, but the LLM answer only vaguely references 'DMA proceedings' without specifying the July 2024 preliminary findings. (4) The LLM answer correctly identifies the multi-hop evolution (2023 corrective orders → 2024 new business models → regulatory scrutiny) but incompletely captures the regulatory escalation trajectory. The answer is directionally correct and contains accurate core facts, but omits important regulatory developments that are central to understanding how Meta's compliance approach evolved, particularly the shift from data transfer compliance to business model compliance scrutiny.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 444,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "In the 2023 filing Linde said that green hydrogen could be made either by electro‑lysis powered with renewable electricity **or** by steam‑methane reforming of biomethane (2023 10‑K p. 4). By the 2024 filing the company had narrowed its definition to renewable hydrogen produced **solely** by electro‑lysis using renewable energy and water, dropping the biomethane route and placing a stronger emphasis on clean‑energy power sources (2024 10‑K p. 4).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer fundamentally misrepresents the evolution of Linde's approach. The ground truth states that in 2024, Linde expanded its description to include green hydrogen produced by electrolysis using renewable energy AND water as feedstock, while ALSO maintaining the biomethane steam methane reforming option as part of its green hydrogen portfolio. The LLM incorrectly claims Linde 'narrowed its definition' and 'dropped the biomethane route' - this is the opposite of what actually occurred. The ground truth explicitly states the company 'expanded its description' and differentiated green from blue hydrogen, not that it eliminated production methods. POSITIVE ASPECTS: (1) Correctly identifies 2023 and 2024 as the comparison years, (2) Accurately notes the 2023 definition included both electrolysis and biomethane steam methane reforming, (3) Correctly identifies electrolysis with renewable energy as a 2024 component, (4) Appropriately cites page 4 of both 10-K filings. MAJOR ISSUES: (1) The characterization of the change as 'narrowing' rather than 'expanding' is factually incorrect, (2) The claim that biomethane route was 'dropped' contradicts the ground truth which indicates it remained part of the offering, (3) Missing the key point about carbon intensity metrics becoming more emphasized in 2024, (4) The use of 'solely' to describe the 2024 approach is incorrect - the ground truth indicates both methods remained available. The answer demonstrates partial understanding of the timeline and some correct details, but the fundamental interpretation of the directional change (expansion vs. narrowing) is inverted, making this a significantly flawed response despite some accurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 477,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company sold its Sequent wholesale‑gas business (completed July 1, 2021); the 2022 filing notes that the transaction produced a pre‑tax gain of about $121 million (≈$92 million after‑tax) and $85 million of additional tax expense, and that wholesale gas services ceased to be a reportable segment【page_57】. The 2023 filing confirms that, because of the Sequent sale, wholesale gas services is no longer a reportable segment in 2023 (or 2022) and continues to reflect the same $121 million pre‑tax gain and $85 million tax expense from the sale【page_302】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the timing of the Sequent sale. The LLM states the sale was 'completed July 1, 2021' and references 2022 filing notes, but the ground truth clearly indicates the sale occurred in 2022 (Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million in 2022). This is a major chronological error that undermines the entire answer's credibility. QUANTITATIVE ISSUES: (1) The LLM correctly identifies the $121 million pre-tax gain and $85 million additional tax expense, which match the ground truth. (2) However, the LLM provides an after-tax figure of approximately $92 million, which is not mentioned in the ground truth and appears to be an unsupported calculation. (3) Most critically, the LLM omits the $159 million sale price, which is a key financial metric in the ground truth. COMPLETENESS PROBLEMS: The LLM fails to address the core question about how the relationship 'evolved between 2022 and 2023.' Instead, it discusses the 2021 sale and then notes that 2023 reflects the same prior-year impacts. The ground truth emphasizes the evolution from ownership in 2022 to completed divestiture in 2023, showing a clear progression. The LLM's answer suggests the transaction was already complete before 2022, which contradicts the ground truth timeline. REASONING ISSUES: The multi-hop synthesis is flawed because the LLM misidentifies when the transaction occurred, making the comparison between 2022 and 2023 meaningless. The answer correctly notes that wholesale gas services ceased to be a reportable segment, but this is presented as a consequence of a 2021 transaction rather than a 2022 transaction. SEMANTIC ISSUES: While the LLM correctly identifies some financial metrics, the fundamental dating error and omission of the $159 million sale price represent significant factual gaps that prevent the answer from accurately conveying the ground truth information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 536,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart’s 2023 10‑K lists Allswell among its U.S. private‑brand lines, and the 2024 filing again includes Allswell in the same private‑brand roster (see page 7 in both filings). The brand’s continued presence shows that Walmart has not altered its relationship with Allswell – it remains a core private label – signalling that Walmart is deliberately keeping Allswell as part of its broader private‑brand strategy to reinforce everyday low‑price leadership and capture higher margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The LLM correctly identifies that Allswell appears in both 2023 and 2024 10-K filings, (2) The reference to page 7 in both filings is plausible and specific, (3) The conclusion that Allswell remains a core private label is factually sound. PROBLEMATIC ASPECTS: (1) The LLM claims Allswell was 'listed among' private brands in 2023, but the ground truth indicates it was 'introduced' in 2023, suggesting it was NEW that year - this is a subtle but important distinction about the nature of its presence, (2) The LLM states there was 'no alteration' in the relationship, but the ground truth explicitly describes an 'evolution' from 'newly introduced' to 'more established' - this misses the key narrative of progression and maturation, (3) The LLM adds interpretive language about 'reinforce everyday low-price leadership and capture higher margins' that goes beyond what the ground truth supports - this is speculation not grounded in the filing data provided, (4) The ground truth emphasizes that Allswell 'transitioned' and 'gained traction,' implying a meaningful evolution, while the LLM characterizes it as static ('has not altered'). MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution aspect - it treats 2023 and 2024 as equivalent snapshots rather than capturing the progression from new introduction to established brand. The question specifically asks 'how has...evolved' and the LLM's answer of 'no alteration' directly contradicts the ground truth's narrative of evolution. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. SEMANTIC EQUIVALENCE: While the LLM conveys that Allswell remains important, it misses the core insight about brand maturation and strategic positioning evolution that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 514,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "In 2023 Texas Instruments’ Embedded‑Processing revenue rose to $3.37 billion, a 3 % increase over the $3.26 billion earned in 2022, and its share of total revenue grew from roughly 16 % of $20.0 billion to about 19 % of $17.5 billion [page_20]. The 2023 MD&A reiterates that analog and embedded‑processing products are the core of TI’s business model and a primary driver of cash‑flow generation, emphasizing that this segment remains a central strategic focus [page_19][page_18].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data that is largely accurate and well-supported. Verification of key numbers: (1) Embedded Processing revenue of $3.37B in 2023 and $3.26B in 2022 appears correct based on the cited page references; (2) The 3% increase calculation is accurate ($3.37B vs $3.26B = ~3.4% increase, close to stated 3%); (3) Total revenue figures of $20.0B (2022) and $17.5B (2023) are correct; (4) Percentage calculations: 2022 share of ~16.3% ($3.26B/$20.0B) and 2023 share of ~19.3% ($3.37B/$17.5B) are accurate. The LLM successfully synthesizes multi-hop information by comparing year-over-year revenue, calculating market share percentages, and connecting this to strategic emphasis statements from MD&A sections. The answer directly addresses the evolution question by showing both absolute growth and relative importance growth. Minor weakness: The original ground truth emphasizes the 'compensatory role' of Embedded Processing offsetting Analog decline, which the LLM answer doesn't explicitly highlight, though it does note the segment 'remained a central strategic focus.' The LLM provides more granular financial detail than the ground truth, which is appropriate and adds value. All entities (TXN, Embedded Processing, years 2022-2023) are correctly identified. The reasoning connecting revenue growth to strategic importance is sound and well-documented with page citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 392,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "In 2022 Chevron’s Angola LNG affiliate was listed as part of its production portfolio and generated $1,857 million of equity earnings (see page 8 and the equity‑earnings line for Angola LNG in page 84). By 2024 the investment balance had fallen to $1,665 million and equity earnings to $405 million, although Chevron still owns a 36.4 % stake in the project (see page 84 and the ownership‑percentage note in page 85), indicating that while the company retains a sizable LNG foothold, the Angola LNG asset’s contribution to earnings has weakened, suggesting a strategic re‑balancing toward other LNG opportunities or market‑driven adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed financial information than the ground truth but contains significant quantitative accuracy issues that undermine its credibility. STRENGTHS: (1) Correctly identifies the 36.4% stake in Angola LNG as of 2024, matching ground truth; (2) Appropriately addresses the evolution question by comparing 2022 vs 2024 positions; (3) Provides reasonable strategic interpretation about re-balancing and market adjustments; (4) Attempts multi-hop synthesis by combining equity earnings, investment balance, and ownership percentage. CRITICAL ISSUES: (1) The specific financial figures cited ($1,857M equity earnings in 2022, $1,665M investment balance in 2024, $405M equity earnings in 2024) cannot be verified against the ground truth provided, which does not include these specific numbers. The ground truth only mentions 'production volumes' in 2022 and '36.4% interest' in 2024, without citing the equity earnings or investment balance figures. (2) The LLM provides page references (pages 8, 84, 85) that suggest these are from actual SEC filings, but without access to verify these specific numbers, their accuracy is questionable. (3) The dramatic decline in equity earnings from $1,857M to $405M is a significant claim that requires verification. REASONING QUALITY: The logical progression from financial decline to strategic re-balancing is sound, but it's built on unverified quantitative claims. The answer goes beyond the ground truth by adding financial metrics, which could be either valuable additional context or potentially incorrect information. The core strategic positioning insight (formalized equity stake, stable LNG position) aligns with ground truth, but the financial deterioration narrative is not supported by the provided ground truth. MULTI-HOP SYNTHESIS: The answer attempts to synthesize ownership percentage with financial performance metrics, which is appropriate for the question, but the unverified numbers create uncertainty about the validity of this synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 544,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "In 2021 the CH‑53K helped lift RMS’s overall sales by $540 million (the bulk of the $794 million RMS net‑sales increase) and added roughly $140 million of operating profit through higher production volume and risk retirements for the Sikorsky helicopter line【page_50】. By 2024 the filing notes that “higher production volume on CH‑53K program” was a key driver of the segment’s higher product‑sales growth, signalling a continued production ramp‑up even though a specific dollar amount is not disclosed【page_34】. Together, these trends show the CH‑53K moving from an early‑stage sales contributor in 2021 to a core, growth‑driving program that underpins RMS’s helicopter portfolio and overall revenue outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key financial metrics and program evolution. STRENGTHS: (1) All quantitative data is accurate - correctly cites $540 million RMS net sales increase in 2021, $140 million operating profit contribution, and identifies the 2024 production ramp-up phase. (2) Proper multi-hop synthesis across years (2021 vs 2024) showing program evolution from early-stage to mature production. (3) Correctly identifies the CH-53K's role within RMS helicopter portfolio and its growth-driving status. (4) Appropriately notes that 2024 filing doesn't disclose specific dollar amounts while still capturing the production ramp-up narrative. (5) Good contextual framing of the transition from 'developing program with growing financial impact' to 'key growth driver.' MINOR WEAKNESSES: (1) The original answer explicitly states the 2024 contribution was '$1.1 billion to higher product sales' - the LLM answer acknowledges no specific dollar amount is disclosed in 2024, which is technically more cautious but misses the ground truth's explicit $1.1 billion figure. This is a notable omission since the original answer clearly provides this metric. (2) The LLM answer could have been more explicit about the magnitude of growth from 2021 to 2024 (roughly doubling from $540M to $1.1B in product sales contribution). CALCULATION VERIFICATION: All 2021 figures are correct ($540M sales, $140M operating profit). The reasoning about production volume and risk retirements is sound. The characterization of program evolution is semantically equivalent to ground truth. The main gap is the missing $1.1 billion 2024 figure, which represents incomplete information synthesis despite otherwise strong analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 477,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "In the 2022 filing PayPal said its revolving‑credit loss curves were built on historical loss data plus macro‑economic inputs of **forecasted unemployment trends and benchmark credit‑card charge‑off rates**, applying a **≈ 2‑year forecast horizon** for the revolving portfolio【page_54】. By the 2023 filing the company had **expanded the macro‑economic assumptions** to also include **forecasted household disposable‑income and retail e‑commerce sales** (while still using unemployment through Q1 2023), **lengthened the forecast period to roughly 5 years + (about 5 years 7 months)**, and updated the revolving‑credit loss models in Q2 2023 (the changes were not material)【page_70】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PayPal's macroeconomic factors between 2022 and 2023, capturing the key shift from unemployment/charge-off rates to household disposable income and retail e-commerce sales. The qualitative accuracy is strong - the answer properly synthesizes the multi-hop information about how the models changed and correctly notes that unemployment was used through Q1 2023 before being replaced. However, there are quantitative accuracy issues: (1) The LLM introduces specific forecast horizon numbers (≈2-year in 2022, 5 years 7 months in 2023) that are not present in the ground truth answer. These appear to be added details not verified against the original filings. (2) The ground truth does not mention a lengthening of the forecast period or provide specific timeframe numbers, so these additions are potentially inaccurate or unsupported. (3) The statement about changes being 'not material' is an interpretation not explicitly stated in the ground truth. The core facts are correct: the macroeconomic factors did evolve as described, unemployment was used through Q1 2023, and new factors (household disposable income, retail e-commerce sales) were added. The answer demonstrates good multi-hop reasoning by connecting 2022 and 2023 filings and explaining the transition. The main weakness is the introduction of specific numerical details about forecast horizons that cannot be verified against the ground truth provided, which reduces quantitative accuracy despite the qualitative understanding being sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 429,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks recorded **$135.2 million** of net gains on foreign‑currency‑denominated debt in AOCI for fiscal 2024, down from **$140.2 million** in fiscal 2023 – a decline of about **$5 million**. The lower gain indicates that the impact of foreign‑currency fluctuations on its hedged debt was slightly reduced, suggesting a modest easing of exposure (or more effective hedging) to currency movements in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and reverses the actual financial narrative. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2024 was $135.2M (correct) but claims 2023 was $140.2M (INCORRECT - ground truth shows 2023 was a LOSS of $6.3M, not a gain of $140.2M). The LLM's calculation of a $5M decline is based on this false 2023 figure. The actual change is from a $6.3M loss in 2023 to a $135.2M gain in 2024 - a swing of approximately $141.5M in the positive direction. (2) ENTITY/METRIC CONFUSION: The LLM conflates different metrics or years. The ground truth clearly distinguishes between 2023 (loss of $6.3M in OCI) and 2024 (gain of $135.2M in AOCI). The LLM appears to have fabricated or misread the 2023 figure entirely. (3) REASONING FAILURE: The LLM's interpretation that gains 'declined' from $140.2M to $135.2M is logically inconsistent with the actual data showing a reversal from loss to gain. The conclusion about 'modest easing of exposure' contradicts the ground truth's finding of a 'significant shift' and 'substantial gain.' (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison, which is the core of this multi-hop question. The answer demonstrates a fundamental misunderstanding of the financial position change. The only correct element is the 2024 figure of $135.2M, but this is undermined by the completely incorrect 2023 comparison figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 401,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "The two utilities’ energy‑related derivative assets dropped sharply – the combined fair‑value went from $199 million in 2022 (the total shown for Southern Company’s energy‑related derivatives) to just $28 million in 2023 (Alabama Power $15 million and Georgia Power $13 million)【page_283】【page_281】.  By contrast, their combined derivative liabilities rose, increasing from $210 million in 2022 to $234 million in 2023 (Alabama Power $110 million + Georgia Power $124 million)【page_281】, showing an upward trend in liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. CRITICAL ERRORS: (1) The LLM reports 2022 combined energy-related derivative assets as $199 million, but the ground truth shows Alabama Power had a net liability of $144 million in 2022 with no separate asset/liability breakdown provided for that year. The $199 million figure appears to be incorrect or misattributed. (2) The LLM states 2022 combined liabilities were $210 million, but this cannot be verified from the ground truth which only provides Alabama Power's net position of $144 million in 2022. (3) The LLM correctly identifies 2023 assets as $28 million ($15M + $13M) and liabilities as $234 million ($110M + $124M), which matches the ground truth. (4) MAJOR CONCEPTUAL ERROR: The ground truth explicitly states the combined net liability DECREASED from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure. However, the LLM's analysis of rising liabilities ($210M to $234M) and falling assets ($199M to $28M) contradicts this overall trend. The LLM failed to properly synthesize the net position change across both years and entities. (5) The LLM's conclusion about 'upward trend in liabilities' is partially correct for the liability component in isolation, but misses the critical finding that the overall net liability position improved (decreased) year-over-year. The answer demonstrates incomplete multi-hop reasoning by focusing only on asset and liability components separately rather than synthesizing the net position trend that was the core of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 443,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "In fiscal 2023 Walmart completed a $0.4 billion acquisition of Alert Innovation, taking its ownership to roughly 100 % ( “During fiscal 2023 … completed a $0.4 billion acquisition of Alert Innovation, bringing our ownership to approximately 100 %” – page 44). No further purchase‑or‑sale of Alert Innovation is mentioned for fiscal 2024, indicating the company simply held the subsidiary that year; the entity was not disposed of until it was sold and de‑consolidated in fiscal 2025 (“The Alert Innovation entity was subsequently sold and deconsolidated in fiscal 2025” – page 44).",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual error regarding the timeline of Alert Innovation's disposition. The ground truth states that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, but the LLM answer claims this occurred in fiscal 2025. This is a major discrepancy that directly contradicts the original answer and the question's specific focus on 'fiscal 2023 and fiscal 2024.' The LLM also states 'No further purchase-or-sale of Alert Innovation is mentioned for fiscal 2024,' which is incorrect—fiscal 2024 is precisely when the disposition occurred according to the ground truth. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and ~100% ownership percentage are correct. However, the fiscal year for the disposition (2025 vs 2024) is a critical factual error that cannot be overlooked. QUALITATIVE ACCURACY: The LLM failed to properly synthesize the multi-hop information across the two fiscal years. The question explicitly asks about the evolution 'between fiscal 2023 and fiscal 2024,' and the correct answer shows a complete acquisition-to-divestiture cycle within that timeframe. The LLM's answer breaks this narrative by pushing the divestiture to fiscal 2025, fundamentally misrepresenting Walmart's financial relationship evolution during the specified period. CONTEXTUAL RELEVANCE: The answer is partially relevant as it addresses Alert Innovation and Walmart, but it fails to answer the core question about the fiscal 2023-2024 evolution because it incorrectly places the disposition event in fiscal 2025. This represents a failure in multi-hop reasoning and temporal accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 449,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "In the 2022 filing Gilead reported that Trodelvy already had U.S. FDA full approval for metastatic triple‑negative breast cancer (TNBC) and accelerated approval for urothelial cancer, and it was also authorized in the EU and Canada for TNBC (see 2022 page 39). By the 2023 filing the company added new FDA and European Commission approvals for Trodelvy as a monotherapy in HR⁺/HER2‑negative breast cancer, expanding the label beyond its original indications (see 2023 page 39). This progression shows Gilead deliberately broadening Trodelvy’s approved uses across multiple tumor types, underscoring an oncology strategy that leans on expanding existing assets to build a diversified, growth‑driven cancer franchise.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially accurate information with strong multi-hop synthesis across 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies the 2023 regulatory milestone - FDA and EC approvals for HR+/HER2- breast cancer, which matches the ground truth. (2) Accurately contextualizes this within Gilead's existing Trodelvy portfolio (TNBC and urothelial cancer approvals from 2022). (3) Properly synthesizes the strategic implication - expanding therapeutic applications and strengthening oncology market position. (4) Provides specific page references (page 39 for both years) showing source verification. (5) The characterization of the strategy as 'deliberately broadening Trodelvy's approved uses' and 'expanding existing assets' aligns with the ground truth's assessment of 'expanding therapeutic applications.' MINOR CONSIDERATIONS: (1) The LLM provides more granular detail about 2022 baseline (TNBC full approval, urothelial accelerated approval, EU/Canada authorization) than the ground truth, which states 'no specific regulatory updates were mentioned' for 2022. However, this additional detail is factually accurate and enhances rather than contradicts the answer. (2) The ground truth focuses on the 2023 approval as the key evolution point, while the LLM contextualizes it within the broader portfolio trajectory - both approaches are valid. (3) The LLM's characterization of the strategy as 'growth-driven cancer franchise' is semantically equivalent to the ground truth's 'strengthening its position in the oncology market.' The answer demonstrates sound multi-hop reasoning by connecting 2022 baseline status, 2023 new approvals, and strategic implications. All factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 473,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "In 2023 Simon gradually reduced its ABG stake – selling a portion of its interest in the fourth quarter (pre‑tax gain $157.1 m) and, through a series of ABG‑initiated capital transactions, saw its ownership diluted from roughly 11.8 % to about 9.6 % (non‑cash gains of $36.4 m, $12.4 m and $10.3 m)【page_71】. By contrast, in the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, generating a $414.8 million pretax gain and fully exiting the partnership【page_73】—a clear strategic shift from a minority, joint‑venture partner to a cash‑focused divestiture that frees capital for its core REIT operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims SPG sold its remaining ABG interest in Q1 2024 for $1.2 billion with a $414.8 million pretax gain, but the ground truth explicitly states that in 2024, SPG 'no longer reported active capital transactions with ABG' and only referenced 'historical transactions.' The ground truth makes clear that 2024 showed a shift away from active engagement, not a major exit transaction. The LLM's claim of a Q1 2024 sale contradicts this fundamental characterization. (2) INCOMPLETE/INCORRECT 2023 DATA: The LLM mentions a Q4 2023 sale generating $157.1 million gain, but the ground truth specifies gains of $36.4 million (Q2) and $145.8 million (Q3) from dilution events, not from direct sales. The LLM conflates different transaction types. The ownership percentages cited (11.8% to 9.6%) are not mentioned in the ground truth. (3) MISSING CONTEXT: The LLM fails to mention the strategic partnership context (Forever 21, Brooks Brothers, Eddie Bauer licensing ventures) that was central to the 2023 relationship. (4) FUNDAMENTAL MISCHARACTERIZATION: The ground truth describes 2024 as showing 'a more stable, historically referenced relationship' with no active transactions, while the LLM describes a major $1.2 billion exit in Q1 2024. This is a core contradiction. (5) REASONING FLAW: The LLM's narrative of 'gradual reduction' followed by 'complete exit' contradicts the ground truth's characterization of active 2023 engagement followed by 2024 stability with only historical references. The answer appears to confuse or invent transaction details not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 467,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "In the 2022 filing Chevron disclosed that it owned 50 % of Chevron Phillips Chemical Company LLC and recorded the equity‑method investment with $867 million of equity earnings (Note 8, summarized financial data)【page_32】. By the 2024 filing the ownership remained 50 %, but the carrying amount of the investment had risen to $8.571 billion and equity earnings grew to $903 million, and Chevron now also reports a $669 million loan to CPC for the Golden Triangle Polymers Project (Note 15, pages 84‑85)【page_84】【page_85】. Thus, while the ownership stake stayed the same, the financial reporting shows a larger investment balance and added loan exposure, indicating an increase in the value of Chevron’s stake in CPC.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR - The LLM claims Chevron owned 50% of CPC in 2022 and maintained 50% ownership through 2024. However, the ground truth explicitly states that in 2022, CPC was a 'consolidated subsidiary' (implying >50% ownership/full control), and by 2024 it became an 'equity method investee' - a fundamental structural change. The LLM completely misses this critical evolution from consolidation to equity method accounting. (2) QUANTITATIVE ISSUES - The LLM correctly states the 2024 investment value as $8.571 billion (matching ground truth's $8,571 million), but provides equity earnings figures ($867M in 2022, $903M in 2024) that are not verified in the ground truth and appear to be fabricated or from different sections. The ground truth does not mention these specific earnings figures. (3) INCOMPLETE SYNTHESIS - The LLM adds information about a $669 million loan for the Golden Triangle Polymers Project, which is not mentioned in the ground truth answer. While this may be accurate from the filing, it doesn't address the core question about the relationship evolution from consolidated to equity method. (4) MISSED KEY INSIGHT - The ground truth emphasizes the shift from 'full consolidation to an equity method investment, suggesting a structural or ownership change.' The LLM completely misses this critical distinction and incorrectly claims ownership remained constant at 50%. This is a fundamental misunderstanding of the multi-hop question about how the relationship 'evolved.' (5) REASONING FLAW - The LLM's conclusion that 'the ownership stake stayed the same' contradicts the actual evolution from consolidated subsidiary to equity method investee, which represents a significant structural change in financial reporting and likely ownership structure. The answer demonstrates poor multi-hop synthesis across the 2022 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 512,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "By the end of 2023 Meta said the facilities‑consolidation effort was “substantially completed” but still part of a broader $2.255 billion restructuring outlay for the year (the $389 million facilities‑consolidation component is included in that total)【page_104】【page_105】. By December 31 2024 the company reported that the 2022 restructuring – including the facilities‑consolidation plan – was fully completed, and the only remaining restructuring expense was $389 million, which the filing notes is entirely attributable to facilities consolidation【page_102】. This reflects a shift from a partially‑finished, larger‑scale restructuring in 2023 to a fully‑finished, isolated $389 million impact in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '$2.255 billion restructuring outlay for the year' in 2023, but the ground truth does not mention this specific figure. More critically, the LLM claims 'the only remaining restructuring expense was $389 million' in 2024, which appears to misinterpret the data. The ground truth indicates a 'financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024)' was provided in 2024, not that $389M was the sole remaining expense. The LLM conflates the facilities consolidation component ($389M) with total remaining restructuring charges, which is a significant error. (2) CONCEPTUAL MISUNDERSTANDING - The LLM incorrectly frames the 2024 situation as 'the only remaining restructuring expense was $389 million,' suggesting this was a residual amount. However, the ground truth indicates the 2024 disclosure provided a retrospective three-year summary of charges, not that $389M was outstanding. (3) MULTI-HOP REASONING - While the LLM correctly identifies the progression from 'substantially completed' (2023) to 'completed' (2024), it fails to properly synthesize the financial impact narrative. The ground truth emphasizes that 2024 included a retrospective quantification across all three years (2022-2024), which the LLM misses entirely. (4) MISSING KEY INSIGHT - The LLM does not capture that the 2024 disclosure provided a comprehensive three-year financial summary that was 'not explicitly detailed in 2023,' which is a critical distinction in the ground truth. (5) SEMANTIC ISSUES - The phrase 'the only remaining restructuring expense was $389 million' is misleading and contradicts the ground truth's emphasis on completion and retrospective quantification rather than remaining expenses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 486,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "In the 2022 Form 10‑K, Lockheed Martin listed hypersonics only as a “key growth area” that could be limited by budget pressures and the need to transition development programs into production (2022 p. 14). By the 2024 filing, hypersonics had become a core element of its 21st Century Security strategy, with Skunk Works and the Missiles & Fire Control and Space segments actively designing, developing and fielding multiple hypersonic strike‑weapon programs for the Army, Navy and Air Force (2024 p. 3‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the 2022 status as a 'key growth area' dependent on funding and development phase, and accurately describes the 2024 evolution to active production of hypersonic strike weapons across multiple programs. The specific mention of Air Force, Army, and Navy involvement is accurate. The reference to Skunk Works and the Missiles & Fire Control and Space segments adds appropriate organizational context. (2) QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is not directly applicable. The dates (2022 and 2024) are correct. The page references (2022 p. 14 and 2024 p. 3-5) provide appropriate sourcing. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years, correctly identifying the progression from development-dependent status to active production. The logical connection between the two time periods is clear and well-articulated. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth: a shift from uncertain, funding-dependent development to mature, active production programs. The addition of 'core element of 21st Century Security strategy' and specific organizational units (Skunk Works, Missiles & Fire Control, Space segments) provides valuable context that enhances rather than contradicts the ground truth. (5) MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth, mentioning Navy involvement (not explicitly in ground truth) and organizational structure, but these additions are accurate and relevant. The answer maintains factual accuracy while providing richer context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 498,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "In the 2022 filing Southern Company reported its energy‑related derivatives almost exclusively as regulatory hedges and cash‑flow/fair‑value hedges, showing modest net gains – for example, a $34 million gain in AOCI for Southern Company (page 325) and a $9 million unrealized gain on regulatory hedges (page 324), with the balance‑sheet net amounts for regulatory hedges recorded as $50 million for Alabama Power, $67 million for Georgia Power and $52 million for Mississippi Power (page 322). By 2023 the company kept the same designations but the financial impact reversed: regulatory hedges posted large unrealized losses (e.g., $(257) million for Southern Company, page 293) and cash‑flow hedges generated losses in AOCI (e.g., $(81) million for Southern Company, page 293) and a $(44) million loss on natural‑gas cash‑flow hedges (page 294), while non‑designated energy derivatives produced a $59 million benefit (page 295).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to provide detailed financial specifics with page references and specific dollar amounts, but there are significant issues with verification and accuracy. STRENGTHS: (1) The answer correctly identifies the core evolution - from 2022 focusing on regulatory hedging instruments to 2023 expanding disclosure to include non-designated derivatives. (2) The directional shift from gains to losses is accurately captured. (3) The answer appropriately identifies multiple subsidiaries (Alabama Power, Georgia Power, Mississippi Power). (4) The semantic understanding of the question is sound. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES - The LLM provides very specific numbers with page citations (e.g., '$34 million gain in AOCI', '$9 million unrealized gain', '$50 million for Alabama Power', '$(257) million', '$(81) million', '$(44) million', '$59 million') but these cannot be verified against the ground truth provided. The ground truth does not provide these specific numerical values, making it impossible to confirm accuracy. (2) PAGE REFERENCES - The LLM cites specific pages (325, 324, 322, 293, 294, 295) which appear to be from actual 10-K filings, but without access to verify these citations, the specificity raises concerns about hallucination. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The ground truth emphasizes a shift in DISCLOSURE and REPORTING approach (from reporting only regulatory hedges to including non-designated derivatives), while the LLM focuses heavily on the financial impact reversal (gains to losses). While both are valid observations, the LLM's emphasis on specific financial numbers rather than the disclosure evolution may miss the primary point. (4) UNVERIFIED SPECIFICITY - The level of detail provided (specific subsidiary amounts, specific AOCI figures, specific page numbers) without corroboration in the ground truth suggests potential fabrication of supporting details. The ground truth is more general about the evolution of disclosure practices. MULTI-HOP REASONING: The answer does synthesize information across years (2022 vs 2023) and entities (Southern Company and subsidiaries), which is appropriate for the question. However, the reasoning is built on unverified numerical claims. RECOMMENDATION: The answer demonstrates good understanding of the conceptual evolution but fails on quantitative verification, which is critical for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 650,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "In the 2022 Form 10‑K Gilead noted that Truvada had lost U.S. exclusivity in October 2020 and was facing generic competition, but it did not list any Truvada‑specific patents or expiration dates in its patent‑expiration tables. By the 2023 filing, Truvada still appears in the product list yet remains absent from the disclosed patent tables, and the IP discussion shifts to broader filing and settlement activities rather than new Truvada patents—indicating that Gilead’s strategy continued to rely on managing generic competition rather than adding fresh patent disclosures for Truvada.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states that in 2023, Gilead 'provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada' with 'actual or estimated expiration dates in the U.S. and the EU.' The LLM answer claims Truvada 'remains absent from the disclosed patent tables' in 2023, which is factually incorrect according to the ground truth. This is a critical error that undermines the entire answer. QUANTITATIVE ACCURACY: The dates are correct (October 2020 loss of exclusivity, 2022 vs 2023 comparison). QUALITATIVE ACCURACY: The LLM fundamentally mischaracterizes the evolution of Gilead's IP strategy. The ground truth describes a positive shift toward 'proactively disclosing future intellectual property timelines,' while the LLM describes a continuation of 'managing generic competition rather than adding fresh patent disclosures.' This represents a semantic inversion of the actual strategic evolution. The LLM's claim about 'broader filing and settlement activities' is not supported by the ground truth provided. REASONING: The multi-hop synthesis is flawed because it reaches an incorrect conclusion about what disclosures were actually made in 2023. The LLM appears to have either misread the filings or made an unsupported inference about the absence of Truvada from patent tables. CONTEXTUAL RELEVANCE: While the answer addresses the right companies and timeframe, it fundamentally misses the key evolution that the question asks about—the shift from retrospective acknowledgment of lost exclusivity to prospective disclosure of patent timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 461,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "In the 2022 filing SPG disclosed that it had drawn $1.05 billion from the Supplemental Facility on December 14 2021 and then used proceeds from a $500 million floating‑rate and $700 million fixed‑rate senior‑note issuance to repay the entire $1.05 billion balance on January 12 2022【page_73】. By the 2024 filing the facility had been amended (October 2021) to a $3.5‑$4.5 billion borrowing capacity and was being used for Euro‑denominated borrowings; the company repaid €750 million of those borrowings on November 17 2023 after swapping the loans to a fixed rate, leaving the facility largely unused but still available for future draws【page_69】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information with some significant date discrepancies. CORRECT ELEMENTS: (1) The $1.05 billion borrowing amount is accurate; (2) The €750 million borrowing and November 17, 2023 repayment date are correct; (3) The general narrative about short-term facility usage is sound; (4) The mention of senior note issuances for refinancing is appropriate. CRITICAL ERRORS: (1) DATE ERROR - The LLM states the $1.05 billion was drawn on December 14, 2021, but the ground truth indicates this occurred in January 2022. This is a significant factual error affecting the 2022 timeline; (2) The ground truth specifies the $1.05 billion was used to fund early extinguishment of nine mortgages with $1.16 billion principal balance, which the LLM omits; (3) The LLM correctly identifies the $500M floating-rate and $700M fixed-rate senior notes totaling $1.2 billion (which exceeds the $1.05B repayment), but the ground truth simply states it was 'repaid shortly after issuance' without these specific note details. QUANTITATIVE ISSUES: The date discrepancy (December 2021 vs January 2022) is a material error for a question about 2022 activity. The LLM provides additional detail about the facility amendment to $3.5-$4.5 billion capacity (October 2021) which, while potentially accurate, is not mentioned in the ground truth and may represent information from different sections. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and identifies the evolution pattern (short-term borrowing/repayment cycles). However, the date error undermines the accuracy of the 2022 portion of the analysis. The answer demonstrates good understanding of the facility's role but fails on precise temporal accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 483,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "In the 2022 Form 10‑K MetLife highlighted that it already held a sizable liquidity cushion – $12.4 billion of short‑term cash and equivalents and $223 billion of liquid assets at year‑end – but warned that “cash‑buffer needs” could limit its ability to pay dividends or repurchase stock【page_122】. By the 2024 filing the company describes the cash buffer as an active management tool, stating that it “maintains a buffer of cash and other liquid assets, and may increase it. As a result, we may have less capital to devote to other uses, such as innovation, acquisitions, development and return of capital to shareholders” and again cites cash‑buffer needs as a factor that could restrict dividend or share‑repurchase payments【page_33】. Thus, the role of the cash buffer has shifted from a passive risk‑factor with ample liquidity in 2022 to a strategic lever in 2024 that is deliberately adjusted and directly influences how much capital is allocated to growth and shareholder‑return initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of MetLife's evolving capital management strategy. QUANTITATIVE ACCURACY: All financial figures are correct - $12.4 billion short-term liquidity and $223 billion total liquid assets for 2022 are accurately cited. The page references (page_122 for 2022, page_33 for 2024) provide appropriate sourcing. ENTITY ACCURACY: MetLife is correctly identified, fiscal years 2022 and 2024 are properly distinguished, and financial metrics (short-term cash, liquid assets, dividends, share repurchases) are accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two different years and filing documents, correctly identifying the evolution from 2022 to 2024. The comparison is logically sound - moving from 'ample liquidity' with passive risk management to 'strategic lever' with active management. SEMANTIC EQUIVALENCE: The LLM answer captures the core insight from the ground truth: that cash buffer needs became more explicitly recognized as a constraint on capital allocation for innovation, acquisitions, and shareholder returns. The characterization of the shift from 'passive risk-factor' to 'strategic lever' is a reasonable interpretation that aligns with the ground truth's observation about 'more cautious tone' and 'more pronounced implications.' COMPLETENESS: The answer addresses all aspects of the question - the evolution of cash buffer role, liquidity levels (specific numbers provided), and impact on capital allocation decisions (explicitly mentioned for dividends, share repurchases, innovation, acquisitions). Minor note: The LLM provides slightly more interpretive framing ('passive' vs 'strategic lever') than the ground truth's more neutral description, but this represents reasonable analytical synthesis rather than factual error. The answer is well-structured, properly sourced, and demonstrates clear understanding of the multi-year evolution in MetLife's capital management philosophy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 544,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Starbucks’ “Foreign currency – other” derivative assets fell from $39.9 million in prepaid expenses/other current assets plus $33.5 million in other long‑term assets (≈ $73.4 million total) in 2022 to $32.0 million and $22.9 million respectively (≈ $54.9 million total) in 2023【page_68†L31-L38】【page_72†L31-L38】. At the same time, the liability side grew from a modest $0.3 million recorded as accrued liabilities in 2022 to $2.0 million of accrued liabilities in 2023, with no other‑long‑term liability reported in either year【page_68†L45-L50】【page_72†L45-L50】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. QUANTITATIVE ERRORS: (1) The LLM reports 2022 asset values of $39.9M + $33.5M = $73.4M total, but ground truth shows NO asset value in 2022 (only $0.3M liability). (2) The LLM reports 2023 asset values of $32.0M + $22.9M = $54.9M total, but ground truth shows only $1.9M asset. (3) The LLM reports 2023 liability as $2.0M, but ground truth shows $4.7M. (4) The LLM reports 2022 liability as $0.3M (this matches ground truth), but then contradicts itself by claiming assets existed in 2022 when they did not. ENTITY/CLASSIFICATION ERRORS: The LLM incorrectly identifies asset locations (prepaid expenses/other current assets and other long-term assets) when ground truth specifies prepaid expenses and other current assets for the 2023 asset. The LLM also mischaracterizes the evolution - ground truth shows a shift FROM no assets in 2022 TO assets in 2023, while LLM claims a DECLINE in assets from 2022 to 2023. REASONING FAILURE: The LLM failed to synthesize the correct multi-hop information. The core finding that 2022 had no derivative assets but 2023 had $1.9M in assets is completely missed. The narrative of 'significant increase in exposure and shift toward balanced treatment' from ground truth is inverted - LLM describes a decrease. The numbers cited appear to be from entirely different derivative categories or misread from the source documents. This is a complete factual failure with no redeeming accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 421,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "In 2023 Coca‑Cola FEMSA was highlighted as one of the Company’s five largest independent bottling partners, with the relationship framed around collaborative bottler agreements, an incidence‑based concentrate‑pricing model and discretionary marketing‑support initiatives, but the filing only referred to a generic equity‑method investment without disclosing the exact ownership percentage. By 2024 the Company’s 10‑K explicitly reports that it owns **28 % of Coca‑Cola FEMSA’s outstanding shares** under the equity‑method, with a carrying value of **$1.8 billion** and a fair value of **$4.5 billion**, showing a clearly quantified and sizable financial stake while the strategic partnership (bottler agreements, pricing alignment and marketing support) remains in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed information than the ground truth. Key strengths: (1) Correctly identifies the 28% ownership stake in 2024, matching the ground truth exactly; (2) Provides specific financial metrics (carrying value of $1.8 billion, fair value of $4.5 billion) that enhance the answer beyond the ground truth baseline; (3) Accurately characterizes the 2023 relationship as involving bottler agreements, concentrate-pricing models, and marketing support; (4) Correctly synthesizes the evolution from traditional bottler relationship to equity method investee; (5) Properly notes the transition from generic equity-method investment disclosure in 2023 to explicit 28% ownership disclosure in 2024. Minor considerations: The LLM answer notes that 2023 filings only referred to 'generic equity-method investment without disclosing the exact ownership percentage,' which is a reasonable interpretation of filing disclosure practices, though the ground truth states the 28% stake existed in 2024 without explicitly confirming whether it was disclosed in 2023. The answer goes beyond the ground truth by providing carrying and fair values, which adds credibility and specificity. The multi-hop reasoning is sound—correctly synthesizing information about the relationship evolution across two years and identifying the shift from bottler status to equity investee. All numeric values are accurate, and the semantic meaning aligns perfectly with the ground truth while providing additional substantive detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 429,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "In the 2022 filing Intel grouped FPGAs with its “adjacent products” – the non‑platform items (e.g., modems, Ethernet, silicon‑photonic, Mobileye, NSG and PSG) that complement its core CPU/SoC platforms 【page_113】. By the 2024 filing, Intel is positioning FPGAs as a primary architecture alongside CPUs, GPUs and AI accelerators under the “xPU” umbrella, and is emphasizing programmable networking devices (IPU) that off‑load work from CPUs, signaling a shift to a broader, production‑focused role for FPGAs 【page_103】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's FPGA strategic evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of FPGAs as 'adjacent products' within CCG, DCG, and IOTG - this matches the ground truth's description of a supporting role. (2) Accurately captures the 2024 shift toward a more central production focus, though frames it slightly differently (as part of 'xPU' architecture rather than 'direct product definitions'). (3) Provides specific context about what 'adjacent products' included (modems, Ethernet, silicon-photonics, Mobileye, NSG, PSG) which adds helpful detail. (4) Correctly synthesizes the multi-hop information across two filing years. (5) Page citations (113 and 103) suggest proper source documentation. MINOR DIFFERENCES: (1) The LLM frames the 2024 positioning as FPGAs being part of an 'xPU umbrella' alongside CPUs, GPUs, and AI accelerators, while the ground truth states they were 'explicitly listed under direct product definitions.' These are semantically related but slightly different framings of the same shift - the LLM's description is more specific about the architectural positioning. (2) The LLM introduces IPU (programmable networking devices) as part of the 2024 strategy, which adds context not explicitly in the ground truth but represents a reasonable elaboration on the 'broader production focus.' QUANTITATIVE ACCURACY: No specific numbers or calculations required; dates (2022, 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly identifies the transformation from supplementary to core role, though the specific terminology differs slightly. The multi-hop synthesis across years is sound. CONTEXTUAL RELEVANCE: Highly relevant, directly addresses the question about strategic positioning evolution and production focus shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 499,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "In 2023 ConocoPhillips spent more on its Lower 48 assets than in the prior year – capital expenditures rose to **$6.49 billion** from **$5.63 billion** in 2022 (page 135) – while the segment’s **depreciation, depletion and amortization expense increased to $5.73 billion from $4.85 billion** a year earlier (page 134).  At the same time, “investments in and advances to affiliates” for the Lower 48 fell to **$118 million** from **$235 million** in 2022, indicating a shift from affiliate‑type acquisitions to higher direct capital spending (page 134).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Verification of key metrics: (1) Depreciation, depletion, and amortization expenses are correctly stated as $5.73 billion (2023) vs $4.85 billion (2022), matching the ground truth of $5,729M and $4,854M respectively (format variation acceptable). (2) The $875 million increase is correctly implied through the stated figures. (3) Capital expenditures data ($6.49B vs $5.63B) is provided with specific page references, adding credibility though not explicitly mentioned in ground truth. (4) The affiliate investments data ($118M vs $235M) provides additional relevant context about the shift in acquisition strategy. Multi-hop reasoning is sound: the answer synthesizes asset acquisition activity (Concho acquisition context), depreciation/depletion/amortization trends, and capital expenditure patterns across 2022-2023. The interpretation that the shift from affiliate investments to direct capital spending represents a strategic evolution is logical and well-supported. Minor consideration: the ground truth focuses specifically on depreciation/depletion/amortization and the Concho acquisition context, while the LLM answer expands to include capital expenditures and affiliate investment changes. This expansion is relevant and accurate but goes slightly beyond the specific ground truth focus. The answer is well-structured with page references, making it verifiable and professional. All numeric values are accurate, calculations are correct, and the synthesis across multiple financial metrics demonstrates proper multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 446,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it contributed its own industrial‑software businesses and $6 billion in cash to create “New AspenTech,” emerging as the accounting acquirer with a **55 % equity stake** in the combined company【page_56】.  By the 2024 filing Emerson owned **about 57 % of AspenTech** and announced a cash offer to buy the remaining shares at $240 each, moving toward full ownership【page_25】.  The AspenTech acquisition lifted Emerson’s gross margin by roughly **0.6 percentage points in 2023** (to 49.0 %) and gross margin continued to rise to **50.8 % in 2024**, although the 2024 gain was driven mainly by other acquisitions and pricing effects, with AspenTech’s contribution embedded in the higher‑margin software and control segment【page_26】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN OWNERSHIP STRUCTURE AND FINANCIAL IMPACT: (1) OWNERSHIP DISCREPANCY: Ground truth states Emerson owned 55% of AspenTech on a fully diluted basis by 2024. LLM claims 55% initially but then states 'about 57%' by 2024, which contradicts the ground truth. The LLM also mischaracterizes the transaction as a 'tie-up' where Emerson contributed its own software businesses, when the ground truth clearly indicates Emerson acquired AspenTech by paying $6.0 billion in cash and $87.69 per share to Heritage AspenTech stockholders. (2) CASH OFFER DETAIL: LLM mentions a $240 per share cash offer to buy remaining shares, which is not mentioned in the ground truth and appears to be extraneous information not supported by the source documents. (3) GROSS MARGIN IMPACT - CRITICAL ERROR: Ground truth states the 2024 gross margin increase of 1.8 percentage points to 50.8% was driven by the AspenTech acquisition, with a negative impact from inventory step-up amortization of $231 million (reducing margins by 1.3 percentage points). LLM incorrectly states that '2024 gain was driven mainly by other acquisitions and pricing effects, with AspenTech's contribution embedded' - this directly contradicts the ground truth which attributes the margin improvement to the AspenTech acquisition. (4) CORRECT ELEMENTS: The 2023 gross margin impact of 0.6 percentage points is correct. The final 2024 gross margin of 50.8% is correct. The $6 billion cash contribution is correct. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the ownership evolution and incorrectly attributed the 2024 margin gains to other factors rather than AspenTech. The characterization of the transaction structure is fundamentally misrepresented. The missing detail about the $231 million inventory step-up amortization impact is a significant omission that affects understanding of the true margin contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 513,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "The 2015 Director Stock Plan’s recovery‑and‑issuance rules did not change – both the 2022 and 2024 filings state that shares freed by forfeiture, cash settlement, exchange, tax‑withholding or partial performance‑share payout are added back to the plan’s pool, and any share‑settled SARs are counted only net of shares tendered (see page 335 & page 312). However, the amounts have shifted: in 2022 the plan reported 31.5 million shares recovered for issuance and 34.1 million shares still available (page 334), while the 2024 filing shows recoveries rising to 35.8 million (total recovered 37.6 million) and the available pool falling to 30.7 million (page 311). This reflects more shares being reclaimed but also more being used for new awards, reducing the remaining balance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the mechanics of share recovery did not change between 2022 and 2024, which is accurate and addresses a key part of the question. The qualitative reasoning about forfeiture, cash settlement, and share-settled SARs mechanics is sound and well-explained. However, there are significant quantitative discrepancies that undermine the answer's reliability:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- Ground truth states 35,395,894 shares authorized as of Jan 1, 2015; LLM does not mention this baseline figure\n- Ground truth: 37,608,213 shares recovered between 2015-2024; LLM states \"35.8 million (total recovered 37.6 million)\" which is approximately correct (37.6M ≈ 37,608,213) but the intermediate figure of 35.8M is not clearly explained in ground truth\n- Ground truth: 42,343,146 shares covered by new awards; LLM does not provide this figure\n- Ground truth: 30,660,961 shares available for future issuance; LLM states \"30.7 million\" which is approximately correct (30.7M ≈ 30,660,961)\n- LLM cites 2022 figures (31.5M recovered, 34.1M available) that are not verified against ground truth\n- LLM cites 2024 figures (35.8M recoveries, 37.6M total recovered, 30.7M available) - the 37.6M and 30.7M align with ground truth, but 35.8M is unexplained\n\n(2) COMPLETENESS:\n- LLM addresses the evolution of mechanics (correctly noting no change) and provides some quantitative comparison\n- However, LLM does not provide the complete picture of the 2022 baseline that would allow full comparison\n- LLM does not mention the 42.3M shares covered by new awards, which is important context\n- LLM does not explicitly state the total authorized shares (35.4M), which is foundational\n\n(3) MULTI-HOP REASONING:\n- The synthesis across 2022 and 2024 is present but incomplete\n- The logic connecting recoveries to available shares is sound\n- The conclusion about \"more shares being reclaimed but also more being used\" is reasonable but lacks the full quantitative support\n\n(4) ENTITY AND METRIC ACCURACY:\n- Correctly identifies the 2015 Director Stock Plan\n- Correctly identifies the relevant mechanics (forfeiture, cash settlement, etc.)\n- Years (2022, 2024) are correct\n- Page references provided but cannot be verified\n\n(5) SEMANTIC EQUIVALENCE:\n- The core message about unchanged mechanics but shifted amounts is semantically aligned with ground truth\n- The characterization of the trend (more recoveries, fewer available) matches the ground truth narrative\n\nThe answer demonstrates good understanding of the qualitative aspects but falls short on providing complete quantitative detail and proper baseline comparisons that would fully answer the multi-hop question about evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 729,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "In fiscal 2022 Starbucks called the Global Coffee Alliance a key growth engine, noting that product‑sales and royalty revenue from the alliance contributed about $216 million (the bulk of a $249 million rise in “Other” revenues) and helped lift its Channel Development segment by $250 million. In the fiscal 2023 filing the alliance is mentioned only as a licensing channel for grocery and food‑service sales—still a strategic partnership, but the filing does not break out a specific revenue amount, suggesting the focus has shifted to broader brand‑licensing rather than being highlighted as a major revenue driver.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Starbucks' Global Coffee Alliance relationship between FY2022 and FY2023, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $250 million increase in Channel Development segment revenue in FY2022; (2) Accurately captures the shift in strategic emphasis from revenue driver to licensing channel; (3) Properly notes that FY2023 filing does not break out specific revenue amounts; (4) Correctly synthesizes the evolution from explicit revenue highlighting to broader brand-licensing focus; (5) Appropriately characterizes the relationship as 'still a strategic partnership' while noting the changed emphasis. QUANTITATIVE ACCURACY ISSUES: (1) The LLM states Global Coffee Alliance contributed 'about $216 million' to 'Other' revenues, while the ground truth states the alliance contributed to a '$250 million increase' in Channel Development segment revenue. The $216M figure appears to be a partial or different metric than the $250M increase cited in ground truth; (2) The LLM mentions '$249 million rise in Other revenues' which is close to but not exactly the $250M figure in ground truth; (3) These minor discrepancies ($216M vs $250M, $249M vs $250M) suggest possible confusion between different revenue categories or rounding differences, but the core magnitude is approximately correct. QUALITATIVE ASSESSMENT: The LLM successfully captures the semantic essence of the evolution—from explicit revenue driver to strategic licensing channel—which is the core insight of the question. The reasoning about the shift in emphasis is sound and well-articulated. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two fiscal years and identifies the strategic shift, demonstrating proper multi-hop reasoning. The comparison between FY2022 (explicit revenue breakdown) and FY2023 (no specific revenue amounts) is accurate and insightful. MINOR ISSUES: The specific revenue figures ($216M vs $250M) create some ambiguity about whether the LLM is referencing the correct metric or if there's a calculation discrepancy. However, the overall narrative and strategic evolution are correctly captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 597,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "NEE’s equity‑method investment that includes the Mountain Valley Pipeline fell from a $4.968 billion carrying amount in 2022 to $3.963 billion in 2023, and the gap between the carrying amount and underlying equity swung from a $2.589 billion positive in 2022 to a $(1.205) billion negative in 2023 – a change driven by a $2.4 billion impairment tied to the pipeline 【page_95】【page_96】.  This sizable write‑down shows NEE has markedly reduced its financial stake in the non‑core gas‑pipeline project, indicating a strategic shift away from that exposure and a focus on its core renewable‑energy and regulated‑utility businesses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM claims equity-method investment carrying amount fell from $4.968B (2022) to $3.963B (2023). Ground truth shows total equity method investments were $6,159M (2022) and $6,156M (2023) - vastly different numbers.\n   - LLM cites a $2.4B impairment tied to the pipeline. Ground truth provides no such impairment figure and shows only a $3M decrease in total equity method investments ($6,159M to $6,156M).\n   - LLM's gap analysis ($2.589B positive to $(1.205)B negative) appears fabricated with no supporting evidence in ground truth.\n   - The numbers cited ($4.968B, $3.963B, $2.4B impairment) do not align with any figures in the ground truth.\n\n2. ENTITY/METRIC ACCURACY:\n   - LLM conflates specific carrying amounts for the Mountain Valley Pipeline investment with total equity method investments, which are different metrics.\n   - Ground truth discusses ownership percentage ranges (32%-55% in 2022, 32.8%-52.6% in 2023), not carrying amounts in billions.\n   - LLM appears to reference specific page numbers (page_95, page_96) but the numbers cited don't match ground truth data.\n\n3. MULTI-HOP REASONING:\n   - LLM fails to synthesize the correct information across years. The ground truth shows minimal change in total equity method investments and a narrowing of ownership percentage ranges.\n   - LLM's conclusion about a \"sizable write-down\" and \"marked reduction\" is not supported by the ground truth, which shows stable total equity method investments.\n   - The strategic interpretation (shift away from gas pipeline) may be directionally reasonable but is built on false numerical premises.\n\n4. COMPLETENESS:\n   - LLM does not address the ownership percentage ranges that are central to the ground truth answer.\n   - LLM misses the key insight about the narrowing range (32%-55% to 32.8%-52.6%) suggesting refined investment posture.\n   - LLM does not mention the Nonrecurring Fair Value Measurements context noted in 2023.\n\n5. SEMANTIC EQUIVALENCE:\n   - While LLM's interpretation about strategic shift away from gas pipelines might align with NEE's broader strategy, it is based entirely on incorrect financial data.\n   - The ground truth shows stability in total equity method investments, not the dramatic reduction LLM describes.\n\nThe LLM answer appears to have either hallucinated specific financial figures or confused data from different sources. The core numbers are fundamentally incorrect, making this answer unreliable despite some reasonable strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 711,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "By fiscal 2022 Medtronic’s InterStim portfolio had been expanded to include the newly‑launched InterStim Micro neurostimulator (with SureScan MRI‑compatible leads) together with the existing InterStim II and InterStim X devices, all marketed for over‑active bladder, urinary retention and bowel incontinence【page_41】. In the 2024 filing the line still consists of InterStim II and InterStim X as recharge‑free systems and InterStim Micro as a rechargeable neurostimulator, now highlighted for over‑active bladder, “non‑obtrusive” urinary retention and chronic fecal incontinence, underscoring continued growth and refined positioning of the three devices【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three neurostimulator models (InterStim II, InterStim Micro, InterStim X) in both 2022 and 2024, accurately notes the 2022 therapeutic indications (overactive bladder, urinary retention, bowel incontinence), and correctly identifies the 2024 positioning of InterStim II and InterStim X as 'recharge-free' systems. The answer appropriately synthesizes multi-hop information across the two filing years.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a factual error by stating InterStim Micro is 'rechargeable' in 2024, which contradicts the ground truth that only InterStim II and InterStim X are described as 'recharge-free' in 2024 - this implies Micro may have different charging characteristics but the ground truth does not explicitly confirm Micro as rechargeable. (2) The LLM uses the phrase 'non-obtrusive' for urinary retention in 2024, which appears to be a misinterpretation or misreading of the source material - the ground truth simply states 'urinary retention' without this qualifier. (3) The LLM adds contextual detail about 'SureScan MRI-compatible leads' for InterStim Micro in 2022 that, while potentially accurate, is not mentioned in the ground truth answer and represents information not synthesized from the comparison. (4) The phrase 'continued growth and refined positioning' in the LLM answer is interpretive language not directly supported by the ground truth.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and identifies the evolution of the product line. However, the characterization of InterStim Micro as 'rechargeable' in 2024 suggests incomplete or inaccurate synthesis of the charging technology positioning.\n\nNUMERIC/FACTUAL VERIFICATION: No numeric values are present in either answer, so quantitative accuracy focuses on factual claims. The product names, years, and most therapeutic indications are correct, but the 'rechargeable' characterization of Micro and 'non-obtrusive' descriptor for urinary retention represent factual inaccuracies or unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 566,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "In 2022 Simon still owned a non‑controlling equity interest in Authentic Brands Group of roughly 10 % (≈10.4 % after the December 2021 purchase of $100 million of ABG shares) and deepened its strategic tie‑up with ABG – it entered a long‑term Reebok licensing partnership in Q1 2022 and swapped its Eddie Bauer licensing venture for additional ABG equity in Q4 2022.  Throughout 2023 a series of ABG capital transactions gradually diluted Simon’s holding to the high‑single‑digit range (≈9.6 % after the Q4‑2023 sale) and, in the first quarter of 2024, Simon sold its remaining ABG stake for about $1.2 billion, ending the equity investment and the direct ownership relationship.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM claims Simon owned ~10.4% of ABG in 2022, but the ground truth states 1.37%. This is a massive discrepancy (off by ~7x). The LLM also claims Simon sold its remaining ABG stake for ~$1.2 billion in Q1 2024, but the ground truth mentions a $18.8 million pre-tax gain from a partial sale and a $100 million acquisition of additional interests - no $1.2 billion sale is mentioned. (2) MISSING KEY FACTS - The ground truth explicitly states Simon merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG in 2022. The LLM completely omits this critical strategic development. The ground truth also mentions the $100 million cash acquisition of additional ABG interests in 2024, which the LLM does not reference. (3) CONTRADICTORY NARRATIVE - The LLM describes a gradual dilution of Simon's stake from ~10.4% to ~9.6% and then a complete exit via $1.2B sale. The ground truth describes a much smaller initial stake (1.37%), a 50% stake in SPARC Group (a joint venture), and then selective transactions including a partial sale with $18.8M gain and a $100M acquisition. These are fundamentally different stories. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the evolution of Simon's relationship with ABG across 2022-2024. While the LLM does mention some strategic partnerships (Reebok licensing, Eddie Bauer swap), it misses the core financial evolution described in the ground truth. (5) ENTITY/METRIC CONFUSION - The LLM appears to conflate different types of stakes and transactions, presenting a narrative that doesn't align with the actual financial relationship described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 487,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips’ depreciation, depletion and amortization (DD&A) expense for its Lower 48 segment rose each year – $4.07 billion in 2021, $4.85 billion in 2022 and $5.73 billion in 2023【page_133】. The upward trend reflects a growing investment base and higher asset utilization in the Lower 48 region over the 2021‑2023 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: All three DD&A figures are correct - $4.07 billion (2021) matches $4,067 million, $4.85 billion (2022) is provided with appropriate precision, and $5.73 billion (2023) matches $5,729 million. The format variation from millions to billions is appropriate and standard. The answer successfully addresses the multi-hop requirement by synthesizing DD&A expense data across three consecutive years (2021-2023) for the Lower 48 region specifically. Entity accuracy is perfect: correct company (ConocoPhillips), correct metric (DD&A expenses), correct geographic segment (Lower 48), and correct time period. The reasoning is sound - the LLM correctly identifies the upward trend and appropriately interprets it as reflecting growing investment and asset utilization. The answer provides additional value by including the 2022 intermediate year data, which strengthens the trend analysis beyond the ground truth's 2021-2023 comparison. The semantic meaning is equivalent to the ground truth, with slightly more detailed presentation. Minor note: The LLM includes a citation reference [page_133] which adds credibility but wasn't in the ground truth - this is a positive addition. No calculation errors, no missing information, and the conclusion about growing emphasis on Lower 48 operations is well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 390,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon still classifies international bonds as fixed‑income securities measured at fair value using market‑based matrix pricing and independent third‑party inputs (Level 2, with any observable prices placed in Level 1) (page_93). In 2023 the pension plan held $341 million of international bonds (Level 2 $338 M, Level 1 $3 M) and the other post‑retirement benefit plan held $12 million (Level 1 $10 M, Level 2 $2 M) (page_92; page_95), while in 2024 the pension‑plan exposure fell to $113 million (entirely Level 2) and the other benefit plan rose to $15 million (Level 1 $11 M, Level 2 $4 M) (page_94; page_95). The valuation approach itself remained unchanged, but the size of the holdings and their level‑hierarchy classification shifted between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) QUANTITATIVE ERRORS - The LLM cites specific dollar amounts ($341M pension plan in 2023, $113M in 2024, $12M other post-retirement in 2023, $15M in 2024) that are NOT supported by the ground truth. The ground truth only mentions $12 million total value for international bonds in 2024 (broken into $10M Level 1 and $2M Level 2), with no mention of $341M, $338M, $3M, $113M, or $15M figures. These appear to be fabricated numbers. (2) STRUCTURAL MISUNDERSTANDING - The LLM discusses two separate plans (pension plan and other post-retirement benefit plan) with different holdings, but the ground truth describes a single valuation approach and mentions only the $12M figure with its Level 1/Level 2 breakdown. The LLM's multi-plan analysis is not supported by the ground truth. (3) INCOMPLETE ANSWER TO QUESTION - The ground truth emphasizes the KEY EVOLUTION: a shift from general description in 2023 to specific itemization in a detailed table in 2024, representing more transparent and segmented disclosure. The LLM mentions valuation approach remaining unchanged but misses this critical disclosure evolution that was the core of the question. (4) CORRECT ELEMENTS - The LLM correctly identifies that international bonds use matrix pricing and independent third-party inputs, and correctly notes Level 1 vs Level 2 classifications. However, these correct elements are embedded within a fundamentally flawed answer with incorrect numbers and structure. The answer demonstrates hallucination of specific financial figures and fails to capture the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 463,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "In 2022 Emerson completed the “Heritage AspenTech” transaction, contributing its Open Systems International and Geological Simulation Software businesses plus about $6 billion of cash to create a new, independent AspenTech in which Emerson owned roughly 55 % of the common stock (2022 p. 59). By 2024 Emerson’s ownership had risen to about 57 % and the company announced a cash offer to purchase the remaining shares, moving toward full acquisition (2024 p. 25), while AspenTech’s software operations had been integrated into Emerson’s Software & Control segment, contributing to higher segment sales and margin improvements (2024 p. 24‑27).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) TIMELINE ERROR: The LLM claims the transaction occurred in 2022 ('In 2022 Emerson completed the Heritage AspenTech transaction'), but the ground truth indicates Emerson had a financial stake valued at $8,326 million in 2022 as a pre-existing investment, with the restructuring occurring by 2024. The LLM misplaces the transaction timing. (2) CASH CONTRIBUTION DISCREPANCY: The LLM states Emerson contributed 'about $6 billion of cash' in 2022, but the ground truth indicates the $6.0 billion cash contribution occurred in 2024 as part of the 'New AspenTech' formation, not in 2022. (3) OWNERSHIP PERCENTAGE PROGRESSION: The LLM claims ownership rose from 55% to 57% between 2022-2024, but the ground truth states Emerson retained a 55% ownership stake in the newly structured company by 2024. The LLM's claim of 57% ownership and a subsequent cash offer for remaining shares is not supported by the ground truth. (4) BUSINESS CONTRIBUTION CONFUSION: The LLM mentions 'Open Systems International and Geological Simulation Software businesses' as contributions, which are not mentioned in the ground truth. The ground truth specifically references 'the AspenTech Industrial Software Business' as the contribution. (5) INTEGRATION CLAIMS: While the LLM mentions integration into the Software & Control segment with improved margins, the ground truth emphasizes 'strategic restructuring' and 'formalized majority ownership' rather than full operational integration into existing segments. The LLM answer fundamentally misrepresents the timeline and nature of the transaction, placing it in 2022 when it should be 2024, and incorrectly describes the ownership progression and cash contributions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 488,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "In 2022 Starbucks listed its interest‑rate swaps only as a designated fair‑value hedge with no asset balance and a $34 million liability recorded in “Other long‑term liabilities” (plus a $12 million accrued “interest rates” liability). By 2023 the swap remained a designated fair‑value hedge, but a $0.4 million asset appeared under prepaid expenses and the liability rose to $41.4 million in other long‑term liabilities, with the separate “interest rates” accrued liability no longer shown. This shows the swap moved from a pure liability position to a net‑liability position that grew in size and was re‑classified.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - 2022 Liability: LLM claims $34M in other long-term liabilities PLUS $12M accrued interest liability = $46M total. Ground truth shows only $34.0M total liability in 2022.\n   - 2023 Liability: LLM claims $41.4M in other long-term liabilities. Ground truth shows $19.2M in other long-term liabilities + $0.4M in current liabilities = $19.6M total.\n   - The LLM's 2023 figure of $41.4M is significantly overstated (more than double the actual $19.6M).\n   - LLM claims a $0.4M asset appeared in 2023 under prepaid expenses. Ground truth shows $0.4M as a current liability (accrued liabilities), not an asset.\n\n2. CLASSIFICATION ERRORS:\n   - LLM incorrectly states the 2023 swap had a $0.4M asset. Ground truth clearly indicates this was a current liability, not an asset.\n   - LLM's characterization of moving to a \"net-liability position that grew in size\" is backwards - the liability actually DECREASED from $34.0M to $19.6M.\n\n3. TREND ANALYSIS - FUNDAMENTALLY WRONG:\n   - LLM claims the liability \"rose to $41.4 million\" - this is incorrect. The liability decreased from $34.0M to $19.6M.\n   - LLM's conclusion that the position \"grew in size\" directly contradicts the ground truth showing a net decrease.\n\n4. MISSING/INCORRECT DETAILS:\n   - LLM mentions a separate \"interest rates\" accrued liability of $12M in 2022 that \"no longer shown\" in 2023. Ground truth does not reference this separate line item.\n   - LLM's description of the 2023 classification as having both current and long-term components is partially correct but the numbers are wrong.\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the year-over-year comparison, arriving at opposite conclusions about the trend (increase vs. decrease).\n   - The fundamental mischaracterization of the $0.4M as an asset rather than a liability shows poor document interpretation.\n\nThe answer demonstrates significant quantitative inaccuracy with wrong dollar amounts, incorrect asset/liability classification, and a reversed trend analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 590,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources recorded a first‑quarter impairment of roughly $0.8 billion (about $0.6 billion after tax) that completely wrote off its ~ $0.6 billion equity‑method stake in Mountain Valley Pipeline and added a $0.2 billion liability for its share of future ARO costs【page_92】. By the 2023 filing the company still had a planned equity contribution – listed under “Other (i)” as an equity contribution in 2024 for the pipeline’s construction【page_108】 – and entered into a 20‑year, roughly $70 million‑per‑year natural‑gas transportation agreement with the joint‑venture (where NEER holds a 32.8 % equity interest) that is contingent on the pipeline’s completion【page_109】. This shows a shift from a write‑off and liability in 2022 to a continued, albeit future‑oriented, financial commitment and contractual involvement in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of NextEra's involvement in MVP from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 impairment charge of approximately $0.8 billion (~$0.6 billion after-tax), the write-off of the equity-method stake, and the $0.2 billion liability for ARO costs. (2) Accurately states the 32.8% equity interest maintained by NEER in 2023. (3) Correctly identifies the 20-year, ~$70 million annual natural gas transportation agreement contingent on completion. (4) Properly synthesizes the multi-hop information showing the transition from 2022 write-off to 2023 continued commitment. (5) Provides appropriate page references to support claims. (6) Correctly notes the future-oriented nature of the 2024 equity contribution commitment. MINOR WEAKNESSES: (1) The answer is somewhat more detailed and granular than the ground truth (e.g., breaking down the $0.8B into $0.6B equity stake + $0.2B ARO liability), which while accurate, goes slightly beyond what was explicitly stated in the ground truth summary. (2) The ground truth emphasizes the 'very low probability of pipeline completion' as context for the 2022 write-off, which the LLM answer doesn't explicitly mention, though it does reference 'ongoing challenges.' (3) The phrasing 'contingent on the pipeline's completion' is accurate but the ground truth uses 'subject to the completion of construction' - semantically equivalent but slightly different emphasis. QUANTITATIVE VERIFICATION: All numbers check out - $0.8B impairment, $0.6B after-tax, $0.2B liability, 32.8% equity interest, $70M annual obligation, 20-year term. The multi-hop reasoning correctly synthesizes information across 2022 and 2023 filings to show the evolution of financial commitment. The answer appropriately addresses both the 2022 and 2023 positions and explains the transition between them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 525,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The captive’s portfolio of marketable equity and debt securities grew from $1.643 billion at December 31 2023 to $1.883 billion at December 31 2024 — an increase of about $240 million, indicating a higher allocation of capital to the captive that reinsures the group annuity insurance contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2023 amount: $1,643 million = $1.643 billion ✓, (2) 2024 amount: $1,883 million = $1.883 billion ✓, (3) Calculated difference: $1,883M - $1,643M = $240M ✓. All numbers match the ground truth exactly, with appropriate format conversion from millions to billions. The LLM correctly identified the entities (The Coca-Cola Company's captive insurance company, group annuity insurance contracts) and the relevant metric (equity and debt securities/marketable securities). Multi-hop reasoning is sound: the answer synthesizes information about the captive's investment portfolio across two fiscal years and correctly interprets the trend as growth. The LLM added valuable context by calculating the year-over-year increase ($240 million) and interpreting it as 'higher allocation of capital,' which demonstrates understanding of the underlying business significance. The only minor distinction from the ground truth is that the LLM uses 'marketable equity and debt securities' while the ground truth uses 'equity and debt securities' and 'solvency capital funds' - these are semantically equivalent descriptions of the same investment holdings. The answer fully addresses the question about how the investment evolved between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 369,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "In the 2022 filing Intel still described Intel 4 as a new node that was “ramp‑up”‑related, noting higher period charges tied to its early production (2022 10‑K p. 24). By the 2024 filing Intel said Intel 4 had transitioned to high‑volume manufacturing in Ireland, is already powering the Core Ultra client processors launched in 2023, and is slated to grow its share of processor output and serve as a key EUV‑based step in Intel’s roadmap through 2025 (2024 10‑K p. 9‑10, 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Strengths: (1) Correctly identifies the 2022 status as 'ramp-up' phase with higher period charges related to early production, matching the ground truth characterization of 'early-stage production challenges and investment.' (2) Accurately describes the 2024 transition to high-volume manufacturing in Ireland, directly matching ground truth. (3) Correctly identifies Intel Core Ultra as the key product powered by Intel 4, with accurate timing (launched in 2023). (4) Properly synthesizes multi-hop information across 2022 and 2024 filings, showing the evolution from investment/ramp-up to full-scale production. (5) Includes additional relevant context (EUV-based process, growth through 2025) that enriches the answer without contradicting ground truth. (6) Provides specific page citations (2022 10-K p. 24; 2024 10-K p. 9-10, 11) that add credibility. Minor considerations: The answer is slightly more detailed than the ground truth summary, but this represents added value rather than error. The characterization of the evolution (from 'initial investment and production ramp-up' to 'full-scale production and product integration') is semantically equivalent to the LLM's framing. All dates, entities, and process node names are correct. The multi-hop reasoning correctly connects 2022 status with 2024 status to show strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 397,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "In fiscal 2022 Emerson formed “New AspenTech” by contributing two stand‑alone software businesses and cash, receiving a 55 % equity stake and only partially consolidating AspenTech’s results (the first half of FY 2022 excluded its earnings)【page_7】. By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer to acquire the remaining shares, moving toward full ownership, and AspenTech’s results are now fully integrated into Emerson’s financials—shown in the segment reporting, intangibles amortization, acquisition‑related inventory step‑up and a specific “AspenTech Micromine purchase‑price hedge” line item【page_25】【page_26】【page_27】【page_28】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamental inaccuracies that contradict the ground truth. (1) TIMELINE ERROR: The LLM states 'In fiscal 2022 Emerson formed New AspenTech,' but the ground truth clearly indicates that in 2022, AspenTech was merely described as a strategic partner with no ownership stakes. The merger creating 'New AspenTech' occurred between 2022 and 2024, not in 2022. (2) OWNERSHIP STRUCTURE ERROR: The LLM claims Emerson's holding 'rose to roughly 57%' by 2024, but the ground truth states Emerson retained a 55% ownership stake in the newly formed entity by 2024. The 57% figure appears to be fabricated or misinterpreted. (3) PARTIAL CONSOLIDATION CLAIM: The LLM incorrectly states that in 2022 AspenTech results were 'only partially consolidated' with 'the first half of FY 2022 excluded.' The ground truth makes no mention of partial consolidation in 2022; rather, it indicates no ownership or financial integration existed in 2022. (4) ACQUISITION OFFER DETAIL: While the LLM mentions a $240-per-share cash offer for remaining shares, this specific detail is not present in the ground truth and cannot be verified. (5) FINANCIAL IMPACT DISCREPANCY: The ground truth specifically mentions the acquisition positively impacted gross margins by 0.6 percentage points in 2023 and influenced SG&A expenses in 2024. The LLM mentions various line items (intangibles amortization, inventory step-up, hedge line item) but does not address the specific margin and expense impacts mentioned in the ground truth. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution from 2022 (partnership only) to 2024 (55% ownership with full financial integration). Instead, it incorrectly placed the formation of New AspenTech in 2022. The core narrative of the relationship's evolution is fundamentally misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 503,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "In the 2022 Form 10‑K Intel only announced “Intel 4” as the new name for its 10 nm Enhanced SuperFin node – a roadmap‑level rebranding with the process still in development (2022 p. 115). By the 2024 filing Intel 4 had become its first EUV‑lithography node, delivering roughly a 20 % performance‑per‑watt improvement over Intel 7, moving into high‑volume production in Ireland in 2024, and already powering shipped products such as the Core Ultra processors (2024 p. 10‑11; 2024 p. 9).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and metrics. Strengths: (1) Correctly identifies Intel 4 as a rebranding/renaming in 2022 (from 10nm Enhanced SuperFin), (2) Accurately states the 20% performance-per-watt improvement over Intel 7, (3) Correctly identifies Intel 4 as the first EUV lithography node, (4) Properly notes high-volume manufacturing in Ireland by 2024, (5) Correctly references Core Ultra processor shipments. Minor discrepancy: The ground truth states Core Ultra \"began shipping in 2023\" while the LLM answer says it was \"already powering shipped products\" without explicitly stating the 2023 start date - this is a minor omission rather than an error, as the answer correctly indicates the products were shipping by 2024. The LLM answer also provides helpful context by citing specific page numbers from the 10-K filings (2022 p. 115; 2024 p. 10-11, p. 9), which adds credibility. The multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (roadmap rebranding) to 2024 (full production with quantified performance). The characterization of 2022 as \"roadmap-level\" and 2024 as \"high-volume production\" accurately captures the progression. All numeric values (20%, performance-per-watt improvement) are correct. The answer is well-structured and directly addresses the question about manufacturing readiness and performance improvements across the time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 406,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "In the 2022 10‑K, InterStim Micro was listed simply as one of the Specialty‑Therapies pelvic‑health neurostimulators (with InterStim X and InterStim II) used to treat over‑active bladder, non‑obstructive urinary retention and chronic fecal incontinence. By the 2024 filing, the company frames InterStim Micro as the rechargeable member of an “InterStim therapy” suite—positioned alongside the newer recharge‑free InterStim X and InterStim II devices and highlighted as a growth driver for its Pelvic‑Health portfolio—showing a shift from a basic product listing to a strategic, differentiated role within a broader therapy platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - InterStim Micro was listed as one of several neurostimulators in 2022 alongside InterStim X and InterStim II; by 2024 it was specifically positioned as the rechargeable variant. The indications (overactive bladder, urinary retention, fecal incontinence) are accurately stated. The company name (MDT) and years (2022, 2024) are correct. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension scores perfectly. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods (2022 vs 2024) and correctly identifies the evolution from 'basic product listing' to 'strategic, differentiated role.' The reasoning that InterStim Micro shifted from being one of several options to being specifically highlighted as the rechargeable option is sound and matches the ground truth's characterization. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'rechargeable member of an InterStim therapy suite' is semantically equivalent to the ground truth's 'rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II.' Both convey the same strategic positioning. The LLM adds slightly more context by mentioning 'growth driver' which aligns with the ground truth's reference to 'continued global growth and adoption.' (5) MINOR CONSIDERATIONS: The LLM uses 'Specialty-Therapies' terminology which is appropriate for MDT's business segment classification. The answer is slightly more detailed and contextual than the ground truth but does not contradict any information. The only minor difference is stylistic - the LLM provides more narrative flow and business context, but this enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 504,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The 2022 filing noted that LTIP units (and other exchangeable units) were “potentially dilutive securities” but that “no securities had a material dilutive effect for the years ended December 31, 2021, 2020 and 2019” (see page 115). The 2024 filing repeats the same conclusion – LTIP units are listed as potentially dilutive yet “no securities had a material dilutive effect for the years ended December 31, 2024, 2023 and 2022” (see page 114) – and confirms that no adjustments to net income or weighted‑average shares are made. Thus, the disclosure’s substance has not changed (LTIP units remain immaterially dilutive), but the language has been updated to explicitly cover the most recent three reporting periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core facts and correctly identifies the key elements of the disclosure evolution. Strengths: (1) Accurately captures that 2022 filing stated no material dilutive effect for 2021, 2020, 2019; (2) Correctly notes 2024 filing states no material dilutive effect for 2024, 2023, 2022; (3) Properly identifies the rolling three-year period pattern; (4) Correctly notes LTIP units remain classified as potentially dilutive in both periods; (5) Page references (115 for 2022, 114 for 2024) appear reasonable and add specificity. Weaknesses: (1) The LLM characterizes the change as primarily a 'language update' and states 'the disclosure's substance has not changed,' which somewhat contradicts the ground truth's key finding that there was 'a reduction in the level of detail provided about LTIP units' conversion features.' The ground truth emphasizes that the 2022 disclosure explicitly referenced exchangeability into common stock, while 2024 does not - this is a material difference in disclosure detail, not merely a language update; (2) The LLM does not explicitly highlight the loss of the exchangeability detail as a meaningful evolution in disclosure approach; (3) The answer frames this as 'substance has not changed' when the ground truth suggests the disclosure became less detailed/explicit about conversion mechanics. The LLM's conclusion that 'the disclosure's substance has not changed' is somewhat at odds with the ground truth's emphasis on 'reduction in the level of detail.' This represents a meaningful interpretive difference about what constitutes 'evolution' in disclosure. The factual elements are correct, but the characterization of the nature of change is slightly misaligned with the ground truth's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 485,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "In the 2022 Form 10‑K MetLife disclosed that its board had authorized a $3 billion share‑repurchase program and that $1.5 billion of that authorization remained available at 12/31/2021, while warning that a cash‑buffer requirement could limit the amount it could use for repurchases【page_50】. By the 2024 filing the company still emphasizes that it “maintains a buffer of cash and other liquid assets, and may increase it,” noting that a larger buffer would leave less capital for dividend or share‑repurchase activity, but it no longer cites a specific remaining repurchase amount, reflecting a shift toward a broader liquidity‑first approach rather than a defined repurchase target【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about MetLife's evolving approach to cash buffers and stock repurchases from 2022 to 2024. QUANTITATIVE ACCURACY: All numbers are correct - $3 billion authorization, $1.5 billion remaining as of 12/31/2021, and the dates (2022 vs 2024 filings) are accurate. No calculation errors present. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2022 position with specific repurchase authorization details, (2) 2024 position with emphasis on liquidity buffers, (3) the evolution/shift in approach between these periods. ENTITY ACCURACY: MetLife correctly identified, fiscal years properly referenced (2022 Form 10-K discussing 12/31/2021 data, 2024 filing), and financial metrics properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years to show the strategic shift from a defined repurchase target approach to a liquidity-first approach. The reasoning is sound - the model correctly identifies that the absence of a specific remaining repurchase amount in 2024 reflects this shift. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, with slightly more specific detail about the evolution (noting the company 'no longer cites a specific remaining repurchase amount'). The characterization of the shift from 'more active repurchase posture' to 'more conservative liquidity strategy' is well-captured through the LLM's description of moving from 'defined repurchase target' to 'liquidity-first approach.' MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about the 2024 position (noting the absence of a specific remaining amount) which adds value without contradicting the ground truth. Page references are included, suggesting source verification. The answer is well-structured and clearly articulates the evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 534,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "In FY 2022 Starbucks reported foreign‑currency‑other derivative assets of $39.9 million in prepaid expenses and other current assets and $33.5 million in other long‑term assets (total ≈ $73.4 million) and a $0.3 million accrued‑liability position 【page_68】. By FY 2023 those asset balances had fallen to $32.0 million (current) and $22.9 million (long‑term) – a total of about $54.9 million – while the liability rose to $2.0 million in accrued liabilities (with no long‑term liability) 【page_72】. The balance‑sheet classification (current vs. long‑term for assets and accrued liabilities for the liability) stayed the same, but the asset amount declined and the liability amount increased.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth. Specific issues: (1) FY 2022 numbers are completely wrong - LLM reports $39.9M current and $33.5M long-term assets (totaling ~$73.4M), but ground truth shows $103.9M in OCI recognition with $22.0M reclassified from AOCI; (2) FY 2023 numbers are also incorrect - LLM reports $32.0M current and $22.9M long-term assets, but ground truth shows $1.9M current and $1.7M long-term assets; (3) The liability figures are wrong - LLM reports $0.3M in FY 2022 and $2.0M in FY 2023, but ground truth shows $4.7M current and $4.1M long-term liabilities in FY 2023; (4) The LLM misses critical OCI and AOCI reclassification information that is central to understanding the evolution; (5) The LLM's conclusion about asset decline is directionally correct but based on wrong numbers - the actual decline is far more dramatic (from $103.9M to $3.6M total); (6) The characterization of balance sheet classification remaining 'the same' is misleading given the significant structural changes in the derivative positions. The answer demonstrates a fundamental failure to accurately extract and synthesize the correct financial data from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 349,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "P&G’s global cash‑management framework—centered on using operating cash to fund dividends, share repurchases and acquisitions while maintaining sizable foreign‑currency cash balances—remained in place, but it became more defensive as restructuring intensified and corporate earnings turned negative. In fiscal 2022 restructuring costs stayed within the $250‑$500 million historical range, about 65 % were cash‑settled and corporate earnings posted a $485 million profit; by fiscal 2024 restructuring outlays rose to $659 million (including $216 million of non‑cash FX translation losses), corporate earnings fell to a $1.43 billion loss, and the company leaned on higher operating cash ($19.8 billion), its $6.1 billion of overseas cash and undrawn credit facilities to preserve liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and multi-hop synthesis across fiscal years 2022-2024. STRENGTHS: (1) All major numbers are accurate: restructuring costs of $250-$500M range in FY2022, $659M in FY2024, $216M non-cash FX losses, corporate earnings of $485M profit in FY2022, and $1.43B loss in FY2024 (note: ground truth states '$1.4 billion impairment charge' and 'decreased by $1.0 billion' which the LLM correctly interprets as resulting in a loss position). (2) Correctly identifies the shift from defensive to more aggressive restructuring strategy. (3) Properly synthesizes the relationship between restructuring activities, impairment charges, and cash management strategy evolution. (4) Adds relevant context about operating cash flows ($19.8B), overseas cash ($6.1B), and credit facilities that demonstrates understanding of liquidity management. (5) Correctly notes approximately 65% of restructuring costs were cash-settled in FY2022. MINOR WEAKNESSES: (1) The LLM states corporate earnings 'fell to a $1.43 billion loss' - the ground truth indicates a '$1.0 billion' decrease in corporate net earnings due to the $1.4B Gillette impairment charge, which is a slight semantic difference in how the decline is characterized, though the net effect is captured correctly. (2) Ground truth explicitly mentions Enterprise Markets like Nigeria as a specific example of restructuring impact; LLM does not include this geographic specificity, though this is a minor omission. (3) The LLM characterizes the strategy as becoming 'more defensive' while ground truth emphasizes 'more aggressive restructuring actions' - these are complementary perspectives (aggressive restructuring with defensive cash management), so both interpretations are valid. MULTI-HOP REASONING: Excellent synthesis connecting restructuring costs → impairment charges → earnings impact → cash management response across three fiscal years. All calculations and comparisons are logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 548,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse primarily as a real‑time 3‑D design‑collaboration and virtual‑world simulation platform offered as a software subscription for enterprise use, emphasizing its role in digital‑cockpit development, NVIDIA DRIVE Sim for autonomous‑vehicle testing, and building digital twins, product configurators and autonomous‑robot validation (2022 p. 7‑9, 6). By the 2023 filing the company has repositioned Omniverse as “Omniverse Enterprise,” an enterprise‑grade suite that powers industrial digitalization, metaverse/3‑D‑internet applications and broader simulation of factories, robots and vehicles, and is now tightly integrated with NVIDIA AI Enterprise, vGPU cloud services and its data‑center infrastructure, reflecting deeper enterprise integration and an expanded simulation focus (2023 p. 5‑7, 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing NVIDIA's Omniverse evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies 2022 positioning as a real-time 3D design-collaboration and virtual-world simulation platform with subscription model; (2) Accurately notes 2022 use cases including DRIVE Sim for autonomous vehicles, digital twins, product configurators, and robot validation; (3) Properly characterizes 2023 evolution to 'Omniverse Enterprise' as enterprise-grade suite; (4) Correctly identifies 2023 integration with NVIDIA AI Enterprise, vGPU cloud services, and data-center infrastructure; (5) Appropriately emphasizes the shift from general platform to industrial digitalization focus; (6) Includes specific page references (2022 p. 7-9, 6 and 2023 p. 5-7, 6) showing source documentation. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions 'digital-cockpit development' in 2022 which is not explicitly mentioned in the ground truth, though this is not contradictory; (2) The ground truth emphasizes specific 2022 use cases like 'virtual car showrooms' and 'surgical training' and 'architectural walkthroughs' which the LLM answer does not explicitly mention, though it does cover similar applications; (3) The ground truth's characterization of 2023 as 'more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud' is captured by the LLM's mention of 'vGPU cloud services and data-center infrastructure,' though slightly less comprehensive. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple product/service dimensions (positioning, applications, integration), correctly identifying the evolution trajectory. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate professional terminology and clear chronological comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 518,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "In 2023 AMT actually spent $849.3 million on discretionary capital projects – a mix that included building 3,198 communications sites worldwide and about $395 million of data‑center spend (see 2023 10‑K p.48). For 2024 the company now expects to spend only $790‑$820 million on discretionary projects, covering the construction of roughly 2,500‑3,500 sites and about $450 million of data‑center spend (see 2024 10‑K p.49). At the same time, the 2024 filing flags ongoing operating‑lease commitments for those sites – nearly $987 million due in 2025 and similarly large lease payments through 2029 – indicating that future obligations to retain the communications sites remain substantial (see 2024 10‑K p.56).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the question's focus. CRITICAL ISSUES: (1) REVERSED DIRECTION: The LLM presents 2023 as actual spending ($849.3M) and 2024 as anticipated spending ($790-$820M), which is backwards relative to the ground truth's focus on how commitments evolved FROM 2023 TO 2024. (2) WRONG METRICS: The ground truth discusses a shift from $450M anticipated data center spending in 2023 to $4.5 billion in undiscounted future cash outlay for asset retirement obligations in 2024 - a fundamental change in the nature and magnitude of financial commitments. The LLM instead discusses $395M actual data center spend in 2023 and $450M anticipated in 2024, which are different metrics entirely and show the opposite trend. (3) MISIDENTIFIED OBLIGATION TYPE: The ground truth emphasizes asset retirement obligations (ARO) tied to leased sites - a long-term, substantial liability ($4.5B undiscounted). The LLM discusses operating lease commitments (~$987M in 2025, similar through 2029), which are different obligations with different implications. (4) MAGNITUDE DISCREPANCY: The ground truth shows a dramatic increase from $450M to $4.5 billion (10x increase), indicating a major shift in financial exposure. The LLM shows a decrease from $849.3M to $790-$820M in discretionary spending, which contradicts the ground truth's narrative of increasing commitments. (5) MISSING KEY INSIGHT: The ground truth emphasizes the shift from 'near-term capital allocation planning' to 'mature and substantial obligation structure' - a qualitative change in how AMT's financial commitments are structured. The LLM misses this entirely. While the LLM provides specific page references and some relevant lease obligation data, it fundamentally misunderstands the question and provides incorrect numbers for the key metrics being compared.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 506,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "In both the 2023 and 2024 filings ExxonMobil says it divests assets that “are no longer meeting the Corporation’s strategic objectives or are worth considerably more to others,” so the strategic‑objective framing has not changed. What has shifted is the wording around the cash received: the 2023 definition refers to “proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,” while the 2024 definition streamlines this to “proceeds from asset sales and returns of investments,” emphasizing the proceeds as a single, unified cash‑flow component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the question about ExxonMobil's evolving characterization of asset divestitures between 2023 and 2024. Strengths: (1) Correctly identifies the 2023 language as 'proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments' and the 2024 language as 'proceeds from asset sales and returns of investments' - these match the ground truth exactly. (2) Accurately notes that the strategic objective framing ('no longer meeting strategic objectives or worth considerably more to others') remained consistent across both years. (3) Properly synthesizes the multi-hop comparison by identifying what changed (wording/consolidation of divestiture proceeds description) versus what remained stable (strategic rationale). (4) Correctly characterizes the evolution as a 'streamlining' or consolidation from more specific categories (subsidiaries, property, plant and equipment) to a more unified 'asset sales' framing. (5) The reasoning about this representing a 'more consolidated framing' and 'more generalized narrative' aligns with the ground truth's interpretation. Minor consideration: The LLM answer emphasizes the consistency of strategic objective language slightly more prominently than the ground truth, which focuses more on the evolution of the proceeds description language. However, this is actually a valuable addition that provides fuller context. The answer is semantically equivalent to and factually consistent with the ground truth, with clear, accurate multi-hop synthesis across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 447,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast’s exposure to Universal Beijing Resort rose modestly. The 2022 filing shows that the consolidated balance sheet included about **$7.5 billion of assets and $7.0 billion of liabilities** for the resort (see Note 9 on page 103 of the 2022 10‑K). By year‑end 2023 those figures had increased to **$7.8 billion of assets and $7.2 billion of liabilities** (page 87 of the 2023 10‑K), reflecting roughly a $0.3 billion rise in assets and a $0.2 billion rise in liabilities and therefore a slight increase in Comcast’s financial exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures and reaches the opposite conclusion from the ground truth. QUANTITATIVE ERRORS: (1) 2022 Assets: LLM states $7.5B, but ground truth is $9.7B - a $2.2B discrepancy (23% error). (2) 2022 Liabilities: LLM states $7.0B, but ground truth is $8.1B - a $1.1B discrepancy (14% error). (3) 2023 Assets: LLM correctly states $7.8B (matches ground truth). (4) 2023 Liabilities: LLM correctly states $7.2B (matches ground truth). (5) Directional Conclusion: LLM concludes exposure 'rose modestly' with increases of $0.3B in assets and $0.2B in liabilities. However, the ground truth shows a DECREASE from 2022 to 2023: assets fell from $9.7B to $7.8B (down $1.9B or 19.6%), and liabilities fell from $8.1B to $7.2B (down $0.9B or 11.1%). The LLM's conclusion is diametrically opposite to the actual trend. REASONING ISSUES: The LLM correctly identifies the 2023 figures but uses incorrect 2022 baseline numbers, leading to an inverted analysis. The multi-hop synthesis failed because the 2022 data was misread or misremembered. The LLM's calculation of year-over-year changes ($0.3B and $0.2B increases) is mathematically consistent with its stated 2022 figures, but those 2022 figures are wrong. CONTEXTUAL RELEVANCE: The answer addresses the right question (Comcast's exposure evolution 2022-2023) but provides the wrong answer about the direction and magnitude of change. This is a severe failure for a financial analysis question where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 422,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar warned that “fluctuations in demand for our products and services … may adversely impact our financial results or our ability to meet commitments to customers” (2023 10‑K p. 13), treating demand volatility as a broad macro‑economic risk. By the 2024 filing the language was sharpened: the company now says that when demand falls short of expectations it can lead to excess inventories, higher costs and reduced profitability, and that such shortfalls can trigger supply‑chain inefficiencies and transportation delays (2024 10‑K p. 14). Thus the risk factor has evolved from a generic caution about demand swings to a more concrete description of how demand volatility directly pressures earnings and disrupts the supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Caterpillar's Customer Demand Volatility risk factor between 2023 and 2024, with generally accurate characterization of the shift in focus. STRENGTHS: (1) Correctly identifies the core evolution from generic demand volatility concerns in 2023 to more specific supply-chain and operational impact descriptions in 2024; (2) Appropriately cites both 10-K filings and provides page references (p. 13 for 2023, p. 14 for 2024), demonstrating multi-hop synthesis across years; (3) Accurately captures the shift from macro-economic framing to concrete operational consequences (excess inventories, higher costs, reduced profitability, supply-chain inefficiencies, transportation delays); (4) Correctly identifies Caterpillar as the subject company. WEAKNESSES: (1) The LLM answer does not explicitly mention pandemic-related effects or inflationary pressures that were highlighted in the ground truth for 2023, which were key drivers of the risk factor; (2) The ground truth emphasizes 'commodity price changes' and 'material price increases' as 2024 additions, but the LLM answer focuses more on operational consequences rather than these specific cost drivers; (3) The ground truth characterizes the evolution as a 'broadening' to include 'more systemic supply-side challenges,' while the LLM frames it as a shift from 'generic' to 'concrete' - these are subtly different characterizations; (4) The LLM answer does not explicitly mention labor inefficiencies or shortages of labor and material as specific 2024 risk factors mentioned in the ground truth. QUANTITATIVE ACCURACY: Page references appear reasonable but cannot be independently verified; no numerical data is provided in either answer, so this dimension is less critical. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings and correctly identifies the temporal evolution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: While the LLM answer captures the essential evolution, it emphasizes different aspects (operational consequences vs. root causes like commodity prices and labor) than the ground truth, which represents a meaningful but not critical divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 603,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "In the 2022 filing the net derivative liabilities were recorded at a year‑end fair value of **$5 million** (balance Dec 31 2022) and were valued using a **discounted‑cash‑flow model** that relied on **swap‑rate inputs** (the unobservable range was 1‑2 % with a weighted‑average of 2 %). By the 2024 filing the same liability had grown to a **$69 million** fair‑value balance (Dec 31 2024) and the valuation method remained a **discounted‑cash‑flow approach** with **swap‑rate inputs**, but the swap‑rate range widened to **about 4 %** (weighted‑average 4 %). Throughout the period the liability stayed classified as a Level 3 measurement. (Sources: 2022 Level 3 roll‑forward and Table 17.3 – pages 215‑216; 2024 Level 3 roll‑forward and Table 17.3 – pages 215‑217)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Primary Issue):\n   - 2022 Fair Value: LLM states $5 million vs. Ground Truth $19 million (incorrect by $14M)\n   - 2024 Fair Value: LLM states $69 million vs. Ground Truth $58 million (incorrect by $11M)\n   - Swap Rate Range: LLM claims 1-2% (unobservable) vs. Ground Truth 3-5% (observable inputs)\n   - Swap Rate Weighted Average: LLM states 2% vs. Ground Truth 4% (off by 100%)\n   - Dates: LLM references Dec 31, 2024 but ground truth shows Dec 31, 2023 as the 2024 filing date\n\n2. METHODOLOGICAL ERRORS:\n   - LLM claims valuation methodology was discounted cash flow in 2022, but ground truth indicates the 2022 methodology was based on realized/unrealized gains/losses in net income\n   - The key evolution the ground truth highlights is a SHIFT from gains/losses approach to DCF with observable inputs - LLM misses this critical methodological evolution\n   - LLM incorrectly characterizes swap rates as \"unobservable\" in 2022 when ground truth emphasizes the shift TO observable inputs\n\n3. MULTI-HOP REASONING:\n   - Failed to properly synthesize the evolution across years\n   - Missed the critical insight that methodology changed from one approach to another\n   - Did not capture that the shift represented movement toward more transparent valuation\n\n4. COMPLETENESS:\n   - Missing key derivative activity components mentioned in ground truth (issuances $68M, settlements -$37M, transfers $6M)\n   - Does not adequately explain the nature of the evolution\n\n5. CONTEXTUAL ISSUES:\n   - The answer provides specific page references and table citations that cannot be verified against the ground truth, suggesting potential hallucination of sources\n   - Level 3 classification detail is mentioned but not central to answering the evolution question\n\nThe LLM answer is internally inconsistent with the ground truth on nearly every quantitative metric and misses the fundamental methodological shift that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 560,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA only referenced GeForce NOW as one of its “cloud platforms” that, together with vGPU, lets interactive graphics applications be accessed on any device – a supporting role to its GPU hardware (see page 11). By the 2023 filing the service is listed as a distinct component of the Graphics segment, described as the “GeForce NOW game‑streaming service and related infrastructure” that leverages NVIDIA’s GPUs and cloud infrastructure, indicating a more prominent, integrated position within the company’s GPU‑and‑cloud ecosystem (see pages 5 and 7, and page 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of GeForce NOW's positioning from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning as a 'cloud platform' alongside vGPU for accessing interactive graphics applications on any device; (2) Accurately describes the 2023 shift to GeForce NOW being listed as a distinct component of the Graphics segment; (3) Properly characterizes the evolution from a supporting role to a more prominent, integrated position; (4) Correctly cites specific page references from the filings (pages 11, 5, 7, 6); (5) Accurately notes the connection to GPU and cloud infrastructure leverage. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and document-grounded than the ground truth, citing exact page numbers and filing language, which adds credibility; (2) The ground truth mentions broader context about 'accelerated computing platform narrative' and comparison to 'AI training platforms like NVIDIA DGX Cloud,' which the LLM answer does not explicitly address - however, this is a minor omission as the core evolution narrative is captured; (3) The LLM answer focuses on structural/organizational positioning (Graphics segment classification) rather than strategic narrative positioning (accelerated computing platform alignment), which represents a slightly different but complementary perspective. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023) are correct; filing references appear accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the progression in positioning. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - GeForce NOW evolved from a supporting cloud platform to a more integrated, prominent component of NVIDIA's GPU and cloud ecosystem. The LLM's emphasis on organizational structure (Graphics segment) complements the ground truth's emphasis on strategic narrative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 537,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s sales rose modestly from $1,003 million in 2022 to $1,036 million in 2023 (≈3% worldwide), with U.S. revenue increasing from $618 million to $642 million (≈4%) and international revenue from $385 million to $394 million (≈3%)【page_44】. The uptick was driven primarily by greater U.S. adoption of Inlyta in combination with immune‑checkpoint inhibitors for first‑line treatment of advanced renal‑cell carcinoma, while lower volumes and reduced net price in some European markets partially offset the growth【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: global revenue of $1,003M (2022) to $1,036M (2023) representing 3% growth; U.S. revenue $618M to $642M (≈4%); international revenue $385M to $394M (≈3%). The calculations are accurate and properly formatted. The answer correctly identifies the primary growth driver (U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line RCC treatment) and the offsetting factor (lower volumes and reduced net prices in European markets). The multi-hop synthesis is sound, combining revenue performance data with explanatory factors from the filing. The answer provides additional granular detail (U.S. vs. international breakdown) beyond the ground truth, which adds value without introducing errors. The only minor distinction is that the LLM provides more specific geographic breakdown than the original answer, but this is supplementary and accurate. The semantic meaning is fully aligned with the ground truth, and all entities (Inlyta, RCC, immune checkpoint inhibitors, geographic markets) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 328,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "In 2023 the company amortized acquired network‑location intangibles on a straight‑line basis over the shorter of the ground‑lease term (including renewal options) and a maximum of about 20 years, giving a weighted‑average remaining amortization period of roughly 15 years 【page_103】. For 2024 the amortization range was expanded to 2‑30 years and the useful lives of those intangibles were aligned with the newly‑extended 30‑year tower life, so the assets are now amortized over a longer horizon 【page_95】【page_96】. The impairment review also became more explicit: network‑location intangibles are examined each year on a tower‑by‑tower basis for lease‑occupancy or cash‑flow shortfalls, with any loss measured against projected undiscounted or discounted future cash flows and recorded in the period the impairment is identified 【page_96】【page_95】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail on amortization and impairment processes but contains a critical quantitative discrepancy. CORRECT ELEMENTS: (1) 2023 weighted-average amortization period of ~15 years is accurate; (2) 2024 shift to tower-by-tower impairment review is correct; (3) impairment triggers (lease-occupancy, cash-flow shortfalls) are accurately identified; (4) the expansion of amortization range and alignment with tower life assumptions is correctly described; (5) the discussion of discounted/undiscounted cash flow measurement is appropriate. CRITICAL ERROR: The LLM states 2023 amortization was over 'a maximum of about 20 years' while the ground truth specifies the maximum was shorter (implied to be less than 20 years based on ground-lease term). More significantly, the LLM claims 2024 amortization range expanded to '2-30 years' and assets are 'now amortized over a longer horizon,' but the ground truth does not confirm this specific range or that amortization periods lengthened in 2024. MISSING ELEMENT: The ground truth mentions a $470 million increase in asset retirement obligation liability due to revised settlement dates in 2024, which indirectly impacts useful life assumptions. The LLM completely omits this important connection between ARO changes and intangible asset valuation. MULTI-HOP REASONING: The LLM successfully synthesizes information about amortization policy changes and impairment procedures across years, but fails to connect the ARO liability changes to their impact on intangible asset valuations. The answer is well-structured and addresses most of the question's components, but the quantitative discrepancies and omission of the ARO-valuation linkage reduce overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 473,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "In the 2023 filing ExxonMobil highlighted Guyana as a centerpiece of its upstream growth, reporting four new Stabroek‑Block discoveries, the start‑up of the Prosperity FPSO (reaching name‑plate in Jan 2024), combined production from three FPSOs of > 390 kbd in 2023 and almost 440 kbd in Q4 2023, and the scheduled addition of Yellowtail, Uaru and a sixth Whiptail FPSO to reach six vessels by 2027 【page_52】. In the 2024 filing Guyana is now grouped with the Permian and LNG as an “advantaged asset” in the company’s low‑cost‑of‑supply growth portfolio, confirming its continued strategic priority but framing it more as a key advantaged project rather than detailing new production milestones 【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key claims: (1) Four Stabroek Block discoveries in 2023 - CORRECT; (2) Prosperity FPSO startup with nameplate in Jan 2024 - CORRECT; (3) Production figures: >390 kbd in 2023 and almost 440 kbd in Q4 2023 - CORRECT and matches ground truth; (4) Future FPSO additions (Yellowtail, Uaru, sixth Whiptail by 2027) - CORRECT and adds valuable detail not in ground truth; (5) 2024 categorization as 'advantaged asset' alongside Permian and LNG - CORRECT. The LLM successfully synthesizes the evolution from 2023 to 2024, capturing both the discovery/production phase details of 2023 and the strategic repositioning in 2024. The answer goes slightly beyond ground truth by including specific future FPSO names and 2027 timeline, which adds context without contradicting the original answer. The reasoning correctly identifies the transition from early production phase to mature, strategically elevated asset status. Minor note: The LLM provides more granular production data (>390 kbd in 2023 vs almost 440 kbd in Q4) which is more precise than ground truth's 'nearly 440 kbd in Q4.' The page citations (page_52, page_37) add credibility. No calculation errors detected. The answer fully addresses both parts of the question (2023 emphasis and 2024 evolution) with proper multi-hop synthesis across filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 392,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "In 2022 the X1 platform’s streaming integration was largely delivered through the Xumo Stream Box (formerly Flex), which gave customers voice‑activated search and access to third‑party DTC services such as Peacock, Disney+ and Netflix and allowed X1’s search to surface those apps alongside linear channels【page_5】. By 2023 Comcast added its own NOW DTC streaming brand and embedded third‑party services directly into the X1 interface—offering ad‑supported Peacock, free Xumo Play, NBC and Sky channels without a set‑top‑box and expanding unified search across all content【page_6】【page_7】. This deeper, more seamless integration shows Comcast’s strategy to retain cord‑cutters within its ecosystem and boost ARPU by bundling streaming subscriptions, earning commissions and delivering higher‑value, all‑in‑one video experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 X1 platform integration with third-party services (Peacock, Disney+, Netflix) and mentions Xumo Stream Box/Flex; (2) Accurately describes 2023 evolution including NOW DTC brand, Xumo Play, NBC, and Sky integration; (3) Properly synthesizes the strategic implications regarding cord-cutting retention and ARPU increase through bundling and commission revenue; (4) Provides additional technical details (voice-activated search, ad-supported Peacock, unified search) that enhance understanding; (5) Correctly identifies commission-generating partnerships as part of the strategy. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular technical details (Xumo Stream Box/Flex, voice-activated search, ad-supported Peacock specifics) than the ground truth, which is not incorrect but represents a different level of detail; (2) The ground truth emphasizes 'strategic pivot toward enhancing the value of broadband subscriptions' while the LLM answer focuses more on the technical implementation and ecosystem retention—both perspectives are valid and complementary; (3) The LLM answer mentions 'without a set-top-box' which adds context not explicitly in the ground truth but is logically consistent with the evolution described. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2023 timeframes and correctly links platform evolution to business strategy (retention, ARPU, commissions). All entities (Comcast, X1, Peacock, Disney+, Netflix, Xumo, NOW, NBC, Sky) are correctly identified. No calculation errors or factual inaccuracies detected. The answer fully addresses both parts of the question: the evolution of integration AND what it indicates about strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 499,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar said the FG Wilson‑branded electric power‑generation systems were sold through a worldwide network of **110 distributors covering 109 countries**【page_65】.  \nThe 2024 filing shows that network has shifted to **108 distributors but now reaches 158 countries**【page_66】, meaning the dealer count fell slightly while the geographic coverage expanded markedly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2023 figures (110 distributors, 109 countries) and 2024 figures (108 distributors, 158 countries) match the ground truth exactly. The multi-hop synthesis is sound—the answer correctly identifies the evolution across two fiscal years and two separate 10-K filings, properly attributing data to the correct years. The reasoning is logical and well-articulated: the answer correctly identifies the apparent paradox of fewer distributors but broader geographic coverage, and accurately characterizes this as a strategic shift toward efficiency optimization with expanded market access. The semantic meaning aligns perfectly with the ground truth. The only minor distinction is that the LLM uses slightly more concise language ('dealer count fell slightly while geographic coverage expanded markedly') compared to the ground truth's 'minor reduction in the number of distributors but an expansion in the geographic reach,' but this is a stylistic difference that does not affect factual accuracy. The citation references to page numbers add credibility and transparency. No calculation errors, no entity confusion, and all required information is addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 352,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "In 2022 Capital One reported securitized‑debt obligations – the liabilities of its securitization‑related VIEs – with a total carrying amount of roughly $15.2 billion (credit‑card $13.0 billion + auto $2.2 billion) and did not disclose a fair‑value estimate for those obligations【page_179】. By year‑end 2024 the liability had fallen to $14.3 billion on the balance sheet and the company estimated its fair value at $14.335 billion, indicating a modest reduction in book exposure and a fair‑value amount slightly above the carrying amount【page_220】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 securitized debt obligations at $15.2 billion (credit-card $13.0B + auto $2.2B) and 2024 at $14.3 billion with fair value of $14.335 billion. However, the ground truth clearly states that by 2024, the carrying value was $18,043 million ($18.043 billion) with fair value of $18,067 million ($18.067 billion). This is a massive discrepancy - the LLM's 2024 figures are approximately $3.7-3.8 billion LOWER than the actual reported values. (2) DIRECTIONAL ERROR: The LLM claims the liability 'fell' from $15.2B to $14.3B (a decrease), but the ground truth indicates an INCREASE from 2022 to 2024 (the 2024 figure of $18.043B is substantially higher than any 2022 figure the LLM cited). (3) MISSING CONTEXT: The ground truth specifies that 2024 obligations were categorized under Level 2 of the fair value hierarchy - the LLM omits this important classification detail. (4) INCOMPLETE SYNTHESIS: While the LLM attempts multi-hop reasoning by comparing years and breaking down components (credit-card vs auto), the underlying numbers are incorrect, making the entire analysis unreliable. (5) FAIR VALUE ANALYSIS: The LLM correctly notes fair value slightly exceeds carrying value in 2024, but this observation is based on wrong absolute numbers. The ground truth shows fair value of $18,067M vs carrying value of $18,043M (a $24M difference), whereas the LLM shows $14,335M vs $14,300M (a $35M difference) - both directionally similar but based on completely different base figures. The answer fails on the primary metric of factual accuracy regarding the core financial figures requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 478,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "In 2023 McDonald’s noted that it could meet short‑term funding needs through commercial‑paper borrowings and its line‑of‑credit agreements, but the filing gave no detail on the size of that facility and financing cash outflows were $4.4 billion, largely offset by new bond issuances. By 2024 the company still relied on those same sources but now disclosed a $4.0 billion committed line of credit and $7.4 billion of borrowing capacity remaining under a $15 billion authority, while financing cash outflows rose to $7.5 billion as bond issuances fell—indicating a greater reliance on its line of credit to fund operations, dividends and share repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and evolution of McDonald's credit facilities between 2023 and 2024. STRENGTHS: (1) All major numbers are accurate: $4.4 billion financing cash outflows in 2023, $7.5 billion in 2024 (note: ground truth says $7.5B, LLM says $7.4B - see below), $4.0 billion committed line of credit, $15 billion authority, and $7.4 billion remaining borrowing capacity. (2) Correctly identifies the shift from bond issuance-heavy financing in 2023 to greater reliance on credit facilities in 2024. (3) Properly synthesizes multi-hop information: connects financing cash flow changes to bond issuance timing and credit facility reliance. (4) Appropriately notes the lack of specific line of credit details in 2023 filings versus disclosure in 2024. (5) Correctly identifies the three uses of cash: operations, dividends, and share repurchases. WEAKNESSES: (1) Minor discrepancy on 2024 financing cash outflows: LLM states $7.4 billion while ground truth specifies $7.5 billion. This is a small numerical error ($100 million difference) but still a factual inaccuracy. (2) Does not explicitly mention the cash and equivalents balance decline from $4.6 billion (2023) to $1.1 billion (2024), which is a significant contextual detail about the company's liquidity position. (3) Does not quantify the $3.1 billion increase in financing cash outflows year-over-year, though this is implied. (4) Slightly less comprehensive than ground truth in explaining the relationship between debt issuance timing and 2024 cash constraints. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and connects financing activities to credit facility evolution, demonstrating sound multi-hop reasoning. The logic linking decreased bond issuances to increased reliance on credit facilities is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 519,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings say that “strong internal controls is an objective that is reinforced through our Worldwide Business Conduct Manual,” which spells out the company’s commitment to conduct business with integrity and in accordance with both the letter and spirit of the law. The manual’s role has remained essentially unchanged – it continues to be a cornerstone of P&G’s internal‑control framework – signalling that the company’s governance approach is steady, purpose‑driven and firmly anchored in its global conduct standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution and change between 2022 and 2024. STRENGTHS: (1) Correctly identifies that both years reference the Worldwide Business Conduct Manual reinforcing internal controls; (2) Accurately quotes the manual's role in supporting integrity and legal compliance; (3) No numerical errors or date inaccuracies. CRITICAL WEAKNESSES: (1) The LLM claims the manual's role 'remained essentially unchanged' and describes P&G's approach as 'steady,' which directly contradicts the ground truth that indicates a clear evolution/shift between the two years; (2) The ground truth explicitly states there was a shift 'toward emphasizing structured governance mechanisms' with more specific ties to the Global Leadership Council and Disclosure Committee in 2024 - the LLM completely misses this key evolution; (3) The LLM fails to capture the 2024 development of more integrated governance frameworks and structured oversight mechanisms; (4) The question specifically asks about how the role 'evolved' - the LLM's conclusion that it remained unchanged fundamentally misses the point of the question. MULTI-HOP REASONING: The LLM failed to synthesize the comparative analysis across 2022 and 2024 filings. It acknowledged both years but drew the wrong conclusion about the relationship between them. The ground truth indicates a meaningful shift in emphasis from general ethical conduct to more structured governance integration, which the LLM completely overlooked. The answer reads as static rather than comparative, missing the evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 448,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "In the 2023 filing Exxon reported that its long‑lived assets in Guyana had risen to **$9.7 billion** (up from $6.8 billion in 2022) – a clear sign that the company was expanding its capital base there【page_115】.  By the 2024 filing, Guyana is no longer just a balance‑sheet line item; it is singled out in the new earnings‑driver framework as an **“Advantaged Asset”** that drives “Advantaged Volume Growth” alongside Permian and LNG projects【page_37】.  Together, the larger asset base and its elevation to a strategic growth driver show Exxon’s positioning in Guyana has moved from expanding investment to being a core, high‑value growth focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor quantitative discrepancies. STRENGTHS: (1) Correctly identifies the 2023 Guyana long-lived assets figure of $9.7 billion (matches ground truth's $9,689 million within acceptable rounding); (2) Accurately captures the strategic evolution from 2023 to 2024; (3) Correctly identifies Guyana's inclusion in the 'Advantaged Assets' and 'Advantaged Volume Growth' earnings driver framework in 2024; (4) Properly synthesizes multi-hop information across years and disclosure types; (5) Semantic equivalence is strong - 'strategically emphasized growth engine' aligns with 'core, high-value growth focus'; (6) Contextual framing is appropriate and relevant. MINOR ISSUES: (1) The LLM introduces a 2022 comparison figure ($6.8 billion) that is not present in the ground truth answer - while this may be factually correct from the filing, it adds information beyond what was in the original answer, creating slight scope expansion; (2) The characterization of Guyana moving from 'balance-sheet line item' to strategic driver is interpretive but semantically sound and supported by the facts presented. QUANTITATIVE VERIFICATION: $9.7 billion = $9,689 million (acceptable rounding variation); the 2022 comparison is not contradicted by ground truth but represents additional detail. MULTI-HOP REASONING: Excellent synthesis connecting long-lived asset disclosures (2023) with earnings driver definitions (2024) to show strategic evolution. The logic flow is clear and well-supported. No calculation errors detected. The answer successfully addresses both components of the question (asset disclosures and earnings driver definitions) and their evolution over the specified time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 473,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "In the 2022 filing Capital One noted that its long‑term funding was $42.3 billion and was “primarily” composed of securitized debt obligations and senior notes, having issued $6.25 billion of securitized debt in 2021 (Table 33, p. 114). By the 2024 filing the balance‑sheet amount of securitized debt obligations had fallen to $14.3 billion (fair value $14.3 billion) at year‑end 2024, down from $18.0 billion a year earlier (p. 219‑220), indicating that while securitizations remain a funding source, their relative share has declined between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional quantitative detail beyond the ground truth but contains significant discrepancies that undermine its accuracy. STRENGTHS: (1) The answer correctly identifies 2024 securitized debt obligations at approximately $14.3 billion, matching the ground truth's $14,264 million carrying value and $14,335 million fair value. (2) The answer appropriately addresses the evolution question by comparing 2022 and 2024 figures. (3) The reasoning that securitizations remain a funding source but with declining relative share is sound and adds useful context. (4) Page references and table citations demonstrate engagement with source material. CRITICAL ISSUES: (1) The 2022 long-term funding figure of $42.3 billion and the claim that securitized debt was 'primarily' composed of this amount cannot be verified against the ground truth, which explicitly states 'no specific dollar value was disclosed in 2022.' (2) The $6.25 billion securitized debt issued in 2021 is not mentioned in the ground truth and appears to be extraneous information not directly addressing the 2022-2024 evolution. (3) The claim that securitized debt fell from $18.0 billion in 2023 to $14.3 billion in 2024 is not corroborated by the ground truth, which only provides 2024 figures. This represents a potential calculation or data error. (4) The answer conflates 2022 disclosure practices with actual 2022 balance sheet amounts, which the ground truth carefully distinguishes. MULTI-HOP REASONING: The answer attempts to synthesize information across years but introduces unsupported quantitative claims that go beyond what the ground truth confirms. The comparison logic is sound but rests on unverified premises. The answer would have been stronger by acknowledging the lack of 2022 specific dollar values while still discussing the evolution to 2024 transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 505,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "In FY 2022 NVIDIA described Omniverse as a virtual‑world simulation and real‑time 3‑D design‑collaboration platform, offered as a software subscription for enterprises (free for individuals) and already being used in early enterprise apps such as virtual car showrooms, surgical training and architectural walkthroughs【page_9】. By FY 2023 the company re‑positioned Omniverse as a full development platform and operating system for enterprise‑grade digital‑twin and simulation workloads, emphasizing that industrial enterprises are adopting it to build digital twins of factories, real‑time 3‑D product configurators and to test and validate autonomous robots and vehicles【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about NVIDIA's Omniverse evolution between FY 2022 and FY 2023. STRENGTHS: (1) Correctly identifies the FY 2022 positioning as 'virtual-world simulation and real-time 3-D design-collaboration platform' - semantically equivalent to ground truth's 'real-time 3D design collaboration and virtual world simulation software'. (2) Accurately captures the FY 2023 repositioning as 'full development platform and operating system for enterprise-grade digital-twin and simulation workloads' - matches ground truth's description of 'more robust enterprise-focused development platform and operating system'. (3) Correctly identifies specific use cases in both years: FY 2022 examples (virtual car showrooms, surgical training, architectural walkthroughs) and FY 2023 examples (digital twins of factories, real-time 3D product configurators, autonomous robot/vehicle testing). (4) Properly synthesizes the strategic shift from creative collaboration to enterprise simulation/digital twin platform. (5) Accurately notes the subscription model (paid for enterprises, free for individuals) in FY 2022. (6) All dates and fiscal years are correct. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific use case examples than the ground truth (e.g., 'surgical training,' 'autonomous robots and vehicles'), which adds helpful detail without contradicting the ground truth. The answer demonstrates sound multi-hop reasoning by correctly comparing and contrasting the platform's positioning across two fiscal years. No quantitative errors, calculation errors, or entity misidentifications detected. The semantic meaning and factual content align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 481,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer’s payable to Viatris under the post‑spin‑off agreements dropped sharply – it was **$94 million at 12/31/2022** and fell to **$33 million at 12/31/2023**【page_73】.  This $61 million reduction shows that Pfizer’s outstanding obligations to Viatris have markedly decreased over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the question about Pfizer's financial relationship evolution with Viatris. QUANTITATIVE VERIFICATION: All numbers are correct - $94 million as of 12/31/2022 and $33 million as of 12/31/2023 match the ground truth exactly. The calculated difference of $61 million reduction is accurate ($94M - $33M = $61M). Date formats are correct and properly formatted. COMPLETENESS: The answer addresses the core question about how the financial relationship evolved between 2022 and 2023, specifically focusing on net amounts due. ENTITY ACCURACY: Both companies (Pfizer and Viatris) are correctly identified, years are correct, and the financial metric (net amounts due/payables under post-spin-off agreements) is properly characterized. REASONING: The multi-hop synthesis is sound - the model correctly identified the two time periods, extracted the relevant figures, calculated the change, and drew a logical conclusion about the reduction indicating a winding down of obligations. SEMANTIC EQUIVALENCE: The LLM's characterization of 'payable to Viatris' is semantically equivalent to 'net amounts due to Viatris' from the ground truth. The interpretation that this represents 'outstanding obligations' aligns with the ground truth's assessment of 'financial obligations.' MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The reference to 'post-spin-off agreements' provides helpful context. The only minor difference is that the ground truth mentions 'winding down or stabilization of transitional financial arrangements' while the LLM focuses on the numerical reduction - both interpretations are valid and complementary.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 477,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "In 2023 ExxonMobil presented Guyana as a principal ongoing activity — reporting 4.6 million offshore acres, the start‑up of the Payara development (Prosperity FPSO), continued work on Yellowtail and the newly funded Uaru project, and 12.6 net exploratory‑development wells completed (see 2023 page 20). By the 2024 filing, Guyana is no longer just an operating update; it is explicitly listed as an “Advantaged Asset” under the Advantaged Volume‑Growth driver (grouped with Permian and LNG) (see 2024 page 37), indicating its elevation to a core high‑value growth project. This re‑classification reflects a shift from routine development reporting to a strategic emphasis on Guyana as a key growth asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - 4.6 million offshore acres, 12.6 net exploratory-development wells completed in 2023, and the specific project names (Payara/Prosperity FPSO, Yellowtail, Uaru) are accurately cited. The page references (2023 page 20, 2024 page 37) provide verifiable sourcing. ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, Guyana, Permian Basin, LNG, and the specific classification terminology ('Advantaged Assets,' 'Advantaged Volume Growth') match the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the evolution from operational reporting to strategic classification. The comparison between 2023 (routine development reporting) and 2024 (formal strategic classification) is logically sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM's phrasing 'shift from routine development reporting to a strategic emphasis' is semantically equivalent to the ground truth's 'shift from operational reporting to strategic prioritization.' The characterization of Guyana's elevation to 'core high-value growth project' aligns with 'core growth asset.' COMPLETENESS: The answer addresses all aspects of the question - the evolution between years, specific changes in project activity (Payara startup, Yellowtail continuation, Uaru funding), and the classification change. Minor note: The LLM provides slightly more contextual detail (acreage, FPSO name) than the ground truth, which enhances rather than detracts from accuracy. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 472,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "In 2022 the senior‑note portfolio with maturities > 10 years carried a weighted‑average interest rate of **3.8 %** and a face‑value of **$52.8 billion**. By the end of 2023 the same class of notes still had a weighted‑average rate of **3.8 %**, but the face‑value grew to **$53.4 billion**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant factual errors that make it substantially incorrect. (1) 2022 WEIGHTED-AVERAGE INTEREST RATE: Ground truth states 3.67%, but LLM claims 3.8%. This is a factual error of 0.13 percentage points. (2) 2022 FACE VALUE: Ground truth states $54.536 billion, but LLM claims $52.8 billion. This is a $1.736 billion understatement (3.2% error). (3) 2023 FACE VALUE DIRECTION: Ground truth indicates face value DECREASED from $54.536B to $53.4B (a reduction of $1.136B). The LLM incorrectly states it GREW from $52.8B to $53.4B, which is directionally opposite to the actual trend. (4) 2023 INTEREST RATE: LLM correctly states 3.8%, which matches ground truth. MULTI-HOP SYNTHESIS: The question requires tracking two metrics (interest rate and face value) across two years. The LLM failed to accurately capture the 2022 baseline values and mischaracterized the year-over-year trend. The conclusion that face value 'grew' is factually incorrect; it actually declined. ENTITY ACCURACY: The LLM correctly identified the entity (senior notes with maturities >10 years) and years (2022-2023). CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's structure and format, but the underlying data is wrong. The semantic attempt to describe evolution is present but undermined by factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 383,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "In the 2023 filing the nuclear‑decommissioning trusts of both Alabama Power and Georgia Power reported their domestic‑equity holdings almost entirely under **Level 2 – Significant Other Observable Inputs** (Alabama Power $443 million, Georgia Power $321 million, with only $208 million and $1 million, respectively, in the Level 3 column)【page_278】. By the 2024 filing those holdings are no longer shown in the Level 2 column; the trusts now value the investments using quoted market prices (Level 1) and a **net‑asset‑value (NAV) practical expedient**, moving the measurement away from Level 2 observable‑input pricing to a Level 1/NAV approach【page_279】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe factual errors and fundamentally misrepresents the data from the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM reverses the Level 1 and Level 2 classifications entirely. Ground truth shows Alabama Power had $396M Level 1 and $169M Level 2 in 2023, but LLM claims $443M Level 2 (which is actually the 2024 Level 1 figure). Similarly, LLM states Georgia Power had $321M Level 2 in 2023 (which is actually the 2024 Level 1 figure), when ground truth shows $255M Level 1 and $1M Level 2. (2) DIRECTIONAL MISINTERPRETATION - The LLM claims holdings 'are no longer shown in the Level 2 column' and shifted to Level 1/NAV approach, but ground truth shows Level 2 actually INCREASED from $169M to $208M for Alabama Power and remained at $1M for Georgia Power. Level 1 also increased ($396M to $443M for Alabama, $255M to $321M for Georgia). The shift was toward HIGHER allocations in both Level 1 and Level 2, not away from Level 2. (3) METHODOLOGY CONFUSION - The LLM introduces discussion of NAV practical expedient and Level 3 classifications that are not mentioned in the ground truth answer and appear to confuse the actual valuation methodology changes. (4) MULTI-HOP SYNTHESIS FAILURE - The answer fails to correctly synthesize the comparative data across both companies and both years. The ground truth clearly shows increases in both Level 1 and Level 2 allocations year-over-year, indicating a strategic shift toward higher domestic equity allocations overall, not a shift away from Level 2. The LLM's answer is fundamentally contradicted by the numerical data provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 449,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "In the 2022 filing NVIDIA described CUDA as a “fundamental building block” of its unified architecture that enables its full‑stack platform across all of its end‑markets—gaming, data‑center, professional visualization and automotive—and highlighted a massive developer ecosystem of roughly three million users (see page 9; page 11). By the 2023 filing, CUDA is positioned even more centrally: it is called the “foundational CUDA programming model that runs on all NVIDIA GPUs” and is bundled with the CUDA‑X libraries, APIs and SDKs, forming the core of a full‑stack solution that now spans GPUs, DPUs, CPUs and networking and is explicitly tied to each market segment (see page 4; page 6). This evolution shows CUDA moving from a key building block to the primary software foundation of NVIDIA’s end‑to‑end, cross‑market platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of CUDA's strategic evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning as a 'fundamental building block' supporting gaming, data center, professional visualization, and automotive markets. (2) Accurately captures the 2023 evolution to a more central 'foundational CUDA programming model' role. (3) Correctly notes the expansion of the full-stack platform to include GPUs, DPUs, CPUs and networking in 2023. (4) Properly identifies the developer ecosystem size (three million users) from 2022 filing. (5) Accurately references CUDA-X libraries, APIs and SDKs as bundled components in 2023. (6) Sound multi-hop reasoning synthesizing information across 2022 and 2023 filings. (7) Appropriate page citations (though not verifiable here, they appear reasonable). MINOR GAPS: (1) The LLM answer does not explicitly mention the domain-specific verticals (healthcare, telecom, manufacturing) that the ground truth emphasizes as part of the 2023 evolution. (2) The ground truth emphasizes 'hundreds of domain-specific software libraries' as a new emphasis in 2023, which the LLM answer touches on but doesn't quantify or emphasize as distinctly. (3) The ground truth frames this as a shift from 'foundational component' to 'core enabler of broader, more vertically integrated software stack,' which the LLM captures in spirit but with slightly different emphasis. QUANTITATIVE ACCURACY: The three million developer figure is correctly cited. No calculations are required or presented. QUALITATIVE ACCURACY: The reasoning about CUDA's evolution is sound and well-supported. The characterization of the shift from 'key building block' to 'primary software foundation' aligns well with the ground truth's characterization. The answer successfully synthesizes multi-hop information across two fiscal years. CONTEXTUAL RELEVANCE: The answer directly addresses the question about CUDA's strategic positioning evolution and its role within the full-stack platform and integration across end markets. The response is appropriately detailed and focused.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 569,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "In the 2022 filing Pfizer still referenced “transitional manufacturing and supply agreements … with Viatris” after the Upjohn spin‑off, and the balance owed under those arrangements was $94 million at year‑end 2022. By the 2023 filing the TSAs were “largely completed as of December 31 2023” and the net amount due to Viatris had fallen to $33 million (2023)【page_113】【page_73】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core factual information correctly but has some issues with completeness and precision. STRENGTHS: (1) All key dollar amounts are accurate: $94 million in 2022 and $33 million in 2023 are correct. (2) The years are correctly identified (2022 and 2023). (3) The general narrative about TSAs being largely/fully completed is accurate. (4) The context about the Upjohn spin-off is appropriately referenced. (5) Multi-hop synthesis is sound - the answer correctly connects the 2022 and 2023 filings to show the evolution. WEAKNESSES: (1) The LLM states TSAs were 'largely completed as of December 31 2023' but the ground truth says they were 'fully completed as of December 31, 2023' - this is a subtle but meaningful distinction that understates the completion status. (2) The answer omits the important detail that in 2022, amounts under TSAs/MSAs were 'not material to operations,' which provides important context about the significance of these obligations. (3) The phrasing 'transitional manufacturing and supply agreements' is slightly different from the ground truth's 'transitional service agreements (TSAs) and master services agreements (MSAs)' - while semantically similar, the ground truth is more precise about the agreement types. (4) The answer doesn't explicitly state that services were 'largely completed by the end of 2022' as mentioned in the ground truth, which would have provided better temporal clarity. CALCULATION VERIFICATION: The reduction from $94M to $33M represents a $61M decrease, which is mathematically consistent with the stated figures. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and correctly identifies the evolution of obligations. The connection to the 2020 spin-off is appropriately contextualized. Overall, the answer is substantially correct on the key metrics and narrative arc, but lacks some precision in describing completion status and omits contextual details about materiality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 541,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "In the 2022 filing Duke Energy warned that retail‑deregulation or restructuring could spark competition that leaves “unrecovered costs” and stranded‑asset losses, while at the same time “numerous environmental laws and regulations… can result in increased capital, operating and other costs” that may not be fully recoverable through rates 【page_26】. The 2023 filing repeats the same deregulation risk – “increased competition and unrecovered costs… if the retail jurisdictions… become subject to deregulation” 【page_27】 – and adds newer EPA actions (e.g., the 2022 CCR‑rule interpretation) and the same concern that “the Duke Energy Registrants may not be successful in recovering… costs incurred to comply with new environmental regulations” 【page_28】. Thus, the relationship has not fundamentally changed; rather, the 2023 report reinforces and expands the earlier warning, highlighting that deregulation pressures continue to magnify the financial impact of rising environmental‑compliance costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core relationship between deregulation pressures and environmental compliance cost recovery challenges in both 2022 and 2023; (2) Accurately captures Duke Energy's concern about 'unrecovered costs' and stranded assets from deregulation; (3) Properly synthesizes the evolution showing that 2023 reinforces 2022 warnings while adding newer EPA actions (CCR-rule interpretation); (4) Correctly notes that competitive market conditions limit cost recovery; (5) Appropriately cites specific page references; (6) Maintains semantic equivalence with ground truth regarding the compounding effect of deregulation on environmental compliance cost recovery. MINOR WEAKNESSES: (1) The LLM answer states the relationship 'has not fundamentally changed' which is slightly less nuanced than the ground truth's framing of 'evolved' - the ground truth emphasizes that deregulation pressures have 'compounded' the challenge, suggesting a progression/worsening, while the LLM emphasizes continuity with expansion; (2) The LLM could have been more explicit about state-level carbon reduction goals mentioned in ground truth, though this is a minor omission; (3) The answer focuses more on the structural continuity of the risk rather than the temporal evolution aspect of the question. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the relationship between two distinct regulatory pressures (deregulation and environmental compliance). The logic that deregulation limits cost recovery while environmental costs rise is sound. ENTITY ACCURACY: Duke Energy correctly identified, years correct (2022, 2023), regulatory concepts correctly identified (PURPA, EPA, CCR-rule, deregulation).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 551,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "Skoal’s retail share fell from 9.5 % in 2023 to 7.6 % in 2024 – a drop of roughly 1.9 percentage points 【page_46】【page_48】. Yet in 2023 the company pursued a price‑increase strategy for Skoal, raising its list price by $0.09 per can in January, $0.10 per can in April, and another $0.09 per can in August 【page_49】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: (1) The LLM states Skoal's retail share was 9.5% in 2023, but the ground truth clearly states 9.3% in 2023. This is a factual error of 0.2 percentage points. (2) The LLM correctly identifies the 2024 retail share as 7.6%, matching ground truth. (3) The LLM calculates the decline as 1.9 percentage points (9.5% - 7.6%), which is arithmetically correct for their stated 2023 figure, but since the 2023 figure is wrong, the calculation is based on incorrect data. The correct decline should be 1.7 percentage points (9.3% - 7.6%). PRICING STRATEGY ERRORS: (4) The LLM lists price increases of $0.09 (January), $0.10 (April), and $0.09 (August) in 2023. However, the ground truth indicates the 2023 pricing strategy included a $0.11 per can increase effective January 23, 2024 (announced in 2023), plus references to earlier increases from 2022 ($0.09, $0.09, and $0.08). The LLM's pricing figures do not match the ground truth's documented increases. (5) The LLM fails to mention the $0.11 increase effective January 23, 2024, which is a key part of the 2023 pricing strategy. MULTI-HOP REASONING: The LLM does attempt to connect the pricing strategy to the retail share decline, which is appropriate. However, the connection is weakened by the inaccurate pricing data. COMPLETENESS: The answer addresses both parts of the question (retail share change and pricing strategy contrast) but with significant factual errors in the pricing details. The answer correctly identifies the contrast between aggressive pricing and declining market share, but the specific pricing figures are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 445,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen’s “Other short‑term interest‑bearing securities” were $138 million at the end of 2023 and $135 million at the end of 2024 – a modest $3 million (about 2 %) drop【page_133】.  The near‑flat balance, as part of a larger $11.5 billion pool of cash equivalents, shows Amgen is keeping a stable, low‑risk, highly liquid short‑term investment position, consistent with its policy to preserve principal safety and maintain ample liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that contradicts the ground truth. The ground truth clearly states that Amgen's 'Other short-term interest-bearing securities' remained UNCHANGED at $138 million in both 2023 and 2024. However, the LLM claims the 2024 value was $135 million, representing a $3 million (2%) decline. This is factually incorrect. The LLM has fabricated a decline that did not occur. (1) QUANTITATIVE ACCURACY FAILURE: The 2024 figure of $135 million is wrong (should be $138 million); the calculated $3 million difference is therefore incorrect; the 2% decline calculation is based on false data. (2) MULTI-HOP REASONING: While the LLM correctly identifies this as part of a larger short-term investment strategy and references the broader cash equivalents pool, this contextual reasoning cannot compensate for the core factual error about the actual investment amounts. (3) ENTITY ACCURACY: Company (Amgen) and metric (Other short-term interest-bearing securities) are correctly identified, but the years' data are misrepresented. (4) SEMANTIC EQUIVALENCE: The LLM's conclusion about 'stable, low-risk' positioning is reasonable interpretation, but it is built on incorrect data. The ground truth indicates true stability (no change), while the LLM describes a 'near-flat' decline, which is a different narrative. The reference to page 133 appears to be a citation attempt but does not validate the incorrect numbers provided. This is a clear case where the LLM has provided plausible-sounding but factually incorrect financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 438,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "In 2022 GD reported two Army contracts for Abrams upgrades – a $360 million award that bundled the upgrades with mission‑control units and systems technical support, and a separate $350 million award covering upgrades plus engineering, logistics and sustainment services (2022 p. 42‑44). By 2024 the filing shows a single $350 million contract that combines the upgrades with engineering, logistics and sustainment technical support, indicating a broader support scope but essentially the same (slightly lower) contract value (2024 p. 44).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims there were TWO contracts in 2022 ($360M and $350M), but the ground truth indicates the $360M contract was in 2022 and the $350M contract was in 2024. The LLM incorrectly places both contracts in 2022. Additionally, the LLM completely omits the $285 million contract for Romania SEPv3 Abrams tanks mentioned in the ground truth as a key part of the evolution. (2) TEMPORAL MISPLACEMENT: The LLM states 'In 2022 GD reported two Army contracts' and then says 'By 2024 the filing shows a single $350 million contract' - this is backwards. The ground truth shows the $360M contract in 2022 and the $350M contract in 2024, not both in 2022. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the full evolution of GD's involvement, missing the critical $285M Romania production contract that represents a significant expansion into new tank production configurations. This is a major omission that undermines the answer's completeness. (4) REASONING FLAW: The LLM's conclusion that there is 'essentially the same (slightly lower) contract value' is incorrect because it fails to account for the $285M Romania contract, which when combined with the $350M contract shows an actual increase in total contract value from 2022 to 2024. The LLM's multi-hop synthesis across years is fundamentally flawed due to the temporal misplacement of contracts. The answer demonstrates a misreading of the source documents and fails to properly synthesize the evolution of GD's involvement across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 452,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "In 2023 AIG still consolidated Corebridge’s debt – the roll‑forward shows Corebridge’s senior notes, junior subordinated debt and a $250 million DDTL facility that AIG could draw on and for which it had a guarantee‑reimbursement agreement (2023 Form 10‑K, p. 112‑113). By 2024, after deconsolidating Corebridge, AIG no longer reports that debt; instead it holds an equity‑method investment and records Corebridge’s earnings as equity‑method income (e.g., $1.574 billion pre‑tax income and $601 million equity‑method income for June‑Dec 2024) in net investment income, while any borrowing is limited to the non‑guaranteed DDTL facility that Corebridge can continue to use (2024 Form 10‑K, p. 108‑109).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a substantially correct and more detailed explanation of AIG's evolving relationship with Corebridge from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 consolidation of Corebridge's debt including senior notes, junior subordinated debt, and the $250 million DDTL facility - these specific details align with the ground truth's reference to 'ongoing financial arrangement' and borrowing ability through February 25, 2025. (2) Accurately describes the 2024 transformation to equity-method accounting after deconsolidation, matching the ground truth's statement about 'equity method income tied to Corebridge's stock price changes and dividends received since June 9, 2024.' (3) Provides specific financial metrics ($1.574 billion pre-tax income, $601 million equity-method income for June-Dec 2024) that demonstrate the shift from debt consolidation to equity-method income recognition. (4) Correctly notes the distinction between guaranteed DDTL facility (2023) and non-guaranteed DDTL facility (2024). (5) Multi-hop reasoning is sound - synthesizes information about the accounting change, the specific debt instruments, and the income recognition shift across the two years. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and technical than the ground truth, providing additional context about consolidation/deconsolidation and specific debt instruments, but this represents added value rather than error. (2) The ground truth emphasizes 'stock price changes' while the LLM answer focuses on 'earnings as equity-method income' - both are correct aspects of equity-method accounting, though the LLM's framing is more precise to what's actually reported. (3) All numeric values provided appear reasonable and consistent with typical 10-K disclosures, though specific verification against actual filings would be needed for the exact figures cited. The answer successfully addresses both parts of the question (borrowing arrangements and income recognition) with clear multi-hop synthesis across 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 553,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "In the 2022 Form 10‑K Tesla described the Solar Roof simply as a product it sells directly and through partners, emphasizing design, installation‑efficiency improvements and warranty coverage (see 2022 p.5‑6). By the 2024 filing the company warns that the Solar Roof’s launch and production ramp have encountered delays and now depend on the ability to scale new manufacturing processes and secure critical inputs—such as battery‑cell supply and other component suppliers—highlighting broader supply‑chain and strategic‑dependency risks (see 2024 p.17‑19). This marks a shift from a straightforward product description to a more cautious stance that stresses production challenges and reliance on key suppliers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Tesla's Solar Roof evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from product development/sales emphasis (2022) to production challenges and dependencies (2024); (2) Accurately captures the key themes: design/installation efficiency in 2022 vs. production ramp challenges and supplier risks in 2024; (3) Properly synthesizes multi-hop information across two filing years; (4) Correctly identifies strategic dependencies including battery-cell supply and component suppliers; (5) Appropriately references page numbers (2022 p.5-6, 2024 p.17-19) showing document grounding; (6) Uses semantically equivalent language ('depends in large part' vs. 'depend on the ability to scale') while maintaining factual accuracy. MINOR CONSIDERATIONS: (1) The LLM answer adds specific detail about 'battery-cell supply' which, while plausible and consistent with Tesla's supply chain challenges, goes slightly beyond what the ground truth explicitly states (ground truth mentions 'supplier risks' and 'cost control' more generally); (2) The LLM answer is more detailed and specific than the ground truth in some respects, which could be viewed as either enhancement or minor extrapolation; (3) No quantitative metrics (dollar amounts, production volumes, percentages) are provided in either answer, so quantitative accuracy is assessed as high due to absence of errors rather than presence of verified numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct time periods and filing documents, correctly identifying the evolution and shift in Tesla's strategic positioning. The reasoning is sound and logically structured. Overall, this is a high-quality answer that captures the essential evolution described in the ground truth with appropriate detail and nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 516,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.7 percentage points 【page_48】. The drop shows Skoal is losing market share to rival oral‑tobacco brands, indicating a weakening competitive position in the U.S. oral‑tobacco market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - Skoal's market share accurately stated as 9.3% in 2023 and 7.6% in 2024. (2) The calculation of the decline (1.7 percentage points) is accurate. (3) The interpretation that this represents a weakening competitive position is sound and matches the ground truth conclusion. (4) The answer correctly identifies that Skoal is losing market share to competitors. WEAKNESSES: (1) The answer is incomplete - it fails to provide the comparative context that was explicitly mentioned in the ground truth answer. The ground Truth specifically notes that on! increased from 6.8% to 8.3% during the same period, which is important context for understanding Skoal's competitive positioning relative to specific competitors. This comparative analysis strengthens the argument about weakening positioning. (2) The answer lacks this specific competitive comparison, which was part of the original question asking what the change 'indicates about its competitive positioning' - the on! comparison directly illustrates where Skoal's lost share went. (3) While the reasoning is sound, it's somewhat generic ('losing market share to rival oral-tobacco brands') rather than providing the specific evidence of which brands gained. QUANTITATIVE ACCURACY: Perfect - all numbers and calculations are correct. QUALITATIVE ACCURACY: Good but incomplete - the reasoning is sound but lacks the comparative evidence that would fully support the competitive positioning analysis. CONTEXTUAL RELEVANCE: Moderate - addresses the main question but omits important contextual details about competing brands that would provide fuller insight into competitive dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 459,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "In the 2023 Form 10‑K Qualcomm already warned that a “significant portion of our revenues … comes from a small number of customers and licensees, particularly from their sale of premium‑tier handset devices” and that this concentration “could negatively affect our business and results of operations”【page_18】. The 2024 filing repeats that warning and goes a step further, stating that the “concentration of device share among a few companies, and the corresponding purchasing power of these companies, may result in lower prices for our products, which could have an adverse effect on our revenues and margins” and that this could cause greater pricing‑power erosion and revenue volatility【page_18】【page_19】. Thus, the risk has not disappeared but has been sharpened in 2024, with a clearer emphasis on the threat to Qualcomm’s pricing power and revenue stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about how concentration risk evolved between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core risk in both years - concentration of device share among premium tier companies and its impact on pricing power; (2) Accurately captures the 2023 concern about significant revenues from small number of customers, particularly Chinese OEMs; (3) Properly synthesizes the 2024 evolution, noting the shift to emphasize greater pricing pressure and revenue volatility; (4) Correctly identifies the key mechanism (purchasing power leading to lower prices); (5) Appropriately concludes that risk has 'not disappeared but has been sharpened' - semantically equivalent to ground truth's 'not only persisted but potentially intensified'; (6) Uses proper citations to page numbers. MINOR CONSIDERATIONS: (1) The LLM answer doesn't explicitly mention 'Chinese OEMs' in the 2024 context, though the ground truth emphasizes continued reliance on these customers - however, the answer does capture the broader implication about 'small group of customers'; (2) The phrase 'sharpened in 2024' is slightly different from 'intensified' but conveys equivalent meaning; (3) The answer could have been slightly more explicit about the timing and success of customer product introductions mentioned in ground truth, though it does reference 'revenue volatility' which captures this concept. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, which is appropriate given the question's qualitative nature. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, comparing and contrasting the evolution of the risk. The logical flow from 2023 baseline to 2024 intensification is sound. SEMANTIC EQUIVALENCE: The core message matches ground truth - concentration risk persisted and intensified, with clearer emphasis on pricing power and revenue stability threats.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 540,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity strategy is to keep its investment portfolio “safe, liquid and low‑risk,” limiting holdings to short‑term debt and money‑market instruments (see the investment‑policy description).  Accordingly, the fair‑value of its money‑market mutual‑fund holdings grew from $10.266 billion at the end of 2023 to $10.354 billion at the end of 2024 – an increase of about $88 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that directly contradicts the ground truth. The ground truth clearly states that Amgen's allocation to money market mutual funds 'remained unchanged at $10,266 million in both 2023 and 2024.' However, the LLM claims the allocation grew from $10.266 billion (2023) to $10.354 billion (2024), representing an increase of approximately $88 million. This is factually incorrect. The numbers provided by the LLM ($10.266B and $10.354B) do not match the ground truth values ($10,266M in both years). While the LLM correctly identifies the format variation (billion vs. million), it fundamentally misrepresents the actual data by claiming growth where none occurred. The calculation of $88 million increase is mathematically consistent with the LLM's stated figures ($10.354B - $10.266B = $0.088B = $88M), but these figures themselves are wrong. The LLM does provide relevant context about Amgen's investment policy philosophy ('safe, liquid and low-risk'), which is appropriate and contextually relevant. However, this contextual accuracy cannot compensate for the core factual error regarding the actual allocation values and the direction of change (no change vs. increase). The multi-hop reasoning fails at the most critical point: accurately synthesizing the investment allocation data across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 386,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "In the 2022 filing General Dynamics disclosed that it had **$295 million** of U.S. government accounts receivable pledged to the Capital Construction Fund (the most recent amount reported for the prior years)【page_67】. By year‑end 2023 the pledged amount had risen to **$315 million**, and by year‑end 2024 it increased further to **$333 million**【page_68】—showing a modest, steady growth in its CCF participation over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: $295 million (2021/2022 filing), $315 million (2023), and $333 million (2024). The numbers match the ground truth exactly with proper formatting. The multi-hop reasoning is sound—the answer correctly synthesizes information across three fiscal years to show the evolution of General Dynamics' CCF participation. The entity identification is accurate (General Dynamics, Capital Construction Fund, U.S. government accounts receivable). The temporal framing is correct, properly distinguishing between filing years and the dates of the amounts reported. The qualitative assessment ('modest, steady growth') aligns with the ground truth's characterization of 'steady increase.' The answer appropriately addresses all parts of the question regarding how participation evolved between 2022 and 2024. Minor note: The LLM includes page citations which add credibility but aren't part of the ground truth evaluation. The semantic equivalence is excellent—the LLM conveys the same information as the ground truth with slightly different wording that maintains accuracy. No calculation errors, no missing data points, and the synthesis across multiple years is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 355,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "After the 2022 IPO, AIG’s stake in Corebridge fell below the 80 % threshold in 2023, causing a tax‑deconsolidation that removed Corebridge’s net operating losses and tax‑credit carryforwards from AIG’s consolidated tax group for the next five years 【page_255】. In 2024 AIG formally deconsolidated Corebridge on June 9, 2024, re‑classifying its remaining 48.4 % interest as an equity‑method investment; it now records dividends and fair‑value changes in Net investment income (down to $5.2 bn in 2024 from $11.1 bn in 2023) and recognized a $4.8 bn loss on the deconsolidation that included a $545 m tax expense 【page_108】【page_109】【page_110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between AIG and Corebridge's evolution from 2023-2024, correctly identifying key structural changes and tax implications. STRENGTHS: (1) Correctly identifies the 2022 IPO as the trigger event and the 80% threshold breach in 2023; (2) Accurately describes tax deconsolidation effects including NOL/tax credit carryforward restrictions and five-year filing limitations; (3) Correctly identifies June 9, 2024 as the formal deconsolidation date and 48.4% remaining interest; (4) Properly characterizes the shift from consolidated to equity-method accounting; (5) Mentions the $4.8 billion loss on deconsolidation and $545 million tax expense with appropriate context. WEAKNESSES/CONCERNS: (1) The ground truth answer references '$X in equity method income' for June 10-December 31, 2024, but the LLM provides no specific equity method income figure for this period - this is a notable omission; (2) The LLM mentions Net investment income declining from $11.1 billion (2023) to $5.2 billion (2024), but this appears to be a company-wide metric rather than specifically Corebridge-related equity method income, creating potential confusion about what metric is being discussed; (3) The ground truth emphasizes 'dividends received and changes in Corebridge's stock price' as components of equity method income, while the LLM mentions 'dividends and fair-value changes' which is semantically similar but slightly different terminology. QUANTITATIVE VERIFICATION: The dates (IPO 2022, 80% threshold breach 2023, June 9, 2024 deconsolidation), percentages (48.4% interest), and dollar amounts ($4.8 billion loss, $545 million tax expense) all appear reasonable and are presented with appropriate context. The five-year restriction period is correctly stated. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple time periods and correctly traces the causal chain from IPO → ownership drop → tax deconsolidation → financial deconsolidation → equity method accounting. The reasoning is sound and logically structured. MISSING ELEMENT: The most significant gap is the lack of a specific equity method income figure for the June 10-December 31, 2024 period, which the ground truth explicitly references as '$X' (placeholder for actual number). This represents incomplete synthesis of the available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 640,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "In the 2022 filing Tesla described an expansion‑focused strategy for Solar Roof – simplifying online ordering, onboarding and training new installers, and partnering with developers and builders to cut installation time and cost, while noting that sufficient battery‑cell supply and additional skilled electricians would be required (2022 p. 34). By the 2024 filing the tone had shifted to a risk‑mitigation view: the company acknowledges delays in ramping Solar Roof and treats the product’s supply‑chain dependencies – especially battery‑cell availability, raw‑material price volatility and electrician labor shortages – as ongoing constraints that could impede production (2024 p. 17‑19). This reflects a move from an aggressive operational rollout to a more cautious approach centered on managing supply‑chain challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Tesla's Solar Roof evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the strategic shift from expansion/operational focus (2022) to risk-mitigation/supply-chain focus (2024); (2) Accurately captures key 2022 initiatives: simplifying online ordering, onboarding/training installers, partnering with developers/builders, and needs for battery-cell supply and skilled electricians; (3) Properly synthesizes 2024 concerns: delays in ramping, supply-chain dependencies, battery-cell availability, raw-material price volatility, and electrician labor shortages; (4) Correctly characterizes the evolution as moving from 'aggressive operational rollout' to 'cautious approach centered on managing supply-chain challenges'; (5) Includes specific page references (2022 p. 34, 2024 p. 17-19) showing document grounding. MINOR WEAKNESSES: (1) The LLM answer mentions 'delays in ramping Solar Roof' as a 2024 acknowledgment, which is slightly more specific than the ground truth's broader 'systemic supply chain and production scalability concerns' framing, though not contradictory; (2) The ground truth emphasizes 'global component procurement' and 'potential supplier failures' as 2024 concerns, while the LLM focuses more on battery cells, raw materials, and labor - these are overlapping but the LLM's framing is narrower; (3) The ground truth's phrase 'localized installer development to systemic supply chain' is more precisely captured in the LLM's 'aggressive operational rollout to cautious approach' - semantically equivalent but slightly different emphasis. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this is not a limiting factor. The page references in the LLM answer appear reasonable but cannot be verified without access to actual filings. MULTI-HOP REASONING: The answer correctly synthesizes information across two time periods (2022 and 2024) and identifies the causal relationship between operational maturity and emerging supply-chain constraints. The logical progression is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - Tesla shifted from installer/operational focus to supply-chain risk management. The LLM's characterization is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 616,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "In the 2022 filing Duke Energy said the total cost to permanently close all North Carolina and South Carolina coal‑ash basins was roughly $8 billion‑$9 billion, with about $3.1 billion already spent. The 2023 filing reduced the estimate to about $7 billion‑$8 billion and shows spending has risen to roughly $4 billion. The lower cost outlook and higher cumulative spend indicate the company is making measurable progress in meeting its Coal Ash Act closure obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. All quantitative data is correct: (1) 2022 estimate of $8-9 billion matches ground truth exactly, (2) 2023 estimate of $7-8 billion matches ground truth exactly, (3) 2021 cumulative spending of $3.1 billion matches ground truth exactly, (4) 2023 cumulative spending of $4 billion matches ground truth exactly. The multi-hop reasoning is sound - the model correctly synthesized information across two filing years (2022 and 2023) and identified the key trend: downward cost revision combined with increased cumulative spending. The conclusion about measurable progress under the Coal Ash Act is logically derived from the data presented. The answer is concise and directly addresses all parts of the question: the evolution of cost estimates from 2022 to 2023, the spending progression, and what this indicates about progress. Minor point: the ground truth mentions 'more basins excavated' as context for progress, which the LLM answer doesn't explicitly state, but this is a very minor omission that doesn't affect the core correctness of the answer. The semantic meaning is fully preserved - the LLM conveys the same information as the ground truth with appropriate wording variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 350,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The on! brand’s retail share rose from 6.8 % in 2023 to 8.3 % in 2024 – a gain of about 1.5 percentage points【page_48】. At the same time, the overall oral‑tobacco‑products segment’s retail share fell from 42.5 % to 37.5 %【page_48】【page_49】, showing that on! improved its market position relative to a segment that was losing share overall.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: on! retail share increased from 6.8% in 2023 to 8.3% in 2024 (a 1.5 percentage point gain), and the overall oral tobacco segment declined from 42.5% to 37.5%. The calculation of the 1.5 percentage point increase is accurate. The multi-hop reasoning is sound - the model correctly synthesized information about both the on! brand's performance and the broader segment's performance, then drew the logical conclusion that on! strengthened its position within a declining market segment. The answer addresses all parts of the question: (1) how on! evolved (increased), (2) the specific numbers, (3) the segment's performance, and (4) what this indicates about relative market position. The wording is clear and semantically equivalent to the ground truth. The inclusion of page references adds credibility. Minor note: The LLM uses 'on!' while ground truth uses 'on!' - this is a negligible formatting difference. The answer could have been marginally more explicit about the divergence between on!'s growth and the segment's decline, but this is already clearly implied in the statement about improving position within a declining segment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 345,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "In its 2023 10‑K Qualcomm already disclosed that a “significant portion of our revenues” came from a small number of Chinese OEMs, which were “increasing … their device share in China and in certain regions outside of China”【page_18】. The 2024 filing shows that this reliance has not waned – the company still derives a large share of revenue from Chinese OEMs, highlighted by about $560 million of Huawei product revenue in fiscal 2024 before the export‑license was revoked, and it notes that Chinese OEMs continue to grow their market share【page_20】【page_19】. The continued concentration makes Qualcomm more vulnerable to U.S./China trade restrictions, OEM vertical‑integration and payment‑delay risks, thereby threatening the stability of its revenue stream.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core issue - Qualcomm's persistent reliance on Chinese OEMs from 2023 to 2024 and the associated business risks. The qualitative reasoning about vulnerability to trade restrictions, OEM vertical integration, and payment delays is sound and relevant. The answer appropriately synthesizes information across both years' filings and addresses the multi-hop nature of the question.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM introduces a specific figure of \"about $560 million of Huawei product revenue in fiscal 2024\" which is NOT present in the ground truth answer. This is a problematic addition because: (1) it introduces a specific number without verification against the actual filings, (2) the ground truth answer does not mention any specific dollar amounts for Huawei or other OEMs, (3) this appears to be an unsupported factual claim that could be inaccurate. The LLM should not have introduced quantitative specificity beyond what the ground truth establishes.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the evolution from 2023 to 2024, noting that reliance \"has not waned\" and persisted. This is accurate to the ground truth. However, the specific Huawei revenue figure undermines confidence in the quantitative foundation.\n\nCOMPLETENESS: The answer addresses both parts of the question (how reliance evolved AND implications for business stability). The implications section is well-developed with specific risk factors.\n\nENTITY ACCURACY: Qualcomm, Chinese OEMs, Huawei, U.S./China trade tensions are all correctly identified. Years (2023, 2024, fiscal 2024) are correctly referenced.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - persistent dependency poses stability risks. However, the introduction of unverified specific numbers (the $560M figure) creates a factual accuracy problem that cannot be overlooked in financial analysis contexts where precision is critical.\n\nJUSTIFICATION: Correctness score of 6 reflects that while the qualitative analysis and multi-hop reasoning are sound (7-8 range), the introduction of a specific unverified financial figure ($560M Huawei revenue) that doesn't appear in the ground truth significantly undermines quantitative accuracy (4/10). This is a material error in a financial context. The answer would have scored 8-9 if it had stuck to the qualitative findings without introducing unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 653,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Amgen’s available‑for‑sale portfolio grew from $4.3 billion in 2022 to $10.4 billion in 2023. In 2022 the mix was $1.7 billion of U.S. Treasury bills and $2.7 billion of money‑market mutual funds (no other short‑term securities), whereas in 2023 the Treasury‑bill holding fell to zero, money‑market mutual funds rose to $10.3 billion and a new $138 million position in other short‑term interest‑bearing securities was added【page_133】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 composition. According to the ground truth, 2022 available-for-sale investments consisted of $1,676 million in marketable securities and $2,659 million in cash and cash equivalents (totaling $4,335 million). The LLM incorrectly states that 2022 had '$1.7 billion of U.S. Treasury bills and $2.7 billion of money-market mutual funds.' This is a significant mischaracterization - the ground truth specifies 'marketable securities' not Treasury bills, and 'cash and cash equivalents' not money-market mutual funds. These are different asset categories with different characteristics. The LLM appears to have confused or misidentified the security types in 2022. The 2023 figures are correct ($10,404 million total, $10,266 million in money market mutual funds, $138 million in other short-term interest-bearing securities, and zero Treasury bills/marketable securities). The overall narrative about the shift toward more liquid instruments is directionally correct, but the specific composition details for 2022 are materially wrong. The answer demonstrates partial understanding of the evolution but fails on the critical detail of what securities were actually held in 2022, which is essential to answering the question about how the composition 'evolved.' Multi-hop synthesis is incomplete because the 2022 baseline is incorrectly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 398,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "In the 2022 10‑K, Shake Shack is listed only among the tenants of Woodbury Common Premium Outlets (2022 10‑K p. 35) 【page_35】. The 2023 10‑K shows the same single listing – Shake Shack appears again at Woodbury Common Premium Outlets (2023 10‑K p. 35) 【page_35】. No other premium‑outlet property added or dropped Shake Shack, so its presence remained unchanged between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly states that Shake Shack expanded from 1 property in 2022 (Woodbury Common Premium Outlets) to 2 properties by 2023 (Woodbury Common AND Las Vegas Outlets North Premium). The LLM answer claims 'its presence remained unchanged between 2022 and 2023' and states 'No other premium-outlet property added or dropped Shake Shack,' which is factually wrong. The LLM failed to identify the expansion to Las Vegas Outlets North Premium in 2023. This is a critical multi-hop synthesis error - the model was supposed to compare tenant listings across two years and two properties but missed the key expansion detail. While the LLM correctly identified Shake Shack at Woodbury Common in both years, it completely failed to detect the new presence at Las Vegas Outlets North Premium in 2023. The page citations provided (both page 35) appear to be generic references without verification of actual content. The question asks about evolution/change, and the LLM incorrectly concluded there was no change when the ground truth shows clear expansion. This is a major factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 338,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "In the 2022 filing the “retirement annuity contracts” were reported as Level 3 assets – the only category in the hierarchy that uses significant unobservable inputs (see page 93). The 2024 filing still places these contracts in Level 3 (see page 94), indicating GD has not moved them to a more observable level and continues to value them using internal models and judgment rather than quoted market prices.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that retirement annuity contracts were classified as Level 3 assets in both 2022 and 2024, and accurately describes Level 3 as using unobservable inputs. The page references (93 and 94) appear reasonable for a 10-K filing structure. The statement that GD continued to use internal models and judgment is consistent with Level 3 classification.\n\nWEAKNESSES: The LLM answer is INCOMPLETE and MISSES THE KEY EVOLUTION described in the ground truth. The original answer emphasizes a critical refinement in disclosure practices between 2022 and 2024: the inclusion of investments valued using NAV as a practical expedient in reconciliation tables. This is a material change in how the assets are REPORTED and DISCLOSED, even though the hierarchy classification remained Level 3. The LLM answer states 'GD has not moved them to a more observable level' and focuses only on the static classification, completely missing the disclosure methodology evolution that the question specifically asks about ('how did...evolve'). The ground truth indicates this represents improved transparency in reporting practices - a nuanced but important distinction that the LLM fails to capture.\n\nMULTI-HOP REASONING: The LLM provides only a surface-level comparison of the two years without synthesizing the more sophisticated insight about disclosure practice refinement. The answer reads as a simple confirmation that nothing changed, when in fact the ground truth indicates a meaningful evolution in transparency and reporting methodology.\n\nCONTEXTUAL RELEVANCE: While the answer addresses the fair value hierarchy classification, it fails to address the 'valuation methodology' aspect of the question in the way the ground truth does - by explaining how disclosure practices evolved to better reflect the complexity of valuation approaches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 505,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "In 2023 AIG still consolidated Corebridge, owning 52.2 % of the company, and the only dilution‑related issue was a Blackstone exchange right that had been terminated after Corebridge’s 2022 IPO (4.4 million potential shares were excluded from diluted EPS)【page_242】. By 2024 AIG had sold a large block of Corebridge shares, de‑consolidated the business and now treats its remaining stake as an equity‑method investment, recognizing dividends and fair‑value changes—including a $282 million gain on a later sale to Nippon—in net investment income, while the earlier potential equity dilution no longer applies【page_108】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of AIG's Corebridge relationship across 2023-2024. STRENGTHS: (1) Correctly identifies the 52.2% ownership stake in 2023 and the consolidated accounting treatment; (2) Accurately references the Blackstone exchange right termination post-2022 IPO with correct exclusion of 4.4 million shares from diluted EPS; (3) Properly describes the 2024 transition to equity method investment with dividend and fair-value recognition; (4) Correctly identifies the $282 million gain on the Nippon sale; (5) Effectively synthesizes the transformation from potential dilution scenario to post-divestiture equity income model. MINOR ISSUES: (1) The answer mentions AIG 'sold a large block of Corebridge shares' but doesn't specify the exact timing (June 9, 2024) or provide the percentage of shares divested, which the ground truth indicates occurred on June 9, 2024; (2) The ground truth mentions 24.1 million potential shares in 2022 and 4.4 million in 2023, but the LLM only references the 4.4 million figure for 2023, missing the comparative context of the 2022 number; (3) The answer could have been more explicit about the June 9, 2024 date for when equity method accounting began. QUANTITATIVE VERIFICATION: All cited numbers (52.2%, 4.4 million shares, $282 million gain) are accurate. The 2022 IPO date (September 19, 2022) is correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple time periods and accounting treatments, correctly linking the Blackstone exchange right to the IPO termination and then to the subsequent equity method transition. The logic flow from consolidated ownership → dilution exclusion → equity method investment is sound and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 492,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "In the 2022 Form 10‑K Comcast disclosed that its 30 % equity interest in Universal Beijing Resort is treated as a variable‑interest entity that it consolidates, and the VIE’s debt that is not guaranteed by Comcast was about **$3.6 billion** (see the “Debt Not Guaranteed” line for Universal Beijing Resort in the debt table)【page_71】.  By the 2024 filing the same VIE is still consolidated, but the outstanding debt had fallen to **$3.4 billion** (including a $3.0 billion term loan) and the consolidated balance sheet now shows **$7.3 billion of assets and $7.0 billion of liabilities** for the resort, indicating a modest reduction in exposure while the consolidation treatment and the maximum loss risk (limited to the 30 % equity stake) remain unchanged【page_86】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and consolidation treatment. STRENGTHS: (1) All primary debt figures are accurate: $3.6 billion (2022), $3.4 billion (2024), matching ground truth exactly. (2) The consolidated balance sheet figures are correct: $7.3 billion assets and $7.0 billion liabilities as of 2024. (3) Correctly identifies the 30% equity interest and VIE consolidation treatment across both years. (4) Properly notes the term loan component ($3.0 billion) and the modest reduction in debt exposure. (5) Multi-hop reasoning is sound - synthesizes information from 2022 and 2024 filings to show evolution of exposure. (6) Correctly identifies that consolidation treatment and maximum loss risk remain unchanged. MINOR GAPS: (1) The answer does not explicitly mention the 2023 debt figure ($3.5 billion) that appears in the ground truth, which would have provided a more complete picture of the 2022-2024 evolution. (2) Does not reference the 2020 and 2021 debt figures ($2.5 billion and $3.6 billion respectively) that the ground truth includes, though these are less critical for the 2022-2024 evolution question. (3) The phrase 'modest reduction' is somewhat understated - the reduction from $3.6B to $3.4B is approximately 5.6%, which is accurate but the characterization could be more precise. VERIFICATION: All cited numbers check against ground truth. The consolidation treatment as a VIE is correctly identified. The page references (71, 86) appear reasonable for 10-K filings. The answer successfully addresses the core question about how exposure evolved from 2022 to 2024 with accurate financial data and proper synthesis of consolidation treatment information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 476,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The trade‑in framework is essentially unchanged – the company still offers customers either an option that sets the aircraft’s fair‑market value about 45 days before delivery or a commitment that locks in a predetermined trade‑in price, with any excess over FMV recorded as a revenue reduction (2022 p.77; 2023 p.79). The only shift in eligibility is that the 2023 filing narrows the language to “some Gulfstream customers” rather than the broader “some customers” used in 2022, while the exposure to market‑value risk for the predetermined‑price commitments remains the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key structural change in customer eligibility (from 'some customers' in 2022 to 'some Gulfstream customers' in 2023) and accurately describes the mechanics of the trade-in framework with the 45-day FMV assessment window. However, the answer has significant gaps in addressing the full scope of the question about how the structure changed between 2022 and 2023. Specifically: (1) The LLM characterizes the framework as 'essentially unchanged,' which contradicts the ground truth's emphasis that the narrowing of eligibility to a specific customer segment (Gulfstream) represents a meaningful structural change. (2) The answer omits the ground truth's important observation about strategic focus and risk concentration in the Gulfstream segment specifically, which is a key insight about how the structure evolved. (3) The answer mentions that 'the exposure to market-value risk for the predetermined-price commitments remains the same' but doesn't address the ground truth's point that 2023 introduced 'more specific framing by highlighting Gulfstream,' suggesting a strategic shift in risk exposure concentration. (4) While the answer correctly notes that both years reported 'not material' changes in fair market values, it doesn't synthesize this as part of the structural analysis. The numeric details about the 45-day window and revenue reduction treatment are accurate, but the answer fails to fully synthesize the multi-hop comparison between 2022 and 2023 structures. The answer reads more as a description of the mechanism rather than an analysis of how the structure changed, which was the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 452,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "In the 2022 filing Tesla only described the Semi as a “planned commercial electric vehicle” among its future models, without any production timeline (2022 p.5). By the 2024 filing the Semi had progressed to “pilot production” at the Nevada plant and is explicitly grouped with newer models such as the Cybertruck as part of Tesla’s effort to expand capacity for next‑generation vehicles (2024 p.36). This shows the Semi moving from a concept‑stage announcement in 2022 to early‑stage manufacturing and a strategic pillar of the company’s expanding product lineup by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct (2022 vs 2024), and the progression from 'planned' to 'pilot production' status is accurately represented. No numerical errors or miscalculations present. QUALITATIVE ACCURACY (9/10): The multi-hop reasoning is sound - the answer correctly synthesizes information across two filing years to show Tesla's strategic evolution. The LLM properly identifies the key entities (Tesla Semi, Nevada facility, Cybertruck) and correctly characterizes the progression from conceptual/announcement phase to early manufacturing. The answer goes slightly beyond the ground truth by providing specific page references (2022 p.5, 2024 p.36) and contextualizing the Semi within Tesla's broader product expansion strategy (grouping with Cybertruck), which adds valuable detail without contradicting the ground truth. ENTITY ACCURACY (10/10): All entities correctly identified - Tesla, Tesla Semi, Nevada facility, Cybertruck, and the correct fiscal years. SEMANTIC EQUIVALENCE (9/10): The LLM's phrasing 'concept-stage announcement' and 'early-stage manufacturing' conveys the same meaning as the ground truth's 'conceptual and development phase' and 'pilot production.' The characterization of this as a 'strategic pillar' is a reasonable inference from the ground truth's statement about 'strategic shift.' COMPLETENESS: The answer addresses all aspects of the multi-part question - production status evolution, strategic positioning, and the timeline between 2022-2024. The only minor consideration is that the LLM provides slightly more interpretive detail than the ground truth (e.g., 'strategic pillar'), but this is supportive rather than contradictory and demonstrates deeper contextual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 497,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Altria’s valuation allowance tied to its Cronos investment rose modestly – about $379 million at year‑end 2022, $397 million at year‑end 2023 and $402 million at year‑end 2024 (see the valuation‑allowance reconciliation in the 2024 filing)【page_84】. Because the allowance essentially equals the Cronos deferred‑tax asset each year, the company is still treating the tax benefit as largely unrealizable, maintaining a full or near‑full allowance on those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: The numbers provided ($379M in 2022, $397M in 2023, $402M in 2024) match the ground truth for the endpoints (2022 and 2024), with the addition of the 2023 intermediate value ($397M) which provides more complete temporal evolution. The ground truth only specified 2022 ($379M) and 2024 ($402M), but the LLM's inclusion of 2023 data enhances completeness without contradicting the ground truth. The modest increase of $23M over two years is accurately characterized. Qualitative assessment: The LLM correctly identifies the key implication - that Altria maintains significant uncertainty about the realizability of deferred tax assets, treating the tax benefit as 'largely unrealizable' with a 'full or near-full allowance.' This semantic equivalence matches the ground truth's statement about 'significant uncertainty' and 'did not expect the temporary difference to reverse in the foreseeable future.' The reasoning is sound: the allowance essentially equaling the deferred tax asset each year logically demonstrates the company's conservative stance. Multi-hop synthesis: The answer correctly synthesizes information about the investment (Cronos), the financial metric (valuation allowance), the time period (2022-2024), and the implication (expectations about asset realizability). The citation to page 84 of the 2024 filing adds credibility. The only minor distinction is that the ground truth emphasizes the 'steady increase' suggesting a 'cautious stance,' while the LLM characterizes it as 'modest' increase - both are accurate characterizations of a $23M increase over two years, representing approximately 6% growth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 472,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023 Amgen changed its accounting for the BeiGene stake from the equity‑method to a fair‑value model, so that changes in the investment’s market value were recorded in earnings; the first‑quarter fair‑value adjustment produced a large unrealized gain that drove the $2.8 billion of other income reported for 2023 【page_78】. By 2024 the fair‑value approach was retained, but the investment’s value fell, generating net unrealized losses on the BeiGene holding and reducing other income to $506 million for the year 【page_77】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amgen's BeiGene investment evolution. STRENGTHS: (1) Correctly identifies the 2023 accounting change from equity method to fair value - this is the critical pivot point. (2) Accurately captures the reversal in financial impact: gains in 2023 to losses in 2024. (3) Provides specific quantitative details: $2.8 billion in other income for 2023 and $506 million for 2024, showing the dramatic decline. (4) Correctly notes that the fair-value approach was retained in 2024, maintaining methodological consistency. (5) Properly synthesizes the multi-hop information: accounting method change → valuation impact → earnings effect across two years. (6) Appropriately attributes the changes to market/valuation movements rather than methodology shifts in 2024. VERIFICATION OF NUMBERS: The specific dollar amounts ($2.8B for 2023 other income, $506M for 2024) are provided with page citations, suggesting they are sourced from actual filings. The magnitude of decline (from $2.8B to $506M) is consistent with the narrative of unrealized losses in 2024. MINOR CONSIDERATIONS: The answer goes slightly beyond the ground truth by providing specific dollar amounts for other income, which adds precision and context. The ground truth uses more general language about 'gains' and 'losses' while the LLM provides quantified figures. This is an enhancement rather than an error. The semantic meaning is fully aligned: both describe the accounting change, the shift from gains to losses, and the reversal in financial benefit. The multi-hop reasoning is sound: connects the 2023 methodology change to its immediate impact, then traces the 2024 continuation with opposite valuation results.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 483,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "In the 2023 filing Disney+ Hotstar was described as a direct‑to‑consumer service “primarily in India” that offers general‑entertainment, family and sports programming (2023 p. 4). By the 2024 filing the company says the service is branded Disney+ Hotstar in India and certain other Southeast Asian markets and is deliberately kept out of any multi‑product bundles, remaining a standalone offering (2024 p. 57; 2024 p. 58).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. While the 2023 description is accurate (Disney+ Hotstar as DTC service in India with general entertainment, family, and sports programming), the 2024 characterization is fundamentally incorrect. The ground truth states that by 2024, Disney+ Hotstar remained branded in India and Southeast Asia, but the company MERGED Star+ and Disney+ services in Latin America into a single Disney+ product by end of June 2024. The LLM answer instead claims Disney+ Hotstar is 'deliberately kept out of any multi-product bundles, remaining a standalone offering' - this is the opposite of what occurred. The ground truth indicates a strategic consolidation/merger of services, while the LLM describes them as deliberately kept separate. This represents a critical misunderstanding of the strategic shift. The LLM also fails to mention the Latin America consolidation entirely, which is a key part of the evolution between 2023-2024. The page citations provided (2024 p. 57-58) cannot be verified but the substantive claim about keeping services separate contradicts the documented merger activity. The quantitative accuracy is reasonable (dates and service names are correct), but the qualitative interpretation of the strategic direction is inverted, making this a partially correct but fundamentally misleading answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 386,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "In the 2023 filing PayPal described its purchase‑ and seller‑protection programs mainly as a line‑item cost – “we estimate and record associated costs in transaction and credit losses during the period the payment transaction is completed” (2023 p. 77). By the 2024 filing the discussion had expanded to stress heightened risk exposure – e.g., possible changes in card‑network charge‑back rules, reimbursement rights, and the threat of losing card‑acceptance if losses become excessive – and to note that while the company “actively seeks to recover transaction losses where possible, such recoveries may be insufficient” (2024 p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the 2023 approach (costs recorded in 'transaction and credit losses' during payment transaction completion) and the 2024 evolution (expanded disclosure with heightened risk acknowledgment). The specific quote from 2023 p. 77 and reference to 2024 p. 24 are appropriately cited. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either the ground truth or LLM answer, so this dimension is not applicable. The answer correctly references page numbers and time periods (2023 vs 2024). (3) ENTITY ACCURACY: PayPal is correctly identified throughout. The fiscal years (2023 and 2024) are accurate. The financial metrics and program names (purchase-and-seller-protection programs, transaction and credit losses) are correctly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, showing the evolution from simple cost recording to more complex risk disclosure. It correctly identifies the shift from basic accounting treatment to explicit risk acknowledgment. The connection between merchant recovery challenges, fraud exposure, and regulatory changes is properly synthesized. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth: (a) 2023 had basic cost recording in transaction/credit losses, (b) 2024 introduced more detailed disclosures, (c) there are challenges in loss recovery from merchants, (d) there are evolving fraud and regulatory risks. The LLM adds specific details about card-network chargeback rules and card-acceptance risk, which are consistent with the ground truth's mention of 'regulatory changes affecting chargeback requirements.' The quote about recoveries being 'insufficient' directly supports the ground truth's statement about 'challenges in recovering losses.' Minor strengths: The LLM provides specific page citations and direct quotes, enhancing credibility. The answer is well-structured and clearly shows the before/after comparison. No significant errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 586,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "In the 2022 filing NextEra had begun divesting its solar assets by selling Class B non‑controlling interests – it kept a controlling stake but recorded redeemable non‑controlling interests that could require cash repayments if certain contingencies were triggered (2022 p.79‑80). By the 2024 filing the company’s solar portfolio is largely held through variable‑interest entities: eight subsidiaries own 50‑67 % of solar‑focused VIEs (and a separate VIE holds a 10 % stake), which are consolidated as the primary beneficiary, and the associated debt is secured only by the solar assets with no recourse to NextEra’s general credit (2024 p.97; solar now 23 % of NEER’s depreciable plant, 2024 p.95).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution from divestiture to VIE-based structures but contains several significant issues: (1) QUANTITATIVE ERRORS: The LLM states 'eight subsidiaries own 50-67% of solar-focused VIEs' which contradicts the ground truth stating NextEra consolidated 'eight VIEs owning solar generation facilities with approximately 765 MW of capacity.' The ownership percentages cited (50-67%) are not mentioned in the ground truth and appear to be incorrect or misinterpreted. The ground truth mentions a 10% direct ownership interest in additional solar facilities, which the LLM references but conflates with the VIE structure. (2) INCOMPLETE SYNTHESIS: The LLM mentions 'Class B non-controlling interests' and 'redeemable non-controlling interests' from 2022, which are not in the ground truth. While these may be accurate filing details, they represent a different transaction structure than the ground truth's focus on the 100 MW Arizona facility sale and 90% portfolio sale. (3) CORRECT ELEMENTS: The LLM correctly identifies the shift from outright ownership/divestiture to VIE-based structures, correctly notes the 2024 consolidation of VIEs as primary beneficiary, and correctly identifies that debt is secured only by solar assets with no recourse to NextEra's general credit. The reference to solar representing 23% of NEER's depreciable plant is a useful metric not in ground truth but appears contextually relevant. (4) MULTI-HOP REASONING: The answer demonstrates understanding of the structural evolution but fails to accurately synthesize the specific quantitative details about capacity (765 MW) and ownership stakes (100% and 90% interests sold in 2022). The reasoning about financial exposure through guarantees and credit support is mentioned in ground truth but not adequately addressed in LLM answer. (5) PAGE CITATIONS: The LLM provides specific page references which adds credibility but cannot be verified against ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 532,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "In 2022 Accenture’s non‑U.S. defined‑benefit pension plans carried $379.989 million of mutual‑fund debt securities, which were measured at Level 2 of the fair‑value hierarchy (quoted prices for similar instruments)【page_89】. The 2023 filing no longer reports any mutual‑fund debt securities, indicating the holding was eliminated and the Level 2 valuation was removed (i.e., the fair‑value measurement shifted away from Level 2).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the 2023 value was eliminated/zero, but the ground truth clearly shows $253,025 in 2023. The LLM also incorrectly formats the 2022 value as '$379.989 million' when the ground truth shows $379,989 (in thousands or base units, not millions - the decimal placement is wrong). (2) COMPLETENESS FAILURE: The question asks about the evolution from 2022 to 2023 and changes in valuation methodology. The LLM fails to report the 2023 value at all, instead claiming the holding was 'eliminated.' This is factually incorrect per the ground truth. (3) ENTITY/METRIC ACCURACY: While the LLM correctly identifies ACN (Accenture) and Level 2 valuation for 2022, it completely misses the 2023 data point and incorrectly characterizes what happened. (4) REASONING FAILURE: The multi-hop synthesis is broken. The LLM should have compared 2022 ($379,989) to 2023 ($253,025) showing a decrease while methodology remained consistent at Level 2. Instead, it incorrectly concludes the holding was eliminated. (5) VALUATION METHODOLOGY: The ground truth states methodology remained consistent (Level 2 in both years), but the LLM claims it 'shifted away from Level 2,' which is incorrect. The LLM fundamentally misread or misinterpreted the 2023 filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 384,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron still owns a 50 % equity interest in Tengizchevroil. The carrying value of that investment grew modestly from $26.5 billion at year‑end 2022 to $27.0 billion at year‑end 2023, but Chevron’s share of TCO’s earnings fell from $4.386 billion in 2022 to $3.375 billion in 2023. The company also continues to fund TCO with a loan of about $4.5 billion (see Note 15, page 82).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) CARRYING VALUE ERROR: Ground truth states 2022 carrying value was $23,727 million ($23.727 billion), but LLM claims $26.5 billion - a $2.773 billion overstatement. For 2023, ground truth indicates approximately $23,807 million (23,727 + 80), but LLM claims $27.0 billion - a $3.193 billion overstatement. (2) EARNINGS ERROR: Ground truth states 2022 equity in earnings was $1,238 million, but LLM claims $4.386 billion - a 254% overstatement. For 2023, ground truth does not provide a specific earnings figure, but LLM claims $3.375 billion without ground truth support. (3) LOAN AMOUNT: The $4.5 billion loan is correctly stated in both answers. (4) EQUITY INTEREST: The 50% ownership is correctly stated. (5) MULTI-HOP SYNTHESIS: The LLM failed to synthesize the key evolution described in ground truth - the shift from simple carrying value reporting in 2022 to a more complex valuation approach in 2023 with the $80 million premium disclosure. The LLM also missed the strategic significance of the FGP/WPMP funding context. The answer presents inflated financial figures that suggest either data retrieval errors or confusion with different metrics. The core narrative about deepening involvement is partially captured through the loan mention, but the quantitative foundation is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 395,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "In 2023 Disney described ABC simply as a core “Domestic” linear network within the Entertainment segment – one of the broadcast‑television properties (along with Disney, Freeform, FX and National Geographic) that, together with eight owned stations, delivered news, daytime, primetime and unscripted programming to a broad audience (page 78). By 2024 the filing shows ABC has become a more integrated hub: ESPN now programs the sports daypart on ABC (branded “ESPN on ABC”) (page 9), ABC’s reach is highlighted as covering almost 100 % of U.S. households (page 5), and its shows are fed to Disney’s streaming arm – with ABC content appearing on Hulu one day after linear airing (page 7). Thus, ABC’s role has shifted from a standalone broadcast outlet to a strategic conduit that links Disney’s linear, sports and Direct‑to‑Consumer businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies ABC's 2023 positioning as a core domestic linear network within the Entertainment segment, matching the ground truth characterization. (2) Accurately captures the 2024 evolution toward digital integration, specifically noting the one-day-after-linear-airing availability on Hulu, which directly matches the ground truth. (3) Provides additional valuable context not contradicting the ground truth: mentions ESPN programming sports on ABC (ESPN on ABC), ABC's ~100% U.S. household coverage, and the integration of linear, sports, and DTC businesses. (4) Correctly synthesizes the multi-hop reasoning showing the shift from standalone linear distribution to integrated digital/streaming strategy. (5) Properly identifies the strategic positioning evolution across the two-year period. MINOR CONSIDERATIONS: (1) The LLM answer includes page references (pages 78, 9, 5, 7) which add specificity but cannot be verified against the ground truth provided. However, these do not contradict the ground truth and enhance credibility. (2) The mention of ESPN on ABC and household coverage percentages are additional details not explicitly in the ground truth but are consistent with and complementary to the core narrative. (3) The ground truth emphasizes the shift away from 'affiliate fees' revenue model toward streaming contribution, while the LLM answer emphasizes the integration of sports and DTC - both perspectives are valid and complementary rather than contradictory. QUANTITATIVE ACCURACY: The ~100% household coverage figure is presented as approximate (almost 100%), which is appropriate for a coverage metric. No specific dollar amounts or precise percentages are provided that could be verified as incorrect. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly identifying the evolution in ABC's strategic role and its integration across multiple Disney business units (linear, sports, streaming). The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 573,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "In the 2022 filing General Dynamics described the ASCOD as a “highly versatile tracked combat vehicle” offered by its European Land Systems (ELS) unit, while Land Systems was building 399 new LAVs for the Canadian army【page_11】. The 2023 filing keeps the ASCOD in the same ELS product line with the same description, but Land Systems’ LAV production fell to 360 units【page_11】—a modest reduction that signals a slight re‑allocation of capacity away from LAVs, yet no new emphasis or expanded investment in the ASCOD itself.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about ASCOD positioning evolution. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces LAV production numbers (399 units in 2022, 360 units in 2023) that are not mentioned in the ground truth answer and appear to be unsupported by the filing data. These numbers are presented as fact but are not verified against the original question's focus. (2) MISSING CORE ANALYSIS: The ground truth explicitly identifies a critical shift in ASCOD language from 'producing and upgrading' (2022) to simply 'offering' (2023), which indicates a strategic de-emphasis. The LLM completely misses this key distinction and instead focuses on LAV production changes, which is tangential to the ASCOD positioning question. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about ASCOD positioning evolution and what it indicates about shifts in production focus. The ground truth correctly synthesizes this by noting the language change suggests resource reallocation to Piranha 5 and AJAX programs. The LLM fails to make this connection and instead discusses LAV capacity reallocation, which is a different product line. (4) ENTITY CONFUSION: While the LLM correctly identifies General Dynamics and ELS, it conflates the ASCOD analysis with LAV production analysis, treating them as related when the ground truth treats them as separate strategic indicators. (5) REASONING QUALITY: The LLM's conclusion that 'no new emphasis or expanded investment in the ASCOD itself' is vague and doesn't capture the actual strategic shift indicated by the language change from active production/upgrading to passive offering. The ground truth's inference about resource reallocation is more analytically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 482,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "In 2023 PayPal had approved the use of $3.0 billion of European customer balances – about 39 % of the balances available for corporate use – to fund credit activities (2023 10‑K, p. 71). By year‑end 2024 that amount fell to $2.0 billion, or roughly 26 % of the available balances (2024 10‑K, p. 46). The drop signals that PayPal is pulling back on relying on its European deposits for credit funding and is likely shifting toward external or more diversified sources of capital to support its loan‑and‑advance programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: $3.0 billion in 2023 (39% of balances), $2.0 billion in 2024 (26% of balances), and accurately characterizes the directional shift toward reduced reliance on European customer balances for credit funding. The numbers are precise and match the ground truth exactly. The reasoning about shifting toward external financing sources is sound and logically derived from the data presented.\n\nWEAKNESSES: The LLM answer is incomplete in a critical way - it fails to mention the specific evidence of PayPal's shift toward external financing sources that the ground truth explicitly provides: the multi-year agreement to sell consumer installment receivables, with $20.8 billion in loans sold in 2024 versus $5.5 billion in 2023. This is a significant omission because it represents concrete, quantifiable evidence of the strategic shift being discussed. The ground truth uses this data point to substantiate the claim about moving toward external financing, making it an essential component of a complete answer to the multi-hop question about what the shift 'indicates about the company's credit funding strategy.' The LLM's statement that PayPal is 'likely shifting toward external or more diversified sources' is speculative language ('likely,' 'more diversified') compared to the ground truth's concrete evidence of actual receivables sales.\n\nQUANTITATIVE VERIFICATION: All numbers are correct - $3.0B (2023), $2.0B (2024), 39%, 26%. No calculation errors.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the year-over-year comparison and draws a logical conclusion about strategy shift, but fails to complete the full multi-hop synthesis by not incorporating the receivables sales data that demonstrates the actual implementation of this strategic shift.\n\nCONTEXTUAL RELEVANCE: While the answer addresses the evolution of European customer balance utilization, it only partially addresses what this shift 'indicates about the company's credit funding strategy' by omitting the concrete evidence of the alternative funding mechanism being employed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 573,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "In the 2022 Form 10‑K, NEE reported equity securities in its Special‑Use Funds of about $5.5 billion, split between Level 1 ($2.5 bn) and Level 2 ($3.0 bn) with no Level 3 holdings【page_89】. By the 2024 filing the equity portion had risen to $6.2 billion, with Level 1 at $2.6 bn, Level 2 at $3.3 bn and a new $229 million classified as Level 3【page_89】. The appearance of a Level 3 component and the larger total balance indicate that the funds have become more diversified into less‑observable securities and that NEE now provides greater transparency by disclosing the fair‑value hierarchy of these investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM reports 2022 equity securities at $5.5 billion total ($2.5B Level 1 + $3.0B Level 2), but the ground truth shows NEE at $906 million and FPL at $672 million for 2022 - a massive discrepancy of over 5x the correct amount. For 2024, the LLM reports $6.2 billion total ($2.6B Level 1 + $3.3B Level 2 + $229M Level 3), but ground truth shows NEE at $2,614 million Level 1 and FPL at $1,028 million Level 1 alone, totaling at least $3.642 billion in Level 1 securities alone, with no mention of Level 2 or Level 3 amounts in the ground truth. (2) CATEGORIZATION ERRORS - The LLM incorrectly claims 2022 had Level 1 and Level 2 breakdowns, when ground truth explicitly states there was 'no detailed categorization by valuation levels' in 2022. The LLM also invents a Level 3 component ($229M) that does not appear in the ground truth. (3) ENTITY CONFUSION - The LLM fails to distinguish between NEE and FPL separately, presenting only combined figures, whereas the ground truth clearly separates the two entities' holdings. (4) DIRECTIONAL ACCURACY - While the LLM correctly identifies that there was an increase in equity securities and improved transparency/disclosure, the specific numbers supporting this conclusion are entirely fabricated. (5) MISSING CONTEXT - The LLM does not mention the distinction between carrying amount and fair value that appears in the 2022 data, nor does it properly address the separate holdings of NEE versus FPL. The answer demonstrates a fundamental failure in multi-hop synthesis and contains no verifiable accurate financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 470,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 2,061,863 Class A shares in the fourth quarter, of which 1,964,612 (about 95 %) were bought under its publicly announced open‑market share‑repurchase program and 97,251 (about 5 %) were acquired in employee‑related transactions such as payroll‑tax withholding (see page 33). The 2023 filing (pages 81‑85) does not provide a new breakdown of purchases, indicating that the open‑market program – which has no expiration and an outstanding authorization of $6.129 billion (see footnote 4, page 33) – continued to be the primary vehicle for repurchases, with employee‑related purchases remaining a small, separate component.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key numbers and proper multi-hop synthesis. Verified facts: (1) Fiscal 2022 Q4 total repurchases of 2,061,863 shares - CORRECT; (2) Public program shares of 1,964,612 - CORRECT; (3) Employee-related transactions of 97,251 - CORRECT; (4) Aggregate price of $576 million for public program - CORRECT; (5) Percentage calculations (~95% public, ~5% employee) - CORRECT. The LLM properly synthesized information across multiple pages and fiscal years, correctly noting the shift from fiscal 2022 to fiscal 2023 where the public program showed reduced/no activity while employee-related acquisitions continued. Minor deduction: The LLM states '2023 filing does not provide a new breakdown of purchases' and infers the open-market program 'continued to be the primary vehicle,' which is a reasonable inference but slightly goes beyond what the ground truth explicitly states. The ground truth more definitively states 'there is no mention of shares purchased under the public program' in fiscal 2023, whereas the LLM's phrasing suggests continued activity without explicit confirmation. The LLM also adds contextual details about the $6.129 billion outstanding authorization and footnote references, which enhance credibility but weren't in the ground truth. Overall, the answer correctly addresses the evolution question, properly identifies the shift in program utilization, and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 410,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron’s 50 % stake in Chevron Phillips Chemical Company LLC was treated the same way in both years – it was not consolidated but reported as an equity‑method investment (2022 Note 8, p. 31; 2023 Note 8, p. 75).  In 2023 the joint‑venture’s net equity continued to be shown as a separate line item on the consolidated balance sheet (“Total CPChem net equity” on p. 76), confirming that the consolidation status and the equity‑method accounting approach did not change from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE CONTRADICTION: The ground truth explicitly states that Chevron Phillips Chemical was consolidated in 2022 but transitioned to equity method accounting in 2023. The LLM claims the treatment 'was the same way in both years' and 'did not change from 2022 to 2023' - this directly contradicts the established fact of a significant structural change. (2) CONSOLIDATION STATUS ERROR: The ground truth indicates consolidation in 2022 (evidenced by 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries), but the LLM states it 'was not consolidated' in both years. This is a fundamental mischaracterization of 2022 status. (3) ACCOUNTING METHOD MISREPRESENTATION: While the LLM correctly identifies equity method accounting for 2023, it incorrectly applies this same treatment retroactively to 2022, missing the key evolution the question asks about. (4) CITATION ACCURACY: The LLM cites specific page numbers and note references, but these citations appear to support an incorrect narrative that contradicts the ground truth's clear statement of a transition between years. (5) MULTI-HOP REASONING FAILURE: The question specifically asks about how the relationship 'evolved' between 2022 and 2023, requiring identification of a change. The LLM explicitly denies any change occurred, which is the opposite of what the ground truth establishes. The answer demonstrates a fundamental misunderstanding of the filing data and fails to identify the significant structural change that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 450,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In the 2022 filing, Hydra‑70 rockets were mentioned only in a $175 million Army contract to produce the rockets 【page 42】. By the 2023 filing, they are highlighted as a core, market‑leading munitions product and OTS secured awards to expand metal‑parts capacity for Hydra‑70 rockets from 18,000 to 86,000 rounds per month (and propellant capacity to 16 million lb/yr) 【page 12】, shifting the focus from a single production contract to a broad capacity‑building effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - $175 million contract in 2022 (✓), production capacity expansion from 18,000 to 86,000 rounds per month (✓), and the additional detail of propellant capacity expansion to 16 million lb/yr (✓). The 2025 timeline is correctly implied through the capacity expansion context. ENTITY ACCURACY: General Dynamics, Combat Systems segment, OTS (Orbital Technologies Corporation), and Hydra-70 rockets are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, correctly identifying the evolution from a single $175M production contract to a broader capacity-building initiative. The characterization of the shift from 'single production contract to broad capacity-building effort' accurately captures the strategic evolution. COMPLETENESS: The answer addresses all key aspects of the question - contract involvement (2022 $175M contract mentioned), production capacity expansion (18,000 to 86,000 rounds/month), and the evolution of role (from single contract to market-leading position with capacity expansion). MINOR CONSIDERATIONS: The LLM answer includes the propellant capacity detail (16 million lb/yr) which, while not explicitly mentioned in the ground truth, is a reasonable and accurate addition that enhances the answer without contradicting the original. The page references provided add credibility. The semantic framing of the evolution is clear and well-articulated. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 448,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 Form 10‑K PayPal listed the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) as an exhibit “incorporated by reference” – a Form 10‑12B/A originally filed on May 14 2015 that includes the accompanying Restricted Stock Unit Award Agreement under the 2015 Equity Incentive Award Plan, and it was not filed with the 10‑K itself【page_124】. The 2024 Form 10‑K repeats the same Exhibit 10.07+ with the same documentation status and agreement (still incorporated by reference, same filing date)【page_121】, while also adding a separate performance‑based RSU grant notice (Exhibit 10.08+), indicating no change to the original global RSU notice’s treatment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key factual elements: (1) Exhibit 10.07+ designation for Global RSU Award Grant Notice in both years, (2) Correct incorporation by reference status, (3) Correct May 14, 2015 filing date for the 10-12B/A, (4) Correct identification of the 2015 Equity Incentive Award Plan, (5) Correct observation that Exhibit 10.08+ (performance-based variant) appears in 2024. All dates and exhibit numbers are accurate.\n\nWEAKNESSES: The LLM answer significantly understates the evolution described in the ground truth. The original answer emphasizes a KEY DISTINCTION: while the base RSU notice (10.07+) remained unchanged, the 2024 filing introduced an UPDATED form of the Global Performance Based RSU Award Grant Notice (10.08+) that was filed under an \"amended and restated plan\" and linked to a more recent 10-Q filing on April 30, 2024. The LLM answer merely notes the addition of 10.08+ without capturing the significance of this being an \"updated form\" with different documentation status (not just incorporated by reference from 2015, but linked to 2024 filings). The LLM states \"no change to the original global RSU notice's treatment\" which is technically correct for 10.07+, but misses the substantive point that the 2024 filing shows active revision and documentation updates specifically for the performance-based variant.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings but fails to fully capture the comparative analysis of how treatment evolved. The ground truth emphasizes the contrast between static treatment of 10.07+ versus dynamic updates to 10.08+, which the LLM acknowledges but doesn't adequately emphasize as the key evolution.\n\nCONCLUSION: While factually accurate on specific details, the answer is incomplete in addressing the full scope of how treatment evolved, particularly regarding the significance of the performance-based variant's updates in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 530,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "In the 2022 filing Opdivo was a core revenue engine, delivering about $7.5 billion in net product sales and ranking among BMS’s top three products【page_110】. By 2024 the drug’s role has broadened from a single‑indication blockbuster to a multi‑indication platform: BMS added a sub‑cutaneous formulation (Opdivo Qvantig, Dec 2024) and new approvals for urothelial carcinoma (Mar 2024), resectable NSCLC (Oct 2024), and the Opdivo + Yervoy combo for MSI‑H/dMMR colorectal cancer (Dec 2024)【page_45】【page_44】, underscoring its continued strategic importance and expanding market reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The 2022 revenue figure of ~$7.5 billion is correct (ground truth states $7,523 million). (2) The March 2024 FDA approval for urothelial carcinoma is correctly identified and matches ground truth. (3) The overall narrative about Opdivo's evolution from single-indication to multi-indication platform is reasonable and contextually relevant. (4) The answer appropriately addresses the 2022-2024 timeframe requested.\n\nWEAKNESSES: (1) CRITICAL ISSUE - The LLM introduces multiple regulatory approvals (resectable NSCLC in Oct 2024, Opdivo + Yervoy combo for MSI-H/dMMR colorectal cancer in Dec 2024, and Opdivo Qvantig subcutaneous formulation in Dec 2024) that are NOT mentioned in the ground truth answer. These appear to be hallucinated or unsupported by the provided knowledge graph. The ground truth only mentions the March 2024 urothelial carcinoma approval. (2) The LLM cites specific page numbers (page_110, page_45, page_44) which cannot be verified against the ground truth and may indicate citation fabrication. (3) The ground truth explicitly states Opdivo showed \"no significant revenue increase from earlier years,\" but the LLM does not address whether revenue grew or remained flat from 2022 to 2024 - this is a notable omission. (4) The LLM's claim about \"Opdivo Qvantig\" (subcutaneous formulation) is not mentioned in ground truth and appears to be added information not supported by the knowledge graph.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and regulatory events, but the synthesis appears to include unsupported claims. The core multi-hop requirement (comparing 2022 revenue to 2024 regulatory approvals) is partially met, but with significant additions not in ground truth.\n\nNUMERIC VERIFICATION: The $7.5 billion figure is correct (matches $7,523 million). However, no 2024 revenue figures are provided in either answer, so revenue comparison cannot be fully assessed.\n\nOVERALL ASSESSMENT: The answer contains the correct 2022 revenue and one correct 2024 approval, but introduces multiple unverified regulatory approvals and product formulations that are not in the ground truth. This represents a significant factual accuracy problem despite the reasonable overall narrative structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 607,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "In 2022 Chevron’s involvement in CPChem was limited to its 50 % equity stake and a $6.8 billion investment balance, with strategic support focused on CPChem’s planned Old Ocean 1‑hexene unit and Cedar Bayou C3‑splitter projects slated for 2023 (2022 10‑K Chemicals Operations, pp. 18‑19). By 2023 the equity stake remained 50 %, but the investment balance rose to $7.8 billion and Chevron added a $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas—where CPChem holds a 51 % interest—signaling a larger financial commitment and the use of direct project‑level financing (2023 10‑K Note 15, p. 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key numeric values are correct: 50% ownership stake in both years, $387 million loan amount, 51% CPChem interest in Golden Triangle Polymers Project. (2) The investment balance figures ($6.8 billion in 2022, $7.8 billion in 2023) are provided with proper context and sourcing. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (equity ownership + project announcements) to 2023 (equity ownership + direct loan financing), matching the ground truth's characterization of a shift from general equity involvement to structured project-level financing. (4) All entities are correctly identified: Chevron, CPChem, Old Ocean 1-hexene unit, Cedar Bayou C3-splitter, Golden Triangle Polymers Project in Orange, Texas. (5) The answer includes specific document citations (2022 10-K, 2023 10-K Note 15) that enhance credibility. (6) The semantic meaning aligns perfectly with the ground truth's narrative of evolving financial involvement. MINOR CONSIDERATIONS: The LLM answer adds investment balance figures ($6.8B and $7.8B) that were not explicitly mentioned in the ground truth, though these appear to be accurate supplementary details from the filings that strengthen rather than contradict the answer. The answer is well-structured, clearly delineates the 2022 vs. 2023 comparison, and accurately captures the shift from general strategic support to direct project financing. No calculation errors detected. All dates and percentages are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 435,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "By 2024 PayPal had raised the reserves that back its consumer‑merchant protection programs. The allowance for transaction losses grew from $64 million at the end of 2023 to $86 million at the end of 2024 (the total allowance balance rose from $282 million to $342 million), and the allowance for negative customer balances increased from $218 million to $256 million, with the 2024 filing adding a detailed reconciliation showing a $1.114 billion provision, $1.218 billion of realized losses and $164 million of recoveries. These figures show a larger financial commitment and more granular disclosure of the protection‑program loss reserves compared with 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: allowance for transaction losses increased from $64M (2023) to $86M (2024), and allowance for negative customer balances rose from $218M to $256M. The LLM answer goes beyond the ground truth by providing additional context: the total allowance balance increased from $282M to $342M, and includes specific reconciliation details ($1.114B provision, $1.218B realized losses, $164M recoveries). These additional figures appear to be accurate supplementary information that enhances the answer without contradicting the ground truth. The multi-hop reasoning is sound—the answer correctly synthesizes the evolution of PayPal's protection programs across 2023-2024, comparing both years and highlighting the increased financial commitments and more granular disclosures. The answer directly addresses the question's core components: (1) financial commitments evolution (reserve increases documented), (2) disclosure improvements (more detailed reconciliation in 2024), and (3) transaction loss reserves specifics (exact amounts provided). The wording is clear and semantically equivalent to the ground truth, with the additional details representing legitimate enhancements rather than errors. Minor deduction from perfect score only because the ground truth didn't explicitly mention the total allowance balance figures or the detailed reconciliation components, though these appear to be accurate supplementary information from the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 423,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "In the 2022 filing McDonald’s merely described its franchise system as a component of the business – “The Company franchises and operates … All restaurants are operated either by the Company or by franchisees, including conventional franchisees, developmental licensees or affiliates” (2022 p. 43) – without stressing franchising as a strategic priority or mentioning co‑investment. By the 2024 filing the tone shifts to a strategic partnership: the company says it is “primarily a franchisor and believes franchising is paramount” (2024 p. 3) and adds that it may “co‑invest with franchisees to fund improvements” and that its “heavily franchised business model” generates stable, predictable revenue (2024 p. 4). This reflects a move from a descriptive to a core‑business framing that highlights franchisee co‑investment as a key growth lever.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the core shift in McDonald's strategic framing between 2022 and 2024. Both the original answer and LLM answer identify the same key evolution: from neutral/descriptive language in 2022 to strategic/value-laden framing in 2024. The LLM provides specific textual evidence (quotes from pages 43 and 3-4 of respective filings) that supports this characterization. (2) QUANTITATIVE ACCURACY: While this question is primarily qualitative, the LLM correctly references page numbers and filing years (2022, 2024) without error. No calculations are required. (3) ENTITY ACCURACY: McDonald's is correctly identified throughout; fiscal years 2022 and 2024 are accurate; the distinction between 'conventional franchisees, developmental licensees or affiliates' is properly noted. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two different filing years and identifies the semantic shift in how McDonald's describes its relationship with franchisees. The reasoning correctly identifies: (a) 2022 as descriptive/structural, (b) 2024 as strategic/value-laden, (c) the specific role of co-investment as a key differentiator. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'move from descriptive to core-business framing' aligns perfectly with the ground truth's 'shift from descriptive to more strategic and value-laden framing.' The emphasis on franchisee co-investment as 'a key growth lever' matches the ground truth's characterization of it as enabling 'high restaurant performance.' Minor deviations: The LLM uses slightly different language ('core-business framing' vs 'strategic and value-laden framing') but conveys identical meaning. The LLM adds the detail about 'stable, predictable revenue' which, while not explicitly in the ground truth summary, is consistent with the strategic framing evolution described. Overall, this is a high-quality answer that accurately captures the nuanced shift in McDonald's strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 562,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K Altria reported that the FDA had **authorized PMTAs for three new tobacco‑flavored Marlboro HeatSticks in January 2023** (see MO 2022 p. 35).  \n- In the 2023 Form 10‑K the company noted that the FDA **has not exempted Marlboro HeatSticks from the graphic‑warning rule and is still reviewing the marketing order on a case‑by‑case basis**, with no further exemption action taken to date (see MO 2023 p. 37).  \n\nTogether, these disclosures show that Altria has moved from gaining its first FDA marketing authorizations for HeatSticks to still awaiting full regulatory clearance—demonstrating incremental progress but continued hurdles for its heated‑tobacco products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental chronological and factual contradiction that undermines its credibility. (1) MAJOR FACTUAL ERROR: The LLM claims the 2022 10-K reported that 'the FDA had authorized PMTAs for three new tobacco-flavored Marlboro HeatSticks in January 2023' - this is logically impossible. A 2022 filing cannot report on events that occurred in January 2023 (after the filing date). The ground truth correctly states that in 2022, the FDA had NOT yet authorized HeatSticks and was considering them case-by-case. (2) REVERSED TIMELINE: The LLM has inverted the regulatory progression. According to ground truth: 2022 = no authorization (case-by-case review), 2023 = authorization of three varieties. The LLM presents this backwards, claiming 2022 had the authorization and 2023 still lacks it. (3) INCOMPLETE ANSWER: The LLM fails to clearly establish the evolution between 2022 and 2023. While it mentions both years, it doesn't properly articulate the progression from 'not authorized' (2022) to 'authorized' (2023). (4) CITATION ISSUES: The LLM cites specific page numbers (p. 35 for 2022, p. 37 for 2023) but the content attributed to these pages contradicts the ground truth and basic logic. (5) CONCLUSION MISALIGNMENT: The LLM concludes Altria moved 'from gaining its first FDA marketing authorizations for HeatSticks to still awaiting full regulatory clearance' - this suggests regression rather than progress, contradicting the ground truth's characterization of 'notable progress.' The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the temporal sequence of regulatory events across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 464,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "In fiscal 2022 Accenture’s non‑U.S. defined‑benefit plans held mutual‑fund equity securities valued at $239,293 (Level 1 $4,954 + Level 2 $234,339)【page_89】. The 2023 filing does not present a comparable dollar amount, but the company’s 2023 target allocation raises the equity share of non‑U.S. plan assets from 21% in 2022 to 27%【page_88】, indicating a strategic shift toward a higher equity exposure in this investment category.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to directly address the core question. CRITICAL ISSUES: (1) The LLM provides the 2022 figure ($239,293 million) correctly but completely fails to provide the 2023 comparable figure ($196,226 million) that is explicitly stated in the ground truth. The LLM incorrectly claims '2023 filing does not present a comparable dollar amount' when the ground truth clearly shows this data exists. (2) The LLM calculates the breakdown of the 2022 figure (Level 1 $4,954 + Level 2 $234,339 = $239,293) which is arithmetically correct but this level of detail is not requested and distracts from the main answer. (3) The LLM pivots to discussing target allocation percentages (21% to 27%) which is tangential information not directly answering the question about valuation evolution. (4) The LLM fails to calculate or mention the $43,067 million decline between years, which is the core metric demonstrating how the valuation 'evolved.' (5) The conclusion about 'strategic shift toward higher equity exposure' based on percentage targets contradicts the ground truth finding of a reduction in absolute dollar amounts held. MULTI-HOP SYNTHESIS FAILURE: The question requires comparing 2022 and 2023 valuations to assess positioning. The LLM only provides 2022 data and percentage targets, failing to synthesize the year-over-year comparison. The answer demonstrates incomplete research or data retrieval, as the 2023 figure was available but not reported. The LLM's reasoning about strategic intent based on target allocations is speculative and not supported by the actual valuation decline shown in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 455,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "In the 2022 filing Chevron’s Angola LNG Limited stake was described in operational terms – a 36.4 % interest in an on‑shore LNG plant that processes associated gas and for which Chevron was still developing non‑associated gas supplies to feed the plant (page 13). By the 2023 filing the emphasis had shifted to the financial side, reporting a lower investment balance ($1.76 billion versus $1.96 billion in 2022) and a steep drop in equity earnings ($513 million versus $1,857 million in 2022) for its Angola LNG investment (page 82), indicating a move from active operational development toward a more investment‑focused stance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Chevron's shift from operational to financial disclosure emphasis regarding Angola LNG Limited, and accurately states the 36.4% interest. However, there are significant quantitative accuracy issues that undermine the response: (1) The investment balance figures ($1.76B vs $1.96B) and equity earnings figures ($513M vs $1.857B) are presented as facts but cannot be verified against the ground truth, which does not provide these specific financial metrics. The ground truth focuses on disclosure emphasis shift rather than detailed financial comparisons. (2) The LLM introduces specific page references (page 13, page 82) and financial data that go beyond what the ground truth confirms, suggesting potential hallucination or unverified sourcing. (3) The qualitative reasoning is sound - the LLM correctly identifies the shift from operational development focus to financial/portfolio integration emphasis, which aligns with the ground truth narrative. (4) The multi-hop synthesis is appropriate, comparing 2022 vs 2023 disclosures as requested. The main weakness is the introduction of unverified financial metrics that, while plausible, cannot be confirmed against the provided ground truth. The answer would be stronger if it stuck to the confirmed facts about the 36.4% interest and disclosure emphasis shift without adding specific dollar amounts and equity earnings figures that lack ground truth validation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 407,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM’s investment in certificates of deposit/time deposits rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  That is an increase of **$28 million**, or roughly a 133 % jump in the balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers. Ground truth shows: 2022 = $14 million, 2023 = $49 million, change = $35 million (250% increase). LLM answer states: 2022 = $21 million, 2023 = $49 million, change = $28 million (133% increase). The 2023 figure of $49 million is correct, but the 2022 baseline is wrong ($21M vs $14M ground truth). This cascades into calculation errors: LLM calculates $49M - $21M = $28M (mathematically correct given their wrong starting number), but the ground truth difference is $49M - $14M = $35M. The percentage calculation is also wrong: LLM shows 133% ($28M/$21M) but ground truth is 250% ($35M/$14M). The LLM correctly identified the company (MMM), the metric (Certificates of Deposit/Time Deposits), and the time period (2022-2023), and appropriately addressed all parts of the question. However, the fundamental factual errors in the 2022 baseline figure undermine the entire answer. The question is relevant and the structure is appropriate, but the execution contains material misstatements of fact that would mislead a user about the actual magnitude of change in this investment category.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 338,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "In 2021, McDonald’s reported that 37,295 of its 40,031 restaurants – about 93 % – were franchised. By year‑end 2024, that share had risen to roughly 95 % of its 43,477 restaurants, showing a modest increase in the proportion of franchised locations.【page_3】【page_3】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2021 data - 37,295 franchised of 40,031 total = 93.2%, correctly rounded to 93%; (2) 2024 data - approximately 95% of 43,477 restaurants is consistent with the ground truth; (3) The percentage increase from 93% to 95% matches the original answer exactly. The LLM answer provides additional valuable context by including the absolute restaurant counts (40,031 in 2021 and 43,477 in 2024), which enhances understanding without contradicting the ground truth. Multi-hop reasoning is sound: the answer correctly synthesizes the temporal comparison across 2021-2024 and identifies the strategic shift toward franchising. The characterization as a 'modest increase' aligns with the ground truth's 'slight but deliberate shift.' Minor note: The LLM answer uses 'roughly 95%' while ground truth says 'approximately 95%' - these are semantically equivalent. The additional restaurant count data strengthens rather than weakens the answer. All facts are accurate, calculations are correct, and the synthesis across the three-year period is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 322,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "In the 2022 Form 10‑K the “2015 Stock Compensation Plan for Non‑Employee Directors” was described as an amendment‑and‑restatement **effective March 31 2021** (see Exhibit 10.21) and the plan provided **703,256 shares** for future issuance (Item 12)【page_117】【page_114】.  \n\nIn the 2023 Form 10‑K the same plan was updated to an amendment‑and‑restatement **effective October 26 2022** (see Exhibit 10.22) and the share pool was reduced to **approximately 589,927 shares** (Item 12)【page_110】【page_107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the evolution of the 2015 Stock Compensation Plan for Non-Employee Directors between 2022 and 2023: (1) Effective dates are correct: March 31, 2021 in 2022 filing, and October 26, 2022 in 2023 filing. (2) The share pool numbers are accurate: 703,256 shares in 2022 and approximately 589,927 shares in 2023. (3) The multi-hop synthesis is sound - the answer properly traces the plan's evolution across two fiscal years and identifies the structural update (new amendment-and-restatement effective October 26, 2022). (4) The answer goes beyond the ground truth by providing additional supporting details (share counts, exhibit references, page numbers) that enhance credibility without introducing errors. (5) All entities are correctly identified (plan name, years, dates). The only minor consideration is that the LLM provides more granular detail than the ground truth (share counts), but this is supplementary and accurate information that strengthens rather than weakens the answer. The answer directly addresses the question about how the effective date and structure evolved, clearly showing the progression from the March 31, 2021 effective date to the October 26, 2022 effective date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 356,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "In fiscal 2022 Accenture’s 16 % equity‑method stake in Duck Creek Technologies was carried at $138.9 million, with an estimated fair value of about $223.2 million (page 70). By fiscal 2023 the company recorded a $253 million investment gain on that stake, reflecting a sizable appreciation and a material positive impact on earnings (page 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about Accenture's Duck Creek Technologies investment evolution. QUANTITATIVE VERIFICATION: All numbers are correct - the 16% ownership stake, $138.9 million carrying amount (matches $138,902 in thousands), $223.2 million fair value (matches $223,166 in thousands), and $253 million gain are all accurate. Number format variations ($138.9M vs $138,902 in thousands) are properly handled. COMPLETENESS: The answer addresses both fiscal years (2022 and 2023) and covers the key dimensions: investment valuation, carrying amount, ownership percentage, and financial impact (the gain). The question asks about 'evolution' and the answer effectively contrasts the two years. ENTITY ACCURACY: Accenture, Duck Creek Technologies, and fiscal years 2022-2023 are all correctly identified. The equity method accounting treatment is properly noted. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - combining the carrying amount, fair value, ownership percentage, and the subsequent gain to show the evolution of the relationship. The logical flow from 'long-term equity stake' to 'active financial realization event' is implicit in the answer structure. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth and doesn't explicitly use the phrase 'equity method' in the fiscal 2022 description (though it's implied by context), and doesn't explicitly state the impact on 'adjusted earnings per share and effective tax rate calculations' - these are very minor omissions that don't affect the core accuracy. The inclusion of page references adds credibility. Overall, the answer is factually sound, numerically precise, and effectively addresses the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 503,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "In the 2022 filing Breyanzi was described as a CD19‑directed CAR‑T therapy approved only for adult patients with relapsed or refractory large B‑cell lymphoma after ≥ two prior lines of systemic therapy【page_72】. By 2024 the product had added several new B‑cell‑malignancy indications – FDA accelerated approvals for relapsed or refractory follicular lymphoma (May 2024)【page_45】, CLL/SLL (March 2024)【page_45】 and mantle‑cell lymphoma (May 2024)【page_45】, plus a Japanese approval for high‑risk follicular lymphoma after one prior line (August 2024)【page_44】 – expanding Breyanzi’s market to multiple B‑cell cancers and earlier lines of therapy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR DISCREPANCY IDENTIFIED: The LLM answer includes a mantle cell lymphoma (MCL) approval in May 2024 that is NOT mentioned in the ground truth answer. This is a significant factual error that introduces false information. CORRECT ELEMENTS: (1) 2022 indication for relapsed/refractory large B-cell lymphoma after ≥2 prior lines is accurate; (2) March 2024 CLL/SLL approval is correct; (3) May 2024 follicular lymphoma approval is correct; (4) The characterization of Breyanzi as CD19-directed CAR-T therapy is accurate and adds helpful context. INCORRECT/UNSUPPORTED ELEMENTS: (1) Mantle cell lymphoma (MCL) approval in May 2024 - NOT in ground truth; (2) Japanese approval for high-risk follicular lymphoma in August 2024 - NOT in ground truth; (3) Reference to 'earlier lines of therapy' for Japanese approval - NOT supported by ground truth. MULTI-HOP REASONING: The LLM correctly synthesized the evolution from 2022 to 2024 and identified the expansion of indications, but added unverified approvals that contradict the ground truth. The ground truth explicitly lists only three indications (large B-cell lymphoma, CLL/SLL, and follicular lymphoma), while the LLM lists five (adding MCL and Japanese FL approval). QUANTITATIVE ACCURACY: Dates are mostly correct (March 2024, May 2024) but the inclusion of August 2024 Japanese approval and MCL approval are factually incorrect per ground truth. The answer demonstrates good structure and reasoning but fails on factual accuracy by introducing false information not present in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 427,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "In the 2022 filing 3M only described its ASC 450 practice for accruing legal‑liability losses – it noted that it records a liability when a loss is probable and reasonably estimable, but it gave no separate discussion of how it estimates or records insurance recoveries for those claims. By the 2023 filing the company added a distinct “Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings,” explaining that it now analyzes policy terms, exclusions, relevant case law and its own experience to determine a recognizable insurance‑receivable amount under ASC 450 (and ASC 610‑30). The 2023 note also discloses that, for the respirator‑mask/asbestos litigation, the company has an immaterial insurance‑receivable balance and continues to pursue coverage, showing a more granular, policy‑driven and transparent approach than in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key evolution in 3M's approach between 2022 and 2023, accurately describing the shift from general ASC 450 compliance discussion to explicit methodology for estimating insurance receivables. The answer correctly names the relevant accounting standards (ASC 450 and ASC 610-30) and accurately characterizes the 2023 approach as more granular and policy-driven. The qualitative description of the 2023 process (analyzing policy terms, exclusions, case law, experience) aligns well with the ground truth. The answer appropriately notes the immaterial insurance-receivable balance for respirator-mask/asbestos litigation in 2023.\n\nCRITICAL WEAKNESS: The LLM answer completely omits the specific quantitative data about claimant numbers that is central to the ground truth answer. The ground truth explicitly states that individual claimants increased from approximately 4,028 in 2022 to 4,042 in 2023, and notes this growing exposure as a factor influencing the more detailed approach. This is a significant omission because: (1) it's a concrete, verifiable metric that demonstrates the evolution's context, (2) the question specifically asks about evolution \"particularly in relation to respirator mask/asbestos litigation,\" and (3) the ground truth explicitly links the claimant increase to the more detailed insurance receivables methodology. The LLM answer mentions \"growing exposure\" conceptually but provides no supporting numbers.\n\nQUANTITATIVE ACCURACY: Score of 4 due to the complete absence of the 4,028 to 4,042 claimant figures. While the LLM doesn't provide incorrect numbers, the failure to include these specific metrics represents a material gap in quantitative completeness.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about the methodological evolution is sound and well-articulated, but the omission of the quantitative context weakens the overall synthesis and explanation of why the approach evolved.\n\nCONTEXTUAL RELEVANCE: Score of 8 because the answer addresses the core question about evolution and methodology, though it misses the quantitative evidence that would strengthen the contextual understanding of the drivers behind that evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 598,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In 2022 PepsiCo sold the Naked juice brand (along with Tropicana) to PAI Partners, but kept a 39 % non‑controlling interest in the new Tropicana Brands Group (TBG) and became the exclusive U.S. distributor for TBG’s portfolio—including Naked—through chilled direct‑store‑delivery (DSD) [PEP_10k_2022 page 8]. The 2023 filing repeats that PepsiCo still holds the 39 % non‑controlling stake in TBG and continues to act as the exclusive distributor for the joint‑venture’s brands, showing no change in either its operational role or its financial ownership of Naked between 2022 and 2023 [PEP_10k_2023 page 5].",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer fundamentally misrepresents the evolution of PepsiCo's relationship with Naked between 2022 and 2023. The LLM states 'showing no change in either its operational role or its financial ownership of Naked between 2022 and 2023,' which directly contradicts the ground truth. The ground truth explicitly states that BY 2023, 'PepsiCo no longer directly distributed Naked products' and that the relationship shifted 'from active distribution to a purely financial stake.' This is a major factual error that goes to the heart of the question asking how the relationship 'evolved.' QUANTITATIVE ACCURACY: The numbers provided are correct (39% noncontrolling interest, 2022-2023 timeframe, DSD distribution method). The entity name is slightly off ('Tropicana Brands Group' vs. 'The Beachbody Company' per ground truth), though both may be acceptable references to the same entity. QUALITATIVE ACCURACY: The LLM failed to identify the key evolution - the LOSS of operational involvement in distribution by 2023. The answer claims continuity where the ground truth shows a clear transition. The LLM correctly identifies the 2022 transaction details but completely misses the 2023 change. REASONING FAILURE: The multi-hop synthesis is incomplete. The LLM should have compared the 2022 filing (showing active distribution role) with the 2023 filing (showing no distribution role) to demonstrate the evolution. Instead, it claims both years show the same operational involvement. This is a fundamental failure to answer the question about how the relationship 'evolved.' The answer reads as if the LLM did not properly synthesize the temporal comparison required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 467,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "In the 2023 filing (see page 131 & 133) CVS said that ExtraBucks Rewards are a **separate performance obligation** at the time of the original purchase; the transaction price is allocated between the sale and the rewards based on their relative standalone selling price, revenue for the rewards is recognized **only when the rewards are redeemed**, and any un‑redeemed balance is recorded as a contract liability (breakage is recognized only for gift cards).  \n\nThe 2024 filing (see page 125 & 126) repeats the same treatment—ExtraBucks Rewards remain a distinct performance obligation, revenue is allocated and recognized upon redemption, and unredeemed rewards stay on the contract‑liability balance—while providing a more detailed breakdown of the liability changes (including acquisition‑related adjustments) but **no substantive change** to the underlying revenue‑recognition policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about ExtraBucks Rewards accounting evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core accounting treatment in both years—separate performance obligation, allocation based on relative standalone selling prices, revenue recognition upon redemption, and contract liability for unredeemed rewards. (2) Accurately captures the key distinction between years: 2023 and 2024 treatments are substantively the same, with 2024 providing more detailed disclosure (acquisition-related adjustments) but no policy change. (3) Properly synthesizes multi-hop information across two fiscal years and multiple filing pages (2023: pages 131 & 133; 2024: pages 125 & 126). (4) Correctly notes the nuance about breakage recognition being limited to gift cards, not ExtraBucks. (5) No quantitative errors or incorrect dates/metrics. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, which mentions 'more refined language' and 'more mature and formalized approach' in 2024. However, the LLM's statement that 2024 provides 'more detailed breakdown' and 'no substantive change' captures the essence of this evolution. The ground truth emphasizes language refinement around 'determination of additional performance obligation tied to customers who accumulate ExtraBucks based on historical spending levels,' which the LLM doesn't explicitly state, though this is a relatively minor omission that doesn't affect the core answer's accuracy. The LLM's characterization of the evolution is semantically equivalent to the ground truth—both convey that the accounting treatment remained consistent while disclosures became more detailed/refined. No calculation errors, no entity misidentification, and the reasoning across both years is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 507,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Both the 2023 and 2024 cost‑of‑revenues disclosures list “payment‑processing fees, including those we pay to our integrated payment partners” as a line‑item within other operating costs. However, neither filing calls out a material change in those fees—in 2024 the cost‑of‑revenues rise is attributed mainly to higher content amortization, while the 2023 increase is tied to content‑related expenses—so Netflix’s reliance on integrated payment partners appears essentially unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that both 2023 and 2024 filings mention 'payment-processing fees, including those we pay to our integrated payment partners' as line items within other operating costs. However, there are significant issues with the response: (1) The LLM claims 'neither filing calls out a material change in those fees' and concludes reliance 'appears essentially unchanged,' which contradicts the ground truth's key finding that the disclosure strategy shifted - the 2024 filing removed granular details about these fees compared to 2023. (2) The LLM's reasoning focuses on attributing cost-of-revenues increases to content amortization rather than addressing the actual question about how disclosure of integrated payment partner reliance evolved. (3) The ground truth emphasizes a 'shift in disclosure strategy' with decreased explicit detail in 2024, while the LLM misses this critical distinction by stating the relationship appears 'essentially unchanged.' (4) The LLM provides no quantitative comparison of the actual payment processing fees between years, which would have been relevant to fully answer the question. (5) The LLM correctly identifies the line item exists in both years but fails to capture the nuanced finding that the level of detail decreased, which is the core insight of the ground truth answer. The response is partially correct on surface-level facts but fundamentally misses the key evolution in disclosure practices that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 413,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "In 2022 3M’s Minnesota program was focused on meeting the May 2007 Settlement Agreement and Consent Order – it had completed remediation at the Oakdale and Woodbury sites, substantially finished work at the Cottage Grove plant and was addressing MPCA‑directed storm‑water PFAS issues through a remediation plan and a December 2022 order 【page_127】. By 2023 the company was responding to a new MPCA Notice of Violation for storm‑water PFAS discharges at Cottage Grove, submitted a written corrective‑action response, and began negotiating a draft Clean Water Act permit that imposes far tighter PFAS limits (some below the limit of quantification) while also evaluating the impact of the Minnesota Department of Health’s newly‑issued, more stringent health‑based values for PFOA and PFOS 【page_99】【page_98】. This marks a shift from completing remediation to actively managing compliance with stricter regulatory limits and updated health‑based standards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key regulatory developments (MPCA Notice of Violation in March 2023, December 2022 MPCA order, draft Clean Water Act permit with tighter PFAS limits, Minnesota Department of Health's updated HBVs for PFOA and PFOS). The answer appropriately synthesizes the evolution from 2022 to 2023 and captures the shift toward stricter compliance requirements. The multi-hop reasoning connecting regulatory changes to 3M's response is sound. CRITICAL ERRORS: (1) The LLM states 3M 'had completed remediation at the Oakdale and Woodbury sites' in 2022, but the ground truth explicitly states 3M was 'continuing operational and maintenance activities' at these sites - remediation was not completed, only at Cottage Grove was work 'substantially completed.' This is a significant factual error. (2) The LLM incorrectly attributes the MPCA Notice of Violation to 'Cottage Grove' when the ground truth clearly states it was issued for the 'Hutchinson facility' in March 2023. This is a major entity misidentification. (3) The LLM omits mention of the Decatur, Alabama facility and the 2020 interim Consent Order with ADEM, which represents incomplete coverage of 3M's PFAS management approach. (4) The LLM states the HBVs were 'newly-issued' but the ground truth specifies they were issued in 'January 2024' - this timing detail is important for understanding the 2023 evolution. QUANTITATIVE ISSUES: Date accuracy is mixed - December 2022 order is correct, March 2023 NOV is correct, but the January 2024 HBV issuance should be noted as occurring after the 2023 period being evaluated. REASONING: The overall narrative structure is sound and captures the regulatory tightening, but the specific factual errors (Oakdale/Woodbury completion status, Hutchinson vs. Cottage Grove NOV location) undermine the accuracy of the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 507,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo’s foreign‑currency derivative program grew from a $3.0 billion notional amount at the end of 2022 to $3.8 billion at the end of 2023, with net‑investment hedges rising from $2.9 billion to $3.0 billion and the fair‑value of its foreign‑exchange hedges increasing from about $88 million to $105 million (cash‑flow hedges $46 million → $34 million and non‑designated hedges $42 million → $71 million)【page_103】【page_105】. This expansion and the broader mix of cash‑flow and non‑designated contracts illustrate a more active, comprehensive foreign‑exchange risk‑management approach that relies on derivatives—including net‑investment hedges—to offset currency exposure rather than for speculative purposes【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) All primary numbers are correct: $3.0B→$3.8B total notional value, $2.9B→$3.0B net-investment hedges, fair-value increase from ~$88M to $105M. (2) Correctly breaks down the fair-value components: cash-flow hedges ($46M→$34M) and non-designated hedges ($42M→$71M), with accurate arithmetic ($46M+$42M=$88M and $34M+$71M=$105M). (3) Effectively synthesizes multi-hop information across multiple data points from different sections (pages 103-105 cited). (4) Provides richer context than ground truth by detailing the composition of hedges and their changes, which strengthens the analysis of risk management strategy evolution. (5) Correctly interprets the strategic implications: expansion indicates more active/comprehensive FX risk management, not speculation. (6) Properly addresses both parts of the question: how derivatives evolved (quantitatively) and what this indicates about strategy (qualitatively). MINOR CONSIDERATIONS: The ground truth mentions 'no material net impact on earnings in 2023,' which the LLM answer doesn't explicitly state, though this is a minor omission that doesn't affect the core answer's accuracy. The LLM answer actually provides more detailed breakdown of the derivative portfolio composition, which adds value beyond the ground truth baseline. All numbers, dates, and entities are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 408,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "In the 2022 filing ExxonMobil emphasized building new chemical capacity – completing an ethane‑cracker joint‑venture near Corpus Christi and restarting Gulf‑Coast projects in Baytown, Texas and Baton Rouge, Louisiana – while also taking a final investment decision on a multi‑billion‑dollar, fully foreign‑owned petrochemical complex in the Dayawan park in Guangdong, China (2022 p. 67). By 2023 the company had moved from construction to operation, launching a 400 k‑t/yr performance‑polymers line and a 350 k‑t/yr linear‑alpha‑olefins unit in Baytown, Texas, and continued to invest in the Dayawan complex that will house >2.5 m t/yr of polyethylene and polypropylene capacity, showing a shift to operating new capacity while maintaining a dual US‑China geographic focus (2023 p. 59).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution and geographic focus shift, but contains several significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) Identification of 2022 ethane cracker completion near Corpus Christi, Texas; (2) Recognition of Baytown, Texas as a key expansion site; (3) Correct identification of Dayawan, China complex as 100% foreign-owned; (4) Correct polyethylene/polypropylene capacity figure of >2.5 million metric tons per year for China; (5) Sound multi-hop reasoning connecting 2022 and 2023 strategic shifts; (6) Appropriate geographic focus analysis (US to China expansion). CRITICAL ERRORS: (1) The LLM states 2023 performance polymers capacity as '400 k-t/yr' and linear alpha olefins as '350 k-t/yr' - these specific numbers are not verified in the ground truth, which only mentions 'expanding performance polymers and linear alpha olefins capacity' without quantifying these additions; (2) The ground truth explicitly mentions '500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026' for 2022, but the LLM omits this entirely, replacing it with vague references to 'restarting Gulf-Coast projects'; (3) The LLM mentions 'Baton Rouge, Louisiana' which is not present in the ground truth answer; (4) The LLM characterizes 2023 as 'moved from construction to operation' but the ground truth indicates these were capacity additions/expansions, not necessarily operational transitions. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2022 to 2023 and identifies the strategic shift toward high-performance products and China investment, demonstrating sound reasoning. However, the introduction of unverified specific capacity numbers (400 k-t/yr, 350 k-t/yr) and omission of the 500,000 metric ton advanced recycling capacity significantly weakens the answer's factual foundation. The answer reads plausibly but contains fabricated or misremembered details that would not pass strict verification against actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 550,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M’s holdings of certificates of deposit / time deposits more than doubled, rising from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  At the same time, its commercial‑paper balance fell to zero, showing the company is moving cash into safer, highly liquid short‑term assets rather than higher‑risk paper—an indication of a more conservative, liquidity‑focused short‑term investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE ACCURACY: All numbers are correct - $21 million in 2022 and $49 million in 2023 match the ground truth exactly. The characterization of 'more than doubling' is accurate (increase of $28M or ~133%). (2) COMPLETENESS: The answer addresses both parts of the question - the evolution of CD/Time Deposits holdings AND what this indicates about short-term investment strategy. (3) ENTITY ACCURACY: 3M is correctly identified, years 2022-2023 are correct, and the financial metric (Certificates of Deposit/Time Deposits) is properly identified. (4) REASONING & SYNTHESIS: The LLM goes beyond the ground truth by adding valuable context about commercial paper falling to zero, which strengthens the analysis of the strategic shift. This additional synthesis demonstrates sound multi-hop reasoning - connecting the CD increase with the commercial paper decrease to paint a fuller picture of the liquidity strategy shift. The conclusion that this represents a 'more conservative, liquidity-focused short-term investment strategy' is well-supported and semantically equivalent to the ground truth's statement about 'increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments.' (5) MINOR CONSIDERATION: The LLM provides slightly more detailed strategic interpretation than the ground truth, but this is additive rather than contradictory, and all core facts remain accurate. The citation reference [page_64] adds credibility. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 430,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "In the 2022 Form 10‑K Mastercard described its value‑added services as providing “proprietary insights, drawing on Mastercard’s **principled use of consumer and merchant data**” and framed the offering as helping parties “transact easily and with confidence”【page_71】. By the 2023 filing the language had been sharpened to say the insights come from “**principled and responsible use of secure consumer and merchant data**,” explicitly highlighting data responsibility and security as part of its trust‑building narrative【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Key strengths: (1) Correctly identifies the 2022 language as 'principled use of consumer and merchant data' and the 2023 evolution to 'principled and responsible use of secure consumer and merchant data' - exact matches to ground truth. (2) Accurately captures the semantic shift from 2022 to 2023, noting the addition of 'responsible' and 'secure' as key enhancements. (3) Properly synthesizes the multi-hop reasoning: identifies the evolution across years, explains the significance (stronger emphasis on data security and trust), and connects this to Mastercard's broader narrative. (4) Includes specific page references (page_71 for 2022, page_49 for 2023) which adds credibility and verifiability. (5) Contextualizes the language shift appropriately as part of a 'trust-building narrative.' Minor observation: The LLM answer includes additional context about 'transact easily and with confidence' from 2022 that wasn't explicitly mentioned in the ground truth, but this is supplementary and doesn't contradict the core answer. The answer fully addresses the question's focus on how the approach evolved in terms of data responsibility and trust-building language. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 362,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "In the 2022 filing PepsiCo said that the assumptions underlying its pension and retiree‑medical plan estimates were driven mainly by “uncertainties, including those related to the COVID‑19 pandemic” (PEP_10k_2022.pdf page 59). By the 2023 filing the company’s discussion of the same critical accounting policies shifted to “business and economic uncertainty resulting from the ongoing conflicts in Ukraine and the Middle East and the high‑interest‑rate and inflationary‑cost environment” (PEP_10k_2023.pdf page 57). This change shows that the external environment affecting the plans has moved from a pandemic‑focused risk to a broader mix of geopolitical tension and macro‑economic pressures, which are likely to alter discount‑rate, inflation and health‑cost assumptions used in the actuarial estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the shift in external factors from COVID-19 pandemic uncertainties in 2022 to geopolitical and macroeconomic concerns in 2023; (2) Accurately cites specific document references (PEP_10k_2022.pdf page 59 and PEP_10k_2023.pdf page 57) with direct quotes that match the ground truth; (3) Properly synthesizes the multi-hop information by comparing the two years and explaining the evolution; (4) Correctly identifies the company as PepsiCo; (5) Accurately characterizes the shift from health-related disruptions to broader macroeconomic and geopolitical concerns. The answer goes slightly beyond the ground truth by explicitly noting how these changes would likely affect specific actuarial assumptions (discount-rate, inflation, and health-cost assumptions), which demonstrates deeper analytical understanding and is logically sound. No quantitative errors detected. The reasoning is clear and the multi-hop synthesis across the two filing years is properly executed. Minor consideration: The answer includes interpretive analysis about how these factors would affect assumptions, which is not explicitly stated in the ground truth but is a reasonable and accurate inference based on pension accounting principles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 365,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil’s undeveloped land in the Other Americas fell from 25,196 gross (11,977 net) thousand acres at year‑end 2022 to 24,221 gross (11,548 net) thousand acres at year‑end 2023 – a drop of about 875 gross and 429 net thousand acres (XOM 2023 10‑K, page 24, footnote 1). The modest decline implies the company is converting or relinquishing a small slice of its inventory while still retaining a large undeveloped base, signalling that significant exploration upside remains in the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN GROSS ACREAGE 2022 FIGURE: The LLM states 25,196 gross thousand acres for 2022, but the ground truth shows 25,096 gross thousand acres. This is a 100-unit discrepancy that propagates into the calculated decline (LLM shows 875 gross decline vs. correct 875 decline, which happens to match by coincidence given the wrong starting number). The net acreage figures are correct (11,977 in 2022, 11,548 in 2023, with 429 net decline). The 2023 gross figure of 24,221 is correct. CALCULATION VERIFICATION: LLM calculates 25,196 - 24,221 = 975 (not stated but implied), but should be 25,096 - 24,221 = 875. The LLM states 'about 875 gross' which is the correct decline amount, but this appears to be coincidental given the wrong starting number was cited. QUALITATIVE ASSESSMENT: The reasoning about conversion/relinquishment and retained exploration potential is sound and matches the ground truth interpretation. The answer correctly identifies this as a modest decline and appropriately contextualizes it within the company's broader portfolio. COMPLETENESS: The answer addresses both the evolution of acreage and what it indicates about exploration potential, fully addressing the multi-part question. ENTITY ACCURACY: Company (ExxonMobil/XOM), region (Other Americas), years (2022-2023), and metrics (gross/net undeveloped acreage) are all correctly identified. The citation to the 2023 10-K is appropriate. The primary issue is the factual error in the 2022 gross acreage figure, which is a material quantitative error despite the coincidental correct final decline figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 436,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "The company kept the same accounting approach – foreign‑currency forwards and options that are **not** placed in cash‑flow or fair‑value hedges are recorded at fair value and any gain or loss is taken directly to earnings 【page 45 (2022 10‑K)】. In 2023 the exposure to these non‑designated contracts fell sharply (gross notional $1.0 bn versus $2.8 bn in 2022) and the earnings impact improved, moving from a $76 million loss in 2022 to only a $9 million loss in 2023 【page 76 (2023 10‑K) – gain/loss table and notional amounts】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides significantly different notional amounts than the ground truth. Ground truth states $3.7 billion in 2022, but LLM claims $2.8 billion in 2022. For 2023, ground truth does not specify a $1.0 billion figure, and the LLM's comparison ($1.0bn vs $2.8bn) contradicts the ground truth baseline of $3.7 billion. This represents a fundamental factual error in the core numeric data. (2) EARNINGS IMPACT DISCREPANCY - The LLM cites specific loss figures ($76 million loss in 2022, $9 million loss in 2023), but the ground truth does not mention these specific earnings impacts or loss amounts. The ground truth focuses on 'fair value gains and losses directly impacting earnings' without quantifying them as losses of these magnitudes. This is a significant factual claim not supported by the ground truth. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that non-designated contracts are recorded at fair value with gains/losses to earnings, it fails to capture the key evolution described in the ground truth: the shift from 'primarily designated hedging strategies to a more direct financial exposure management approach.' The LLM states the company 'kept the same accounting approach,' which contradicts the ground truth's assertion of a strategic shift. (4) MULTI-HOP REASONING - The LLM attempts to synthesize 2022 and 2023 data but does so with incorrect baseline numbers, undermining the validity of the year-over-year comparison. The ground truth emphasizes an evolution in strategy, while the LLM emphasizes continuity with only quantitative changes. (5) CONTEXTUAL ISSUES - The LLM provides page citations that cannot be verified against the ground truth, and the specific loss figures appear to be fabricated or misattributed. The ground truth's focus on the shift in hedging strategy is largely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 518,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "In the 2022 filing, cyber‑and‑intelligence solutions were mentioned only as one line item among a broad set of “other value‑added services” (e.g., batch and real‑time payments, consulting, loyalty, gateway services) and were bundled with $1.3 billion of unsatisfied performance obligations for those services【page_81】. By the 2023 filing, Mastercard’s Business Overview and revenue description call out cyber‑and‑intelligence solutions as a distinct, security‑focused offering that “allows all parties to transact securely, easily and with confidence” and is priced for fraud‑prevention and transaction safety【page_49】【page_80】, indicating a stronger, more prominent role in its value proposition.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Cyber and Intelligence Solutions within Mastercard's value proposition between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning as a supporting role within a broader list of value-added services, matching the ground truth characterization. (2) Accurately captures the 2023 shift toward more prominent positioning with explicit security-focused language ('transact securely, easily and with confidence'). (3) Provides specific page references (page_81, page_49, page_80) that add credibility and traceability. (4) Demonstrates sound multi-hop reasoning by synthesizing information across both 2022 and 2023 filings to show the evolution. (5) Semantic equivalence is strong - the LLM's description of the shift from 'one line item among broad services' to 'distinct, security-focused offering' aligns well with the ground truth's characterization of moving from 'supporting role' to 'core component.' WEAKNESSES: (1) The mention of '$1.3 billion of unsatisfied performance obligations' is a specific quantitative detail that cannot be verified against the ground truth answer, which does not include this number. While this detail may be accurate from the filing, it introduces information not present in the ground truth, creating minor uncertainty about whether this specific figure is correct. (2) The ground truth emphasizes the strategic shift toward 'elevating the importance of cybersecurity,' while the LLM focuses more on the positioning and pricing aspects. This is a minor semantic difference rather than an error. (3) No calculation errors detected. The answer correctly synthesizes the comparative evolution without mathematical claims. Overall, the answer is substantively correct and well-reasoned, with the primary concern being the unverified $1.3 billion figure that goes beyond the ground truth scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 516,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list “income tax expense and accruals” as one of the four critical accounting policies, and the accompanying description is essentially the same – it explains that the annual tax rate is based on income, statutory rates and transfer‑pricing, that significant judgment is required, reserves are set for positions that may be challenged, and the estimated effective tax rate is applied to quarterly results. Thus, the treatment and disclosure of income‑tax expense and accruals did not materially change between 2022 and 2023. (2022 pp. 59‑61; 2023 pp. 59‑61)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that 'the treatment and disclosure of income-tax expense and accruals did not materially change between 2022 and 2023,' but the ground truth explicitly states there WAS an evolution: in 2022 it was listed as a critical accounting policy, while in 2023 it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with more structured presentation and deeper transparency through Note 5. The LLM's conclusion is the opposite of what actually occurred. While the LLM correctly identifies that both years list this as a critical accounting policy and provides accurate page references (pp. 59-61 for both years), it misses the key structural and organizational changes that constitute the evolution in treatment. The LLM also correctly notes that the accompanying descriptions are similar in content, but this observation actually supports the ground truth's point about reorganization rather than substantive content change. The LLM's reasoning that 'no material change' occurred is logically flawed because it conflates content similarity with structural/presentational changes. The question specifically asks about 'evolution' in treatment or disclosure, which the ground truth identifies as a shift toward more detailed and organized reporting. The LLM's answer directly contradicts this finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 396,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "In 2023 Intel announced the Universal Chiplet Interconnect Express (UCIe) as a new standard for chip‑to‑chip communication and showed a first silicon demonstration, positioning it as a cornerstone of its “systems of chips” and advanced‑packaging roadmap【page_37】. By the 2024 filing Intel is no longer just showcasing a prototype – it says it “continues to drive … the Universal Chiplet Interconnect Express standard … which we demonstrated in silicon in 2023,” framing UCIe as an ongoing, core element of its broader systems‑of‑chips and Open System Foundry strategy to accelerate customer designs【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies UCIe (Universal Chiplet Interconnect Express) as the standard in question; (2) Accurately captures the 2023 timeline with 'first silicon demonstration' language matching the ground truth's 'demonstrated it in silicon'; (3) Properly synthesizes the evolution from 2023 to 2024, showing progression from demonstration phase to active production/ongoing integration; (4) Correctly contextualizes UCIe within Intel's broader 'systems of chips' strategy; (5) Appropriately references advanced packaging technologies and system-level standards as core components; (6) Includes relevant supporting details like 'Open System Foundry strategy' and 'accelerate customer designs' that enhance understanding without contradicting ground truth; (7) Provides specific page citations (page_37, page_22) indicating source documentation. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('continues to drive' vs. 'actively producing based on') but conveys the same semantic meaning of progression and ongoing commitment; (2) The ground truth mentions 'advanced semiconductor assembly and test offerings' while LLM emphasizes 'Open System Foundry strategy' - both are valid contextual framings of Intel's broader strategy, not contradictory; (3) The LLM answer is more detailed in showing the specific evolution narrative ('no longer just showcasing a prototype') which adds clarity without introducing errors. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the progression in Intel's positioning of UCIe from demonstration to production/integration phase. No calculation errors or factual inaccuracies detected. All dates, entities, and strategic positioning elements are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 515,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "In both the 2023 and 2024 10‑K filings CVS records each ASR as an initial treasury‑stock purchase for the bulk of the notional amount and a forward contract for the remainder, which is first placed in capital surplus and then re‑classified to treasury stock when the final shares are delivered (2023: $1.6 bn treasury + $0.4 bn forward; 2024: $2.6 bn treasury + $0.4 bn forward)【page_75†L1-L9】【page_92†L1-L9】. The 2023 filing shows the ASRs concluding one month after the purchase (January receipt, February final receipt)【page_75†L9-L12】, whereas the 2024 filing’s $3.0 bn ASR extended the settlement to March 2024 and added language about optional cash or share settlement and a maximum share cap of 73.9 million shares【page_74†L13-L20】【page_92†L9-L13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) Accounting treatment consistency identified correctly - both years used initial treasury stock purchase plus forward contract reclassification from capital surplus to treasury stock; (2) Timeline evolution correctly noted - 2023 ASR completed in one month vs 2024 in two months; (3) General structure of the accounting approach is accurate; (4) Identification of Morgan Stanley as 2024 counterparty and Citibank as 2023 counterparty is correct. CRITICAL ERRORS: (1) Share quantities are significantly wrong - LLM states 2023 received 17.4M shares initially but breaks it down as '$1.6bn treasury + $0.4bn forward' without stating share counts; for 2024, LLM omits the critical share quantities (31.4M initial + 8.3M final) entirely, only mentioning the 73.9M maximum cap; (2) Dollar amount breakdown is incorrect - LLM states 2023 as '$1.6bn treasury + $0.4bn forward' but ground truth shows $2.0B total ASR with 80% initial receipt (17.4M shares) and 20% final (5.4M shares); (3) 2024 ASR dollar breakdown missing - LLM doesn't specify the $2.6bn vs $0.4bn split or verify it sums to $3.0B; (4) Initial share percentages not mentioned - ground truth specifies 80% for 2023 and 85% for 2024, which LLM omits. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the evolution pattern, but fails to provide complete quantitative synthesis. The comparison of timelines is sound, but the share quantity data is incomplete or missing. SEMANTIC ISSUES: While the accounting treatment description is conceptually correct, the lack of specific share counts and percentage allocations weakens the answer's precision for a question specifically asking about 'evolution' of these transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 499,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "In the 2022 filing UPS reported a $5.1 billion pre‑tax actuarial gain for the Central States Pension Fund, reflecting a reduction in the estimated coordinating‑benefit liability and itemizing the gain into discount‑rate, coordinating‑benefits and demographic components (page 101). By the 2023 filing the company had shifted to a forward‑looking approach, referencing the potential CSPF coordinating‑benefit liability in note 5 and adding a 25‑basis‑point sensitivity analysis that quantifies how changes in discount rates and asset returns would affect projected benefit obligations and net periodic benefit cost (page 56).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the 2022 figure. The ground truth states UPS disclosed a $2.3 billion PRE-TAX ACTUARIAL LOSS in 2022, but the LLM claims a $5.1 billion PRE-TAX ACTUARIAL GAIN. This is a major quantitative error on two dimensions: (1) the dollar amount is wrong ($5.1B vs $2.3B), and (2) the direction is inverted (gain vs loss). This is not a minor discrepancy but a fundamental misstatement of the financial position. The LLM also incorrectly characterizes the 2022 disclosure as itemizing the gain into discount-rate, coordinating-benefits and demographic components, when the ground truth indicates it was a loss related to potential coordinating benefits. The 2023 portion of the answer is more accurate - the LLM correctly identifies the shift to sensitivity analysis and the 25 basis point reference, which aligns with the ground truth. However, the 2023 description adds details about 'discount rates and asset returns' affecting 'projected benefit obligations and net periodic benefit cost' that go beyond what the ground truth specifies. The multi-hop reasoning fails because the comparison between 2022 and 2023 is built on an incorrect 2022 baseline. The answer does address the evolution question and attempts to show the shift from specific obligation quantification to sensitivity analysis, but the foundational error undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 395,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "In the 2022 filing Mastercard positioned its cyber‑and‑intelligence solutions as a core “value‑added service … to allow all parties to transact **easily and with confidence**” and even called them a primary driver of revenue growth (“Cyber & Intelligence … solutions” – 2022 Business Overview p.46; financial highlights p.48). By the 2023 filing the messaging had evolved to stress that these solutions let parties “**transact securely, easily and with confidence**” and are built on a “principled and **responsible use of secure** consumer and merchant data,” shifting the value proposition toward a stronger security‑and‑trust narrative for stakeholders (2023 Business Overview p.49).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Mastercard's messaging around Cyber and Intelligence Solutions between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning using the exact phrase 'allow all parties to transact easily and with confidence' matching ground truth; (2) Accurately captures the 2023 evolution to 'transact securely, easily and with confidence' with the addition of 'securely' as a key shift; (3) Properly synthesizes the multi-hop comparison showing how messaging evolved from basic confidence/ease to emphasizing security and trust; (4) Correctly identifies the shift toward 'principled and responsible use of secure consumer and merchant data' in 2023; (5) Appropriately contextualizes this within the broader infrastructure narrative. MINOR WEAKNESSES: (1) The LLM adds specific page references (p.46, p.48, p.49) and characterizes cyber solutions as 'primary driver of revenue growth' - while these details may be accurate, they go slightly beyond what the ground truth explicitly confirms, introducing minor specificity that wasn't in the original answer; (2) The ground truth mentions 'strategic investments in new networks like open banking and digital identity' as part of the 2023 evolution, which the LLM answer does not explicitly address, though this is a relatively minor omission; (3) The phrase 'responsible use of secure' appears to be a slight paraphrase of 'principled use' from ground truth. QUANTITATIVE ACCURACY: No calculations or specific numbers are required for this qualitative question, so this scores high. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution across two years and identifies the key semantic shifts in messaging. CONTEXTUAL RELEVANCE: The answer directly addresses the question about positioning evolution and value proposition changes. Overall, this is a strong answer with minor gaps in comprehensiveness regarding the open banking/digital identity strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 544,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 Form 10‑K the 4.450% Senior Note due 2046 is listed as Exhibit 4.11 and is incorporated by reference to Exhibit 4.4 of a Current Report on Form 8‑K filed on October 14 2015【page_125】. In the 2023 Form 10‑K the same note appears as Exhibit 4.13, still referencing Exhibit 4.4, but the underlying 8‑K filing date is updated to February 24 2016【page_126】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) EXHIBIT NUMBER ERROR - 2022 FILING: The LLM states the note was listed as Exhibit 4.11 in the 2022 Form 10-K, but the ground truth clearly indicates it was Exhibit 4.12. This is a direct factual error. (2) EXHIBIT NUMBER ACCURACY - 2023 FILING: The LLM correctly identifies Exhibit 4.13 for the 2023 filing, matching the ground truth. (3) DATE ACCURACY: Both dates are correct - October 14, 2015 for the 2022 filing reference and February 24, 2016 for the 2023 filing reference. These match the ground truth. (4) ADDITIONAL DETAIL: The LLM adds information about 'Exhibit 4.4' being referenced within the 8-K filings, which is not mentioned in the ground truth but appears to be supplementary detail. This doesn't contradict the ground truth but represents additional specificity. (5) MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across two years and identifies the shift in exhibit numbering and documentation dates. However, the fundamental error in the 2022 exhibit number (4.11 vs. 4.12) undermines the core accuracy of the answer. (6) SEMANTIC UNDERSTANDING: The LLM demonstrates understanding of the question's intent regarding how the presentation evolved, but the factual error in the primary exhibit number for 2022 is a critical failure. The answer would mislead someone trying to locate the correct exhibit in the 2022 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 409,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel’s disclosures in both the 2023 and 2024 10‑K show the same post‑sanctions stance: after the April 2021 Treasury designation, Intel resumed security‑research communications with Positive Technologies under an OFAC General License and has generated no gross revenue or profit from those interactions. The 2024 filing repeats the 2023 language, indicating that Intel’s engagement with Positive Technologies remains unchanged and will continue in accordance with the OFAC license.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) Both filings mention OFAC licensing/General License for communications with Positive Technologies, (2) No gross revenues or net profits from these interactions, (3) Communications relate to IT security research and vulnerability disclosure. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states the relationship 'remains unchanged' and that 2024 'repeats the 2023 language,' which directly contradicts the ground truth that shows an EVOLUTION from 2023 to 2024. The ground truth explicitly states the relationship 'evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions' - this is a meaningful distinction the LLM missed. (2) The LLM characterizes both years as having 'the same post-sanctions stance,' failing to capture the forward-looking and sustained partnership posture that emerged in 2024. (3) The date 'April 2021' for Treasury designation is not verified in the ground truth and appears to be an unsupported detail. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between 2023 and 2024. The question specifically asks 'how has...evolved' (implying change), but the LLM concluded there was no meaningful evolution, which contradicts the ground truth's clear statement of evolution. This represents a fundamental failure in comparative analysis across the two years. QUANTITATIVE ACCURACY: Numbers and dates mentioned are either correct or unverifiable, but the core issue is qualitative - the failure to identify the evolution in Intel's posture and language between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 453,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of the 4.78 % senior notes due March 2038 was $5.0 billion at both year‑end 2023 and year‑end 2024 (2023 $5,000 m vs 2024 $5,000 m)【page_168】【page_161】. The unchanged amount shows CVS has neither retired nor added to this tranche, indicating that this large, fixed‑rate, long‑dated issue remains a stable pillar of its long‑term debt mix and reflects a deliberate strategy to preserve a diversified, long‑maturity financing profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All primary numbers are correct - the 4.78% Senior Notes balance is accurately stated as $5,000 million ($5.0 billion) for both 2023 and 2024. (2) The percentage rate (4.78%) and maturity date (March 2038) are correct. (3) The core finding that the balance remained stable/unchanged is accurate. (4) Number formatting is appropriately flexible ($5.0 billion vs $5,000 million). (5) The LLM correctly identifies this as a 'fixed-rate, long-dated issue' and notes it as a 'stable pillar' of debt. WEAKNESSES: (1) The LLM answer is INCOMPLETE - it fails to address the comparative context provided in the ground truth about other senior notes (the 2.7% notes due August 2040 that decreased from $1,250M to $367M). The original answer explicitly uses this comparison to illustrate 'selective debt management and refinancing activity,' which provides important context about what the stability of the 4.78% notes indicates relative to CVS's broader debt strategy. (2) The LLM's interpretation of 'what this indicates about the company's long-term debt structure' is somewhat generic ('deliberate strategy to preserve a diversified, long-maturity financing profile') rather than the more specific insight that this stability contrasts with active refinancing in other instruments. (3) The question asks about what the evolution 'indicates' - the ground truth provides a more complete answer by showing selective debt management across the portfolio, while the LLM only addresses the single instrument. CALCULATION VERIFICATION: No calculations required; all stated figures are accurate. MULTI-HOP REASONING: The LLM partially addresses the multi-hop aspect (comparing 2023 to 2024 for this specific note) but fails to synthesize the comparative information about other debt instruments that would fully answer what the stability indicates about overall debt structure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 510,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "In the 2022 Form 10‑K, Exxon Mobil’s 0.835 % Notes due 2032 (ticker XOM32) are listed among the securities registered under Section 12(b), showing they were outstanding at that filing 【page_1】. The 2024 Form 10‑K again lists the same 0.835 % Notes due 2032 as a registered security (XOM32) on the NYSE, indicating the notes remain outstanding and there has been no change in their status between the two filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors in its core conclusion despite getting some details correct. CORRECT ELEMENTS: (1) The 0.835% Notes due 2032 with ticker XOM32 are correctly identified in both 2022 and 2024 filings, (2) The numeric values (0.835%, 2032 maturity date) are accurate, (3) The ticker symbol XOM32 is correct. CRITICAL ERRORS: (1) The LLM claims 'there has been no change in their status between the two filings,' which directly contradicts the ground truth. The ground truth explicitly states that while the 0.835% Notes remained, the 0.142% Notes due 2024 (XOM24B) were present in 2022 but absent in 2024, indicating a significant change in debt composition. (2) The LLM completely fails to address the 0.142% Notes due 2024 (XOM24B), which is a critical part of the multi-hop analysis required by the question. The ground truth emphasizes that the removal of the 2024 notes represents a meaningful evolution in the company's debt structure. (3) The LLM's conclusion that 'there has been no change' is fundamentally incorrect - the question asks how the status 'evolved,' and the ground truth demonstrates clear evolution through the removal of shorter-term debt instruments. MULTI-HOP REASONING FAILURE: The question requires synthesizing information about multiple debt instruments across two years. The LLM only addresses one instrument (the 0.835% Notes) and ignores the comparative analysis of what changed (the 2024 notes disappearance). This represents a failure to perform the required multi-hop synthesis. The LLM's answer is incomplete and reaches an incorrect conclusion about the overall evolution of Exxon Mobil's debt structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 457,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "In the 2022 filing (covering 2021) American Express held about **$1.704 billion of U.S. Treasury securities at fair value**, with the portfolio split roughly **49 % due within one year and 51 % due in the 1‑to‑5‑year bucket**【page_120†L31-L38】【page_121†L31-L38】. By the 2024 filing the Treasury position had **shrank to roughly $287 million at fair value**, and the maturity mix had become more short‑dated – **about two‑thirds now maturing within one year and the balance in the 1‑to‑5‑year range**【page_124†L31-L38】【page_126†L9-L13】. This reflects a clear shift from a larger, more evenly‑distributed Treasury holding to a much smaller, more short‑term‑focused allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims 2022 holdings of $1.704 billion, but ground truth shows $477 million (a 3.6x overstatement). The LLM claims 2024 holdings of $287 million, but ground truth shows $189 million short-term + $98 million intermediate-term = $287 million total, which happens to match the LLM's aggregate but the LLM mischaracterizes the composition. (2) MATURITY DISTRIBUTION ERRORS - The LLM claims 2022 had a 49/51 split between short-term and 1-5 year buckets, but ground truth explicitly states 2022 had EXCLUSIVELY short-term instruments with NO long-term exposure. This is a critical factual error. (3) DIRECTIONAL MISINTERPRETATION - The LLM characterizes the shift as moving from 'larger, more evenly-distributed' to 'smaller, more short-term-focused,' but ground truth shows the opposite evolution: from exclusively short-term ($477M) to a diversified portfolio including intermediate-term holdings ($189M + $98M). The LLM's narrative of 'shrinking and becoming more short-dated' contradicts the ground truth's narrative of 'expanding and diversifying into longer maturities.' (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused or misread the source data, presenting a completely different portfolio composition than what the ground truth documents show. (5) The only partial alignment is that both mention a shift in strategy, but the direction and magnitude of that shift are entirely wrong in the LLM answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 448,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "In Amazon’s 2022 Form 10‑K the 2.500 % senior note due 2050 is disclosed for the first time in Exhibit 4.5 – an Officers’ Certificate dated June 3 2020 that lists that note (along with other senior notes) 【page_72†L31-L38】. By the 2024 Form 10‑K the same 2.500 % Note due 2050 is again included in an updated Officers’ Certificate (now Exhibit 4.6), indicating the note remained outstanding and was carried forward unchanged in the company’s filings 【page_75†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amazon's 2.500% Note due 2050 evolution between 2022 and 2024. STRENGTHS: (1) All numeric values are correct - the 2.500% rate is accurate, the 2050 maturity date is correct, and the years 2022 and 2024 are properly identified. (2) The Officers' Certificate date of June 3, 2020 is correctly cited. (3) The exhibit references are accurate - Exhibit 4.5 in 2022 and Exhibit 4.6 in 2024 are correctly identified. (4) The multi-hop synthesis is sound: the answer correctly traces the note from its introduction in 2022 (via the 2020 Officers' Certificate) through its reintroduction in 2024, establishing continuity and lack of modification. (5) The semantic meaning aligns perfectly with the ground truth - both convey that the note was introduced in 2022, remained outstanding, and was carried forward unchanged by 2024. (6) The answer appropriately notes that Exhibit 4.6 in 2024 was an exact replication of the earlier exhibit, demonstrating the note's unchanged status. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'carried forward unchanged' vs. 'continued to maintain...without modification'), but these are semantically equivalent. The inclusion of page references with citation markers adds helpful specificity. The answer fully addresses the evolution question by showing both the 2022 introduction and 2024 continuation. No calculation errors, no factual inaccuracies, and the reasoning chain is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 433,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Costco’s 2022 Form 10‑K exhibit list for the Citibank, N.A. Co‑Branded Credit Card Agreement includes amendments through the Tenth Amendment (10.8.10)【page_68】. The 2023 Form 10‑K adds the Eleventh and Twelfth Amendments, with the Twelfth Amendment (10.8.12) shown【page_68】. Thus, the total amendments rose from ten in 2022 to twelve in 2023 – an increase of two amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a different interpretation of the amendment evolution than the ground truth, with significant discrepancies in the specific amendment numbers cited. QUANTITATIVE ISSUES: (1) Ground truth states the Eighth Amendment was most recent in 2022 (filed March 10, 2022), but LLM claims the Tenth Amendment was in 2022's exhibit list - this is a 2-amendment discrepancy. (2) Ground truth indicates the Twelfth Amendment was filed October 11, 2023, which the LLM correctly identifies. (3) Ground truth explicitly states 'four additional amendments during this period' (from Eighth to Twelfth = 8th, 9th, 10th, 11th, 12th = 4 additional), but LLM calculates only 2 amendments added (from 10 to 12). This is a fundamental calculation error. (4) The LLM's claim that 2022 had 'ten' amendments total contradicts the ground truth's statement that the Eighth Amendment was the most recent in 2022. MULTI-HOP REASONING: The LLM correctly attempts to synthesize information from both 2022 and 2023 Form 10-K filings and properly identifies the Twelfth Amendment date. However, it fails to correctly identify which amendment was the baseline in 2022, leading to an incorrect count of new amendments. ENTITY ACCURACY: Correctly identifies Costco, Citibank N.A. Co-Branded Credit Card Agreement, and the relevant years. SEMANTIC ISSUES: The core finding (evolution of amendments between 2022-2023) is addressed, but the specific numbers and the magnitude of change are materially incorrect. The answer demonstrates partial understanding but contains critical factual errors in amendment numbering that undermine the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 446,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "In 2022 NVIDIA presented CUDA as the core GPU‑programming model that, together with its GPUs, CPUs and networking, formed the “fundamental building blocks” of a unified architecture and was used by roughly three million developers (​pages 7 & 11). By 2024 CUDA has become the centerpiece of a full‑stack software ecosystem—augmented by CUDA‑X libraries, SDKs and APIs—and is now explicitly integrated with new hardware layers such as DPUs, the Grace CPU and the forthcoming Blackwell GPU architecture, while its developer base has grown to almost six million (​pages 4, 5, 6, 7).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about CUDA's evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of CUDA as foundational building blocks with developer base of ~3 million; (2) Accurately describes 2024 evolution to full-stack ecosystem with CUDA-X libraries, SDKs, and APIs; (3) Properly synthesizes integration with new hardware (DPUs, Grace CPU, Blackwell GPU); (4) Correctly notes developer base growth to ~6 million by 2024; (5) Provides specific page references supporting claims; (6) Captures the strategic shift from unified architecture to heterogeneous computing platform. MINOR GAPS: (1) The LLM answer mentions 'CPUs and networking' in 2022 description, but the ground truth indicates CPUs were introduced in fiscal 2024, not 2022 - this is a subtle but important distinction that the LLM slightly conflates; (2) The ground truth emphasizes 'enterprise-grade AI ecosystems' as a key 2024 development, which the LLM answer doesn't explicitly highlight, though it's implied through the full-stack platform description. QUANTITATIVE VERIFICATION: Developer numbers (3 million in 2022, ~6 million in 2024) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and correctly identifies the progression from foundational component to integrated platform. The connection between new hardware architectures (DPUs, Grace, Blackwell) and CUDA integration is properly established. SEMANTIC EQUIVALENCE: The answer conveys the essential evolution narrative accurately, with only minor omissions regarding the specific timing of CPU introduction and enterprise ecosystem emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 473,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "In 2023 Pfizer reported only $1.279 billion of Paxlovid sales and booked a $3.5 billion non‑cash revenue reversal for the expected return of EUA‑labeled government inventory, leaving $5.1 billion of Paxlovid‑related deferred revenue on its balance sheet 【page_107†L31-L34】【page_108†L1-L9】【page_110†L1-L5】. By 2024 Paxlovid revenue had risen to $5.716 billion as the company recognized about $2.9 billion of the previously deferred amounts (including a $771 million favorable adjustment for returned courses and $442 million revenue from a U.S. Strategic National Stockpile supply) and the remaining contracted‑revenue obligation for Paxlovid fell to roughly $1 billion 【page_107†L31-L34】【page_108†L9-L13】【page_109†L31-L34】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental misunderstanding of the financial structure and introduces incorrect numbers that contradict the ground truth. SPECIFIC ISSUES: (1) MAJOR ERROR - The LLM claims 2024 Paxlovid revenue was $5.716 billion, which is NOT supported by the ground truth. The ground truth does not provide a total 2024 revenue figure, only describing the components ($771M favorable adjustment + $442M SNS revenue). This appears to be a fabricated number. (2) INCORRECT DEFERRED REVENUE CLAIM - The LLM states '$5.1 billion of Paxlovid-related deferred revenue on its balance sheet' in 2023. The ground truth makes no such claim about deferred revenue on the balance sheet. The $3.5 billion is explicitly a non-cash revenue REVERSAL, not deferred revenue. (3) CALCULATION ERROR - The LLM claims '$2.9 billion of the previously deferred amounts' were recognized in 2024, but this calculation ($771M + $442M = $1.213B, not $2.9B) is incorrect and the premise of 'deferred amounts' is unsupported. (4) CORRECT ELEMENTS - The LLM correctly identifies: 2023 revenue of $1.279 billion, the $3.5 billion non-cash reversal, the $771 million favorable adjustment, the $442 million SNS revenue, and the ~$1 billion remaining performance obligations in 2024. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the information. It incorrectly framed the 2023 reversal as creating 'deferred revenue' when it was actually a reduction in recognized revenue. The 2024 narrative about recognizing 'previously deferred amounts' is fabricated and contradicts the ground truth's description of the evolution. SEMANTIC ISSUES: The ground truth emphasizes a shift from 'high-volume, government-driven revenue model' to 'stable, contracted future delivery model,' which the LLM fails to capture. The LLM's framing of the financial relationship is fundamentally misleading despite getting some individual numbers correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 526,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "By the end of 2022 the 2003 Incentive Program still had roughly 65.8 million shares available for grant (the filing notes “65,754,069 shares available for award under the 2003 Incentive Program” 【page_43】). At the close of 2024 that pool had fallen to about 47 million shares (“remaining shares available for award … were 47 million” 【page_102】). The program’s design – a 220‑million‑share ceiling that can be used for stock options, SARs, restricted stock and other awards, with a 10‑year option life, no fixed term and new awards allowed until the pool is exhausted – has remained unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key numeric values: 65.8 million shares available in 2022 (matching 65,754,069), 47 million remaining in 2024, and the 220 million share ceiling. However, there is a significant omission in addressing the question's core requirement about how the program 'evolved.' The ground truth explicitly states that 'the total maximum number of shares that could be issued under the program was increased to 220 million' - indicating a structural change/expansion occurred between 2022 and 2024. The LLM answer claims 'The program's design...has remained unchanged between the two years,' which directly contradicts the ground truth's assertion of an increase to 220 million. This is a critical error in understanding the evolution of the program's structure. Additionally, the LLM omits the important detail about RSU grants increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024, which demonstrates how actual usage evolved. The LLM provides accurate numbers for available shares and correctly describes the program mechanics, but fails to capture the key structural evolution (the increase in maximum shares to 220 million) and mischaracterizes it as 'unchanged.' The quantitative accuracy is good for the specific share counts cited, but the qualitative reasoning about program evolution is flawed, making this a partially correct answer that misses a fundamental aspect of what changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 397,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "In the 2022 Form 10‑K, Alphabet still highlighted AdSense as a distinct pillar of its “Google Network” business – it was named alongside AdMob and Google Ad Manager as a primary driver of network‑revenue growth, even though impressions from AdSense had slipped (see page 35). By the 2024 filing, the company no longer calls out AdSense by name; the narrative groups it under “Google Network partners’ properties” and presents advertising as a unified, AI‑enhanced platform that spans Search, YouTube and the network, indicating that AdSense has moved from a highlighted standalone product to a component of a broader, integrated advertising‑technology portfolio (see page 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of AdSense as a key growth driver alongside AdMob and Google Ad Manager within the Google Network; (2) Accurately captures the $8.6 billion year-over-year revenue increase mentioned in ground truth; (3) Correctly notes that AdSense impressions had declined in 2022; (4) Accurately describes the 2024 shift where AdSense is no longer explicitly called out by name; (5) Properly identifies the strategic pivot toward AI-powered products (Demand Gen, Performance Max) as central to advertiser success; (6) Correctly characterizes the evolution from 'highlighted standalone product' to 'component of broader integrated advertising-technology portfolio'; (7) Appropriately cites specific page references (page 35 for 2022, page 8 for 2024) showing document-level verification. MINOR CONSIDERATIONS: (1) The LLM answer includes parenthetical page citations that add specificity but weren't explicitly in the ground truth statement - this is a strength rather than weakness as it demonstrates source verification; (2) The phrasing 'Google Network partners' properties' is slightly different from ground truth's 'Google Network' but semantically equivalent and reflects actual filing language; (3) The answer successfully synthesizes multi-hop information across two fiscal years and multiple product lines. QUANTITATIVE VERIFICATION: The $8.6 billion figure is correctly cited and contextually placed. The multi-hop reasoning correctly connects: 2022 AdSense prominence → 2024 de-emphasis → shift to AI products, demonstrating proper synthesis across time periods and product categories. The answer fully addresses the question's core inquiry about AdSense's evolving role within Google's advertising technology portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 505,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "In the 2022 filing the UPS Retirement Plan was still a non‑contributory defined‑benefit plan that accrued benefits based on average compensation for all eligible employees, including non‑union participants, although it disclosed that accruals for non‑union participants would end on January 1, 2023 (see 2022 Note 6). By the 2023 filing the plan had implemented that change, formally ceasing all future‑service and compensation‑based benefit accruals for non‑union participants as of January 1, 2023 (see 2023 Note 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about the UPS Retirement Plan's evolution between 2022 and 2023. STRENGTHS: (1) All dates are correct - the January 1, 2023 effective date for the accrual freeze is accurately stated; (2) The plan structure is correctly identified as non-contributory defined-benefit; (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 (when accruals were still occurring but cessation was disclosed) to 2023 (when the freeze was implemented); (4) The specific change is clearly articulated: cessation of future-service and compensation-based benefit accruals for non-union participants; (5) The answer correctly distinguishes between the disclosure of the planned change in 2022 and the actual implementation in 2023; (6) Filing references (2022 Note 6, 2023 Note 5) add credibility and specificity. MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth but captures all essential information; (2) The ground truth uses language like 'transformational change' and 'strategic shift' which the LLM answer doesn't explicitly state, but this is a stylistic difference rather than a factual omission - the substance of the change is clearly conveyed; (3) The LLM answer focuses on the factual evolution without editorial commentary, which is appropriate for a direct answer. VERIFICATION: The core facts align perfectly with the ground truth: the plan was active in 2022 with disclosed future cessation, and the cessation was implemented in 2023 as planned. No numerical errors, date errors, or logical inconsistencies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 453,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "In the 2022 filing Amazon’s short‑term financing was anchored by a $7 billion unsecured revolving credit facility that bore a benchmark rate + 0.50% with a 0.04% commitment fee and had no borrowings, a $1 billion secured revolving facility (LIBOR + 1.40%, 0.50% fee) that carried $803 million of debt, and a commercial‑paper program of up to $10 billion that had about $725 million outstanding 【page_57】, 【page_56】. By the 2024 filing the company had replaced the secured line with a larger $15 billion unsecured revolving credit agreement (benchmark + 0.45%, 0.03% fee) and added a $5 billion 364‑day revolving facility (SOFR + 0.45%, 0.03% fee); neither of these facilities had any borrowings, while only $151 million of other short‑term credit facilities were outstanding at year‑end (up from $147 million in 2023) 【page_58】, and the commercial‑paper capacity was expanded to $20 billion with no borrowings reported as of Dec 31 2024 【page_58】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a structured comparison of Amazon's short-term credit facilities between 2022 and 2024, but contains several significant factual errors and introduces information not present in the ground truth.\n\nCORRECT ELEMENTS:\n- 2024 main facility: $15 billion unsecured revolving credit (benchmark + 0.45%, 0.03% fee) ✓\n- 2024 364-day facility: $5 billion (SOFR + 0.45%, 0.03% fee) ✓\n- No borrowings under main Credit Agreement or Short-Term Credit Agreement in 2024 ✓\n- Other short-term credit facilities: $147M (2023) and $151M (2024) ✓\n- 2022 main facility: $7 billion (benchmark + 0.50%, 0.04% fee) ✓\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. 2022 SECURED REVOLVING FACILITY: The LLM claims a \"$1 billion secured revolving facility (LIBOR + 1.40%, 0.50% fee)\" with \"$803 million of debt\" outstanding. The ground truth makes NO mention of any secured facility in 2022. This appears to be fabricated information.\n\n2. COMMERCIAL PAPER PROGRAM: The LLM states \"commercial-paper program of up to $10 billion that had about $725 million outstanding\" in 2022 and \"expanded to $20 billion with no borrowings reported as of Dec 31 2024.\" The ground truth contains NO information about commercial paper programs at all. This is entirely unsupported.\n\n3. LETTERS OF CREDIT: The ground truth mentions $7.2 billion in unused letters of credit as of December 31, 2021 (not 2022) and $8.3 billion by end of 2024. The LLM answer completely omits this information.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution from 2022 to 2024 for the main facilities that are actually documented (unsecured revolving credit expansion, addition of 364-day facility, reduction in rates and fees). However, the introduction of unsupported information about secured facilities and commercial paper programs undermines the credibility of the analysis.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Introduces $1B secured facility (not in ground truth)\n- Claims $803M outstanding debt in 2022 (not in ground truth)\n- Claims $725M commercial paper outstanding in 2022 (not in ground truth)\n- Claims $20B commercial paper capacity in 2024 (not in ground truth)\n- Omits $7.2B letters of credit (2021) and $8.3B letters of credit (2024)\n\nThe answer demonstrates good structural organization and correctly identifies the main evolution of the primary unsecured facilities, but the fabrication of material information about secured facilities and commercial paper programs, combined with omission of letters of credit data, represents significant factual errors that would mislead a reader about Amazon's actual credit structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 698,
        "total_tokens": 2237
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "In the 2022 filing Costco said it used variable‑priced contracts on an index basis for some electricity **and** natural‑gas purchases (plus fuel for its gas stations). The 2023 filing narrows that language to variable‑priced contracts only for natural‑gas (and gas‑station fuel), with electricity exposure now largely covered by fixed‑price contracts. The change indicates Costco is tightening its commodity‑price risk management—locking in electricity prices while still using index‑linked contracts where it judges the risk to be acceptable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that Costco's strategy 'remains consistent' between 2022 and 2023, with 'no significant shift away from index-based pricing mechanisms.' However, the LLM answer claims a material change occurred: that electricity exposure 'is now largely covered by fixed-price contracts' in 2023, representing a 'tightening' of risk management. This is factually incorrect according to the knowledge graph. The ground truth indicates both years show continued reliance on variable-priced contracts on an index basis for electricity and natural gas. The LLM's characterization of a shift from variable to fixed-price contracts for electricity is unsupported and contradicts the ground truth's emphasis on strategy stability. While the LLM correctly identifies that both years involved variable-priced contracts for natural gas and gas station fuel, the core interpretation of the evolution is wrong. The answer demonstrates a fundamental misreading of the filing data, inferring a strategic shift that did not occur. The reasoning about 'tightening' commodity price risk management is speculative and not supported by the actual filing information. The question asks about evolution and what it indicates about strategy; the correct answer is that there was minimal evolution and the strategy remained stable, not that it shifted toward fixed-price contracts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 404,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "In the 2022 filing NVIDIA described AI Enterprise as “essentially an operating system for enterprise AI applications,” positioning it as a core, internally‑delivered software layer of its data‑center stack (page 78). By the 2024 filing the product is presented as a commercial, paid‑license suite – listed alongside DGX Cloud as a key compute offering (page 4) and described as “a comprehensive suite of enterprise‑grade AI software” (page 6) that now includes NIM, Nemo and AI Blueprints to simplify generative‑AI development (page 7). Thus, AI Enterprise has shifted from a foundational OS‑type component to a monetized, feature‑rich software platform that drives NVIDIA’s data‑center revenue and strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and tracks the evolution of NVIDIA AI Enterprise positioning; (2) Accurately characterizes the 2022 positioning as foundational/OS-like component and 2024 positioning as monetized commercial offering; (3) Properly synthesizes the multi-hop information showing progression from strategic initiative to key revenue driver; (4) Correctly identifies supporting products (DGX Cloud, NIM, Nemo, AI Blueprints) and their roles in the broader ecosystem; (5) Uses appropriate descriptive language ('comprehensive suite of enterprise-grade AI software') that matches ground truth; (6) Demonstrates sound reasoning about the shift from internal strategic component to external monetization vehicle. MINOR CONSIDERATIONS: (1) The LLM provides specific page references (78, 4, 6, 7) which add credibility but cannot be independently verified against the ground truth provided; however, these do not contradict the ground truth and appear consistent with typical 10-K filing structures; (2) The characterization of AI Enterprise as 'essentially an operating system' in 2022 is a reasonable interpretation of foundational positioning, though the ground truth uses slightly different language ('foundational role'); (3) The answer goes slightly beyond the ground truth by explicitly naming component products (NIM, Nemo, AI Blueprints) but this represents appropriate elaboration rather than error. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are claimed, so quantitative precision is not directly testable, but the temporal framework (2022 vs 2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and correctly identifies the causal relationship between product evolution and strategic positioning changes. The connection between monetization and broader data center platform expansion is logically sound and matches the ground truth's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 558,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "In 2023 Pfizer carried roughly $5.1 billion of deferred revenue for Paxlovid (and Comirnaty), which fell to about $2.2 billion by year‑end 2024 as large advance‑payment balances were recognized (including a $771 million favorable adjustment)【page_110】.  At the same time, the company’s remaining performance‑obligation balance for Paxlovid was about $1 billion as of Dec 31 2024, to be recognized over 2025‑2028, signalling that most of the earlier government‑stockpiled inventory has been delivered and that future Paxlovid revenue will be modest but spread across several years【page_109】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites $5.1 billion deferred revenue in 2023 and $2.2 billion in 2024, but the ground truth makes no mention of these figures. Instead, the ground truth specifically references a $3.5 billion non-cash revenue reversal in Q4 2023 related to expected return of 6.5 million treatment courses under EUA - a fundamentally different metric. The LLM conflates deferred revenue (balance sheet liability) with revenue reversals (income statement impact), which are distinct concepts. (2) MISSING CRITICAL INFORMATION: The LLM fails to mention the $3.5 billion revenue reversal and the 6.5 million treatment course return, which are central to understanding 2023's contractual obligation changes. (3) PARTIAL ACCURACY: The LLM correctly identifies the ~$1 billion remaining performance obligation as of Dec 31, 2024, and correctly interprets this as signaling stabilization and modest future revenue spread across 2025-2028. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution between years, it does so using incorrect baseline data for 2023. The ground truth's narrative about moving from uncertainty (revenue reversal) to stability (defined RPO) is more accurate than the LLM's framing of deferred revenue decline. (5) SEMANTIC ISSUES: The LLM's interpretation that 'government-stockpiled inventory has been delivered' is reasonable inference but not explicitly stated in ground truth. The $771 million favorable adjustment is mentioned but not explained in context of the ground truth narrative. Overall, while the LLM captures the 2024 RPO figure correctly and provides reasonable forward-looking interpretation, the 2023 baseline is fundamentally wrong, undermining the comparative analysis that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 505,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "In the 2022 Form 10‑K Google said that an “evolving foreign‑policy landscape” could create new regulatory costs and challenges – chiefly the need to comply with data‑transfer rules between the EU and the United Kingdom and other new customer‑requirement obligations, together with the usual foreign‑ownership, exchange‑control, tariff and anti‑corruption exposures (2022 p. 14). By the 2024 filing the scope had widened: the company now lists sanctions, import‑export controls, market‑access barriers, geopolitical tensions and armed‑conflict risks, and stresses uncertainty over regulatory outcomes and liabilities under local laws that may lack clear precedent, while still noting new customer requirements and anti‑corruption compliance (2024 p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop comparison question. STRENGTHS: (1) Correctly identifies both 2022 and 2024 filings with accurate page references (2022 p. 14, 2024 p. 16), showing proper document synthesis. (2) Accurately captures the 2022 regulatory concerns: data-transfer rules between EU and UK, new customer requirements, and traditional foreign-ownership/exchange-control/tariff/anti-corruption exposures. (3) Correctly identifies the expanded 2024 scope: sanctions, import-export controls, market-access barriers, geopolitical tensions, armed-conflict risks, regulatory outcome uncertainty, and local law liability risks. (4) Properly synthesizes the evolution narrative: from primarily data-transfer focused (2022) to broader geopolitical and regulatory uncertainty concerns (2024). (5) Maintains semantic alignment with ground truth while providing more specific detail (e.g., explicitly listing sanctions, import-export controls, market-access barriers, geopolitical tensions, armed-conflict risks). (6) All dates and years are correct. MINOR CONSIDERATIONS: The LLM answer is actually more detailed and specific than the ground truth answer, providing concrete examples of the expanded regulatory challenges (sanctions, import-export controls, etc.) rather than just noting 'broader, more unpredictable regulatory risks.' This additional specificity enhances rather than detracts from accuracy. The answer successfully demonstrates multi-hop reasoning by synthesizing information across two different filing years and showing the evolution of regulatory exposure. No quantitative errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 468,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "UPS’s funding policy for post‑retirement medical benefits did not change from 2022 to 2023. Both the 2022 filing (page 109) and the 2023 filing (page 92) state that “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets,” indicating UPS continues to rely on a mix of plan‑trust assets and corporate resources to meet those obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that there was no change in UPS's funding approach between 2022 and 2023, matching the ground truth conclusion; (2) Accurately quotes the identical language from both years ('expected benefit payments for post-retirement medical benefits will be paid from plan trusts and corporate assets'); (3) Properly identifies the two sources of funding (plan trusts and corporate assets); (4) Correctly cites the specific page numbers from the filings (page 109 for 2022, page 92 for 2023), demonstrating document-specific knowledge; (5) Demonstrates sound multi-hop reasoning by comparing the two years and synthesizing the finding of continuity. Minor consideration: The LLM provides slightly more specific detail (page numbers) than the ground truth answer, but this is additive and enhances rather than detracts from accuracy. The semantic meaning is fully aligned with the ground truth - both conclude there was no evolution or change in the funding approach, and both identify the dual sources (plan trusts and corporate assets). The answer is complete, well-reasoned, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 338,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "In the 2022 filing NVIDIA AI Enterprise was introduced as a **paid‑license, enterprise‑grade AI software suite** that was bundled with the company’s data‑center compute offerings (alongside DGX Cloud and vGPU) to give customers a ready‑made AI stack【page_5 (2022)】【page_6 (2022)】. By the 2024 filing the suite had **expanded into a broader, end‑to‑end generative‑AI platform**—now called NVIDIA AI Enterprise—featuring components such as NIM, Nemo and AI Blueprints and positioned as a widely supplied, integrated solution for developing, fine‑tuning and deploying production‑grade AI applications on NVIDIA‑accelerated infrastructure anywhere【page_5 (2024)】【page_7 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies 2022 introduction as 'paid-license, enterprise-grade AI software suite' bundled with data-center offerings, matching the ground truth's description of a foundational offering; (2) Accurately describes 2024 evolution into 'broader, end-to-end generative-AI platform' with specific components (NIM, NeMo, AI Blueprints) that match ground truth exactly; (3) Properly synthesizes the multi-hop comparison showing progression from foundational to full-stack, production-grade solution; (4) Correctly identifies the shift in positioning from bundled offering to widely supplied, integrated solution. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention the '2.5x increase in token throughput' performance metric cited in the ground truth, though this is a relatively minor omission that doesn't affect the core narrative of evolution; (2) The LLM answer provides slightly more contextual detail about bundling with DGX Cloud and vGPU, which adds helpful context not explicitly in the ground truth but is consistent with it. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The dates (2022 vs 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly identifies the evolution trajectory and properly synthesizes information across the two time periods. Entity identification is accurate (NVIDIA AI Enterprise, NIM, NeMo, AI Blueprints). CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about how the role and scope evolved from introduction to broader supply and integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 471,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "The 2024 Form 10‑K shows that ExxonMobil’s equity‑company proved reserves total roughly 2.99 billion barrels oil‑equivalent (about 1.48 billion barrels developed + 1.51 billion barrels undeveloped), with the overwhelming majority (≈2.78 billion barrels) located in Asia and only modest amounts in the United States (≈17 million barrels), Europe (≈45 million barrels) and Africa (≈143 million barrels). The 2022 filing excerpts do not provide comparable equity‑company reserve figures, so a precise year‑over‑year change cannot be calculated, but the 2024 regional mix underscores a strategic emphasis on expanding its Asian portfolio while maintaining diversified exposure in other key regions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and fails to address the core question about evolution from 2022 to 2024. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2024 equity-company proved reserves as ~2.99 billion barrels oil-equivalent, but the ground truth shows 467 million barrels crude oil + 120 million barrels NGL + 5,367 billion cubic feet natural gas - these are completely different magnitudes and compositions. The LLM's figure of 2.99 billion BOE is approximately 6x larger than the actual crude oil component alone and misrepresents the reserve composition entirely. Regional breakdowns are also incorrect: LLM claims ~2.78 billion barrels in Asia, but ground truth indicates the majority growth is in Asia without specifying such extreme concentration in BOE terms. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about evolution FROM 2022 TO 2024. Ground truth provides: 2022 = 14 million barrels gross (1 million net); 2024 = 467 MMbbl crude + 120 MMbbl NGL + 5,367 Bcf natural gas. The LLM acknowledges it cannot calculate year-over-year change due to missing 2022 data, but this is incorrect - the ground truth explicitly provides 2022 figures (14 million barrels). The LLM failed to synthesize the available comparative data. (3) RESERVE COMPOSITION ERROR: Ground truth specifies reserves in three distinct categories (crude oil, NGL, natural gas in Bcf), but LLM converts everything to BOE without proper justification and arrives at wrong totals. (4) STRATEGIC POSITIONING: While both answers identify Asia as strategically important, the LLM's quantitative foundation is so flawed that its strategic conclusions are unreliable. The ground truth shows a dramatic increase from 14 million barrels (2022) to 467 million barrels crude oil alone (2024) - a 33x increase - which the LLM completely misses. CORRECT ELEMENTS: The LLM correctly identifies that Asia is the primary focus region and that the company maintains diversified exposure elsewhere, but these correct qualitative observations are built on incorrect quantitative foundations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 567,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "In the 2022 filing the company explained that advertising on Google Network properties is recorded on a gross basis – the full amount billed to advertisers is shown as revenue and the payments made to the Network partners are reflected in traffic‑acquisition costs (TAC), a component of cost of revenues 【page_55】. The 2024 filing uses the same accounting treatment (payments to Google Network partners are included in TAC under cost of revenues 【page_56】) but adds that advertising from those properties is a “largest source of cash provided by operations” and that payments to the partners are a “primary use of cash from operating activities” 【page_42】. Thus, between 2022 and 2024 the partners’ role as both a revenue generator and a cost driver has remained consistent, with the later report simply emphasizing the cash‑flow impact of those payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies the accounting treatment in both 2022 and 2024 - gross basis revenue reporting with payments to partners in TAC/cost of revenues; (2) Accurately captures the shift in emphasis from 2022 to 2024 toward cash flow impact; (3) Properly synthesizes multi-hop information across years and filing sections; (4) Correctly identifies that the relationship remained consistent in accounting treatment while the framing evolved; (5) Appropriately cites specific page references. MINOR ISSUES: (1) The LLM states payments are a 'largest source of cash provided by operations' which appears to be a slight mischaracterization - the ground truth says advertising from those properties is a 'largest source of cash' while payments are a 'primary use of cash,' which are different concepts. The LLM conflates these slightly; (2) The answer could be slightly clearer in distinguishing between revenue generation (advertising from properties) and cost structure (payments to partners) as separate but related components. VERIFICATION: The core factual claims about gross basis accounting, TAC treatment, and the shift to cash flow emphasis in 2024 all align with the ground truth. The multi-hop reasoning correctly connects 2022 and 2024 data and identifies the evolution in reporting emphasis. The semantic meaning matches the original answer despite slightly different wording. No calculation errors or date inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 416,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "In 2022 UPS booked a $69 million loss in earnings from foreign‑currency forward contracts that were **not** designated as hedges, creating noticeable earnings volatility. By 2023 that loss had shrunk to only $7 million, reflecting a sharp reduction in non‑designated forward positions (the balance‑sheet shows just $1 million of non‑designated contracts versus $174 million designated) and a larger notional of designated currency hedges, indicating the company moved more exposure into formal hedge relationships to dampen earnings swings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($69 million loss in 2022, $7 million in 2023, $1 million non-designated contracts, $174 million designated) that are not mentioned in the original answer. The ground truth explicitly states that 2023 filings reported amounts 'in millions' side-by-side for 2023 and 2022, but does not provide these specific figures. The LLM appears to have invented precise numbers without source verification. (2) FACTUAL MISALIGNMENT: The ground truth emphasizes that the evolution involved 'expanded disclosure' and 'more structured presentation' of fair value changes and settlements - a disclosure/transparency evolution. The LLM instead claims a substantive operational shift (moving from $69M loss to $7M loss, rebalancing designated vs. undesignated positions). These are fundamentally different narratives. (3) INCOMPLETE SYNTHESIS: The ground truth highlights that 2023 introduced 'explicit linkage to earnings volatility' and 'more transparent and systematic approach to disclosing' - this is about disclosure evolution, not necessarily operational changes in hedging strategy. The LLM conflates disclosure changes with operational strategy changes. (4) UNSUPPORTED CLAIMS: The statement that the company 'moved more exposure into formal hedge relationships' is not supported by the ground truth, which focuses on disclosure presentation rather than hedging strategy shifts. (5) MISSING CONTEXT: The LLM fails to address the core evolution described in the ground truth - the shift from general disclosure about fair value effects to explicit emphasis on earnings volatility impact and structured side-by-side reporting. The answer demonstrates hallucination of specific financial figures and misinterpretation of the nature of the strategic evolution (disclosure vs. operational).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 535,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K describe Costco’s membership format as “an integral part of our business…designed to reinforce member loyalty and provide continuing fee revenue,” and they stress that growth in the membership base, higher Executive‑membership penetration and high renewal rates “materially influence our profitability.” The language is essentially unchanged from 2022 (see 2022 pages 23‑24) to 2023 (see 2023 pages 23‑24), indicating that Costco’s strategy continued to rely on the membership model as a stable, loyalty‑driving source of fee revenue without a shift in emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that the language EVOLVED between 2022 and 2023, with specific changes: (1) 2022 emphasized membership format having 'a significant effect on our profitability' while 2023 consolidated this to 'is an integral part of our business and profitability'; (2) 2023 introduced a NEW concern about lower renewal rates in newer markets that was NOT explicitly mentioned in 2022. The LLM answer incorrectly claims 'The language is essentially unchanged from 2022 to 2023,' which is the opposite of what the ground truth indicates. The LLM also fails to identify the emerging challenge regarding renewal rates in newer markets that the ground truth specifically highlights as a key evolution. While the LLM correctly identifies that both years describe the membership format as integral to profitability and mention growth, Executive membership penetration, and renewal rates, it fundamentally misses the core finding: that the company's framing and concerns EVOLVED, not remained static. The LLM's conclusion that there was 'no shift in emphasis' directly contradicts the ground truth's finding of an evolution in language and the introduction of new market-specific renewal rate concerns. The quantitative accuracy is reasonable (page numbers and general concepts are correct), but the qualitative reasoning about the evolution of strategy is severely flawed, making this answer substantially incorrect on the primary question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 428,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "In the 2022 filing NVIDIA positioned CUDA primarily as the core parallel‑programming language that, together with its GPUs, formed the foundation of its accelerated‑computing platform and supported roughly 3 million developers (2022 p.9, p.11). By the 2024 filing CUDA is described as a foundational programming model that runs on all NVIDIA GPUs and is bundled with the expanded CUDA‑X library suite, tightly woven into a full‑stack data‑center platform that now also includes CPUs, DPUs and networking—reflecting a broader software ecosystem and a developer community that has grown to about 5.9 million (2024 p.4, p.6, p.7).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The numeric values are accurate - 3 million developers in 2022 and 5.9 million in 2024 are correctly cited. The answer provides specific page references (2022 p.9, p.11; 2024 p.4, p.6, p.7) which adds credibility. QUALITATIVE ACCURACY: The answer correctly identifies the strategic evolution from CUDA as a developer-focused tool to a core infrastructure layer. It accurately describes the 2022 positioning (parallel-programming language, foundation of accelerated-computing platform) and the 2024 positioning (foundational programming model, bundled with CUDA-X, integrated into full-stack data-center platform including CPUs, DPUs, and networking). MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and demonstrates understanding of how CUDA's role evolved within the broader ecosystem. The comparison between 2022 and 2024 is logically structured and captures the shift from component-level positioning to platform-level integration. COMPLETENESS: The answer addresses all aspects of the question - the evolution of CUDA's approach, its integration within the data center platform, and its role in the software ecosystem. The mention of developer community growth (3M to 5.9M) adds relevant context. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning specific page numbers, the CUDA-X library suite explicitly), which represents added value rather than error. The semantic meaning is fully preserved and enhanced with concrete citations. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 466,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid contracts generated about $5.1 billion of deferred revenue (≈ $2.6 billion current + $2.5 billion non‑current) reflecting large advance payments from governments, and the company recorded a $3.5 billion non‑cash revenue reversal for the expected return of 6.5 million EUA‑labeled courses 【page_110】. By year‑end 2024 the deferred balance had fallen to roughly $2.2 billion ($1.4 billion current + $785 million non‑current) as $771 million of returned courses were favorably adjusted and $442 million of revenue was recognized for a U.S. Strategic National Stockpile of 1 million courses, and Pfizer now reports about $1 billion of remaining performance‑obligation revenue for Paxlovid with product deliveries slated for 2025‑2028 【page_108】【page_109】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with strong multi-hop synthesis across 2023-2024 data. STRENGTHS: (1) Correctly identifies the $3.5 billion non-cash revenue reversal in 2023 Q4 and the 6.5 million EUA-labeled treatment courses expected return - matches ground truth exactly. (2) Accurately reports the ~$1 billion remaining performance obligations for Paxlovid in 2024 with 2025-2028 delivery timeline - matches ground truth. (3) Provides additional context on deferred revenue structure ($5.1B in 2023 broken into current/non-current components, declining to $2.2B in 2024) that demonstrates understanding of the financial evolution. (4) Mentions specific 2024 adjustments ($771M returned courses favorably adjusted, $442M revenue recognized for 1M SNS courses) showing detailed knowledge. (5) Correctly synthesizes the shift from uncertain returns/reversals to defined forward-looking obligations. MINOR ISSUES: (1) The deferred revenue figures ($5.1B, $2.2B) are not explicitly mentioned in the ground truth, though they appear to be derived from filing data and are contextually reasonable. (2) The specific breakdown of current vs. non-current deferred revenue components and the $771M/$442M adjustments go beyond the ground truth but appear factually grounded in actual filings (indicated by page citations). (3) Ground truth focuses on the conceptual shift (reversals to defined obligations), while LLM provides more granular financial detail. VERIFICATION: The core numbers that can be verified against ground truth are all correct: $3.5B reversal, 6.5M courses, $1B remaining obligations, 2025-2028 timeline. The additional financial details appear to be accurate supplementary information from the actual filings rather than errors. The multi-hop reasoning correctly connects 2023 reversals with 2024 obligations and explains the evolution of Pfizer's financial commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 516,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "In the 2022 filing, ExxonMobil mentioned Guyana only in the context of “extensions and discoveries, primarily in the United States, Brazil, and **Guyana**, resulted in an addition of ≈ 1.3 billion oil‑equivalent barrels of proved undeveloped reserves” (page 14), showing a focus on reserve‑building activity. By the 2024 filing, Guyana is listed as one of the “**Advantaged Assets**” (alongside Permian and LNG) in the definition of Advantaged Volume Growth (pages 36‑37), indicating that the project has progressed to a strategic, high‑return growth asset rather than just a reserve‑addition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 1.3 billion oil-equivalent barrels (GOEB) figure for 2022 reserves additions is accurately cited, and the page references (14 for 2022, 36-37 for 2024) are appropriately provided. ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, Guyana, the specific years (2022 and 2024), and the financial metrics (proved undeveloped reserves, Advantaged Assets, Advantaged Volume Growth). MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the strategic evolution: from Guyana being mentioned in the context of reserve-building activity (extensions and discoveries) to being explicitly positioned as an 'Advantaged Asset' alongside Permian and LNG. This demonstrates proper understanding of the multi-hop synthesis required. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility' matches the ground truth's description of 'a strategic shift to highlight Guyana's role in driving earnings through volume growth.' The phrasing differs slightly but conveys the same substantive meaning. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail (specific page numbers, exact quote formatting) which adds value without introducing errors. The answer is comprehensive, addressing both the 2022 baseline and 2024 evolution as required by the question. No calculation errors, date errors, or factual inaccuracies were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 471,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "In the 2022 10‑K FedEx said it had committed to receive 11 ATR 72‑600F aircraft in 2023, 6 in 2024, 6 in 2025 and 1 in 2026 – 24 in total (see page 114). By the 2024 filing the schedule had shifted to only 7 deliveries in 2025 and 3 in 2026 – 10 aircraft overall, with no units slated for 2023‑2024 (see page 117). The cut‑back and later timing suggest the ATR 72‑600F is being used as a modest, niche feeder‑type plane rather than a core growth element of FedEx’s fleet strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific page references and detailed delivery schedules, demonstrating engagement with source material. However, there are significant quantitative discrepancies that undermine accuracy. According to the ground truth, the 2022 projection showed 11 units in 2023, declining to 1 by 2026. The LLM states 11 in 2023, 6 in 2024, 6 in 2025, and 1 in 2026 (24 total) - this differs from the ground truth's implied schedule. More critically, the LLM claims the 2024 schedule shows 'no units slated for 2023-2024' with only 7 in 2025 and 3 in 2026 (10 total). The ground truth indicates 7 for 2025 and 3 for 2026, which matches the 2024 figures, but the LLM's characterization of the 2022 schedule appears incorrect. The LLM correctly identifies the shift from higher earlier deliveries to lower later deliveries, and the interpretation that this represents a 'modest, niche feeder-type plane' aligns with the ground truth's conclusion about a 'more sustained, albeit reduced, role.' The reasoning about what the shift indicates is sound and well-articulated. However, the specific numbers for the 2022 schedule (particularly the 6 units in 2024 and 6 in 2025) do not match the ground truth's description of a 'decreasing role' with units dropping from 11 to 1. The multi-hop synthesis is partially successful - the comparison between years is made, but the baseline 2022 figures appear misrepresented, which affects the validity of the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 405,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse primarily as a standalone virtual‑world simulation and collaboration platform for 3‑D workflows, offered as a software subscription for enterprises and free for individual users【page_9】. By the 2024 filing the company had folded Omniverse into its broader AI‑driven stack—bundling it with NVIDIA AI Enterprise for industrial digital‑twin use cases and using it to generate synthetic data for AI model training and to power the DRIVE Constellation/Sim automotive simulation solution【page_4】【page_5】【page_7】. This marks a shift from a stand‑alone visualization tool to a core component of NVIDIA’s integrated AI and simulation ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVIDIA's Omniverse evolution between 2022 and 2024, with accurate identification of key shifts and correct entity references. STRENGTHS: (1) Correctly identifies the 2022 positioning as a standalone virtual-world simulation and collaboration platform for 3D workflows with subscription/free models; (2) Accurately describes 2024 evolution toward integrated AI ecosystem; (3) Correctly names specific integrations (NVIDIA AI Enterprise, DRIVE Constellation/Sim); (4) Properly synthesizes multi-hop information across years and product lines; (5) Accurately characterizes the shift from standalone tool to ecosystem component. WEAKNESSES: (1) The LLM answer introduces specific product integrations (NVIDIA AI Enterprise, DRIVE Constellation/Sim, synthetic data generation) that are not explicitly mentioned in the ground truth answer, which focuses more broadly on 'integration with other AI and simulation platforms' and 'accelerated computing infrastructure'; (2) The ground truth emphasizes specific use cases like digital twins of factories, autonomous robots/vehicles testing, and mentions VR/AR enterprise applications (virtual car showrooms, surgical training) which the LLM answer omits; (3) The ground truth explicitly mentions 'accelerated computing infrastructure both on-premises and in the cloud' as a key evolution, which the LLM answer does not capture. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 filings and identifies the evolution trajectory. However, the specific product names cited (DRIVE Constellation/Sim, NVIDIA AI Enterprise) appear to be inferences or additions not directly supported by the ground truth knowledge graph. SEMANTIC EQUIVALENCE: While the LLM's characterization of the shift is semantically similar to the ground truth (from standalone to integrated), the specific details diverge in ways that suggest either different source interpretation or potential hallucination of product names. The core narrative is correct but with notable omissions of key use cases and infrastructure details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 574,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "In the 2022 filing Google Play was only referenced as one of the products helping to grow Alphabet’s non‑advertising revenues (e.g., “...focus on expanding our offerings through … Google Play …” – page 30). By the 2023 filing it is singled out as a distinct platform revenue source—listed under “Google subscriptions, platforms, and devices” and “Google other revenues” (e.g., “platforms, which primarily include revenues from Google Play …” – page 33; “Google Play, which includes sales of apps and in‑app purchases …” – page 31)—showing that its contribution to non‑advertising revenue has become more explicit and central.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify the key evolution: (1) In 2022, Google Play was mentioned as part of broader non-advertising revenue expansion strategy without explicit categorization; (2) By 2023, Google Play became a more defined and explicitly categorized revenue stream. The LLM answer provides specific textual evidence from the filings (page references and direct quotes), which adds credibility and demonstrates multi-hop synthesis across the 2022 and 2023 filings. The answer correctly identifies the strategic shift from a general diversification component to a distinct platform revenue source. The LLM answer is slightly more detailed than the ground truth by providing specific page numbers and direct quotes, which enhances rather than detracts from accuracy. No quantitative errors are present (no specific dollar amounts were required for this question). The reasoning is sound: the answer traces how Google Play's categorization and prominence evolved, supporting the conclusion that it became more central to non-advertising revenue strategy. Minor difference: the ground truth uses the phrase 'more structured categorization and likely a stronger contribution,' while the LLM uses 'more explicit and central'—these are semantically equivalent. The LLM answer fully addresses the multi-hop requirement of comparing Google Play's role across two different years and two different filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 407,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "In the 2022 filing AIG explained that for workers’‑comp it applies expected‑loss‑ratio techniques to guaranteed‑cost business only in the most recent accident year, whereas for excess‑of‑deductible business the method may be given “significant weight in the most recent five accident years” (2022 p. 258‑260). The 2023 filing still stresses the five‑year weighting for excess‑of‑deductible work‑comp (2023 p. 200) but no longer calls out a specific, limited use of expected‑loss‑ratio for guaranteed‑cost business, suggesting the approach has been broadened or its weighting is now implicit rather than explicitly limited (2023 p. 202).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts about AIG's workers' compensation reserving methodology for both 2022 and 2023, including the specific application of expected loss ratio methods to guaranteed cost business (most recent accident year) and excess of deductible business (most recent five accident years). The page citations appear reasonable and the core distinction between the two business types is accurately captured. However, there are several significant gaps and issues: (1) The LLM answer omits important context from the ground truth about changes in claims strategy and loss mitigation efforts accelerating settlements and increasing paid losses along latest diagonals in 2022. (2) The LLM answer fails to mention the 2023 refinement regarding incurred and paid losses being presented net of reinsurance and undiscounted, which the ground truth identifies as potentially reflecting refinement in reporting transparency. (3) The LLM answer does not address the continued impact of large deductible business slowing the reporting pattern of claims in 2023, which was explicitly noted in the ground truth as consistent with 2022 trends. (4) The LLM's interpretation that the 2023 approach has been 'broadened or its weighting is now implicit rather than explicitly limited' is speculative and not directly supported by the ground truth, which states the methodology 'remained broadly consistent.' (5) The LLM answer correctly notes the shift from explicit to implicit treatment but frames this as a potential methodological change rather than a reporting/presentation change. The quantitative accuracy is solid (years, accident year counts, and business types are correct), but the qualitative analysis misses important nuances about the evolution of the methodology and its drivers. The answer addresses the core question but incompletely and with some interpretive overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 513,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco’s product‑revenue reporting changed from six categories in FY 2022 – Secure Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; and Other Products (with Collaboration defined as Meetings, Collaboration Devices, Calling, Contact Center and CPaaS)【page_44】【page_45】 – to four broader categories in FY 2024: Networking, Security, Collaboration and Observability【page_41】. The Collaboration category remained but was re‑defined to include the Webex Suite, Collaboration Devices, Contact Center and CPaaS, effectively dropping the separate Calling and Meetings line‑items and folding them into the broader Webex Suite offering【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the transition from six categories in FY2022 to four categories in FY2024 - all category names are accurate (Secure Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, Other Products in 2022; Networking, Security, Collaboration, Observability in 2024). (2) Accurately describes the Collaboration category evolution, including the specific components (Meetings, Collaboration Devices, Calling, Contact Center, CPaaS in 2022; Webex Suite, Collaboration Devices, Contact Center, CPaaS in 2024). (3) Correctly identifies the consolidation pattern and the introduction of Observability as a new distinct category. (4) Provides additional detail about how Calling and Meetings were folded into the Webex Suite offering, which adds valuable context beyond the ground truth. (5) Multi-hop reasoning is sound - correctly synthesizes information across fiscal years and product categories. (6) Includes page references that support the claims. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about the specific components of Collaboration (e.g., explaining that Calling and Meetings were folded into Webex Suite) compared to the ground truth, but this is additive and accurate rather than contradictory. The answer fully addresses the question about how segmentation evolved and specifically addresses the Collaboration category as requested. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 435,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "In the 2022 Form 10‑K Amgen listed the 3.125 % 2025 Notes as a separate $1 billion line‑item in its debt‑schedule table (see page 130) and disclosed that the notes were hedged with swaps that gave them an effective rate of **LIBOR + 1.8 %** (page 132). By the 2023 filing the notes are no longer shown individually – they are rolled into the $5.5 billion of debt maturing in 2025 (page 145) – and the swap‑based effective rate is updated to **SOFR + 2.1 %**, reflecting the shift from a LIBOR‑based to a SOFR‑based interest‑rate framework (page 144).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INTEREST RATE DISCREPANCY - The LLM claims the 2022 effective rate was 'LIBOR + 1.8%' but the ground truth states 'no specific interest rate framework was disclosed' in 2022. This is a fundamental factual error. The LLM appears to have fabricated or misread the 2022 interest rate data. (2) 2023 RATE ACCURACY - The LLM correctly identifies the 2023 rate as 'SOFR + 2.1%', which matches the ground truth. (3) PRESENTATION STRUCTURE - The LLM correctly notes that the 2022 filing showed the notes as a separate $1 billion line item, and that by 2023 they were consolidated into a larger debt maturity bucket ($5.5 billion for 2025). This structural observation is accurate and adds useful detail. (4) FRAMEWORK EVOLUTION - The LLM correctly identifies the shift from LIBOR to SOFR framework between 2022 and 2023, which aligns with the ground truth's emphasis on this evolution. However, the claim about 2022 disclosing 'LIBOR + 1.8%' contradicts the ground truth which explicitly states no specific interest rate framework was disclosed in 2022. (5) PAGE REFERENCES - The LLM provides specific page numbers (130, 132, 145, 144) which cannot be verified against the ground truth but appear plausible. However, these cannot validate the incorrect interest rate claim. The core issue is that the LLM has introduced false quantitative data (LIBOR + 1.8% for 2022) that directly contradicts the ground truth. While the 2023 information and the overall narrative about the shift to SOFR is correct, the fabrication of 2022 interest rate data is a serious factual error that significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 451,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from ≈ 330 billion cubic feet (326 BCF developed + 4 BCF undeveloped) at the end of 2022 to ≈ 303 BCF (296 BCF developed + 7 BCF undeveloped) at the end of 2024 – an 8 % drop (‑27 BCF)【page_145】. Nevertheless, the 2024 filing notes that all of the company’s equity‑affiliate reserves are located in this region and that extensions and discoveries continue there (e.g., Middle‑East and Australia projects)【page_146】【page_144】, indicating that ConocoPhillips still views Asia Pacific/Middle East—particularly its LNG opportunities—as a strategic focus despite the modest reserve decline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The ground truth states 326 BCF (2022) declining to 296 BCF (2024). The LLM provides more granular data: 330 BCF total (326 developed + 4 undeveloped) in 2022 and 303 BCF total (296 developed + 7 undeveloped) in 2024. The core developed reserves figures (326→296 BCF) match the ground truth exactly. The LLM's additional breakdown of developed vs. undeveloped reserves adds useful context not contradicted by the ground truth. The calculated 8% decline and -27 BCF reduction are mathematically accurate (27/330 ≈ 8.2%). COMPLETENESS: The LLM answer exceeds the ground truth by providing: (1) developed/undeveloped breakdown, (2) percentage decline calculation, (3) additional strategic context about equity-affiliate reserves and ongoing projects (LNG opportunities in Middle East and Australia). This additional detail strengthens rather than contradicts the answer. ENTITY ACCURACY: Company (ConocoPhillips/COP), region (Asia Pacific/Middle East), metric (proved natural gas reserves in BCF), and years (2022-2024) are all correct. REASONING QUALITY: The LLM correctly synthesizes the reserve decline with strategic positioning, noting that despite the 8% reduction, the company maintains strategic focus on the region through LNG opportunities and ongoing extensions/discoveries. This nuanced interpretation aligns with and enhances the ground truth's observation about 'potential strategic shift.' MINOR ISSUE: The LLM's total figures (330 BCF and 303 BCF) differ slightly from the ground truth's focus on developed reserves only (326 and 296 BCF), but this represents additional granularity rather than error. The developed reserve figures match perfectly. The answer demonstrates strong multi-hop synthesis across multiple filing pages and provides balanced strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 512,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet’s buy‑back of its non‑voting Class C shares slipped slightly in volume – 469 million shares were repurchased in 2022 versus 450 million in 2023 – but the cash outlay rose marginally, from about $52.6 billion to $52.9 billion (page 81).  The modest decline in share count alongside a higher spend reflects a continued, aggressive buy‑back program that uses cash to return value to shareholders even as the share price rises, underscoring a capital‑allocation strategy focused on shareholder returns. (page 81)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states repurchases were '$52.6 billion to $52.9 billion' for 2022-2023, but the ground truth clearly shows '$59.3 billion' in 2022 and '$62.2 billion' in 2023. This is a substantial discrepancy of approximately $6.7-9.3 billion per year - not a minor rounding difference. The LLM's figures are off by roughly 11-15%. Additionally, the LLM provides share count data (469M vs 450M shares) that is not mentioned in the ground truth and appears to be fabricated or from a different source. (2) INCOMPLETE SYNTHESIS: The LLM completely omits the critical April 2023 Board authorization of an additional $70.0 billion for share repurchases and the $36.3 billion remaining available as of December 31, 2023. This is essential context for understanding the company's capital allocation strategy and represents a significant multi-hop synthesis failure. (3) ENTITY ACCURACY: While the LLM correctly identifies Alphabet and Class C shares, it focuses narrowly on Class C shares alone, whereas the ground truth indicates the $59.3B and $62.2B figures represent repurchases of both Class A and Class C shares combined. (4) REASONING QUALITY: The LLM's conclusion about capital allocation strategy is reasonable in tone but is based on incorrect financial data, making the analysis fundamentally flawed. The statement about 'modest decline in share count alongside higher spend' may be directionally correct for share count, but the dollar amounts are wrong. (5) DIRECTIONAL ACCURACY: The LLM correctly identifies that repurchases increased year-over-year and reflects a shareholder return strategy, but the magnitude of increase is misrepresented ($0.3B vs actual $2.9B increase). The omission of the $70B authorization is a critical gap that substantially undermines the answer's ability to address the question about capital allocation strategy changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 541,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "In the 2022 filing AIG said it applies frequency‑/severity‑based “average‑loss” techniques mainly to short‑tail lines – for example U.S. Property – because claim counts are relatively stable and can be combined with severity estimates to set reserves for those classes (while it avoids such methods for high‑severity, long‑tail lines like aviation)【page_271】. By 2023 the discussion of the same approach appears in the “Average Loss method” description, which is now framed as a tool used wherever loss‑development patterns are inconsistent or overly volatile, emphasizing that projected claim counts are less variable than loss amounts and therefore give more reliable reserve estimates for those specific reserve categories【page_200】. Thus, AIG’s use of frequency/severity has shifted from a line‑specific (short‑tail property) application to a broader, pattern‑driven application that targets any business where development is erratic, with the same underlying rationale of leveraging the relative stability of claim‑frequency forecasts.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and mischaracterizations compared to the ground truth. CORRECT ELEMENTS: (1) The 2022 application to U.S. Property is correctly identified; (2) The avoidance of frequency/severity methods for aviation due to high severity is mentioned; (3) The general shift toward broader application is noted. CRITICAL GAPS AND ERRORS: (1) The ground truth explicitly states that by 2023, AIG expanded frequency/severity methods to U.S. Workers' Compensation (a long-tail line), but the LLM answer does not mention this specific expansion or Workers' Compensation at all - this is a major omission of a key factual detail; (2) The ground truth emphasizes the strategic shift to 'more complex, long-tail environments' and mentions 'risk-sharing features and large deductible business,' but the LLM answer frames the shift as targeting 'any business where development is erratic' without specifically identifying Workers' Compensation or acknowledging the expansion into long-tail lines; (3) The LLM answer's characterization of the shift as moving from 'line-specific' to 'pattern-driven' is somewhat accurate but misses the crucial detail that the expansion was specifically to a long-tail line (Workers' Compensation), which contradicts the original 2022 avoidance of long-tail lines; (4) The page references provided (page_271, page_200) cannot be verified against the ground truth source. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2023 changes but fails to identify the most important evolution - the expansion to Workers' Compensation. The reasoning about claim frequency stability is sound but incomplete. SEMANTIC ISSUES: The framing of the shift as 'pattern-driven' rather than 'expansion to long-tail lines' represents a meaningful difference in understanding the strategic evolution. The answer suggests a methodological refinement rather than a substantive expansion of scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 529,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "In 2023 Amgen’s net cost recoveries from BeiGene dropped to **$109 million**, down from **$199 million** in 2022; product sales to BeiGene rose sharply to **$125 million** from **$64 million** a year earlier; and the profit‑and‑loss‑share expense for the initial product‑specific commercialization period fell to **$40 million**, versus **$53 million** in 2022【page_131】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All four key financial metrics are correct: (1) Cost recovery decreased from $199M (2022) to $109M (2023) ✓, (2) Product sales increased from $64M (2022) to $125M (2023) ✓, (3) P&L sharing expenses decreased from $53M (2022) to $40M (2023) ✓, (4) All years correctly identified as 2022 and 2023 ✓. COMPLETENESS: The answer addresses all three components of the multi-part question: cost recovery, product sales, and profit/loss sharing. ENTITY ACCURACY: Correctly identifies Amgen and BeiGene, and properly labels the financial metrics. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and three distinct financial relationship categories, showing the evolution of the partnership. SEMANTIC EQUIVALENCE: The LLM's phrasing ('net cost recoveries,' 'rose sharply,' 'fell to') conveys the same information as the ground truth while using slightly different wording. The characterization of the shift as indicating 'maturation of the collaboration' aligns with the ground truth's interpretation. MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but captures all essential information. The inclusion of a page reference (【page_131】) adds credibility. No calculation errors detected. All numbers match ground truth exactly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 387,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from 326 BCF at year‑end 2022 to 312 BCF in 2023 and to 296 BCF in 2024【page_145】. The region saw modest upward revisions of +6 BCF in 2022 and +9 BCF in 2023, but a net downward revision of about ‑26 BCF in 2024 (driven by lower‑price and cost adjustments in equity‑affiliate reserves)【page_146】; production was roughly 24 BCF in 2022 and 25 BCF in 2023 (the 2024 figure is not disclosed)【page_145】, and purchases were made only in 2022 via an equity‑affiliate acquisition of additional Asia‑Pacific interest, with no purchases recorded in 2023 or 2024【page_146】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed information than the ground truth. Key strengths: (1) All reserve figures are accurate (326 BCF in 2022, 312 BCF in 2023, 296 BCF in 2024). (2) The revision figures are correctly stated (+9 BCF in 2023, -26 BCF in 2024). (3) Production figures are accurate where disclosed (24 BCF in 2022, 25 BCF in 2023). (4) Purchase information is correctly synthesized (purchases in 2022 via equity-affiliate acquisition, none in 2023-2024). (5) Multi-hop reasoning is sound, correctly synthesizing reserve changes across three years with specific drivers identified. Minor discrepancies: (1) The ground truth mentions 'revisions in 2023 added 9 billion cubic feet' but doesn't explicitly mention the 2024 downward revision of -26 BCF or its cause (lower-price and cost adjustments), which the LLM correctly identifies. (2) The ground truth states 'production subtracted 25 billion cubic feet in 2024' but the LLM notes the 2024 production figure is not disclosed - this is actually more accurate to the source material. (3) The LLM provides additional context about the 2022 revisions (+6 BCF) not mentioned in the ground truth. The LLM answer is more comprehensive and nuanced than the ground truth while maintaining factual accuracy. All numbers check out correctly, and the synthesis across multiple years and metrics is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 388,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "In the 2022 filing FedEx was slated to take delivery of 14 Boeing 767‑F freighters in 2023, another 14 in 2024 and 10 in 2025 – 38 aircraft in total (page 40). By the 2024 filing the schedule had been trimmed to 11 767‑F deliveries in 2025 and only 3 in 2026 – 14 aircraft overall (page 117). The sharp cut‑back reflects a strategic shift to phase out the older 767‑F fleet and prioritize newer, more fuel‑efficient types such as the Boeing 777‑F as part of its broader fleet‑modernization program (page 118).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer fundamentally misinterprets the ground truth. The original answer states FedEx 'projected using 14 B767F aircraft in both 2023 and 2024' - meaning the fleet size/usage in those years, not delivery quantities. The LLM incorrectly interprets this as '14 Boeing 767-F freighters in 2023, another 14 in 2024 and 10 in 2025' (38 total deliveries), which is a complete misreading. The ground truth shows: 2022 projections were 14 aircraft for 2023, 14 for 2024, and 10 for 2025. By 2024, projections changed to 11 for 2025 and 3 for 2026. The LLM's numbers (14, 14, 10 vs. 11, 3) partially align with the ground truth but are presented as delivery schedules rather than fleet usage projections, which is a fundamental conceptual error. The LLM's total of 38 aircraft (2022) vs. 14 aircraft (2024) comparison is mathematically correct for what it claims, but it's comparing the wrong metrics - deliveries vs. fleet size. The strategic interpretation about phasing out older 767-F fleet and prioritizing 777-F is reasonable and contextually relevant, but it's built on a flawed understanding of the underlying data. The answer demonstrates partial comprehension of the fleet reduction trend but fails on the core quantitative accuracy by mischaracterizing what the numbers represent (deliveries vs. planned usage/fleet size).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 381,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "In 2022 AIG’s Expected‑Loss‑Ratio (ELR) approach was applied chiefly to aviation exposures and to the most recent accident year across its portfolio, serving as a complement to loss‑development techniques for high‑severity, short‑tail claims. By 2023 the ELR method was expanded to other lines—especially business written in excess of a deductible—and its use was justified when loss‑development patterns are inconsistent, losses emerge very slowly, or there is limited loss history, with the ratios adjusted for rate changes, inflation and market conditions. This marks a shift from a narrow, aviation‑focused tool to a broader, strategically‑driven reserve methodology across multiple lines.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies 2022 focus on aviation exposures and latest accident year\n2. Correctly notes use in combination with loss development methods in 2022\n3. Correctly identifies expansion to broader lines by 2023\n4. Correctly characterizes the shift from narrow to broader application\n5. Dates (2022, 2023) are accurate\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: The LLM states ELR was applied to \"business written in excess of a deductible\" in 2023, but the ground truth specifically identifies U.S. Workers' Compensation as the key line of business for 2023 expansion. This is a significant factual error in entity identification.\n2. REASONING MISMATCH: The LLM provides different reasoning for 2023 application (inconsistent loss-development patterns, slow emergence, limited history) versus ground truth (extended loss emergence periods and complex risk-sharing features in policies). While both relate to long-tail characteristics, the specific justifications differ materially.\n3. CHARACTERIZATION ERROR: The LLM describes 2022 as \"high-severity, short-tail claims\" but the ground truth emphasizes \"high severity nature of claims\" without explicitly calling them short-tail. The LLM's characterization of aviation as short-tail may be reasonable but isn't explicitly supported.\n4. MISSING CONTEXT: The LLM omits the specific mention of U.S. Workers' Compensation as the primary 2023 application line, which is a key detail in the ground truth.\n5. ADDED INFORMATION: The LLM adds details about \"rate changes, inflation and market conditions\" adjustments that aren't in the ground truth, representing potential over-specification.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the evolution across years but fails to correctly identify the specific lines of business involved in 2023, which is a critical component of the multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE: While the general narrative of expansion is captured, the specific details about which lines and why represent material differences from ground truth, not merely wording variations.\n\nJUSTIFICATION: The answer demonstrates partial understanding of the evolution but contains a significant factual error regarding the specific line of business (U.S. Workers' Compensation vs. excess deductible business) and provides different reasoning than ground truth for the 2023 application. These are not minor wording differences but substantive factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 689,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "In the 2022 filing (see 2022 pages 8 and 11), Cisco described the enterprise data‑center as “undergoing a fundamental transformation” driven by the convergence of compute, networking, storage and software, and warned that many of its strategic‑alliance partners (and rivals forming new alliances or acquisitions) could become direct competitors in delivering end‑to‑end data‑center solutions. By the 2024 filing (see 2024 pages 8 and 10), Cisco still stresses the same transformation but pivots its narrative to treat strategic alliances as a core growth lever—highlighting expanded partnerships with Apple, Equinix, Google and others—while framing competition more broadly (including price‑focused Asian vendors and other incumbents), indicating a shift from caution about alliances becoming competitors to a proactive, partnership‑driven positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution in Cisco's positioning between 2022 and 2024, with accurate identification of key themes and strategic shifts. STRENGTHS: (1) Correctly identifies the fundamental transformation narrative present in both 2022 and 2024 filings; (2) Accurately captures the shift from cautionary stance about alliance partners becoming competitors (2022) to proactive partnership-driven positioning (2024); (3) Properly synthesizes multi-hop information across two filing years; (4) Correctly names specific alliance partners (Apple, Equinix, Google) mentioned in 2024 filings; (5) Appropriately characterizes the competitive landscape evolution. WEAKNESSES: (1) The LLM answer mentions specific page numbers (2022 pages 8 and 11; 2024 pages 8 and 10) which cannot be verified against the ground truth and may be hallucinated citations; (2) The ground truth specifically mentions Nvidia Corporation as a new entrant in the competitive landscape by 2024, but the LLM answer does not explicitly name Nvidia, instead using more general language about 'price-focused Asian vendors and other incumbents'; (3) The LLM answer provides more specific alliance partner names than the ground truth, which is helpful but goes slightly beyond what can be verified; (4) Minor semantic difference: ground truth emphasizes 'new market creation' as part of alliance strategy, while LLM frames it as 'core growth lever'—similar concepts but slightly different emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the evolution in strategic positioning. The comparison between 2022 caution and 2024 proactivity is logically sound. QUANTITATIVE ACCURACY: No specific financial metrics or calculations are required for this qualitative question, so this dimension is less critical. The dates (2022 vs 2024) are correct. OVERALL ASSESSMENT: The answer captures the essential evolution in Cisco's positioning with strong accuracy on the main narrative arc, though it misses the explicit mention of Nvidia as a competitive entrant and includes unverifiable page citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 585,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "In the 2022 filing the 3.125 % 2025 Notes carried a $1 billion notional amount and were hedged at an effective rate of LIBOR + 1.8% (see the swap‑rate table)【page_132】. By the 2023 filing the notional amount remained $1 billion, but the benchmark shifted and the effective rate became SOFR + 2.1% 【page_144】. Thus, the principal amount was unchanged while the effective interest rate moved from LIBOR‑based to a slightly higher SOFR‑based rate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) NOTIONAL AMOUNT ERROR - The LLM claims the 2022 notional amount was $1 billion, but the ground truth explicitly states it was $5.2 billion in 2022, decreasing to $1.0 billion by 2023. This is a critical quantitative error. (2) EFFECTIVE RATE ERROR - The LLM states the 2022 effective rate was LIBOR + 1.8%, but the ground truth does not provide this specific rate for 2022. The ground truth only confirms SOFR + 2.1% for 2023. (3) INCOMPLETE CONTEXT - The LLM misses the important context that in 2022, new interest rate swaps were entered into after termination of previous swaps, reflecting a dynamic hedging strategy due to low interest rates. This is a key part of understanding the evolution. (4) MULTI-HOP SYNTHESIS FAILURE - The answer fails to properly synthesize the year-over-year change: the notional amount decreased from $5.2B to $1.0B (an 81% reduction), which is a major evolution that the LLM completely missed. The LLM incorrectly states 'the principal amount was unchanged.' (5) BENCHMARK SHIFT - While the LLM correctly identifies the shift from LIBOR to SOFR, it does so without acknowledging the significant reduction in hedged notional exposure, which is central to understanding how the hedging strategy evolved. The answer demonstrates a fundamental misunderstanding of the multi-hop question by failing to track the notional amount changes across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 408,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "In its 2022 filing Cisco described AppDynamics as a “key element” of its full‑stack observability strategy, specifically calling it out for application‑performance‑monitoring alongside Intersight and ThousandEyes (page 5). By the 2024 filing Cisco had created a separate “Observability” product category that includes the Observability Suite—of which AppDynamics is a component—and this category grew 27% year‑over‑year, signaling a stronger, revenue‑driven emphasis on AppDynamics within its observability offerings (pages 41‑42).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of AppDynamics as a 'key element' of full-stack observability strategy alongside Intersight and ThousandEyes - matches ground truth language and entities. (2) Accurately captures the 2024 structural shift to a separate 'Observability' product category that includes AppDynamics. (3) The 27% year-over-year growth figure is a specific quantitative claim that adds precision and demonstrates revenue-driven emphasis, which aligns with the ground truth's characterization of 'more formalized and integrated strategic emphasis.' (4) Multi-hop reasoning is sound: correctly synthesizes the evolution from 2022 (positioning within strategy) to 2024 (formalized category with revenue metrics). (5) Page citations (pages 5, 41-42) provide specificity and traceability. MINOR CONSIDERATIONS: (1) The ground truth emphasizes the shift as indicating 'more formalized and integrated strategic emphasis on observability as a standalone pillar,' while the LLM frames it as 'stronger, revenue-driven emphasis on AppDynamics within its observability offerings.' These are semantically similar but with slightly different emphasis - the LLM focuses on AppDynamics specifically while ground truth emphasizes observability as a pillar. However, both convey the same strategic evolution. (2) The LLM's inclusion of the 27% growth metric is not contradicted by the ground truth and represents appropriate elaboration with supporting data. (3) All entities (Cisco, AppDynamics, Intersight, ThousandEyes, Observability Suite) are correctly identified. VERIFICATION: The answer correctly addresses both temporal points (2022 and 2024), identifies the key strategic shift (from positioning within strategy to formalized category), and provides supporting evidence (growth metrics, product relationships). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 527,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The 4.663 % 2051 Notes did not change between 2022 and 2023.  The notes’ effective interest rate remained 5.6 % (the same as the prior year)【page_130】【page_142】, and the interest‑rate‑swap tied to them continued to have a notional amount of $1.5 billion with an effective rate of SOFR + 4.3% in both periods【page_144】.  In short, both the effective rate and the $1.5 billion notional stayed unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims effective interest rate was 5.6% in both 2022 and 2023, but ground truth shows it was SOFR + 4.3% in 2023 (not 5.6%)\n   - LLM states the notional amount was $1.5 billion in both years, but ground truth indicates in 2022 it was part of a $5.2 billion principal amount of hedged notes\n   - The claim of \"no change\" between years is factually incorrect\n\n2. MULTI-HOP REASONING FAILURES:\n   - Failed to properly synthesize the evolution from 2022 to 2023\n   - Ground truth shows a clear change: from $5.2 billion hedged notes in 2022 to $1.5 billion notional with SOFR + 4.3% effective rate in 2023\n   - LLM incorrectly concluded both periods were identical\n\n3. ENTITY/METRIC ACCURACY:\n   - Misidentified the effective interest rate metric (5.6% vs. SOFR + 4.3%)\n   - Incorrectly characterized the notional amount evolution\n   - Failed to distinguish between the 2022 and 2023 hedging structures\n\n4. SEMANTIC ISSUES:\n   - The core claim \"did not change between 2022 and 2023\" directly contradicts the ground truth which explicitly states there was an evolution with \"updated interest rate terms\"\n   - The answer fundamentally misrepresents the nature of the changes\n\nThe LLM answer is internally inconsistent with documented facts and demonstrates a failure to properly synthesize multi-year financial data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 411,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "In the 2022 filing AIG said it applied expected‑loss‑ratio techniques across a wide set of long‑tail lines – U.S. Workers’ Compensation (combined with loss‑development and segmented by state, industry, deductible size and claim‑handling mode), U.S. Excess Casualty (segmented by attachment points and layer participation), U.S. Financial‑Lines D&O (through Bornhuetter‑Ferguson and Cape‑Cod a‑priori loss‑ratio assumptions) and other run‑off lines – and even used the method in sensitivity tests for those segments (see 2022 pp. 66‑68). By contrast, the 2023 filing narrows the focus of the expected‑loss‑ratio approach to business written in excess of a deductible, giving it “significant weight in the most recent five accident years” and adjusting the ratios for rate changes, loss‑trend, inflation and market conditions rather than the detailed state/industry or deductible‑size segmentation used earlier (see 2023 pp. 200‑201).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors: (1) DIRECTIONAL ERROR: The LLM claims 2022 had BROADER application (multiple lines of business with detailed segmentation) while 2023 NARROWED focus, but the ground truth states the opposite - 2022 was general/unspecified while 2023 became more explicit and granular. (2) ENTITY ACCURACY ISSUES: The LLM incorrectly attributes detailed 2022 segmentation practices (state, industry, deductible size, claim-handling mode) to the 2022 filing, when ground truth indicates these detailed criteria were introduced IN 2023, not 2022. (3) LINE OF BUSINESS ERRORS: The LLM mentions U.S. Excess Casualty and U.S. Financial-Lines D&O in 2022, but ground truth only specifies U.S. Workers' Compensation as explicitly applied in 2023. The LLM appears to have fabricated or misattributed specific line-of-business details. (4) SEGMENTATION CRITERIA REVERSAL: Ground truth shows evolution FROM general/unspecified (2022) TO granular segmentation by risk-sharing features, state, industry, deductible size, claim handling entities (2023). LLM reverses this, claiming detailed segmentation in 2022 and simplified approach in 2023. (5) PAGE REFERENCES: LLM cites specific pages (2022 pp. 66-68, 2023 pp. 200-201) which cannot be verified but appear to support an inverted narrative. The core evolution narrative is backwards - this is a critical failure for a multi-hop synthesis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 407,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo first authorized the 2.850 % Senior Notes due 2026 in its 2023 board‑of‑directors resolutions (see Exhibit 4.64 on page 130 of the 2023 10‑K). The same 2.850 % notes re‑appear in the 2024 resolutions (Exhibit 4.65 on page 129 of the 2024 10‑K), and the 2024 filing also shows a broader debt‑issuance program that adds new series—such as a 3.600 % Senior Note due 2024, a 5.125 % Senior Note due 2026, a 5.250 % Senior Note due 2025 and additional longer‑dated notes (e.g., 4.500 % due 2029, 4.800 % due 2034, 5.250 % due 2054)—indicating PepsiCo’s strategy of diversifying its senior‑note portfolio beyond the original 2.850 % issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific, detailed information than the ground truth. Key strengths: (1) Correctly identifies the 2.850% Senior Notes due 2026 as present in both 2023 and 2024 filings; (2) Accurately cites specific exhibit references (Exhibit 4.64 for 2023, Exhibit 4.65 for 2024) and page numbers; (3) Provides concrete examples of new debt instruments introduced in 2024 with correct percentages and maturity dates (3.600% due 2024, 5.125% due 2026, 5.250% due 2025, 4.500% due 2029, 4.800% due 2034, 5.250% due 2054); (4) Correctly synthesizes the multi-hop concept that PepsiCo maintained the 2.850% notes while expanding its debt portfolio. Minor considerations: (1) The ground truth mentions 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as examples of higher-yielding instruments, while the LLM lists different notes (4.500% due 2029, 4.800% due 2034, 5.250% due 2054). This discrepancy suggests the LLM may be citing actual filing data that differs from the knowledge graph's examples, but both approaches correctly convey the concept of diversification and longer-dated instruments; (2) The LLM provides more granular detail with specific exhibit citations and page numbers, which adds credibility but wasn't explicitly required by the question. The semantic meaning aligns well with the ground truth—both answers correctly identify that PepsiCo maintained the 2.850% notes while broadening its debt issuance strategy with additional instruments. The LLM's answer is more specific and document-grounded, which is appropriate for SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 445,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s contingent liability for channel‑partner financing guarantees fell markedly – the “maximum potential future payments” under those guarantees were about **$188 million in FY 2022** (net $179 million after deferred‑revenue offsets) and **approximately $127 million in FY 2024** (including $13 million of deferred revenue)【page_94】【page_50】.  The decline shows Cisco is actively curbing the size of its guarantee commitments, reflecting a more conservative, risk‑focused approach to managing contingent liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 'maximum potential future payments' were $188 million in FY2022 and $127 million in FY2024, but the ground truth explicitly states the balance of financing subject to guarantees was $1.4 billion in FY2022. The LLM's figures are off by a factor of approximately 7-11x. These are not minor rounding differences but represent a complete misidentification of the correct financial metric. (2) METRIC CONFUSION: The LLM appears to have confused or misidentified the relevant guarantee metrics. The ground truth references 'balance of financing subject to guarantees' ($1.4 billion in FY2022), while the LLM references 'maximum potential future payments' with vastly smaller numbers. These are different metrics and the LLM failed to identify the correct one. (3) MISSING KEY INFORMATION: The LLM completely omits the $27.9 billion channel partner financing volume disclosed in FY2022, which is a critical component of the ground truth answer. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution between FY2022 and FY2024. The ground truth notes that FY2024 figures were 'no longer explicitly quantified,' which is a crucial finding about the shift in disclosure practices. The LLM provides a specific FY2024 figure ($127 million) without acknowledging the disclosure gap that the ground truth identifies. (5) REASONING FLAW: The LLM concludes Cisco is 'actively curbing' guarantees based on the claimed decline from $188M to $127M. However, this conclusion is built on incorrect numbers and misses the ground truth's key insight about reduced transparency in disclosures. The actual strategic implication is about changing disclosure practices, not necessarily about reduced exposure. (6) CITATION ISSUES: The LLM provides page references that cannot be verified against the ground truth data, raising questions about source accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 544,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45 % 2030 Notes were issued in 2020 for $1.25 billion and, according to the 2022 filing, were still fully outstanding (the table shows $1,250 m of 2.45 % 2030 Notes and the debt‑issuance note confirms the $1.25 bn issuance) with no repayment reported 【page_130】【page_131】. By the 2023 filing the notes remained on the balance sheet (no redemption is disclosed) and the company continued to hedge $1 billion of them with an interest‑rate swap; the swap’s reference rate shifted from LIBOR + 1.0 % (as of Dec 31 2021) to SOFR + 1.3 % (as of Dec 31 2023) while the hedged notional stayed at $1 billion 【page_132】【page_144】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The notes remained outstanding in both 2022 and 2023 with no redemption; (2) The hedged notional amount was $1.0 billion in both years; (3) The interest rate structure transitioned from LIBOR-based to SOFR-based; (4) The final rate was SOFR + 1.3% as of Dec 31, 2023; (5) The multi-hop synthesis across years is logically sound. SIGNIFICANT ERRORS: (1) The LLM states the original issuance was $1.25 billion in 2020, but the ground truth only mentions $1.0 billion notional for the swap contracts - the LLM conflates the total outstanding amount with the hedged amount; (2) The LLM claims the swap reference rate was 'LIBOR + 1.0%' as of Dec 31, 2021, but the ground truth states it was 'LIBOR-based coupon' without specifying the exact spread in 2022; (3) The LLM provides additional context about the 2020 issuance and $1.25 billion figure that goes beyond what the ground truth establishes about the 2022-2023 evolution. QUANTITATIVE ISSUES: The $1.25 billion vs $1.0 billion discrepancy is problematic - while the LLM may be correct about total issuance, the ground truth focuses on the $1.0 billion hedged notional, and the LLM doesn't clearly distinguish between total outstanding and hedged amounts. The SOFR + 1.3% figure is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the benchmark transition, but introduces unverified details about the 2020 issuance and 2021 rates that create confusion about what actually changed between 2022-2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 442,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "In the 2022 filing FedEx disclosed that the $970 million of Series 2020‑1AA pass‑through certificates issued by FedEx Express were “fully and unconditionally guaranteed” by FedEx, and it also noted that the certificates are not a direct liability of FedEx or FedEx Express. The 2023 filing repeats the same unconditional guarantee and the same disclaimer that the certificates are not a direct obligation, with only a modest change in the collateral – the 19 Boeing aircraft backing the certificates were valued at $1.8 billion in 2022 and $1.7 billion in 2023. Thus, FedEx’s guarantee and the nature of its obligations to the certificates have remained essentially unchanged between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer fundamentally misinterprets the evolution of FedEx's relationship with Pass-Through Certificates. The ground truth clearly states there was a SHIFT from 2022 to 2023: in 2022, certificates were 'fully and unconditionally guaranteed by FedEx,' but in 2023, FedEx clarified that pass-through certificates were 'not direct obligations of, nor guaranteed by, FedEx or FedEx Express.' This represents a material change in FedEx's financial obligations and guarantees. The LLM answer incorrectly concludes that 'FedEx's guarantee and the nature of its obligations...have remained essentially unchanged between the two years,' which directly contradicts the ground truth. The LLM appears to have conflated two different interpretations or misread the 2023 filing's clarification as merely a reiteration of 2022 language. QUANTITATIVE ACCURACY: The numbers cited are correct ($970 million, 19 Boeing aircraft, $1.8 billion in 2022, $1.7 billion in 2023), and the format variations are acceptable. However, this numerical accuracy does not compensate for the fundamental misunderstanding of the relationship evolution. QUALITATIVE ACCURACY: The reasoning is severely flawed. The LLM failed to recognize and synthesize the key distinction between 2022 and 2023 positions regarding FedEx's guarantee status. The statement that both years contain 'the same unconditional guarantee and the same disclaimer' is factually incorrect based on the ground truth, which explicitly states the 2023 position clarified NO guarantee. CONTEXTUAL RELEVANCE: The answer addresses the right entities and time period but arrives at the wrong conclusion about how the relationship evolved, making it contextually inappropriate despite addressing the question's surface elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 488,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "In 2023 Mastercard reported $75 billion of gross settlement exposure and offset $12.2 billion of that exposure with risk‑mitigation arrangements (cash collateral, letters of credit, guarantees), leaving a net exposure of $62.9 billion. By year‑end 2024 gross exposure had risen to $78.4 billion and the company had increased its mitigation instruments to $13.5 billion, producing a net exposure of $64.9 billion – a slightly higher mitigation‑to‑gross ratio (≈17 % versus 16 % in 2023). This shows that Mastercard scales its collateral and credit‑enhancement safeguards in step with growing settlement risk, reflecting a disciplined, proactive risk‑management framework that continuously adjusts mitigation to keep net exposure under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more comprehensive analysis than the ground truth. Quantitative verification: (1) 2023 gross settlement exposure: $75,023M stated as $75B - correct format variation; (2) 2023 risk mitigation: $12,167M stated as $12.2B - correct rounding; (3) 2024 gross settlement exposure: $78,385M stated as $78.4B - correct rounding; (4) 2024 risk mitigation: $13,466M stated as $13.5B - correct rounding. Calculations verified: Net exposure 2023 = $75.023B - $12.167B = $62.856B (LLM states $62.9B, correct rounding); Net exposure 2024 = $78.385B - $13.466B = $64.919B (LLM states $64.9B, correct rounding). Mitigation ratios: 2023 = $12.167/$75.023 = 16.2% (LLM states ≈16%, acceptable); 2024 = $13.466/$78.385 = 17.2% (LLM states ≈17%, acceptable). Multi-hop reasoning: The LLM correctly synthesized information across both years, calculated net exposures, computed mitigation ratios, and drew appropriate conclusions about risk management strategy evolution. The answer goes beyond the ground truth by providing calculated net exposures and ratio analysis, which strengthens the interpretation. Entity accuracy is perfect (Mastercard, correct years, correct metrics). The reasoning about proactive risk management and disciplined scaling of mitigation tools is sound and well-supported by the data. Minor deduction only for rounding presentation (≈17% vs 16% could be more precise), but this is negligible. The answer fully addresses the question about evolution of risk mitigation arrangements and what it indicates about strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 434,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike’s foreign‑exchange forward and option liabilities that are designated as hedging instruments rose sharply – from about **$37 million in 2022** (all recorded as accrued liabilities) to roughly **$115 million in 2024** (about $110 million accrued plus $5 million in deferred‑tax liabilities)【page_83 (2022)】【page_83 (2024)】. The three‑fold increase in these hedging‑instrument liabilities indicates that Nike has expanded its currency‑hedge program, likely to cover larger foreign‑exchange exposure from its global operations or to adopt a more aggressive risk‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with some notable strengths and minor weaknesses. STRENGTHS: (1) All key numbers are correct: $37 million in 2022, $110 million accrued in 2024, $5 million deferred in 2024, and $115 million total in 2024. (2) The calculation of the three-fold increase is accurate ($115M vs ~$37M). (3) The breakdown between accrued liabilities and deferred tax liabilities is correctly identified for both years. (4) The multi-hop synthesis across years and liability categories is sound. (5) The interpretation about expanded hedging programs and foreign exchange exposure is reasonable and aligns with the ground truth's assessment. WEAKNESSES: (1) The LLM states the 2022 amount was 'all recorded as accrued liabilities' when the ground truth shows $37 million in accrued liabilities AND $11 million in deferred income taxes/other liabilities, totaling $48 million in 2022. This is a factual error - the LLM missed the $11 million component in 2022. (2) The comparison should be from $48 million (2022 total) to $115 million (2024 total), not from $37 million to $115 million. This makes the stated increase less precise. (3) The phrase 'about $37 million in 2022' is misleading since the actual total was $48 million. The LLM appears to have focused only on the accrued liabilities portion for 2022 rather than the complete picture. CALCULATION VERIFICATION: The 2024 figures are correct ($110M + $5M = $115M). However, the 2022 baseline should be $48M total, not $37M. The actual increase is from $48M to $115M (approximately 139% increase), not a three-fold increase from $37M. MULTI-HOP REASONING: The synthesis across years and liability categories is mostly correct, but the incomplete treatment of 2022 data undermines the accuracy of the comparison. The strategic interpretation is sound and appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 502,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10‑K, Bounty was listed among the Baby, Feminine & Family Care segment’s “Major Brands” (as “Tampax Bounty”) and was mentioned only as part of the family‑care business 【page_19】. By the 2023 10‑K, Bounty remains a major brand in the same segment (still shown as “Tampax Bounty”), but the filing now highlights its strength – noting “North America market shares are over 40 % for Bounty” 【page_18】. Adding a specific market‑share figure indicates that P&G is giving Bounty greater prominence and brand visibility within the segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) ENTITY CONFUSION: The LLM refers to 'Tampax Bounty' as a combined brand name, which appears to be incorrect. Tampax and Bounty are separate brands within P&G's portfolio - Tampax is a feminine care brand while Bounty is a family care (paper towels) brand. This fundamental confusion undermines the entire answer. (2) CONTRADICTORY CLAIMS: The ground truth states that in 2022, Bounty was NOT explicitly listed among key brands, but the LLM claims it was listed as 'Major Brands' in the 2022 10-K. This directly contradicts the ground truth assertion that explicit mention only appeared in 2023. (3) UNSUPPORTED MARKET SHARE DATA: The LLM introduces a specific market share figure ('North America market shares are over 40% for Bounty') that is not mentioned in the ground truth answer. While this could be accurate from the actual filings, it represents information not validated by the ground truth and appears to be fabricated or misattributed. (4) INCOMPLETE ANALYSIS: The LLM fails to capture the core finding from the ground truth - that the KEY CHANGE was the shift from implicit/non-explicit mention in 2022 to explicit listing in 2023. Instead, the LLM claims Bounty was already listed in 2022, missing the actual evolution being described. (5) REASONING FLAW: The conclusion about 'greater prominence' is based on the market share figure, which itself appears to be unsupported by the ground truth evidence. The ground truth explicitly states 'the filings do not provide specific market share or sales figures to quantify this shift.' This is a direct contradiction. The answer demonstrates poor multi-hop synthesis and contains fundamental factual errors about brand categorization and filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 495,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "In FY 2022 Oracle explained that hardware – including Oracle Engineered Systems – is accounted for as a product‑plus‑software bundle whose revenue is recognized at the point in time the equipment and its essential software are delivered, while hardware‑support fees are recognized ratably over the contract term【page_105】. By FY 2023 the same point‑in‑time and ratable treatment is retained, but Oracle now highlights the hardware line as about 6 % of total revenue, stresses continued R&D investment to improve and add new Engineered Systems, and emphasizes that the hardware and its software are a combined performance obligation, indicating a more explicit, integrated strategic focus on the hardware portfolio【page_43】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Oracle's hardware business approach between FY2022 and FY2023. STRENGTHS: (1) Correctly identifies the key shift from general contractual descriptions in FY2022 to more explicit emphasis on combined performance obligations in FY2023; (2) Accurately captures the revenue recognition mechanics (point-in-time for equipment/software delivery, ratable for support fees) that remained consistent across both years; (3) Properly synthesizes the new strategic emphasis on R&D investments and hardware innovation in FY2023 that was not explicitly mentioned in FY2022; (4) Correctly identifies Oracle Engineered Systems as the specific hardware product line; (5) Appropriately notes the integration of hardware and software as a combined performance obligation. MINOR CONSIDERATIONS: (1) The LLM introduces a specific quantitative detail (hardware as ~6% of total revenue) that is not present in the ground truth answer. While this detail may be factually accurate from the source documents, it represents additional information beyond what the ground truth explicitly states, creating a slight divergence in scope; (2) The ground truth emphasizes 'more detailed explanation' and 'shift toward strategic focus on innovation,' while the LLM uses 'more explicit, integrated strategic focus' - these are semantically equivalent but the LLM's phrasing is slightly more precise; (3) Page citations are provided by LLM but cannot be verified against ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly identifying what changed (emphasis and strategic focus) versus what remained consistent (revenue recognition mechanics). The logical flow from FY2022 to FY2023 is sound and well-articulated. QUANTITATIVE ACCURACY: The 6% figure is presented without qualification, and while potentially accurate, it introduces a specific metric not in the ground truth baseline. This is a minor concern but does not constitute a factual error if the source documents support it. Overall, the answer demonstrates strong comprehension of the evolution and provides appropriate context for the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 597,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA’s sales climbed from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% increase (27.5% operational growth)【page_31】.  The company attributes this jump to “continued share gains and market growth in metastatic castration‑resistant prostate cancer,” indicating a strong, upward market trajectory for the product【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2022 sales of $1.881 billion ($1,881 million) - CORRECT; (2) 2023 sales of $2.387 billion ($2,387 million) - CORRECT; (3) Growth calculation: ($2,387M - $1,881M) / $1,881M = $506M / $1,881M = 26.9% - CORRECT; (4) The mention of '27.5% operational growth' adds nuance beyond the ground truth's 26.9% figure, suggesting the LLM captured additional context from the source material (likely distinguishing reported vs. operational growth metrics). Multi-hop synthesis: The answer correctly synthesizes sales data across two years and provides market context by citing the company's attribution to 'share gains and market growth in metastatic castration-resistant prostate cancer.' Entity accuracy: ERLEADA product correctly identified, years 2022-2023 correct, financial metrics properly formatted. The answer goes beyond the ground truth by providing the company's own explanation for the growth, which strengthens the market trajectory assessment. Minor note: The ground truth uses 'million' while LLM uses 'billion' format, but these are equivalent ($1,881M = $1.881B). The inclusion of page references and operational growth percentage demonstrates thorough source documentation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 362,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "In the 2023 filing Comcast framed local broadcast stations largely as **competitors‑turned‑necessary partners** – it said the company “competes … with … local broadcast television stations” for talent and content and that its domestic broadcast networks must “secure affiliations with independently owned local broadcast television stations … to ensure the effective distribution of broadcast‑network programming”【page_14】.  \n\nBy the 2024 filing the tone has shifted to one of **greater dependency and cost pressure**: Comcast now highlights that programming expenses include “payments to certain local broadcast television stations in exchange for their required consent for the retransmission of broadcast network programming” and that it will “continue to be subject to demands for payment and other concessions” from those stations, while still needing “network affiliation agreements with third‑party local broadcast television stations” for distribution【page_23】【page_22】.  \n\nThus, the relationship has moved from a competitive‑affiliation focus in 2023 to a more bargaining‑heavy, cost‑driven dependence on local stations for retransmission consent and distribution in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core evolution from competitive positioning in 2023 to dependency in 2024, matching the ground truth's characterization of the shift from 'competition to dependency.' (2) Accurately captures the 2023 framing where CMCSA competed with local broadcast stations while needing affiliations for distribution. (3) Precisely identifies the 2024 shift toward cost-driven dependency, specifically mentioning retransmission consent payments and ongoing demands for concessions. (4) Properly synthesizes multi-hop information across two fiscal years, showing how the relationship evolved. (5) Uses appropriate terminology ('competitors-turned-necessary partners,' 'bargaining-heavy, cost-driven dependence') that semantically matches the ground truth's 'shift from competition to dependency.' (6) Includes specific page references to support claims, enhancing credibility. (7) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about 'cost pressure' and 'payments' than the ground truth explicitly states, though this is a reasonable inference from the filing language cited. (2) The phrase 'competitors-turned-necessary partners' is a reasonable characterization but adds interpretive framing beyond the ground truth's more straightforward 'interdependent' description. (3) The answer emphasizes 'bargaining-heavy' dynamics which, while supported by the cited language about 'demands for payment and other concessions,' represents a slightly more adversarial framing than the ground truth's neutral 'interdependent' characterization. These are minor semantic variations that don't undermine factual accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple aspects of the relationship (competitive positioning, content distribution, financial dependency), demonstrating sound multi-hop reasoning. The comparison structure effectively highlights the evolution from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 573,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "Mastercard’s held‑to‑maturity securities fell from **$306 million at the end of 2023** to **$38 million at the end of 2024**, a decline of about $268 million【page_86】【page_83】. This dramatic reduction indicates the company is moving away from a large time‑deposit (HTM) portfolio toward more liquid, available‑for‑sale investments, reflecting a strategic shift to greater flexibility and liquidity in its investment approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $306 million for 2023 HTM securities, $38 million for 2024, and the calculated decline of $268 million ($306M - $38M = $268M). The calculation is accurate and properly presented. ENTITY ACCURACY: Correctly identifies Mastercard (MA) and the proper financial metric (Held-to-Maturity securities) with correct fiscal years (2023 and 2024). MULTI-HOP REASONING: The answer successfully synthesizes the numerical comparison across two years and connects it to strategic implications. The reasoning that the reduction indicates a shift toward more liquid investments is sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses both parts of the question - the evolution of HTM securities (with specific numbers and calculation) and what this indicates about investment strategy. The explanation about moving toward available-for-sale investments and greater liquidity is a reasonable and accurate interpretation of the strategic shift. MINOR OBSERVATIONS: The LLM provides slightly more detailed strategic context (mentioning 'available-for-sale investments' and 'greater flexibility') compared to the ground truth's more general statement about 'more liquid or short-term investment positions,' but this represents appropriate elaboration rather than inaccuracy. The citation references (page_86, page_83) add credibility. The only minor distinction is that the ground truth uses 'short-term' while the LLM uses 'available-for-sale,' but these are semantically compatible concepts in investment strategy. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 482,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "In the 2022 filing the “Baby, Feminine & Family Care” segment was broken out into three sub‑categories – Baby Care, Feminine Care (Adult Incontinence and Feminine Care) and Family Care – and Always was listed among the segment’s major brands under the generic Feminine Care sub‑category【page_19】. By the 2023 filing the segment’s product categories were trimmed to Feminine Care (Adult Incontinence and Menstrual Care) and Family Care, and Always is now positioned explicitly in the Menstrual Care sub‑category of Feminine Care (with Always Discreet still in Adult Incontinence)【page_18】. This reflects a shift from a broader “Feminine Care” grouping to a more specific “Menstrual Care” categorization for the Always brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) Correctly identifies the 2022 structure with three sub-categories (Baby Care, Feminine Care, Family Care) and accurately notes that Always was under the generic Feminine Care sub-category; (2) Accurately describes the 2023 evolution where the segment was restructured to two main categories (Feminine Care and Family Care), with Feminine Care further divided into Adult Incontinence and Menstrual Care; (3) Correctly identifies that Always shifted from generic 'Feminine Care' positioning to specific 'Menstrual Care' sub-category positioning; (4) Appropriately notes the distinction that Always Discreet remained in Adult Incontinence, showing nuanced understanding; (5) Provides clear synthesis of the multi-hop comparison across 2022 and 2023 filings; (6) Correctly interprets the strategic shift from broader to more targeted positioning. Minor considerations: The LLM answer provides slightly more granular detail than the ground truth (mentioning Always Discreet's positioning in Adult Incontinence), which is actually a strength as it demonstrates deeper understanding. The page references cited (page_19 and page_18) add credibility though cannot be independently verified in this evaluation. The semantic meaning aligns perfectly with the ground truth - both convey the same evolution from generic Feminine Care to specific Menstrual Care positioning. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 416,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "In the 2022 filing Oracle described Engineered Systems simply as a component of its hardware segment, noting that “revenues from the sale of hardware products represent amounts earned primarily from the sale of our Oracle Engineered Systems…​” and that “the revenues for this combined performance obligation are generally recognized at the point in time that the hardware product is delivered” (Notes – Revenue Recognition, p. 74‑76). By the 2023 filing the company still positions Engineered Systems within the hardware business, but now calls out that the hardware segment (which includes Engineered Systems) contributed roughly 6 % of total revenue and stresses “continued investments in research and development to improve existing hardware products and services and to develop new hardware products and services” (Business Overview – Hardware, p. 43). Thus, the accounting treatment (point‑in‑time revenue recognition) remains unchanged, while the strategic narrative has shifted from a purely accounting focus in 2022 to an explicit growth‑and‑R&D emphasis and a disclosed 6 % revenue contribution in 2023.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings describe the same approach: Comcast works with representation firms as an extension of its own sales force, using them to sell a portion of the advertising units allocated to the company and recording the revenue net of agency commissions【page_75】. The language is essentially identical in each year, indicating that the advertising‑sales strategy involving representation firms has remained unchanged between 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that Comcast's relationship with representation firms EVOLVED between 2023 and 2024, shifting from a co-selling model (where firms acted as extensions of sales force) to a more formalized representation structure (where firms sell advertising on behalf of third parties). The LLM answer directly contradicts this by claiming the approach 'remained unchanged' and that 'the language is essentially identical in each year.' This is a critical factual error that misses the entire premise of the question. The LLM correctly identifies that both years involved representation firms and revenue recording net of agency commissions, but fails to recognize the strategic evolution described in the ground truth. The LLM appears to have only found similarities between the two years rather than identifying the key differences that constitute the 'evolution' mentioned in the question. The citation provided (page_75) does not validate the claim of unchanged language. The answer demonstrates poor multi-hop reasoning by failing to synthesize the comparative analysis across 2023 and 2024 filings that would reveal the shift from co-selling to formal representation agreements. This is a case where the LLM missed the nuanced but significant strategic change that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 387,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle’s accounting for its industry‑specific hardware remained unchanged – both the 2022 filing (see page 105) and the 2023 filing (see page 43) state that hardware products and the related software are treated as a single performance obligation and revenue is recognized at the point of delivery, with hardware‑support fees recognized ratably over the contract term. However, the strategic emphasis shifted: hardware now represents about 6 % of total revenue in fiscal 2023 (down from roughly 7‑8 % in fiscal 2022) and the 2023 discussion stresses a broader, integrated hardware portfolio and continued R&D investment, indicating a modest but sustained focus amid a stronger push toward cloud and license growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue percentages (6% in 2023, 7-8% in 2022) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated numbers. (2) CONTRADICTORY CLAIMS: The LLM states 'Oracle's accounting for its industry-specific hardware remained unchanged' and that both years treat hardware and software as 'a single performance obligation,' but the ground truth explicitly states that fiscal 2023 introduced 'a more detailed explanation' of revenue recognition, indicating a change in how the company described/explained its approach, even if the underlying accounting remained similar. The LLM misses this nuance. (3) MISSING KEY INFORMATION: The ground truth emphasizes Oracle's 'ongoing investments in R&D to improve existing hardware offerings and develop new products' as a 'more strategic focus on innovation' compared to 2022's 'more general' description. While the LLM mentions 'continued R&D investment,' it downplays this as 'modest' and frames it as secondary to cloud/license growth, which contradicts the ground truth's emphasis on this as a meaningful strategic shift. (4) PAGE CITATIONS: The LLM provides specific page numbers (105, 43) that cannot be verified against the ground truth and may be inaccurate. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between years - it claims 'unchanged' accounting while the ground truth indicates a shift from general description to detailed explanation of combined performance obligations. The LLM's conclusion about strategic emphasis is partially correct but understates the significance of the R&D investment emphasis shift. Overall, the answer contains unverified quantitative claims and misses the key distinction between accounting treatment remaining similar while the explanation and strategic emphasis evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 533,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA sales fell from $3.784 billion in 2022 to $3.264 billion in 2023, a 13.7% decline driven by a 13.2% operational drop and a 0.5% adverse currency impact (page_31). The company attributed the operational decline to global competitive pressures on the drug (page_32).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All key financial numbers are correct: $3.784B (2022), $3.264B (2023), and 13.7% decline are accurate. (2) The quantitative breakdown is precise: 13.2% operational drop and 0.5% currency impact are correctly identified and sum appropriately to the total decline. (3) The LLM correctly identified the primary driver as competitive pressures. (4) Page citations suggest proper source documentation. WEAKNESSES: (1) The LLM answer is narrower in scope than the ground truth - it focuses primarily on competitive pressures but omits other contextual factors mentioned in the original answer such as pandemic-related delays in new patient starts and market saturation/treatment shifts. (2) The ground truth provides more comprehensive context about the 2022 baseline (noting growth was already being offset) and characterizes the 2023 decline as a continuation of a downward trend, whereas the LLM answer treats the factors more superficially. (3) The LLM answer provides more technical/operational detail (breaking down operational vs. currency impacts) but less strategic/market context. CALCULATION VERIFICATION: 13.2% operational decline + 0.5% currency impact = 13.7% total decline is mathematically sound and consistent with the stated figures. MULTI-HOP REASONING: The answer correctly synthesizes the sales figures across two years and identifies the relationship between them, though it could have better synthesized the broader market dynamics context. The answer is factually accurate on numbers but somewhat incomplete on the fuller context of contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 435,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "In 2023 Comcast’s 30 % stake in Universal Beijing Resort was backed by about $3.5 billion of debt (including a $3.1 billion term loan) and the resort’s assets and liabilities were $7.8 billion and $7.2 billion, respectively. By year‑end 2024 the debt had slipped to roughly $3.4 billion (term loan $3.0 billion) and the consolidated assets and liabilities fell to $7.3 billion and $7.0 billion, while Comcast’s ownership remained unchanged at 30 % and there are still no liquidity arrangements, guarantees or other commitments – meaning its maximum financial loss is limited to that 30 % equity interest【page_86†L9-L15】【page_86†L16-L22】【page_56†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key numbers are correct - 2023 debt of $3.5 billion (term loan $3.1 billion), 2024 debt of $3.4 billion (term loan $3.0 billion), and 30% ownership stake maintained. The additional balance sheet data (2023 assets $7.8B, liabilities $7.2B; 2024 assets $7.3B, liabilities $7.0B) is accurate and provides useful context not in the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple dimensions - debt levels (2023 vs 2024), ownership structure (30% unchanged), and financial risk exposure (limited to equity interest). The reasoning that 'maximum financial loss is limited to that 30% equity interest' correctly interprets the VIE consolidation structure and lack of guarantees. COMPLETENESS: The answer addresses all three sub-components of the question: (1) debt evolution (correctly shows slight decrease), (2) ownership structure (correctly identifies 30% stake maintained), and (3) financial risk exposure (correctly characterizes as limited to equity interest). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM provides additional balance sheet detail (assets/liabilities figures) that the ground truth doesn't include, but this is supplementary and accurate rather than contradictory. The characterization of the evolution as 'slipped' for debt reduction is slightly informal but semantically appropriate. The explicit mention of 'no liquidity arrangements, guarantees or other commitments' adds helpful specificity about why risk is limited. ENTITY ACCURACY: Comcast, Universal Beijing Resort, VIE structure, and all time periods correctly identified. The answer demonstrates sound multi-hop reasoning by connecting debt reduction, stable ownership, and limited risk exposure into a coherent narrative about the relationship's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 516,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "- In the 2022 filing FedEx said that “additional leases … for build‑to‑suit facilities … have undiscounted future payments of approximately **$3.4 billion**” (page 96).  \n- The 2023 filing shows that the same type of commitment is now only about **$0.9 billion** (page 98).  \n\nThe drop from $3.4 billion to $0.9 billion indicates FedEx is scaling back its build‑to‑suit lease program, adopting a more restrained and selective leasing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All key financial numbers are correct: $3.4 billion for 2022 and $0.9 billion for 2023 are accurately cited. (2) The quantitative comparison and calculation of the reduction is accurate. (3) The company identification (FedEx) and fiscal years (2022 vs 2023) are correct. (4) Page references provided add credibility. (5) The core interpretation that FedEx is scaling back build-to-suit leases is sound. WEAKNESSES: (1) The LLM answer omits important contextual details from the ground truth regarding the expected commencement dates (2023-2024 in 2022 vs 2025-2027 in 2023), which is a key indicator of the strategic shift. (2) The ground truth explicitly notes this represents 'a more extended timeline for asset utilization,' which the LLM answer does not capture. (3) The LLM characterizes the shift as 'more restrained and selective' while the ground truth uses 'fewer long-term build-to-suit lease commitments and a more extended timeline' - these are related but not identical characterizations. (4) The LLM answer doesn't address the equipment component mentioned in the 2023 figure ('build-to-suit facilities and equipment'), though this is a minor omission. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the trend, but misses the temporal dimension (commencement dates) that provides deeper insight into the strategic shift. The reasoning is sound but incomplete in capturing the full strategic picture presented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 418,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "In 2023 Mastercard completed the purchase‑accounting for its 2022 acquisition of Dynamic Yield, integrating the firm’s intangible assets and goodwill into its books【page_79】. By the 2024 filing the acquisition is listed only as a historic transaction, while value‑added services revenue (which includes Dynamic Yield’s personalization capabilities) grew to $10.8 billion, indicating that Mastercard is now leveraging Dynamic Yield as part of a broader strategic push to expand data‑driven, digital and personalization services【page_77】【page_81】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Dynamic Yield was acquired in 2022 and that by 2024 it is treated as a historic transaction. The answer appropriately notes that Mastercard is leveraging Dynamic Yield's capabilities for personalization services. The multi-hop reasoning connecting the acquisition to strategic focus is sound.\n\nWEAKNESSES: (1) MISSING CRITICAL NUMBERS: The ground truth specifies the $325 million acquisition price and $200 million goodwill attribution - the LLM completely omits these key quantitative details. (2) INCOMPLETE STRATEGIC NARRATIVE: The ground truth explicitly mentions the strategic pivot to cybersecurity/threat intelligence via the Recorded Future acquisition in 2024 as evidence of shifting focus. The LLM mentions value-added services revenue of $10.8 billion but doesn't address the Recorded Future pivot, which is central to understanding the strategic evolution. (3) PARTIAL ANSWER: While the LLM describes how Dynamic Yield is being used (personalization/data-driven services), it doesn't fully capture the strategic shift indicated by the new Recorded Future acquisition. (4) QUANTITATIVE GAPS: The $10.8 billion figure for value-added services revenue is provided but lacks context about whether this represents growth or change from prior year, and the absence of the $325M/$200M acquisition figures is a significant omission.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes that Dynamic Yield moved from active acquisition to integrated historic asset, but fails to complete the full multi-hop chain by not connecting this to the newer Recorded Future acquisition as evidence of strategic pivot.\n\nVERIFICATION: Ground truth states acquisition was April 2022 for $325M with $200M goodwill - LLM mentions 2022 acquisition but omits these specific figures. Ground truth emphasizes strategic pivot to cybersecurity via Recorded Future in 2024 - LLM does not mention this at all.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 524,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers was last amended on May 26, 2022. In the 2022 Form 10‑K the plan was disclosed as Exhibit 10.28 reflecting that May 2022 amendment, and the 2024 Form 10‑K again references the same amendment but re‑files the exhibit on November 27, 2024 (Exhibit 10.28)【page_79】. This shows that the amendment itself has not changed since 2022, but the filing of the exhibit was updated in the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The May 26, 2022 amendment date is accurate. (2) The November 27, 2024 filing date is correct. (3) The identification of Exhibit 10.28 in the 2024 filing is accurate. (4) The observation that the amendment itself hasn't changed since 2022 is reasonable. INCORRECT/INCOMPLETE ELEMENTS: (1) The LLM states the plan was 'disclosed as Exhibit 10.28' in the 2022 Form 10-K, but the ground truth indicates it was Exhibit 10.29 in 2022. This is a factual error in exhibit numbering. (2) The LLM fails to mention the earlier 2020 amendment date (May 29, 2020) and its August 26, 2020 filing, which is relevant context for understanding the plan's evolution. (3) The answer doesn't fully address the evolution between 2022 and 2024 - it focuses primarily on the 2024 filing rather than comparing the two years. (4) The ground truth indicates there was an update/amendment between 2022 and 2024 (the May 26, 2022 amendment appearing in 2024 filings), but the LLM's characterization that 'the amendment itself has not changed since 2022' is somewhat misleading about the evolution question. MULTI-HOP REASONING: The LLM partially synthesizes information across the 2022 and 2024 filings but misses the comparative evolution aspect and the earlier 2020 baseline. The answer is incomplete in addressing how the plan 'evolved' - it should have discussed the progression from 2020 to 2022 to 2024. QUANTITATIVE ACCURACY: Dates are mostly correct (May 26, 2022 and November 27, 2024 are accurate), but the exhibit number discrepancy (10.28 vs 10.29) for 2022 is a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 451,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair‑value of Netflix’s 6.375 % Senior Notes was $999 million on December 31 2021 and fell to $872 million on December 31 2023 – a decline of about $127 million (≈13 %)【page_56】. The lower price indicates that investors were demanding a higher yield (or perceived greater risk) for the company’s debt, suggesting a weaker market perception of Netflix’s credit profile over the two‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $999 million (Dec 31, 2021), $872 million (Dec 31, 2023), decline of $127 million ($999M - $872M = $127M ✓), and percentage decline of approximately 12.7% (≈13% is accurate rounding). (2) ENTITY ACCURACY: Netflix, 6.375% Senior Notes, and correct fiscal year dates are all properly identified. (3) MULTI-HOP SYNTHESIS: The answer correctly synthesizes the two-year comparison and draws appropriate conclusions about market perception. The interpretation that lower fair value indicates higher required yields and weaker credit perception is economically sound and matches the ground truth's implication about 'decline in market confidence.' (4) COMPLETENESS: The answer addresses both parts of the question - the numerical change and what it indicates about market perceptions. The LLM provides slightly more detailed economic reasoning (explaining that lower prices mean investors demand higher yields) compared to the ground truth, which is a minor enhancement. (5) WORDING: The phrasing 'fell to' and 'decline' are semantically equivalent to the ground truth's description of the change. The inclusion of the citation reference [page_56] adds credibility. Minor note: The ground truth states 'decrease in fair value' while also saying 'increase from $999M to $872M' which is internally contradictory - the LLM correctly interprets this as a decrease (from higher to lower value), which is the accurate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 422,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a decline of roughly 13‑14 % (operations ‑13.2 %)【page_31】. Because the overall oncology portfolio grew 10.5 % in the same period, the drop reflects “global competitive pressures” on IMBRUVICA and suggests it is losing share and its market position is weakening within the oncology segment【page_32】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 sales figures for IMBRUVICA. Ground truth shows $4,369 million in 2022, but LLM states $3.784 billion ($3,784 million). This is a significant discrepancy of $585 million (13.4% understatement). The 2023 figure of $3,264 million is correct. CALCULATION ERROR: The LLM calculates the decline as 13-14% based on its incorrect 2022 figure ($3,784M to $3,264M = 13.7% decline). However, using the correct 2022 figure ($4,369M to $3,264M), the actual decline is 25.2% as stated in the ground truth. This is a major calculation error stemming from the wrong starting number. QUALITATIVE ASSESSMENT: The LLM correctly identifies the weakening market position and competitive pressures, and appropriately contextualizes this against overall oncology portfolio growth (10.5%). The reasoning about market share loss is sound and aligns with the ground truth conclusion. However, the fundamental numerical errors severely undermine the credibility of the analysis. The LLM also provides page citations which add some credibility but cannot compensate for the factual inaccuracies. MULTI-HOP REASONING: The synthesis comparing IMBRUVICA's decline to overall portfolio growth is appropriate and demonstrates understanding of the question's multi-part nature, but this strength is overshadowed by the quantitative failures. The answer addresses both the sales evolution and market position implications, meeting the completeness requirement, but with incorrect supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 422,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "In fiscal 2022 Lowe’s reported an inventory‑shrink reserve of **$414 million** and an LCNRV reserve of **$168 million**【LOW_10k_2022.pdf page 33】. By fiscal 2024 the shrink reserve had risen modestly to **$427 million** (≈ +$13 million) and the LCNRV reserve had grown to **$222 million** (≈ +$54 million)【LOW_10k_2024.pdf page 34】. The company notes that a 10 % change in the shrink reserve would shift net earnings by roughly **$32 million**, and a 10 % change in the LCNRV reserve would affect net earnings by about **$17 million** in fiscal 2024, highlighting the material impact of these reserves on earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental reversal of the sensitivity metrics that directly contradicts the ground truth. Specifically: (1) SHRINK RESERVE SENSITIVITY: Ground truth states a 10% change in shrinkage rate impacts net earnings by ~$32 million. LLM correctly reports this. However, (2) LCNRV RESERVE SENSITIVITY: Ground truth states a 10% change in LCNRV affects net earnings by ~$17 million. LLM also correctly reports this. BUT (3) THE CRITICAL ERROR: The LLM states 'a 10% change in the shrink reserve would shift net earnings by roughly $32 million, and a 10% change in the LCNRV reserve would affect net earnings by about $17 million' - this is CORRECT and matches ground truth. Upon re-examination, the numeric values are actually accurate: shrink reserve $414M→$427M (+$13M), LCNRV reserve $168M→$222M (+$54M), and the sensitivity metrics ($32M for shrink, $17M for LCNRV) are correct. The reserve values and changes are properly calculated. However, the presentation could be clearer about which sensitivity applies to which reserve. The answer does correctly synthesize information across 2022 and 2024 filings and provides the earnings implications. The multi-hop reasoning is sound - combining reserve values from different years and linking them to earnings sensitivity. All numeric values check out against ground truth. The main weakness is that the answer could more explicitly state the implications of these growing reserves (indicating 'growing need for reserves, particularly for shrinkage') as mentioned in the ground truth's interpretive conclusion. The answer is factually accurate on all numbers but slightly less comprehensive on the qualitative implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 468,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "In 2022 Qulipta was still a newly launched migraine‑preventive therapy, posting only $158 million of U.S. net revenue and essentially no international sales (product‑revenue table shows $158 M U.S. and $‑ M abroad)【page_42】. By 2023 the drug had cleared key development milestones – FDA approval for chronic migraine in April 2023 and European Commission approval in August 2023 – and its sales more than doubled, rising to $405 million in the United States and $408 million internationally, a “greater than 100 %” increase driven by the new indication and broader market uptake【page_40】【page_44】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) 2022 REVENUE ERROR: The LLM claims Qulipta had $158M in U.S. revenue in 2022, but the ground truth states Qulipta was among products that contributed to reclassification of indefinite-lived R&D assets in 2022, implying it was still in development phase, not generating substantial revenue. The $158M figure appears to be fabricated or misattributed. (2) 2023 INTERNATIONAL REVENUE ERROR: The LLM states $408 million in international sales for 2023, but the ground truth clearly specifies only $3 million internationally. This is a massive discrepancy (408 vs 3) - off by a factor of 136x. This is a critical quantitative error. (3) REGULATORY APPROVAL DATES: The LLM provides specific FDA approval dates (April 2023) and European Commission approval (August 2023) that are not mentioned in the ground truth and cannot be verified from the provided context. While these dates may be factually accurate in reality, they represent information not in the source documents. (4) DEVELOPMENT STATUS: The LLM correctly identifies the transition from development to commercialization, which aligns with the ground truth. However, the 2022 characterization as 'newly launched' contradicts the ground truth's implication that it was still in development phase in 2022. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the financial data across years. The core answer should emphasize the shift from indefinite-lived R&D asset (2022) to revenue-generating product (2023), with 2023 showing $405M U.S. and $3M international revenue. The LLM's claim of $408M international revenue is fundamentally incorrect and undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 483,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "In 2022 Honeywell recorded a $157 million receivable from Resideo (the $140 million short‑term portion plus $474 million long‑term) and collected $140 million in reimbursements; in 2023 the receivable grew to $187 million (still $140 million short‑term, $521 million long‑term) while the reimbursement remained capped at $140 million. The larger receivable shows a modest increase in Honeywell’s reliance on Resideo to offset environmental costs, but the fixed $140 million annual cap limits the company’s overall risk exposure to those liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($157M, $474M, $187M, $521M) that do not appear in the ground truth and appear to be fabricated. The ground truth makes no mention of these specific receivable amounts or their composition. The LLM's arithmetic (claiming $140M + $474M = $157M) is mathematically nonsensical. (2) MISREPRESENTATION OF CORE FACT: The ground truth explicitly states the arrangement 'remained consistent between 2022 and 2023' with a fixed 90% obligation up to $140M annually. The LLM incorrectly characterizes this as showing 'a modest increase in Honeywell's reliance on Resideo' based on fabricated receivable growth figures. (3) MISSING KEY INFORMATION: The LLM completely omits the critical 90% obligation metric that defines the arrangement, instead focusing on invented receivable balances. (4) LOGICAL INCONSISTENCY: The LLM's claim that receivables 'grew' from $157M to $187M contradicts the ground truth's assertion that the arrangement remained unchanged. (5) MULTI-HOP REASONING FAILURE: The answer fails to correctly synthesize the relationship between the indemnification agreement terms (90%, $140M cap) and what they indicate about risk exposure. The ground truth correctly identifies this as a consistent risk mitigation strategy; the LLM invents a narrative of increasing reliance based on non-existent data. The answer demonstrates hallucination of specific financial figures and misinterpretation of the fundamental nature of the Honeywell-Resideo environmental liability arrangement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 459,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target’s definition of cash equivalents has not changed – in both the 2022 and 2024 filings the company says cash equivalents are “highly liquid investments with an original maturity of three months or less from the time of purchase” (2022 Note 9, p. 48; 2024 Note 7, p. 52). The unchanged three‑month‑or‑less criterion shows Target continues to treat only very short‑term instruments as cash equivalents, signaling a steady, liquidity‑focused cash‑management policy, even as the actual amount of short‑term investments fell (from $4.985 bn in 2022 to $2.897 bn in 2024), suggesting it may be deploying cash elsewhere or tightening its short‑term investment holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Target's definition of cash equivalents remained unchanged between 2022 and 2024 (three months or less), which aligns with the ground truth. The LLM also provides specific citations (2022 Note 9, p. 48; 2024 Note 7, p. 52) and includes relevant quantitative data about short-term investments declining from $4.985 billion to $2.897 billion. However, there are significant issues: (1) The LLM claims the definition is 'unchanged' and emphasizes continuity, while the ground truth indicates an 'evolution' with Target adding 'a broader discussion around fair value measurements for other short-term assets and liabilities' by 2024, suggesting a more comprehensive approach. The LLM misses this qualitative evolution entirely. (2) The LLM's interpretation that the unchanged definition 'signals a steady, liquidity-focused cash-management policy' contradicts the ground truth's characterization of this as a 'refinement' in how Target evaluates and manages cash within a 'broader financial framework.' (3) While the LLM provides additional context about cash deployment (not in ground truth), it fails to capture the key insight about the evolution in Target's broader approach to short-term financial instruments. (4) The quantitative data appears reasonable but cannot be fully verified against the ground truth provided. The answer is partially correct on the definitional continuity but fundamentally misses the evolution in Target's broader financial framework and fair value measurement approach that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 432,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "In the 2023 filing the 3.50 % Notes Due 2040 were disclosed as a Level 2 fair‑value liability with a market value of about **$870 million**, while the notes were carried on the balance sheet at their original issuance amount of **$1 billion** as a long‑term unsecured senior obligation. In the 2024 filing the same notes were still classified as Level 2 but their fair‑value fell to **$851 million** and the carrying amount remained **$1 billion** (entirely in the long‑term portion). The modest decline in market value combined with the unchanged long‑term classification shows NVIDIA is retaining the low‑cost, long‑dated debt rather than refinancing or retiring it, reflecting a strategy of preserving stable, inexpensive long‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM states 2023 fair value was ~$870M and 2024 fair value was $851M, but ground truth shows the opposite direction - 2023 carrying value was $851M and 2024 valuation increased to $1,000M. The LLM also claims the carrying amount was $1 billion in both years, but ground truth shows $851M in 2023. (2) DIRECTIONAL REVERSAL: The LLM describes a 'modest decline in market value' from $870M to $851M, when the ground truth indicates an INCREASE from $851M to $1,000M - a fundamental misrepresentation of the valuation trend. (3) MISSING KEY DETAILS: The LLM fails to mention the effective interest rate of 3.54% and remaining term of 15.2 years disclosed in 2024, which are material details in the ground truth. (4) CLASSIFICATION ACCURACY: While the LLM correctly identifies Level 2 classification in both years, this is overshadowed by the major numerical errors. (5) STRATEGIC INTERPRETATION: The LLM's conclusion about 'preserving stable, inexpensive long-term financing' is reasonable in tone but is based on incorrect valuation trends - the actual increase in valuation to $1B suggests different market conditions than the LLM's narrative of decline. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison, getting the temporal sequence and magnitude of changes backwards. This is a critical failure for a multi-hop financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 419,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta’s worldwide net revenues rose from $2.009 billion in 2022 to $2.288 billion in 2023, a gain of roughly 15 percent (13.9 % at actual currency rates and about 15 % on a constant‑currency basis)【page_42】. The 2023 filing notes that “Net revenues for Venclexta increased 15 % in 2023”【page_43】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and growth rates. Verification of key numbers: (1) 2022 revenue of $2.009 billion ($2,009 million) - CORRECT; (2) 2023 revenue of $2.288 billion ($2,288 million) - CORRECT; (3) 2023 growth rate of 13.9% - CORRECT and matches ground truth exactly. The LLM also mentions a 15% growth figure on a constant-currency basis, which is a reasonable supplementary detail not contradicting the ground truth. The answer correctly identifies the upward trend in both absolute revenue and growth rate. Minor deduction: The LLM presents the growth rate information in a slightly more complex way (mentioning both 13.9% at actual currency rates and ~15% on constant-currency basis) compared to the ground truth's straightforward presentation of 10.4% (2022) and 13.9% (2023). However, the core facts are accurate. The answer demonstrates proper multi-hop synthesis by comparing 2022 and 2023 figures and calculating the year-over-year change. The citation references (page_42, page_43) suggest proper sourcing from SEC filings. The semantic meaning aligns well with the ground truth - both convey that Venclexta experienced revenue growth from 2022 to 2023 with an improving growth rate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 350,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Netflix’s Executive Severance and Retention Incentive Plan was shown only as the “Amended and Restated Executive Severance and Retention Incentive Plan” that had been filed on September 10 2021 (exhibit 10.6†) 【page_66】. By the 2023 filing the company had issued a new amendment that restates the plan with a future effective date of January 1 2024 (exhibit 10.16†) and also added a separate “Executive Officer Severance Plan” (exhibit 10.15†) 【page_68】. Thus Netflix moved from a 2021‑dated amendment to a fresh 2024‑effective amendment and broadened its severance framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates and plan names. Strengths: (1) Correctly identifies the 2022 filing reference to 'Amended and Restated Executive Severance and Retention Incentive Plan' with September 10, 2021 filing date; (2) Accurately captures the 2023 evolution showing a new amendment effective January 1, 2024 with December 8, 2023 filing date; (3) Properly synthesizes the multi-hop comparison between 2022 and 2023 filings; (4) All dates are factually correct and properly formatted. Minor enhancement: The LLM answer goes slightly beyond the ground truth by identifying an additional 'Executive Officer Severance Plan' (exhibit 10.15) introduced in 2023, which adds useful context about Netflix broadening its severance framework. This is not contradicted by the ground truth but represents additional detail. The answer effectively demonstrates the evolution from a 2021-dated amendment to a forward-looking 2024-effective amendment. The multi-hop reasoning is sound, correctly synthesizing information across the 2022 and 2023 filings to show the progression of Netflix's executive compensation frameworks. The exhibit references (10.6, 10.15, 10.16) and page citations add credibility, though these specific details weren't in the ground truth. Overall, the answer is semantically equivalent to the ground truth with enhanced detail that strengthens rather than contradicts the core findings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 405,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "In the 2022 Form 10‑K the Benefit Restoration Plan was only described in the retirement‑plan note (page 68), where Lowe’s said the plan “supplements benefits … provides for employee salary deferrals and employer contributions in the form of a Company Match.” By the 2024 filing the plan appears as a stand‑alone exhibit (Exhibit 10.3 – “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025,” page 78), indicating it has been formally amended, restated and filed as a separate document. This move from a brief narrative disclosure to a formal, updated exhibit shows that Lowe’s is actively refining and formalizing its retirement‑benefit structure, underscoring a proactive, compliance‑focused approach to protecting employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and references are correct - the 2022 Form 10-K reference, the January 1, 2025 effective date, and the exhibit designation (10.3) are all accurate. No numerical errors or miscalculations present. ENTITY ACCURACY: Correctly identifies Lowe's Companies, the Benefit Restoration Plan, the 401(k) Plan context, and the specific filing years (2022 vs 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and documents, correctly identifying the evolution from narrative disclosure to formal exhibit filing. The logical progression is sound. COMPLETENESS: Addresses all aspects of the question - how documentation evolved (narrative to formal exhibit), the structure (employee deferrals and employer match), and what this indicates about company approach (proactive, compliance-focused, formalizing retirement benefits). SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as moving from \"brief narrative disclosure to a formal, updated exhibit\" aligns well with the ground truth's description of \"formally introduced an updated and restated version.\" Both answers convey the same strategic intent regarding employee retirement benefits management. MINOR CONSIDERATIONS: The LLM provides slightly more specific page references (page 68 for 2022, page 78 for 2024) which adds helpful detail beyond the ground truth. The phrase \"compliance-focused approach\" is a reasonable interpretation of the ground truth's \"more strategic and forward-looking approach.\" Both characterizations are semantically equivalent in describing Lowe's deliberate effort to formalize and enhance the plan structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 488,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA’s liability for the 0.584 % Notes Due 2024 grew modestly. At the end of fiscal 2023 the notes were recorded at about $1.185 billion, while by fiscal 2024 they were carried at roughly $1.228 billion (fair‑value) and $1.250 billion (net carrying amount) – an increase of roughly $45‑$65 million【page_67】【page_72】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. Ground truth states: (1) FY2023 liability was $1,185 million, (2) By FY2024, the obligation was FULLY REPAID/resolved. LLM answer claims: (1) FY2023 was ~$1.185 billion (correct), (2) FY2024 was ~$1.228-$1.250 billion (INCORRECT - should be $0 or fully repaid), (3) The notes GREW by $45-65 million (INCORRECT - they were eliminated). The LLM fundamentally misunderstood the evolution of this debt obligation. The ground truth explicitly states 'this obligation was fully repaid' and 'complete resolution of this specific debt obligation,' meaning the liability should have decreased to zero, not increased. The LLM's claim of an increase of $45-65 million is the opposite of what occurred. While the LLM correctly identified the FY2023 amount and the note details (contextually relevant), it completely failed on the critical finding: that the debt was fully repaid by FY2024. This is a major factual error that undermines the entire answer. The question asks how the obligation 'evolved' - the correct answer is it was eliminated; the LLM answer incorrectly states it grew.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 333,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret’s total net revenue fell from $1.541 billion in 2022 to $1.430 billion in 2023 – a decline of roughly 7 percent (‑$111 million) 【page_43】.  The U.S. portion dropped more sharply, from $755 million to $659 million (‑12.7 %), while international sales slipped only modestly, from $786 million to $771 million (‑1.9 %) 【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2022 total revenue of $1.541 billion ($1,541 million), 2023 total revenue of $1.430 billion ($1,430 million), U.S. revenue decline from $755M to $659M (-12.7%), and international revenue decline from $786M to $771M (-1.9%). The calculated overall decline of approximately 7% (-$111 million) is mathematically accurate. The answer correctly synthesizes multi-hop information by comparing performance across two years and two geographic segments. The LLM properly identifies the key trend: a more pronounced decline in the U.S. market (-12.7%) versus a marginal decline internationally (-1.9%), which matches the ground truth assessment. The semantic meaning is equivalent to the original answer, with clear presentation of the data and appropriate characterization of the trends. Minor formatting differences (billion vs. million notation) are acceptable and do not affect accuracy. The answer directly addresses all components of the multi-part question regarding global revenue evolution, U.S. market trends, and international market trends between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 330,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "In the 2022 filing (see page 56) Netflix noted that its senior notes could be repaid on a change‑of‑control event at 101 % of principal plus accrued interest, could be redeemed early with a premium, and were subject to covenants that barred the company from creating additional liens, entering sale‑and‑lease‑back transactions, incurring or guaranteeing extra subsidiary debt, or merging or transferring substantially all of its assets – and the company was in compliance with those covenants as of Dec 31 2021 (and 2020). By the 2024 filing (see page 54) the same core restrictions remained, but the company clarified that “certain” notes impose additional limits on sale‑and‑lease‑backs and subsidiary indebtedness, and it disclosed that it had repaid the $400 million of 5.750 % senior notes that matured in March 2024 while still being in compliance with all covenant requirements as of Dec 31 2024 (and 2023).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Netflix's covenant compliance evolution but contains some issues: (1) CORRECT ELEMENTS: The core covenant restrictions are accurately identified (liens, sale-and-lease-back transactions, subsidiary indebtedness, mergers/asset transfers). The $400 million repayment of 5.750% Senior Notes in March 2024 is correct. Compliance status in both years is correctly stated. The characterization of 'certain' notes having narrowed scope is accurate. (2) QUANTITATIVE ISSUES: The LLM references 'Dec 31 2021 (and 2020)' for 2022 filing compliance, which is technically correct but creates confusion about the 2022 vs 2021 distinction. The ground truth specifies 2022 compliance, while the LLM discusses 2021/2020 compliance dates. The 101% change-of-control premium is mentioned but not in the ground truth, suggesting additional detail rather than error. (3) MISSING INFORMATION: The LLM does not mention the euro-denominated tranches totaling €5,170 million, which is a specific quantitative detail in the ground truth. This is a notable omission for a multi-hop financial question. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings, showing evolution of covenant scope and debt management actions. The logic connecting compliance status, covenant changes, and debt repayment is sound. (5) SEMANTIC ISSUES: The phrase 'certain notes impose additional limits' in the LLM answer is slightly confusing—the ground truth indicates restrictions were narrowed (removed), not added. This represents a minor semantic misalignment. (6) PAGE REFERENCES: The LLM provides specific page citations (56, 54) which adds credibility but cannot be verified against the ground truth provided. Overall, the answer is substantially correct on core facts but lacks the euro-denominated debt detail and has minor semantic/temporal clarity issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 518,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "In 2022 Honeywell still reported a distinct “Safety and Retail” line within the Safety and Productivity Solutions segment, but in July 2022 it combined that unit with Advanced Sensing Technologies to create a new “Sensing and Safety Technologies” business unit【page_68】. The 2023 filing no longer lists a separate Safety and Retail line; instead the segment now reports a “Sensing and Safety Technologies” sub‑segment, reflecting the structural re‑classification of the product line introduced in 2023【page_68】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structural change (merger of Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies) and the timing (July 2022, reported in 2023 filing). However, there are significant quantitative omissions and a critical dating inconsistency: (1) The ground truth specifies that Safety and Retail generated $2,387 million in revenue in 2022 - this specific financial metric is completely absent from the LLM answer, representing a material omission for a financial question. (2) The LLM states the change was 'introduced in July 2022 but reported in the 2023 filing' which is somewhat confusing wording - the ground truth more clearly states it was 'introduced in July 2022 but reported in the 2023 filing,' so the LLM's phrasing is awkward but not technically wrong. (3) The LLM correctly identifies that 2022 showed Safety and Retail as a standalone component and 2023 shows the merged Sensing and Safety Technologies unit. (4) The multi-hop reasoning is sound - the LLM successfully synthesizes the evolution across two years and identifies the structural change. However, the failure to include the $2,387 million revenue figure is a significant gap for a financial analysis question. The answer addresses the 'how did it evolve' and 'what structural change' parts of the question but incompletely on the quantitative dimension. The qualitative reasoning about the strategic shift toward integration is present but less detailed than the ground truth's explanation of 'integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 452,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "In the 2023 filing Visa explained that Class B‑2 common stock is a convertible class – it can be turned into Class A common stock, which would increase the number of Class A shares and dilute the voting power of existing Class A holders – and that, although its voting rights are limited, B‑2 holders can vote on “certain significant transactions” such as a merger, a consolidation or a decision to exit the core payments business (see page 34). By the 2024 filing the company had actually issued 49 shares of Class B‑2 (none existed in 2023) as shown in the equity table and footnote (see page 59), but the same convertibility and limited‑vote rights remain, so B‑2 still can affect corporate‑governance decisions and any conversion would again dilute Class A voting power (page 34).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual contradiction with the ground truth regarding Class B-2 share issuance. Ground Truth states: 'no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer' in 2024, indicating B-2 shares did NOT exist in 2023 and were not outstanding in 2024. LLM Answer claims: '49 shares of Class B-2 (none existed in 2023)' were issued by 2024. This is a direct contradiction - the LLM asserts shares were issued when ground truth indicates none were outstanding. The LLM's statement that '49 shares of Class B-2' existed in 2024 contradicts the ground truth's core finding that no shares were outstanding. QUANTITATIVE ACCURACY: The LLM provides a specific number (49 shares) that appears to be incorrect based on ground truth's statement of non-outstanding status. QUALITATIVE ACCURACY: While the LLM correctly identifies convertibility features and governance voting rights on significant transactions (merger, consolidation, exit from core payments), it fundamentally mischaracterizes the evolution of Class B-2's role. Ground truth emphasizes a transformation from 'active governance and conversion position to a non-outstanding status,' while LLM suggests an expansion from zero to 49 shares with maintained governance influence. MULTI-HOP REASONING: The LLM fails to properly synthesize the key finding that Class B-2 moved from a potential/described structure in 2023 to a non-outstanding status in 2024, instead claiming new issuance occurred. CONTEXTUAL RELEVANCE: The answer addresses the right company (Visa) and timeframe (2023-2024) but fundamentally misrepresents the evolution of Class B-2's status, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 477,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "In fiscal 2023 Home Depot’s “ease‑of‑shopping” plan centered on adding digital and in‑store conveniences such as way‑finding signage, store‑refresh packages, self‑service lockers, curbside pickup, electronic‑shelf‑label capabilities, re‑designed front‑end and checkout layouts, expanded self‑checkout and a mobile‑app that provides store‑specific maps, together with website upgrades that improved search, navigation, product content and checkout speed (2023 pages 9‑8). In fiscal 2024 the company deepened that strategy—spending $3.5 billion on capex to broaden self‑checkout, mobile‑app navigation and omnichannel pickup programs (BOSS, BOPIS, BODFS, BORIS), while also deploying new associate‑focused digital tools (hdPhone devices, Sidekick and computer‑vision inventory assistance) and further integrating stores into a seamless online‑offline fulfillment network (2024 pages 9‑8‑6‑10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and specific information than the ground truth answer. STRENGTHS: (1) Correctly identifies 2023 initiatives (mobile app store navigation, electronic shelf labels, self-checkout, curbside pickup, website improvements) that align with ground truth. (2) Accurately captures 2024 expansion with specific capex figure of $3.5 billion and detailed omnichannel programs (BOSS, BOPIS, BODFS, BORIS). (3) Introduces additional 2024 details (hdPhone devices, Sidekick, computer-vision inventory assistance) that represent legitimate enhancements beyond ground truth scope. (4) Correctly identifies the evolution from basic convenience features to more integrated omnichannel fulfillment. (5) Provides specific page references to source documents. MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'personalized digital experiences' and 'customer product review summaries' as 2024 additions, which the LLM answer does not explicitly mention. However, the LLM answer's focus on 'seamless online-offline fulfillment network' and associate-focused tools represents a different but complementary perspective on 2024 strategy evolution. (2) The ground truth mentions 'data-driven insights' and 'personalized expectations' as a strategic shift, while the LLM answer emphasizes operational/technical implementations. These are not contradictory but represent different angles of the same evolution. QUANTITATIVE VERIFICATION: The $3.5 billion capex figure is specific and appears credible for a major retailer's digital transformation investment. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 fiscal years, correctly identifying the progression from basic convenience features to integrated omnichannel capabilities. The comparison between years is logically sound and well-structured. SEMANTIC EQUIVALENCE: While the LLM answer provides more operational detail than the ground truth, it captures the core evolution: from basic digital/in-store conveniences to deeper integration and personalization. The answer is more comprehensive and specific than ground truth without being contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 597,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "In the 2022 filing the Long‑Term Incentive Plan was described as providing **price‑vested stock options, restricted‑stock units, performance‑based RSUs, performance‑share units and non‑employee director stock‑option and RSU awards** (see Exhibit list showing Forms U, V, W, X, Y and Z)【page_68】.  \nBy the 2024 filing the same core awards remain, but the plan now also includes **cliff‑vested RSU agreements and a new performance‑award performance‑share‑unit agreement**, and it references the 2022 SPP I and SPP II plan statements as part of the LTIP (see Exhibit list showing Forms 10.4.5* and 10.4.6* in addition to the earlier RSU, performance‑RSU and performance‑share‑unit forms)【page_73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Target Corporation's Long-Term Incentive Plan evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies all major equity award forms from 2022 (price-vested stock options, restricted stock units, performance-based RSUs, performance share units, non-employee director awards), matching the ground truth. (2) Accurately identifies the new forms introduced by 2024 (cliff-vested RSU agreements and performance award performance share unit agreement), which aligns with the ground truth's statement about plan expansion. (3) Properly synthesizes the multi-hop information by comparing the two years and highlighting both continuity and evolution. (4) Provides specific exhibit references and page numbers, adding credibility. (5) Uses appropriate terminology and formatting. MINOR WEAKNESSES: (1) The LLM answer mentions 'SPP I and SPP II plan statements' as part of the LTIP in 2024, which is not explicitly mentioned in the ground truth answer. While this may be accurate from the filing, it represents additional detail not in the ground truth that could be considered either supplementary information or a minor deviation. (2) The ground truth explicitly mentions 'Non-Qualified Stock Options' as a 2022 form, while the LLM answer uses 'price-vested stock options' - these appear to be related but the LLM may have conflated or simplified the terminology. The ground truth lists both separately. (3) The answer could have been slightly more explicit about the distinction between non-employee director awards and regular employee awards. QUANTITATIVE ACCURACY: All dates (2022, 2024) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about plan evolution is sound and properly synthesizes information across the two filing years. The identification of new vs. existing forms is accurate. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about structural evolution and specific equity award forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 551,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was first cleared by the FDA in September 2021 for episodic migraine, but recorded no sales that year (U.S. and international net revenues shown as “‑” in the 2021 product table)【page_62】. In 2022 it generated about $158 million of U.S. net revenue (with essentially no international sales)【page_42】, and by 2023 total net revenue had risen to roughly $408 million (U.S. $405 million + $3 million abroad)【page_42】, a rise of more than 100% year‑over‑year driven by strong market‑share uptake and the April 2023 FDA approval for chronic migraine【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FDA approval in September 2021, zero revenue in 2021, $158 million U.S. revenue in 2022, and $408 million total revenue in 2023 ($405M U.S. + $3M international). The calculation of >100% year-over-year growth from 2022 to 2023 is accurate ($158M to $408M represents approximately 158% growth). The multi-hop synthesis is sound, correctly tracing Qulipta's commercial evolution across three years and two companies' fiscal disclosures. The answer appropriately identifies the FDA approval date and indication (episodic migraine prevention in adults), and adds valuable context about the April 2023 FDA approval for chronic migraine, which explains the strong 2023 performance. The entity identification is correct (Qulipta, AbbVie, FDA). The only minor distinction from the ground truth is that the LLM answer provides slightly more analytical depth by explaining the growth driver (chronic migraine approval), which enhances rather than detracts from accuracy. The answer properly addresses all components of the question regarding commercial performance evolution from 2021 through 2023. Citation references to specific pages add credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 364,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2020 Stock Plan is mentioned only in the exhibit index – it appears as “2020 Stock Plan” (Exhibit 10.4†) and the related “Form of Stock Option Agreement under the 2020 Stock Plan” (Exhibit 10.12†) are listed, but the filing contains no narrative description or activity tables for the plan【page_65】【page_66】.  \n\nBy the 2024 filing, Netflix describes the plan in the body of the report, stating that the “Netflix, Inc. 2020 Stock Plan is a stockholder‑approved plan that provides for the grant of incentive stock options … and for the grant of non‑statutory stock options, stock appreciation rights, restricted stock and restricted stock units to employees, directors and consultants”【page_60】, and it now discloses detailed equity‑compensation activity—including tables of options outstanding, granted, exercised and expired, intrinsic value of exercises, and related stock‑based compensation expense and RSU activity【page_61】.  \n\nThus, the disclosure evolved from a simple exhibit reference in 2022 to a full structural description and quantitative reporting of the plan’s equity‑compensation activities in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 filing approach as exhibit-only reference with no narrative description, citing specific exhibit numbers (10.4 and 10.12) and page references. (2) Accurately describes the 2024 evolution to include detailed structural description with specific plan provisions (incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, and RSUs). (3) Properly synthesizes the multi-hop comparison showing the progression from documentation-only to comprehensive operational disclosure. (4) Correctly identifies the specific equity compensation activities disclosed in 2024 (options outstanding, granted, exercised, expired, intrinsic value, RSU activity). (5) Uses appropriate page citations (page_60, page_61, page_65, page_66) that support the narrative. (6) The semantic meaning matches ground truth perfectly - both convey the shift from 'mere documentation' to 'comprehensive disclosure.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes additional plan elements like stock appreciation rights), but this represents enhancement rather than error. The answer fully addresses all parts of the multi-part question: structural description evolution, disclosure treatment changes, and associated equity compensation activities. The reasoning is sound and the synthesis across 2022 and 2024 filings is logically coherent. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 444,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "In the 2022 filing the company said its aluminum purchase agreements were “derivative instruments for accounting purposes” whose quantities simply offset and were priced at prevailing market rates, with no explicit hedge‑accounting treatment noted (see page 122). By the 2023 filing the firm tied those same contracts to a long‑term strategic‑sourcing and non‑U.S. business objective and listed them in the derivative tables, showing commodity contracts both designated as hedging instruments and as non‑hedged contracts—indicating a shift to using the aluminum agreements as cash‑flow hedges (see pages 103 and 102).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) REVERSED TIMELINE: The LLM claims 2022 described agreements as 'derivative instruments' with offsetting quantities at market prices, while 2023 added strategic sourcing language. The ground truth states the OPPOSITE - 2022 described them as derivatives for strategic sourcing, and 2023 added the offsetting/market pricing clarity. This is a critical reversal of the evolution described. (2) INCORRECT HEDGE CLASSIFICATION: The LLM claims 2023 showed a 'shift to using aluminum agreements as cash-flow hedges' with 'designated as hedging instruments.' The ground truth makes no mention of hedge accounting designation or a shift to cash-flow hedges - it only notes 'refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.' The LLM appears to have invented hedge accounting treatment not supported by the ground truth. (3) PAGE REFERENCES: The LLM cites specific pages (122, 103, 102) which cannot be verified against the ground truth and appear to be fabricated details. (4) MISSING CORE INSIGHT: The ground truth emphasizes the evolution toward 'market pricing alignment' and 'offsetting positions' as a refinement strategy. The LLM completely misses this key strategic evolution and instead focuses on hedge accounting treatment that isn't mentioned in the ground truth. (5) SEMANTIC INVERSION: The LLM's description of the evolution is backwards - it describes 2022 as having market pricing language and 2023 as adding strategic sourcing language, when the ground truth indicates the opposite progression. This represents a fundamental misunderstanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 478,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "In the 2023 Form 10‑K BNY Mellon disclosed its Directors’ Code of Conduct with a full URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and a statement that the code “applies to all directors of BNY Mellon.” The 2024 filing still makes the same applicability statement but updates the hyperlink to a revised path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) and nests the disclosure together with the employee Code of Conduct, making the code’s location on the website more streamlined while leaving its scope unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 URL and confirms the URL change in 2024, which aligns with the ground truth. However, there are significant issues with completeness and accuracy: (1) The LLM provides an incomplete/incorrect 2024 URL - it states 'bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' without the full domain prefix, whereas the ground truth shows the complete URL should be 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf'. This is a material error in the URL path itself (missing '/content/dam/' and using 'bny.com' instead of 'bnymellon.com'). (2) The LLM completely omits the critical new development mentioned in the ground truth: the introduction of a new 'INSIDER TRADING POLICIES AND PROCEDURES' section in 2024 that was not present in 2023. This is a major omission that directly addresses the 'scope' aspect of the question. (3) The LLM's characterization of the change as merely 'streamlined' and 'nesting the disclosure together with the employee Code of Conduct' is not supported by the ground truth, which emphasizes the expanded focus on compliance mechanisms. (4) The LLM correctly notes the applicability statement remained the same, which is accurate. The answer addresses the accessibility aspect partially but fails to adequately address the scope expansion, which is a key component of the original question about how treatment 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 410,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023 Home Depot’s 4.95 % senior‑note program consisted of a single $750 million tranche issued in November 2023, due September 30 2026 and sold at a $1.6 million discount, giving a net carrying amount of about $744 million as of the 2023 filing【page_60】【page_59】. By the 2024 filing the original 2026 notes show a slightly higher carrying amount of $745‑$747 million (reflecting discount amortization)【page_62】, and the company added a new $1.75 billion tranche of 4.95 % senior notes due June 2034 (discount $16.7 million)【page_63】. This growth and extension of the 4.95 % series indicates that HD is deliberately expanding its low‑coupon, fixed‑rate debt and lengthening maturities to lock in inexpensive financing, diversify its debt profile and support long‑term growth and acquisition plans.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the 2026 notes had a carrying amount of ~$744M in 2023 and $745-$747M in 2024, but the ground truth states the 2024 carrying amount was $747M (the LLM's range is correct but the 2023 figure is not verified in ground truth). More critically, the LLM identifies a NEW $1.75 billion tranche of 4.95% senior notes due June 2034 with a $16.7M discount, but the ground truth makes NO mention of June 2034 notes. Instead, the ground truth explicitly states that by 2024, HD reported $980 million in 4.95% senior notes due September 2052. (2) ENTITY/STRUCTURAL ERROR: The LLM completely misidentifies the second tranche of debt. The ground truth indicates the company issued/reported 4.95% notes due September 2052 (not June 2034), and the amount was $980M (not $1.75B). This is a fundamental factual error in identifying which debt instruments were actually issued. (3) MULTI-HOP REASONING: While the LLM correctly synthesizes the concept that HD is extending maturities and locking in fixed rates, it does so based on incorrect debt instruments. The reasoning about debt strategy is sound in principle but applied to wrong data. (4) COMPLETENESS: The LLM fails to identify the correct 2052 notes that are central to the ground truth's conclusion about maturity extension strategy. The ground truth emphasizes the 2026 notes remaining outstanding with slight carrying value reduction PLUS the addition of much longer-dated 2052 notes, which is a more dramatic maturity extension than the LLM's claimed June 2034 notes. The LLM's answer demonstrates partial understanding of debt strategy but is built on incorrect factual foundations regarding which notes were actually issued.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 495,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "In 2021 Intel recorded a $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd., reflecting an upward revaluation of that investment. By the end of 2023 the investment’s net book value was $1.1 billion (the same as at the end of 2022), and the observable‑price adjustments on non‑marketable equity securities – which include the Unisoc holding – had shrunk to just $17 million in 2023 (down from $299 million in 2022).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) The $471 million observable price adjustment in 2021 is correct. (2) The $1.1 billion net book value as of December 30, 2023 (same as December 31, 2022) is correct. (3) The LLM correctly identifies the investment as a non-marketable equity security. (4) The LLM provides additional valuable context not in the ground truth answer: observable-price adjustments on non-marketable equity securities shrunk to $17 million in 2023 from $299 million in 2022. This additional detail enhances the answer by showing the broader trend in observable price adjustments across Intel's non-marketable equity portfolio. The multi-hop reasoning is sound - the answer correctly synthesizes information about the investment's treatment, valuation stability, and the changing observable price adjustments over the period. The characterization of the 2021 adjustment as an 'upward revaluation' is reasonable given the positive adjustment amount. All numbers are accurate, the timeline is correct (2021, 2022, 2023), and the entity identification (Intel, Beijing Unisoc Technology Ltd.) is precise. The answer directly addresses all aspects of the question regarding financial treatment evolution and valuation changes. Minor note: The ground truth answer doesn't explicitly mention the $17M and $299M figures, but the LLM's inclusion of these figures appears to be accurate supplementary information that strengthens the response without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 422,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022 Qulipta was already a marketed product—having been re‑classified to a developed‑product right after its earlier regulatory approval—and generated $158 million of U.S. net revenue (with no international sales) (2022 10‑K Note 7, page_100; revenue table, page_42). By 2023 AbbVie added new clearances—U.S. FDA approval for chronic migraine in April and European Commission approval in August—and U.S. sales rose to $405 million, showing an expanded commercial rollout (2023 10‑K Neuroscience section, page_40; revenue table, page_42).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. Verified facts: (1) 2022 revenue of $158 million U.S. is accurate; (2) 2023 revenue of $405 million U.S. is accurate; (3) FDA approval in April 2023 for chronic migraine prevention is correct; (4) EC approval in August 2023 for migraine prevention is correct. The LLM correctly identifies the product's evolution from reclassified asset to marketed product with expanding commercial presence. Multi-hop synthesis is sound: the answer traces Qulipta's progression across two years, connecting regulatory milestones to revenue growth. One minor discrepancy: The ground truth emphasizes that in 2022 the $1.0 billion reclassification occurred 'after regulatory approvals,' implying Qulipta had already received approval before 2022. The LLM states Qulipta was 'already a marketed product' in 2022 with 'earlier regulatory approval,' which is consistent with this interpretation but slightly less explicit about the timing of the initial approval relative to the 2022 reclassification. The LLM provides more commercial detail (specific revenue figures, geographic breakdown) than the ground truth, which adds value. The answer correctly addresses both regulatory and commercial development aspects requested in the question. No calculation errors detected. The semantic meaning aligns well with the ground truth despite different emphasis and presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 400,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "In the 2022 Form 10‑K (see page 3), Boeing simply listed “upgrades and conversions” as one line‑item in the Global Services portfolio – a neutral description among many other services. By the 2023 filing (see page 3 for the unchanged Business description and page 5 for the Competition narrative), the same phrase still appears, but the discussion now spotlights “modifications and upgrades” as a key capability for winning business, effectively shifting the strategic framing toward upgrades (and dropping the explicit mention of conversions) as a growth focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in its core analysis despite some correct elements. CORRECT ELEMENTS: (1) The answer correctly identifies that 'upgrades and conversions' appeared in both 2022 and 2023 filings; (2) The answer correctly notes that the framing evolved between the two years; (3) The answer appropriately references specific page numbers (pages 3 and 5). CRITICAL ERRORS: (1) The LLM claims that the 2023 filing shifted focus to 'modifications and upgrades' while 'dropping the explicit mention of conversions' - this contradicts the ground truth, which states that 'upgrades and conversions' remained included in 2023, just with different strategic positioning. The LLM appears to have misread the filing language; (2) The LLM's characterization of the shift as 'spotlighting modifications and upgrades as a key capability for winning business' is not supported by the ground truth, which describes a more subtle shift toward positioning it as a 'core capability' within a 'more structured narrative' about sustaining aerospace platforms; (3) The LLM's claim that conversions were 'dropped' in 2023 is factually incorrect - the ground truth explicitly states the service 'was still included' in 2023. MULTI-HOP REASONING ASSESSMENT: The question requires synthesizing language evolution across two years of filings. The LLM failed to accurately synthesize the actual evolution described in the ground truth. The ground truth emphasizes a shift from 'general and lacked strategic framing' to 'more integrated and strategic role,' whereas the LLM incorrectly claims a shift in terminology (from 'upgrades and conversions' to 'modifications and upgrades'). This represents a fundamental misunderstanding of the filing content. The answer demonstrates poor document synthesis and appears to have fabricated details about terminology changes that don't align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 514,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel recorded its interest in Beijing Unisoc Technology Ltd. as a non‑marketable equity security.  In 2021 the stake was carried at $1.1 billion and Intel recognized a $471 million observable‑price adjustment that year, raising the investment’s carrying amount【page_52】.  By the end of 2022 and again at year‑end 2023 the net book value of the Unisoc investment remained $1.1 billion, indicating that after the 2021 adjustment the valuation was unchanged【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Verification of key facts: (1) Beijing Unisoc Technology Ltd. correctly identified as Intel's investment; (2) $1.1 billion net book value correctly stated for both 2021 and 2023; (3) $471 million observable price adjustment in 2021 correctly cited; (4) The characterization as a non-marketable equity security is accurate and adds helpful context. Multi-hop reasoning is sound: the answer correctly synthesizes information across multiple years (2021, 2022, 2023) and identifies the key evolution - a significant revaluation in 2021 followed by stabilization. The answer appropriately notes that the 2023 filing did not mention explicit observable price adjustments, suggesting stabilization. Minor observation: The LLM mentions 'end of 2022' but the ground truth specifically references December 30, 2023 from the 2023 filing and December 25, 2021 from the 2022 filing - however, the LLM's reference to 2022 year-end is not contradicted by the ground truth and represents reasonable inference about the investment's trajectory. All numeric values are correct, calculations are accurate, and the semantic meaning matches the ground truth perfectly. The answer directly addresses how the relationship 'evolved' by showing the 2021 adjustment event followed by stability, which is the core insight of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 381,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "In fiscal 2023 Home Depot first highlighted self‑service lockers as a store‑refresh investment that gave shoppers a convenient front‑entrance spot for picking up online orders and helped launch its “interconnected shopping experience” 【page_8】. By fiscal 2024 the lockers were no longer a new add‑on but a core piece of a broader omnichannel fulfillment suite—listed alongside BOSS, BOPIS, BODFS and BORIS and paired with curb‑side pickup—to further streamline the frictionless, end‑to‑end shopping journey across stores, online and delivery 【page_9】【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Self-Service Lockers from a convenience feature in 2023 to a core omnichannel component in 2024, and accurately mentions the associated fulfillment programs (BOSS, BOPIS, BODFS, BORIS). The qualitative narrative about the shift from 'new add-on' to 'core piece' aligns well with the ground truth's characterization of moving from 'convenience-focused feature to core component of omnichannel delivery strategy.' However, there is a critical omission: the LLM answer completely fails to include the specific quantitative metric that the ground truth emphasizes—that approximately 50% of U.S. online orders were fulfilled through stores in 2024. This is a significant factual gap, as the ground truth explicitly highlights this statistic as evidence of the 'more integrated and operationally significant role' of Self-Service Lockers. The LLM correctly identifies the fiscal years (2023 and 2024), the company (Home Depot), and the relevant fulfillment programs, demonstrating sound multi-hop reasoning across the two years. The semantic equivalence is strong regarding the evolution narrative, but the missing quantitative data represents a material incompleteness in addressing the full scope of how the role evolved. The answer would have scored 8-9 if the 50% fulfillment metric had been included.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 377,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "In the 2023 filing Costco explained that insurance/self‑insurance liabilities are “estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions,” and warned that the accruals could change if future claims or expenses differ from those assumptions. The 2024 filing expands on that description – it still cites the same actuarial inputs but adds that claim costs are “highly unpredictable” because of inflation, regulatory or legal changes and other unforeseen developments, and it notes that historically adjustments have been immaterial, making the disclosure more detailed and specific than in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual inversion that contradicts the ground truth. The LLM claims that in 2023, Costco already disclosed 'historical claims experience, demographic factors, severity factors, and other actuarial assumptions' - but the ground truth explicitly states that in 2023, Costco 'did not specify the factors used in estimating liabilities' and only provided 'a general description.' The LLM then claims 2024 'still cites the same actuarial inputs' - which is incorrect because those specific inputs were NOT cited in 2023 according to the ground truth. This represents a major mischaracterization of the evolution of disclosure. The LLM correctly identifies that 2024 added discussion of unpredictability and specific factors like inflation and regulatory changes, but this is presented as an expansion of already-detailed 2023 language, when in fact 2023 lacked this specificity entirely. The LLM also correctly notes that 2024 mentions historical adjustments being immaterial, which aligns with the ground truth's mention of 'potential for significant differences between actual and recorded liabilities.' However, the core claim about what was disclosed in 2023 is backwards - the LLM suggests 2023 had detailed actuarial methodology when it actually had only general descriptions. This is a semantic and factual reversal of the key finding about how disclosure evolved. The answer fails to capture the 'meaningful increase in transparency' that occurred because it incorrectly suggests the detailed methodology was already present in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 436,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "In the 2022 filing the company said that the rise in cost of sales was partly offset by a **lower incremental acquisition‑related charge for fair‑value inventory adjustments tied to the 2021 Aldevron acquisition** (the $59 million inventory impact recorded in 2021 was reduced)【page_46】. By contrast, the 2023 filing disclosed a **$87 million inventory charge in Q2, mainly from excess inventory in the Biotechnology segment**, indicating a larger inventory‑related cost impact than the modest, reduced effect seen in 2022【page_46】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $87 million inventory charge in Q2 2023 related to excess inventory in the Biotechnology segment is accurate. (2) The identification of the shift from acquisition-driven to operational inventory challenges is conceptually sound. (3) The general narrative structure comparing 2022 to 2023 is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM mischaracterizes the 2022 impact by stating it was a 'reduced' effect from the prior year ($59M in 2021 reduced to something less in 2022). The ground truth clearly states that in 2022, the Aldevron acquisition contributed a $59 million increase in cost of sales - this is the 2022 figure, not a reduction from 2021. (2) The phrasing 'the $59 million inventory impact recorded in 2021 was reduced' is misleading and incorrect - the ground truth indicates $59M was the 2022 impact, not a reduction of a 2021 figure. (3) The LLM's characterization of the 2022 charge as 'modest, reduced effect' contradicts the ground truth which presents $59M as a significant acquisition-related charge in 2022. MULTI-HOP REASONING: The LLM correctly synthesizes that there was a shift between years and identifies both the 2022 and 2023 figures, but the interpretation of what happened in 2022 is fundamentally flawed. The comparison between $59M (2022) and $87M (2023) should show an increase in absolute terms, but the LLM frames 2022 as a 'modest, reduced' impact, which misrepresents the data. QUANTITATIVE ACCURACY: While both numbers ($59M and $87M) are mentioned, the contextual interpretation of the $59M figure is incorrect, reducing the quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 460,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Costco’s accounting for shop‑card balances did not change from 2023 to 2024 – the company still records outstanding shop‑card amounts as a liability “net of estimated breakage” and recognizes revenue only when cards are redeemed, with the net liability shown in other current liabilities [page_48]. This continuity signals a consistent, prudent approach that treats unredeemed balances as breakage and reduces the liability accordingly.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misinterpretation of the question and ground truth. CRITICAL ERROR: The LLM states that 'Costco's accounting for shop-card balances did not change from 2023 to 2024,' which directly contradicts the ground truth that indicates an evolution/refinement in the approach. The ground truth explicitly states 'the specific mention of estimated breakage and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach.' The LLM missed this key distinction entirely. WHAT WAS CORRECT: The LLM accurately describes the mechanics of shop card accounting (revenue recognized upon redemption, liability net of estimated breakage, shown in other current liabilities). The reference to page 48 is appropriately cited. WHAT WAS INCORRECT: (1) The LLM claims no change occurred when the ground truth indicates a meaningful evolution in emphasis and formalization of methodology; (2) The LLM characterizes the approach as merely 'consistent' rather than 'refined' or 'improved,' missing the nuance of enhanced estimation techniques; (3) The LLM fails to address the question's core inquiry about how treatment 'evolved' - it instead argues for continuity. MULTI-HOP REASONING: The LLM failed to synthesize the comparative analysis between 2023 and 2024 that the question explicitly requires. The answer reads as a single-year snapshot rather than a year-over-year comparison. SEMANTIC ISSUE: While the LLM's description of the accounting mechanics is accurate, it fundamentally misses the evolution narrative that is central to both the question and the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 452,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "In 2022 Intel introduced Intel Foundry Services (IFS) as a new pillar of its IDM 2.0 strategy, emphasizing the creation of a world‑class foundry business with dedicated U.S. and European capacity, advanced packaging, and a broad IP portfolio, but the filing only described the strategic intent and internal capabilities (2022 10‑K pp. 7‑9). By 2023 the IFS model had matured into an ecosystem: the IFS Accelerator Alliance doubled to > 40 strategic agreements, Intel signed multigenerational deals with ARM and a definitive agreement with Synopsys, expanded the DoD RAMP‑C program to include customers such as Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, and secured a commercial foundry contract with Tower for 300 mm advanced analog processing (2023 10‑K pp. 36‑37).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall evolution of Intel's Foundry Services from 2022 to 2023, correctly identifying the shift from strategic intent to concrete engagements. However, there are significant discrepancies with the ground truth that warrant careful evaluation:\n\nCORRECT ELEMENTS:\n- Correctly identifies IFS as part of IDM 2.0 strategy in 2022\n- Accurately notes the 2022 focus on strategic intent and capabilities\n- Correctly states the IFS Accelerator Alliance expanded to >40 strategic agreements in 2023\n- Correctly mentions multigenerational agreements with ARM and Synopsys\n- Properly characterizes the evolution from intent to concrete engagements\n- Appropriate page citations (2022 10-K pp. 7-9, 2023 10-K pp. 36-37)\n\nINCORRECT/MISSING ELEMENTS:\n- The ground truth specifically mentions \"four design wins on Intel 18A, including a major high-performance computing customer\" - the LLM answer does not mention these design wins at all\n- The ground truth mentions \"five new design wins in advanced packaging, particularly for AI-related designs\" - completely absent from LLM answer\n- The LLM answer introduces information about DoD RAMP-C program expansion with Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman - this is NOT mentioned in the ground truth and appears to be either fabricated or from a different source\n- The LLM answer mentions a \"commercial foundry contract with Tower for 300 mm advanced analog processing\" - this is also NOT in the ground truth\n\nQUANTITATIVE ACCURACY ISSUES:\n- The claim about IFS Accelerator Alliance \"doubling\" to >40 is not explicitly stated in ground truth (which only says \"expanded to over 40\")\n- Missing specific design win numbers (4 on Intel 18A, 5 in advanced packaging)\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the 2022-to-2023 evolution and identifies the key strategic shift. However, the introduction of unverified information (DoD RAMP-C details, Tower contract) suggests either hallucination or reliance on information not in the ground truth knowledge graph.\n\nOVERALL ASSESSMENT:\nWhile the LLM captures the main narrative arc correctly, it fails to include critical quantitative details about design wins that are central to demonstrating the evolution from intent to concrete customer engagement. Additionally, the introduction of unverified information about DoD RAMP-C and Tower contracts raises concerns about factual accuracy beyond the ground truth baseline. The answer is partially correct but incomplete on key metrics and potentially contains fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 692,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Danaher said the Aldevron purchase generated about **$6.1 billion of goodwill** and was funded with an **approximately $9.6 billion cash purchase price** (see page 83). The 2023 filing now records the same deal with **$6.149 billion of goodwill** and a **net cash consideration of $9.561 billion** (see page 74), reflecting a modest rise in goodwill and a slight dip in the cash outlay.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT: The 2022 goodwill figure of $6.1 billion is accurate, the 2023 goodwill of $6.149 billion is accurate, and the 2023 net cash consideration of $9.561 billion is accurate. The company identification (DHR/Danaher) and acquisition identification (Aldevron) are correct. PROBLEMATIC: The LLM states the 2022 cash purchase price was 'approximately $9.6 billion' but the ground truth indicates this was a preliminary assessment in 2022. More critically, the LLM characterizes the evolution as 'a slight dip in the cash outlay' when comparing the 2022 figure (~$9.6B) to the 2023 figure ($9.561B). However, the ground truth explicitly states 'the net cash consideration for Aldevron increased to $9.561 billion,' suggesting an increase rather than a decrease. This represents a fundamental misinterpretation of the financial evolution. The LLM also describes the goodwill change as 'modest' when it actually increased from $6.1B to $6.149B (approximately $49 million increase), which is indeed modest but the characterization of the cash consideration direction is inverted. The multi-hop reasoning is partially sound - the LLM correctly synthesizes information across 2022 and 2023 filings and identifies the key metrics - but the interpretation of the directional change in cash consideration contradicts the ground truth's explicit statement that it 'increased.' This is a significant analytical error that affects the core conclusion about how the financial impact 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 424,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The 1.800 % Global Notes listed in AT&T’s 2022 Form 10‑K were due September 5 2026 (with a separate series due September 14 2039) and the 2024 Form 10‑K shows the same two maturity dates for those series【T_10k_2022.pdf page_2】【T_10k_2024.pdf page_2】.  The unchanged schedule indicates that AT&T has retained its existing medium‑ and long‑term fixed‑rate debt, reflecting a stable, long‑dated debt structure rather than a shift toward shorter‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Critical errors: (1) FACTUAL ERROR - The LLM claims there were TWO separate series of 1.800% Global Notes in 2022 (one due Sept 5, 2026 and another due Sept 14, 2039), but the ground truth clearly states that in 2022, the maturity date was September 5, 2026 only. The September 14, 2039 date appears in the 2024 filing, not 2022. (2) MISINTERPRETATION OF CHANGE - The LLM incorrectly concludes the debt structure is 'unchanged' and 'stable,' when the ground truth indicates a significant 13+ year extension of the maturity date for this specific note class from 2026 to 2039. This is a major structural change, not stability. (3) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the comparison between 2022 and 2024 filings. It appears to have conflated information from both years rather than identifying the actual change that occurred. (4) CONTRADICTORY CONCLUSION - The LLM's interpretation that this represents 'stable, long-dated debt structure' directly contradicts the ground truth's assessment that this represents 'a significant shift' in debt structure. The dates are correct (Sept 5, 2026 and Sept 14, 2039 are accurate), but their assignment to the respective years is wrong, and the analytical conclusion is inverted from the correct interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 378,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target said it was “in compliance” with its debt‑leverage covenant in both years – the 2023 filing notes that “We are, and expect to remain, in compliance with these covenants” 【page_54】 and the 2024 filing repeats the same statement 【page_35】.  The underlying credit‑facility structure was adjusted: in October 2023 Target replaced its prior 364‑day revolving line with a new $1.0 billion 364‑day facility (expiring Oct 2024) and extended its existing $3.0 billion five‑year revolving facility to Oct 2028 【page_54】; in October 2024 it again renewed the $1.0 billion 364‑day facility (now expiring Oct 2025) while keeping the $3.0 billion facility through 2028 【page_35】.  These renewals and extensions provided additional borrowing capacity that helped sustain covenant compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Target stated compliance with debt leverage covenant in both 2023 and 2024; (2) All dollar amounts are correct: $1.0 billion 364-day facility and $3.0 billion five-year facility; (3) All dates are accurate: October 2024 expiration for 2023 364-day facility, October 2025 for 2024 renewal, October 2028 for five-year facility; (4) The multi-hop synthesis is sound - the answer correctly traces the evolution of the credit facility structure across both years and explains how renewals supported covenant compliance. The LLM properly identified that in October 2023 Target renewed/extended facilities, and in October 2024 it again renewed the 364-day facility. The reasoning about how these renewals provided 'additional borrowing capacity' to sustain compliance is logical and well-supported. The answer directly addresses both parts of the question: (a) compliance evolution (compliant in both years), and (b) changes in credit facility structure (renewal and extension of facilities). The only minor observation is that the LLM's phrasing 'replaced its prior 364-day revolving line with a new $1.0 billion 364-day facility' in October 2023 is slightly more detailed than the ground truth's simpler statement about the 2023 facility structure, but this is actually a strength as it provides helpful context. The page citations add credibility. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 410,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "In 2022 Intel’s 10‑K described the RISE strategy as a high‑level pledge to work with customers and the Alliance for Global Inclusion to “accelerate the adoption of inclusive business practices… and expand digital readiness for millions of people,” but the discussion was largely aspirational. By 2023 the company had turned that pledge into concrete action—publishing the third Global Inclusion Index (recognizing 18 firms, including Intel), scaling its AI‑for‑Youth and AI‑for‑Workforce digital‑readiness programs in partnership with governments and institutions, and using the RISE Technology Initiative to fund projects that explicitly broaden digital readiness—showing a shift from a stated commitment to measurable, collaborative execution.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's approach from 2022 to 2023 and correctly identifies key elements: the RISE strategy, Alliance for Global Inclusion, the third Global Inclusion Index publication, and the shift from aspirational to concrete action. Numeric accuracy is strong: correctly states 18 recognized organizations (matching ground truth) and appropriately characterizes the progression. The answer adds valuable context about AI-for-Youth, AI-for-Workforce programs, and the RISE Technology Initiative that, while not explicitly mentioned in the ground truth, are consistent with the described evolution toward measurable execution. However, there are some minor discrepancies: (1) The ground truth specifies '27 respondents' with 18 recognized, providing a completion rate context (18/27 ≈ 67%), which the LLM omits. (2) The ground truth emphasizes the 'scoring 50% or higher' benchmark criterion for recognition, which the LLM does not mention—this is a key structural detail about how the index system works. (3) The LLM's characterization of 2022 as 'largely aspirational' is reasonable but the ground truth is more specific about the 'collaborative frameworks' focus. The multi-hop reasoning is sound: the answer correctly synthesizes information across years and identifies the progression from framework-building to performance measurement. The semantic equivalence is strong—both answers convey the same fundamental narrative of maturation from commitment to execution. The additional programs mentioned (AI-for-Youth, AI-for-Workforce, RISE Technology Initiative) enhance the answer but cannot be verified against the provided ground truth, creating minor uncertainty about completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 469,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson’s AspenTech unit moved from planning to buy Micromine (an AU $900/≈US $623 deal announced in July 2022) to cancelling that deal in August 2023, ending the relationship without paying any termination fee【page_52】. The only measurable financial effect was a $24 million mark‑to‑market foreign‑currency gain in 2023 (versus a $50 million loss in 2022) tied to forward contracts that were unwound when the acquisition was terminated, and no further cash impact appeared in 2024【page_55】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH DATES AND TIMELINE: The LLM answer contains a critical factual error regarding the announcement date. It states the deal was 'announced in July 2022,' but the ground truth indicates the acquisition agreement was entered into in 2023 with termination occurring due to Russian regulatory uncertainty. The LLM conflates the timeline by suggesting the deal was announced in 2022 and cancelled in August 2023, which contradicts the ground truth's clear statement that the agreement was in 2023 and terminated in 2024. QUANTITATIVE ACCURACY: The financial figures are partially correct - the AU$900/US$623 amount is accurate, and the $24 million mark-to-market gain in 2023 is correct. However, the LLM introduces a $50 million loss in 2022 that is not mentioned in the ground truth, which raises questions about whether this is accurate or an unsupported claim. The statement about 'no termination fee' is not explicitly confirmed in the ground truth. COMPLETENESS: The LLM answer addresses the evolution of the relationship and financial implications, but the timeline confusion undermines the answer's reliability. The ground truth clearly states the relationship evolved from 2023 (agreement entered) to 2024 (termination of forward contracts), whereas the LLM suggests a 2022-2023 timeline. MULTI-HOP REASONING: The answer attempts to synthesize information about the deal progression and financial impacts, but the temporal errors suggest the model may have confused different fiscal years or mixed information from different sources. The connection between the deal termination and the unwinding of forward contracts is correctly identified, but the timeline placement is wrong. SEMANTIC ISSUES: While the general narrative of 'planning to buy then cancelling' is correct, the specific dates and year references are materially incorrect, which is a critical flaw in a financial question requiring precise temporal accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 524,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The U.S. ESPP’s share pool shrank from roughly 17 million shares at the end of fiscal 2022 (≈ Jan 30 2022) to about 15 million shares at the end of fiscal 2023 (≈ Jan 28 2024)【page_70】.  At the same time, the average price paid for ESPP shares fell from about $305 per share to $277 per share【page_70】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key facts: (1) Share availability: Ground truth states 17 million shares in 2022 and 15 million in 2023; LLM correctly identifies these as 'roughly 17 million' and 'about 15 million' - appropriate rounding language. (2) Average purchase prices: Ground truth specifies $305.14 in 2022 and $277.19 in 2023; LLM rounds to 'about $305 per share' and '$277 per share' - acceptable rounding for summary presentation. (3) Shares purchased: Ground truth mentions 'approximately one million shares' in both years; LLM does not explicitly state the purchase quantity, which is a minor omission. (4) Multi-hop synthesis: The LLM correctly synthesizes information across multiple pages (70, 68) and identifies the fiscal year endpoints correctly (Jan 30, 2022 for fiscal 2022 and Jan 28, 2024 for fiscal 2023). (5) Trend identification: Both answers correctly identify the reduction in share availability and decrease in average purchase price. The LLM's use of approximate language ('roughly,' 'about') is appropriate given the context of summarizing financial data. The only minor weakness is the omission of the explicit statement about the number of shares purchased (~1 million in both years), but this does not significantly detract from the answer's overall accuracy and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 385,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "In the 2022 filing the company only reported impairment triggers in the Diagnostics segment (Q1 2021) and in both Diagnostics and Environmental & Applied Solutions (Q1 and Q3 2020), resulting in modest charges of $10 million (2021) and $22 million (2020) and no impairment in 2022 【page_100】. By the 2023 filing the triggers had moved to the Biotechnology segment (Q2 2023 and Q4 2023) and again to Diagnostics in Q4 2023, producing a much larger $77 million charge in 2023 while 2022 saw no impairments 【page_89】. This shift signals that risk in Danaher’s intangible‑asset portfolio is now concentrating on technology‑based intangibles in its Biotechnology business—likely driven by recent biotech acquisitions—rather than the earlier focus on Diagnostics and Environmental assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces significant factual errors not present in the ground truth. It claims impairments in Environmental & Applied Solutions segment in Q1 and Q3 2020 with $22 million charge - this is NOT mentioned in the original answer and appears to be fabricated data. The ground truth explicitly states the 2022 filing reported impairment triggers ONLY in the Diagnostics segment (Q1 2021, $10M). The LLM conflates or invents additional segments and years. (2) SEGMENT IDENTIFICATION - The LLM correctly identifies the shift to Biotechnology segment in 2023 and the $77 million charge, which matches ground truth. However, the addition of Environmental & Applied Solutions data is unsupported and contradicts the ground truth's clear statement that only Diagnostics was affected in the 2022 filing. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize the evolution pattern and draw conclusions about risk concentration, it does so based on partially incorrect data. The core insight about Biotechnology becoming a focus is correct, but the foundation is flawed. (4) COMPLETENESS - The LLM does address the comparative analysis between 2022 and 2023 filings and attempts to explain what the shift indicates, but the introduction of unsupported data (Environmental & Applied Solutions, 2020 impairments) undermines the answer's reliability. (5) VERIFICATION - Ground truth states: 2022 filing = Diagnostics only ($10M in 2021); 2023 filing = Biotechnology (Q2, Q4 2023) and Diagnostics (Q4 2023, Q1 2021 comparative) with $77M in 2023. The LLM's claim of $22M in 2020 Environmental & Applied Solutions impairments cannot be verified against the ground truth and appears to be hallucinated data. This is a critical error that significantly reduces the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 499,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The company’s outstanding letters of credit rose from $362 million at the end of 2022 (HD 10‑K 2022 p.70) to $598 million at the end of 2023 (HD 10‑K 2023 p.67), an increase of about $236 million. This jump signals that Home Depot is using more letters of credit to back its trade‑related business transactions, reflecting a larger exposure and greater involvement in contracts tied to trade activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $362 million (2022), $598 million (2023), and the calculated increase of $236 million ($598M - $362M = $236M). The calculation is accurate and properly presented. ENTITY ACCURACY: The company is correctly identified as Home Depot (HD), with proper 10-K filing references (2022 p.70, 2023 p.67), demonstrating proper source attribution. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in value between years, and (2) what this indicates about the company's involvement in trade contracts. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical change to its business implications, noting increased exposure and greater involvement in trade-related activities. The interpretation that a $236 million increase in letters of credit indicates expanded trade contract involvement is logically sound and matches the ground truth's assessment of 'growing involvement or expansion.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'using more letters of credit to back its trade-related business transactions' and 'larger exposure and greater involvement' conveys the same meaning as the ground truth's 'growing involvement or expansion in business activities tied to trade contracts.' MINOR OBSERVATION: The LLM provides additional context (specific page numbers, company name identification) that enhances clarity without introducing errors. The answer is comprehensive, accurate, and properly synthesizes information across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 444,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "In the 2023 Form 10‑K the 0.300 % Notes due 2028 are mentioned only in the exhibit list – IBM notes that “the instrument defining the rights of the holders of the 0.300 % Notes due 2028 … is Exhibit 4.1 to Form 8‑K, filed February 10 2020”【page_20】. In the 2024 Form 10‑K the same notes appear in the Section 12(b) securities‑registration table as an active security (ticker IBM28B)【page_1】. This change shows IBM’s disclosures have moved from a historical reference to an explicit, current registration of the notes, underscoring the company’s ongoing, transparent reporting of its debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about the evolution of the 0.300% Notes due 2028 between 2023 and 2024 SEC filings. STRENGTHS: (1) All numeric values are correct - the interest rate (0.300%), maturity year (2028), filing date (February 10, 2020), and ticker symbol (IBM28B) are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies the shift from 2023 (exhibit list reference) to 2024 (Section 12(b) securities registration table) and properly connects this to the underlying financial instruments disclosure. (3) Entity identification is precise - correctly names IBM, the specific notes, the relevant SEC forms (10-K, 8-K, Form 12(b)), and the NYSE listing. (4) The reasoning about what this shift indicates is logical and well-supported: moving from historical reference to active registration does suggest increased market engagement or transparency. (5) The answer includes appropriate source citations (page references). MINOR CONSIDERATIONS: The LLM answer uses slightly different framing than the ground truth - it emphasizes 'transparent reporting of debt instruments' while the ground truth emphasizes 'increased market engagement or liquidity.' Both interpretations are valid and complementary; the LLM's framing is arguably more conservative and accurate to what the data shows (explicit registration = transparent reporting). The answer is semantically equivalent to the ground truth while maintaining slightly different emphasis. No factual errors detected. The answer fully addresses both parts of the question: (1) how the status evolved, and (2) what this indicates about IBM's disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 463,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 1.750 % Notes due 2031 were disclosed only by incorporation‑by‑reference – the filing notes that the instrument defining the holders’ rights is Exhibit 4.4 to a Form 8‑K filed on January 30 2019 (see page 20). By the 2024 Form 10‑K, the same notes are listed in the Section 12(b) securities table with ticker IBM31 and shown as trading on the New York Stock Exchange (see page 1), indicating that IBM now registers the notes as an exchange‑listed security rather than merely referencing the prior 8‑K instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about IBM's treatment of the 1.750% Notes due 2031 between 2023 and 2024. STRENGTHS: (1) All numeric values are correct - the interest rate (1.750%), the maturity year (2031), the filing date (January 30, 2019), and the ticker symbol (IBM31) are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies the evolution from 2023 (incorporation by reference via Exhibit 4.4 to Form 8-K) to 2024 (formal registration under Section 12(b) with NYSE listing). (3) Entity identification is precise: IBM is correctly identified, the specific debt instrument is properly characterized, and the NYSE is correctly named. (4) The reasoning captures the key distinction between the two years - from disclosure-only to active exchange listing. (5) Page references (page 20 for 2023, page 1 for 2024) add credibility and specificity. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth (e.g., 'Section 12(b) securities table' vs. 'formally registered under a trading symbol') but the semantic meaning is equivalent and arguably more precise in citing the specific regulatory framework. The characterization of the shift from 'mere disclosure' to 'formal recognition and active listing' is accurately conveyed through the LLM's description of the transition from incorporation-by-reference to Section 12(b) registration. No calculation errors, no factual inaccuracies, and the answer fully addresses both the disclosure evolution and the registration/exchange listing aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "In 2023 Eli Lilly recorded Zyprexa’s contribution as part of net product revenue – $1.7 billion in total, driven mainly by the one‑time sale of the olanzapine‑portfolio rights that included Zyprexa [page_48]. By the 2024 filing that same rights‑sale is presented under “collaboration and other revenue,” with the company explaining that revenue from the 2023 sale of Zyprexa’s rights is now treated as a licensing/collaboration transaction and is recognized when control of the asset transfers (or the performance obligation is satisfied) rather than at product shipment [page_64][page_66]. This marks a shift from a product‑sale model to a rights‑sale/licensing business model for Zyprexa.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM states Zyprexa contributed '$1.7 billion in total' to net product revenue in 2023, but the ground truth clearly indicates $1.45 billion from the sale of olanzapine portfolio rights. This is a significant discrepancy ($250 million difference, ~17% error). The LLM provides no source justification for the $1.7B figure, and this appears to be factually incorrect. QUALITATIVE ACCURACY - PARTIALLY CORRECT: The LLM correctly identifies the core business model shift from direct product sales (2023) to licensing/collaboration revenue recognition (2024). The explanation of the shift from product shipment recognition to control transfer/performance obligation satisfaction is accurate and well-articulated. The characterization of moving from 'product-sale model to rights-sale/licensing business model' aligns with the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years and correctly identifies the revenue recognition methodology change. However, the foundational quantitative error undermines the analysis. COMPLETENESS: The answer addresses both years and the shift in revenue recognition approach, but the incorrect 2023 revenue figure is a material omission/error. The ground truth's emphasis on $1.45 billion is specific and verifiable; the LLM's $1.7 billion cannot be reconciled with provided ground truth. SEMANTIC EQUIVALENCE: While the qualitative description of the business model shift is semantically sound, the quantitative foundation is broken. The page references provided by LLM (page_48, page_64, page_66) cannot be verified against the ground truth provided, raising concerns about hallucination or misreading of source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 474,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023 AT&T was forced to recognize a redemption liability for its Mobility II preferred interests.  Because the AT&T pension‑trust notice required the company to buy back the remaining 213 million interests (≈ $5.4 billion), the interests were re‑classified from equity to a liability with about $2.67 billion recorded in current liabilities and $2.67 billion in non‑current liabilities, and the full repurchase was completed in April 2023 for $5.414 billion 【page_90†L13-L22】【page_90†L23-L27】.  For the portion of 2023 before the buy‑back, the ability to settle the interests in stock was reflected in diluted EPS (72 dilutive shares in the numerator and 71 in the denominator) 【page_53†L15-L22】【page_53†L31-L38】.  By 2024 the Mobility preferred interests had been fully repurchased, no redemption obligation remained, and they were omitted from the diluted EPS calculation (no Mobility‑interest shares shown) 【page_53†L15-L22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct: $2.67 billion in current liabilities, $2.67 billion in noncurrent liabilities, $5.414 billion repurchase price in April 2023. (2) The multi-hop reasoning is sound - the answer correctly synthesizes the evolution from 2023 to 2024, showing the reclassification from equity to liability, the redemption obligation, the April 2023 repurchase completion, and the shift to retrospective EPS treatment. (3) Entity identification is accurate: AT&T, Mobility Preferred Interests (also called Mobility II), and the correct time periods (2023 vs 2024). (4) The answer correctly explains the ASU 2020-06 treatment and how the interests were reflected in diluted EPS calculations before repurchase (72 dilutive shares in numerator, 71 in denominator) and omitted after. (5) The pension-trust notice context is appropriately included. MINOR CONSIDERATIONS: The LLM answer uses 'Mobility II preferred interests' while the ground truth uses 'Mobility Preferred Interests' - these are semantically equivalent references to the same instrument. The answer provides slightly more operational detail (213 million interests, specific EPS share counts) than the ground truth, which adds helpful context without introducing errors. The citation references to specific pages strengthen the answer's credibility. The explanation of the shift from 'active financial obligations to retrospective accounting treatment' is well-captured through the discussion of the EPS treatment change. No calculation errors detected, all dates are correct (April 2023, 2023 vs 2024 comparison), and the logical flow of the evolution is clear and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 478,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In the 2023 Form 10‑K IBM only mentioned the 0.875 % Notes due 2030 in its exhibit schedule, stating that the holders’ rights were set out in Exhibit 4.1 to a Form 8‑K filed on Feb 8 2022 (see page 20). By the 2024 filing the notes are listed in the Section 12(b) securities table with ticker IBM30A and shown as trading on the New York Stock Exchange (see page 1), indicating that IBM now treats them as a registered, listed security rather than merely an exhibit‑referenced instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about IBM's evolving treatment of the 0.875% Notes due 2030 between 2023 and 2024. STRENGTHS: (1) All key facts are correct - the 2023 disclosure via Exhibit 4.1 to Form 8-K filed February 8, 2022 is accurately stated; the 2024 listing in Section 12(b) securities table with ticker IBM30A on NYSE is correct. (2) Numeric accuracy is perfect - the percentage (0.875%), year (2030), and dates (Feb 8, 2022) all match ground truth. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution from referenced disclosure to registered/listed status across two fiscal years. (4) The semantic meaning aligns well with ground truth: both answers convey the shift from 'referenced disclosure' to 'fully listed and registered financial instrument.' (5) Page references (page 20 for 2023, page 1 for 2024) add credibility and specificity. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('exhibit-referenced instrument' vs 'referenced disclosure') but this is semantically equivalent and actually more precise. The answer is well-structured and clearly explains the evolution. No calculation errors, no missing entities, and the reasoning chain is logical and complete. The answer fully addresses all aspects of the question regarding treatment, disclosure, listing, and registration status changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 392,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "In the 2023 filing AT&T reported three series of Telco LLC preferred interests – Class A‑1 ($2 bn) paying a 4.25 % annual distribution and resetting every seven years, and Class A‑2 and A‑3 ($5.25 bn) paying 6.85 % annually and resetting on Nov 1 2027 and every seven years thereafter – for a total of $7.25 bn of preferred equity 【page_90】. The 2024 filing shows the same three series still outstanding at $7.25 bn, but adds a planned Class A‑4 issuance of $2.25 bn that will pay 5.94 % annually, reset on Nov 1 2028 and every four years, and be callable on that date 【page_89】【page_88】. This evolution – adding a new class with a distinct rate and reset schedule while retaining call and redemption features – signals that AT&T is using cumulative non‑convertible preferred interests as a flexible financing tool, tailoring terms to raise capital and manage liquidity without restricting common‑stock dividends or repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the question's structure. Key issues: (1) QUANTITATIVE ERRORS: The LLM states 2023 had $7.25 bn total ($2 bn + $5.25 bn), but the ground truth clearly indicates $7.25 bn total ($2,000 + $5,250 in millions, not billions). The LLM appears to have confused millions with billions throughout. The ground truth shows $2,000 million (Class A-1) + $5,250 million (Class A-2/A-3) = $7,250 million total, not $7.25 billion. (2) MISSING INFORMATION: The LLM introduces a Class A-4 issuance ($2.25 bn at 5.94%) that is NOT mentioned in the ground truth answer. This appears to be fabricated or from a different source not validated by the knowledge graph. The ground truth makes no mention of a planned Class A-4 issuance. (3) RESET SCHEDULE DISCREPANCY: The LLM states Class A-2/A-3 reset on 'Nov 1 2027 and every seven years thereafter,' but the ground truth simply states they reset 'every seven years' without specifying a November 1 date. (4) CORRECT ELEMENTS: The LLM correctly identifies the three series (A-1, A-2, A-3), the 4.25% and 6.85% rates, the seven-year reset cycles for A-1 and A-2/A-3, and the general financing strategy interpretation. (5) MULTI-HOP REASONING: The LLM's synthesis of how AT&T uses preferred equity as a flexible financing tool is sound and well-reasoned, matching the ground truth's conclusion about continued reliance on preferred equity. However, the introduction of unvalidated Class A-4 information significantly compromises the answer's reliability. The magnitude error (millions vs. billions) is particularly problematic for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 458,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One continues to originate multifamily commercial‑real‑estate loans for sale to the government‑sponsored enterprises and to retain risk through loss‑sharing agreements, but the amount of that retained risk rose sharply – the liability for loss‑sharing agreements grew from $82 million at 12/31/2022 to $137 million at 12/31/2023, a $55 million increase【page_216】.  Multifamily CRE loans remain a material part of its loan portfolio (about 12‑13 % of loans held for investment in the most recent disclosed period)【page_99】, indicating that while the overall involvement is steady, the exposure to potential losses under the GSE loss‑sharing arrangements has increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: the liability increased from $82 million (12/31/2022) to $137 million (12/31/2023), representing a $55 million increase. The calculation of the difference is accurate. The answer correctly identifies Capital One as the company, the correct fiscal years (2022-2023), and the proper financial metrics (loss sharing agreement liabilities). The multi-hop reasoning is sound - the model synthesizes information about Capital One's involvement in multifamily CRE loans, their sale to GSEs, and the corresponding risk exposure through loss sharing agreements. The answer goes beyond the ground truth by adding contextual detail about multifamily CRE loans representing 12-13% of loans held for investment, which provides additional relevant context about the materiality of this business line. The semantic meaning matches the ground truth perfectly - both convey that Capital One's risk exposure under loss sharing agreements increased significantly between 2022 and 2023. The only minor distinction is that the LLM answer provides slightly more nuanced interpretation (noting that 'overall involvement is steady' while 'exposure to potential losses has increased'), which is a reasonable inference from the data and adds value without contradicting the ground truth. All entities are correctly identified and the temporal sequence is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 397,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "In the 2022 filing Amazon only warned that its co‑branded credit‑card programs “could adversely affect our operating results if renewed on less favorable terms or terminated” (2022 10‑K p. 13). By the 2023 filing the company added that these programs are now subject to “additional regulations and compliance requirements (including obligations to implement enhanced authentication processes)” and to stricter payment‑card association rules, which could raise costs, trigger fines and materially impact operating results (2023 10‑K p. 14). The language therefore shifts the programs from a peripheral contractual‑risk item in 2022 to a strategically significant service that now carries new compliance obligations and heightened regulatory risk in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core shift in Amazon's co-branded credit card programs from 2022 to 2023, accurately capturing that 2022 focused on contractual renewal risks while 2023 added compliance obligations. The answer correctly cites specific page numbers (2022 10-K p. 13, 2023 10-K p. 14) and accurately quotes the 2022 language about adverse effects from unfavorable renewal or termination. The identification of 'enhanced authentication processes' as a new 2023 compliance requirement is accurate. The characterization of the strategic shift from 'peripheral contractual-risk item' to 'strategically significant service' is well-reasoned.\n\nWEAKNESSES: (1) The LLM answer mentions 'stricter payment-card association rules' in 2023 but does not specifically address the data localization rules that the ground truth identifies as a key new regulatory risk in 2023. This is a significant omission because data localization represents a material expansion of regulatory scope, particularly for international jurisdictions. (2) The answer references 'enhanced authentication processes' but the ground truth emphasizes data localization rules as the primary new compliance obligation, suggesting the LLM may have identified a secondary compliance element rather than the primary one. (3) The ground truth explicitly notes that data localization rules 'were not mentioned in 2022,' highlighting this as a critical new development, but the LLM answer does not make this distinction clear. (4) The ground truth emphasizes the international/cross-border data transfer dimension of the new risks, which the LLM answer does not explicitly address.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023 filings and identifies the temporal shift in regulatory focus. However, it appears to have missed or underweighted the data localization component that represents the most significant expansion of regulatory scope between the two years.\n\nNUMERIC/FACTUAL VERIFICATION: Page numbers and quoted language appear accurate based on the ground truth context. No calculation errors present. The characterization of risk escalation is reasonable but incomplete regarding the specific nature of new compliance obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 606,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "In the 2022 filing PMI still treated Rothmans, Benson & Hedges (RBH) as a de‑consolidated subsidiary – it had been removed from the consolidated balance sheet in March 2019 and was carried only as an equity security with no readily determinable fair value, the de‑consolidation being reflected in other‑comprehensive‑loss reclassifications (see 2022 Note 20/Note 16, p. 113‑112). By the 2024 filing PMI continued not to consolidate RBH, but it performed a quantitative fair‑value assessment of the equity investment, concluded the carrying amount exceeded fair value, recorded a $2.316 bn non‑cash impairment and reported the remaining stake at an estimated $714 mn fair value based on a discounted‑cash‑flow analysis (see 2024 Note 6 and the Critical Audit Matters discussion, p. 147‑148). This shows the relationship evolving from a simple de‑consolidated equity holding to an actively valued and impaired investment in PMI’s consolidated statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PM's evolving relationship with RBH between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2019 deconsolidation date and explains RBH's status as a deconsolidated equity holding in 2022; (2) Accurately cites the 2024 impairment charge of $2.316 billion and the resulting fair value estimate of $714 million; (3) Properly synthesizes the evolution from simple equity holding to actively valued/impaired investment; (4) References appropriate filing sections (Note 20/16 for 2022, Note 6 and Critical Audit Matters for 2024); (5) Explains the shift in valuation methodology from no readily determinable fair value to discounted cash flow analysis. MINOR GAPS: (1) The original answer mentions the CAD 3.1 billion allocation of compensatory damages from Canadian tobacco litigation, which the LLM answer omits entirely - this is a material contextual detail about potential impacts on RBH's valuation; (2) The LLM answer doesn't explicitly mention the judgment considerations around discount rates, sales volumes, operating margins, and tax treatment of global settlement that the original answer highlights as part of the audit emphasis; (3) The original answer frames the relationship as shifting from 'deconsolidated subsidiary' to 'equity investment requiring impairment analysis,' while the LLM frames it as 'deconsolidated equity holding' to 'actively valued and impaired investment' - semantically similar but the original emphasizes the valuation judgment aspect more. QUANTITATIVE VERIFICATION: The $2.316 billion impairment and $714 million fair value figures appear consistent with typical PMI filings and are presented with appropriate precision. The 2019 deconsolidation date is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the consolidation status change and valuation methodology evolution. The reasoning is sound and logically structured. The omission of the Canadian litigation context and impairment judgment factors prevents a perfect score, as these are material to understanding the full evolution of the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 600,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "In 2023 Baqsimi moved from a modest product line to a fast‑growing one, delivering $677.6 million of net product revenue (U.S. $645.7 m + outside‑U.S. $31.9 m) and generating $579 million of cash from the sale of its rights, which together boosted Lilly’s total revenue (see pages 48 and 47). By 2024 the product no longer appears in net product revenue; the Baqsimi rights‑sale proceeds are instead reflected in the $4.3 billion of “collaboration and other revenue,” indicating that Lilly has shifted Baqsimi from an ongoing sales driver to a monetized asset within its portfolio (see page 64). This transition marks a strategic repositioning from a revenue‑generating product in 2023 to a cash‑generating transaction in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative of Baqsimi's transition from a direct product revenue contributor in 2023 to a divested asset in 2024, and accurately cites the 2023 revenue figures ($677.6M total, $645.7M U.S., $31.9M outside U.S.). However, there is a significant quantitative error: the LLM states that the sale of Baqsimi rights generated '$579 million of cash from the sale of its rights' in 2023. This number does not appear in the ground truth and appears to be either fabricated or misattributed. The ground truth makes no mention of a $579M cash figure associated with the rights sale. The LLM correctly notes that Baqsimi no longer appears in direct product revenue in 2024 and is instead reflected in collaboration and other revenue, which aligns with the ground truth's statement about the 'sale of rights' disclosure. The reasoning about the strategic shift from an internally commercialized product to a divested asset is sound and well-articulated. The LLM demonstrates good multi-hop synthesis by connecting 2023 product revenue data to 2024's absence from direct revenue and its reclassification. However, the introduction of the unsupported $579M figure is a material error that undermines confidence in the answer's accuracy. The page references provided (48, 47, 64) cannot be verified against the ground truth but suggest the LLM attempted to cite sources. The qualitative reasoning about the transition from 'revenue-generating product' to 'monetized asset' is appropriate and matches the ground truth's characterization of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 433,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "In the 2022 filing Union Pacific reported 48,962 owned containers and 1,856 leased (≈96 % owned) and 29,875 owned chassis versus 14,148 leased (≈68 % owned) (page_24). By 2024 the mix had shifted dramatically to 46,375 owned containers and only 288 leased (≈99 % owned) and 4,356 owned chassis versus 1,197 leased (≈79 % owned), raising the owned‑to‑leased ratio from roughly 26 : 1 to 161 : 1 for containers and from about 2.1 : 1 to 3.6 : 1 for chassis (page_19).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across multiple data points. (1) OWNED CONTAINERS: LLM reports 48,962 (2022) and 46,375 (2024), but ground truth indicates total owned units were 78,837 (2022) and 50,731 (2024). The LLM appears to have isolated container numbers only, not total equipment. (2) LEASED CONTAINERS: LLM correctly identifies 1,856 (2022) and 288 (2024), matching ground truth. (3) OWNED CHASSIS: LLM correctly reports 29,875 (2022) and 4,356 (2024). (4) LEASED CHASSIS: LLM reports 14,148 (2022) and 1,197 (2024), but ground truth does not provide these specific numbers - the ground truth only mentions total leased units of 16,004 (2022) and 1,485 (2024). The LLM appears to have fabricated or misinterpreted the 2022 leased chassis figure. (5) RATIO CALCULATIONS: The LLM's ratio calculations (26:1 to 161:1 for containers, 2.1:1 to 3.6:1 for chassis) are mathematically inconsistent with the numbers provided and don't align with ground truth totals. (6) MISSING CONTEXT: The LLM fails to address the overall strategic shift comprehensively - it focuses only on containers and chassis but doesn't acknowledge the total equipment reduction from 94,841 units (2022) to 52,216 units (2024). The answer demonstrates partial understanding of the trend (reduction in leased equipment) but contains fundamental numerical errors that undermine credibility. The LLM appears to have cherry-picked or misread specific line items rather than synthesizing the complete picture from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 428,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s securitized‑debt portfolio grew modestly from one year to the next.  At year‑end 2022 the company carried $16.973 billion of securitized debt obligations (fair value $16.918 billion) 【page_211】, and by year‑end 2023 that balance had risen to $18.043 billion (fair value $18.067 billion) 【page_210】.  Because deposits and other borrowings rose only slightly, the securitized‑debt line moved from roughly 13 % of total funding sources (deposits + notes + securitized debt + federal funds + interest payable) in 2022 to about 14 % in 2023, indicating a modest increase in both absolute size and relative importance within Capital One’s overall funding mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate quantitative data and demonstrates sound multi-hop reasoning. Strengths: (1) All dollar amounts are correct ($16.973B in 2022, $18.043B in 2023), with fair values also accurately cited; (2) The calculation of percentage changes in funding mix (13% to 14%) is logically sound and properly contextualized; (3) The answer correctly identifies the growth trajectory and relative importance shift; (4) Multi-hop synthesis is effective, combining balance sheet data with funding structure analysis. Minor weaknesses: (1) The original answer emphasizes a shift in fair value hierarchy classification (Level 2) and suggests a move toward 'more standardized valuation methods' and 'less volatile role,' which the LLM answer does not address; (2) The original answer frames the evolution more qualitatively in terms of valuation methodology changes, while the LLM focuses primarily on quantitative growth and funding mix percentages; (3) The LLM answer doesn't explicitly discuss the categorization shift or its implications for volatility/standardization. The LLM answer is factually accurate and addresses the core question about evolution in securitized debt's role, but misses the nuanced discussion of fair value hierarchy classification changes that the ground truth emphasizes. The quantitative analysis is superior to the original in some ways (providing specific percentages), but the qualitative interpretation of what the evolution means is less complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 411,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "In 2023 Eli Lilly booked Zyprexa revenue as **net product revenue** – it was the “sale of the rights for the olanzapine portfolio” and was recognized as product revenue when the product (or its rights) was sold 【page_67】. By 2024 that same transaction is shown under **collaboration and other revenue**, because the sale of the olanzapine rights (including Zyprexa) is treated as a one‑time intellectual‑property sale and is recognized when control of the rights transfers to the buyer 【page_64】【page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Zyprexa revenue evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 revenue source as 'sale of the rights for the olanzapine portfolio' matching the ground truth exactly; (2) Accurately captures the shift in revenue categorization from 'net product revenue' in 2023 to 'collaboration and other revenue' in 2024; (3) Properly explains the recognition method difference - product revenue recognition in 2023 vs. IP sale recognition in 2024; (4) Provides appropriate page citations (67, 64, 66) suggesting source verification; (5) Uses clear, precise language that conveys the semantic meaning of the ground truth answer. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed in explaining the 'when' of recognition (when control transfers) compared to the ground truth, but this adds helpful context rather than introducing errors. The answer successfully synthesizes the multi-hop requirement of comparing two different years and explaining both the source and recognition method changes. No numerical errors, date errors, or entity misidentifications present. The answer demonstrates sound reasoning about how the same transaction (olanzapine rights sale) was categorized differently across fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 370,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "In the 2022 filing the plan said that Federal Government Securities “are valued using a bid‑evaluation process with bid data provided by independent pricing sources” and are classified as **Level 2** investments (UNP 10‑K 2022 p. 70‑72). The 2024 filing repeats the same language – they are still valued by a bid‑evaluation process using independent pricing data and remain **Level 2** securities (UNP 10‑K 2024 p. 56). Thus, the valuation methodology and classification of these securities have not changed from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERROR - The LLM fails to mention the $742 million valuation for Federal Government Securities in 2022, which is explicitly stated in the ground truth. This is a material omission of a specific financial figure. (2) METHODOLOGY EVOLUTION - The ground truth indicates that while the classification remained Level 2, there was an evolution in how the methodology was explained/clarified from 2022 to 2024. The LLM incorrectly concludes that 'the valuation methodology and classification of these securities have not changed from 2022 to 2024,' which misses the nuance that the ground truth identifies: the company 'clarified' and added 'specificity in methodology explanation' in 2024. This represents a change in disclosure/explanation, not a complete absence of change. (3) INCOMPLETE SYNTHESIS - The LLM provides a comparison of language between years but fails to capture the full evolution described in the ground truth, which notes both continuity (Level 2 classification) and evolution (clarification and added specificity). (4) CITATION ACCURACY - While the LLM cites specific pages (UNP 10-K 2022 p. 70-72 and UNP 10-K 2024 p. 56), these cannot be verified against the ground truth provided, and the substantive answer contradicts what the ground truth states. The answer demonstrates partial understanding of the question but arrives at an incorrect conclusion by missing the $742 million figure and mischaracterizing the nature of the evolution as 'no change' when the ground truth indicates clarification and added specificity occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 453,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One’s 10‑K disclosures show that the firm’s approach to using credit‑score data for product segmentation remained unchanged – the 2022 filing notes that borrower credit scores are “used … in some cases, to drive product segmentation decisions” (2022 p.103) and the 2023 filing repeats the same language (2023 p.95).  The 2023 table, however, shows a modest shift in the underlying score mix (credit‑card balances with scores > 660 fell from 69 % to 68 % while the auto‑loan >660 share stayed at 53 %) (2023 p.95 vs. 2022 p.103), indicating that Capital One continues to embed credit‑score information in its proprietary risk models for segmentation but is fine‑tuning the models to a slightly broader borrower risk profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the ground truth. Key issues: (1) FUNDAMENTAL MISUNDERSTANDING: The ground truth states that Capital One UPDATED its data from 2020-2021 distributions (2022) to 2022-2023 distributions (2023), indicating evolution in their credit risk modeling strategy. The LLM incorrectly claims the approach 'remained unchanged' and that only the 'underlying score mix' shifted modestly. This is a critical misreading of what constitutes the evolution. (2) QUANTITATIVE ERRORS: The LLM cites specific percentages (69% to 68% for credit-card balances >660, 53% for auto-loan >660) but these appear to be cherry-picked data points that don't align with the ground truth's description of the shift from 2020-2021 to 2022-2023 historical distributions. The ground truth emphasizes the TIME PERIOD of the data used changed, not just the score mix percentages. (3) REASONING FAILURE: The LLM concludes Capital One is 'fine-tuning models to a slightly broader borrower risk profile' based on modest percentage shifts, but misses the core insight that the ground truth identifies: the shift to MORE CURRENT data (2022-2023 vs 2020-2021) indicates a 'more current and dynamic credit risk modeling strategy' and 'proactive approach to managing credit risk in evolving economic conditions.' (4) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the evolution from 2022 to 2023 by not recognizing that the key change was updating the historical reference period used for segmentation decisions, not just minor percentage fluctuations. (5) CONTEXTUAL RELEVANCE: While the LLM addresses Capital One and credit score usage, it fundamentally mischaracterizes the nature of the evolution, making the answer contextually misleading despite touching on relevant topics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 492,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "In the 2022 filing, AWS was presented mainly as a key investment area within Amazon’s broader technology and content spending—“We are investing in AWS, which offers a broad set of on‑demand technology services…to developers and enterprises of all sizes” (2022 p. 19). By the 2023 filing, AWS is elevated to a core operating segment—“We have organized our operations into three segments: North America, International, and Amazon Web Services (‘AWS’)” (2023 p. 3)—with its own CEO and a distinct focus on serving developers and enterprises, signaling a stronger strategic priority and central role in Amazon’s overall business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of AWS as a key investment area within broader technology and content spending, with accurate quote attribution to page 19 of 2022 filing. (2) Accurately captures the 2023 evolution where AWS became one of three core operating segments (North America, International, AWS), with correct quote attribution to page 3 of 2023 filing. (3) Properly synthesizes the multi-hop comparison showing the transformation from 'strategic investment area' to 'standalone, mission-critical business segment.' (4) Correctly notes AWS's role serving developers and enterprises with on-demand technology services. (5) Mentions the organizational structure change with AWS having its own CEO, adding relevant detail. (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the core structural/organizational shift rather than elaborating on the specific service categories (compute, storage, database, analytics, machine learning) mentioned in the ground truth. However, this is a matter of depth rather than accuracy. (2) The ground truth emphasizes 'geographic expansion, new product categories, and internal operational efficiencies' as 2022 investment priorities, which the LLM answer doesn't explicitly mention, though this is a minor omission that doesn't affect the core narrative. The LLM answer successfully captures the essential evolution of AWS's strategic positioning and the shift in its organizational importance within Amazon's business model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 460,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "In the 2022 filing PMI still treated Rothmans, Benson & Hedges (RBH) as a de‑consolidated subsidiary – it recorded only the CAD ≈ 257 million security‑deposit required by the Canadian judgments (a $194 million pre‑tax charge) and disclosed a contingent liability but did not accrue a loss because the outcome was not deemed probable or estimable (see pages 113‑114 and the credit‑risk discussion on page 112)【page_113】【page_114】【page_112】. By the 2024 filing PMI’s relationship had shifted to an equity investment in RBH, and because the CCAA‑mediated settlement of the CAD 32.5 billion claim remains unresolved, PMI recognized a non‑cash impairment of $2.3 billion (≈ $1.49 per share) on that investment, reflecting a much larger potential financial exposure (see Item 8, Note 6 on page 30 and the diluted‑EPS table on page 32)【page_30】【page_32】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PMI's evolving relationship with RBH across 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 deconsolidation status and the contingent liability treatment without loss accrual due to inability to estimate losses - matches ground truth. (2) Accurately captures the 2024 shift to equity investment model with the CAD 32.5 billion settlement context. (3) Correctly states the $2.3 billion impairment charge (ground truth: $2,316 million - minor rounding acceptable). (4) Properly synthesizes multi-hop information across years and accounting treatments. (5) Appropriately references specific filing locations and page numbers. (6) Correctly identifies the non-cash nature of the impairment and its impact on EPS. MINOR ISSUES: (1) The 2022 security deposit amount is stated as 'CAD ≈ 257 million' with a '$194 million pre-tax charge' - while the ground truth doesn't explicitly state these exact figures, the answer presents them with appropriate hedging language ('≈'). (2) The EPS impact is stated as '≈ $1.49 per share' - ground truth doesn't provide this specific EPS figure, so this appears to be additional detail from the filing rather than an error. (3) Ground truth mentions 'comprehensive stay of Canadian tobacco litigation until March 31, 2022' which the LLM answer doesn't explicitly reference, though it's a minor contextual detail. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2024), correctly identifying the accounting treatment change from deconsolidation to equity investment, and properly connecting the CAD 32.5 billion settlement proposal to the impairment charge. The logic flow is sound and demonstrates understanding of how litigation developments drove accounting changes. QUANTITATIVE VERIFICATION: The $2.3 billion figure is essentially correct (ground truth: $2,316 million - acceptable rounding). The CAD 32.5 billion settlement amount matches ground truth exactly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 541,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Gilead reported that Biktarvy produced $8.6 billion of sales in 2021 – roughly half of the company’s $16.3 billion HIV portfolio and a major component of total revenue. By the 2024 filing, Gilead still cites Biktarvy (and its other HIV products) as a “substantial portion” of its revenue, but it now highlights the drug among products subject to heightened commercial risk – including competition from generics, reliance on the tenofovir‑alafenamide (TAF) platform and possible shifts in HIV treatment paradigms that could erode sales. Thus, Biktarvy’s commercial importance remains high, while the risk narrative around its future sales has become more pronounced.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) YEAR MISMATCH - LLM states 'Biktarvy produced $8.6 billion of sales in 2021' from the 2022 Form 10-K, but the ground truth specifies $8,624 million in 2022 (not 2021). This is a fundamental factual error in the temporal attribution. (2) INCOMPLETE 2024 DATA - The LLM correctly notes that 'specific revenue figures are not provided' for 2024, which aligns with ground truth, but this should be more explicitly stated as a limitation. (3) PARTIAL CREDIT FOR RISK NARRATIVE - The LLM correctly identifies the shift toward heightened risk disclosure in 2024, including competition from generics, TAF platform reliance, and treatment paradigm shifts. This qualitative assessment matches the ground truth. (4) CONTEXT ACCURACY - The LLM appropriately contextualizes Biktarvy as roughly half of the HIV portfolio (~$8.6B of $16.3B), which is mathematically sound and adds useful context. STRENGTHS: The LLM correctly synthesizes the evolution from strong revenue driver (2022) to maintained importance with elevated risks (2024). The multi-hop reasoning across years is sound in structure. WEAKNESSES: The year attribution error (2021 vs 2022) is a significant factual mistake that undermines credibility. The answer conflates the 2022 filing's reporting of 2021 data with 2022 data itself. The ground truth explicitly states 2022 figures, not 2021. This is not a formatting variation but a substantive temporal error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 397,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "In 2022 Union Pacific owned a 36.79 % economic interest in TTX, recorded as a $1.6 billion equity investment, and incurred about $402 million of TTX car‑hire expenses. By 2024 that interest had risen to 37.03 % with the investment growing to roughly $1.9 billion and car‑hire costs climbing to $432 million, showing a modest increase in both its financial stake and its operational use of TTX’s pooled rail‑car fleet【page_88†L1-L3】【page_89†L1-L3】【page_68†L1-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial metrics and shows proper multi-hop synthesis across 2022-2024 data. The investment values ($1.6B in 2022, $1.9B in 2024) and final car-hire expense ($432M in 2024) are accurate. The ownership percentages (36.79% in 2022, 37.03% in 2024) are correctly stated. The answer appropriately addresses the question's focus on evolution of financial stake and operational relationship.\n\nWEAKNESSES: Critical discrepancy in car-hire expenses for 2022. The LLM states \"about $402 million of TTX car-hire expenses\" in 2022, but the ground truth indicates $375 million in 2021 (referenced in 2022 filing). The LLM appears to have conflated or misread the 2022 car-hire figure. The ground truth shows the progression was $375M (2021) → $432M (2024), not $402M (2022) → $432M (2024). This is a material quantitative error.\n\nMULTI-HOP REASONING: The synthesis is sound - the model correctly connected ownership percentages, investment values, and car-hire expenses across the time period. However, the temporal mapping of the car-hire expense data is incorrect.\n\nCALCULATION VERIFICATION: The investment increase from $1.6B to $1.9B ($300M increase) is correctly identified. The car-hire increase from stated $402M to $432M ($30M) is mathematically consistent with the numbers provided, but the baseline year figure appears wrong.\n\nOVERALL: The answer demonstrates good understanding of the question and mostly correct synthesis, but contains a significant quantitative error in the 2022 car-hire expense figure that undermines the accuracy of the trend analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 442,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "In 2022 Tesla said it would grow Solar Roof by expanding its installer network – “on‑boarding and training new installers, as well as collaborating with real‑estate developers and builders to reduce installation time and costs”【page_34】. By the 2023 filing the focus had shifted to supply‑chain resilience – the company now stresses the risk of component shortages, the need to diversify and tightly manage suppliers, and discusses training only in the broader context of hiring and retaining qualified staff rather than a dedicated installer program【page_16】【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the 2022 focus on installer training, on-boarding, collaboration with real estate developers, and cost reduction. It accurately captures the 2023 shift toward supply chain resilience, component constraints, and supplier management. The characterization of the transition from 'installer-focused growth to risk-averse strategy' is semantically equivalent to the ground truth's description. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension is not applicable. The answer appropriately avoids introducing unsupported numerical claims. (3) ENTITY ACCURACY: Tesla is correctly identified, years 2022 and 2023 are accurate, and the relevant business segments (Solar Roof production, installer network, supply chain) are properly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and filing documents, correctly identifying the strategic shift and its underlying drivers. The logic connecting installer training in 2022 to supply chain focus in 2023 is sound and well-articulated. (5) COMPLETENESS: The answer addresses both sub-components of the question: installer training initiatives (2022 emphasis, 2023 de-emphasis) and supply chain risk management (2023 emphasis). The inclusion of specific quotes with page references adds credibility. Minor observation: The answer could have slightly more explicitly mentioned the 2022 emphasis on hiring skilled electricians (mentioned in ground truth), though this is a minor omission that doesn't significantly impact the overall accuracy. The semantic equivalence is strong throughout, with the LLM's phrasing capturing the essential meaning of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 513,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "In the 2022 filing the Company explained that it manufactures fountain syrups in the United States and sells them either directly to fountain retailers or through authorized fountain wholesalers (including some bottlers), while U.S. bottlers are not permitted to produce those syrups (page 6‑8). The 2023 filing repeats the same arrangement – Coca‑Cola still is the sole U.S. manufacturer of fountain syrups and continues to supply them to fountain retailers directly or via authorized wholesalers, with bottlers excluded from syrup production (page 37). Thus, the relationship with fountain retailers has remained essentially unchanged between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer fundamentally misinterprets the evolution between 2022 and 2023. The ground truth explicitly states there WAS a change - a 'more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.' The LLM incorrectly concludes 'the relationship with fountain retailers has remained essentially unchanged between 2022 and 2023,' which directly contradicts the ground truth. SPECIFIC ISSUES: (1) The LLM correctly identifies that both years involve direct sales to retailers and sales through authorized wholesalers/bottlers, and that bottlers cannot manufacture syrups - these factual elements are accurate. (2) However, the LLM misses the KEY DISTINCTION: In 2022, the Company sold to 'authorized fountain wholesalers (including some bottlers)' - bottlers were mentioned as wholesalers. In 2023, the Company explicitly sells to 'authorized fountain wholesalers or bottling partners' - a clearer delineation of roles. (3) The ground truth emphasizes this represents 'a more explicit acknowledgment of a tiered distribution model' and 'potential expansion of their distribution network or clarification of roles.' The LLM dismisses this as 'essentially unchanged,' missing the nuanced evolution in how the relationship is described and structured. (4) The LLM's page citations (6-8 for 2022, 37 for 2023) cannot be verified but appear plausible. (5) The quantitative accuracy is high because no specific numbers are involved, but the qualitative reasoning is severely flawed - the LLM failed to recognize and articulate the meaningful evolution in the distribution model that the ground truth identifies. This is a multi-hop synthesis failure where the model was supposed to compare and contrast the 2022 and 2023 arrangements but instead concluded they were the same.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 521,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "In IBM’s 2022 Form 10‑K (see pages 28‑32) the 0.950 % Notes due 2025 were mentioned only as a debt instrument in the footnotes and were not shown in a separate Section 12(b) registration table. By the 2024 Form 10‑K (see page 1) IBM continues to classify the instrument as a note (debt security) but now lists it explicitly in the Section 12(b) securities‑registration table, assigning it the ticker IBM25B and indicating that it trades on the New York Stock Exchange.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements but has some discrepancies with the ground truth regarding specific details and sourcing. CORRECT ELEMENTS: (1) The 0.950% Notes due 2025 is correctly identified as a debt instrument; (2) The ticker symbol 'IBM25B' and NYSE listing are correctly stated; (3) The classification as a note/debt security is accurate; (4) The evolution from 2022 to 2024 showing a shift in disclosure/registration is correctly captured; (5) The mention of Section 12(b) registration table in 2024 is appropriate. DISCREPANCIES: (1) The ground truth references Form 8-K filings and Exhibit 4.1 from May 22, 2017 for 2022 disclosure, while the LLM cites Form 10-K pages 28-32 for 2022 - these are different document types and the LLM's sourcing appears less precise; (2) The ground truth emphasizes the shift from 'merely disclosing' to 'formally registering and listing,' while the LLM frames it as moving from footnotes to Section 12(b) table - semantically similar but with different emphasis; (3) The LLM provides specific page references (pages 28-32 for 2022, page 1 for 2024) which cannot be verified against the ground truth and may be inaccurate. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the key change in how the instrument is presented. The logic connecting disclosure evolution to registration is sound. QUANTITATIVE ELEMENTS: All numbers and percentages (0.950%, 2025 maturity, ticker IBM25B) are accurate. No calculation errors present. The answer is contextually relevant and addresses the core question about evolution of treatment and disclosure, though with some sourcing imprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 465,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "In the 2022 filing Gilead listed Biktarvy as a flagship TAF‑based HIV regimen in its product portfolio and stressed that its growth could be supported by the company’s broad resource‑allocation strategy (see product list on page 63). By the 2024 filing the tone has shifted: Biktarvy is still highlighted for its efficacy and TAF‑based differentiation, but the company now flags heightened financial‑risk exposure from pricing reforms, reimbursement pressures and growing generic/competitor competition, emphasizing the need to protect market share and potentially launch new HIV products (see risk factors on page 18 and competition discussion on page 20).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Biktarvy's strategic evolution from 2022 to 2024 and correctly identifies the key shift in positioning. STRENGTHS: (1) Accurately captures the core narrative - Biktarvy listed as flagship product in 2022, with shifted tone by 2024 emphasizing financial risks; (2) Correctly identifies TAF-based differentiation as a key product characteristic; (3) Properly synthesizes multi-hop information about competitive pressures, generic competition, and reimbursement challenges; (4) Appropriately references specific filing sections (page numbers) to support claims; (5) Semantic equivalence is strong - 'flagship TAF-based HIV regimen' aligns with 'key marketed products' and 'central role in HIV portfolio'; (6) Correctly identifies the shift from growth-focused positioning to risk-focused positioning. WEAKNESSES: (1) The LLM answer adds specific page references (page 63, page 18, page 20) that cannot be verified against the ground truth and may be hallucinated - this is a minor concern as the substantive content appears accurate; (2) The ground truth emphasizes 'potential shift in HIV treatment paradigms away from TAF-based regimens' as a specific risk factor, while the LLM answer focuses more on pricing/reimbursement/generic competition without explicitly mentioning the paradigm shift concern; (3) The phrase 'need to launch new HIV products' in the LLM answer is a reasonable inference but not explicitly stated in the ground truth, which focuses on Biktarvy's own sustainability concerns. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods and multiple risk dimensions (competitive, financial, reimbursement), demonstrating sound multi-hop reasoning. The comparison between 2022 and 2024 positioning is logically structured and accurate. OVERALL ASSESSMENT: The answer is substantially correct in its core claims and demonstrates good understanding of the strategic evolution. The main limitation is the omission of the specific 'paradigm shift away from TAF-based regimens' risk that the ground truth emphasizes, and the unverifiable page references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 622,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "In 2022 Lockheed Martin accelerated its move to an enhanced defined‑contribution retirement savings plan by purchasing group‑annuity contracts that transferred roughly $4.3 billion of defined‑benefit pension obligations to insurers, which produced a $1.5 billion non‑cash pension‑settlement charge (shown as a $1.47 billion expense in FAS income). By 2023 the company shifted to cash lump‑sum settlements – a $414 million payment to about 6,500 former employees – and recorded no settlement charge, while the unfunded liability on the remaining plans rose to about $6.2 billion, reflecting the continued transition to the defined‑contribution model.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the strategic evolution of Lockheed Martin's retirement plan approach. STRENGTHS: (1) All primary numbers are accurate: $4.3 billion pension obligation transfer in 2022, $1.5 billion noncash settlement charge, $414 million settlement payments in 2023 to 6,500 former employees. (2) Correctly identifies the shift from group annuity contracts (2022) to direct cash lump-sum settlements (2023). (3) Properly synthesizes multi-hop information across two fiscal years showing strategic evolution. (4) Accurately notes the transition to defined-contribution model. (5) Number format variations are handled appropriately ($1.5 billion vs $1.47 billion reference - minor notation difference). MINOR ISSUES: (1) The LLM introduces the $6.2 billion unfunded liability figure for remaining plans, which is not mentioned in the ground truth answer. While this may be factually accurate from the source documents, it represents additional information beyond what was in the original answer - this is not an error but an expansion. (2) The phrase 'FAS income' appears to be a notation reference that adds technical detail but doesn't contradict the ground truth. (3) The LLM's characterization of 'accelerated move to enhanced defined-contribution' is a reasonable interpretation of the strategic shift, though the ground truth focuses more neutrally on the evolution. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023, properly comparing the two approaches and identifying the strategic shift. The logic connecting pension obligation transfers to the broader defined-contribution transition is sound. SEMANTIC EQUIVALENCE: The core message matches ground truth - a shift from large-scale annuity purchases to direct settlements with participants. The answer conveys the same strategic evolution with appropriate financial context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 530,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "In the 2022 Form 10‑K IBM reported four securities maturing in 2025 – the 2.875 % notes (IBM 25A), 0.950 % notes (IBM 25B), 0.875 % notes (IBM 25C) and a 7 % debenture (IBM 25)【page_1†L1-L12】. The 2024 filing still lists the 2.875 % notes (IBM 25A) together with the 0.950 % notes and the 7 % debenture, but the 0.875 % notes (IBM 25C) are no longer shown【page_1†L1-L8】. Thus, the 2.875 % notes due 2025 have remained outstanding, while the overall 2025 debt basket has narrowed with the 0.875 % notes being retired.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies all four debt instruments maturing in 2025 in 2022: 2.875% Notes (IBM 25A), 0.950% Notes (IBM 25B), 0.875% Notes (IBM 25C), and 7% debenture. (2) Accurately reports the 2024 composition showing 2.875% Notes, 0.950% Notes, and 7% debenture remaining, with 0.875% Notes no longer listed. (3) Properly synthesizes the multi-hop comparison across 2022 and 2024 filings. (4) Correctly interprets the evolution as a narrowing of the debt basket with retirement of the 0.875% Notes. (5) All percentages and note designations are accurate. MINOR ISSUES: (1) The LLM mentions a '7% debenture (IBM 25)' in 2022 which the ground truth does not explicitly reference in its listing of 2022 instruments. However, the ground truth states 'among other Notes due in 2025' suggesting there were additional instruments beyond the three specifically named, so this is not necessarily an error but rather additional detail. (2) The ground truth emphasizes the 2.875% Notes as 'a key part of IBM's debt structure' and mentions 'strategic decision,' while the LLM uses more neutral language ('remained outstanding'). This is a wording difference rather than factual error. (3) The LLM provides slightly more comprehensive information by explicitly mentioning the 7% debenture in both years, which adds context to the answer. The multi-hop reasoning is sound: comparing 2022 composition to 2024 composition and identifying which instruments were retired. All numeric values (percentages, note designations) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 443,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "In the 2022 filing Gilead described Biktarvy as the “growth engine” of its HIV franchise – sales rose worldwide, offsetting the loss of Truvada/Atripla and even prompting a new low‑dose pediatric tablet (see pages 38 & 41), and the company’s 2022 strategy explicitly called for maintaining leadership in HIV (page 40). By the 2024 filing the drug is still portrayed as a core product, but the risk discussion now stresses that “if there are any changes to the treatment or prevention paradigm for HIV, and nucleoside‑based therapeutics do not remain the preferred regimen, our HIV product sales would be adversely impacted” (page 18) and that “we face significant competition…including generics and new agents” together with pricing/reimbursement pressures (page 20). Thus Biktarvy’s strategic importance remains high, while its risk profile has risen because of intensified competitive pressure and the possibility of a shift away from nucleoside‑based regimens.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Biktarvy's evolving strategic position within Gilead's HIV portfolio from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as a growth driver with worldwide sales growth; (2) Accurately captures the 2024 risk profile shift, including specific language about nucleoside-based therapy paradigm risks and competitive pressures; (3) Properly synthesizes multi-hop information across two filing years; (4) Correctly notes the introduction of pediatric formulation as evidence of 2022 strategic importance; (5) Accurately references competitive threats including generics and new agents. MINOR ISSUES: (1) The LLM characterizes Biktarvy as a 'growth engine' in 2022, while the ground truth uses 'key growth driver' - these are semantically equivalent but the LLM's phrasing is slightly more emphatic than the source material explicitly states; (2) The LLM provides specific page references (38, 41, 40, 18, 20) which add credibility but cannot be verified against the ground truth provided; (3) The ground truth emphasizes that strategic importance became 'more precarious' by 2024, while the LLM states it 'remains high' - this is a subtle but meaningful difference in emphasis. The LLM's characterization that importance 'remains high' while risk 'has risen' is logically sound and supported by the evidence presented, though the ground truth suggests a more significant shift in strategic positioning. QUANTITATIVE ACCURACY: No specific financial figures are provided in either answer, so this dimension is not directly testable. The 11% revenue increase mentioned in ground truth is not referenced in LLM answer, representing a minor omission of quantitative support. MULTI-HOP REASONING: Both answers correctly synthesize information across 2022 and 2024 filings, comparing strategic positioning and risk profiles. The LLM's reasoning is sound and well-structured. OVERALL: The answer is substantially correct with strong multi-hop synthesis, though it slightly understates the degree of strategic vulnerability that emerged by 2024 compared to the ground truth characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 577,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The escrow balance was $1.449 billion at the end of FY 2022 (the “balance as of beginning of period” for 2023) and rose to $1.764 billion at the end of FY 2023【page_73†L1-L4】. The company put $850 million into the escrow during FY 2022【page_102†L1-L3】 and added $1.0 billion in FY 2023【page_73†L5-L7】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) ENDING BALANCE FY2023: LLM states $1.764 billion, but ground truth shows $3.089 billion - a massive discrepancy of $1.325 billion or 43% understatement. (2) ENDING BALANCE FY2022: LLM correctly identifies $1.449 billion. (3) DEPOSIT FY2022: LLM states $850 million, but ground truth shows $1.000 billion - a $150 million error (15% understatement). (4) DEPOSIT FY2023: LLM states $1.0 billion, but ground truth shows $1.500 billion - a $500 million error (33% understatement). The LLM failed to correctly synthesize the multi-hop information across fiscal years. The answer demonstrates poor quantitative accuracy with all three deposit/balance figures for FY2023 being significantly wrong. While the LLM correctly identified the account type (U.S. litigation escrow) and attempted to address both the balance evolution and deposit contributions, the numerical errors are severe and would lead to completely incorrect financial analysis. The reasoning structure is present but built on incorrect data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 318,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "In both the 2022 and 2023 Form 10‑K filings Coca‑Cola’s North America segment still includes the company’s own production of fountain syrups in the United States, with the syrups sold either directly to fountain retailers or to authorized fountain wholesalers or bottling partners that then distribute them to those retailers【page_35】. The language describing these manufacturing and distribution responsibilities is unchanged between the two years, indicating that the role of fountain syrups in the North America segment has remained the same【page_36】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and provides an incomplete response. (1) CRITICAL ERROR - MISSED KEY EVOLUTION: The ground truth explicitly states there WAS an evolution between 2022 and 2023. The original answer indicates that by 2023, Coca-Cola's description shifted to emphasize a 'more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S.' The LLM answer directly contradicts this by claiming 'the language describing these manufacturing and distribution responsibilities is unchanged between the two years' and 'the role of fountain syrups in the North America segment has remained the same.' This is factually incorrect according to the ground truth. (2) INCOMPLETE SYNTHESIS: The LLM failed to identify and synthesize the key distinction that emerged in 2023 regarding bottling partners being 'authorized to manufacture fountain syrups using company concentrates' outside the U.S. This represents a meaningful shift in the authorization-based model that the ground truth emphasizes. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about evolution 'between 2022 and 2023' - a comparative analysis across two years. The LLM failed to perform this comparison correctly, instead asserting no change occurred. (4) QUANTITATIVE ACCURACY: The LLM correctly identifies the basic operational facts (manufacturing in U.S., selling to retailers/wholesalers/bottling partners) but this accuracy is undermined by the failure to identify the actual evolution. (5) The LLM's citation references (page_35, page_36) suggest document review but the conclusions drawn are contradictory to the ground truth's documented evolution. The answer demonstrates a failure to understand the nuanced shift from direct manufacturing emphasis to authorization-based decentralization that occurred between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 518,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM reported three separate notes that mature in 2025 – a 2.875 % note (IBM 25A), a 0.950 % note (IBM 25B) and a 0.875 % note (IBM 25C) – together with a 7.00 % debenture due 2025 (IBM 25)【page_1】. The 2024 filing still lists the 2.875 % and the 0.950 % notes and the 7.00 % debenture, but the 0.875 % note is no longer shown, indicating that the 0.950 % Notes due 2025 remained outstanding while the 0.875 % issue was retired, narrowing the 2025 debt composition【page_1】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - FACTUAL ERROR: The LLM answer introduces a '7.00% debenture due 2025 (IBM 25)' that is NOT mentioned in the ground truth answer. This is a significant factual error that contradicts the original answer's explicit statement about which instruments existed in 2022 and 2024. The ground truth clearly states only THREE notes in 2022 (2.875%, 0.950%, and 0.875%), not four instruments including a 7.00% debenture. This addition appears to be fabricated or confused with different debt instruments. CORRECT ELEMENTS: (1) The three notes identified in 2022 are correct (2.875%, 0.950%, 0.875%), (2) The identification of IBM 25A, 25B, and 25C designations is correct, (3) The observation that the 0.875% note was retired by 2024 is correct, (4) The conclusion that 0.950% Notes remained outstanding is correct, (5) The characterization of narrowed debt composition is semantically equivalent to 'reduction in diversity.' QUANTITATIVE ACCURACY PENALTY: The introduction of the 7.00% debenture is a major factual error that significantly undermines the answer's reliability. While the percentages for the three main notes are correct (2.875%, 0.950%, 0.875%), the addition of an unmentioned fourth instrument is a critical mistake. MULTI-HOP REASONING: The synthesis across 2022 and 2024 is logically sound for the instruments actually discussed, but the inclusion of the 7.00% debenture breaks the factual foundation. The reasoning about retirement and composition changes is valid for the correct instruments. SEMANTIC EQUIVALENCE: The core narrative about the 0.950% Notes remaining and the 0.875% Notes being retired matches the ground truth, but the extra instrument fundamentally alters the completeness and accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 475,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "In the 2022 filing Disney’s cruise‑ship strategy was centered on a single new destination – it disclosed that it had acquired about 550 acres at Lighthouse Point, Eleuthera, which was slated to open as a Disney Cruise Line destination in 2024. By the 2024 filing the focus had broadened to a fleet‑expansion approach – the company announced “additional expansion of our fleet of cruise ships” and further investment in its Experiences segment, while also noting the closure of the Star Wars Galactic Starcruiser concept and the higher costs of launching new ships. (2022 p. 22; 2024 p. 22)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, verifiable details that enhance the ground truth answer but introduces some concerns about completeness and potential over-specificity. STRENGTHS: (1) The LLM correctly identifies the Lighthouse Point acquisition (550 acres, Eleuthera, 2024 opening) - a concrete detail not in the ground truth that demonstrates deeper filing analysis. (2) Correctly cites the 2024 filing's 'additional expansion of our fleet of cruise ships' language, matching the ground truth. (3) Accurately notes the closure of Star Wars Galactic Starcruiser, showing multi-year synthesis. (4) Properly identifies the shift from destination-focused (2022) to fleet-expansion strategy (2024). (5) Page citations (p. 22 for both years) add credibility. WEAKNESSES: (1) The ground truth emphasizes a shift from 'general dependence on consumer demand' (passive) to 'active investment and growth strategy' (active), but the LLM frames it as 'single destination' to 'fleet-expansion' - a slightly different characterization that may not fully capture the strategic evolution in mindset. (2) The ground truth mentions 'increased costs and uncertain returns' as a key 2024 disclosure; the LLM mentions 'higher costs of launching new ships' which is similar but less explicitly tied to 'uncertain returns.' (3) The LLM doesn't explicitly address the 2022 framing of cruise ships as part of 'broader travel and resort experiences' dependent on consumer demand, though this is implied. QUANTITATIVE ACCURACY: The 550 acres figure and 2024 opening date are specific and appear accurate based on public Disney disclosures. No calculation errors. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and identifies the strategic evolution. The logic is sound - moving from a single destination project to fleet expansion represents a meaningful strategic shift. SEMANTIC EQUIVALENCE: The core message aligns with ground truth (evolution from limited/passive to active/expansive strategy), though the specific framing differs slightly. The answer is more concrete and detailed than ground truth but potentially misses some of the strategic philosophy shift emphasized in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 594,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "In the 2022 filing Lockheed Martin reported that a 2021 group‑annuity‑contract purchase transferred about $4.9 billion of defined‑benefit obligations and triggered a $1.7 billion pretax non‑cash pension‑settlement charge (page 60).  That transaction under‑pinned its 2022 outlook of $460 million of FAS pension income and a net $2.3 billion pension benefit (page 62), and the company said it would continue to seek additional risk‑transfer deals to reduce volatility (page 60).  \n\nBy the 2023 filing the discussion had become more forward‑looking: the company again notes it will “continue to evaluate” pension‑risk‑transfer transactions, acknowledges that some GACs may still leave it responsible for benefit payments and that future deals could require extra contributions or new non‑cash settlement charges, but no comparable large charge is reported for 2023 (page 19).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key quantitative facts from 2022 ($4.9 billion transferred, $1.7 billion noncash charge) and accurately notes the shift in tone from 2022 to 2023 toward forward-looking risk discussion. However, there are significant omissions and incomplete synthesis:\n\nSTRENGTHS:\n- Correctly cites the $4.9 billion and $1.7 billion figures from 2022\n- Accurately identifies the shift from specific transaction reporting (2022) to forward-looking evaluation (2023)\n- Correctly notes that 2023 discusses potential future liabilities and residual exposure\n- Properly identifies that no comparable large charge occurred in 2023\n- Appropriate page references provided\n\nWEAKNESSES:\n1. MAJOR OMISSION: The ground truth emphasizes that since December 2018, Lockheed had transferred ~$11.6 billion in obligations affecting ~95,000 retirees. The LLM answer completely omits this cumulative context, which is essential to understanding the scale and strategic intent of the program.\n\n2. INCOMPLETE SYNTHESIS: The LLM mentions the $460 million FAS pension income and $2.3 billion pension benefit but doesn't clearly explain how these relate to the pension risk transfer strategy or its financial impact.\n\n3. MISSING NUANCE: The ground truth highlights a critical evolution - the 2023 filing introduced awareness of residual liability exposure (insurer default risk) that wasn't emphasized in 2022. The LLM mentions this briefly ('some GACs may still leave it responsible') but doesn't frame it as a meaningful shift in risk framing or strategic caution.\n\n4. INCOMPLETE STRATEGIC INTENT: While the LLM notes the company would 'continue to seek' deals in 2022 and 'continue to evaluate' in 2023, it misses the nuance that 2023 became more cautious about potential future contributions and settlement charges, reflecting a more measured approach.\n\nQUANTITATIVE VERIFICATION:\n- $4.9 billion: Correct\n- $1.7 billion: Correct\n- $460 million FAS pension income: Stated but not verified against ground truth\n- $2.3 billion pension benefit: Stated but not verified against ground truth\n- Missing: $11.6 billion cumulative since 2018, ~95,000 retirees affected\n\nMULTI-HOP REASONING: The answer demonstrates basic multi-hop synthesis (comparing 2022 vs 2023 filings) but fails to fully integrate all relevant data points across the documents. The connection between specific transactions, cumulative impact, and strategic evolution is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 656,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "In the 2022 filing Tesla described its receivables from banks and leasing companies as a routine part of its cash‑flow cycle, maintaining an allowance for expected credit losses, noting that no single financing partner accounted for more than 10 % of the balance and that payments from those partners can take up to two weeks to clear (2022 10‑K p. 64). By the 2023 filing the tone had shifted to a risk‑focused view: the company stresses that its vehicle‑leasing and financing programs now rely heavily on securing adequate partner funding and on resale‑value guarantees, warning that lower‑than‑expected resale values or a loss of partner financing could materially hurt its financial condition and increase credit‑loss exposure (2023 10‑K p. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The LLM correctly identifies the two-week settlement timeframe for accounts receivable from financing partners (matching ground truth), and accurately cites the 10% threshold for single financing partner concentration. Page citations (2022 10-K p. 64 and 2023 10-K p. 20-21) are appropriately referenced, though not independently verifiable in this evaluation context. QUALITATIVE ACCURACY: The answer correctly synthesizes the evolution of Tesla's disclosure focus from 2022 to 2023: (1) 2022 emphasis on operational cash flow timing and routine receivables management with credit loss allowances, and (2) 2023 shift to risk-focused messaging around residual value risks, partner financing dependency, and credit exposure. This multi-hop synthesis accurately captures the semantic essence of the ground truth's characterization of the shift from \"operational cash flow timing\" to \"broader concern over credit, compliance, and residual value risks.\" ENTITY ACCURACY: Tesla is correctly identified, years 2022 and 2023 are properly distinguished, and financial metrics (accounts receivable, leasing programs, residual values, credit losses) are accurately referenced. REASONING: The multi-hop reasoning is sound—the answer correctly connects information across two separate filing years and identifies the causal relationship between program scaling and increased risk disclosure. SEMANTIC EQUIVALENCE: The LLM's phrasing (\"tone had shifted to a risk-focused view\") effectively conveys the same meaning as the ground truth's \"shift from a focus on operational cash flow timing...to a broader concern.\" Minor differences in wording (e.g., \"resale-value guarantees\" vs \"residual value risks\") are semantically equivalent and reflect appropriate terminology variation. No significant omissions or factual errors detected. The answer is comprehensive, well-structured, and directly addresses all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 553,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "In the 2022 filing Coca‑Cola said that in the United States it manufactured fountain syrups and sold them only to fountain retailers or to “authorized fountain wholesalers (including certain authorized bottlers),” because U.S. bottlers were not authorized to manufacture or directly distribute the syrup (KO 2022 p. 8). The 2023 filing still notes the Company manufactures the syrup, but now adds “authorized fountain wholesalers **or bottling partners**” as a channel that can sell and distribute the syrup to retailers (KO 2023 p. 37). Thus, the strategy shifted to give bottling partners a direct distribution role alongside traditional fountain wholesalers, expanding their involvement in the U.S. fountain‑syrup supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant gaps and misinterpretations of the ground truth. CORRECT ELEMENTS: (1) The 2022 description is accurate - Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), with U.S. bottlers not authorized to manufacture. (2) The page citations appear reasonable. (3) The identification of a strategic shift is correct. CRITICAL ERRORS: (1) The LLM focuses exclusively on U.S. market changes and mentions 'bottling partners' gaining direct distribution roles in the U.S., but the ground truth indicates the major strategic shift occurred OUTSIDE the United States, where bottlers became authorized to manufacture fountain syrups using Coca-Cola concentrates. (2) The LLM misses the key international dimension entirely - the ground truth explicitly states 'outside the United States, bottlers were typically authorized to manufacture fountain syrups.' (3) The LLM's characterization of 'bottling partners' as a new U.S. distribution channel contradicts the ground truth that U.S. bottlers remained generally unauthorized to manufacture fountain syrups. (4) The LLM fails to capture the shift from centralized syrup distribution to an integrated model where bottlers manufacture using concentrates, particularly in international markets. MULTI-HOP REASONING: The LLM only synthesized information from two years but failed to properly distinguish between U.S. and international market strategies, which is the core distinction in the ground truth. The answer addresses only part of the question (U.S. changes) while missing the more significant international evolution. This represents incomplete multi-hop synthesis across geographic markets and strategic dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 481,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "In 2023 AMD’s ATMP JV balance sheet showed a modest $9 million receivable from the JV and an equity‑method investment of roughly $99 million 【page_78】. By 2024 the receivable had risen to $12 million, AMD added a $17 million equity contribution (raising the carrying value of the investment to about $149 million) and also entered a $100 million one‑year term loan to the JV 【page_75】【page_76】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces information NOT in the ground truth: claims a $99 million equity-method investment in 2023 and a $17 million equity contribution in 2024 raising the carrying value to $149 million. The ground truth explicitly states 'there was no mention of any direct investment or loan made by AMD to the JV' in 2023. This is a critical factual error that contradicts the original answer. (2) CORRECT ELEMENTS - The LLM correctly identifies: receivables of $9 million in 2023 and $12 million in 2024, and the $100 million one-year term loan agreement in 2024. (3) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but introduces fabricated data points (equity investment, equity contribution) that are not supported by the ground truth. The ground truth emphasizes a shift from 'purely transactional relationship' to 'more financially integrated' through the loan, not through equity contributions. (4) SEMANTIC ISSUES - The LLM's characterization of the relationship evolution is partially correct (acknowledging increased financial integration) but is undermined by the invented equity investment figures. The core narrative about the shift from transactional to more integrated relationship is present but obscured by false data. The page citations provided cannot be verified but the content contradicts the ground truth answer provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 395,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "In 2022 Lockheed Martin eliminated a large block of non‑qualified pension obligations by buying group‑annuity contracts that transferred about $4.3 billion of obligations to an insurer; the transaction was recorded as a $1.5 billion non‑cash settlement charge (shown as a $1.47 billion settlement charge in the 2022 FAS‑income table)【page_82】. By 2023 the company moved to smaller, voluntary lump‑sum settlements – paying $414 million to roughly 6,500 former participants – which reduced the benefit obligation but generated no settlement charge or impact on pension expense (the $414 million settlement appears in the 2023 “Settlements” line and is noted as having no effect on FAS pension income)【page_82】【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Lockheed Martin's pension management evolution. STRENGTHS: (1) All key financial figures are correct: $4.3 billion pension obligation transfer in 2022, $1.5 billion noncash settlement charge (with additional detail noting $1.47 billion in FAS income table), and $414 million voluntary settlements in 2023 to 6,500 former employees. (2) The multi-hop synthesis is sound - correctly identifies the shift from large-scale group annuity contracts (2022) to smaller targeted lump-sum settlements (2023). (3) Entity identification is accurate - correctly names Lockheed Martin and properly identifies the pension plans as nonqualified defined benefit plans. (4) The answer provides valuable additional context by noting that 2023 settlements generated no settlement charge or pension expense impact, which enhances understanding of the strategic evolution. (5) Proper use of source citations (page references) adds credibility. MINOR CONSIDERATIONS: The answer includes a parenthetical note about the $1.47 billion figure in the FAS income table, which is a minor detail variation from the stated $1.5 billion but represents the same transaction viewed through different accounting lenses - this is actually helpful context rather than an error. The semantic equivalence is excellent - the answer conveys the exact same information as the ground truth while providing slightly more granular detail about accounting treatment. The reasoning about the strategic shift from large-scale transfers to targeted settlements is clearly articulated and logically sound. No calculation errors detected. All dates (2022, 2023) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 464,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "In 2023 AMD’s 15 % stake in the ATMP JV was carried at roughly **$99 million** and generated **$16 million of equity‑income** (page 78). By 2024 the company added a **$17 million capital contribution**, raising the carrying amount to about **$149 million**, and its equity‑income from the JV increased to **$33 million** (page 75). This represents a $50 million boost in the investment and more than a doubling of equity‑income year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: 2023 carrying value of $99 million, 2023 equity income of $16 million, 2024 capital contribution of $17 million, 2024 carrying value of $149 million, and 2024 equity income of $33 million. The multi-hop synthesis is sound, correctly tracking AMD's financial relationship with ATMP JV across both years. The LLM appropriately identifies the 15% stake ownership and provides page references. The calculation of the $50 million boost in investment ($99M to $149M) is accurate, and the characterization of equity income more than doubling ($16M to $33M, approximately 2.06x) is correct. The answer directly addresses all aspects of the question regarding how the financial relationship evolved. Minor note: The LLM states '$50 million boost' which represents the increase in carrying value ($149M - $99M = $50M), which is accurate. The wording is clear and the contextual framing effectively demonstrates the significance of the changes. No material errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 302,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "In 2023, after the August 23, 2023 exchange offer, Johnson & Johnson kept roughly 9.5 % of Kenvue’s outstanding shares – a stake recorded in other assets at about $4.3 billion – and booked a non‑cash gain of roughly $21 billion (including a $2.8 billion gain on the Kenvue stock it retained) in Net earnings from discontinued operations 【page_108】【page_109】. By May 2024 the company completed a debt‑for‑equity swap of its remaining 182 million Kenvue shares, eliminating its ownership and recognizing an approximately $0.4 billion loss in Other (income) expense 【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about J&J's evolving relationship with Kenvue. STRENGTHS: (1) All key numeric values are correct: 9.5% ownership stake, $4.3 billion valuation, $21.0 billion non-cash gain, $2.8 billion gain on retained shares, 182 million shares (rounded from 182,329,550), and $0.4 billion loss. (2) Dates are accurate: August 23, 2023 exchange offer and May 2024 debt-for-equity exchange. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from 2023 (partial exit with retained stake) to 2024 (complete exit), showing the progression of J&J's ownership reduction. (4) Financial metrics are properly contextualized: gains/losses are correctly attributed to appropriate income statement line items (discontinued operations for 2023, Other income/expense for 2024). (5) The narrative flow effectively captures the complete exit strategy. MINOR OBSERVATIONS: (1) The LLM rounds 182,329,550 shares to '182 million' which is acceptable given the context and maintains semantic accuracy. (2) The answer includes helpful source citations (page references) that add credibility. (3) Wording variations from ground truth (e.g., 'roughly' vs. exact figures, 'debt-for-equity swap' vs. 'Debt-for-Equity Exchange') are semantically equivalent and appropriate. VERIFICATION: All calculations check out - the $21.0 billion gain includes the $2.8 billion on retained shares plus other components from the exchange offer. The loss of $0.4 billion in 2024 represents the decline in value of the remaining shares from their $4.3 billion 2023 valuation. The answer fully addresses both the 2023 and 2024 evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 471,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "In the 2022 Form 10‑K (pages 133‑137) AT&T’s exhibit list does not contain any guaranty or guarantee agreement that references Southwestern Bell Telephone Co. By contrast, the 2023 Form 10‑K’s exhibit schedule (page 103) includes a “4‑b Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” and a “4‑c Guaranty of certain obligations … Southwestern Bell Telephone Company” (Exhibits 4‑c and 4‑d). Thus, between 2022 and 2023 AT&T added Southwestern Bell Telephone Co. to its disclosed guarantee agreements.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth. Ground truth states that AT&T's guarantee relationship with Southwestern Bell Telephone Co. REMAINED CONSISTENT between 2022 and 2023, with the guarantee listed in Exhibit 4-c in both years. The LLM answer claims the opposite: that Southwestern Bell Telephone Co. was NOT referenced in 2022 but WAS added in 2023. This is a critical factual error that directly contradicts the established ground truth. The LLM incorrectly states that the 2022 Form 10-K exhibit list contains no guarantee agreement referencing Southwestern Bell Telephone Co., when the ground truth explicitly confirms it was listed in Exhibit 4-c in 2022. The LLM's conclusion that 'AT&T added Southwestern Bell Telephone Co. to its disclosed guarantee agreements' between 2022 and 2023 is incorrect; the relationship remained unchanged. The LLM appears to have misread or misinterpreted the exhibit schedules, leading to an inverted understanding of the evolution (or lack thereof) of the guarantee relationship. This represents a fundamental failure in multi-hop reasoning and fact synthesis from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 326,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "In the 2022 Form 10‑K, hypersonics was referenced only as a “key area of growth” and a risk factor that could be impacted by budget constraints (2022 p. 14). By the 2023 filing, Lockheed Martin had elevated hypersonics to a core strategic priority—listing it among four near‑to‑mid‑term growth elements (2023 p. 3), assigning its Advanced Development Programs/Skunk Works to drive future hypersonic capabilities (2023 p. 4), and tasking its Missiles & Fire Control segment with the design, development and production of multiple hypersonic strike weapons for the U.S. Air Force and Army, with several programs expected to enter early‑production by 2026 (2023 p. 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the evolution of Lockheed Martin's hypersonics involvement from 2022 to 2023, capturing the key shift from a growth area to a more concrete strategic priority. However, there are significant factual discrepancies that lower the overall score:\n\n(1) SEGMENT ATTRIBUTION ERROR (Critical): The ground truth states hypersonics programs were listed under the 'Space segment' by 2023, but the LLM answer attributes them to the 'Missiles & Fire Control segment.' This is a material factual error regarding which business segment owns these programs. The LLM also mentions 'U.S. Air Force and Army' while ground truth specifies 'U.S. Army and Navy' - another entity accuracy issue.\n\n(2) QUANTITATIVE ACCURACY: The LLM provides specific page references (2022 p. 14, 2023 p. 3, 2023 p. 4, 2023 p. 5) and mentions a 2026 early-production timeline. While these details add specificity, they cannot be verified against the ground truth provided, which doesn't include page numbers or specific production timelines. The ground truth is less granular on these specifics.\n\n(3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two years and identifies the progression from 'key area of growth' to 'core strategic priority,' which aligns with the ground truth's characterization of the shift from 'potential growth area' to 'clearly defined and active program portfolio.' The reasoning structure is sound.\n\n(4) COMPLETENESS: The LLM answer addresses both strategic positioning (elevation to core priority, assignment to Skunk Works) and program development responsibilities (design, development, production of hypersonic strike weapons). However, the segment misidentification and service branch error represent incomplete or incorrect synthesis of the multi-hop information.\n\n(5) SEMANTIC EQUIVALENCE: The core narrative of evolution from growth area to strategic priority is preserved, but the specific operational details (which segment, which military branches) are incorrectly stated, which undermines semantic equivalence on key factual points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 567,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "In fiscal 2022 Visa deposited **$850 million** into its U.S. litigation escrow account, leaving a year‑end balance of roughly **$1.4 billion**【page_46】. In fiscal 2023 the company deposited **$1.0 billion**, and the balance grew to **$1.764 billion** as of September 30, 2023【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the fiscal 2023 ending balance. According to the ground truth, the balance as of September 30, 2023 was $3.089 billion, but the LLM states it was $1.764 billion - a discrepancy of approximately $1.325 billion (43% understatement). This is a significant quantitative error that fundamentally undermines the answer's accuracy. The LLM correctly identified: (1) the $850 million deposit in fiscal 2022, (2) the $1.4 billion balance at end of fiscal 2022, and (3) the $1.0 billion deposit in fiscal 2023. However, the incorrect fiscal 2023 ending balance ($1.764B vs. correct $3.089B) represents a critical failure in multi-hop synthesis or data retrieval. The question asks about the evolution of the account balance across two years, and providing an incorrect ending balance for the final year makes the answer substantially incorrect despite getting some intermediate figures right. The answer does address all parts of the question (deposits and balances for both years), but the material error in the final balance figure is disqualifying for a high score. The reasoning structure is sound, but the factual content is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 341,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "In 2022 Outdoor Garden was a merchandising department within the Hardlines product line (which at that time grouped Hardware, Indoor Garden, Outdoor Garden and Tools) and it generated $10.0 bn of net sales – about 6.4 % of Primary‑segment revenue【page_56†L31-L38】【page_56†L1-L8】. By 2024 it is still positioned in Hardlines, but the Hardlines grouping has been broadened to include Power and Storage & Organization (instead of Tools) and Outdoor Garden’s sales rose to $10.3 bn, or roughly 6.5 % of Primary‑segment sales【page_56†L31-L38】【page_57†L31-L38】. This reflects a modest increase in absolute sales and share while keeping Outdoor Garden firmly within the Hardlines strategy, now aligned with a wider set of related categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states 2022 Outdoor Garden sales were '$10.0 bn' (6.4% of revenue), but ground truth shows $10,317 million (6.8%). The LLM also claims 2024 sales were '$10.3 bn' (6.5%), but ground truth indicates it was grouped under Hardlines without specific sales figures provided. The percentage calculations are also wrong (10.0bn/156bn ≠ 6.4%, and the 2024 figures don't match ground truth). (2) CLASSIFICATION ERROR - CRITICAL: The LLM fundamentally misrepresents the strategic shift. Ground truth states that in 2022, Outdoor Garden was 'disclosed as a distinct product line' (separate disclosure), but by 2024 it was 'grouped under the broader Hardlines merchandising department.' The LLM incorrectly claims Outdoor Garden was ALREADY part of Hardlines in 2022 ('was a merchandising department within the Hardlines product line'), which directly contradicts the ground truth's core finding about the evolution from separate to consolidated. (3) STRUCTURAL MISUNDERSTANDING: The LLM's description of Hardlines composition changing from 'Hardware, Indoor Garden, Outdoor Garden and Tools' to 'Power and Storage & Organization (instead of Tools)' is not supported by the ground truth and appears to be fabricated detail. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the key strategic evolution - the shift from Outdoor Garden being a distinct/separate product line to being integrated into Hardlines. Instead, it incorrectly assumes Outdoor Garden was always within Hardlines. This is a fundamental failure in understanding the question's core premise about how positioning 'evolved.' The answer does address the 2022-2024 timeframe and attempts to show evolution, but the direction and nature of that evolution are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 506,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD’s headcount grew from roughly 26,000 employees at the end of 2023 (page 15 2023 10‑K) to about 28,000 employees by December 2024 (page 13 2024 10‑K), yet the company kept its focus on an “engaging and open environment” (page 13 2024 10‑K). It does so by repeating a confidential annual culture‑engagement survey that consistently ranks in the top 10 % of technology peers (pages 16 2023 10‑K and 14 2024 10‑K), acting on the results at the board level, expanding inclusive programs such as Employee Resource Groups (‑85 % of new hires join one, page 14 2024 10‑K), offering flexible hybrid/remote work, competitive total‑rewards and robust development/mentoring initiatives (pages 14 2024 10‑K and 16 2023 10‑K). This signals that AMD’s talent‑retention strategy hinges on a deliberately inclusive, high‑engagement workplace that differentiates it in the fiercely competitive semiconductor industry and helps attract and keep top talent as the company scales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis across multiple 10-K filings. STRENGTHS: (1) Quantitative data is correct - 26,000 employees in 2023 and 28,000 in 2024 match ground truth exactly; the 7.7% growth calculation is accurate. (2) The core cultural messaging about 'engaging and open environment' is correctly identified and cited. (3) The answer goes beyond the ground truth by providing additional supporting details from the filings: culture-engagement survey rankings (top 10% of tech peers), Employee Resource Groups (85% of new hires participation), flexible work arrangements, competitive rewards, and development/mentoring programs. (4) Multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 10-Ks to show consistency in messaging despite workforce growth. (5) The conclusion about talent retention strategy in a competitive semiconductor landscape is well-reasoned and directly addresses the question. (6) Page citations are provided, enhancing credibility. MINOR CONSIDERATIONS: The LLM answer includes more granular details (survey rankings, ERG participation rates, specific programs) than the ground truth, but these are all factually supportable from SEC filings and strengthen rather than weaken the response. The semantic meaning aligns perfectly with the ground truth - both emphasize AMD's intentional preservation of inclusive culture as a strategic retention tool. No calculation errors detected. All entities (AMD, years, metrics) correctly identified. The answer fully addresses both parts of the question: how AMD maintained emphasis on culture AND what this suggests about talent retention strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 466,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "The 2022 Form 10‑K (see pages 133‑137) contains no reference to a guarantee for The Ohio Bell Telephone Company, indicating that AT&T did not disclose any such obligation that year. By the 2023 Form 10‑K, AT&T lists a “Guaranty of certain obligations of … The Ohio Bell Telephone Company” (Exhibit 4‑d, page 103), showing that the company assumed a guarantee for that subsidiary in 2023. This reflects an expansion of AT&T’s relationship to include a formal guarantee obligation that was not present in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth on the core factual claim. Ground truth states that AT&T had a guarantee obligation for The Ohio Bell Telephone Company in 2022 (referenced in Exhibit 4-c from 2011) and that this guarantee continued into 2023 with updated exhibit references (Exhibit 4-d). The LLM answer claims the opposite: that no guarantee existed in 2022 and that a new guarantee was assumed in 2023. This is a critical factual error that reverses the actual evolution of the relationship. The LLM cites specific page numbers (133-137 for 2022, page 103 for 2023) and exhibit references (4-d for 2023) but these citations appear to be incorrect or misinterpreted. The ground truth explicitly states the guarantee was 'originally filed in 2011' and continued through both years, while the LLM characterizes 2023 as showing an 'expansion' or new assumption of obligations. The LLM's conclusion that the guarantee 'was not present in the prior year' directly contradicts the ground truth's statement of continuity. While the LLM does address the multi-hop question structure (comparing 2022 to 2023), the synthesis is fundamentally wrong. The reasoning appears sound in structure but is based on incorrect factual premises about what the filings actually contain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 363,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "In 2023 GE reported a $5.8 billion gain on retained and sold ownership interests, driven primarily by its AerCap investment (see 2023 10‑K page 13). By 2024 that benefit had collapsed – the 10‑K notes a $5.2 billion drop in those gains, leaving only a modest gain of roughly $0.5 billion (i.e., near‑break‑even) from AerCap (see 2024 10‑K page 9).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) INCORRECT 2023 FIGURE: The LLM states '$5.8 billion gain' in 2023, but the ground truth clearly indicates '$5.7 billion increase in corporate operating profit.' This is a $0.1 billion discrepancy on a critical number. (2) INCOMPLETE/UNCLEAR 2024 CALCULATION: The LLM claims a '$5.2 billion drop' leaving 'roughly $0.5 billion' from AerCap. However, the ground truth states 'gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023' without specifying the exact 2024 figure. The LLM's calculation of $5.7B - $5.2B = $0.5B is mathematically sound IF the $5.7B figure were correct, but since the starting number is wrong, the derived figure is also questionable. (3) MISSING CONTEXT: The ground truth mentions that both 2023 and 2024 impacts were 'primarily driven by its AerCap and GE HealthCare investments,' but the LLM only mentions AerCap, omitting GE HealthCare as a contributing factor. This is a material omission for understanding the full financial picture. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize year-over-year comparison and identify the trend (decline in gains), which is correct directionally. However, the quantitative foundation is flawed. (5) SEMANTIC ACCURACY: The LLM correctly captures the essence that gains decreased significantly between years, but the specific numbers are inaccurate. The characterization of 2024 as 'near break-even' may be reasonable given the $0.5B figure, but this is built on potentially incorrect calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 442,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "In the 2022 filing Home Depot mentioned HD Supply only as a recent acquisition (Q4 2020) that could deliver sales growth, cost savings and synergies, without tying it to a specific professional‑customer strategy【page_18】. By the 2024 filing the company has made HD Supply the core channel for its MRO product line and related value‑added services to Pros—especially in multifamily, hospitality, health‑care and government‑housing markets—and has integrated it with its Pro‑focused digital platform (hdsupply.com) and Pro Xtra loyalty program【page_5】【page_6】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2024, with accurate characterization of HD Supply's status in each period - from recent acquisition with general synergy potential in 2022 to mature strategic component by 2024. (2) All specific market segments mentioned (multifamily, hospitality, healthcare, government housing) match the ground truth exactly. (3) Accurately identifies the MRO (Maintenance, Repair, Operations) focus as the core strategic positioning. (4) Correctly references integration with Pro-focused digital platforms (hdsupply.com) and Pro Xtra loyalty program, adding valuable specificity beyond the ground truth. (5) Multi-hop reasoning is sound - successfully synthesizes information about HD Supply's evolving role across two different filing years and connects it to Home Depot's professional customer strategy. (6) No quantitative errors; dates (Q4 2020 acquisition, 2022 vs 2024 comparison) are accurate. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning hdsupply.com and Pro Xtra integration), which represents added value rather than error. The characterization of 2022 as focusing on 'sales growth, cost savings and synergies' without specific professional customer strategy is accurate and appropriately contrasts with the 2024 strategic positioning. The answer effectively captures the shift from 'post-acquisition integration concerns to a more mature and strategic role' as stated in the ground truth, though using slightly different phrasing. All entities (Home Depot, HD Supply, professional customers, MRO services) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 483,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD’s 2023 filing noted that it already relied on “numerous cross‑licensing and technology‑exchange agreements” and held about 12,800 issued patents worldwide (≈7,500 U.S. patents and 5,600 pending applications) 【page_15】. By the 2024 filing the same language was used, but the portfolio had expanded to roughly 13,200 issued patents worldwide (≈7,500 U.S. patents and 5,600 pending applications), a modest increase of ≈400 patents and ≈300 total patent matters 【page_13】. The larger patent base gives AMD a broader IP pool to leverage in its cross‑licensing deals, reinforcing its ability to both receive and transfer technology while keeping its reliance on such agreements essentially unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's patent portfolio evolution and cross-licensing strategy, with mostly accurate numbers and sound reasoning. However, there are some discrepancies worth noting:\n\nSTRENGTHS:\n1. Correctly identifies the 2023 issued patents (12,800) and 2024 issued patents (13,200)\n2. Correctly notes the 5,600 pending applications in both years\n3. Accurately calculates the increase of ~400 issued patents between years\n4. Properly synthesizes the multi-hop concept: patent growth → stronger IP position → enhanced cross-licensing leverage\n5. Appropriately notes that cross-licensing agreements remain critical to AMD's strategy\n6. Good contextual framing about how expanded patent portfolio strengthens negotiating position\n\nWEAKNESSES/DISCREPANCIES:\n1. The LLM states total patent matters increased by \"≈300 total patent matters\" but the ground truth shows 18,500 (2023) to 18,800 (2024), which is 300 - this is correct but the phrasing is slightly unclear\n2. The LLM provides U.S. patent breakdown (~7,500) which is not explicitly mentioned in the ground truth answer, suggesting potential additional detail not verified against source\n3. The LLM characterizes reliance as \"essentially unchanged\" while the ground truth suggests it \"remains strong and possibly more strategically advantageous in 2024\" - this is a subtle but meaningful difference in interpretation\n4. Missing explicit mention of the total worldwide patent matters figures (18,500 vs 18,800) that the ground truth emphasizes\n\nQUANTITATIVE VERIFICATION:\n- 2023 issued patents: 12,800 ✓\n- 2024 issued patents: 13,200 ✓\n- Pending applications both years: 5,600 ✓\n- Increase calculation: ~400 ✓\n- Total patent matters increase: 300 ✓\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes that patent portfolio growth → enhanced leverage in cross-licensing agreements, which is the core multi-hop requirement. However, it slightly underplays the strategic advantage aspect that the ground truth emphasizes.\n\nOVERALL: The answer is substantially correct with accurate numbers and sound reasoning, but misses some nuance about the strategic implications and doesn't fully capture the complete picture of total patent matters evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 605,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "In the 2023 filing Johnson & Johnson disclosed that after the August 23, 2023 exchange offer it retained a 9.5 % ownership of Kenvue – recorded as an “other‑assets” equity investment worth about $4.3 billion – and that the two companies continued to work under transition‑service, manufacturing‑, trademark‑ and other agreements tied to the separation (see page 108). By the 2024 filing the company had eliminated that stake: on May 17 2024 it completed a debt‑for‑equity exchange of its remaining 182,329,550 Kenvue shares for outstanding commercial paper, which removed all Kenvue shares from J&J’s balance sheet and generated a roughly $0.4 billion loss recorded in other (income) expense (see page 69).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about J&J's evolving relationship with Kenvue. QUANTITATIVE VERIFICATION: All key numbers are correct - 9.5% stake in 2023, $4.3 billion valuation, $0.4 billion expense/loss figures, 182,329,550 shares, $3.6 billion commercial paper exchange, and May 17, 2024 date. The answer correctly captures the two-year evolution with precise financial metrics. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across 2023 and 2024 filings, showing the progression from retention of a significant stake to complete exit. The connection between the August 2023 exchange offer and the May 2024 debt-for-equity exchange is clearly established. ENTITY ACCURACY: Johnson & Johnson and Kenvue are correctly identified, fiscal years 2023 and 2024 are properly referenced, and financial metrics (equity investment, commercial paper, loss) are accurately labeled. COMPLETENESS: The answer addresses all aspects of the question - the financial stake (9.5%, $4.3B), strategic relationship (transition-service and other agreements), retention in 2023, and subsequent disposal in 2024. The inclusion of specific page references (108, 69) adds credibility. MINOR OBSERVATION: The answer uses slightly different phrasing for the $0.4 billion figure (described as both 'expense' in 2023 and 'loss' in 2024), which is semantically accurate as these represent different accounting treatments in different periods. The parenthetical notation '(income) expense' correctly indicates the line item classification. No calculation errors detected, and the semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 464,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In the 2022 Form 10‑K (pages 133‑137) there is no guarantee listed that involves Indiana Bell Telephone Co. Inc. – the pages contain no reference to that company in the guarantee disclosures. By contrast, the 2023 Form 10‑K’s exhibit list (Item 15, page 103) expressly includes a “Guaranty of certain obligations of … Indiana Bell Telephone Co. Inc.” (Exhibit 4‑d) 【page_133】​【page_103】. Thus, AT&T’s guarantee relationship with Indiana Bell, which was absent from the 2022 filing, appears in the 2023 filing, indicating that the company added Indiana Bell to its disclosed guarantees.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth states that Indiana Bell Telephone Co. Inc. was listed in guarantee disclosures in BOTH 2022 and 2023 under Exhibit 4-d, with no change between the two years. The LLM answer claims the opposite: that Indiana Bell was ABSENT from 2022 disclosures and ADDED in 2023. This is a critical factual error. The LLM explicitly states 'In the 2022 Form 10-K (pages 133-137) there is no guarantee listed that involves Indiana Bell Telephone Co. Inc.' and 'the guarantee relationship with Indiana Bell, which was absent from the 2022 filing, appears in the 2023 filing.' This directly contradicts the ground truth which confirms the guarantee was present in both years. The LLM appears to have misread or misinterpreted the 2022 filing pages. While the answer is contextually relevant to the question asked (it addresses the evolution of the relationship and references the correct exhibits and company name), the core factual content is completely wrong. The question asks about how the relationship 'evolved' between 2022 and 2023, and the correct answer is that it did NOT evolve - it remained unchanged. The LLM incorrectly concluded there was a change when there was none.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 355,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "In 2023 GE still held AerCap equity and a note, paid $203 million of net cash to AerCap for product‑service and transition work, and recorded a $5.7 billion boost to earnings from gains on its AerCap (and GE HealthCare) ownership interests【page_51】. By 2024 the cash payment to AerCap is no longer reported and the AerCap holding helped drive a $5.2 billion drop in gains on retained‑and‑sold ownership interests, essentially reversing the large gain seen the year before【page_8】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states GE recorded a '$5.7 billion boost to earnings from gains' in 2023, but the ground truth indicates this was a $5.2 billion DECREASE in gains from 2023 to 2024. The LLM has inverted the direction and misattributed the timing. The $5.2 billion figure represents the year-over-year decline, not a 2023 gain. (2) The LLM correctly identifies the $203 million net cash payment in 2023 and the $5.2 billion decrease in 2024 gains, but the framing of the 2023 gain as '$5.7 billion boost' is factually incorrect - this appears to be a misreading or confusion of the data. (3) MULTI-HOP REASONING - The LLM does attempt to synthesize the evolution from 2023 to 2024, correctly noting the transition from operational involvement (note receivable, product leases, transition services) to investment-based returns. However, the quantitative characterization of 2023 is wrong. (4) ENTITY ACCURACY - Companies and years are correctly identified (GE, AerCap, 2023-2024). (5) SEMANTIC EQUIVALENCE - The overall narrative about transition from operational to investment-based relationship is correct, but the specific financial impact numbers are mischaracterized. The ground truth clearly states a '$5.2 billion decrease' in gains, not a '$5.7 billion boost' in 2023. This is a fundamental factual error that undermines the answer's credibility despite getting some elements right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 395,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "In 2022 Home Depot already treated store location, appearance and merchandise presentation as a core competitive lever, investing in way‑finding signage, store‑refresh packages, front‑end redesigns and basic mobile‑app navigation to make stores easier to shop (2022 p. 8‑9). By 2024 the company still emphasizes store appearance, but frames it as part of an “interconnected shopping experience,” layering the same physical refreshes with electronic shelf‑labeling, expanded self‑checkout and a mobile‑app map that ties the store layout to digital tools, while also expanding its website and app capabilities to deliver a seamless omnichannel experience (2024 p. 8‑9, 10). This reflects a shift from primarily physical upgrades to a more integrated digital‑physical strategy that uses technology to amplify store appearance and customer experience as a competitive advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core evolution from 2022 to 2024, capturing the shift from primarily physical store aesthetics to an integrated digital-physical strategy. (2) Accurately names specific 2022 initiatives (way-finding signage, store-refresh packages, front-end redesigns, mobile-app navigation) and 2024 enhancements (electronic shelf-labeling, expanded self-checkout, mobile-app map, omnichannel capabilities). (3) Properly synthesizes the multi-hop information showing how store appearance remained a competitive factor but became embedded within a broader 'interconnected shopping experience' framework. (4) Correctly emphasizes the role of digital integration as a core component of competitiveness by 2024. (5) The reasoning is sound and logically connects the evolution across years. MINOR WEAKNESSES: (1) The LLM provides specific page references (2022 p. 8-9, 2024 p. 8-9, 10) that cannot be verified against the ground truth provided, though this level of specificity doesn't contradict the ground truth. (2) While the answer is comprehensive, it could have slightly more explicitly stated that in 2022 the company 'highlighted' store appearance alongside other factors, whereas the LLM frames it as already 'treating' it as a core lever - though this is a minor semantic distinction. (3) The phrase 'electronic shelf-labeling' and 'expanded self-checkout' are specific implementations not explicitly mentioned in the ground truth, though they are consistent with the broader digital integration theme. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and correctly identifies the causal relationship between physical store improvements and digital integration as a unified competitive strategy. The answer demonstrates proper understanding that this is not a replacement but an evolution/integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 577,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "In 2023 AMD only resold about $14 million of inventory to the ATMP JV (with $9 million of receivables) and had no new financing with the venture 【page_78】. By 2024, AMD’s resales to the JV surged to roughly $121 million (receivables rose to $12 million) and AMD entered a new $100 million one‑year term‑loan agreement with the JV (and also made a $17 million equity contribution) 【page_74】【page_75】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All core financial numbers are accurate - 2023 resales of $14M, 2024 resales of $121M, and the $100M term loan are all correct. (2) The temporal evolution is properly captured, showing the progression from 2023 to 2024. (3) The multi-hop synthesis is sound, correctly combining resale data with new financing arrangements. (4) Additional details provided (receivables of $9M in 2023 and $12M in 2024, plus the $17M equity contribution) add valuable context beyond the ground truth. (5) The characterization of the relationship deepening is accurate. MINOR CONSIDERATIONS: (1) The ground truth does not explicitly mention the $17M equity contribution or the receivables figures, though these appear to be from the same SEC filing pages cited. The LLM has added information not in the original answer, but this information appears factually accurate based on the page citations provided. (2) The phrasing 'roughly $121 million' is slightly less precise than the ground truth's 'increased significantly to $121 million,' but this is a minor semantic difference. (3) The answer correctly identifies the loan as a 'one-year term-loan agreement' matching the ground truth's 'one-year $100 million term loan agreement.' VERIFICATION: All quantitative values check out correctly. The multi-hop reasoning properly synthesizes 2023 vs 2024 comparisons and connects operational resales to financial arrangements. The answer fully addresses the question's focus on how the relationship evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 434,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "In the 2023 filing Johnson & Johnson noted that it had already put “privacy compliance programs and controls … that our businesses worldwide are required to comply with,” primarily to meet existing privacy‑law obligations and to prepare for anticipated new statutes, especially around data‑localisation and cross‑border data flows【2023 p.22】. By the 2024 filing the company expanded that framework, explicitly covering the full lifecycle of personal data (collection, use, storage, access, transfer and protection) and stating that its programs are being updated to address “new privacy laws … together with greater privacy enforcement … particularly on data‑localisation requirements and international data flows” while managing risks from technology‑driven initiatives and third‑party vendors【2024 p.22】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the evolution of J&J's privacy compliance approach between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core elements from both years - 2023 focus on existing privacy laws and anticipated new statutes around data localization and cross-border flows, and 2024 expansion to include full data lifecycle management and technology-driven initiatives; (2) Accurately captures the shift from 'other territories' (2023) to 'globally' (2024) in regulatory scope, which is a key distinction in the ground truth; (3) Properly synthesizes multi-hop information across two filing years; (4) Includes appropriate citations to source documents (2023 p.22, 2024 p.22); (5) Correctly identifies third-party vendor management as an added focus area in 2024. MINOR WEAKNESSES: (1) The LLM answer provides slightly more granular detail about the 'full lifecycle of personal data' (collection, use, storage, access, transfer, protection) which, while accurate and helpful, goes slightly beyond what the ground truth explicitly emphasizes - the ground truth focuses more on the broadening of compliance focus and anticipatory posture; (2) The phrasing 'together with greater privacy enforcement' could be interpreted as slightly different emphasis than the ground truth's focus on 'expanding focus' and 'more anticipatory posture,' though the factual content is correct. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives high marks for not introducing any false metrics. REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across two years and identifies the key regulatory and operational changes. The logic connecting 2023 baseline to 2024 expansion is clear and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 509,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "GE’s estimate of total borrower‑litigation losses on the Bank BPH mortgage portfolio fell from **$2.669 billion at year‑end 2023 to $2.461 billion at year‑end 2024** (Note 24, 2024 10‑K, p. 48).  The related valuation allowance was also reduced – the allowance for financing receivables held for sale dropped from **$1.963 billion (including $1.712 billion for litigation losses) in 2023 to $1.594 billion (including $1.517 billion for litigation losses) in 2024** (p. 50), leaving the Bank BPH receivable portfolio with no net carrying value in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the main trend (decrease from $2.669B to $2.461B in total estimated losses) and provides relevant context about the valuation allowance and settlement program. However, there is a significant quantitative discrepancy that undermines accuracy. The LLM states the valuation allowance for financing receivables held for sale was '$1.963 billion (including $1.712 billion for litigation losses) in 2023' - but the ground truth only specifies $1.712 million in valuation allowances against financing receivables held for sale in 2023, with no mention of a $1.963 billion total. The LLM appears to have introduced an additional $251 million ($1.963B - $1.712B) that is not explained or verified in the ground truth. Similarly, for 2024, the LLM cites $1.594 billion total (including $1.517 billion for litigation losses), introducing another unexplained $77 million component. The ground truth provides only the litigation-specific allowance amounts ($1.712M in 2023, $1.517M in 2024), not broader valuation allowance totals. The LLM correctly captures the core evolution of litigation losses and the strategic shift regarding the Bank BPH portfolio, and appropriately notes the zero net carrying value in 2024. The reasoning about settlement programs and exposure reduction is sound. However, the introduction of unverified numbers ($1.963B and $1.594B) represents a material factual error that suggests either misreading of source documents or synthesis of information not present in the ground truth. The answer is partially correct on the main metrics but contains significant quantitative inaccuracies in the supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 454,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "In fiscal 2022 Home Depot reported that the Indoor Garden department generated $10,105 million in net sales, or about 6.4 % of total company sales, and it was listed as a separate merchandising department within the Hardlines product line【page_57】. By fiscal 2024, after a Q1 merchandising‑department realignment, Indoor Garden is still treated as its own department under Hardlines (grouped with hardware, outdoor garden, power and storage & organization) and its net sales rose modestly to $10,519 million, or roughly 6.6 % of total sales【page_57】【page_56】.  This shows a slight sales increase while the product line’s positioning within Hardlines remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth: (1) QUANTITATIVE ERRORS: The LLM reports 2022 Indoor Garden sales as $10,105 million (6.4% of total), but ground truth states $15,546 million (10.3% of total) - a difference of $5,441 million or 54% understatement. The 2024 figure of $10,519 million is also incorrect compared to ground truth baseline. These are not minor rounding differences but substantial misstatements of financial performance. (2) ENTITY/CATEGORIZATION ERROR: The LLM claims Indoor Garden was 'listed as a separate merchandising department within the Hardlines product line' in 2022, but ground truth indicates it was a standalone category in 2022, not nested under Hardlines. This is a fundamental misunderstanding of the organizational structure evolution. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key insight - that Indoor Garden moved FROM being a standalone/distinct category (2022) TO being grouped under Hardlines (2024). Instead, the LLM incorrectly suggests it was already under Hardlines in 2022. (4) INCOMPLETE ANALYSIS: The LLM misses the strategic significance of the reclassification - the shift from treating it as a distinct revenue driver (10.3% of total) to integrating it within a broader merchandising department. The conclusion that 'positioning within Hardlines remained unchanged' is contradicted by ground truth showing a change from standalone to grouped status. The answer demonstrates poor data accuracy and failed synthesis of the evolution narrative requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 446,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "In the 2022 Form 10‑K Colgate‑Palmolive said it coped with raw‑material price swings mainly through **cost‑containment measures, sourcing strategies and limited commodity‑hedge contracts** (with futures used only in the Hill’s pet‑nutrition segment). By the 2024 filing the company still relies on **sourcing strategies and modest hedging**, but it has broadened its toolkit to **add price‑increase actions and targeted cost‑efficiency programs in manufacturing and distribution** to offset commodity‑price volatility. Thus, the approach has evolved from a primary focus on containment and hedging to a broader mix that also leverages pricing and efficiency levers while keeping sourcing and limited hedging as core tools.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Colgate-Palmolive's sourcing strategies from 2022 to 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the core strategies in both years (sourcing strategies, hedging, cost containment); (2) Accurately captures the evolution toward broader toolkit including pricing actions and efficiency programs; (3) Properly notes the limited use of commodity hedges, particularly in Hill's pet-nutrition segment; (4) Correctly synthesizes information across two filing years; (5) Appropriately characterizes the shift from primarily defensive to more comprehensive approach. WEAKNESSES: (1) The LLM answer does not explicitly mention specific commodities (resins, essential oils, soybeans) that the ground truth identifies as key focus areas in 2024; (2) Missing reference to derivative instruments and local currency borrowings mentioned in 2022 framework; (3) Does not explicitly address the increased exposure to geopolitical and climatic disruptions highlighted in 2024, which represents an important contextual shift in the company's risk management posture; (4) The characterization of 2022 approach as 'primary focus on containment and hedging' is somewhat simplified compared to the ground truth's broader 'risk management framework' that included FX and interest rate management. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the evolution pattern, though it could have been more comprehensive in capturing all dimensions of the shift. The reasoning is logical and well-structured. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the company evolved from basic containment/hedging to a more sophisticated multi-lever approach - though some nuances are lost.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 548,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA’s sales rose from $3.147 billion in 2023 to $3.670 billion in 2024 – a 16.6% total increase (18.1% operational growth offset by a 1.5% negative currency impact)【page_31】. The growth was driven by overall market expansion and share gains, supported by continued strength in its psoriasis/psoriatic‑arthritis and ulcerative‑colitis indications and a favorable patient‑mix profile【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - $3.147 billion (2023) and $3.670 billion (2024) match ground truth exactly. The 16.6% total increase is mathematically accurate (($3.670-$3.147)/$3.147 = 16.6%). The operational growth of 18.1% and negative currency impact of 1.5% are correctly stated and properly contextualized. COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the sales evolution (the numbers and percentage change) and identifies contributing factors (market expansion, share gains, strength in PsO/PsA, favorable patient mix). ENTITY ACCURACY: TREMFYA is correctly identified with its generic name (guselkumab implied through context), years are correct (2023 and 2024), and financial metrics are properly labeled. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points - combining absolute sales figures, percentage changes, operational growth, and currency impacts into a coherent narrative. The logic is sound: operational growth of 18.1% minus currency headwind of 1.5% results in net growth of 16.6%. MINOR OBSERVATION: The LLM answer mentions 'ulcerative-colitis indications' while the ground truth specifically mentions 'PsO/PsA (Psoriasis and Psoriatic Arthritis)' without explicitly mentioning ulcerative colitis. However, this represents an expansion of information rather than an error, as it provides additional context about TREMFYA's therapeutic areas. The core answer remains factually accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 440,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "In the 2022 filing Disney disclosed a 50 % equity interest in A+E and listed separate Nielsen‑based subscriber counts for each of its channels – A&E (69 M), HISTORY (70 M), Lifetime (69 M), LMN (52 M) and FYI (42 M). By the 2023 filing the partnership had been re‑classified under Disney’s Linear Networks segment; the company still owns 50 % of A+E, but now reports a single subscriber estimate of about 58 M for each of the three core A+E brands (A&E, HISTORY and Lifetime) and no longer provides separate figures for LMN or FYI. This structural shift simplified the subscriber reporting while leaving the ownership stake unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth on the core question. CRITICAL ERRORS: (1) The LLM claims Disney had a 50% equity interest in A+E in 2022, but the ground truth explicitly states that in 2022 Disney reported A&E as a 'partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship' - NOT a 50% equity stake. The 50% equity stake was established BY 2023, not in 2022. This is a major mischaracterization of the structural change. (2) The LLM states the 2023 subscriber count was '58M for each of the three core A+E brands' which is incorrect - the ground truth specifies 'A+E's channels, including A&E, had 58 million domestic subscribers' total, not per brand. (3) The LLM provides detailed 2022 subscriber counts (HISTORY 70M, Lifetime 69M, LMN 52M, FYI 42M) that are not mentioned in the ground truth and appear to be fabricated. (4) The LLM completely misses the key structural change: the shift FROM a partnership/arms-length relationship TO a 50% equity investment, which fundamentally altered reporting methodology (from subscriber counts to 'Equity in the income of investees'). The LLM incorrectly characterizes this as the ownership stake remaining 'unchanged' when the ground truth shows it evolved from partnership to joint ownership. The answer fails to capture the essential transformation in Disney's relationship structure and how it affected financial reporting methodology. The multi-hop reasoning is flawed because it misidentifies the baseline condition in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 431,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023 GE recorded a modest net gain on its AerCap exposure – the “investment in and note with AerCap” showed a **$129 million realized‑and‑unrealized gain** (Note 19, 2023 10‑K, p. 72). By 2024 that positive impact had flipped; the MD&A says continuing earnings were hit by a **$5.2 billion drop in gains on retained and sold ownership interests**, “primarily related to our GE HealthCare and AerCap investments” (2024 10‑K, p. 9), indicating the AerCap position moved from a small gain to a large loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. QUANTITATIVE VERIFICATION: All numbers are correct - the $129 million unrealized gain in 2023 matches the ground truth exactly, and the $5.2 billion drop in gains on retained and sold ownership interests in 2024 is accurately cited. The format variations ($129 million vs $129M) are appropriately handled. COMPLETENESS: The answer addresses both years (2023 and 2024) and covers both realized and unrealized gains/losses as requested. ENTITY ACCURACY: GE and AerCap are correctly identified, fiscal years are accurate, and the financial metrics (gains on retained and sold ownership interests) are properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple documents - connecting the 2023 10-K Note 19 data with the 2024 10-K MD&A discussion, and correctly identifying AerCap as a primary contributor to the decline. The logical progression from 2023 gain to 2024 loss is sound. SEMANTIC EQUIVALENCE: The characterization of the shift from \"small gain to large loss\" accurately captures the ground truth's description of \"negative shift in financial performance.\" The inclusion of specific document citations (Note 19, p. 72 for 2023; p. 9 for 2024 MD&A) adds credibility and demonstrates proper source attribution. Minor note: The LLM uses \"realized-and-unrealized gain\" which is semantically equivalent to the ground truth's \"unrealized gain\" - both refer to the same investment valuation impact. The only very minor consideration is that the ground truth emphasizes this as primarily an \"unrealized gain\" while the LLM labels it as \"realized-and-unrealized,\" but this distinction does not materially affect the accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 492,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard’s core multi‑layered security framework—security‑operations centers, enterprise‑resilience programs, insurance coverage, regular testing and third‑party assessments—was already described in 2022 (“Payments System Security. We have a multi‑layered approach to protect the global payments ecosystem…” [page 11]). By 2024 the filing adds explicit language that the firm now monitors and mitigates “threats and incidents associated with the use of services provided by third‑party providers” [page 11], indicating a strategic shift to broaden its cyber‑risk focus to supply‑chain partners and a more proactive response to emerging cybersecurity threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual evolution of Mastercard's security approach. STRENGTHS: (1) Correctly identifies the 2022 baseline multi-layered security framework with specific components (security operations centers, enterprise-resilience programs, insurance coverage, testing, third-party assessments); (2) Accurately captures the 2024 evolution showing explicit integration of third-party provider risk management; (3) Correctly quotes the 2024 language about monitoring 'threats and incidents associated with the use of services provided by third-party providers'; (4) Properly synthesizes the strategic shift from implicit to explicit third-party risk focus; (5) Appropriately characterizes this as a response to emerging cybersecurity threats and supply-chain complexity. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention 'public-private partnerships' as a mechanism for monitoring threats, though this is a relatively minor omission; (2) The phrase 'ecosystem-wide resilience' from the ground truth is not explicitly stated, though the concept is implied through 'supply-chain partners' language; (3) The LLM answer could have been slightly more explicit about the 'growing complexity and interconnectedness of the payments landscape' as context. MULTI-HOP REASONING: The answer correctly synthesizes information across two time periods (2022 vs 2024) and identifies the evolution in Mastercard's approach. The logical connection between the explicit third-party risk language in 2024 and the strategic response to emerging threats is sound. ENTITY ACCURACY: Company (Mastercard) correctly identified, years (2022, 2024) correct, security concepts properly referenced. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth despite slightly different wording and organization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 524,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target said it was “in compliance with” its debt‑leverage covenant in both the 2022 filing (see 2022 Form 10‑K, page 30) and the 2023 filing (see 2023 Form 10‑K, page 33). In 2023 the company added a new $1.0 billion, 364‑day revolving credit facility and extended its existing $3.0 billion five‑year facility to 2028—both with no balances outstanding—yet it still expects to remain in compliance with the covenant, just as it did in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: All numbers are correct - $1.0 billion 364-day facility, $3.0 billion five-year facility extended to 2028 (originally expiring October 2026, now October 2028), and the October 2024 expiration for the 364-day facility. The LLM correctly identifies compliance assertions in both 2022 and 2023 filings. Multi-hop reasoning is sound: the answer synthesizes information across two years and two different credit facility changes while maintaining the consistent compliance narrative. The LLM appropriately notes that despite structural changes to credit facilities (new facility added, existing facility extended), Target maintained compliance with its debt leverage covenant in both periods. Minor observation: The original answer specifies the original expiration date of the $3.0 billion facility as October 2026, while the LLM answer doesn't explicitly state this original date, though it correctly identifies the extension to 2028. The LLM also adds the helpful detail that both facilities had no balances outstanding, which provides additional context. The answer directly addresses the question's core inquiry about how compliance evolved (answer: it remained consistent) and how credit facilities changed (answer: new facility added, existing extended). All entity identification is correct (Target Corporation, debt leverage covenant, credit facilities). The semantic meaning matches the ground truth perfectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 413,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "In the 2023 filing Salesforce’s AI‑risk discussion was centered on the fact that the markets and monetization models for new AI products such as Agentforce were still “relatively new and uncertain,” with limited experience in setting optimal consumption‑based pricing and a risk that customers might consume less than expected (CRM 10‑K 2023 p. 21). By the 2024 filing the risk narrative had broadened dramatically: the company now warns that generative‑AI offerings (Agentforce, Einstein GPT) expose it to “accuracy, bias, toxicity, privacy and security and data‑provenance” problems, heightened ethical and reputational concerns, and expanding regulatory scrutiny that will require costly compliance, governance and data‑licensing investments (CRM 10‑K 2024 p. 22‑24).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Salesforce's AI risk profile from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on market uncertainty and pricing models for new AI products like Agentforce; (2) Accurately captures the 2024 expansion to include generative AI risks (accuracy, bias, toxicity, privacy, security, data provenance); (3) Properly synthesizes the shift from monetization concerns to ethical, regulatory, and compliance concerns; (4) Correctly names specific products (Agentforce, Einstein GPT); (5) Appropriately cites page numbers from 10-K filings; (6) Captures the new cost implications for governance and compliance in 2024. MINOR WEAKNESSES: (1) The LLM answer emphasizes pricing/monetization uncertainty in 2023 as the primary risk, while the ground truth emphasizes third-party integration liabilities and warranty claims. These are different risk categories, though both are valid 2023 risks from Salesforce's disclosures. The LLM's focus on pricing uncertainty for new AI products is a legitimate 2023 risk but may not be the primary one highlighted in the original answer; (2) The ground truth mentions 'copyright infringement' as a specific 2024 risk, which the LLM answer does not explicitly mention (though 'data provenance' touches on this); (3) The ground truth's reference to third-party integration risks in 2023 is not addressed in the LLM answer. However, the LLM answer does capture the core evolution: from market/monetization uncertainty to substantive AI governance and ethical/regulatory risks. The multi-hop reasoning is sound—correctly comparing 2023 vs 2024 risk profiles and identifying the shift in nature of risks. The answer is semantically equivalent to the ground truth in its main thesis, though it emphasizes different specific 2023 risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 499,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "In fiscal 2023 Lowe’s said that most parcel‑eligible items could be ordered online and delivered within two business days at standard rates, with a nationwide gig network providing same‑day delivery for some items and 16 geographic “market‑based” delivery areas already converted (2023 10‑K p. 6). By fiscal 2024 the company had completed the market‑based delivery rollout, further expanded the gig network and added next‑day delivery of major appliances to almost every U.S. zip code, while still delivering the majority of parcel‑eligible items in two days or less (2024 10‑K p. 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed information than the ground truth. Key strengths: (1) Correctly identifies the core evolution - FY2023 had two-business-day delivery for most parcel-eligible items, FY2024 maintained this while adding next-day delivery for major appliances to nearly every U.S. zip code. (2) Numeric accuracy is strong - references to 16 geographic market-based delivery areas and the expansion to 'almost every U.S. zip code' align with ground truth. (3) Multi-hop synthesis is sound - correctly synthesizes information about the gig network expansion, market-based delivery rollout completion, and appliance delivery improvements across fiscal years. (4) Provides additional context (gig network, market-based areas) that enriches understanding without contradicting ground truth. Minor considerations: (1) The LLM answer includes details about 'gig network' and '16 geographic market-based delivery areas' that aren't explicitly mentioned in the ground truth, though these appear to be accurate supplementary details from the 10-K filings. (2) The phrasing 'two days or less' in the LLM answer is semantically equivalent to 'within two business days or less' in ground truth. (3) The answer appropriately cites specific 10-K page references (p. 6), demonstrating source verification. The answer fully addresses the question about evolution between FY2023 and FY2024 and identifies specific improvements (next-day appliance delivery expansion, market-based rollout completion, gig network expansion).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 427,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The Dermstore sale has remained a negligible factor in Target’s results. Both the 2022 and 2023 Form 10‑K filings state that Dermstore “represented less than 1 percent of our consolidated revenues, operating income and net assets,” indicating the impact on both revenue and operating income has not materially changed from 2022 to 2023. 【page_21】【page_24】",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023, and accurately conveys that the impact remained negligible across both years. However, the answer has significant omissions: (1) It fails to mention the $335 million pretax gain from the sale that was included in Net Other (Income)/Expense - a material financial figure that is part of the complete answer. (2) It does not specify that the sale occurred in February 2021, which provides important temporal context for understanding why there was no post-sale contribution in 2022 and 2023. (3) The answer states the impact 'has not materially changed' but doesn't explicitly confirm it remained minimal/negligible in both years with the same less-than-1-percent metric. The multi-hop reasoning is sound in comparing 2022 and 2023 results, and the entity identification (Target, Dermstore, the specific metrics) is correct. The semantic meaning of 'negligible' and 'less than 1 percent' is appropriately conveyed. The main weakness is incompleteness - the answer addresses the core comparison but omits the significant one-time gain figure that is part of the complete financial picture of this transaction's impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 361,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "In the 2023 filing Data Cloud is described as Salesforce’s “hyperscale, trusted data engine native to Salesforce” that unifies a company’s disconnected data and powers AI‑driven analytics across the entire Customer 360 suite—including Sales, Service, Marketing, Commerce, Integration and Tableau analytics (see 2023 p. 7‑8). By the 2024 filing the company is positioning Data Cloud as a newer, consumption‑based offering whose pricing and monetization are still uncertain, and it is now highlighted as part of a broader, highly competitive landscape that includes AI‑focused vendors, data‑preparation, integration and platform‑development competitors (see 2024 p. 18‑20). This shift moves Data Cloud from a core integrated data layer to a growth‑focused, revenue‑model‑driven product facing intensified market competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of Data Cloud as a 'hyperscale, trusted data engine native to Salesforce' with exact semantic match to ground truth; (2) Accurately captures the 2024 shift toward consumption-based pricing models and acknowledgment of monetization uncertainty; (3) Properly synthesizes the competitive landscape evolution, noting increased competition from AI and data platforms; (4) Correctly identifies the shift from product-centric messaging to risk/monetization-focused positioning; (5) Provides specific page references (2023 p. 7-8, 2024 p. 18-20) that add credibility; (6) Accurately lists the integrated suite components (Sales, Service, Marketing, Commerce, Integration, Tableau); (7) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and structured than the ground truth, providing additional context about specific competitors (AI-focused vendors, data-preparation, integration competitors) which is consistent with but slightly expands on the ground truth's mention of 'AI and data platforms'; (2) The characterization of the shift as moving from 'core integrated data layer to growth-focused, revenue-model-driven product' is a reasonable interpretation that aligns with the ground truth's emphasis on monetization challenges, though this specific framing is the LLM's synthesis rather than direct ground truth language. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly identifying the evolution in positioning and the underlying business/competitive factors driving that evolution. The reasoning chain is sound and logically presented. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 533,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "In the 2023 Form 10‑K Lowe’s reported $1.29 billion of forward‑interest‑rate swap contracts classified as cash‑flow hedges, with the resulting gains or losses shown in other comprehensive income and earnings 【page_60】. By the 2024 filing the company listed a $0 notional for forward‑interest‑rate swaps, meaning none were designated as cash‑flow hedges and any effect would flow through earnings rather than OCI 【page_58】. The fair‑value hedge for its fixed‑to‑floating interest‑rate swaps remained unchanged at $850 million in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM states 2023 forward interest rate swaps were $1.29 billion, but ground truth indicates $2.0 billion notional amount\n   - LLM claims 2024 forward interest rate swaps had $0 notional, but ground truth indicates they still existed and were accounted for as fair value hedges\n   - LLM states fair-value hedges remained at $850 million in both years, but ground truth makes no mention of this figure\n   - LLM misses the critical $247 million settlement amount from 2023\n\n2. HEDGE DESIGNATION ERRORS (Critical):\n   - LLM correctly identifies 2023 as cash flow hedges, but the 2024 characterization is wrong\n   - Ground truth states 2024 contracts are \"fixed-to-floating interest rate swap agreements accounted for as fair value hedges using the shortcut method\"\n   - LLM incorrectly claims 2024 had $0 notional forward interest rate swaps, suggesting they were eliminated\n   - This represents a fundamental misunderstanding of the evolution described in ground truth\n\n3. ACCOUNTING TREATMENT ERRORS:\n   - LLM suggests 2024 swaps would \"flow through earnings rather than OCI\" but ground truth indicates they use the shortcut method with \"no net impact on consolidated statements of earnings\"\n   - This is a material difference in accounting impact\n\n4. MULTI-HOP REASONING:\n   - LLM failed to synthesize the key evolution: from cash flow hedges (2023) to fair value hedges using shortcut method (2024)\n   - LLM appears to have confused or misread the data, possibly conflating different swap categories\n   - The answer suggests swaps were eliminated in 2024 when they were actually reclassified\n\n5. MISSING CONTEXT:\n   - No mention of March 2023 Notes connection\n   - No discussion of the shortcut method or perfect effectiveness assumption\n   - No explanation of why there was no net earnings impact in 2024\n\nThe LLM answer demonstrates poor data accuracy and failed to capture the core evolution of hedge accounting treatment between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 565,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "In 2022 Target highlighted the sheer size of its owned‑brand portfolio, even listing dozens of owned and exclusive brands and stating that “strengthening our owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” was a core growth driver (2022 10‑K, Item 1, p. 3; owned‑brands list, p. 5). By the 2023 filing the same language remains—Target still seeks to “strengthen our owned brands portfolio” to deliver newness, style and value and to expand relevance, traffic and market‑share—but the company drops the detailed brand list, shifting the emphasis from a granular portfolio inventory to a broader strategic focus on owned‑brand differentiation as a key lever in its overall growth strategy (2023 10‑K, Item 1, p. 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed, nuanced analysis than the ground truth. Key strengths: (1) Correctly identifies the evolution from 2022 to 2023 with accurate characterization of the shift from descriptive portfolio showcase to strategic differentiation; (2) Accurately captures the core strategic language ('delight with newness, style, and value,' 'strengthen our owned brands portfolio,' 'expand relevance, traffic and market-share'); (3) Provides specific filing references (2022 10-K Item 1 p.3, p.5; 2023 10-K Item 1 p.3) that add credibility; (4) Correctly notes the shift from detailed brand list in 2022 to broader strategic focus in 2023; (5) Accurately synthesizes the multi-hop comparison across two years and two filings. Minor considerations: The LLM answer is actually more comprehensive than the ground truth, providing specific page citations and more detailed explanation of the strategic shift (from 'granular portfolio inventory' to 'broader strategic focus'). The phrase 'dozens of owned and exclusive brands' in the LLM answer is slightly less precise than the ground truth's 'over 40 such brands,' but this is a minor semantic difference that doesn't materially affect accuracy. The LLM correctly identifies that the same core language persists but the emphasis and presentation evolved. All factual claims are verifiable and accurate based on the ground truth framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 398,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "In the 2022 filing GM’s software‑enabled services were described mainly as after‑sale, bundled offerings—OnStar, vehicle‑connectivity, maintenance and extended‑warranty plans—whose revenue was deferred and recognized over up to seven years. By the 2023 filing GM is promoting an end‑to‑end, over‑the‑air software platform that powers a broader suite of subscriptions (OnStar, Super Cruise, security, climate, EV‑ownership features) and is being rolled out across many new models (e.g., 2024 Cadillac LYRIQ, Chevrolet Silverado EV), indicating a clear shift toward a scalable, platform‑based digital ecosystem and a deeper investment in software infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution in GM's software-enabled services approach from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 approach as general/after-sale bundled offerings (OnStar, vehicle connectivity, maintenance, extended warranty), (2) Accurately describes the 2023 shift to an end-to-end, over-the-air software platform, (3) Correctly names specific features (Super Cruise, active safety, infotainment, EV ownership experience, security, climate), (4) Accurately identifies specific 2024 model deployments (Cadillac LYRIQ, Chevrolet Silverado EV), (5) Properly synthesizes the multi-hop comparison showing evolution from general services to concrete platform deployment, (6) Correctly characterizes the strategic shift toward scalable, platform-based digital ecosystem. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds specific detail about revenue deferral and recognition over up to seven years—this is accurate but represents additional detail not explicitly mentioned in the ground truth summary, (2) The LLM characterizes 2022 services as 'after-sale, bundled offerings' while ground truth uses 'general terms' and 'broader operations'—both characterizations are accurate but represent slightly different framings. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the progression and its implications for investment in digital solutions. The logic connecting platform deployment to scalable digital solutions is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly more operational detail about revenue recognition, which adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 541,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "In fiscal 2022 the Optimized Application Experiences category rose 11% to $729 million, a gain of $75 million that Cisco said was “driven by growth in our ThousandEyes … offerings.” In fiscal 2023 the newly‑named Observability category grew 14% to $661 million, a $80 million increase “driven by growth in our ThousandEyes … offerings.” Thus ThousandEyes’ contribution grew modestly, adding about $5 million more in FY 2023 than it did in FY 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR CALCULATION ERROR: The LLM states 'ThousandEyes' contribution grew modestly, adding about $5 million more in FY 2023 than it did in FY 2022.' This is mathematically incorrect. The ground truth shows $75M growth in FY2022 and $80M growth in FY2023, which is a $5M DIFFERENCE in the growth amounts, NOT the contribution itself. The LLM conflates growth increment with actual contribution. (2) CONTRADICTORY LOGIC: The LLM provides absolute category revenue figures ($729M in FY2022, $661M in FY2023) showing a DECREASE of $68M overall, yet claims ThousandEyes contribution 'grew modestly.' This is internally inconsistent - if the category shrank while ThousandEyes grew, other products must have declined significantly. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies the $75M and $80M growth figures and the 11% and 14% growth rates, which are accurate. However, it fails to properly synthesize what these numbers mean for ThousandEyes' evolution. (4) MISINTERPRETATION: The ground truth indicates 'continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023' - meaning ThousandEyes itself grew more in FY2023 than FY2022. The LLM's conclusion that growth was 'modest' and only '$5 million more' misrepresents the actual trend. (5) POSITIVE ELEMENTS: The LLM correctly identifies the category names, fiscal years, percentage growth rates (11% and 14%), and the $75M/$80M figures. The quotations from Cisco are appropriately cited. However, these correct elements are undermined by the fundamental calculation error in the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 451,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 Form 10‑K the amendment was listed as Exhibit 10.34 – “Amendment No. 4 to the Lockheed Martin Executive Severance Plan,” incorporated by reference to the September 2022 10‑Q. In the 2024 Form 10‑K the same amendment is still disclosed, but it now appears as Exhibit 10.36 (still incorporated by reference to the same 10‑Q), with the exhibit numbers shifted to make room for Amendments 2 and 3. The change shows that the company continues to include Amendment 4 in its filings, but has reorganized the exhibit schedule to present a more complete, sequential set of severance‑plan amendments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) Exhibit number discrepancy - The LLM claims Amendment No. 4 moved from Exhibit 10.34 in 2023 to Exhibit 10.36 in 2024, but the ground truth does not mention Exhibit 10.36 at all. The ground truth states it remained as Exhibit 10.34 in both years, just with different presentation contexts. This is a major quantitative error. (2) The LLM introduces information about 'Amendments 2 and 3' requiring exhibit number shifts, which is not supported by the ground truth and appears to be fabricated reasoning. (3) The LLM's characterization of the change is partially correct (reorganization/consolidation) but is built on incorrect exhibit numbers. WHAT WAS CORRECT: The LLM correctly identifies that Amendment No. 4 was incorporated by reference to the September 2022 10-Q in both years, and correctly notes that the amendment remained disclosed in both filings. The general concept that the treatment shifted from highlighted to integrated is directionally aligned with the ground truth. MULTI-HOP REASONING: The LLM failed to accurately synthesize the exhibit information across the two years. The ground truth indicates a shift in how the amendment was presented (standalone vs. part of a sequence), but the LLM misidentified the exhibit numbers, which is a fundamental factual error in a question specifically about disclosure treatment evolution. The reasoning about 'making room for Amendments 2 and 3' is speculative and not grounded in the provided ground truth. OVERALL: While the LLM grasps the general concept of disclosure evolution, the specific factual errors regarding exhibit numbers and the unsupported claims about other amendments significantly compromise the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 489,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan’s Tier 1 leverage ratio was unchanged at 7.2 % in both 2023 and 2024, well above the 4.0 % regulatory minimum 【page_104】. Its Standardized CET1 capital ratio improved from 15.0 % in 2023 to 15.7 % in 2024, also comfortably exceeding the required floors of 11.4 % (2023) and 12.3 % (2024) 【page_104】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ANALYSIS: The LLM answer provides more detailed information than the ground truth but contains a critical factual discrepancy that undermines accuracy.\n\nCORRECT ELEMENTS:\n1. Tier 1 leverage ratio of 7.2% in 2024 is correct\n2. Regulatory minimum of 4.0% for Tier 1 leverage ratio is correct\n3. Standardized CET1 capital ratio of 15.0% in 2023 is correct\n4. Required floor of 11.4% for 2023 CET1 is correct\n5. The statement that JPMorgan maintained compliance is correct\n6. The characterization of ratios as \"well above\" and \"comfortably exceeding\" requirements is appropriate\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: The LLM claims the Tier 1 leverage ratio was \"unchanged at 7.2% in both 2023 and 2024.\" The ground truth only provides the 2024 figure (7.2%), with no 2023 data mentioned. The LLM fabricated a 2023 comparison that cannot be verified from the ground truth.\n2. UNVERIFIED DATA: The LLM provides a 2024 CET1 ratio of 15.7% and a 2024 required floor of 12.3%, neither of which appear in the ground truth. While these could be accurate from the source documents, they represent information beyond what the ground truth confirms.\n3. INCOMPLETE GROUND TRUTH MATCH: The ground truth does not provide 2024 CET1 data, only 2023 data. The LLM appears to have added information not in the ground truth.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the concept of comparing actual ratios to regulatory requirements across years. However, the synthesis is compromised by the unverified claim about 2023 Tier 1 leverage ratio consistency.\n\nQUANTITATIVE ACCURACY PENALTY:\nThe claim that Tier 1 leverage ratio was \"unchanged\" at 7.2% in both years is a factual error or unsupported claim. This is a significant quantitative accuracy issue.\n\nSCORE JUSTIFICATION:\n- Correctness: 6/10 - Core compliance narrative is correct, but the \"unchanged\" claim about Tier 1 leverage ratio across years is either incorrect or unsupported by ground truth\n- Quantitative Accuracy: 5/10 - While individual numbers provided are plausible, the comparison claim (unchanged 7.2%) cannot be verified and appears incorrect\n- Qualitative Accuracy: 7/10 - Good synthesis of compliance concepts, but marred by unverified claims\n- Contextual Relevance: 8/10 - Directly addresses the question about evolution of capital ratios, though the \"evolution\" claim is undermined by the \"unchanged\" assertion",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 645,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "In the 2022 filing GM Financial was shown as a stand‑alone reportable segment that the chief operating decision‑maker evaluates on an EBT‑adjusted basis, with its own net‑sales, earnings and assets disclosed (e.g., $13.4 bn of sales and $5.0 bn of EBIT‑adjusted for 2021)【page_99】. By the 2023 filing the segment is still presented separately, but Note 1 now explains that GM Financial’s amounts are adjusted for its inclusion in the consolidated tax return and for eliminating inter‑segment transactions, signalling tighter integration into the consolidated statements【page_63】, and the cash‑flow statement continues to show GM Financial interest expense as a distinct line that fell from $2.9 bn in 2022 to $2.5 bn in 2023【page_61】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to address the evolution of GM Financial's role between 2022 and 2023, and correctly identifies the key conceptual shift toward tighter integration and more explicit disclosure of tax and consolidation adjustments. However, there are significant quantitative accuracy issues that undermine the response.\n\nSTRENGTHS:\n1. Correctly identifies the core evolution: GM Financial moved from a simpler description to one emphasizing consolidated tax return impacts and intercompany adjustments\n2. Appropriately notes the shift toward 'tighter integration' language in 2023\n3. Correctly identifies that the segment is still presented separately in both years\n4. Semantic understanding of the question is sound\n\nCRITICAL ERRORS:\n1. QUANTITATIVE ACCURACY FAILURE: The LLM cites \"$13.4 bn of sales and $5.0 bn of EBIT-adjusted for 2021\" as 2022 data. These appear to be 2021 figures, not 2022, creating a year mismatch that is factually incorrect.\n2. The interest expense figures ($2.9 bn in 2022 declining to $2.5 bn in 2023) cannot be verified against the ground truth and appear potentially inaccurate or misattributed.\n3. The LLM provides specific page references (page_99, page_63, page_61) that cannot be verified and may be hallucinated.\n4. The ground truth does not mention specific dollar amounts for sales, EBIT, or interest expense, suggesting the LLM may have fabricated these numbers.\n\nMULTI-HOP REASONING:\nThe LLM does attempt to synthesize information across 2022 and 2023 filings and correctly identifies the evolution in how GM Financial is described and integrated. However, the inclusion of unverified or incorrect numbers undermines the credibility of this synthesis.\n\nSEMANTIC ALIGNMENT:\nThe qualitative description of the evolution (from stand-alone segment to more integrated presentation with explicit tax consolidation language) aligns with the ground truth's core message about 'more explicit focus on integration and financial alignment.'\n\nJUSTIFICATION:\nThe answer demonstrates reasonable understanding of the conceptual question but fails on quantitative precision, which is critical for financial analysis. The specific numbers provided appear to be either incorrect or hallucinated, and the page references cannot be verified. This combination of correct conceptual understanding but flawed numerical support results in a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 640,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "In both the 2022 and 2024 filings Costco treats step‑rent provisions the same way – they are spread on a straight‑line basis over the lease’s original term and any extensions that are reasonably certain to be exercised. The key change is that the 2024 filing now explicitly states that periodic rent increases tied to price‑index adjustments or sales‑volume thresholds are accounted for as **variable lease payments**, whereas the 2022 filing only mentioned those escalations without specifying that classification. This added disclosure clarifies the treatment of index‑ or sales‑based rent escalations under the newer lease‑accounting guidance.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution between 2022 and 2024. The LLM states that 'In both the 2022 and 2024 filings Costco treats step-rent provisions the same way – they are spread on a straight-line basis,' which directly conflicts with the ground truth that indicates a SHIFT in accounting treatment. The ground truth explicitly states: '2022: accounted for on a straight-line basis' vs '2024: recognized as variable lease payments rather than being straight-lined.' This is a material accounting change, not merely a disclosure clarification. The LLM incorrectly characterizes the evolution as only a 'clarification' or 'added disclosure' of the same treatment, when the ground truth indicates the actual accounting method changed from straight-line to variable lease payment recognition. The LLM's statement that 'the 2024 filing now explicitly states...whereas the 2022 filing only mentioned those escalations without specifying that classification' misrepresents the nature of the change - it was not just a classification clarification but a substantive shift in how these amounts are recognized. The LLM does correctly identify that the 2024 treatment involves variable lease payments and that price indices/sales volume are involved, but fundamentally misses the core evolution: the shift FROM straight-line accounting TO variable lease payment treatment. This is a major conceptual error in understanding the multi-hop synthesis required to answer this question about how treatment evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 437,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "- In the 2023 Form 10‑K the company said it expected to pay **$1.86 billion** in 2025 for its qualified defined‑benefit pension plans and **$10.02 billion** in total over the 2029‑2033 horizon【page_89】.  \n- In the 2024 Form 10‑K the 2025 estimate was lowered to **$1.80 billion**, and the long‑term outlook was revised to **about $9.99 billion** for the comparable multi‑year window (the filing shows $1.99 billion for 2029 and $9.99 billion for 2030‑2034)【page_88】.  \n\nThus, from 2023 to 2024 the projected funding obligation for 2025 fell by roughly **$60 million**, and the long‑term projection for the 2029‑2033 period slipped by roughly **$30 million** (from $10.02 billion to just under $10 billion).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) 2023 PROJECTIONS: Ground truth states $1,860 million for 2025 and $10,020 million for 2029-2033. LLM correctly converts these to $1.86 billion and $10.02 billion - this is CORRECT. (2) 2024 PROJECTIONS - MAJOR ERROR: Ground truth clearly states the 2025 projection remained at $1,860 million (unchanged from 2023), but the LLM claims it was 'lowered to $1.80 billion' - this is INCORRECT. The LLM misread or fabricated a $60 million decrease that did not occur. (3) LONG-TERM PERIOD MISMATCH: Ground truth compares 2029-2033 (2023) to 2030-2034 (2024) - different periods due to rolling forward one year. The LLM acknowledges this discrepancy but then conflates the periods, stating the 2024 figure applies to '2029-2033 period' when it actually applies to 2030-2034. (4) CALCULATION ERROR: The LLM calculates a $60 million decrease for 2025 ($1.86B to $1.80B), but ground truth shows NO CHANGE ($1,860M to $1,860M). This is a fundamental calculation error. (5) LONG-TERM CALCULATION: The $30 million decrease ($10.02B to $9.99B) is approximately correct in magnitude, though the comparison is between different time periods (2029-2033 vs 2030-2034), which the LLM acknowledges but doesn't clearly resolve. STRENGTHS: The LLM correctly identifies the company (Lockheed Martin), the pension plan type (qualified defined benefit), and attempts to synthesize multi-year comparisons. The format conversions (billions vs millions) are handled appropriately. WEAKNESSES: The core factual error regarding the 2025 projection change is a critical failure. The LLM appears to have either misread the source documents or introduced fabricated data. The period mismatch (2029-2033 vs 2030-2034) is acknowledged but not properly resolved in the analysis. The answer would mislead readers about the actual evolution of funding obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 528,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "In the 2023 Form 10‑K JPMorgan Chase warned that meeting the funding requirements of its resolution plan could push up its funding costs and that, if access to stable, low‑cost sources such as deposits or Federal Home‑Loan‑Bank borrowings were curtailed, the bank would have to rely on more expensive alternative funding while maintaining strong liquidity buffers. The 2024 filing repeats the same points—again noting that actions taken to satisfy resolution‑plan obligations may increase funding costs and that the firm’s liquidity‑risk strategy is to raise funding from alternative sources when needed—showing essentially no material change in how the resolution‑plan exposure is described.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The original answer clearly states that JPMorgan Chase EXPANDED its disclosures in 2024 to include how resolution plan obligations interact with dynamic regulatory expectations and systemic events, reflecting a shift toward framing risks within broader regulatory evolution and macroeconomic uncertainty. The LLM answer explicitly claims the opposite—that the 2024 filing 'repeats the same points' and shows 'essentially no material change.' This is a critical mischaracterization of the evolution between years. The LLM correctly identifies the 2023 content (funding costs, liquidity buffers, alternative funding sources, deposits, Federal Home Loan Bank borrowings) with accurate details. However, it completely misses the key distinction that the 2024 disclosure evolved to include new elements: (1) interaction with dynamic regulatory expectations, (2) systemic events context, (3) changes in laws/rules/regulations in response to economic effects of systemic events, and (4) broader regulatory evolution and macroeconomic uncertainty framing. The question specifically asks about how disclosures 'evolved,' and the LLM's conclusion that there was 'no material change' is factually incorrect based on the ground truth. The quantitative accuracy is high (no numbers to verify, dates are correct), but the qualitative accuracy is severely compromised by the fundamental misunderstanding of the year-over-year evolution. The answer fails to synthesize the multi-hop comparison across 2023 and 2024 filings correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 442,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Optum Rx still records product revenue when a prescription is actually dispensed (with services revenue recognized as the services are performed), a policy that has not changed from the prior year【page_46】.  At the same time, the balance of accounts receivable tied to its pharmacy‑care business rose from $7.1 billion at year‑end 2022 to $8.6 billion at year‑end 2023, a $1.5 billion increase【page_46】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper multi-hop synthesis. Strengths: (1) All quantitative data is accurate - accounts receivable figures of $7.1B (2022) and $8.6B (2023) are correct, and the calculated $1.5B increase is accurate; (2) Revenue recognition policy is correctly stated - product revenue at point of dispensing and services revenue as performed; (3) The answer properly synthesizes information across the two-year period showing both the consistency of the revenue model and the change in receivables; (4) Page citations (page_46) provide appropriate sourcing. Minor weaknesses: (1) The LLM answer emphasizes that the revenue recognition policy 'has not changed from the prior year,' which is accurate but slightly de-emphasizes the ground truth's framing that the structure 'remained aligned' while highlighting the evolution aspect of the question; (2) The answer could have been slightly more explicit about the gross revenue reporting model context mentioned in the ground truth, though this is implicit in the description of paying network pharmacy providers; (3) The answer doesn't explicitly interpret what the $1.5B increase suggests (increased transaction volume or payment timing changes), though the ground truth does provide this analytical context. Overall, the LLM answer correctly addresses the core question about financial structure evolution, provides accurate numbers, and demonstrates proper multi-hop reasoning across the 2022-2023 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 421,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS’s floating‑to‑fixed interest‑rate swap exposure fell sharply. In 2022 the company reported roughly $2.5 billion of notional floating‑to‑fixed swaps that were designated as cash‑flow hedges to lock in fixed rates on forecasted debt payments (UPS 10‑K 2022, p. 138). By the end of 2024 the “Outstanding Positions” table shows only currency hedges and no interest‑rate swap notional, indicating the floating‑to‑fixed swap book has been essentially eliminated (UPS 10‑K 2024, p. 137), while the risk‑management discussion still cites swaps—now emphasizing forward‑starting swaps, interest‑rate locks and fair‑value hedges—as the primary tool for managing interest‑rate mix (UPS 10‑K 2024, p. 136).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims UPS had '$2.5 billion of notional floating-to-fixed swaps' in 2022, but the ground truth explicitly states the 2022 notional amount was '$28 million.' This is a 89x overstatement ($2.5B vs $28M). This is not a minor rounding difference—it's a catastrophic numerical error that undermines the entire answer. (2) DIRECTIONAL ERROR: The LLM describes the evolution as a 'sharp fall' from $2.5B to essentially zero, suggesting a reduction in swap usage. However, the ground truth indicates the opposite trajectory: from a 'limited use' of $28M in 2022 to a 'more comprehensive interest rate risk management approach' in 2024. The LLM's narrative of elimination contradicts the ground truth's narrative of strategic expansion. (3) STRATEGIC INTERPRETATION MISMATCH: The ground truth emphasizes evolution toward 'a more intentional and strategic deployment' with broader portfolio management goals. The LLM describes elimination of the swap book, which is inconsistent with the ground truth's characterization of increased strategic sophistication. (4) PARTIAL CREDIT FOR STRUCTURE: The LLM does correctly identify that the answer should address both quantitative exposure and strategic approach, and it attempts to cite specific 10-K pages. However, the cited numbers appear to be fabricated or sourced from incorrect sections. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022 and 2024 data points, producing an internally inconsistent narrative that contradicts the ground truth's documented evolution. The answer demonstrates poor document verification and contains material factual errors that make it unsuitable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 492,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "In the 2022 filing GM only announced the creation of Ultium Cells LLC – an equally‑owned joint‑venture with LG Energy Solution to mass‑produce battery cells for its EVs (see page 4). By the 2023 filing the relationship had moved to the operational stage: GM said commercial negotiations with LGES resolved other matters tied to the Ultium Cells JV and that LGES agreed to reimburse GM for the Chevrolet Bolt recall, so GM accrued $2.6 billion of recall costs (with $0.6 billion still on the books) and recognized $1.6 billion of receivables from LGES (see page 92). This reflects a shift from merely forming the JV in 2022 to using the partnership to offset substantial recall‑related expenses in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc correctly—a shift from strategic JV formation in 2022 to financial/transactional dynamics in 2023 involving recall costs and reimbursements. However, there is a significant quantitative discrepancy that undermines accuracy. The LLM states '$0.6 billion still on the books' regarding recall costs, but the ground truth does not mention this figure. The ground truth specifies: $2.6 billion accrued for recall costs and $1.6 billion recognized as receivables from LG. The LLM's introduction of '$0.6 billion' appears to be either an error or an unsupported inference not present in the ground truth. The core numbers ($2.6 billion accrual, $1.6 billion receivables) are correct. The LLM correctly identifies the 2022 JV formation and 2023 operational/financial shift. The multi-hop reasoning is sound—synthesizing information about the JV's evolution and connecting it to recall-related financial impacts. The qualitative description of the relationship transition is accurate and well-articulated. However, the unexplained '$0.6 billion' figure introduces a factual error that cannot be verified against the ground truth, reducing quantitative accuracy. The answer is contextually relevant and addresses all parts of the question, but the numerical discrepancy is a material flaw in a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 386,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The Observability category grew from $581 million in fiscal 2022 to $661 million in fiscal 2023 – a $80 million (≈14 %) increase – and Cisco said that growth was “driven by growth in our ThousandEyes offering and the contribution from Observability Suite”【page_41】. Thus, the revenue contribution from ThousandEyes rose as part of that $80 million uplift to the Observability product line between FY 2022 and FY 2023【page_42】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth data. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the Observability category grew from $581M to $661M (a $80M increase of ~14%), but the ground truth indicates a 27% increase of $176M in fiscal 2023. The LLM's numbers and percentage are fundamentally incorrect. (2) INCOMPLETE SYNTHESIS: The LLM fails to address the fiscal 2023 growth metrics entirely. The ground truth explicitly states fiscal 2023 saw a 27% revenue increase ($176M) with ThousandEyes and Splunk's Observability Suite as key contributors. The LLM only discusses fiscal 2022 growth ($80M). (3) MISSING CRITICAL INFORMATION: The ground truth provides crucial context about fiscal 2023 growth (27% increase, $176M) and organic growth excluding Splunk (15%), which the LLM completely omits. (4) MULTI-HOP REASONING FAILURE: The question asks how ThousandEyes revenue contribution 'evolved' from FY2022 to FY2023 (a comparison across two years). The LLM only addresses FY2022 and fails to synthesize the FY2023 data, making it impossible to show the evolution. (5) CALCULATION ERROR: The stated $80M increase with ~14% growth is mathematically inconsistent with the stated $581M to $661M figures (which would be approximately 13.6%, not 14%, but more importantly, this contradicts the ground truth's $176M increase in FY2023). The LLM appears to have confused or conflated fiscal year data, presenting incomplete and inaccurate information that fails to answer the core question about how ThousandEyes contribution evolved across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 438,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS’s 7.620 % debentures have not changed materially between the 2022 and 2024 filings. Both reports describe the $276 million notes, due April 1 2030, as redeemable at UPS’s option at any time for the greater of (i) principal + accrued interest or (ii) the present value of remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps, and they continue to pay interest semi‑annually in April and October. The 2022 filing notes that the rate was reduced from 8.375 % to 7.620 % in April 2020, and the 2024 filing repeats the same redemption and payment terms, indicating the relationship remains unchanged【page_120†L1-L8】【page_108†L1-L7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key quantitative facts: $276 million principal amount, April 1, 2030 maturity date, 7.620% interest rate, semi-annual payment schedule (April and October), and the redemption formula (greater of principal + accrued interest OR present value of remaining payments discounted at benchmark Treasury + 5 bps). The historical reference to the rate reduction from 8.375% to 7.620% in April 2020 is accurate. All numeric values and dates are correct.\n\nWEAKNESSES: The LLM's core conclusion is problematic. The ground truth explicitly states there was an 'evolution' and 'shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.' The LLM contradicts this by claiming the relationship 'has not changed materially' and that the 2024 filing 'repeats the same redemption and payment terms.' This misses the key insight: in 2022, these details were NOT specified (only principal, maturity, and carrying value were listed), while in 2024, UPS provided detailed clarification of redemption terms and interest payment structure. The LLM conflates the SUBSTANCE of the terms (which remained the same) with the DISCLOSURE EVOLUTION (which changed significantly). The question specifically asks about how the 'relationship...evolved,' which is fundamentally about the change in disclosure and explanation, not whether the underlying terms changed. The LLM's interpretation that 'no material change' means the relationship hasn't evolved is a semantic misreading of what 'evolution' means in this context—it refers to the evolution of disclosure clarity and detail, not necessarily changes to the terms themselves.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis between 2022 and 2024 filings. It correctly identified that both years mention the same terms but incorrectly concluded this means no evolution occurred, when the ground truth indicates the evolution is in HOW these terms are presented and explained across the two years.\n\nCONTEXTUAL RELEVANCE: While the answer provides accurate financial details, it fundamentally misinterprets what the question is asking about—the evolution of disclosure and explanation, not whether the underlying terms changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 622,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "In 2022 MetLife’s Fixed‑Maturity Securities held as assets‑forward‑sale (AFS) were valued at **$8.058 billion**; by 31 December 2023 that total had slipped to **$7.988 billion** (a $70 million decline)【page_308】.  Within the portfolio, **corporate securities rose from $3.206 billion to $3.250 billion** (up $44 million) and **U.S. government bonds grew from $1.575 billion to $1.633 billion** (up $58 million), indicating a modest shift toward these two asset types as other fixed‑maturity holdings fell.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all major metrics. Specific issues: (1) TOTAL FAIR VALUE: LLM claims 2022 = $8.058 billion and 2023 = $7.988 billion, but ground truth shows 2023 = $6.714 million (note: ground truth appears to reference 2021 carrying amount of $2.164 million and 2023 fair value of $6.714 million). The LLM's figures are approximately 20% higher than ground truth and show a decline rather than growth. (2) CORPORATE SECURITIES: LLM states $3.206B (2022) to $3.250B (2023), but ground truth shows $3.083 million in 2023 with $3.029 million at Level 2. The LLM's numbers are roughly 1000x larger than ground truth values. (3) U.S. GOVERNMENT BONDS: LLM claims $1.575B (2022) to $1.633B (2023), but ground truth shows $1.575 million in 2023 with $1.537 million at Level 1. Again, the LLM's figures are approximately 1000x the ground truth values. (4) DIRECTION OF CHANGE: LLM describes a modest decline in total portfolio with increases in corporate and government bonds, while ground truth indicates significant growth from 2021-2023 with specific fair value increases. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year evolution and misidentified the magnitude of holdings by orders of magnitude. The answer appears to reference different data entirely or contains a systematic unit conversion error (billions vs. millions). The only partially correct element is the identification of corporate securities and U.S. government bonds as components, but all quantitative values are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 444,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "In the 2022 filing GM recorded a $0.5 billion cash outflow as an “Investment in Ultium Cells LLC” under its investing activities (see 2022 10‑K, page 42). By the 2023 filing the focus had shifted to regulatory exposure: GM disclosed that the Ultium Cells joint‑venture was found to have potential TSCA violations and, in November 2023, settled with the EPA under a consent agreement that includes civil penalties of roughly $5.1 million (see 2023 10‑K, page 28). Thus, GM’s relationship moved from a capital‑investment role in 2022 to addressing compliance and liability issues in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GM's evolving relationship with Ultium Cells LLC from 2022 to 2023. QUANTITATIVE ACCURACY (10/10): All financial figures are correct - the $0.5 billion investment in 2022 and the $5.1 million settlement penalty in November 2023 match the ground truth exactly. The dates (2022, February 2023, November 2023) are all accurate. ENTITY ACCURACY: General Motors, Ultium Cells LLC, EPA, TSCA, and the consent agreement are all correctly identified. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across two fiscal years and multiple regulatory documents, correctly identifying the shift from investment-focused to compliance-focused relationship. The logical progression from capital investment to regulatory liability is clearly articulated. COMPLETENESS: The answer addresses both key aspects of the question - financial involvement (the $0.5B investment) and regulatory implications (TSCA violations and EPA settlement). The answer captures the essential evolution of the relationship. SEMANTIC EQUIVALENCE: The LLM's phrasing 'moved from a capital-investment role in 2022 to addressing compliance and liability issues in 2023' effectively conveys the same meaning as the ground truth's 'shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.' Minor note: The LLM answer is slightly more concise than the ground truth but loses no material information. The reference to specific page numbers (2022 10-K page 42, 2023 10-K page 28) adds credibility, though these cannot be independently verified from the provided context. Overall, this is a high-quality answer that correctly synthesizes multi-hop financial and regulatory information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 499,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company’s practice of using variable‑priced, index‑based contracts for a portion of its natural‑gas purchases and for fuel at its gas stations was disclosed in both the 2022 and 2024 filings. In 2022 the filing simply noted that the company “enters into variable‑priced contracts for some purchases of natural gas, in addition to fuel for its gas stations, on an index basis”【page_46】. By 2024 the company still uses those same contracts, but adds that they “meet the characteristics of derivative instruments, but generally qualify for the ‘normal purchases and normal sales’ exception… and require no mark‑to‑market adjustment”【page_47】. This reflects a consistent use of variable‑priced contracts, with the later filing providing a clearer accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that variable-priced contracts were used in both 2022 and 2024, accurately captures the 2022 disclosure (contracts on an index basis for natural gas and fuel), and correctly describes the 2024 evolution (explicit mention of derivative instrument characteristics and the 'normal purchases and normal sales' exception with no mark-to-market adjustment). (2) QUANTITATIVE ACCURACY: No specific numerical values were required in either the ground truth or LLM answer, so this is not applicable. The dates (2022 and 2024) are correct. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing information across two different filing years and correctly identifying the evolution from a simple disclosure to a more formalized accounting treatment. The characterization of this as 'a consistent use of variable-priced contracts, with the later filing providing a clearer accounting treatment' accurately reflects the ground truth's observation about 'more formalized or strategic use' and alignment with accounting frameworks. (4) ENTITY ACCURACY: The answer correctly identifies the relevant metrics (variable-priced contracts, index basis, derivative instruments, normal purchases and normal sales exception, mark-to-market adjustment) and time periods (2022 and 2024). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording but equivalent meaning. The inclusion of page references adds credibility. Minor note: The LLM uses 'index‑based' (with special character) while ground truth uses 'index basis,' but these are semantically equivalent. The answer is comprehensive, accurate, and directly addresses the evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 508,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco’s segment reporting for APJC did not change from fiscal 2022 to fiscal 2023. In both years Cisco said it “does not allocate research and development, sales and marketing, or general and administrative expenses … and … does not allocate amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges” to the segment’s gross‑margin performance measurement【page_105】【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that there was NO CHANGE in Cisco's reporting approach for APJC between fiscal 2022 and fiscal 2023, which is the core finding; (2) Accurately lists all excluded expense categories: R&D, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, charges related to asset impairments and restructurings, and certain other charges; (3) Properly cites the relevant page numbers (104-105) from the SEC filings; (4) Uses direct quotes from the filings, demonstrating source verification; (5) Correctly identifies the segment as APJC and the fiscal years as 2022 and 2023. Minor considerations: (1) The LLM answer is more concise than the ground truth but captures all essential information; (2) The phrasing 'did not change' is semantically equivalent to the ground truth's 'remained unchanged' and 'consistency in exclusions indicates no change'; (3) The answer could have been slightly more explicit about the consistency aspect, though it is clearly implied by stating the same exclusions applied in both years. The multi-hop reasoning is sound—the answer correctly synthesizes information across two fiscal years and identifies the key finding that the approach remained consistent. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 414,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "In 2022 UNH mainly managed medical‑cost trends through underwriting criteria, product design, competitive provider‑contract negotiations and care‑management programs, pricing its risk‑based products on cost forecasts (see page _17). By 2023, after a surge in senior outpatient procedures, UNH moved to more proactive containment – engaging physicians and consumers with information, using data‑analytics to steer care to lower‑cost settings, expanding value‑based and accountable‑care plans, and integrating delivery‑system innovations to curb those outpatient costs (see pages _27‑_28 and the outpatient‑cost discussion on page _29).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of UNH's approach from 2022 to 2023 and correctly identifies the shift toward more proactive strategies. STRENGTHS: (1) Correctly identifies 2022 focus on underwriting, product design, provider negotiations, and care management; (2) Accurately describes 2023 shift to data-driven engagement with physicians and consumers; (3) Properly identifies rising outpatient procedure costs for seniors as the key trend; (4) Mentions value-based and accountable-care plans as part of 2023 strategy; (5) Correctly synthesizes multi-hop information across years. WEAKNESSES: (1) The LLM answer provides more specific operational details (underwriting criteria, competitive provider-contract negotiations, value-based plans, delivery-system innovations) that go beyond what the ground truth explicitly states - while not necessarily incorrect, these add specificity not confirmed in the original answer; (2) The ground truth emphasizes the shift from 'general concern' to 'targeted intervention,' while the LLM answer frames it more as operational evolution from one set of tactics to another; (3) The LLM answer references specific page numbers which cannot be verified against the ground truth; (4) The ground truth emphasizes 'accurate cost prediction and effective management under risk-based arrangements' in 2022, while the LLM answer focuses more on underwriting and product design. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023, identifying the temporal evolution and the specific challenge (senior outpatient costs). The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns - UNH moved from general cost management approaches to more targeted, data-driven interventions focused on senior outpatient procedures. The answer is contextually relevant and addresses all parts of the question, though with some added operational detail not explicitly confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 537,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "In 2022 UPS framed its time‑definite delivery as a core offering for express letters, documents, packages and palletized freight moved by air or ground, all of which were “combined … within our single, global network” for efficiency【page_5】. By 2024 the company had broadened the scope to cover every service type—air, ground, domestic, international, commercial and residential—and tied them together in a “single, global smart logistics network” that leverages digital tools (e.g., the Digital Access Program) to deliver greater operational and capital efficiencies【page_5】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misses key details from the ground truth. CORRECT ELEMENTS: (1) The 2022 characterization of UPS's integrated global network approach is accurate; (2) The 2024 expansion to broader service scope is mentioned; (3) The reference to digital tools and operational efficiencies is appropriate. CRITICAL OMISSIONS: (1) The ground truth specifically mentions UPS's insourcing of final delivery for non-urgent, lightweight residential shipments previously handled by USPS through UPS SurePost—this is a major strategic shift that the LLM answer completely omits; (2) The ground truth highlights same-day pickup seven days a week in 2024, which is not mentioned in the LLM answer; (3) The ground truth specifies expansion of returns services across approximately 150 countries, a concrete metric that the LLM answer lacks. ACCURACY ISSUES: The LLM answer describes the 2024 network as a 'single, global smart logistics network' with digital tools, but this is somewhat vague and doesn't capture the specific operational changes (SurePost insourcing) that represent the actual evolution. The answer reads more as a general description of service broadening rather than identifying the specific strategic shifts between 2022 and 2024. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2024 comparisons but fails to identify the most significant evolution—the insourcing strategy change. The reasoning is incomplete because it doesn't explain HOW the approach evolved in terms of operational control and service delivery model changes. The answer focuses on scope expansion but misses the fundamental shift in network integration strategy (moving from outsourced to insourced final-mile delivery for certain segments).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 487,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Lowe’s continued to list the 2.50 % notes due April 2026 as part of its Thirteenth Supplemental Indenture (Exhibit 4.14) in both the 2022 and 2023 Form 10‑K filings, with no amendment, redemption or re‑classification noted – the notes remained disclosed as outstanding debt in the same exhibit in each report【page_82†L1-L4】【page_76†L1-L4】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors that fundamentally misrepresent the ground truth. QUANTITATIVE ACCURACY (8/10): The numeric values are correct - 2.50% interest rate, April 2026 maturity date, Thirteenth Supplemental Indenture reference, and exhibit citations (4.14) are all accurate. QUALITATIVE ACCURACY (2/10): This is where the answer critically fails. The ground truth explicitly states there was an EVOLUTION or SHIFT in treatment between 2022 and 2023 - specifically from 'referenced as part of historical documentation' in 2022 to 'explicitly recognized as issued instruments' in 2023, representing a 'procedural or administrative transition from planning or documentation phase to more active recognition.' The LLM answer directly contradicts this by stating 'no amendment, redemption or re-classification noted' and that 'the notes remained disclosed as outstanding debt in the same exhibit in each report.' This fundamentally misses the core finding that the treatment EVOLVED between the two years. The LLM presents the notes as static/unchanged when the ground truth indicates a meaningful shift in recognition and disclosure treatment. CONTEXTUAL RELEVANCE (4/10): The question specifically asks HOW the treatment 'evolved' - implying change. The LLM answer focuses on continuity and sameness rather than identifying and explaining the evolution. The answer acknowledges the same indenture and exhibit but fails to capture the substantive shift in how the notes were recognized and treated between the two filing periods. MULTI-HOP REASONING: The LLM failed to synthesize the comparative analysis across 2022 and 2023 filings that would reveal the evolution in treatment. Instead, it presented a static view of consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 481,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "In the 2022 filing Costco warned that “sovereign‑debt crises … could adversely affect demand for our products and services, require a change in product mix, or impact the cost of or ability to purchase inventory” (2022 10‑K p. 15). The 2024 filing repeats the same language, again listing sovereign‑debt crises among the economic factors that may affect demand, product mix and merchandise‑costs (2024 10‑K pp. 13‑14). Thus, the company’s assessment of the risk has remained essentially unchanged – sovereign‑debt crises continue to be a potential head‑wind for sourcing and cost structure, but no new or heightened impact is disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key finding. The ground truth explicitly states that the framing 'shifted' from 2022 to 2024, with 2024 showing 'explicitly stated to negatively impact' and 'heightened concern.' The LLM answer claims the assessment 'remained essentially unchanged' and that 'no new or heightened impact is disclosed.' This is a direct contradiction of the ground truth's central claim about evolution over time. QUANTITATIVE ACCURACY: The LLM correctly cites page numbers (2022 10-K p. 15, 2024 10-K pp. 13-14) and accurately quotes the 2022 language about sovereign debt crises affecting demand, product mix, and inventory costs. However, the LLM fails to identify or acknowledge the critical shift in language between 2022 and 2024 that the ground truth emphasizes. QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed. It concludes that because similar language appears in both years, there has been no change. However, the ground truth indicates that while the 2022 filing presented sovereign debt crises as one of several potential macroeconomic factors, the 2024 filing elevated the concern by explicitly stating these crises 'negatively impact' the business and by broadening the context to include supply chain risks, supplier standards, and geopolitical instability. The LLM missed this nuanced evolution entirely. CONTEXTUAL RELEVANCE: The question specifically asks 'how has the impact...evolved,' requiring identification of changes over time. The LLM's answer that nothing has changed directly fails to address the question's core requirement. The ground truth clearly documents an evolution from conditional/potential risk language to more definitive negative impact language, plus expanded contextual concerns. The LLM answer is internally consistent but factually incorrect relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 518,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "UnitedHealth had 64 million shares available for future grants under its 2020 Stock Incentive Plan at 12/31/2021, but that pool fell to 53 million shares by 12/31/2023 – a drop of roughly 11 million shares【page_67】. The decline shows the company has drawn down part of its award pool, yet it still retains a sizable reserve, meaning it remains able to issue new share‑based awards, albeit with somewhat less headroom than in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2021 figure of 64 million shares - CORRECT; (2) 2023 figure of 53 million shares - CORRECT; (3) Calculated difference of 11 million shares - CORRECT (64-53=11). All numeric values match the ground truth exactly. Entity accuracy: UnitedHealth Group correctly identified, 2020 Stock Incentive Plan correctly named, fiscal year dates (12/31/2021 and 12/31/2023) properly specified. Multi-hop reasoning: The answer successfully synthesizes the two-year comparison and correctly interprets what the decline means for the company's capacity. The LLM goes beyond the ground truth by adding interpretive context - noting that while capacity has decreased, the company 'still retains a sizable reserve' and 'remains able to issue new share-based awards, albeit with somewhat less headroom.' This additional analysis is logical, reasonable, and enhances understanding without contradicting the ground truth. The answer directly addresses both parts of the question: (1) the change in available shares (64M to 53M, a decrease of 11M), and (2) what this indicates about capacity (reduced but still adequate). Minor note: The citation reference [page_67] adds credibility but is not part of the ground truth evaluation. Overall, this is a well-reasoned, factually accurate response that properly synthesizes multi-hop information and provides appropriate contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 402,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "In the 2022 filing UPS noted that the IAM National Pension Fund / National Pension Plan was covered by a collective‑bargaining agreement that expires on **July 31 2024**, and UPS contributed **$48 million in 2022**, which was **more than 5 % of the plan’s total employer contributions**【page_112】. By the 2024 filing the same plan’s agreement had been extended to **July 31 2029**, and UPS’s contribution rose to **$53 million in 2024** (with $50 million in 2023 and $48 million in 2022), still **exceeding the 5 % contribution threshold**【page_98】【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key dates are correct - July 31, 2024 expiration in 2022 filing and July 31, 2029 in 2024 filing match ground truth exactly. (2) The contribution threshold is correctly identified as 'more than 5%' in both periods, matching the ground truth language. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution of the relationship across 2022 and 2024 filings, showing both the extension of the agreement and the sustained significance of UPS contributions. (4) Specific dollar amounts ($48M in 2022, $50M in 2023, $53M in 2024) are provided with appropriate context showing the trend. (5) The answer properly addresses both components of the question: expiration date evolution AND contribution significance evolution. (6) Entity identification is correct (IAM National Pension Fund/National Pension Plan, UPS). MINOR CONSIDERATIONS: The ground truth answer emphasizes that UPS contributed 'more than 5% of total plan contributions from all employers for the years 2019 through 2021' in the 2022 context, while the LLM answer provides specific dollar amounts for 2022-2024. The LLM's approach of providing concrete contribution figures alongside the percentage threshold is actually more informative and still semantically consistent with the ground truth's emphasis on contribution significance. The LLM answer goes beyond the ground truth by providing year-by-year contribution amounts, which adds valuable detail without contradicting the original answer. All factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 450,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "In FY 2022 the 2020 Credit Agreement (amended in December 2021) gave Lowe’s a $2 billion revolving facility that matured in March 2025 and had no borrowings, contributing to a $4 billion total combined availability across its credit facilities 【page_60】. By FY 2023 the 2023 Credit Agreement amended and restated the 2020 facility, extending its term to September 2028 while keeping the $2 billion borrowing capacity (still unused), so the combined availability remained $4 billion 【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion availability in both 2022 and 2023, $4 billion combined total in both years, March 2025 maturity in 2022, September 2028 maturity in 2023. Dates are accurate (December 2021 amendment, September 2023 amendment/restatement). COMPLETENESS: The answer successfully synthesizes the multi-hop information required: (1) FY 2022 status of 2020 Credit Agreement, (2) FY 2023 evolution through amendment/restatement into 2023 Credit Agreement, (3) comparison of terms between the two years, (4) impact on combined availability. ENTITY ACCURACY: Correctly identifies LOW (Lowe's), the 2020 Credit Agreement, the 2023 Credit Agreement, and the Third Amended and Restated Credit Agreement (implied through combined $4B figure). REASONING: The multi-hop synthesis is sound - the model correctly traces the evolution from 2022 to 2023, showing how the 2020 agreement was replaced/amended into the 2023 agreement while maintaining the same $2B capacity and total $4B combined availability. MINOR OBSERVATION: The LLM answer includes additional context about the December 2021 amendment and explicitly notes 'no borrowings' and 'still unused,' which adds helpful detail beyond the ground truth but doesn't contradict it. The semantic meaning is fully equivalent to the ground truth answer. All factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 405,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ expanded its net‑investment‑hedge program, with the aggregate notional amount of those derivative contracts rising from roughly $7.5 billion in the prior‑year period (the level after 2022) to $8.6 billion at year‑end 2024—an increase of about $1 billion【page_96】. This growth shows a clear upward trend in the use of NIH derivative contracts between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the main evolution of MDLZ's Net Investment Hedge Derivative Contracts between 2022 and 2024, with generally accurate numbers and correct directional trend. STRENGTHS: (1) The key figures are correct: $7.5 billion (2023) and $8.6 billion (2024) match the ground truth of $7,456 million and $8,647 million respectively. (2) The calculated increase of ~$1 billion is accurate ($8,647M - $7,456M = $1,191M, reasonably approximated as ~$1B). (3) The answer correctly identifies the upward trend and growing reliance on these contracts. (4) The company (MDLZ) and metric (Net Investment Hedge Derivative Contracts) are correctly identified. WEAKNESSES: (1) The answer is incomplete regarding the full 2022-2024 evolution. The ground truth provides 2022 data ($4,551 million as of Dec 31, 2022) and 2020 data ($4,551 million as of Dec 31, 2020), but the LLM only addresses 2023-2024, missing the earlier part of the requested timeframe. (2) The phrase 'the level after 2022' is vague and potentially confusing—it should explicitly state this is 2023 data. (3) The answer doesn't provide the full picture of the evolution from 2022 ($4,551M) through 2024 ($8,647M), which would show a more dramatic increase of approximately 90% over the two-year period. (4) Minor: The LLM uses approximate language ('roughly,' 'about') which is acceptable but less precise than the ground truth's exact figures. MULTI-HOP REASONING: The answer demonstrates sound reasoning in comparing year-over-year changes and identifying trends, though it only partially synthesizes the full requested timeframe. The calculation of the increase is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 450,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "By 2022 Microsoft 365 was already framed as an “AI‑first” platform that bundles Office, Windows, Copilot and Enterprise Mobility + Security, with Copilot for Microsoft 365 using AI and Microsoft Graph data to augment Office apps and Teams (2022 p. 4). In the 2024 filing the AI layer was deepened: Microsoft added Copilot Pro—a consumer‑subscription service that delivers faster, more powerful AI assistance across Microsoft 365 apps and the web—and expanded AI‑driven features in Teams (single‑pane integration of all apps) and Viva, turning the suite into an even more unified productivity‑and‑collaboration hub (2024 p. 4‑5).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACY ON 2022 FRAMING: The LLM claims Microsoft 365 was already described as an 'AI-first' platform in 2022 with Copilot for Microsoft 365. The ground truth explicitly states that in 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with 'AI-backed tools' (not 'AI-first'), and that Copilot for Microsoft 365 was introduced BY 2024, not in 2022. This is a critical factual error that misrepresents the evolution timeline. (2) INCORRECT PRODUCT INTRODUCTION: The LLM introduces 'Copilot Pro' as a 2024 development, but the ground truth makes no mention of Copilot Pro. The ground truth specifically identifies the 2024 introductions as: Copilot for Microsoft 365 (combining AI with Microsoft Graph data), Copilot for Sales, Copilot for Service, and Copilot for Finance. The LLM conflates different products and timelines. (3) MISSING KEY ROLE-SPECIFIC EXTENSIONS: The LLM fails to mention the role-specific Copilot extensions (Copilot for Sales, Service, Finance) that were specifically highlighted in the ground truth as important 2024 developments. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution between years, it fundamentally mischaracterizes the 2022 baseline and misidentifies the 2024 innovations. The multi-hop reasoning is flawed because the foundational facts about what existed in each year are incorrect. (5) CITATION ISSUES: The LLM cites specific page numbers (2022 p. 4, 2024 p. 4-5) but these cannot be verified against the ground truth, and the content cited appears inconsistent with the actual evolution described in the knowledge graph. The answer demonstrates a significant misunderstanding of the timeline and specific product developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 483,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "In the 2022 10‑K, 3M said it had discovered that its Decatur, Ala., NPDES permit did not fully capture the PFAS it was discharging, filed an application to add the missing PFAS, installed additional wastewater‑treatment controls and entered a July 2020 interim consent order that required it to conduct analytical and characterization studies. By the 2024 10‑K, the company’s approach had shifted to operating under that interim consent order as the primary mechanism, with explicit, ongoing obligations to provide notices and reports, perform continual analytical/characterization work and fund capital improvements—turning a one‑time permit‑amendment effort into a sustained, consent‑order‑driven PFAS‑discharge‑characterization program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces a July 2020 interim consent order that is NOT mentioned in the ground truth and appears to be fabricated or confused with other regulatory documents. This is a critical error that fundamentally misrepresents 3M's regulatory framework for the Decatur facility. The ground truth makes no reference to any consent order as the primary mechanism driving the 2024 approach. CORRECT ELEMENTS: The LLM correctly identifies (1) the 2022 issue of incomplete PFAS characterization in the NPDES permit, (2) the filing of an application to add PFAS to the permit, and (3) the installation of wastewater treatment controls. INCORRECT/UNSUPPORTED ELEMENTS: (1) The July 2020 interim consent order is not mentioned in the ground truth and appears to be a fabrication; (2) The characterization of the 2024 approach as 'operating under that interim consent order as the primary mechanism' contradicts the ground truth, which states ADEM had not yet acted on the permit modification request; (3) The claim about 'explicit, ongoing obligations to provide notices and reports' under a consent order is not supported by the ground truth; (4) The framing of a 'consent-order-driven PFAS-discharge-characterization program' misrepresents the actual regulatory status. MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution described in the ground truth. The ground truth shows a progression from (2022) identifying the problem and submitting a permit amendment application → (2024) installing and upgrading treatment controls while awaiting regulatory approval. The LLM instead invents a consent order framework that shifts the narrative entirely. QUANTITATIVE ACCURACY: The date 'July 2020' for the consent order cannot be verified against the ground truth and appears to be incorrect or confused with another document. The ground truth provides no dates for when controls were installed or upgraded. SEMANTIC EQUIVALENCE: While the LLM attempts to describe an evolution in approach, it does so by introducing false regulatory mechanisms that fundamentally alter the factual basis of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 574,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "In the 2022 filing Lowe’s still listed its 4.550 % notes as part of the Fifteenth Supplemental Indenture (issued April 5 2019, due 2049) 【page_76】. By the 2023 filing the most recent supplemental indentures were a 4.400 % issue in September 2022 and a 4.800 % issue in March 2023, with no new 4.550 % notes mentioned 【page_77】【page_78】, indicating that the company did not issue additional 4.550 % notes between 2022 and 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.550% Notes were indeed part of the Fifteenth Supplemental Indenture dated April 5, 2019, due 2049 - this matches the ground truth. (2) The identification that no new 4.550% notes were issued between 2022-2023 is correct. (3) The mention of other notes issued in 2022-2023 (4.400% in September 2022, 4.800% in March 2023) provides relevant context. PROBLEMATIC ELEMENTS: (1) The LLM states that in the 2023 filing 'no new 4.550% notes mentioned,' implying the notes disappeared or were no longer referenced. However, the ground truth explicitly states the 4.550% Notes 'continued to be referenced under the same Fifteenth Supplemental Indenture' in 2023. This is a significant semantic difference - the notes were still in effect and referenced, not absent. (2) The LLM's framing suggests a discontinuity or removal of the 4.550% notes from 2023 filings, when the ground truth indicates continuity with no changes. (3) The answer conflates 'not issuing new notes' with 'not being mentioned,' which are different concepts. The ground truth emphasizes that the notes remained in effect with no modifications. MULTI-HOP REASONING: The LLM correctly synthesized information across 2022 and 2023 filings but drew an incomplete conclusion about the evolution. The answer should have emphasized continuity and lack of change, not the absence of new issuances. QUANTITATIVE ACCURACY: All dates and percentages cited are correct (April 5, 2019; 2049 maturity; 4.550%, 4.400%, 4.800%). QUALITATIVE ACCURACY: The reasoning about no new issuances is sound, but the overall characterization of how the notes 'evolved' is misleading - they didn't evolve; they remained static.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 477,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "MDLZ’s KDP stake was still accounted for under the equity‑method in 2022.  In the first quarter of 2023 its ownership fell below 5 %, so the investment was re‑classified to a marketable‑securities basis (and the remaining shares were sold later that year) 【page_88】.  Before the re‑classification MDLZ recorded a pre‑tax equity‑method gain of $493 million, and the sale of the re‑classified shares generated a $593 million pre‑tax gain on marketable securities 【page_89】.  By 2024 the KDP investment was fully exited and no further KDP‑related gains were reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states a $493 million pre-tax equity-method gain was recorded BEFORE reclassification in Q1 2023, but ground truth indicates this $493 million gain was recorded in 2024 as a result of the accounting change\n   - LLM mentions a $593 million pre-tax gain on marketable securities from share sales in 2023, which is not mentioned in the ground truth\n   - Ground truth clearly states: 2022 had a $71 million pre-tax gain ($54 million after-tax), and 2024 had a $493 million pre-tax gain ($368 million after-tax)\n   - The LLM's $493 million figure is correct in absolute value but is attributed to the wrong year and wrong accounting treatment\n\n2. ENTITY/TIMELINE ACCURACY ISSUES:\n   - LLM incorrectly places the $493 million gain in 2023 as an equity-method gain before reclassification\n   - Ground truth indicates the $493 million gain occurred in 2024 due to a change in accounting for the investment\n   - LLM misses the 2022 $71 million gain entirely, which is a key data point for showing the evolution\n   - LLM introduces a $593 million figure not present in ground truth\n\n3. MULTI-HOP REASONING:\n   - The question asks about evolution between 2022 and 2024\n   - Ground truth shows: 2022 ($71M pre-tax) → 2024 ($493M pre-tax), demonstrating significant growth\n   - LLM's narrative about reclassification in Q1 2023 and subsequent share sales may be technically accurate about the mechanics, but it fundamentally misattributes the timing and nature of the $493 million gain\n   - LLM fails to properly synthesize the 2022-2024 comparison requested\n\n4. CONTEXTUAL RELEVANCE:\n   - LLM does address the evolution question but provides incorrect temporal attribution\n   - The answer about full exit by 2024 is relevant but doesn't properly answer the core question about gains evolution\n   - The focus on 2023 reclassification details, while potentially accurate, obscures the main 2022-2024 comparison\n\n5. CRITICAL ERROR:\n   - The ground truth explicitly states the $493 million gain was recorded in 2024 due to a change in accounting\n   - The LLM places this same $493 million figure in 2023 as an equity-method gain before reclassification\n   - This is a fundamental chronological and accounting treatment error that undermines the entire answer",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 640,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "In FY 2022 Microsoft said Xbox Game Pass gave members “access to a curated library of **over 100** first‑ and third‑party console and PC titles”【page_6】. By FY 2024 the filing describes the service as a “subscription … with access to a curated library of **over 400** first‑ and third‑party console and PC titles” and positions Game Pass as the **cornerstone of the Xbox platform**, stressing its role in expanding the content‑community‑cloud ecosystem, reaching gamers on many devices, and differentiating Microsoft’s gaming business【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) CORRECTNESS: All factual information is accurate. The 2022 figure of 'over 100' titles and 2024 figure of 'over 400' titles match the ground truth exactly. The characterization of Game Pass as the 'cornerstone' of Microsoft's gaming platform in 2024 is correctly identified and cited. The strategic positioning evolution from 'key part' to 'cornerstone' is properly captured. (2) QUANTITATIVE ACCURACY: Both numeric values (100 and 400 titles) are correct with proper qualification ('over'). No calculations are required for this question, and the numbers are presented accurately. (3) QUALITATIVE ACCURACY: The LLM correctly identifies the multi-hop synthesis required - comparing Game Pass positioning across two fiscal years (2022 vs 2024) and extracting both scale metrics and strategic emphasis. The answer properly synthesizes information about: (a) scale evolution (100→400 titles), (b) strategic positioning shift (key part→cornerstone), and (c) the broader ecosystem context (content-community-cloud). The reasoning is sound and logically structured. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all components of the question - scale evolution (title count), positioning evolution (strategic emphasis), and the time period (2022-2024). The inclusion of specific filing references (page numbers) adds credibility. Minor note: The LLM answer is slightly more detailed than the ground truth in explaining the strategic context (mentioning 'expanding the content-community-cloud ecosystem' and 'reaching gamers on many devices'), but this represents appropriate elaboration rather than error. The answer fully captures the 'significant transformation' concept implied in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 483,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit schedule does not contain a separate item describing a Deferred Stock Unit (DSU) award agreement for non‑employee directors, so the agreement is not explicitly disclosed in the sections provided. By the 2024 Form 10‑K, the company adds Exhibit 10.7 – “Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non‑Employee Directors under the 3M 2016 Long‑Term Incentive Plan,” incorporated by reference to the 2018 Form 10‑K. This change shows that the DSU award agreement for non‑employee directors, while unchanged in substance, moved from being omitted to being specifically listed as a referenced exhibit, providing a clearer disclosure of its structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT 2022: The LLM states the DSU agreement 'is not explicitly disclosed' in 2022, but the ground truth confirms it WAS referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan. (2) INCORRECT INCORPORATION REFERENCE: The LLM claims the 2024 agreement is 'incorporated by reference to the 2018 Form 10-K,' but the ground truth states it references the 2023 10-K with amendments as of May 8, 2023. This is a material factual error regarding the source document. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes the change as moving 'from being omitted to being specifically listed,' but the ground truth indicates the agreement was already disclosed in 2022 and continued through 2024 with no change in effective date (January 1, 2019) or structure. (4) CORRECT ELEMENTS: The LLM correctly identifies the agreement applies to grants on or after January 1, 2019 and correctly names the plan (3M 2016 Long-Term Incentive Plan). However, these correct elements are embedded within a fundamentally flawed narrative about the evolution of disclosure. The answer fails the core requirement of accurately describing how the disclosure evolved from 2022 to 2024, instead inventing a narrative of omission-to-inclusion that contradicts the ground truth's finding of continuity with updated incorporation references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 404,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024 the First‑Mortgage balance grew modestly (to $27.4 billion from $26.2 billion) while the HELOC balance fell (to $424 million from $479 million), and the pool’s un‑amortized premiums, discounts and direct origination costs rose to **$112 million** from **$100 million**.  At the same time the geographic concentration in California slipped slightly, from **about 43 %** of the portfolio in 2023 to **about 42 %** in 2024【page_88†L71-L78】【page_88†L79-L82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: unamortized premiums/discounts/origination costs increased from $100 million to $112 million (matching ground truth exactly), California concentration decreased from 43% to 42% (matching ground truth exactly). The answer goes beyond the ground truth by providing additional relevant context about the First Mortgage balance growth ($26.2B to $27.4B) and HELOC balance decline ($479M to $424M), which enriches understanding of portfolio composition evolution without introducing any inaccuracies. The multi-hop reasoning is sound - the model correctly synthesized information about both origination costs and geographic concentration across the 2023-2024 period. Entity identification is accurate (Charles Schwab Bank, First Mortgages, HELOCs, California). The semantic meaning aligns perfectly with the ground truth, with appropriate use of 'about' for percentages reflecting the approximate nature of concentration metrics. The inclusion of source citations adds credibility. Minor consideration: the answer provides more detail than the ground truth's interpretive statement about 'shift in geographic risk exposure,' but this is additive rather than contradictory. No calculation errors detected. All numbers are presented in consistent format and are factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 384,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike’s product‑research narrative already highlighted Dri‑FIT as a core performance fabric in fiscal 2023, listing it with other marquee technologies (e.g., Air, Zoom, Free, Flyknit, etc.)【page_6】. The fiscal 2024 filing repeats that language, again naming Dri‑FIT alongside Air, Zoom, Flyknit, FlyEase, ZoomX, Air Max and React, showing that the strategic emphasis on Dri‑FIT has remained steady rather than shifting dramatically【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question. (1) CORRECTNESS: The answer correctly identifies that Nike's strategic emphasis on Dri-FIT remained stable/steady between fiscal 2023 and fiscal 2024, matching the ground truth conclusion. The LLM accurately lists the same technologies mentioned in both years (Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, React), demonstrating proper multi-hop synthesis across both fiscal years. (2) QUANTITATIVE ACCURACY: No numeric values are present in this question, so this dimension is not applicable. The answer correctly references both fiscal years (2023 and 2024) without error. (3) ENTITY ACCURACY: Nike is correctly identified, fiscal years 2023 and 2024 are correct, and Dri-FIT technology is properly named. All supporting technologies are accurately listed. (4) REASONING: The multi-hop reasoning is sound - the LLM correctly synthesized information from both the 2023 and 2024 10-K filings to compare the language and emphasis. The conclusion that emphasis 'remained steady rather than shifting dramatically' is logically sound and matches the ground truth finding of 'remained stable' and 'no change.' (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('remained steady,' 'strategic emphasis...has remained steady') is semantically equivalent to the ground truth's 'remained stable' and 'consistent strategic importance.' Minor wording differences ('steady' vs 'stable') do not affect factual accuracy. The answer appropriately notes that 'exact same language was used' is reflected in the LLM's statement that 'fiscal 2024 filing repeats that language.' One minor observation: the LLM includes page references (【page_6】) which add helpful specificity, though the ground truth does not include these citations. This is a strength rather than a weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 497,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "In the 2022 Form 10‑K, Mondelez noted that it was “on heightened alert and dedicate[d] focused resources to network security, **backup and disaster recovery**” as part of its response to growing cyber‑risk exposure【page_45】. By the 2024 filing, the company says it is “continuing to **invest and augment** our cybersecurity program…including **backup and disaster recovery**” along with broader upgrades such as identity‑management, multi‑factor authentication and advanced threat protection, indicating a deeper, more expansive commitment as cyber threats have become more frequent and sophisticated【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Mondelez's cybersecurity investment evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 baseline where Mondelez was 'on heightened alert' and dedicated resources to 'backup and disaster recovery' - this matches the ground truth exactly. (2) Accurately captures the 2024 evolution showing the company 'continuing to invest and augment' its cybersecurity program with backup and disaster recovery solutions. (3) Properly synthesizes the multi-hop information across two different filing years, showing progression from heightened alert to expanded/deeper commitment. (4) Includes relevant contextual details about additional security measures (identity-management, multi-factor authentication, advanced threat protection) that demonstrate the broader cybersecurity program expansion. (5) Correctly cites page references (page_45 for 2022, page_20 for 2024) showing source documentation. (6) Uses direct quotes appropriately to support claims. MINOR CONSIDERATIONS: The LLM answer does not explicitly mention 'state-sponsored actors' or 'artificial intelligence' threats that appear in the ground truth's 2024 description, though it does note threats have become 'more frequent and sophisticated.' This is a minor omission of contextual detail rather than a factual error. The answer effectively conveys the semantic meaning that Mondelez's investment has evolved from a reactive, heightened-alert posture in 2022 to a more proactive, expansive augmentation strategy by 2024. No numerical errors, date errors, or calculation issues present. The reasoning correctly synthesizes information across multiple years and documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 475,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "In the FY 2022 filing Microsoft’s 10‑K contains no disclosed monetary commitment or spend target for Black‑ and African‑American‑owned suppliers (see FY 2022 page 8). By FY 2024 the company announced a $150 million commitment to minority‑depository institutions and funds for Black‑owned small businesses, set a $500 million spend goal to double the number of Black‑ and African‑American‑owned suppliers, and extended 162 low‑ or no‑interest loans through its Partner Capital Fund (see FY 2024 page 7). This reflects a substantial increase in both the amount of capital allocated and the breadth of supplier engagement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on critical facts. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims FY 2022 had 'no disclosed monetary commitment' but the ground truth explicitly states Microsoft reported 'reaching more than 90% of its goal to spend $500 million' in FY 2022. This is a fundamental factual error. The LLM then states the $500 million goal was 'set' in FY 2024, when it was actually already a goal in FY 2022 (at 90% achievement). The LLM correctly identifies the $150 million commitment to Minority Depository Institutions in FY 2024 and the 162 loans through Partner Capital Fund, but these are presented as new information without acknowledging the pre-existing $500 million goal from FY 2022. (2) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the evolution correctly. The ground truth shows: FY 2022 = 90% toward $500M goal with doubled supplier count; FY 2024 = $500M goal achieved PLUS $150M new commitment. The LLM presents these as separate timeline events rather than showing the progression of achievement. (3) ENTITY/METRIC ACCURACY: While the LLM correctly identifies Microsoft, the fiscal years, and some metrics (150M, 162 loans), it mischaracterizes the timing and status of the $500 million commitment. (4) SEMANTIC ISSUES: The LLM's framing that FY 2022 had 'no disclosed' commitment is factually incorrect per the ground truth. The answer creates a false narrative of starting from zero in FY 2024 rather than showing evolution from 90% achievement in FY 2022 to full achievement plus expansion in FY 2024. This is a critical failure in answering the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 458,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The 2022 Form 10‑K reported that **10,638,639** common shares were available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non‑U.S. Employees【page_83】. By the 2023 filing, that pool had fallen to **8,565,087** shares【page_84】—a reduction of roughly 2 million shares. The decline shows the plan has been actively used and that Abbott is tightening the remaining share reserve, reflecting a strategy of leveraging stock‑based incentives while managing dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: Both key figures are correct—10,638,639 shares in 2022 and 8,565,087 shares in 2023. The calculated reduction of 'roughly 2 million shares' is accurate (2,073,552 shares difference, which rounds to approximately 2 million). ENTITY ACCURACY: Correctly identifies Abbott Laboratories, the Employee Stock Purchase Plan for Non-U.S. Employees, and the relevant fiscal years (2022 and 2023 filings). MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly interprets the trend—a decline in available shares. INTERPRETATION: The LLM provides sound strategic analysis, noting that the decline reflects active plan usage and Abbott's approach to managing dilution while leveraging stock-based incentives. This interpretation aligns with the ground truth's assessment that it indicates 'a tightening or adjustment in Abbott's stock-based incentive strategy.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (adding context about 'managing dilution'), but this represents value-added analysis rather than inaccuracy. The page references (page_83, page_84) add specificity. The answer fully addresses both components of the multi-part question: the evolution of share availability and what it indicates about strategy. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 400,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "In FY 2023 Nike Air was referenced mainly as one of the core technology platforms that drive new product designs – it appears in the list of “Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, Zoom X, Air Max and React” technologies that underpin the company’s innovation pipeline【page_6】. By FY 2024 Nike not only continues to tout Air but also explicitly ties the technology to its wholly‑owned Air Manufacturing Innovation subsidiary, which supplies the Nike Air‑Sole cushioning components used in footwear, signaling a more integrated, vertically‑controlled emphasis on Air technology in product development【page_7】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Nike Air's treatment. Key issues: (1) FACTUAL ERROR - The LLM claims that in FY2024, Nike 'explicitly ties the technology to its wholly-owned Air Manufacturing Innovation subsidiary' and references vertical control of Air technology. The ground truth makes no mention of this subsidiary or vertical integration strategy in FY2024. This appears to be fabricated or misattributed information. (2) INCOMPLETE ANALYSIS - The LLM fails to capture the core insight from the ground truth: the strategic shift from Nike Air being positioned as an 'emerging innovation' (FY2023) to becoming a 'standard component' and 'foundational offering' (FY2024). Instead, the LLM focuses on vertical integration claims that aren't supported by the ground truth. (3) MISCHARACTERIZATION - The ground truth indicates Nike Air moved from being emphasized as a distinct growth driver to being embedded alongside mature technologies (Zoom, Free, React), suggesting maturation and integration into the broader platform. The LLM's narrative about manufacturing subsidiaries and vertical control doesn't align with this strategic positioning shift. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize FY2023 and FY2024 information, it does so incorrectly by introducing unsupported claims about manufacturing subsidiaries rather than accurately comparing how Nike Air was positioned in each year's product development strategy. (5) The LLM does correctly identify that Nike Air appears in both years' technology lists, but this is a minor correct element overshadowed by the major factual errors and misinterpretation of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 467,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "In the 2022 10‑K, Osmolite was listed as one of the enteral‑feeding products in the Nutritional Products segment, grouped with Jevity, Glucerna, Oxepa, Freego, Nepro and Vital (ABT_10k_2022 p. 3). The 2023 filing repeats this placement, again positioning Osmolite within the same enteral‑feeding portfolio and product line (ABT_10k_2023 p. 4), showing that Abbott’s strategy for Osmolite has remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. STRENGTHS: (1) Correctly identifies Osmolite's positioning in both 2022 and 2023 10-K filings; (2) Accurately lists all companion enteral feeding products (Jevity, Glucerna, Oxepa, Freego, Nepro, Vital) with proper formatting; (3) Correctly synthesizes the multi-hop comparison across two fiscal years; (4) Accurately concludes that Abbott's strategy for Osmolite remained unchanged/stable between 2022 and 2023; (5) Provides appropriate source citations (ABT_10k_2022 p. 3, ABT_10k_2023 p. 4); (6) No calculation errors or numeric inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit statement about 'no indication of Osmolite being newly introduced, discontinued, or significantly repositioned,' though this is implied by the conclusion that strategy remained unchanged; (2) The ground truth uses the phrase 'stable strategic positioning' while the LLM uses 'unchanged strategy' - these are semantically equivalent; (3) The LLM answer does not explicitly mention 'institutional enteral nutrition segment' but this is a minor contextual detail that doesn't affect the core accuracy. The answer fully addresses the question's inquiry about how Osmolite's positioning evolved (or didn't evolve) between 2022 and 2023, correctly identifying the consistency in product line strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 394,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "In the 2022 filing, 3M said its Minnesota work was governed by the 2007 Settlement Agreement and Consent Order (SACO) with the MPCA – remediation at the Cottage Grove site was largely finished and a new PFAS‑treatment system was being installed – while in Alabama it was operating under a voluntary remedial‑action agreement and a July 2020 interim consent order with ADEM that required a multilayer cap, ongoing remediation, reporting and other site‑operation commitments. By the 2024 filing, the Minnesota obligations had broadened to include a new wastewater‑treatment system, a storm‑water compliance order, response to stricter Minnesota health‑based values, and active participation in a draft Clean Water Act permit that imposes tighter PFAS effluent limits, whereas the Alabama effort now centers on upgrading and optimizing the installed wastewater controls, a pending amendment to the NPDES permit, and continued cooperation with EPA, ADEM and the DOJ to satisfy the interim consent order’s ongoing operational and remediation duties.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key dates (2007 Settlement Agreement, July 2020 Interim Consent Order with ADEM) and accurately captures the evolution between 2022 and 2024. It correctly notes the 2024 regulatory intensification with stricter PFAS limits and mentions the multilayer cap at Decatur facility. The answer appropriately addresses both Minnesota and Alabama jurisdictions and demonstrates understanding of the multi-hop synthesis required.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces unsupported claims not in the ground truth: 'new PFAS-treatment system being installed' in 2022 and 'new wastewater-treatment system' in 2024 are not explicitly mentioned in the original answer. (2) The LLM mentions 'voluntary remedial-action agreement' in Alabama for 2022, which is not corroborated by the ground truth that only references the July 2020 Interim Consent Order. (3) The LLM states 'storm-water compliance order' as a 2024 obligation in Minnesota, which is not mentioned in the ground truth. (4) The LLM references 'pending amendment to the NPDES permit' in Alabama 2024, which is not in the original answer. (5) The LLM omits important 2024 details from the ground truth: the December 2024 revised draft permit from MPCA, the January 2024 updated HBVs from MDH, and the October 2024 proposed HRLs. (6) The LLM does not mention the significant adverse impact warning regarding the Cottage Grove facility's operations from the December 2024 permit.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis across years and jurisdictions, but introduces details not supported by the knowledge graph while omitting key regulatory developments. The reasoning structure is sound but the factual foundation is compromised by both additions and omissions.\n\nNUMERIC/DATE VERIFICATION: All dates mentioned (2007, 2020, 2022, 2024) are correct. No calculations are required. However, the characterization of regulatory developments is incomplete and partially inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 540,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "In the 2024 Form 10‑K the Company reports its Coca‑Cola HBC AG holding as an equity‑method investment, owning 22 % of the bottler’s outstanding shares (page 87). The 2022 filing’s disclosed sections (pages 116‑120) do not list Coca‑Cola HBC AG among equity‑method investments, indicating it was previously accounted for within the broader bottling‑investment segment and that the ownership stake has been reduced from a higher level in 2022 to 22 % in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) CRITICAL ERROR - The LLM claims that in 2022, Coca-Cola HBC AG was NOT listed among equity method investees (stating it was 'previously accounted for within the broader bottling-investment segment'), but the ground truth explicitly states it WAS among listed equity method investees in 2022. This is a fundamental mischaracterization of the 2022 position. (2) CRITICAL ERROR - The LLM asserts the ownership stake 'has been reduced from a higher level in 2022 to 22% in 2024,' but the ground truth makes no such claim. The ground truth states the 2022 percentage was 'not disclosed' - not that it was higher. The LLM invented a narrative of stake reduction without evidence. (3) CORRECT - The 22% ownership stake as of December 31, 2024 is accurate. (4) CORRECT - The classification as equity method investee in 2024 is accurate. (5) PARTIALLY CORRECT - The observation about formalization and quantification is conceptually aligned with the ground truth's point about 'formalization and quantification of the relationship,' but the LLM's framing of a stake reduction contradicts this. The LLM failed the multi-hop synthesis by incorrectly inferring a reduction in stake rather than simply noting that the percentage was not previously disclosed. The answer demonstrates poor reasoning about what 'not disclosed' means versus what 'reduced' means.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 397,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle’s 2022 filing makes hybrid‑deployment a distinct pillar of its strategy – it highlights the Oracle Cloud@Customer hybrid offering and notes that it spent **$7.2 billion on R&D in fiscal 2022** to enhance its portfolio and enable on‑premise/cloud integration【page_6】. By fiscal 2024 the company still stresses hybrid as a core option, but frames it as part of a **“flexible and interoperable” suite of on‑premise, cloud‑based and hybrid models that are tightly integrated with its Oracle SaaS and OCI services**【page_72】, indicating the emphasis has broadened from specific hybrid products to a universal, integrated deployment approach, with continued (though undisclosed) product‑development investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Oracle's strategic evolution. QUANTITATIVE ACCURACY: The $7.2 billion R&D figure for fiscal 2022 is correctly cited and matches the ground truth exactly. The numeric data is accurate with proper formatting. QUALITATIVE ACCURACY: The answer effectively synthesizes the multi-hop information across fiscal 2022 and fiscal 2024, correctly identifying: (1) the 2022 emphasis on hybrid deployments as a distinct pillar with Oracle Cloud@Customer as a specific product example, (2) the 2024 evolution toward integration of hybrid as one of multiple deployment models within a broader ecosystem, and (3) the strategic shift from product-specific focus to universal interoperability. The reasoning correctly captures the progression from development-focused to mature, integrated approach. ENTITY ACCURACY: All entities are correct - Oracle is properly identified, fiscal years 2022 and 2024 are accurate, and deployment models (on-premise, cloud-based, hybrid) are correctly referenced. COMPLETENESS: The answer addresses both parts of the question - product development investment (with specific $7.2B figure) and deployment model integration (showing evolution from distinct pillar to integrated suite). SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as moving from 'specific hybrid products to a universal, integrated deployment approach' aligns well with the ground truth's description of evolution 'from a development-focused approach to a more mature, integrated deployment model.' Minor note: The LLM appropriately acknowledges that fiscal 2024 R&D investment figures are undisclosed, showing careful attention to what data is actually available. The citation references (page_6, page_72) add credibility though cannot be independently verified. Overall, the answer is factually sound, well-reasoned, and comprehensively addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 524,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "In the 2023 Form 10‑K, the Mandatory Clawback Policy appears as Exhibit 97 and is listed as “Filed herewith.” In the 2024 Form 10‑K, the same policy (Exhibit 97) is no longer filed anew; it is “Incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023.” Thus the filing moved from a direct attachment in 2023 to a reference to the prior‑year filing in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about the evolution of the Mandatory Clawback Policy filing status between 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company. (1) CORRECTNESS: The answer correctly identifies that in 2023 the policy was filed directly as Exhibit 97 ('Filed herewith') and in 2024 it was incorporated by reference to the prior year's Exhibit 97. This matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: No calculations or numeric values are required for this question; the years (2023, 2024) and exhibit numbers (Exhibit 97) are all correct. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing the filing status across two different years and correctly identifying the procedural change. The distinction between 'Filed herewith' and 'Incorporated by reference' is accurately captured. The answer also appropriately notes this represents a procedural rather than substantive change, which aligns with the ground truth interpretation. (4) ENTITY ACCURACY: Wells Fargo & Company is correctly identified, the years 2023 and 2024 are correct, and Exhibit 97 is the correct exhibit number. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more detailed language ('Form 10‑K' vs '10-K filing') but conveys identical information to the ground truth. The phrasing 'moved from a direct attachment in 2023 to a reference to the prior‑year filing in 2024' is semantically equivalent to the ground truth's description of the change. Minor: The LLM could have explicitly stated this was a 'procedural change' as the ground truth does, but this is a very minor omission that doesn't affect the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 466,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher went from buying CorEvitas in 2023 to having it operate as an integrated part of the business in 2024.  The August 14, 2023 acquisition was completed for a $910 million purchase price (cash $730 million plus $184 million of debt assumed), generated $627 million of goodwill and produced a $0.91 billion cash outflow in investing activities 【page_65】【page_66】【page_24】, and by 2024 CorEvitas’s contribution was reflected in the Laboratory Products and Biopharma Services segment’s 2 % revenue increase and 17 % segment‑income increase with no additional acquisition cash outlay recorded 【page_22】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the CorEvitas acquisition and its evolution. Strengths: (1) Correctly identifies the August 14, 2023 acquisition date and $0.91 billion ($910 million) purchase price; (2) Accurately breaks down the purchase consideration ($730 million cash + $184 million debt assumed = $914 million, which rounds to the stated $910M); (3) Correctly identifies $627 million in goodwill generated; (4) Properly notes integration into Laboratory Products and Biopharma Services segment in 2024; (5) Accurately cites the 2% revenue increase and 17% segment-income increase for 2024; (6) Correctly states no additional acquisition cash outlay in 2024. Minor gaps: (1) The original answer mentions the 18-year weighted average amortization period for definite-lived intangible assets, which the LLM answer omits; (2) The original answer provides broader strategic context (the $5.94 billion senior notes issuance and $3.00 billion stock repurchase), which the LLM answer does not include, though these are contextual rather than directly about the CorEvitas relationship evolution; (3) The LLM answer provides more granular transaction details (cash vs. debt components) than the original, which is actually more informative. The multi-hop reasoning is sound—the answer correctly synthesizes the 2023 acquisition details with 2024 operational integration and financial performance. The quantitative data is accurate with proper number formatting. The answer directly addresses how the relationship evolved and the specific financial implications, though it could have included the amortization period detail for completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 460,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "In the 2022 Form 10‑K the V2500 flight‑hour payments were listed under “Other commercial aerospace commitments” with $735 million expected in 2022 and $1,053 million in 2023 【page_112】. By the 2023 filing those near‑term amounts had been removed and the remaining schedule now shows $836 million in 2024, $862 million in 2025, $705 million in 2026 and $687 million in 2027, indicating the obligations have been pushed into later years 【page_101】. In both years the company said each flight‑hour payment will be capitalized as a collaboration intangible asset as the payments are made 【page_112】【page_101】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR DISCREPANCY ON CORE FACTS: The ground truth explicitly states there was 'no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.' The LLM answer claims the opposite - that obligations were 'pushed into later years' with specific dollar amounts ($735M in 2022, $1,053M in 2023 removed, then $836M in 2024, etc.). This is a fundamental contradiction. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific dollar amounts ($735M, $1,053M, $836M, $862M, $705M, $687M) that cannot be verified against the ground truth, which makes no mention of these specific figures. The ground truth indicates a stable structure with no changes between years, while the LLM claims significant year-over-year shifts in payment schedules. (3) CAPITALIZATION TREATMENT: The LLM correctly identifies that payments were capitalized as collaboration intangible assets in both years, which aligns with the ground truth. However, this is the only element that matches. (4) MULTI-HOP REASONING: The LLM failed to synthesize the key finding from the ground truth - that the obligation structure remained stable across 2022-2023. Instead, it created a narrative of changing payment schedules that directly contradicts the source material. (5) TIMING AND STRUCTURE: The ground truth emphasizes the contingent nature tied to flight hours through June 2027 and the stable commitment structure. The LLM focuses on specific dollar amounts and year-by-year changes that are not supported by the ground truth. The answer demonstrates a fundamental misunderstanding or misrepresentation of the actual filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 480,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "In the 2022 filing Coca‑Cola’s fairlife relationship was limited to the acquisition of the remaining ownership interest, which was recorded as a $902 million gain and a $40 million tax benefit (KO 10‑K 2022 p.55; p.53). By the 2024 filing the company reports a $6.126 billion contingent‑consideration liability for a milestone payment that is contingent on fairlife meeting specified financial targets through 2024, and it has already paid $275 million toward that milestone in 2023 (KO 10‑K 2024 p.111‑112).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR ERROR - The LLM claims a '$6.126 billion contingent-consideration liability' for fairlife in 2024, which is not supported by the ground truth and appears to be fabricated or confused with another acquisition. The ground truth states there was 'a remaining milestone payment' but does not specify this amount. (2) MAJOR ERROR - The LLM claims '$275 million toward that milestone in 2023' was already paid, which contradicts the ground truth stating the payment was 'scheduled for 2025' (future tense, not past). (3) PARTIAL ACCURACY - The LLM correctly identifies that the 2020 acquisition of remaining fairlife ownership occurred and that contingent payments tied to performance milestones exist. (4) PARTIAL ACCURACY - The LLM correctly notes the evolution from 2022 (no contingent payments mentioned) to 2024 (contingent payments disclosed). (5) INCORRECT DETAIL - The LLM references a '$902 million gain' and '$40 million tax benefit' from 2022, which may relate to the 2020 acquisition but are not directly addressed in the ground truth and appear to be extraneous details that don't clarify the contingent payment evolution. (6) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, it does so with fabricated numbers that severely undermine credibility. The core insight about evolution from 2022 to 2024 is present but buried under false quantitative claims. The answer fails on quantitative accuracy due to the unsupported $6.126 billion figure and the incorrect timing of the $275 million payment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 452,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "In the 2022 filing Oracle described its Cloud Services as a flexible, interoperable suite that bundles SaaS and OCI to help customers migrate and run their existing on‑premise applications and infrastructure on Oracle’s cloud, emphasizing that its applications and infrastructure technologies are the “building blocks” of both Oracle‑run and customer‑run clouds (2022 p. 6‑7). By the 2024 filing the company positions Oracle Cloud Services as a single, comprehensive platform—Oracle SaaS together with OCI—delivered as a managed, subscription‑based service that tightly integrates enterprise applications with the underlying infrastructure, giving customers a choice‑driven, fully integrated cloud experience (2024 p. 72‑73). This marks a shift from a migration‑and‑flexibility narrative to a more unified, service‑centric strategy that stresses seamless application‑infrastructure integration.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Oracle's strategic evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning emphasizing flexibility, interoperability, and the 'building blocks' concept for both Oracle-run and customer-run clouds; (2) Accurately captures the 2024 shift toward a unified, comprehensive platform with tight application-infrastructure integration; (3) Properly synthesizes the evolution narrative from migration-and-flexibility to service-centric strategy; (4) Includes specific page references (2022 p. 6-7, 2024 p. 72-73) that ground the answer in source material; (5) Correctly identifies key technologies and concepts (SaaS, OCI, Autonomous Database context implied). MINOR GAPS: (1) The ground truth explicitly mentions Oracle Autonomous Database as a key 2022 offering with machine learning capabilities—the LLM answer doesn't specifically highlight this innovation, though it captures the broader positioning; (2) The ground truth emphasizes the 'customer-centric' and 'choice-driven' language more explicitly in 2024, while the LLM frames it as 'choice-driven' but could have emphasized the 'customer-centric' evolution more clearly; (3) The ground truth notes the shift from 'promoting individual innovations' to 'holistic platform'—the LLM captures this but less explicitly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The page references provided by the LLM appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple strategic dimensions (applications, infrastructure, deployment models, customer choice), demonstrating sound multi-hop reasoning. The comparison between 2022 and 2024 is logically structured and accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different emphasis and wording, but the factual content aligns well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 564,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "In the 2023 Form 10‑K the Key/Specified Employee Policy is listed as Exhibit 10(r)* and is incorporated by reference to Exhibit 10(v) of the company’s 2018 Form 10‑K Annual Report 【page_17】. The 2024 Form 10‑K shows the same Exhibit 10(r)* and still incorporates the policy by reference to the same 2018 Annual Report (Exhibit 10(v)) 【page_20】, indicating that its documentation and filing status have not changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the policy is listed as 'Exhibit 10(r)' in both 2023 and 2024 filings, but the ground truth explicitly states it is 'incorporated by reference to Exhibit 10(v) from the 2018 filing.' The LLM conflates the exhibit number where the policy appears in the current filing (10(r)) with the exhibit it references (10(v)). This is a fundamental factual error. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution from 'newly introduced' in 2023 to 'continuing policy' in 2024, indicating a change in how the policy was presented/characterized. The LLM completely misses this important distinction about the policy's status evolution, instead only noting that documentation hasn't changed. (3) MISSING CONTEXT: The ground truth highlights that the policy remained unchanged (no new amendments or updates), which the LLM does mention but frames differently. (4) ACCURACY OF CORE CLAIM: While the LLM correctly identifies that both years reference the same 2018 Exhibit 10(v), it introduces confusion by prominently featuring 'Exhibit 10(r)' as the primary identifier, which appears to be incorrect or at least misleading. The ground truth focuses on the incorporation by reference to Exhibit 10(v), not 10(r). (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution aspect of the question - it should have identified and explained the shift from 'newly introduced' to 'continuing' status between years. The answer is partially responsive but contains significant factual inaccuracies that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 442,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The 6.700% notes due 2028 carried an aggregate principal balance of **$285 million at the end of 2022 and the same $285 million at the end of 2023** (see the long‑term debt tables for 2022 and 2023)【page_84】【page_94】.  Keeping this tranche unchanged indicates RTX deliberately left this portion of its debt untouched, preserving a stable maturity profile while focusing its refinancing and repayment activity on other issuances.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the aggregate principal balance was $285 million at the end of 2022 and remained $285 million at the end of 2023. The ground truth clearly shows: 2022 = $115 million, 2023 = $285 million. This is a major factual error on the 2022 figure - the LLM got it wrong by $170 million (148% error). (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the balance 'evolved between 2022 and 2023' - this requires comparing two different years. The LLM failed to identify the significant increase from $115M to $285M, which is the core finding. Instead, it incorrectly claims the balance remained unchanged. (3) INTERPRETATION ERROR: The LLM's conclusion that RTX 'deliberately left this portion of its debt untouched' is contradicted by the actual data showing a $170 million increase. This represents a fundamental misunderstanding of the debt evolution. (4) ENTITY/METRIC ACCURACY: While RTX and the 6.700% notes due 2028 are correctly identified, the financial metrics are completely wrong. The LLM appears to have confused or misread the 2022 and 2023 figures. (5) SEMANTIC EQUIVALENCE: The LLM's narrative about 'preserving a stable maturity profile' is semantically opposite to what the data shows - an expansion of this debt tranche. The ground truth indicates strategic debt expansion, not preservation. This is a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 426,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The 1.95 % 12‑year senior notes (due 7/24/2029, euro‑denominated) were carried at $773 million at the end of 2023 and fell to $725 million at the end of 2024, a reduction of about $48 million.  Their effective interest rate slipped slightly, from roughly 2.08 % in 2023 to about 2.07 % in 2024【page_62】【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: carrying value of $773 million in 2023 and $725 million in 2024 (reduction of $48 million calculated correctly), and effective interest rates of 2.08% in 2023 and 2.07% in 2024. The answer correctly identifies the notes as TMO's 1.95% 12-Year Senior Notes and accurately characterizes the evolution as a reduction in carrying value and marginal improvement in effective borrowing cost. The LLM provides additional helpful context by noting the euro-denomination and maturity date (7/24/2029), which adds relevant detail without contradicting the ground truth. The multi-hop synthesis is sound - the answer correctly combines information about both the carrying value and effective interest rate changes across the two years. The calculation of the $48 million reduction is accurate ($773M - $725M = $48M). The only minor distinction from the ground truth is that the LLM uses slightly more cautious language ('roughly,' 'about,' 'slipped slightly') rather than stating the figures as definitive, but this is a stylistic choice that doesn't affect factual accuracy. The answer fully addresses all parts of the question regarding how both metrics evolved between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 358,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was tucked under a broad “Code of Ethics” section, with a simple web link and a statement that any amendments or waivers would be posted online. By the 2024 filing, the Directors’ Code of Conduct is listed together with the corporate‑governance guidelines, bylaws and committee charters as a formal document incorporated by reference. This change elevates the code from a peripheral ethics posting to a core governance instrument, reinforcing board accountability, transparency and the enforceability of director‑level standards.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that in 2022, the Directors' Code of Conduct was explicitly detailed with a direct URL link, and by 2024 it was listed among other governance materials WITHOUT a direct link. However, the LLM answer reverses this narrative, claiming the 2022 filing had it 'tucked under a broad Code of Ethics section with a simple web link' and that by 2024 it was 'incorporated by reference' as a core governance instrument. This is the opposite of what the ground truth indicates. The LLM's interpretation that the change 'elevates the code from peripheral to core' directly contradicts the ground truth's assessment that the change represents a 'more streamlined or consolidated approach' that could 'reduce visibility' and 'affect transparency.' The LLM correctly identifies the years (2022 vs 2024) and the company (BNY Mellon), and it does address the governance implications question. However, the directional interpretation of the change is inverted—the LLM sees it as elevation and reinforcement of accountability, while the ground truth suggests it may reduce standalone visibility and transparency. The LLM's reasoning about 'incorporating by reference' and 'core governance instrument' appears to mischaracterize the actual shift described in the ground truth. This is a critical error in understanding the nature and implications of the presentation change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 405,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "In the 2023 Form 10‑K Amazon disclosed that it entered a $5 billion unsecured 364‑day revolving “Short‑Term Credit Agreement” in **November 2023**, which **matures in October 2024** (with one optional 364‑day extension). In the 2024 Form 10‑K the company replaced that facility with a new **$5 billion unsecured 364‑day revolving agreement signed in October 2024**, extending the **maturity to October 2025** (again with a one‑period extension option). Thus the facility size stayed at $5 billion, the maturity was pushed out by one year, and the agreement was re‑established roughly a year after the original signing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 facility: $5 billion unsecured 364-day revolving credit - CORRECT; November 2023 establishment - CORRECT; October 2024 maturity - CORRECT. (2) 2024 facility: $5 billion unsecured 364-day revolving credit - CORRECT; October 2024 establishment - CORRECT; October 2025 maturity - CORRECT. (3) Facility size consistency at $5 billion - CORRECT. (4) One-year maturity extension (Oct 2024 to Oct 2025) - CORRECT. The LLM correctly identified the optional 364-day extension feature, which adds helpful detail. Multi-hop synthesis is sound: the answer properly compares the 2023 and 2024 agreements across all three dimensions requested (facility size, maturity date, timing of establishment). The characterization as a 'procedural renewal rather than substantive change' is implicit in the LLM's description. Minor note: The ground truth mentions the 2023 agreement replaced a 'prior agreement from November 2022,' which the LLM does not explicitly state, but this is not required to answer the specific question about 2023-2024 evolution. The LLM's phrasing 'roughly a year after the original signing' accurately captures the November 2023 to October 2024 timeline. All numbers, dates, and financial metrics are factually correct with no calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 374,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "In 2022 AMD’s APU strategy was focused on integrating a CPU and a GPU on a single chip to deliver visual‑processing capability for value‑oriented and mainstream PCs (page 8). By 2024 the company added a dedicated neural‑processing unit (NPU) to its APUs – the Ryzen AI 300 Series – positioning them for next‑generation AI PCs (page 7; page 5). This shift expands AMD’s addressable market into the fast‑growing AI‑PC segment, creating a new high‑margin revenue stream and giving the company upside to increase AI‑PC sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of AMD's APU strategy from 2022 to 2024 and correctly identifies key product developments (Ryzen AI 300 Series with NPU integration). The answer accurately reflects the shift from traditional CPU-GPU combinations to integrated NPU solutions for AI PCs. However, there are notable gaps compared to the ground truth: (1) The LLM answer omits AMD's 2022 emphasis on external GPU-based solutions (Instinct MI200 series, Radeon PRO V620) for data center and cloud applications, which is important context for understanding the strategic pivot. (2) The ground truth emphasizes AMD becoming 'the first company' to integrate a dedicated NPU on the same SoC as an x86 CPU, a competitive differentiation point that the LLM answer doesn't explicitly highlight. (3) The LLM answer mentions 'high-margin revenue stream' without supporting data, while the ground truth focuses on 'differentiated player' positioning. (4) The LLM answer references specific page numbers (pages 8, 7, 5) which adds credibility but cannot be verified. Quantitatively, no specific financial figures are provided in either answer, so no calculation errors exist. The multi-hop reasoning is sound in the LLM answer—it correctly synthesizes the 2022-to-2024 evolution and connects it to market implications. The main weakness is incomplete coverage of the 2022 baseline (missing external GPU solutions context) and less emphasis on competitive differentiation. The answer is directionally correct and addresses the question's core elements but lacks the comprehensive context provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 444,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K state the same rule: Irish dividends are subject to a 25 % withholding tax unless a U.S. shareholder qualifies for an exemption (U.S. address on the broker’s records for DTC holdings or a valid Form 6166/Irish Form V2 for record owners). If a U.S. shareholder does incur the withholding tax, that payment discharges any Irish income‑tax liability once the shareholder provides a statement to the Irish Revenue. The language and treatment are unchanged between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key facts from the ground truth. Strengths: (1) Correctly identifies the 25% withholding tax rate in both years; (2) Accurately describes exemption criteria (U.S. address on broker records for DTC holdings, Form 6166, Irish Form V2); (3) Correctly states that withholding tax payment discharges Irish income tax liability when proper statement is submitted; (4) Accurately concludes no change between 2023 and 2024; (5) All numeric values (25%) are correct. Minor weaknesses: (1) The LLM mentions 'U.S. address on the broker's records for DTC holdings' as an exemption criterion, while the ground truth emphasizes 'residency documentation' and specifically mentions Form 6166 and Irish Non-Resident Form V2 - the LLM's phrasing about DTC holdings is slightly different from the ground truth's emphasis on documentation-based exemptions; (2) The ground truth explicitly notes that U.S. residents 'generally had no Irish income tax liability' if they met exemption criteria and didn't hold shares through an Irish branch - the LLM doesn't explicitly mention the Irish branch caveat, though this is a minor omission; (3) The LLM uses slightly different language ('U.S. address on the broker's records') versus the ground truth's focus on 'residency documentation' - these may refer to the same concept but the LLM's phrasing is less precise. Overall, the answer correctly synthesizes the multi-hop information (comparing 2023 and 2024 treatment) and reaches the correct conclusion that there was no evolution/change between the years. The core factual content is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 445,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "In the 2022 Form 10‑K the risk‑factor section only warned that “new lines of business, new products and services … subject us to new or additional risks,” but it did not call out the platforms operating model at all (see 2022 page 4). By the 2024 filing the same language about new products and services remains, and a new bullet was added stating the company “may not realize some or all of the expected benefits of our transition to a platforms operating model” (see 2024 page 5), while the forward‑looking statements also explicitly reference the “transition to a platforms operating model” as a strategic initiative (see 2024 page 3). This reflects an evolution from a generic new‑product risk to a specific risk tied to the platforms operating model initiative.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about risk disclosure evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies that 2022 filing contained only generic language about 'new lines of business, new products and services' without specific mention of platforms operating model; (2) Accurately captures the 2024 evolution where the platforms operating model is explicitly called out as a risk; (3) Correctly quotes the key 2024 language: 'may not realize some or all of the expected benefits of our transition to a platforms operating model'; (4) Properly synthesizes the multi-hop comparison showing the shift from generic to specific risk disclosure; (5) Appropriately references page numbers and filing sections, demonstrating document-level accuracy; (6) Correctly identifies BNY Mellon as the company (implicit from context); (7) Accurately characterizes the evolution as moving from 'generic new-product risk to a specific risk tied to the platforms operating model initiative.' MINOR CONSIDERATIONS: The answer includes specific page references (2022 page 4, 2024 page 5, 2024 page 3) which cannot be independently verified from the ground truth but are presented with appropriate citation format. The semantic content aligns perfectly with the ground truth answer. The reasoning is sound and the multi-hop synthesis correctly combines information about both years' filings to demonstrate the evolution. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all aspects of the question regarding how risk disclosure evolved and specifically how the platforms operating model became a focal point of risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 473,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "In the 2023 Form 10‑K Amazon listed the 3.600 % Note due 2032 as a component of its supplemental indenture (Exhibit 4.2) – the note is explicitly named among the long‑term debt instruments (see 2023 p. 74). By the 2024 filing the exhibit list no longer includes that note (the 2024 exhibit schedule on p. 76 shows only other certificates and does not mention the 3.600 % Note), indicating the instrument has been retired, repurchased or otherwise removed from Amazon’s disclosed debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual matter. Ground truth states: (1) The 3.600% Note due 2032 was disclosed in both 2023 and 2024, (2) The note remained outstanding in both years with no changes to terms or interest rate, (3) The evolution involved a trustee transition from Wells Fargo Bank to Computershare Trust Company. LLM answer claims: (1) The note was listed in 2023 but NOT in 2024, (2) The instrument was 'retired, repurchased or otherwise removed' from Amazon's debt portfolio. This is a critical factual error - the LLM misread the exhibit schedules and incorrectly concluded the note was removed from disclosure. The ground truth explicitly states the same note was 'referenced under the same Supplemental Indenture' in 2024, indicating continued disclosure and outstanding status. The LLM's interpretation that the note's absence from the exhibit list means retirement/repurchase is incorrect - the ground truth shows the note remained disclosed but with updated trustee information. The LLM failed to identify the actual evolution (trustee transition) and instead invented a false narrative about debt retirement. This represents a fundamental failure in multi-hop reasoning and document synthesis, as the LLM did not properly cross-reference the actual debt disclosures between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 378,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "In 2023 MDLZ reported its net‑investment‑hedge derivatives as a **net liability** of roughly $219 million (fair‑value) – shown in the derivative‑volume table as $163 million of asset contracts offset by $382 million of liability contracts and reflected as a $185 million after‑tax loss in other comprehensive earnings【page_94†L13-L21】【page_96†L13-L21】. By 2024 the same hedges were presented as a **net asset** of about $255 million (fair‑value), with $305 million of asset contracts and only $50 million of liability contracts, and the footnote still classifies them as accounting hedges but now shows a positive fair‑value impact that flows through other income【page_94†L13-L21】【page_95†L13-L21】. The disclosure therefore shifted from a negative‑valued hedge liability in 2023 to a positive‑valued hedge asset in 2024, while remaining recorded at fair value on the consolidated balance sheet and disclosed in the same derivative‑volume and fair‑value tables.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) CRITICAL ERRORS: The ground truth states that in 2023, MDLZ disclosed $1,347 million and $377 million in derivative assets/liabilities in other current assets, and $250 million and $413 million in other assets (as of Dec 31, 2023 and 2022 respectively). The LLM answer claims a 'net liability of roughly $219 million' and provides completely different numbers ($163M assets, $382M liabilities) that do not match the ground truth figures. The LLM also invents a '$185 million after-tax loss in other comprehensive earnings' that is not mentioned in the ground truth. (2) MISCHARACTERIZATION: The ground truth emphasizes a shift in disclosure focus from balance sheet valuation (2023) to income statement impact (2024), specifically regarding 'Other income, net' and amounts excluded from hedge effectiveness assessment. The LLM answer instead focuses on a supposed shift from 'net liability' to 'net asset' position, which is not the actual evolution described in the ground truth. (3) FABRICATED DETAILS: The LLM provides specific numbers for 2024 ($305M assets, $50M liabilities, $255M net asset) that are not present in the ground truth, which only discusses a shift in presentation emphasis, not specific 2024 balance sheet figures. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so incorrectly by inventing numbers and misinterpreting the nature of the disclosure change. The ground truth's key insight—that the evolution involved a shift from balance sheet focus to income statement impact—is completely missed. (5) CITATION ISSUES: The LLM provides page references that cannot be verified against the ground truth provided, suggesting potential hallucination of source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 499,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "In 2023 General Dynamics said its Abrams‑modernization effort was focused on fielding the SEPv3 upgrade package and launching the new M1E3 program, noting “strong demand by NATO members and other allies and partners… reflected by a growing installed base in Europe, the Middle East, North Africa and Indo‑Pacific theaters”【page_10】. By 2024 the strategy remained the same on the technology side—continuing SEPv3 upgrades and advancing the M1E3—but the filing now emphasizes “upgrading Abrams tanks for several non‑U.S. partners” and highlights export opportunities to allies, showing that international demand stays robust and is being met through partner upgrades【page_10】【page_11】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Abrams tank modernization evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies both SEPv3 and M1E3 programs in 2023, matching the ground truth; (2) Accurately captures the shift in emphasis from 2023 (technical roadmap focus) to 2024 (global strategic relevance and procurement momentum); (3) Properly synthesizes the international demand aspect across both years, citing specific geographic regions (Europe, Middle East, North Africa, Indo-Pacific) that match the ground truth; (4) Correctly notes the evolution from announcing development to emphasizing capability enhancement and partner upgrades; (5) Includes appropriate source citations (page references) suggesting document-based extraction. MINOR WEAKNESSES: (1) The LLM answer slightly reorders the emphasis compared to ground truth—it presents 2023 as having 'strong demand' language, while the ground truth suggests 2023 focused more on technical roadmap with 2024 highlighting global strategic relevance. However, this is a subtle framing difference rather than factual error; (2) The answer could have been more explicit about the 'engineering change' aspect of M1E3 aimed at 'future threats,' though it does mention 'advancing the M1E3'; (3) Minor semantic difference: ground truth emphasizes 'reduced sustainment footprint' for M1E3, which the LLM answer doesn't explicitly mention. QUANTITATIVE ACCURACY: No numerical errors detected. All dates (2023, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across two fiscal years and multiple geographic regions, correctly identifying the evolution in strategy. The answer properly connects technological development (SEPv3, M1E3) with international demand metrics. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—the modernization strategy evolved from technical focus to emphasizing global procurement momentum and partner upgrades.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 537,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "In the 2022 filing AMD described its APUs as integrated CPU‑GPU chips that “deliver visual‑processing functionality for value and mainstream PCs” and are used in notebooks, embedded devices and semi‑custom consoles, emphasizing power‑efficiency, heterogeneous computing and a unified‑platform strategy for consumer‑grade markets【page_7】【page_8】【page_9】【page_10】. By the 2024 filing AMD now lists APUs as a distinct component of both the Client segment (desktops and notebooks) and the Data Center segment—signaling a strategic shift to leverage APUs for AI, HPC and cloud workloads while still serving traditional PC customers【page_69】【page_70】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's APU evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of APUs as integrated CPU-GPU chips for consumer/value markets (notebooks, embedded devices, semi-custom consoles), (2) Accurately captures the 2024 shift to explicit inclusion in two reportable segments (Client and Data Center), (3) Properly synthesizes the strategic evolution from general consumer focus to broader enterprise/AI applications, (4) Correctly notes the shift from power-efficiency/heterogeneous computing emphasis to AI/HPC/cloud workload positioning, (5) Appropriately cites page references suggesting source verification. MINOR WEAKNESSES: (1) The 2022 description emphasizes specific use cases (visual-processing, value/mainstream PCs) which, while accurate, slightly differs from the ground truth's characterization of APUs being discussed 'in general terms without specific market segmentation' - the LLM provides more specific detail than the ground truth suggests was present, (2) The ground truth explicitly mentions APUs were part of 'Enterprise, Embedded and Semi-Custom product portfolio' in 2022, which the LLM doesn't explicitly reference as a portfolio grouping, though it does mention these use cases, (3) The ground truth notes APUs were listed 'alongside AI accelerators, CPUs, GPUs, and DPUs' in Data Center segment - the LLM mentions AI/HPC/cloud but doesn't explicitly list these companion products. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across two filing years and identifies the strategic shift in market positioning and segment classification. The reasoning connecting the evolution from consumer-focused to enterprise/data center inclusion is sound. SEMANTIC EQUIVALENCE: The core message matches - APUs evolved from general consumer positioning to explicit strategic integration in two major business segments with different use case emphases.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 547,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement that the Irish Financial Transfers Act 1992 allows the Irish Minister for Finance to restrict “financial transfers” between Ireland and other countries, that the Minister has already imposed such restrictions on a number of third‑country jurisdictions, and that the list of restricted countries is “subject to ongoing change.” The wording of this disclosure is essentially unchanged from 2023 to 2024, indicating no new restrictions or material revisions to the statement.【page_31】",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the key finding. Ground truth states that by 2024, Medtronic 'no longer emphasized the dynamic nature of the list of restricted countries,' suggesting a shift in disclosure focus or stabilization. However, the LLM answer claims 'The wording of this disclosure is essentially unchanged from 2023 to 2024' and that the list is still described as 'subject to ongoing change' in both years. This is a fundamental factual error regarding the evolution of the disclosure. The LLM correctly identifies the basic regulatory framework (Financial Transfers Act 1992, Irish Minister for Finance, restrictions on third countries) and dates (2023 vs 2024), but fails to capture the critical distinction that the ground truth emphasizes: the de-emphasis of the dynamic nature of the restricted countries list in 2024 compared to 2023. The LLM's conclusion that there was 'no new restrictions or material revisions' directly contradicts the ground truth's assertion of a shift in emphasis/focus. This is a multi-hop reasoning failure where the model was supposed to synthesize and compare disclosure language across two years to identify the evolution, but instead reported static similarity where the ground truth indicates meaningful change in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 363,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In the 2023 Form 10‑K, General Dynamics said the ultra‑long‑range G700 was still awaiting FAA certification and was expected to enter service “following certification … in early 2024” (see page 5). By the 2024 filing, the company reported that the G700 had already begun deliveries in the second quarter of 2024 and that production was being ramped up, reflected in a rise in work‑in‑process inventory for the model (see page 70).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Verification of key claims: (1) 2023 status - correctly identifies G700 as awaiting FAA certification with expected early 2024 entry into service, matching ground truth; (2) 2024 status - correctly states G700 began deliveries in Q2 2024, matching ground truth; (3) Production outlook - appropriately notes ramping up of production reflected in work-in-process inventory increase, which is a reasonable inference from the data and adds relevant context. The answer demonstrates sound multi-hop reasoning by synthesizing information across two fiscal years (2023 and 2024 10-K filings) and correctly tracing the evolution from pre-certification development stage to active production and delivery. The specific page references (page 5 and page 70) add credibility and demonstrate document-level precision. The terminology is accurate (ultra-long-range G700, FAA certification, Q2 2024 deliveries, work-in-process inventory). The answer is complete, addressing both the status evolution and production outlook aspects of the question. Minor note: The answer includes slightly more detail than the ground truth (mentioning work-in-process inventory rise) but this is additive and accurate rather than contradictory. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 369,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In the 2023 filing PMI portrayed its KT&G deal as a 15‑year, exclusive, worldwide collaboration that gives PMI “continued exclusive access to KT&G’s smoke‑free brands and product‑innovation pipeline,” underscoring a strategic dependency on KT&G for new smoke‑free offerings (see page 59). By the 2024 filing the relationship is described mainly as a licensing arrangement—PMI’s heat‑not‑burn portfolio now “includes licensed KT&G heat‑not‑burn products” and the KT&G‑licensed brands Fiit and Miix are listed among its HTU offerings (see pages 38, 40‑41)—showing a shift from a broad strategic partnership to a more product‑specific commercialization model.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts: the 15-year agreement duration, the exclusive worldwide scope (excluding South Korea implied), and the shift in how the relationship is characterized between 2023 and 2024. The specific brand names (Fiit and Miix) are accurate. The page references (59 for 2023, 38, 40-41 for 2024) add credibility. The LLM accurately captures the evolution from 'exclusive access to KT&G's smoke-free brands and product-innovation pipeline' language in 2023 to 'licensed KT&G heat-not-burn products' in 2024.\n\nWEAKNESSES: (1) The LLM characterizes the 2024 relationship as a 'shift from a broad strategic partnership to a more product-specific commercialization model,' which contradicts the ground truth's characterization of evolution into 'more integrated dependency' and 'deeper strategic alignment and operational integration.' The ground truth emphasizes that KT&G products became part of PMI's broader portfolio strategy, not a narrowing to product-specific licensing. (2) The LLM misses the key insight that by 2024, KT&G's heat-not-burn products were 'explicitly referenced as part of PMI's heat-not-burn product portfolio,' suggesting deeper integration rather than a more limited licensing arrangement. (3) The framing of 'shift from broad strategic partnership to more product-specific' is semantically opposite to the ground truth's 'shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy.' (4) The LLM doesn't adequately convey the concept of 'operational integration' that the ground truth emphasizes.\n\nMULTI-HOP REASONING: The LLM does synthesize information across 2023 and 2024 filings and identifies the evolution correctly in terms of language/characterization changes. However, the interpretation of what that evolution means is inverted—the LLM sees narrowing/specialization while the ground truth indicates deepening/integration.\n\nNUMERIC VERIFICATION: The 15-year duration and January 29, 2038 end date are correct. The characterization of exclusivity and worldwide scope (excluding South Korea) aligns with ground truth.\n\nSEMANTIC ISSUE: The core problem is interpretive rather than factual. The LLM correctly identifies the linguistic shift but misinterprets its strategic meaning, suggesting the relationship became more limited when the ground truth indicates it became more integrated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 641,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "In the 2022 filing AMD treated semi‑custom SoCs mainly as a revenue‑generating service – non‑recurring engineering fees and sales that depend on a third‑party’s product success and that the company has little control over (2022 p. 25). By the 2024 filing the company positions semi‑custom SoCs as a core, co‑engineered component of its broader high‑performance portfolio, tightly integrated with its Adaptive SoCs, chiplet platform, Infinity Architecture and software stack and used to power leading gaming consoles and handheld devices, reflecting a strategic, ecosystem‑wide approach (2024 pp. 5‑7).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing AMD's evolution of semi-custom SoC strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as revenue-dependent on third-party success with NRE fees and limited control, matching the ground truth characterization of dependency model. (2) Accurately describes the 2024 shift to integrated ecosystem positioning with specific technical details (Adaptive SoCs, chiplet platform, Infinity Architecture, NPU integration). (3) Properly synthesizes multi-hop information across two filing years showing strategic evolution. (4) Correctly identifies applications (gaming consoles, handheld devices, AI PCs) and integration with broader portfolio (CPUs, GPUs, APUs). (5) Page citations (2022 p. 25, 2024 pp. 5-7) add credibility and specificity. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'co-engineered component' and 'chiplet platform' which are valid 2024 positioning details but the ground truth emphasizes broader ecosystem integration including cloud services and embedded systems across multiple industries - the LLM focuses more narrowly on gaming/handheld devices. (2) The ground truth explicitly mentions AI accelerators as part of the broader ecosystem; the LLM mentions NPU but doesn't explicitly call out AI accelerators as a separate category. (3) The ground truth emphasizes the shift from 'dependency model to proactive, integrated product leadership strategy' - a strategic framing that the LLM captures implicitly but doesn't state as explicitly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension scores high. MULTI-HOP REASONING: The answer correctly synthesizes information across two different filing years and identifies the strategic evolution, demonstrating sound multi-hop reasoning. The comparison between 2022 and 2024 positioning is logically structured and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 530,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "In the 2023 filing (page 26) Medtronic explained that Irish dividend‑withholding tax (25 %) could apply, but U.S. shareholders who held their shares through the Depository Trust Company (DTC) with a U.S. address were exempt; those exempt from withholding were also not liable for Irish income tax on the dividend unless they had another Irish connection. The 2024 filing (page 31) keeps the 25 % rate but expands the exemption – a record‑owner can claim it by furnishing a U.S. Certification of Residence (Form 6166) or an Irish Non‑Resident Form V2, and it clarifies that any withholding tax paid discharges any Irish income‑tax liability on the dividend.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 25% withholding tax rate is correctly identified for both 2023 and 2024; (2) The general concept that exemptions from withholding tax relate to Irish income tax liability is accurate; (3) The mention of Form 6166 and Irish Non-Resident Form V2 as documentation methods appears reasonable for tax exemption claims. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific details about DTC (Depository Trust Company) and U.S. address requirements that are NOT mentioned in the ground truth, which only references 'U.S. residents' generally; (2) The LLM claims the 2024 filing 'expands the exemption' with specific form requirements, but the ground truth indicates the 2024 disclosure 'clarified' conditions rather than expanded them - this is a subtle but important distinction; (3) The LLM's characterization of 2023 exemptions as tied to DTC shareholding is more specific than the ground truth, which simply states exemptions applied to those 'exempt from Irish dividend withholding tax' without specifying the mechanism; (4) The ground truth emphasizes that 2024 provided 'more structured conditions' and clarified 'post-withholding tax procedures,' while the LLM focuses on the exemption claim process itself. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2023 and 2024, showing understanding that the treatment changed from general exemption statements to more specific procedural clarifications. However, the specific details about DTC and Form 6166 appear to be inferred rather than directly supported by the ground truth. QUANTITATIVE ACCURACY: The 25% rate is correct for both years (8/10 - no calculation errors but introduced unsupported specific details). QUALITATIVE ACCURACY: The reasoning about exemption evolution is sound but introduces details not in ground truth (5/10 - partially correct synthesis with added specificity not verified). CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution between years and discusses exemptions and withholding obligations (7/10 - relevant but with unverified details).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 581,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "In 2023 General Dynamics’ Marine Systems segment posted higher revenue ( $12.5 bn) largely from increased volume on the Columbia‑class submarine program, but its operating margin slipped to 7.0% because of supply‑chain cost pressures on the Virginia‑class submarine schedule and cost growth on the Arleigh Burke‑class (DDG‑51) destroyer program (page 36). For 2024 the company now projects Marine Systems revenue to rise to about $12.8‑$12.9 bn with an operating margin near 7.6%, indicating that cost pressures are expected to be contained and that the Columbia‑class submarine initiative remains a key revenue driver (page 37).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key entities (General Dynamics, Marine Systems segment, Virginia-class, DDG-51/Arleigh Burke-class, Columbia-class), correctly states the 2024 revenue projection ($12.8-$12.9 billion), correctly identifies the 2024 operating margin projection (7.6%), and accurately describes the strategic shift from cost pressures in 2023 to improved outlook in 2024. The multi-hop synthesis across years and programs is sound. CRITICAL ERRORS: (1) The 2023 operating margin is stated as 7.0% in the LLM answer, but the ground truth indicates a 110 basis point DECLINE in operating margin, which would mean the margin fell FROM a higher level TO approximately 7.0%. The ground truth does not explicitly state 7.0% as the 2023 margin - it only describes the decline. The LLM appears to have inferred or stated a specific 2023 margin that may not be directly supported. (2) The LLM states 2023 revenue as $12.5 billion, but the ground truth does not provide this specific figure - it only states that 'revenue from U.S. Navy ship construction rose' without quantifying the 2023 Marine Systems segment revenue. This is a factual claim not supported by the ground truth. REASONING QUALITY: The qualitative reasoning about the shift from cost pressures to improved outlook is sound and matches the ground truth narrative. The identification of Columbia-class as a key revenue driver is correct. However, the introduction of unsupported quantitative claims (2023 revenue of $12.5bn, 2023 margin of 7.0%) undermines the answer's reliability. The answer demonstrates good understanding of the multi-hop synthesis required but introduces specific numbers that appear to be inferred rather than directly stated in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 479,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Booking.com’s accommodation‑reservation services generated roughly 89 % of Booking Holdings’ total revenue in both 2022 and 2023 (the filing notes “approximately 89 %, 89 % and 87 % … for the years ended 2023, 2022 and 2021” respectively)【page_87】. Thus, the company’s financial reliance on Booking.com stayed essentially flat over the period, with no material change in the revenue share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Booking.com's accommodation reservations contributed approximately 89% of BKNG's total revenue in both 2022 and 2023, matching the ground truth. The conclusion that financial dependency remained essentially flat is accurate. The answer appropriately cites the source (page 87) and provides the three-year comparison (2023, 2022, 2021 at 89%, 89%, 87% respectively), which adds helpful context. CRITICAL ISSUE: The LLM states the 2023 figure is 'approximately 89%' but the filing quote shows 2023 was actually 89% while 2022 was 89% and 2021 was 87%. The LLM's presentation is slightly ambiguous about which year had which percentage, though the parenthetical quote clarifies this. DISCREPANCY WITH GROUND TRUTH: The ground truth states 'the proportion...slightly increased between 2022 and 2023' but then contradicts itself by saying it 'remained unchanged at 89%' in both years. The LLM correctly identifies no material change (89% to 89%), which is factually accurate based on the filing data. The LLM's answer is more precise than the ground truth's contradictory language. REASONING: The multi-hop synthesis is sound - the LLM correctly connects BKNG's revenue dependency to Booking.com's specific service line across two years. The conclusion about 'essentially flat' dependency is logically sound. MINOR WEAKNESS: The LLM could have been clearer about the year-over-year comparison format, though the parenthetical quote resolves this. Overall, the LLM provides a more internally consistent answer than the ground truth itself, with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 444,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The Swiss‑franc note was $299 million outstanding at December 31 2023 (Swiss franc note, 1.625 %, due 2024)【PM_10k_2023.pdf page 105】, but by December 31 2024 the line shows “‑” (no amount) after the CHF 250 note maturing in May 2024 was repaid【PM_10k_2024.pdf page 102】【PM_10k_2024.pdf page 107】. This removal of the note means PMI eliminated its Swiss‑franc‑denominated debt, thereby reducing its foreign‑currency obligations and exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - the $299 million Swiss Franc note outstanding at December 31, 2023 is accurately stated, and the removal/elimination of this obligation by December 31, 2024 is correctly identified. The specific detail about the CHF 250 note maturing in May 2024 being repaid adds valuable context. (2) QUANTITATIVE ACCURACY: The $299 million figure matches the ground truth exactly. The dates (December 31, 2023 and December 31, 2024) are correct. The interest rate (1.625%) and maturity date (2024) are accurately cited. No calculation errors present. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two 10-K filings (2023 and 2024) to show the evolution of the Swiss Franc obligation. It correctly identifies that the note was present in 2023 but absent in 2024, and provides the mechanism (repayment of the CHF 250 note in May 2024). (4) ENTITY ACCURACY: The company is correctly identified as PMI (Philip Morris International), the metric is correctly identified as Swiss Franc-denominated debt, and the time periods are accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that the company eliminated its Swiss Franc obligation between 2023 and 2024, reducing foreign currency exposure. The LLM provides slightly more detail (specific maturity date, interest rate, repayment mechanism) which enhances rather than detracts from the answer. Minor: The LLM uses 'CHF 250' notation which is consistent with SEC filing conventions. The answer fully addresses both parts of the question (how the position evolved AND what it indicates about foreign currency obligations).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 472,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs disclosed a pre‑2015 Non‑Employee Director RSU Award Agreement as Exhibit 10.8, the current RSU agreement as Exhibit 10.31, a cash‑settled version as Exhibit 10.32, and an amendment to certain director equity award agreements as Exhibit 10.17. In the 2024 filing the same three agreements are retained but renumbered – the pre‑2015 form is now Exhibit 10.9, the standard form is Exhibit 10.32, the cash‑settled form is Exhibit 10.33, and the amendment is Exhibit 10.18 – reflecting a re‑ordering of the exhibit schedule rather than the addition of new agreement types.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERING ERRORS: The LLM claims the 2023 filing had Exhibits 10.31, 10.32, and 10.17 for various RSU agreements and amendments. The ground truth states only Exhibit 10.8 (pre-2015 RSU) was referenced in 2023, with the amendment appearing as Exhibit 10.18 in 2024 (not 10.17 in 2023). The LLM's claim that an amendment existed as Exhibit 10.17 in 2023 directly contradicts the ground truth which explicitly states the amendment was 'not present in the 2023 filing.' (2) MISCHARACTERIZATION OF CHANGE: The LLM describes the evolution as merely 'a re-ordering of the exhibit schedule rather than the addition of new agreement types,' but the ground truth clearly indicates that the 'Amendments to Certain Non-Employee Director Equity Award Agreements' (Exhibit 10.18) was newly introduced in 2024 and was not present in 2023. This is a substantive addition, not just renumbering. (3) INCOMPLETE ACCURACY: While the LLM correctly identifies that Exhibit 10.8 relates to pre-2015 agreements and that renumbering occurred, the fundamental claim about what was in the 2023 filing is incorrect. The LLM invents exhibits (10.31, 10.32, 10.17) that the ground truth does not mention for 2023. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparison between 2023 and 2024 filings. The core finding—that Goldman Sachs expanded disclosures by introducing amendments in 2024—is missed entirely. The answer is contextually relevant to the question asked but factually incorrect in nearly all specific claims about exhibit numbers and what was present in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 459,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "By the end of 2023 PMI still carried €6.1 billion (≈ $6.1 bn) of Euro‑denominated credit‑facility borrowings that were tied to the Swedish Match acquisition. At year‑end 2024 that balance had fallen to €2.6 billion (≈ $2.6 bn) – the company prepaid the entire €3 billion (≈ $3.2 bn) 3‑year tranche of the €5.5 billion senior unsecured term‑loan facility in November 2024, leaving only the €2.5 billion 5‑year tranche (due 2027) outstanding. This reduction is reflected in the long‑term‑debt schedule, which shows the “Euro credit facility borrowings related to Swedish Match AB acquisition” dropping from $6,121 million in 2023 to $2,610 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All key numbers are correct - $6,121 million in 2023, $2,610 million in 2024, matching the ground truth exactly. The additional detail about the €3 billion prepayment in November 2024 and the remaining €2.5 billion 5-year tranche (due 2027) are accurate and add valuable context. Currency conversions (€6.1 billion ≈ $6.1 bn, €2.6 billion ≈ $2.6 bn, €3 billion ≈ $3.2 bn) are reasonable approximations. COMPLETENESS: The answer fully addresses the question about how PM's financial relationship with Swedish Match AB evolved between 2023 and 2024, specifically regarding long-term debt obligations. It provides both the headline numbers and the underlying mechanics (the prepayment of the 3-year tranche). ENTITY ACCURACY: Correctly identifies PM/PMI, Swedish Match AB acquisition, and the specific debt instrument (Euro credit facility borrowings). Years 2023 and 2024 are correctly referenced. REASONING: The multi-hop synthesis is sound - the answer connects the debt reduction to specific actions (the November 2024 prepayment) and explains the composition of remaining debt. The conclusion that PM's financial exposure lessened is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys all information from the ground truth while adding substantive detail about the mechanism of debt reduction. Minor note: The LLM uses both currency denominations (€ and $) which adds clarity but wasn't in the original answer - this is a value-add rather than an error. The answer demonstrates superior understanding by explaining not just the 'what' but the 'how' of the debt reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 455,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "In 2023 BMS presented the Mirati deal as a way to add a “best‑in‑class” KRAS‑G12C inhibitor — Krazati — to its oncology portfolio, noting its FDA approval for second‑line NSCLC and the opportunity to expand the KRAS program with additional inhibitors and combination studies (see 2023 page 87). By 2024, after the acquisition closed, Krazati was recorded as a definite‑life marketed‑product right with FDA and EMA approvals for NSCLC and KRAS‑mutated colorectal cancer, and BMS was actively advancing it in first‑line PD‑1‑combination trials, cementing KRAS inhibition as a core, revenue‑generating focus (see 2024 pages 93‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the timeline and acquisition status. CRITICAL ERROR: The LLM states 'In 2023 BMS presented the Mirati deal' and discusses it as if it were announced/presented in 2023, when the ground truth clearly indicates BMY had NOT acquired Mirati in 2023. The acquisition was completed BY 2024, not presented in 2023. This is a fundamental misrepresentation of the timeline. The LLM also fails to mention the $4.8 billion acquisition price, which is a key quantitative detail. CORRECT ELEMENTS: (1) Krazati is correctly identified as a KRAS G12C inhibitor; (2) FDA approval for second-line NSCLC is correct; (3) First-line NSCLC combination with PD-1 inhibitor is correct; (4) FDA approval for KRAS-mutated colorectal cancer is correct; (5) The characterization of KRAS inhibition becoming a core focus is appropriate. MISSING INFORMATION: The LLM does not provide the $4.8 billion acquisition price, which is a material omission for understanding the strategic significance. The LLM's citation format (page numbers) cannot be verified against the ground truth but appears to be fabricated or inaccurate. MULTI-HOP REASONING: The answer attempts to synthesize 2023 vs 2024 positioning but fails on the fundamental point that the acquisition had not occurred in 2023. The comparison is therefore logically flawed. The answer conflates the announcement/presentation of the deal with its completion. SEMANTIC ISSUES: The phrasing 'In 2023 BMS presented the Mirati deal' is misleading - it suggests active negotiation or announcement in 2023, when the ground truth indicates the acquisition was completed in 2024 with no mention of 2023 involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 462,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the Restricted Partner Compensation Plan was disclosed simply as “The Goldman Sachs Amended and Restated Restricted Partner Compensation Plan” (exhibit 10.3, incorporated by reference to a 2006 10‑Q) and listed among the other compensation‑related exhibits. In the 2024 Form 10‑K the same plan appears again (now exhibit 10.4 with the identical reference) but is now positioned after a newly‑added “Amended and Restated Goldman Sachs Group Clawback Policy (effective Dec 1 2023)” and other updated compensation‑governance items (e.g., the 2021 Stock Incentive Plan), indicating that while the plan’s disclosure itself has not changed, Goldman Sachs has introduced newer governance policies—most notably the 2023 clawback rule—to strengthen oversight of its compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the question. STRENGTHS: (1) All numeric/exhibit references are correct: Exhibit 10.3 in 2023, Exhibit 10.4 in 2024, and the Clawback Policy effective date of December 1, 2023 are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies the shift in exhibit positioning between years and connects this to the introduction of new governance policies. (3) Entity identification is precise: Goldman Sachs, the Restricted Partner Compensation Plan, and the Clawback Policy are all correctly named and contextualized. (4) The answer captures the core insight from the ground truth: while the plan itself remained substantively unchanged, its relative positioning shifted and new governance policies (particularly the clawback rule) were introduced to strengthen compensation oversight. (5) The semantic equivalence is strong - the LLM conveys the same strategic repositioning narrative as the ground truth. MINOR CONSIDERATIONS: (1) The LLM provides slightly more granular detail (e.g., the 2006 10-Q reference, mention of the 2021 Stock Incentive Plan) which adds helpful context but goes slightly beyond the ground truth's scope. This is not an error but rather additional supporting detail. (2) The phrasing 'effective Dec 1 2023' in the 2024 10-K is accurate and shows the clawback policy was introduced in 2023 but disclosed in the 2024 filing. (3) The answer correctly emphasizes that the plan disclosure itself has not changed substantively, only its relative positioning and the governance context around it. The multi-hop reasoning connecting exhibit placement changes to strategic governance repositioning is logically sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 478,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "In the 2022 filing PMI defined its heat‑not‑burn offering simply as “Heated Tobacco Units (HTU),” covering a fixed set of brands – HEETS (and its Creations/Dimensions), Marlboro HeatSticks, Parliament HeatSticks, TEREA and the KT&G‑licensed Fiit and Miix (Item 1 Business, p. 5). By the 2023 filing the HTU definition was expanded to include new families (BLENDS, DELIA, SENTIA, TEREA Crafted, TEREA Dimensions) and a zero‑tobacco line (LEVIA) (Consolidated Operating Results, p. 40), and HTU performance is now reported within the broader “smoke‑free products” segment while the Swedish Match acquisition is shown as a separate segment that adds to the overall smoke‑free portfolio (Net Revenues by Product Category, p. 39).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific product names and filing page references that demonstrate detailed knowledge of the 10-K documents, which is a strength. However, there are significant gaps in addressing the core question about evolution in approach and categorization.\n\nSTRENGTHS:\n1. Correctly identifies specific HTU brands in 2022 (HEETS, Marlboro HeatSticks, Parliament HeatSticks, TEREA, Fiit, Miix)\n2. Accurately lists new product families added by 2023 (BLENDS, DELIA, SENTIA, TEREA Crafted, TEREA Dimensions, LEVIA)\n3. Correctly notes the shift to reporting within 'smoke-free products' segment in 2023\n4. Mentions Swedish Match acquisition as separate segment\n5. Provides specific page references suggesting document verification\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The ground truth emphasizes that 2022 categorized heat-not-burn as part of 'Reduced-Risk Products (RRPs)' portfolio - the LLM answer completely fails to mention this important 2022 framing\n2. INCOMPLETE EVOLUTION NARRATIVE: The LLM answer doesn't clearly articulate the conceptual shift from 'RRPs' (2022) to 'smoke-free products' (2023) as a broader categorization change\n3. MISSING CONTEXT: The ground truth notes that 2023 explicitly grouped heat-not-burn with e-vapor, oral nicotine, wellness and healthcare offerings - the LLM answer doesn't capture this broader portfolio integration\n4. INCOMPLETE INTEGRATION DISCUSSION: While the LLM mentions KT&G-licensed products (Fiit, Miix) in 2022, it doesn't emphasize that 2023 'explicitly stated' inclusion of licensed KT&G products as an expansion indicator\n5. SEGMENT REPORTING vs. STRATEGIC POSITIONING: The LLM focuses heavily on segment reporting mechanics but underemphasizes the strategic evolution in how PMI positioned these products\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2023 filings and identifies the product categorization evolution. However, it misses the higher-level strategic categorization shift (RRPs → smoke-free products) that is central to understanding the evolution of approach.\n\nSEMANTIC EQUIVALENCE:\nThe answer addresses product evolution but frames it primarily as product line expansion rather than strategic repositioning. The ground truth emphasizes a conceptual shift in how PMI categorizes and positions these products within its portfolio strategy.\n\nJUSTIFICATION:\nThe answer is partially correct on product details but fails to capture the fundamental strategic evolution in categorization approach that the question specifically asks about. The omission of the RRPs framework and the broader smoke-free portfolio integration represents a significant gap in addressing the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 717,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "In the 2023 filing BMS disclosed that, to satisfy the 2004 SEC Consent Order, it **created** a “business risk and disclosure group” as one of several new controls—including a formal SEC‑report review and a governance‑escalation process for any sales‑policy questions 【page_65】. By the 2024 filing the same group is no longer described as a new entity but as an **ongoing, integral part of a company‑wide policy** that continuously monitors compliance, escalates issues to senior management and, together with the other procedures, is deemed to provide a reasonable basis for meeting the Consent requirements 【page_63】【page_66】. This reflects a shift from establishing the group in 2023 to embedding and relying on it as a permanent governance mechanism in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Bristol-Myers Squibb and the 2004 SEC Consent Order context; (2) Accurately captures the 2023 establishment of the business risk and disclosure group with specific controls (formal SEC-report review, governance-escalation process); (3) Properly synthesizes the evolution from 2023 to 2024, showing the shift from 'new entity' to 'ongoing, integral part'; (4) Correctly identifies the group's role in compliance monitoring and escalation to senior management; (5) Appropriately characterizes the governance mechanism as permanent rather than temporary; (6) Provides specific page references (pages 63, 65, 66) that ground the answer in source material. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more specific language about the evolution ('shift from establishing...to embedding') which adds interpretive clarity beyond the ground truth's 'fully integrated' phrasing, but this is semantically equivalent and arguably more precise; (2) The mention of 'sales-policy questions' in the LLM answer is a reasonable specification that aligns with the ground truth's reference to 'compliance-related questions'; (3) No quantitative errors or date discrepancies; (4) Multi-hop reasoning is sound—correctly synthesizes information across 2023 and 2024 filings to show governance evolution. The answer fully addresses the question's core inquiry about how BMS's approach evolved between the two years, particularly regarding the business risk and disclosure group's role. The characterization of the group's transition from new control to embedded governance mechanism is accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 472,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "In the 2023 filing UNP explained that the pension‑plan’s expected return is “based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions” and applied a 5.25% long‑term target rate. The 2024 filing repeats the same linkage—still tying the expected return to the asset‑allocation mix and historical performance with a 5.25% target—and merely adds the clarification that the expectation also reflects current and expected market conditions, indicating no substantive change in how the relationship is treated.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM states a 5.25% long-term target rate for both 2023 and 2024, but the ground truth explicitly mentions a 6% actual return for 2023 with no 5.25% figure mentioned. The LLM's percentage is factually incorrect. (2) CORE FACTUAL CONTRADICTION: The ground truth clearly states there WAS a substantive change between 2023 and 2024 - from a comprehensive explanation (asset allocation mix, historical returns, AND market conditions) to a narrower focus (asset allocation mix alone, with no explicit mention of historical returns or market conditions). The LLM concludes 'no substantive change,' which directly contradicts the ground truth's core finding. (3) MISSING KEY DETAIL: The ground truth notes that 2024 had 'no disclosure of the actual return for 2024,' but the LLM makes no mention of this important distinction about disclosure differences. (4) MISCHARACTERIZATION OF 2024 LANGUAGE: The ground truth indicates 2024 language shifted to 'depends on' the asset allocation mix alone, while the LLM claims 2024 'repeats the same linkage' and 'still tying' to historical performance - this is factually incorrect per the ground truth. (5) REASONING FAILURE: The LLM failed to perform the required multi-hop comparison between 2023 and 2024 filings, instead concluding no change when the ground truth explicitly documents an evolution/shift in treatment. The answer is fundamentally wrong on the main question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 426,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "In the 2022 Form 10‑K, BNY Mellon listed the Directors’ Code of Conduct under Item 10 and gave a specific URL ( https://www.bnymellon.com/.../directors‑code‑of‑conduct.pdf ) while noting that any amendments or waivers would be posted on its website. In the 2023 filing, the Code is bundled with the corporate‑governance guidelines, bylaws and committee charters in the “Available Information” section, and the filing states that the entire set of governance documents—including the Directors’ Code—is freely accessible on the company’s website and incorporated by reference, showing a more integrated and prominently accessible disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of BNY Mellon's disclosure approach between 2022 and 2023, correctly identifying that the Directors' Code of Conduct moved from being referenced individually to being bundled with other governance documents. However, there are significant issues with specificity and verifiability: (1) The LLM provides a specific URL (https://www.bnymellon.com/.../directors-code-of-conduct.pdf) that cannot be verified against the ground truth and appears to be fabricated or hallucinated detail. This is a critical error as it introduces unverifiable factual claims. (2) The LLM correctly identifies the shift from Item 10 placement in 2022 to an 'Available Information' section in 2023, which aligns with the ground truth's description of more structured/centralized approach. (3) The characterization of the evolution is semantically similar to the ground truth - both describe movement toward more integrated, accessible disclosure. However, the ground truth emphasizes 'more directly tied to the company's overall governance framework' while the LLM emphasizes 'incorporated by reference' - these are related but not identical concepts. (4) The LLM adds details about 'amendments or waivers' that are not mentioned in the ground truth, suggesting either additional research or potential fabrication. (5) The core multi-hop reasoning is sound - comparing 2022 vs 2023 disclosures and identifying the evolution - but the introduction of unverifiable specific details undermines confidence in the answer. The answer would score higher if it stuck to verifiable facts from the filings without adding specific URLs or other details not confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 463,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "In 2023 Oracle framed the Oracle Database as a “flexible, open” platform that could be run on‑premise, in Oracle Cloud (OCI) or in a hybrid model such as Exadata Cloud@Customer, and it stressed that the database was tightly bundled with its engineered‑system portfolio (e.g., the Exadata Database Machine) to deliver superior performance, scalability and ease of maintenance (page 10; page 12; page 13). By 2024 the messaging was broadened to a full suite of hybrid‑ and multicloud options—including OCI Dedicated Region, OCI Sovereign Cloud, Oracle Alloy and Roving Edge—while still positioning the database (including Autonomous Database) as integrated with Exadata engineered systems and available as cloud, on‑premise, or hybrid services (page 11; page 12; page 13). This shift signals Oracle’s deeper emphasis on engineered‑system‑backed, deployment‑agnostic database offerings that simplify cloud migration and support customers’ increasingly hybrid IT environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning emphasizing flexibility across deployment models (on-premise, OCI, hybrid/Exadata Cloud@Customer), (2) Accurately captures the 2024 shift toward deeper integration with engineered systems like Exadata Database Machine, (3) Properly synthesizes the multi-hop evolution showing progression from flexible standalone services to integrated solutions, (4) Correctly identifies key offerings (Exadata Cloud@Customer, Roving Edge Infrastructure, OCI Dedicated Region, OCI Sovereign Cloud, Oracle Alloy, Autonomous Database), (5) Accurately characterizes the strategic implications regarding cloud migration and hybrid IT environments, (6) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'deployment-agnostic' vs 'multiple deployment models'), (7) Includes page references that add credibility. MINOR CONSIDERATIONS: (1) The LLM answer slightly reorders the chronological presentation by mentioning 2023 bundling with engineered systems before discussing 2024 expansion, whereas ground truth emphasizes 2023 as flexible deployment and 2024 as the shift to engineered systems integration. However, the LLM does clarify this was 'still positioning' in 2024, suggesting continuity rather than contradiction, (2) The ground truth emphasizes the shift as more pronounced ('shifted toward deeper integration'), while LLM frames it as 'broadened' and 'deeper emphasis'—these are semantically compatible but slightly different framings. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The years (2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple deployment options, time periods, and strategic implications, correctly linking product offerings to broader strategic positioning. The conclusion about maturation of cloud migration strategy is well-supported by the evidence presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 570,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The 2023 Form 10‑K first disclosed that, under the SEC Consent Order, Bristol‑Myers Squibb instituted a formal review‑and‑certification process for its annual and quarterly reports, created a dedicated business‑risk and disclosure group, retained an outside consultant, and put in place a governance‑escalation path with “regular” compliance monitoring of the sales‑policy procedures【page_63】. The 2024 Form 10‑K repeats the same set of controls—formal review and certification, the risk‑disclosure group, external consultant support, and a governance process that escalates compliance questions and is monitored on an ongoing basis—showing that the initial 2023 measures have been institutionalized and are now a sustained, regularly‑monitored governance framework【page_65】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the question about evolution of formal review and certification processes between 2023 and 2024. STRENGTHS: (1) Correctly identifies Bristol-Myers Squibb as the company and references the SEC Consent Order context; (2) Accurately describes the 2023 implementation including formal review-and-certification process, dedicated business-risk and disclosure group, outside consultant retention, and governance-escalation procedures with regular monitoring; (3) Properly characterizes the 2024 continuation showing institutionalization and sustained monitoring; (4) Correctly synthesizes the multi-hop information showing evolution from initial implementation to sustained enforcement; (5) Provides specific page references (page_63 and page_65) demonstrating source verification; (6) Uses appropriate terminology matching the ground truth (governance procedures, compliance monitoring, escalation path). MINOR CONSIDERATIONS: (1) The LLM answer emphasizes the 'same set of controls' being repeated rather than explicitly highlighting the shift to 'integration into broader operational frameworks' mentioned in the ground truth, though this is a subtle distinction in emphasis rather than factual error; (2) The ground truth mentions integration into 'company-wide sales policies' while the LLM answer references 'sales-policy procedures' - semantically equivalent but slightly different phrasing; (3) The LLM answer is more detailed about specific mechanisms (dedicated group, external consultant) which adds value beyond the ground truth without contradicting it. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. Dates (2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and demonstrates understanding of the progression from initial establishment to sustained implementation. The logic is sound and the comparison is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 554,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "In the 2022 filing PMI described its heat‑not‑burn offerings only as part of the broader “Reduced‑risk products” umbrella and the “Platform 1” heating device, without a separate product line (PM_10k_2022.pdf p. 76). By the 2023 filing the company created a distinct “Heated Tobacco Units (HTU)” category that groups all heat‑not‑burn consumables—including HEETS, Marlboro HeatSticks, TEREA, Fiit, Miix and the zero‑tobacco LEVIA product—and positioned HTUs as a core growth driver, reporting a 14.7% rise in HTU shipments and a 14.8% increase in adjusted in‑market sales (PM_10k_2023.pdf p. 40‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific, detailed information than the ground truth. Key strengths: (1) Correctly identifies the 2022 positioning as part of 'Reduced-risk products' umbrella with Platform 1 device, matching ground truth; (2) Accurately describes the 2023 evolution with creation of distinct 'Heated Tobacco Units (HTU)' category, which is more specific than ground truth's general 'smoke-free product segment' reference; (3) Provides specific product examples (HEETS, Marlboro HeatSticks, TEREA, Fiit, Miix, LEVIA) that demonstrate detailed knowledge; (4) Includes quantitative metrics (14.7% HTU shipment rise, 14.8% adjusted in-market sales increase) that are specific and verifiable; (5) Correctly cites source documents with page numbers. Minor considerations: (1) The ground truth mentions 'licensed KT&G heat-not-burn products' as part of 2023 evolution, which the LLM answer does not explicitly address—this represents a slight incompleteness regarding partnership expansion; (2) The LLM answer emphasizes product categorization and growth metrics more than the strategic shift from internal development to commercialization mentioned in ground truth, though this is more of a different emphasis than an error. The numeric data provided (14.7% and 14.8%) appears reasonable for growth metrics but cannot be independently verified from the ground truth provided. Overall, the LLM answer is more granular and specific than the ground truth while maintaining factual accuracy on the core evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 430,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "In the 2023 filing Oracle framed the Oracle Database primarily as a flexible‑deployment asset—customers could run it on‑premise, in the public Oracle Cloud or in hybrid‑cloud models and could “pivot” existing licenses to cloud‑based deployments. By the 2024 filing the database is positioned as a tightly integrated core of the OCI ecosystem—delivered as Autonomous Database, Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud and other edge options—and is bundled with Oracle Middleware, Java, APEX and multicloud networking, giving customers even broader choice to run the database across public, private and sovereign environments while leveraging the full suite of Oracle technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2023 to 2024, capturing the shift from standalone flexible deployment to integrated ecosystem positioning. It accurately mentions key 2024 offerings (Autonomous Database, Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) and correctly notes the bundling with other Oracle technologies (Middleware, Java, APEX). The answer demonstrates understanding of the multi-hop synthesis required across two years of filings. WEAKNESSES: (1) The LLM answer introduces specific product offerings and bundling details (Autonomous Database, Middleware, Java, APEX, multicloud networking) that are not explicitly mentioned in the ground truth answer. While these may be accurate from the 2024 filing, they represent additions beyond what the ground truth validates. (2) The ground truth specifically emphasizes Oracle Exadata Database Machine as the key engineered system integration point, while the LLM answer mentions Exadata Cloud@Customer and other cloud variants but doesn't emphasize the on-premise Exadata Database Machine as prominently. (3) The ground truth's framing of the 2023 positioning around 'perpetual licensing model' and 'customer choice' is not captured in the LLM answer, which focuses more on deployment flexibility. (4) The LLM answer's claim about 'tightly integrated core of the OCI ecosystem' goes slightly beyond the ground truth's more measured statement about 'deeper integration' and 'core element of Oracle Engineered Systems.' QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension scores high (8) for consistency and appropriate absence of numbers. QUALITATIVE ACCURACY: The reasoning is sound but introduces details not validated by ground truth (5/10). CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about strategic positioning evolution and deployment flexibility (7/10), though with some unvalidated elaborations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 533,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "In the 2023 filing BMS only highlighted that Krazati – acquired through Mirati – was a “strategic fit” for its NSCLC portfolio (2023 p. 43). By the 2024 filing BMS had completed the Mirati transaction, allocating $640 million to the definite‑lived acquired marketed product rights for Krazati and committing a total $4.935 billion (cash, equity awards and a CVR) to acquire Mirati and secure Krazati (2024 p. 93‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The 2023 characterization of Krazati as a 'strategic fit' is accurate; (2) The completion of the Mirati acquisition by 2024 is correct; (3) The mention of FDA and EMA approvals for NSCLC is appropriate context; (4) The reference to CVR (contingent value rights) is correct. QUANTITATIVE ERRORS: (1) The LLM states the total acquisition was '$4.935 billion' but the ground truth specifies '$4.8 billion' for the Mirati acquisition - this is a material discrepancy of $135 million; (2) The LLM mentions '$640 million' allocated to definite-lived acquired marketed product rights for Krazati, which is a specific accounting detail not mentioned in the ground truth but appears to be a reasonable allocation detail; (3) CRITICAL OMISSION: The LLM completely fails to mention the '$1.0 billion in contingent value rights tied to PRMT5 Inhibitor development,' which is explicitly stated in the ground truth as a key financial commitment reflecting the strategic evolution. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution from 2023 to 2024 by contrasting the earlier mention with the completed transaction, but it misses the full scope of financial commitments. The answer addresses the acquisition but incompletely captures the strategic financial commitments that demonstrate the evolution. SEMANTIC ISSUES: While the LLM correctly identifies this as an evolution from 2023 to 2024, it fails to fully articulate the depth of BMY's long-term investment strategy through the PRMT5 Inhibitor CVR commitment. The answer is partially correct but materially incomplete on the financial commitments dimension of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 484,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV as a separate class of preferred stock (ticker BK/P) that is “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation” and traded on the NYSE【page_1†L9-L13】【page_1†L9-L13】. Thus, the securities’ classification, guarantee and exchange listing remained unchanged between the two years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV: (1) ticker symbol BK/P is correct, (2) NYSE listing is correct, (3) full and unconditional guarantee by The Bank of New York Mellon Corporation is correct, and (4) the conclusion that there was no change between 2022 and 2023 is correct. The quantitative accuracy is high - all specific identifiers (percentage rate, ticker, exchange) are accurate. However, the LLM answer is less complete than the ground truth in several ways: (1) it does not explicitly mention Section 12(b) registration status, which was a key detail in the original answer, (2) it does not explicitly state that the securities were 'introduced' in 2022 or provide temporal context about when they first appeared, and (3) it uses the phrase 'separate class of preferred stock' which is slightly different terminology than the ground truth's 'Preferred Capital Securities.' The multi-hop reasoning is sound - the answer correctly synthesizes information from both 2022 and 2023 filings to reach the conclusion that status remained unchanged. The semantic meaning is largely equivalent to the ground truth, though some specific regulatory details (Section 12(b)) are omitted. The answer appropriately addresses the core question about evolution/change between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 386,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "In 2022 PMI’s uncommitted short‑term credit arrangements totaled about **$1.9 billion**, of which **$295 million** was drawn. By year‑end 2023 the available capacity had risen to roughly **$2.7 billion**, while borrowings fell slightly to **$283 million**. The larger credit cushion and lower utilization indicate PMI has strengthened its near‑term liquidity buffer and is maintaining a conservative, low‑use stance on short‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. Quantitative verification: All four key numbers are correct - 2022 capacity of $1.9 billion, 2022 utilization of $295 million, 2023 capacity of $2.7 billion, and 2023 utilization of $283 million. The capacity increase ($1.9B to $2.7B) and utilization decrease ($295M to $283M) are both accurately stated. The multi-hop synthesis is sound: the answer correctly identifies the trend (expanded capacity, reduced drawdown) and draws the appropriate inference about liquidity posture (strengthened buffer, conservative stance). The terminology is precise (\"uncommitted short-term credit arrangements\") and the characterization of PMI's approach as \"conservative, low-use stance\" accurately reflects the implications of the data. The answer fully addresses both parts of the multi-part question: (1) how capacity and utilization changed, and (2) what this suggests about liquidity posture. Minor note: The LLM uses \"roughly\" and \"about\" which appropriately conveys the approximate nature of these figures while maintaining accuracy. The semantic equivalence between the ground truth's \"more conservative approach\" and the LLM's \"conservative, low-use stance\" is complete. No calculation errors, no missing entities, and no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 371,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "In the 2023 filing Oracle presented the Autonomous Database as a self‑driving, automated service delivered through OCI that “integrates … with other Oracle Cloud services, such as Java Cloud and the Oracle APEX low‑code service” and automates routine DBA tasks (maintenance, tuning, scaling, security) via policy‑ and machine‑learning‑driven optimization【page_12】. By the 2024 filing the core self‑driving, AI‑enabled automation narrative remains, but Oracle expands the positioning to stress tighter integration with Oracle Analytics Cloud and third‑party analytics tools and highlights built‑in developer automation that lets customers “quickly deploy new data marts and data warehouses, move existing ones to the cloud, and create data lake houses”【page_12】. This reflects a broader ecosystem linkage and a stronger emphasis on developer‑focused automation while retaining the original autonomous capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) MAJOR FACTUAL ERROR - The LLM claims that in 2023, Oracle already positioned the Autonomous Database as integrating 'with other Oracle Cloud services, such as Java Cloud and the Oracle APEX low-code service.' However, the ground truth explicitly states this deeper integration with Java Cloud and Oracle APEX was a 2024 development, NOT a 2023 positioning. The 2023 positioning focused on 'automated database operations' and 'reducing IT process time and resources' without specific mention of these integrations. This is a fundamental misrepresentation of the temporal evolution being asked about. (2) INCOMPLETE SYNTHESIS - The LLM mentions Oracle Analytics Cloud integration in 2024 but the ground truth does not specifically highlight this as a key differentiator between 2023 and 2024. The ground truth emphasizes 'deeper integration with other Oracle Cloud services' more broadly. (3) MISSING KEY DETAILS - The ground truth emphasizes that 2024 introduced 'stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection' - these specific ML-powered automation capabilities are not adequately captured in the LLM answer. (4) CORRECT ELEMENTS - The LLM correctly identifies the self-driving/autonomous nature, the role of machine learning, and the 2024 emphasis on data lake houses and developer automation. The mention of policy and ML-driven optimization is appropriate. QUANTITATIVE ACCURACY: No specific numbers or dates are incorrect (8/10 - minor issue with temporal attribution). QUALITATIVE ACCURACY: The core error of attributing 2024 features to 2023 is a significant reasoning failure (4/10). CONTEXTUAL RELEVANCE: The answer addresses the question's structure but with fundamental temporal misalignment (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 496,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "In the 2023 filing GM reported that it had **committed $0.8 billion** to Ultium Cells Holdings LLC as part of a non‑consolidated VIE, noting a maximum loss exposure of $3.5 billion and that it “lacks the power through voting or similar rights to direct the activities” of the entity. By the 2024 filing the cash‑flow statement shows a **$0.7 billion investment** in Ultium Cells (the same amount recorded in 2023), indicating a modest reduction in capital outlay while still maintaining a non‑controlling, strategic partnership to secure battery‑cell supply for GM’s EV program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key facts about GM's relationship with Ultium Cells but contains a critical quantitative error that undermines the core narrative. CORRECT ELEMENTS: (1) 2023 committed contribution of $0.8 billion is accurate; (2) VIE classification and lack of voting control are correctly stated; (3) Maximum loss exposure of $3.5 billion is accurate; (4) The characterization of the relationship as non-controlling and strategic is appropriate; (5) The connection to EV battery supply is relevant context. CRITICAL ERROR: The LLM states that the 2024 cash-flow statement shows a '$0.7 billion investment' that is 'the same amount recorded in 2023,' which is contradictory and factually incorrect. The ground truth indicates that 2024 involved a 'more direct investment of $0.7 billion,' representing a shift FROM the $0.8 billion committed obligation TO a $0.7 billion realized investment. The LLM's phrasing 'modest reduction in capital outlay while still maintaining' obscures the actual strategic evolution: the transition from contingent commitment to direct investment stake. MULTI-HOP REASONING: The LLM partially captures the evolution but mischaracterizes it as merely a reduction in capital outlay rather than a fundamental shift in the nature of GM's involvement (from contingent to realized, from potential obligation to actual stake). The ground truth emphasizes this represents 'a shift from a potential future obligation to a realized investment stake' and 'strategic realignment,' which the LLM does not adequately convey. The answer reads as if $0.7 billion was invested in both years, when the actual story is about the transformation of the relationship structure. QUANTITATIVE ACCURACY PENALTY: The statement that '$0.7 billion investment (the same amount recorded in 2023)' is misleading—2023 had a $0.8 billion commitment, not a $0.7 billion investment. This is a significant factual error in the synthesis of multi-year data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 531,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "The litigation‑management deed released ≈ $3.5 billion of as‑converted value and issued 176,655 series A preferred shares at the sixth‑anniversary release in 2022 (see page 74). By the eighth‑anniversary release in 2024 the amount released fell to ≈ $2.7 billion and only 99,264 series A preferred shares were issued (see page 75), showing a decline in both the value freed and the shares issued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2022 sixth-anniversary release shows $3.5 billion as-converted value and 176,655 series A preferred shares; 2024 eighth-anniversary release shows $2.7 billion and 99,264 shares. The multi-hop synthesis is sound, correctly identifying the evolution across the two time periods and drawing the appropriate conclusion about the declining financial burden. The answer properly identifies the Visa litigation management deed context and accurately characterizes the trend (decrease in both value released and shares issued). The use of approximate symbols (≈) is appropriate given potential rounding in source documents. Page references (74, 75) add credibility though cannot be independently verified. Minor stylistic differences from ground truth (e.g., 'freed' vs 'released', 'showing a decline' vs 'suggesting a reduction') are semantically equivalent and do not detract from accuracy. The answer fully addresses all parts of the multi-part question regarding the evolution between 2022 and 2024, the as-converted value released, and the number of shares issued.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 329,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "In 2023, after the Aearo Entities were reconsolidated, 3M recorded a $4.2 billion pre‑tax charge and added a $4.3 billion accrual for Combat Arms Earplugs as part of the CAE Settlement, with those litigation costs appearing as corporate special items (and historically in the Safety & Industrial segment). By 2024 the one‑time settlement charges had been absorbed, corporate‑special‑item costs fell year‑over‑year, and the Aearo Entities’ sales are now shown as an acquisition impact in the Transportation & Electronics segment—signalling a shift from a litigation‑driven, separate‑entity relationship to an integrated, post‑settlement operating structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about the evolution of 3M's relationship with the Aearo Entities between 2023 and 2024, correctly identifying the shift from litigation-focused involvement to integrated operations. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2023 reconsolidation of Aearo Entities\n- Correctly references CAE Settlement in 2023\n- Correctly identifies the shift to Transportation & Electronics segment treatment in 2024\n- Correctly notes the transition from litigation-driven to integrated structure\n- Appropriately characterizes the settlement charges as one-time items\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- The LLM provides specific dollar amounts ($4.2 billion pre-tax charge and $4.3 billion accrual) that are NOT mentioned in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be hallucinated or from sources not reflected in the ground truth.\n- The ground truth explicitly states the reconsolidation had \"an immaterial income statement impact,\" which contradicts the LLM's assertion of material $4.2-4.3 billion charges.\n- The LLM references \"Safety & Industrial segment\" as the historical location of litigation costs, which is not mentioned in the ground truth.\n- The LLM's claim about \"corporate-special-item costs fell year-over-year\" is not substantiated in the ground truth.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the multi-hop relationship evolution (2023 reconsolidation → CAE Settlement → 2024 segment treatment), matching the ground truth's narrative arc. However, the introduction of unsupported financial figures undermines the credibility of this synthesis.\n\nQUANTITATIVE ACCURACY PENALTY:\nThe specific dollar amounts ($4.2B and $4.3B) are critical factual claims that directly contradict the ground truth's characterization of \"immaterial\" impact. This is a major quantitative accuracy failure that warrants a low score in this dimension.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good qualitative understanding of the strategic evolution but fails on quantitative precision by introducing unsupported numbers. The core narrative is sound, but the specific financial claims are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 620,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "In 2022 Visa’s Class C common stock was a non‑traded, non‑voting class that earned $28.03 basic (and $28.00 diluted) earnings per share and was accounted for separately in the EPS allocation (2022 10‑K, p. 91). By 2024 the company had redenominated its Class B‑1 shares and, through a May‑2024 exchange offer, issued roughly 48 million new Class C shares (which have no transfer restrictions and limited voting rights) and expanded the authorized pool to 1.1 billion shares (2024 10‑K, pp. 89‑90). As a result, Class C’s basic and diluted EPS rose to about $38.97 and $38.92 respectively in 2024, reflecting a higher earnings‑per‑share contribution within the as‑converted share base (2024 10‑K, p. 90).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) 2022 EPS: LLM claims $28.03 basic/$28.00 diluted for Class C, but ground truth states this comparison wasn't provided for 2022 in the original answer's framing. More critically, the 2024 EPS figures are completely wrong: LLM states $38.97 basic/$38.92 diluted, but ground truth clearly shows $33.17 basic EPS and $33.13 diluted EPS for Class C in 2024. This is a ~17% overstatement of the actual EPS figures. (2) The LLM also incorrectly describes Class C as 'non-traded, non-voting' in 2022, whereas ground truth indicates it had governance considerations and voting rights context. The description of 'limited voting rights' in 2024 contradicts the ground truth's statement that 'its governance role appeared unchanged.' (3) The LLM introduces details about Class B-1 redenomination and a May 2024 exchange offer that, while potentially accurate operational details, are not part of the ground truth answer and may represent hallucinated specificity. (4) Multi-hop reasoning: The LLM attempts to synthesize 2022 vs 2024 changes but does so with incorrect numbers, undermining the core comparison the question asks for. The ground truth emphasizes a shift from governance-focused discussion in 2022 to financial performance comparison in 2024, with Class C significantly outperforming Class A. The LLM misses this key insight and instead focuses on structural changes that aren't validated by the ground truth. (5) The fundamental error is the EPS figures for 2024—$33.17/$33.13 vs claimed $38.97/$38.92—which is a critical factual mistake that makes the answer substantially incorrect despite some contextual relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 478,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm’s ADAS/AD work was still framed as a research‑and‑development and strategic‑investment effort – the 2022 filing notes that its R&D “continues … for … ADAS/AD” and that the company acquired Veoneer’s Arriver business to gain ADAS capabilities, but ADAS/AD was not called out as a separate revenue line (it was rolled into the broader automotive and licensing categories)【page_14】【page_16】. By fiscal 2024 the company is reporting ADAS/AD explicitly as part of its QCT “automotive” revenue stream (“connectivity, digital cockpit and ADAS/AD”) and that automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024, showing a shift from pure development to commercial sales of ADAS/AD technology【page_73】【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The specific revenue figures cited ($1.5 billion in 2022 and $2.9 billion in 2024 for automotive) are accurate and properly contextualized. The answer correctly identifies the fiscal years and provides concrete numerical evidence of the transition from development to commercialization. QUALITATIVE ACCURACY: The answer correctly identifies the multi-hop synthesis required: (1) fiscal 2022 status as R&D/strategic investment, (2) the Veoneer/Arriver acquisition as evidence of capability building, (3) fiscal 2024 status as explicit revenue line item. The reasoning chain is sound - moving from development phase (where ADAS/AD was not separately reported) to commercialization phase (where it appears explicitly in automotive revenue). ENTITY ACCURACY: All entities are correctly identified - Qualcomm, QSI segment, Qualcomm Ventures, Veoneer's Arriver business, QCT automotive segment. Fiscal years are correct (2022 vs 2024). COMPLETENESS: The answer addresses all aspects of the question: the evolution of involvement, specific changes in strategic activities (from R&D investment to commercial product), and revenue categorization changes (from rolled-in to explicit line item). The answer goes beyond the ground truth by providing specific supporting details (Veoneer acquisition, explicit revenue categories like 'connectivity, digital cockpit and ADAS/AD') while maintaining factual accuracy. MINOR CONSIDERATIONS: The answer includes page citations which add credibility but are not part of the ground truth evaluation. The semantic meaning is fully preserved and enhanced with concrete examples. No calculation errors detected. The narrative flow clearly demonstrates the transition from development to commercialization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 501,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "In the 2022 filing Visa described its U.S. Retrospective Responsibility Plan as a bundle of mechanisms – a litigation‑escrow account, a “conversion feature” that dilutes class B shares when escrow is funded, make‑whole agreements with stock‑exchange participants, indemnification obligations of Visa U.S.A. members, and interchange‑judgment‑sharing, loss‑sharing and omnibus agreements that spread liability among Visa, its members and Mastercard【page_48】. By 2024 the same suite of tools remains in place but the escrow fund has been substantially enlarged (deposits rose from $850 million in 2022 to $1.5 billion in 2024, with the balance growing to $3.1 billion) and the loss‑sharing and omnibus agreements now spell out precise allocation percentages (66.7 % to Visa, 33.3 % to Mastercard) and include payments to opt‑out merchants【page_73】【page_74】【page_72】. This evolution shows Visa tightening its financial safeguards, increasing the pool of dedicated funds, and formalizing risk‑sharing arrangements, indicating a more proactive and structured approach to capping and managing litigation exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY ON CORE CLAIM: The LLM states that in 2022 Visa's plan included 'a conversion feature, make-whole agreements, indemnification obligations, interchange-judgment-sharing, loss-sharing and omnibus agreements.' However, the ground truth explicitly states that in 2022, the plan was described as 'a mechanism to address monetary liabilities...utilizing a U.S. litigation escrow account' with NO mention of these additional mechanisms. The ground truth clearly indicates these mechanisms were ADDED BY 2024, not present in 2022. This is a fundamental misrepresentation of the evolution being asked about. (2) UNVERIFIABLE NUMBERS: The LLM provides specific dollar amounts ($850 million in 2022, $1.5 billion in 2024, $3.1 billion balance) and allocation percentages (66.7% to Visa, 33.3% to Mastercard) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be fabricated or hallucinated. (3) MASTERCARD REFERENCE ERROR: The ground truth makes no mention of Mastercard being part of Visa's Retrospective Responsibility Plan. The LLM's claim that loss-sharing agreements include 'Mastercard' is unsupported and likely incorrect. (4) INCOMPLETE UNDERSTANDING OF EVOLUTION: While the LLM correctly identifies that mechanisms were added and the approach became more structured, it fundamentally mischaracterizes the 2022 baseline by claiming mechanisms existed then that only appeared in 2024. (5) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the temporal evolution - it conflated 2022 and 2024 descriptions rather than showing clear progression from simpler (2022) to more complex (2024) mechanisms. The answer demonstrates hallucination of specific financial figures and misrepresentation of the timeline of plan evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 504,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck’s accounting for the Lynparza partnership shows that the net intangible‑asset value of the collaboration was $1.5 billion at 31 Dec 2023 (page 101) and the company’s share of Lynparza’s profits (alliance revenue) rose from $1.199 billion in 2023 to $1.311 billion in 2024 – a 9 % increase (page 53).  The 2024 filing notes that this revenue growth was driven by higher demand in most international markets (page 55) and that China’s regulator approved Lynparza as an adjuvant treatment for early‑stage breast cancer in January 2025, underscoring both improved product performance and growing strategic importance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $1.5 billion net intangible asset at Dec 31, 2023 (verified), alliance revenue of $1.199 billion in 2023 and $1.311 billion in 2024 (verified), and the 9% growth calculation is accurate ($1.311B/$1.199B = 1.0935 or 9.35%, rounded to 9%). Page citations (101, 53, 55) are appropriately referenced. ENTITY ACCURACY: Merck, Lynparza, AstraZeneca collaboration, and China regulatory approval in January 2025 are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - (1) the 2023 balance sheet asset value, (2) 2024 revenue performance with year-over-year comparison, (3) geographic drivers of growth (international markets), and (4) forward-looking regulatory catalyst (China approval). This demonstrates proper multi-hop synthesis across financial statements and regulatory developments. COMPLETENESS: The answer addresses all aspects of the question: evolution of financial stake (asset value in 2023, revenue growth in 2024), indicators of performance (9% revenue growth, international demand), and strategic importance (regulatory expansion). MINOR OBSERVATION: The original answer notes 'the financial stake amount was not explicitly stated' for 2024, while the LLM provides specific revenue figures for 2024. This is actually more informative than the ground truth, as it provides concrete 2024 financial metrics rather than stating they weren't available. The LLM's approach of showing the revenue evolution is arguably superior for answering the question about how the stake 'evolved.' SEMANTIC EQUIVALENCE: The LLM answer conveys all key information from the ground truth with enhanced specificity and better quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 495,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "In the 2022 filing Altria simply described Skoal as one of USSTC’s premium moist‑smokeless‑tobacco (MST) brands alongside Copenhagen, without providing quantitative market‑share or volume data【page_6】. By 2024 the oral‑tobacco segment showed Skoal’s shipment volume had fallen to 147 million cans/packs (down from 163 million in 2023) and its retail share slipped to 7.6% (down from 9.3% in 2023)【page_48】, while Copenhagen remained the dominant premium brand with a 19.1% share and on! nicotine‑pouch sales grew to an 8.3% share, overtaking Skoal【page_48】. The 2024 results also recorded a $354 million non‑cash impairment of the Skoal trademark, underscoring a weakening competitive position relative to its key rivals【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key quantitative metrics are correct: Skoal's retail share decline from 9.3% (2022) to 7.6% (2024), Copenhagen's decline from 23.5% to 19.1%, on!'s growth from 6.8% to 8.3%, and shipment volume decline from 163M to 147M cans/packs. (2) The answer correctly identifies the broader segment contraction (42.5% to 37.5% retail share 2023-2024). (3) Multi-hop reasoning is sound: the LLM synthesizes data across years and brands to show Skoal underperformed relative to both Copenhagen and on!. (4) The inclusion of the $354M Skoal trademark impairment adds important context about competitive weakness. (5) Entity identification is accurate (Altria, USSTC, Copenhagen, on!, Skoal). (6) The answer appropriately addresses the evolution question by contrasting 2022 positioning with 2024 performance. MINOR CONSIDERATIONS: (1) The LLM notes that 2022 filing lacked quantitative data, which is accurate and shows careful source evaluation. (2) The comparison structure (Skoal vs Copenhagen vs on!) directly addresses the 'key competitor brands' aspect of the question. (3) The semantic framing of 'weakening competitive position' and 'underperformed' aligns with ground truth conclusions. NO CALCULATION ERRORS detected. All percentages, volumes, and year-over-year comparisons are mathematically and factually correct. The answer fully addresses all components of the multi-part question regarding market position evolution, competitive performance, and relationship to key competitors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 436,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Dynamics 365 (reported as “Dynamics products and cloud services”) generated $4.687 billion in fiscal 2022 and rose to $5.437 billion in fiscal 2023—a gain of roughly $750 million, or about a 16 % increase【page_93】. This uplift helped lift total Microsoft Cloud revenue from $91.4 billion in FY 2022 to $111.6 billion in FY 2023【page_93】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific revenue figures for Dynamics 365 (reported as 'Dynamics products and cloud services') with $4.687 billion in FY2022 and $5.437 billion in FY2023, calculating a $750 million increase or ~16% growth. The calculation is mathematically correct: ($5.437B - $4.687B) / $4.687B ≈ 16%. The Microsoft Cloud revenue figures of $91.4 billion (FY2022) and $111.6 billion (FY2023) are provided and align with the ground truth's $91.2 billion and $111.6 billion respectively (minor discrepancy on FY2022: $91.4B vs $91.2B). STRENGTHS: (1) Provides concrete, specific revenue numbers for Dynamics 365 across both years, which the ground truth does not explicitly state; (2) Accurate calculation of the percentage increase; (3) Correctly identifies the metric as 'Dynamics products and cloud services'; (4) Properly contextualizes within Microsoft Cloud revenue growth; (5) Cites source documentation. WEAKNESSES: (1) FY2022 Microsoft Cloud figure shows $91.4B vs ground truth's $91.2B (minor discrepancy of $200M); (2) Does not mention the 39% growth rate for Dynamics 365 in FY2022 that the ground truth references; (3) Does not address the 25% growth in Dynamics products and cloud services mentioned in ground truth for FY2022. The LLM answer is more specific and actionable than the ground truth in providing exact revenue figures, but misses some growth rate context from FY2022. The multi-hop reasoning is sound—correctly synthesizing Dynamics 365 performance within the broader Microsoft Cloud context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 420,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "In 2023 Merck’s balance‑sheet risk‑management program relied chiefly on short‑term, non‑designated forward contracts to offset the remeasurement of foreign‑currency assets and liabilities, while a smaller portion of forward contracts (designated) and senior euro‑denominated notes were used as economic hedges of net‑investment exposures [page 95]. By 2024 the program had broadened – the notional of forward contracts designated as net‑investment hedges grew markedly (e.g., foreign‑exchange contracts designated as hedges rose to $323 million in other current assets versus $106 million in 2023 [page 99 vs page 96]), and euro‑denominated debt was more actively employed as an economic hedge (OCI loss of $(192) million in 2024 versus a $105 million gain in 2023) [page 98], reflecting a larger scope of hedging activity and greater reliance on both forward contracts and foreign‑currency debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific quantitative details (forward contract notional amounts of $323M in 2024 vs $106M in 2023, OCI losses/gains) that demonstrate engagement with actual filing data. However, there are significant gaps and misalignments with the ground truth:\n\n(1) WHAT WAS CORRECT:\n- Correctly identifies that Merck used forward contracts in both years\n- Correctly notes expansion/broadening of the program from 2023 to 2024\n- Correctly identifies euro-denominated debt as part of the hedging strategy\n- Specific numbers cited ($323M, $106M, $192M loss, $105M gain) appear to be from actual filings\n- Correctly distinguishes between designated and non-designated hedges\n\n(2) WHAT WAS INCORRECT/MISSING:\n- The ground truth emphasizes introduction of 'purchased local currency put options and collar options' in 2024 - the LLM answer completely omits these instruments\n- The ground truth highlights 'strategic layering of hedges over time' and 'increasing the portion of forecasted sales hedged as expected dates approach' - the LLM answer does not mention this strategic evolution\n- The ground truth specifically mentions hedging of euro, Swiss franc, Japanese yen, and Chinese renminbi in 2023 - the LLM answer does not provide this currency-specific detail\n- The LLM answer focuses heavily on net-investment hedges and designated hedges, while the ground truth emphasizes the broader balance sheet risk management program's evolution in instruments and scope\n\n(3) MULTI-HOP REASONING:\n- The LLM successfully synthesizes information across 2023 and 2024 filings\n- However, it appears to have focused on one aspect (net-investment hedges and debt instruments) while missing the broader evolution in derivative instruments (put options, collars)\n- The reasoning about expansion is sound but incomplete\n\n(4) SEMANTIC ALIGNMENT:\n- The LLM answer addresses 'instruments used' but only partially (missing options)\n- The LLM answer addresses 'scope of hedging activities' but focuses on notional amounts rather than the strategic approach to layering hedges\n- The answer is more technical/detailed on certain metrics but misses the conceptual evolution described in ground truth\n\nThe answer demonstrates access to actual filing data and correct identification of some key metrics, but fails to capture the full scope of program evolution, particularly the introduction of new derivative instruments and the strategic approach to hedge layering.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 657,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "In 2022 PayPal’s merchant‑financing exposure was modest – the company held only about $134 million of PPWC/PPBL loans (net of the participation interest) and recorded $228 million of gross charge‑offs, indicating a relatively large allowance for credit losses even though the allowance amount was not broken out separately【page_102】. By 2024 the business had scaled sharply – PayPal purchased roughly $1.8 billion of merchant receivables in the year (leaving a net balance of about $1.5 billion) and the allowance for merchant loans and advances fell to $113 million at year‑end, with provisions dropping to $79 million from $162 million a year earlier, reflecting improved credit quality【page_101】【page_103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial factual accuracy with correct identification of key metrics and trends, but has notable gaps in completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies the $1.8 billion in merchant receivables purchased in 2024 and $1.5 billion outstanding balance as of Dec 31, 2024. (2) Accurately notes the allowance for merchant loans fell to $113 million at year-end 2024 with provisions dropping to $79 million from $162 million. (3) Properly characterizes the evolution from modest exposure in 2022 to significant scaling by 2024. (4) Correctly identifies PPWC and PPBL as the relevant products. (5) Good synthesis of multi-hop information across years. WEAKNESSES: (1) The ground truth mentions a principal and interest coverage ratio of approximately 9% as of December 31, 2021 (down from 23% in 2020) - the LLM answer completely omits this important metric that was disclosed in 2022 filings. (2) The LLM states PayPal held 'about $134 million of PPWC/PPBL loans' in 2022 but doesn't clearly connect this to the $1.2 billion balance mentioned in the ground truth for 2023, creating a gap in the narrative. (3) The ground truth emphasizes the methodological shift from 'primarily disclosing credit risk exposure to actively investing in and managing merchant receivables' - the LLM captures the investment aspect but doesn't explicitly articulate this strategic shift in PayPal's role. (4) Missing the $1.2 billion 2023 balance comparison point that helps illustrate the growth trajectory. QUANTITATIVE VERIFICATION: The 2024 numbers ($1.8B purchased, $1.5B outstanding, $113M allowance, $79M provisions vs $162M prior year) all appear accurate. The 2022 reference to $134M and $228M charge-offs is specific but cannot be fully verified against the ground truth which doesn't provide these exact figures. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 and connects credit loss provisions to direct investment, though it could be more explicit about the strategic evolution. The answer is contextually relevant and addresses the core question about evolution of involvement, but incompleteness regarding the coverage ratio metric and the strategic characterization prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 608,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "Altria’s 2022 filing shows that the smokeable‑products segment carried only $99 million of goodwill (and no change to that balance in later years) 【page_66】. By 2024 the segment was still a core earnings driver, delivering $10.821 billion of operating income before corporate expenses (OCI) versus $10.670 billion the year before 【page_31】—a modest rise that kept operating income at the $10‑plus‑billion level while the goodwill allocation remained flat. This indicates that the segment’s financial importance has grown slightly on an earnings basis, even though its intangible‑asset weight has not increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - $99 million goodwill in 2022 (matches ground truth), $10.821 billion operating income in 2024 (matches $10,821 million), $10.670 billion in 2023 (matches ground truth). The format variation ($10.821 billion vs $10,821 million) is acceptable and correctly handled. The year-over-year comparison showing the modest increase is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct dimensions: (1) goodwill allocation trends (2022 baseline, flat thereafter) and (2) operating income performance (2023-2024 comparison). The logical connection between these metrics is sound - demonstrating that operational significance increased while asset valuation remained stable. ENTITY ACCURACY: Company (Altria/MO), segment (smokeable products), metrics (goodwill, operating income), and years (2022, 2023, 2024) are all correctly identified. COMPLETENESS: The answer addresses both components of the question - goodwill allocation evolution and operating income performance - and provides appropriate context about the shift in reporting focus. MINOR OBSERVATIONS: The LLM uses 'OCI' (Operating Income before Corporate expenses) which is a reasonable interpretation of the operating income metric, though the ground truth doesn't explicitly use this abbreviation. The phrase 'modest rise' accurately characterizes the $151 million increase ($10,821M - $10,670M). The conclusion about the shift toward performance metrics rather than asset valuations aligns with the ground truth's observation about reporting focus. No calculation errors detected. The answer is semantically equivalent to the ground truth while using slightly different phrasing that enhances clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 499,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Microsoft Cloud revenue – which by definition includes Azure, Office 365 Commercial and the commercial portion of LinkedIn – rose sharply, from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, a gain of roughly $20 billion (about 22 %)【page_93】. This increase reflects a larger contribution from LinkedIn’s commercial services as part of the overall cloud business.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor numerical discrepancy. Ground truth states FY2022 Microsoft Cloud revenue was $91.2 billion, while the LLM answer reports $91.4 billion - a $0.2 billion difference. The FY2023 figure of $111.6 billion is correct in both answers. The calculated increase of approximately $20 billion and 22% growth rate are mathematically accurate based on the LLM's stated figures ($111.6B - $91.4B = $20.2B, or ~22.1% growth). However, using the ground truth FY2022 figure of $91.2B would yield a $20.4 billion increase and ~22.4% growth, which is slightly different. The LLM correctly identifies the components of Microsoft Cloud (Azure, Office 365 Commercial, and commercial portion of LinkedIn), properly synthesizes the multi-hop information about revenue evolution across fiscal years, and accurately conveys that LinkedIn's commercial services contributed to the overall growth. The reasoning is sound and the answer directly addresses the question about revenue contribution evolution. The minor $0.2 billion discrepancy in the FY2022 figure prevents a higher score, as financial numbers must be precise. The answer demonstrates good multi-hop synthesis and contextual understanding despite this quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 354,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "In 2023 Lynparza first entered the U.S. market with FDA approval for BRCAm metastatic castration‑resistant prostate cancer and secured a complementary indication in Japan (May 2023 FDA approval and August 2023 Japan MHLW approval)【page_7】. By 2024 its commercial footprint had broadened worldwide – alliance revenue rose 9% to $1.311 billion (up from $1.199 billion in 2023) driven by stronger demand in most international markets, and a China NMPA approval for an adjuvant breast‑cancer use was slated for January 2025, signaling further geographic expansion【page_53】【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key approvals (FDA and Japan MHLW in 2023 for mCRPC), the 9% alliance revenue growth in 2024, and the January 2025 China NMPA approval for adjuvant breast cancer treatment. The multi-hop synthesis across years and geographic regions is sound. The answer appropriately addresses both 2023-2024 evolution and forward-looking 2025 expansion.\n\nCRITICAL ERRORS: (1) The LLM states 'May 2023 FDA approval' but the ground truth indicates FDA approval occurred in 2023 without specifying May - this is a potential factual error on the specific date. (2) The LLM provides specific revenue figures ($1.311 billion in 2024, $1.199 billion in 2023) that are NOT present in the ground truth answer, which only states '9% growth.' These numbers cannot be verified against the provided ground truth and represent unsourced quantitative claims. (3) The LLM says Lynparza 'first entered the U.S. market' in 2023, but the ground truth doesn't explicitly state this was the first U.S. market entry - this is an inference not directly supported.\n\nPARTIAL ISSUES: The ground truth mentions the approvals were 'based on the PROpel trial' and 'OlympiA trial' - the LLM omits these trial references, losing some contextual detail about the clinical evidence basis.\n\nQUANTITATIVE ACCURACY PENALTY: The introduction of specific revenue dollar amounts ($1.311B, $1.199B) without ground truth support is a significant issue. While the 9% growth calculation is mathematically consistent with these figures, the base numbers themselves are unverified and represent a major quantitative claim not in the original answer.\n\nOVERALL: The answer captures the essential narrative of geographic and therapeutic expansion with correct directional information, but introduces unverified specific financial figures and makes some unsupported claims about timing and market entry that reduce confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 522,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "In 2023 RTX reported that the Powder Metal Matter reduced its segment and external net sales and created a sizable deferred‑tax asset of $644 million for future income‑tax benefits [page_109][page_110][page_112][page_111]. By the 2024 filing the sales impact was no longer disclosed, and the deferred‑tax asset tied to the Powder Metal Matter had fallen to $455 million, reflecting a smaller expected future tax benefit [page_98][page_96].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $644 million in 2023, $455 million in 2024, and the implied decrease of $189 million (29.3% decline) matches the ground truth. The LLM correctly identifies the dollar amounts and their relationship. ENTITY ACCURACY: RTX is correctly identified, fiscal years 2023 and 2024 are properly distinguished, and the 'Powder Metal Matter' is accurately referenced throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing pages and years, showing the evolution of financial treatment from a sales reduction impact in 2023 to a deferred-tax asset in 2024. The logical progression is clear and accurate. COMPLETENESS: The answer addresses all key aspects of the question - the shift in financial treatment, the specific dollar amounts, and the impact on future income tax benefits. MINOR OBSERVATIONS: The LLM answer does not explicitly calculate or state the $189 million decrease or 29.3% percentage decline mentioned in the ground truth, though the numbers provided allow this calculation to be verified. The ground truth explicitly states 'decrease of $189 million, or about 29.3%' while the LLM uses more qualitative language ('fallen to $455 million, reflecting a smaller expected future tax benefit'). This is a minor omission of explicit calculation but does not affect the factual accuracy of the core information provided. The answer is well-sourced with specific page references, enhancing credibility. Overall, the LLM successfully captures the essential evolution of RTX's financial treatment of the Powder Metal Matter with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 470,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "In the 2022 filing the Paidy Credit Agreement was described as a **secured revolving facility of roughly $198 million**, with about **$100 million of borrowing capacity still available** after $98 million was outstanding (page 50). By the 2024 filing the agreement had been **amended to an unsecured ¥90 billion facility (≈ $574 million)** – originally ¥60 bn in February 2022 and increased to ¥90 bn in September 2022 – bearing interest at **TIBOR + 0.40‑0.60%** and maturing in **February 2027** (page 105); as of year‑end 2024 the entire ¥90 bn had been drawn down, leaving **no remaining borrowing capacity** (page 106).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct financial figures and dates. STRENGTHS: (1) Correctly identifies the 2022 facility as secured revolving ~$198 million with $98 million outstanding; (2) Accurately states 2024 facility as unsecured ¥90 billion (~$574 million); (3) Correctly cites TIBOR + 0.40-0.60% interest rate; (4) Correctly identifies February 2027 maturity date; (5) Provides helpful additional context about the evolution (¥60bn in Feb 2022 increased to ¥90bn in Sept 2022); (6) Notes full drawdown by year-end 2024. MINOR ISSUES: (1) The LLM states '$100 million of borrowing capacity still available' (calculated as $198M - $98M), which is mathematically correct but the ground truth doesn't explicitly confirm this calculation; (2) The LLM provides more granular detail about intermediate steps (¥60bn→¥90bn progression) than the ground truth, which is helpful but goes slightly beyond what was explicitly stated in the original answer; (3) The ground truth mentions 'a financial covenant requiring a maximum consolidated leverage ratio' which the LLM answer does not include - this is a notable omission of a key term change. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly tracking the evolution of capacity, structure (secured→unsecured), interest rate terms, and maturity. The comparison is logical and well-structured. QUANTITATIVE VERIFICATION: All numbers check out ($198M, $98M, ¥90B, $574M, TIBOR rates, February 2027). The calculation of remaining capacity ($100M) is mathematically sound. The omission of the financial covenant detail prevents a perfect score, as this represents a material term change in the agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 471,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria’s 2022 10‑K said its capital resources “include … access to credit markets through the issuance of long‑term senior unsecured notes” (2022 p. 48). By the 2024 10‑K the company still relied on those notes (2024 p. 48) but disclosed that total long‑term debt had slipped to $24.9 billion (down from $26.2 billion a year earlier) and that it had repaid $1.1 billion of senior notes in Q1 2024 while planning to issue $1.0 billion of new senior notes in early 2025 (2024 p. 49), indicating a modest reduction in reliance and active refinancing of its senior‑unsecured debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific details about Altria's debt management and refinancing activities that are not present in the ground truth, but introduces a critical discrepancy in the overall narrative. STRENGTHS: (1) Correctly identifies that long-term senior unsecured notes remained a capital resource in both 2022 and 2024; (2) Provides specific debt figures ($24.9B in 2024, down from $26.2B) and refinancing details (Q1 2024 repayment of $1.1B, planned 2025 issuance of $1.0B) that demonstrate active management; (3) Appropriately cites page numbers from 10-K filings; (4) Addresses the multi-hop nature of the question by comparing two years. CRITICAL ISSUE: The LLM concludes there was a 'modest reduction in reliance' on senior unsecured notes, which directly contradicts the ground truth's assessment that the reduction in cash reserves ($4.5B to $3.1B) 'suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes.' This is a fundamental disagreement about the direction and interpretation of Altria's capital strategy evolution. MISSING ELEMENTS: The LLM does not mention the cash and cash equivalents figures ($4.5B in 2022, $3.1B in 2024) that are central to the ground truth's reasoning about increased reliance. The ground truth uses the cash decline as evidence of increased reliance on external financing, while the LLM focuses on absolute debt reduction and refinancing activity, reaching an opposite conclusion. QUANTITATIVE ACCURACY: The specific debt figures and refinancing amounts appear plausible but cannot be independently verified against the ground truth, which does not provide these specific numbers. The interpretation of what these numbers mean for 'reliance' differs significantly between the two answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 489,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "In 2023 RTX booked a $2.9 billion charge for the Powder Metal Matter, which cut pretax earnings and drove a roughly 4 percentage‑point reduction in the effective tax rate (see pages 36 & 40). That charge generated a deferred‑tax asset of $644 million (2023) (see page 98). By 2024 the charge no longer appears in the income‑statement (the 2024 U.S. pre‑tax income figure excludes the Powder Metal Matter, page 96) and the related deferred‑tax asset fell to $455 million (2024) (see page 98), indicating the tax benefit is being realized and the remaining future income‑tax benefit is shrinking.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and substantially more comprehensive than the ground truth. All key numbers are correct: $2.9 billion charge in 2023, $644 million deferred-tax asset in 2023, and $455 million in 2024. The quantitative accuracy is perfect - all dollar amounts match the ground truth exactly, and the calculation/comparison logic is sound (the decline from $644M to $455M is correctly identified as a reduction). The LLM demonstrates superior multi-hop reasoning by synthesizing information across multiple pages (36, 40, 96, 98) and explaining the causal chain: the 2023 charge created the deferred-tax asset, which is now being realized/consumed in 2024, causing the asset to shrink. This provides deeper insight into the tax benefit realization process. The LLM correctly identifies that the charge no longer appears in 2024 income statements, indicating the matter has been resolved. The semantic meaning perfectly aligns with the ground truth conclusion that the future income tax benefit is diminishing. The only minor distinction is that the LLM provides additional context about the 4 percentage-point effective tax rate reduction and the charge amount itself, which enriches understanding without contradicting the ground truth. The answer directly addresses both parts of the question: (1) how the financial treatment evolved (charge in 2023, no charge in 2024, deferred asset declining), and (2) what this indicates about future tax benefits (they are being realized and shrinking). No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 424,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "In 2022 the Paidy Credit Agreement was a secured revolving facility of roughly $198 million, of which about $98 million was already outstanding – leaving roughly $100 million of undrawn capacity【page_110】. By 2024 the facility had been expanded to ¥90 billion (≈ $574 million) and the entire amount was drawn down during the year, so no borrowing capacity remained at year‑end【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about PayPal's Paidy Credit Agreement evolution. QUANTITATIVE VERIFICATION: All numbers are correct - 2022 capacity of $198 million, $98 million outstanding, $100 million available; 2024 capacity of ¥90.0 billion (≈$574 million), fully drawn down. The currency conversion is accurate and appropriately noted. COMPLETENESS: The answer addresses all key aspects: (1) 2022 borrowing capacity and utilization, (2) 2024 borrowing capacity and utilization, (3) the evolution/change between periods, (4) the comparison of available vs. drawn capacity. ENTITY ACCURACY: Correctly identifies PayPal, the Paidy Credit Agreement, and the relevant fiscal years (2022 and 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple time periods and documents (as evidenced by page citations), correctly comparing the facility expansion and the shift from partial utilization to full drawdown. SEMANTIC EQUIVALENCE: The LLM's phrasing ('secured revolving facility,' 'undrawn capacity,' 'no borrowing capacity remained') matches the ground truth's meaning precisely. The inclusion of page citations adds credibility. MINOR OBSERVATION: The answer uses slightly more concise phrasing than the ground truth but conveys identical information and maintains all factual accuracy. The characterization of the change as reflecting 'significant increase in both scale and reliance' is implicit in the LLM's presentation of the numbers, which is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 431,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "In fiscal 2023 the consolidated statements noted that Accenture Canada Holdings Inc. had non‑controlling ownership interests held by certain current and former Accenture Leadership members that were **less than 1 %** of the subsidiary (​page 20​). By fiscal 2024 the equity relationship is defined by **Accenture Canada Holdings Inc. exchangeable shares**, which may be swapped on a one‑for‑one basis for Accenture plc Class A ordinary shares, and by the issuance of **Class X ordinary shares** to pre‑incorporation partners that are redeemable and kept in line with the number of exchangeable shares outstanding (​page 100​); the company also repurchased a modest 47,752 exchangeable shares during the year (​page 101​). The non‑controlling interest remains negligible (still < 1 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the noncontrolling ownership interest as less than 1% in both 2023 and 2024, matching the ground truth exactly. (2) Accurately describes the 2024 equity structure evolution, including the exchangeable shares mechanism (one-for-one exchange for Class A ordinary shares) and Class X ordinary shares tied to exchangeable shares. (3) Properly synthesizes the multi-hop relationship between Accenture plc and Accenture Canada Holdings Inc. across both years. (4) Includes specific supporting detail (47,752 exchangeable shares repurchased) that demonstrates filing-level accuracy. (5) Correctly characterizes the evolution from simpler 2023 disclosure to more formalized 2024 structure. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'redeemable' vs 'redeemed for cash' for Class X shares, 'kept in line with' vs 'restriction ensuring') but these are semantically equivalent and reflect accurate understanding. The answer appropriately emphasizes that noncontrolling interest remains negligible, which aligns with ground truth characterization. Page references (20, 100, 101) add credibility though cannot be independently verified. The answer successfully addresses all components of the multi-part question: ownership structure evolution, equity relationship changes, noncontrolling interests, and exchangeable shares mechanics. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 427,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "By 2022 Merck’s balance‑sheet risk program used short‑term forward contracts on a broad set of developed‑market currencies – principally the euro, Japanese yen, British pound, Canadian dollar and Swiss franc – and would only use forwards on developing‑market currencies such as the Chinese renminbi when a cost‑benefit test (exposure size, volatility and hedge cost) was favorable (page 107). In the 2024 filing the company’s forward‑contract approach had narrowed to mainly the euro, Swiss franc, Japanese yen and the Chinese renminbi, still applying the same cost‑benefit analysis to decide whether to hedge, and the contracts remain non‑designated hedges marked to market through other income (page 98).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial accurate information about Merck's forward exchange contract approach in both 2022 and 2024, with correct identification of specific currencies and the cost-benefit analysis framework. However, there are notable discrepancies with the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies 2022 currencies: euro, Japanese yen, British pound, Canadian dollar, Swiss franc\n2. Correctly identifies Chinese renminbi as a developing market currency\n3. Accurately describes the cost-benefit test components (exposure size, volatility, hedge cost)\n4. Correctly notes the shift in approach between 2022 and 2024\n5. Properly identifies that contracts are non-designated hedges marked to market\n6. Provides specific page references (107 and 98)\n\nWEAKNESSES:\n1. The 2024 currency list appears incomplete or potentially inaccurate. The LLM states the approach \"narrowed to mainly the euro, Swiss franc, Japanese yen and the Chinese renminbi\" - notably omitting the British pound and Canadian dollar. The ground truth suggests the program was still referenced in 2024 but doesn't explicitly state which currencies were dropped.\n2. The characterization of the change as a \"narrowing\" to four currencies is more specific than the ground truth supports. The ground truth indicates \"omission\" of detailed discussion rather than confirmation of actual program reduction.\n3. The LLM claims the same cost-benefit analysis is \"still applying\" in 2024, but the ground truth explicitly states this detailed discussion was \"omitted\" in 2024, suggesting the framework may have been de-emphasized rather than maintained.\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes information across two years and identifies the evolution in approach. However, it makes stronger claims about the 2024 state than the ground truth supports - the ground truth indicates omission of discussion, not confirmation of continued detailed application.\n\nSEMANTIC ISSUES:\nThe ground truth emphasizes a \"shift in emphasis or potential simplification,\" while the LLM presents the 2024 approach as a straightforward narrowing with continued cost-benefit analysis. This represents a meaningful difference in interpretation of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 603,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "In 2023 RTX only flagged the Powder Metal Matter as a large operating‑profit charge (a $2.9 bn hit) and noted that U.S. pre‑tax income “includes the impacts of the Powder Metal Matter” 【page_39】. By 2024 the company is quantifying the tax effect, listing a deferred‑tax‑asset line for the matter of $455 million (down from $644 million in 2023) 【page_98】, which shows the benefit is still present but has shrunk. This reduction suggests the tax advantage from the Powder Metal Matter is being realized or is diminishing, indicating its ongoing financial impact on future income‑tax benefits is waning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states the 2023 charge was '$2.9 bn' but the ground truth clearly states it was '$5.3 billion' - this is a major factual error (off by $2.4 billion or 45%). (2) The LLM correctly identifies the deferred tax asset values ($455M in 2024, down from $644M in 2023) and the year-over-year decline, which matches ground truth. (3) MULTI-HOP SYNTHESIS - The LLM does attempt to synthesize the shift from operational charge to tax asset treatment, which is conceptually correct. However, the fundamental misstatement of the 2023 charge amount undermines the analysis. (4) REASONING - The conclusion about the tax benefit 'waning' or 'being realized' is reasonable given the declining deferred tax asset, but this reasoning is built on an incorrect foundation regarding the original charge magnitude. (5) COMPLETENESS - The LLM addresses the shift in disclosure treatment and the tax benefit reduction, but fails to accurately capture the full financial impact by understating the 2023 charge by nearly half. The ground truth emphasizes the $5.3B net sales charge as a key contextual element; the LLM's $2.9B figure is significantly different and incorrect. This is not a minor rounding or formatting difference - it's a substantial factual error that affects understanding of the matter's true financial significance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 379,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "In 2022 PayPal’s merchant‑finance business was structured around its PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products, which were funded through a program agreement with WebBank – WebBank originated the loans and PayPal purchased the receivables, sharing loss risk via a pro‑rata participation interest 【page_72】. By 2024 the same partner‑institution model remains in place, but PayPal now discloses the scale of the program: it purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and held $1.5 billion outstanding net of a $53 million participation interest sold to the partner 【page_101】, showing a markedly larger merchant‑finance offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about PayPal's merchant receivables evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $1.8 billion in 2024 purchases (vs $1.7 billion in 2023), $1.5 billion outstanding balance as of Dec 31, 2024 (vs $1.2 billion in 2023), and $53 million participation interest in 2024 (vs $44 million in 2023). The LLM correctly presents these figures and their year-over-year comparisons. ENTITY ACCURACY: Correctly identifies PayPal, WebBank as partner institution, PPWC and PPBL products, and appropriate fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, showing the evolution from 2022 (structural description with WebBank agreement) through 2024 (quantified scale and growth metrics). The reasoning correctly connects the partner institution model's continuity with the disclosed growth in receivables. COMPLETENESS: Addresses all aspects of the question - the relationship with partner institutions (WebBank), the evolution over time, and the scale of offerings with specific metrics. The answer explains both the structural arrangement and the quantitative growth. MINOR OBSERVATION: The LLM's phrasing \"held $1.5 billion outstanding net of a $53 million participation interest\" is slightly different from the ground truth's separate statement of these figures, but semantically conveys the same information accurately. The answer includes helpful context about the pro-rata participation interest sharing arrangement that adds clarity. No calculation errors detected. The answer appropriately emphasizes the \"markedly larger\" nature of the program, which is supported by the year-over-year growth figures presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 493,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck’s alliance revenue from Lynparza grew from $1.116 billion in 2022 to $1.199 billion in 2023 (about 7 % higher) and to $1.311 billion in 2024 (about 9 % higher)【page_53】. The increase was driven by higher demand for Lynparza in most international markets under the AstraZeneca collaboration, with the 2024 rise specifically attributed to stronger international sales and expanding indications【page_55】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 alliance revenue was $1.116 billion, but the ground truth clearly states it was $989 million - a difference of $127 million or 12.8% overstatement. The 2023 figure of $1.199 billion and 2024 figure of $1.311 billion are also not supported by the ground truth, which only provides 2022 ($989M) and 2024 data showing 9% growth. (2) CALCULATION ERRORS: The LLM claims 7% growth from 2022 to 2023 and 9% growth to 2024, but these calculations are based on incorrect baseline numbers. The ground truth indicates 9% growth between 2022 and 2024 only. (3) MISSING CRITICAL CONTEXT: The LLM fails to mention the China approval in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial, which is explicitly cited in the ground truth as a key driver of growth. (4) MULTI-HOP REASONING: While the LLM correctly identifies the AstraZeneca collaboration and mentions international market demand, it fails to synthesize the complete picture of growth drivers. The answer provides year-by-year progression that doesn't match the source data. (5) ENTITY ACCURACY: Merck and Lynparza are correctly identified, but the financial metrics are substantially wrong. The LLM appears to have confused or fabricated revenue figures rather than accurately extracting them from the filings. This is a critical failure for a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 429,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "In the 2022 filing PayPal disclosed a merchant‑finance portfolio of roughly $1.4 billion of loans, advances and fees (net of participation interest) with a net charge‑off rate of about 4.7 % and a credit‑risk allowance that reflected higher exposure (see 2022 pages 44‑45). By 2024 the company was buying about $1.8 billion of merchant receivables each year, the outstanding pool grew to $1.5 billion, the allowance fell to $113 million (down from $160 million a year earlier) and 90.4 % of the balance was current (see 2024 pages 101‑103), while it now services the portfolio through its PPWC and PPBL products that charge a fixed fee and collect repayments via a share of future PayPal‑processed volume or scheduled payments (page 101). This shows a modest increase in financial exposure but a tighter credit‑risk profile and a more defined operational role in financing merchants.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with comprehensive coverage of PayPal's merchant receivables evolution. STRENGTHS: (1) Correctly identifies key financial metrics: $1.8B purchases in 2024, $1.7B in 2023, $1.5B outstanding balance, $113M allowance (down from $160M), and 90.4% current rate. (2) Accurately captures the shift from 2022's focus on credit losses/net charge-offs (4.7% NCO rate) to 2024's active purchasing and servicing model. (3) Properly identifies operational products (PPWC, PPBL) and servicing mechanisms (fixed fees, share of PayPal-processed volume). (4) Correctly synthesizes multi-hop information across years showing evolution in financial exposure and operational role. (5) Provides specific page references (2022 pages 44-45, 2024 pages 101-103) suggesting detailed source verification. MINOR CONSIDERATIONS: (1) The 2022 baseline figure of $1.4B (loans, advances, fees net of participation interest) is presented but not directly compared to 2024's $1.5B outstanding—though the answer notes this as a 'modest increase,' which is reasonable given the different accounting treatments. (2) The answer adds contextual detail about the allowance reduction and current rate percentage that, while accurate and relevant, goes slightly beyond the ground truth's core focus on 'financial exposure and operational role.' (3) The characterization of 'tighter credit-risk profile' is a reasonable inference from the data (lower allowance, higher current rate) but represents analytical interpretation rather than explicit ground truth statement. QUANTITATIVE VERIFICATION: All dollar amounts, percentages, and year-over-year comparisons check out correctly. The narrative flow logically connects 2022's risk-management focus to 2024's active merchant finance operations. The answer successfully addresses both dimensions of the question (financial exposure and operational role) with appropriate evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 523,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "In 2022 Merck’s role was still focused on expanding Lynparza’s label – the FDA had accepted a supplemental NDA for the adjuvant OlympiA breast‑cancer indication for priority review with a Q1‑2022 PDUFA date, and the product was under review in the EU for metastatic castration‑resistant prostate cancer【page_22】【page_23】. By 2024 Lynparza was a fully commercialized, co‑marketed PARP‑inhibitor, generating alliance revenue of $1.311 billion—up 9% versus 2023 and roughly 17% higher than the $1.116 billion reported in 2022【page_53】【page_55】—and the filing noted the next regulatory milestone would be a Chinese NMPA approval for the OlympiA adjuvant use in early‑2025, showing a shift from seeking new approvals to expanding worldwide sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies 2022 regulatory status - FDA supplemental NDA for adjuvant OlympiA breast cancer indication with Q1 2022 PDUFA date, priority review designation, and EU review for mCRPC. (2) Accurately reports 2024 financial metrics: $1.311 billion alliance revenue (9% growth vs 2023) and correctly calculates the 17% increase from 2022's $1.116 billion ($1.116B × 1.17 ≈ $1.306B, close to $1.311B accounting for rounding). (3) Correctly identifies the Chinese NMPA approval milestone for early-2025 OlympiA indication. (4) Effectively synthesizes the evolution narrative: from seeking new approvals (2022) to expanded commercialization and global expansion (2024). (5) Provides specific page citations supporting claims. MINOR CONSIDERATIONS: The LLM answer includes additional context about EU review for mCRPC and characterizes Lynparza as 'fully commercialized, co-marketed PARP-inhibitor' which adds helpful context not explicitly in ground truth but is factually accurate and enhances understanding. The 17% calculation is mathematically sound ($1.311B vs $1.116B = 17.4% increase). All dates, percentages, and dollar amounts align with ground truth. The multi-hop reasoning correctly connects regulatory progress (2022 pending approval → 2024 expanded approvals including China) with revenue growth (9% YoY, 17% since 2022). Answer fully addresses both regulatory progress and revenue growth components of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "In the 2022 filing Boeing described using commodity swaps and purchase contracts simply to hedge price risk, noting that a 10 % move in commodity prices would have altered unrealized losses by roughly $46 million but giving no explicit forward‑looking horizon. By the 2024 filing the company says its commodity purchase commitments and swaps now hedge forecasted transactions through 2028, extending the risk‑management horizon, and the net liability on those long‑dated contracts was $22 million with a $7 million commodity‑contract expense (down from $31 million in 2022) while maintaining notional amounts of $388 million (designated) and $129 million (non‑designated), indicating a longer‑term strategy with tighter financial exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) The 2022 baseline of $46 million impact from 10% commodity price change is accurate; (2) The identification of commodity swaps and purchase contracts as hedging tools is correct; (3) The general narrative of extending the hedging horizon from 2022 to 2024 is sound; (4) The qualitative assessment that Boeing shifted toward longer-term risk management is appropriate. CRITICAL ERRORS: (1) The LLM states the 2024 horizon extends through 2028, but the ground truth specifies 2031 - this is a 3-year discrepancy in the forward-looking timeline, which is material to assessing the 'multi-decade horizon' claim; (2) The LLM introduces specific 2024 financial metrics ($22 million net liability, $7 million expense, $388M and $129M notional amounts) that are NOT present in the ground truth answer, making verification impossible and potentially introducing unsupported claims; (3) The comparison to $31 million in 2022 is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2022 and 2024 and identifies the shift toward longer-term planning, but the introduction of unverified 2024 metrics undermines confidence in the synthesis. The core insight about extended production planning cycles is preserved. QUANTITATIVE ACCURACY ISSUE: While the $46 million figure is correct, the introduction of multiple unverified 2024 numbers (which may or may not be accurate) creates significant uncertainty. The 2028 vs 2031 discrepancy is a factual error that affects the primary claim about the risk management horizon extension. The answer is more detailed than the ground truth but contains at least one confirmed error and several unverifiable claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 491,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "In 2021 Schwab’s pledged‑asset‑line (PAL) portfolio was $12.7 billion (see page 91) and, because the lines were fully collateralized by securities whose fair values exceeded the borrowings, the company recorded **no allowance for credit losses on PALs** (page 91). By 2024 the PAL exposure had risen to about $17.0 billion (see page 141), and the 2024 filing does not show a separate allowance for PALs—suggesting that the lines remain fully collateralized and no specific credit‑loss allowance is required, even as the amount pledged has grown.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that by 2024, Schwab 'observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics.' The LLM answer claims '2024 filing does not show a separate allowance for PALs—suggesting that the lines remain fully collateralized and no specific credit-loss allowance is required,' which directly contradicts the ground truth that an allowance existed in 2024. (2) The LLM misinterprets the evolution of risk assessment: the ground truth indicates a shift from 'full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections,' meaning an allowance for credit losses WAS recorded in 2024. The LLM incorrectly concludes no allowance was required in 2024. (3) While the LLM correctly identifies that in 2021 no allowance was required due to full collateralization, it fails to capture the key change: that by 2024, despite full collateralization, Schwab did establish an allowance for credit losses reflecting improved credit quality metrics and lower projected loss rates. (4) The specific dollar amounts ($12.7B in 2021, $17.0B in 2024) appear reasonable but cannot be verified against the ground truth which does not provide these specific figures. (5) The multi-hop reasoning is flawed: the LLM assumes 'no separate allowance shown = no allowance required' when the ground truth indicates an allowance was actually recorded in 2024. The answer fundamentally misses the core evolution described in the ground truth—the shift from relying solely on collateralization to incorporating credit loss allowances based on improved credit quality assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 487,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "In the 2022 Form 10‑K Boeing disclosed that the 777X generated a “reach‑forward loss” that pushed cost‑of‑sales higher and that R&D on the model was cut, resulting in a $227 million drop in R&D expense in 2021 and lower spending on the 777X. By the 2024 filing the company was still recording reach‑forward losses on the 777X (and 767) but had reversed the R&D trend, increasing 777X development spend by $525 million in 2023 and another $435 million in 2024, reflecting a strategic shift to invest more heavily in the program’s eventual entry into service despite ongoing delivery‑delay and backlog‑impact concerns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key R&D investment figures ($525 million increase in 2023, $435 million increase in 2024) and accurately describes the strategic shift from cost burden to investment priority. However, there are significant issues: (1) The answer introduces information about a '$227 million drop in R&D expense in 2021' which is not part of the ground truth answer and appears to be extraneous or incorrect context that confuses the 2022-2024 timeline being asked about. (2) The answer correctly notes the 'reach-forward loss' in 2022 but then states the company was 'still recording reach-forward losses on the 777X (and 767)' in 2024, which is not addressed in the ground truth and may be inaccurate or unsupported. (3) The core narrative is sound: the program went from being a cost burden in 2022 to a strategic investment priority by 2024, with the specific R&D increases correctly cited. (4) The multi-hop reasoning is mostly correct - synthesizing the shift from negative financial impact to strategic priority across the 2022-2024 period. (5) The answer adds contextual details about 'delivery-delay and backlog-impact concerns' that, while potentially relevant, are not in the ground truth and may introduce unverified claims. The quantitative accuracy is reduced due to the introduction of the 2021 figure and unverified 2024 loss claims, while the core R&D numbers are correct. The qualitative reasoning about the strategic shift is sound, but the answer strays from the ground truth by adding unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 426,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab’s 2022 filing described PALs as a distinct bank‑loan segment and said the allowance for credit losses is estimated using a practical‑expedient that relies on the loans’ over‑collateralization and daily monitoring of collateral (see pages 76‑78). By 2024 the pledged‑asset‑line segment – the PALs portfolio – had expanded to roughly $17 billion (see page 141), and the company continued to apply the same collateral‑maintenance‑based practical‑expedient for its credit‑loss allowance, indicating consistent risk‑management while exposure grew.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key aspects of Schwab's PAL risk management evolution but has some gaps in completeness. STRENGTHS: (1) Accurately describes the 2022 practical expedient approach based on over-collateralization and daily collateral monitoring - this matches the ground truth. (2) Correctly identifies the 2024 PAL portfolio size at roughly $17 billion, which is a specific quantitative detail. (3) Properly notes the consistency of the collateral-maintenance-based practical expedient methodology across both years. (4) Correctly identifies PALs as a pledged-asset-line segment. WEAKNESSES: (1) The answer mentions the portfolio expanded to $17 billion by 2024 but does not address the 'slight decrease in 2023' mentioned in the ground truth, which is relevant to understanding the evolution. (2) The answer does not discuss the key finding about the overall decrease in allowance for credit losses as a ratio to year-end loans in 2024, or the improved credit quality metrics and lower projected loss rates that indicate reduced risk profile - these are important elements of how risk management evolved. (3) The answer focuses more on consistency of methodology rather than the evolution of risk profile (from the ground truth's emphasis on improved credit quality and reduced risk despite growth). QUANTITATIVE VERIFICATION: The $17 billion figure for 2024 PAL portfolio appears reasonable and specific. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information about methodology consistency across years and portfolio growth, but incompletely addresses the credit quality improvement aspect that represents the actual evolution in risk management. The answer is partially complete - it addresses methodology evolution but misses the credit quality/allowance ratio evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 507,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ reported a $45 million after‑tax gain on its British‑pound‑sterling net‑investment‑hedge notes in 2022, but the 2023 filing shows no gain or loss on those notes (‑ $0)【page_98】.  The move from a positive GBP‑related result to a neutral one indicates the company has largely eliminated or fully offset its exposure to the British pound, reflecting a tighter, more targeted foreign‑exchange risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims MDLZ reported a $45 million gain on GBP notes in 2022 with $0 in 2023, but the ground truth states the opposite - $3 million in 2022 and $45 million in 2023. This is a critical reversal of the year-to-year comparison. The LLM has inverted the timeline entirely. (2) METRIC CONFUSION: The LLM discusses 'after-tax gains/losses on net-investment-hedge notes' which appears to be a different metric than the 'value of British pound sterling notes' referenced in the ground truth. The LLM may be conflating gains/losses with holdings/values. (3) MULTI-HOP REASONING FAILURE: The question asks about how the VALUE changed from 2022 to 2023. The ground truth shows an increase from $3M to $45M (a 15x increase). The LLM's answer describes a movement from a $45M gain to $0, which is not the same metric and represents the opposite directional change. (4) INTERPRETATION ERROR: The LLM concludes the company 'eliminated or fully offset its exposure' based on moving to $0, but the ground truth indicates increased exposure (from $3M to $45M in holdings). The LLM's interpretation of risk management strategy is therefore backwards. (5) MISSING CONTEXT: The LLM fails to identify the actual magnitude of change ($3M to $45M) which is central to understanding the strategic shift. The answer demonstrates a fundamental misunderstanding of both the data and the question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 415,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 Form 10‑K Amgen reported that its $1 billion of 3.125 % 2025 notes were hedged with interest‑rate swaps that produced an effective floating rate of **LIBOR + 1.8 %** (see page 132). In the 2024 filing the same $1 billion of 3.125 % 2025 notes are still hedged for the full notional amount, but the swaps now reference **SOFR + 2.1 %** (see page 149). This shows Amgen consistently uses swaps to convert fixed‑rate debt to floating‑rate exposure and has transitioned its benchmark from LIBOR to SOFR, reflecting a proactive, market‑aligned approach to managing interest‑rate risk on this instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally contradicts the ground truth on a key factual claim. Ground truth states the 2022 filing showed a FIXED 3.125% rate with NO variable rate terms, while the 2024 filing revealed SOFR + 2.1%. However, the LLM claims the 2022 filing already disclosed LIBOR + 1.8% hedging swaps. This is a major factual error that changes the entire narrative of the comparison. The LLM's claim that Amgen 'consistently uses swaps' contradicts the ground truth's assertion of a 'shift from purely fixed-rate structure to floating-rate mechanism.' QUANTITATIVE ERRORS: (1) The LLM cites LIBOR + 1.8% for 2022, but ground truth specifies 3.125% fixed with no variable rate disclosure in 2022. (2) The LLM correctly identifies SOFR + 2.1% for 2024, matching ground truth. (3) Page references (132 vs 149) cannot be verified against ground truth but appear specific. REASONING ISSUES: The LLM's multi-hop synthesis is internally consistent but based on incorrect 2022 data. The conclusion about 'proactive market-aligned approach' and 'transition from LIBOR to SOFR' may be accurate IF the 2022 hedging disclosure is correct, but this contradicts the ground truth's explicit statement that 2022 showed no variable rate terms. COMPLETENESS: The LLM does address both years and attempts to explain the company's approach, but the fundamental factual error about what was disclosed in 2022 undermines the entire answer. The ground truth reveals a disclosure change (fixed to floating), while the LLM describes a benchmark change (LIBOR to SOFR) within an already-floating structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 440,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "In the 2022 filing Schwab described its commercial‑paper issuance program as one of several external‑financing tools—alongside uncommitted bank lines—and cautioned that a disruption in credit markets could make that source unavailable or costly (page 23). By the 2024 filing the program is still listed as part of its funding mix, but the company stresses that the rapid rise in short‑term rates and client cash outflows have pushed it to rely more on higher‑cost supplemental funding and that commercial‑paper access may be constrained by market conditions (page 16; see also the discussion of rising rates and supplemental funding in page 14).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Schwab's evolving reliance on its Commercial Paper Issuance Program between 2022 and 2024, correctly identifying: (1) the program's introduction in 2022 as one of several financing tools, (2) the cautionary language about credit market disruptions, (3) the shift by 2024 toward increased reliance on supplemental funding sources, and (4) the role of rising short-term interest rates and client cash outflows as drivers. The answer demonstrates sound multi-hop reasoning by synthesizing information across two filing years and connecting market conditions to funding strategy changes. However, there are some minor issues: (1) The LLM references 'uncommitted bank lines' while the ground truth mentions 'unsecured bank credit lines'—these are semantically similar but the LLM's phrasing is slightly less precise. (2) The LLM mentions 'page 23' and 'page 16' references, which cannot be verified against the ground truth and may be hallucinated page numbers—this is a minor concern but adds uncertainty. (3) The LLM could have been more explicit about the specific mechanism (client cash outflows outpacing maturities/paydowns) that necessitated supplemental funding, though it does mention 'client cash outflows.' (4) The answer correctly identifies that the program's role evolved from a potential tool to a more actively relied-upon mechanism, matching the ground truth's narrative arc. The quantitative accuracy is strong since no specific dollar amounts or percentages were required to be cited. The qualitative reasoning is sound, correctly synthesizing the relationship between market conditions, interest rates, and funding strategy evolution. Overall, the answer is substantially correct with minor omissions and potential page number inaccuracies that don't affect the core factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 500,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625 % notes that matured in 2022 were fully redeemed in 2021, leaving only the $1.4 bn 3.625 % notes due 2024 outstanding in 2022 (the balance sheet shows a $1,400 mm balance for the 2024 series and a “‑” for the 2022 series)【page_130】; the company hedged those 2024 notes with interest‑rate swaps at an effective LIBOR + 3.2 % in 2020‑2021【page_132】. By 2023 the swap rate had been reset to SOFR + 3.4 % while the notes remained outstanding【page_149】, and in 2024 the 3.625 % 2024 notes were repaid and the related $1.4 bn swap contracts were terminated【page_150】. This shows the firm’s strategy of retiring maturing fixed‑rate debt, using swaps to convert fixed coupons to floating‑rate exposure, and unwinding the hedges at maturity to manage interest‑rate risk and optimize financing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed information than the ground truth. Key strengths: (1) Correctly identifies the $1,400 million carrying value in 2022 and confirms full repayment in 2024; (2) Accurately traces the interest rate structure evolution from fixed 3.625% to floating SOFR-based rates; (3) Provides specific swap details (LIBOR + 3.2% in 2020-2021, SOFR + 3.4% by 2023) that enhance understanding; (4) Correctly identifies the 2024 maturity and repayment; (5) Demonstrates sound multi-hop reasoning by synthesizing information across multiple years and connecting debt management strategy to hedging practices. Minor considerations: (1) The ground truth states notes were 'replaced with floating interest rates tied to SOFR' which could be interpreted as the company issuing new floating-rate debt, while the LLM answer clarifies this was achieved through interest rate swaps on the existing fixed-rate debt - this is actually more precise; (2) The LLM provides additional context about the 2022 series redemption in 2021, which adds clarity; (3) All numeric values ($1.4bn, percentages) are accurate and properly formatted. The LLM answer goes beyond the ground truth by explaining the mechanics of how the fixed-to-floating conversion occurred (via swaps) and provides more granular timeline details, which strengthens rather than weakens the response. The debt management strategy interpretation is sound and well-supported by the specific facts presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 417,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "In the 2022 Form 10‑K Schwab said it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide,” and that any remaining funding commitments would be made only if certain conditions were met, with most of those commitments expected to be satisfied between 2022‑2025 (see 2022 p. 98). The 2024 filing (pages 17‑21) contains no VIE‑related disclosure, indicating that Schwab has not added new support commitments or altered its intent – the prior stance of providing no extra support and conditioning any funding on specific events remains unchanged (or the VIE exposure is no longer material).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims the 2024 filing contains 'no VIE-related disclosure' and concludes there is 'no shift' in Schwab's stance. However, the ground truth explicitly states that by 2024, Schwab's disclosures show a clear shift where the company 'now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity.' This is a material change from 2022. (2) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the evolution between 2022 and 2024. The ground truth shows: 2022 = 'did not provide or intend to provide' support; 2024 = 'may choose to provide' support under certain conditions. The LLM incorrectly concluded the stance 'remains unchanged.' (3) INCOMPLETE ANALYSIS - The LLM speculates that 'VIE exposure is no longer material' rather than acknowledging the actual shift in disclosure and intent regarding discretionary support. (4) MISINTERPRETATION OF ABSENCE - The LLM interprets the absence of certain disclosures as evidence of no change, when the ground truth indicates the 2024 filing actually contains different language reflecting a more proactive stance. The core answer is inverted from the correct conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 389,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "In 2022 MDLZ’s JDE Peet’s stake was still being “settled” – the company issued €300 million of zero‑interest exchangeable notes that could be redeemed for cash or JDE Peet’s shares 【page_45】 and recorded a large equity‑method gain of $740 million (and related transaction costs) on the investment 【page_46】, showing the deal’s direct impact on financing and earnings. By 2023 the firm frames the same investment as a source of “additional flexibility” that does not hurt its funding sources 【page_54】, and its balance‑sheet metrics reflect a stronger capital structure – total debt fell from $22.9 billion to $19.4 billion and the debt‑to‑capitalization ratio improved from 0.46 to 0.41 【page_55】, indicating the JDE Peet’s holding now bolsters liquidity rather than creating financing strain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) The ground truth describes a relationship classification change from 'Has_Stake_In' (2022) to 'Invests_In' (2023), but the LLM answer focuses entirely on financing mechanics (exchangeable notes, equity-method gains, debt metrics) without mentioning this core relationship reclassification. (2) The LLM introduces specific financial numbers (€300 million exchangeable notes, $740 million equity-method gain, $22.9B to $19.4B debt reduction, debt-to-capitalization ratios of 0.46 to 0.41) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific figures. (3) The LLM's framing around 'settlement' and exchangeable notes is not present in the ground truth, which focuses on the strategic reclassification and its implications for capital planning. (4) While the LLM correctly identifies that the investment shifted from creating strain to providing flexibility, it does so through a different analytical lens (debt metrics) rather than the ground truth's emphasis on relationship classification and strategic positioning. (5) The page citations (page_45, page_46, page_54, page_55) cannot be verified and suggest the model may be hallucinating specific document references. The answer demonstrates partial understanding of the evolution from constraint to flexibility, but fundamentally misses the core insight about relationship reclassification and provides unverified quantitative claims that contradict the ground truth's qualitative focus on strategic positioning and capital structure alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 464,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "In the 2022 filing the $1 billion of 3.125 % 2025 Notes were hedged with an interest‑rate swap that paid **LIBOR + 1.8 %** (see page 132). By the 2024 filing the same $1 billion of notes were hedged with a swap tied to **SOFR + 2.1 %** (see page 149), reflecting the shift from LIBOR to the SOFR benchmark and a modest increase in the spread.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the 2022 swap rate was 'LIBOR + 1.8%', but the ground truth explicitly states 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. This is a factual error - the LLM fabricated a specific rate (LIBOR + 1.8%) that was not in the source documents. (2) The 2024 rate of SOFR + 2.1% is correct and matches ground truth. (3) The notional amount of $1,000 million ($1 billion) is correct for both years. (4) MULTI-HOP REASONING - The LLM correctly identified the evolution from LIBOR to SOFR benchmark and noted the spread increase, which shows sound reasoning about the transition. However, this correct reasoning is undermined by the fabricated 2022 rate. (5) COMPLETENESS - The answer addresses the core question about how the strategy evolved, but does so with false information for the 2022 baseline. The ground truth indicates uncertainty/non-disclosure for 2022, which the LLM should have acknowledged rather than inventing a specific rate. (6) ENTITY ACCURACY - Correct identification of the 3.125% 2025 Notes, correct years (2022 vs 2024), correct benchmark shift (LIBOR to SOFR). The page references (132 and 149) cannot be verified but appear plausible. VERDICT: While the 2024 information and the overall narrative of the evolution are correct, the fabrication of the 2022 rate is a serious factual error that significantly undermines the answer's reliability. The answer should have stated that the 2022 rate was not explicitly disclosed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 422,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart’s equity investments measured using Level 2 inputs were valued at **$5.819 billion** at fiscal‑year end 2022 and fell to **$5.570 billion** at fiscal‑year end 2023.  This represents a decline of roughly **$249 million** (about $0.25 billion).【page_72】【page_71】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Verification of key facts: (1) FY2022 value: $5,819 million (stated as $5.819 billion) - CORRECT; (2) FY2023 value: $5,570 million (stated as $5.570 billion) - CORRECT; (3) Magnitude of change: $249 million decline - CORRECT (5,819 - 5,570 = 249). The answer properly converts between million and billion formats ($5,819M = $5.819B), which is an acceptable format variation. The calculation of the decline is accurate. The answer correctly identifies this as a 'decline' or 'fell,' which accurately characterizes the negative change. The multi-hop synthesis is sound - the model correctly extracted and compared values from two different fiscal years and calculated the difference. The answer is complete, addressing both the evolution (direction and magnitude of change) and the specific numerical values. Minor note: The LLM uses slightly different phrasing ('fell to' vs. 'decreased from') but this is semantically equivalent and actually more natural. The inclusion of page references adds credibility. The only minor consideration is that the original answer uses 'moderate decline' while the LLM uses 'roughly' to describe the magnitude, but both convey appropriate context for a $249M change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 357,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple’s description of the role of marketing has not changed. Both the 2023 and the 2024 Form 10‑K state that the Company “relies primarily on the innovative skills, technical competence and **marketing abilities** of its personnel” (page 6 of each filing), indicating a consistent view of marketing as a core driver of its success.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The question asks how Apple's characterization EVOLVED between 2023 and 2024, and the ground truth clearly documents a significant shift in language: from 'relies primarily' (2023) to 'depends heavily' (2024). The LLM explicitly states 'Apple's description of the role of marketing has not changed' and claims both filings use identical language ('relies primarily'), which is factually wrong. The ground truth demonstrates a deliberate evolution in emphasis—from 'relies primarily' to 'depends heavily'—reflecting stronger strategic importance. The LLM failed to identify this key linguistic and substantive change. Additionally, the LLM's citation of 'page 6 of each filing' cannot be verified as accurate from the ground truth provided. The LLM completely missed the multi-hop synthesis required: comparing the 2023 filing language with the 2024 filing language to identify the evolution. This is a critical failure on the core question being asked. The answer demonstrates a fundamental misunderstanding of the question's intent and provides incorrect information about the actual content of both filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 335,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "In 2022 Amgen still had a $1.4 billion interest‑rate‑swap hedge on the 3.625 % 2024 Notes that converted the fixed coupon to a floating LIBOR + 3.2 % rate (page 132). By the end of 2024 the swap had been terminated – the notional amount is shown as “‑” and no interest‑rate term is listed (page 149), after having been re‑priced to SOFR + 3.4 % in 2023. This drop to zero notional and the shift from LIBOR to SOFR before termination shows Amgen actively unwinds hedges as the debt matures and moves away from LIBOR‑based structures.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the 2022 position and interest rate structure. (1) WRONG 2022 AMOUNT: LLM states '$1.4 billion interest-rate-swap hedge' in 2022, but ground truth indicates the 2022 termination involved a $5.2 billion notional amount of swaps that were terminated and reentered. The $1.4 billion figure actually refers to the 2023 position, not 2022. (2) WRONG INTEREST RATE FOR 2022: LLM claims 'LIBOR + 3.2%' for 2022, but ground truth does not specify this rate for 2022 - it only mentions SOFR+3.4% for 2023. The LLM appears to have confused or misread the interest rate structure. (3) CORRECT 2024 POSITION: LLM correctly identifies that the notional amount dropped to $0 (shown as '-') by end of 2024, which matches ground truth. (4) CORRECT SOFR TRANSITION: LLM correctly notes the shift from LIBOR to SOFR and the repricing to SOFR+3.4% in 2023. (5) REASONING QUALITY: The LLM's interpretation about unwinding hedges as debt matures is sound and aligns with ground truth conclusions, but this correct reasoning is undermined by the factual errors in the specific numbers and rates cited. (6) MISSING CONTEXT: LLM fails to mention the 2022 termination and re-entry of the $5.2 billion swap agreements, which is a key part of understanding Amgen's hedging strategy evolution. The answer demonstrates partial understanding of the hedging strategy but contains material errors in the quantitative details that are critical to answering the question accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 427,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "In the 2022 filing Schwab said it had **incorporated TD Ameritrade Institutional’s iRebal customizable portfolio‑rebalancing solution into its offering for independent‑advisor clients** (2022 p. 4). By the 2023 filing the integration overview notes that **Schwab is still retaining iRebal as a core component of its unified platform for advisor clients** (2023 p. 6), indicating the tool has moved from an initial add‑on to a permanent, leveraged capability. This continued integration shows Schwab is strengthening its technology stack for RIAs, using iRebal to differentiate its Advisor Services and sharpen its competitive positioning in the RIA market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual reversal that contradicts the ground truth. The LLM states that in 2022 Schwab 'incorporated' iRebal and by 2023 it was 'retaining' it as a core component. This is backwards. The ground truth clearly indicates: (1) In 2022, Schwab was RETAINING iRebal (acknowledging its value but not fully integrating it), and (2) By 2023, Schwab had INCORPORATED iRebal as a core part of offerings (deeper integration). The LLM reversed this evolution trajectory, which is a major factual error that undermines the entire answer's credibility. MISSING CRITICAL CONTEXT: The LLM answer omits the significant quantitative context provided in the ground truth - the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to Schwab by 2023. This is material information that demonstrates the scale of the integration effort and strengthens the competitive positioning narrative. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to connect iRebal integration to competitive positioning, it fails to synthesize the broader integration context (asset transfers, account migrations) that the ground truth uses to support the competitive positioning argument. REASONING QUALITY: The LLM's reasoning about iRebal moving from 'add-on to permanent capability' is sound in concept, but is built on the reversed factual foundation, making the conclusion unreliable. The connection to competitive positioning is present but weakly supported without the quantitative context. CITATION ISSUES: The LLM provides specific page references (2022 p. 4, 2023 p. 6) but these cannot be verified and the content described contradicts the ground truth, suggesting potential hallucination of sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 489,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "In Apple’s 2023 Form 10‑K the iMac is only referenced as one of the desktop models in the Mac family (“desktops iMac, Mac mini, Mac Studio and Mac Pro”) with no specific product‑update discussion (see 2023 p. 4). By contrast, the 2024 Form 10‑K lists a new iMac among the first‑quarter product announcements, indicating that Apple is actively refreshing the iMac line in 2024 (see 2024 p. 24). This reflects a shift from a static product‑line mention in 2023 to a concrete, newly‑launched iMac offering in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the key evolution - iMac moved from a routine product-line mention in 2023 to a highlighted product announcement in 2024; (2) Accurately cites specific page references (2023 p. 4 and 2024 p. 24) showing detailed filing review; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly characterizes the 2023 treatment as part of the standard Mac family listing and the 2024 treatment as a first-quarter product announcement; (5) Accurately interprets the strategic significance of this shift as reflecting a product refresh/redesign. MINOR CONSIDERATIONS: The LLM answer uses slightly more specific language ('first-quarter product announcements' and 'newly-launched') compared to the ground truth's more general 'significant product announcement' and 'product refresh or redesign,' but this represents appropriate specificity rather than inaccuracy. The LLM provides concrete textual evidence ('desktops iMac, Mac mini, Mac Studio and Mac Pro') which strengthens the answer. All factual claims are verifiable and correct. The reasoning chain is sound: 2023 = routine mention → 2024 = highlighted announcement = strategic elevation. No calculation errors, no entity misidentification, and the answer directly addresses the evolution question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 390,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX’s $1 billion of 2.820 % notes that mature in 2051 were still on the balance sheet in the 2022 filing (the long‑term‑debt schedule shows a $1 bn balance for those notes)【page_94】and were unchanged at $1 bn in the 2024 filing【page_89】. The company has neither retired nor refinanced this low‑coupon, 30‑year issue, indicating that RTX deliberately retains a sizable, low‑cost, long‑dated tranche of debt as a stable pillar of its overall long‑term debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1 billion principal balance of the 2.820% Notes Due 2051 in both 2022 and 2024, accurately noting no repayment or refinancing occurred. The characterization of this as a 'low-cost, long-dated tranche' and 'stable pillar' of debt structure is semantically sound and aligns with the ground truth's conclusion about stability. WEAKNESSES: (1) The LLM answer is significantly incomplete - it fails to address the broader long-term debt structure evolution that is central to the question. The ground truth explicitly states total principal long-term debt increased from $40,078 million (2022) to $41,146 million (2024), representing a $1,068 million increase. This is critical context for understanding how the 2.820% Notes fit within RTX's overall debt strategy. (2) The LLM does not synthesize the multi-hop relationship: that while the specific notes remained static, RTX's total debt burden expanded significantly through other issuances. This is a key insight about the company's long-term debt structure evolution. (3) The answer lacks quantitative depth - it provides no numbers on the broader debt portfolio changes, which the question explicitly asks about ('what does this indicate about the company's long-term debt structure'). (4) The LLM provides page references but no supporting data on the total debt figures. CALCULATION VERIFICATION: The $1 billion figure is correct for both years. However, the absence of the $40,078M→$41,146M debt growth analysis represents a major gap in answering the second part of the question about what this indicates about long-term debt structure. The answer reads more as a partial response focused only on the specific notes rather than a comprehensive analysis of how this relates to RTX's broader debt evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 490,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "In the 2022 Form 10‑K Schwab reported that the amended Inter‑Depository Agreement (IDA) lowered the service fee on client cash held at the TD Depository Institutions from 25 basis points to 15 basis points. By the 2023 filing, Schwab said the IDA (and related inter‑company loans) had been re‑based off LIBOR to alternative reference rates as part of its LIBOR transition, completing the rate‑adjustment change while the fee level remained at the 15‑basis‑point amount introduced in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Schwab's IDA agreement evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the service fee reduction from 25 basis points to 15 basis points is accurately stated, and the years (2022 and 2023) are correctly identified. ENTITY ACCURACY: All entities are correctly identified - Schwab, the IDA (Inter-Depository Agreement), TD Depository Institutions, LIBOR, and alternative reference rates are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly identifying the 2022 fee structure change and the 2023 reference rate transition. The logical progression from fee adjustments to rate mechanism changes is sound. COMPLETENESS: The answer addresses both key aspects of the question - service fees (25 to 15 basis points) and reference rate adjustments (LIBOR to alternatives). The additional detail that the fee remained at 15 basis points in 2023 while rates were adjusted adds helpful context. SEMANTIC EQUIVALENCE: The LLM's phrasing 're-based off LIBOR to alternative reference rates' effectively conveys the same meaning as the ground truth's 'transitioned reference rates previously tied to LIBOR to other appropriate benchmarks.' The characterization of this as part of 'LIBOR phase-out preparation' vs 'LIBOR transition' is semantically equivalent. MINOR OBSERVATION: The LLM includes a parenthetical reference to 'related inter-company loans' which is not explicitly mentioned in the ground truth, but this appears to be accurate contextual information that doesn't contradict the original answer. Overall, the answer is factually accurate, well-synthesized across the two-year period, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 499,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "In 2023 Colgate‑Palmolive still treated Filorga as a separate reporting unit, carrying $221 million of goodwill and testing that unit’s fair value on its own (see 2023 Note 13, page 59). By 2024 the brand is simply listed among a long list of global trademarks (see 2024 Nature of Operations, page 79) with no distinct goodwill disclosed, indicating the company has folded Filorga into a broader brand portfolio and now values it as part of an aggregated trademark segment rather than as a stand‑alone, strategically‑critical unit. This shift suggests a reduced emphasis on Filorga’s independent strategic weight and a move to a more consolidated valuation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Filorga's changing financial treatment. QUANTITATIVE ACCURACY: All numeric values are correct - $221 million goodwill in 2023 is accurately cited, and the years 2023 and 2024 are correctly identified. The answer properly references specific document locations (2023 Note 13, page 59; 2024 Nature of Operations, page 79), which adds credibility. ENTITY ACCURACY: Correctly identifies Colgate-Palmolive as the parent company and Filorga as the brand in question. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, comparing the 2023 standalone reporting unit status with the 2024 consolidated approach. The logical progression from 'separate reporting unit with distinct goodwill' to 'listed among other trademarks without separate disclosure' is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insights as the ground truth: (1) 2023 showed Filorga as a distinct, strategically important unit with $221M goodwill, (2) 2024 shows integration into broader segments, (3) this suggests reduced strategic emphasis and consolidated valuation. The phrase 'folded Filorga into a broader brand portfolio' effectively captures the consolidation concept. MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention 'divestiture, investment, or brand prioritization' as potential future strategic implications, but this is a minor omission that doesn't affect the core correctness. The answer is well-structured, cites sources appropriately, and demonstrates clear understanding of the financial reporting changes and their strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 475,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "In the 2023 Form 10‑K the iPhone discussion is limited to aggregate net‑sales (see 2023 page 26, which mentions only “iPhone net sales” without naming any specific model), whereas the 2024 Form 10‑K explicitly lists the iPhone 16 Pro in the product description (2024 page 4) and announces its launch in the fourth‑quarter product rollout (2024 page 24). This change shows Apple moving from a generic, historical‑sales focus to a forward‑looking strategy that highlights a new generation iPhone, reflecting both the development of the iPhone 16 Pro line and a more detailed, product‑specific reporting approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The ground truth states that in the 2023 10-K, Apple ANNOUNCED the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup (forward-looking), and by 2024 10-K it was listed among existing products (retrospective). The LLM answer reverses this logic, claiming the 2023 10-K had only 'aggregate net-sales' without specific models, while the 2024 10-K 'announces its launch' - this is backwards. The iPhone 16 Pro should have been announced/forward-looking in 2023, not 2024. (2) PAGE REFERENCES: The LLM cites specific pages (2023 page 26, 2024 pages 4 and 24) but these cannot be verified and appear to be fabricated details that don't align with the ground truth narrative. (3) CONCEPTUAL MISUNDERSTANDING: The ground truth emphasizes a transition from 'planning/launch phase' (2023) to 'established product' (2024), showing product lifecycle maturation. The LLM incorrectly frames this as moving from 'historical-sales focus' to 'forward-looking strategy,' which is the opposite of what actually occurred. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal relationship between the two filings and the product's lifecycle stage. The answer demonstrates a fundamental misunderstanding of the question's core premise about how disclosure evolved between years. (5) MISSING KEY INSIGHT: The ground truth's key point about the shift from 'forward-looking product planning in 2023 to retrospective inclusion in 2024' is entirely absent from the LLM response, which instead inverts this relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 448,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "In 2022 Schwab’s EVE simulations were a largely static, theoretical exercise that applied instantaneous interest‑rate shifts to a balance‑sheet snapshot built on historical asset‑liability behavior, using proprietary and third‑party term‑structure, pre‑payment and cash‑run‑off models with key assumptions such as rate‑floor scenarios, pre‑payment speeds, non‑maturity deposit behavior and pricing. By 2023 the firm had refined the framework – adding interest‑rate swap derivatives into the EVE analysis, updating deposit‑beta and liability‑duration assumptions to reflect a shortening liability duration as rates rose, and explicitly modeling client‑cash allocation changes – while still relying on the same mix of internal and external models.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the company as Schwab (though not explicitly stated in original answer, this is contextually appropriate); (2) Accurately captures the 2022-2023 timeframe comparison; (3) Correctly identifies key 2022 assumptions including prepayment speeds, non-maturity deposit behavior, and rate-floor scenarios; (4) Accurately notes the 2023 expansion to include client cash allocation changes; (5) Correctly identifies deposit beta assumption updates in 2023. WEAKNESSES: (1) The LLM introduces 'interest-rate swap derivatives' as a 2023 addition to EVE analysis - this specific detail is NOT mentioned in the ground truth answer and cannot be verified; (2) The LLM describes 2022 EVE as 'largely static, theoretical exercise' with 'instantaneous interest-rate shifts' - while this characterization may be reasonable, it adds interpretive language not explicitly in the ground truth; (3) The LLM mentions 'shortening liability duration as rates rose' - this is a specific directional claim about balance sheet dynamics that is not explicitly confirmed in the ground truth; (4) The LLM states the company 'still relying on the same mix of internal and external models' - this continuity claim is not addressed in the ground truth. MULTI-HOP REASONING: The answer does synthesize information across 2022 and 2023, showing evolution in modeling approach. However, it introduces details (swap derivatives, specific duration changes) that go beyond what the ground truth confirms. The core evolution (static to dynamic, addition of client cash allocation modeling, deposit beta updates) is captured correctly. SEMANTIC EQUIVALENCE: The answer conveys similar information about the evolution but adds interpretive details and specific technical elements not in the ground truth, which creates uncertainty about factual accuracy versus inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 528,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "In 2022 Qualcomm’s role in the Wi‑Fi market was largely that of an enabler – it supplied the core Wi‑Fi, Bluetooth and WLAN chipsets and licensed the underlying patents that let other OEMs build access‑point equipment 【page_10】. By fiscal 2023 the company had moved up the value chain and began offering complete wireless‑access‑point and router solutions as part of a broader networking portfolio that now also includes Ethernet, PON chips, network processors and broadband‑gateway equipment 【page_12】. This shift gives Qualcomm a stronger competitive position by capturing more of the networking‑hardware value chain and broadening its product breadth across the entire networking market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022-2023 strategic shift from enabling/supplying chipsets to direct production of wireless access points and routers. (2) Accurately characterizes 2022 role as providing foundational technologies (Wi-Fi, Bluetooth, WLAN chipsets) and patents rather than finished products. (3) Properly identifies the expanded 2023 product portfolio including Ethernet, PON chips, network processors, and broadband-gateway equipment. (4) Correctly synthesizes the competitive positioning implications - moving up the value chain to capture more of the networking hardware value chain and compete more directly with players like Broadcom and Intel. (5) Multi-hop reasoning is sound: connects the strategic shift to portfolio breadth expansion to competitive positioning. (6) No quantitative errors - dates (2022/2023, fiscal 2023) are correct. (7) Entity identification is accurate (Qualcomm, Broadcom, Intel, Wi-Fi/WLAN technologies). MINOR CONSIDERATIONS: The LLM answer provides slightly more specific product details (Ethernet, PON chips, broadband-gateway equipment) compared to the ground truth's more general reference to 'network processors' and 'routers,' but this represents appropriate elaboration rather than error. The semantic meaning and factual content align well with the ground truth. The answer effectively addresses both parts of the question: competitive positioning (moving up value chain, stronger position) and product portfolio breadth (expanded from chipsets to complete solutions across networking market).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 451,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Schwab’s HELOC product showed essentially no shift in its interest‑only profile. In both 2022 and 2023, roughly 27 percent of the adjustable‑rate mortgage balance was interest‑only, and about 86 percent of those interest‑only loans were not scheduled to reset for three or more years, indicating a stable interest‑only payment structure across the two years【page_93†L1-L4】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) 2022 METRICS - Ground truth states 28% of ARM were interest-only in 2022, but LLM claims 'roughly 27 percent' for both years, missing the 1 percentage point difference. (2) 2023 METRICS - Ground truth states 89% of interest-only loans not scheduled to reset for 3+ years in 2022, but LLM claims 'about 86 percent' for both years, missing the 3 percentage point difference. (3) CORE CLAIM ERROR - LLM states 'essentially no shift' and 'stable' structure across both years, but ground truth explicitly documents a decline from 28% to 27% in interest-only ARM percentage AND a decline from 89% to 86% in the reset-protected portion. This is a material mischaracterization of the evolution. (4) INCOMPLETE SYNTHESIS - The LLM failed to properly synthesize the year-over-year comparison, collapsing 2022 and 2023 data into a single 'both years' statement rather than showing the documented changes. (5) REASONING FLAW - The conclusion of 'stability' directly contradicts the documented decreases in both metrics. The answer demonstrates poor multi-hop reasoning by failing to properly compare the two years' data points. While the LLM correctly identified the company (Schwab), product (HELOC), and general metrics (interest-only percentages and reset schedules), the specific numerical values and the characterization of change are fundamentally incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 407,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "In the 2022 Form 10‑K Qualcomm explicitly said its QSI (Qualcomm Ventures) unit was making “strategic investments … in … XR” as part of its early‑stage portfolio (see page 14). By the 2023 filing, XR is no longer called out as a separate investment focus; it is folded into the broader IoT product line, and the IoT segment (which includes XR) fell from $7.353 billion in 2022 to $5.94 billion in 2023 (see page 73), showing that Qualcomm’s XR involvement shifted from a highlighted venture‑investment push to a modest, declining revenue contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth states that by 2023, XR was 'explicitly listed among the industries and applications for which Qualcomm sold products,' indicating a shift TO commercialization and direct revenue. The LLM answer incorrectly claims XR 'is no longer called out as a separate investment focus' and was 'folded into the broader IoT product line,' which misrepresents the evolution. (2) The LLM provides specific revenue numbers ($7.353 billion in 2022 declining to $5.94 billion in 2023 for IoT) but these appear to be unsupported by the ground truth and may be inaccurate. The ground truth does not mention these specific figures or attribute them to XR revenue. (3) The LLM's interpretation that XR became a 'modest, declining revenue contribution' contradicts the ground truth's narrative of evolution from investment to commercialization. (4) The LLM correctly identifies Qualcomm Ventures (QSI) involvement in 2022 with XR investments, which aligns with ground truth. (5) However, the characterization of 2023 as showing XR 'folded into IoT' and declining is not supported by the ground truth, which emphasizes XR becoming explicitly listed as a product revenue source. The multi-hop reasoning is flawed because it misinterprets the nature of the evolution (from investment to commercialization) as a decline or de-emphasis. The answer partially addresses the question but reaches incorrect conclusions about the direction and nature of Qualcomm's XR involvement evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 434,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The 3.030 % notes due 2052 carried an aggregate principal balance of **$1.1 billion at year‑end 2022** (see the 2022 10‑K table where the first column lists $1,100 million) and the same **$1.1 billion at year‑end 2023 and 2024** (the 2024 10‑K shows $1,100 million for both years). The unchanged balance indicates that RTX has left this long‑dated issuance untouched, making it a stable, long‑term anchor in its debt portfolio and contributing to a diversified maturity schedule that extends well beyond the next decade.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $1,100 million ($1.1 billion) for 2022, 2023, and 2024. The format variation ($1.1 billion vs $1,100 million) is appropriately handled and semantically equivalent. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the balance evolved (remained stable at $1.1B across all three years), and (2) what this indicates about RTX's long-term debt structure. ENTITY ACCURACY: Correct identification of RTX, the specific debt instrument (3.030% Notes Due 2052), and all relevant fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and documents (2022 10-K and 2024 10-K) to establish the stability pattern. REASONING QUALITY: The interpretation is sound - the unchanged balance indicates strategic consistency and stability in the debt portfolio. The additional context about it being a 'stable, long-term anchor' and contributing to 'diversified maturity schedule' adds valuable insight beyond the ground truth, which is appropriate elaboration. MINOR DIFFERENCES: The LLM answer includes 2023 data (which wasn't explicitly mentioned in the ground truth but is factually correct and adds completeness), and provides slightly more detailed interpretation about the debt portfolio's role. These are enhancements rather than errors. The answer demonstrates clear understanding of the multi-hop synthesis required and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 427,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "In the 2023 filing American Express said it would “evolve our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions” as a key part of its commercial‑payments focus【page_8】. By the 2024 filing the language expands to “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating the corporate‑card is now being woven into a broader suite of financial services【page_8】. This shift suggests AXP is moving from simply enhancing its corporate‑card product to building a more integrated, end‑to‑end commercial‑payments platform for business customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. STRENGTHS: (1) Correctly identifies the 2023 focus on 'evolving card value propositions' and differentiating 'corporate card and accounts payable expense management solutions' - exact quote match with ground truth. (2) Accurately captures the 2024 shift toward 'designing innovative products and features, including financing, banking and payment solutions for our business customers' - again matching the ground truth language. (3) Properly synthesizes the multi-hop comparison between 2023 and 2024 filings, showing clear evolution from product differentiation to integrated solutions. (4) Correctly identifies AXP as the company in question. (5) The reasoning about moving from 'simply enhancing corporate card product' to 'integrated, end-to-end commercial payments platform' is logically sound and semantically equivalent to the ground truth's characterization of 'expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services.' (6) No quantitative errors - no numbers, dates, or calculations are present that could be incorrect. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('woven into' vs 'embedding,' 'end-to-end commercial payments platform' vs 'holistic commercial needs') but these are semantic variations that enhance clarity rather than detract from accuracy. The citation references (page_8) add credibility though they cannot be independently verified in this context. The answer fully addresses both parts of the multi-part question (evolution between years AND what it suggests about strategy).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 460,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K, PCA SKIN is listed among the global brands that sit in the Oral, Personal and Home Care segment, and the segment’s products are described as being sold “primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals,” with “some … sold direct‑to‑consumer” (2023 & 2024 Nature of Operations, p. 79). The language is unchanged, showing that PCA SKIN’s strategic positioning stayed the same – a skin‑health brand marketed through the same mix of traditional retail/professional channels and an expanding e‑commerce/direct‑to‑consumer channel – between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the key finding. The ground truth states that PCA SKIN's distribution channels EXPANDED between 2023 and 2024 to specifically include 'sales to skin health professionals in some geographies' as a NEW addition. The LLM answer claims 'the language is unchanged' and that positioning 'stayed the same,' which is factually incorrect according to the knowledge graph. This is a fundamental misreading of the multi-hop comparison task. The LLM correctly identifies that PCA SKIN is listed as a principal trademark in both years and correctly cites the distribution channels (retailers, wholesalers, distributors, dentists, skin-health professionals, direct-to-consumer), but FAILS to recognize the evolution/refinement that occurred. The ground truth explicitly states this represents 'a refinement in positioning PCA SKIN within more specialized skincare distribution channels,' indicating a strategic shift. The LLM's conclusion that there was no change between 2023 and 2024 is the opposite of what the ground truth indicates. While the LLM provides accurate page references and correctly identifies the segment and brands involved, it fundamentally fails the core analytical task of identifying how the positioning evolved. The quantitative accuracy is high (correct years, correct segment identification, correct channel names), but the qualitative reasoning is severely flawed because it missed the key distinction between 2023 and 2024 positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 422,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "In 2022 Opdivo was already marketed across a broad set of cancers (bladder, CRC, head‑and‑neck, RCC, HCC, lung, melanoma, MPM, stomach) and its Opdivo + Yervoy combos were highlighted as growth engines, while the company emphasized ongoing registrational studies to push Opdivo into earlier lines and new tumor types (​page 71​). By 2023 the pipeline translated into concrete approvals – adjuvant treatment of stage IIB/IIC melanoma in the U.S. and EU, neoadjuvant resectable NSCLC with platinum‑based chemotherapy in the EU and Japan, and a move toward a fixed‑dose Opdivo + Yervoy (Opdualag) – reflecting a sharpened focus on earlier‑line, adjuvant and neoadjuvant indications and additional combos (​page 42​, ​page 43​). Those new labels have made Opdivo a key growth driver, helping offset the company’s overall revenue decline in 2023 and positioning the product for incremental revenue expansion as the new indications mature (​page 41​, ​page 45​).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 baseline indications (bladder, CRC, head-and-neck, RCC, HCC, lung, melanoma, MPM, stomach) matching the ground truth; (2) Accurately captures the Opdivo + Yervoy combination as a growth engine in 2022; (3) Correctly identifies specific 2023 approvals including adjuvant melanoma (stage IIB/IIC), neoadjuvant resectable NSCLC, and the fixed-dose Opdualag combination; (4) Properly synthesizes the strategic evolution from 2022 to 2023, showing progression from ongoing studies to concrete approvals; (5) Correctly identifies the shift toward earlier-line, adjuvant, and neoadjuvant indications; (6) Appropriately contextualizes revenue implications, noting Opdivo as a growth driver offsetting overall revenue decline in 2023. MINOR GAPS: (1) The ground truth mentions 'blood cancers' as an approved indication in 2022, which the LLM answer omits (though this is a minor omission); (2) The ground truth explicitly mentions the subcutaneous formulation as a strategic element for enhancing patient benefits and driving adoption, which the LLM answer does not address; (3) The LLM answer references specific page numbers from filings, which adds credibility but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, correctly identifying the progression of approvals and strategic shifts. The connection between new indications and revenue growth trajectory is properly established. QUANTITATIVE ACCURACY: No specific financial figures are provided in either answer, so this dimension is not directly testable. The temporal progression (2022 to 2023) is correctly maintained. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same strategic narrative as the ground truth, with slightly different emphasis and organization but equivalent core content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 538,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express’s foreign‑government bond portfolio slipped slightly in value, from an estimated fair value of **$770 million in 2023** to **$765 million in 2024** (a $5 million decline).  The maturity mix stayed almost entirely short‑term: in 2023, **$768 million** was due within one year and **$2 million** in the 1‑to‑5‑year bucket; in 2024 it was **$764 million** due within one year and **$1 million** in the 1‑to‑5‑year bucket, with no holdings beyond five years.【page_119】【page_120】【page_124】【page_126】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) 2023 Fair Value: LLM states $770 million, but ground truth shows $549 million - a $221 million error (40% overstatement). (2) 2023 Maturity Distribution: LLM claims $768 million due within one year and $2 million in 1-5 year bucket, but ground truth states ALL $549 million matured in 12 months or more (meaning 0 within one year). This is a fundamental mischaracterization of the 2023 portfolio. (3) 2024 Fair Value: LLM correctly states $765 million (matches ground truth). (4) 2024 Maturity Distribution: LLM correctly states $764 million within one year and $1 million in 1-5 year bucket (matches ground truth). (5) Trend Analysis: LLM describes a $5 million decline from 2023-2024, but the actual change was a $216 million INCREASE ($549M to $765M). The LLM also completely misses the critical insight that the portfolio shifted from long-term maturities (2023) to predominantly short-term maturities (2024). The answer demonstrates poor multi-hop synthesis - while it correctly identifies 2024 data, it fundamentally misrepresents 2023 data and therefore fails to accurately characterize the evolution between years. The reasoning about 'short-term maturity mix' is partially correct for 2024 but entirely wrong for 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 375,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "In 2022 Walmart reported that about $4.3 billion of its cash and cash equivalents could not be freely transferred to the United States, and roughly $2.2 billion of that amount could be accessed only through dividends or inter‑company financing arrangements that required approval of Flipkart’s minority shareholders【page_60】. By fiscal 2024 the non‑transferable balance had fallen to about $3.5 billion, and any repatriation is now limited by local laws or other restrictions and may require the approval of the non‑controlling‑interest shareholders rather than a specific Flipkart‑shareholder vote【page_43】. The company continues to rely on inter‑company financing to move cash where needed at minimum cost, but the pool of restricted cash has shrunk and the approval mechanism has broadened.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Walmart's intercompany financing arrangements and provides relevant context about the evolution between 2022 and 2024. However, there is a critical quantitative discrepancy: The LLM states the 2024 non-transferable balance was '$3.5 billion,' while the ground truth specifies '$3.3 billion.' This is a material difference of $200 million that affects the accuracy of the comparison. The 2022 figures are correct ($4.3 billion total, $2.2 billion subject to Flipkart minority shareholder approval). The LLM correctly identifies the shift from Flipkart-specific approval language to broader noncontrolling interest shareholder approval, which is an important qualitative evolution. The reasoning about the shrinking pool of restricted cash and broadened approval mechanism is sound and well-articulated. The multi-hop synthesis across years and the identification of the structural shift in intercompany financing arrangements demonstrates good qualitative reasoning. However, the quantitative error in the 2024 figure is significant enough to lower the overall correctness score, as financial precision is critical in SEC filing analysis. The answer would have been 8-9 if the 2024 number had been correct ($3.3 billion instead of $3.5 billion).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 362,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "In 2023 the U.S. Retiree Health Care Plan held $210 million of fixed‑income securities and cash equivalents and $54 million of equity securities – roughly 80 % fixed income and 20 % equity of a $264 million total (page 46). By the 2024 filing those balances had slipped to $198 million and $50 million respectively, still about 80 %/20 % of the $248 million portfolio (page 46), and the weighted‑average allocation percentages remained unchanged at 80 % fixed income and 20 % equity (page 48).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. The ground truth explicitly states that the composition remained 'completely unchanged' between 2023 and 2024 filings, with identical figures: $210M fixed income and $54M equity in both years, totaling $264M. However, the LLM claims significant changes occurred: (1) Fixed income decreased from $210M to $198M (a $12M reduction), (2) Equity decreased from $54M to $50M (a $4M reduction), (3) Total portfolio decreased from $264M to $248M (a $16M reduction). These are all factually incorrect according to the ground truth. The LLM's statement that 'those balances had slipped' directly contradicts the ground truth's assertion of no evolution. While the LLM correctly identifies the 2023 figures ($210M fixed income, $54M equity, $264M total, ~80%/20% allocation), it introduces entirely fabricated 2024 figures that do not match the actual filing data. The percentage allocations (80%/20%) happen to be approximately correct for both years, but this is coincidental given the wrong dollar amounts for 2024. The question asks specifically about how the composition 'evolved,' and the correct answer is that it did not evolve at all - it remained static. The LLM's answer suggests material changes that never occurred, representing a critical failure in multi-hop synthesis and factual accuracy. The contextual relevance score reflects that the LLM at least attempted to address the right question and company, but the execution is severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 418,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2006 Stock Plan for Non‑Employee Directors was shown to provide a **Form of Option Agreement** (Exhibit 10.29) and an **Omnibus Amendment to that Option Agreement** (Exhibit 10.30) 【page_123】. The 2024 filing still lists those same two award forms, but also includes updated amendment exhibits (10.27‑10.28) that revise the plan’s terms, indicating Honeywell is refining the existing option‑award language rather than adding new award types—suggesting a modest modernization of its non‑employee director compensation structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) EXHIBIT NUMBER ERRORS: The LLM claims the 2022 filing showed 'Form of Option Agreement' as Exhibit 10.29 and 'Omnibus Amendment' as Exhibit 10.30, but the ground truth states it was 'Form of Option Agreement' (Exhibit 10.30) and 'Form of Restricted Unit Agreement' (Exhibit 10.32). The LLM has misidentified both the exhibit numbers and the second award type entirely. (2) MISSING KEY EVOLUTION: The ground truth explicitly identifies that the 'Form of Restricted Unit Agreement' (Exhibit 10.32) was present in 2022 but NO LONGER explicitly mentioned in 2024. This is the core finding about the evolution of the plan. The LLM completely fails to identify this critical change—the shift away from restricted units toward options. (3) INCORRECT CHARACTERIZATION: The LLM claims both award forms were 'still listed' in 2024, which is factually wrong. The ground truth shows the restricted unit agreement was removed from the exhibit list. (4) WRONG CONCLUSION: The LLM concludes Honeywell is 'refining existing option-award language' and 'not adding new award types,' which misses the actual story: a shift away from restricted units. The ground truth explicitly states this 'suggests a shift in the types of equity awards offered' and 'a strategic move toward emphasizing stock options over restricted units.' (5) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the 2022 vs. 2024 comparison, which is the core multi-hop requirement of the question. The answer demonstrates fundamental misunderstanding of the exhibit structure and the actual changes between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 458,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "In the 2022 filing Walmart said it raised about $3.2 billion by selling a minority portion of its Flipkart holding, cutting its ownership from roughly 83 % to about 75 % and thereby monetizing part of the investment. By the 2024 filing the company still holds a majority stake, but it is now confronting Indian regulatory scrutiny—a Directorate of Enforcement foreign‑direct‑investment show‑cause notice and a Competition Commission of India antitrust investigation—so the remaining stake carries exposure to possible fines, share‑ownership restrictions or other relief that cannot be quantified. This marks a shift from cash‑generating divestiture to managing heightened legal and regulatory risk on the residual ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts: $3.2 billion equity funding in 2022, ownership reduction from 83% to 75%, and that Walmart maintained majority control. The timeline (2022 to 2024) is accurate. The characterization of the shift from financial participation to managing regulatory risks is semantically sound. WEAKNESSES: (1) The LLM introduces a 'Competition Commission of India antitrust investigation' that is NOT mentioned in the ground truth answer. The ground truth specifically references only the Directorate of Enforcement show cause notice (July 2021) and information requests related to FDI violations during 2009-2015. This is a factual error—adding regulatory scrutiny not supported by the source material. (2) The LLM mentions 'Directorate of Enforcement foreign-direct-investment show-cause notice' which is somewhat awkwardly phrased compared to ground truth's clearer reference to 'show cause notice issued in July 2021' related to FDI rules. (3) The LLM omits the specific temporal context that the regulatory issues relate to pre-acquisition violations (2009-2015, before Walmart's 2018 acquisition), which is an important detail in the ground truth explaining why Walmart faces legacy risks. (4) The LLM omits the specific mention of 'indemnification proceeds from prior shareholders' which is a material detail about Walmart's exposure. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2022-2024 and connects financial actions to regulatory consequences. However, the introduction of the CCI investigation represents a synthesis error—adding information not in the ground truth. CALCULATION/NUMBERS: All numeric values are correct (83%, 75%, $3.2 billion). The characterization of the transaction as a 'minority portion' sale is accurate. OVERALL: Core facts are mostly correct, but the introduction of unsupported regulatory details (CCI investigation) and omission of important contextual elements (pre-acquisition timing, indemnification) prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 549,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "In the 2022 filing Honeywell noted that its liquidity strategy for U.S. cash balances was “primarily safety of principal and secondarily maximizing yield” and that it diversified cash among counterparties, reporting $11.5 billion of cash‑and‑cash‑equivalents (including short‑term investments) as of Dec. 31 2021 (the most recent figure disclosed)【page_41】. By the 2024 filing total cash‑and‑cash‑equivalents had slipped slightly to $11.0 billion, but the company disclosed that $8.0 billion of those funds were held in non‑U.S. subsidiaries—leaving roughly $3.0 billion in U.S. cash—while reiterating the same safety‑first, yield‑second, diversification emphasis【page_39】. This reflects a shift toward a larger overseas cash pool while maintaining the same strategic focus on protecting principal and optimizing yield.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key numbers are correct - $11.5 billion cash as of Dec 31, 2021 (from 2022 filing), $11.0 billion as of Dec 31, 2024 (from 2024 filing), $8.0 billion held in non-U.S. subsidiaries, and the implied $3.0 billion in U.S. cash ($11.0B - $8.0B). The arithmetic is accurate. ENTITY ACCURACY: Correctly identifies HON (Honeywell), proper fiscal year references (2022 filing reporting 2021 year-end data, 2024 filing reporting 2024 year-end data), and appropriate financial metrics. MULTI-HOP REASONING: Excellent synthesis across two separate filings showing the evolution of cash composition and geographic distribution. The answer correctly identifies the strategic shift toward larger overseas positioning while maintaining consistent strategic principles. STRATEGIC EMPHASIS: Accurately captures the 'safety of principal' and 'diversification among counterparties' emphasis from both periods, with proper characterization of the yield-secondary approach. MINOR CONSIDERATIONS: The LLM adds interpretive language like 'slipped slightly' and 'shift toward a larger overseas cash pool' which, while reasonable inferences from the data, go slightly beyond the ground truth's more neutral presentation. However, these characterizations are logically sound and don't contradict the facts. The inclusion of page references adds credibility. The answer fully addresses both components of the question: composition evolution (total cash holdings) and geographic distribution changes. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 448,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "In the 2023 filing American Express recorded a separate “deferred card and other fees, net” line of $3.4 billion that bundled deferred acquisition costs and cancellation reserves for Membership Rewards participants, and it estimated the rewards liability by applying a weighted‑average cost per point (WAC) and an ultimate redemption rate (URR) derived from statistical‑actuarial models of redemption trends, spend, tenure and credit attributes. The 2024 filing still bases the Membership Rewards liability on the same WAC‑and‑URR methodology, but it now discloses the sensitivity of the liability (e.g., a 25‑bp URR change would add $197 million; a 1‑bp WAC change would add $220 million) and no longer shows a distinct net deferred‑fees balance for the program, suggesting the deferred acquisition‑cost and cancellation‑reserve amounts have been integrated into other liability presentations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed information than the ground truth in several respects. STRENGTHS: (1) All quantitative values are correct: $3.4 billion deferred fees in 2023, $197 million sensitivity for 25 bp URR change, $220 million sensitivity for 1 bp WAC change. (2) The core methodology is accurately described: WAC and URR-based approach using statistical-actuarial models. (3) The evolution narrative is sound: 2023 showed simpler deferred fees presentation, 2024 shows more detailed sensitivity disclosures. (4) The observation about integration of deferred acquisition costs and cancellation reserves into other liability presentations adds valuable context not explicitly in the ground truth. (5) Multi-hop synthesis is correct - properly connects 2023 and 2024 filings with specific metrics. MINOR CONSIDERATIONS: (1) The LLM provides additional detail about the 2023 methodology (mentioning WAC and URR were already used in 2023) that goes slightly beyond the ground truth's characterization of 2023 as showing 'simpler mention of deferred fees.' However, this is not contradictory - it's an enhancement showing the methodology existed in 2023 but was less transparently disclosed. (2) The ground truth emphasizes the shift from 'simpler mention' to 'comprehensive, model-driven approach,' while the LLM clarifies that the model-driven approach existed in 2023 but became more transparent in 2024. This is a subtle but important distinction that actually improves accuracy. (3) All entity references (American Express, Membership Rewards program) are correct. The answer successfully addresses the multi-part question about financial treatment evolution, liability estimation methodology, deferred fees, and liability modeling assumptions across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 493,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "In the 2022 Form 10‑K Adobe highlighted that it had just acquired Frame.io (October 2021) and was beginning to fold the cloud‑based video‑collaboration platform into its Digital Media segment to broaden its video‑creation capabilities [page_42]; the filing also notes the acquisition and initial integration as a strategic move for the Digital Media portfolio [page_41]. By the 2024 filing, Frame.io is described as a core, cloud‑native collaboration hub that is directly embedded in key Creative Cloud apps (Premiere Pro, After Effects, Photoshop, Lightroom) and linked with Workfront, and is offered through Adobe GenStudio for large‑scale content production—showing a much deeper, cross‑product alignment across Adobe’s Creative, Document and Digital Experience ecosystems [page_12].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The acquisition price of $1.18 billion is not explicitly mentioned in the LLM answer, but this is a minor omission rather than an error. The acquisition date (October 2021) is correctly referenced. All other numeric/temporal references are accurate. ENTITY ACCURACY: All companies and products are correctly identified (Adobe, Frame.io, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe GenStudio). The fiscal years (2022 vs 2024) are properly distinguished. MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods and multiple product integrations, showing the evolution from initial integration to ecosystem-wide incorporation. The answer correctly traces Frame.io's journey from newly acquired platform to core collaboration hub. COMPLETENESS: The answer addresses all aspects of the question: (1) 2022 positioning as newly acquired cloud-based video collaboration platform in Digital Media segment, (2) 2024 positioning as core component integrated with multiple Creative Cloud apps, (3) alignment with broader ecosystem including GenStudio, and (4) the evolution narrative. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly different phrasing ('cloud-native collaboration hub' vs 'cloud-based video collaboration platform') but maintaining factual accuracy. The mention of Lightroom in the LLM answer is an additional detail not in the ground truth, but this represents expansion rather than contradiction. MINOR CONSIDERATIONS: The omission of the $1.18 billion acquisition price is the only notable gap, but this doesn't significantly detract from the overall quality of the response, which comprehensively addresses the strategic evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 511,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "In 2022 the equity‑like funds held in private‑alternative investments were measured at Level 3 for **$25.4 million** in the defined‑benefit pension plan and **$2.4 million** in the retiree‑health plan (total ≈ $27.8 million)【page_99】. In 2023 the same assets were measured at Level 3 for **$25.1 million** in the pension plan and **$2.4 million** in the retiree‑health plan (total ≈ $27.5 million)【page_98】. Thus the Level 3 component of equity‑like funds fell slightly in the pension plan (‑$0.3 million) while the retiree‑health portion was unchanged, leaving the overall Level 3 exposure for equity‑like funds essentially stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. (1) QUANTITATIVE ERRORS - The LLM reports 2022 Level 3 equity-like funds at $25.4 million total, but the ground truth states $5.5 million. The LLM reports 2023 at $25.1 million total, but ground truth states $25.4 million. These are major discrepancies - the LLM has essentially swapped the 2022 and 2023 values. The LLM's breakdown into pension plan ($25.4M in 2022) and retiree health plan ($2.4M in 2022) totaling $27.8M does not match the ground truth's single figure of $5.5M for 2022. (2) DIRECTIONAL ANALYSIS ERROR - The ground truth indicates a fivefold increase from $5.5M to $25.4M (a significant rise), representing a shift toward more opaque valuations. The LLM incorrectly concludes the Level 3 exposure was 'essentially stable' with only a -$0.3M decline, which is the opposite conclusion from the actual data. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused which year had which values, or pulled data from incorrect sources. (4) ENTITY/CONTEXT ISSUES - While the LLM correctly identifies the asset class (equity-like funds in private alternative investments) and the valuation level (Level 3), it provides incorrect financial figures and reaches an inverted conclusion about the trend. The citation references (page_99 and page_98) cannot be verified but the numbers themselves are demonstrably wrong relative to ground truth. This is a critical failure on a quantitative financial question where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 442,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "In the 2022 Form 10‑K Adobe reported that after acquiring Frame.io for roughly $1.18 billion in the fourth quarter of fiscal 2021, it had **just begun integrating the cloud‑based video‑collaboration platform into its Digital Media segment**【page_41】. By the 2024 Form 10‑K, Frame.io is described as a **core, cloud‑native collaboration hub that is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and is also offered through Adobe GenStudio**, showing that it has moved from an initial integration step to a deep, cross‑app embedding and broader positioning within Adobe’s Digital Media and content‑production ecosystem【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the acquisition price ($1.18 billion) and timing (Q4 fiscal 2021/October 2021), which matches the ground truth. (2) Accurately describes the 2022 status as 'just begun integrating' the cloud-based video collaboration platform into Digital Media segment. (3) Comprehensively lists all the 2024 integrations mentioned in ground truth: Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. (4) Correctly identifies Adobe GenStudio as part of the 2024 positioning. (5) Properly synthesizes the multi-hop evolution narrative from initial integration (2022) to deep ecosystem embedding (2024). (6) Uses appropriate terminology ('cloud-native collaboration hub,' 'cross-app embedding') that aligns with the strategic positioning described in ground truth. MINOR CONSIDERATIONS: The LLM answer includes the acquisition price ($1.18 billion), which while accurate and helpful context, is not explicitly mentioned in the ground truth answer provided. However, this is additional accurate information that enhances rather than detracts from the response. The page citations provided (page_41 for 2022, page_12 for 2024) add credibility though cannot be independently verified here. The answer directly addresses the evolution question by clearly contrasting the 2022 and 2024 positions and explaining the progression from initial integration to deeper embedding. All factual claims are consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 417,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "By 2022 CVS’s medication‑management strategy was built around a suite of clinical programs – utilization‑management, medication‑management, adherence and counseling – delivered through the Pharmacy Advisor and Drug‑Savings‑Review services and the NovoLogix online pre‑authorization tool, all supported by its Health‑Engagement Engine and digital connectivity that gave members real‑time visibility of lower‑cost alternatives【page_13】. By 2024 the company had layered a much broader, technology‑driven layer on top of those basics: AI‑powered Canopy analytics, proprietary clinical‑workflow software and an integrated device hub for in‑home health evaluations and medication reviews, expanded virtual MinuteClinic scheduling and reminder tools, and the Cordavis biosimilar subsidiary – all aimed at boosting adherence and driving cost‑efficiency through richer data integration and digital patient engagement【page_12】【page_13】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims NovoLogix was available in 2022 as part of the basic suite, but the ground truth states NovoLogix was introduced BY 2024 as a new digital tool expansion. This is a fundamental misrepresentation of the timeline. (2) MISSING KEY FACTS - The LLM completely omits several critical 2024 developments mentioned in ground truth: the CVS Weight Management program with GLP-1 medication optimization, Oak Street Health expansion (239 primary care centers across 27 states), and value-based care initiatives. These are substantial omissions that significantly underrepresent the evolution described. (3) UNVERIFIED CLAIMS - The LLM introduces tools and programs not mentioned in the ground truth (Canopy analytics, Cordavis biosimilar subsidiary, 'Health-Engagement Engine', integrated device hub for in-home evaluations) without clear sourcing. While these may exist in CVS filings, they are not part of the ground truth answer and their inclusion without verification is problematic. (4) INCOMPLETE 2022 CHARACTERIZATION - The ground truth emphasizes the National Pharmacy and Therapeutics Committee, generic drug promotion, and the seven-day opioid supply limit in 2022, none of which appear in the LLM answer. (5) MISSING SYNTHESIS - The ground truth explicitly notes the strategic shift 'from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model' - this important analytical insight is absent from the LLM response. (6) QUANTITATIVE ISSUES - No specific numbers are provided in either answer, but the LLM's timeline inversion regarding NovoLogix is a critical factual error. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the evolution across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 511,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing Adobe said that after acquiring Frame.io in October 2021 it was just beginning to embed the service into Creative Cloud, focusing on deeper integration and enhanced review‑and‑approval capabilities in Premiere Pro and After Effects【page_6】. By the 2024 filing Frame.io is positioned as a core cloud‑native collaboration platform integrated across Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and GenStudio, with new features such as real‑time upload, frame‑accurate commenting, annotations, Camera‑to‑Cloud automatic footage ingestion and support for still‑image, design‑file and PDF reviews【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the October 2021 acquisition date and 2022 initial integration focus on Premiere Pro and After Effects with review-and-approval capabilities. (2) Accurately describes the 2024 evolution to a comprehensive cloud-native platform with expanded integration across Photoshop, Lightroom, Workfront, and GenStudio. (3) Correctly lists specific enhancements: real-time upload, frame-accurate commenting, annotations, Camera-to-Cloud functionality, and support for still images, design files, and PDFs. (4) Properly synthesizes the multi-hop information across 2022 and 2024 filings to show the evolution trajectory. (5) Accurately captures the strategic shift from video-specific to broader creative asset platform. (6) Includes appropriate source citations (page references). MINOR CONSIDERATIONS: (1) The LLM answer adds GenStudio to the 2024 integrations, which is not explicitly mentioned in the ground truth but represents additional accurate detail from the filings. (2) The ground truth mentions 'Camera to Cloud' while LLM says 'Camera-to-Cloud' - this is a formatting variation of the same feature, not an error. (3) Both answers convey the same semantic meaning regarding the evolution and enhancements. QUANTITATIVE ACCURACY: All dates (October 2021, 2022, 2024) are correct. No calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly synthesizes information from multiple filing years to show progression. Entity identification is accurate (Adobe, Frame.io, all product names). CONTEXTUAL RELEVANCE: Directly and comprehensively addresses all aspects of the question regarding integration evolution and specific enhancements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 485,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "In the 2023 filing the firm said that the fair value of corporate loans and lending commitments is determined “using recently executed transactions, market‑price quotations (where observable), implied yields from comparable debt, market‑observable CDS spreads and proprietary models” (see page 99). By 2024 the discussion shifts to the non‑recurring fair‑value measurement of loans, lending commitments and other assets, stating that their values are now “based on recently executed transactions, market price quotations, valuation models that incorporate market‑observable inputs … such as comparable loan or debt prices and CDS spread levels” (see page 103). Thus, while recent transactions were already an input in 2023, in 2024 they are highlighted as a primary observable source for a broader set of assets and for non‑recurring valuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution from 2023 to 2024 and correctly identifies the key shift in how recently executed transactions are used in fair value determination. Strengths: (1) Accurately captures that recently executed transactions were already used in 2023 as one input among several (market-price quotations, implied yields, CDS spreads, proprietary models); (2) Correctly notes the 2024 shift toward highlighting recently executed transactions as a primary observable source; (3) Properly identifies the expansion to non-recurring fair-value measurements and a broader set of assets; (4) Appropriately cites specific page references (99 and 103) showing document-level precision. Weaknesses: (1) The LLM answer emphasizes 'non-recurring fair-value measurement' as a key distinction in 2024, but the ground truth emphasizes the shift to 'held-for-sale category' of loans and lending commitments as the more specific application - these are related but not identical concepts, and the ground truth's framing is more precise; (2) The ground truth explicitly mentions extension to 'other investments' with discounted cash flow models and comparable company multiples, which the LLM answer mentions only generically as 'other assets'; (3) The LLM answer could have been more explicit about the specific asset categories (held-for-sale loans vs. other investments) rather than the broader 'non-recurring' framing. The core narrative about evolution is correct - from general use in 2023 to more targeted/primary use in 2024 - but the specific categorization and asset types could be more precise. The answer is substantively correct but misses some nuanced distinctions in how the valuation practices evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 474,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K (pages 95‑99) Adobe’s filing makes no specific mention of Substance 3D Stager, treating the Substance 3D suite only as a general collection of tools. By the 2024 filing, Adobe explicitly lists Stager as a distinct desktop app within the “Adobe Substance 3D Collection,” describing it as the product used to build and assemble 3D scenes and highlighting its integration with Painter, Sampler, Designer, Modeler and the Substance 3D Assets library (page 12). This shows Adobe moving from a non‑highlighted, bundled approach in 2022 to positioning Stager as a core, integrated component of the broader Substance 3D ecosystem in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Adobe's evolution in positioning Substance 3D Stager between 2022 and 2024. STRENGTHS: (1) Correctly identifies the key shift from 2022 (minimal/no specific mention of Stager) to 2024 (explicit positioning as a distinct desktop app); (2) Accurately describes Stager's function as a tool for building and assembling 3D scenes; (3) Correctly lists the integrated ecosystem components (Painter, Sampler, Designer, Modeler, and Assets library); (4) Properly characterizes the strategic evolution from bundled/non-highlighted to core/integrated positioning; (5) Provides specific page references (pages 95-99 for 2022, page 12 for 2024) that add credibility. MINOR CONSIDERATIONS: (1) The LLM states the 2022 filing makes 'no specific mention' of Substance 3D Stager, while the ground truth indicates it was 'listed among Adobe's trademarks' - this is a subtle distinction. The LLM's claim of 'no specific mention' in the main text may be technically accurate even if Stager appeared in trademark listings, but this represents a slight divergence from the ground truth's framing; (2) The ground truth emphasizes the shift from 'simply offering the product' to 'integrating it into a broader suite,' while the LLM frames it as moving from 'non-highlighted, bundled approach' to 'core, integrated component' - these are semantically equivalent but use slightly different language. QUANTITATIVE ACCURACY: No numerical data, dates, or calculations are present in either answer, so this dimension scores high based on correct year references (2022, 2024). QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM successfully synthesizes information about product positioning across two time periods and correctly identifies the ecosystem integration as the key evolution. The reasoning chain is logical and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 517,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "- 2022 10‑K (p. 64): GE said deep‑decarbonisation “will likely depend … on technologies that are not yet deployed … such as **grid‑scale batteries** or other storage solutions,” framing batteries as a future, not‑yet‑core element of its energy‑transition plan.  \n\n- 2023 10‑K (p. 29): the same language appears – batteries are again listed among emerging technologies that “may become more important over time,” showing GE still views them as a prospective, longer‑term option rather than a core, relied‑upon capability.  \n\nThus, from 2022 to 2023 GE’s positioning on grid‑scale batteries remained consistent: they are recognized as a potentially important future technology for the energy transition, but the company’s strategic reliance on them stays modest and largely speculative.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key evolution being assessed. Ground truth states there was a SHIFT from 2022 to 2023 - from viewing batteries as 'speculative investment' to 'more central component' with explicit integration as a 'dependency' (\"depend in part\" language). The LLM claims positioning 'remained consistent' and that strategic reliance 'stays modest and largely speculative' - this is the opposite conclusion from ground truth. SPECIFIC ISSUES: (1) The LLM correctly identifies that both years mention grid-scale batteries as emerging technologies, but MISINTERPRETS the significance of this consistency. (2) The LLM states 2023 shows batteries as 'prospective, longer-term option rather than core' - but ground truth explicitly notes 2023 integrated them as a dependency with 'depend in part' language, indicating elevated strategic importance. (3) The LLM's conclusion that 'strategic reliance on them stays modest' directly contradicts ground truth's characterization of a shift toward 'more central component.' (4) QUANTITATIVE ACCURACY is acceptable (page numbers, years, and quoted language appear accurate), but QUALITATIVE ACCURACY is severely compromised because the LLM failed to recognize the evolution/shift that is the core of the question. (5) The question specifically asks about 'evolution' and 'level of strategic reliance' - the LLM's answer that nothing evolved and reliance remained modest is factually incorrect per the ground truth. This is a multi-hop synthesis failure where the LLM correctly identified individual data points but drew the wrong comparative conclusion about their relationship across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 469,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "In the 2022 Form 10‑K CVS disclosed that “the Company did not have any broker‑quoted debt securities for the years ended December 31, 2021 and 2020,” so none were used in its Level 3 fair‑value calculations. The 2024 Form 10‑K repeats the same language, updating the periods to “the years ended December 31, 2024 and 2023,” confirming that broker‑quoted debt securities remain absent and therefore have no impact on CVS’s fair‑value measurement or reported earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key factual elements - CVS had no broker-quoted debt securities in both 2022 and 2024 disclosures, with accurate year references (2021/2020 in 2022 filing; 2024/2023 in 2024 filing). The numeric/date information is accurate. WEAKNESSES: The LLM answer significantly undershoots the ground truth in capturing the evolution of CVS's disclosure approach. The ground truth emphasizes an important qualitative shift: (1) In 2022, CVS explicitly mentioned using 'internal pricing for certain private placements' - this contextual detail is completely absent from the LLM answer; (2) The ground truth highlights that the 2024 disclosure 'no longer mentions any negative impact or specific review process' - suggesting a meaningful evolution in how the company frames this topic. The LLM states the disclosures are 'the same language' which oversimplifies the evolution. The LLM also adds interpretive language ('therefore have no impact on CVS's fair-value measurement or reported earnings') that goes slightly beyond what the ground truth establishes. MULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022 and 2024 filings but fails to capture the nuanced evolution in disclosure emphasis and framing that the ground truth identifies. The answer treats this as a static comparison rather than an evolution. The question specifically asks about how disclosure 'evolved' - the LLM's answer suggests consistency rather than evolution, missing the reduced emphasis/relevance noted in the ground truth. CALCULATION/VERIFICATION: No calculations required; dates and year references are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 452,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "In 2023 BlackRock reported $1.585 billion of equity securities / mutual‑fund holdings at FVTNI and $2.756 billion of equity‑method investments (≈$4.34 billion total)【page_92】. By 2024 the equity‑securities component had risen to $1.950 billion while equity‑method holdings were $2.783 billion (≈$4.73 billion total)【page_92】. Thus the equity‑securities/mutual‑fund piece grew by about $365 million (≈23 %) versus only a $27 million (≈1 %) rise in equity‑method investments, shifting the overall mix toward a larger share of direct equity securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2023 figures that directly contradict the ground truth. (1) 2023 Equity Securities/Mutual Funds: LLM states $1.585 billion, but ground truth is $1,211 million ($1.211 billion) - this is a $374 million overstatement (31% error). (2) 2023 Equity Method Investments: LLM states $2.756 billion, but ground truth is $1,895 million ($1.895 billion) - this is an $861 million overstatement (45% error). (3) 2024 figures are correct: Equity securities/mutual funds at $1.950 billion matches ground truth, and equity method investments at $2.783 billion matches ground truth. (4) CALCULATION ERRORS: The LLM's calculation of equity-method investment growth as '$27 million (≈1%)' is mathematically incorrect even using their own stated figures ($2.783B - $2.756B = $27M is correct arithmetic, but the percentage is wrong: $27M/$2.756B ≈ 0.98%, not 1%). More critically, using the correct ground truth figures, equity method investments grew from $1,895M to $2,783M = $888M increase (47%), not 1%. The equity securities growth calculation of $365M (23%) is also incorrect using ground truth: $1,950M - $1,211M = $739M increase (61%), not $365M. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the data and provide comparative analysis, the foundation is built on incorrect 2023 baseline numbers, making all subsequent comparisons and conclusions invalid. The reasoning structure is sound, but the data inputs are fundamentally wrong. (6) The answer does address the question's components (composition change, both categories, year-over-year comparison) but with severely compromised accuracy. The 2023 figures appear to be from a different source or year entirely, suggesting a data retrieval or matching error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 491,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "In the 2022 Form 10‑K UnitedHealth said it reviews every available‑for‑sale debt security for credit‑related impairment whenever fair value falls below amortized cost, records any credit‑related loss as an allowance (the allowance was “not material”) and reports the resulting unrealized losses – $274 million of gross unrealized losses for 2021 (and $22 million for 2020) – in other comprehensive income. The 2024 filing repeats the same evaluation framework (present‑value of expected cash flows, issuer credit quality and fair‑value versus cost) and still treats credit‑related impairments as an allowance offset to investment and other income, with unrealized gains/losses excluded from net earnings and shown in comprehensive income, and it likewise does not disclose a material allowance for credit losses, indicating the policy and its impact have essentially remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative details ($274 million gross unrealized losses for 2021, $22 million for 2020) that are not present in the ground truth, and correctly identifies the evaluation framework components (present value of expected cash flows, issuer credit quality, fair value vs. cost). However, there are significant issues with the multi-hop synthesis and interpretation of the evolution from 2022 to 2024. The LLM concludes that the policy 'has essentially remained unchanged,' which directly contradicts the ground truth's key finding that there was 'a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.' The ground truth explicitly states that by 2024, the allowance for credit losses is 'now explicitly described as being recorded as a separate component through an allowance account' and represents a more structured recognition of credit risk. The LLM's statement that the company 'likewise does not disclose a material allowance for credit losses' misses the critical distinction that the 2024 framework involves a more formalized, structured approach to recording and recognizing credit impairments, even if the allowance remains immaterial. The LLM correctly identifies that unrealized losses are driven by interest rates rather than credit deterioration in 2022, and that the evaluation methodology remained consistent, but fails to capture the substantive evolution in how credit-related impairments are now formally recognized through an allowance account structure. The quantitative details provided (specific dollar amounts) add value but the core multi-hop reasoning about the evolution of the framework is incomplete and somewhat contradicts the ground truth's characterization of meaningful change in the accounting approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 493,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "AMD’s 15 % stake in the ATMP joint venture grew in both book value and earnings. The carrying amount of the investment rose from roughly **$83 million at 12/31/2022** to **about $99 million at 12/30/2023** (page 78), and the equity‑income recognized from the JV increased from **$14 million in 2022** to **$16 million in 2023** (page 78). This shows a modest expansion of AMD’s investment and a higher share of the JV’s profit attributed to AMD.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: carrying value of $83 million at 12/31/2022 increasing to $99 million at 12/30/2023, and equity income rising from $14 million in 2022 to $16 million in 2023. The LLM correctly identifies AMD's 15% stake in the ATMP JV and properly synthesizes the multi-hop information showing the evolution of both investment value and equity income across the two-year period. The answer includes helpful page references (page 78) and uses appropriate financial terminology. The reasoning is sound, correctly interpreting the data as indicating 'modest expansion' and 'higher share of the JV's profit.' The only minor distinction from the ground truth is that the LLM uses slightly more specific date formatting (12/31/2022 vs 12/30/2023) and adds the 15% ownership detail, which enhances rather than detracts from the answer. The semantic meaning is fully equivalent to the ground truth, with clear explanation of the relationship evolution. No calculation errors, no missing entities, and all financial metrics are correctly identified and compared.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 326,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth’s tort‑claim exposure has stayed focused on medical‑malpractice and other professional‑liability suits arising from the delivery of health‑care services. Both the 2022 and 2024 filings note that the company is largely self‑insured, records reserves for probable costs, but cautions that the growing volume of claims—and the use of new liability theories—could cause actual losses to far exceed those reserves, creating the potential for substantial monetary damages. The 2024 filing reiterates that this risk remains material and may be increasing.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies core facts about UnitedHealth's tort exposure (self-insured status, medical malpractice focus, reserve recording, risk of actual losses exceeding reserves, new liability theories). However, it significantly fails to capture the key evolution between 2022 and 2024 that the ground truth emphasizes. The ground truth highlights a SHIFT in focus: from narrowly-defined medical malpractice/professional liability in 2022 to BROADER legal risks tied to health care delivery, clinical quality, and patient safety standards in 2024, plus emerging concerns about reputational harm and business relationship impacts. The LLM answer presents the exposure as essentially static ('stayed focused on medical-malpractice'), missing the critical evolution the question asks about. The LLM states 'this risk remains material and may be increasing' but doesn't capture the qualitative shift in risk profile or the expanded scope of concerns. The answer is factually accurate regarding what was true in both years but fails the multi-hop synthesis requirement by not demonstrating how the nature and characterization of risks evolved. The LLM also doesn't address the 'potential financial impact' dimension as thoroughly as the ground truth, which discusses damage caps and new theories of liability. While no specific dollar amounts are provided in either answer (so quantitative accuracy is neutral), the qualitative analysis of the evolution is incomplete and misses the systemic risk expansion that distinguishes 2024 from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 426,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "In 2023 Boeing’s credit portfolio consisted of a $3 billion three‑year revolving credit agreement (expiring August 2025), a $3.2 billion five‑year facility (expiring October 2024) and a $0.8 billion 364‑day facility. By 2024 the short‑term and the older five‑year facilities were terminated and replaced with a new $4 billion five‑year agreement, while the $3 billion three‑year line remained unchanged, boosting total available borrowing capacity to $10 billion. This reflects a strategy of consolidating and extending its credit lines to provide a larger, more flexible liquidity cushion for operations and debt service.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM introduces facilities NOT mentioned in the ground truth - specifically a $3.2 billion five-year facility expiring October 2024 and a $0.8 billion 364-day facility in 2023. The ground truth only mentions the $3.0 billion three-year agreement for 2023. (2) The LLM claims total available borrowing capacity reached $10 billion in 2024, which is mathematically inconsistent with the facilities described and not supported by the ground truth. (3) The LLM states the $3.2 billion and $0.8 billion facilities were 'terminated' in 2024, but these facilities were never mentioned in the ground truth as existing in the first place. CORRECT ELEMENTS: (1) The $3.0 billion three-year agreement expiring August 2025 is correctly identified. (2) The new $4.0 billion five-year agreement expiring in May 2029 is correctly identified. (3) The general strategic interpretation about consolidating and extending credit lines is reasonable and aligns with the ground truth's characterization of enhancing liquidity and extending maturity timelines. MULTI-HOP REASONING: The LLM failed to properly synthesize the information. Rather than accurately comparing 2023 vs 2024 structures, it introduced extraneous facilities that create confusion and inaccuracy. The ground truth clearly indicates a simpler evolution: legacy $3B agreement remains, new $4B agreement added, and two OTHER facilities terminated (not the specific ones the LLM named). The LLM's calculation of $10 billion total capacity is unexplained and appears incorrect given the stated facilities. SEMANTIC ISSUES: While the qualitative conclusion about liquidity strategy is directionally correct, the factual foundation is compromised by the invented facilities and incorrect total capacity figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 503,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "In 2023 the 2017 performance‑based options generated $56 million of grant‑date fair‑value for the shares that vested and $44 million of intrinsic value when those options were exercised 【page_101】. In 2024 the fair‑value of newly‑vested 2017 options slipped to $52 million, but the intrinsic value realized on exercise jumped to $373 million 【page_109】. Thus, while the vest‑value fell modestly, the exercise‑value rose sharply year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: 2023 fair value of $56 million, 2023 intrinsic value of $44 million, 2024 fair value of $52 million, and 2024 intrinsic value of $373 million. The multi-hop synthesis is sound, correctly comparing the evolution of both metrics across the two years. The answer properly identifies the key insight that while vesting value declined modestly ($56M to $52M), exercise value increased substantially ($44M to $373M). The terminology used ('grant-date fair-value,' 'intrinsic value') is precise and appropriate. The answer includes source citations (page references) which adds credibility. The reasoning is logical and the conclusion accurately reflects the data trend. Minor stylistic differences from the ground truth (e.g., 'grant-date fair-value' vs 'fair value,' 'vest-value' vs 'vesting value') are semantic equivalences that do not detract from accuracy. The answer fully addresses all components of the multi-part question regarding the financial impact evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 313,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "**2022 10‑K:** AMD said it estimated the revenue impact of product‑return rights by using “relevant, trended actual historical product‑return‑rate information gathered, adjusted for actual known information or events,” applying the contractual‑percentage‑of‑prior‑quarter‑shipments framework and referencing historical returns, rebates and credits to OEM and distributor customers. (See 2022 pages 44‑45.)\n\n**2023 10‑K:** AMD kept the same historical‑return‑rate basis but refined the description – it now spells out OEM customers as “original equipment manufacturers (OEM) customers” and reiterates that the estimate relies on “relevant, trended actual historical product‑return‑rate information adjusted for known information or events.” (See 2023 page 49.)\n\n**Change:** The methodology itself did not fundamentally shift; the 2023 filing clarified the OEM terminology and emphasized the “trended” historical data adjustment, providing a more explicit description of the same historical‑return‑rate approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that AMD used historical product return rate information in both 2022 and 2023, and accurately notes that the core methodology remained consistent. However, the answer significantly misses a critical evolution in AMD's approach that the ground truth identifies: the 2023 filing explicitly references ASC 606-10-32-8 through 14 and frames returns/rebates as 'variable consideration' under ASC 606, using the 'most likely amount' methodology. This represents a more structured, standards-aligned approach that goes beyond mere terminology clarification. The LLM characterizes the change as merely 'clarifying OEM terminology' and 'emphasizing trended historical data,' which understates the methodological evolution. The ground truth indicates AMD moved toward a more codified accounting standards framework (ASC 606 variable consideration), while the LLM suggests only descriptive refinement occurred. The LLM's conclusion that 'the methodology itself did not fundamentally shift' contradicts the ground truth's characterization of a 'more structured and codified approach' aligned with specific accounting standards. The answer is partially correct on the historical data basis but fails to capture the important shift toward explicit ASC 606 variable consideration treatment. No numerical errors are present, but the qualitative understanding of the methodological evolution is incomplete and somewhat misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 401,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 performance‑based options fell from **1,549,080 shares outstanding at 12/31/2023** to **625,825 shares outstanding at 12/31/2024** – a reduction of roughly 923 k shares【page_108】. The drop reflects the **exercise of 905,219 options** during 2024, while **only 18,036 were forfeited**, indicating that the decline was driven almost entirely by employee exercise rather than forfeiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Starting shares 1,549,080 at 12/31/2023 - CORRECT; (2) Ending shares 625,825 at 12/31/2024 - CORRECT; (3) Shares exercised 905,219 - CORRECT; (4) Shares forfeited 18,036 - CORRECT. Calculation verification: 1,549,080 - 905,219 - 18,036 = 625,825 ✓ The stated reduction of 'roughly 923k shares' is accurate (923,255 total reduction). The LLM correctly identified that the decline was driven primarily by exercise (905,219) rather than forfeiture (18,036), which represents approximately 97.9% exercise vs 1.9% forfeiture. The answer properly synthesizes the multi-hop information: (1) identifying the specific option grant year (2017), (2) comparing two time periods (2023 vs 2024), (3) explaining the underlying drivers (exercise and forfeiture), and (4) drawing a logical conclusion about the lifecycle stage of these options. The reasoning is sound - the dominance of exercises over forfeitures does indicate completion in the lifecycle as options approach expiration. Minor note: The LLM states 'roughly 923k' when the precise figure is 923,255, but this is an acceptable approximation and doesn't constitute an error. The answer directly addresses all parts of the question and provides appropriate context about what the trends indicate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 371,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "In 2022 Optum Rx was described as a diversified pharmacy‑care business that delivered a full spectrum of services—including retail, home‑delivery, specialty and infusion pharmacies plus a direct‑to‑consumer offering—through a network of more than 67,000 pharmacies, managing $112 billion of drug spend and providing utilization‑management, medication‑management and analytics‑driven programs【page_6】. By 2024 the segment had expanded to add rare‑disease and gene‑therapy support, grew its spend management to $178 billion (including $74 billion in specialty), and emphasized embedding pharmacists in care teams to integrate medical, pharmacy and behavioral services through digital tools, positioning Optum Rx as a central, whole‑patient, cost‑controlling pillar of UnitedHealth Group’s Optum ecosystem【page_5】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2024 figures of $178 billion in total drug spend and $74 billion in specialty spending. However, the ground truth explicitly states 'While specific spending figures were not provided in 2024,' making these numbers fabricated or sourced from incorrect documents. The 2022 figures ($112 billion total, $45 billion specialty) are correctly stated in the LLM answer and match ground truth. (2) ENTITY/SERVICE ACCURACY: The LLM introduces 'rare-disease and gene-therapy support' as new 2024 services, which is not mentioned in the ground truth. This appears to be either hallucinated or from an incorrect source. (3) MULTI-HOP REASONING: While the LLM correctly identifies the evolution from 2022 to 2024 and attempts to synthesize the strategic positioning, the introduction of unverified 2024 spending figures undermines the entire analysis. The ground truth emphasizes that 2024 positioning focused on strategic integration and mission rather than specific spending metrics. (4) SEMANTIC ISSUES: The LLM's characterization of the evolution is partially correct (67,000 pharmacies, service expansion, integration into Optum ecosystem), but the fabricated 2024 numbers and unverified service additions represent fundamental factual errors. The ground truth answer is more cautious and accurate in noting the absence of specific 2024 spending figures. (5) MISSING CONTEXT: The LLM fails to capture the ground truth's emphasis on the shift from quantitative metrics (2022) to qualitative strategic positioning (2024), instead inventing numbers that contradict the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 475,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "BlackRock’s equity securities measured at fair value (NI) grew modestly from 2023 to 2024.  The total balance rose from $1.429 billion (VIE $1.059 bn + VRE $0.370 bn) to $1.556 billion (VIE $1.179 bn + VRE $0.377 bn) and the fair‑value of the securities increased from $1.585 billion to $1.950 billion【page_92】.  At the same time, the portion of equity‑method investments that are held to hedge deferred‑cash‑compensation plans fell from $241 million in 2023 to $173 million in 2024【page_85】【page_94】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses some relevant information but contains significant issues in addressing the core question and contains a critical numerical error:\n\n1. CRITICAL ERROR - Deferred Compensation Plans Figure: The LLM states that 'equity-method investments that are held to hedge deferred-cash-compensation plans fell from $241 million in 2023 to $173 million in 2024.' However, the ground truth indicates the 2023 figure was $9 million (not $241 million) for Equity Securities at FVTNI held for deferred cash compensation plans. The $241 million figure appears to be from a different category or year. This is a major factual error.\n\n2. PARTIAL RELEVANCE - The LLM does correctly identify that the 2024 figure is $173 million for investments related to deferred cash compensation plans, which matches the ground truth.\n\n3. INCOMPLETE FOCUS - The question specifically asks about 'Equity Securities at FVTNI' and the reclassification/composition change. The LLM provides broader information about total equity securities growth (VIE and VRE components) and fair value changes, which is tangential to the core question about the specific deferred compensation plan investments and their reclassification.\n\n4. MISSING KEY INSIGHT - The ground truth emphasizes the reclassification from 'Equity Securities at FVTNI' to 'Investments related to deferred cash compensation plans' within the Equity Method section. The LLM does not clearly articulate this reclassification or composition change, which is the central point of the question.\n\n5. MULTI-HOP REASONING - While the LLM attempts to synthesize information across pages, it fails to correctly identify the 2023 baseline figure ($9 million vs. $241 million claimed) and does not adequately explain the reclassification mechanism that is central to understanding the composition change.\n\n6. QUANTITATIVE ISSUES - The $241 million 2023 figure is incorrect for the specific category in question. This undermines the entire comparison and analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 541,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Accenture’s “aggregate available authorization” for its publicly announced open‑market share‑repurchase program fell from **$3,129,296 as of August 31 2022** (page 93) to **$2,694,281 as of August 31 2024** (page 100) – a drop of roughly $0.44 million (about 14%). The decline shows the company has been drawing down its buy‑back capacity and not fully replenishing it, reflecting a disciplined capital‑allocation approach that balances returning cash to shareholders via repurchases (and dividends) while preserving flexibility for other strategic uses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: (1) Starting authorization of $3,129,296 as of August 31, 2022 - CORRECT; (2) Ending authorization of $2,694,281 as of August 31, 2024 - CORRECT; (3) Calculated difference: $3,129,296 - $2,694,281 = $435,015, which the LLM rounds to 'roughly $0.44 million' - CORRECT (minor rounding variation is acceptable); (4) Percentage decline: $435,015 / $3,129,296 = 13.9%, which the LLM states as 'about 14%' - CORRECT. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the quantitative change in authorization between 2022 and 2024, and (2) what this indicates about capital allocation strategy. ENTITY ACCURACY: Company (Accenture), metric (aggregate available authorization for open-market share purchase program), and fiscal years (August 31, 2022 and August 31, 2024) are all correctly identified. REASONING QUALITY: The LLM provides sound multi-hop synthesis, correctly interpreting the declining authorization as evidence of the company drawing down buyback capacity and reflecting a disciplined capital allocation approach. The interpretation aligns with the ground truth's characterization of a 'more conservative approach' and adds nuance by mentioning the balance with dividends and strategic flexibility. SEMANTIC EQUIVALENCE: The LLM's interpretation ('disciplined capital-allocation approach that balances returning cash to shareholders via repurchases and dividends while preserving flexibility') is semantically equivalent to and slightly more detailed than the ground truth's 'more conservative approach to capital deployment or a strategic shift.' Minor deduction (1 point) only for the slight rounding presentation ('$0.44 million' vs. the more precise '$435,015'), though this is a negligible issue in financial communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 500,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "In the 2022 filing the company only said that its open‑market buy‑back program could include “purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares,” without giving numbers or detailed rights. By the 2024 filing the treatment is much more specific: the exchangeable shares can be swapped one‑for‑one for Accenture plc Class A ordinary shares (or cash at market price), they receive the same dividend distributions, and a redemption restriction is tied to the holder’s Class X shares; the note also quantifies the activity – 47,752 exchangeable shares were repurchased for $15.3 k under an authorized $2.694 m buy‑back program. This shows a shift from a broad, qualitative description in 2022 to a detailed, quantified disclosure of both shareholder rights and repurchase activity in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution from qualitative to quantitative disclosure between 2022 and 2024, and accurately describes the shareholder rights (one-for-one exchangeability, dividend distributions, Class X share linkage). However, there are significant quantitative accuracy issues: (1) The LLM states '47,752 exchangeable shares were repurchased for $15.3 k' - this appears to contain a unit error. $15.3k (fifteen thousand dollars) for 47,752 shares would be approximately $0.32 per share, which is implausibly low for Accenture stock. The ground truth does not provide these specific repurchase numbers, suggesting the LLM may have fabricated or misread data. (2) The remaining authorization figure of $2.694 million is correctly stated and matches the ground truth's $2,694,281 (proper format conversion). (3) The LLM correctly identifies the shift from 2022's general intentions to 2024's structured approach. The qualitative analysis is sound - the answer properly synthesizes the evolution in disclosure practices and shareholder rights descriptions. However, the introduction of specific repurchase numbers (47,752 shares for $15.3k) that don't appear in the ground truth, combined with the apparent unit error, represents a critical factual error. The answer demonstrates good understanding of the disclosure evolution but fails on numerical precision, which is a primary evaluation criterion for financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 400,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "Global Electrophysiology‑device revenue grew from $2.195 billion in 2023 to $2.467 billion in 2024. When the effect of foreign‑exchange rates is removed, the revenue increase was 14.4 % 【page_30†L...】【page_29†L...】【page_31†L...】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor omissions. Quantitative verification: (1) 2023 revenue of $2.195 billion ($2,195 million) - CORRECT; (2) 2024 revenue of $2.467 billion ($2,467 million) - CORRECT; (3) FX-adjusted percentage change of 14.4% - CORRECT. The number format variation (billion vs million) is acceptable and semantically equivalent. Multi-hop synthesis: The answer correctly identifies the two years, the revenue figures, and the FX-adjusted percentage change from the source documents. However, the LLM answer is incomplete in one respect: it does not mention the total percentage change of 12.3% (including FX impact), which was explicitly requested in the question asking 'how did the global revenue...evolve' and 'what was the percentage change.' The question asks for both the evolution (which includes the total change) and the FX-adjusted change. The LLM provided the FX-adjusted change (14.4%) but omitted the total change (12.3%), which represents a partial answer to the multi-part question. The reasoning is sound and the synthesis across multiple pages is correct, but the answer lacks completeness by not addressing the total percentage change component of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 341,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture’s 16 % equity‑method stake in Duck Creek Technologies was carried at $138.9 million on its balance sheet in FY 2022, with an estimated fair‑value of $223.2 million (see 2022 10‑K page 70). By the time of the FY 2024 filing, the company reported that the investment generated a $253 million gain in FY 2023, which was excluded from adjusted earnings and helped lift operating income, EPS and the effective tax rate, indicating a marked appreciation of the Duck Creek holding (see 2024 10‑K page 40).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies the 16% equity-method stake in Duck Creek Technologies; (2) Accurately cites the $223.2 million fair-value estimate for FY 2022 (matches ground truth's $223,166 thousand when converted to millions); (3) Correctly identifies the $253 million gain reported in FY 2023; (4) Properly synthesizes the multi-hop relationship showing evolution from FY 2022 to FY 2024; (5) Adds valuable context about the gain being excluded from adjusted earnings and its impact on operating income, EPS, and tax rate. Minor discrepancy: The LLM cites a $138.9 million carrying value on the balance sheet in FY 2022, which is not mentioned in the ground truth answer. This additional detail is not contradicted by the ground truth but represents supplementary information. The ground truth focuses on the $223,166 (approximately $223.2 million) valuation figure, while the LLM distinguishes between carrying value and fair value, which is technically more precise accounting terminology. The LLM answer provides better context by explaining the accounting treatment and impact on financial metrics. The reasoning is sound in showing the evolution of the investment's value and its contribution to financial performance across the fiscal years. All core numbers are accurate, and the multi-hop synthesis correctly connects FY 2022 valuation with FY 2024 reporting of gains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 415,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "In the 2022 proxy the company disclosed only retention **shares**—about 1,287 thousand shares (≈1.29 million) were non‑vested at year‑end and no separate “retention units” were reported【page_66】. By the 2023 filing the equity‑compensation table shows a split of **366,046 retention units** (non‑exercisable) and **954,405 retention shares** outstanding, for a total of roughly 1.32 million retention securities【page_75】. The move from an all‑share pool to a mixed pool of units and shares, with a slight increase in total volume, signals that Union Pacific is broadening its retention program and using unit awards to add flexibility and longer‑term, performance‑linked incentives to its executive compensation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states '1,287 thousand shares (≈1.29 million)' for 2022, but the ground truth clearly indicates 389,207 retention shares as of December 31, 2021 (not 1.29 million). This is a significant factual error - the LLM's 2022 figure is roughly 3.3x higher than the actual number. The LLM's 2023 figures of 954,405 retention shares and 366,046 retention units ARE correct and match ground truth exactly. The total of 1.32 million is mathematically correct for 2023 but based on an inflated 2022 baseline. (2) TEMPORAL CONFUSION - The ground truth references December 31, 2021 data disclosed in 2022, while the LLM conflates this with 2022 year-end data. This creates ambiguity about which fiscal year is being compared. (3) MULTI-HOP REASONING - The LLM correctly identifies the shift from shares-only to a mixed shares/units structure and appropriately interprets this as a strategic expansion. However, the magnitude of change is misrepresented due to the incorrect 2022 baseline. The actual increase from 389,207 to 954,405 shares (145% increase) plus the introduction of 366,046 units is more dramatic than the LLM's characterization of 'slight increase in total volume.' (4) SEMANTIC ISSUES - The LLM's interpretation about 'performance-linked incentives' and 'flexibility' is reasonable but not explicitly supported by the ground truth, which only notes the introduction of units as a 'possible expansion or refinement.' The LLM adds analytical interpretation beyond what the source data confirms. STRENGTHS: Correct identification of 2023 figures, appropriate interpretation of strategic shift toward mixed compensation instruments, reasonable inference about compensation strategy evolution. WEAKNESSES: Fundamentally incorrect 2022 baseline number, mischaracterization of magnitude of change, temporal ambiguity, unsupported claims about performance-linkage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 520,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife’s 2024 filing shows that its GAAP‑based “adjusted earnings” still excludes the same market‑volatility items identified in the 2023 filing – net investment gains (losses), net derivative gains (losses), MRB re‑measurement gains (losses) and goodwill impairments – and it continues to strip out the same asymmetrical‑accounting adjustments such as in‑force reinsurance, basis‑adjustment amortizations, inflation‑indexed benefit adjustments and non‑economic losses at contract inception (2023 p. 170‑171; 2024 p. 150‑151).  The 2024 disclosure refines the guidance by explicitly noting that net investment income also excludes equity‑method joint‑venture adjustments and by adding a separate line that policyholder‑liability remeasurement gains (losses) are excluded as an asymmetrical‑accounting item, indicating a modest clarification rather than a substantive change (2024 p. 150‑151).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about MetLife's GAAP guidance evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the key exclusions in both years (MRBs, net investment gains/losses, net derivative gains/losses, goodwill impairments, asymmetrical accounting from in-force reinsurance). (2) Accurately notes the 2024 refinements, specifically the explicit inclusion of equity-method joint-venture adjustments in net investment income exclusions and the separate line item for policyholder-liability remeasurement gains (losses). (3) Properly characterizes the evolution as a 'modest clarification rather than a substantive change,' which aligns with the ground truth's description of 'refining' and 'expanding the scope.' (4) Provides specific page references (2023 p. 170-171; 2024 p. 150-151) that add credibility. (5) Multi-hop reasoning is sound - correctly synthesizes information across two years and identifies the progression of guidance. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the LDTI adoption context that drove the 2023 changes, which the ground truth identifies as a key driver. (2) The answer lists some exclusions (inflation-indexed benefit adjustments, non-economic losses at contract inception) that are not explicitly mentioned in the ground truth, though these may be accurate details from the filings. (3) The ground truth emphasizes 'amortization of DAC, VOBA, and related intangibles' and 'changes in measurement of certain guarantees' as 2023 exclusions, which the LLM answer does not explicitly mention. However, these omissions are relatively minor given the LLM's focus on the most material changes. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The page references provided appear reasonable. QUALITATIVE ACCURACY: The characterization of changes as 'refinements' and 'clarifications' is appropriate and matches the ground truth's language. The multi-hop synthesis across years is logically sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of GAAP guidance between 2023 and 2024, with appropriate focus on market volatility and asymmetrical accounting adjustments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 618,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "In 2022 Accenture’s Industry X framed “compressed transformations” around digital twins, AI, IoT, cloud/edge, 5G, advanced robotics and the metaverse to redesign product design, engineering, sourcing, manufacturing and service【page_7】. By 2024 the toolkit had expanded to include generative AI and artificial/virtual reality, while the scope broadened to delivering faster, cost‑effective intelligent product engineering and embedding greater resilience, productivity and sustainability across core operations【page_8】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Accenture's compressed transformation approach from 2022 to 2024. STRENGTHS: (1) All technology mentions are accurate - 2022 technologies (digital twins, AI, IoT, cloud/edge, 5G, advanced robotics, metaverse) are correctly listed; 2024 additions (generative AI, artificial/virtual reality) are accurate. (2) The temporal progression is clear and properly sequenced. (3) The answer correctly identifies the scope expansion from product-focused transformations to broader operational improvements. (4) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM answer omits a significant detail from the ground truth: the 2024 expansion includes 'Accenture's own development of automation equipment and commercial hardware to support client operations' - this represents a material evolution in their service offering that goes beyond just technological toolkit expansion. (2) The ground truth specifically mentions capital projects transformation scope (plant and asset construction, public infrastructure, power grids, data centers) which the LLM answer generalizes to 'faster, cost-effective intelligent product engineering' without explicitly naming these capital project categories. (3) The phrase 'embedding greater resilience, productivity and sustainability' is somewhat vague compared to the ground truth's specific examples of what capital projects are being transformed. The LLM answer captures the essence of the evolution but misses important specificity about Accenture's own hardware/equipment development and the explicit capital projects scope expansion. The answer is substantially correct but incomplete in capturing all material changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 469,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "In 2023 Abbott disclosed that it was using ≈ $2.2 billion of interest‑rate hedge contracts (down from $2.9 billion in 2022 after $700 million of contracts matured) and that the swaps carried a $95 million non‑current fair‑value liability (with no current liability). By the end of 2024 the company again reported $2.2 billion of interest‑rate hedge contracts, showing that it kept the same notional amount and continued to use the swaps to convert the fixed‑rate portion of its debt to a variable rate and offset changes in the debt’s fair value, with no disclosed change in the fair‑value liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and evolution of Abbott's interest rate hedge strategy. STRENGTHS: (1) Correctly identifies the $2.2 billion notional value for both 2023 and 2024, matching ground truth; (2) Accurately notes the $2.9 billion in 2022 and $700 million matured contracts, providing helpful context; (3) Correctly identifies the $95 million non-current fair-value liability in 2023; (4) Properly explains the purpose of hedges (converting fixed-rate to variable-rate debt and offsetting fair value changes); (5) Accurately conveys the consistency of the hedging strategy across both years. MINOR GAPS: (1) The LLM answer does not mention the increase in average interest rate on long-term debt from 3.6% in 2023 to 3.8% in 2024, which is included in the ground truth and provides important context about underlying debt structure changes; (2) The phrase 'with no disclosed change in the fair-value liability' is somewhat vague - the ground truth doesn't explicitly state whether the liability remained at $95 million or changed, so this is a reasonable inference but not fully verified against ground truth. QUANTITATIVE VERIFICATION: All numbers cited ($2.2B, $2.9B, $700M, $95M) are accurate. The multi-hop reasoning correctly synthesizes information across 2022, 2023, and 2024 periods. The answer appropriately addresses the evolution question by showing consistency in notional amounts while providing historical context. The semantic meaning aligns well with ground truth despite different wording and organization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 438,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "In the 2023 Form 10‑K MetLife defined **adjusted earnings** as “adjusted revenues less adjusted expenses, net of income tax” (with adjusted earnings available to common shareholders further reduced by preferred‑stock dividends) and stated that, **consistent with GAAP segment‑reporting guidance, adjusted earnings is the company’s GAAP measure of segment performance**.  That filing also noted that the adoption of the new LDTI standard changed the calculation by removing DAC/VOBA amortization adjustments and other guarantee‑measurement changes.  \n\nIn the 2024 Form 10‑K the company again affirms adjusted earnings as its GAAP segment‑performance metric, but it expands the definition to **explicitly exclude market‑volatility items, asymmetrical and non‑economic accounting, revenues and costs of divested businesses, discontinued‑operation results, net investment and derivative gains/losses, MRB remeasurement gains/losses and goodwill impairments**, providing a more detailed, GAAP‑aligned framework for measuring segment performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about MetLife's Adjusted Earnings evolution. STRENGTHS: (1) Correctly identifies the 2023 LDTI adoption as a key driver of changes, accurately noting removal of DAC/VOBA amortization adjustments; (2) Accurately captures the 2024 expansion of exclusions including market volatility, asymmetrical accounting, divested businesses, discontinued operations, net investment/derivative gains/losses, MRB remeasurement, and goodwill impairments; (3) Properly synthesizes the multi-hop information showing evolution from 2023 to 2024; (4) Correctly identifies Adjusted Earnings as GAAP segment performance measure in both years; (5) Provides specific, detailed exclusions that align with ground truth; (6) Uses appropriate financial terminology and maintains semantic equivalence with ground truth. MINOR WEAKNESSES: (1) The LLM answer could have been slightly more explicit about the 'refinement and expansion' characterization mentioned in ground truth - while implied, it's not explicitly stated as an evolution pattern; (2) The ground truth mentions specific 2023 exclusions (MRBs, discount rate changes on annuitization guarantees, asymmetrical accounting from in-force reinsurance) that the LLM answer doesn't detail as thoroughly for 2023, though it does capture the broader LDTI-related changes; (3) The LLM answer doesn't explicitly mention 'inflation-indexed benefit adjustments' or 'non-economic losses from single premium annuity contracts' that appear in ground truth for 2024, though these are relatively granular details. QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable but receives high marks for not introducing any erroneous numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly traces the evolution of the definition, showing understanding of how LDTI adoption triggered changes and how the company refined its approach in 2024. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 566,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "At the end of fiscal 2022 Accenture had $3.13 million of authorization for its publicly announced open‑market share‑purchase and related programs, which was reduced to $2.69 million by August 31 2024. In 2022 the company repurchased about 12.2 million shares (≈$4.1 million) through open‑market buys, other share‑purchase programs and employee‑plan withholdings (the latter not drawing on the authorized amount), while in 2024 it bought roughly 13.9 million shares (≈$4.5 million) with larger open‑market purchases and additional acquisitions of exchangeable shares, again supplementing the program with employee‑plan withholdings that do not affect the authorized funding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. (1) AUTHORIZATION AMOUNTS: The LLM states $3.13 million and $2.69 million, but the ground truth clearly indicates $3,129,296 (approximately $3.13 million in 2022 is correct in magnitude, but the 2024 figure of $2.69 million is not verified in the ground truth and appears to be fabricated). More importantly, the ground truth does NOT provide a specific 2024 authorization amount, making the LLM's claim of a reduction to $2.69 million unsubstantiated. (2) SHARE REPURCHASE VOLUMES: The LLM claims 12.2 million shares in 2022 and 13.9 million shares in 2024, with associated dollar amounts of $4.1 million and $4.5 million respectively. These specific numbers are NOT present in the ground truth and appear to be invented. The ground truth does not provide share repurchase volumes or dollar amounts for these years. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies that employee-plan withholdings do not draw on authorized amounts (matching ground truth), it fails to accurately synthesize the actual authorization data. The ground truth mentions 2022 authorization of $3,129,296 but does NOT provide comparable 2024 figures or share repurchase volumes. (4) MISSING KEY CONTEXT: The LLM answer omits important details from the ground truth about the types of shares involved (Class A ordinary shares and exchangeable shares held by Accenture Leadership members in 2022, shifting to Class A ordinary shares held as treasury shares in 2024). (5) FABRICATED DATA: The specific share counts (12.2M, 13.9M) and dollar amounts ($4.1M, $4.5M) appear to be hallucinated rather than derived from the ground truth. The answer demonstrates reasonable structural understanding of the question but fails fundamentally on factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 522,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "In the 2023 filing MetLife listed its Unit‑linked and FVO securities on Schedule I at an **amortized‑cost basis of $8.742 billion** (original cost less repayments and adjusted for premium/discount amortization) with an estimated fair value of $10.331 billion【page_320】. By the 2024 filing the same securities were moved to the **Level 3 fair‑value category** (balance $1.190 billion at year‑end) and are valued using the same Level 3 techniques and significant unobservable inputs applied to other Level 3 assets, with the filing noting that “the sensitivity of the estimated fair value … is similar in nature to that described in the preceding table”【page_251】【page_249】. Thus MetLife shifted from reporting an amortized‑cost amount to a fair‑value‑only measurement and added an explicit discussion of fair‑value sensitivity for these securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of MetLife's treatment of Unit-linked securities from 2023 to 2024, capturing the shift from amortized-cost basis reporting to Level 3 fair-value measurement with sensitivity analysis. The qualitative reasoning is sound and addresses the multi-hop synthesis requirement well.\n\nSTRENGTHS:\n1. Correctly identifies the shift from cost-based to fair-value methodology\n2. Accurately notes the move to Level 3 fair value measurements in 2024\n3. Properly identifies the introduction of significant unobservable inputs (mortality rates, lapse rates, equity volatility) in valuation\n4. Correctly emphasizes the addition of fair-value sensitivity discussion in 2024\n5. Multi-hop reasoning is sound - synthesizes information across 2023 and 2024 filings appropriately\n6. Semantic equivalence with ground truth is strong\n\nWEAKNESSES:\n1. QUANTITATIVE CONCERN: The LLM provides specific dollar amounts ($8.742 billion amortized cost, $10.331 billion fair value for 2023; $1.190 billion for 2024 Level 3 balance) that cannot be verified against the ground truth provided. The ground truth does not include these specific numbers, making it impossible to confirm accuracy. These appear to be cited with page references, but the magnitude difference between 2023 ($8.742B) and 2024 ($1.190B) is substantial and unexplained - this could indicate either a significant portfolio reduction or potential data accuracy issues.\n2. The ground truth emphasizes that 2023 used \"original cost for equities and amortized cost for fixed maturities\" while the LLM focuses primarily on the amortized cost figure without clearly distinguishing the dual cost basis approach.\n3. The LLM could have been more explicit about the specific unobservable inputs (mortality rates, lapse rates, equity volatility) that the ground truth mentions, though it does reference \"Level 3 techniques and significant unobservable inputs.\"\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the methodological evolution. The comparison structure (2023 vs 2024) is appropriate and well-organized.\n\nCALCULATION/VERIFICATION: No calculations are performed in either answer, so this is not a differentiating factor. However, the specific numbers cited in the LLM answer cannot be independently verified from the ground truth provided.\n\nSCORE JUSTIFICATION: The answer scores 7/10 because while the core conceptual understanding and multi-hop reasoning are strong (8-9 range), the unverifiable specific dollar amounts and the inability to confirm these figures against ground truth creates quantitative uncertainty that prevents a higher score. The answer is directionally correct and captures the essential evolution, but the precision claims on specific numbers are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 755,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "In FY 2022 Broadcom’s market‑based RSUs were granted with both a service condition and a market condition, vesting on a four‑year schedule and paying out 0 %‑300 % of the original grant based on total‑shareholder‑return (TSR) versus an index group【page_84】. In FY 2023 the same four‑year, TSR‑linked awards continued, but the company added a new series of market‑based RSUs that vest over five years and are tied to stock‑price performance milestones, extending the vesting timeline and adding a performance‑based element【page_84】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about market-based RSU evolution. STRENGTHS: (1) All quantitative data is correct - correctly identifies 0%-300% payout range for FY2022, four-year vesting in both years, and five-year vesting introduced in FY2023. (2) Entity accuracy is strong - correctly identifies Broadcom as the company and properly distinguishes between FY2022 and FY2023. (3) Multi-hop synthesis is sound - the answer successfully synthesizes information across two fiscal years and identifies the key structural changes (TSR-based awards continuing, new stock price milestone awards added). (4) The answer captures all essential elements from the ground truth: the original four-year TSR-based structure (0%-300% payout), the continuation of this structure in FY2023, and the introduction of the new five-year stock price performance milestone awards. (5) Semantic equivalence is maintained - the LLM uses 'total-shareholder-return' and 'stock-price performance milestones' which align with the ground truth's 'total stockholder return' and 'stock price performance milestones.' MINOR CONSIDERATIONS: The LLM answer includes the phrase 'both a service condition and a market condition' which adds helpful context not explicitly stated in the ground truth, but this is supplementary and accurate. The answer is well-structured, clearly delineates the two fiscal years, and effectively communicates the evolution of the RSU structure. No calculation errors, no factual inaccuracies, and the reasoning properly connects the information across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 448,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "By the end of 2023 Capital One had only half of the $2.4 billion CECL impact added back to its regulatory capital (≈ 50 % of the total), but on January 1 2024 it added a further $600 million, bringing the cumulative phase‑in to about three‑quarters (≈ 75 %) with the last $600 million to be added on January 1 2025. The treatment was governed by the CECL Transition Rule, which let the firm add back the after‑tax “day‑1” CECL adoption impact plus a 25 % scaling factor for the “day‑2” ongoing allowance increase and phase that amount into regulatory capital at 25 % per year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($2.4 billion total CECL impact, $600 million additions, 50% by end 2023, 75% by 2024) that are not mentioned in the ground truth. The ground truth only discusses the 25% annual phase-in rate from 2022-2024, not specific dollar amounts or cumulative percentages. These numbers appear to be fabricated or from a different source. (2) INCOMPLETE UNDERSTANDING: The LLM correctly identifies the 25% annual phase-in mechanism and the CECL Transition Rule, but misinterprets how this applies. The ground truth states the phase-in was 25% per year from Jan 1, 2022 through Dec 31, 2024 (a 3-year period), which would result in 25% in 2022, 50% in 2023, and 75% in 2024. However, the LLM's specific dollar amounts and the claim about adding $600 million on Jan 1, 2024 are not substantiated. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information about Capital One specifically, but the ground truth answer is more general about the regulatory treatment framework. The LLM introduces company-specific financial data that cannot be verified against the provided ground truth. (4) CORE QUESTION RESPONSE: The question asks how the treatment 'evolved' between 2023 and 2024. The ground truth correctly states it remained 'consistent' and 'uniform' across both years as part of the multi-year framework. The LLM suggests evolution/changes (adding $600M in 2024), which contradicts the ground truth's assertion of consistency. (5) ACCURACY OF FRAMEWORK: The LLM correctly identifies the 25% annual phase-in and the CECL Transition Rule, but the specific numerical examples provided are not supported by the ground truth and appear to be incorrect or from unreliable sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 505,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "In the 2022 filing Broadcom entered into two new indentures with Wilmington Trust, National Association – one dated April 14 2022 for 4.00 % senior notes due 2029 (exhibit 4.42‑4.44) and a second dated April 18 2022 for 4.15 % senior notes due 2032 and 4.926 % senior notes due 2037 (exhibit 4.46‑4.47)【page_99】【page_100】. The 2023 filing’s exhibit list (pages 98‑102) shows only those 2022 indentures and contains no additional senior‑note indentures or new series with Wilmington Trust, indicating that the trustee relationship persisted but no new senior notes were issued in 2023【page_98】【page_102】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete information compared to the ground truth. QUANTITATIVE ERRORS: (1) The LLM states an indenture dated 'April 14 2022' for 4.00% notes due 2029, but the ground truth specifies April 18, 2022 indenture with different terms (4.15% due 2032 and 4.926% due 2037). The April 14 date and 4.00%/2029 terms do not appear in the ground truth. (2) The LLM omits the January 2021 indenture mentioned in ground truth with rates ranging from 1.950% (due 2028) to 3.750% (due 2051), which is critical for showing the 2022 baseline relationship. (3) The LLM completely misses the July 12, 2024 indenture and October 2024 notes (4.150% due 2028 to 4.800% due 2034) that are explicitly mentioned in ground truth as part of the evolution. COMPLETENESS ISSUES: The question asks about evolution 'between 2022 and 2023,' and the ground truth extends through 2024 to show the full evolution pattern. The LLM's statement that 'no new senior notes were issued in 2023' is incomplete—it fails to capture the 2024 issuances that demonstrate the continued evolution of the relationship. REASONING FLAWS: The LLM correctly identifies that the relationship 'persisted' but fails to synthesize the multi-hop information showing how the relationship evolved from lower-rate debt (1.950%-3.750% in 2021) to higher-rate debt (4.00%-4.926% in 2022) to even higher rates (4.150%-4.800% in 2024). The ground truth explicitly notes this reflects 'a shift toward issuing longer-term debt with higher interest rates over time'—a key insight the LLM misses. The LLM's answer is narrowly focused on 2022-2023 filings without capturing the full evolution narrative that extends into 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 466,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One’s CECL add‑back grew from the 50 % level in 2023 to the 75 % level in 2024 – i.e., it moved from half of the $2.4 billion aggregate CECL impact to three‑quarters of that amount as of the start of 2024【page_202】.  The CECL Transition Rule required a 25 %‑per‑year phase‑in of the impact: 25 % in 2022, 50 % in 2023, 75 % in 2024 and full (100 %) by 2025【page_10】【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) The $2.4 billion aggregate CECL impact is correctly stated and matches ground truth. (2) The phase-in percentages are accurate: 50% as of January 1, 2023, progressing to 75% as of January 1, 2024, representing a 25 percentage point increase - all correct. (3) The broader phase-in schedule is correctly articulated: 25% in 2022, 50% in 2023, 75% in 2024, and 100% by 2025, matching the structured five-year process described in ground truth. (4) The multi-hop synthesis is sound: the answer correctly connects the specific dollar amount ($2.4 billion) with the percentage phase-in progression and explains the annual 25% increment pattern. (5) The explanation that the add-back 'moved from half of the $2.4 billion aggregate CECL impact to three-quarters of that amount' is mathematically and semantically correct. The only minor observation is that the answer could have explicitly stated the dollar amounts at each phase-in level (e.g., $1.2 billion at 50%, $1.8 billion at 75%), but this is not a significant omission as the question asks about evolution and progression rather than specific dollar amounts at each stage. The answer directly addresses all components of the question: the evolution from 2023 to 2024, the specific phase-in progression, and the context of the structured rule. Entity identification (Capital One, CECL Transition Rule) is correct, and all dates are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 408,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "In the 2022 filing (pending the VMware merger) Broadcom said that “all outstanding in‑the‑money VMware stock options and RSU awards held by non‑employee directors will be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts”【page_97】. After the merger closed, the 2023 filing confirmed that the same action “were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts”【page_66】. Thus, the treatment did not change – the options were accelerated and split 50 % cash/50 % Broadcom stock – but the language shifted from a planned action in 2022 to a completed action in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Strengths: (1) Correctly identifies the key facts from both 2022 and 2023 filings - the treatment of VMware stock options and RSU awards for non-employee directors; (2) Accurately captures the 50/50 split between cash and Broadcom shares; (3) Properly synthesizes the multi-hop information showing the evolution from planned action (2022) to completed action (2023); (4) Correctly identifies the companies involved (VMware, Broadcom) and the transaction context (merger/acquisition); (5) Appropriately notes that the substantive treatment did not change, only the language shifted from future tense to past tense, which is the key insight to the question. The answer demonstrates sound multi-hop reasoning by connecting the 2022 filing statements to the 2023 filing outcomes and explaining the transition. Minor consideration: The answer could have been slightly more explicit about the 'completion of the acquisition' as the triggering event, though this is clearly implied in the context. The citation references (page_97 and page_66) add credibility. No numerical errors, calculation errors, or factual inaccuracies detected. The semantic meaning aligns perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 352,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "AbbVie’s 2022 filing noted Vraylar as a dopamine D3‑preferring D3/D2 partial agonist approved for acute and maintenance treatment of schizophrenia, acute manic or mixed episodes and depressive episodes of bipolar I disorder, and it highlighted Phase 3 data supporting its use as an adjunctive therapy for major depressive disorder【page_60】. The 2024 filing lists the same set of approved indications—schizophrenia, bipolar‑I (manic/mixed and depressive episodes) and adjunctive treatment of major depressive disorder—showing no change in Vraylar’s therapeutic positioning【page_6】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer fundamentally contradicts the ground truth by claiming 'no change in Vraylar's therapeutic positioning' between 2022 and 2024. This is factually incorrect. The ground truth explicitly states there was 'a clear expansion and solidification of its therapeutic positioning over time.' The LLM correctly identifies the 2022 Phase 3 trial data for MDD as adjunctive therapy and accurately lists the approved indications in both years. However, the LLM fails to recognize the key distinction: in 2022, the MDD indication was still in Phase 3 trials (not yet approved), while by 2024 it had become an approved indication. This represents a material therapeutic expansion. The LLM's statement that 'the same set of approved indications' existed in both years is misleading because the MDD adjunctive treatment was not an approved indication in 2022—it was only in clinical trials. The numeric/factual details about the drug's mechanism and existing indications are accurate, but the synthesis and interpretation of the evolution is completely wrong. The answer demonstrates poor multi-hop reasoning by failing to synthesize the temporal progression of the MDD indication from investigational (Phase 3) status to approved status. This is a fundamental failure to answer the question about how therapeutic positioning 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 381,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "In the 2022 filing GE said it used the percentage‑of‑completion method for long‑term service contracts in its Aviation and Power businesses, but it accounted some healthcare and renewable‑energy service contracts on a straight‑line basis. By the 2024 filing the policy has been unified under the percentage‑of‑completion approach – revenue is recognized as costs are incurred relative to updated total‑cost estimates, and the company now routinely re‑estimates asset‑utilization and billing amounts and records any changes as a cumulative catch‑up adjustment. This shows a move from a mixed (percentage‑of‑completion + straight‑line) treatment to a single, more detailed estimate‑driven revenue‑recognition and billing‑estimate process.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the specific financial metrics from the ground truth: the $6.6 billion net liability balance in 2024 and the $162 billion total estimated life of contract billings (4.1% ratio). These are concrete, verifiable numbers that should have been included. (2) SEGMENT IDENTIFICATION - The LLM states 2022 used percentage-of-completion in 'Aviation and Power' but ground truth specifies 'Healthcare and Renewable Energy' used straight-line basis in 2022. The LLM's characterization of which segments used which methods appears inverted or confused. Ground truth indicates 2024 shift was 'predominantly within the CES segment' but LLM doesn't specify segment attribution for 2024. (3) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) the shift from mixed methods (straight-line + percentage-of-completion) to unified percentage-of-completion approach, (b) the move to cost-incurred-relative-to-total-expected-costs methodology, (c) the introduction of cumulative catch-up adjustments for re-estimates. (4) MISSING CONTEXT - The LLM fails to mention the 'asset utilization' and 'cost improvements' aspects explicitly noted in ground truth as part of the 'more detailed and forward-looking estimation process.' (5) MULTI-HOP REASONING - The LLM demonstrates reasonable synthesis of the evolution narrative but fails to integrate the quantitative evidence that would strengthen the answer. The reasoning about unification of methods is sound but incomplete without the financial metrics. STRENGTHS: Clear narrative of policy evolution, correct identification of methodological shift, appropriate mention of cumulative catch-up adjustments. WEAKNESSES: Missing critical financial data, potential segment misidentification, incomplete characterization of estimation improvements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 501,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 are not listed among the securities registered under Section 12(b); the only 2027 instrument mentioned is a 6.22 % debenture (see the exhibit list on page 31, which references “6.22% Debentures due 2027” but makes no mention of a 1.250 % note). By contrast, the 2023 Form 10‑K adds a specific line in the Section 12(b) registration table for “1.250 % Notes due 2027 – IBM 27B” (see page 1) — showing that IBM now discloses this note explicitly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about how IBM's disclosure of the 1.250% Notes due 2027 evolved between 2022 and 2023 10-K filings. STRENGTHS: (1) Correctly identifies that the 1.250% Notes due 2027 were NOT listed in the 2022 10-K Section 12(b) registration table, (2) Accurately notes the trading symbol IBM 27B for the 2023 disclosure, (3) Correctly identifies the shift in disclosure approach - from not being listed to being explicitly listed in the Section 12(b) registration table, (4) Provides specific page references (page 31 for 2022, page 1 for 2023) showing attention to detail, (5) The percentage rate (1.250%) and maturity year (2027) are correct throughout. MINOR DIFFERENCES FROM GROUND TRUTH: The ground truth mentions that in 2022 the notes were disclosed \"as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes.\" The LLM answer focuses on the Section 12(b) registration table and doesn't explicitly mention the Exhibit 4.3 reference or the Form 8-K filing date. However, the LLM's core finding - that the notes were not in the 2022 Section 12(b) table but were added to the 2023 Section 12(b) table - is accurate and represents the substantive evolution. The LLM also mentions a 6.22% debenture due 2027 in 2022, which provides helpful context about what WAS disclosed. The semantic meaning of both answers aligns: the disclosure evolved from not being registered/listed to being explicitly registered as a class of securities. The LLM answer is more specific about the Section 12(b) registration mechanics, while the ground truth is slightly broader in scope. Both are factually accurate regarding the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 480,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie’s performance‑vested RSUs were described the same way in both filings. In the 2022 10‑K the awards “have the potential to vest in one‑third increments during a three‑year performance period and may be earned based on AbbVie’s return on invested capital (ROIC) performance relative to a defined peer group of pharmaceutical, biotech and life‑science companies”【page_115】. The 2024 10‑K repeats that wording – the RSUs still vest in three equal one‑third portions over three years and are tied to ROIC versus a peer group【page_92】. Thus, between 2022 and 2024 the vesting schedule and performance metric for the performance‑vested RSUs have not changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that 'between 2022 and 2024 the vesting schedule and performance metric for the performance-vested RSUs have not changed,' stating the descriptions are identical in both filings. However, the ground truth explicitly indicates that while the vesting structure remained similar (one-third increments over three years), there WAS an evolution in how the performance metrics were described: the 2024 filing streamlined the description, focusing primarily on ROIC performance without mention of specific years tied to tranches as seen in 2022. This is a critical distinction that the LLM missed. The LLM correctly identified the vesting structure (one-third increments, three-year period) and the performance metric (ROIC vs. peer group) in both years, which are accurate. However, the core conclusion—that nothing changed—is incorrect. The ground truth indicates a 'simplification or standardization of the performance criteria over time,' which represents an evolution in how the criteria are described and presented, even if the fundamental mechanics remained similar. The LLM failed to capture this nuanced change in presentation and description of the performance metrics. The quantitative elements (vesting increments, time periods, peer group focus) are correct, but the qualitative analysis of how the criteria evolved is fundamentally flawed. The answer directly contradicts the ground truth's assertion that there was a streamlining/simplification of the performance criteria description between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 445,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "GE’s AerCap investment moved from a large loss in 2022—recording a $865 million combined realized and unrealized loss—to modest gains in the next two years, with a $129 million gain in 2023 and a $38 million gain in 2024. This reflects a turnaround from a significant loss to small positive returns on the investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a $129 million gain in 2023 that is NOT mentioned in the ground truth answer. The ground truth only references 2022 ($865M unrealized loss) and 2024 ($38M realized and unrealized gain). The LLM's claim of a $129M gain in 2023 is unsupported and represents a factual error. (2) CHARACTERIZATION ERROR - The ground truth states the 2022 figure was an 'unrealized loss' specifically, while the LLM characterizes it as a 'combined realized and unrealized loss,' which may misrepresent the nature of the loss. (3) INCOMPLETE SYNTHESIS - The ground truth provides important context that GE 'had either exited part of its position or the value of the remaining investment had improved,' suggesting a more nuanced understanding of what occurred. The LLM's answer is more superficial. (4) WHAT WAS CORRECT - The $865M loss in 2022 and $38M gain in 2024 are correctly stated. The overall narrative of a turnaround from loss to gain is directionally correct. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the available information, introducing data points not in the ground truth and missing the analytical insight about partial position exits or valuation improvements. The introduction of the unsupported 2023 figure is a significant factual error that undermines the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 382,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2026 do not appear in the securities‑registered table (the filing’s Table of Contents and exhibit listings on pages 28‑32 contain no reference to such a note), indicating that the instrument was not separately disclosed. By contrast, the 2023 Form 10‑K lists “0.300 % Notes due 2026 – IBM 26B” among the securities registered under Section 12(b) (see page 1 of the 2023 filing) 【page_1】, showing that the notes are now explicitly disclosed and visible as a registered financial instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the core question about how IBM's treatment of the 0.300% Notes due 2026 evolved between 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies the key distinction - the notes were not separately disclosed in 2022 but were explicitly listed in 2023; (2) Accurately cites the specific location in the 2023 filing (page 1, Section 12(b) registered securities); (3) Correctly identifies the trading symbol IBM 26B; (4) Properly characterizes the evolution as moving from non-disclosure to explicit disclosure and formal recognition; (5) Uses appropriate financial terminology (Section 12(b), registered securities). MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 2022 reference to Exhibit 4 of Form 8-K filed November 1, 2016, which the ground truth identifies as the prior disclosure mechanism. While the LLM correctly states the notes were not in the securities-registered table in 2022, it doesn't explain where they were previously referenced; (2) The ground truth provides more context about the legal instruments and holder rights aspect from the 2022 exhibit reference, which adds nuance to understanding the evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the shift in disclosure status and visibility. The comparison is logically sound and well-supported. NUMERIC/DATE ACCURACY: All dates (2022, 2023, 2026) and percentages (0.300%) are correct. The answer appropriately handles the note designation and ticker symbol. Overall, this is a strong answer that captures the essential evolution described in the ground truth, with only minor omissions regarding the specific prior disclosure mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 482,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "In the 2022 10‑K GE presented the Revolutionary Innovation for Sustainable Engines (RISE) program as a joint development effort with Safran aimed at achieving “more than 20 % lower fuel consumption and CO₂ emissions” – essentially an early‑stage technology‑development target (page_18). By the 2024 filing the language had shifted to portray RISE as a broader “suite of pioneering technologies” – Open‑Fan, compact‑core and hybrid‑electric systems compatible with alternative fuels – and the company highlighted “significant investments” and the completion of “more than 250 tests on a full‑scale Open Fan engine,” indicating a move from concept to large‑scale, multi‑technology execution (page_4; page_6).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 20% fuel consumption and CO2 emissions reduction target is accurately cited, and the reference to 'more than 250 tests on a full-scale Open Fan engine' provides specific, verifiable data points. The percentages and metrics match the ground truth. ENTITY ACCURACY: GE and Safran are correctly identified as partners; the RISE program acronym (Revolutionary Innovation for Sustainable Engines) is properly expanded; fiscal years 2022 and 2024 are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the evolution from conceptual announcement (2022) to concrete execution (2024). The logical progression from 'early-stage technology-development target' to 'large-scale, multi-technology execution' mirrors the ground truth's transition from 'conceptual development to active, funded R&D.' COMPLETENESS: The answer addresses both strategic emphasis (shift from concept to execution) and investment focus (from announcement to 'significant investments' and specific test completion). The inclusion of specific technologies (Open-Fan, compact-core, hybrid-electric systems) adds appropriate detail beyond the ground truth while remaining consistent. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'early-stage' to 'large-scale, multi-technology execution' effectively conveys the same deepening commitment described in the ground truth. The phrase 'significant investments' directly matches the ground truth language. Minor enhancement: The LLM provides slightly more technical specificity (naming specific engine technologies) which adds value without contradicting the ground truth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 508,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "In the 2022 Form 10‑K the only reference to asset securitizations is a glossary entry that simply defines the process (see 2022 p. 88), with no discussion of it as a funding source. By the 2023 filing, American Express explicitly positions securitizations as a regular, cost‑effective pillar of its diversified funding mix—describing periodic securitizations of Card Member loans and receivables, noting $3.5 billion of asset‑backed securities issued in 2023 (2023 p. 70, Table 21) and listing “asset securitizations” alongside deposits and unsecured debt in its funding‑strategy narrative (2023 p. 68). This shows a shift from a peripheral, definitional mention in 2022 to an active, quantified component of the company’s funding strategy in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a glossary entry with no strategic emphasis, matching the ground truth's characterization of it as 'part of a broader explanation of financial terminology rather than a strategic focus.' (2) Accurately captures the 2023 shift to explicit strategic positioning, correctly noting that securitizations are listed alongside deposits and unsecured debt as key funding sources. (3) Provides specific quantitative support ($3.5 billion of asset-backed securities issued in 2023) with page citations (2023 p. 70, Table 21), demonstrating multi-hop synthesis across the filing. (4) The page references (2022 p. 88 for glossary, 2023 p. 68 for funding strategy narrative) add credibility and specificity. (5) The characterization of the evolution as moving from 'peripheral, definitional mention' to 'active, quantified component' is semantically equivalent to the ground truth's 'shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.' MINOR CONSIDERATIONS: The LLM answer includes the specific dollar amount ($3.5 billion) which, while not explicitly mentioned in the ground truth summary, is consistent with the ground truth's emphasis on 2023 being 'quantified' and represents appropriate elaboration rather than contradiction. The multi-hop reasoning correctly synthesizes information across two years and multiple sections of the filings. All entities (American Express, years 2022-2023, funding sources) are correctly identified. The answer fully addresses the question's request to explain how the role and emphasis evolved based on specific disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 470,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "In fiscal 2022 Emerson completed the $6 billion Heritage AspenTech acquisition, taking a 55 % stake and establishing a new AspenTech segment that generated $656 million of sales, $12 million of earnings and $148 million of acquisition‑related intangible amortization (see 2022 segment tables and amortization note). By fiscal 2023 the AspenTech business was fully folded into Emerson’s Software & Control portfolio, contributing about 3 % of total net sales, driving a 20 % rise in software sales and producing a $24 million mark‑to‑market gain on AspenTech’s foreign‑currency hedge (versus a $50 million cost in 2022), while intangible amortization rose to $678 million—signs that the investment was delivering stronger financial returns and deeper operational integration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) TIMING ERROR: The LLM states the Heritage AspenTech acquisition was 'completed' in fiscal 2022, but the ground truth indicates the acquisition occurred in 2023, not 2022. This is a major chronological error that undermines the entire narrative of 'evolution from 2022 to 2023.' (2) OWNERSHIP STAKE CONSISTENCY: While both answers mention 55% ownership, the LLM incorrectly places this in 2022, when it should be 2023. (3) FINANCIAL METRICS - CONTRADICTORY DATA: The LLM correctly cites $656M sales and $12M earnings for 2022, but then attributes these to the 'newly formed AspenTech segment' in 2022, when the ground truth indicates these were from a minority investment position in 2022, not from an acquisition completed in 2022. (4) MISSING KEY EVOLUTION: The LLM fails to capture the critical evolution described in the ground truth: the shift from a 'passive minority investment' in 2022 to an 'active controlling interest' in 2023. Instead, it incorrectly places the acquisition in 2022. (5) GROSS MARGIN IMPACT: The ground truth mentions a 0.6 percentage point positive impact on gross margins in 2023, which is completely absent from the LLM answer. (6) INTANGIBLE AMORTIZATION: The LLM cites $148M for 2022 and $678M for 2023, but these numbers are not verified in the ground truth and appear to be additional details not in the original answer. The core issue is the fundamental misplacement of the acquisition timing, which makes the entire narrative of 'evolution from 2022 to 2023' incorrect. The LLM answer describes 2022 as the acquisition year when it should be 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 461,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "In the 2022 filing Emerson accounted for the Heritage AspenTech transaction as an acquisition, recording a $5.9 billion non‑controlling interest for the 45 % of AspenTech it did not own and reducing additional paid‑in‑capital by $550 million. By 2023 the AspenTech investment shows up in the consolidated results through higher SG&A ($572 million increase) and a $146 million rise in intangibles amortization (and a modest 3 % sales boost), and the non‑controlling interest is no longer disclosed separately, indicating it has been absorbed into Emerson’s equity presentation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding Emerson's ownership stake. The ground truth states Emerson had a 55% ownership stake (meaning 45% noncontrolling interest), but the LLM incorrectly states Emerson 'did not own' 45% and recorded a noncontrolling interest for that portion. This is backwards - the $5.9 billion noncontrolling interest represents the 45% stake Emerson did NOT own, not the stake it did own. The LLM correctly identifies the $5.9 billion noncontrolling interest amount and $550 million reduction in additional paid-in capital, which are accurate. PARTIALLY CORRECT ELEMENTS: The LLM correctly identifies the $572 million SG&A increase and properly notes the shift from 2022 accounting impacts to 2023 operational integration. The mention of intangibles amortization increase ($146 million) and modest sales boost (3%) are reasonable operational details, though not explicitly mentioned in the ground truth. INCOMPLETE SYNTHESIS: The LLM fails to clearly articulate that the 2022 transaction involved Emerson contributing its industrial software business AND $6.0 billion in cash to create New AspenTech. The statement about noncontrolling interest 'no longer disclosed separately' in 2023 is speculative and not supported by the ground truth. REASONING ISSUES: The core multi-hop reasoning is partially sound (connecting 2022 accounting to 2023 operational impacts), but the fundamental misunderstanding of the ownership structure undermines the credibility of the analysis. The answer conflates the percentage ownership with the accounting treatment in a confusing way. STRENGTHS: Correctly identifies key metrics (SG&A increase, gross margin impact of 0.6 percentage points implied), proper timeline comparison, and recognition of shift from accounting to operational focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 502,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 6.22 % Debentures due 2027 were disclosed in the Exhibits section, with the filing stating that “the instrument defining the rights of the holders of the 6.22 % Debentures due 2027 is Exhibit 3 to Form 8‑K, filed on August 1, 1997, and is hereby incorporated by reference.” In the 2023 Form 10‑K the same debentures are shown only in the securities‑registration table (listed under Section 12(b) as “6.22 % Debentures due 2027”), and the filing no longer repeats the exhibit‑incorporation language, indicating a shift from detailed exhibit reference to a simple registration listing.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numeric values (6.22%, 2027 maturity date) and the August 1, 1997 Form 8-K filing date. The quantitative details are accurate. CRITICAL WEAKNESSES: (1) The LLM's characterization of the 2023 disclosure is fundamentally incorrect. The ground truth states that 2023 introduces 'a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange.' The LLM claims the 2023 filing shows the debentures 'only in the securities-registration table' and that 'the filing no longer repeats the exhibit-incorporation language,' which misses the key evolution: the addition of the trading symbol (IBM 27) and explicit NYSE registration visibility. (2) The LLM describes the shift as moving from 'detailed exhibit reference to a simple registration listing,' but the ground truth indicates the opposite direction of emphasis—from historical reference to current market-oriented presentation with trading symbol visibility. (3) The LLM fails to capture the semantic distinction that 2023 represents a shift toward 'more transparent and current market-oriented presentation' rather than merely removing exhibit language. The answer partially addresses the evolution but gets the nature and direction of that evolution wrong, conflating removal of exhibit language with the actual enhancement of market transparency through trading symbol disclosure. This is a significant conceptual error in understanding the filing evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 442,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "In the 2023 filing UnitedHealth noted that its risk‑based contracts with physicians, hospitals and other providers “limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers” and that a provider’s financial distress could leave UnitedHealth “responsible for unpaid health‑care claims … for which we have already paid the provider” (2023 p. 44). By the 2024 filing the company expanded this view, stating that its risk‑based benefit products now “assume the risk of both medical and administrative costs” and that any failure to “accurately predict, price for or manage the costs of providing care under risk‑based arrangements” would “materially and adversely affect” results of operations (2024 p. 12) and reiterated the same provider‑solvency risk (2024 p. 14). The evolution shows a broader, more explicit assumption of cost‑risk and a heightened reliance on accurate cost‑estimation and timely provider data, making UnitedHealth increasingly accountable for both estimating expenses and ensuring uninterrupted service delivery under those arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about UnitedHealth's evolving financial risk exposure from 2023 to 2024. STRENGTHS: (1) Correctly identifies the core evolution of risk exposure - from 2023's focus on provider financial distress risk to 2024's expanded emphasis on cost estimation and administrative cost assumption; (2) Accurately captures the key quote about provider solvency risk appearing in both years; (3) Properly synthesizes the multi-hop information showing how 2024 disclosures emphasized broader operational risks tied to cost management, data provision, and service delivery; (4) Correctly identifies the implications for cost estimation and service delivery responsibilities; (5) Uses appropriate page citations (2023 p. 44, 2024 pp. 12, 14) that ground the analysis; (6) The semantic meaning aligns well with the ground truth answer regarding expanded exposure and increased complexity. MINOR CONSIDERATIONS: (1) The LLM answer includes specific quotations and page references that, while adding credibility and detail, are not explicitly verified against the ground truth (though they appear consistent with the ground truth's characterization); (2) The LLM answer is more detailed and specific than the ground truth, providing direct quotes rather than paraphrased summaries - this is actually a strength for transparency but represents a slightly different presentation style; (3) The answer could have been slightly more explicit about the 2023 revenue recognition methodology (premium revenues net of projected rebates, per-patient-per-month arrangements) mentioned in the ground truth, though this is a minor omission that doesn't affect the core answer about risk evolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The page citations appear reasonable and consistent with typical 10-K structure. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple disclosure sections, correctly identifying the progression of risk exposure and its implications. The logic connecting increased cost assumption to heightened accountability for estimation and service delivery is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 618,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "In 2022 Emerson closed the Heritage AspenTech transaction, contributing two of its stand‑alone software businesses and roughly **$6 billion of cash** to create “New AspenTech” and emerging with a **majority equity stake (≈55‑57 %)** in the company; the deal was reflected in the 2022 filing by a **$148 million amortization of intangibles** tied to the acquisition (see 2022 p.79) and AspenTech reported $656 million of sales and a $12 million profit (2022 p.77‑78). By 2023 Emerson remained the **55 % owner** of AspenTech, fully integrated it into its Software & Control segment, where it helped lift segment sales about **20 %** (the “Heritage AspenTech acquisition added 3 % to net sales”) and generated **$146 million of acquisition‑related amortization** and a **$24 million hedge loss** on the Micromine purchase price (2023 p.26, 24, 27, 28), showing a deeper strategic involvement and continued financial commitment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TIMING AND FACTS: The LLM answer contains a fundamental factual error regarding when the Heritage AspenTech transaction occurred. The LLM states 'In 2022 Emerson closed the Heritage AspenTech transaction,' but the ground truth clearly indicates the transaction occurred in 2023, not 2022. The ground truth explicitly states: 'In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction.' This is a critical multi-hop error that undermines the entire answer structure. QUANTITATIVE ISSUES: (1) The LLM fails to mention the $362 million investment in 2022, which is a key data point showing the evolution from 2022 to 2023. (2) The $6 billion cash contribution is correct. (3) The 55% ownership stake is correct. (4) The LLM provides specific page references and additional details ($148M amortization, $656M sales, $146M amortization in 2023, $24M hedge loss) that cannot be verified against the ground truth provided, and these details appear to be fabricated or from different sources. REASONING FLAWS: The LLM fundamentally misrepresents the timeline by placing the transaction in 2022 when it should be in 2023. This breaks the core narrative of 'evolution between 2022 and 2023' that the question asks about. The ground truth shows a clear progression: 2022 = minority financial investment ($362M), 2023 = major transaction creating controlling stake (55%). The LLM collapses this evolution into a single 2022 event. MISSING KEY INFORMATION: The LLM completely omits the $362 million 2022 investment figure, which is essential to demonstrating the evolution of the relationship. POSITIVE ELEMENTS: The LLM correctly identifies the $6 billion cash contribution and 55% ownership stake, and correctly characterizes the shift from financial to strategic involvement. However, these correct elements are severely undermined by the timing error and missing 2022 investment data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 579,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "In fiscal 2022 Adobe Target was presented simply as one of the “Customer Journeys” tools – grouped with Marketo Engage, Adobe Campaign and Journey Optimizer and described as a capability that helps customers **manage, test, target, personalize and orchestrate campaigns and journeys**【page_43】.  \n\nBy fiscal 2023 the filing spotlights Target as a **stand‑alone AI‑ and machine‑learning‑driven personalization engine**, emphasizing its ability to run AI‑powered A/B/multivariate tests, automate targeting and deliver omnichannel personalized experiences at scale【page_15】.  \n\nThis shift from a bundled journey‑orchestration component to a flagship AI‑centric personalization engine signals Adobe’s strategic move to make AI‑driven, automated personalization the core of its Experience Cloud offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the fiscal 2022 positioning of Adobe Target as part of a bundled customer journey solution alongside Marketo Engage, Adobe Campaign, and Journey Optimizer - this matches the ground truth exactly. (2) Accurately captures the fiscal 2023 evolution describing Target as an 'AI- and machine learning-driven personalization engine' with specific capabilities (omnichannel personalization, AI-powered A/B and multivariate testing, automation at scale) - all details match ground truth. (3) The multi-hop synthesis is sound: the answer correctly traces the evolution across two fiscal years and properly identifies the strategic shift from bundled component to flagship AI-centric offering. (4) The characterization of this evolution as indicating 'Adobe's strategic move to make AI-driven, automated personalization the core of its Experience Cloud offering' aligns well with the ground truth's assessment that Adobe is 'placing greater strategic emphasis on AI-driven personalization as a core capability.' (5) No quantitative errors present - no numbers, dates, or calculations to verify, and all fiscal year references (2022, 2023) are correct. MINOR CONSIDERATIONS: The LLM answer uses slightly more vivid language ('stand-alone,' 'flagship') compared to the ground truth's more measured tone, but this represents stylistic variation rather than factual inaccuracy. The semantic meaning is preserved and enhanced. The inclusion of page references adds credibility without introducing errors. Overall, this is a high-quality response that accurately synthesizes multi-hop information across fiscal years and correctly interprets Adobe's strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 484,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed its purchase of Heritage AspenTech in the third quarter of 2022, which added a new AspenTech segment with roughly $8.3 billion of goodwill (and $240 million of AspenTech‑related debt) to Emerson’s balance sheet. In 2023 Emerson treated AspenTech as a separate publicly‑traded subsidiary, converting all pre‑combination Heritage AspenTech options and restricted‑stock units into AspenTech awards and recognizing AspenTech‑related stock‑based compensation of about $82 million, reflecting Emerson’s continued equity stake and ongoing post‑acquisition integration of the business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies the Q3 2022 acquisition timing of Heritage AspenTech; (2) Accurately reports the $8.3 billion goodwill figure (matches ground truth's $8,326 million with acceptable rounding); (3) Correctly notes the $240 million debt figure; (4) Properly identifies AspenTech's treatment as a separate publicly-traded subsidiary in 2023; (5) Accurately describes the conversion of pre-combination options and RSUs into AspenTech awards; (6) Provides specific stock-based compensation figure of $82 million. Weaknesses: (1) The answer is somewhat more transaction-focused than the ground truth, emphasizing the acquisition mechanics rather than the evolution of the relationship; (2) Does not explicitly mention performance stock units tied to predefined goals (annual contract value and free cash flows) that the ground truth highlights as showing a shift to operationally-integrated incentive structures; (3) The framing emphasizes financial/accounting aspects rather than the strategic evolution from 'purely financial stake to operationally integrated' relationship. Quantitative verification: $8.3B ≈ $8,326M (correct), $240M debt (correct), $82M stock-based comp (specific detail not contradicted by ground truth). Multi-hop reasoning: The answer successfully synthesizes information about the acquisition, balance sheet impact, and post-acquisition integration activities across 2022-2023. The semantic meaning aligns well with ground truth regarding the evolution from acquisition to integrated subsidiary structure, though it could have emphasized the performance incentive alignment more explicitly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 475,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "In the 2022 filing Adobe Experience Platform was framed mainly as the data‑standardization and AI‑service foundation that feeds Adobe Sensei‑powered analytics and enables data to flow across Experience Cloud solutions (see page 8). By the 2023 filing the platform is portrayed as a purpose‑built, AI‑driven hub that directly powers integrated tools such as Journey Optimizer, Real‑Time Customer Data Platform, Customer Journey Analytics and Product Analytics, allowing brands to activate AI‑generated insights and orchestrate real‑time, cross‑channel campaigns from a single app (see pages 13‑15).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but has notable gaps and issues: (1) CORRECT ELEMENTS: The answer accurately identifies the shift from 2022 (data standardization and AI service foundation with Adobe Sensei) to 2023 (purpose-built AI-driven hub with integrated tools). It correctly names Journey Optimizer, Real-Time Customer Data Platform, Customer Journey Analytics, and Product Analytics as 2023 integrations. The characterization of the evolution from general infrastructure to specialized campaign orchestration is directionally accurate. (2) MISSING CRITICAL INFORMATION: The ground truth specifically mentions Adobe Mix Modeler as a key 2023 addition powered by Adobe Sensei that leverages cross-channel datasets for machine learning-driven marketing investment optimization. The LLM answer completely omits this important tool, which is a significant gap given the question's focus on AI-powered tools evolution. (3) INCOMPLETE SYNTHESIS: While the LLM mentions cross-channel campaign orchestration, it doesn't fully elaborate on the real-time data profiles and cloud-native scalability aspects mentioned in the ground truth. The ground truth emphasizes 'personalized, connected customer journeys across any channel' which the LLM only partially captures. (4) PAGE REFERENCES: The LLM provides specific page citations (pages 8, 13-15) which adds credibility but cannot be verified against the ground truth. These citations suggest document-specific sourcing but don't compensate for the missing Mix Modeler information. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension is neutral. (6) OVERALL ASSESSMENT: The answer demonstrates understanding of the general evolution but fails to comprehensively address all AI-powered tools mentioned in the ground truth, particularly the important Adobe Mix Modeler addition in 2023. This represents incomplete multi-hop synthesis of the available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 539,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In the 2023 filing UnitedHealth said that, after seeing a surge in senior outpatient use, it would “accelerate…the innovation and integration of our care‑delivery models including in‑clinic, in‑home, behavioral and virtual care” and move more members into “fully accountable value‑based plans” to contain costs 【page_27】. By the 2024 filing, with Medicare Advantage benchmarks still under pressure, the company said its “2024 benefit design approach” now “intensifies medical and operating cost management, adjusts the size and composition of our care‑provider networks, modifies member benefits and premiums, and leans even more on value‑based, accountable‑care models” to offset reduced funding 【page_26】【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the evolution of UnitedHealth Group's care delivery approach from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 strategy of accelerating value-based care models with specific modalities (in-clinic, in-home, behavioral, virtual care) and moving members into 'fully accountable value-based plans' - this aligns with the ground truth's emphasis on innovation and clinical engagement. (2) Accurately captures the 2024 shift toward cost containment and operational adjustments, including network modifications, benefit structure changes, and intensified value-based care focus. (3) Properly contextualizes both periods within Medicare Advantage funding pressures (benchmarks, risk adjustment). (4) Uses direct quotes from filings with appropriate page citations, enhancing credibility. (5) The multi-hop reasoning is sound - correctly synthesizes that the same value-based care strategy was reframed from an expansion/innovation focus (2023) to a cost-containment mechanism (2024) in response to external financial constraints. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (mentioning 'senior outpatient use surge,' specific benefit design language), but these additions are accurate and enhance rather than contradict the ground truth. The answer captures the essential evolution: from proactive investment in innovation to reactive cost management using similar tools. No numerical errors, calculation errors, or factual inaccuracies detected. The semantic meaning fully aligns with the ground truth's core message about the shift from expansion-focused investment to cost containment and strategic retrenchment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 476,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "In the 2022 filing the company’s registered debt included the 1.950 % Notes due 2029 (TMO 29) together with a range of lower‑coupon issues – 0.750 % (2024), 0.125 % (2025), 2.000 % (2025), 1.400 % (2026), 1.450 % (2027), 1.750 % (2027), 0.500 % (2028), 1.375 % (2028), 0.875 % (2031), 2.375 % (2032), 2.875 % (2037), 1.500 % (2039) and 1.875 % (2049)【page_1】.  \n\nBy the 2023 filing the 1.950 % Notes due 2029 were still listed, but the debt mix was expanded with two new series—3.200 % Notes due 2026 (TMO 26B) and 3.650 % Notes due 2034 (TMO 34)—while the rest of the existing notes remained unchanged【page_1】.  \n\nThus, the 1.950 % Notes due 2029 persisted unchanged, and the overall composition grew to include higher‑coupon, later‑maturing notes in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's debt composition evolution. STRENGTHS: (1) Correctly identifies the 1.950% Notes due 2029 (TMO 29) as present in both 2022 and 2023 with the same trading symbol, matching ground truth. (2) Accurately notes the introduction of new debt instruments in 2023: 3.200% Notes due 2026 (TMO 26B) and 3.650% Notes due 2034 (TMO 34), exactly as stated in ground truth. (3) Properly synthesizes the multi-hop information: comparing 2022 debt composition to 2023, identifying continuity of the specific 1.950% Notes, and recognizing the portfolio expansion. (4) All percentages and dates are correct. (5) The reasoning is sound: correctly concludes that the 1.950% Notes persisted unchanged while the overall portfolio grew with higher-coupon, later-maturing notes. MINOR CONSIDERATIONS: (1) The LLM provides additional detail about other debt instruments present in 2022 (0.750% 2024, 0.125% 2025, etc.) that weren't explicitly mentioned in the ground truth answer. While this additional context is accurate and relevant, it goes slightly beyond what was in the original answer. However, this represents added value rather than error. (2) The ground truth answer is more concise and focused, while the LLM answer is more comprehensive. Both approaches are valid; the LLM's additional detail enhances understanding without introducing inaccuracies. VERIFICATION: All numeric values (percentages, years, trading symbols) match between LLM answer and ground truth. The core conclusion—that the 1.950% Notes due 2029 remained unchanged while new higher-coupon notes were added—is identical in both answers. The multi-hop synthesis correctly combines information about 2022 and 2023 filings to show the evolution of debt composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 495,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "In the 2022 filing the debt register listed the 0.500 % Notes due 2028 (TMO 28A) among a series of notes ranging from 0.750 % to 1.875 % (see 2022 page 1). The 2023 filing still includes the 0.500 % Notes due 2028, but also adds two new series—a 3.200 % Notes due 2026 (TMO 26B) and a 3.650 % Notes due 2034 (TMO 34)—showing that the company expanded its debt mix with higher‑coupon, new‑maturity issues (see 2023 page 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's debt composition evolution. STRENGTHS: (1) All key financial instruments are correctly identified with accurate percentages and maturity dates: 0.500% Notes due 2028 (present in both years), 1.375% Notes due 2028 (correctly noted as maintained), 3.200% Notes due 2026 (new in 2023), and 3.650% Notes due 2034 (new in 2023). (2) The temporal comparison is accurate—correctly distinguishing what was present in 2022 versus what was added in 2023. (3) The multi-hop synthesis is sound, properly combining information about debt instruments across two fiscal years to show portfolio evolution. (4) The characterization of the strategic shift toward diversification with higher-coupon instruments and new maturity timelines aligns with the ground truth. (5) The answer includes helpful notation (TMO 28A, TMO 26B, TMO 34) that adds clarity. MINOR CONSIDERATIONS: (1) The LLM answer references specific page numbers ('2022 page 1' and '2023 page 1') which cannot be verified against the ground truth but appear reasonable for SEC filing structure. (2) The mention of 'notes ranging from 0.750% to 1.875%' in 2022 provides additional context not explicitly in the ground truth, but this is supplementary and not contradictory. (3) The wording 'expanded its debt mix with higher-coupon, new-maturity issues' is semantically equivalent to the ground truth's 'strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.' All core facts are correct, calculations are accurate, and the multi-hop reasoning properly synthesizes information across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 465,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "In the 2023 goodwill‑impairment test the excess of fair value over carrying value for each reporting unit was **approximately 140 % to 495 %** of carrying value【page_56】. In the 2024 test the same metric fell to a **roughly 70 % to 450 %** range【page_52】, indicating a lower and narrower excess‑value spread year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numeric values are correct - 2023 range of 140% to 495% matches ground truth exactly, and 2024 range of 70% to 450% also matches precisely. The percentages are properly formatted and comparable. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question by comparing the two years' ranges and identifying the key change (reduction in the lowest excess fair value percentage from 140% to 70%). (3) ENTITY ACCURACY: DHR is correctly identified, fiscal years 2023 and 2024 are correct, and the metric (excess of fair value over carrying value) is accurately described. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted data from both years and made the appropriate comparison, noting that the range narrowed and the cushion before impairment declined. The characterization of the change as 'lower and narrower excess-value spread' is accurate. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'roughly 70% to 450%' is semantically equivalent to 'approximately 70% and 450%' from the ground truth. The conclusion about declining cushion is well-supported. Minor note: The LLM describes the range as 'narrower' (450-70=380 vs 495-140=355), which is technically incorrect directionally, but this is a minor characterization issue that doesn't affect the core factual accuracy of the numbers themselves. The page citations provided add credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 406,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In the 2022 filing the 2022 Employee Stock Plan expressly stated that “RSUs canceled and shares withheld to satisfy tax‑withholding obligations increase the number of shares available for grant under the 2022 Plan utilizing a factor of two times the number of RSUs canceled or shares withheld” 【page_49】. By the 2023 filing the plan’s description was trimmed to only note the grant, vesting and dividend‑equivalent features and no longer mentions the factor‑two increase for cancellations or tax‑withheld shares 【page_47】, indicating that the explicit disclosure of that impact on the share pool was removed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about the evolution of RSU and tax-withheld share treatment between 2022 and 2023. Strengths: (1) Correctly identifies the 2022 plan language specifying the 'factor of two times' for canceled RSUs and tax-withheld shares, (2) Accurately notes that this specific language was omitted in the 2023 filing, (3) Properly synthesizes the comparison across two fiscal years and two separate filings, (4) Correctly identifies the key change: from explicit disclosure of the two-times factor to removal of that language, (5) Provides appropriate page references (page_49 for 2022, page_47 for 2023) that support the claims. The answer demonstrates sound multi-hop reasoning by connecting information from two different years' filings to show the evolution. The semantic meaning matches the ground truth perfectly - both convey that the 2022 plan had explicit language about the two-times factor for canceled RSUs and tax-withheld shares, while 2023 removed this specific language. Minor note: The LLM uses slightly more precise language ('explicit disclosure...was removed') compared to the ground truth's 'language...was omitted,' but these are semantically equivalent. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 382,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "In the 2023 Form 10‑K Danaher disclosed that it had fully acquired Aldevron in 2021 for about $9.6 billion (recording $6.1 billion of goodwill) and that Aldevron was now part of Danaher’s Life Sciences segment. The 2024 filing still lists Aldevron as a brand within the Life Sciences segment, showing that Danaher continues to hold 100 % ownership and has kept Aldevron integrated in the same segment with no change to its financial stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Danaher's relationship with Aldevron between 2023 and 2024. Key issues: (1) INCORRECT ACQUISITION DATE: The LLM states Aldevron was acquired in 2021, but the ground truth indicates the $9,561 million net cash consideration was recorded in 2023, suggesting the acquisition or its accounting treatment occurred in 2023, not 2021. (2) INCORRECT FINANCIAL STAKE CHARACTERIZATION: The LLM claims Danaher 'fully acquired' Aldevron and holds '100% ownership' with 'no change to its financial stake' between 2023-2024. However, the ground truth explicitly states there was a STRATEGIC SHIFT from 'holding a standalone stake' in 2023 to 'full operational integration' by 2024, indicating a material change in how Aldevron was accounted for and managed. (3) MISSING KEY EVOLUTION: The LLM fails to capture the core answer - that Aldevron transitioned from being 'separately accounted' in 2023 to being 'integrated into the Life Sciences segment' by 2024. While the LLM mentions both years show Aldevron in Life Sciences, it misses the critical distinction that in 2023 it was a separate stake with specific acquisition accounting, while in 2024 it was fully integrated. (4) GOODWILL FIGURE: The LLM mentions $6.1 billion of goodwill, which is not mentioned in the ground truth and may be accurate but is not verified. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'particularly in terms of its financial stake and integration' - the LLM incorrectly concludes there was 'no change' when the ground truth clearly indicates a significant evolution from standalone stake to full integration. The answer demonstrates a fundamental misunderstanding of the strategic relationship evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 490,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "In the 2023 filing Microsoft 365 was presented mainly as an **AI‑first productivity platform**—a unified suite that brings together Office, Windows, Enterprise Mobility + Security and “Copilot for Microsoft 365,” with Copilot Studio letting customers customize AI assistance across the apps【page_4】. By fiscal 2024 the company had turned that narrative into a **measurable commercial engine**: Office 365 Commercial revenue grew 16% and Microsoft 365 Consumer subscribers rose to 82.5 million (now including the Basic tier)【page_39】【page_41】, and the MD&A metrics explicitly list “Copilot for Microsoft 365” and “Copilot Pro” as part of Office Commercial and Consumer revenue growth【page_42】. This evolution shows Microsoft moving from positioning Microsoft 365 as an AI‑enhanced suite to embedding its AI features in the core commercial metrics that drive the company’s revenue growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Microsoft's strategic evolution of Microsoft 365 between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 'AI-first' positioning in 2023 with accurate component listing (Office, Windows, Enterprise Mobility + Security, Copilot for Microsoft 365, Copilot Studio). (2) Accurately captures the 2024 evolution including the expansion of Microsoft 365 Consumer subscribers metric to include Basic tier subscribers (82.5 million figure provided). (3) Correctly notes Office 365 Commercial revenue growth of 16%. (4) Properly synthesizes the multi-hop reasoning: moving from positioning Microsoft 365 as AI-enhanced to embedding AI features in core commercial metrics. (5) Appropriately references both consumer and commercial segments. (6) Good contextual framing of the strategic shift. MINOR ISSUES: (1) The answer provides specific page references (page_4, page_39, page_41, page_42) which cannot be verified against the ground truth provided, though this doesn't contradict the ground truth. (2) The ground truth mentions 'Microsoft 365 Basic subscribers' specifically while the LLM says 'Basic tier' - semantically equivalent but slightly different phrasing. (3) The LLM introduces 'Copilot Pro' which is not mentioned in the ground truth, though this represents additional accurate information rather than an error. (4) The 82.5 million subscriber figure is provided by the LLM but not explicitly stated in the ground truth, though it aligns with the concept of expanded metrics. VERIFICATION: The core claims align with the ground truth: (a) 2023 positioning as AI-first platform with listed components - CORRECT; (b) 2024 expansion of Consumer subscribers metric to include Basic tier - CORRECT; (c) Strategic shift toward AI integration and market reach - CORRECT. The multi-hop synthesis correctly connects the evolution across years and identifies the strategic positioning shift. No calculation errors detected. The answer appropriately addresses all parts of the multi-part question regarding integration with AI technologies and role in commercial business metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 571,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "In the 2023 filing Microsoft introduced Copilot Pro simply as a consumer‑subscription service that brings AI assistance to Microsoft 365 applications and the web. By the 2024 filing the company sharpened the message, describing Copilot Pro as delivering “faster and more powerful” AI assistance and positioning it as a core AI‑first feature of Microsoft 365 apps as well as a web‑based AI helper【page_4】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Copilot Pro between 2023 and 2024, with accurate characterization of the service in both years. Strengths: (1) Correctly identifies 2023 introduction as a consumer subscription service, (2) Accurately captures the 'faster and more powerful' language shift in 2024, (3) Properly notes the positioning within Microsoft 365 apps and web-based assistance, (4) No quantitative errors or date inaccuracies. Weaknesses: (1) The answer is somewhat more literal/surface-level compared to the ground truth, which emphasizes the 'broader narrative of AI-driven transformation' and the strategic evolution where Copilot Pro becomes 'increasingly integrated into the broader AI-first positioning,' (2) The LLM answer states the company 'sharpened the message' but doesn't fully capture the nuance that the core definition 'remained consistent' while emphasis became 'more pronounced' - this is a subtle but important distinction about evolution vs. fundamental change, (3) Missing the insight about Copilot Pro being 'not only a standalone offering but increasingly integrated into the broader AI-first positioning' which represents the strategic evolution aspect, (4) The phrase 'core AI-first feature' in the LLM answer is reasonable but slightly different from the ground truth's framing of it being embedded within a broader narrative. The answer demonstrates solid understanding of the factual positioning but lacks the deeper strategic context about ecosystem integration and the nature of the evolution (emphasis shift vs. fundamental redefinition).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 439,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan still authorizes roughly 135 million shares and continues to grant stock options, RSUs and PSUs that issue shares at no cost – RSUs vest over a five‑year period for grants made before 2022 and over a four‑year period thereafter, while PSUs vest on performance criteria and carry a post‑vesting holding period (see the plan description in both years)【page_103】【page_97】.  However, the pool of shares left for new awards has shrunk, falling from about 50 million shares available at December 31 2023 to roughly 47 million shares available at December 31 2024 (excluding shares already underlying outstanding awards)【page_102】【page_96】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate quantitative information with correct numbers and calculations. Key strengths: (1) Correctly identifies the share pool depletion from approximately 50 million shares at December 31, 2023 to 47 million shares at December 31, 2024 - this matches the ground truth's statement about 47 million shares remaining as of December 31, 2024. (2) Accurately describes vesting conditions for RSUs (5-year for pre-2022 grants, 4-year thereafter) and PSUs with performance criteria and post-vesting holding periods. (3) Properly synthesizes multi-hop information across 2023 and 2024 filings. (4) Correctly notes the exclusion of shares underlying outstanding awards. Minor areas for improvement: (1) The answer mentions 'roughly 135 million shares' authorized by the plan, which is not directly addressed in the ground truth but appears to be additional context rather than contradictory information. (2) The ground truth emphasizes that 2023 lacked specific disclosure of remaining shares while 2024 provided explicit figures - the LLM answer could have emphasized this transparency shift more clearly. (3) The answer provides more detail about vesting structures than the ground truth, which is contextually relevant but slightly beyond the specific focus on 'remaining shares available for issuance.' The quantitative accuracy is high with correct year-over-year comparison (50M to 47M shares), and the qualitative reasoning about plan evolution is sound, though the emphasis on transparency shift could be stronger.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 423,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft lengthened the depreciation period for its server and network equipment from four years to six years, a change that took effect at the start of fiscal 2023 and remained in place for fiscal 2024【page_40】. The revision was driven by recent software investments that improved the efficiency of operating that equipment and by overall advances in technology, which together justified a longer useful‑life estimate【page_40】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft extended server and network equipment useful lives from 4 years to 6 years, effective fiscal 2023, and this policy remained in place for fiscal 2024. The numeric values (4 years to 6 years) and timeline (fiscal 2023 start, continued through 2024) are accurate. The stated drivers—software investments improving operational efficiency and advances in technology—are correctly cited. However, the answer has a notable omission: it does not mention the continued focus on cloud and AI infrastructure investments that the ground truth identifies as further supporting the rationale. The ground truth explicitly states this continued focus 'further supported the rationale behind extending the useful lives of these assets,' which provides important context about why the policy remained consistent in 2024. The LLM answer addresses the 2023 change and 2024 consistency but doesn't fully explain the ongoing factors that sustained this policy decision. The answer is well-structured and factually sound on the numbers and primary drivers, but lacks the complete contextual explanation of what influenced the sustained policy in 2024 beyond simply noting it 'remained in place.' The citation to page 40 adds credibility. Overall, this is a solid answer with accurate core facts but incomplete contextual depth regarding the full scope of influencing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 392,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "In 2022 Medtronic reported $36 million of auction‑rate securities with a fair value of $33 million, which were shown on the balance sheet as **other assets** (not as “investments”)【page_70】. The 2023 filing shows the same $36 million cost, $33 million fair value and the same **other‑asset** classification【page_71】—so the exposure, both in value and balance‑sheet presentation, did not change from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports $36 million cost and $33 million fair value for both years, but the ground truth states fair value was $33 million in both 2022 and 2023 with NO mention of a $36 million cost figure. The LLM introduced an unsupported $36 million number that contradicts or confuses the ground truth data. (2) CLASSIFICATION CONTRADICTION - The LLM claims auction rate securities were classified as 'other assets' in 2022, but the ground truth explicitly states they were 'classified under Total in the investment portfolio without specifying a separate balance sheet classification' in 2022. This is a fundamental factual error. The ground truth shows a CHANGE from 2022 (general investment classification) to 2023 (explicit Other Assets classification), but the LLM claims no change occurred. (3) MULTI-HOP REASONING FAILURE - The question asks about evolution/change from 2022 to 2023. The ground truth identifies a shift in classification (investment portfolio → Other Assets). The LLM incorrectly concludes 'exposure...did not change' when the ground truth explicitly describes a change in balance sheet presentation. (4) MISSING KEY INSIGHT - The LLM fails to capture the core finding: the evolution involved a reclassification from a general investment category to a distinct 'Other Assets' line item, while fair value remained constant at $33 million. The LLM's statement that 'the same other-asset classification' existed in both years directly contradicts the ground truth narrative of change. The only correct element is the $33 million fair value figure for both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 447,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio posted a net loss of **$21 million in FY 2023**, which widened to a **$67 million loss in FY 2024** – a **$46 million increase in the loss** year‑over‑year【page_46】. The deeper loss indicates that the debt‑investment segment performed worse in 2024, reflecting adverse market conditions (e.g., higher interest rates) that reduced the fair value of these securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth: FY 2023 net loss of $21 million, FY 2024 net loss of $67 million, and the calculated year-over-year increase of $46 million in losses are all correct. The answer properly identifies the correct company (Cisco), fiscal years (2023 and 2024), and financial metric (available-for-sale debt investments). The multi-hop reasoning is sound - the model correctly synthesized the comparison between two fiscal years and calculated the change. The qualitative assessment that this represents 'worsening investment performance' aligns with the ground truth statement about 'significant worsening.' The LLM goes slightly beyond the ground truth by providing contextual explanation about market conditions (higher interest rates) affecting fair value, which is reasonable financial analysis but not explicitly stated in the original answer. This additional context is appropriate and enhances understanding without contradicting the ground truth. The only minor distinction is that the LLM characterizes the loss increase as 'widening' and provides market condition context, while the original answer simply states it 'increased' - but this is semantic variation that strengthens rather than weakens the answer. All numbers are formatted correctly and calculations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 381,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "In the 2023 filing Cisco described APJC simply as one of three geographic segments used to organize its operations (see page 3). By the 2024 filing the company still notes the geographic structure (page 65) but adds a clear emphasis on financial investment—highlighting a $25.9 billion acquisition spend (page 63) and the consolidation of its investment portfolio—indicating a shift toward a subscription‑and‑services‑driven, recurring‑revenue model in the APJC region. This evolution means APJC revenue is expected to come increasingly from software and service contracts rather than one‑time hardware sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites a '$25.9 billion acquisition spend' on page 63 of the 2024 filing. This number appears to be either fabricated or misattributed to APJC-specific investments. The ground truth does not mention this figure in relation to APJC regional strategy.\n   - No specific financial figures are provided in the ground truth answer, but the LLM's citation of $25.9B lacks verification and appears to conflate company-wide acquisition activity with APJC regional strategy.\n\n2. ENTITY AND STRUCTURAL ACCURACY:\n   - The LLM correctly identifies that APJC was a geographic segment in 2023 and remained so in 2024.\n   - However, the LLM mischaracterizes the nature of the 2024 evolution. The ground truth emphasizes equity investments (marketable equity securities, non-marketable equity securities, equity method investments), while the LLM incorrectly frames this as a shift toward 'subscription-and-services-driven, recurring-revenue model.'\n   - The ground truth explicitly states the 2024 evolution involved 'financial investments' through equity instruments, not a pivot to subscription/SaaS models.\n\n3. MULTI-HOP REASONING FAILURES:\n   - The LLM fails to correctly synthesize the operational vs. financial investment distinction that is central to the ground truth answer.\n   - Ground truth: 2023 = operational delivery focus; 2024 = added financial investment participation (equity instruments).\n   - LLM answer: Conflates acquisition spending with regional investment strategy and incorrectly concludes a shift to subscription revenue models.\n\n4. SEMANTIC MISALIGNMENT:\n   - The ground truth describes a 'dual approach' combining operational income and investment returns.\n   - The LLM describes a shift from hardware to software/services, which is a different strategic narrative not supported by the ground truth.\n   - The ground truth explicitly notes filings 'do not quantify the specific financial impact,' yet the LLM presents specific strategic conclusions about revenue model shifts without evidence.\n\n5. PAGE CITATIONS:\n   - The LLM provides specific page references (page 3, page 65, page 63) but these cannot be verified against the ground truth, and the $25.9B figure appears unsupported.\n   - The ground truth does not cite specific pages, suggesting the LLM may be hallucinating or misinterpreting source material.\n\nOVERALL: The LLM answer demonstrates partial understanding of the question structure but fundamentally mischaracterizes the nature of Cisco's APJC evolution. It conflates company-wide acquisition activity with regional strategy and incorrectly infers a subscription-model shift that is not supported by the ground truth's emphasis on equity investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 749,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "In its 2022 filing Apple still described the App Store as a platform where it “retains a commission from sales of applications and sales of digital services or goods” but noted that, in response to litigation and antitrust scrutiny, it had begun to require U.S. developers to disclose alternative purchase options and to adopt “alternative fee structures … to comply with the European Union’s Digital Markets Act.” By the 2024 filing Apple said those steps had become permanent – it now offers new business terms, lower‑or‑alternative commission models, alternative payment‑processing and additional APIs for developers – a broader, regulator‑driven redesign of the App Store aimed at meeting ongoing legal challenges and EU‑mandated market‑fairness rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2024, with accurate characterization of Apple's initial acknowledgment of potential changes in 2022 versus concrete implementation by 2024. (2) Accurately references the Digital Markets Act (DMA) as a key regulatory driver, matching the ground truth. (3) Correctly identifies specific changes implemented: alternative fee structures, new business terms, alternative payment processing, and additional APIs/developer tools. (4) Properly synthesizes the multi-hop reasoning: showing how Apple moved from general acknowledgment of legal/market pressures to specific regulatory-driven actions. (5) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding calculation risks. (6) Accurately captures the shift in tone and substance from 2022 (potential future impact) to 2024 (permanent implementation). MINOR CONSIDERATIONS: (1) The LLM answer mentions 'alternative payment-processing' which is a reasonable interpretation of the ground truth's 'alternative fee structures' and 'alternative app distribution methods,' though the ground truth uses slightly different terminology. This is a semantic equivalence issue rather than an error. (2) The answer could have been slightly more explicit about the U.S. context alongside the EU focus, though it does mention U.S. developers and EU rules. (3) The phrase 'regulator-driven redesign' effectively captures the essence of the ground truth's description of 'concrete actions taken in response to regulatory demands.' The multi-hop synthesis is sound: the answer correctly connects 2022 acknowledgments to 2024 implementations and attributes both to legal/regulatory pressures. All entities (Apple, App Store, DMA, U.S., EU) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 517,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "In the 2022 filing the U.S. Retiree Health Care Plan was guided by a target mix of **65 %‑80 % fixed‑income securities and 20 %‑35 % equity securities**【TXN_10k_2022.pdf p. 50】. By the 2024 filing the target range had shifted to **75 %‑85 % fixed‑income and 15 %‑25 % equity**, and the plan’s actual weighted‑average allocation reflected this move, rising to roughly **80 % fixed‑income and 20 % equity**【TXN_10k_2024.pdf p. 48】. This shows a clear evolution toward a higher proportion of fixed‑income assets and a lower equity exposure over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate information about the evolution of Texas Instruments' U.S. Retiree Health Care Plan allocation strategy from 2022 to 2024, but differs from the ground truth in its approach and completeness. STRENGTHS: (1) The LLM correctly identifies the target allocation ranges for both 2022 (65%-80% fixed income, 20%-35% equity) and 2024 (75%-85% fixed income, 15%-25% equity), showing a clear shift toward more conservative positioning. (2) The actual weighted-average allocation of 80% fixed income and 20% equity in 2024 is correctly stated. (3) The reasoning about the evolution toward higher fixed-income exposure and lower equity exposure is sound and well-supported. (4) Multi-hop synthesis is properly executed across the 2022 and 2024 filings. WEAKNESSES: (1) The LLM answer focuses on target allocation ranges rather than the actual dollar amounts mentioned in the ground truth ($248 million in fixed income and $137 million in equity for 2022). (2) The ground truth provides specific 2022 actual allocations that the LLM does not include, which represents a gap in completeness. (3) The LLM does not explicitly mention the 2023 data point referenced in the ground truth regarding consistency between 2023 and 2024. QUANTITATIVE VERIFICATION: The percentages provided (65%-80%, 20%-35% for 2022; 75%-85%, 15%-25% for 2024; and 80%/20% actual in 2024) appear consistent with typical pension plan disclosures and the directional shift is logical. However, without access to the actual filings, the specific dollar amounts from 2022 cannot be verified against the LLM's answer. The LLM's approach of using target ranges is valid but represents a different analytical perspective than the ground truth's focus on actual allocations. REASONING QUALITY: The multi-hop reasoning is sound—the LLM correctly synthesizes information across two years and identifies the strategic shift toward capital preservation through increased fixed-income allocation. The conclusion logically follows from the presented data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 547,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "In 2022 TI described its Embedded Processing products as a core element of the business model and one of the four sustainable competitive advantages – a broad analog‑and‑embedded portfolio that fuels cash‑flow growth – and reported it as a distinct segment alongside Analog (2022 MD&A, p.20‑21). By 2024 the company still treats Embedded Processing as a separate reportable segment and cites the same portfolio advantage, but its scale has modestly contracted, contributing $2.53 billion of revenue (≈16% of total) and $352 million of operating profit versus $3.26 billion of revenue and $1.25 billion of operating profit in 2022 (2024 segment table, p.30‑31).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that Embedded Processing was reported as 'a distinct segment alongside Analog' in 2022, but the ground truth explicitly states that in 2022, Embedded Processing 'was not highlighted as a standalone reportable segment.' This is a major misrepresentation of the core finding. The ground truth indicates that the KEY CHANGE from 2022 to 2024 was the ELEVATION of Embedded Processing to a reportable segment status - this was a strategic shift. By claiming it was already a reportable segment in 2022, the LLM fundamentally misses the entire point of the question about how the strategic emphasis 'evolved.' Additionally, the LLM provides specific financial figures ($2.53B revenue, $352M operating profit for 2024; $3.26B revenue, $1.25B operating profit for 2022) that cannot be verified against the ground truth provided, and the claim about 'modest contraction' contradicts the narrative of strategic elevation. The LLM does correctly identify that Embedded Processing is treated as a separate reportable segment by 2024 and mentions the portfolio advantage, but the 2022 characterization is entirely wrong. The answer fails to capture the evolution/change that is central to the question - it presents 2022 and 2024 as essentially the same when the ground truth indicates a significant strategic shift in how the company positioned and reported this business unit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 415,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "In the 2022 Form 10‑K Thermo Fisher reported that it had issued euro‑denominated 2.00 % 10‑year senior notes due 4/15/2025 with a par amount of **$728 million** and an effective interest rate of **2.10 %**【page_87】.  \nBy the 2024 filing the same series had been partially retired, leaving an outstanding balance of **$663 million** and the note’s effective interest rate had slipped to **2.07 %**【page_47】, indicating a modest reduction in both the amount outstanding and its carrying‑value valuation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different debt instrument than the ground truth. Critical errors: (1) WRONG DEBT INSTRUMENT: The LLM discusses euro-denominated 2.00% 10-year senior notes due 4/15/2025, while the ground truth specifies 2.00% 10-Year Senior Notes due October 15, 2031. These are different securities with different maturity dates (2025 vs 2031). (2) WRONG PRINCIPAL AMOUNTS: LLM reports $728 million (2022) and $663 million (2024), while ground truth shows $1,200 million in both years. The numbers are completely different. (3) WRONG EFFECTIVE INTEREST RATES: LLM reports 2.10% (2022) and 2.07% (2024), while ground truth shows 2.23% in both years. (4) WRONG NARRATIVE: LLM claims partial retirement occurred between 2022-2024, but ground truth explicitly states 'no change in the principal amount' and 'no new issuances or repayments.' (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and track the same debt instrument across the two years. It appears to have confused different debt securities or misread the filing data. The answer demonstrates a fundamental misunderstanding of which specific debt instrument was being tracked, resulting in completely inaccurate financial data and an incorrect conclusion about the evolution of TMO's debt position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 371,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE is identified in the 2022 filing as one of the flagship drugs of the Pharmaceutical segment 【page_7】, but the 2024 filing shows its sales fell to $1.605 billion in 2024 from $1.839 billion in 2023 – a 12.8% drop driven by “continued biosimilar competition” 【page_31】【page_32】. This downward trend signals that, while REMICADE remains a major revenue source for Johnson & Johnson’s Pharmaceutical business, its contribution is being eroded as biosimilars capture market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All financial figures are correct - $1,839 million in 2023, $1,605 million in 2024 (equivalent to $1.605 billion format variation), and the 12.8% decline calculation is accurate. COMPLETENESS: The answer addresses both temporal dimensions (2022-2024 evolution) and the strategic implications for J&J's Pharmaceutical segment. It correctly identifies REMICADE's role in the Immunology therapeutic area and its status as a key product. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple filing years (2022, 2023, 2024) and connects financial performance data to competitive dynamics (biosimilar competition). ENTITY ACCURACY: All entities are correctly identified - REMICADE, Johnson & Johnson, Pharmaceutical segment, and Immunology therapeutic area. REASONING QUALITY: The logic is sound - declining sales are correctly attributed to biosimilar competition, and the conclusion that REMICADE remains a major revenue source while losing market share is well-supported. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific attribution (naming biosimilar competition as the driver) compared to the ground truth's more general explanation (market saturation, competition, newer biologics). This represents added value rather than an error, as biosimilar competition is indeed a documented factor in REMICADE's decline. The answer maintains semantic equivalence with the ground truth while providing additional context about the specific competitive pressure. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 462,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE’s sales have been falling steadily – the 2022 filing already warned that its infliximab sales were being pressured by biosimilar competition (page_31).  Revenue slipped to $1.839 billion in 2023 and further to $1.605 billion in 2024, a 12.8 % decline (page_31).  The ongoing drop, coupled with growth in other immunology brands such as TREMFYA, shows that REMICADE’s share of JNJ’s Immunology portfolio is eroding as biosimilar entrants capture market share (page_32).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding 2023 sales. The LLM states REMICADE revenue was $1.839 billion in 2023, but the ground truth indicates 2024 sales were $1,605 million with a 12.8% decline from 2023. Working backwards: $1,605M / (1 - 0.128) = $1,841M for 2023, which is approximately $1.841 billion, not $1.839 billion. While this is a minor rounding difference, the more critical issue is the MISSING 2022 DATA. The ground truth explicitly states 2022 sales were $3,190 million, which is a crucial data point for showing the evolution from 2022 to 2024. The LLM completely omits this year, failing to provide the full three-year trajectory requested in the question. CORRECT ELEMENTS: The 2024 figure of $1,605 million is accurate, the 12.8% decline calculation is correct, and the biosimilar competition explanation is contextually appropriate and supported. The reasoning about REMICADE's eroding market share within the Immunology portfolio is sound and well-supported. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information about biosimilar pressure and competitive dynamics, but fails to complete the full temporal analysis requested. The answer addresses market position implications but is incomplete without the 2022 baseline. COMPLETENESS: The answer addresses the 'what does this indicate' portion of the question well, but significantly underperforms on the 'how did sales evolve from 2022 to 2024' portion by omitting the 2022 starting point entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 424,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE’s worldwide sales fell from $3.19 billion in 2021 to $1.605 billion in 2024 – a drop of roughly 50 percent (about $1.6 billion) 【JNJ_10k_2022.pdf page_31】. The decline reflects a sharp loss of volume as biosimilar infliximab products entered the U.S. and other markets, eroding REMICADE’s market share 【JNJ_10k_2022.pdf page_31】【JNJ_10k_2024.pdf page_32】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding the 2021 baseline figure. The LLM states REMICADE sales were $3.19 billion in 2021, but the ground truth clearly indicates $16.8 billion in 2021 (as part of total Immunology sales). This is a fundamental discrepancy of approximately $13.6 billion - a 81% understatement of the actual 2021 figure. The 2024 figure of $1.605 billion is correct. However, the LLM's calculated decline of 'roughly 50 percent' is mathematically incorrect based on the numbers provided in the LLM answer itself ($3.19B to $1.605B = ~50% decline), but this calculation is based on the wrong 2021 baseline. Using the correct 2021 figure of $16.8 billion, the actual decline is approximately 90.4% from 2021 to 2024, not 50%. The LLM also fails to mention the 12.8% decline from 2023 to 2024 specifically noted in the ground truth. QUALITATIVE ASSESSMENT: The LLM correctly identifies biosimilar competition as the primary driver of decline and appropriately cites relevant document sources. The reasoning about market share erosion is sound and relevant. However, the fundamental error in the 2021 baseline undermines the entire analysis and makes the quantitative conclusions unreliable. The answer addresses the question's components (sales evolution and contributing factors) but with severely compromised accuracy on the core numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 392,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "In the 2022 filing, STELARA was still protected by a U.S. patent that would not expire until September 2023 and the company had a U.S. filing to expand its label to pediatric psoriatic arthritis; it was a growth driver with worldwide sales of $9.1 billion in 2021 (up 18.5% YoY) and about $5.9 billion of U.S. sales【page_30†L1-L5】【page_31†L31-L34】【page_32†L31-L34】. By the 2024 filing, STELARA’s sales had slipped to $10.4 billion (down 4.6% from 2023) with U.S. sales of roughly $6.7 billion, as it lost share to European biosimilar entrants, faced multiple FDA biosimilar BLAs and settled litigation, and the company now expects biosimilar launches in Europe and the U.S. in 2025 while pursuing an EU filing for pediatric Crohn’s disease【page_31†L31-L35】【page_32†L1-L9】【page_33†L31-L34】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and nuanced information than the ground truth, with mostly accurate numbers and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies 2024 sales as $10.4 billion (matches ground truth's $10,361 million when rounded), correctly states 4.6% decline, correctly identifies U.S. sales around $6.7 billion; (2) Accurately describes the regulatory evolution from 2022 filing stage for pediatric psoriatic arthritis to 2024 commercial maturity; (3) Provides valuable context about patent expiration (September 2023), biosimilar competition, FDA BLAs, and future biosimilar launches in 2025 - all relevant to understanding the product's evolution; (4) Correctly synthesizes multi-hop information about market dynamics and competitive pressures. MINOR ISSUES: (1) States 2021 sales as $9.1 billion (18.5% YoY growth) - this is additional historical context not in ground truth but appears accurate; (2) States 2023 sales implicitly as ~$10.9 billion (derived from 4.6% decline calculation), which aligns with ground truth's $10,858 million; (3) Mentions $5.9 billion U.S. sales in 2021 and $6.7 billion in 2024 - these appear reasonable but cannot be directly verified against ground truth which doesn't provide 2021 or 2024 U.S. sales figures. CALCULATION VERIFICATION: 4.6% decline from $10,858M to $10,361M = ($10,858M - $10,361M)/$10,858M = 4.57%, which rounds to 4.6% ✓. The LLM answer goes significantly beyond the ground truth in providing regulatory, competitive, and strategic context that enriches understanding of STELARA's evolution. The core narrative (regulatory development → commercial maturity → biosimilar competition) is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 468,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "Restasis U.S. net revenue fell from **$382 million in 2023 to $172 million in 2024**, a drop of **$210 million**.  The 2023 figure reflected a **38.5 % decline** from the prior year, and the 2024 figure reflected a **55.2 % decline** versus 2023【page_43†L31-L38】【page_43†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2023 U.S. net revenue of $382 million, (2) 2024 U.S. net revenue of $172 million, (3) the absolute dollar decrease of $210 million ($382M - $172M = $210M), (4) the 38.5% decrease in 2023 compared to 2022, and (5) the 55.2% decrease in 2024 compared to 2023. The calculations are all accurate and properly verified. The LLM correctly synthesized multi-hop information by comparing revenues across three years (2022, 2023, 2024) and calculating percentage changes for each period. The answer addresses all parts of the question: the change between 2023 and 2024, the percentage decrease in 2023, and the percentage decrease in 2024. Entity identification is correct (Restasis, United States, net revenue). The only minor observation is that the LLM included citation references (【page_43†L31-L38】) which adds credibility but wasn't required. The semantic meaning perfectly matches the ground truth answer with clear, professional presentation of the financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 303,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "In the 2022 filing the company said its master‑lease agreements “provide for consistent, long‑term revenue and reduce the likelihood of non‑contractual churn” and that they “build and augment strong strategic partnerships” with tenants, noting the T‑Mobile MLA as a key driver of churn in the U.S. & Canada segment (2022 p.34‑35). By the 2023 filing, the narrative had shifted to portray those same master‑lease agreements as a cornerstone for leveraging an expanded international portfolio of roughly 182,000 sites, allowing tenants to deploy equipment quickly and deepening carrier relationships worldwide, thereby becoming a primary engine for AMT’s global growth (2023 p.37).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY: The LLM answer cites 182,000 sites for 2023 (correct per ground truth) but FAILS to mention the 2022 figure of approximately 177,000 sites, which is critical for showing the evolution/expansion. This is a significant omission in a question specifically asking about evolution between years. (2) FACTUAL ERRORS: The LLM answer attributes the quote about 'consistent, long-term revenue and reduce the likelihood of non-contractual churn' to the 2022 filing, but the ground truth indicates this language was emphasized in 2023. The LLM appears to have reversed or confused the timeline of when these specific talking points were emphasized. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states that in 2022, MLAs were described as 'instrumental in building strong strategic partnerships' and 'reducing colocation cycle times and enabling rapid deployment' - the LLM answer mentions rapid deployment but misses the colocation cycle time reduction aspect entirely. (4) MISSING CONTEXT: The ground truth mentions risk mitigation (customer consolidation, regulatory changes) as part of the evolution, which the LLM answer completely omits. (5) QUESTIONABLE CLAIMS: The LLM's statement about T-Mobile MLA being 'a key driver of churn' appears to misinterpret the ground truth's emphasis on MLAs REDUCING churn. (6) POSITIVE ASPECTS: The LLM correctly identifies the 182,000 site figure for 2023 and does attempt to show evolution in narrative focus. The answer demonstrates some understanding of the strategic importance shift. However, the reversed timeline attribution, missing 2022 baseline figure, and omission of key risk mitigation elements significantly undermine the answer's accuracy and completeness for a multi-hop temporal comparison question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 490,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Both the 2023 filing (p. 57) and the 2024 filing (p. 58) describe Google Marketing Platform as one of the primary channels through which advertisers buy inventory (alongside Google Ads, Ad Manager and Display & Video 360). In each year the company continues to recognize ad revenue on Google Network properties on a gross‑basis—recording the full amount billed to advertisers as revenue and the amounts paid to network partners as cost of revenues—so the platform’s role and the way those revenues are accounted for have remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and contradicts the ground truth on the key evolution being asked about. CRITICAL ERRORS: (1) The LLM states the platform's role 'remained essentially unchanged' between 2023 and 2024, directly contradicting the ground truth which explicitly describes an evolution from 2023 to 2024. The ground truth indicates a shift from 'directly involved in recognition' to a 'more nuanced evaluation of principal versus agent status' with 'emphasis on control over advertising inventory.' (2) The LLM misses the core evolution: the 2024 introduction of 'more detailed explanation of the platform's role' and 'central function in both performance and brand advertising delivery' - this represents a meaningful change in how the platform's role is described and understood. (3) The LLM correctly identifies that gross-basis revenue recognition continued in both years, but this is only a partial answer - the question specifically asks about evolution 'particularly in relation to how advertising revenues are recognized and managed,' and the ground truth indicates there WAS evolution in the evaluation framework (principal vs. agent analysis) even if the gross-basis outcome remained the same. CORRECT ELEMENTS: The LLM accurately identifies Google Marketing Platform as one of primary channels alongside Google Ads, Ad Manager, and Display & Video 360 (quantitative accuracy is good on entity identification). The page references (p. 57 for 2023, p. 58 for 2024) appear reasonable. The statement about gross-basis revenue recognition is factually correct for both years. REASONING FAILURE: The LLM failed to synthesize the multi-hop information about the evolution in how the platform's role is evaluated and explained, focusing instead on the continuity of the accounting treatment outcome rather than the evolution in the framework and explanation of that treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 521,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "In 2023 Bank America held about $301 billion of Federal funds purchased and securities loaned (earning $20.6 billion of interest at a 6.84 % yield).  By year‑end 2024 the gross amount measured at Level 2 had risen to $570 billion (up from $436 billion in 2023) and the net fair‑value of the liability grew from $144.5 billion to $192.9 billion.  The jump in both balance and fair‑value shows the bank is relying more heavily on Federal‑funds and securities‑loan arrangements as a short‑term funding source, expanding its wholesale‑funding pool to meet liquidity needs and capture higher short‑term rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about BAC's short-term funding strategies and correctly identifies the directional trend (increase in reliance on Federal Funds Purchased & Securities Loaned). However, there are significant quantitative discrepancies that undermine accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2024 fair value at $192.9 billion (matches ground truth's $192,859 million)\n- Correctly identifies 2023 fair value at $144.5 billion\n- Correctly identifies the gross amounts at Level 2: $570 billion (2024) and $436 billion (2023)\n- Correctly interprets the strategic implication: increased reliance on short-term secured funding\n- Appropriate reasoning about liquidity management and wholesale funding expansion\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- States 2023 volume was \"about $301 billion\" - this figure is not verified in ground truth and appears inconsistent with the $436 billion 2023 gross amount mentioned later\n- Includes interest income ($20.6 billion) and yield (6.84%) that are not mentioned in the ground truth answer and may be from a different metric or year\n- Ground truth mentions a \"net change of $16,466 million\" in 2023, which the LLM answer does not address\n- The LLM provides more detailed Level 2 gross amounts ($570B, $436B) than the ground truth, which focuses on fair value changes\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2023-2024 and connects the numerical changes to strategic implications. However, the inclusion of unverified figures (the $301 billion 2023 amount and interest metrics) suggests potential data confusion or hallucination.\n\nQUANTITATIVE ACCURACY ISSUES:\nThe primary concern is the $301 billion figure for 2023 and the interest/yield data that cannot be verified against the ground truth. The fair value numbers ($192.9B, $144.5B) are accurate, but the gross amounts and other metrics create confusion about data sources.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the strategic implications and gets the key fair value numbers correct, but introduces unverified quantitative information that reduces confidence in the response. The reasoning is sound but the data accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 600,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo’s “Market Risks” section (page 40) only stated that its pension and retiree‑medical plan assets and liabilities are **exposed** to market‑rate changes and pointed readers to the “Critical Accounting Policies and Estimates” discussion for details. By the 2024 Form 10‑K (pages 40‑42) the company still makes that same reference, but now places it within a broader market‑risk narrative that explicitly links the sensitivity of those pension and retiree‑medical plan liabilities to interest‑rate, inflationary and other market‑condition fluctuations, providing a more integrated discussion of the risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in PepsiCo's disclosure between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core evolution - from basic exposure discussion to broader macroeconomic risk characterization; (2) Accurately captures that both years reference 'Critical Accounting Policies and Estimates'; (3) Properly synthesizes the multi-hop information showing how 2024 expanded the narrative to include interest-rate, inflationary, and other market conditions; (4) Correctly identifies the companies (PepsiCo), years (2022 and 2024), and document types (Form 10-K); (5) Provides specific page references (page 40 for 2022, pages 40-42 for 2024) which adds credibility. MINOR ISSUES: (1) The LLM mentions 'interest-rate' sensitivity in 2024 disclosure, while the ground truth emphasizes 'inflationary, deflationary, and recessionary conditions' - these are related but not identical characterizations. The ground truth doesn't explicitly mention interest-rate sensitivity as the primary addition; (2) The LLM's phrasing 'still makes that same reference' could be slightly misleading as it suggests continuity rather than expansion, though the answer does clarify the expansion occurred. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this question, so this scores high based on correct identification of years and document references. QUALITATIVE ACCURACY: The reasoning about the evolution is sound and demonstrates proper multi-hop synthesis across the two filing years. The semantic meaning aligns well with the ground truth - both convey that disclosure became more comprehensive and integrated. The slight difference in emphasis (interest-rate vs. inflationary/deflationary/recessionary) is a minor deviation but doesn't fundamentally undermine the answer's correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 500,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "In the 2023 filing Adobe Scan was described mainly as a free mobile‑only scanner that captures paper, converts it to PDFs and offers OCR, and it was listed as a separate free download alongside Acrobat Reader (ADBE_10k_2023.pdf p.13). By the 2024 filing the company positions Scan as an integral part of Adobe Document Cloud—highlighting its tight integration with Acrobat, Acrobat Sign and other Document Cloud APIs to provide a seamless, end‑to‑end cloud‑based document workflow (ADBE_10k_2024.pdf p.12‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of Adobe Scan as a free mobile scanning tool converting paper to PDFs with OCR capabilities; (2) Accurately captures the 2024 evolution showing deeper integration within Adobe Document Cloud ecosystem; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly identifies the shift from standalone tool to integrated enterprise solution; (5) Appropriately cites specific document pages (ADBE_10k_2023.pdf p.13, ADBE_10k_2024.pdf p.12-13) showing source verification. MINOR GAPS: (1) The LLM answer mentions integration with Acrobat, Acrobat Sign, and Document Cloud APIs but does not explicitly highlight the AI-driven features (Content Credentials, Firefly-powered generative AI workflows) and digital trust mechanisms emphasized in the ground truth; (2) The ground truth specifically mentions 'Content Credentials and Firefly-powered generative AI workflows' as key 2024 enhancements, which the LLM answer omits; (3) The ground truth emphasizes 'enhanced digital trust mechanisms' as part of the 2024 positioning, which is not captured in the LLM response. ENTITY ACCURACY: All entities correctly identified (Adobe, Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign, years 2023-2024). REASONING: The multi-hop synthesis is sound—the LLM correctly compares positioning across two years and identifies the evolution from standalone to integrated tool. The logic connecting the changes to enterprise workflows is appropriate. SEMANTIC EQUIVALENCE: The core message matches—Adobe Scan evolved from a standalone free tool to an integrated component of a broader ecosystem. The LLM's emphasis on 'seamless, end-to-end cloud-based document workflow' aligns with the ground truth's mention of 'deeper integration within enterprise document workflows.' The omission of specific AI features (Firefly, Content Credentials) and digital trust mechanisms prevents a perfect score, but the fundamental answer structure and evolution narrative are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 570,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini was first introduced in 2023 as Google’s native multimodal model that could understand and generate text, code, audio, images and video, and was initially used in early AI features. By 2024 the upgraded Gemini 2.0—described as the most capable model—was embedded in all seven of Google’s core consumer products (Android, Chrome, Gmail, Maps, Play Store, Search and YouTube) and extended to Google Cloud, Workspace, the Gemini app and research prototypes such as Project Astra and Project Mariner, adding deeper general‑purpose multimodal reasoning and new generation abilities like image creation, coding assistance and app‑integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key dates are correct (2023 initial launch, 2024 evolution with Gemini 2.0). (2) All seven Google products are correctly identified and listed (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube). (3) Multimodal capabilities are accurately described for both 2023 (text, code, audio, images, video) and 2024 (with additions like image creation and coding assistance). (4) Research prototypes (Project Astra and Project Mariner) are correctly mentioned. (5) The multi-hop synthesis is sound—the answer correctly traces Gemini's evolution from initial launch through 2024 integration. (6) Additional context about Google Cloud, Workspace, and the Gemini app is provided, which adds value beyond the ground truth without contradicting it. MINOR CONSIDERATIONS: (1) The ground truth specifically emphasizes the 'two billion-user products' descriptor, which the LLM answer omits but this is a minor contextual detail rather than a factual error. (2) The LLM answer adds information about 'deeper general-purpose multimodal reasoning' and specific capabilities like 'image creation' and 'app-integration' which represent reasonable elaborations on the multimodal advancements mentioned in the ground truth. (3) The characterization of Gemini 2.0 as 'the most capable model' matches the ground truth exactly. All quantitative data (dates, product names, capability types) are accurate with no calculation errors or misidentifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 426,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "In the 2022 filing helium was only noted as one of the small businesses bundled in the “Other” segment (along with Surface Technologies and GIST), which posted about $2.0 bn of sales and a $56 m operating loss in 2021 (no specific helium‑related commentary)【page_31】. By the 2024 filing helium is again grouped in “Other” (now with LAMT) but the company explicitly says that lower global‑helium volumes reduced “Other” sales by $32 m (‑2 %) and that higher helium‑related costs weighed on operating profit, even though the segment’s operating profit rose to $43 m due to insurance recoveries【page_28】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the evolution of helium's impact from neutral/positive in 2022 to negative in 2024; (2) Accurately cites the 2% decrease in 'Other' segment sales ($32M reduction); (3) Properly notes that higher helium costs offset insurance recovery gains in LAMT; (4) Correctly identifies the segment structure changes (helium bundled with Surface Technologies/GIST in 2022, with LAMT in 2024); (5) Provides specific operating profit figures ($56M loss in 2021, $43M in 2024); (6) Demonstrates sound multi-hop reasoning by connecting helium volumes to segment performance. MINOR ISSUES: (1) The answer references 2021 data ($56M operating loss) which is outside the 2022-2024 timeframe specified in the question, though this provides useful context; (2) The statement about 44% overall increase in operating profit for 'Other' segment mentioned in the ground truth is not explicitly stated in the LLM answer, though the $43M figure is provided; (3) The answer could have been slightly more explicit about the shift from 'neutral' in 2022 to 'negative' in 2024, though this is clearly implied. QUANTITATIVE VERIFICATION: The $32M reduction and 2% decrease are accurate; the operating profit figures align with ground truth. The multi-hop synthesis correctly connects helium volume declines to segment sales impact and cost pressures on profitability. Overall, the answer captures the essential evolution of Linde's helium relationship and its financial impacts with strong supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 449,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net carrying amount of acquired franchise rights slipped from $1.891 billion in 2022 to $1.858 billion in 2024, a decline of roughly $33 million【page_85】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. (1) QUANTITATIVE ERRORS: The LLM reports 2022 value as $1.891 billion and 2024 value as $1.858 billion, but the ground truth shows $789 million (2022) and $598 million (2024). These are completely different numbers - the LLM's figures are approximately 2.4x larger than the actual values. The calculated decline of $33 million is also wrong; the correct decline is $191 million ($789M - $598M). (2) METRIC CONFUSION: The LLM appears to be reporting 'net carrying amount' while the ground truth refers to 'net value' - these may be different line items or the LLM may have pulled data from the wrong section of the filing. The magnitude of discrepancy (billions vs hundreds of millions) suggests the LLM accessed incorrect data entirely. (3) MULTI-HOP SYNTHESIS: The question asks for evolution from 2022 to 2024 with magnitude of change. While the LLM attempted to address both years and calculate the change, it did so with entirely incorrect numbers. (4) CALCULATION: Even if the LLM's numbers were correct, $1.891B - $1.858B = $0.033B = $33M is arithmetically correct, but this is irrelevant given the underlying data is wrong. The correct calculation should be $789M - $598M = $191M decline. The answer demonstrates a complete failure to retrieve or synthesize the correct financial data from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1079,
        "completion_tokens": 382,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "In the 2023 filing Chevron promised to deliver roughly 813 billion cubic feet of U.S. natural gas (and 3.2 trillion cf abroad) for 2025‑27, but the 2024 filing moved those contracts forward to 2024‑26 and cut the U.S. commitment to about 746 billion cf (with the overseas commitment falling to 2.9 trillion cf).  By contrast, Chevron’s share of production from its Kazakhstan partner Tengizchevroil was essentially flat – about 45 million barrels of oil‑equivalent per day (≈26 MBD crude and 114 MMCFD gas) in both 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and addresses a different question than what was asked. CRITICAL ISSUES: (1) The original question asks about natural gas delivery commitments and production volumes related to Tengizchevroil specifically, comparing 2023 to 2024. The ground truth provides specific metrics: 596 vs 609 MMCFD consumed, and 7,148 vs 7,569 MMCFD sold in 2023 vs 2024. (2) The LLM answer instead discusses future delivery commitments for 2025-27 (2023 filing) vs 2024-26 (2024 filing) - a completely different metric and time period not mentioned in the ground truth. The numbers cited (813 billion cf, 746 billion cf, 3.2 trillion cf, 2.9 trillion cf) do not appear in the ground truth answer. (3) While the LLM does mention Tengizchevroil production volumes (45 MBD oil-equivalent, 26 MBD crude, 114 MMCFD gas), these figures are not in the ground truth answer either, and the claim that they were 'essentially flat' contradicts the ground truth showing increases from 2023 to 2024. (4) The LLM conflates future delivery commitments with actual production volumes - these are different concepts. (5) Multi-hop reasoning failure: The LLM did not synthesize the correct information about how Chevron's natural gas volumes (consumed and sold) evolved from 2023 to 2024 as specifically related to Tengizchevroil. The answer appears to be from a different filing section entirely. QUANTITATIVE ACCURACY: The numbers provided (813B, 746B, 3.2T, 2.9T cf) cannot be verified against the ground truth figures (596, 609, 7,148, 7,569 MMCFD), suggesting fundamental data retrieval error. QUALITATIVE ACCURACY: The reasoning about 'flat' production contradicts the ground truth showing growth. The answer addresses future commitments rather than actual production evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 485,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "In the 2023 filing the payments to Google Network partners were mentioned only as a line‑item in cost of revenues – “amounts paid to Google Network partners primarily for ads displayed on their properties” (2023 10‑K p. 59). By the 2024 filing Alphabet now spells out the accounting relationship, stating that it evaluates whether it is a principal or an agent for network ads and “generally…report advertising revenues for ads placed on Google Network properties on a gross basis, with amounts paid to Google Network partners recorded as cost of revenues” (2024 10‑K p. 58). Thus the partner role has shifted from a generic cost component to an explicitly defined principal‑agent arrangement, with Google now treating most network ads as gross‑basis revenue and the partner payments as a cost of revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific textual citations and page numbers (2023 10-K p. 59, 2024 10-K p. 58) that add credibility, but there are significant issues with the core claim and reasoning. STRENGTHS: (1) The answer correctly identifies that payments to Google Network partners are described as costs of revenues in both years; (2) The citation of specific page numbers and quotes demonstrates engagement with source material; (3) The answer correctly notes that Google treats network ads on a gross basis with partner payments as cost of revenues. CRITICAL WEAKNESSES: (1) The ground truth states the evolution was from 'operating activities' description to 'Traffic Acquisition Costs (TAC)' categorization, but the LLM answer claims the shift was from 'generic cost component' to 'principal-agent arrangement' - these are fundamentally different characterizations of the evolution; (2) The LLM answer does not mention TAC (Traffic Acquisition Costs) at all, which is explicitly stated in the ground truth as the 2024 categorization; (3) The ground truth emphasizes a shift in how payments are 'described' and 'categorized' (from operating activities to TAC), while the LLM focuses on accounting treatment (principal vs. agent), which may be a different dimension of change; (4) The LLM's characterization of the 2023 description as 'generic cost component' is not supported by the ground truth, which specifically mentions 'primary uses of cash from operating activities'; (5) The principal-agent accounting discussion, while potentially relevant to accounting standards, does not directly address the specific evolution described in the ground truth regarding TAC categorization. MULTI-HOP REASONING: The LLM attempts to synthesize information across two years but appears to have misidentified the key evolution point. The ground truth points to a shift in categorization methodology (operating activities → TAC), while the LLM identifies a shift in accounting treatment disclosure (generic → principal-agent). These may be related but are not the same evolution. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The page number citations in the LLM answer cannot be verified without access to actual filings, but they appear plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 613,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "In the 2023 10‑K Bank of America said a growing global regulatory focus on climate change was spawning “new or heightened” requirements and “potential jurisdictional divergence,” which it expected would raise its legal, compliance and public‑disclosure costs. By the 2024 10‑K the language had shifted to note that “existing and pending” climate‑disclosure rules are already in place across multiple jurisdictions, with clear jurisdictional divergence that is now expected to increase its compliance and disclosure risks and associated costs, reflecting a move from emerging requirements to a more concrete, fragmented regulatory landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of Bank of America's climate-related regulatory concerns from 2023 to 2024. (1) CORRECTNESS: All factual information is accurate. The answer correctly identifies that in 2023, BofA anticipated 'new or heightened' requirements with 'potential jurisdictional divergence,' and by 2024, the language shifted to 'existing and pending' requirements with 'clear jurisdictional divergence' that is now actively impacting compliance. The characterization of the shift from anticipation to tangible impact is accurate and well-supported. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this criterion is not applicable. The dates (2023 vs 2024) are correctly referenced. Score of 10 reflects accurate temporal framing. (3) ENTITY ACCURACY: Bank of America is correctly identified throughout. The fiscal years (2023 and 2024 10-Ks) are properly referenced. The metrics discussed (legal costs, compliance costs, public disclosure risks) align with the ground truth. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings, correctly identifying the progression from 'expected to increase' risks to 'now actively impacting' risks. The logical connection between jurisdictional divergence and compliance challenges is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('fragmented regulatory landscape' vs 'jurisdictional divergence') but conveys the same essential meaning. The characterization of the shift from 'emerging requirements to concrete, fragmented regulatory landscape' is semantically equivalent to the ground truth's 'shift from anticipation of increased risk to experiencing tangible impacts.' Minor deduction (1 point) only because the LLM uses 'expected to increase' in the 2024 description rather than stating it is 'now actively impacting,' though this is a very minor semantic distinction that doesn't materially affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 560,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "In the 2022 filing GM only flagged the “success of our current line of full‑size SUVs and full‑size pickup trucks” as a forward‑looking priority (2022 p.48). By 2024 the MD&A shows that full‑size pickups have become a concrete growth driver – they lifted wholesale vehicle sales by 317 k units (10.1% YoY), raised the truck share to 23.7% of units (up from 21.9% in 2023) and generated $12.8 billion of volume‑related net‑sales growth plus $2.5 billion of mix‑related growth (2024 p.32‑34). These numbers indicate a clear shift to stronger performance and a more dominant market position for the full‑size pickup segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2022 (flagged as priority/risk factor) to 2024 (demonstrated strength), properly synthesizes multi-hop information across years, and provides specific quantitative indicators (317k units, 10.1% YoY growth, 23.7% truck share, $12.8B volume growth, $2.5B mix growth). The reasoning about shift from forward-looking priority to concrete growth driver is sound and well-supported. Page references (2022 p.48, 2024 p.32-34) add credibility.\n\nCRITICAL ISSUES: (1) The ground truth mentions a key metric - 'variable profit of approximately 160% for trucks on a weighted-average basis' - which the LLM answer completely omits. This is a significant quantitative indicator of improved profitability explicitly mentioned in the original answer. (2) The LLM provides specific wholesale volume numbers (317k units, 10.1% YoY, 23.7% share) that cannot be verified against the ground truth, which only mentions 'significant increase in net wholesale volumes' without these specific figures. While these numbers may be accurate from the filing, they represent additional detail not in the ground truth rather than verification of it. (3) The ground truth emphasizes EBIT-adjusted results and variable profit contribution, which are profitability metrics, but the LLM focuses primarily on volume and sales growth metrics.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 filings and identifies the strategic shift. However, it misses the profitability dimension that was central to the ground truth answer.\n\nQUANTITATIVE ACCURACY: While the specific numbers provided (317k, 10.1%, 23.7%, $12.8B, $2.5B) appear detailed and plausible, they cannot be confirmed against the ground truth. The critical omission is the 160% variable profit metric, which is a key quantitative indicator mentioned in the original answer. This represents incomplete capture of the quantitative evidence.\n\nSEMANTIC EQUIVALENCE: The answer conveys similar directional information but misses the profitability story that was central to demonstrating 'stronger performance and market positioning.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 579,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "The nuclear‑decommissioning trusts held about **$314 million of U.S. Treasury and government‑agency securities at the end of 2022**【page_310】, but that balance fell to **only $9 million by the end of 2024**【page_275】.  The dramatic cut‑back shows Southern Company is moving out of low‑yield Treasury holdings and reallocating the trust assets toward other fixed‑income and alternative investments, indicating a shift toward a more diversified, higher‑return investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers and fails to properly synthesize the multi-hop information required by the question. CRITICAL ERRORS: (1) The LLM claims total U.S. Treasury and government agency securities were $314 million in 2022 and $9 million in 2024. The ground truth shows Alabama Power had $21M (2022) and $20M (2024), while Georgia Power had $293M (2022) and $349M (2024), totaling $314M in 2022 and $369M in 2024. The LLM's 2024 figure of $9M is dramatically incorrect - off by approximately $360M. (2) The LLM failed to disaggregate by subsidiary (Alabama Power vs. Georgia Power), which is essential to understanding the actual allocation shift. The ground truth shows Georgia Power's allocation INCREASED from $293M to $349M, while Alabama Power's remained relatively flat ($21M to $20M). (3) The LLM's interpretation is backwards - it claims a 'dramatic cut-back' and 'moving out of low-yield Treasury holdings,' when the actual data shows a net INCREASE in these holdings from $314M to $369M. (4) The reasoning about 'shift toward more diversified, higher-return investment strategy' contradicts the actual data, which shows increased allocation to safer government securities, particularly at Georgia Power. (5) The LLM did not properly synthesize information across the two subsidiaries to understand the company-wide strategy. The ground truth indicates a reallocation toward Georgia Power's portfolio with increased government securities holdings, not a reduction. The answer demonstrates a fundamental failure in multi-hop reasoning and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 439,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "In 2022 PepsiCo described its support for independent bottlers as “bottler funding” that was part of its overall sales‑incentive program, with payments based on annual targets and accrued during the year as a reduction of revenue【page_60】. By 2024 the relationship is framed around exclusive manufacturing and distribution contracts and annually‑negotiated bottler funding that now funds a broader suite of programs—consumer‑price incentives, advertising, new‑product launches and vending‑equipment placement—and the filing explicitly notes that major retailers such as Walmart depend on those bottlers, underscoring a deeper strategic reliance on the bottling network【page_9】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of PepsiCo's bottler relationship from 2022 to 2024, capturing the key structural changes: from basic sales incentives/discounts to more comprehensive annually-negotiated bottler funding programs. The qualitative description of the evolution is accurate and well-reasoned.\n\nSTRENGTHS:\n1. Correctly identifies 2022 approach: bottler funding as sales-incentive program with annual targets and revenue reduction accruals\n2. Accurately describes 2024 evolution: broader suite of programs (consumer-price incentives, advertising, new-product launches, vending equipment)\n3. Properly synthesizes multi-hop information about strategic dependency\n4. Correctly identifies Walmart as a major retailer (14% of consolidated net revenue per ground truth)\n5. Good semantic equivalence in describing the relationship shift from transactional to strategic\n\nWEAKNESSES:\n1. QUANTITATIVE ISSUE: The LLM states \"Walmart depend on those bottlers\" but the ground truth specifies \"Walmart alone accounting for approximately 14% of consolidated net revenue.\" The LLM mentions Walmart but does not include the specific 14% figure, which is a concrete quantitative detail from the ground truth.\n2. The LLM's phrasing \"major retailers such as Walmart depend on those bottlers\" is slightly ambiguous - it could be read as retailers depending on bottlers, when the ground truth emphasizes PepsiCo's strategic dependency on bottlers for Walmart sales.\n3. Missing explicit mention that bottler funding was \"accrued during the year as a reduction of revenue\" in the 2024 description (though this may not have changed)\n\nMULTI-HOP REASONING: Sound. The answer correctly synthesizes information about how the relationship evolved across years and connects bottler funding mechanisms to strategic dependency.\n\nCALCULATIONS: No calculations required; no errors present.\n\nThe answer is substantially correct but loses points for omitting the specific 14% Walmart revenue figure and for slight ambiguity in phrasing the dependency relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 559,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "In the 2023 Form 10‑K Adobe’s trademark schedule lists “Adobe Firefly” as a protected brand name, indicating the company’s initial focus on securing the mark (see the trademark‑listing section of the filing)【page_94】. By the 2024 Form 10‑K, Firefly is highlighted in the risk‑factor discussion as a flagship generative‑AI product that is being integrated across Adobe’s portfolio and that brings reputational, regulatory and competitive risks, showing its evolution from a merely‑registered trademark to a central pillar of Adobe’s AI‑driven product‑innovation strategy【page_23】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024, with accurate characterization of Adobe Firefly's positioning in each year; (2) Accurately captures the shift from trademark listing to risk factor disclosure; (3) Properly synthesizes multi-hop information across different sections of the 10-K filings (trademark section vs. risk factors section); (4) Correctly identifies the strategic significance of the product's evolution; (5) Appropriately notes the integration across Adobe's portfolio and associated risks (reputational, regulatory, competitive). MINOR CONSIDERATIONS: (1) The LLM answer adds slightly more specific detail about the types of risks (reputational, regulatory, competitive) compared to the ground truth, which is appropriate elaboration rather than error; (2) The page references provided (page_94 for 2023 trademark listing, page_23 for 2024 risk factors) appear reasonable for 10-K structure but cannot be independently verified from the ground truth provided; (3) The characterization of the 2023 listing as 'initial focus on securing the mark' is a reasonable interpretation, though the ground truth simply states it was 'established' - this is a minor semantic difference that doesn't affect accuracy. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension is not heavily weighted. The dates (2023, 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly identifies the multi-hop synthesis needed (trademark listings + risk disclosures across two years) and executes it soundly. The logic connecting trademark protection to strategic importance is sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of Adobe Firefly's role within Adobe's product innovation strategy, using the specified sources (trademark listings and risk disclosures).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 540,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "In 2022 the company said that “contractual rent escalations on existing tenant leases” were one of the three primary drivers of tenant‑billing growth (alongside new colocation space and new‑site leases) and that churn was modest – about 4 % of billings 【page_33】. In 2023 the same escalations remain a core growth lever, but their net effect is now being offset by higher churn and lease cancellations – especially T‑Mobile‑related terminations that keep churn elevated (≈ 3 % of billings) and reduce the net contribution of the escalations to overall billing growth 【page_35】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative shift between 2022 and 2023 regarding contractual rent escalations and their role in tenant billing growth. It accurately captures that escalations were a primary driver in 2022, remain important in 2023, but are now offset by higher churn. The identification of T-Mobile lease cancellations as a key factor is correct. The semantic understanding of the multi-hop relationship (escalations vs. churn as countervailing forces) is sound.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM states 2022 churn was \"about 4% of billings\" but the ground truth indicates it was \"modest\" without specifying 4%. More importantly, the LLM states 2023 churn is \"≈ 3% of billings\" which matches the ground truth of \"approximately 3%\". However, the 4% figure for 2022 appears to be introduced without clear sourcing and may be inaccurate or unsupported by the ground truth provided.\n\nMINOR ISSUES: The LLM provides page references (page_33, page_35) which add specificity but cannot be verified against the ground truth. The ground truth does not mention a specific 4% churn rate for 2022, only that it was \"modest.\"\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023, properly identifying the shift in context and the offsetting effects of escalations vs. churn. The reasoning that escalations' \"net contribution\" is reduced by higher churn is logically sound and matches the ground truth's concept of a \"countervailing force.\"\n\nCOMPLETENESS: The answer addresses all parts of the question - the role of escalations in both years, the change between years, and the impact of increased churn/cancellations in 2023.\n\nThe primary deduction is for the unsupported 4% churn figure for 2022, which introduces a quantitative inaccuracy that affects the comparison between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 509,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "In 2023 Chevron’s affiliate capital spending was $3.5 billion, with “nearly half” of that amount earmarked for Tengizchevroil’s FGP/WPMP project in Kazakhstan (roughly $1.7 billion)【page_50】. For 2024 the company expects total affiliate capex of about $3 billion but does not disclose a specific allocation to Tengizchevroil, implying a lower or unchanged commitment relative to 2023【page_50】. Production from the joint‑venture, shown in the Kazakhstan figures, stayed flat at roughly 45 thousand barrels of oil‑equivalent per day in both 2023 and 2024【page_9】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: (1) The LLM states 2023 affiliate capex was $3.5 billion, but the ground truth indicates it was expected to be $3 billion in 2024 based on 2023 guidance. The LLM appears to have confused or inverted the years. (2) The LLM calculates 'nearly half' of $3.5B as $1.7B, which is mathematically correct for that amount, but the base number itself is wrong. The ground truth states nearly half of the $3 billion (2024 expected) was allocated to Tengizchevroil, which would be approximately $1.5 billion, not $1.7 billion. (3) The LLM correctly identifies that 2024 does not disclose specific allocation to Tengizchevroil, which aligns with the ground truth's observation of a shift from investment to operational phase. (4) Production figures of 45 KBOE/d appear reasonable but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution between 2023 and 2024 but makes a fundamental error in the baseline numbers, which undermines the entire comparison. The conceptual understanding that there's a shift from capital commitments to production emphasis is present but weakly supported by incorrect numbers. COMPLETENESS: The answer addresses both capital expenditure commitments and production involvement, but the quantitative foundation is flawed. The ground truth emphasizes a shift from investment to operational phase; the LLM mentions this implicitly but doesn't clearly articulate this evolution. ENTITY ACCURACY: Chevron, Tengizchevroil, Kazakhstan, and FGP/WPMP Project are all correctly identified. SEMANTIC ISSUES: The LLM's statement about 'lower or unchanged commitment' is speculative and not clearly supported by the ground truth, which focuses on the shift in emphasis rather than absolute commitment levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 493,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K describe the same method: UPS “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments,” and notes that this reflects the process it would employ to settle the pension and post‑retirement obligations (2023 Note 5, p. 84; 2024 Note 5, p. 88). The wording is essentially unchanged, indicating that the specificity of the bond‑matching approach did not evolve between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core question. The ground truth explicitly states that the language evolved between 2023 and 2024, with the 2024 disclosure including 'a more precise statement indicating that the approach guides the selection process' and describing 'a subtle shift in how the policy is framed operationally.' The LLM answer claims 'the wording is essentially unchanged' and that 'the specificity of the bond-matching approach did not evolve,' which is factually incorrect according to the ground truth. While the LLM correctly identifies the basic method (bond-matching approach) and provides accurate page references (2023 Note 5, p. 84; 2024 Note 5, p. 88), it fundamentally misses the key finding: that there WAS an evolution in language and framing between the two years. The question specifically asks 'how has...evolved,' expecting a description of changes. The LLM's conclusion that there was no evolution is the opposite of what the ground truth indicates. The quantitative accuracy is relatively high (correct years, page numbers, company name), but the qualitative accuracy is very low because the LLM failed to identify and articulate the subtle but meaningful shift in language from 2023 to 2024 regarding how the bond-matching approach 'guides' the selection process. This represents a failure in multi-hop reasoning and synthesis of the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 399,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "The 2022 filing makes no specific reference to helium, indicating that the gas was a minor, unsegmented part of Linde’s business at that time. By 2024 the company explicitly lists “global helium wholesale” in its “Other” segment and notes that lower helium volumes reduced segment sales by $32 million (≈2 %) versus the prior year, while operating profit in the segment rose $19 million (≈44 %) thanks to insurance recoveries that partially offset higher helium‑related costs【page_28】. This shows a shift from an unremarked revenue source in 2022 to a cost‑pressured line that trimmed sales but was mitigated by other profit‑boosting items in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of helium's evolving role at Linde from 2022 to 2024, but contains a critical quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) The $32 million sales decrease in the Other segment due to lower helium volumes is accurate; (2) The ~2% percentage is correct; (3) The identification of helium as unremarked/minor in 2022 and explicitly listed in 2024 is accurate; (4) The mention of insurance recoveries offsetting helium-related costs is correct; (5) The overall narrative of shift from neutral to cost-pressured is sound. CRITICAL ERROR: The LLM states operating profit in the segment 'rose $19 million (≈44%)' thanks to insurance recoveries. However, the ground truth indicates that helium-related costs contributed to 'downward pressure on operating profit, partially offset by an insurance recovery.' The LLM's framing suggests net positive operating profit impact ($19M increase), which contradicts the ground truth's characterization of helium as having a negative impact that was only partially mitigated. This is a significant misinterpretation of the financial impact direction. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and identifies the relationship evolution. However, the interpretation of operating profit impact is flawed. The ground truth emphasizes helium's negative operational impact despite insurance recovery, while the LLM emphasizes the positive recovery amount without adequately conveying the underlying negative pressure. COMPLETENESS: The answer addresses both the relationship evolution and financial impact questions, though the financial impact interpretation is problematic. The quantitative error regarding operating profit direction/interpretation is the primary weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 493,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America’s unfunded capital contributions for renewable‑energy projects fell from $6.2 billion at year‑end 2023 to $4.6 billion at year‑end 2024 – a reduction of about $1.6 billion.  In the same period, the tax credits and other tax benefits it recognized from those renewable‑energy equity investments slipped from $4.0 billion in 2023 to $3.9 billion in 2024, a decline of roughly $0.1 billion【page_132】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: unfunded capital contributions decreased from $6.2 billion (2023) to $4.6 billion (2024), a reduction of $1.6 billion; recognized tax credits declined from $4.0 billion (2023) to $3.9 billion (2024), a decline of $0.1 billion. The calculations are correct ($6.2B - $4.6B = $1.6B and $4.0B - $3.9B = $0.1B). All entities are correctly identified (Bank of America, renewable energy investments, tax credits). The multi-hop synthesis is sound, properly connecting the evolution of unfunded contributions with the corresponding change in tax credits across both years. The answer addresses all parts of the question comprehensively. The only minor difference from the ground truth is stylistic: the LLM uses slightly more concise phrasing (\"slipped\" vs \"slightly declined\") and includes a page reference, but these are enhancements rather than detractions. The semantic meaning is fully preserved and the answer effectively conveys the relationship between the two metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 310,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "In the 2022 filing GM explained that it sells to commercial‑fleet customers both directly and through its dealer network, but it warned that fleet transactions—particularly those to daily‑rental companies—are generally less profitable than retail sales. The 2024 filing still describes fleet sales being carried out through the dealer network with “some cases” of direct‑to‑fleet sales, but it no longer calls out the lower profitability of those sales, indicating a shift away from emphasizing that profit‑margin gap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GM's fleet sales evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 position: fleet sales through both direct and dealer channels with emphasis on lower profitability vs. retail, particularly for daily rental companies. (2) Accurately describes the 2024 position: fleet sales through dealer network with some direct-to-fleet sales, without emphasizing profitability concerns. (3) Properly synthesizes the evolution as a strategic shift away from highlighting the profit-margin gap. (4) All entities (General Motors, commercial fleet customers, daily rental companies, dealer network) are correctly identified. (5) No quantitative errors or date inaccuracies. (6) The reasoning about the shift in emphasis (from highlighting lower profitability to not calling it out) is sound and represents a meaningful strategic evolution. MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive in characterizing the shift as 'away from emphasizing that profit-margin gap' rather than 'balancing fleet sales with profitability by leveraging both channels,' but both characterizations are semantically equivalent and supported by the facts presented. The LLM's interpretation is arguably more precise in identifying what actually changed (the messaging about profitability) rather than inferring strategic intent. The answer fully addresses all aspects of the multi-part question regarding sales channels and profitability considerations across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "In the 2022 filing PepsiCo disclosed that it owned a 50 % equity stake in the Sabra joint‑venture, listing the partnership among its trademark‑licensed ventures but reporting no specific earnings impact. By the 2024 filing the company had re‑measured that former 50 % equity ownership at fair value, recognizing a pre‑tax gain of $122 million (about $92 million after‑tax) in the FLNA division’s selling‑general‑and‑administrative line— the primary financial effect of the changed Sabra relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that in 2022, PepsiCo owned the Sabra brand (full ownership as part of joint venture portfolio), and by 2024 held only a 50% equity stake after divesting a portion. However, the LLM answer reverses this timeline, claiming PepsiCo had a 50% stake in 2022 and then remeasured it in 2024. This is a critical error in the multi-hop reasoning that fails to capture the actual evolution of the relationship. The LLM correctly identifies the $122 million pre-tax gain and the $92 million after-tax figure, and correctly places this in the FLNA division's SG&A line, which are accurate details. However, these correct numbers cannot compensate for the fundamental mischaracterization of the ownership transition. The answer also adds details about 'trademark-licensed ventures' and 'no specific earnings impact' in 2022 that are not present in the ground truth, suggesting potential hallucination or confusion with other ventures. The core narrative of how the relationship evolved—from full ownership to 50% stake—is inverted, making this answer substantially incorrect despite some accurate financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 344,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "In the 2023 filing the product overview contains no discussion of Adobe Scan – the sections that are provided (pages 94‑98) list only exhibits and signatures and make no mention of the Scan app. By the 2024 filing, Adobe Scan is highlighted as a free mobile‑only scanning app that creates PDFs through Adobe Document Cloud and is listed alongside Acrobat Reader as a separate free download, showing that Adobe now positions Scan explicitly as an integrated, stand‑alone component of its Document Cloud ecosystem【page_94】【page_13】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the evolution of Adobe Scan between 2023 and 2024. Key strengths: (1) Correctly identifies that Adobe Scan was not prominently discussed in 2023 filing product overview sections, (2) Accurately describes 2024 positioning as a free mobile-only scanning app integrated with Adobe Document Cloud, (3) Properly notes the shift from minimal mention to explicit integration, (4) Correctly identifies Acrobat Reader as a comparison point for free downloads. Quantitative accuracy is high - no numeric errors present. Multi-hop reasoning is sound: the answer synthesizes information across two filing years and correctly identifies the evolution in product positioning. Minor weaknesses: (1) The LLM answer is more specific about the 2023 absence (noting pages 94-98 contain no mention) compared to the ground truth which states Adobe Scan was 'listed among Adobe's trademarks' - these are not necessarily contradictory but represent different levels of detail about 2023 positioning, (2) The ground truth emphasizes the shift from 'trademark recognition to integrated role' while the LLM emphasizes the shift from 'no discussion to explicit integration' - slightly different framing but semantically compatible, (3) The LLM provides more granular detail about the 2024 positioning (free mobile-only, creates PDFs, listed alongside Acrobat Reader) which adds value beyond the ground truth. The answer successfully addresses the core question about evolution and positioning within the product ecosystem. The citation references (page numbers) add credibility though they cannot be independently verified in this context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 462,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "In the 2022 filing GM disclosed that, as part of the 2017 sale of the Opel/Vauxhall business, it had entered into a guarantee for Stellantis and agreed to indemnify Stellantis for any losses arising from inaccurate representations, covenant breaches, emissions and product‑liability claims, with the obligations subject to time limits, thresholds and caps and with no material loss estimate possible (2022 p. 89). By the 2024 filing the same indemnification framework remained, but GM added that it had already paid an immaterial amount to cover Stellantis‑conducted recalls—including Takata inflator recalls—and noted that further Takata‑related indemnifications were possible though remote, while still being unable to quantify any material exposure (2024 p. 93).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of GM's evolving relationship with Stellantis but has some notable gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2017 Opel/Vauxhall sale as the origin of obligations; (2) Accurately describes the indemnification framework covering emissions, product liability, and representation/covenant breaches; (3) Correctly notes the presence of time limits, thresholds, and caps on obligations; (4) Properly identifies that no material loss estimate was possible in 2022; (5) Accurately reports that by 2024 an immaterial amount had been paid for Takata recalls; (6) Correctly notes continued inability to quantify material exposure in 2024; (7) Appropriately cites specific page numbers (p. 89 for 2022, p. 93 for 2024). WEAKNESSES: (1) The LLM answer focuses heavily on the indemnification framework itself but provides less emphasis on the EVOLUTION/TRANSFORMATION aspect that the question specifically asks about—the shift from 'operational supplies' (2022) to 'financial guarantees and indemnifications tied to legacy liabilities' (2024); (2) Missing explicit mention of European regulatory investigations into end-of-life vehicle practices, which the ground truth identifies as a specific exposure area; (3) The answer doesn't clearly articulate the conceptual shift from 'active supply chain involvement to passive, indemnification-based financial relationship' that characterizes the evolution; (4) While the LLM mentions Takata recalls were paid, it doesn't emphasize this as evidence of the transformation from potential to realized obligations. QUANTITATIVE ACCURACY: All dates (2017, 2022, 2024) and page references are correct. The characterization of amounts as 'immaterial' and 'no material loss estimate possible' aligns with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly identifies the causal relationship between the 2017 sale and subsequent obligations. However, it could better synthesize the temporal evolution narrative. SEMANTIC EQUIVALENCE: The core factual content is accurate, though the framing emphasizes the legal/financial mechanics more than the strategic evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 605,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo’s 2022 filing already noted that, beyond its own owned and leased plants, the company “utilizes a highly distributed network of … contract manufacturers, **co‑packers**, strategic alliances or joint‑ventures in which we have an equity interest” (2022 Form 10‑K Item 2, p. 27). The 2024 filing repeats the same language, again describing co‑packers as part of that distributed network and stating the combined facilities are “suitable, adequate and of sufficient capacity for our current operations” (2024 Form 10‑K Item 2, p. 30). Thus, between 2022 and 2024 PepsiCo’s reliance on co‑packers has remained essentially unchanged – they continue to be an operationally‑dependent, third‑party capacity source, with no new strategic partnership or deeper integration disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer directly contradicts the ground truth on the core finding. The ground truth states that PepsiCo's language SHIFTED between 2022 and 2024 from describing co-packers as part of a 'highly distributed network' (operational dependency focus) to emphasizing them as 'strategic alliances or joint ventures in which we have an equity interest' (strategic involvement focus). The LLM claims the language remained 'essentially unchanged' and that there was 'no new strategic partnership or deeper integration disclosed.' This is factually incorrect based on the ground truth. The LLM appears to have found similar language in both years but failed to recognize the semantic shift in emphasis and framing that the ground truth identifies. QUANTITATIVE ACCURACY: The LLM correctly cites page numbers (p. 27 for 2022, p. 30 for 2024) and years (2022, 2024), and accurately quotes the language about 'highly distributed network' and 'strategic alliances or joint ventures.' These details are correct. QUALITATIVE ACCURACY: The fundamental reasoning is flawed. The LLM's conclusion that the relationship 'remained essentially unchanged' directly contradicts the ground truth's identification of an evolution from operational dependency to strategic involvement. The LLM failed to synthesize the multi-hop comparison correctly—it identified the same language appearing in both years but missed the shift in emphasis and strategic positioning that the ground truth highlights. CONTEXTUAL RELEVANCE: The answer addresses the right companies and timeframe but arrives at the wrong conclusion about how the relationship evolved. The question specifically asks about evolution 'particularly in terms of operational dependency and strategic involvement,' and the LLM's answer that nothing changed is directly contrary to the ground truth's identification of a meaningful shift in how PepsiCo frames its co-packer relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 523,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "In 2023 Simon Property Group was still trimming its ABG holding – it sold a slice of its stake for a $157.1 million pretax gain and, because ABG’s capital‑transaction dilutions forced “deemed disposals,” it booked roughly $59 million (plus a $10.3 million non‑cash gain) of pretax gains on those disposals【page_65】.  The company had also made a strategic cash investment in ABG (a $100 million purchase of additional ABG interests) as part of its broader licensing partnership【page_74】.  By early 2024 Simon completed the exit, selling the balance of its ABG interest for $1.2 billion and recognizing a $414.8 million pretax gain, effectively ending the ABG investment relationship【page_73】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) MAJOR ERROR - The LLM claims SPG 'completed the exit' in early 2024 by selling its ABG interest for $1.2 billion with a $414.8 million gain, effectively ending the relationship. However, the ground truth explicitly states that in 2024, SPG entered into a STRATEGIC PARTNERSHIP with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating deeper operational collaboration. This is a fundamental mischaracterization of the 2024 relationship evolution. (2) INCORRECT 2024 FIGURES - The LLM provides a $414.8 million gain from a complete exit in 2024, but the ground truth shows a $18.8 million gain from a December 2021 sale disclosed in 2024, which is a different transaction entirely. The LLM appears to have confused or fabricated the $1.2 billion exit figure and $414.8 million gain. (3) PARTIAL ACCURACY ON 2023 - The LLM correctly identifies the $157.1 million gain from the sale of ABG interests and approximately $59 million from deemed disposals in 2023, though it adds a $10.3 million figure not mentioned in the ground truth. (4) MISSING KEY CONTEXT - The LLM mentions a $100 million cash investment in ABG but doesn't clearly establish this as part of the 2023-2024 evolution. More critically, it completely misses the strategic shift toward operational partnership (Reebok licensing) that defines the 2024 relationship evolution. (5) MULTI-HOP REASONING FAILURE - The answer fails to properly synthesize the evolution from financial transactions (2023) to strategic operational partnership (2024). Instead, it incorrectly portrays a complete exit. The core narrative of the answer is fundamentally wrong regarding 2024 developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 486,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "In the 2022 filing Lockheed Martin said that “higher production volume on various Sikorsky helicopter programs” lifted RMS product‑costs by about $560 million (2022 10‑K, p. 43). By the 2024 filing the company’s Sikorsky work is highlighted by two flagship platforms – the CH‑53K King Stallion heavy‑lift helicopter and the VH‑92A Marine One presidential helicopter – and it notes that the VH‑92A program delivered its final aircraft in 2024, showing a shift from broadly increasing production volumes to focusing on specific, high‑profile program deliveries (2024 10‑K, p. 3 & 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $560 million increase in RMS product costs in 2022 related to Sikorsky helicopter programs - this matches the ground truth exactly. (2) The 2024 reference to CH-53K King Stallion is accurate and appears in both answers. (3) The citation format and page references add credibility. (4) The VH-92A Marine One helicopter is correctly identified as a 2024 focus area.\n\nWEAKNESSES: (1) The ground truth mentions Black Hawk and Seahawk programs as key 2024 components, but the LLM answer only mentions CH-53K King Stallion and VH-92A. This is a significant omission of specific program names that were explicitly listed in the original answer. (2) The LLM's characterization of the evolution differs from ground truth: the LLM frames it as a shift from 'broadly increasing production volumes to focusing on specific, high-profile program deliveries,' while the ground truth describes it as 'a shift from being a cost driver to being a clearly defined strategic product line.' These are subtly different interpretations. (3) The LLM introduces the VH-92A final delivery in 2024 as a key point, which is not mentioned in the ground truth answer at all - while this may be factually accurate, it represents an addition beyond what the ground truth established. (4) The ground truth emphasizes that 2024 shows 'continued and potentially expanded focus' with explicit listing of programs, whereas the LLM suggests a narrowing to 'specific, high-profile' programs.\n\nMULTI-HOP REASONING: The LLM does synthesize information across 2022 and 2024 filings, but the synthesis is incomplete. It correctly connects the 2022 cost impact to 2024 program focus, but misses the full portfolio of programs mentioned in the ground truth.\n\nNUMERIC VERIFICATION: The $560 million figure is correct. No calculations are required or performed. Page references cannot be verified but appear plausible.\n\nOVERALL: The answer is partially correct with accurate core numbers but incomplete program identification and a somewhat different characterization of the evolution than the ground truth provides.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 570,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023 Walmart bought Alert Innovation for about $0.4 billion, which lifted its ownership to roughly 100 % of the company【page_45】. In fiscal 2024 there was no further purchase or sale of Alert Innovation reported, so Walmart continued to hold the full 100 % stake with no additional cash investment disclosed【page_65】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer fundamentally contradicts the ground truth on the key evolution between fiscal 2023 and 2024. (1) CORRECT ELEMENTS: The quantitative facts about fiscal 2023 are accurate - Walmart did acquire Alert Innovation for $0.4 billion and increased ownership to approximately 100%. The dollar amount and percentage are correctly stated. (2) INCORRECT CONCLUSION: The LLM claims that in fiscal 2024 'Walmart continued to hold the full 100% stake with no additional cash investment disclosed.' This directly contradicts the ground truth, which explicitly states 'By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.' The LLM failed to identify that Walmart had EXITED its position entirely by fiscal 2024. (3) MULTI-HOP REASONING FAILURE: The question asks how the ownership stake 'evolved' between the two years. The ground truth shows a clear evolution: 100% ownership in 2023 → complete exit/divestiture by 2024. The LLM incorrectly concluded there was no change ('continued to hold the full 100% stake'), missing the critical divestiture that occurred. (4) MISSING KEY INFORMATION: The LLM failed to synthesize that the absence of mention in fiscal 2024 filings indicates a divestiture or sale, which is the essential evolution the question asks about. The answer demonstrates poor document synthesis and failed to identify the material change in Walmart's position. This is a fundamental failure to answer the core question about how the stake 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 446,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "In 2023 the Operating Partnership eliminated its use of the Supplemental Facility – it issued €750 million of senior unsecured bonds and used the entire proceeds to repay the €750 million balance that was outstanding under the Supplemental Facility on Nov 17 2023【page_61】. By 2024 the facility remained in place as a $3.5‑$4.5 billion revolving credit line (maturing Jan 31 2029, extendable to 2030) but the filing shows no new draws, indicating the company is now keeping the Supplemental Facility available as an undrawn source of liquidity rather than actively borrowing against it【page_68】【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - €750 million borrowing in 2023, repayment on November 17, 2023, $3.5-$4.5 billion revolving credit facility, maturity date of January 31, 2029 with extension to 2030. These match the ground truth data. COMPLETENESS: The answer addresses both 2023 and 2024 evolution as requested, covering borrowing activity (€750M draw in 2023), repayment strategy (senior unsecured bonds issuance used to repay), and 2024 status (no outstanding balance, facility maintained as undrawn liquidity). MULTI-HOP REASONING: The LLM correctly synthesized information across multiple filing pages (61, 68, 69) to show the evolution from active borrowing to strategic liquidity reserve. The connection between the bond issuance and facility repayment is clearly established. ENTITY ACCURACY: Correctly identifies SPG (through reference to Operating Partnership), the Supplemental Facility, and distinguishes between the facility's status in different years. MINOR CONSIDERATIONS: The ground truth mentions a $1.0 billion unsecured notes issuance in September 2024 as part of the refinancing strategy, which the LLM answer does not include. However, this is not directly asked about in the question regarding the Supplemental Facility's evolution. The LLM's characterization of the shift from active borrowing to maintaining the facility as available liquidity is semantically equivalent to the ground truth's description of 'strategic reduction in reliance.' The answer is well-structured, provides specific page references, and demonstrates clear understanding of the capital strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 468,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "In the 2023 filing Linde already listed helium as a core process gas – one of its primary industrial‑gases products – and explained that it can be supplied through on‑site plants, merchant bulk shipments (which can be shipped long distances under 3‑ to 7‑year supply agreements without minimum‑purchase requirements) and packaged cylinders【page_100】. The 2024 filing continues to treat helium as a primary process gas (now grouped with hydrogen, carbon dioxide and carbon monoxide) and retains the same three‑method supply model (on‑site, merchant and packaged), so its positioning and supply strategy have remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental question. The ground truth explicitly states that helium was NO LONGER specifically named as a distinct product in the 2024 filing and was subsumed under more general descriptions, indicating a strategic repositioning and reduced emphasis. However, the LLM claims the 2024 filing 'continues to treat helium as a primary process gas' and that positioning 'have remained essentially unchanged.' This is factually incorrect and represents a complete misunderstanding of the evolution described in the question. The LLM correctly identifies that helium was listed as a primary product in 2023 with the three supply methods (on-site, merchant, packaged) and correctly cites the 3-7 year contract terms without minimum purchase requirements. The numeric/date information is accurate (2023, 2024, 3-7 years). However, the LLM fails to recognize the KEY CHANGE: the shift from helium being explicitly named and distinct in 2023 to being subsumed under general descriptions in 2024. The LLM's conclusion that supply strategy 'remained essentially unchanged' misses the strategic repositioning aspect entirely. The answer demonstrates poor multi-hop reasoning by failing to synthesize the comparative analysis between the two years that the question explicitly asks for. The LLM appears to have focused only on confirming helium's presence in both years rather than analyzing how its treatment evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 412,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care plan held about $182 million of fixed‑income securities and cash equivalents and $98 million of equity securities – roughly a 65% / 35% split【page_48】. By year‑end 2023 those balances had shifted to $210 million in fixed‑income and $54 million in equity, moving the allocation to roughly 80% fixed‑income and 20% equity【page_47】【page_49】. This represents a clear move toward more fixed‑income assets and away from equities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 figures. Ground truth shows 2022 had $248M in fixed income and $137M in equity (totaling $385M), but the LLM states $182M and $98M respectively. This is a major discrepancy - the LLM's 2022 numbers are substantially incorrect (off by $66M for fixed income and $39M for equity). The 2023 figures are partially correct ($210M fixed income is accurate, $54M equity is accurate), but the 2022 baseline is fundamentally wrong. CALCULATION ERRORS: The LLM calculates 2022 as 65% fixed income / 35% equity based on incorrect numbers ($182M/$280M = 65%, $98M/$280M = 35%). Using the correct ground truth figures, 2022 should be approximately 64% fixed income / 36% equity ($248M/$385M = 64.4%, $137M/$385M = 35.6%). The 2023 percentages (80%/20%) are approximately correct based on the accurate $210M/$54M figures ($210M/$264M = 79.5%, $54M/$264M = 20.5%). MULTI-HOP REASONING: The LLM correctly identifies the trend (shift toward fixed income, away from equities) and properly synthesizes the comparison between years, but this reasoning is built on incorrect 2022 data. The semantic understanding of the question is appropriate, but the factual foundation is flawed. COMPLETENESS: The answer addresses both years and both asset categories as requested, but the accuracy of the 2022 data undermines the entire response. The answer would mislead readers about the actual magnitude of changes in the plan's allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 416,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "In 2022 Trodelvy generated $680 million in total product sales; by 2023 that rose to $1.063 billion – a 56 % jump driven by stronger demand in the United States, Europe and other markets 【page_40】. 2023 also marked a major regulatory breakthrough: Trodelvy received both FDA approval and European Commission (EC) approval as a monotherapy for adult patients with unresectable or metastatic HR⁺/HER2‑negative breast cancer, expanding its label and strengthening its oncology positioning 【page_39】【page_41】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 Trodelvy revenue was $680 million, but the ground truth clearly states $380 million - a 79% overstatement. The LLM claims 2023 revenue reached $1.063 billion, but the ground truth explicitly states 'specific revenue figures for 2023 are not provided.' The LLM fabricated a 2023 revenue figure and calculated a 56% growth rate based on false data. (2) FACTUAL VERIFICATION: Ground truth: 2022 = $380M, 2023 = not disclosed. LLM: 2022 = $680M, 2023 = $1.063B. These are material misstatements of financial performance. (3) REGULATORY MILESTONES: The LLM correctly identifies the FDA and EC approvals for HR+/HER2- metastatic breast cancer in 2023, which aligns with the ground truth. This is the only accurate component. (4) MULTI-HOP REASONING: While the LLM properly synthesized the regulatory information across sources, it completely failed on the revenue synthesis task by providing invented numbers rather than acknowledging the ground truth's explicit statement that 2023 figures were not provided. (5) SEMANTIC EQUIVALENCE: The regulatory portion is semantically equivalent to ground truth, but the revenue claims are factually incompatible. The LLM's answer demonstrates a pattern of hallucination on quantitative data while partially succeeding on qualitative regulatory information. This is a severe failure on the primary metric (financial performance) of a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 431,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron’s downstream segment earnings fell sharply – from about **$8.2 billion in 2022** (U.S. $5.4 bn + International $2.8 bn) to roughly **$6.1 billion in 2023** (U.S. $3.9 bn + International $2.2 bn)【page_83】.  At the same time, the equity‑method earnings from its 50 %‑owned joint‑venture **GS Caltex dropped from $874 million in 2022 to $437 million in 2023 and to just $58 million in 2024**, while Chevron’s investment balance stayed near **$4.1‑$4.3 billion**【page_84】 (the JV is described as a 50 % ownership in the 2022 filing【page_85】).  The trend shows that, although the GS Caltex JV remains a strategic foothold for Chevron in the Korean market, its contribution to downstream profitability has been rapidly declining.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 50% ownership stake in GS Caltex and recognizes it as a joint venture with GS Energy. (2) The directional trend is correct - equity-method earnings from GS Caltex declined significantly from 2022 to 2024. (3) The reasoning about declining profitability contribution is sound and addresses the strategic importance question. (4) The investment balance figure of $4.1-$4.3 billion appears reasonable for a 50% stake. (5) Multi-hop synthesis across years and entities is logically structured.\n\nWEAKNESSES: (1) CRITICAL: The LLM provides equity-method earnings figures ($874M in 2022, $437M in 2023, $58M in 2024) that cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth only mentions 'higher downstream-related earnings from GS Caltex' in 2022 without quantifying the equity-method earnings. (2) The LLM introduces downstream segment earnings data ($8.2B in 2022, $6.1B in 2023) that is not mentioned in the ground truth and appears to conflate overall downstream segment performance with GS Caltex-specific earnings. (3) SIGNIFICANT OMISSION: The ground truth specifically mentions sales/revenues with affiliated companies ($13,850M in 2024 vs $16,286M in 2022), which the LLM completely omits. This is a key metric showing the evolution of the relationship. (4) The LLM focuses heavily on equity-method earnings decline but doesn't address the revenue relationship metric that the ground truth emphasizes. (5) The page citations (page_83, page_84, page_85) cannot be verified and may be fabricated.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2022-2024 and connect GS Caltex performance to strategic importance, which is appropriate. However, the synthesis appears to introduce numbers not in the ground truth rather than synthesizing from provided sources.\n\nNUMBER VERIFICATION: The specific equity-method earnings figures provided by the LLM ($874M, $437M, $58M) are presented with confidence but lack corroboration in the ground truth. The ground truth's revenue figures ($13,850M in 2024, $16,286M in 2022) are entirely absent from the LLM answer, representing a significant gap in addressing the question's focus on the earnings and investment relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 616,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "In the 2022 filing Lockheed Martin’s RMS segment reported $16.1 bn of net sales and $1.9 bn of operating profit, but the CH‑53K was not called out for any risk‑retirement benefit – the only recent risk‑retirement credit for the helicopter had been noted in the prior year’s discussion (≈$140 m of operating profit from CH‑53K risk retirements in 2021)【page_41】【page_50】. By the 2024 filing the focus had shifted to output: higher production volume on the CH‑53K added roughly $140 million to RMS net sales, signalling a clear ramp‑up in deliveries, while risk‑retirement adjustments were no longer emphasized for the program【page_41】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY:\n\n1. CRITICAL ERROR - Risk Retirement Attribution: The LLM claims the ~$140M risk retirement benefit occurred in 2021, not 2022. The ground truth explicitly states this occurred in 2022 ('In 2022, the CH-53K program contributed to higher operating profit...with approximately $140 million in increased profit driven by higher risk retirements'). The LLM's statement that 'the only recent risk-retirement credit for the helicopter had been noted in the prior year's discussion (≈$140 m of operating profit from CH‑53K risk retirements in 2021)' directly contradicts the ground truth.\n\n2. INCOMPLETE 2022 ANALYSIS: The LLM states CH-53K 'was not called out for any risk-retirement benefit' in 2022, which is factually incorrect. The ground truth clearly indicates the $140M profit increase in 2022 was driven by risk retirements and production volume.\n\n3. MISSING 2024 CONTEXT: The LLM mentions $140M added to net sales from higher production volume in 2024, but fails to address the critical finding in the ground truth: the 73% decline in RMS operating profit by 2024. This is a major omission that fundamentally misrepresents the program's financial trajectory.\n\n4. INCOMPLETE SYNTHESIS: The LLM does not adequately synthesize the evolution from 2022 to 2024. The ground truth emphasizes that gains from risk retirements 'may have diminished as the program matured and entered higher-volume production' - a key insight about the program's lifecycle transition that the LLM fails to capture.\n\n5. LOGICAL INCONSISTENCY: The LLM presents the $140M figure twice (once attributed to 2021, once to 2024 production volume), creating confusion about whether these are the same or different amounts and their respective years.\n\nCORRECT ELEMENTS:\n- RMS segment 2022 figures ($16.1B net sales, $1.9B operating profit) are accurate\n- Recognition that production volume increased is correct\n- Acknowledgment that risk-retirement adjustments were no longer emphasized in later years is directionally correct\n\nThe answer demonstrates partial understanding but contains a fundamental chronological error regarding when the risk retirement benefit occurred, and critically omits the 73% operating profit decline in 2024, which is essential to answering the question about program evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 620,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "In the 2022 Form 10‑K PayPal treated its seller‑protection (along with buyer‑protection) chiefly as a risk‑management line‑item – it disclosed that losses from these programs drive its “transaction loss” allowance and that loss rates have historically run between 0.09 % and 0.15 % of total payment volume, with allowances set based on past experience and macro‑economic factors (2022 10‑K p. 51‑53). By the 2023 filing the tone had shifted: seller‑protection is highlighted as a strategic differentiator that “reduces merchant losses” and is part of PayPal’s value‑proposition for merchants, backed by continued investment in technology and risk‑management systems, while still noting the need to monitor exposure (2023 10‑K p. 9‑10). Thus the program moved from a primarily accounting‑risk focus in 2022 to a growth‑oriented, risk‑mitigation emphasis in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The loss rate percentages (0.09%-0.15% of TPV) are correctly cited and match the ground truth exactly. Page references (2022 10-K p. 51-53 and 2023 10-K p. 9-10) are appropriately cited, though not verifiable in this context, they appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The answer correctly identifies the strategic shift from 2022 to 2023. The characterization of 2022 as 'risk-management line-item' with focus on transaction loss allowances aligns with ground truth's 'risk management and potential loss implications.' The 2023 characterization as 'strategic differentiator' linked to 'merchant trust and platform growth' matches the ground truth's description of 'competitive differentiator' and 'value proposition to attract and retain merchants.' MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly identifying the evolution in emphasis from risk exposure (2022) to strategic positioning (2023). The connection between seller protection programs and merchant retention/growth is properly established. COMPLETENESS: The answer addresses all aspects of the question: (1) how the approach evolved, (2) risk exposure considerations, and (3) strategic emphasis changes. SEMANTIC EQUIVALENCE: The LLM's phrasing 'moved from a primarily accounting-risk focus in 2022 to a growth-oriented, risk-mitigation emphasis in 2023' effectively captures the same evolution described in the ground truth. Minor differences in wording ('accounting-risk focus' vs 'risk management') are semantically equivalent. POTENTIAL MINOR ISSUES: The LLM includes specific page numbers which, while appearing reasonable, cannot be independently verified. However, this adds credibility rather than detracting from accuracy. The answer is slightly more detailed than the ground truth but does not contradict any information provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 536,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "In the 2023 Form 10‑K, Starbucks grouped ready‑to‑drink (RTD) beverages with its “Other revenues” and said that sales of those products “are generally recognized upon shipment to customers, depending on contract terms” 【page_65】. The 2024 filing still records RTD sales at shipment, but now explicitly notes that the beverages are “purchased from several specialty suppliers, usually under long‑term supply contracts,” highlighting a more explicit reliance on external suppliers for the RTD portfolio 【page_13】【page_12】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Starbucks' approach to ready-to-drink beverages between 2023 and 2024. STRENGTHS: (1) Correctly identifies that 2023 classified RTD beverages under 'Other revenues' with revenue recognition upon shipment depending on contract terms - this matches the ground truth. (2) Accurately notes the 2024 shift to emphasizing supplier dependency and long-term supply contracts. (3) Properly synthesizes the multi-hop information showing the evolution from revenue-centric reporting to supply-chain risk management focus. (4) Includes appropriate page citations (page_65, page_13, page_12) suggesting document verification. (5) No quantitative errors - no specific dollar amounts were claimed that could be incorrect. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and doesn't explicitly state the shift from 'revenue-centric reporting to supply-chain risk management focus' as clearly as the original answer does. The ground truth emphasizes this conceptual shift more explicitly ('signaling a shift from revenue-centric reporting to a supply-chain risk management focus'), while the LLM answer implies it through the phrase 'highlighting a more explicit reliance on external suppliers.' (2) The LLM answer could have been slightly more explicit about the strategic implications of this shift (securing stable supply vs. just reporting revenue). VERIFICATION: The core facts align - 2023 treatment under Other Revenues with shipment-based recognition, 2024 emphasis on supplier relationships and long-term contracts. The multi-hop reasoning correctly synthesizes information across both years and identifies the key evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "In 2022, Trodelvy was already marketed in the United States (accelerated approval for metastatic urothelial cancer and full approval for metastatic triple‑negative breast cancer), had a European‑Commission marketing authorization for metastatic TNBC, and was approved in Canada (joining Australia, the United Kingdom, Switzerland and the U.S. under the Project Orbis collaborative review). By 2023 Gilead added both European‑Commission and U.S. FDA approvals for Trodelvy as a monotherapy in hormone‑receptor‑positive/HER2‑negative breast cancer, expanding its label and geographic footprint and driving higher sales in new and existing markets worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Trodelvy received FDA and EC approvals for HR+/HER2- breast cancer in 2023, which matches the ground truth. It also correctly notes the expansion of geographic reach and therapeutic applications. The mention of Project Orbis and multiple country approvals (Canada, Australia, UK, Switzerland) adds relevant context about regulatory pathways. WEAKNESSES: (1) The LLM answer provides extensive detail about 2022 approvals (urothelial cancer, TNBC, Canada, Australia, UK, Switzerland) that are NOT mentioned in the ground truth, which specifically states 'no sales reported in other international markets' in 2022 beyond U.S. and Europe. This suggests the LLM may be conflating information or providing details not supported by the source data. (2) The ground truth provides specific 2022 sales figures ($370M U.S., $10M Europe) which the LLM answer completely omits. These quantitative metrics are important for assessing 'geographic reach' evolution. (3) The LLM answer does not quantify the 2023 sales impact or provide comparable metrics to show how the evolution manifested in actual market performance. (4) The ground truth's characterization of 2022 as 'limited geographic reach' (only U.S. and Europe) contradicts the LLM's assertion of approvals in multiple countries in 2022. This is a significant discrepancy in the multi-hop synthesis. MULTI-HOP REASONING: The LLM correctly synthesizes that 2023 approvals expanded the label and geographic footprint, but fails to properly establish the baseline from 2022 as described in the ground truth. The answer appears to draw from different source data than the ground truth, particularly regarding 2022 regulatory status. CALCULATION/VERIFICATION: No calculations required, but the factual assertions about 2022 geographic presence cannot be verified against the ground truth and appear contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 515,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "In 2023 Simon’s ownership of ABG was progressively diluted – it fell from roughly 12.3 % at the start of the year to about 9.6 % by year‑end – and the company recorded a series of non‑cash deemed‑disposal gains of $36.4 million (Q2), $12.4 million (Q3) and $10.3 million (Q4) together with a cash pre‑tax gain of $157.1 million from selling a portion of its interest [page_114] [page_113]. In the first quarter of 2024 Simon sold its remaining ABG stake, exiting the investment entirely and realizing a cash pre‑tax gain of $414.8 million [page_73].",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent the ground truth:\n\n1. MAJOR ERRORS - 2023 TRANSACTIONS:\n   - LLM claims a 'cash pre-tax gain of $157.1 million from selling a portion of its interest' in 2023. The ground truth makes no mention of this $157.1M figure.\n   - Ground truth specifies three non-cash deemed-disposal gains in 2023: $36.4M, $12.4M, and $10.3M (totaling $59.1M), not a single $157.1M cash gain.\n   - The LLM conflates or invents a transaction not documented in the ground truth.\n\n2. MAJOR ERRORS - 2024 TRANSACTIONS:\n   - LLM claims 'Simon sold its remaining ABG stake, exiting the investment entirely and realizing a cash pre-tax gain of $414.8 million' in Q1 2024.\n   - Ground truth explicitly states: 'in 2024, SPG no longer disclosed active changes in its ownership stake in ABG' and 'no new transactions reported.'\n   - The $414.8M gain and complete exit in 2024 are entirely fabricated and directly contradict the ground truth.\n   - Ground truth references only a prior 2021 transaction ($18.8M gain, $100.0M acquisition) as historical context.\n\n3. OWNERSHIP STAKE ACCURACY:\n   - LLM correctly identifies the 2023 dilution from ~12.3% to ~9.6%, which matches ground truth.\n   - However, this correct detail is overshadowed by the invented 2024 transaction.\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to properly synthesize the key distinction between 2023 (active transactions with gains) and 2024 (passive disclosure, no new transactions).\n   - Instead, it fabricated a major 2024 exit transaction that contradicts the ground truth's explicit statement about lack of disclosed changes in 2024.\n\n5. SEMANTIC EQUIVALENCE:\n   - The answer fundamentally misrepresents the evolution described in the ground truth.\n   - Ground truth: 2023 = active dilution with gains; 2024 = no new transactions\n   - LLM answer: 2023 = dilution + $157.1M gain; 2024 = complete exit + $414.8M gain\n   - These are not semantically equivalent; they tell opposite stories.\n\nThe LLM appears to have hallucinated or confused data from other sources, introducing numbers ($157.1M, $414.8M) and transactions (2024 complete exit) that are not supported by the ground truth and directly contradict it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 604,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2023 filing listed the 2012 Equity Incentive Plan “as amended” with a **Third Amendment** (10.2(A) & 10.2(B)) and a series of award‑agreement forms through 10.2(L) (April 2023) 【page_128】【page_129】. In the 2024 filing the plan received a **Fourth Amendment** (10.2(C), filed Aug 1 2024) and a new award‑agreement form (10.2(K)+, filed Apr 25 2024), extending the prior set of disclosed forms (10.2(D)‑10.2(K)) 【page_127】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in identifying the key evolution of the 2012 Equity Incentive Plan between 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies Third Amendment in 2023 filing and Fourth Amendment in 2024 filing with accurate date (August 1, 2024); (2) Accurately notes the introduction of new award agreement forms in April 2024 (April 25, 2024 date provided); (3) Properly synthesizes the multi-hop information showing plan evolution across two filing years; (4) Provides specific exhibit references (10.2(A), 10.2(B), 10.2(C), 10.2(K), etc.) that add credibility; (5) Correctly conveys that the 2024 filing extended the prior set of disclosed forms. MINOR WEAKNESSES: (1) The answer is more detailed and technical than the ground truth, including specific exhibit numbers and page references that, while accurate, go beyond what was explicitly stated in the original answer; (2) The phrasing about \"10.2(K)+\" and \"10.2(D)-10.2(K)\" is somewhat unclear in its notation, though the intent appears correct; (3) The ground truth mentions forms from \"2012 and 2017\" in the 2023 filing, while the LLM answer references \"April 2023\" forms - this is a minor discrepancy in how the forms are characterized, though both are technically accurate descriptions of different aspects. QUANTITATIVE VERIFICATION: All dates are correct (August 1, 2024 for Fourth Amendment, April 2024/April 25, 2024 for new forms). The amendment progression (Third to Fourth) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings to show the evolution of the plan, which is the core requirement of the question. The comparison between the two years is logically sound and demonstrates proper understanding of the document progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 489,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The company’s accounting for software licenses did not change – capitalized software licenses are still amortized on a straight‑line basis over the term of the license (page 36).  However, the balance of capitalized licenses grew from $152 million at the end of 2022 to $223 million at the end of 2023 (page 27), and the related amortization expense rose from $54 million to $63 million (page 28).  This increase in both the asset balance and amortization charge indicates that Texas Instruments has been investing more heavily in software licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: capitalized software licenses increased from $152 million (2022) to $223 million (2023), and amortization expense rose from $54 million to $63 million. The accounting method (straight-line amortization over license term) is correctly identified as unchanged. The multi-hop reasoning is sound - the answer synthesizes information across multiple pages (36, 27, 28) and correctly interprets the evolution: unchanged policy but growing asset values and expenses indicating increased investment. The company is correctly identified as Texas Instruments. The LLM answer actually provides MORE detail than the ground truth by including the amortization expense figures ($54M to $63M), which strengthens the conclusion about increased investment. The semantic meaning is equivalent to the ground truth - both convey that the accounting method remained constant while the actual investment in software licenses grew substantially. The only minor distinction is that the LLM answer is more specific and data-rich, providing additional supporting metrics that reinforce the main conclusion. No calculation errors detected. All entities, dates, and metrics are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 351,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "In 2022 PayPal had $3.8 billion of European customer balances – roughly 37 % of the balances available for corporate use – approved for funding credit activities. By year‑end 2023 the approved amount fell to $3.0 billion, but it now covered about 39 % of the available balances. The drop in absolute size coupled with a higher utilization rate signals that PayPal is tightening the pool of internal funds it draws on while increasingly leveraging a larger share of those balances to finance its credit products, underscoring a more efficient, internally‑focused funding strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative data: $3.8 billion (2022), $3.0 billion (2023), 37% (2022), and 39% (2023). The numbers are accurate and properly formatted. The basic comparison and trend analysis are sound - correctly noting the decrease in absolute amount while percentage utilization increased.\n\nWEAKNESSES: The LLM answer is INCOMPLETE on a critical multi-hop element. The ground truth explicitly mentions PayPal's strategic shift toward EXTERNAL FUNDING MECHANISMS, specifically: (1) a new €40 billion agreement in 2023 to sell consumer installment receivables, and (2) $5.5 billion sold during the year. This is a major strategic development that directly answers the question about PayPal's strategic approach to funding credit products. The LLM answer only discusses internal efficiency and does not mention this external funding strategy at all.\n\nThe LLM's interpretation of the data as signaling an \"internally-focused funding strategy\" is actually contradicted by the ground truth, which indicates a strategic SHIFT TOWARD external funding mechanisms. This represents a significant mischaracterization of PayPal's strategic direction.\n\nQUANTITATIVE VERIFICATION: All numbers are correct (9/10 - perfect on the numbers presented).\n\nQUALITATIVE ASSESSMENT: While the reasoning about efficiency is logical, the answer fails to synthesize the complete multi-hop picture. The question asks about strategic approach, and the ground truth provides two key strategic elements: (1) more efficient internal use, AND (2) shift to external funding via receivables sales. The LLM only addresses the first element and misinterprets it as the primary strategy, missing the more significant strategic pivot (5/10).\n\nCONTEXTUAL RELEVANCE: The answer addresses part of the question but misses the strategic shift component that is central to understanding PayPal's overall approach (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 521,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks disclosed that its limited‑partnership interest in Valor Siren Ventures I LP (and II LP) was carried at $211.9 million as of September 29, 2024, essentially unchanged from the prior year, and the share of income or loss from these private‑equity interests continues to be recorded in “interest income and other, net” on the consolidated statements of earnings, with the related activity described as not material in both FY 2023 and FY 2024【SBUX_10k_2024.pdf page_76】【SBUX_10k_2023.pdf page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $211.9 million carrying value as of September 29, 2024, which matches the ground truth. (2) Correctly identifies that both Valor Siren Ventures I L.P. and II L.P. are included in this amount. (3) Accurately states the financial impact is recorded in 'interest income and other, net' and is non-material. (4) Proper citation of source documents. WEAKNESSES: (1) CRITICAL ERROR - The LLM states the carrying value was 'essentially unchanged from the prior year,' but the ground truth explicitly states that in fiscal 2023, the carrying value was 'not specifically disclosed.' This is a significant factual error that misrepresents the evolution of the investment relationship. The LLM cannot claim the value was unchanged when FY2023 had no specific disclosure. (2) INCOMPLETE SYNTHESIS - The question asks how the relationship 'evolved' between FY2023 and FY2024. The ground truth describes an evolution from 'a general equity stake to a more defined and quantified investment with ongoing monitoring.' The LLM fails to capture this qualitative evolution and instead suggests continuity ('essentially unchanged'). (3) MISSING CONTEXT - The LLM does not address that in FY2023 the investment was held but not specifically quantified, whereas in FY2024 it became a defined $211.9 million investment. This is a key aspect of how the relationship evolved. (4) The answer is too brief and doesn't adequately address the multi-hop nature of comparing two fiscal years' disclosures. QUANTITATIVE ACCURACY: The $211.9 million figure is correct, but the claim of 'essentially unchanged from prior year' is unsupported and contradicts the ground truth's statement that FY2023 values were not specifically disclosed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 477,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Both 2022 and 2023 filings stress that analog products remain a core pillar of TI’s business model, built on the four sustainable competitive advantages—manufacturing & technology foundation, broad portfolio, extensive market‑channel reach, and product diversity—and continue to be emphasized for industrial and automotive end‑markets (2022 p.21; 2023 p.19). Nevertheless, the analog segment’s financial contribution weakened: revenue fell from $15.4 billion in 2022 to $13.0 billion in 2023 (‑15%) and operating profit dropped from $8.36 billion to $5.82 billion (‑30%), cutting its operating‑margin from 54.4% to 44.6% (2023 p.20).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Analog Products remained a core pillar in both years and accurately cites the four sustainable competitive advantages. The financial metrics provided (2022 revenue $15.4B, 2023 revenue $13.0B, operating profit $8.36B to $5.82B, margin decline from 54.4% to 44.6%) appear internally consistent and mathematically accurate (15.4-13.0=2.4B decline; 8.36-5.82=2.54B decline; 13.0/5.82=44.6% margin). The percentage calculations are correct.\n\nWEAKNESSES: The LLM answer diverges significantly from the ground truth in its framing and emphasis. The original answer emphasizes the STRATEGIC POSITIONING evolution—specifically how Analog Products were framed within TI's four competitive advantages in 2023 (with emphasis on lower costs and supply chain control) and the renewed focus on free cash flow per share as a performance metric. The LLM instead focuses heavily on the FINANCIAL DECLINE of the segment, which is factually accurate but represents a different interpretation of 'strategic positioning.' The ground truth suggests a strategic reframing/emphasis shift, while the LLM emphasizes deteriorating financial performance. The original answer mentions the 67.5% gross margin in 2022 and 300-millimeter production efficiency, which the LLM does not address. The LLM's focus on operating margin (54.4% to 44.6%) differs from the ground truth's emphasis on gross margin (67.5%) and manufacturing strategy.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the competitive advantages framework. However, it misses the nuanced strategic positioning evolution that the ground truth emphasizes—the shift from general strategic focus to explicit framing within competitive advantages and the emphasis on cash generation metrics.\n\nCONTEXTUAL RELEVANCE: While the LLM provides accurate financial data, it partially misses the core question about 'strategic positioning evolution' by overemphasizing financial decline rather than strategic reframing. The answer is partially relevant but incomplete in addressing the strategic dimension of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 581,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron’s Lower 48 segment recorded $4.854 billion of depreciation, depletion, amortization and impairments in 2022, which rose to $5.729 billion in 2023—an increase of roughly $875 million【page_133】. The higher non‑cash expense reflects a larger asset base and greater capital spending, indicating that Chevron shifted to a more aggressive capital‑allocation stance in the Lower 48 region in 2023 versus 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. QUANTITATIVE VERIFICATION: All numbers are correct - $4.854 billion (2022) and $5.729 billion (2023) match the ground truth values of $4,854 million and $5,729 million respectively. The calculated increase of $875 million is accurate ($5,729M - $4,854M = $875M). Number format variations ($4.854 billion vs $4,854 million) are semantically equivalent and acceptable. ENTITY ACCURACY: Correctly identifies Chevron, the Lower 48 region, and the relevant metric (depreciation, depletion, amortization, and impairments). Years 2022 and 2023 are correctly specified. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between increased DD&A/impairments and capital allocation strategy, correctly interpreting that higher non-cash expenses reflect a larger asset base and greater capital spending. The conclusion about a shift to more aggressive capital allocation is logically sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses the core question about how capital allocation strategy evolved, providing both the numerical evidence and the strategic interpretation. The mention of contrasting with other segments (implied in ground truth) is not explicitly stated in the LLM answer, but this is a minor omission that doesn't affect the core correctness. MINOR OBSERVATION: The LLM answer includes a page reference【page_133】which adds credibility but wasn't in the ground truth statement. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 447,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "In the 2023 filing Verizon presented Fixed‑Wireless Access (FWA) as a stand‑alone broadband product that was offered to both residential consumers and business customers – it was described as “fixed wireless access (FWA) broadband … as an alternative to traditional landline internet access” in the Consumer segment and as part of the Business segment’s portfolio, and the company even disclosed about 3.1 million FWA connections at year‑end 2023【page_4】【page_5】. By the 2024 filing the language still places FWA under both segments, but the Consumer description now frames it primarily as an extension of the 5G/4G LTE network within the residential broadband suite (“We also provide FWA broadband … as an alternative to traditional landline internet access”), while the Business segment merely lists it among a broader set of services for enterprises, public‑sector and carrier customers, indicating a shift toward a more integrated, consumer‑centric positioning and less separate emphasis on the business‑specific FWA offering【page_100】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 3.1 million FWA connections figure for 2023, matching the ground truth exactly. (2) The quantitative data is accurate - no calculation errors or incorrect numbers. (3) The LLM properly identifies that FWA was offered to both Consumer and Business segments in both years. (4) The answer correctly notes the positioning as 'an alternative to traditional landline internet access' which appears in both filings. (5) The multi-hop synthesis across 2023 and 2024 filings is logically sound and addresses the evolution question.\n\nWEAKNESSES: (1) The ground truth mentions a shift from 'provides' (2023) to 'produces' (2024) as indicating a more strategic, product-centric approach. The LLM answer does not explicitly capture this linguistic/conceptual shift, which is a key insight in the original answer about the evolution of approach. (2) The ground truth emphasizes FWA's integration 'as part of a broader portfolio that includes IoT and advanced communication services' - the LLM answer focuses more on the consumer-centric positioning but doesn't explicitly mention the broader portfolio integration with IoT and advanced services. (3) The LLM's characterization of the Business segment shift as 'less separate emphasis' is somewhat vague compared to the ground truth's clearer statement about more integrated positioning.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings, comparing positioning and customer segments. The reasoning is sound and addresses the evolution question appropriately.\n\nSEMANTIC EQUIVALENCE: While the LLM answer conveys similar information about the evolution and positioning, it misses some nuanced aspects of the ground truth regarding the 'provides' vs 'produces' distinction and the broader portfolio integration context. The core narrative about consumer-centric shift is present but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 520,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it contributed its two stand‑alone industrial‑software businesses and $6 billion of cash to Heritage AspenTech, receiving a 55 % ownership of the newly formed “New AspenTech” 【page_3】. By 2024 Emerson still owned a majority stake—about 57 %—and on November 5 2024 announced a cash offer to purchase all of the remaining AspenTech shares, moving the relationship toward full ownership 【page_25】. The 2022‑23 AspenTech acquisition lifted Emerson’s gross margin by roughly 0.6 percentage point in 2023 (part of the 3.3‑point rise to 49.0 %) and gross margin continued to improve to 50.8 % in 2024, while the equity structure shifted from a 55 % joint‑venture to a near‑complete (potential 100 %) owned subsidiary, increasing the proportion of AspenTech earnings reflected in Emerson’s consolidated equity 【page_26】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2022 partnership structure where Emerson contributed two industrial-software businesses and $6 billion in cash to Heritage AspenTech, receiving 55% ownership of 'New AspenTech' - this matches ground truth. (2) Accurately tracks the evolution to 2024, noting Emerson's ownership increased to approximately 57% and announced a cash offer on November 5, 2024 for remaining shares - this represents proper temporal progression. (3) Correctly quantifies the gross margin impact: 0.6 percentage point benefit in 2023 (part of 3.3-point rise to 49.0%) and further improvement to 50.8% in 2024 - all numbers align with ground truth. (4) Properly synthesizes the equity structure evolution from 55% joint venture to near-complete ownership, explaining the financial impact on consolidated equity. (5) Addresses all three components of the multi-part question: relationship evolution, gross margin impact, and equity structure changes. MINOR CONSIDERATIONS: The LLM provides slightly more specific detail (57% ownership in 2024, November 5 date, $6 billion cash contribution) than the ground truth summary, but these details are consistent with and enhance the answer without contradicting the original. The answer demonstrates sound multi-hop reasoning by connecting the 2022 transaction structure to 2024 ownership changes and linking these to specific financial metrics (gross margin percentages, equity structure shifts). All calculations and percentages are accurate. The semantic meaning fully aligns with ground truth while providing additional specificity that strengthens the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 468,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "In the 2022 proxy the link between NEE (through its subsidiary FPL Group) and FPL Group Capital Inc was essentially a guarantee arrangement – FPL Group acted as guarantor of Capital’s obligations (see the “Guarantee Agreement … dated Oct 14 1998” listed as Exhibit *10(vv) on page 124). By the 2023 filing that relationship had expanded: Capital (now NextEra Energy Capital Holdings) is issuing its own unsecured debt – a series of debentures and floating‑rate notes documented in the Indenture (Exhibit *4(l)), the supplemental indenture (Exhibit *4(m)), a new guarantee agreement (Exhibit *4(n)) and a host of officer‑certificate and amendment letters on page 118 – showing NEE/FPL still providing guarantees but now actively involved in Capital’s capital‑structure financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution from a guarantee arrangement in 2022 to a more complex capital structure involvement in 2023. The date of the guarantee agreement (October 14, 1998) is accurate. The LLM correctly notes the transition from simple guarantee to long-term capital financing. The identification of multiple debenture series (B, C, L, M, N, O, P) and maturity date ranges (2057-2082) aligns with ground truth. The exhibit references and document types mentioned are contextually appropriate.\n\nWEAKNESSES: (1) The LLM introduces 'NextEra Energy Capital Holdings' as an alternative name for FPL Group Capital Inc in 2023, which is not mentioned in the ground truth and may introduce confusion about entity identity. (2) The LLM provides specific exhibit numbers and page references that cannot be verified against the ground truth and may be hallucinated details. (3) The LLM's description of 'unsecured debt' and 'floating-rate notes' goes beyond what the ground truth specifies (which only mentions 'junior subordinated debentures'). (4) The characterization of the relationship as 'Capital (now NextEra Energy Capital Holdings)' suggests a name change that is not confirmed in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the evolution of the relationship. However, the introduction of unverified entity names and document details weakens the synthesis quality.\n\nNUMERIC/DATE ACCURACY: The October 14, 1998 date is correct. The maturity date ranges (2057-2082) and debenture series letters are accurate. No calculations are required for this question.\n\nSEMANTIC EQUIVALENCE: The core message matches - evolution from guarantee to capital structure involvement - but the LLM adds details not in ground truth that create uncertainty about accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 510,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic noted that **InterStim II was part of the broader InterStim therapy suite**—alongside InterStim Micro and InterStim X—whose “continued acceptance and growth” was driving the Pelvic Health segment (MDT 2022 10‑K, p. 42). By the 2024 filing the company **re‑positions InterStim II as a distinct “recharge‑free neurostimulator,”** highlighting its differentiation from the rechargeable InterStim Micro and the newer InterStim X, while again emphasizing “continued acceptance and growth” of the Pelvic Health therapies that include all three devices (MDT 2024 10‑K, p. 39). This evolution shows that InterStim II’s market acceptance has been sustained and its positioning sharpened to stress its recharge‑free advantage within an expanding Pelvic Health portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of InterStim II as part of a suite including InterStim Micro and InterStim X with emphasis on 'continued acceptance and growth'; (2) Accurately captures the 2024 evolution toward emphasizing InterStim II as a 'recharge-free neurostimulator' with differentiation from rechargeable alternatives; (3) Properly synthesizes the multi-hop information showing how positioning shifted from generic suite membership to device-specific attribute emphasis; (4) Correctly identifies the broader Pelvic Health therapy context in both years; (5) Provides specific filing references (MDT 2022 10-K p. 42, MDT 2024 10-K p. 39) that enhance credibility. QUANTITATIVE ACCURACY: No numeric values were required for this qualitative question, so this dimension is fully satisfied. QUALITATIVE ACCURACY: The reasoning is sound—the model correctly identifies the evolution from generic product suite positioning to differentiated attribute-based positioning, which matches the ground truth's characterization of 'shift toward emphasizing device-specific attributes.' MINOR CONSIDERATIONS: The LLM answer adds interpretive language ('sharpened to stress its recharge-free advantage') that goes slightly beyond the ground truth's more neutral description, but this represents reasonable inference rather than factual error. The answer maintains semantic equivalence with the ground truth while providing slightly more explicit business interpretation. MULTI-HOP SYNTHESIS: Successfully combines information across 2022 and 2024 filings, correctly identifies product portfolio context, and properly traces the evolution of positioning language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 481,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Supplemental Facility was described as a $3.5 billion revolving line (expandable to $4.5 billion) that would mature on January 31 2026, with borrowings priced at SOFR + 72.5 bps (or other benchmark options) plus a margin tied to Simon’s credit rating. By the 2024 filing the capacity range remained $3.5‑$4.5 billion but the maturity was extended to January 31 2029 (extendable to 2030) and the same SOFR + 72.5 bps pricing is still used; the company also repaid the €750 million of Euro‑denominated borrowings under the Supplemental Facility in November 2023 using proceeds from a €750 million senior unsecured bond issuance and terminated the related interest‑rate swaps.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the Supplemental Facility's evolution but contains a critical factual error regarding the maturity date extension. STRENGTHS: (1) Correctly identifies the 2022 borrowing capacity of $3.5 billion expandable to $4.5 billion; (2) Accurately states the SOFR + 72.5 bps pricing structure; (3) Correctly reports the €750 million borrowing repaid in November 2023; (4) Accurately notes the use of interest rate swaps and their termination; (5) Properly identifies the senior unsecured bond issuance as the repayment source; (6) Demonstrates good multi-hop synthesis across 2022 and 2024 filings. CRITICAL ERROR: The LLM states the maturity was 'extended to January 31 2029 (extendable to 2030)' by 2024, but the ground truth indicates the maturity date remained January 31, 2026 in 2022 with no mention of extension to 2029 in the ground truth. This is a significant factual discrepancy that undermines the answer's reliability. MINOR ISSUES: (1) The ground truth mentions 'shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024,' which the LLM captures implicitly but doesn't explicitly articulate the strategic evolution narrative as clearly; (2) The ground truth emphasizes the 3.81% fixed rate achieved through swaps, while the LLM mentions swap termination but doesn't highlight this specific rate achievement. QUANTITATIVE ACCURACY PENALTY: The maturity date discrepancy is a major quantitative error (dates are critical in financial analysis). The pricing details (SOFR + 72.5 bps) are correct and well-specified. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and connects the borrowing, repayment, and swap activities logically. The reasoning about the evolution is sound despite the maturity date error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 504,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "In the 2023 filing Verizon only said that customers could “acquire equipment … using device payment plans, which permit the customer to pay for the device in installments over time” (page 5). By 2024 the description had become more detailed: the plan is a non‑interest‑bearing installment note—typically 36 months—paired with a month‑to‑month service contract, and Verizon now adds promotional billing‑credit incentives and upgrade/trade‑in rights that are accounted for as variable consideration and a guarantee liability (pages 60‑61). Thus, the financing structure remains an installment note, but the company has layered in explicit promotional incentives and more granular accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 baseline as a simple device payment plan mechanism without structured promotional incentives or trade-in rights, matching the ground truth's characterization. (2) Accurately describes the 2024 evolution to a formalized non-interest-bearing installment note with a 36-month term, which matches the original answer exactly. (3) Properly synthesizes the introduction of promotional features (billing credits, upgrade/trade-in rights) in 2024, capturing the shift from general financing to incentive-driven model. (4) Adds valuable detail about accounting treatment (variable consideration, guarantee liability) that enriches understanding without contradicting the ground truth. (5) Correctly cites page references (pages 5 for 2023, pages 60-61 for 2024) showing document-specific sourcing. (6) The multi-hop reasoning is sound—comparing 2023 vs 2024 structures and identifying the evolution pattern. MINOR CONSIDERATIONS: The LLM answer includes additional accounting details (variable consideration, guarantee liability) not explicitly mentioned in the ground truth, but these are complementary rather than contradictory and demonstrate deeper filing analysis. The characterization of the shift from 'general financing mechanism' to 'structured and incentive-driven model' is semantically equivalent across both answers. No quantitative errors detected. The answer fully addresses all parts of the multi-part question regarding customer financing structure and promotional incentives evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 447,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings describe the Aqua‑Chem matter in the same terms: the Company still maintains that it “has no obligation … for any past, present or future liabilities … in connection with any claims or lawsuits against Aqua‑Chem,” including the asbestos‑related claims (see 2023 p. 30 and 2024 p. 30). The litigation status is unchanged – the Georgia case remains stayed, the Wisconsin case was voluntarily dismissed, and the Company continues to defend its position and pursue coverage settlements, with a summary‑judgment ruling in its favor (see 2023 p. 31 and 2024 p. 31).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains accurate factual details about Coca-Cola's stated position on liability (maintaining 'no obligation') and correctly identifies the litigation status (Georgia case stayed, Wisconsin case dismissed). However, it fundamentally misses the core insight of the ground truth answer regarding the evolution of Coca-Cola's legal stance between 2023 and 2024. The ground truth explicitly states there was a 'shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.' The LLM answer contradicts this by claiming the filings 'describe the Aqua-Chem matter in the same terms' and that 'the litigation status is unchanged,' thereby missing the key evolution the question asks about. While the LLM correctly identifies that both years maintain the 'no obligation' language and references the correct page numbers (p. 30 and p. 31), it fails to recognize or articulate the shift in disclosure emphasis regarding insurance policies and multiple insurers that the ground truth identifies as the meaningful change between years. The LLM's conclusion that nothing has evolved contradicts the ground truth's identification of a shift in emphasis and stance. This represents a significant failure in multi-hop reasoning and synthesis - the model did not properly compare the two years' disclosures to identify the nuanced changes in how Coca-Cola presented its position, particularly regarding insurance coverage details and shared responsibility among insurers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 428,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel’s long‑term tax payable shrank dramatically – it was $4.3 billion in the 2022 filing (Dec 25 2021) and fell to $1.6 billion in the 2024 filing (Dec 28 2024) – and both footnotes note that the balance is “reduced by … non‑US tax credits”【page_92】 and “reduced by … non‑US tax credits”【page_83】. The steep decline shows Intel is actively using foreign tax credits to offset U.S. transition‑tax and uncertain‑position liabilities, indicating a deliberate international tax strategy that leverages its overseas operations to lower its overall tax burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - $4.3 billion for 2022 and $1.6 billion for 2024 long-term income tax payables are accurate. The dates are correctly identified (Dec 25, 2021 for 2022 filing and Dec 28, 2024 for 2024 filing). The calculation of the decline is implicit and correct. ENTITY ACCURACY: Intel is correctly identified, the metric (long-term income taxes payable) is correct, and the years (2022 vs 2024) are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years, correctly identifying that both footnotes reference non-US tax credits as a reducing factor. The logical connection between the declining liability and increased utilization of non-US tax credits is sound. COMPLETENESS: The answer addresses all parts of the question - it shows the comparison between 2022 and 2024, explains the impact of non-US tax credits, and provides interpretation of what this indicates about Intel's international tax strategy. SEMANTIC EQUIVALENCE: The LLM's phrasing 'steep decline shows Intel is actively using foreign tax credits' and 'deliberate international tax strategy' conveys the same meaning as the ground truth's 'stronger offsetting effect' and 'strategic shift or increased effectiveness.' The answer goes slightly further by explicitly mentioning 'U.S. transition-tax and uncertain-position liabilities,' which adds helpful context without contradicting the ground truth. MINOR CONSIDERATIONS: The inclusion of specific page references and filing dates adds credibility and detail beyond the ground truth, which is appropriate for a comprehensive answer. No factual errors or calculation mistakes were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 484,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "In the 2022 filing, pension risk transfers were grouped in the Retirement‑and‑Income‑Solutions (RIS) segment and were explicitly modelled for interest‑rate risk – the company projected earnings impacts for RIS under both declining‑ and rising‑rate scenarios (e.g., ‑$5 M to +$15 M in adjusted earnings, page 61) and noted that lower rates increase pension‑liability values (page 63). By the 2024 filing, the focus shifted to regulatory drivers: new or revised defined‑benefit funding rules are expected to alter the mix of pension‑risk‑transfer transactions and push the business toward more non‑guaranteed funding products (page 32), while the detailed interest‑rate sensitivity of those transfers is no longer highlighted.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the Retirement-and-Income-Solutions (RIS) segment as the relevant business unit in 2022; (2) Accurately captures the shift from interest-rate sensitivity focus in 2022 to regulatory drivers in 2024; (3) Correctly identifies the regulatory change around defined-benefit pension plan funding rules; (4) Properly synthesizes that regulatory changes are expected to shift the mix toward non-guaranteed funding products; (5) Semantic equivalence is strong - the answer conveys the same evolution described in ground truth. WEAKNESSES/CONCERNS: (1) The specific earnings impact numbers cited ($-5M to +$15M) and page references (61, 63, 32) cannot be verified against the ground truth provided, which does not include these specific citations. While these details appear plausible and support the narrative, they represent specific quantitative claims that go beyond what the ground truth explicitly confirms. (2) The ground truth mentions 'interest rate scenarios that could impact asset-liability management (ALM) strategies' but the LLM provides more specific modeling details about declining/rising rate scenarios. (3) Minor: The ground truth uses 'pension risk transfers' while LLM uses 'pension-risk-transfer transactions' - semantically equivalent but slightly different phrasing. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2022 vs 2024) and correctly identifies the evolution from operational/financial metrics focus to regulatory/strategic focus. The logic connecting regulatory changes to product mix shifts is sound and matches the ground truth narrative. QUANTITATIVE ACCURACY DEDUCTION: The specific dollar amounts and page numbers cited cannot be independently verified from the ground truth provided, creating uncertainty about their accuracy despite appearing reasonable. This prevents a higher quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 546,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "In 2022 Medtronic presented the InterStim Micro as a **newly launched** rechargeable neurostimulator that was a key driver of growth in its Specialty‑Therapies/Pelvic‑Health segment (e.g., “growth was led by sales of the recently launched InterStim Micro neurostimulator” – 2022 10‑K p. 41; and the InterStim portfolio description – 2022 10‑K p. 42). By 2024 the company treats the InterStim Micro as an **established component** of a broader InterStim therapy suite (InterStim X, InterStim II and InterStim Micro) and emphasizes **continued acceptance and growth** of the device within its Pelvic‑Health portfolio (2024 10‑K p. 39).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Medtronic's InterStim Micro positioning between 2022 and 2024. STRENGTHS: (1) Correctly identifies the key temporal shift from 'newly launched' (2022) to 'established component' (2024), which captures the essential strategic evolution. (2) Accurately references the 2022 10-K statement about InterStim Micro being a growth driver ('recently launched' language). (3) Properly identifies the broader InterStim portfolio context (InterStim X, InterStim II, InterStim Micro). (4) Correctly notes the emphasis on 'continued acceptance and growth' in 2024. (5) Appropriately cites specific 10-K pages (2022 p. 41-42, 2024 p. 39) showing document verification. (6) Correctly identifies the Specialty-Therapies/Pelvic-Health segment context. MINOR DISCREPANCIES: (1) The LLM characterizes InterStim Micro as 'newly launched' in 2022, while the ground truth describes it as 'part of its broader InterStim therapy offering' without explicitly emphasizing 'newly launched' status. However, the 10-K citation supports this characterization. (2) The ground truth emphasizes the 'rechargeable' differentiation more explicitly in 2024 (contrasting with 'recharge-free' models), while the LLM mentions rechargeable in 2022 but doesn't emphasize the differentiation strategy as clearly in the 2024 comparison. (3) The LLM's framing of the evolution is slightly more product-lifecycle focused (new→established) versus the ground truth's emphasis on marketing differentiation strategy. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic shift in positioning. The logic is sound and the comparison is appropriate. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is less critical. The dates (2022, 2024) and document references are accurate. OVERALL: The answer captures the essential evolution accurately with strong document support, though it could have emphasized the rechargeable/recharge-free differentiation strategy more explicitly as a key element of the 2024 positioning shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 592,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "In the 2022 filing the Operating Partnership had drawn $1.05 billion from the Supplemental Facility in December 2021 and then fully repaid that amount on January 12 2022 with proceeds from newly issued senior notes (see page 125). By the 2024 filing the only Supplemental‑Facility borrowing left was a €750 million ($815 million) draw that was retired in November 2023 when the Partnership issued €750 million of senior bonds (see page 70), and the year‑end 2024 aggregate outstanding balance across all credit facilities was just $325.1 million, indicating the Supplemental Facility is now essentially unused (pages 68‑69).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant and mostly accurate information about Simon Property Group's Supplemental Facility evolution, but differs from the ground truth in scope and emphasis. STRENGTHS: (1) The €750 million ($815 million) repayment on November 17, 2023 is correctly cited with accurate dollar conversion; (2) The characterization that the Supplemental Facility is 'essentially unused' by 2024 aligns with the ground truth's 'strategic reduction'; (3) The specific transaction details (December 2021 draw, January 12, 2022 repayment, November 2023 senior bonds issuance) are accurate and provide helpful context; (4) Year-end 2024 aggregate outstanding balance of $325.1 million is cited (ground truth mentions weighted average of $311.1 million for 2024, which are different metrics but both correct). WEAKNESSES: (1) The LLM answer focuses heavily on specific transaction history (2021-2022 activity) rather than the 2022-2024 comparison requested; (2) The ground truth emphasizes weighted average outstanding balances ($519.9M in 2022 vs $311.1M in 2024) as the primary metric showing evolution, while the LLM answer emphasizes year-end balances and transaction history; (3) The maximum aggregate outstanding balance of $2.1 billion in 2022 mentioned in ground truth is not addressed; (4) The answer provides more granular transaction-level detail than the ground truth's higher-level summary approach. QUANTITATIVE VERIFICATION: €750M = $815M conversion is accurate (minor rounding: ground truth shows $815.4M, LLM shows $815M); $325.1M year-end 2024 balance is correctly stated. The answer doesn't directly compare the weighted average metrics that form the core of the ground truth's evolution narrative. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and documents, correctly linking the 2021-2022 transactions to the 2023-2024 refinancing activity. However, it takes a different analytical approach than the ground truth, focusing on transaction history rather than outstanding balance trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 551,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "In 2022 the Lower 48 segment recorded $4.854 billion of depreciation, depletion, amortization and impairments; in 2023 that amount grew to $5.729 billion – an increase of roughly $875 million (about 18%). The higher expense indicates that COP’s investment activity in the Lower 48 region rose in 2023 relative to the prior year.【page_133】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2022 figure of $4.854 billion ($4,854 million) matches ground truth exactly; (2) 2023 figure of $5.729 billion ($5,729 million) matches ground truth exactly; (3) calculated difference of $875 million is correct ($5,729M - $4,854M = $875M); (4) percentage increase of approximately 18% is accurate (875/4,854 = 0.1803 or ~18%). The LLM correctly converted the ground truth numbers from millions to billions format, which is an acceptable format variation. Multi-hop reasoning is sound: the answer synthesizes the two-year comparison and correctly interprets the increase in DD&A expenses as indicating higher investment activity or asset utilization. The answer directly addresses the question about how investment activity evolved from 2022 to 2023. The only minor observation is that the LLM provides slightly more analytical detail (percentage calculation) than the ground truth, but this adds value without introducing errors. Entity identification is correct (COP, Lower 48 region, DD&A expenses, fiscal years 2022-2023). The semantic meaning aligns perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 334,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "In the 2023 filing Verizon described its Business segment’s corporate networking offering as one of a set of services – “wireless and wireline communications … including FWA broadband, data, video and conferencing services, **corporate networking solutions**, security and managed network services, …”【page_5】. By the 2024 filing the language had been broadened to place corporate networking inside a larger “**advanced communication services**” suite – “wireless and wireline communications … including FWAbroadband, data, video and **advanced communication services, corporate networking solutions**, security and managed network services, …”【page_100】.  \n\nAt the same time, the Business segment’s revenue mix shifted. In 2023, Business Markets and Other (which houses the corporate‑networking products for small‑ and medium‑size firms) accounted for about $12.7 billion of $30.1 billion in Business revenue (≈42%)【page_101】. In 2024 that line grew to $13.1 billion of $29.5 billion (≈44%) while Enterprise and Public Sector fell slightly, indicating a stronger emphasis on the Business Markets and Other segment – and thus on corporate networking solutions – in 2024.【page_100】",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides useful insights about the evolution of Verizon's corporate networking messaging and attempts to address the revenue mix shift, but contains significant quantitative errors that undermine its credibility. STRENGTHS: (1) Correctly identifies the shift in service description language from 2023 to 2024, noting the addition of 'advanced communication services' framing; (2) Appropriately addresses both service description and business segment emphasis aspects of the question; (3) Sound reasoning about what the changes signify strategically. CRITICAL ERRORS: (1) The LLM cites Business Markets and Other revenues of $12.7B (2023) and $13.1B (2024), but the ground truth states Enterprise and Public Sector reached $15.1B in 2023 - these are different segments and the LLM appears to have confused or misidentified which segment represents corporate networking; (2) The percentages calculated (42% and 44%) are mathematically correct for the numbers provided ($12.7B/$30.1B ≈ 42%, $13.1B/$29.5B ≈ 44%), but if the underlying revenue figures are incorrect, the percentages are also misleading; (3) The ground truth emphasizes that Enterprise and Public Sector (which includes corporate networking) was ~50% of Business revenues in 2023, but the LLM's answer suggests Business Markets and Other (a different segment) is the primary corporate networking vehicle and only ~42-44% of revenues. MULTI-HOP REASONING: The LLM attempts to synthesize service description changes with revenue mix shifts, which is appropriate, but the segment identification appears flawed. The answer conflates or misidentifies which business segment houses corporate networking solutions. SEMANTIC ISSUES: While the LLM correctly identifies a shift toward 'advanced communication services' framing, it may be overstating the degree of change compared to the ground truth's characterization of a 'more streamlined' and 'generalized presentation.' The ground truth suggests simplification/consolidation, while the LLM suggests broadening/expansion into a larger suite.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 554,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "In the 2022 Form 10‑K MetLife disclosed that its FVO securities were measured at fair value using Level 3 techniques and that a 10 % appreciation of the U.S. dollar would reduce their estimated fair value by roughly **$7 million** (see the “U.S.‑dollar appreciation” sensitivity table – page 150, and footnote 7 on page 151). By the 2024 filing the company placed FVO securities together with unit‑linked assets under a single “Unit‑linked and FVO securities” Level 3 line, applying the same matrix‑pricing, offered‑quote and other significant‑unobservable‑input methods described for all Level 3 assets (page 249), and the dollar‑strength effect is now captured only in the broader foreign‑currency exchange‑rate sensitivity discussion (footnote 7 on page 250) rather than a separate dollar‑amount, indicating a shift to a more integrated valuation framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error on the primary quantitative claim. The ground truth states that a 10% U.S. dollar appreciation would lead to a $54 million decrease in FVO securities value in 2022, but the LLM claims it would reduce value by 'roughly $7 million.' This is a massive discrepancy (off by ~87%) and represents a core factual error that undermines the entire answer. The LLM cites specific page numbers (150, 151, 249, 250) and footnote references that cannot be verified against the ground truth, and the $7 million figure directly contradicts the established $54 million sensitivity metric. While the LLM correctly identifies that MetLife used Level 3 valuation techniques and that there was an evolution toward a more integrated framework by 2024, the quantitative foundation of the answer is severely compromised. The LLM also fails to mention the $1.6 billion fair value figure for FVO securities in 2022, which is a significant omission. The qualitative description of the evolution (from static sensitivity model to more complex, duration- and currency-dependent approach) is conceptually aligned with the ground truth, but this cannot compensate for the major quantitative error. The answer demonstrates partial understanding of the structural changes in valuation methodology but fails on the most critical numerical claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 384,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy’s NEER segment continued to “provide full energy and capacity‑requirements services … engage in power and fuel marketing and trading activities” in both years (2022 description of energy‑trading services 【page_77】; 2023 reaffirmation of the same activities 【page_40】).  The financial contribution of those activities, however, swung dramatically: 2022 saw a $2.67 billion loss from non‑qualifying commodity hedges, while 2023 generated a $2.53 billion gain, which was a primary driver of the $5.95 billion increase in operating revenues for 2023 (see operating‑revenues discussion 【page_40】).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM cites a '$2.67 billion loss from non-qualifying commodity hedges' in 2022 and a '$2.53 billion gain' in 2023, with a claimed '$5.95 billion increase in operating revenues.' These numbers do not appear in the ground truth and appear to be fabricated or misattributed. The ground truth clearly states NEER's net income rose from $285 million in 2022 to $3,558 million in 2023 - a $3,273 million increase, NOT a $5.95 billion operating revenue increase. The LLM conflates different financial metrics (operating revenues vs. net income) and provides unsupported numerical claims. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that NEER continued providing energy trading services in both years, it fails to mention the actual net income figures that are central to demonstrating financial performance evolution. The ground truth explicitly highlights the net income increase from $285M to $3,558M as the key indicator of growth. (3) ENTITY/METRIC CONFUSION: The LLM discusses 'non-qualifying commodity hedges' and 'operating revenues' without clear grounding in the source documents, and these specific metrics are not mentioned in the ground truth answer. (4) REASONING QUALITY: The multi-hop reasoning is flawed - the LLM attempts to explain the financial evolution through hedge gains/losses rather than the actual net income growth documented in the ground truth. The connection between the cited figures and the actual financial performance is not established. (5) MISSING CORE INFORMATION: The LLM completely omits the specific net income figures ($285M to $3,558M) that are essential to answering the 'financial performance' aspect of the question. The ground truth emphasizes this 'substantial evolution and growth in the scale or profitability' as the key finding, which the LLM fails to capture with correct numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 539,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca‑Cola Company’s ownership of Coca‑Cola FEMSA remained essentially unchanged – it still held a 28 % equity stake in 2024, the same level reported for 2023【page_87】.  That stable ownership translated into a modest rise in the company’s equity‑income line, which grew from $1.691 billion in 2023 to $1.770 billion in 2024, reflecting stronger proportionate earnings from its bottling partners, including FEMSA【page_87】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Ownership Stake Claim: The LLM states the 28% ownership stake was 'the same level reported for 2023,' but the ground truth explicitly indicates this was NOT the case in 2023. The original answer clearly states that in 2023, FEMSA was referenced as a key bottler with an 'indirect financial dependency' relationship, and only 'by 2024' did Coca-Cola hold a 28% ownership stake. This represents a strategic shift FROM indirect dependency TO direct 28% ownership - not a stable relationship. The LLM fundamentally mischaracterized the evolution of the relationship. (2) QUANTITATIVE ISSUES - Equity Income Numbers: The LLM provides specific equity income figures ($1.691 billion in 2023 and $1.770 billion in 2024), but these cannot be verified against the ground truth provided. The ground truth does not provide these specific numbers, making it impossible to confirm accuracy. The LLM appears to have cited page 87 as a source, but the ground truth does not reference these specific equity income values. (3) MULTI-HOP REASONING FAILURE: The question asks about the evolution of the relationship 'between 2023 and 2024.' The ground truth identifies a clear strategic shift: from an indirect relationship (2023) to direct ownership with equity method accounting (2024). The LLM completely missed this evolution by claiming the ownership stake 'remained essentially unchanged,' which directly contradicts the ground truth's characterization of a 'strategic evolution.' (4) MISSING KEY CONTEXT: The LLM failed to address the shift from dependency-based relationship to direct ownership stake, which is the core of the 'evolution' the question asks about. The answer also doesn't explain the implications for equity income in terms of the accounting method change (equity method accounting), which is mentioned in the ground truth. The LLM's answer is internally consistent but factually incorrect regarding the fundamental nature of the relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 554,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "The Lower 48 segment’s depreciation expense rose from $4.854 billion in 2022 to $5.729 billion in 2023 (≈18 % increase)【page_133】, and capital spending grew from $5.630 billion to $6.487 billion over the same period【page_135】, indicating a stronger financial commitment to the region.  Although the excerpts only show the Lower 48’s 2021 production of 447 k bbl/d of crude oil, 110 k bbl/d of NGL and 1,340 mmcf/d of natural gas【page_169】, the higher depreciation and capex imply that production was sustained or expanded in 2022‑23, reflecting an intensified operational focus on the Lower 48.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All core financial numbers are correct: depreciation/depletion/amortization/impairments rose from $4.854B (2022) to $5.729B (2023), matching ground truth exactly. (2) The 18% increase calculation is accurate ($5.729B - $4.854B = $0.875B; $0.875B/$4.854B ≈ 18%). (3) Production volumes cited (447 k bbl/d crude oil, 1,340 mmcf/d natural gas) match ground truth. (4) Multi-hop synthesis is sound: LLM correctly connected depreciation expense increases with capital spending increases to infer sustained/expanded production focus. (5) Appropriate use of source citations. WEAKNESSES: (1) The LLM attributes 2021 production data to support 2022-23 analysis, which is a minor temporal inconsistency - the ground truth explicitly states 2022 production volumes, while LLM only cites 2021 data and infers 2022-23 production was 'sustained or expanded.' This is a logical inference but not as direct as the ground truth's explicit 2022 production statement. (2) The LLM introduces capital spending data ($5.630B to $6.487B) which, while relevant and accurate, goes beyond what the ground truth explicitly addresses - the ground truth focuses specifically on depreciation expenses and production volumes. (3) Minor: The LLM uses 'depreciation expense' terminology while ground truth uses the fuller 'depreciation, depletion, amortization, and impairments' - though these refer to the same line item, the precision matters for SEC filing accuracy. CALCULATION VERIFICATION: All numbers check out correctly. MULTI-HOP REASONING: The LLM successfully synthesized information across production data, depreciation trends, and capital spending to draw conclusions about operational focus evolution. The reasoning is sound though slightly inferential on the 2022-23 production levels. OVERALL: The answer is substantially correct with accurate numbers and sound reasoning, but has minor issues with temporal precision in production data attribution and slight scope expansion beyond the original question's focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 542,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "In the 2023 filing, Verizon’s 4G LTE network is mentioned mainly as a platform for Fixed‑Wireless Access (FWA) broadband—an alternative to traditional land‑line service (see 2023 page 97). By the 2024 filing, the 4G LTE network is described as a core element of the company’s overall network infrastructure, alongside C‑Band and millimeter‑wave spectrum and fiber, and is explicitly cited as a driver of new products, services and growth initiatives (see 2024 page 23). This reflects a shift from a supporting role for FWA to a strategic pillar that underpins Verizon’s growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Verizon's 4G LTE network strategy from 2023 to 2024. Both the original and LLM answers correctly identify: (a) 2023 positioning as primarily supporting FWA broadband as an alternative to traditional landline service, and (b) 2024 positioning as part of an integrated multi-technology ecosystem including C-Band, millimeter-wave, and fiber. The semantic meaning is equivalent despite slightly different wording. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question about strategic evolution. The page references provided (2023 page 97, 2024 page 23) are contextual citations that support the answer but cannot be verified against the ground truth format. (3) ENTITY ACCURACY: All entities are correctly identified - Verizon, 4G LTE network, FWA broadband, C-Band spectrum, millimeter-wave spectrum, and fiber infrastructure. Years (2023 and 2024) are correct. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years and correctly identifies the strategic shift from a supporting role (FWA delivery) to a strategic pillar within a broader ecosystem. The reasoning is sound and logically structured. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'shift from a supporting role for FWA to a strategic pillar' is semantically equivalent to the ground truth's 'move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.' Minor deduction (1 point) for not explicitly stating the shift represents movement from 'service delivery context' to 'multi-technology ecosystem' framing, though the core concept is captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 496,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in fiscal 2022 when it closed the Heritage AspenTech transaction, paying roughly $6 billion in cash and emerging with a 55 % equity stake in the software firm (page 26).  The deal swelled the consolidated order backlog – AspenTech’s backlog jumped from $328 million in 2021 to $1,042 million in 2022 (page 10) – and added about 0.6 percentage‑points to Emerson’s gross margin in 2023 (gross margin rose to 49.0 % that year, page 26).  By 2024 Emerson’s ownership had risen to about 57 % and it announced a $240‑per‑share cash offer to buy the remaining shares, valuing AspenTech at roughly $15.3 billion (page 25).  The AspenTech acquisition continued to lift overall gross margin, which climbed to 50.8 % in 2024 (page 26).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Emerson's relationship with AspenTech but contains several factual discrepancies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 55% ownership stake resulting from the transaction\n- Correctly states AspenTech's backlog jumped from $328M (2021) to $1,042M (2022)\n- Correctly identifies the gross margin impact in 2023 (though with slight discrepancy in magnitude)\n- Correctly notes the 2024 ownership increase to ~57% and the $240/share buyout offer\n- Correctly identifies the $15.3B valuation\n- Correctly states 2024 gross margin reached 50.8%\n- Properly synthesizes multi-hop information across years and metrics\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE DISCREPANCY: The LLM states the AspenTech acquisition added \"about 0.6 percentage-points\" to gross margin in 2023, but the ground truth indicates a 3.3 percentage point increase. This is a significant numerical error (off by a factor of 5.5x).\n2. TIMING ISSUE: The LLM describes the Heritage AspenTech transaction as closing in \"fiscal 2022,\" but the ground truth indicates the relationship existed in 2022 with the transaction completing by 2024 (\"New AspenTech\" creation). The LLM's framing suggests the transaction closed in 2022, which may be misleading about the timeline.\n3. BACKLOG METRIC: The ground truth mentions 2024 backlog reached $8,053M (up from $6,533M in 2021), but the LLM does not provide the 2024 backlog figure, only the 2022 figure of $1,042M for AspenTech specifically.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and connects stake ownership, financial metrics, and transaction details. The reasoning is sound in structure, though the gross margin impact calculation is materially incorrect.\n\nSEMANTIC EQUIVALENCE: The answer conveys the general evolution of the relationship but with the critical error in the gross margin impact magnitude, which undermines the accuracy of the financial metrics assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 550,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "In the 2022 10‑K NEE noted that, after a $1.5 billion impairment in 2020, it recorded an additional impairment in Q1 2022 that **completely wrote off its investment in the Mountain Valley Pipeline** (see page 96). By the 2023 filing the company is **committing new equity contributions and a 20‑year, roughly $70 million‑per‑year, transportation agreement with the pipeline** (see pages 108‑109), indicating a shift from exiting the project to re‑engaging with it and pursuing long‑term natural‑gas infrastructure as part of a broader, diversified investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) IMPAIRMENT CLAIM - The LLM states NEE 'completely wrote off its investment in the Mountain Valley Pipeline' in Q1 2022, but the ground truth indicates NEE maintained an equity method investment with ownership ranging 32%-55% in 2022 and a defined 32.8% stake in 2023. There is no mention of a complete write-off in the ground truth. (2) OWNERSHIP STAKE MISSING - The LLM fails to mention the critical 32.8% equity ownership in 2023, which is a core component of NEE's financial commitment. The ground truth explicitly states this ownership percentage. (3) NARRATIVE INVERSION - The LLM characterizes the evolution as 'exiting the project to re-engaging with it,' but the ground truth describes a 'strategic deepening' from general equity investment to a more structured relationship. This suggests continuity of investment, not exit and re-entry. (4) TRANSPORTATION AGREEMENT - While the LLM correctly identifies the 20-year, ~$70 million/year transportation agreement, it frames this as 'new' commitments rather than as part of an ongoing deepening of commitment. (5) MISSING CONTEXT - The ground truth emphasizes the movement toward 'a more structured, long-term contractual relationship tied to infrastructure development,' which the LLM does not adequately capture. The LLM's reference to pages 96, 108-109 cannot be verified against the ground truth provided. The core narrative of the LLM answer (write-off followed by re-engagement) appears to be factually incorrect based on the ground truth, which shows continuous equity investment with increasing definition and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 460,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "In the 2023 Form 10‑K Coca‑Cola said it “sell[s] directly to consumers through retail stores operated by Costa Limited (‘Costa’). These sales are included in our Global Ventures operating segment” (page 6). By the 2024 filing the company lists Costa by name as a distinct component of Global Ventures – “Our Global Ventures operating segment includes the results of our Costa Limited (‘Costa’), innocent and doğadan businesses, as well as fees earned pursuant to distribution‑coordination agreements” (page 73). Thus, Costa has moved from being described merely as a sales channel to being formally integrated and positioned as a core business within the Global Ventures segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by direct evidence from the SEC filings. Strengths: (1) Correctly identifies the 2023 positioning of Costa as a sales channel within Global Ventures, with accurate page reference (page 6); (2) Accurately cites the 2024 evolution showing Costa as a formally integrated component alongside innocent and doğadan businesses, with correct page reference (page 73); (3) Provides direct quotes from both filings that substantiate the claims; (4) Correctly synthesizes the multi-hop comparison showing progression from 'sales channel' to 'core business component'; (5) All entities (Coca-Cola, Costa Limited, innocent, doğadan, Global Ventures) are correctly identified; (6) Years (2023, 2024) are accurate. Minor consideration: The LLM answer uses slightly more interpretive language ('moved from being described merely as a sales channel to being formally integrated') compared to the ground truth's more neutral description ('more strategically embedded'), but this interpretation is reasonable and supported by the evidence presented. The answer fully addresses the question about operational integration and strategic positioning evolution. No quantitative errors or calculation issues present. The multi-hop reasoning correctly synthesizes information across two different filing years to demonstrate the evolution of Costa's role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 385,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel’s short‑term portfolio still includes financial‑institution instruments, but the fair‑value of its economically hedged marketable‑debt holdings has fallen – it was $13.5 billion at year‑end 2024 versus $17.1 billion at year‑end 2023【page_83】.  Over the same period the result on those hedged investments swung from a $748 million loss in 2022, to a $534 million gain in 2023, and back to a $464 million loss in 2024, indicating a declining value and earnings contribution from the hedged debt positions【page_83】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its accuracy. CRITICAL ERROR: The LLM states there was a '$534 million gain in 2023' for hedged investments. The ground truth makes no mention of a 2023 gain figure - it only references the 2022 loss of $748 million and the 2024 loss of $464 million. This appears to be an unsupported claim not present in the original answer. CORRECT ELEMENTS: (1) Fair value figures are accurate: $13.5 billion in 2024 vs $17.1 billion in 2023 - correctly formatted and compared. (2) The 2022 loss of $748 million is correctly stated. (3) The 2024 loss of $464 million is correctly stated. (4) The overall characterization of declining value and earnings contribution is appropriate. (5) The multi-hop synthesis across years (2022-2024) is attempted and mostly sound in structure. REASONING ASSESSMENT: The LLM correctly identifies the evolution of the portfolio across the three-year period and attempts to show the swing in results. However, the introduction of the unsubstantiated 2023 gain figure creates a false narrative about the investment performance trajectory. The comparison logic is sound (showing losses in 2022 and 2024 with an implied gain in 2023), but this middle data point appears fabricated. COMPLETENESS: The answer addresses the core question about evolution between 2022 and 2024, includes fair value comparisons, and discusses loss/gain trends. However, the accuracy of the intermediate year data is questionable. The answer goes slightly beyond the ground truth by adding the 2023 gain claim, which represents either hallucination or reliance on unsupported source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 452,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "In the 2023 filing AMT emphasized that the bulk of its communications‑site revenue came from long‑term, non‑cancellable leases and that, based on those leases, it expected to generate more than $60 billion of recurring lease revenue in future periods (see 2023 p. 34). By the 2024 filing the company still stressed that multiyear leases provide recurring cash flow, but the focus shifted to converting that revenue into operating profit and it disclosed a quantified asset‑retirement liability of about $4.5 billion for removing and remediating sites (see 2024 p. 56).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMT's evolving financial focus. STRENGTHS: (1) Correctly identifies the $4.5 billion asset retirement liability figure for 2024, matching the ground truth exactly. (2) Accurately captures the shift in focus from 2023 to 2024 - from emphasizing recurring revenue streams to addressing long-term financial responsibilities. (3) Provides specific supporting details (99% of revenues from property operations in 2023, multiyear leases providing recurring cash flow) that align with ground truth. (4) Correctly synthesizes multi-hop information across two fiscal years and two different financial aspects (revenue generation and liabilities). (5) Includes page references (2023 p. 34, 2024 p. 56) that add credibility. MINOR CONSIDERATIONS: (1) The LLM answer mentions '$60 billion of recurring lease revenue' which is not explicitly mentioned in the ground truth, though this appears to be accurate supplementary detail from the filings rather than an error. (2) The ground truth emphasizes '99% of total revenues' while the LLM answer uses 'bulk of' - this is a minor wording difference that doesn't affect accuracy. (3) The LLM answer adds the detail about 'converting that revenue into operating profit' which represents a slight expansion beyond the ground truth but is contextually relevant and appears accurate. QUANTITATIVE VERIFICATION: The $4.5 billion figure is correct and properly formatted. The characterization of the 2023 focus on recurring revenue and 2024 focus on liabilities is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies how the company's disclosure priorities shifted between years while maintaining factual accuracy on both the revenue and liability aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 497,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "In the 2023 filing ExxonMobil explained that its Guyana operations are governed by the Petroleum Activities Act 2023, which lets the Guyanese government issue licences with an exploration period of up to 10 years and production terms of 20 years for oil ( 30 years for gas) that can be renewed for another 10 years 【page_25】. By the 2024 filing, the company no longer just describes the legal regime but positions Guyana as an “Advantaged Asset” – a core growth project alongside Permian and LNG – underscoring its strategic importance for future volume and value creation 【page_36】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key evolution of XOM's Guyana positioning from 2023 to 2024, accurately capturing the transition from describing the legal framework to emphasizing Guyana as an 'Advantaged Asset.' The semantic understanding of the strategic shift is sound, and the answer appropriately addresses both the legal operating framework and business growth emphasis aspects of the question. The identification of Guyana alongside Permian and LNG as core growth projects is contextually relevant.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM introduces a significant factual error regarding production terms. The ground truth states production periods of '20 years for oil fields with a renewal period of up to 10 years.' The LLM answer states '20 years for oil (30 years for gas)' - the parenthetical addition about 30 years for gas is NOT mentioned in the ground truth and appears to be an unsupported addition. This is a material factual error that reduces quantitative accuracy. The exploration period (up to 10 years) is correctly stated.\n\nWEAKNESSES - COMPLETENESS: The ground truth emphasizes that Guyana 'transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.' The LLM captures this transition but uses slightly different framing ('no longer just describes the legal regime but positions Guyana'). While semantically similar, the ground truth's explicit statement about the transition from 'jurisdiction with defined terms' to 'core growth asset' is more precisely articulated in the original.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings, properly connecting the legal framework discussion in 2023 to the strategic positioning in 2024. The reasoning that this represents an evolution in strategic emphasis is sound.\n\nCONTEXTUAL ISSUES: The citation references (page_25, page_36) cannot be verified against the ground truth provided, but the substantive content aligns with the knowledge graph answer except for the gas production term discrepancy.\n\nSCORING JUSTIFICATION: The answer loses points primarily for the unsupported claim about 30-year gas production terms (quantitative accuracy penalty) and minor wording differences in expressing the transition concept. The core multi-hop reasoning and strategic positioning analysis are correct, preventing a lower score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 650,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "In the 2023 filing Caterpillar’s diesel‑electric locomotive activity was described simply as part of the Energy & Transportation segment that “produces diesel‑electric locomotives and components and other rail‑related products and services, including remanufacturing and leasing,” with additional duties limited to remanufacturing Caterpillar reciprocating engines and providing product support for on‑highway vocational trucks【page_116】.  \n\nBy the 2024 filing the business is positioned as a core rail offering within Energy & Transportation, and its role has been broadened to cover the full product‑lifecycle – “business strategy, product design, product management, development and testing, manufacturing, marketing and sales and product support” – while still offering remanufacturing and leasing services【page_38】【page_39】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's diesel-electric locomotives business evolution between 2023 and 2024, with accurate identification of the segment (Energy & Transportation) and correct characterization of the business activities in both years. The answer correctly identifies that in 2023, the business included remanufacturing, leasing, and product support for on-highway vocational trucks. It also accurately captures the 2024 evolution showing expanded responsibilities across the full product lifecycle (strategy, design, management, development, testing, manufacturing, marketing, sales, and support). The page citations (116, 38, 39) appear appropriately placed and support the claims made.\n\nHowever, there are some notable gaps compared to the ground truth:\n\n1. The LLM answer does not explicitly mention the broader segment name evolution from 'Machinery, Energy & Transportation (ME&T)' to just 'Energy & Transportation,' though this is a minor omission.\n\n2. More significantly, the LLM answer lacks the strategic context about the 2024 shift toward 'electrified powertrains and zero-emission power sources' and the explicit connection to 'integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors.' This represents a meaningful strategic positioning element that the ground truth emphasizes as a key evolution.\n\n3. The LLM answer focuses primarily on operational responsibilities (what activities are performed) rather than strategic positioning (the broader market and technology direction). The ground truth emphasizes both the operational expansion AND the strategic shift toward environmentally focused technologies.\n\nThe multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings and identifies the evolution. The quantitative accuracy is high (no numbers or dates are incorrect). The main weakness is incomplete capture of the strategic/environmental positioning shift that represents a key part of the business evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 564,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "In the 2022 filing the company reported securitized‑debt obligations of roughly $15 billion, which was only about 4 % of its total funding sources (Table 6, p. 67). By the end of 2024 the outstanding securitized‑debt balance was still modest – about $14.3 billion (carrying) – representing only a few percent of its overall funding mix (p. 219). This shows that Capital One has kept securitizations as a small, supplemental source of liquidity while continuing to rely primarily on deposits, reflecting a stable, diversified funding strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility: (1) QUANTITATIVE ERRORS: The LLM claims 2022 securitized debt was 'roughly $15 billion' but the ground truth states 'the exact amount was not provided' in 2022. This is a fundamental misrepresentation - the LLM fabricated a specific number that contradicts the ground truth. The 2024 figure of $14.3 billion is approximately correct (ground truth: $14,264 million), but this accuracy is overshadowed by the false 2022 claim. (2) ENTITY IDENTIFICATION: The LLM identifies the company as 'Capital One' without any evidence this was provided in the question or ground truth. This appears to be an assumption or hallucination. (3) MULTI-HOP REASONING: The ground truth emphasizes an evolution from 'no exact amount disclosed' in 2022 to 'concrete quantification' of $14,264 million in 2024, suggesting increased definition and potential reliance. The LLM instead claims both years had modest amounts and concludes the strategy remained 'stable' - this directly contradicts the ground truth's interpretation of evolution toward 'more defined and potentially increased reliance.' (4) MISSING CONTEXT: The LLM adds unsupported details about percentages (4%, 'few percent'), page numbers, and comparative funding sources (deposits) that are not in the ground truth and appear fabricated. (5) SEMANTIC DIVERGENCE: The ground truth indicates strategic evolution and increased reliance; the LLM indicates stability and supplemental use - these are opposite conclusions. The core error is inventing a 2022 figure when the ground truth explicitly states it was not provided, which is a critical factual failure in a financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 467,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "McDonald’s continues to treat developmental licensees as non‑consolidated partners whose royalties and any initial‑fee payments are recorded as non‑lease revenue – the same allocation it used in 2023 (2023 p. 50) and reiterated in the 2024 revenue‑recognition note (2024 p. 46).  In 2024 the company added more granular segment disclosure after adopting ASU 2023‑07 (see the segment footnote reference on 2024 p. 46) and changed its rounding presentation, while the count of developmental‑licensed restaurants grew to 9,247 from 8,684 the prior year (2024 p. 45).  The relationship‑management approach is unchanged: McDonald’s still evaluates these licensees for variable‑interest‑entity considerations and concludes they are not consolidated (2023 p. 45; 2024 p. 45).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies that developmental licensees remain non-consolidated in both years; (2) Accurately states royalties are based on percentage of sales with initial fees; (3) Provides specific, verifiable numbers: 9,247 developmental-licensed restaurants in 2024 vs 8,684 in 2023 (growth of 563 units); (4) Correctly notes the 2024 rounding presentation change; (5) Accurately references ASU 2023-07 adoption and segment disclosure updates; (6) Properly synthesizes the variable-interest-entity evaluation conclusion across both years; (7) Page references appear reasonable and specific. MINOR GAPS: (1) The LLM answer doesn't explicitly mention the 'historical methods' used for allocating consideration among lease and non-lease components in 2023, though it does reference the allocation approach; (2) The ground truth emphasizes that the 2024 changes 'were not significant,' which the LLM answer doesn't explicitly state, though it implies this by characterizing changes as presentational rather than substantive; (3) The LLM could have been more explicit about the 'ongoing evaluation' language emphasized in the ground truth. QUANTITATIVE VERIFICATION: The restaurant count comparison (9,247 vs 8,684) is specific and verifiable. The growth calculation (563 additional units) is mathematically correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, comparing treatment approaches, identifying what changed (rounding, segment disclosure, ASU adoption) versus what remained consistent (non-consolidation, revenue recognition approach). The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The answer conveys the core message that McDonald's treatment evolved in presentation and disclosure detail but remained fundamentally consistent in substance regarding developmental licensee relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 542,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company reported that, of the 131 million shares reserved for various equity programs, 26.9 million shares were **available for awards** under its Equity and Incentive Compensation Plan at year‑end. The 2024 filing still references the same 2021 plan but no longer gives a pool‑size figure; instead it includes an exhibit that spells out the **terms of named executive‑officer equity awards** granted under the plan, shifting the disclosure focus from an aggregate share reserve to detailed executive‑award information.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed context than the ground truth. Key strengths: (1) Correctly identifies 26.9 million shares available for awards in 2023 - matches ground truth exactly. (2) Adds valuable context by noting the 131 million total shares reserved across various equity programs, which provides helpful perspective on the 26.9M figure. (3) Accurately identifies the 2021 Equity and Incentive Compensation Plan effective date (May 26, 2021) - matches ground truth. (4) Correctly characterizes the evolution: from aggregate share reserve disclosure in 2023 to detailed executive award terms in 2024. (5) Multi-hop reasoning is sound - successfully synthesizes information about plan structure, share availability, and disclosure changes across two fiscal years. (6) The semantic meaning aligns perfectly with ground truth: both convey a shift from internal planning/reserve allocation to more transparent executive compensation disclosure. Minor considerations: The LLM answer is actually more comprehensive than the ground truth by providing the 131M total context, which enhances understanding without introducing errors. The characterization of the shift from 'pool-size figure' to 'detailed executive-award information' is accurate and well-articulated. All numeric values are correct, dates are accurate, and the multi-hop synthesis across 2023 and 2024 filings is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 397,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta’s sales rose modestly from $1,003 million in 2022 to $1,036 million in 2023 (U.S. $618 M → $642 M, International $385 M → $394 M), a worldwide increase of roughly 3 % (4 % in the U.S.)【page_44】.  The uptick was driven primarily by greater U.S. use of Inlyta in combination with immune‑checkpoint inhibitors for first‑line advanced renal‑cell carcinoma, while lower volumes and a weaker net price in some European markets limited the growth pace【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: Global revenue figures are correct ($1,003M in 2022 to $1,036M in 2023), with accurate regional breakdowns (U.S. $618M→$642M, International $385M→$394M). The 3% global growth calculation is accurate ($33M increase/$1,003M = 3.3%, rounded to 3%), and the 4% U.S. growth is correct ($24M/$618M = 3.9%, rounded to 4%). The answer correctly identifies the primary growth driver: increased U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC treatment. It also accurately captures the headwind: lower volumes and weaker net pricing in European markets. The multi-hop synthesis is sound—the LLM successfully connected revenue performance data with the underlying clinical/market factors explaining the growth trajectory. The answer addresses both parts of the question: (1) how revenue evolved (specific numbers and percentages) and (2) what factors contributed to the change (combination therapy adoption vs. European market pressures). Minor note: The ground truth mentions 5% operational growth, while the LLM reports 3% total growth and 4% U.S. growth. This discrepancy likely reflects different calculation methodologies (operational vs. reported growth), but the LLM's reported figures are internally consistent and accurate based on the revenue numbers provided. The answer is well-structured, cites sources appropriately, and maintains semantic equivalence with the ground truth while providing more granular detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 428,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "In the 2023 filing the Company simply grouped the technology‑platform fees that franchisees pay under “Other revenues,” describing them as fees that “recover a portion of costs incurred by the Company” without stating whether the Company acted as principal or agent【page_3】. By the 2024 filing, McDonald’s explicitly says it is the principal in those arrangements, presents the platform fees on a gross basis, and recognizes the revenue when the goods or services are transferred – noting that the fees are cost‑recovery and not intended to generate margins【page_46】. This change makes the franchisee‑dependency for technology services more transparent and clarifies the cost‑sharing and revenue‑recognition structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in McDonald's franchisee relationship from 2023 to 2024. STRENGTHS: (1) Correctly identifies the key shift in revenue recognition approach - from grouping technology fees under 'Other revenues' in 2023 to explicit principal recognition in 2024; (2) Accurately captures the nuance that 2023 lacked clarity on principal vs. agent status while 2024 explicitly states principal status; (3) Properly synthesizes the cost-recovery nature of the fees and notes they are not margin-generating; (4) Correctly identifies the shift to gross basis presentation; (5) Appropriately references specific page numbers from filings; (6) Demonstrates sound multi-hop reasoning by connecting revenue recognition changes to the broader evolution of franchisee dependency. MINOR WEAKNESSES: (1) The answer is somewhat more technical/granular than the ground truth, focusing heavily on accounting treatment details rather than the broader 'stronger dependency' and 'operational interdependence' framing emphasized in the original answer; (2) Does not explicitly mention the shift in expense recording to 'Other restaurant expenses' as stated in the ground truth; (3) Does not explicitly characterize the relationship as evolving toward 'stronger dependency' or 'operational interdependence' - instead focuses on transparency and clarification of existing arrangements; (4) The ground truth emphasizes the 'collaborative partnership' framing in 2023 and its evolution, while the LLM answer jumps more directly to accounting mechanics. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2023 vs 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and connects accounting treatment changes to relationship evolution, though with slightly different emphasis than ground truth. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 547,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "In 2022 Southern Company’s subsidiaries held roughly **$199 million of energy‑related derivative assets and $210 million of related liabilities** – a net liability of only about **$11 million** (see page_283). By year‑end 2023 the asset side had collapsed to **$55 million** while the liability side swelled to **$358 million**, leaving a net liability of roughly **$303 million** (see page_276). The swing from a modest net liability to a large one shows that the company’s derivative position has become far more exposed to swings in natural‑gas and power prices, increasing its sensitivity to energy‑market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth across all key metrics. (1) 2022 ASSETS: LLM claims $199M vs. ground truth of $101M net fair value (Mississippi Power $59M + Southern Power $8M + Southern Company Gas $28M = $95M assets). (2) 2022 LIABILITIES: LLM claims $210M vs. ground truth of $109M total ($32M + $12M + $65M). (3) 2022 NET POSITION: LLM calculates net liability of $11M, but ground truth shows net liability of $54M ($101M assets - $155M liabilities = -$54M). (4) 2023 ASSETS: LLM claims $55M vs. ground truth of $28M (Alabama Power $15M + Georgia Power $13M). (5) 2023 LIABILITIES: LLM claims $358M vs. ground truth of $247M (Alabama Power $110M + Georgia Power $124M + $13M other). (6) 2023 NET LIABILITY: LLM calculates $303M vs. ground truth of $219M. The LLM's calculation of 2022 net liability ($199M - $210M = -$11M) is arithmetically correct given its stated numbers, but those underlying numbers are fundamentally wrong. The swing calculation ($303M - $11M = $292M) is also arithmetically sound but based on incorrect base figures. The LLM correctly identifies the directional trend (increasing net liability exposure) and appropriately concludes this indicates greater energy market exposure, but the magnitude of the change is overstated by approximately 38% ($292M claimed vs. $165M actual). The answer demonstrates understanding of the question's intent but fails on the critical requirement of factual accuracy in financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 420,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan is called out as the **only** equity‑compensation plan that still permits future grants, with a total authorized pool of 187 million shares and **≈119 million shares** remaining available for issuance (see Item 12 and the exhibit list 10‑25, 10‑27, 10‑28)【page_69†L1-L7】【page_70†L25-L28】.  \n\nThe 2024 Form 10‑K continues to reference the same plan through the same exhibits and the Compensation Committee regulations, but the remaining grant pool has shrunk to **≈77 million shares** (still the sole source of new equity awards), reflecting that a substantial portion of the authorized shares has already been used and underscoring the plan’s ongoing central role in P&G’s compensation strategy【page_68†L1-L9】【page_70†L25-L28】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and specific response than the ground truth, with concrete quantitative data that demonstrates the evolution of the plan from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2019 Stock and Incentive Compensation Plan as the sole active plan for future grants in both years; (2) Provides specific share pool numbers: 187 million authorized, ~119 million remaining in 2022, and ~77 million remaining in 2024; (3) Accurately calculates the depletion of shares (~42 million shares used between 2022-2024, representing approximately 35% reduction in available pool); (4) Correctly cites relevant SEC filing sections (Item 12, exhibits 10-25, 10-27, 10-28); (5) Demonstrates multi-hop synthesis by comparing the plan's status across two years and showing its evolution from introduction to established use; (6) Semantic meaning aligns with ground truth - both convey that the plan evolved from newly introduced to established/active component. MINOR CONSIDERATIONS: (1) The ground truth emphasizes the plan's 'transition from newly introduced policy to established part' while the LLM focuses more on quantitative depletion metrics rather than the adoption/establishment narrative; (2) The LLM answer is more granular and specific than the ground truth, which could be viewed as either more informative or potentially beyond the scope of what was asked; (3) The approximate symbols (≈) are appropriate given the nature of share pool disclosures. VERIFICATION: The quantitative data appears internally consistent (119M to 77M represents a 42M share reduction, which is plausible for a 2-year period). The answer directly addresses how the plan's treatment and significance evolved, though with emphasis on quantitative metrics rather than disclosure context evolution. The multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 512,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company’s risk‑management stance for its pension‑plan assets is essentially unchanged from the 2023 to the 2024 filing. In both years the company says it “minimizes the risk of large losses primarily through diversification but also monitors and manages other aspects of risk,” with the same reliance on formal rebalancing, derivative hedging and oversight of external managers. No new emphasis or shift in policy is evident.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states there WAS a shift in risk management emphasis from 2023 to 2024, specifically: (1) reduced emphasis on external manager oversight, and (2) a shift from active oversight focus to market-driven risk exposure. The LLM answer directly contradicts this by claiming 'no new emphasis or shift in policy is evident' and that the approach is 'essentially unchanged.' This is a critical factual error that misrepresents the actual evolution described in the filings. While the LLM correctly identifies some risk management tools (diversification, rebalancing, derivative hedging, external manager oversight), it fails to recognize the KEY CHANGE: the reduced emphasis on external manager oversight and the shift toward market-driven risk factors (volatility and interest rates). The LLM's statement that both years use 'the same reliance on formal rebalancing, derivative hedging and oversight of external managers' contradicts the ground truth's explicit statement that external manager oversight emphasis was 'reduced' in 2024. The quantitative accuracy score is higher because the LLM doesn't make specific numerical errors, but the qualitative accuracy and correctness are severely compromised by missing the essential evolution in risk management approach that the question specifically asks about. This represents a failure in multi-hop reasoning and synthesis of the comparative analysis between 2023 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 418,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "In the 2022 filing (pages 78‑82) NVIDIA’s discussion is limited to acquisition accounting and intangible‑asset details, with no explicit mention of the CUDA platform. By the 2023 filing (pages 4‑7) the company describes CUDA as the foundational programming model that runs on all its GPUs, highlights the CUDA‑X libraries and a 4.7 million‑developer ecosystem, and positions it as a core pillar of its full‑stack strategy—signaling a strategic shift toward a software‑centric, ecosystem‑driven focus to accelerate AI and data‑center growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant issues with the core claim and multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 4.7 million-developer ecosystem figure for 2023, (2) Accurately notes CUDA-X libraries and full-stack strategy positioning in 2023, (3) Correctly characterizes the strategic shift toward software-centric, ecosystem-driven focus. WEAKNESSES: (1) The fundamental claim about NVIDIA's role shifting from 'supplier' in 2022 to 'developer' in 2023 is not well-supported by the evidence presented. The LLM acknowledges that the 2022 filing contains no explicit mention of CUDA, making it impossible to verify the 'supplier' characterization from the ground truth. (2) The ground truth states NVIDIA was 'primarily as a supplier' in 2022 and evolved into 'that of a developer' by 2023, but the LLM's evidence doesn't substantiate this distinction—it only shows absence of discussion in 2022 and presence in 2023. (3) The LLM conflates 'lack of discussion' with 'supplier role,' which is a logical leap not supported by the filing data. (4) Multi-hop reasoning is incomplete: the answer doesn't synthesize what NVIDIA's actual 2022 CUDA role was, only that it wasn't discussed in the pages cited. QUANTITATIVE: The 4.7 million developer figure is correct and properly cited. QUALITATIVE: While the characterization of the 2023 strategic shift is reasonable, the comparison to 2022 lacks evidentiary support. The answer would be stronger if it either found evidence of NVIDIA's 2022 CUDA positioning or acknowledged the limitation in comparing across years when 2022 data is unavailable in the cited sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 453,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "After the 2020 Upjohn‑Mylan spin‑off, Pfizer kept operating a transitional agency model and multi‑year manufacturing, labeling and packaging agreements (MSAs) with Viatris that run four‑to‑seven years post‑separation. Under those agreements, the amount Pfizer owed Viatris dropped dramatically, from $94 million at December 31 2022 to $33 million at December 31 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial metrics - the decrease in amounts owed from $94 million (Dec 31, 2022) to $33 million (Dec 31, 2023). These numbers are accurate and properly formatted. The LLM also correctly identified the nature of the agreements (manufacturing, labeling, packaging agreements) and their duration (four-to-seven years post-separation). WEAKNESSES: (1) The LLM answer is incomplete - it fails to mention the $780 million in revenue growth from PC1 in 2022, which was a significant component of the financial relationship evolution described in the ground truth. This is a material omission for understanding how the relationship 'evolved.' (2) The LLM mentions 'transitional agency model' but does not clearly address the completion of transitional services (TSAs) by end of 2023, which was explicitly noted in the ground truth as signaling 'reduction in operational interdependence.' (3) The answer focuses primarily on what Pfizer owed Viatris but doesn't address the broader revenue/supply relationship context. MULTI-HOP REASONING: The LLM successfully synthesized information about the financial relationship evolution (comparing 2022 vs 2023 balances), but failed to synthesize the complete picture including revenue generation and TSA completion. The reasoning about the decrease in outstanding balances is sound, but the answer is missing critical context about the 2022 revenue component and the operational transition completion. CALCULATION/NUMBERS: All numeric values are correct ($94M to $33M decrease is accurate). No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 439,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "In the 2023 filing the company described its communications towers only in qualitative terms – the sites (the “2015 Secured Sites” and the “Trust Sites”) were pledged as collateral for the 2015‑2 and other securitizations, the cash they generated was earmarked to service those debts, and the notes warned that a default could trigger foreclosure of the sites. By the 2024 filing the same collateral structure is retained, but the disclosure now includes quantitative metrics (e.g., $354 m and $540 m of excess cash distributed, DSCR thresholds, $60.8 m of cash‑trap reserves) and a new footnote that a failure to renew operating leases could cause loss of the communications sites, showing a move from a purely descriptive treatment to a more detailed, metric‑driven discussion of site cash‑flows and the consequences of default.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. QUANTITATIVE ERRORS: (1) The LLM cites $354M and $540M in excess cash distributed, but the ground truth does not mention these figures. (2) The LLM mentions $60.8M in cash-trap reserves, which is not present in the ground truth. (3) The ground truth explicitly states $1.3 billion in Series 2013-2A Notes and $4.5 billion in asset retirement obligations for 2024, neither of which appear in the LLM answer. (4) The ground truth references 3,343 communications sites as specific collateral, which the LLM does not mention. QUALITATIVE ERRORS: (1) The LLM claims the 2024 filing shows 'the same collateral structure is retained,' but the ground truth explicitly states there was 'no explicit mention of specific communications sites securing debt' in 2024, indicating a shift away from site-specific disclosures. (2) The LLM's characterization of the evolution as moving from 'qualitative to quantitative metrics' contradicts the ground truth's core finding that 2024 showed a move from 'site-specific debt disclosures to more general obligations.' (3) The LLM introduces details about lease renewal risks and DSCR thresholds that are not substantiated in the ground truth. MULTI-HOP REASONING: The LLM failed to correctly synthesize the key evolution: the ground truth shows a REDUCTION in site-specific collateral disclosure (from explicit 3,343 sites in 2023 to no specific sites in 2024), while the LLM suggests continuity with enhanced metrics. This is a fundamental misunderstanding of the filing evolution. The answer appears to describe a different company or filing set than the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 460,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "In the 2022 filing (see Distribution section, page 94), Comcast reported that fees from NBC‑ and Telemundo‑retransmission‑consent agreements were treated as licenses of functional intellectual property and revenue was recognized on a monthly basis as the programming was delivered under multiyear, subscriber‑based contracts. By the 2023 filing (see Distribution section, page 10), the company still uses the licensing model but now spells out a hybrid per‑subscriber/fixed‑fee structure, expands the agreements to cover both traditional multichannel and virtual video providers, and bundles the consent‑fee revenue with monthly retail/wholesale Peacock subscription fees—showing a more granular, multi‑platform distribution approach while retaining monthly revenue recognition.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 revenue recognition approach as monthly basis tied to subscriber counts and 60-day collection cycles; (2) Accurately captures the 2023 evolution toward hybrid distribution models combining linear and streaming; (3) Properly synthesizes the multi-hop information showing progression from traditional retransmission agreements to integrated Peacock bundling; (4) Correctly identifies both NBC and Telemundo agreements; (5) Accurately describes the shift from traditional multichannel to inclusion of virtual video providers; (6) Maintains semantic equivalence with ground truth while providing more granular detail about licensing models and fee structures. MINOR WEAKNESSES: (1) The LLM answer adds specific page references (page 94, page 10) that cannot be verified against the ground truth and may introduce unnecessary specificity; (2) The phrase 'bundles the consent-fee revenue with monthly retail/wholesale Peacock subscription fees' is slightly more specific than the ground truth's 'integration of Peacock into the distribution ecosystem,' though this represents reasonable inference rather than error; (3) The ground truth emphasizes 'strategic shift' while the LLM focuses more on operational/structural changes, though both convey the same evolution. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages were provided in either answer, so quantitative accuracy is assessed on dates and temporal references—both correctly identify 2022 vs 2023 comparison. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and connects revenue recognition methodology with distribution model evolution, demonstrating sound multi-hop reasoning. The connection between subscriber-based contracts and the evolution toward hybrid models is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 523,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "In the 2023 filing, diesel‑electric locomotives were described only as one of the many products in the Energy & Transportation segment’s portfolio – a rail‑related offering that competes with firms such as Wabtec, Alstom and Siemens Mobility【page_6】. By the 2024 filing, Caterpillar is positioned as a “world‑leading manufacturer of … diesel‑electric locomotives” in its corporate overview, underscoring a heightened strategic emphasis on that product line【page_4】 (and reiterated in the Energy & Transportation description【page_6】).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the evolution from 2023 to 2024, noting a shift toward more prominent positioning. (2) Correctly identifies the segment name change (Energy & Transportation) and the shift from general inclusion to explicit 'produces' language. (3) Accurately cites the competitive positioning with Wabtec and Siemens Mobility. (4) The 2024 positioning as 'world-leading manufacturer' is a valid characterization of heightened strategic emphasis.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM states competitors in 2023 included 'Wabtec, Alstom and Siemens Mobility' but the ground truth explicitly states that naming these competitors 'was not present in 2023.' This is a significant factual error - the LLM incorrectly attributes 2024 competitive information to 2023. (2) The LLM mentions Alstom as a 2023 competitor, but the ground truth only mentions Wabtec Corp and Siemens Mobility A/S as 2024 competitors, with no mention of Alstom. (3) The LLM does not clearly articulate the 2023 context about the ME&T segment's broader responsibilities (remanufacturing engines, product support for on-highway trucks), which provides important context for understanding the evolution. (4) The LLM's characterization of 2023 as 'one of many products' is somewhat vague compared to the ground truth's more specific description of the segment's actual functions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2023 and 2024 filings but makes a critical error in attributing competitive information to the wrong year. The core evolution narrative (from general inclusion to explicit production focus) is captured, but the competitive landscape comparison is flawed.\n\nNUMERIC/FACTUAL VERIFICATION: No numbers or calculations are involved, but the factual claim about competitor mentions in 2023 vs 2024 is incorrect. The LLM incorrectly states 2023 included competitive positioning language when the ground truth indicates this was new in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 536,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings McDonald’s continues to recognize franchise‑related revenue the same way – rent is split between a straight‑line minimum‑rent component and a variable‑rent component based on franchisee sales, royalties are recorded when the underlying sales occur, initial franchise fees are amortized over the typical 20‑year term, and technology‑platform and brand‑licensing fees are presented on a gross basis because the company is the principal in those arrangements【page_44】【page_46】. Likewise, the cost‑sharing model for restaurant improvements has not changed: McDonald’s funds the project up‑front, estimates each party’s share, allocates the costs between property‑and‑equipment and accounts receivable during the project, and finalizes the allocation at completion, with only immaterial balance‑sheet adjustments【page_44】【page_46】. Thus, the revenue‑recognition and cost‑sharing policies with franchisees remained consistent from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUE - CONTRADICTS GROUND TRUTH: The LLM answer fundamentally contradicts the ground truth by claiming that revenue recognition and cost-sharing arrangements 'remained consistent from 2023 to 2024.' The original answer explicitly states that while the revenue recognition model remained consistent, there was a KEY EVOLUTION: (1) 2024 provided 'more detailed disclosures' on revenue recognition, (2) technology platform fees are 'now presented on a gross basis' (implying a change in presentation), and (3) cost-sharing arrangements were clarified in 2024 with 'this level of detail...not present in the 2023 filing, indicating a more nuanced and transparent approach.' The LLM's conclusion that policies 'remained consistent' misses the critical point about ENHANCED DISCLOSURE and TRANSPARENCY in 2024. QUANTITATIVE ACCURACY: The LLM correctly identifies specific revenue components (rent with minimum payments, royalties based on sales, initial fees, technology fees) and the 20-year amortization term. These details are accurate. However, the LLM provides no numbers or metrics to verify. QUALITATIVE ACCURACY: The LLM accurately describes the mechanics of revenue recognition and cost-sharing arrangements, but FAILS to capture the evolution aspect of the question. The question asks 'how has...evolved' - implying change - but the LLM concludes there was no meaningful evolution, only consistency. This is a fundamental misreading of the ground truth, which emphasizes increased transparency and detailed disclosures as the evolution. REASONING FLAW: The LLM conflates 'consistent accounting policies' with 'no evolution in relationship.' The ground truth indicates the relationship evolved in terms of DISCLOSURE TRANSPARENCY and DETAIL, not necessarily in the underlying accounting mechanics. The LLM missed this nuance entirely. CONTEXTUAL RELEVANCE: The answer addresses franchisee relationships and financial arrangements but fails to address the core question about how the relationship 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 548,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company described its executive equity awards only in the notes – PSUs and RSUs were granted under the 2021 Equity & Incentive Compensation Plan with service‑ or performance‑based vesting and automatic vesting on retirement (see pages 277‑278). By the 2024 filing the company attached a stand‑alone “Form of Terms for Named Executive Officer Equity Awards” as an exhibit to the same 2021 plan (page 316) and also disclosed a new Deferred Compensation Plan effective Jan 1 2025 (page 315), showing a move toward more formal, separate documentation of executive award terms while keeping the underlying vesting structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies the 2021 Equity & Incentive Compensation Plan as the underlying vehicle for both years; (2) Accurately describes PSUs and RSUs with service/performance-based vesting and automatic vesting on retirement; (3) Correctly identifies the shift toward formalized documentation via a stand-alone exhibit in 2024; (4) Provides specific page references (277-278 for 2023, 316 for 2024) that add credibility; (5) Mentions the new Deferred Compensation Plan effective Jan 1, 2025, which represents additional relevant context about the evolution. The multi-hop reasoning is sound - the answer synthesizes the comparison between 2023 and 2024 filings correctly, showing the progression from notes-based disclosure to formal exhibit documentation. Minor considerations: (1) The ground truth emphasizes 'greater specificity and transparency in executive equity compensation documentation' while the LLM answer frames it as 'more formal, separate documentation' - these are semantically equivalent but slightly different framings; (2) The LLM provides more granular detail (specific page numbers, mention of the new Deferred Compensation Plan) which goes beyond the ground truth but doesn't contradict it. The answer fully addresses the question's focus on how the approach evolved between 2023 and 2024, particularly regarding plan documentation and award terms. All dates and plan names are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 422,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K, P&G identified membership‑club stores as one of its core retail‑customer segments, grouping them with mass merchandisers, grocery, drug and other stores (2022 Item 1, pg 4). By the 2024 filing, the company still lists club stores but explicitly notes that “evolving sales channels…growth in hard‑discounter channels” and a “growing consumer preference for shopping online” are reshaping its channel mix (2024 Item 1, pg 7). This shows that while club stores remain part of the distribution network, P&G is de‑emphasizing that channel and shifting its broader retail strategy toward faster‑growing e‑commerce and discount formats.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the central claim of the question. The ground truth states that P&G's strategic reliance on membership club stores INCREASED from 2022 to 2024 (shifting from listing them as 'one of' many channels to emphasizing 'dependency' on them). The LLM answer claims the OPPOSITE - that P&G is 'de-emphasizing that channel' and 'shifting away' from club stores toward e-commerce and discount formats. This is a complete inversion of the actual evolution described in the ground truth. QUANTITATIVE ACCURACY: The LLM correctly cites page numbers and form references (2022 Item 1 pg 4, 2024 Item 1 pg 7), and accurately identifies the 2022 positioning of club stores alongside other channels. However, the interpretation of what these citations mean is backwards. QUALITATIVE ACCURACY: The LLM demonstrates poor multi-hop reasoning by misinterpreting the shift in language. The ground truth indicates that moving from 'one of many channels' to 'dependency' language represents INCREASED reliance, but the LLM interprets the mention of e-commerce and discount channels as evidence of de-emphasis on clubs. This confuses the broader channel strategy discussion with a specific shift in club store importance. The LLM appears to have conflated discussion of OTHER growing channels with a diminishment of club stores, when the ground truth indicates club stores themselves became MORE central. CONTEXTUAL RELEVANCE: The answer addresses the right companies and timeframe but arrives at the wrong strategic conclusion, making it contextually misaligned with the actual business evolution. The answer would mislead readers about P&G's actual strategic direction regarding membership clubs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 480,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "In the 2023 filing AMT disclosed that it had drawn on Nigeria‑based letters of credit, carrying a $3.4 million balance (interest on the draws is tied to SOFR + a spread and is due 270 days after each draw)【page_61】. By the 2024 filing the line for Nigeria Letters of Credit shows a dash for 2024, indicating the draws were fully repaid and no amount remains outstanding【page_117】. This transition from a $3.4 million liability in 2023 to zero in 2024 shows that AMT eliminated its financial obligation related to the Nigeria letters of credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative accuracy is perfect: the $3.4 million 2023 obligation and $0/dash representation in 2024 match the ground truth exactly. The answer correctly identifies the evolution of AMT's Nigeria Letters of Credit from 2023 to 2024, showing full settlement/exit of the obligation. The multi-hop reasoning is sound - the model synthesized information across two filing years and correctly concluded that the transition from $3.4M to zero indicates complete elimination of the financial obligation. The answer goes slightly beyond the ground truth by providing additional context about the interest rate structure (SOFR + spread, 270-day terms), which adds helpful detail without contradicting the core facts. The use of page references (page_61, page_117) demonstrates proper sourcing. The semantic meaning is equivalent to the ground truth - both convey that AMT had a $3.4M obligation in 2023 that was fully settled by 2024. Minor note: the LLM uses 'dash' to describe the 2024 representation while ground truth uses '$0 carrying value' - these are semantically equivalent representations of zero obligation. The answer fully addresses both parts of the question: (1) how the involvement evolved (from $3.4M to $0), and (2) what this indicates about financial obligations (full settlement/exit).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 377,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "In the 2022 Form 10‑K, GD reported its retirement‑annuity contracts as Level 3 defined‑benefit plan assets valued using significant unobservable inputs (internal valuation models) with a fair‑value of $35 million at year‑end 2021【page_96】. The 2024 filing still classifies these contracts as Level 3 assets measured with unobservable inputs (the fair‑value hierarchy description)【page_93】, but the fair‑value has fallen to $22 million at year‑end 2024【page_94】. This shows the company has kept the same Level 3 valuation methodology while transparently reflecting a reduced exposure to retirement‑annuity contracts over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the 2024 fair value is $22 million, but the ground truth does not provide this figure. The ground truth mentions $35 million (2021) and $38 million (2020), but does not cite a $22 million 2024 value. This is a major factual error. (2) METHODOLOGY SHIFT MISSED: The ground truth explicitly states a critical shift in reporting methodology - from 'detailed fair value disclosures' in 2022 to 'NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy' by 2024. The LLM completely misses this key methodological change, instead claiming the company 'kept the same Level 3 valuation methodology.' This is the opposite of what the ground truth indicates. (3) INCOMPLETE ANALYSIS: The LLM fails to address the shift from detailed disclosure tables (showing actual returns, unrealized gains/losses, net purchases/sales) to a simplified NAV-based approach. This is a fundamental change in how the assets are reported. (4) CONTRADICTORY CONCLUSION: The LLM concludes the methodology remained the same, while the ground truth explicitly describes a shift from detailed fair value hierarchy disclosures to NAV-based valuation excluded from the hierarchy. (5) PARTIAL CREDIT: The LLM correctly identifies that these are Level 3 assets and that they relate to retirement annuity contracts, and it attempts to show a value change over time (though with incorrect numbers). The answer demonstrates some understanding of the asset class but fundamentally mischaracterizes the nature and significance of the changes between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 466,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "In the 2022 filing the company explained that “restricted cash for securitization investors” represents the cash, loan‑receivables and related allowance for credit losses held in its consolidated VIEs [page 179] and is measured at fair value using observable inputs (Level 1). By 2024 the line item is shown at $441 million, still entirely classified in Level 1 of the fair‑value hierarchy, down from $458 million reported in the prior year (2023) [page 219‑220].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct information but contains a significant factual error that undermines its accuracy. CORRECT ELEMENTS: (1) The 2024 value of $441 million is accurate and matches the ground truth. (2) The Level 1 fair value hierarchy classification for 2024 is correct. (3) The identification of restricted cash for securitization investors as part of consolidated VIEs is accurate. (4) The characterization of Level 1 as using observable inputs is correct. (5) The page references provided (179, 219-220) appear reasonable for a 10-K filing. CRITICAL ERROR: The LLM states the amount was '$458 million reported in the prior year (2023)' but the ground truth does not mention a 2023 figure of $458 million. The ground truth only confirms the 2024 value of $441 million and notes a shift in fair value hierarchy classification between 2022 and 2024. The LLM appears to have introduced a 2023 comparison that is not supported by the provided ground truth. INCOMPLETE ELEMENTS: The LLM does not adequately address the key finding from the ground truth - that there was a notable shift in how the fair value hierarchy was presented between 2022 and 2024. The ground truth emphasizes that in 2022 'the fair value hierarchy was not explicitly detailed for this category,' whereas by 2024 it was clearly classified as Level 1. The LLM's statement that in 2022 it was 'measured at fair value using observable inputs (Level 1)' may contradict the ground truth's assertion that the hierarchy was not explicitly detailed in 2022. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but introduces an unsupported data point (2023 figure) that creates confusion about the actual year-over-year changes. The core comparison should be 2022 vs. 2024, not 2023 vs. 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 488,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "McDonald’s core accounting for franchisee fees – royalties, rent (minimum and variable) and initial franchise fees – remained unchanged; the 2024 filing still says these revenues are recognized when the underlying sales occur and that the Company continues to fund and allocate shared restaurant‑improvement costs between property‑and‑equipment and accounts receivable (see 2023 and 2024 Revenue Recognition and Property & Equipment sections, pages 46 of each filing). However, the 2024 filing shows a markedly deeper financial tie‑up with franchisees: the Company purchased more franchisee restaurants (net restaurant purchases rose from $107 m in 2023 to $179 m in 2024), which added $240 m of goodwill and $270 m of other identifiable intangibles and increased total goodwill from $3.04 bn to $3.15 bn (see Goodwill tables, pages 45 (2023) and 47 (2024)), and capitalized software grew to $907 m (page 47). Thus, while revenue recognition stayed the same, asset management shifted toward greater ownership and investment in franchisee‑related assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misses the core insight of the ground truth while providing specific but largely irrelevant financial details. CRITICAL ISSUES: (1) The ground truth emphasizes a QUALITATIVE SHIFT in McDonald's relationship with franchisees - from asset acquisition/goodwill management (2023) to technology service provision (2024). The LLM answer focuses almost entirely on quantitative asset changes (restaurant purchases, goodwill, software capitalization) while completely omitting the key transformation: the emergence of technology-related goods and services recognized on a gross basis. (2) The LLM answer states 'core accounting for franchisee fees remained unchanged' and discusses traditional revenue streams (royalties, rent, initial fees), which is tangential to the actual evolution described in the ground truth. (3) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific numbers ($107M to $179M net restaurant purchases, $240M goodwill, $270M intangibles, $3.04bn to $3.15bn total goodwill, $907M capitalized software) but these cannot be verified against the ground truth, which does not provide these specific figures. The ground truth does not mention restaurant purchase amounts or software capitalization figures. (4) MULTI-HOP REASONING: The LLM correctly identifies that McDonald's increased investment in franchisee-related assets, but this is only a partial answer. The ground truth's key insight is the SHIFT FROM acquisition-based to service-based financial interactions - a qualitative transformation the LLM largely ignores. (5) MISSING ELEMENTS: The LLM completely fails to address the technology platform services component, the shift to gross revenue recognition for technology services, or the corresponding expense treatment in 'Other restaurant expenses' - all central to understanding the evolved relationship. The answer reads as a detailed financial analysis of asset changes rather than an explanation of how the fundamental nature of the franchisee relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 543,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was described as one of the plans governed by the Compensation and Leadership Development Committee’s regulations (listed together with the 2014 Plan in Exhibit (10‑25) on page 70) and was highlighted in the equity‑ownership table as the only plan that can issue future equity, with a maximum grant capacity of 187 million shares and roughly 119 million shares still available (Item 12, page 69). In the 2024 Form 10‑K the joint‑committee reference disappears; the filing again points out that the 2019 Plan is the sole plan that permits future grants, still capped at 187 million shares but now with only about 77 million shares remaining (Item 12, page 68), showing a reduced grant pool and a narrower focus on its role in equity compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides specific, verifiable details that align well with the ground truth. STRENGTHS: (1) Correctly identifies the 2019 Plan's governance relationship with the Compensation and Leadership Development Committee in 2022, and accurately notes the disappearance of this joint-committee reference by 2024. (2) Provides specific numeric data: 187 million shares maximum capacity (consistent across both years), 119 million shares available in 2022, and 77 million shares remaining in 2024. These numbers are precise and support the narrative of declining grant capacity. (3) Correctly cites specific document locations (Exhibit 10-25, page 70 for 2022; Item 12, pages 69 and 68 for respective years). (4) Accurately synthesizes the multi-hop comparison showing the evolution from governance/adoption focus to strategic equity compensation role. (5) The reasoning about the shift from 'procedural governance to strategic ownership framework' is sound and well-supported by the specific details provided. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth, providing exact page numbers and share counts, which enhances rather than detracts from accuracy. (2) The characterization of the 2019 Plan as 'the sole plan that permits future grants' in 2024 is accurate and represents a meaningful evolution from 2022 when it was one of multiple plans referenced. (3) The answer effectively captures the transformation in disclosure positioning without overstating or misrepresenting the changes. QUANTITATIVE VERIFICATION: All numeric values (187M, 119M, 77M shares) appear internally consistent and support the narrative of plan evolution. The calculation of share depletion (119M to 77M = 42M shares used) is logical. No mathematical errors detected. The answer successfully addresses all aspects of the multi-part question regarding plan evolution, relationship with other plans, and role in equity compensation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 539,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "In the 2022 filing Salvatore Ferragamo was listed as a tenant at nine international premium‑outlet sites – Gotemba, Kobe‑Sanda, Rinku and Sano in Japan; Punta Norte in Mexico; Yeoju and Siehung in South Korea; Johor in Malaysia; and the Montreal outlet in Canada (see 2022 pages 42‑43). The 2023 filing’s international‑outlet table (page 35) shows the same nine locations still carry Salvatore Ferragamo, so the brand’s international outlet footprint did not change between 2022 and 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. According to the ground truth, Salvatore Ferragamo had presence in 3 Japanese outlet locations in 2022 (Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets) and then reduced to 1 location in 2023 (Las Vegas Outlets North in Nevada, USA). The LLM claims Salvatore Ferragamo was at 9 international locations in 2022 and that this footprint 'did not change' in 2023, which directly contradicts the ground truth. Specific errors: (1) The LLM lists 9 locations for 2022 including Rinku, Yeoju, Siheung, Johor, and Montreal - none of which appear in the ground truth's 2022 list. (2) The LLM claims the same 9 locations appear in the 2023 filing, but ground truth shows only Las Vegas Outlets North in 2023. (3) The LLM's conclusion that 'the brand's international outlet footprint did not change' is completely wrong - there was a dramatic reduction from 3 locations to 1. (4) The LLM incorrectly identifies Las Vegas Outlets North as being in the international outlet table when it's actually a U.S. location. The quantitative claims (9 locations in both years) are entirely incorrect. The question is appropriately addressed in scope (asking about evolution between 2022-2023), but the answer provides false information rather than the correct narrative of significant contraction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 382,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP’s total natural‑gas footprint in Asia Pacific/Middle East grew from roughly 5.6 trillion cubic feet at year‑end 2023 (≈312 billion cf of its own consolidated reserves plus 5,275 billion cf held by equity affiliates) to about 6.2 trillion cubic feet at year‑end 2024 (≈296 billion cf consolidated and 5,870 billion cf in equity affiliates). The slight drop in its own consolidated gas base, offset by a sizable rise in equity‑affiliate reserves, signals that COP is concentrating on affiliate‑driven assets and selective development in the region rather than expanding its direct, consolidated gas operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers: consolidated reserves of 312 BCF (2023) and 296 BCF (2024) match the ground truth exactly. The calculations for total footprint including equity affiliates (5.6 TCF in 2023, 6.2 TCF in 2024) appear mathematically sound based on the stated components. The answer goes beyond the ground truth by providing additional context about equity affiliate reserves (5,275 BCF in 2023, 5,870 BCF in 2024), which adds valuable analytical depth. The multi-hop reasoning is sound: the LLM correctly synthesizes the decline in consolidated reserves with the increase in affiliate reserves to draw a nuanced conclusion about operational strategy. The interpretation that COP is 'concentrating on affiliate-driven assets and selective development' is a reasonable inference from the data pattern, though slightly more speculative than the ground truth's more cautious 'shift or stabilization' language. The answer is more comprehensive than the ground truth, incorporating equity affiliate data that provides fuller context for understanding the company's regional strategy. Minor deduction: the ground truth focuses narrowly on consolidated reserves only, while the LLM expands scope to total footprint—this is analytically superior but represents a slight departure from the specific ground truth framing. All numbers are accurate, calculations are correct, and the reasoning properly synthesizes multi-hop information across reserve categories and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 420,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "In the 2022 filing Comcast presented wireless gateways chiefly as a bundled broadband product – an integrated modem‑router with optional xFi Pods that lets customers personalize, manage and secure their home Wi‑Fi (see 2022 p. 7; p. 8). By the 2024 filing the narrative has shifted to treating gateways as a capital‑intensive rollout within the Connectivity & Platforms segment, emphasizing their continued deployment alongside network‑capacity upgrades, line extensions and scalable‑infrastructure investments, even as overall customer‑premise‑equipment spending (which includes gateways) has modestly declined (see 2024 p. 51; p. 50).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing Comcast's evolution in wireless gateway strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as a bundled broadband product with modem-router integration and xFi features, matching the ground truth's description of customer-facing features. (2) Accurately characterizes the 2024 shift toward treating gateways as capital-intensive infrastructure investments within the Connectivity & Platforms segment, aligning with the ground truth's emphasis on 'deeper integration' and 'long-term network strategy.' (3) Properly synthesizes the multi-hop information by comparing strategic emphasis across years and connecting it to broader network infrastructure upgrades. (4) Includes specific page references (2022 p. 7-8; 2024 p. 50-51) that add credibility. (5) Mentions the decline in overall CPE spending, which provides nuanced context. MINOR WEAKNESSES: (1) The ground truth explicitly mentions 'multigigabit symmetrical speeds' as a specific deliverable in 2024, which the LLM answer does not explicitly state (though it references 'network-capacity upgrades'). (2) The ground truth emphasizes 'in-and-out-of-home coverage' in 2022, which the LLM answer doesn't explicitly mention. (3) The phrase 'capital-intensive rollout' is accurate but slightly different from the ground truth's 'actively investing in their deployment' - though semantically equivalent. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is not directly testable. The mention of CPE spending decline is appropriately qualified as 'modest' without specific figures. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and connects product positioning to strategic infrastructure investment, demonstrating sound multi-hop reasoning. The evolution narrative is clear and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 525,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "The G600, introduced in 2019 as a clean‑sheet large‑cabin jet that replaced the G450/G550, has seen its installed base roughly double – cumulative deliveries of the G500/G600 family rose from “almost 150” at year‑end 2021 (2022 filing) to “more than 300” at year‑end 2024 (2024 filing)【page_6】【page_5】.  It remains a cornerstone of Gulfstream’s modern portfolio, anchoring the core G500/G600 line‑up while newer models such as the G700, G800 and G400 expand the family【page_5】【page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate - cumulative deliveries of G500/G600 correctly stated as 'almost 150' at year-end 2021 and 'more than 300' at year-end 2024, matching ground truth exactly. (2) The doubling characterization is mathematically sound (150→300 represents a 2x increase). (3) Multi-hop synthesis is correct - properly connects 2022 filing data with 2024 filing data and synthesizes the evolution narrative. (4) Entity identification is accurate - correctly identifies G500/G600 as a family, mentions G450/G550 as predecessors, and newer models (G700, G800, G400) as part of expanded lineup. (5) The introduction date of 2019 is reasonable context. MINOR ISSUES: (1) The ground truth emphasizes that by 2024 the G600 'was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup' - the LLM answer states it 'remains a cornerstone' and 'anchoring the core G500/G600 line-up' which captures the essence of this evolution but uses slightly different framing. The LLM's characterization is semantically equivalent and perhaps more direct. (2) The LLM mentions G700 in the newer models list, while the ground truth specifically mentions G800 and G400 - G700 is not explicitly mentioned in the ground truth, though this is a minor addition that doesn't contradict the source material. (3) The answer could have been slightly more explicit about the shift in focus from G600 as 'new product' to 'established product,' though the 'cornerstone' language implies this. Overall, the answer correctly synthesizes multi-hop information across years and documents, maintains factual accuracy on all critical numbers, and appropriately addresses the question's focus on market presence evolution and product lineup role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 520,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "In 2023 AIG still owned a majority of Corebridge – 52.2 % of the common stock as of 12/31/23 and reported a $902 million gain from Corebridge in discontinued‑operations net income (2023 attributable to AIG)【page_27】.  By 2024 AIG had de‑consolidated Corebridge, cutting its stake to 48.4 % at the June 9 de‑consolidation date and to just 22.7 % by 12/31/24 【page_108】, and now treats the remaining interest under the equity‑method, recognizing $601 million of equity‑method income for the June‑Dec 2024 period and recording share‑sale gains (e.g., a $282 million gain in Q4 2024) – which together contributed to a $4.1 billion loss attributable to discontinued operations in 2024 【page_109】【page_110】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial detail and mostly accurate information about AIG's evolving relationship with Corebridge. STRENGTHS: (1) Correctly identifies the 52.2% ownership stake in 2023 and the shift to equity method accounting by 2024. (2) Accurately captures the de-consolidation event on June 9, 2024, and the subsequent ownership percentages (48.4% at de-consolidation, 22.7% by 12/31/24). (3) Provides specific financial metrics including the $902 million gain in 2023, $601 million equity-method income for June-Dec 2024, and $282 million Q4 2024 gain. (4) Correctly synthesizes the multi-hop relationship evolution across 2023-2024. (5) Appropriately references page numbers for source verification. (6) Captures the shift from majority ownership/control to passive investment approach via equity method. MINOR WEAKNESSES: (1) The answer includes additional detail about discontinued operations losses ($4.1 billion) that, while factually accurate, goes slightly beyond the core question about equity ownership and income recognition evolution. (2) The presentation of the $4.1 billion loss figure could be clearer in terms of how it relates to the equity method income and share-sale gains mentioned. (3) The answer could more explicitly state that the transition represents a change from consolidation to equity method accounting, though this is implied. QUANTITATIVE VERIFICATION: All percentages (52.2%, 48.4%, 22.7%) and dollar amounts ($902M, $601M, $282M) appear consistent with typical SEC filing disclosures. The timeline and sequence of events (2023 ownership → June 2024 de-consolidation → 2024 equity method) is logically sound. The answer successfully addresses both components of the question: equity ownership evolution and income recognition changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 484,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "In 2022 Tesla’s Solar Roof was produced at a single, dedicated site – Gigafactory New York in Buffalo – under a lease and research‑development agreement with the SUNY Foundation, and the company had already met the facility’s investment and hiring targets after a COVID‑19‑related shutdown (2022 p9‑10). By the 2024 filing the company flags that Solar Roof production has encountered ramp‑up delays and now hinges on new manufacturing processes, broader supply‑chain constraints and other operational challenges, reflecting a shift from a location‑specific, target‑driven approach to a more uncertain, multi‑facility production strategy (2024 p17).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Tesla's Solar Roof production strategy evolution. STRENGTHS: (1) Correctly identifies Gigafactory New York in Buffalo as the 2022 production facility with accurate reference to SUNY Foundation lease/R&D agreement; (2) Accurately captures the 2024 shift toward acknowledging ramp-up delays and production challenges; (3) Properly synthesizes the transition from a focused, location-specific approach to a more complex, multi-facility strategy; (4) Correctly references page numbers (2022 p9-10, 2024 p17) indicating proper source verification; (5) Appropriately mentions COVID-19 shutdown context and investment/hiring targets met; (6) Captures key operational challenges including supply-chain constraints and manufacturing process requirements. MINOR GAPS: (1) The LLM answer could have been slightly more explicit about the 'design tolerances, high quality and output rates' requirements mentioned in the ground truth; (2) Could have elaborated more on the financing options integration mentioned in the original answer as part of the 2022 strategic push; (3) The phrase 'multi-facility production strategy' in the LLM answer is somewhat inferred rather than explicitly stated in ground truth, though the inference is reasonable. QUANTITATIVE VERIFICATION: All dates (2022, 2024) are correct; facility name and location are accurate; no numerical calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the strategic evolution and operational dependencies. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 508,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "In its 2023 filing Qualcomm positioned on‑device AI as a core element of its “high‑performance and low‑power computing” platform that it was **scaling across existing markets – mobile handsets, automotive and IoT**【page_65】. By the 2024 filing the company still calls on‑device AI a foundational technology, but now ties it to a **broader investment strategy that includes new product‑area initiatives, industry expansion and strategic acquisitions** to push AI‑enabled solutions beyond the handset business【page_20】【page_21】. This reflects a shift from primarily scaling AI within its existing portfolio to using AI as a catalyst for diversified growth and strategic investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of on-device AI as a core element within Qualcomm's high-performance, low-power computing platform; (2) Accurately captures the 2024 evolution toward a more investment-centric strategy; (3) Properly synthesizes the multi-hop information showing the shift from product scaling to strategic investments and acquisitions; (4) Correctly identifies the market expansion from mobile handsets to automotive and IoT; (5) Appropriately characterizes the transition from direct product commercialization to ecosystem development and third-party integration enablement. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('diversified growth and strategic investments' vs. the ground truth's emphasis on 'long-term growth and ecosystem development'); however, these are semantically equivalent and both capture the core strategic shift; (2) The answer could have been slightly more explicit about the shift from 'core product offering' to 'investment-centric strategy,' though this distinction is clearly implied in the text. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The years (2023, 2024) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the evolution in Qualcomm's strategic approach. The logic connecting the 2023 positioning to the 2024 investment strategy is sound and well-articulated. ENTITY ACCURACY: Qualcomm is correctly identified, years are correct, and all referenced markets (mobile handsets, automotive, IoT) are accurately mentioned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 491,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "In the 2022 filing Dolce & Gabbana was listed as a tenant at several international premium outlets – Gotemba, Kobe‑Sanda and Rinku in Japan and Punta Norte in Mexico【page 42】【page 43】. By the 2023 filing the brand appears only at Las Vegas Premium Outlets in the United States【page 34】. This drop‑off signals that SPG is pulling the luxury label out of many overseas sites and concentrating it in a few high‑traffic U.S. flagship outlets, using Dolce & Gabbana to underscore an aspirational, premium positioning in its most prominent domestic outlet locations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic shift from multi-location Japan presence to U.S. concentration. The reasoning about premium positioning and flagship strategy is sound and well-articulated. The answer appropriately synthesizes the multi-hop comparison across 2022 and 2023 filings. CRITICAL ERRORS: (1) The LLM introduces 'Punta Norte in Mexico' as a 2022 location, which is NOT mentioned in the ground truth answer. This is a factual error that adds incorrect information. (2) The LLM states the brand appears 'only at Las Vegas Premium Outlets' in 2023, but the ground truth specifies 'Las Vegas Outlets North Premium NV' - while semantically similar, the exact property name matters for precision. (3) The LLM cites page numbers (42, 43, 34) which cannot be verified against the ground truth and may be hallucinated. QUANTITATIVE ISSUES: The location count is problematic - ground truth lists 3 Japan locations in 2022 (Gotemba, Kobe-Sanda, Rinku), but the LLM adds a 4th location (Punta Norte) without ground truth support. This is a significant factual error that undermines accuracy. REASONING QUALITY: The multi-hop synthesis and strategic interpretation are well-reasoned and align with the ground truth's conclusion about brand repositioning. The explanation of 'aspirational, premium positioning' and 'flagship outlets' effectively captures the strategic shift. OVERALL: While the qualitative reasoning and strategic interpretation are strong, the introduction of unsupported location data (Punta Norte) and potential page number hallucinations represent material factual errors that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 449,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "In 2023 ConocoPhillips spent $49 million on exploration in its consolidated Asia Pacific/Middle East operations and $46 million in its equity‑affiliate assets (about $95 million in total). The 2024 filing notes that the company again recorded extensions and discoveries in the Middle East and Australia, showing that it is maintaining – and arguably sharpening – its strategic emphasis on growing its Asia Pacific/Middle East portfolio, even though a separate 2024 exploration‑spend figure is not disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM introduces numbers ($46 million in equity-affiliate assets, ~$95 million total) that are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth clearly states $49 million in 2023 exploration expenditures and $0 in 2024. The LLM's claim of $46 million in equity-affiliate exploration spending cannot be verified against the provided ground truth. (2) CORE FACTUAL CONTRADICTION: The ground truth explicitly states that 2024 showed '$0 in new exploration activities' in the Asia Pacific/Middle East region, indicating a complete withdrawal. The LLM claims the company is 'maintaining – and arguably sharpening – its strategic emphasis' on this region, which is the opposite conclusion. (3) MISSING 2024 DATA: The ground truth provides a specific 2024 figure ($0), while the LLM states 'a separate 2024 exploration-spend figure is not disclosed.' This is factually incorrect per the ground truth. (4) MISINTERPRETATION OF STRATEGIC DIRECTION: The LLM references 'extensions and discoveries' as evidence of continued strategic focus, but the ground truth indicates the $0 exploration spend in 2024 represents a strategic shift away from the region. The LLM fundamentally misread the data to reach an opposite conclusion about strategic intent. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison ($49M in 2023 to $0 in 2024) and draw the correct inference about strategic withdrawal. The answer is internally inconsistent with the ground truth on all major points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 462,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast’s equity interest in Universal Beijing Resort has stayed at 30% since at least 2022, when the project was financed through a Chinese‑syndicated loan with a ¥29.7 billion (≈$4.2 billion) borrowing limit【page_86】.  The resort’s debt has been trimmed modestly – $3.5 billion of debt (including a $3.1 billion term loan) was outstanding at year‑end 2023, falling to $3.4 billion (including a $3.0 billion term loan) at year‑end 2024【page_86】 – while Comcast’s ownership share remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate debt figures and ownership percentages but has significant gaps in completeness compared to the ground truth. CORRECT ELEMENTS: (1) 30% ownership interest is accurate, (2) Debt figures are correct: $3.5 billion in 2023 and $3.4 billion in 2024, (3) Term loan amounts ($3.1 billion in 2023, $3.0 billion in 2024) are accurate, (4) The debt reduction trend is correctly identified. MISSING/INCOMPLETE ELEMENTS: (1) The LLM claims the 30% stake existed 'since at least 2022' but the ground truth explicitly states that in 2022, 'no specific financial stake or debt figures were provided at that time' - this is a subtle but important distinction about what was disclosed when, (2) The LLM completely omits the asset and liability figures for 2024 ($7.3 billion assets, $7.0 billion liabilities) and 2023 ($7.8 billion assets, $7.2 billion liabilities), which are key components of the financial evolution, (3) The LLM mentions the Chinese-syndicated loan with ¥29.7 billion limit, which adds context not in the ground truth but doesn't contradict it. MULTI-HOP REASONING: The answer correctly synthesizes debt information across 2023-2024 but fails to provide the complete financial picture by omitting balance sheet items. The statement about ownership 'remaining unchanged' is reasonable but the ground truth suggests the explicit disclosure of the 30% stake may have been new in 2024, not continuous from 2022. QUANTITATIVE ACCURACY: All debt numbers are correct; the ¥29.7 billion figure appears accurate but represents additional detail. QUALITATIVE ACCURACY: The reasoning about debt reduction is sound, but the incomplete coverage of the financial evolution (missing asset/liability data) represents a significant gap in addressing the 'evolved' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 490,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy’s consolidated net‑derivative position shrank sharply – the net balance fell from $29 million at year‑end 2022 to $13 million at year‑end 2023 – while the amount settled more than doubled, rising from $32 million in 2022 to $68 million in 2023 (purchases also fell from $74 million to $42 million and a $10 million gain replaced a $35 million loss)【page_191】.  This swing shows the company actively unwound and settled existing contracts, reducing its net exposure to derivatives and moving from a net loss to a modest net gain on its derivative portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. All core quantitative facts are correct: net derivatives balance fell from $29M (2022) to $13M (2023), settlements increased from $32M to $68M. The answer correctly identifies the more-than-doubling of settlements (32M to 68M represents a 112.5% increase). Additional details provided (purchases declining from $74M to $42M, shift from $35M loss to $10M gain) are accurate and enhance the analysis beyond the ground truth baseline. The multi-hop reasoning is sound: the answer synthesizes the balance sheet changes with settlement activity and correctly interprets what this indicates about derivative management strategy (active unwinding, reduced exposure, improved portfolio performance). The semantic interpretation that the company 'actively unwound and settled existing contracts' and moved 'from a net loss to a modest net gain' provides valuable context about the company's derivative management approach. The answer fully addresses all aspects of the question regarding evolution from 2022 to 2023 and what it indicates about exposure/management. Minor note: the answer includes a page reference citation that adds credibility. No calculation errors detected. The only reason this is not a perfect 10 is that the additional details about purchases and gains/losses, while accurate and valuable, go slightly beyond what was explicitly in the ground truth answer, though this represents enhancement rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 413,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "In the 2022 filing SPG only flagged LTIP units as “potentially dilutive securities” in its EPS discussion and noted that they had **no material dilutive effect** for the years presented, without describing how the awards were valued 【page_116】. By the 2023 filing the company had expanded the disclosure: LTIP units are treated as participating securities under the two‑class method, the grant‑date fair values of market‑based LTIP awards are **estimated using a Monte‑Carlo model**, and the filing lists the **maximum potential fair value of the 2023 LTI program ($42.5 million)** and a table of award‑date fair values for each year 【page_127】【page_129】. This shows a shift from a brief, immaterial‑dilution note to a detailed valuation methodology and explicit fair‑value disclosure while still acknowledging the units’ dilutive potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 in SPG's LTIP Units disclosure; (2) Accurately captures the 2022 position: LTIP units flagged as 'potentially dilutive securities' with 'no material dilutive effect'; (3) Accurately describes the 2023 enhancements: treatment as participating securities under two-class method, use of Monte Carlo model for market-based LTIP unit valuation, and specific fair value disclosures; (4) The specific dollar amount ($42.5 million maximum potential fair value of 2023 LTI program) is included and appears reasonable for a REIT of SPG's scale; (5) Multi-hop synthesis is sound - correctly connects the shift from immaterial dilution disclosure to detailed valuation methodology across the two years; (6) Page citations (116, 127, 129) provide appropriate sourcing; (7) Semantic equivalence is strong - conveys the same substantive evolution as ground truth. MINOR CONSIDERATIONS: The $42.5 million figure, while specific and detailed, cannot be independently verified against the ground truth statement which does not provide this specific number. However, this addition enhances rather than contradicts the answer, providing concrete detail that supports the narrative of expanded disclosure. The answer maintains factual accuracy on all core points: the shift from general dilution statements to specific valuation methodologies, the Monte Carlo model usage, and the participating securities classification. The reasoning about the evolution of disclosure practices is logical and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 451,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "In the 2022 filing Comcast said its Atairos agreement limited total funding to **up to $4.5 billion** (down from $5 billion), capped annual capital calls at **$400 million**, and included a **$45 million‑per‑year management‑fee commitment**; the company had about **$1.5 billion of unfunded capital** remaining 【page_106】. By the 2024 filing the company was actually **contributing $73 million in 2024 (up from $52 million in 2022)**, the annual management‑fee commitment had been **reduced to $40 million**, and the **unfunded capital commitment fell to roughly $1.4 billion** 【page_85】. This reflects a modest cut in fee obligations and unfunded exposure while cash contributions to Atairos have increased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) CAPITAL COMMITMENT: Ground truth states the 2022 commitment was $5 billion, decreasing to $4.5 billion by 2024. The LLM incorrectly claims the 2022 filing said 'up to $4.5 billion (down from $5 billion)' - this is backwards and confusing. The LLM appears to have conflated the 2022 and 2024 figures. (2) MANAGEMENT FEE: Ground truth clearly states $40 million annually in 2024. The LLM claims the 2022 commitment was '$45 million-per-year' and was 'reduced to $40 million' by 2024. This is partially correct on the 2024 figure but introduces an unsupported $45 million figure for 2022 that doesn't appear in the ground truth. (3) UNFUNDED CAPITAL: The LLM provides specific figures ($1.5 billion in 2022, $1.4 billion in 2024) that are not mentioned in the ground truth, making these unverifiable claims. (4) ACTUAL CONTRIBUTIONS: The LLM discusses actual cash contributions ($73 million in 2024, $52 million in 2022) which are entirely absent from the ground truth answer and appear to be fabricated details. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to show evolution between years, it does so with incorrect numbers and introduces unsupported details. The core evolution (from $5B to $4.5B capital commitment, with $40M annual management fee) is muddled in the LLM response. The answer demonstrates poor accuracy on the primary quantitative metrics that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 417,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East area fell from 312 billion cubic feet (BCF) at the end of 2023 (305 BCF developed + 7 BCF undeveloped) to 296 BCF at the end of 2024 (289 BCF developed + 7 BCF undeveloped) – a decline of roughly 16 BCF (about 5 %)【page_145】. The footnote notes that “All Equity Affiliate reserves are located in our Asia Pacific/Middle East Region,” and the 2024 discussion cites only modest revisions and limited extensions in that region【page_146】. This modest drop, combined with the fact that the reserves are held mainly through equity affiliates, indicates that ConocoPhillips’ operational focus in Asia Pacific/Middle East is relatively small and affiliate‑centric rather than driven by large‑scale direct development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detail than the ground truth. Quantitative verification: (1) 2023 reserves of 312 BCF - CORRECT; (2) 2024 reserves of 296 BCF - CORRECT; (3) Decline calculation of 16 BCF - CORRECT (312-296=16); (4) Percentage decline of ~5% - CORRECT (16/312≈5.1%); (5) Breakdown into developed/undeveloped components (305+7 in 2023, 289+7 in 2024) - CORRECT and adds valuable detail not in ground truth. Multi-hop synthesis: The answer correctly synthesizes information across multiple pages (145-146) and connects reserve figures to operational structure (equity affiliates). The reasoning about what the decline indicates is sound and more nuanced than the ground truth - the LLM identifies that the affiliate-centric structure and modest revisions/extensions suggest limited direct operational focus, which is a reasonable inference from the data. The answer goes beyond the ground truth by providing developed/undeveloped breakdowns and citing specific footnote information about equity affiliates, which strengthens rather than contradicts the core finding. The semantic meaning aligns perfectly with the ground truth's conclusion about a modest reduction suggesting potential shift in operational focus. Minor consideration: The ground truth uses simpler language ('modest reduction'), while the LLM provides more technical detail and context, but this represents added value rather than error. All numbers, calculations, and entity references (COP/ConocoPhillips, Asia Pacific/Middle East region, years 2023-2024) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 440,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022 Comcast’s wireless‑gateway approach was essentially a procurement play – the company bought a large volume of customer‑premise equipment, including wireless gateways, from a **limited number of suppliers** (see page 6 & page 8). By 2024 the emphasis had shifted to **network‑deployment spending**, with capital expenditures directed to **scalable infrastructure, line extensions and support capital** to expand capacity and roll out multigigabit symmetric speeds, while still continuing the rollout of wireless gateways as part of the broader connectivity build‑out (see page 50 & page 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core comparison - 2022 as a procurement-focused approach versus 2024 as a strategic network deployment investment. All major factual claims are correct: limited supplier relationships in 2022, shift to capital expenditures in 2024, focus on multigigabit symmetric speeds, and wireless gateways as infrastructure components. (2) QUANTITATIVE ACCURACY: No specific numbers are provided in either the ground truth or LLM answer, which is appropriate given the question's qualitative nature. The temporal markers (2022 vs 2024) are correct. (3) QUALITATIVE ACCURACY: The LLM successfully synthesizes the multi-hop comparison across two different time periods and strategic approaches. The characterization of 2022 as 'passive procurement' versus 2024 as 'active integration' is semantically equivalent to the ground truth's distinction. The mention of 'scalable infrastructure, line extensions and support capital' adds appropriate specificity that aligns with the ground truth's emphasis on 'network scalability and capacity expansion.' (4) MULTI-HOP REASONING: The answer correctly identifies and synthesizes information about: (a) supplier relationships in 2022, (b) capital expenditure strategy in 2024, (c) the role of wireless gateways in both periods, and (d) the strategic evolution from procurement to deployment. (5) MINOR OBSERVATIONS: The LLM includes page references (pages 6, 8, 50, 51) which add credibility but cannot be verified against the ground truth. The phrasing 'network-deployment spending' is a clear, concise way to express the 2024 shift. The answer maintains semantic equivalence while using slightly different wording than the ground truth (e.g., 'procurement play' vs 'procurement-centered'). No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 519,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "In the 2022 Form 10‑K Tesla presented Solar Roof as a key growth driver for its Energy Generation & Storage segment – deployments were rising sharply and unit costs were falling, but the product’s larger share pulled the segment’s gross margin down because the manufacturing line was still under‑utilized during the ramp‑up (see page 40 & page 39). By the 2024 filing the tone had shifted: Solar Roof is still treated as a strategic energy product, but the filing now highlights it mainly as a production‑ramp risk, warning that delays or difficulties in scaling Solar Roof manufacturing could adversely affect results (see page 17).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Tesla's Solar Roof evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as a growth driver with rising deployments and falling unit costs; (2) Accurately captures the shift by 2024 to emphasizing production ramp risks and manufacturing challenges; (3) Properly synthesizes the multi-hop comparison across two filing years; (4) Correctly identifies the Energy Generation & Storage segment context; (5) Appropriately notes the strategic importance in both periods while highlighting the tonal shift from success to caution. MINOR ISSUES: (1) The LLM provides additional detail about gross margin compression due to under-utilized manufacturing lines in 2022 - while this is plausible and consistent with typical ramp-up dynamics, the ground truth does not explicitly mention this specific detail, representing a minor elaboration beyond the source material; (2) Page references (page 40, 39, 17) are provided but cannot be verified against the ground truth which does not include specific page citations; (3) The phrase 'unit costs were falling' is presented as fact but the ground truth does not explicitly confirm this detail. VERIFICATION: The core factual claims align well - 2022 as growth driver period, 2024 as production risk period, the shift in framing from deployment success to manufacturing challenges. The multi-hop reasoning correctly synthesizes information across the two filing years. No numerical errors or calculation mistakes detected. The answer appropriately addresses both components of the question (strategic importance and production challenges) and their evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 470,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy’s “Net pending transactions and other investments” in the Master Retirement Trust grew from **$14 million at 12/31/2022** to **$54 million at 12/31/2023**—a $40 million (roughly 4‑times) increase. The sizable rise signals that the company is deliberately expanding its exposure to this category, reflecting a more aggressive or opportunistic strategic positioning within its retirement‑plan asset mix.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The numbers are completely reversed: Ground truth shows $53M (2022) → $14M (2023), but LLM states $14M (2022) → $54M (2023). This is a directional reversal of the change. The LLM calculates a $40M increase, when the actual change was a $39M decrease. (2) ENTITY CONFUSION - The LLM introduces 'Master Retirement Trust' as the context, which is not mentioned in the original question or ground truth answer. This appears to be a different investment category or account than what the question asks about. The ground truth refers to Duke Energy's overall 'Net Pending Transactions and Other Investments' without specifying a retirement trust context. (3) STRATEGIC INTERPRETATION ERROR - The LLM's conclusion about 'deliberately expanding exposure' and 'aggressive or opportunistic positioning' is the opposite of what the ground truth indicates. The ground truth correctly identifies the decrease as indicating 'a strategic shift or completion of certain initiatives.' The LLM's interpretation is contradicted by the actual data direction. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison. It appears to have either reversed the years or confused different data sources entirely. (5) CALCULATION VERIFICATION - Even if the numbers were correct, the LLM's characterization of a $40M change as 'roughly 4-times' is approximately correct mathematically ($40M/$14M ≈ 2.86x, closer to 3x), but this is moot given the fundamental number reversal. The answer demonstrates a critical failure in data accuracy and contradicts the ground truth on both the direction and magnitude of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 469,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "In 2023 the company reported $109 million of expense for its tax‑qualified defined‑contribution plans; that amount rose to $112 million in 2024, reflecting a modest increase in contributions.  While the liability‑driven investment targets stayed the same (20 % equity/80 % fixed‑income for pension assets and 55 %/45 % for post‑retirement assets), the actual mix shifted in 2024 – pension equity grew to about 21 % (from 18 %), corporate bonds to roughly 63 % (from 57 %), and treasury holdings fell – and the 2024 filing added a far more granular fair‑value disclosure, showing Level 1/Level 2 breakdowns and NAV‑based collective‑fund values for both pension and post‑retirement plan assets, whereas the 2023 filing only provided summary percentage allocations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific asset allocation percentages (21% equity, 63% corporate bonds, 18% prior equity, 57% prior bonds) that are NOT present in the ground truth. The ground truth only confirms the 20%/80% target allocation remained the same; it does NOT provide actual composition percentages or year-over-year shifts. The LLM also introduces a 55%/45% post-retirement asset allocation that is not mentioned in the ground truth. (2) UNSUPPORTED CLAIMS - The LLM claims 'the actual mix shifted in 2024' with specific numbers, but the ground truth only states the 2024 filing 'added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized' - this is about FUTURE disclosure capability, not actual reported shifts. (3) FAIR-VALUE DISCLOSURE FABRICATION - The LLM describes 'Level 1/Level 2 breakdowns and NAV-based collective-fund values' as new 2024 disclosures, but the ground truth makes no mention of these specific fair-value measurement levels or NAV disclosures. (4) CORRECT ELEMENTS - The LLM correctly identifies: $109M (2023) and $112M (2024) defined contribution expenses, the 20%/80% target allocation maintenance, and that 2024 added more detailed transparency. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution between years, it does so by introducing fabricated data points not supported by the ground truth. The core answer structure is reasonable but built on false premises. The answer demonstrates a pattern of hallucinating specific financial metrics to make the narrative more detailed and compelling, which is a critical failure in financial reporting evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 467,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "In fiscal 2023 Qualcomm’s 10‑K did not call out on‑device AI as a separate strategic priority, focusing its discussion on 5G, handset, automotive and IoT revenue streams (see FY 2023 pages 43‑47). By fiscal 2024 the filing explicitly states that “5G combined with high‑performance, low‑power computing and on‑device artificial intelligence will continue to drive adoption” (FY 2024 p. 45) and adds that the company is devoting additional resources to foundational technologies—including on‑device AI—while raising R&D to $8.9 billion, planning higher near‑term capital expenditures to support production and testing for AI‑related diversification, and pursuing strategic investments and acquisitions to expand its AI capabilities (FY 2024 p. 20, 47).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth and the question's premise. Key issues: (1) MAJOR CONTRADICTION: The LLM claims that in fiscal 2023 Qualcomm 'did not call out on-device AI as a separate strategic priority,' directly contradicting the ground truth which explicitly states that in fiscal 2023, Qualcomm 'emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption.' This is a fundamental mischaracterization of FY2023 positioning. (2) QUANTITATIVE ERROR: The LLM cites R&D of '$8.9 billion' for FY2024 but provides no verification or context for this number. Without access to the actual filings, this cannot be confirmed, but the ground truth does not mention this specific figure. (3) INCOMPLETE SYNTHESIS: The LLM does address the evolution from FY2023 to FY2024 and mentions investments/acquisitions, which aligns with the ground truth's characterization of a shift from 'strategic vision to active investment.' However, the FY2023 baseline is incorrectly stated. (4) CITATION ISSUES: The LLM provides specific page references (FY 2023 pages 43-47, FY 2024 p. 45, 20, 47) but these cannot be verified against the ground truth, and the characterization of FY2023 content appears incorrect. (5) MULTI-HOP REASONING: The answer attempts to synthesize across two fiscal years but fails on the FY2023 characterization, which undermines the entire comparison. The ground truth clearly indicates On-Device AI was already a strategic focus in FY2023, not a new emphasis in FY2024. The LLM's answer reverses the actual evolution of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 449,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "In the 2022 Form 10‑K the voting‑trust documents are listed in the exhibit index simply as “9.1 Second Amended and Restated Voting Trust Agreement …” and “9.2 Voting Trust Agreement …” 【page_144】. In the 2023 filing the same agreements appear in the same section but are now labeled “9.1 (a) Second Amended and Restated Voting Trust Agreement …” and “9.2 Voting Trust Agreement …” 【page_140】. The only change is a minor renumbering (adding the “(a)” sub‑item); the agreement’s content and purpose are unchanged, indicating that the Simon family’s voting‑trust arrangement remains in place and the company’s governance framework continues to be stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth states that in 2022 the agreement was described as 'Second Amended and Restated' but in 2023 it was presented WITHOUT this modifier - a meaningful change in classification. The LLM claims the opposite: that both years show 'Second Amended and Restated' in item 9.1, with only a minor renumbering change from '9.1' to '9.1(a)'. This is a fundamental misrepresentation of the evolution described in the ground truth. (2) The ground truth emphasizes that the shift from 'Second Amended and Restated' to simply 'Voting Trust Agreement' is significant and indicates no further amendments were made. The LLM misses this key distinction entirely and instead focuses on a renumbering technicality that is not mentioned in the ground truth. (3) The LLM's conclusion about stability is correct in spirit, but it reaches this conclusion through incorrect reasoning - it attributes stability to 'no content changes' rather than to 'no further amendments since 2004' as the ground truth indicates. (4) The page references (144 and 140) cannot be verified against the ground truth but appear to be specific citations that may or may not be accurate. (5) The core multi-hop synthesis fails: the LLM did not correctly identify and compare the actual classification changes between the two years. The answer demonstrates a fundamental misunderstanding of what changed between the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 412,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves grew from roughly 5.6 trillion cubic feet at year‑end 2023 (312 BCF in consolidated operations + 5,275 BCF in equity‑affiliate holdings) to about 6.2 trillion cubic feet at year‑end 2024 (296 BCF + 5,870 BCF) – a net increase of ≈580 BCF, driven mainly by a 595 BCF rise in equity‑affiliate reserves【page_145】.  This expansion, especially the surge in affiliate holdings from purchases and extensions, signals that the Asia Pacific/Middle East region is becoming increasingly strategic to COP’s overall reserve portfolio【page_146】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misinterprets the data and reaches the opposite conclusion from the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims consolidated operations decreased from 312 BCF (2023) to 296 BCF (2024), which is correct, but then contradicts the ground truth's interpretation by claiming this represents a net INCREASE in total reserves. The LLM calculates 5.6 TCF (2023) vs 6.2 TCF (2024), a 580 BCF increase. However, the ground truth explicitly states the consolidated reserves DECREASED by 16 BCF (312 to 296), and while equity affiliates increased from 5,275 to 5,870 BCF (595 BCF increase), the ground truth characterizes this as a 'slight decrease' in consolidated operations with a 'potential reevaluation' of the region's role. (2) INTERPRETATION ERROR: The LLM claims the expansion 'signals that the Asia Pacific/Middle East region is becoming increasingly strategic,' which directly contradicts the ground truth's assessment that 'the slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions.' This is a fundamental misreading of what the data indicates about strategic importance. (3) MULTI-HOP REASONING FLAW: While the LLM correctly identifies both consolidated and equity-affiliate components, it fails to properly weight the significance of the consolidated reserve decline (the primary metric) versus the affiliate increase. The ground truth emphasizes the consolidated decline as the key indicator, while the LLM focuses on the total increase to reach an opposite conclusion. (4) MISSING CONTEXT: The ground truth notes the consolidated decline 'may suggest a shift in emphasis or extraction focus in favor of other regions,' indicating a strategic reorientation. The LLM completely misses this nuance and instead claims increasing strategic importance. The numbers themselves are mostly correct, but the interpretation and conclusion are inverted from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 529,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s full debt package on its balance sheet – $9.368 billion of senior unsecured notes, junior subordinated debt and a $1.5 billion DDTL facility (net $250 million after repayments) that was guaranteed or collateralized by AIG【page_112】. After Corebridge was de‑consolidated in June 2024, that debt was removed from AIG’s consolidated liabilities, leaving only the $250 million DDTL loan that Corebridge can continue to draw (as shown in the 2024 debt‑maturity schedule)【page_113】, and AIG’s remaining interest is now recorded as an equity‑method investment, producing $601 million of equity‑method income for the June‑Dec 2024 period【page_108】【page_109】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and introduces unsupported details that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims $9.368 billion in 2023 debt, but the ground truth specifies $9,368 million total with $6,452 million in senior unsecured notes and $989 million in junior subordinated debt - the LLM conflates these figures and adds an unsupported $1.5 billion DDTL facility not mentioned in the ground truth. (2) The LLM introduces a '$250 million DDTL loan' and claims it remained after de-consolidation, which is not mentioned in the ground truth answer. (3) The LLM states '$601 million of equity-method income for the June-Dec 2024 period,' but the ground truth only mentions that 'AIG reported equity method income from Corebridge' without specifying this amount - this appears to be an unsupported specific figure. CORRECT ELEMENTS: (1) The timing of de-consolidation in June 2024 is correct. (2) The shift from consolidated debt relationship to equity method investment is correctly identified. (3) The removal of Corebridge debt from consolidated liabilities is correct in concept. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across 2023-2024 but introduces fabricated details (DDTL facility, specific equity income amount) that are not in the ground truth. The reasoning structure is sound, but the factual foundation is compromised. The answer demonstrates partial understanding of the relationship evolution but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 429,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "In the 2022 filing the special‑use funds were essentially a debt‑only pool – NEE held about $2.5 billion of fixed‑income securities (and FPL about $1.9 billion) with no material equity component disclosed (see 2022 Note 5, p. 55). By 2024 the mix had turned upside‑down: equity securities now total roughly $6.2 billion for NEE and $4.2 billion for FPL, while fixed‑income holdings are only about $2.3 billion and $1.7 billion respectively (see 2024 Note 4, p. 89‑90). The shift toward a much larger equity allocation indicates a higher risk appetite and a strategy to capture higher returns, while still keeping a core of liquid debt assets to meet short‑term liquidity and regulatory requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic shift and provides relevant context, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the fundamental strategic shift from fixed-income-only to equity-heavy allocation; (2) Properly synthesizes the multi-hop comparison across 2022-2024; (3) Provides sound reasoning about risk appetite and liquidity strategy; (4) Includes helpful context about FPL subsidiary and regulatory requirements; (5) Correctly interprets the strategic implications. CRITICAL ERRORS: (1) NEE 2024 equity securities stated as ~$6.2 billion vs. ground truth of $6,164 million (acceptable rounding); (2) NEE 2024 fixed-income total stated as ~$2.3 billion, but ground truth shows $722M (bonds) + $685M (corporate) + $873M (ABS) = $2,280 million, which actually matches the LLM figure when properly calculated; (3) However, the LLM answer omits the detailed breakdown of fixed-income components (U.S. Government/municipal bonds, corporate debt, asset-backed securities) that the ground truth specifies; (4) NEE 2022 figure of $2.5 billion is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two entities (NEE and FPL), though the inclusion of FPL data, while contextually useful, goes beyond what the ground truth explicitly addresses. The comparison logic is sound. QUANTITATIVE ISSUES: While the aggregate numbers are approximately correct, the answer lacks the granular breakdown of fixed-income components that demonstrates complete understanding of the portfolio composition. The omission of specific bond types, corporate debt, and ABS allocations represents incomplete disclosure of the strategic shift's details. The answer would score higher if it included the specific $722M, $685M, and $873M breakdowns mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 512,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "In the 2022 Form 10‑K the company warned that “extensive sharing of site infrastructure … including due to increases in advanced network technology such as 5G … may cause new‑lease activity to slow” (2022 p. 15). By the 2024 filing the same risk is framed more strongly – it now says that “extensive sharing of site infrastructure … including due to 5G … may cause new‑lease activity to slow … and could be **materially and adversely** affect our growth, revenue and cash‑flow” (2024 p. 16). Thus, while the nature of the risk (5G‑driven site‑sharing reducing new leases) is unchanged, the company has elevated its magnitude, indicating a greater potential impact on financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of the risk from 2022 to 2024 and accurately captures the shift in language from general concern to emphasis on material adverse effects. The page references (2022 p. 15, 2024 p. 16) and quoted language appear reasonable and the identification of the company as AMT is correct. However, the answer has significant limitations: (1) It focuses primarily on the escalation of language/magnitude rather than the evolution in specificity of the risk nature. The ground truth emphasizes that by 2024, the risk evolved into a 'more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements' with explicit mention of 'lack of compensation to AMT when carriers opted for shared infrastructure.' The LLM answer does not capture this important shift toward RAN-specific language or the compensation aspect. (2) The LLM characterizes the risk nature as 'unchanged' when the ground truth indicates meaningful evolution in how the risk is framed - from general 'site infrastructure sharing' to specific 'RAN sharing, roaming, or resale arrangements.' (3) The answer correctly identifies the magnitude escalation (adding 'materially and adversely' language) but misses the nuance that this reflects 'a more mature and impactful shift in carrier behavior driven by 5G deployment' with specific financial impact mechanisms. (4) The multi-hop synthesis is incomplete - while the answer traces the evolution across years, it doesn't fully synthesize the relationship between 5G adoption, RAN-specific sharing arrangements, and the lack of compensation mechanism that the ground truth emphasizes. The answer is partially correct on the magnitude dimension but incomplete on the nature dimension of the risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 485,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron continues to hold a 36.4 % equity interest in Angola LNG Limited, which is accounted for under the equity‑method (see Note 15 description on page 78).  The carrying amount of that investment fell from $1.963 billion in 2022 to $1.762 billion in 2023, and Chevron’s share of Angola LNG’s earnings dropped sharply from $1.857 billion to $513 million over the same period (see the investment and equity‑in‑earnings figures on page 82).  The ownership percentage and accounting method remained unchanged, but both the investment balance and equity‑method earnings declined.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCY IN ANSWERING THE QUESTION: The LLM answer provides detailed financial metrics (carrying amounts, equity-in-earnings figures) that are internally consistent and appear to be sourced from actual 10-K filings. However, it fundamentally fails to address the core question about the evolution of Chevron's relationship with Angola LNG Limited between 2022 and 2023. The ground truth specifically identifies a critical change: the relationship classification shifted from 'Depends_On' (2022) to 'Invests_In' (2023), indicating a shift in how Chevron views or manages its investment. The LLM answer explicitly states 'The ownership percentage and accounting method remained unchanged,' which directly contradicts the ground truth's assertion that the relationship was 'reclassified' from a dependency-based structure to a more direct investment model. QUANTITATIVE ACCURACY: The LLM provides specific numbers (36.4% interest, $1.963B to $1.762B carrying amount, $1.857B to $513M earnings) that appear plausible and internally consistent with 10-K reporting, earning a 7/10 for numeric precision. However, these numbers cannot be verified against the ground truth provided. QUALITATIVE ACCURACY: The LLM completely misses the primary analytical insight - the relationship reclassification from 'Depends_On' to 'Invests_In' - which is the key evolution described in the ground truth. The answer focuses on financial metrics rather than the structural/strategic relationship evolution that the question asks about. This represents a fundamental failure in multi-hop reasoning and synthesis (2/10). CONTEXTUAL RELEVANCE: While the answer discusses Angola LNG Limited and Chevron's investment, it addresses the wrong dimension of the question. The question asks about evolution in 'investment structure' and relationship type, not just financial performance metrics (4/10). The LLM appears to have accessed actual filing data but failed to synthesize the relationship classification changes that constitute the actual answer to this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 551,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "In the 2022 filing Gulfstream described the G600 (along with the G500) as a new large‑cabin jet that replaced the G450/G550 with higher speed, better fuel efficiency, larger cabin volume, longer range and upgraded flight‑control systems, noting that cumulative deliveries of the two models were “almost 150” by year‑end 2021【page_5】. By the 2023 filing those same performance advantages were still emphasized, the aircraft now contributed to more than 90 city‑pair speed records, and cumulative deliveries had risen to “over 250” units by year‑end 2023, showing the G600’s transition from early rollout to a mature, high‑volume product in Gulfstream’s lineup【page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the G600's role evolution from 2022 to 2023, (2) Accurately cites cumulative deliveries: ~150 by end-2021 and over 250 by end-2023, (3) Properly synthesizes performance metrics (speed, fuel efficiency, cabin volume, range, flight-control systems) across both years, (4) Correctly notes the G600 contributed to 90+ city-pair speed records by 2023, (5) Appropriately characterizes the transition from 'new' product to 'mature, high-volume product', (6) Mentions the G500 alongside G600 as replacement for G450/G550. MINOR GAPS: (1) The ground truth specifically mentions the G600's Symmetry Flight Deck being extended to newer models (G700, G800, G400) in 2023, which the LLM answer does not explicitly address - this represents a notable omission regarding how the G600's technologies were integrated into the broader platform, (2) The ground truth emphasizes the shift from 'recent addition' (2019 entry) to 'mature product' more explicitly, while the LLM frames it as 'early rollout to mature product'. QUANTITATIVE VERIFICATION: All numbers are accurate - 'almost 150' deliveries by end-2021 and 'over 250' by end-2023 match ground truth exactly. The 90+ city-pair speed records is a valid additional metric not contradicting the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, comparing product positioning and delivery metrics across the two-year period. The logic connecting performance metrics to market maturity is sound. The omission of the Symmetry Flight Deck's extension to other models prevents this from being a perfect 9-10 score, as it represents incomplete coverage of the G600's evolving role in the broader platform strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 503,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "In the 2022 filing McDonald’s described its franchise model mainly as a fee‑based relationship – franchisees paid rent, royalties and initial fees while reinvesting capital on their own, and the Company’s co‑investment was limited to occasional restaurant‑improvement projects 【page_44】. By the 2024 filing the partnership had become more collaborative: the Company now routinely co‑invests with franchisees to fund restaurant modernizations and operating‑system initiatives, provides upfront funding for these projects, and leverages joint technology‑platform fees, while the franchisee base has grown to about 95 % of a 43,477‑restaurant system 【page_3】【page_4】. This reflects a shift from a primarily fee‑driven arrangement to a deeper financial and strategic collaboration with franchisees.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of McDonald's franchisee relationships from 2022 to 2024, accurately describing the shift from a primarily fee-based model to a more collaborative partnership with co-investments. The qualitative reasoning is sound and well-synthesized across the two time periods.\n\nSTRENGTHS:\n1. Correctly identifies the 2022 model as fee-based (rent, royalties, initial fees) with limited company co-investment\n2. Accurately describes the 2024 shift to routine co-investments in restaurant modernizations and operating-system initiatives\n3. Properly characterizes this as a strategic evolution from passive to active financial engagement\n4. Good multi-hop synthesis connecting financial involvement changes to strategic collaboration\n5. Appropriate use of citations to support claims\n\nWEAKNESSES/CONCERNS:\n1. QUANTITATIVE ISSUE: The LLM provides specific numbers (95% franchisee base, 43,477-restaurant system) that are not present in the ground truth answer. While these may be factually accurate from the filings, they introduce specificity beyond what the ground truth validates. The ground truth does not mention these specific percentages or restaurant counts, making it difficult to verify their accuracy against the provided ground truth.\n2. The ground truth mentions \"developmental licenses\" specifically, which the LLM answer does not reference\n3. Minor: The LLM adds detail about \"joint technology-platform fees\" which, while potentially accurate, goes slightly beyond the ground truth's scope\n\nMULTI-HOP REASONING: Excellent - the answer successfully synthesizes information across 2022 and 2024 filings to show the evolution, comparing and contrasting the two periods appropriately.\n\nSEMANTIC EQUIVALENCE: High - the core message matches the ground truth despite some additional details provided by the LLM.\n\nThe score reflects strong overall accuracy with minor deductions for introducing unverified specific numbers and omitting the \"developmental licenses\" reference from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 555,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The consolidated operating results show that smokeable‑product net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023** (a drop of about $720 million, ≈ 3%).  Operating income (OCI) for the segment slipped slightly, from **$10.688 billion in 2022 to $10.670 billion in 2023** (a $18 million decline, ≈ 0.2%).【page_29】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All financial figures are correct: 2022 smokeable products net revenues of $22.476 billion ($22,476 million), 2023 net revenues of $21.756 billion ($21,756 million), 2022 operating income of $10.688 billion ($10,688 million), and 2023 operating income of $10.670 billion ($10,670 million). The calculations are accurate: revenue decline of $720 million (22,476 - 21,756 = 720) representing approximately 3% decrease (720/22,476 ≈ 3.2%), and operating income decline of $18 million (10,688 - 10,670 = 18) representing approximately 0.2% decrease (18/10,688 ≈ 0.17%). The LLM correctly synthesized the multi-hop information by comparing the same segment across two fiscal years and providing both absolute and percentage changes. The answer properly identifies the metrics (net revenues and operating income), the product category (smokeable products), and the time period (2022 to 2023). The presentation is clear and well-organized with specific page reference. The only minor observation is that the LLM uses slightly different terminology ('consolidated operating results' and 'OCI' for operating income) compared to the ground truth's more straightforward language, but this represents stylistic variation rather than factual error. The semantic meaning is fully equivalent to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 381,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "In the 2022 filing, Opdivo was chiefly a product of a regional alliance with Ono—BMS held worldwide exclusive rights except in Japan, South Korea and Taiwan, and the two companies shared development costs (80 %/20 % or 50 %/50 % for combination regimens) and royalties on sales【page_113】【page_114】. By the 2024 filing, Opdivo is portrayed as a cornerstone of BMS’s immuno‑oncology platform, with a wave of new approvals—including FDA clearances for urothelial carcinoma (March 2024) and resectable NSCLC (Oct 2024), the sub‑cutaneous Opdivo Qvantig co‑formulation (Dec 2024), and an EC‑approved Opdivo + Yervoy combo (Dec 2024)【page_44】【page_46】—showing an expanded global commercialization strategy that builds on the earlier regional collaboration while adding new indications and formulations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 collaborative framework with Ono, accurately stating the cost-sharing splits (80/20 and 50/50 for combinations), and the regional exclusivity arrangement (worldwide rights except Japan, South Korea, Taiwan). (2) Accurately cites the March 2024 FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine, matching the ground truth. (3) Provides additional relevant approvals (October 2024 resectable NSCLC, December 2024 subcutaneous formulation, December 2024 EC approval for Opdivo + Yervoy combo) that demonstrate the evolution of the product strategy beyond the ground truth's single example. (4) Correctly synthesizes the multi-hop evolution from co-development focus (2022) to independent product expansion (2024). (5) Appropriately characterizes the shift in BMY's strategic positioning. MINOR CONSIDERATIONS: (1) The ground truth mentions Opdivo being part of a broader alliance including Yervoy and Orencia with co-promotion responsibilities, which the LLM answer does not explicitly address in the 2022 context, though this is a relatively minor omission. (2) The LLM answer goes beyond the ground truth by including additional 2024 approvals not mentioned in the original answer, which adds value but represents information synthesis beyond what was explicitly stated in the ground truth. (3) The characterization of the shift is semantically equivalent—both describe movement from co-development to more independent/expanded commercialization. QUANTITATIVE VERIFICATION: All dates are correct (March 2024, October 2024, December 2024), percentages are accurate (80/20, 50/50), and the therapeutic indication details match. No calculation errors detected. The answer successfully addresses all parts of the multi-part question regarding collaborative framework evolution and new therapeutic approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 533,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "In the 2022 filing (see pages 52‑53) AMT said its revolving credit facilities were priced off floating benchmarks – LIBOR, EURIBOR or a defined base rate – with spreads (e.g., 0.875 %‑1.75 % over LIBOR/EURIBOR) and the loan agreements contained generic reporting, financial‑operating and debt‑incurrence covenants (limitations on additional debt, guaranties, asset sales, liens, etc.). By the 2024 filing (see pages 115‑117) the company’s debt is described by fixed coupons on specific notes and securitizations (e.g., 3.029 % on the 2015 notes, 3.652 %/4.459 % on the 2018 securities, 5.490 %/5.735 % on the 2023 securities) and the related agreements now focus on cash‑flow‑coverage covenants – DSCR thresholds, cash‑trap reserve accounts, amortization triggers and explicit prohibitions on incurring additional indebtedness. This shows a shift from benchmark‑linked pricing with broad covenants to fixed‑rate securitized debt with detailed performance‑based covenants.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific coupon rates (3.029%, 3.652%/4.459%, 5.490%/5.735%) and spread ranges (0.875%-1.75%) that are not mentioned in the ground truth and cannot be verified. The ground truth specifies commitment fees of 0.080%-0.300%, which the LLM omits entirely. (2) FACTUAL DISCREPANCIES: The ground truth explicitly mentions SOFR (Secured Overnight Financing Rate) as the 2024 benchmark for letters of credit in Nigeria - a critical detail the LLM completely misses. Instead, the LLM focuses on fixed-rate securitized debt with specific coupon rates, which is a different product category than the SOFR-based instruments mentioned in ground truth. (3) COVENANT ANALYSIS: The LLM describes detailed performance-based covenants (DSCR thresholds, cash-trap reserves, amortization triggers) in 2024, but the ground truth states that 2024 disclosures 'focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms.' This is a fundamental mischaracterization. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022 vs 2024 evolution, it does so incorrectly by conflating different debt instruments (floating-rate credit facilities vs. fixed-rate securitizations) and missing the LIBOR-to-SOFR transition that is central to the ground truth answer. (5) MISSING ELEMENTS: The LLM fails to mention EURIBOR, the base rate for USD/EUR denominations, or the shift away from LIBOR-based instruments that is explicitly highlighted in the ground truth. The answer demonstrates partial understanding of debt covenant structures but fundamentally misses the benchmark rate evolution (LIBOR/EURIBOR → SOFR) that is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 495,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "In the 2022 filing McDonald’s said it “generally owns or secures a long‑term lease on the land and building for conventional franchised and Company‑operated restaurant sites” as the core of its real‑estate model (2022 10‑K PROPERTIES, p. 35). By the 2024 filing the company still relies on that ownership/lease structure, but now emphasizes that “ownership of real estate, combined with the co‑investment by franchisees” is used to drive performance and that it “may co‑invest with franchisees to fund improvements to their restaurants or operating systems” (2024 10‑K Conventional Franchise, p. 3; co‑investment paragraph, p. 4). Thus, the relationship has shifted from a pure real‑estate ownership model to one that pairs ownership with active co‑investment alongside franchisees.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses when compared to the ground truth. STRENGTHS: (1) The LLM correctly identifies that McDonald's owns or secures long-term leases on land and buildings in both 2022 and 2024, which is accurate. (2) The answer correctly notes the co-investment model where franchisees invest in equipment, signs, seating, and décor. (3) The citation format and page references appear reasonable. (4) The core insight about a shift from pure ownership to ownership-plus-co-investment is directionally correct. WEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims the 2022 filing explicitly stated McDonald's 'generally owns or secures a long-term lease on the land and building' but the ground truth explicitly states 'the specific role of franchisees in real estate ownership was not detailed' in 2022. This is a direct contradiction - the LLM is attributing 2024-level clarity to 2022 when the ground truth indicates this was NOT detailed in 2022. (2) The LLM mischaracterizes the 2022 position as a 'pure real-estate ownership model' when the ground truth indicates 2022 emphasized 'Systemwide coordination and alignment to manage ESG initiatives' - a different focus entirely. (3) The LLM's framing of the evolution is inverted: it suggests the model existed in 2022 and was merely emphasized more in 2024, when the ground truth indicates the detailed real estate/co-investment strategy was EXPLICITLY OUTLINED for the first time in 2024. (4) The answer misses the key contextual shift from ESG/collaboration focus in 2022 to structured real estate strategy in 2024. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal evolution - it treated the 2022 and 2024 positions as more similar than they actually were according to the ground truth. The ground truth emphasizes a shift from general collaboration emphasis to explicit strategic definition, while the LLM presents it as a shift from implicit to explicit co-investment language. These are different narratives. QUANTITATIVE ACCURACY: No specific numbers were required, so this scores reasonably well, though the citation page numbers cannot be verified. OVERALL: The answer demonstrates partial understanding but contains a fundamental factual error about what was stated in 2022 versus 2024, which undermines the core thesis about how the relationship 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 636,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors was simply listed as an approved equity‑compensation plan with **703,256 shares still available for future issuance** [114†L...‑3]. By the 2023 filing the plan had been **amended and restated effective October 26 2022** [110†L...‑22] and the remaining share pool had fallen to **589,927 shares** [107†L...‑3]. This shift—updating the plan’s terms and reducing its authorized share reserve—shows Altria actively revises and monitors director equity compensation, reflecting a disciplined governance stance that aligns director pay with actual usage and shareholder oversight.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key data points and dates. Strengths: (1) Correctly identifies the 2015 Stock Compensation Plan for Non-Employee Directors; (2) Accurately states 703,256 shares available in 2022; (3) Correctly identifies the amendment and restatement effective October 26, 2022; (4) Provides the 2023 share pool figure of 589,927 shares; (5) Properly synthesizes the multi-hop information across 2022 and 2023 filings. The quantitative data is accurate and the calculation implied (reduction from 703,256 to 589,927 shares) is mathematically correct. The LLM adds interpretive value by noting the share reduction and characterizing it as reflecting 'disciplined governance.' Minor considerations: (1) The ground truth mentions the plan was 'incorporated by reference from Altria's September 30, 2022, Form 10-Q filing,' which the LLM does not explicitly state, though this is a minor omission that doesn't affect core accuracy; (2) The LLM's interpretation about 'actual usage' driving the share reduction is reasonable inference but goes slightly beyond what the ground truth explicitly states. The answer correctly addresses all parts of the multi-part question: the status change (amendment/restatement), documentation change (incorporation by reference), share availability change, and governance implications. The reasoning is sound and the synthesis across years is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 403,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "In its 2022 Form 10‑K, AMT warned that extensive site‑sharing, roaming and resale arrangements among wireless carriers could “slow new lease activity” (Risk Factors 2022 p. 15). By the 2024 filing the company repeats the same risk and adds that the growth of 5G and greater network‑sharing make the effect more acute, potentially curbing new leases and even prompting equipment de‑commissioning (Risk Factors 2024 p. 16). This evolution shows that competitive pressure from carrier‑sharing arrangements has intensified, increasingly limiting AMT’s ability to generate new lease growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about AMT's roaming/resale risk evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 concern about roaming/resale arrangements slowing new lease activity; (2) Accurately captures the 2024 evolution showing intensified risk including equipment decommissioning; (3) Properly synthesizes the multi-hop information across two filing years; (4) Correctly identifies the underlying competitive pressure mechanism (infrastructure sharing as alternative to leasing); (5) Appropriately cites specific document locations (Risk Factors pages). QUANTITATIVE ACCURACY: The answer contains no specific dollar amounts or percentages to verify, but correctly references the temporal progression (2022 to 2024) and accurately characterizes the risk escalation. QUALITATIVE ACCURACY: The reasoning is sound - the model correctly identifies that the risk evolved from a potential concern about slowing new leases to a more acute threat involving both new lease growth and existing equipment decommissioning. This represents proper multi-hop synthesis showing how competitive pressures intensified. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential elements. The phrase \"increasingly limiting AMT's ability to generate new lease growth\" is semantically equivalent to the ground truth's \"directly impacting AMT's revenue growth prospects.\" The answer appropriately emphasizes the evolution and intensification of competitive pressure, which directly addresses the question's focus on how the impact has \"evolved.\" No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 465,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "In the 2022 filing, McDonald’s stressed that franchisees were expected to fund and execute major, capital‑intensive initiatives on their own and stay aligned with the company’s operating, promotional and reinvestment plans, warning that a lack of financing could impede growth【page_30】. By the 2024 filing, the relationship had become more collaborative: franchisees still must reinvest capital and meet rigorous Global Brand Standards, but McDonald’s now co‑invests with them to accelerate restaurant modernisation and system upgrades, reflecting a deeper strategic partnership【page_4】【page_2】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2024, capturing the shift from pandemic-driven operational challenges to strategic investment partnerships. (2) Accurately characterizes 2022 focus on franchisees' independent capital funding and alignment with company plans, with appropriate mention of financing constraints as growth impediments. (3) Properly synthesizes the 2024 shift toward co-investment initiatives and collaborative modernization efforts. (4) Correctly identifies key concepts like 'Global Brand Standards' and 'restaurant modernisation' that reflect actual filing language. (5) Multi-hop reasoning is sound - successfully connects information across two filing years to show relationship evolution. (6) No quantitative errors detected (no specific dollar amounts or percentages were claimed, avoiding calculation risks). MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth, omitting some contextual details like specific mention of 'Accelerating the Arches' strategy and COVID-19 pandemic impacts on labor/supply chain. However, this is not an error - it's a stylistic choice that doesn't contradict the ground truth. (2) The ground truth mentions 'structured co-investment initiatives' while the LLM says 'co-invests with them' - semantically equivalent but slightly less specific. (3) The LLM appropriately cites page references, adding credibility. SEMANTIC EQUIVALENCE: The core message is preserved - McDonald's moved from expecting franchisees to independently fund operations to actively co-investing in modernization, representing a strategic partnership shift. The answer captures the essential evolution without factual errors. The characterization of 2022 expectations and 2024 collaborative approach matches the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 518,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "In the 2022 filing the company did not break out a separate “equity‑securities” line for its Special‑Use Funds – the balance sheet only showed total special‑use‑fund assets of $8.9 billion (see page 63), implying a modest equity component. By 2023 the equity portion had risen to $5.29 billion (Level 1 $2.35 billion, Level 2 $2.74 billion, Level 3 $0.20 billion) and by 2024 it grew further to $6.16 billion (Level 1 $2.61 billion, Level 2 $3.32 billion, Level 3 $0.23 billion) (see pages 90 and 89), reflecting a clear strategic shift toward larger equity allocations and a greater reliance on Level 2 commingled‑fund investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct numerical values and multi-hop synthesis across years. Strengths: (1) All key numbers are accurate - 2022 total of $8.9 billion matches ground truth's $8,922 million; 2024 equity allocation of $6.16 billion matches ground truth's $6,164 million; 2023 intermediate value of $5.29 billion is provided with detailed fair value hierarchy breakdown (Level 1 $2.35B, Level 2 $2.74B, Level 3 $0.20B). (2) The answer correctly identifies the evolution from 2022 (no explicit equity breakdown) to 2024 (explicit $6.16B equity allocation), matching the ground truth's characterization of increased transparency. (3) Multi-hop reasoning is sound - the answer synthesizes data across three fiscal years and identifies the strategic shift toward equity investments. (4) The answer goes beyond ground truth by providing fair value hierarchy details and identifying the specific reliance on Level 2 commingled-fund investments, which adds valuable context. Minor considerations: (1) The 2023 intermediate year data ($5.29B) is not mentioned in the ground truth, though it doesn't contradict it - this represents additional information rather than an error. (2) The characterization of the shift as 'greater reliance on Level 2 commingled-fund investments' is a reasonable inference from the data provided. (3) The ground truth notes the total decreased while equities increased, which the LLM answer implicitly addresses by showing equity growth from 2023 to 2024. The answer is more comprehensive than the ground truth while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 440,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "In the smokeable‑products segment, net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023**, a decline of roughly $720 million (about 3 %). Operating income (OCI) for the same segment slipped slightly, from **$10.688 billion in 2022 to $10.670 billion in 2023**, a drop of about $18 million (≈0.2%)【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All financial figures are correct: 2022 net revenues of $22.476 billion ($22,476 million), 2023 net revenues of $21.756 billion ($21,756 million), 2022 operating income of $10.688 billion ($10,688 million), and 2023 operating income of $10.670 billion ($10,670 million). The calculations are accurate: revenue decline of $720 million (3.0% decrease: 720/22,476 = 3.2%, rounded to ~3%), and operating income decline of $18 million (0.17% decrease, rounded to ~0.2%). The LLM correctly synthesized the multi-hop comparison across two fiscal years and two financial metrics. The answer effectively addresses all parts of the question regarding how smokeable products' financial performance evolved. The presentation is clear with proper formatting of numbers in billions and percentages. The only minor observation is that the LLM uses 'OCI' as an abbreviation for operating income, which while understandable, differs slightly from the ground truth's direct use of 'operating income,' but this is a negligible semantic difference. The characterization of changes as 'marginal' and 'slight' aligns with the ground truth's assessment. The citation reference [page_29] adds credibility though it cannot be verified in this context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 359,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "In fiscal 2022 Accenture had $3.13 million of authorized funding for its publicly announced open‑market share‑purchase program and other share‑purchase initiatives, and it used those funds to acquire 12.18 million Class A ordinary shares (≈$4.11 million) that were held as treasury shares for employee equity awards and other corporate purposes; the Board later added $3 million of repurchase authority, raising total outstanding authority to $6.13 million【page_93†L1-L5】【page_94†L1-L9】【page_94†L31-L34】. The 2023 filing excerpts (pages 81‑85) contain no updated share‑purchase activity, so no change in utilization or new purpose for the Class A shares is disclosed in the sections provided【page_81†L1-L5】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '$3.13 million' and '$3 million' and '$6.13 million' in authorized funding, but the ground truth clearly states '$3,129,296' (approximately $3.1 million, not $3.13 million as a round number). More critically, the LLM claims the company acquired '12.18 million Class A ordinary shares (≈$4.11 million)' - this is a significant factual error not supported by the ground truth. The ground truth makes no mention of 12.18 million shares acquired or $4.11 million spent. The LLM appears to have fabricated specific share count and acquisition cost data. (2) INCOMPLETENESS - The ground truth explicitly states that by 2023, the company clarified that Class A Ordinary Shares were being held as treasury shares for employee benefits/equity awards, and that in fiscal 2024, shares were acquired via share withholding for payroll tax obligations. The LLM dismisses the 2023 filing as containing 'no updated share-purchase activity' and 'no change in utilization,' which directly contradicts the ground truth's assertion that 2023 showed a clarification of intended usage (treasury shares for employee benefits). (3) MULTI-HOP REASONING - The LLM failed to synthesize the evolution between 2022 and 2023 as requested. The ground truth shows a clear progression: 2022 had authorization amounts, 2023 clarified the intended use (treasury/employee benefits), and 2024 showed additional mechanisms (share withholding). The LLM only partially addresses 2022 and dismisses 2023 entirely. (4) ENTITY/METRIC ERRORS - The LLM conflates different types of share acquisitions and programs without clearly distinguishing between publicly announced buyback programs and employee equity plan mechanisms, which the ground truth carefully separates. (5) SEMANTIC ISSUES - The claim that 2023 filings contain 'no updated share-purchase activity' is factually incorrect per the ground truth, which explicitly states 2023 provided clarification on intended usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 539,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "In the 2022 filing the operating covenants were limited to the 2021 USD‑ and EUR‑denominated revolving credit facilities and delayed‑draw term loans, which required the Company to meet reporting, leverage and debt‑incurrence limits and used floating benchmarks – LIBOR for the USD facilities and EURIBOR for the EUR facilities, each with a 1.125 % spread (see 2022 pp. 113‑114). By the 2024 filing the covenant regime had broadened to also govern the company’s securitizations (the 2015, 2018 and 2023 secured revenue notes), adding DSCR and cash‑trap thresholds, amortisation triggers and pre‑payment provisions, and these securities carry fixed rates (e.g., 5.490 %/5.735 % for the 2023 securities and 3.652 %/4.459 % for the 2018 securities) while the original credit‑facility covenants remain tied to LIBOR/EURIBOR + 1.125 % (see 2024 pp. 115‑117).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) BENCHMARK TRANSITION ERROR - The ground truth explicitly states a shift FROM LIBOR/EURIBOR TO SOFR by 2024, with specific mention of SOFR-based letters of credit in Nigeria. The LLM answer claims the original credit-facility covenants 'remain tied to LIBOR/EURIBOR + 1.125%' in 2024, directly contradicting the ground truth's core finding about the SOFR transition. (2) INCOMPLETE EVOLUTION NARRATIVE - The LLM answer focuses heavily on securitization covenant expansion (2015, 2018, 2023 secured revenue notes with DSCR, cash-trap thresholds, etc.) which is not mentioned in the ground truth at all. While this may be factually accurate about AMT's filings, it represents a different evolution narrative than what the ground truth identifies as the primary structural change. (3) MISSING SOFR DISCUSSION - The LLM completely omits any mention of SOFR, which is the central element of the ground truth's answer about the 2022-2024 evolution. (4) SPREAD ACCURACY - The LLM correctly identifies the 1.125% spread for LIBOR/EURIBOR facilities, and provides specific fixed rates for securitizations (5.490%/5.735% for 2023, 3.652%/4.459% for 2018), but these details don't address the core question about the benchmark transition. (5) MULTI-HOP REASONING - The LLM failed to synthesize the key multi-hop insight: that AMT transitioned from LIBOR/EURIBOR benchmarks to SOFR between 2022 and 2024. Instead, it identified a different evolution (covenant expansion to securitizations) while maintaining that LIBOR/EURIBOR remained the benchmark in 2024. This is a fundamental misalignment with the ground truth's core finding. The answer demonstrates partial understanding of AMT's covenant structure but misses or contradicts the primary evolution the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 507,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Disney + Hotstar’s paid‑subscriber base rose to roughly 36 million by September 28 2024 (page 7), whereas the 2023 filing did not report a separate Hotstar subscriber count, indicating that the service grew to that level over the year. In Latin America, Disney merged Star+ into Disney+ at the end of June 2024, folding the 10.8 million Combo+ subscribers into a single Disney+ product (pages 57‑58), which streamlines the international streaming lineup and reinforces a unified Disney+ brand across markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Correctly identified the 36 million Disney+ Hotstar subscriber count as of September 28, 2024. (2) Accurately noted the consolidation of Star+ into Disney+ in Latin America by end of June 2024. (3) Properly synthesized the strategic implications of the consolidation toward unified branding and operational efficiency. (4) Correctly identified that the 2023 filing did not report separate Hotstar subscriber counts. (5) Good multi-hop reasoning connecting the Latin America consolidation to broader international strategy.\n\nWEAKNESSES: (1) CRITICAL ERROR: The LLM introduced a specific number (10.8 million Combo+ subscribers) that is NOT present in the ground truth answer. This appears to be fabricated or misattributed data. The ground truth makes no mention of 10.8 million subscribers being folded into the consolidation. (2) The LLM cites specific page numbers (pages 7, 57-58) which cannot be verified against the ground truth and may be hallucinated. (3) The ground truth states the 36 million figure was from the 2023 SEC filing (as of September 28, 2024), but the LLM's phrasing could be misinterpreted as coming from the 2024 filing. (4) The ground truth emphasizes this was a comparison between 2023 and 2024 filings, but the LLM doesn't clearly establish what the 2023 filing showed for comparison.\n\nQUANTITATIVE ACCURACY ISSUES: The introduction of the 10.8 million Combo+ figure without ground truth support is a significant factual error. This number appears nowhere in the original answer and represents either fabrication or confusion with other data points. This is a major red flag for quantitative accuracy.\n\nMULTI-HOP REASONING: The LLM correctly synthesized information about the consolidation strategy, but the addition of unsupported numbers undermines the reliability of the synthesis.\n\nJUSTIFICATION: While the core narrative about subscriber growth and the Star+/Disney+ consolidation is correct, the introduction of specific numbers not in the ground truth (10.8 million Combo+ subscribers) and page citations that cannot be verified significantly reduces confidence in the answer. This appears to be a case of the LLM adding plausible-sounding but unverified details, which is a critical failure in financial reporting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 609,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "In 2022 the company said it expected to renegotiate 21 collective‑labor agreements covering roughly 3,000 employees (≈ one‑fifth of its workforce) 【page_77】.  By year‑end 2023, about one‑fifth of its employees were still working under collectively‑bargained terms, now spread across 62 agreements 【page_79】.  The share of union‑covered workers has therefore stayed roughly constant, showing that General Dynamics is maintaining a stable level of union coverage while systematically renegotiating a manageable set of agreements without material disruption.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states that in 2023 'about one-fifth of its employees were still working under collectively-bargained terms' with '62 agreements,' but the ground truth indicates the company projected negotiations covering 2,100 employees for the upcoming year in 2023 - not a statement about current coverage. (2) The LLM conflates two different metrics: the number of employees expected to be involved in renegotiations (2,100 in 2023) with the total percentage of union-covered workers. These are distinct concepts. (3) The ground truth clearly shows a REDUCTION from 3,000 employees (2022) to 2,100 employees (2023) in labor renegotiations, indicating a shift in strategy. The LLM's claim that 'the share of union-covered workers has therefore stayed roughly constant' is not supported by the ground truth and appears to be based on misinterpreted data. (4) The LLM introduces information about '62 agreements' and 'one-fifth of workforce' that is not present in the ground truth answer, suggesting the model may have fabricated or misread source material. CORRECT ELEMENTS: The LLM correctly identifies 3,000 employees for 2022 and attempts to address the multi-hop nature of comparing years. However, the core finding - that there was a reduction from 3,000 to 2,100 employees in projected negotiations - is completely missed. The LLM's interpretation that this represents stability rather than a strategic shift directly contradicts the ground truth's assessment. The answer fails to accurately synthesize the year-over-year comparison that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 457,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "The 2024 filing shows that NextEra Energy held $722 million of U.S. Government and municipal bonds for NEE and $561 million for FPL, for a combined total of **$1.283 billion**【page_89】. The 2022 filing does not disclose a comparable total for these bonds in the pages provided, so the change in value from 2022 to 2024 cannot be calculated from the available documents.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question properly. Critical issues: (1) WRONG NUMBERS: The LLM reports $722M for NEE and $561M for FPL in 2024, totaling $1.283B. However, the ground truth states NextEra Energy's investment in U.S. Government and municipal bonds was $161M in 2024 (not $722M). The LLM appears to have cited incorrect figures or confused different bond categories/entities. (2) MISSING 2022 DATA: The LLM claims 2022 data is not available, but the ground truth clearly shows $137M in 2022. The LLM failed to locate or synthesize this information. (3) FAILED MULTI-HOP SYNTHESIS: The question explicitly asks for evolution from 2022 to 2024 and the change in total value. The LLM only provided 2024 figures (and incorrect ones at that) and explicitly stated it cannot calculate the change - directly contradicting the ground truth which shows a $24M increase (17.5% growth). (4) ENTITY CONFUSION: The LLM distinguishes between NEE and FPL separately, but the question asks about NextEra Energy's consolidated investment. The ground truth answer focuses on NEE's 'Other investments' category at $161M in 2024. (5) CALCULATION ERROR: Even if the LLM's numbers were correct, it failed to perform the basic subtraction needed to show the year-over-year change. The ground truth demonstrates clear multi-hop reasoning: identifying 2022 value ($137M), identifying 2024 value ($161M), calculating difference ($24M), and computing percentage change (17.5%). The LLM answer demonstrates a complete failure to answer the question accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 434,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "In the 2022 filing, Opdivo was presented as a core immuno‑oncology asset that BMS could manufacture internally but also backed with third‑party supply arrangements (Manufacturing and Quality Assurance, p.27), and its portfolio presence rested on earlier approvals such as the Opdivo + Yervoy combination and Project Orbis/real‑time oncology reviews (FDA OCE discussion, p.25). By the 2024 filing, Opdivo’s role had broadened substantially, adding a subcutaneous formulation (Opdivo Qvantig) and new indications for resectable NSCLC, urothelial carcinoma and other solid‑tumor uses (Approvals table, p.44), while the company continued to rely on its internal capability but increasingly shifted mature products to third‑party manufacturers as part of a strategic productivity initiative (Strategy, p.46).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about Opdivo's evolution between 2022 and 2024 but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Opdivo had internal manufacturing capability with third-party support in 2022, and that new therapeutic approvals occurred by 2024, including urothelial carcinoma indication. The mention of manufacturing strategy shift toward third-party manufacturers for mature products is appropriate. (2) PROBLEMATIC ELEMENTS: The LLM introduces 'Opdivo Qvantig' (subcutaneous formulation) and 'resectable NSCLC' as 2024 approvals, but the ground truth only specifically mentions the March 2024 FDA approval for combination therapy with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma. The LLM appears to have added details not confirmed in the ground truth. (3) CITATION ISSUES: The LLM provides specific page references (p.27, p.25, p.44, p.46) that cannot be verified against the ground truth, which raises concerns about hallucinated citations. (4) MULTI-HOP REASONING: The answer does synthesize information across 2022 and 2024 filings appropriately, showing evolution in both manufacturing strategy and therapeutic approvals. However, the specific new indications mentioned beyond urothelial carcinoma are not confirmed in the ground truth. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this is less critical. However, the March 2024 date for the urothelial carcinoma approval is mentioned in ground truth but not explicitly in the LLM answer. (6) SEMANTIC EQUIVALENCE: The core message about manufacturing evolution and therapeutic expansion is conveyed, but the LLM adds unverified details that diverge from the ground truth's more conservative scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 492,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "In both the 2023 and 2024 filings Disney continued to own 73 percent of National Geographic magazine and to report it within the Content Sales/Licensing line of the Entertainment segment. That unchanged ownership and segment classification shows the magazine remains positioned as a core content‑licensing asset that supports Disney’s broader National Geographic brand across its linear channels and direct‑to‑consumer platforms.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer explicitly states that by 2024, 'the emphasis on its ownership percentage was removed' and describes a shift from an ownership-focused to an operational relationship. The LLM answer claims the opposite - that the 73% ownership continued to be reported in both years with 'unchanged ownership and segment classification.' This is a fundamental misreading of the evolution described in the ground truth. While the LLM correctly identifies that National Geographic was 73% owned by Disney and reported under Content Sales/Licensing in the Entertainment segment, it fails to capture the key strategic shift between 2023 and 2024. The ground truth indicates a deliberate de-emphasis of the ownership stake in 2024 filings, moving from describing it as 'a business in which Disney has a direct equity stake' to describing it as a 'publication published by the company.' The LLM's assertion of 'unchanged' positioning directly contradicts this documented evolution. The answer also adds unsupported details about 'linear channels and direct-to-consumer platforms' that are not mentioned in the ground truth. The quantitative accuracy is partially correct (73% ownership figure is right) but the qualitative understanding of the relationship evolution is severely flawed, making this answer fundamentally incorrect in addressing the core question about how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 410,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "In the 2023 filing PayPal said its transaction‑management databases (and related user‑interface and network‑integration tools) underpin a platform that lets consumers send payments in roughly 200 markets and ≈140 currencies, withdraw to bank accounts in 57 currencies and hold balances in 24 currencies. The 2024 filing repeats the same description of the databases but updates the currency coverage – payments can now be sent in about 150 currencies (still ≈200 markets), withdrawals are supported in 56 currencies, and balances remain in 24 currencies – reflecting an expanded global‑payment capability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. Critical issues: (1) CURRENCY NUMBERS REVERSED: The LLM states 2023 had 57 currencies for withdrawals and 2024 had 56 currencies, but the ground truth explicitly states the opposite - 2023 had 56 currencies and 2024 had 57 currencies. This is a fundamental factual error on the core metric being tracked. (2) ADDITIONAL UNVERIFIED CLAIMS: The LLM introduces specific numbers (200 markets, ~140 currencies for payments, 24 currencies for balances, 150 currencies in 2024) that are not present in the ground truth answer. These appear to be fabricated details not supported by the source material. (3) MISSING KEY INSIGHT: The ground truth emphasizes an important qualitative change - the 2024 filing introduced a more consumer-centric framing by placing 'consumers' ahead of 'merchants'. The LLM completely omits this significant evolution in how PayPal positions its transaction management systems. (4) INCORRECT DIRECTION OF CHANGE: The LLM claims an 'expanded global-payment capability' but actually describes a decrease in withdrawal currencies (57 to 56), which contradicts the claimed expansion. The ground truth correctly identifies the expansion as 56 to 57 currencies. The LLM answer demonstrates a fundamental misunderstanding of the question and provides inverted data on the primary metric being evaluated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 391,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "In the 2023 filing NEE disclosed that its February 2020 Series K debentures (due March 1, 2025) were remarketed and the coupon was reset to **6.051 % per year**, with interest payable semi‑annually on March 1 and September 1. The 2024 filing still references the same Series K debentures with no new reset, implying the **6.051 % rate and payment schedule remained unchanged**. This shows NEE’s financing strategy of remarketing equity‑unit‑linked debentures to lock in a market‑aligned fixed rate and then maintaining that rate for predictable, stable debt costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: the Series K Debentures were remarketed with a 6.051% coupon rate in 2023 and this rate remained unchanged in 2024. The interest payment schedule (semi-annually on March 1 and September 1) is also accurate. The maturity date of March 1, 2025 is correctly stated. However, there are some issues with the multi-hop synthesis and completeness: (1) The original answer mentions a letter dated March 1, 2023 that 'set forth certain terms effective March 1, 2023,' which the LLM answer does not explicitly address or clarify. (2) The LLM answer states the debentures were 'due March 1, 2025' but doesn't fully explain the timeline of events - the remarketing occurred in March 2023 with the rate reset, and the letter referenced in the ground truth appears to be related to that same event. (3) The LLM's characterization of the strategy as 'remarketing equity-unit-linked debentures to lock in a market-aligned fixed rate and then maintaining that rate' is reasonable and aligns with the ground truth's statement about 'adjusting financing strategy in response to market conditions, locking in a higher interest rate.' (4) The LLM correctly notes no new reset occurred between 2023 and 2024, which is consistent with the ground truth's implication of continuation. The main weakness is that the LLM doesn't fully synthesize the specific reference to the March 1, 2023 letter mentioned in the ground truth, though it captures the essential evolution (reset in 2023, maintained in 2024). The quantitative data is accurate, and the strategic interpretation is sound, but the multi-hop synthesis could be more complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 457,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil’s unit‑of‑production depreciation policy was essentially unchanged from 2022 to 2023. In both years the company still calculates depreciation as the ratio of asset cost to total proved (or proved‑developed) reserves applied to actual production, uses straight‑line depreciation only when an asset’s useful life does not track its reserve life, and, when proved reserves are substantially de‑booked, re‑bases depreciation on the most recent SEC‑price‑derived reserve estimate adjusted for production and technical changes (see 2023 p.73 and 2022 p.77).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core methodology and accurately states that the basic unit-of-production depreciation approach remained consistent between 2022 and 2023. The page references (2023 p.73 and 2022 p.77) appear reasonable for SEC filings. However, the answer has significant weaknesses in addressing the question's specific focus on 'evolution' and 'changes': (1) The LLM states the policy was 'essentially unchanged,' which directly contradicts the ground truth's assertion that there was a 'refinement' and 'greater emphasis' on using the most recent SEC price in 2023. (2) The ground truth explicitly identifies a meaningful evolution: the 2023 approach placed 'greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced,' whereas the LLM characterizes this as unchanged methodology. (3) The LLM misses the contextual nuance that the 2023 refinement was specifically designed to 'align depreciation with updated economic conditions and production realities' - a key aspect of how the methodology evolved. (4) While the LLM correctly describes the mechanics of the depreciation method (proved reserves, straight-line fallback, SEC price re-basing), it fails to capture the qualitative shift in emphasis and application that occurred between years. The answer is partially correct on technical details but fundamentally misses the evolution that the question specifically asks about, instead characterizing the changes as 'essentially unchanged.' This represents a failure in multi-hop reasoning to synthesize the comparative analysis across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 455,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "In the 2023 Form 10‑K Netflix still stressed that it “contracts with third parties related to the development, production, marketing and distribution of our original programming” while it was “scaling our own studio operations to produce original content, **including through acquisitions such as Scanline and Animal Logic**” (page 7). By the 2024 filing the company again notes reliance on third‑party partners but now emphasizes “scaling our own studio operations to produce original content” without referencing those acquisitions, signalling a shift toward a larger in‑house production capability (page 7). This reflects Netflix moving from a heavier dependence on external producers toward a stronger internal studio focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts: Netflix's 2023 emphasis on third-party partnerships and acquisitions (Scanline and Animal Logic), and the 2024 shift toward internal studio scaling. However, there are significant gaps in addressing the ground truth's core insight. The ground truth emphasizes that Netflix explicitly mentioned risks associated with third-party partners in 2023 (liability, legal violations, insolvency, fraud) and that this language was omitted in 2024—a critical indicator of strategic shift. The LLM answer fails to capture this important distinction about the explicit risk discussion in 2023 and its absence in 2024. The LLM also mischaracterizes the 2024 position by stating acquisitions were not referenced, when the ground truth suggests the shift was more about reduced emphasis on third-party risks rather than complete omission of internal scaling language. The LLM correctly identifies the general trajectory (external to internal focus) but misses the nuanced evidence supporting this conclusion. The answer is partially correct on the strategic direction but incomplete in explaining the underlying evidence from the filings. The page references (page 7) are provided but cannot be verified against the actual documents. The reasoning about 'moving from heavier dependence on external producers toward stronger internal studio focus' is sound but lacks the specific risk-language analysis that distinguishes the two years' strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 411,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "In the 2022 filing, Mastercard’s cyber‑and‑intelligence solutions were mentioned only as one component of a broad “other value‑added services” portfolio (alongside batch and real‑time account‑based payments), with $1.3 billion of related performance obligations slated for recognition through 2024【page_81】【page_82】. By the 2023 filing, the company had repositioned those solutions as a distinct, security‑focused offering—highlighting their role in fraud detection, prevention and enabling all parties to transact “securely, easily and with confidence” and tying them to proprietary data‑analytics and consulting services【page_49】【page_80】. This shift signals a move from a peripheral service to a flagship, strategically emphasized capability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift in Cyber and Intelligence Solutions positioning between 2022 and 2023, capturing the evolution from a peripheral service to a more strategically emphasized capability. The qualitative description of the shift (from 'other value-added services' to a distinct, security-focused offering) aligns well with the ground truth. The answer appropriately references the fraud prevention/detection and confidence-enabling aspects mentioned in the original answer.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific dollar figure ($1.3 billion in performance obligations through 2024) that is NOT present in the ground truth answer. This is a significant factual addition that cannot be verified against the provided ground truth and represents unsupported quantitative claims. (2) INCOMPLETE SYNTHESIS - While the LLM mentions 'batch and real-time account-based payments' as context, the ground truth focuses specifically on the evolution of Cyber and Intelligence Solutions positioning without introducing these additional service categories. (3) PAGE REFERENCES - The LLM provides specific page citations (page_81, page_82, page_49, page_80) which cannot be verified against the ground truth and may represent hallucinated citations. (4) TERMINOLOGY - The LLM uses 'peripheral service' and 'flagship' characterizations that, while semantically reasonable, go slightly beyond the ground truth's more measured language about 'elevation in strategic importance.'\n\nMULTI-HOP REASONING: The answer does correctly synthesize the 2022 vs 2023 comparison across years, which is appropriate for this multi-hop question. However, the introduction of unverified quantitative data undermines the reliability of the synthesis.\n\nCORE ISSUE: The primary concern is the introduction of specific financial figures ($1.3 billion) and page references that are not supported by the ground truth. This represents either hallucination or information from sources not reflected in the provided ground truth, which significantly impacts correctness despite the qualitatively sound strategic positioning analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 582,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "In the 2023 filing Tesla portrayed its storage line (Powerwall and Megapack) as a modular, vehicle‑technology‑derived product family that could be scaled through standardized design, software control and in‑house manufacturing, with only a brief mention of developing a new proprietary lithium‑ion cell to boost supply 【page_5】 【page_7】 【page_6】. By the 2024 filing the company is flagging concrete ramp‑up risks for those storage products and stressing that production now hinges on a limited set of external cell suppliers (Panasonic, CATL) while outlining a strategic shift to manufacture its own cells to lessen that dependency 【page_17】 【page_18】 【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning emphasizing modular design, in-house expertise in power electronics and software, and optimization of manufacturing/performance - matching the original answer's core characterization. (2) Accurately captures the 2024 shift toward addressing production ramps and supply chain dependencies, specifically naming Panasonic and CATL as external cell suppliers - this is a concrete detail that validates the multi-hop synthesis. (3) Properly identifies the strategic evolution from reliance on external suppliers to plans for in-house cell manufacturing to reduce dependency - this directly addresses the 'strategic dependencies' aspect of the question. (4) Correctly names both Powerwall and Megapack as the relevant energy storage products. (5) The multi-hop reasoning is sound: comparing 2023 vs 2024 filings and synthesizing the evolution in approach across both production challenges and strategic dependencies. (6) No quantitative errors - no specific numbers were claimed that could be verified as incorrect. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (naming specific suppliers like Panasonic and CATL, mentioning Powerwall alongside Megapack), but this represents added value rather than inaccuracy. The page citations provided suggest proper source documentation. The semantic meaning is fully preserved and the answer comprehensively addresses all aspects of the multi-part question regarding production challenges and strategic dependencies evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 455,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "In the 2023 filing NEE Capital disclosed that it sold **$600 million of floating‑rate debentures**, all of which **mature in 2026**. By the 2024 filing the company had kept that 2026 series and **added a new floating‑rate series that matures in 2028** (the “Floating‑Rate Debentures, Series due February 4, 2028”), showing a move from a single short‑dated issuance to a broader maturity profile that extends the floating‑rate debt horizon. This shift signals an expansion of the floating‑rate program both in size (beyond the $600 million of 2023) and in maturity range.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims a new 2028 floating-rate debenture series was added by 2024, but the ground truth explicitly states 'the principal amount was not explicitly updated in 2024' and 'the maturity structure remained consistent with the 2026 horizon.' The LLM fabricated the existence of a 2028 series with a specific date (February 4, 2028) that does not appear in the ground truth. (2) INCORRECT INTERPRETATION: The LLM mischaracterizes the evolution as an 'expansion' and 'move from a single short-dated issuance to a broader maturity profile,' when the ground truth clearly indicates 'a continuation of the prior year's approach without significant expansion or restructuring.' (3) CORRECT ELEMENTS: The LLM correctly identifies the $600 million 2023 issuance and the 2026 maturity date. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the 2023 and 2024 information, instead inventing new details not supported by the ground truth. The answer demonstrates a fundamental misunderstanding of the actual issuance strategy, which was characterized by continuity rather than expansion. The claim about 'size expansion beyond the $600 million' is unsupported and contradicts the ground truth's statement that principal amount was 'not explicitly updated.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 386,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "In Intel’s 2023 10‑K the company said it was “significantly expanding the number of suppliers covered by our engagement activities,” with the supply‑chain environmental team measuring suppliers’ GHG footprints, pursuing a net‑zero upstream Scope 3 goal and setting a $2 billion diverse‑supplier spending target, while also leading industry collaborations on climate‑water transparency and responsible‑minerals sourcing 【page_20】. The 2024 filing still notes that Intel “actively collaborates with other companies and lead industry initiatives … on improving transparency around climate and water impacts … and responsible minerals sourcing,” but it no longer highlights the expansion of supplier coverage or the specific emissions‑reduction and diversity‑spending goals, indicating a shift from broadening engagement to maintaining the existing collaborative focus 【page_13】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the core evolution from 2023 to 2024 - from announcing expansion of supplier coverage to maintaining existing collaborative focus. (2) Accurately captures the 2023 initiatives including net-zero upstream Scope 3 goal and the $2 billion diverse-supplier spending target (specific quantitative detail not in ground truth but appears factually grounded). (3) Properly synthesizes the multi-hop comparison showing what was emphasized in 2023 (expansion, specific goals) versus 2024 (collaboration, transparency, responsible sourcing). (4) Correctly identifies the shift in messaging from broadening engagement to maintaining existing partnerships. (5) Appropriately cites page references to support claims. MINOR CONSIDERATIONS: (1) The $2 billion diverse-supplier spending target is mentioned in the LLM answer but not explicitly in the ground truth - this appears to be additional accurate detail from the filings rather than an error. (2) The ground truth emphasizes 'without explicit mention of expanding the number of suppliers engaged' in 2024, which the LLM answer captures by noting Intel 'no longer highlights the expansion of supplier coverage.' (3) Both answers correctly identify the shift from strategic expansion announcements to reinforcing existing partnerships. QUANTITATIVE ACCURACY: The specific numbers provided ($2 billion) and years (2023, 2024) are accurate. No calculation errors detected. QUALITATIVE ACCURACY: The reasoning about the evolution of Intel's approach is sound and properly synthesizes information across the two filing years. The characterization of the shift is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the multi-part question regarding collaboration focus and supplier engagement scope evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 517,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "In the 2022 Form 10‑K the company simply noted that the standardized measure is computed using “first‑day‑of‑the‑month average prices, year‑end costs and legislated tax rates” (see XOM 10‑K 2022, pp. 128‑132) without qualifying that price input. By contrast, the 2023 filing adds a cautionary statement that the first‑day‑of‑the‑month average price “represents discrete points in time and therefore may cause significant variability in cash flows from year to year as prices change” (see XOM 10‑K 2023, p. 133). Thus, the company moved from a neutral description of the assumption to explicitly framing the reliance on a single‑day price as a source of potential variability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in XOM's characterization of standardized measure assumptions between 2022 and 2023 filings. STRENGTHS: (1) Accurately captures the shift from neutral description ('computed using') to explicit cautionary framing ('may cause significant variability'); (2) Correctly identifies the specific language about 'discrete points in time' from the 2023 filing; (3) Properly cites the methodology components (first-day-of-the-month average prices, year-end costs, legislated tax rates); (4) Correctly notes that the actual calculation methodology remained unchanged; (5) Appropriately emphasizes the shift in tone/framing rather than substantive methodological change. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 10 percent discount factor that the ground truth references as part of the unchanged methodology - this is a minor omission but the ground truth specifically notes this detail; (2) The LLM characterizes the 2022 framing as 'neutral' while the ground truth uses 'foundational' language - semantically similar but slightly different emphasis; (3) The LLM does not explicitly state that the 2022 filing described assumptions as 'prescribed' which is a nuanced distinction in how the assumptions were characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the evolution in language/framing. The comparison is logically sound and addresses the core question about how the characterization evolved. NUMERIC/DATE ACCURACY: Years (2022, 2023) are correct; page references appear reasonable for 10-K filings though cannot be independently verified. No calculations required. Overall, this is a strong answer that captures the essential evolution in XOM's disclosure approach with only minor omissions of supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 508,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "In the 2022 filing Mastercard described its digital‑identity suite as a privacy‑by‑design, consent‑centric set of tools that verify people, devices and transactions and sit alongside an open‑banking platform that “enables data providers and third parties … to reliably access, securely transmit and confidently manage consumer data” 【page_17】. By 2023 the company had woven those identity services into the open‑banking platform – launching an ACH bill‑payment solution that uses the same open‑banking capabilities – and the platform now reaches “over 95 % of deposit accounts in the U.S. and approximately 3,000 banks across Europe” 【page_17】. This marks a shift from a standalone identity offering to an integrated, widely‑connected solution that serves a far larger swath of financial institutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - '95% of deposit accounts in the U.S.' and 'approximately 3,000 banks across Europe' match the ground truth exactly. No calculation errors present. ENTITY ACCURACY: Correctly identifies Mastercard (MA) and the relevant time periods (2022 vs 2023). COMPLETENESS: The answer addresses all three sub-components of the multi-part question: (1) evolution of digital identity solutions, (2) integration with open banking capabilities, and (3) reach across financial institutions. MULTI-HOP REASONING: Successfully synthesizes information across 2022 and 2023 filings, correctly tracing the evolution from standalone identity offering to integrated solution. The logical progression is sound: 2022 introduced privacy-by-design identity tools with open banking platform → 2023 expanded reach and integrated ACH payment solution. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution ('shift from standalone identity offering to an integrated, widely-connected solution') accurately captures the ground truth's narrative of expansion and deeper integration. The description of the 2022 platform as enabling 'data providers and third parties to reliably access, securely transmit and confidently manage consumer data' is semantically equivalent to the ground truth's description. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The citation format [page_17] adds transparency. The answer effectively emphasizes the integration aspect ('woven those identity services into the open-banking platform') which is a key evolution point. No factual errors, omissions of critical information, or logical inconsistencies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 502,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "In 2023 Tesla described Solar Roof as a commercially‑available product it sold directly and through channel partners, stressing that it had engineered many iterations, was designing and making some of its own components, was improving installation efficiency, and offered limited warranties for defects and weatherization (see 2023 10‑K pp. 6‑7, 9). By the 2024 filing the tone had shifted to a risk‑focused view, noting that the ramp‑up of Solar Roof production has been slower than planned and now hinges on the successful build‑out of new factories, reliable supply‑chain and component‑supplier deliveries, and its integration with Tesla’s broader battery‑cell and energy‑storage manufacturing strategy (see 2024 10‑K pp. 17‑18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Tesla's Solar Roof evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift in Tesla's messaging from emphasizing product maturity and commercial availability in 2023 to acknowledging production challenges in 2024; (2) Accurately captures specific 2023 positioning details (direct sales, channel partners, component manufacturing, installation efficiency, warranties); (3) Properly synthesizes 2024 challenges including slower-than-planned ramp-up, factory build-out dependencies, supply chain issues, and integration with broader energy strategy; (4) Provides specific page references (2023 10-K pp. 6-7, 9 and 2024 10-K pp. 17-18) that add credibility; (5) The tone shift from product-focused to risk-focused messaging is accurately captured. MINOR GAPS: (1) The LLM answer does not explicitly mention the 'depends in large part' language regarding mass-market vehicle production prioritization noted in the ground truth, though it does reference integration with broader battery-cell and energy-storage manufacturing strategy which captures related strategic dependencies; (2) The ground truth emphasizes 'strategic prioritization shift' more explicitly, while the LLM focuses on production/supply chain dependencies. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2023 vs 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and identifies the evolution in Tesla's approach, demonstrating proper multi-hop synthesis. The connection between production challenges and strategic dependencies is appropriately made. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different emphasis and organization, but maintains factual correctness throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 541,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "In the 2023 filing the only pledge arrangement disclosed was a **Pledge Agreement dated September 1 2022** between NextEra Energy, Inc., **Deutsche Bank Trust Company Americas** (as collateral, custodial and securities intermediary) and **The Bank of New York Mellon** (as purchase‑contract agent)【page_123】.  \n\nThe 2024 filing shows that the company has entered into **two additional pledge agreements** – one **dated June 1 2024** and another **dated October 1 2024** – and both are again with Deutsche Bank Trust Company Americas and The Bank of New York Mellon【page_123】.  \n\nThus, while the counterparties remain the same, NextEra Energy has expanded its use of pledge agreements in 2024 by adding newer agreements with the same parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) The 2023 filing disclosed a Pledge Agreement dated September 1, 2022 with Deutsche Bank Trust Company Americas and The Bank of New York Mellon - this matches the ground truth exactly. (2) The 2024 filing introduced two new agreements dated June 1, 2024 and October 1, 2024 with the same counterparties - this also matches perfectly. (3) All dates are formatted correctly and match the ground truth. (4) The counterparties are correctly identified with their roles specified (collateral/custodial/securities intermediary for Deutsche Bank; purchase-contract agent for BNY Mellon). The multi-hop reasoning is sound: the answer correctly synthesizes information across 2023 and 2024 filings to show the evolution from one agreement to three total agreements. The conclusion that counterparties remained the same while the company expanded its use of pledge agreements is logically sound and directly addresses the question. The only minor observation is that the LLM provides slightly more detail about the roles of the counterparties than the ground truth statement, but this is additional helpful context rather than an error. The answer fully addresses all parts of the question regarding dates, counterparties, and the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 371,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "In 2023 Intel’s Edge‑AI story was built around an “edge‑native software platform with modular building blocks” that let developers build, deploy, run, manage, connect and secure distributed edge infrastructure and AI, and it was backed by a broad ecosystem of > 500 network builders and partners such as Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft (2023 p.31‑30). By 2024 the company deepened that positioning by coupling the same open, modular platform with new AI‑optimized silicon (Xeon 6 processors with E‑cores/P‑cores, Gaudi 3 accelerators and the upcoming Jaguar Shores GPU) and open‑source frameworks (vRAN Boost, FlexRAN, FlexCore), while continuing to leverage and expand its ecosystem partners to accelerate software‑defined edge‑AI deployments (2024 p.18‑17). This marks a shift from a primarily software‑centric, partnership‑driven approach in 2023 to a more tightly integrated hardware‑software‑partner model for Edge AI in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core evolution of Intel's Edge AI strategy from 2023 to 2024. It accurately identifies the 2023 positioning around 'edge-native software platform with modular building blocks' and the 2024 shift toward integrated hardware-software-partner model. The mention of specific 2024 hardware (Xeon 6, Gaudi 3, Jaguar Shores) and software frameworks (vRAN Boost, FlexRAN, FlexCore) demonstrates good detail. The answer appropriately synthesizes the multi-hop information about ecosystem partnerships and the evolution toward cloud-native programmability. WEAKNESSES: (1) QUANTITATIVE ISSUE - The LLM cites '>500 network builders and partners' with a specific page reference (2023 p.31-30), but the ground truth does not mention this specific number. This appears to be an unsupported quantitative claim that cannot be verified against the ground truth. (2) The page citations (2023 p.31-30, 2024 p.18-17) use unusual formatting and may not be accurate references. (3) The ground truth mentions Intel's 'NEX initiative' specifically, which the LLM answer does not reference by name, though it captures the essence of the initiative. (4) The ground truth emphasizes 'avoiding vendor lock-in' and 'horizontal approach to scaling infrastructure' more explicitly than the LLM answer does. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 documents and correctly identifies the progression from software-centric to integrated hardware-software approach. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate wording variations. The characterization of the shift is accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 481,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The 10‑K tables show that CVS’s 2030 senior‑note portfolio was unchanged from 2023 to 2024. Both years list three 2030 issues—5.125% notes due February 2030 ($1.5 bn), 3.75% notes due April 2030 ($1.5 bn) and 1.75% notes due August 2030 ($1.25 bn)—and the 1.75% tranche remained at $1.25 billion in both periods, indicating no shift in composition or value for that note. (2023 table page 168; 2024 table page 161)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All key numeric values are accurate - correctly identifies the 1.75% notes at $1.25 billion for both 2023 and 2024, the 3.75% notes at $1.5 billion, and adds the 5.125% notes at $1.5 billion. (2) Correctly identifies all three 2030 senior note tranches with proper interest rates and maturity dates. (3) Properly synthesizes the multi-hop information showing stability/no change across both years. (4) Provides specific page references (168 for 2023, 161 for 2024) which adds credibility. (5) Uses appropriate financial terminology and formatting ($1.25 bn, $1.5 bn). MINOR WEAKNESSES: (1) The original answer mentions the 3.75% notes 'decreased from $1,500 million in 2023 to $1,500 million in 2024' which is awkwardly worded (no actual decrease), but the LLM correctly interprets this as stability by stating the value remained at $1.5 billion in both periods. (2) The LLM answer is slightly more comprehensive than the original by including the 5.125% notes, which the original answer did not mention. This is actually a strength as it provides more complete information about the 2030 debt composition. (3) The original answer's phrasing about the 3.75% notes is confusing (says 'decreased' but shows same value), while the LLM clarifies this as unchanged. QUANTITATIVE VERIFICATION: All dollar amounts ($1.25B, $1.5B) and years (2023, 2024) are correct. The multi-hop synthesis correctly compares values across both years and identifies the lack of change. The answer directly addresses the specific question about the 1.75% notes and their evolution (or lack thereof) between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 457,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "In the 2023 Form 10‑K Netflix said it had just rolled out a new, lower‑priced ad‑supported subscription tier and framed it as part of a broader set of pricing plans meant to meet a variety of consumer needs and to help drive membership growth【page_3】【page_6】【page_7】. The 2024 filing’s introductory material still lists the ad‑supported tier among its pricing options, showing that the offering has moved from a newly‑launched experiment to an established component of Netflix’s pricing strategy that continues to be used to attract and retain members, with no further changes disclosed【page_1】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2023 introduction of the ad-supported tier as a new, lower-priced option, matching the ground truth's characterization. (2) Accurately captures the evolution from 2023 to 2024, showing progression from newly-launched to established component. (3) Properly synthesizes the multi-hop information across 2023 and 2024 filings, demonstrating understanding of how the plan's role changed over time. (4) Correctly identifies the strategic purpose (membership growth, meeting varied consumer needs, competitive positioning). (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer is somewhat more cautious in its framing ('no further changes disclosed') compared to the ground truth's more definitive statement about 'integration into long-term growth framework.' (2) The phrase 'moved from a newly-launched experiment to an established component' is slightly less emphatic than the ground truth's characterization of a 'shift from experimental pricing to a strategic offering.' (3) The answer could have been slightly more explicit about the plan's role in 'addressing competitive pressures,' though this is implied. VERIFICATION: All key facts check out - 2023 introduction, lower-priced positioning, membership growth objective, integration into pricing strategy by 2024, and the evolution from new offering to core component. The multi-hop reasoning correctly synthesizes information across both years' filings. The semantic meaning aligns well with the ground truth despite minor wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 455,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "In the 2023 filing Tesla said the Semi had moved into “early production and deliveries” – a limited, nascent rollout of the commercial truck【page_5】. By the 2024 filing the Semi is listed as being in “pilot production” at the Nevada plant and is called out as a key part of Tesla’s plan to expand capacity for newer models and its next‑generation vehicle platform【page_36】, showing a shift from initial low‑volume output to a more structured, strategic scaling effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 status as 'early production and deliveries' with accurate characterization as 'limited, nascent rollout'; (2) Accurately states the 2024 progression to 'pilot production' at Nevada facility; (3) Properly synthesizes the multi-hop comparison showing evolution from initial rollout to more structured scaling; (4) Correctly identifies this as part of Tesla's strategic positioning for capacity expansion and next-generation platforms; (5) No quantitative errors - all dates (2023, 2024) and facility locations (Nevada) are correct. MINOR CONSIDERATIONS: (1) The LLM answer adds contextual detail about 'next-generation vehicle platform' which, while not contradicting the ground truth, goes slightly beyond the core comparison stated in the original answer - this is a minor enhancement rather than an error; (2) The citation references (page_5, page_36) suggest document sourcing but cannot be verified against the ground truth provided; (3) The phrasing 'key part of Tesla's plan to expand capacity' is a reasonable inference from the progression described but adds interpretive layer. The semantic equivalence is strong - both answers convey the same fundamental narrative of progression from early production to pilot production with increasing strategic maturity. The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings to show evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 424,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The 2024 filing shows that NextEra Energy added two new Executive Retention Employment Agreements—one for Nicole J. Daggs (effective 1 Jan 2024) and one for Brian W. Bolster (effective 6 May 2024)—to the two agreements already in place for Mark Lemasney and Armando Pimentel in 2023【page_125】. By extending retention contracts to additional senior leaders (Bolster is listed as Executive Vice President, Finance and CFO)【page_127】, the company signals a deliberate strategy to preserve leadership continuity and to lock in key executive talent as part of its long‑term performance‑driven compensation framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information regarding NextEra Energy's Executive Retention Employment Agreements. CORRECT ELEMENTS: (1) The answer correctly identifies Brian W. Bolster as a new executive with a retention agreement dated May 6, 2024, matching the ground truth. (2) The answer correctly identifies Mark Lemasney and Armando Pimentel as having agreements in 2023. (3) The qualitative reasoning about leadership continuity and talent retention strategy is sound and aligns with the ground truth's interpretation. (4) The identification of Bolster as Executive Vice President, Finance and CFO is accurate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM introduces Nicole J. Daggs as having a new retention agreement effective January 1, 2024, which is NOT mentioned in the ground truth answer. This is a significant factual discrepancy—the ground truth only mentions three executives total (Lemasney, Pimentel, and Bolster), while the LLM claims four. (2) The LLM states there were 'two agreements already in place for Mark Lemasney and Armando Pimentel in 2023' and then adds 'two new' agreements in 2024, which would total four. However, the ground truth indicates the expansion was from two (2023) to three (2024 with Bolster added). MULTI-HOP REASONING: The LLM correctly synthesizes information across years and identifies the expansion pattern, though it appears to have added an extra executive not supported by the ground truth. The reasoning about strategic importance and talent management is appropriate and well-articulated. QUANTITATIVE ACCURACY ISSUE: The count of executives is incorrect (4 vs. 3 total), which affects the accuracy of the expansion narrative. The dates provided are accurate where they overlap with ground truth. The answer demonstrates good understanding of the strategic implications but contains a factual error regarding Nicole J. Daggs that undermines overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 522,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "In the 2023 Form 10‑K Intel described xPU mainly as a research‑and‑development priority – “we are focusing our R&D efforts … on our xPU products and features” and noted that it had recently expanded its portfolio to include discrete GPUs, AI accelerators, IPU products and silicon‑photonics (2023 p. 51‑53). By the 2024 filing the company had elevated xPU to a strategic pillar, saying it will “lead and democratize compute with Intel x86 and xPU” and outlining a family of accelerators (client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators) that serve AI, edge and autonomous‑driving workloads, backed by increased R&D and IP investment to deliver leading x86 and xPU products (2024 p. 5, 7). This reflects a shift from a broad R&D focus to a market‑oriented, core‑product strategy for xPU.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 R&D focus on xPU products and accurately cites the portfolio expansion to include discrete GPUs, AI accelerators, IPUs, and silicon-photonics; (2) Accurately captures the 2024 evolution where xPU was elevated to a strategic pillar with the specific language 'lead and democratize compute with Intel x86 and xPU'; (3) Correctly identifies the xPU family components (client and data center GPUs, IPUs, FPGAs, other accelerators) matching ground truth exactly; (4) Properly synthesizes the multi-hop comparison showing the shift from 'broad R&D focus' to 'market-oriented, core-product strategy'; (5) Appropriately cites specific page numbers from 10-K filings (2023 p. 51-53, 2024 p. 5, 7) demonstrating document-level verification; (6) The semantic meaning matches ground truth: both describe a progression from general R&D priority to strategic product initiative. MINOR CONSIDERATIONS: (1) The ground truth mentions the $16.0 billion R&D spend in 2023 and the creation of an advisory group for x86 ecosystem expansion, which the LLM answer does not include - however, these are supplementary details rather than core to the evolution narrative; (2) The LLM answer emphasizes 'market-oriented' framing which is a reasonable interpretation of the strategic shift but not explicitly stated in ground truth; (3) The LLM answer adds context about 'AI, edge and autonomous-driving workloads' which represents appropriate elaboration on the strategic focus. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer regarding the evolution itself, so this dimension is not heavily tested. The answer correctly avoids introducing unsupported figures. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the directional shift in strategic emphasis. The reasoning is sound and logically presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 545,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "In the 2023 filing Netflix said it was still in the early‑stage of its ad business, focusing on “develop[ing] and expand[ing] an advertising‑sales organization team” and on “develop[ing] the technology and related infrastructure to support advertising”【page_10】. By the 2024 filing the company had added a dedicated “advertising‑sales and advertising‑technology organization team” and stressed its ability to “develop the technology and related infrastructure to support advertising and drive value to advertisers,” showing a more mature, purpose‑built ad‑tech organization and a stronger commitment to infrastructure investment【page_10】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inversion that contradicts the ground truth. The ground truth clearly states that in 2023, Netflix 'emphasized its limited experience with advertising' and 'outlined several dependencies, particularly on third-party service providers,' while by 2024 it 'shifted toward a more proactive stance' with internal development. However, the LLM answer reverses this timeline, claiming that in 2023 Netflix was 'develop[ing] and expand[ing]' its organization and technology, and that by 2024 it 'had added' these capabilities. This is backwards from the actual evolution described in the ground truth. The LLM correctly identifies the 2024 language about 'develop the technology and related infrastructure to support advertising and drive value to advertisers,' but incorrectly attributes similar language to 2023 and mischaracterizes the progression. The ground truth emphasizes a shift FROM external dependency TO internal capability development, while the LLM presents it as a continuous progression of building capabilities in both years without capturing the strategic pivot. Additionally, the LLM provides page references ('page_10') that cannot be verified and may be fabricated. The answer fails to capture the key insight about Netflix's transition from acknowledging limitations and third-party dependencies in 2023 to emphasizing internal development capabilities in 2024. This represents a failure in multi-hop reasoning and temporal synthesis across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 426,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "In the 2023 filing Tesla said that unlimited free Supercharging is a “stand‑ready” service that is provisioned when a vehicle is delivered and is recognized on a straight‑line basis over the vehicle’s expected ownership life, while limited free‑Supercharging incentives are recognized when the customer actually uses them or when they expire (see 2023 p.37). By the 2024 filing the company now records the free‑Supercharging component in a dedicated deferred‑revenue liability – showing the beginning balance, additions and the amount recognized each year – but still recognizes the revenue over time on a straight‑line basis and continues to separate unlimited from limited incentives (see 2024 p.58 and p.57). This reflects a shift from a purely performance‑obligation description to a more formalized deferred‑revenue accounting and tracking of the program.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, specific information than the ground truth answer. Key strengths: (1) Correctly identifies the 2023 approach distinguishing between unlimited free Supercharging (recognized straight-line over vehicle ownership life) and limited free Supercharging incentives (recognized upon use or expiration); (2) Accurately describes the 2024 shift to dedicated deferred-revenue liability accounting with tracking of beginning balance, additions, and recognized amounts; (3) Properly cites specific page references (2023 p.37, 2024 p.58 and p.57) showing detailed filing knowledge; (4) Correctly characterizes the evolution as moving from performance-obligation description to formalized deferred-revenue accounting. The answer is more granular and precise than the ground truth, distinguishing between unlimited and limited programs and explaining the specific accounting mechanics. Minor considerations: (1) The ground truth mentions FSD (Supervised) and internet connectivity alongside free Supercharging as part of the broader 2024 shift, while the LLM answer focuses exclusively on free Supercharging - however, this is not an error but rather a narrower focus appropriate to the question's specific focus on free Supercharging; (2) Both answers correctly identify the core evolution: from bundled/immediate recognition in 2023 to deferred/segmented recognition in 2024. The LLM answer provides superior detail on the mechanics of revenue recognition (straight-line basis, distinction between unlimited/limited) and the formalization of accounting treatment, making it more informative while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 462,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "In the 2023 filing the only Series O instrument listed was the original Series O Junior Subordinated Debentures created in 2019, which carry a traditional fixed‑rate coupon and a very long maturity of May 1 2079 (see page 123). The 2024 filing shows a new Series O issuance that matures on November 1 2029 (see page 121), indicating a move to a much shorter‑term debt and, by contrast with the ultra‑long, fixed‑coupon series, a likely revised (lower‑ or floating‑rate) coupon structure—suggesting the company is tightening its debt maturity profile and seeking more flexible, lower‑cost financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) COUPON RATE DISCREPANCY: The LLM claims the 2024 Series O has a 'likely revised (lower- or floating-rate) coupon structure' but the ground truth explicitly states it has a 5.55% coupon rate. This is a major factual error - the LLM speculates about the coupon rather than stating the known 5.55% rate. (2) COUPON CHARACTERIZATION FOR 2023: The LLM states the 2023 Series O carries a 'traditional fixed-rate coupon,' but the ground truth indicates 'no explicit coupon rate disclosed in the filing,' suggesting a potentially deferred or non-traditional structure. The LLM incorrectly characterizes the 2023 instrument. (3) DATES CORRECT: Both the 2023 maturity (May 1, 2079) and 2024 maturity (November 1, 2029) are correctly stated. (4) MULTI-HOP REASONING FLAWED: While the LLM correctly identifies the shift from longer to shorter maturity, it fails to accurately synthesize the coupon information. The ground truth shows a clear evolution from undisclosed/deferred coupon to explicit 5.55% fixed coupon, indicating a move toward more conventional, transparent debt instruments. The LLM's speculation about 'lower- or floating-rate' contradicts the actual 5.55% fixed rate. (5) STRATEGIC INTERPRETATION PARTIALLY CORRECT: The LLM correctly identifies a shift toward shorter-term debt, but the characterization of 'more flexible, lower-cost financing' is speculative and potentially incorrect given the 5.55% coupon is not particularly low. The ground truth's interpretation of 'more conventional debt instruments with clearly defined interest costs' is more accurate. STRENGTHS: Correct identification of maturity dates, correct company (NextEra Energy), correct instrument type (Series O Junior Subordinated Debentures), and correct general direction of strategy shift. WEAKNESSES: Missing the specific 5.55% coupon rate for 2024, mischaracterizing the 2023 coupon structure, and providing speculative analysis instead of factual reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 529,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil’s 2022 and 2023 10‑K filings both state that temporary price drops do not by themselves trigger an impairment, but that long‑term oil prices must be high enough to sustain investment and that “OPEC investment activities and production policies also have an impact on world oil supplies.” The 2023 filing repeats the same language, indicating that the company’s view of OPEC’s role in long‑term supply dynamics has remained consistent rather than changed. 【page_94】【page_88】",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core question. The ground truth explicitly states there WAS an evolution/shift in how ExxonMobil considered OPEC from 2022 to 2023 - moving from a direct focus on OPEC's role to a more integrated view including environmental factors and net-zero targets. The LLM answer claims the opposite: that the company's view 'has remained consistent rather than changed' and that 'the 2023 filing repeats the same language.' This is a critical factual error that directly contradicts the ground truth's central finding. The LLM correctly identifies that both years mention OPEC's impact on world oil supplies (quantitative accuracy is reasonable here - the quote appears accurate), but completely misses the qualitative shift in the broader assessment framework. The question specifically asks about evolution 'from 2022 to 2023' and the LLM fails to identify the key evolution: the incorporation of greenhouse gas emission costs and net-zero targets into the impairment assessment framework in 2023. The LLM's conclusion that there is consistency rather than change represents a fundamental misunderstanding of the multi-hop synthesis required - comparing not just the OPEC language but the entire impairment assessment framework across both years. The page citations provided (94, 88) may be accurate for the quoted language, but the interpretation drawn from those pages is incorrect relative to the ground truth analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 409,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "In the 2023 filing, the ad‑supported subscription plan appears only in a risk‑factor discussion that stresses the lack of operating history and the difficulty of forecasting consumer adoption of “the ad‑supported subscription plan” (2023 p. 18). By the 2024 filing, the same plan is woven into the core business description as a standard pricing tier “including our ad‑supported subscription plan, to meet a variety of consumer needs” (2024 p. 3), showing that Netflix has moved from treating it as a tentative, uncertain experiment to positioning it as an established, strategic offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Netflix's ad-supported plan positioning from 2023 to 2024. Both the original answer and LLM answer correctly identify the shift from risk-focused language (uncertainty, lack of operating history, forecasting challenges) in 2023 to strategic positioning as a core business offering in 2024. The semantic meaning is preserved and enhanced with specific textual references. (2) QUANTITATIVE ACCURACY: No numerical data is required for this qualitative question about strategic positioning evolution. The answer appropriately avoids introducing unsupported numbers. (3) ENTITY ACCURACY: Netflix is correctly identified, years 2023 and 2024 are accurate, and the specific product (ad-supported subscription plan) is correctly referenced throughout. Page citations (2023 p. 18, 2024 p. 3) add credibility, though these cannot be independently verified from the provided context. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the contrast between how the same product is presented in different contexts (risk factors vs. core business description). The logical progression from 'tentative experiment' to 'established strategic offering' is sound and matches the ground truth's characterization of moving from 'risk-focused perspective to confident strategic positioning.' (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth with slightly more specific detail (direct quotes, page numbers, explicit characterization of the shift). Minor difference: LLM uses 'tentative, uncertain experiment' while ground truth says 'risk-focused perspective'—these are semantically equivalent. The answer is comprehensive, well-reasoned, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 515,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "In 2022 Amazon portrayed its shipping offers as a permanent worldwide marketing tool to keep prices low, but warned that shipping costs were rising because of higher carrier rates, increasing wages and incentives, and fulfillment‑network inefficiencies tied to a tight labor market and rapid network expansion. By 2024 the company still emphasizes shipping offers as an indefinite marketing lever, yet the primary cost pressure now comes from higher sales volumes and continued investment in expanding the fulfillment network—partially offset by network efficiencies and foreign‑exchange gains—reflecting a strategic shift toward leveraging fulfillment‑capacity growth and efficiency improvements to sustain low‑price shipping.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer fails to include the specific $76.7 billion shipping cost figure from 2021 that was explicitly mentioned in the ground truth as a key data point. This is a significant omission of concrete financial data. (2) FACTUAL INACCURACIES: The LLM introduces claims not supported by the ground truth, including: (a) 'higher carrier rates' as a 2022 cost driver - the ground truth attributes costs to customer adoption and faster delivery methods, not carrier rates; (b) 'increasing wages and incentives' - not mentioned in ground truth; (c) 'fulfillment-network inefficiencies tied to tight labor market' - the ground truth does not attribute inefficiencies to labor market tightness; (d) 'foreign-exchange gains' as a 2024 offset - this is not mentioned in the ground truth. (3) INCOMPLETE SYNTHESIS: The LLM answer misses the core strategic evolution described in the ground truth: the shift from 'customer-driven cost increase' (2022) to 'operations-centric efficiency focus' (2024). Instead, the LLM presents both years as emphasizing shipping offers as a marketing tool, which obscures the actual strategic shift. (4) REASONING QUALITY: While the LLM attempts to identify a strategic evolution, it frames it incorrectly as a shift in 'cost pressure sources' rather than the actual shift from customer-adoption-driven costs to efficiency-driven mitigation. The multi-hop synthesis is incomplete and partially contradicts the ground truth narrative. (5) CONTEXTUAL ISSUES: The answer introduces specificity about 'carrier rates' and 'labor market' that appears to be hallucinated rather than derived from the actual filings. The ground truth emphasizes network optimization and operational efficiencies as mitigation strategies, which the LLM mentions but does not properly contextualize within the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 508,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "In 2023 the Master Retirement Trust held about $7.24 billion of assets (≈$2.0 b Level 1, $4.9 b Level 2, $76 m Level 3) with the RCBP portfolio allocated roughly 45 % equity, 35 % debt and 8 % cash/real‑estate, and the DELPP portfolio at 14 % equity, 80 % debt, 2 % cash/real‑estate and a 2 % hedge‑fund tilt; securities‑lending was still in place (≈$2 m on loan). By 2024 total assets fell to $6.97 b (Level 1 $2.24 b, Level 2 $4.48 b, Level 3 $68 m), the RCBP mix shifted to 44 % equity, 33 % debt and 10 % cash/real‑estate, the DELPP mix added equity to 15 % and cash/real‑estate to 4 % while eliminating hedge‑fund exposure, and the filing added a more granular fair‑value hierarchy (Level 1/2/3 and “not‑categorized” totals), a Level‑3 reconciliation, explicit subsidiary allocation percentages and a note that securities‑lending was discontinued—significantly enhancing disclosure compared with 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail on the evolution of Duke Energy's Master Retirement Trust between 2023 and 2024, with strong qualitative accuracy on the key disclosure improvements mentioned in the ground truth (subsidiary allocation percentages, Level 3 reconciliation, fair-value hierarchy details, securities-lending discontinuation). However, there are significant quantitative concerns: (1) The ground truth does not provide specific asset values ($7.24B, $6.97B) or detailed portfolio allocations (45% equity, 35% debt, etc.) for either year—these numbers cannot be verified against the knowledge graph and may be fabricated or from sources not in the ground truth. (2) The LLM introduces specific percentages for RCBP and DELPP portfolios that are not mentioned in the ground truth answer, raising questions about accuracy. (3) The ground truth mentions VEBA trusts and their target/actual allocations in 2023, which the LLM answer does not address. (4) The ground truth specifically mentions Duke Energy Progress at 15% and Duke Energy Florida at 18% allocations in 2024, which the LLM answer does not include. The LLM correctly identifies the shift toward more granular reporting, Level 3 fair value disclosures, subsidiary allocation percentages, and securities-lending discontinuation—all core elements from the ground truth. The multi-hop reasoning is sound in comparing 2023 vs 2024 evolution. However, the introduction of unverified specific numbers and omission of the VEBA trust context and specific subsidiary percentages mentioned in the ground truth represent material gaps. The answer reads as plausible but contains details that cannot be confirmed against the provided ground truth, suggesting potential hallucination of specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 484,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "In the 2022 filing Google disclosed that the amounts it pays to Google Network partners are recorded as TAC within cost of revenues, and it explicitly noted that this makes the cost‑of‑revenues for ads served on Network properties “significantly higher” than for Search ads. By the 2024 filing the same partner payments are no longer broken out as a cost‑of‑revenues line‑item but are highlighted as one of the “primary uses of cash from operating activities,” showing that the cash‑outflow obligation to Network partners remains (and has grown with higher Network ad revenue) even though the reporting emphasis has shifted from a cost‑percentage to a cash‑payment focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core evolution of Google's financial relationship with Network partners between 2022 and 2024. Both answers correctly identify that in 2022, TAC payments were recorded as cost of revenues with higher percentages for Network properties versus Search, and by 2024, these payments shifted to being highlighted as primary operating cash outflows. The LLM answer adds helpful specificity by noting the payments are 'no longer broken out as a cost-of-revenues line-item' and explicitly mentions the cash-outflow obligation 'remains (and has grown with higher Network ad revenue).' (2) QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or dates are provided in either answer, which is appropriate given the question's focus on structural evolution rather than specific figures. The temporal markers (2022 vs 2024) are correct. (3) ENTITY ACCURACY: Google and Google Network partners are correctly identified throughout. The financial metrics (TAC, cost of revenues, operating cash flows) are accurately referenced. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two different time periods and two different accounting/reporting frameworks (cost-of-revenues vs. operating cash flows), demonstrating sound multi-hop reasoning. The logical connection between the shift in reporting emphasis and the underlying business relationship is well-articulated. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth but with slightly more explicit detail about the reporting shift ('no longer broken out as a cost-of-revenues line-item but are highlighted as...primary uses of cash'). The phrase 'transformation in the nature of the financial relationship' in the ground truth is effectively captured by the LLM's description of the 'shift from a cost-percentage to a cash-payment focus.' Minor strength: The LLM answer provides slightly more concrete explanation of the mechanism (linking growth to higher Network ad revenue), which enhances clarity without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 591,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "In 2022 UPS still carried a floating‑to‑fixed interest‑rate swap (about $28 million of notional) and, together with its non‑designated foreign‑currency forwards, recognized a $69 million loss in the statement of consolidated income; by 2023 the interest‑rate swap had been terminated (no notional amount) and the loss from those non‑designated derivatives shrank to $7 million【page_130】【page_132】. Although the company has master‑netting arrangements with counterparties, it has not elected to offset the fair‑value positions on the balance sheet, so the reduction reflects the elimination of the offsetting swap positions and a much smaller fair‑value impact in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative details that are not present in the ground truth, which creates a verification challenge. Key observations: (1) QUANTITATIVE ISSUES: The LLM cites specific figures ($28 million notional in 2022, $69 million loss in 2022, $7 million loss in 2023) that cannot be verified against the ground truth provided. The ground truth mentions $163M net gain in 2021 and $124M net gain in 2020 for non-designated hedges, but does NOT provide the specific 2022 or 2023 figures the LLM claims. This is a significant concern - the LLM appears to be providing precise numbers without ground truth support. (2) ENTITY ACCURACY: Correctly identifies UPS and the relevant derivative instruments (interest-rate swaps, foreign-currency forwards). (3) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution between 2022 and 2023, noting the termination of the swap and reduction in losses. This reasoning is sound and addresses the core question about how treatment evolved. (4) SEMANTIC ALIGNMENT: The LLM correctly captures the key concept from ground truth - that offsetting swap positions were eliminated and there was a shift in financial impact. However, the ground truth explicitly states 'the financial impact in 2023 was not quantified in the excerpt,' yet the LLM provides a specific $7 million figure for 2023. (5) CRITICAL GAP: The ground truth emphasizes a 'change in transparency around current-year derivative impacts,' suggesting the 2023 figures may not have been disclosed. The LLM's provision of specific 2023 numbers contradicts this. The answer demonstrates good qualitative understanding of the evolution and proper multi-hop synthesis, but the unverified quantitative claims significantly undermine confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 484,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 Form 10‑K expands the discussion of the Directors’ Savings Plan, explaining that outside directors may defer all or a portion of their annual retainers into an unfunded account that is adjusted for phantom‑stock performance and paid when they leave the board (see page 239). In the 2023 filing the plan was only mentioned in an exhibit list (e.g., an amendment to the Directors’ Savings Plan in Exhibit 10.12) without such detail (see page 245). This shift shows Duke Energy is making the Directors’ Savings Plan a more central, deferred‑compensation component of director pay, emphasizing performance‑linked, non‑cash remuneration compared with 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core finding: Duke Energy increased the prominence of the Directors' Savings Plan in 2024 disclosures compared to 2023. STRENGTHS: (1) Correctly identifies the key shift from 2023 (exhibit-only references) to 2024 (substantive description); (2) Accurately describes the plan mechanics (deferral of annual retainers, phantom-stock performance adjustments, payment upon board departure); (3) Properly synthesizes the multi-hop comparison across two years; (4) Correctly characterizes the strategic implication (more central, transparent approach to director compensation); (5) Provides specific page references (239 and 245) that ground the answer in actual filing locations. MINOR ISSUES: (1) The LLM describes the account as 'unfunded' and emphasizes 'non-cash remuneration' with 'phantom-stock performance,' which is accurate but slightly more specific/technical than the ground truth's broader characterization of 'phantom investment options' and 'balances adjusted accordingly.' This is not an error but a more detailed interpretation; (2) The phrase 'performance-linked, non-cash remuneration' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about the strategic shift. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The page references (239, 245) appear reasonable for a 10-K filing structure. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years (2023 vs 2024) and identifies the comparative shift in disclosure prominence and strategic emphasis. The logic is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly more operational detail about the plan mechanics, which enhances rather than detracts from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 529,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "In the 2022 filing American Express largely framed its value‑proposition work as a defensive need – it warned that it must “differentiate ourselves from our competitors, develop compelling value propositions” and that evolving those propositions would raise reward‑and‑service costs, while most of its focus was on protecting and extending cobrand and partnership relationships amid intense competition (see 2022 p. 28‑26). By the 2024 filing the tone has shifted to a proactive, investment‑driven strategy: the company now says it will “continue investing at high levels… in our brand, value propositions, coverage, marketing, technology and talent,” and is explicitly building premium, digitally‑enabled benefits, partner‑funded rewards and new products for Millennial and Gen‑Z customers, using data, marketing efficiency and technology to adapt to competitive pressure and changing customer behavior (see 2024 p. 91‑94, 93).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of American Express's strategic evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from defensive/reactive positioning in 2022 to proactive/investment-driven strategy in 2024 - this core insight matches the ground truth. (2) Accurately captures 2022 concerns about competition from alternative payment providers and the need to differentiate. (3) Properly identifies 2024 focus on premium segments (Millennial/Gen-Z), digital capabilities, and partnerships. (4) Correctly notes the evolution from protecting existing relationships to building new value propositions. (5) Page citations (2022 p. 28-26, 2024 p. 91-94, 93) demonstrate specific filing references. MINOR GAPS: (1) The LLM answer doesn't explicitly mention specific 2024 initiatives like Tock and Rooam dining platform expansion that appear in ground truth, though it does reference 'partner-funded rewards and new products.' (2) Doesn't explicitly mention AI and automation investments highlighted in ground truth, though 'technology' is mentioned broadly. (3) Doesn't explicitly reference 'global merchant coverage growth' as a key enabler. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this scores high. The page references appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the model correctly synthesizes the 2022 vs 2024 positioning across multiple dimensions (competitive response, customer targeting, investment approach). The characterization of the shift from 'reactive' to 'proactive' is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of value propositions in response to competitive pressures and changing customer behaviors. The framing of the strategic shift is appropriate and insightful. Overall, this is a strong answer that captures the essential evolution while missing some specific tactical details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 550,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "In the 2022 filing Exxon Mobil’s long‑term debt portfolio included a short‑dated, ultra‑low‑coupon issue – a 0.142 % note due 2024 – together with three longer‑dated notes (0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039)【page_1】. By the 2024 filing the 0.142 % 2024 note had been retired, leaving only the 0.524 % note due 2028, the 0.835 % note due 2032 and the 1.408 % note due 2039【page_1】, indicating a shift toward a longer‑maturity, higher‑coupon debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the specific debt instruments and their coupon rates/maturity dates for both 2022 and 2024. All numeric values (0.142%, 0.524%, 0.835%, 1.408%, and years 2024, 2028, 2032, 2039) are accurate. The core factual observation that the 0.142% Notes due 2024 were retired between 2022 and 2024 is correct. However, there is a CRITICAL ERROR in the composition statement for 2024: The LLM claims that by 2024 'only the 0.524% note due 2028, the 0.835% note due 2032 and the 1.408% note due 2039' remained. The ground truth explicitly states that the 1.408% Notes due 2039 'remained in the disclosure,' but does NOT confirm that the 0.524% and 0.835% notes remained. The LLM appears to have assumed continuity of all non-2024 notes without verification. This is a significant omission/error in the multi-hop synthesis. Additionally, while the LLM correctly characterizes the shift as moving toward 'longer-maturity, higher-coupon debt mix,' the ground truth uses slightly different language ('extended-term debt while retiring shorter-duration obligations'). The reasoning about strategic capital structure evolution is present but less developed than the ground truth. The answer demonstrates partial understanding of the evolution but fails to accurately verify which specific instruments remained in 2024 beyond the confirmed 1.408% Notes due 2039.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 383,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express’s corporate‑card strategy has not shifted dramatically – in both the 2022 and 2024 filings the company says it will “build on our strong position in commercial payments by evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions and designing innovative products and features, including financing, banking and payment solutions for our business customers”【page_8】. The identical language in the two “Our Business Strategies” sections shows a continued emphasis on differentiation and innovation rather than a new strategic direction.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and contradicts the ground truth. CRITICAL ISSUES: (1) The LLM claims there was NO dramatic shift in strategy between 2022 and 2024, citing identical language in both years' filings. However, the ground truth explicitly states there WAS a shift: from 'internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.' (2) The LLM's conclusion that 'identical language shows continued emphasis rather than new strategic direction' directly contradicts the ground truth's assertion of evolution toward 'integrated global network approach' and 'externally integrated ecosystem strategy.' (3) The LLM failed to identify the key strategic evolution mentioned in the ground truth: the 2024 shift toward increasing merchant acceptance, enhanced fraud protection, and marketing insights - elements not present in the 2022 characterization. (4) By focusing only on overlapping language about 'evolving card value propositions' and 'differentiating corporate card solutions,' the LLM missed the substantive strategic shift in HOW these goals were to be achieved (internal vs. external/ecosystem approach). QUANTITATIVE ACCURACY: The dates (2022, 2024) are correct, and the quoted language appears to be accurately cited from filings (8/10). QUALITATIVE ACCURACY: The reasoning is fundamentally flawed - the LLM used textual similarity as evidence of strategic continuity when the ground truth indicates strategic evolution occurred despite some overlapping language (2/10). CONTEXTUAL RELEVANCE: The answer addresses the right companies and timeframe but fails to answer the core question about how the approach 'evolved' - it argues against evolution rather than explaining it (4/10). The LLM's answer would mislead a reader about American Express's strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 506,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "By 2022 Amazon already treated AWS as a core growth engine – it had a dedicated CEO for the unit (page 5) and highlighted AWS in its technology‑infrastructure strategy (pages 6‑7). In the 2024 filing AWS’s financial weight expanded markedly: net sales rose 19% to $107.6 billion, its share of total sales grew to 17% (page 24), operating cash flow jumped to $115.9 billion (page 22), and cash capital expenditures rose to $77.7 billion, “primarily … to support AWS business growth” (page 23), underscoring a stronger cash‑generating role and heightened strategic emphasis on AWS.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of AWS from 2022 to 2024, properly cites the $115.9 billion operating cash flow figure for 2024, and accurately reports AWS net sales of $107.6 billion with 19% growth and 17% of total sales. The qualitative assessment of AWS's transition to a 'core growth engine' and 'key financial contributor' aligns well with the ground truth narrative. The answer appropriately synthesizes multi-hop information across years and metrics.\n\nCRITICAL ERRORS: (1) The LLM conflates different metrics: it states 'operating cash flow jumped to $115.9 billion' but attributes this to AWS specifically, when the ground truth clearly states this is Amazon's TOTAL operating cash flow for 2024 (up from $84.9 billion in 2023), with AWS being 'a part' of this increase, not the sole driver. (2) The $77.7 billion capital expenditures figure is cited as supporting AWS growth, but this appears to be total capex, not AWS-specific capex. (3) The LLM claims AWS had 'a dedicated CEO for the unit' in 2022 (page 5 reference), but this is not verified in the ground truth and represents an unsupported assertion.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 and connects financial metrics to strategic emphasis. However, the attribution of the $115.9 billion operating cash flow figure directly to AWS is a significant logical error - the ground truth indicates this is total company cash flow with AWS as a contributor.\n\nNUMBER VERIFICATION: $107.6B AWS sales (correct), 19% growth (correct), 17% of total sales (correct), $115.9B operating cash flow (correct number but incorrect attribution), $84.9B 2023 comparison (not mentioned by LLM but ground truth includes it), $77.7B capex (cited but attribution unclear).\n\nThe answer demonstrates good understanding of the overall narrative but contains a material factual error in attributing total company operating cash flow to AWS specifically, which undermines the quantitative accuracy despite correct individual numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 552,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Both the 2023 and 2024 audit reports say the auditors “utilized trend analyses to evaluate the historical consistency of regulatory asset balances.” While the 2024 audit added other procedures (e.g., coal‑ash and storm‑cost analyses), the trend‑analysis itself remained focused on checking the historical consistency of the regulatory‑asset balances, with no change in its core scope.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and contradicts the ground truth on the key finding. CRITICAL ERRORS: (1) The LLM claims 'the trend-analysis itself remained focused on checking the historical consistency of the regulatory-asset balances, with no change in its core scope' - this directly contradicts the ground truth which explicitly states there WAS a shift in focus toward more specialized regulatory compliance areas (specifically asset retirement obligations related to coal ash). (2) The LLM acknowledges that 2024 added 'coal-ash and storm-cost analyses' as 'other procedures' but fails to recognize that the ground truth indicates these represent an evolution/expansion of the scope of trend analyses themselves, not merely additional separate procedures. (3) The LLM's conclusion that 'the trend-analysis itself remained focused...with no change' is the opposite of what the ground truth indicates - the ground truth explicitly describes an evolution where the scope expanded to include specific evaluation of asset retirement obligations. WHAT WAS CORRECT: The LLM accurately identifies that both years used trend analyses for regulatory asset balances (quantitative accuracy is high). REASONING FAILURE: The multi-hop synthesis is flawed - the LLM correctly identifies that procedures expanded but incorrectly concludes this means the trend analysis scope itself didn't change. The ground truth indicates the trend analysis scope DID evolve to include more specialized areas. This is a semantic/interpretive error that fundamentally misses the answer to the question about how the scope 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 450,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "- In the 2022 filing Costco said that higher‑than‑expected inflation and merchandise‑cost pressures prompted it to “adjust…our pricing and merchandise mix, **including increasing the penetration of our private‑label items**” as a way to protect margins【page_22】.  \n- In the 2023 filing the company reiterated that same lever, noting that “adjustments to our pricing and merchandise mix, **including increasing the penetration of our private‑label items**, … remain a key response to cost and pricing pressures”【page_23】.  \n\nThus, between 2022 and 2023 Costco’s approach evolved from initiating a push to raise private‑label share to maintaining—and further emphasizing—that push as an ongoing strategy to offset cost and pricing challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Costco's private-label strategy evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the core strategy in both years - increasing private-label penetration as a response to cost/pricing pressures; (2) Accurately cites direct quotes from the 2022 and 2023 filings showing the company's messaging on this topic; (3) Properly synthesizes the multi-hop information by comparing the two years and identifying the evolution from initiation to sustained emphasis; (4) The reasoning is sound - the answer correctly characterizes 2022 as the initiation phase and 2023 as the continuation/emphasis phase; (5) Page references (page_22 and page_23) are provided, adding credibility. MINOR GAPS: (1) The LLM answer is somewhat more concise than the ground truth, which provides additional context about 2022 strategies (absorbing costs internally, purchasing earlier/larger volumes, selective price increases) that aren't mentioned in the LLM response; (2) The ground truth explicitly frames this as 'a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis in 2023,' while the LLM characterizes it as 'from initiating a push to maintaining and further emphasizing that push' - these are semantically similar but the ground truth provides slightly more nuanced framing about the nature of the strategic shift. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023) are correct. ENTITY ACCURACY: Costco is correctly identified; fiscal years 2022 and 2023 are correct; the metric (private-label penetration) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the evolution in strategy. The logic connecting cost pressures to private-label strategy is sound. The answer would have been stronger with the additional 2022 context provided in the ground truth, but the core answer is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 578,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Pfizer’s 2024 Form 10‑K reports that, as of December 31 2024, it had about **$1 billion of remaining performance‑obligation revenue for Paxlovid**, covering deliveries through 2025‑2028. The 2023 filing did not disclose a comparable amount (the obligations were either not significant or much lower), so the Paxlovid outlook has become markedly stronger in 2024 versus 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the $1 billion remaining performance obligations for Paxlovid as of December 31, 2024 - this matches the ground truth exactly. (2) Accurately notes that 2023 did not disclose comparable amounts, consistent with ground truth stating obligations were 'not disclosed' in 2023. (3) Provides additional helpful context by specifying the delivery timeline (2025-2028), which adds value without contradicting the ground truth. (4) Correctly synthesizes the multi-hop comparison between 2023 and 2024, concluding that the outlook 'became markedly stronger' - semantically equivalent to ground truth's 'increased contractual certainty and forward-looking revenue expectations.' (5) Properly identifies the source (2024 Form 10-K) and uses correct date formatting. Minor considerations: The LLM adds the delivery timeline detail (2025-2028) which is not explicitly mentioned in the ground truth but appears to be accurate supplementary information from the filing. The characterization of 2023 obligations as 'either not significant or much lower' is a reasonable inference given the lack of disclosure, though the ground truth simply states they were not disclosed. No factual errors detected. The answer directly addresses the question about how the financial outlook evolved between the two years with proper multi-hop reasoning across both years' filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 403,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has not altered the fundamentals of its R&S‑Period methodology – in both the 2022 filing and the 2024 filing the company says it “estimates lifetime expected credit losses by incorporating historical loss experience, as well as current and future economic conditions over a reasonable and supportable period (R&S Period) beyond the balance‑sheet date… Within the R&S Period the models use past loss experience and current/future economic conditions, and beyond the R&S Period expected losses are estimated by immediately reverting to long‑term average loss rates” (2022 10‑K, Note 3, p. 95; 2024 10‑K, Note 3, p. 97). The language is essentially unchanged, with the later filing adding a continued emphasis on qualitative reserves to capture risks not fully reflected in the quantitative models. This consistency shows a disciplined, forward‑looking risk‑management framework that relies on a stable, data‑driven horizon while still monitoring emerging risks through qualitative adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides an answer that contradicts the ground truth. Key issues: (1) CONTRADICTORY CORE CLAIM: The LLM states 'American Express has not altered the fundamentals of its R&S-Period methodology' and emphasizes 'The language is essentially unchanged,' which directly contradicts the ground truth's central finding that the R&S Period evolved from being 'explicitly described' and 'newly explained' in 2022 to being 'embedded within a more mature and established process' and 'no longer introduced as a newly explained concept' by 2024. (2) MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifically cites the reserve amount of $3.3 billion as of December 31, 2021, which is completely absent from the LLM answer. This is a material omission for a financial question. (3) MISINTERPRETATION OF EVOLUTION: The ground truth describes a methodological evolution from introduction/explanation phase to mature/embedded phase - a qualitative shift in how the concept is presented and integrated. The LLM incorrectly interprets this as 'consistency' and 'stability' rather than recognizing the shift in presentation and integration. (4) INCOMPLETE SYNTHESIS: The LLM focuses narrowly on identical language quotes but fails to synthesize the broader contextual change in how the methodology is presented across the two filings. (5) REASONING ERROR: The LLM's conclusion that 'consistency shows a disciplined, forward-looking risk-management framework' misses the actual insight - that the evolution from explicit explanation to embedded assumption indicates maturation of the framework, not mere consistency. The answer reads as technically accurate in quoting language but fundamentally fails to address what the question asks about evolution and what it indicates about risk management approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 501,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "In the 2022 Form 10‑K Amazon’s 0.800 % Note due 2025 was disclosed in Exhibit 4.5 (the June 3 2020 Officers’ Certificate) as one of its existing low‑rate senior notes. By the 2024 Form 10‑K the same note appears in Exhibit 4.6, but the filing also adds new revolving‑credit facilities (a five‑year and a 364‑day facility) and other higher‑rate notes, indicating that Amazon has broadened its debt program to include more flexible, short‑term borrowing while still retaining the low‑cost 0.800 % Note due 2025.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 0.800% Note due 2025 as existing in both 2022 and 2024 filings; (2) Accurately references the June 3, 2020 Officers' Certificate date; (3) Correctly notes the exhibit locations (4.5 in 2022, 4.6 in 2024); (4) All numeric values (0.800%, 2025 maturity) are accurate. The multi-hop synthesis is sound - the answer correctly traces the note across years and identifies the evolution in debt strategy. However, there are some notable differences from the ground truth: (1) The LLM introduces specific details about 'revolving-credit facilities (five-year and 364-day)' that are not mentioned in the ground truth answer, which focuses on the 4.600% Note due 2025 as the example of new instruments; (2) The ground truth specifically mentions the 4.600% Note due 2025 as evidence of the strategy shift, while the LLM pivots to discussing revolving credit facilities instead; (3) The LLM's characterization of the strategy shift emphasizes 'flexible, short-term borrowing' while the ground truth emphasizes 'managing cash flow and interest rate risk' through a 'wider range of interest rates and maturities.' These represent different interpretations of the same underlying evolution, though both are reasonable. The LLM answer is more specific about exhibit locations and facility types, which adds detail, but diverges from the ground truth's specific example (4.600% Note) and strategic rationale. The answer is substantively correct but takes a slightly different analytical angle than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 439,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "In the 2022 Form 10‑K the “Twenty‑third Supplemental Indenture” is listed as a recent amendment dated May 15 2020 and is incorporated by reference to a 2020 Form 8‑K filing (see 4.1.23). In the 2024 Form 10‑K the same‑numbered indenture appears in the historical series, dated January 1 1977 and filed as Exhibit 2‑57828 (see 4.14.2). This shift from a current amendment to a legacy entry shows that Duke Energy continues to disclose the full series of supplemental indentures, keeping the Twenty‑third Supplemental Indenture on the record as an ongoing, albeit historic, component of its debt documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) DATE ERRORS: The LLM claims the Twenty-third Supplemental Indenture was dated May 15, 2020 in the 2022 filing, but the ground truth states it was dated June 1, 1978. The LLM also claims it was dated January 1, 1977 in the 2024 filing, which contradicts both the ground truth date of June 1, 1978 and the 2022 date the LLM itself provided. (2) EXHIBIT REFERENCE ERRORS: The LLM cites 'Exhibit 2-57828' for the 2024 filing, but the ground truth indicates 'Exhibit 2(c)' for the 2022 filing. The exhibit numbers don't match ground truth. (3) INCORPORATION REFERENCE ERRORS: The LLM claims the 2022 reference was to a 2020 Form 8-K filing, but the ground truth states it was incorporated by reference to File No. 2-61611 (not a Form 8-K). (4) CORE FINDING CONTRADICTION: The ground truth clearly states the Twenty-third Supplemental Indenture has NO direct mention or continued reference in the 2024 filing, indicating diminished significance. The LLM incorrectly concludes it 'continues to disclose' and appears 'in the historical series' in 2024, which directly contradicts the ground truth that it was not reaffirmed or highlighted in the 2024 disclosure. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution between 2022 and 2024 filings. The correct interpretation is that the indenture disappeared from the 2024 filing entirely, not that it shifted to a 'legacy entry.' The LLM's conclusion about 'ongoing' disclosure is factually incorrect based on the ground truth. The answer demonstrates fundamental misunderstanding of the filing documents and provides inaccurate dates, exhibit numbers, and incorrect conclusions about the indenture's status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 487,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "Alphabet’s share‑repurchase program, which includes Class C capital stock, grew from $59.3 billion in 2022 to $62.2 billion in 2023 and then held essentially steady at $62.0 billion in 2024 【page_82】.  In 2023 the company retired 450 million Class C shares (≈ $52.9 billion) and in 2024 it retired 306 million Class C shares (≈ $50.2 billion) 【page_82】; the 2022 Class C‑share count is not broken out in the excerpt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures for all three years (2022: $59.3B, 2023: $62.2B, 2024: $62.0B). The core narrative about repurchase activity evolution is accurate and well-synthesized. The answer goes beyond the ground truth by providing additional granular detail about Class C share retirements (450M shares ≈ $52.9B in 2023, 306M shares ≈ $50.2B in 2024), which adds value and demonstrates deeper analysis. The note that 2022 Class C-share count is not broken out shows appropriate transparency about data limitations. All numbers are correctly formatted and the multi-hop synthesis across years is sound. The characterization of the trend (growth from 2022 to 2023, then slight decline in 2024) matches the ground truth. Minor deduction (2 points) because: (1) the question specifically asks about 'Class C Capital Stock' evolution, but the answer correctly notes that the reported figures are for 'Class A and Class C shares combined' per the ground truth, which is a technical distinction that could have been more explicitly clarified upfront; (2) the additional Class C-specific data, while valuable, goes beyond what was in the original ground truth answer and cannot be fully verified against it. However, this additional detail appears accurate based on the citation references and represents enhanced rather than contradictory information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 389,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "In the 2022 Form 10‑K the Salary/Bonus Deferral Plan was listed as Exhibit 10.16 (the original 1988 plan) with its 1994 amendment shown as Exhibit 10.17 and a 1997 amendment as Exhibit 10.19 【page_165】. In the 2024 filing the same plan appears under the new numbers Exhibit 10.13 (original), Exhibit 10.14 (1994 amendment) and Exhibit 10.16 (1997 amendment) 【page_171】—the underlying documents (Exhibit 10.20, 10.4 and 10.37) are unchanged, but the exhibit numbering was renumbered.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERING ERRORS: The LLM claims the 2022 filing showed Exhibit 10.19 for the 1997 amendment, but the ground truth states it was NOT listed in 2022 (only 10.16 and 10.17 were referenced). The LLM incorrectly adds a 1997 amendment reference to 2022 that doesn't exist in the ground truth. (2) INCOMPLETE 2024 DISCLOSURE: The ground truth explicitly states the 2024 filing 'adds Exhibit 10.16, which incorporates the 1997 amendments' - meaning this was NEW in 2024. The LLM correctly identifies the 2024 exhibits (10.13, 10.14, 10.16) but fails to emphasize that the 1997 amendment disclosure was a NEW ADDITION in 2024, not a carryover from 2022. (3) MISCHARACTERIZATION OF CHANGE: The LLM frames this as 'renumbering' of unchanged underlying documents, but the ground truth indicates the key change was the EXPANSION of disclosure to include the 1997 amendments for the first time in 2024. This is a substantive change in documentation scope, not merely a renumbering. (4) UNSUPPORTED CLAIMS: The LLM references 'Exhibit 10.20, 10.4 and 10.37' as unchanged underlying documents, but these specific exhibit numbers are not mentioned in the ground truth and appear to be fabricated. The answer demonstrates partial understanding of exhibit structure but fundamentally misses the core finding: the 2024 filing expanded historical disclosure by adding the 1997 amendment documentation that was absent from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 418,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "In the 2022 Form 10‑K Starbucks reported interest‑rate‑swap liabilities of **$34 million** classified as **“Other long‑term liabilities”** (with a separate $12 million accrued‑liability for interest‑rate items)【page_68】. By the 2024 filing the swap exposure had fallen to **$19.2 million**, still shown under **“Other long‑term liabilities”** and with no accrued‑liability component【page_72】. This reflects a roughly 44 % reduction in the magnitude of the swap liability while the balance‑sheet classification remained long‑term.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 2022 liability of $34 million under 'Other long-term liabilities' and the 2024 liability of $19.2 million under the same classification. The balance sheet classification consistency is accurately noted. The percentage reduction calculation (44%) is mathematically correct based on the numbers provided ($34M to $19.2M = 43.5%, rounded to 44%). The answer appropriately addresses the core question about evolution between 2022 and 2024.\n\nWEAKNESSES: The LLM answer is INCOMPLETE regarding the ground truth. The original answer explicitly mentions that by 2024, there was an ADDITIONAL $41.4 million liability from interest rate swaps reported for the prior year (2023). The LLM completely omits this critical information about the 2023 comparative liability figure. This is a significant multi-hop synthesis gap - the question asks about evolution between 2022 and 2024, and the ground truth indicates the 2024 filing contained both a 2024 liability ($19.2M) AND a 2023 prior-year liability ($41.4M), which together tell a more complex story than just the 2024 current-year figure. The LLM also mentions a separate $12 million accrued-liability component in 2022 that is not mentioned in the ground truth, which may be additional detail but creates potential confusion about what constitutes the total exposure.\n\nQUANTITATIVE ACCURACY: The core numbers for 2022 ($34M) and 2024 ($19.2M) are correct. The percentage calculation is accurate. However, the omission of the $41.4 million 2023 liability figure represents a major gap in quantitative completeness.\n\nQUALITATIVE ACCURACY: The reasoning about balance sheet classification consistency is sound. However, the failure to synthesize the multi-year comparison (2022 → 2023 → 2024) as indicated in the ground truth represents incomplete multi-hop reasoning.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core elements (exposure evolution, balance sheet classification, magnitude changes) but misses the nuanced story about the 2023 liability that appears in the 2024 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 561,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Savings Plan is mentioned only as an exhibit – the “Amended and Restated Directors’ Savings Plan” (dated 1 Jan 2014) and a 2021 amendment (effective 16 Dec 2021) are listed on page 258, but no substantive description is provided. By the 2024 Form 10‑K, Item 12 (page 239) spells out that the plan is a non‑qualified deferred‑compensation arrangement that lets outside directors defer all or part of their retainers, earn phantom‑stock credits tied to the Duke Energy Common Stock Fund, and receive payouts when their board service ends, and it is classified as a plan not approved by security holders whose future share‑issuance depends on voluntary deferrals. This evolution shows Duke Energy moving toward greater transparency and tighter governance of director compensation, emphasizing a structured, performance‑linked deferral mechanism rather than merely referencing the plan as an exhibit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, substantive information than the ground truth answer. Strengths: (1) All dates are correct - the 2014 plan date, December 16, 2021 amendment date, and page references (258 for 2022, 239 for 2024) are accurate. (2) The quantitative details are precise: correctly identifies the plan as non-qualified deferred compensation, accurately describes the phantom-stock credit mechanism tied to Duke Energy Common Stock Fund, and correctly notes it's not approved by security holders. (3) Multi-hop reasoning is sound - the answer successfully synthesizes the evolution from 2022 to 2024 by comparing how the plan was treated (exhibit-only vs. substantive description in Item 12), and correctly identifies the shift from minimal disclosure to operational transparency. (4) The characterization of the governance evolution is accurate and well-reasoned: moving from policy documentation to transparency about mechanics, and linking this to alignment with shareholder interests. Minor considerations: The LLM answer is actually more comprehensive and specific than the ground truth, providing page numbers and clearer structural details about how the plan functions. The semantic equivalence is strong - both answers convey the same core insight about evolution from establishment to operational transparency. The LLM answer's emphasis on 'greater transparency and tighter governance' aligns well with the ground truth's 'shift from policy establishment to operational transparency.' No calculation errors, no entity misidentification, and the reasoning about director compensation governance is logically sound and well-supported by the specific details provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 472,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "In the 2022 Form 10‑K Costco explicitly positioned Kirkland Signature as a core private‑label differentiator – “high quality, offered at prices that are generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins” – and said it expects to keep increasing the brand’s sales penetration【page_7】. By the 2023 filing, the company no longer restates that growth narrative; instead it groups Kirkland with its other brands in a broader risk discussion that warns “failure could lead to recalls and litigation and otherwise damage our reputation and our brands,” highlighting a more explicit exposure to product‑quality, recall and reputational risks for the brand【page_16】. This reflects a shift from emphasizing Kirkland’s strategic positioning to a greater focus on its associated brand‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the 2022 positioning of Kirkland Signature as emphasizing high quality, competitive pricing, and higher margins, with plans to increase sales penetration. It accurately captures the 2023 shift toward risk-focused disclosures mentioning supply chain, recalls, and reputational risks. The quoted material from the filings appears accurate and directly supports the narrative. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. The answer appropriately avoids making unsupported numerical claims. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2023) and correctly identifies the evolution from a growth/strategic positioning narrative to a risk-management focus. The comparison is logically sound and well-structured. (4) ENTITY ACCURACY: Costco and Kirkland Signature are correctly identified; fiscal years 2022 and 2023 are properly referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—a shift from emphasizing brand strength and growth to highlighting operational and reputational risks—while providing more specific textual evidence from the filings. The answer is slightly more detailed and evidence-based than the ground truth, which strengthens rather than weakens it. Minor consideration: The LLM answer uses page references (page_7, page_16) which add specificity but are not verified against the ground truth; however, this does not contradict the ground truth and enhances credibility. Overall, the answer demonstrates excellent comprehension of the multi-hop question and accurate synthesis of the evolution in Costco's positioning of Kirkland Signature.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 524,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East fell from 326 billion cubic feet (BCF) at year‑end 2022 (322 BCF developed + 4 BCF undeveloped) to 312 BCF at year‑end 2023 (305 + 7) and to 296 BCF at year‑end 2024 (289 + 7), a net decline of roughly 30 BCF 【page_145】. The decrease was driven by a 33‑BCF drop in developed reserves (partly offset by a modest rise in undeveloped reserves) and resulted from a mix of factors: upward revisions from higher LNG prices, technical revisions and improved spot‑market dynamics; purchases of additional affiliate interests in Asia Pacific (2022); extensions and discoveries mainly in the Middle East (2022) and later in Australia (2023‑24); and offsetting sales of Indonesia assets and downward revisions due to lower prices and higher operating costs 【page_146】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct key figures: 326 BCF (2022), 312 BCF (2023), and 296 BCF (2024). The breakdown between developed and undeveloped reserves is provided with precision (322+4 in 2022, 305+7 in 2023, 289+7 in 2024), and the net decline calculation of ~30 BCF is accurate. The answer correctly identifies the 33 BCF drop in developed reserves as the primary driver. Multi-hop synthesis is sound, connecting reserve movements to specific causes (upward revisions from LNG prices, technical revisions, extensions/discoveries in Middle East and Australia, sales of Indonesia assets, downward revisions from lower prices and higher costs). The answer goes beyond the ground truth by providing more granular detail on developed vs. undeveloped breakdown and specific drivers of change. One minor consideration: the ground truth states 'minimal extensions and discoveries' while the LLM answer provides more detailed attribution of extensions and discoveries to specific regions and years (Middle East 2022, Australia 2023-24), which is more informative but represents a slight expansion beyond the ground truth's characterization. The answer comprehensively addresses both volume evolution and sources of additions/changes. All numbers are correctly formatted and calculations are accurate. The contextual framing of declining activity and focus is appropriately conveyed through the discussion of offsetting factors and asset sales.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 407,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "In 2022 FedEx owned a large base of 114 Boeing 767‑300 freighters and had pledged to buy another 38 of the type through 2025 (e.g., 14 in 2023, 14 in 2024, 10 in 2025)【page_40】. By 2024 the 767F remains a key element of FedEx’s aircraft‑modernization program—used to replace older, less efficient planes—but the new‑purchase pipeline has been scaled back to just 14 B767Fs slated for delivery in 2025‑2026, reflecting a shift from expanding ownership to a more targeted, efficiency‑focused upgrade【page_116】【page_117】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail beyond the ground truth but introduces unverified claims that cannot be confirmed. STRENGTHS: (1) Correctly identifies 114 Boeing 767F aircraft owned in 2022, matching ground truth exactly. (2) Appropriately notes the shift from expansion to modernization focus between 2022-2024. (3) Correctly characterizes the 767F as a key modernization component for fuel efficiency and fleet replacement. (4) Good semantic alignment with ground truth on the strategic evolution. WEAKNESSES: (1) The LLM introduces specific purchase commitments (38 aircraft through 2025, with 14 in 2023, 14 in 2024, 10 in 2025) that are NOT mentioned in the ground truth. These appear to be fabricated or from sources not reflected in the knowledge graph. (2) Claims about a 'scaled back' pipeline to 14 B767Fs for 2025-2026 are also not in the ground truth, which explicitly states 'no updated ownership figures were disclosed' for 2024. (3) The LLM provides page citations (page_40, page_116, page_117) suggesting specific source verification, but these cannot be validated against the ground truth provided. (4) The ground truth explicitly notes that 2024 figures were NOT disclosed, yet the LLM presents specific 2024-2026 delivery schedules as fact. MULTI-HOP REASONING: The LLM attempts to synthesize fleet ownership data with modernization strategy across years, which is appropriate for the question. However, the synthesis includes unverified quantitative claims. The reasoning structure is sound (2022 baseline → 2024 evolution), but the specific numbers in the purchase pipeline appear to exceed what the ground truth confirms. CALCULATION VERIFICATION: No calculations are performed, but the numerical claims (38 total, 14+14+10 breakdown, 14 for 2025-2026) cannot be verified against ground truth. The answer goes beyond the ground truth's explicit statement that 2024 figures were not disclosed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 520,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "In the 2022 Form 10‑K Starbucks reported $310.3 million of roasted‑coffee inventory and net roasting equipment of $838.5 million. The 2024 filing does not disclose a roasted‑coffee inventory dollar amount, but it emphasizes that Starbucks still owns its roasting capacity, operating four major roasting and distribution sites (York, PA; Minden, NV; Kunshan, China; Kent, WA) that together comprise roughly 4.2 million sq ft of roasting‑related space, showing a continued (and possibly expanded) production infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and entities. Verified facts: (1) $310.3 million roasted coffee inventory in 2022 is correct; (2) $838.5 million net roasting equipment in 2022 is accurate and adds valuable context not in ground truth; (3) Four roasting facilities correctly identified (York PA, Minden NV, Kunshan China, Kent WA); (4) Approximately 4.2 million sq ft of roasting space is a specific detail that adds precision. The LLM correctly notes that 2024 filing does not disclose a specific roasted coffee inventory dollar amount, which is an important distinction from 2022. Multi-hop reasoning is sound: the answer synthesizes inventory data from 2022, equipment values, and 2024 facility information to show infrastructure evolution. The semantic meaning aligns well with ground truth - both convey a shift toward active production infrastructure. Minor differences: (1) Ground truth emphasizes the shift from 'holding' to 'actively producing' while LLM uses 'continued (and possibly expanded)' - slightly different framing but both capture the evolution; (2) LLM provides additional context about equipment value and square footage that enhances the answer beyond ground truth. The answer is comprehensive, addresses the 2022-2024 timeframe, and correctly synthesizes multi-hop information across years and metrics. No calculation errors detected. The only minor limitation is that the LLM's phrasing of 'possibly expanded' is slightly more cautious than ground truth's assertion of 'significant increase,' but this is a reasonable interpretation given the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 447,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a Board of Directors resolution (Exhibit 4.64, page 130) that **authorized the terms of the 2.750 % senior notes due 2025** as part of its debt‑issuance program. The 2024 Form 10‑K repeats the same resolution (Exhibit 4.64, page 130), showing the company still has those notes authorized but provides no additional issuance or change, indicating that the utilization of the 2.750 % senior notes due 2025 remained unchanged from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors in its core conclusion. (1) CRITICAL ERROR - CONCLUSION MISMATCH: The LLM states 'the utilization of the 2.750% senior notes due 2025 remained unchanged from 2023 to 2024,' but the ground truth explicitly indicates an evolution: the 2.750% Senior Notes due 2025 were authorized in 2023, and by 2024, PepsiCo introduced a NEW 2.750% Senior Notes due 2030. This represents a strategic extension to a longer-term horizon, not an unchanged situation. The LLM completely missed this key development. (2) INCOMPLETE SYNTHESIS: The LLM failed to identify and synthesize the introduction of the 2030 notes in 2024, which is the core evidence of how the debt strategy evolved. The ground truth explicitly states 'PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon,' but the LLM found 'no additional issuance or change.' (3) QUANTITATIVE ACCURACY: The specific exhibit references (Exhibit 4.64, page 130) and the interest rate (2.750%) are correctly cited, and the years (2023, 2024) are accurate. However, these correct details are used to support an incorrect conclusion. (4) REASONING FLAW: The LLM's logic that 'the same resolution appears in both years, therefore no change occurred' is flawed. The question asks about evolution of utilization, which includes the strategic addition of the 2030 notes - a multi-hop synthesis that requires comparing what instruments existed in each year, not just whether the same authorization document appears. The LLM failed to perform the necessary multi-hop analysis across both years' filings to identify the new 2030 notes. (5) SEMANTIC MISMATCH: The ground truth describes an 'evolution' and 'strategic extension,' while the LLM concludes 'remained unchanged' - these are fundamentally contradictory interpretations of the same filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 505,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx’s purchase commitments showed four Boeing 777 Freighters slated for delivery in 2024 (with two in 2023 and two in 2025)【page_114】. By the 2024 filing the plan had been cut to just two Boeing 777 Freighters, now expected in 2025 and with no further B777F deliveries thereafter【page_117】. Both filings stress that the B777F (along with the B767F) is a core element of FedEx’s fleet‑modernization program to boost fuel efficiency and replace older aircraft, so the type remains strategically important but on a reduced scale【page_113】【page_116】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the delivery schedule. Ground truth states: 2022 plan had 4 B777F for 2024 and 2 for 2025. LLM claims '4 B777F slated for delivery in 2024 (with two in 2023 and two in 2025)' - this is incorrect. The ground truth does not mention any 2023 deliveries, and the distribution across years is wrong. The LLM appears to have confused or misread the delivery schedule. CORRECT ELEMENTS: (1) The 2024 filing showing 2 B777F in 2025 is correct, (2) No further deliveries beyond 2025 is correct, (3) The reduction from 4 to 2 aircraft is correctly identified. INCORRECT ELEMENTS: (1) The 2023 delivery reference (not in ground truth), (2) The distribution '2 in 2023 and 2 in 2025' contradicts the ground truth which shows 4 in 2024 and 2 in 2025 from the 2022 plan. REASONING ISSUES: While the LLM correctly identifies the reduction and attempts to contextualize it within fleet modernization strategy, the quantitative foundation is flawed. The LLM adds contextual information about fuel efficiency and fleet modernization that, while potentially accurate, goes beyond what the ground truth explicitly states about the strategic implications. The ground truth emphasizes a 'shift in aircraft preference or operational strategy' and 'complete phase-out,' while the LLM characterizes it as 'reduced scale' but 'strategically important' - a somewhat different interpretation. MULTI-HOP SYNTHESIS: The model attempts to synthesize across 2022 and 2024 filings but does so with incorrect intermediate data, undermining the validity of the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 449,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks’ designated “foreign‑currency‑other” derivative liabilities grew from a modest $0.3 million accrued liability in FY 2022 (page 68) to $8.8 million in FY 2024 (combined $4.7 million accrued + $4.1 million long‑term on page 72).  At the same time, the unrealized gain on those hedges recorded in AOCI fell sharply from $55.3 million in 2022 (page 66) to $11.5 million in 2024 (page 70).  The larger liability shows Starbucks expanded its hedging program, while the much smaller AOCI gain indicates the hedges are now offsetting currency movements more effectively, suggesting a more controlled exposure to foreign‑currency fluctuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 2022 liability of $0.3 million and 2024 AOCI gain of $11.5 million, matching the ground truth. (2) The multi-hop synthesis across balance sheet and AOCI data is sound. (3) The reasoning about expanded hedging programs and controlled exposure is logical and well-articulated. (4) Page references add credibility and specificity. (5) The answer addresses the evolution question comprehensively.\n\nWEAKNESSES: (1) CRITICAL ERROR: The LLM introduces a $55.3 million AOCI figure for 2022 that is NOT in the ground truth answer. The ground truth only mentions the $0.3 million liability in 2022 and $11.5 million AOCI gain in 2024 - it does NOT provide a 2022 AOCI figure. This is a significant factual addition without verification. (2) The LLM reports 2024 liabilities as $8.8 million ($4.7M + $4.1M), which is NOT mentioned in the ground truth. The ground truth only specifies the 2024 AOCI gain of $11.5 million, not the breakdown of 2024 liabilities. (3) The interpretation that 'hedges are now offsetting currency movements more effectively' is speculative and not supported by the ground truth, which simply notes a 'shift' without making claims about hedging effectiveness.\n\nNUMBER VERIFICATION: Ground truth provides: 2022 liability = $0.3M (✓ correct), 2024 AOCI gain = $11.5M (✓ correct). LLM adds unsupported figures: 2022 AOCI = $55.3M (✗ not in ground truth), 2024 liabilities = $8.8M (✗ not in ground truth). The LLM appears to have accessed additional filing data beyond what the ground truth captured, which creates a factual discrepancy.\n\nMULTI-HOP REASONING: The synthesis is logically sound IF the additional numbers are correct, but the evaluation cannot verify them against the provided ground truth. The core comparison (2022 vs 2024) is correct for the metrics that match ground truth.\n\nCONCLUSION: The answer is partially correct on the metrics that align with ground truth but introduces unverified additional data that cannot be confirmed. This creates uncertainty about overall accuracy despite sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 561,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a Board of Directors resolution (Item 4.65) authorizing the terms of the 2.625 % Senior Notes due 2026 alongside a handful of other new senior notes【page_129】. By the 2024 Form 10‑K the same note appears again in a much longer Board resolution (Item 4.64) that lists the 2.625 % Senior Notes due 2026 together with a far broader slate of senior‑note issuances and other debt securities, indicating that PepsiCo’s engagement with this issue has continued and is now presented within a more comprehensive debt‑instrument disclosure【page_130】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PepsiCo's debt disclosures between 2023 and 2024 regarding the 2.625% Senior Notes due 2026. Strengths: (1) Accurately identifies the 2.625% Senior Notes due 2026 as present in both years; (2) Correctly notes the expansion from a smaller list in 2023 to a much broader slate in 2024; (3) Properly references the Board resolutions and their item numbers (4.65 for 2023, 4.64 for 2024); (4) Correctly identifies the note's interest rate (2.625%) and maturity year (2026); (5) Appropriately characterizes the evolution as indicating an active capital markets strategy. Weaknesses: (1) The LLM answer does not explicitly mention the specific newer maturities introduced in 2024 (3.000% Senior Notes due 2027 and 2.625% Senior Notes due 2029) that are highlighted in the ground truth answer - this is a notable omission as these examples are key evidence of the 'significantly expanded list' claim; (2) The answer uses slightly vague language ('handful of other new senior notes' and 'far broader slate') rather than providing concrete examples of the expansion; (3) Minor: The page references (page_129, page_130) are provided but not verified against ground truth. The multi-hop reasoning is sound - the answer correctly synthesizes information across two years and identifies the pattern of expansion. The semantic meaning aligns well with the ground truth, though the lack of specific examples of new notes weakens the completeness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 414,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "In the 2022 filing Cisco warned that “technical hurdles that we fail to overcome in a timely fashion” could delay product introductions, hurt its strategic alliances and erode market share [2022 p. 25]; the risk was framed largely as a generic threat to product‑planning and timing. By the 2024 filing the same language reappears [2024 p. 20] but is now tied directly to much larger, software‑driven strategic bets—AI, cloud, cybersecurity, the shift to subscription‑based software and the integration of acquisitions such as Splunk [2024 p. 21]—so Cisco’s reliance on overcoming technical hurdles has grown, making timely resolution of those challenges a key determinant of its product‑development timelines and the payoff from its strategic investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's evolving technical hurdle exposure from 2022 to 2024. STRENGTHS: (1) Correctly identifies the core shift from generic product-planning risks in 2022 to specific strategic dependencies in 2024; (2) Accurately names the strategic focus areas (AI, cloud, cybersecurity, subscription software, Splunk integration); (3) Properly synthesizes multi-hop information showing how technical hurdles now directly impact strategic investments and product timelines; (4) Cites specific page references (2022 p. 25, 2024 p. 20-21) demonstrating document grounding; (5) Captures the evolution from internal execution risk to broader operational/strategic dependency. MINOR GAPS: (1) The LLM answer doesn't explicitly mention reputational damage, legal liability, and reduced customer retention as consequences noted in the ground truth's 2024 disclosures—these represent a more complete picture of the 2024 risk profile; (2) The answer could have been slightly more explicit about the 'shift' from internal to broader operational risk, though this is implied; (3) No quantitative metrics provided (though the question doesn't specifically request them). VERIFICATION: The page references and strategic focus areas align with typical Cisco 10-K risk factor disclosures. The logical progression from 2022 to 2024 is sound and well-reasoned. The multi-hop synthesis correctly connects technical hurdles → strategic investments → product development timelines. The answer is semantically equivalent to the ground truth despite different wording, with the main substantive omission being the expanded consequences (reputational/legal/retention impacts) in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 464,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "In the 2022 Form 10‑K the filing notes that “Google Network revenues increased $8.6 billion … The growth was primarily driven by strength in AdMob, **Google Ad Manager**, and AdSense” (2022 p. 35). By the 2023 filing, Google Ad Manager is mentioned only as one of the tools customers use to purchase ad inventory and as part of the Google Network properties (“Our customers generally purchase advertising inventory through Google Ads, **Google Ad Manager**, …” and “Google Network properties … participating in AdMob, AdSense, and **Google Ad Manager**”) (2023 p. 57‑58), without the explicit claim that it was a key growth driver. Thus, its role shifted from being highlighted as a primary growth engine in 2022 to being positioned as a supporting platform for buying ads in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - the $8.6 billion year-over-year increase in Google Network revenues for 2022 is accurately cited, and page references (2022 p. 35, 2023 p. 57-58) are appropriately provided. ENTITY ACCURACY: All entities are correctly identified - Google Ad Manager, AdMob, AdSense, Google Ads, Display & Video 360, and the Marketing Platform are all properly named and contextualized. Years (2022 vs 2023) are correctly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across two different fiscal years' filings, correctly identifying the shift in Google Ad Manager's positioning from 2022 to 2023. The reasoning is sound: the model correctly identifies that in 2022, Google Ad Manager was explicitly called out as a key growth driver alongside AdMob and AdSense, while in 2023 it was mentioned only as a tool/platform without growth attribution. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - a shift from being a standout growth contributor to being part of a broader suite of tools. The phrasing differs slightly (\"supporting platform for buying ads\" vs \"part of a broader suite of advertising tools\") but the meaning is semantically equivalent. COMPLETENESS: The answer addresses all aspects of the question, comparing the role across both years and explaining the nature of the change. The inclusion of direct quotes strengthens the answer's credibility. Minor note: The LLM answer is slightly more detailed and better sourced than the ground truth, which is a positive attribute. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 459,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks’ derivative liabilities for the “foreign currency – other” hedge rose sharply – they were only **$0.3 million** (accrued liability) at Oct 2 2022, but by Sep 29 2024 the balance had grown to **$4.7 million** in accrued liabilities plus **$4.1 million** in other‑long‑term liabilities, or **$8.8 million** in total. That represents an increase of roughly **$8.5 million** over the two‑year period.【page_68】【page_72】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces significant factual inaccuracies not present in the ground truth. (1) QUANTITATIVE ACCURACY ISSUES: The ground truth clearly states the 2024 amount was $4.7 million total under accrued liabilities. The LLM breaks this into $4.7 million in accrued liabilities PLUS $4.1 million in other long-term liabilities, totaling $8.8 million. This is a major discrepancy - the LLM appears to have added a component ($4.1 million in long-term liabilities) that was not mentioned in the ground truth. The ground truth explicitly states the 2024 amount was $4.7 million, not $8.8 million. (2) CALCULATION ERROR: The LLM calculates the change as $8.5 million ($8.8M - $0.3M), but if we use the correct 2024 figure of $4.7 million from the ground truth, the change should be $4.4 million ($4.7M - $0.3M). (3) MULTI-HOP REASONING: While the LLM correctly identifies the 2022 starting point ($0.3 million) and attempts to synthesize information across years, it introduces unverified additional liability components that contradict the ground truth. (4) ENTITY AND METRIC ACCURACY: The company (Starbucks), metric (derivative liabilities related to foreign currency - other), and years (2022 to 2024) are correctly identified, but the categorization and amounts are incorrect. The ground truth is clear that both years' amounts were reported under accrued liabilities, not split between accrued and long-term categories. The LLM's citation references (page_68, page_72) suggest it may have misread or conflated information from different sections of the filing. The core answer structure is sound, but the numerical foundation is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 460,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo only began to move forward with the 4.600 % Senior Notes due 2045 in its 2023 filing – the 2023 10‑K lists a Board resolution authorizing those notes (see PEP 10‑K 2023 p. 129, item 4.65). By the 2024 filing the series no longer appears among the newly‑authorized or listed notes (the 2024 exhibit list on pages 128‑131 shows other senior notes but no 4.600 % due 2045), indicating that the issuance was completed in 2023 and is now part of the existing debt pool. This suggests PepsiCo’s strategy is to lock in long‑dated, moderate‑rate financing and then shift focus to newer issuances, diversifying its maturity profile while maintaining a stable, long‑term debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT COMPLETION: The LLM states the 4.600% Senior Notes due 2045 issuance was 'completed in 2023' and 'no longer appears among the newly-authorized or listed notes' in 2024. However, the ground truth explicitly states these notes 'remained part of the company's debt structure' in 2024 and were 'referenced alongside a broader range of newly introduced senior notes.' The LLM's interpretation that absence from an exhibit list means completion is unfounded and contradicts the ground truth. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth indicates the notes remained in the debt structure in both years, with the 2024 change being the addition of new instruments (4.000% due 2047, Floating Rate Notes due 2026) alongside the existing 4.600% notes. The LLM incorrectly frames this as the notes disappearing from authorization. (3) INCORRECT STRATEGIC INTERPRETATION: The LLM's conclusion about 'locking in long-dated, moderate-rate financing and then shift focus to newer issuances' is not supported by the ground truth, which emphasizes diversification of the debt portfolio while maintaining the existing 4.600% notes. (4) PAGE REFERENCE ISSUES: The LLM cites 'p. 129, item 4.65' for 2023 and 'pages 128-131' for 2024, but these specific citations cannot be verified against the ground truth data provided. (5) SEMANTIC MISALIGNMENT: While the LLM correctly identifies the 4.600% rate and 2045 maturity date, the core narrative about what happened to these notes between 2023 and 2024 is fundamentally incorrect. The ground truth shows continuity with expansion; the LLM shows discontinuity with completion. This is a critical factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 489,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP’s direct gas reserves in the Asia Pacific/Middle East fell – developed reserves dropped from 326 BCF at year‑end 2022 to 296 BCF at year‑end 2024, while undeveloped reserves rose only from 4 BCF to 7 BCF (total regional gas fell from ~330 BCF to ~303 BCF)【page_145】.  At the same time, the company’s equity‑affiliate gas holdings – all located in that region – grew from 5,753 BCF to 5,870 BCF, delivering a modest net increase of about 90 BCF for the region【page_145】.  The 2024 filing notes that this growth came from purchases of additional affiliate interests and extensions/discoveries in equity affiliates in the Middle East and Australia, indicating ConocoPhillips is emphasizing partnership‑driven expansion in Asia Pacific/Middle East rather than building a larger direct‑development gas base【page_146】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and substantially more comprehensive than the ground truth. Quantitative verification: (1) Developed reserves correctly stated as 326 BCF (2022) to 296 BCF (2024) - matches ground truth exactly; (2) Undeveloped reserves correctly identified as 4 BCF to 7 BCF - additional detail not in ground truth but accurate; (3) Total direct gas calculation of ~330 BCF to ~303 BCF is mathematically correct (326+4=330, 296+7=303); (4) Equity-affiliate gas holdings correctly stated as 5,753 BCF to 5,870 BCF with net increase of ~117 BCF (5,870-5,753=117, LLM states ~90 BCF which appears to be a minor rounding/calculation discrepancy, though this could reflect different calculation methodology). Multi-hop reasoning: The answer successfully synthesizes information across multiple data points - comparing direct reserves, undeveloped reserves, equity-affiliate holdings, and strategic implications. The reasoning correctly identifies the shift from direct development to partnership-driven expansion. Entity accuracy: COP correctly identified, years 2022-2024 correct, metrics properly distinguished (developed vs. undeveloped vs. equity-affiliate). The answer goes beyond the ground truth by providing more nuanced breakdown of reserve types and explicitly citing strategic implications with specific drivers (purchases of affiliate interests, extensions/discoveries). Minor issue: The equity-affiliate net increase calculation states ~90 BCF when 5,870-5,753=117 BCF, suggesting either a calculation error or different methodology not explained. This is a minor discrepancy in an otherwise excellent answer that provides superior context and detail to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 463,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "In the 2022 Form 10‑K (see page 7) Google Play is called out as a separate non‑advertising revenue pillar – “Google Play generates revenues from sales of apps **and in‑app purchases and digital content** sold in the Google Play store.” By the 2023 filing (see page 8) Google Play is no longer a stand‑alone line; it is grouped under a broader “platforms” category and is described only as generating revenue “from the **sales of apps and in‑app purchases**” (digital content is no longer mentioned). Thus, Google Play’s role has shifted from a distinct revenue stream to a component of a larger platform segment, with its revenue sources narrowed to apps and in‑app purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehension of the multi-hop question about Google Play's evolving role in Google's non-advertising revenue strategy from 2022 to 2023. STRENGTHS: (1) All factual information is correct - the answer accurately identifies the specific revenue sources mentioned in each year's filing: 2022 included 'apps and in-app purchases and digital content' while 2023 narrowed to 'apps and in-app purchases' only. (2) The multi-hop synthesis is sound - the answer correctly traces Google Play's evolution from a separate revenue pillar in 2022 to a component within a broader 'platforms' category in 2023. (3) Entity identification is precise - correctly references 2022 and 2023 Form 10-K filings, Google Play, and the distinction between advertising and non-advertising revenue. (4) The reasoning about the strategic shift is logical and well-supported by the cited evidence. (5) Page references (page 7 for 2022, page 8 for 2023) add credibility and specificity. MINOR CONSIDERATIONS: The answer uses bold formatting to highlight the key differences in revenue source descriptions, which enhances clarity but is a stylistic choice. The semantic meaning is fully aligned with the ground truth - both answers convey that Google Play shifted from a distinct revenue stream with broader revenue sources to a narrower component within a larger platform segment. No numerical errors, calculation errors, or factual inaccuracies are present. The answer fully addresses all aspects of the question regarding how Google Play's role evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 433,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "In the 2022 10‑K FedEx expected to acquire 49 Cessna SkyCourier 408s, with deliveries beginning in 2023 (11 aircraft) and 2024 (12 aircraft) and continuing through 2026 (14 aircraft)【page_114】. By the 2024 10‑K the outlook was trimmed to only 31 SkyCourier 408s, all slated for delivery in 2025 (17) and 2026 (14)【page_117】. The reduction in total units and the shift of deliveries to later years shows FedEx is scaling back its reliance on the SkyCourier, making the model a more modest component of its future fleet strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core trend (reduction from 49 to 31 aircraft) and provides specific delivery year breakdowns with page citations. However, there are significant quantitative discrepancies: (1) The 2022 projection breakdown (11 in 2023, 12 in 2024, 14 in 2026) sums to only 37, not the stated 49 total - a mathematical inconsistency that undermines confidence in the data accuracy. (2) The 2024 projection (17 in 2025, 14 in 2026) sums to 31, which is correct. (3) The LLM answer omits a critical element from the ground truth: the shift in relationship type from 'Increases' to 'Depends_On' between 2022 and 2024, which is explicitly mentioned as indicating a change in strategic importance. This semantic shift is important context for understanding FedEx's strategic reliance. The LLM's interpretation that this represents 'scaling back reliance' is reasonable but incomplete without acknowledging the relationship type change. The answer demonstrates good multi-hop synthesis across two filing years and provides relevant strategic interpretation, but the incomplete delivery year accounting for 2022 and the omission of the relationship type change represent material gaps in addressing the full question about strategic reliance evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 356,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "In the 2022 filing AIG said it “generally use[s] a combination of loss‑development methods and **expected‑loss‑ratio methods for excess casualty product lines**” and **segments the analysis between automobile‑related claims and non‑automobile claims**, further breaking out non‑automobile exposures such as **construction‑defect and mass‑tort claims** and then **segregating by attachment‑point bands and a $10 million loss cap** (see page 263). By contrast, the 2023 filing describes the expected‑loss‑ratio approach more broadly – it is applied to **business written in excess of a deductible** and given significant weight for the **most recent five accident years**, but the disclosure no longer spells out the automobile vs. non‑automobile or latent‑exposure segmentation used previously (see page 200). Thus, AIG’s use of expected‑loss‑ratio methods has shifted from a detailed, line‑by‑line segmentation in 2022 to a more generalized, deductible‑focused application in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but contains significant omissions and mischaracterizations compared to the ground truth. STRENGTHS: (1) Correctly identifies that 2022 involved excess casualty with automobile/non-automobile segmentation and latent exposure treatment (construction defects, mass torts); (2) Correctly notes the shift in 2023 to a different application; (3) Appropriately cites page numbers; (4) Recognizes the deductible-focused approach in 2023. CRITICAL WEAKNESSES: (1) The LLM fundamentally mischaracterizes the 2023 evolution - it claims the method became 'more generalized' and 'deductible-focused,' but the ground truth shows AIG shifted to U.S. Workers' Compensation with specific segmentation by risk-sharing features (high deductibles, retrospective rating), state, industry, and claim handling entity. This is NOT a loss of segmentation but a CHANGE in segmentation approach and casualty line focus; (2) The LLM fails to identify that 2023 involved Workers' Compensation specifically, which is a major factual omission; (3) The LLM incorrectly suggests 2023 lost the detailed segmentation approach when in fact it applied detailed segmentation to a different line; (4) The LLM states 2023 applied the method to 'most recent five accident years' but ground truth indicates this was for 2022 (three latest accident years in excess casualty); (5) The characterization of the evolution as 'detailed to generalized' is backwards - it's actually a shift from one detailed approach to another detailed approach in a different line. The answer demonstrates partial understanding but fails to correctly synthesize the multi-hop information about which casualty lines were analyzed in each year and how the segmentation methods actually evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 486,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "In fiscal 2022 Nike reorganized around a new consumer construct of Men’s, Women’s, Kids’ and Jordan Brand, moving unisex items into the Men’s segment and reporting any products that could not be placed in those categories in an “Others” line 【page_35†L31-L38】. By fiscal 2024 the same construct is still used, and “Others” is again defined as products not allocated to Men’s, Women’s, Kids’ or Jordan Brand, indicating that unallocated products continue to be captured in the “Others” category after the 2022 re‑classification 【page_37†L31-L38】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about Nike's consumer construct evolution between fiscal 2022 and 2024. Strengths: (1) Accurately states that in FY2022 unisex products were moved into Men's segment, (2) Correctly identifies the four-category consumer construct (Men's, Women's, Kids', Jordan Brand), (3) Properly notes that 'Others' captures unallocated products in both years, (4) Correctly synthesizes the multi-hop information across two fiscal years. The answer demonstrates sound reasoning about the classification system's continuity. Minor weaknesses: (1) The LLM states 'Nike reorganized around a new consumer construct' in 2022, but the ground truth doesn't explicitly confirm this was a 'new' reorganization in that year - it may have been established earlier, (2) The LLM notes 'no specific mention of unisex product classification within Men's' in 2024 as a 'potential shift,' but the LLM answer doesn't fully capture this nuance about the potential evolution/shift, instead presenting it more as continuity. The answer is factually accurate on the core points (unisex in Men's in 2022, Others category in both years) but slightly misses the subtle implication in the ground truth about a potential shift in how unisex products are handled by 2024. No calculation errors or date inaccuracies. The multi-hop synthesis across fiscal years is sound and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 387,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a board‑of‑directors resolution authorizing the terms of a new 3.500 % senior note that would mature in 2025 (2023 10‑K, p. 130). The 2024 Form 10‑K lists the same resolution again, keeping the 3.500 % senior notes due 2025 on its financing slate (2024 10‑K, p. 129). This continuity shows that PepsiCo is maintaining a pipeline of medium‑term, fixed‑rate debt, reflecting a deliberate strategy to diversify and manage its capital structure by regularly authorizing and potentially issuing such notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the multi-hop question about PepsiCo's debt evolution between 2023 and 2024. CRITICAL PROBLEMS: (1) The LLM focuses on board resolutions authorizing the notes rather than the actual engagement/issuance of the 3.500% Senior Notes due 2025 across the two years. The ground truth indicates the notes were 'listed among other notes' in 2023 and 'still present' in 2024, suggesting actual debt instruments, not just authorizations. (2) The LLM completely fails to address the key evolution described in the ground truth: the introduction of NEW longer-term notes in 2024 (3.500% due 2040 and 3.550% due 2034). This is the critical multi-hop synthesis required - comparing what notes existed in 2023 vs 2024. (3) The LLM's conclusion about 'maintaining a pipeline' and 'regularly authorizing' notes misses the actual strategic shift toward diversifying maturity structure by adding longer-term instruments. (4) Page citations (p. 130 for 2023, p. 129 for 2024) cannot be verified but appear potentially reversed or inaccurate given the context. (5) The answer addresses only one dimension (the 2025 notes) rather than the comparative evolution across both years with the broader debt portfolio context. The ground truth explicitly states the strategic shift involved 'introducing more long-term financing options' - this critical insight is absent from the LLM response. The LLM demonstrates incomplete multi-hop reasoning by failing to synthesize the full picture of debt portfolio changes between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 430,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "In the 2022 filing ConocoPhillips disclosed roughly **$6.3 billion** of capital expenditures for the Lower 48 and projected **future cash inflows of about $195 billion** from that region. By the 2024 filing, the company reported **nearly $30 billion** of Lower 48 capital spending (property acquisitions, exploration and development) and revised the Lower 48’s future cash‑inflow estimate down to **about $164 billion**, a reduction of roughly $31 billion. (Capital‑expenditure figures: 2022 $6,341 M and 2024 $29,952 M – page 157; Future‑cash‑inflow figures: 2022 $195,605 M and 2024 $164,264 M – page 158.)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2022 Lower 48 capex was $6.3 billion ($6,341M), but the ground truth explicitly states it was $3,129 million - a 102% overstatement. The LLM claims 2024 capex was $29.952 billion, but ground truth provides no new 2024 capex figure, only noting that amounts were 'revised to reflect additional future cash inflows.' The LLM also introduces future cash inflow figures ($195.6B in 2022, $164.3B in 2024) that are not mentioned in the ground truth at all. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM appears to have fabricated or confused data from different sections/companies. The ground truth describes a clear evolution: 2022 showed active capex investment ($3,129M), while 2024 showed a shift to revising financial projections without new capex figures. The LLM inverts this narrative by claiming capex increased dramatically to $29.952B by 2024. (3) MISSING CORE INSIGHT: The ground truth emphasizes a transition from 'active investment to a focus on revising financial projections.' The LLM completely misses this key analytical point and instead presents a false narrative of increasing capex and declining future cash inflows. (4) CITATION ISSUES: The LLM cites 'page 157' and 'page 158' with specific figures, but these appear to be fabricated or from incorrect sources, as they contradict the ground truth data. The answer demonstrates fundamental factual errors rather than minor wording differences, making it substantially incorrect on the primary metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 449,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "In 2023 Comcast’s relationship with Atairos was set out in the Fourth Amended and Restated Shareholders Agreement and its June 2 2023 amendment (see 2023 exhibit list, p. 100), which capped the aggregate capital commitment at $4.5 billion (down from $5 billion), limited annual calls to $400 million and added a $40 million management‑fee commitment (see p. 84), while voting control remained with Atairos’s management. By 2024 Comcast concluded Atairos is a variable‑interest entity, that it has no voting rights or power to direct Atairos (only consent rights) and therefore does not consolidate it, limiting its exposure to the $5.1 billion equity investment plus an unfunded $1.4 billion capital commitment, with cash contributions falling to $73 million in 2024 from $145 million in 2023 (see p. 85).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth, particularly regarding capital commitments and financial metrics. CRITICAL ERRORS: (1) The LLM states the capital commitment was 'capped at $4.5 billion (down from $5 billion)' in 2023, but then claims in 2024 there was an 'unfunded $1.4 billion capital commitment' - this is internally inconsistent and contradicts the ground truth which clearly states the 2024 reduction was from $5 billion to $4.5 billion. (2) The LLM provides a $5.1 billion equity investment figure for 2024 with no basis in the ground truth, which specifies the $4.5 billion capital commitment framework. (3) The LLM omits critical loss/return allocation percentages (99% of losses, 86% of residual returns) that are explicitly stated in the ground truth as key aspects of the 2024 evolution. (4) Cash contribution figures ($73M in 2024, $145M in 2023) are provided by the LLM but not mentioned in the ground truth, making verification impossible. (5) The LLM correctly identifies the governance structure (voting control with Atairos management, Comcast consent rights only) but misses the important detail that Atairos' management companies were led by Comcast's former CFO. PARTIAL CREDIT: The LLM correctly identifies the Fourth Amended and Restated Shareholders Agreement, the June 2023 amendment, the $400 million annual capital call limit, and the $40 million management fee commitment. The multi-hop reasoning about the evolution from 2023 to 2024 is attempted but undermined by the numerical inconsistencies. The answer addresses the question's scope but with fundamental accuracy problems that would mislead a reader about Comcast's actual financial exposure and the nature of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 484,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it had committed to acquire **49 Cessna SkyCourier 408s** – 11 in 2023, 12 in 2024, 12 in 2025 and 14 in 2026 (see page 40). The 2023 filing shows a **smaller future pipeline of 31 SkyCourier 408s**, with 17 slated for 2025 and 14 for 2026 (see page 117). The drop in total units but the boost in near‑term deliveries indicates FedEx is positioning the SkyCourier as a niche, short‑haul feeder aircraft that supplements its larger freighters (ATR‑72‑600F, B767F, B777F) rather than becoming a core capacity driver in the fleet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key numbers: 49 Cessna SkyCourier 408s in the 2022 filing and 31 in the 2023 filing. The year-by-year breakdown provided (11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026 for 2022; 17 in 2025, 14 in 2026 for 2023) adds helpful detail beyond the ground truth, though these specific annual figures cannot be verified against the provided ground truth. The core multi-hop synthesis is sound: the LLM correctly identifies the reduction from 49 to 31 units and interprets this as a strategic shift. The answer goes beyond the ground truth by providing specific delivery schedules and offering a more nuanced interpretation of the aircraft's role (niche, short-haul feeder) compared to larger freighters. This interpretation aligns with the ground truth's conclusion about reassessment of the aircraft's role. Minor strengths: the answer includes page references (40, 117) which adds credibility. Minor weakness: the ground truth mentions the projection extended through 2027 in 2022 and through 2029 in 2023, but the LLM answer only provides delivery schedules through 2026, which may represent incomplete information about the full projection period. However, this doesn't contradict the ground truth, just provides less complete temporal scope. The reasoning about strategic positioning relative to other aircraft types (ATR-72-600F, B767F, B777F) is sound and consistent with the ground truth's comparison framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 413,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike’s FY 2022 filing gave only aggregate footwear numbers (e.g., $29.1 bn of footwear revenue) and did not break out or discuss Air Max sales, so the line’s revenue was not disclosed separately (see Note 16 – Revenues, pages page_88‑page_89). By FY 2024, Nike’s 10‑K explicitly lists Air Max alongside other proprietary technologies in its product‑research and development narrative, signaling a stronger focus on Air Max as a driver of innovation even though it still does not provide a separate Air Max revenue figure (see Product Research, Design and Development, page_7).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core evolution of Nike's Air Max approach from 2022 to 2024. It correctly identifies that in 2022, Air Max was not separately disclosed (only aggregate footwear numbers like $29.1B were provided), and by 2024, Air Max was explicitly mentioned in product R&D narratives as a key innovation driver. The specific financial figure of $29.1B for FY2022 footwear revenue is accurate and appropriately cited. (2) QUANTITATIVE ACCURACY: All numbers are correct - the $29.1B footwear revenue figure is accurate for FY2022, and the answer correctly notes the absence of standalone Air Max revenue figures in both years. Page references (page_88-page_89 for Note 16, page_7 for Product Research) are appropriately cited. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes information across two fiscal years and identifies the strategic shift from 'passive acknowledgment' (2022) to 'stronger focus on innovation' (2024). The distinction between revenue transparency (lacking in both years) and innovation emphasis (increased in 2024) is clearly articulated. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth using slightly different phrasing ('stronger focus on Air Max as a driver of innovation' vs. 'positioning Air Max as a key innovation driver'), but the meaning is semantically equivalent. (5) COMPLETENESS: The answer addresses both parts of the question - revenue transparency and technological innovation emphasis - with appropriate detail. Minor note: The LLM uses 'FY 2022' and 'FY 2024' terminology while ground truth uses '2022' and '2024', but this is a stylistic variation that doesn't affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 501,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In 2023 Comcast lifted its spending on the Epic Universe project – the cap‑ex line for the park rose to fund land‑acquisition for a possible expansion and early development work (see page 50; also page 37). By 2024 total capital spending was essentially flat, but the company shifted the focus of that spending to the construction phase of Epic Universe, increasing outlays on theme‑park attractions and keeping the new park a top development priority (see page 50), although a separate dollar amount for the Epic Universe investment is not disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer fails to cite the key $8.2 billion figure for Connectivity & Platforms in 2023 that the ground truth explicitly mentions. This is a critical omission of a specific investment amount that directly answers part of the question about 'specific investment amounts.' The ground truth clearly states '$8.2 billion allocated to Connectivity & Platforms' in 2023, but the LLM provides no comparable figure. (2) INCOMPLETE SYNTHESIS - The LLM answer mentions 'land-acquisition for a possible expansion and early development work' but the ground truth emphasizes 'scalable infrastructure and line extensions' as part of the $8.2B allocation. The LLM's characterization is vague and potentially inaccurate regarding what the 2023 capex actually funded. (3) VAGUE CHARACTERIZATION OF 2024 - The LLM states 'total capital spending was essentially flat' in 2024, but the ground truth does not make this claim. The ground truth simply notes that 'specific figures for Epic Universe alone were not disclosed in 2024' - this is different from saying total spending was flat. The LLM appears to be inferring information not present in the ground truth. (4) MISSING CONTEXT - The ground truth explicitly describes an 'evolution' showing 'a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.' The LLM captures some of this (shift to construction phase) but misses the broader strategic evolution narrative. (5) CORRECT ELEMENTS - The LLM correctly identifies that specific figures for Epic Universe alone were not disclosed in 2024, and correctly notes the shift toward construction/attractions in 2024. The page references appear reasonable but cannot be verified. OVERALL: The answer is partially correct on directional trends but fails on the most important quantitative element ($8.2B in 2023) and provides some unsupported claims about 2024 spending being 'flat.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 550,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "FedEx’s 2022 filing projected six ATR‑72‑600F aircraft to be added in 2025 and just one in 2026, but the 2023 filing lifted those forecasts to seven for 2025 and three for 2026, showing a modest increase in the planned use of the ATR‑72‑600F fleet【page_40】【page_117】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM states the 2022 filing projected 'six ATR-72-600F aircraft' for 2025 and 'one' for 2026, but the ground truth clearly shows 2022 projections were 11 for 2023, 6 for 2024, 6 for 2025, and 1 for 2026. The LLM omitted the 2023 and 2024 projections entirely from the 2022 baseline. (2) DIRECTIONAL ERROR: The LLM concludes there was a 'modest increase' in planned use, but the ground truth explicitly states this 'indicates a notable reduction in planned usage.' The comparison shows: 2022 projected 6 for 2025 vs 2023 projected 7 for 2025 (increase of 1), but 2022 projected 1 for 2026 vs 2023 projected 3 for 2026 (increase of 2). However, the ground truth's characterization of 'notable reduction' suggests the overall fleet trajectory declined significantly when considering the full multi-year picture (11→6→6→1 in 2022 vs 7→3 in 2023 for comparable years). (3) INCOMPLETE SYNTHESIS: The LLM failed to capture the complete 2022 projection timeline and the full context of how projections evolved. It only compared 2025 and 2026 figures without acknowledging the earlier years' projections. (4) SEMANTIC CONTRADICTION: The LLM's characterization of 'modest increase' directly contradicts the ground truth's assessment of 'notable reduction,' representing a fundamental misunderstanding of the data's implications. The answer demonstrates incomplete multi-hop reasoning by not synthesizing the full projection timeline across both filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 428,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "In FY 2022 Nike reported a sales‑related reserve of about $1.0 billion and an estimated $194 million of inventory cost for expected product returns, treating the reserve as a balance‑sheet adjustment after revenue was recorded【page_89】. By FY 2024 the company says it now estimates the “most likely” amount of returns, discounts and other claims up‑front, reduces revenue at the time of recognition and records a matching accrued‑liability and inventory cost, showing a shift to a more integrated ASC 606‑style variable‑consideration approach to revenue recognition【page_66】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states FY2022 had '$194 million of inventory cost for expected product returns' but the ground truth clearly states '$269 million' - this is a material discrepancy of $75 million (28% error). The LLM also introduces a '$1.0 billion sales-related reserve' that is not mentioned in the ground truth at all, appearing to conflate or fabricate information. (2) METHODOLOGY DESCRIPTION: While the LLM correctly identifies the shift toward ASC 606-style variable consideration and the 'most likely amount' language for FY2024, it mischaracterizes the FY2022 approach. The ground truth indicates FY2022 reserves were recorded in 'Prepaid expenses and other current assets' (an asset account), not as a 'balance-sheet adjustment after revenue was recorded' as the LLM suggests. (3) DISCLOSURE COMPLETENESS: The ground truth explicitly states that 'by fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed' - the LLM should have acknowledged this lack of FY2024 quantitative disclosure rather than implying comparable measurement. (4) MULTI-HOP REASONING: The LLM attempts to synthesize the evolution but does so with incorrect base numbers and introduces unsupported figures. The core insight about the shift to probabilistic/forward-looking methodology is present but undermined by the quantitative errors. (5) SEMANTIC ISSUES: The characterization of the evolution is partially correct in spirit but factually compromised by the wrong numbers and the introduction of the unexplained $1.0 billion figure. The answer demonstrates understanding of the conceptual shift but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 494,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The 2022 filing showed 12 Cessna SkyCourier 408s scheduled for delivery in 2025 and 14 in 2026, with no further deliveries beyond 2026 (page 114). The 2023 filing increased the 2025 commitment to 17 aircraft while the 2026 figure remained at 14 and still listed no deliveries after 2026 (page 117). This rise in the 2025 allocation signals a stronger near‑term strategic reliance on the SkyCourier, even as the overall planned SkyCourier fleet was trimmed to focus on those later‑delivery units.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 projection. According to the ground truth, the 2022 filing showed 12 Cessna SkyCourier 408s projected for 2025 AND 12 for 2026 (maintained at that level). However, the LLM claims the 2022 filing showed '12 Cessna SkyCourier 408s scheduled for delivery in 2025 and 14 in 2026.' This is incorrect - the 2022 figure for 2026 was 12, not 14. The LLM appears to have confused the 2023 projection (14 for 2026) with the 2022 projection. This is a significant quantitative error that undermines the entire multi-hop comparison. The 2023 numbers are stated correctly (17 for 2025, 14 for 2026), but the baseline comparison is wrong, making the year-over-year analysis flawed. The reasoning about 'stronger near-term strategic reliance' is partially sound, but it's based on an incorrect 2022 baseline. The LLM also adds interpretive language about 'overall planned SkyCourier fleet was trimmed' which is not clearly supported by the ground truth answer and appears to be an unsupported inference. The page citations (114, 117) cannot be verified from the ground truth but are presented with false confidence. The answer demonstrates partial understanding of the question structure but fails on the core quantitative accuracy required for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 376,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "In 2023 Mastercard said its real‑time account‑based payments capability was operating or being rolled out in 13 markets and was built on a “multi‑layered” security framework that protects the network with cyber‑security programs, tokenization, fraud‑scoring and other controls (page 11). By 2024 the platform’s scale had grown sharply – settlement obligations rose to $922 million (from $282 million) and settlement assets moved to a $(593) million outflow (from a $40 million positive balance), reflecting a far larger real‑time payments footprint – while the same integrated, multi‑layered security approach continues to underpin the infrastructure (page 71 and page 11).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 13 markets operating in 2023 and accurately describes the multi-layered security framework with specific controls (tokenization, fraud-scoring, cyber-security programs). The qualitative evolution narrative is sound and addresses both operational scale and security capabilities as requested. However, there are significant quantitative accuracy issues: (1) The settlement obligations figure of $922 million and prior year $282 million cannot be verified against the ground truth, which does not mention these specific balance sheet numbers. (2) The settlement assets figures of $(593) million and $40 million positive balance are presented as evidence of scale growth, but these appear to be balance sheet line items rather than operational metrics directly measuring real-time payments infrastructure scale. (3) The ground truth emphasizes 'distributed network architecture' and 'intelligent routing' as key 2023 capabilities, which the LLM answer omits. (4) The ground truth mentions 'instant payments with enhanced data and messaging capabilities' in 2023, not captured in the LLM response. The LLM answer introduces financial metrics (settlement obligations/assets) that, while potentially relevant to scale, are not mentioned in the ground truth and their connection to 'real-time payments infrastructure evolution' is inferential rather than explicitly stated. The page citations (page 11, page 71) suggest these are from actual filings, but the specific financial figures cannot be cross-verified against the provided ground truth. The answer demonstrates good understanding of the security evolution but oversimplifies the operational scale discussion by relying on balance sheet metrics rather than the operational metrics (market count, network capabilities) emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 499,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike trimmed its foreign‑exchange hedge program after 2022.  The notional amount of forwards and options that were formally designated as cash‑flow hedges fell from $18.5 billion in 2022 to $16.2 billion in 2024, while the pool of undesignated forwards and options grew from $3 billion to $4.4 billion【page_85】.  As a result, derivative liabilities tied to these contracts dropped to $146 million for designated hedges and $5 million for undesignated hedges (total $151 million) on the 2024 balance sheet【page_83】, and the amount of deferred gains expected to be re‑classified from OCI fell from $607 million in 2022 to $231 million in 2024, reflecting a tighter, more actively realized hedging strategy【page_85】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Nike's foreign exchange hedging evolution between 2022 and 2024, with good contextual framing of the strategic shift. However, there are significant discrepancies with the ground truth that affect the quantitative accuracy score.\n\nCORRECT ELEMENTS:\n- The LLM correctly identifies a strategic evolution/trimming of the FX hedge program\n- The notional amounts cited ($18.5B to $16.2B for designated hedges, $3B to $4.4B for undesignated) appear reasonable and show the directional shift\n- The OCI reclassification decline ($607M to $231M) is correctly cited\n- The overall narrative of a \"tighter, more actively realized hedging strategy\" aligns with the ground truth's mention of \"strategic evolution\"\n- The page citations suggest proper sourcing\n\nCRITICAL DISCREPANCIES:\n- Ground truth states 2024 liabilities were $110M (accrued liabilities) + $5M (deferred taxes) = $115M total\n- LLM states 2024 liabilities were $146M (designated) + $5M (undesignated) = $151M total\n- This is a $36M difference (31% variance), which is material\n- Ground truth mentions 2022 had a net gain of $8M after tax, which the LLM does not address\n- The LLM provides more granular breakdown (designated vs. undesignated) than ground truth, but the total liability figure appears inconsistent\n\nMULTI-HOP REASONING:\n- The LLM successfully synthesizes information across multiple years and balance sheet line items\n- The connection between notional amounts, derivative liabilities, and OCI reclassifications is logically sound\n- However, the numerical inconsistency undermines the reliability of the synthesis\n\nCOMPLETENESS:\n- The LLM addresses the evolution of the hedging program comprehensively\n- It covers both designated and undesignated instruments\n- It includes impact on financial liabilities and hedging strategy as requested\n- However, it omits the 2022 net gain impact mentioned in ground truth\n\nThe answer demonstrates good understanding of the topic and provides relevant detail, but the material discrepancy in the 2024 liability figures (particularly the total of $151M vs. expected ~$115M) is a significant quantitative error that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 594,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In the 2022 Form 10‑K, Puffs is listed as a major brand in the Baby, Feminine & Family Care segment under the **Family Care** sub‑category (paper‑towel, tissue, toilet‑paper products)【page_19】. The 2023 Form 10‑K still places Puffs in the same **Family Care** sub‑category of the Baby, Feminine & Family Care segment, even though the segment’s product‑category breakdown was trimmed to only Feminine Care and Family Care (the Baby Care sub‑category was removed)【page_18】. Thus, Puffs’ classification remained in Family Care across both years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Puffs remained in the Family Care sub-category in both 2022 and 2023, which aligns with the ground truth. The answer also accurately notes that the Baby Care sub-category was removed between these years. However, there are significant issues with the answer's characterization of the evolution: (1) The ground truth states that the classification 'remained' in Family Care with a 'simplification or consolidation' of reporting, suggesting minimal substantive change. The LLM answer goes further by claiming the segment breakdown was 'trimmed' and that Baby Care was 'removed,' which adds interpretive detail not clearly present in the ground truth statement. (2) The ground truth mentions 'Tissues' being replaced with 'Tissues' (which appears to be a transcription error in the original), but the LLM answer doesn't address any changes in how tissue products were specifically listed or described. (3) The LLM answer provides more structural context about the segment reorganization (removal of Baby Care sub-category) which, while potentially accurate, goes beyond what the ground truth explicitly states about Puffs' classification evolution. (4) The answer correctly uses 2022 and 2023 as the comparison years and properly identifies the segment and sub-category names. The quantitative accuracy is high since no specific numbers are involved, but the qualitative accuracy is lower because the answer makes claims about segment restructuring that aren't clearly supported by the ground truth statement about Puffs' classification specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 436,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "In the 2022 filing, Tampax was placed in the Baby, Feminine & Family Care segment under the “Feminine Care (Adult Incontinence, Feminine Care)” sub‑category (see 2022 page 19). In the 2023 filing, Tampax remains in the same segment but the sub‑category is now described as “Feminine Care (Adult Incontinence, Menstrual Care)” and the narrative calls it a leader in the menstrual‑care sub‑category (see 2023 page 18). Thus, Tampax’s positioning shifted from a broad feminine‑care grouping to a more specific focus on menstrual‑care products within the same overall segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information. CORRECT ELEMENTS: (1) The core finding that Tampax's positioning shifted from a broader 'Feminine Care' categorization to a more specific 'Menstrual Care' focus is accurate and matches the ground truth. (2) The identification of the segment as 'Baby, Feminine & Family Care' is correct. (3) The years 2022 and 2023 are correctly identified. (4) The general narrative about moving from broad to specific positioning is sound. PROBLEMATIC ELEMENTS: (1) The LLM states that in 2022, Tampax was under 'Feminine Care (Adult Incontinence, Feminine Care)' - this appears to conflate Adult Incontinence with Feminine Care, which is inaccurate. The ground truth indicates Tampax was simply under 'Feminine Care' as a sub-category, not grouped with Adult Incontinence in 2022. (2) The LLM claims that in 2023, the sub-category became 'Feminine Care (Adult Incontinence, Menstrual Care)' - this also appears to incorrectly associate Adult Incontinence with the Tampax categorization. The ground truth indicates Tampax was associated solely with 'Menstrual Care' in 2023, not with Adult Incontinence. (3) The specific page references (2022 page 19, 2023 page 18) cannot be verified against the ground truth but appear to be fabricated details. MULTI-HOP REASONING: The LLM correctly synthesized the evolution across two years and identified the key shift in positioning. However, the specific sub-category descriptions contain factual errors regarding the inclusion of Adult Incontinence. The core insight about the shift from 'Feminine Care' to 'Menstrual Care' is correct, but the intermediate categorization details are inaccurate. This represents a partial understanding with significant categorical errors that undermine the precision of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 491,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "In fiscal 2022 Oracle’s hardware segment—driven by sales of Oracle Engineered Systems, servers and storage—produced $3.2 billion of revenue, a 5% decline from the prior year and roughly a 6‑7% share of total company revenue, and the filing already noted that “we intend to continue to invest significantly in our research and development efforts” (2022 p 51; 2022 p 53). By fiscal 2023 the company positioned the hardware business (including Engineered Systems) as a stable 6% of total revenue and again emphasized that “we expect to continue to make investments in research and development to improve existing hardware products and services and to develop new hardware products and services” (2023 p 43). This reflects a shift from a period of declining hardware sales to a steadier contribution while maintaining a strong, forward‑looking R&D commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear problematic: (1) The claim that hardware revenue was '$3.2 billion' in fiscal 2022 with a '5% decline' and '6-7% share' is not mentioned in the ground truth, which explicitly states 'a figure not specified in 2022.' This is a critical factual error—the LLM fabricated specific numbers not present in the original filings. (2) The ground truth confirms that in fiscal 2023, hardware represented 6% of total revenues, which the LLM correctly states. (3) The LLM correctly identifies the R&D investment language from both years and accurately captures the shift in emphasis from fiscal 2022 to fiscal 2023. (4) The multi-hop reasoning about the evolution from declining sales to steadier contribution is logical but is based on unverified quantitative claims. (5) The LLM appropriately addresses both revenue contribution and R&D investment expectations as requested. However, the introduction of specific dollar amounts ($3.2 billion) and percentage declines (5%) that are not in the ground truth represents a significant accuracy problem. The LLM appears to have either hallucinated these numbers or drawn them from sources not validated against the knowledge graph. The qualitative analysis of the strategic shift is sound, but the quantitative foundation is compromised. The answer demonstrates good understanding of the question's multi-part nature but fails on factual accuracy regarding specific numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 419,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Honeywell’s Non‑U.S. pension plans held $90 million of private‑fund assets in 2022, all classified as Level 2 ($54 m) or Level 3 ($36 m) with no Level 1 holdings. By year‑end 2023 the total rose to $115 million, still with zero Level 1, but the mix shifted to $41 million at Level 2 and $74 million at Level 3 – a $25 million increase overall and a clear move toward more Level 3 (unobservable‑input) assets【page_110】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ENTITY MISMATCH - The LLM answer discusses Non-U.S. pension plans for both 2022 and 2023, but the ground truth explicitly states that 2022 data ($1,105 million) was for U.S. pension plans, not Non-U.S. plans. The LLM conflates these two different pension plan categories. (2) QUANTITATIVE ERRORS - The LLM reports 2022 Non-U.S. private funds as $90 million ($54M Level 2 + $36M Level 3), but the ground truth does not provide 2022 Non-U.S. data; it only provides 2022 U.S. data of $1,105 million (Level 3). The $90 million figure appears to be fabricated or misattributed. (3) INCOMPLETE SYNTHESIS - The question asks about evolution between 2022 and 2023, but the ground truth indicates a major structural change: 2022 had $1,105M in U.S. plans (Level 3), while 2023 had $115M in Non-U.S. plans ($41M Level 2, $74M Level 3). The LLM fails to capture this significant shift from U.S. to Non-U.S. classification and the dramatic decrease from $1,105M to $115M. (4) MISSING CONTEXT - The LLM does not acknowledge or explain the shift from U.S. pension plans in 2022 to Non-U.S. pension plans in 2023, which is a critical aspect of the evolution. (5) CALCULATION VERIFICATION - The LLM's $25 million increase ($90M to $115M) is mathematically correct for the numbers it cites, but those numbers themselves are incorrect relative to the ground truth. The correct comparison should highlight the $1,105M to $115M decrease, representing a 90% reduction in private fund allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 415,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 USD Notes (3.375 % senior notes due April 2024) were still on the balance sheet and were classified as short‑term debt, net of discounts and issuance costs 【page_97】.  In the 2024 filing the company reports that “in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid,” and consequently the earliest remaining debt maturity is now March 2025, indicating the notes were fully retired 【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative facts are correct: the 2014 USD Notes had a 3.375% coupon rate, maturity date of April 2024, principal amount of $1 billion, and were paid in full in April 2024. The answer correctly identifies the 2023 classification as short-term debt net of discounts and issuance costs, and accurately describes the 2024 transition to full retirement. The multi-hop reasoning is sound - the answer synthesizes information across two fiscal years (2023 and 2024 filings) to show the evolution from near-term liability to settled obligation. The inclusion of specific page references (page_97 for 2023, page_58 for 2024) adds credibility. The additional detail about the earliest remaining debt maturity shifting to March 2025 provides useful context that enhances understanding of the debt management. The answer fully addresses all parts of the question: status in 2023 (short-term debt), status in 2024 (fully retired), and specific actions taken (matured and paid in full in April 2024). Minor note: the LLM provides slightly more contextual detail (coupon rate, next maturity date) than the ground truth, but this is additive and not contradictory. Semantic equivalence is maintained throughout - 'fully retired' and 'fully settled' convey the same meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 368,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings list the same “Form of Lowe’s Companies, Inc. Officer Indemnification Agreement” as Exhibit 10.23 (filed April 2 2019) 【page_79†L1-L5】【page_79†L1-L5】. The agreement’s description, exhibit number and filing date are unchanged, showing that Lowe’s continues to rely on the same indemnification framework for its officers, which signals a stable executive‑risk‑management approach and continuity in its governance practices.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM states the Officer Indemnification Agreement is listed as 'Exhibit 10.23' in both 2022 and 2024 filings, but the ground truth clearly identifies it as 'Exhibit 10.43'. This is a significant factual error that undermines the credibility of the answer, as exhibit numbers are precise, verifiable data points. The LLM correctly identifies: (1) the same form was used in both years, (2) the original filing date of April 2, 2019, (3) no amendments were made, and (4) the interpretation about governance continuity and stable executive risk management. However, the exhibit number discrepancy is a material error in quantitative accuracy. The reasoning about what the unchanged agreement indicates (stable governance, predictable leadership protections, aligned corporate governance) is sound and semantically equivalent to the ground truth. The multi-hop synthesis is correct - the LLM properly connected the 2022 and 2024 filings to show continuity. The contextual interpretation about executive risk management and governance is appropriate and relevant. The core narrative is correct, but the specific exhibit number error (10.23 vs 10.43) is a factual mistake that cannot be overlooked in financial document analysis where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 363,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "In the 2022 filing P&G noted that it “compete[s] in the adult‑incontinence category … behind **Always Discreet**, with **over 10 %** market share in the key markets”【page_19】. The 2023 filing says it still “compete[s] … behind **Always Discreet**, with **about 15 %** market share in the markets in which we compete”【page_18】. Thus, Always Discreet’s share rose from just above 10 % to roughly 15 %, while its status as the category leader (P&G competing “behind” it) remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2023 market share figure. The ground truth states that the 2023 filing provides NO specific market share figure for Always Discreet, yet the LLM claims it states 'about 15% market share.' This is a direct contradiction to the original answer which explicitly notes 'no specific market share figure is provided for the brand' in 2023. The LLM appears to have fabricated or misread the 2023 data. Additionally, the LLM's interpretation of 'compete[s] behind Always Discreet' as indicating P&G competing 'behind' (i.e., in second place to) Always Discreet is questionable - this phrasing more likely means P&G competes in the category with Always Discreet as one of its brands, not that Always Discreet is a competitor. The 2022 figure of 'over 10%' is correctly identified. The core issue is the invention of a 15% figure for 2023 that contradicts the ground truth's explicit statement that no specific market share is provided in 2023. The multi-hop reasoning fails because it's based on an incorrect premise about what the 2023 filing contains. The answer does address the question's structure but with fundamentally incorrect data that undermines the entire analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 354,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "In the 2022 filing Oracle described its Engineered Systems as **“core to our cloud‑based and on‑premise data‑center infrastructure offerings”**, emphasizing that they are pre‑integrated appliances that can be delivered on‑premise, as a cloud service in OCI, or as a hybrid‑cloud solution (see page 13). By the 2023 filing, Engineered Systems are mentioned only as one of the products in the **hardware segment, which contributed about 6 % of total revenue**, and the discussion focuses on the hardware business’s lower margins, manufacturing and competition rather than on a cloud‑enabling role (see page 43). This reflects a shift from positioning Engineered Systems as a flagship, cloud‑transformation platform in 2022 to treating them as a supporting line‑item within a modest hardware business in 2023, while Oracle’s overall narrative now leans more heavily on its cloud‑and‑license operations for growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the strategic evolution of Oracle's Engineered Systems between 2022 and 2023, with mostly accurate factual content and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2022 positioning as 'core to cloud-based and on-premise data-center infrastructure' with accurate characterization of pre-integrated appliances and hybrid-cloud delivery options; (2) Accurately cites the 6% hardware revenue contribution figure for 2023/2024; (3) Correctly identifies the shift in narrative emphasis from cloud-transformation platform to supporting hardware line item; (4) Appropriately notes the lower-margin nature of the hardware business; (5) Good multi-hop synthesis connecting the strategic repositioning to Oracle's broader cloud transformation narrative. WEAKNESSES: (1) The LLM characterizes the 2023 positioning as a 'shift' or 'demotion' from 2022, but the ground truth suggests a more nuanced 'elevation' of strategic importance by integrating Engineered Systems into a broader hardware business that includes servers, storage, and operating systems as combined performance obligations - the LLM misses this integration aspect; (2) The LLM emphasizes the de-emphasis of cloud-enabling role in 2023, but the ground truth indicates Oracle was actually leveraging Engineered Systems as 'foundational components in its hybrid cloud and on-premise strategies' - suggesting continued strategic importance rather than diminishment; (3) Missing the specific detail about combined performance obligations and the integration of multiple hardware components; (4) The tone suggests a downgrade in importance, whereas the ground truth suggests a strategic repositioning within a broader hardware ecosystem. QUANTITATIVE VERIFICATION: The 6% revenue figure is correct and properly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and connects to Oracle's cloud transformation narrative, though the interpretation of the strategic direction differs from ground truth. The answer is directionally reasonable but misses the nuance that the 2023 positioning represents elevation through integration rather than demotion to a supporting role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 601,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The 2022 10‑K only said that the 2020 Stock Plan was approved in June 2020 and described its grant provisions, without referencing the earlier plan. The 2023 10‑K adds that the 2020 Stock Plan is the successor to the 2011 Stock Plan and notes that the 5,530,106 shares previously available under the 2011 Plan are now available under the 2020 Plan【page_61】. This new language clarifies the relationship and the carry‑over of shares from the 2011 Plan【page_59】.",
      "correctness_score": 1,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth states that the 2022 10-K included the specific reference to 5,530,106 shares carried forward from the 2011 Stock Plan, while the 2023 10-K OMITTED this reference. The LLM answer reverses this relationship entirely, claiming the 2022 10-K lacked this reference and the 2023 10-K ADDED it. This is a critical factual error that completely inverts the evolution described in the question. The numeric value of 5,530,106 shares is correct, but it is applied to the wrong year's filing. The LLM also incorrectly characterizes the 2022 filing as only describing approval and grant provisions without referencing the earlier plan, when in fact the 2022 filing explicitly mentioned the carry-forward from the 2011 Plan. The multi-hop reasoning failed because the model did not correctly synthesize the temporal evolution between the two filings - it got the direction of change backwards. This is not a minor wording difference but a fundamental misunderstanding of how the disclosure evolved, making the answer semantically opposite to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 326,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s pension portfolios have been moving more capital into private‑fund assets.  In 2023 the non‑U.S. plan’s private‑fund balance rose from $90 million in 2022 to $115 million (Level‑3 funds grew from $36 million to $74 million) and the U.S. plan’s direct private‑investment balance rose from $1,284 million to $1,293 million (Level‑3 private‑funds up from $36 million to $74 million)【page_110】【page_109】【page_111】.  This increase signals a deliberate tilt toward alternative/private‑equity‑type investments, reflecting a priority to diversify the pension assets and pursue higher long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Honeywell's private fund allocation strategy. CRITICAL ERRORS: (1) The LLM reports U.S. plan private-investment balance as $1,284M in 2022 rising to $1,293M in 2023, but the ground truth states $1,244M in 2022 and $1,265M in 2023. The LLM's numbers are incorrect by approximately $40M in 2022 and $28M in 2023. (2) The LLM calculates an increase of only $9M ($1,284M to $1,293M), which is approximately 0.7%, whereas the correct increase is $21M ($1,244M to $1,265M), representing 1.7%. This is a material calculation error. (3) The LLM focuses heavily on non-U.S. plan data ($90M to $115M) and Level-3 fund details that are not part of the ground truth answer, suggesting the model may have confused or conflated different pension plan segments. (4) While the LLM correctly identifies the strategic direction (increased allocation to private funds for diversification and higher returns), the quantitative foundation supporting this conclusion is wrong. The ground truth emphasizes the U.S. plans' total private fund allocation of $1,244M to $1,265M as the primary metric, not the non-U.S. plan figures. The LLM's answer demonstrates partial understanding of the strategic intent but fails on the core quantitative accuracy required for a multi-hop financial question. The reasoning about diversification and long-term returns is sound, but it is built on incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 403,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "In the 2023 filing Visa disclosed that **no Class B‑2 common shares were outstanding** – the Note 15 footnote explicitly says “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer” (page 87). By the 2024 filing the May 2024 exchange offer had created Class B‑2, issuing roughly 120 million shares (49 million weighted‑average shares outstanding for EPS) with a conversion rate of 1.5430 to Class A common stock and a “double‑impact” on conversion‑rate adjustments versus the newly‑renamed Class B‑1 shares (page 89). The 2024 capital‑stock table also shows 123 million authorized Class B‑2 shares, confirming its status as a distinct, outstanding class alongside Class B‑1 and Class C (page 88; EPS table footnote on page 59).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that by 2024, Class B-2 shares were CREATED and OUTSTANDING (~120 million shares issued, 49 million weighted-average for EPS), with a conversion rate of 1.5430. However, the ground truth explicitly states that in 2024, the 10-K filing only referenced Class B-2 in relation to its LACK of outstanding shares prior to the Class B-1 exchange offer, with NO further updates on conversion mechanics. This is a direct contradiction. (2) The LLM references a 'May 2024 exchange offer' that created Class B-2 shares, but the ground truth makes no mention of such an offer creating Class B-2 shares in 2024. (3) The LLM cites specific page numbers (87, 89, 88, 59) and share counts (120 million, 49 million weighted-average, 123 million authorized) that cannot be verified against the ground truth and appear to be fabricated or misattributed. (4) The LLM's characterization of 2024 as showing Class B-2 as 'a distinct, outstanding class' directly contradicts the ground truth's statement that 2024 showed 'no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role.' CORRECT ELEMENTS: The LLM correctly identifies that in 2023, no Class B-2 shares were outstanding prior to the Class B-1 exchange offer. However, this correct element is overshadowed by the major factual errors regarding 2024. The multi-hop reasoning fails because the LLM invents a narrative about Class B-2 becoming active in 2024 that is not supported by the ground truth. The answer demonstrates a fundamental misunderstanding of the evolution described in the ground truth, which shows Class B-2 becoming LESS prominent in 2024, not more.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 497,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle liability grew from $89 million of deferred revenue in fiscal 2022 (as of January 29, 2022) to $117 million in fiscal 2024 (as of February 3, 2024)【page_46】【page_50】—an increase of roughly $28 million (about 30%). This rise shows the loyalty program is expanding, with more members earning rewards and a larger accrued‑revenue obligation, indicating stronger participation and growth of the Target Circle offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the two key deferred revenue figures ($89 million in 2022 and $117 million in 2024) and accurately calculated the increase of $28 million and the percentage growth of approximately 30%. The dates are correct (January 29, 2022 and February 3, 2024). The reasoning about program expansion and increased participation is sound and logically derived from the data. WEAKNESSES: The LLM answer is significantly incomplete. The ground truth explicitly mentions a third critical data point—the sharp drop to $19 million as of February 1, 2025—which fundamentally changes the narrative about the program's evolution. This 2025 figure is essential to answering the question about what the financial obligations 'indicate about the program's evolution,' as it reveals a dramatic reversal that suggests either a surge in redemptions or a strategic change in liability recognition. By omitting this crucial information, the LLM provides an incomplete picture that misses the most recent and significant development. The LLM's interpretation that the 2022-2024 increase 'shows the loyalty program is expanding' is reasonable but becomes misleading when the 2025 collapse is not mentioned. The answer addresses the 2022-2024 comparison adequately but fails to provide the complete evolution narrative that the question asks for. The omission of the 2025 data point represents a substantial gap in answering a multi-year evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 405,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The Level 2 fair‑value of Netflix’s 4.375 % senior notes rose from **$980 million at 12/31/2022 to $996 million at 12/31/2023** – an increase of roughly $16 million (about 1½ % of the $1 billion principal). This gain indicates that investors were willing to pay a higher price for the notes, reflecting a more favorable view of Netflix’s credit standing or broader market conditions (e.g., lower yields or stronger demand for its debt).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value increased from $980 million (12/31/2022) to $996 million (12/31/2023), representing a $16 million increase or approximately 1.6% gain (LLM states ~1.5%, which is a minor rounding variation acceptable for this context). The principal amount of $1 billion is correctly identified. ENTITY ACCURACY: Netflix, the 4.375% Senior Notes, and the specific dates are all correctly identified. The Level 2 fair-value classification is appropriately noted. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by (1) identifying the fair value change, (2) calculating the dollar and percentage increase, and (3) interpreting what this means for investor perception. The interpretation that the increase reflects improved credit standing or favorable market conditions is logically sound and represents a reasonable inference from the data. COMPARISON TO GROUND TRUTH: The ground truth states the fair value 'moved closer to the principal amount at par, suggesting a stabilization or improved outlook.' The LLM's interpretation of 'more favorable view of Netflix's credit standing or broader market conditions' is semantically equivalent and perhaps slightly more detailed in explaining the mechanism (lower yields, stronger demand). Both answers correctly identify that the change indicates positive market sentiment. MINOR DIFFERENCES: The ground truth uses the phrase 'moved closer to par' while the LLM focuses on the absolute increase and investor willingness to pay higher prices - both perspectives are valid and complementary. The LLM provides slightly more granular analysis by specifying Level 2 fair value and offering multiple explanatory factors. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 493,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "The balance‑sheet line for Class C common stock still shows only 10 shares issued and outstanding in both years, listed under “Common stock, $0.0001 par value”【page_58】.  In fiscal 2024 the company issued additional Class C shares – about 48 million shares in the May 2024 class‑B‑1 exchange offer – which pushed the weighted‑average Class C shares from 10 in 2023 to 16 in 2024【page_59】【page_40】, but the equity classification remained unchanged as common stock.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) TIMING ERROR: The LLM states the 48 million Class C shares were issued in 'May 2024', but the ground truth clearly indicates this exchange occurred in 2023, not 2024. This is a critical chronological error that fundamentally misrepresents the evolution timeline. (2) BALANCE SHEET CONTRADICTION: The LLM claims the balance sheet shows 10 shares in both years, which aligns with ground truth. However, it then contradicts itself by stating 48 million shares were issued in 2024, which would change the balance sheet figure - yet the ground truth indicates the balance remained at 10 shares in 2024, suggesting the 48 million issuance was a 2023 event. (3) WEIGHTED AVERAGE SHARES: The LLM introduces weighted-average share data (10 in 2023 to 16 in 2024) that is not mentioned in the ground truth and appears to be fabricated or misinterpreted. The ground truth focuses on actual issued and outstanding shares, not weighted averages. (4) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop information about the Class B-1 to Class C exchange mechanism. The ground truth clearly states 241 million Class B-1 shares were tendered in exchange for 48 million Class C shares in 2023. The LLM mentions the exchange but misplaces it in 2024 and doesn't clearly articulate the B-1 to C conversion ratio. (5) EQUITY CLASSIFICATION: While the LLM correctly notes the equity classification remained unchanged as common stock, this is a minor point that doesn't offset the major chronological and quantitative errors. The core narrative of the answer is inverted - the restructuring activity occurred in 2023 with stabilization in 2024, not ongoing issuance in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 487,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "In the 2022 Form 10‑K, Rough Plumbing was treated as a sub‑category of the “Building Products” segment (2022 net‑sales table, p. 55) and was mentioned only as one of the product lines eligible for extended protection plans (p. 54). By the 2024 filing, Rough Plumbing is listed as a distinct product line (p. 6) and is highlighted as a major driver of both installed‑sales services and protection‑plan coverage (p. 7), showing that Lowe’s has moved from a simple product classification to a broader service‑oriented engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Rough Plumbing from a product classification in 2022 to a service-oriented approach by 2024, and accurately captures the shift from 'Building Products' category to integration with installation services and protection plans. The qualitative reasoning about the strategic shift is sound and well-articulated.\n\nHowever, there are significant issues with quantitative accuracy:\n\n1. MISSING KEY METRIC: The ground truth specifically mentions 'approximately 5% of total sales attributed to installed sales in 2024' - a concrete quantitative anchor that the LLM answer completely omits. This is a material omission for a question asking about business evolution.\n\n2. PAGE REFERENCES: The LLM provides specific page citations (p. 55, p. 54, p. 6, p. 7) that cannot be verified against the ground truth. While these citations may be accurate to actual 10-K filings, they are not confirmed in the provided ground truth and represent unverified claims.\n\n3. INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 2022 classification and 2024 expansion, it fails to quantify the impact of this evolution with the 5% installed sales figure, which is a key metric demonstrating the significance of the shift.\n\n4. ENTITY ACCURACY: All entities (Lowe's, Rough Plumbing, years 2022-2024, Building Products category) are correctly identified.\n\n5. REASONING QUALITY: The multi-hop reasoning is sound - the model correctly synthesizes information about classification changes and service expansion across the two time periods.\n\nThe answer demonstrates good qualitative understanding but falls short on quantitative completeness, which is critical for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 473,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "In the 2023 filing the company reported **no Class B‑2 shares** – the note on page 91 states “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer.” The 2024 filing shows that the **Class B‑2 series was created in 2024** as part of the May 2024 exchange offer (page 89 describes Visa issuing “approximately 120 million shares of class B‑2 common stock” in exchange for retired B‑1 shares). By fiscal‑year‑end 2024 the equity section (page 57) lists 125 million B‑2 shares issued and the earnings‑per‑share tables (pages 59 and 90) record 49 million weighted‑average B‑2 shares outstanding. This evolution indicates that B‑2 was introduced as a new tier within the restricted class‑B capital structure, serving as a transitional vehicle to retire B‑1 shares and move toward freely tradable class C stock while retaining the limited‑voting, litigation‑linked characteristics of the broader class‑B equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on the fundamental timeline and facts. Ground truth states: (1) Class B-2 was NEWLY INTRODUCED in 2023 with 77 million shares outstanding, and (2) By 2024, no shares were outstanding prior to the exchange offer. The LLM answer reverses this entirely, claiming: (1) 2023 had NO Class B-2 shares, and (2) Class B-2 was CREATED IN 2024. This is a complete inversion of the actual evolution. QUANTITATIVE ERRORS: The LLM cites 120 million shares issued in May 2024 and 125 million issued by year-end 2024, with 49 million weighted-average outstanding. The ground truth indicates 77 million shares in 2023. The LLM's numbers don't align with the stated 2023 baseline. The LLM appears to be describing a 2024 exchange offer that may have involved B-2 shares, but this contradicts the ground truth statement that B-2 was introduced in 2023 and then had no shares outstanding prior to the 2024 exchange offer. REASONING FAILURE: The LLM failed to correctly synthesize the multi-hop information about the evolution between 2023 and 2024. The ground truth indicates a transformation where B-2 went from 77 million shares (2023) to zero outstanding prior to an exchange offer (2024), suggesting replacement or restructuring. The LLM instead describes B-2 as newly created in 2024, which contradicts the ground truth's statement of 2023 introduction. The LLM's interpretation of B-2 as a 'transitional vehicle' may be partially correct conceptually, but the timeline and factual basis are fundamentally wrong. ENTITY/DATE ACCURACY: The LLM correctly identifies Visa and the May 2024 exchange offer, but misplaces the introduction date of Class B-2 by one year, which is a critical error for a question specifically about evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 493,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The 2022 Form 10‑K only describes the Target Circle loyalty program (see page 5) and does not disclose a specific liability for it, while the 2024 Form 10‑K reports a deferred‑revenue liability of $117 million as of February 3 2024 and $19 million as of February 1 2025 (see page 50). The $98 million drop in the liability over the two‑year period shows that the program’s outstanding rewards have been largely redeemed or its accounting treatment has tightened, indicating a shift from a rapid‑growth phase to a more mature, lower‑liability stage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a $19 million figure for February 1, 2025, which is NOT part of the ground truth answer and appears to be fabricated or from an unreliable source. The ground truth only addresses 2022 vs 2024 data. The LLM then calculates a $98 million drop (from $117M to $19M), which is mathematically correct IF those numbers were valid, but the $19M figure is not supported by the original answer. (2) FACTUAL CONTRADICTION - The ground truth states that in 2022 'no specific liability figure was disclosed,' and by 2024 there was $117 million in deferred revenue. The LLM correctly identifies the $117 million figure but then contradicts the ground truth's interpretation by introducing unsupported 2025 data and drawing conclusions about program maturity based on a non-existent decline. (3) REASONING FLAW - The LLM's conclusion that the program shifted 'from a rapid-growth phase to a more mature, lower-liability stage' is NOT supported by the ground truth, which indicates the $117 million represents 'substantial growth or expansion.' The LLM's interpretation of declining liability as maturity contradicts the ground truth's interpretation of increasing liability as growth. (4) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize across years, it does so incorrectly by introducing data points not in the ground truth. The correct synthesis should compare 2022 (no disclosed liability) to 2024 ($117 million), indicating growth. (5) WHAT WAS CORRECT - The LLM correctly identifies that 2022 had no specific liability disclosure and that 2024 showed $117 million in deferred revenue. The page references appear reasonable but cannot be verified against ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 474,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "In the 2023 filing NVIDIA first flagged pollution‑limit regulations as a climate‑related risk that could raise direct costs (e.g., changes to manufacturing processes, raw‑material sourcing, capital‑expenditure upgrades) and indirect costs passed on by customers or suppliers, potentially forcing the company to alter its operations or product design【page_22】. By the 2024 filing the company still warned of those cost pressures, but it expanded the exposure to note that regulations limiting energy, water or land – including pollution limits – could also restrict customers’ ability to expand data‑center capacity, thereby threatening demand for NVIDIA’s products and services【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about NVDA's evolving pollution limit concerns between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 baseline concerns about direct costs (manufacturing process changes, raw-material sourcing, capital expenditures) and indirect costs from customers/suppliers. (2) Accurately captures the 2024 expansion of concerns to include land and permitting constraints affecting customer data center expansion capacity. (3) Properly synthesizes the multi-hop connection: pollution regulations → customer data center constraints → reduced demand for NVIDIA products. (4) Uses appropriate company name (NVIDIA) and correct fiscal year references. (5) The semantic meaning aligns perfectly with the ground truth answer despite different wording. (6) Correctly identifies the progression from cost-focused concerns to demand-focused concerns. MINOR OBSERVATIONS: The LLM answer includes citation markers (【page_22】) which are not present in the ground truth but add credibility without detracting from accuracy. The phrasing 'regulations limiting energy, water or land – including pollution limits' is slightly broader than the ground truth's focus on 'pollution limits' specifically, but this represents appropriate contextual expansion rather than error. All factual claims are verifiable and correct. The answer demonstrates sound multi-hop reasoning by connecting regulatory constraints → operational/customer impacts → business implications for NVIDIA.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 428,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "In 2023 Costco’s Japanese subsidiary issued four Guaranteed Senior Notes worth roughly $500, which were recorded under “Other long‑term debt” and valued using Level 3 (unobservable) inputs; the balance of that line was $484 at year‑end 2023. By September 2024 the subsidiary had repaid $77 of the notes, raising “Other long‑term debt” to $919 (reflecting the net $500 issuance less the $77 repayment) and contributing to a decline in the total fair‑value of long‑term debt from about $5,738 to $5,412. The valuation of the Guaranteed Senior Notes continues to rely on Level 3 inputs, while the other senior notes are measured with Level 2 inputs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CALCULATION ERROR - The LLM states 'Other long-term debt' was raised to $919 'reflecting the net $500 issuance less the $77 repayment.' This calculation is fundamentally flawed. $500 - $77 = $423, not $919. The LLM's math is incorrect. (2) INCONSISTENCY - The LLM claims the balance was $484 at year-end 2023, then says it became $919 after a $77 repayment in 2024. This doesn't reconcile: if $484 + $500 (new issuance) - $77 (repayment) = $907, still not $919. The numbers don't add up logically. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) four Guaranteed Senior Notes issued in 2023 totaling ~$500, (b) $77 repayment in 2024, (c) Level 3 valuation inputs for Guaranteed Senior Notes, (d) fair value of long-term debt declining from $5,738 to $5,412, (e) the company is Costco's Japanese subsidiary. (4) MISSING INFORMATION - The LLM does not mention the interest rate ranges (1.400% to 2.120%) that were part of the original answer, which is a notable omission. (5) MULTI-HOP REASONING - The LLM attempts to synthesize information across years and connect the Guaranteed Senior Notes to overall long-term debt fair value changes, which is appropriate, but the calculation errors undermine the credibility of this synthesis. The core narrative is present but marred by mathematical inconsistencies that suggest the LLM may have confused or misinterpreted the underlying data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 393,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "In the 2022 filing Netflix said its technology‑and‑development spend jumped 24% to $2.27 billion, largely because “personnel‑related costs” rose $384 million as the company added head‑count to support more production activity and continued improvements to the streaming service. By the 2024 filing the narrative shifts to risk mitigation: Netflix describes an enterprise‑wide security program overseen by a Vice President of Security and Privacy Engineering, expanded security tools, bug‑bounty and third‑party risk programs, and regular board‑level reporting of cyber‑risk assessments, showing a greater focus on protecting the streaming platform from cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and excellent multi-hop synthesis. Verification of key claims: (1) The $384 million personnel-related cost increase is correctly cited and matches the ground truth exactly. (2) The 24% technology-and-development spend increase to $2.27 billion is accurate and provides additional context not contradicted by the ground truth. (3) The 2022-to-2024 evolution narrative is correctly captured, showing the shift from growth-oriented investment to risk-aware posture. (4) The 2024 cybersecurity details are accurately described: Vice President of Security and Privacy Engineering, enterprise-wide security programs, third-party risk management, bug-bounty programs, and board-level cyber-risk reporting all align with the ground truth's emphasis on cybersecurity focus. (5) The answer correctly synthesizes information across multiple years and filing documents, demonstrating proper multi-hop reasoning. The only minor consideration is that the LLM provides slightly more granular detail about specific security roles and programs than the ground truth explicitly states, but this is additive and not contradictory—it represents legitimate filing disclosures that enhance rather than diminish the answer. The semantic equivalence is strong: both answers convey the same core narrative of evolution from personnel/production investment to cybersecurity risk management. No calculation errors detected. All entities (Netflix, years 2022-2024, specific metrics) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 422,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "In the 2023 10‑K the company disclosed only a single “2023 Form of Restricted Stock Unit Agreement” (Exhibit 10.27/10.24), whereas the 2024 10‑K added a new “2024 Form of Restricted Stock Unit Agreement” (Exhibit 10.29/10.26) and, for the first time, a forward‑looking “2025 Form of Restricted Stock Unit Agreement” (Exhibit 10.29). This shift signals a move from a one‑year‑only RSU template to a staged, lifecycle‑managed program that pre‑positions future RSU issuances, enabling BNY Mellon to align equity vesting and performance criteria more deliberately with its executive compensation and retention strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) ENTITY/FORM IDENTIFICATION ERROR: The LLM claims the 2023 10-K disclosed only a '2023 Form of Restricted Stock Unit Agreement,' but the ground truth explicitly states the 2023 filing introduced the '2024 Form of Restricted Stock Unit Agreement' marked as 'Filed herewith.' This is a fundamental misidentification of which form was disclosed in which year. (2) MISSING KEY INFORMATION: The LLM completely fails to capture the critical distinction that in 2023, the '2024 Form' was newly filed ('Filed herewith'), whereas by 2024, this same form transitioned to 'Previously filed' status. This lifecycle transition is central to the ground truth answer and demonstrates the company's iterative approach. (3) INCOMPLETE SYNTHESIS: The LLM mentions a '2025 Form' in 2024 but misses the crucial context that the '2024 Form' from 2023 became 'Previously filed' in 2024, showing the rolling update pattern. (4) REASONING QUALITY: While the LLM's conclusion about 'staged, lifecycle-managed program' is directionally reasonable, it is built on incorrect foundational facts about which forms appeared in which filings. The ground truth emphasizes the annual introduction of new forms with prior forms becoming reference documents—a specific pattern the LLM does not accurately capture. (5) EXHIBIT NUMBERS: The LLM provides exhibit numbers (10.27/10.24, 10.29/10.26, 10.29) that cannot be verified against the ground truth and appear potentially incorrect or confused. The ground truth does not reference specific exhibit numbers in this manner. The answer demonstrates a fundamental misunderstanding of the filing sequence and the key evolution being tracked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 479,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90 % senior notes consist of two $750 million tranches – one due September 2026 and one due April 2029 – that were issued in November 2023. In the 2023 filing the notes carried $744 million (Sept 2026) and $743 million (Apr 2029) on the balance sheet (HD 10‑K 2023 p. 59), and by the 2024 filing the same tranches show slightly higher carrying amounts of $747 million and $744 million respectively (HD 10‑K 2024 p. 62), while their scheduled maturities (Sept 2026 and Apr 2029) remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) MAJOR ERROR - The LLM claims there are TWO tranches of 4.90% Senior Notes ($750M each due Sept 2026 and Apr 2029), but the ground truth clearly states there is ONE issuance of $750M principal with a maturity date of April 15, 2029 only. There is no September 2026 maturity mentioned in the ground truth. (2) QUANTITATIVE ERRORS - The LLM provides carrying amounts of $744M and $743M for 2023, and $747M and $744M for 2024. The ground truth states the carrying amount was $743M as of January 28, 2024 (after the November 2023 issuance with $3.4M discount from $750M principal). The LLM's numbers don't align with the ground truth's single-tranche structure. (3) STRUCTURAL MISUNDERSTANDING - The LLM fundamentally misrepresents the debt structure by inventing a second tranche with a September 2026 maturity date that doesn't exist in the ground truth. (4) MULTI-HOP REASONING FAILURE - The answer fails to correctly synthesize the evolution from 2023 to 2024 because it's based on an incorrect understanding of the underlying debt structure. (5) MISSING KEY DETAILS - The LLM omits the initial discount of $3.4M and the semi-annual interest payment schedule starting April 15, 2024, which are important structural details mentioned in the ground truth. The answer appears to confuse or conflate different debt instruments or misread the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 399,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Costco’s Japan subsidiary issued four Guaranteed Senior Notes in November 2023, raising about $500 million of debt. In July 2024 it repaid $77 million of those notes, so the “Other long‑term debt” (which consists of the Guaranteed Senior Notes) rose to $919 million at the end of 2024 from $484 million at the end of 2023【page_52】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: issuance of four Guaranteed Senior Notes in November 2023 (~$500 million), repayment of $77 million in July 2024, and the subsidiary involved. However, there are significant quantitative issues: (1) The LLM states 'Other long-term debt' rose to $919 million from $484 million, but this calculation and these specific figures are not verified in the ground truth. The ground truth only mentions the $500 million issuance and $77 million repayment, without providing the ending balance figures cited by the LLM. (2) The LLM provides specific dates (November 2023, July 2024) that are not mentioned in the ground truth, which only references '2023' and '2024' generally. (3) The LLM omits the interest rate ranges (1.400% to 2.120%) that were explicitly mentioned in the ground truth as part of the note characteristics. (4) The LLM adds information about 'Other long-term debt' balances that goes beyond what the ground truth states. While the core narrative about issuance and repayment is correct, the introduction of unverified balance sheet figures and the omission of interest rate details represent incomplete and potentially inaccurate synthesis. The multi-hop reasoning is sound in connecting the 2023 issuance to the 2024 repayment, but the additional financial metrics lack ground truth support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 377,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K risk‑factor sections contain the same warning that “competitors may also develop after‑market services and parts for our products which may detract from our sales,” and that this could “adversely affect our business and financial statements.” The language is essentially unchanged from 2022 to 2023, indicating the risk remains a consistent concern with no new escalation or mitigation noted. (2022 Risk Factors – page 20; 2023 Risk Factors – page 20)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that the risk framing SHIFTED from 2022 to 2023 - from being described as a 'direct threat that could detract from our sales' to being 'Impacted By' competition within a broader context of healthcare industry cost containment trends. The ground truth indicates a relative de-emphasis in severity or strategic recalibration. However, the LLM answer claims 'the language is essentially unchanged from 2022 to 2023, indicating the risk remains a consistent concern with no new escalation or mitigation noted.' This is a direct contradiction of the ground truth's key finding. The LLM correctly identifies that both years contain similar boilerplate language about competitors developing after-market parts, but it fails to recognize the critical distinction in how the risk is contextualized and framed - the shift from primary threat to one of several external pressures. The LLM's conclusion that there is 'no new escalation or mitigation noted' directly contradicts the ground truth's assessment of a strategic recalibration and relative de-emphasis. While the LLM provides accurate page references (page 20 for both years) and correctly cites the basic risk language, it completely misses the nuanced evolution in risk presentation that is central to answering the question. The multi-hop reasoning required here involves comparing not just the literal text but the contextual framing and emphasis across years, which the LLM failed to synthesize properly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 428,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "In the 2022 filing Netflix still relied on a tiered, region‑based pricing model – paid plans ranged roughly from $2 to $27 a month and the company used periodic price hikes to lift average monthly revenue per paying member as net membership additions slowed and inflation pressure grew 【page_24】. By the 2024 filing the company had introduced a lower‑priced ad‑supported tier, tightened enforcement of shared‑account rules and begun bundling new features such as games, advertising and live programming to broaden the value proposition 【page_6】, 【page_7】. These shifts were intended to attract price‑sensitive consumers, boost ARPU and counter competitive, macro‑economic and content‑cost challenges that were threatening member growth and margin expansion 【page_6】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Netflix's evolution from 2022 to 2024, accurately capturing the introduction of ad-supported tiers, enforcement of shared-account rules, and bundling of features like games and live programming. The reasoning about addressing price-sensitive consumers, boosting ARPU, and countering competitive/macroeconomic challenges is sound and well-synthesized. The answer appropriately addresses all parts of the multi-part question regarding pricing strategy, service features, and business challenges.\n\nWEAKNESSES: (1) MISSING QUANTITATIVE DATA: The LLM answer fails to include specific metrics from the ground truth that are central to the question - notably the 19% revenue increase in 2022, 11% growth in average paying memberships, 7% rise in ARPU, and the 50% drop in paid net membership additions. These numbers are critical for demonstrating the evolution and challenges. (2) INCOMPLETE CONTEXT: The answer mentions 'inflation pressure' but doesn't explicitly connect this to the broader macroeconomic conditions acknowledged in the ground truth. (3) VAGUE PRICING RANGES: The statement 'paid plans ranged roughly from $2 to $27 a month' lacks specificity and isn't verified against ground truth data.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound - the model correctly connects early membership acquisition challenges (implied by the need for changes) to the 2024 responses. However, the reasoning would be stronger with the specific quantitative evidence of the 50% drop in net additions that motivated the strategic shift.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - Netflix moved from price-increase-focused strategy to a diversified approach with ad-supported tiers and account enforcement. The identification of challenges (competition, macroeconomic conditions, member growth pressures) matches the ground truth.\n\nJUSTIFICATION: The answer is substantially correct in its qualitative assessment and multi-hop reasoning but loses points for omitting key quantitative evidence that would strengthen the answer and demonstrate deeper engagement with the source material. The missing specific percentages and membership growth figures represent a significant gap in completeness for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 618,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "In the 2022 filing Boeing only warned that a satellite’s failure to meet specifications could **trigger the loss of in‑orbit incentive payments**, treating those payments as a potential exposure but not describing how they are accounted for【page_45】. By the 2023 filing the company says it **recognizes the net present value of the incentive fees as revenue in the construction period**, while still noting that if the satellite does not perform for up to 15 years the customer can stop payments and Boeing may have to refund amounts, making the revenue‑recognition policy explicit and the performance risk more clearly quantified【page_15】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Boeing's disclosure approach between 2022 and 2023, capturing the key shift from general risk acknowledgment to explicit revenue recognition practices and quantified performance risks. The qualitative reasoning about the evolution is sound and addresses the core question well.\n\nHowever, there are significant quantitative gaps:\n\n1. MISSING CRITICAL NUMBER: The ground truth explicitly states that \"By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs.\" This is a concrete, material financial figure that directly demonstrates the financial exposure evolution. The LLM answer completely omits this quantification, which is a major omission for a financial question.\n\n2. INCOMPLETE PROGRAM CONTEXT: The ground truth mentions specific programs (Commercial Crew, KC-46A Tanker, VC-25B) that provide context for the in-orbit incentive payments. The LLM answer does not reference these programs, missing important contextual detail about which programs are affected.\n\n3. PERFORMANCE CRITERIA TIMEFRAME: While the LLM correctly mentions \"up to 15 years post-acceptance,\" the ground truth emphasizes this is tied to the five most significant fixed-price development programs and the $1,585 million in losses, creating a more complete picture of financial exposure.\n\n4. REVENUE RECOGNITION DETAIL: The LLM correctly captures that net present value is recognized as revenue during construction period, but doesn't connect this to the broader context of the $1,585 million loss quantification.\n\nThe LLM answer demonstrates good qualitative understanding of the disclosure evolution and correctly identifies the shift in accounting treatment and risk quantification. The semantic content about revenue recognition and performance risk is accurate. However, the omission of the $1,585 million figure—a key quantitative measure of financial exposure—significantly weakens the answer's completeness for a financial analysis question. The answer reads more like a disclosure/accounting evolution narrative rather than a comprehensive financial exposure analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 586,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the Directors’ Code of Conduct was only mentioned in the “Code of Ethics” section with a specific PDF link ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and a statement that any amendments or waivers would be posted there 【page_13】. By the 2024 filing, the Code is listed together with the Corporate Governance Guidelines, By‑laws and committee charters as a document that is “made available on our website, free of charge,” indicating a more formal, prominent and easily accessible disclosure 【page_3】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) URL DISCREPANCY: The LLM provides a URL with 'inv relations' (with space) while the ground truth shows 'invrelations' (no space). This is a factual error in the specific URL cited. (2) CONTRADICTORY CHARACTERIZATION: The LLM claims the 2024 disclosure is 'more formal, prominent and easily accessible' - this directly contradicts the ground truth which states the 2024 approach represents 'a streamlined but less direct approach to public access.' The ground truth explicitly notes a shift FROM detailed disclosure WITH direct URL TO more general/consolidated reference WITHOUT the direct URL. The LLM has reversed the direction of change. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies that 2023 had a specific PDF link with amendment/waiver disclosure statement, but fails to accurately characterize the 2024 change. The ground truth emphasizes that 2024 removed the direct URL and made references more general/implicit, whereas the LLM suggests 2024 made it MORE accessible. (4) MISSING KEY INSIGHT: The ground truth's central point is that accessibility became LESS direct in 2024 (consolidated reference vs. explicit URL), but the LLM concludes the opposite. (5) PARTIAL CREDIT: The LLM does correctly identify that both years had the Code available on the website and that 2024 grouped it with other governance materials. However, the fundamental interpretation of the evolution is inverted, making this answer substantially incorrect despite capturing some surface-level facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 419,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "In 2022 Mobileye Drive™ was introduced as an SAE L4 self‑driving system (the “Level 4 self‑driving system, Mobileye Drive”) and was first used in early commercial pilots – e.g., collaborations with Udelv for autonomous cargo delivery, Transdev for mobility services, and a consumer L4 design win with Geely 【page_30】. By 2023 the company shifted Mobileye Drive’s role to be the flagship eyes‑off/hands‑off autonomous‑driving platform for AMaaS, targeting transportation‑network companies, public‑transit operators and suppliers of AV‑ready vehicle platforms, often bundled with Moovit’s urban‑mobility and transit‑intelligence services 【page_34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the evolution of Mobileye Drive™ between 2022 and 2023. STRENGTHS: (1) All factual information is correct - accurately identifies 2022 launch as SAE L4 system, correctly names all three 2022 partnerships (Udelv, Transdev, Geely), and properly characterizes the 2023 strategic shift. (2) Quantitative accuracy is perfect - no numeric errors, dates are correct (2022 vs 2023), and all entities are properly identified. (3) Multi-hop reasoning is sound - the answer successfully synthesizes information across two years and multiple sources, showing clear understanding of the strategic evolution from early pilots to defined go-to-market strategy. (4) The answer captures the key strategic shift: from initial commercial pilots with specific partners to a broader targeting of transportation network companies, public transit operators, and AV-ready vehicle platform suppliers. (5) The bundling with Moovit's services is correctly identified as part of the 2023 strategy. (6) Terminology is accurate (AMaaS, eyes-off/hands-off, L4). MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'flagship eyes-off/hands-off autonomous-driving platform for AMaaS' vs 'focus on supplying...to transportation network companies'), but this represents semantic equivalence rather than factual error. The LLM's characterization of the 2023 strategy as 'flagship' and explicitly mentioning 'eyes-off/hands-off' adds helpful context without contradicting the ground truth. The answer is well-structured, cites sources appropriately, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 466,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "In the 2022 filing the Tower Holdings preferred interests were a single $6 billion non‑convertible cumulative issue split into two fixed‑rate series – a September Class A‑1 of $1.5 bn paying a 5.0% preferred distribution and a December Class A‑2 of $4.5 bn paying 4.75%, with quarterly payouts and a five‑year reset. By the 2024 filing AT&T had amended those interests: the original series were re‑designated as Fixed‑Rate Class A Limited Membership Interests that pay a 5.90% distribution and Floating‑Rate Class A Limited Membership Interests that pay SOFR + 250 bps, with a portion moving to the floating class each year over a five‑year transition, while the total principal amount remains $6 bn.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the 2022 structure and 2024 amendments. Quantitative verification: (1) 2022 amounts correct - September Class A-1 at $1.5bn (matches $1,500M in ground truth), December Class A-2 at $4.5bn (matches $4,500M), total $6bn correct; (2) 2022 rates correct - 5.0% and 4.75% match ground truth; (3) 2024 rates correct - 5.90% fixed rate and SOFR + 250 bps floating rate match ground truth; (4) Five-year reset/transition period correctly identified. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from two fixed-rate series in 2022 to a hybrid fixed/floating structure in 2024 with annual transitions. The LLM appropriately identifies this as both structural and rate evolution. Minor observations: (1) The LLM refers to 'Tower Holdings' while ground truth uses 'Tower Preferred Interests' - this is a minor entity naming variation but semantically equivalent in context; (2) The LLM adds context about 'AT&T' making the amendment, which is reasonable contextual information not contradicted by ground truth; (3) The LLM specifies 'quarterly payouts' which is a reasonable detail about distribution frequency not contradicted by ground truth; (4) The LLM correctly notes the total principal remains $6bn through the transition. The answer is comprehensive, addresses the evolution question fully, and maintains factual accuracy throughout. The only minor gap is that the ground truth emphasizes these are '2019 Tower preferred interests' being reclassified, while the LLM doesn't explicitly mention the 2019 vintage, though this is a minor omission that doesn't affect the core answer about structure and rate evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 468,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The OPB plan’s balanced‑index fund was still valued with a market approach that uses the quoted price of an identical Level 1 instrument in both years【page_96】.  In 2022 the Level 3 assets underlying that fund posted net unrealized losses of roughly $42 million (‑$16 M corporate, ‑$11 M mortgage‑backed, ‑$14 M municipal and ‑$1 M real‑asset)【page_96】, whereas in 2023 the same assets recorded net unrealized gains of about $10 million (+$2 M corporate, +$6 M mortgage‑backed, +$3 M other, offset by a $1 M loss on real assets)【page_96】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail beyond the ground truth but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The identification of Level 3 assets and their shift from losses to gains is accurate; (2) The specific values for corporate fixed income ($16M loss in 2022, $2M gain in 2023) and mortgage-backed/asset-backed securities ($11M loss in 2022, $6M gain in 2023) match the ground truth exactly; (3) The reference to market approach and Level 1 valuation is appropriate; (4) The overall narrative of turnaround from losses to gains is correct. SIGNIFICANT ERRORS: (1) The LLM claims 2022 net unrealized losses of 'roughly $42 million' but the ground truth only specifies ($16M) + ($11M) = ($27M) for the two categories mentioned. The LLM adds municipal ($14M) and real-asset ($1M) losses not mentioned in the ground truth, inflating the total; (2) The 2023 net unrealized gains are stated as 'about $10 million' but the ground truth only confirms $2M + $6M = $8M for the two main categories. The LLM adds $3M for 'other' and subtracts $1M for real assets, creating a calculation that doesn't align with ground truth data; (3) The ground truth explicitly mentions the 60/40 equity/debt composition in both years, which the LLM answer omits entirely. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the valuation methodology shift, but the introduction of additional asset categories (municipal, real-asset) not in the ground truth suggests either source confusion or extrapolation beyond what was provided. The quantitative discrepancies are material enough to affect the reliability of the answer, even though the directional narrative is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 476,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "BNY Mellon’s forward‑looking language is essentially unchanged – both the 2023 and 2024 Form 10‑K forward‑looking sections list “accounting developments” alongside regulatory, technology, market and economic factors (2023 p. 3; 2024 p. 3). The identical placement shows that accounting standards remain a recognized material influence, but they have not been elevated to a primary strategic focus, with the firm’s priorities still centered on broader operational, risk‑management and growth initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fundamentally misinterprets the ground truth. (1) FACTUAL ERRORS: The LLM claims the language is 'essentially unchanged' between 2023 and 2024, directly contradicting the ground truth which explicitly documents an expansion of language. The ground truth shows 2023 used simpler language ('may impact our businesses') while 2024 expanded to 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' The LLM completely misses this documented evolution. (2) QUANTITATIVE ACCURACY: The page references (p. 3 for both years) are reasonable but cannot be verified as correct or incorrect from the provided context. However, the claim of identical placement is contradicted by the ground truth's explicit documentation of expanded language. (3) QUALITATIVE/REASONING ERRORS: The LLM's core interpretation is backwards - it concludes accounting standards 'have not been elevated to a primary strategic focus' when the ground truth explicitly states the shift 'indicates a more integrated view of accounting changes as part of strategic risk and planning considerations.' The LLM also misses the key insight that 2024 language tied accounting developments to 'concrete business decisions and performance metrics' including 'capital plans including dividends and repurchases' and 'efficiency savings.' (4) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the evolution across the two years. It treats both years as static rather than identifying the specific changes documented in the ground truth. The answer demonstrates a fundamental misunderstanding of what the question asks - it seeks to understand how emphasis EVOLVED, not whether it remained static. The LLM's conclusion that accounting standards remain 'a recognized material influence' but haven't been 'elevated' directly contradicts the ground truth's finding of increased integration and strategic relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 542,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In the 2023 filing Home Depot warned that a failure to keep stores safe –‑ from organized retail crime, “shrink” and other safety incidents –‑ or to protect its data from cyber‑attacks could “erode trust and confidence with … associates, … impact associate morale and retention” and even damage the brand (2023 p. 20‑22). By contrast, the 2022 filing highlighted a suite of engagement‑focused programs –‑ regular pulse‑check and Voice‑of‑Associate surveys, a digital engagement platform, recognition awards, DEI initiatives and expanded compensation/benefits –‑ that were designed to drive high associate commitment and a positive experience (2022 p. 13). Thus, the newer safety and cybersecurity risks identified in 2023 pose a potential threat to the associate experience that the 2022 engagement initiatives had sought to strengthen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information across 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies the core contrast between 2022 engagement initiatives (pulse surveys, Voice-of-Associate surveys, digital engagement platform, recognition awards, DEI, compensation/benefits) and 2023 risk factors (organized retail crime, shrink, cybersecurity threats). (2) Accurately captures the specific impact language from 2023 filing regarding erosion of trust, associate morale/retention impacts, and brand damage. (3) Properly synthesizes the multi-hop reasoning: 2022 built engagement → 2023 risks threaten those gains. (4) Correctly cites page references (2023 p. 20-22, 2022 p. 13) showing document grounding. (5) No quantitative errors - all numbers and dates are accurate. (6) Semantic equivalence is strong - conveys the same substantive meaning as ground truth while using slightly different phrasing. MINOR CONSIDERATIONS: The LLM answer doesn't explicitly mention the 'four out of five associates emotionally committed' statistic from the ground truth, though this is a minor detail that doesn't affect the core answer's correctness. The answer is slightly more concise than the ground truth but captures all essential elements. The multi-hop synthesis is sound: correctly identifies that 2022 focused on engagement initiatives while 2023 introduced external risks that could undermine those initiatives. Overall, this is a high-quality response that accurately addresses the question's requirement to compare 2022 engagement initiatives with 2023 risk evolution and their potential impact on associate experience.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 459,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "In the 2022 filing the learning curve is mentioned only in a broad “risk‑factor” paragraph – a possible element that could erode program margins if expected cost‑savings from experience fail to materialize. By the 2023 filing, the learning curve is listed explicitly among the key inputs that drive the quarterly cost‑and‑production estimates, and the company notes that it directly influences program gross‑margin forecasts and is factored into its risk‑management and profitability assessments. This reflects a shift from a peripheral risk consideration in 2022 to a core component of the 2023 cost‑model and profit‑risk analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core evolution of the learning curve's role from 2022 to 2023. Both answers correctly identify that in 2022, the learning curve was treated as a risk factor that could negatively impact profitability, while in 2023 it became integrated into cost estimation and production planning. The LLM's characterization of the 2022 treatment as 'peripheral risk consideration' and 2023 treatment as 'core component of cost-model' aligns semantically with the ground truth's distinction between 'unpredictable risk' versus 'predictable and manageable component.' (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required in this question, so this dimension scores perfectly. The answer contains no numeric claims that could be verified or falsified. (3) ENTITY ACCURACY: The answer correctly identifies Boeing as the company, correctly references 2022 and 2023 filings, and correctly identifies the learning curve as the key metric/concept. The mention of 'quarterly cost-and-production estimates' and 'program gross-margin forecasts' are appropriate contextual details. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two years and demonstrates understanding of how the same concept (learning curve) evolved in its treatment and application. The logical progression from risk factor to integrated planning component is sound. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing differs slightly from the ground truth but conveys equivalent meaning. For example, 'erode program margins if expected cost-savings fail to materialize' is semantically equivalent to 'negatively impact program profitability due to production complexities.' The mention of 'supplier performance trends' and 'internal labor efficiency projections' in the ground truth is not explicitly stated in the LLM answer, but this represents a minor omission of supporting details rather than a factual error. The core narrative and conclusion are correct. Minor weakness: The LLM could have been slightly more explicit about the specific production complexities (like the 787 example) mentioned in the ground truth, though this is a detail rather than a core factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 622,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings contain the same disclosure that “certain of our officers or directors have made elections to participate in, and are participating in, our dividend reinvestment plan … and have made, and may from time to time make, elections to have shares withheld … which may be designed to satisfy the affirmative‑defense conditions of Rule 10b5‑1 … or may constitute non‑Rule 10b5‑1 trading arrangements” (Item 9B(b) on page 12 of each filing). Thus, the treatment of the dividend‑reinvestment plan has not materially changed – the 2024 filing repeats the 2023 language, confirming continued officer/director participation and the same caveat about potential Rule 10b5‑1 or non‑Rule 10b5‑1 trading arrangements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core finding. The ground truth states that the 2024 filing OMITTED the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a simplification of disclosure. The LLM answer claims the treatment 'has not materially changed' and that 'the 2024 filing repeats the 2023 language,' which is factually incorrect according to the knowledge graph. The LLM states both filings contain identical language about Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, but the ground truth explicitly indicates this detailed explanation was removed in 2024. The LLM also provides specific page references (Item 9B(b) on page 12) that cannot be verified against the ground truth but appear to be fabricated details. The question asks about how the treatment 'evolved' between years, and the correct answer is that it simplified/changed by removing specificity, not that it remained the same. This is a fundamental misunderstanding of the multi-hop comparison required between 2023 and 2024 filings. The LLM failed to identify the key distinction: presence of detailed trading arrangement disclosure in 2023 versus absence in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 350,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot’s spend on the “interconnected, frictionless” shopping platform rose from $2.6 billion of capital expenditures in fiscal 2021 to $3.2 billion in fiscal 2023 (2021 $2.6 B 【page_6】; 2023 $3.2 B 【page_5】). In 2021 the focus was on blending digital and physical channels, whereas by 2023 the company added mobile‑app navigation, richer product‑landing pages with related items and multiple fulfillment options, personalized marketing messages, and a suite of in‑store upgrades—self‑service lockers, curb‑side pickup, electronic shelf‑labels, re‑designed service desks and expanded self‑checkout—to tailor the experience to each customer’s shopping intent and location (2023 digital/experience details 【page_8】; store upgrades 【page_9】; merchandising tools 【page_7】).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - QUANTITATIVE DISCREPANCY: The LLM claims capital expenditures rose from $2.6B (fiscal 2021) to $3.2B (fiscal 2023), but the ground truth does not mention a $3.2B figure for fiscal 2023. The ground truth only confirms the $2.6B in fiscal 2021 and does not provide a specific capex number for fiscal 2023. The LLM appears to have fabricated or misattributed the $3.2B figure, which is a major factual error on a primary quantitative claim. QUALITATIVE STRENGTHS: The LLM correctly identifies the evolution from general interconnectedness investment (2021) to more refined, data-driven personalization (2023). The specific examples of enhancements are relevant and well-detailed (mobile-app navigation, personalized marketing, in-store upgrades like self-service lockers, curbside pickup, electronic shelf labels, redesigned service desks, expanded self-checkout). These align with the ground truth's description of 'enhanced merchandising information technology tools' and tailoring to 'customers' shopping intent and location.' MULTI-HOP REASONING: The model correctly synthesizes the evolution across fiscal years and identifies the shift in strategy. However, the fabricated capex number undermines the entire quantitative foundation of the answer. ENTITY ACCURACY: Company name and fiscal years are correct. OVERALL ASSESSMENT: While the qualitative description of the evolution is sound and relevant, the introduction of an unverified $3.2B figure for fiscal 2023 is a significant factual error that cannot be overlooked, especially given the emphasis on quantitative accuracy in financial analysis. The answer would have been stronger if it had acknowledged uncertainty about the specific fiscal 2023 capex figure or omitted it entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 478,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "In 2022 Danaher projected about $1.5 billion of capital spending, including $87 million of property‑plant‑and‑equipment purchases funded by government assistance, and in 2023 that PP&E outlay rose to $136 million (up from $87 million) as the company continued to expand manufacturing capacity for its Life Sciences segment, which now includes Aldevron (see page 72). The Aldevron transaction itself was a one‑time cash purchase of roughly $9.6 billion recorded in 2021 with $28 million of transaction costs and $30 million of fair‑value adjustments, and no new Aldevron‑specific acquisition expenses are reported in the 2022 or 2023 filings (see pages 73‑74). Thus, after the 2021 acquisition, Danaher’s financial relationship with Aldevron shifted from large acquisition outlays to ongoing capital investment to grow the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context but contains significant quantitative inaccuracies and introduces information not present in the ground truth. STRENGTHS: (1) Correctly identifies the 2022 capital expenditure projection of ~$1.5 billion; (2) Correctly states the Aldevron acquisition was ~$9.6 billion (matches ground truth's $9,561 million); (3) Correctly notes the shift from acquisition outlays to ongoing capital investment; (4) Appropriately contextualizes Aldevron as part of Life Sciences segment. CRITICAL ERRORS: (1) The LLM introduces specific PP&E figures ($87 million in 2022, $136 million in 2023) that are NOT mentioned in the ground truth answer and appear to be fabricated or misattributed details; (2) The LLM states the Aldevron transaction was 'recorded in 2021' with specific transaction costs ($28 million) and fair-value adjustments ($30 million) - while the acquisition did occur in 2021, the ground truth specifically references 'net cash consideration paid to Aldevron amounting to $9,561 million' in 2023, suggesting the payment/recognition occurred in 2023, not 2021; (3) The LLM's claim that 'no new Aldevron-specific acquisition expenses are reported in the 2022 or 2023 filings' contradicts the ground truth which explicitly mentions $9,561 million in net cash consideration paid in 2023. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but misinterprets the timing and nature of the Aldevron financial relationship. The ground truth indicates a 2023 payment/recognition, while the LLM conflates this with 2021 acquisition timing. SEMANTIC ISSUES: While the conclusion about the relationship shift is reasonable, the specific financial details provided are either unsupported or contradictory to the ground truth. The answer demonstrates good contextual understanding but fails on factual precision regarding key numbers and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 513,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "In the 2022 filing AT&T reported that Telco LLC held a single series of non‑convertible cumulative preferred interests – $2 billion of “Class A‑1” interests that paid an initial 4.25 % annual distribution and reset every seven years 【page_130】. By the 2024 filing the preferred structure had been expanded: a $5.25 billion issuance in April 2023 added “Class A‑2” and “Class A‑3” interests (bringing total Telco preferred interests to $7.25 billion) that pay a higher 6.85 % annual distribution and reset on Nov 1 2027 and every seven years thereafter 【page_87】; and in October 2024 AT&T entered into an agreement to issue a further $2.25 billion of “Class A‑4” interests (to be issued in Q1 2025) with a 5.94 % distribution and a reset on Nov 1 2028 and every four years thereafter 【page_88】. Thus, from 2022 to 2024 the preferred pool grew from $2 billion to $7.25 billion, added new classes with higher rates, and moved from a single seven‑year reset to staggered reset dates (Nov 1 2027 for the 2023‑issued classes and Nov 1 2028 for the planned 2025 issuance).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "MAJOR ISSUE - UNIT CONVERSION ERROR: The LLM answer contains a critical quantitative error in unit conversion. The ground truth states values in millions ($2,000 = $2,000 million = $2 billion; $5,250 = $5,250 million = $5.25 billion; $7,250 = $7,250 million = $7.25 billion). The LLM correctly converted these to billions in the narrative ($2 billion, $5.25 billion, $7.25 billion), which is semantically equivalent and acceptable. However, the LLM introduced ADDITIONAL INFORMATION NOT IN THE GROUND TRUTH: (1) A $2.25 billion Class A-4 issuance planned for Q1 2025 with 5.94% distribution and 4-year reset schedule starting Nov 1 2028. This information is beyond the 2022-2024 timeframe specified in the question and was not mentioned in the original answer. While this may be factually accurate from the 10-K filings, it goes beyond what was provided as ground truth and represents scope creep. CORRECT ELEMENTS: (1) 2022 baseline: $2 billion Class A-1 at 4.25% with 7-year reset - CORRECT; (2) 2023 issuance: $5.25 billion Class A-2/A-3 at 6.85% with Nov 1 2027 reset and 7-year thereafter - CORRECT; (3) Total by 2024: $7.25 billion - CORRECT; (4) Structural expansion and higher-yielding shift - CORRECT. REASONING QUALITY: The multi-hop synthesis is sound - correctly tracking evolution from 2022 to 2024, identifying the April 2023 issuance as the key structural change, and noting the shift to higher distribution rates. The comparison of reset schedules is accurate. ISSUE WITH SCOPE: The question asks specifically about evolution from 2022 to 2024, and the Class A-4 information (October 2024 agreement for Q1 2025 issuance) technically falls outside the 2022-2024 evolution period being asked about, though it was announced in 2024. This represents partial scope creep. The core answer about 2022-2024 evolution is correct, but the addition of forward-looking information not in the ground truth reduces alignment with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 527,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "In the 2022 filing AIG said it applied Expected‑Loss‑Ratio (ELR) methods mainly to **aviation** (for all but the most recent accident year) and to **U.S. workers‑compensation** (including the latest year), using the method where loss‑development data were sparse or severity‑driven. By the 2024 filing the ELR approach is described as a **standard tool across any line** whose loss development is inconsistent, slow‑emerging or has little history—especially for **excess‑of‑deductible business**—and the ratios are now calibrated for rate changes, loss‑trend, inflation and market conditions, showing a broader, more systematic use.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) ENTITY/YEAR CONFUSION: The LLM claims that in 2022, AIG applied ELR to 'aviation (for all but the most recent accident year) and U.S. workers-compensation (including the latest year).' However, the ground truth explicitly states that in 2022, ELR was used 'primarily for the latest accident year' in aviation, NOT for all but the most recent year. This is a direct contradiction. Additionally, the ground truth makes no mention of U.S. Workers' Compensation being used with ELR in 2022—it only appears in 2024. (2) INCORRECT 2022 CHARACTERIZATION: The LLM incorrectly attributes the 2024 characteristics (broader application across lines, excess-of-deductible business, calibration for rate changes, loss-trend, inflation) to the 2022 filing. The ground truth clearly shows these represent the EVOLUTION TO 2024, not the 2022 state. (3) MISSING KEY DISTINCTION: The ground truth emphasizes that U.S. Workers' Compensation is a 'long-tail line of business' added in 2024, which is a significant evolution. The LLM fails to clearly distinguish this as a NEW application in 2024 versus existing in 2022. (4) INCOMPLETE SYNTHESIS: While the LLM does attempt to show evolution, it misplaces the timeline of when each application occurred, fundamentally breaking the multi-hop reasoning required to answer the question correctly. (5) PARTIAL CREDIT: The LLM does correctly identify that there was an expansion/evolution of ELR methods between 2022 and 2024, and it does mention aviation and workers' compensation, but the temporal attribution is severely flawed. The answer demonstrates some understanding of the broader concept but fails on the critical factual details needed for accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 493,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "In the 2023 filing Target’s strategy simply called out “strengthening our owned brands portfolio” as a way to deliver newness, style and value (2023 Form 10‑K Strategy, p. 3). By the 2024 filing the company had turned that intent into measurable execution – owned and exclusive brands now generate roughly one‑third of merchandise sales and the filing lists a much larger, diversified set of owned‑brand names across categories (2024 Form 10‑K Owned Brands, p. 6). This shows a shift from a strategic emphasis on owned‑brand development to a concrete expansion of the product portfolio and a larger share of sales coming from those brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic shift from 2023 to 2024 and correctly identifies the evolution from emphasis to execution. However, there are significant quantitative accuracy issues that prevent a higher score. STRENGTHS: (1) Correctly captures the core narrative - 2023 focused on 'strengthening' owned brands as strategy, 2024 shows concrete execution; (2) Properly identifies the shift from strategic emphasis to portfolio diversification; (3) Good multi-hop synthesis across two years of filings; (4) Appropriate use of filing citations. CRITICAL ISSUES: (1) The claim that 'owned and exclusive brands now generate roughly one-third of merchandise sales' is presented as a specific quantitative fact but cannot be verified against the ground truth, which does not mention this percentage. This is a significant quantitative claim that requires verification; (2) The ground truth states 'over 40 distinct brands' but the LLM answer says 'a much larger, diversified set' without specifying the number, which is less precise; (3) The LLM adds specific page references (p. 3, p. 6) that cannot be verified. REASONING ASSESSMENT: The multi-hop reasoning is sound - the model correctly synthesizes information from 2023 and 2024 filings to show evolution. However, the introduction of unverified quantitative data (the one-third sales figure) is problematic for a financial analysis context where precision is critical. The answer would be stronger if it either verified this number or presented it more cautiously. The semantic equivalence to the ground truth is good regarding the strategic shift narrative, but the additional quantitative claims create factual accuracy concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 467,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM’s 2024 registration still shows the legacy 0.875 % Notes due 2030 (IBM30A) and adds a new 2.900 % Notes due 2030 (IBM30C) — the 0.875 % issue appears in the 2023 filing, while the 2.900 % issue first appears in the 2024 filing (see IBM 10‑K 2024 page 1 and IBM 10‑K 2023 page 1). This mix indicates that IBM is keeping its ultra‑low‑coupon debt on the books while issuing fresh long‑dated paper at the higher rates now prevailing, a strategy that diversifies its maturity profile and leverages its strong credit to obtain new funding despite a higher‑rate environment for long‑term borrowing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key elements of IBM's debt financing strategy. STRENGTHS: (1) All numeric values are correct—0.875% and 2.900% coupon rates are accurately stated, and the trading symbols (IBM30A and IBM30C) are correct. (2) The temporal sequencing is accurate: 0.875% Notes first appear in 2023, 2.900% Notes in 2024. (3) The multi-hop reasoning is sound—the model correctly synthesizes information across two filing years and draws logical conclusions about market conditions and financing strategy. (4) The interpretation that IBM is maintaining legacy low-coupon debt while issuing new debt at higher rates reflects the ground truth's core insight about less favorable interest rate conditions in 2024. MINOR DIFFERENCES: (1) The LLM answer uses slightly different phrasing ('ultra-low-coupon debt,' 'fresh long-dated paper') compared to the ground truth's more formal language, but the semantic meaning is equivalent. (2) The LLM answer emphasizes 'diversifies its maturity profile' while the ground truth emphasizes 'diversify its debt portfolio and manage refinancing risks'—both convey similar strategic intent but with slightly different emphasis. (3) The ground truth explicitly mentions 'targeting different investor segments with varied risk-return profiles,' which the LLM answer does not explicitly address, though it's implied in the discussion of leveraging strong credit. (4) The LLM answer references specific page numbers ('page 1') which adds helpful specificity but is not verified against the actual filings. Overall, the answer captures the essential insight that IBM's dual listing reflects a strategic response to changed market conditions while maintaining financial flexibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 481,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "In the 2022 Form 10‑K AT&T’s long‑term debt was limited to a series of global notes that mostly matured through 2025‑2026 and the 4.000 % Global Notes due June 1 2049 do not appear on that list【page_1】. By the 2024 Form 10‑K the register had been expanded to include the 4.000 % Global Notes due June 1 2049 (T 49A) and a host of newer, longer‑dated issues such as 4.250 % notes due March 1 2050, 3.750 % notes due September 1 2050, and 5.350 %/5.625 % notes due 2066‑2067【page_2】, showing a shift toward longer‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 4.000% Global Notes due June 1, 2049 'do not appear on that list' in the 2022 Form 10-K, but the ground truth explicitly states these notes WERE listed in 2022. This is a fundamental misreading of the source material. (2) MISSING KEY INFORMATION - The ground truth specifically mentions the 4.300% Global Notes due November 18, 2034 (T 34C) as the new addition in 2024, which the LLM completely omits. Instead, the LLM lists different notes (4.250% due 2050, 3.750% due 2050, 5.350%/5.625% due 2066-2067) that are not mentioned in the ground truth answer. (3) INCORRECT CHARACTERIZATION - The LLM incorrectly states that in 2022 AT&T's debt 'mostly matured through 2025-2026,' which misrepresents the debt portfolio composition. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the evolution of the specific debt instruments mentioned in the question. The ground truth focuses on the persistence of the 2049 notes and the addition of the 2034 notes, but the LLM provides a different narrative with different instruments. (5) QUANTITATIVE ACCURACY - While the percentages and dates mentioned are formatted correctly, they reference the wrong instruments entirely. The answer demonstrates a fundamental misunderstanding of what debt instruments were present in each year and how they evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 401,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech deal added $258 million of intangibles amortization (intellectual‑property and customer‑relationship amortization) in 2023, while the company recorded $72 million of restructuring costs that year. In 2024 total intangibles amortization rose to $1,077 million – but the $560 million portion now relates to the NI acquisition, so the AspenTech‑related amortization has essentially faded – and restructuring costs jumped to $228 million【page_55】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect figures for Heritage AspenTech intangibles amortization in 2024. Ground truth states the 2024 figure is $97 million, but the LLM claims it 'has essentially faded' without providing the correct $97 million number. The LLM instead discusses total intangibles amortization of $1,077 million and attributes $560 million to NI acquisition, which is irrelevant to the Heritage AspenTech question and introduces confusion. (2) INCOMPLETE ANSWER - The LLM fails to directly state the 2024 Heritage AspenTech intangibles amortization figure ($97M), which is a critical data point for answering the question about how the financial impact 'evolved.' (3) CORRECT ELEMENTS - The LLM correctly identifies: 2023 intangibles amortization as $258 million, 2023 restructuring costs as $72 million, and 2024 restructuring costs as $228 million. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years and acquisitions, it conflates the Heritage AspenTech acquisition with the NI acquisition, which muddies the analysis. The question specifically asks about Heritage AspenTech evolution, not comparative analysis with other acquisitions. (5) SEMANTIC ISSUES - The phrase 'has essentially faded' is vague and misleading; the correct statement is that amortization decreased from $258M to $97M. The LLM's introduction of NI acquisition data, while potentially from the filing, is not responsive to the specific question about Heritage AspenTech's financial impact evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 430,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s workers‑compensation reserving still relies on a blend of loss‑development, frequency‑severity and expected‑loss‑ratio (ELR) techniques, but the company has sharpened its segmentation – separating guaranteed‑cost and excess‑of‑deductible business, further breaking out the excess segment by deductible size and whether the claim is handled by AIG or a third‑party administrator – and it notes that the proportion of large‑deductible accounts has continued to rise, slowing claim reporting (2022 10‑K p. 260‑261; 2024 10‑K p. 151). The ELR method now receives “significant weight” for excess‑of‑deductible business for the five most recent accident years (and only for the most recent year for guaranteed‑cost), a weighting that is reiterated in the 2024 reserving methodology (2024 10‑K p. 149) and was already described in the 2022 filing (2022 10‑K p. 259). The 2022 filing also referenced specific tail‑factor adjustments and the use of individually priced large accounts, whereas the 2024 filing emphasizes a more uniform application of ELR, indicating a refinement rather than a fundamental shift.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's workers' compensation reserving methodology evolution between 2022 and 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the core methodologies (loss-development, frequency-severity, ELR) used across both years; (2) Accurately describes the segmentation evolution - from basic guaranteed-cost vs. excess-of-deductible in 2022 to more granular segmentation by deductible size and claim handler in 2024; (3) Correctly notes that ELR receives 'significant weight' for excess-of-deductible business across five most recent accident years vs. only most recent year for guaranteed-cost; (4) Properly synthesizes the impact of large deductible accounts on claim reporting patterns; (5) Provides specific page references (2022 10-K p. 260-261, 2024 10-K p. 151, etc.) that add credibility; (6) Correctly identifies the shift toward more uniform ELR application. WEAKNESSES: (1) The LLM answer introduces a claim about 'tail-factor adjustments' and 'individually priced large accounts' in 2022 that are not mentioned in the ground truth, and states these were de-emphasized in 2024 - this represents potential over-specification not supported by the original answer; (2) The ground truth explicitly emphasizes that 2024 disclosures highlighted 'limitations in claim count data due to aggregation and reinsurance exclusions' as a new emphasis not present in 2022, but the LLM answer does not capture this important distinction; (3) The characterization of the change as 'refinement rather than fundamental shift' is reasonable but slightly downplays the increased emphasis on segmentation and large deductible impact noted in the ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is less critical. The page references in the LLM answer appear plausible but cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the evolution in methodology and emphasis. The reasoning connecting segmentation changes to large deductible account impacts is sound. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - AIG evolved from simpler to more granular segmentation, with continued emphasis on ELR methods and growing impact of large deductible accounts. The omission of the claim count data limitations issue and the introduction of unverified details about tail factors represent the primary gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 685,
        "total_tokens": 2186
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "In its 2023 filing Target said it “runs a cyber fusion centre to investigate and respond to threats” and that it “shares threat‑intelligence and collaborates with organizations across different industries” (2023 Form 10‑K p. 17). The 2024 filing repeats the cyber‑fusion‑center model but now frames it as part of a “proactive threat‑intelligence program” that is validated by internal and independent assessments, uses a coordinated escalation process, and is bolstered by third‑party vendor assessments, insurance coverage and continued cross‑industry information‑sharing (2024 Form 10‑K p. 21). Thus, Target’s approach has become more proactive and integrated—still centered on the cyber‑fusion‑center, but with stronger threat‑intelligence, risk‑validation and external‑partner collaboration.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the evolution of Target's cybersecurity approach from 2023 to 2024. STRENGTHS: (1) Correctly identifies the core continuity element (Cyber Fusion Center maintained in both years); (2) Accurately captures the 2023 baseline of threat investigation, response, and cross-industry collaboration; (3) Properly identifies key 2024 enhancements including the coordinated escalation process, third-party vendor assessments, and proactive threat-intelligence framing; (4) Provides specific page citations (2023 Form 10-K p. 17, 2024 Form 10-K p. 21) that add credibility; (5) Correctly synthesizes the multi-hop comparison across two years and multiple operational dimensions; (6) Uses appropriate terminology ('proactive threat-intelligence program,' 'coordinated escalation process,' 'risk-validation'). MINOR GAPS: (1) The ground truth mentions 'regular training and compliance activities for team members' as a 2024 addition, which the LLM answer does not explicitly address (though it does mention 'continued cross-industry information-sharing'); (2) The ground truth specifically mentions informing 'management and the Board of Directors during security incidents,' while the LLM answer references 'coordinated escalation process' without explicitly naming these recipients. QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not directly applicable, but the answer correctly identifies years (2023, 2024) and maintains temporal accuracy throughout. REASONING: The multi-hop synthesis is sound—the answer correctly compares two different time periods, identifies continuities and changes, and explains how the approach became 'more comprehensive and mature' (ground truth language) or 'more proactive and integrated' (LLM language), which are semantically equivalent. The answer demonstrates proper understanding that this is an evolution, not a replacement, of Target's cybersecurity strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 540,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "In 2023 Eli Lilly booked Baqsimi as a product sale – the revenue table shows $677.6 million of Baqsimi net product revenue, driven largely by a $579 million upfront payment for the sale of Baqsimi rights 【page 48】, and the accompanying discussion notes that the “sale of the rights for Baqsimi” contributed to 2023 revenue 【page 47】. In the 2024 filing the same transaction is presented under Collaboration and Other Revenue, with the note that “collaboration and other revenue … includes … the 2023 sales of rights for Baqsimi” 【page 64】, and the company’s collaboration‑revenue policy says such rights‑sale revenue is recognized when control of the asset transfers 【page 66】. This reflects a re‑classification from product‑sale accounting in 2023 to a licensing/collaboration arrangement recognized as collaboration revenue in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Baqsimi's revenue recognition from 2023 to 2024 and accurately captures the strategic shift from product revenue to collaboration/licensing revenue. However, there is a significant quantitative error: the LLM states '$677.6 million of Baqsimi net product revenue' in 2023, but the ground truth specifies only '$579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi.' The $677.6 million figure appears to be incorrect or conflates different revenue categories. The LLM correctly identifies the $579 million upfront payment and accurately describes the reclassification mechanism in 2024 where Baqsimi revenue is now included in 'Collaboration and Other Revenue' rather than standalone product revenue. The reasoning about the shift from direct product revenue to collaborative arrangements is sound and well-supported. The multi-hop synthesis across 2023 and 2024 filings is logically coherent. The main weakness is the introduction of the $677.6 million figure without clear justification and its apparent contradiction to the ground truth's $579.0 million figure. The answer demonstrates good understanding of the accounting treatment and strategic implications but fails on quantitative precision regarding the total Baqsimi revenue amount in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 374,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "In 2023 AT&T eliminated its Mobility II Series A cumulative perpetual preferred interests, repurchasing the remaining 213 million interests for about $5.4 billion – a buy‑back that was largely funded by the $5.25 billion of new non‑convertible cumulative preferred interests issued by Telco LLC in April 2023 (the “April preferreds”) and left no Mobility preferred interests outstanding at year‑end 2023【page_38†L31-L38】【page_86†L31-L38】. By 2024 the focus shifted to reshaping subsidiary capital: AT&T amended its 2019 Tower Holdings preferred interests, creating a 5.90 % fixed‑rate class and a floating‑rate class tied to SOFR + 250 bps (effective November 2024)【page_87†L9-L19】, and announced a further $2.25 billion issuance of Telco LLC preferred interests (adding to the $7.25 billion already outstanding) to fund future redemptions【page_87†L31-L38】【page_88†L1-L9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2023-2024 AT&T capital structure changes. STRENGTHS: (1) Quantitative accuracy is excellent - all key numbers are correct: 213 million Mobility Preferred Interests repurchased for ~$5.4 billion ($5,414M in ground truth), $5.25 billion Telco LLC issuance in April 2023, 5.90% fixed rate and SOFR + 250 bps floating rate for Tower Holdings restructuring, $7.25 billion total Telco LLC preferred interests outstanding. (2) Multi-hop synthesis is sound - correctly connects the 2023 Mobility repurchase funding to the Telco LLC issuance, then pivots to 2024 Tower Holdings restructuring and additional Telco LLC issuance plans. (3) Entity identification is accurate - properly distinguishes between Mobility Preferred Interests, Telco LLC preferred interests, and Tower Holdings preferred interests. (4) Timeline and strategic narrative are correct - captures the shift from repurchasing legacy interests to expanding new preferred structures. MINOR WEAKNESSES: (1) The ground truth specifies the exact balance sheet line items affected ($2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities'), which the LLM answer omits. (2) The ground truth mentions the original $2,000 Telco Class A-1 component within the $7,250 total, providing more granular composition detail that the LLM doesn't explicitly state. (3) The LLM mentions a '$2.25 billion issuance' of Telco LLC preferred interests announced for 2024, which is not explicitly mentioned in the ground truth (though the ground truth does note the total increased to $7,250, suggesting additions beyond the original $5,250). This appears to be additional detail from the source documents rather than an error. CALCULATION VERIFICATION: All arithmetic checks out - $5,250 (2023 Telco issuance) + $2,000 (original Telco Class A-1) = $7,250 total Telco LLC preferred interests. The answer correctly conveys the strategic evolution and capital structure management approach without material factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 565,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson’s tie‑up with AspenTech deepened – after the 2022 Heritage AspenTech deal Emerson held a 55 % majority stake in 2023, and by 2024 it owned about 57 % of the company and announced a cash offer to purchase all remaining shares, moving toward full ownership【EMR_10k_2024.pdf page 26】【EMR_10k_2024.pdf page 25】.  During the same period Emerson’s gross margin rose from roughly 49.0 % in 2023 to 50.8 % in 2024, reflecting the AspenTech integration and related acquisition effects【EMR_10k_2024.pdf page 26】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) TIMELINE ERROR: The LLM claims Emerson held a 55% stake in 2023 following a 2022 Heritage AspenTech deal, but the ground truth indicates the 55% acquisition occurred in 2024, not 2023. The relationship in 2023 was a business partnership, not majority ownership. (2) OWNERSHIP PROGRESSION ERROR: The LLM states ownership went from 55% in 2023 to 57% in 2024, but ground truth shows the 55% stake was acquired in 2024 as the transformational event. The LLM misplaced the timeline by one year. (3) CASH AMOUNT MISSING: The ground truth specifies approximately $6.0 billion in cash was involved in the transaction, which the LLM completely omits. (4) GROSS MARGIN ATTRIBUTION ERROR: The LLM attributes the gross margin increases (49.0% to 50.8% in 2024, a 1.8 percentage point increase) to AspenTech integration, but the ground truth indicates AspenTech contributed a 3.3 percentage point increase in 2023 and 1.8 percentage point increase in 2024 - these are separate contributions, not a single 1.8 point increase from 2023 to 2024. The LLM conflates the 2024 contribution with the overall margin change. (5) STRUCTURAL SHIFT MISSING: The LLM fails to emphasize the fundamental transformation from 'partner' to 'majority shareholder' that occurred in 2024. The LLM does mention moving toward full ownership but misses the significance of the 2024 acquisition as the pivotal transformation point. CORRECT ELEMENTS: The LLM correctly identifies that Emerson increased its ownership stake and announced plans for full acquisition, and correctly cites the 2024 gross margin figure of 50.8%. However, the fundamental chronology is wrong, making the answer misleading about when the relationship transformation occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG’s Japan pension plans continued to represent roughly one‑half of the company’s total non‑U.S. pension obligations – about 50 % of the non‑U.S. projected benefit obligation in the 2022 filing (≈50 % at 12/31/2021) and still about 50 % in the 2024 filing (≈50 % at 12/31/2024)【page_310†L9-L12】【page_183†L9-L12】.  Over the same span the weighted‑average discount rate applied to the Japan plans rose sharply, from roughly 0.52 % at 12/31/2021 (2022 filing) to about 1.81 % at 12/31/2024 (2024 filing)【page_310†L13-L15】【page_183†L13-L16】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) PERCENTAGE CLAIMS: The LLM claims Japan pension plans were 'roughly one-half' (~50%) at 12/31/2021 and remained ~50% at 12/31/2024. However, the ground truth explicitly states: 2022 data shows 61% (not 50%), 2023 shows 54%, and 2024 shows 50%. The LLM fundamentally misrepresents the 2022 baseline and the evolution pattern. (2) DISCOUNT RATE ERRORS: The LLM states the discount rate rose from 'roughly 0.52%' at 12/31/2021 to 1.81% at 12/31/2024. The ground truth shows: 2022 expected long-term rate of return was 1.85%, 2023 discount rate was 1.48%, and 2024 was 1.81%. The 0.52% figure appears to be fabricated or from an incorrect source. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the key narrative of DECLINE from 61% (2022) → 54% (2023) → 50% (2024), instead presenting a static picture. (4) MISSING CONTEXT: The ground truth notes this represents a 'relative decline in the size of the Japan pension plans' - a critical insight the LLM misses by claiming stability. (5) METRIC CONFUSION: The ground truth distinguishes between 'expected long-term rate of return' (1.85% in 2022) and 'weighted average discount rate' (1.48% in 2023, 1.81% in 2024), but the LLM conflates these or uses incorrect values. The answer demonstrates poor multi-hop reasoning and contains multiple factual errors that would mislead users about AIG's pension plan evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 410,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "In the 2022 Form 10‑K Amazon listed competition as a discrete risk, stating that “the introduction of competitive stores, websites, products, services, price decreases, or improvements” could directly affect its sales and operating results【page_9】. By the 2023 Form 10‑K the same competitive‑store risk was embedded in a broader macro‑environmental discussion, noting that competition is amplified by “general economic, business, and geopolitical conditions worldwide,” a “softening of demand,” and shifts in internet/e‑commerce usage, thereby framing competitive pressure as part of external market conditions【page_9】. This reflects a shift from a stand‑alone competition risk to a risk contextualized within wider economic and market dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in Amazon's disclosure between 2022 and 2023 10-K filings. STRENGTHS: (1) Correctly identifies the core competitive language from 2022 ('the introduction of competitive stores, websites, products, services, price decreases, or improvements') that appears in both years; (2) Accurately captures the shift in framing from a discrete risk to one embedded in broader macro-environmental context; (3) Properly synthesizes the multi-hop comparison across two filing years; (4) Correctly identifies the additional contextual elements in 2023 (general economic, business, and geopolitical conditions, softening of demand, shifts in internet/e-commerce usage); (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer adds some specific details ('softening of demand,' 'shifts in internet/e-commerce usage') that, while consistent with the spirit of the ground truth's broader context emphasis, are not explicitly mentioned in the original answer's quoted language. These appear to be reasonable inferences about what 'external economic and geopolitical conditions' encompasses, but they represent slight elaboration beyond what the ground truth explicitly states; (2) The ground truth emphasizes that the 2023 filing 'retained the same core language' while embedding it in broader context - the LLM captures this well but could have been more explicit about the retention of identical language. MULTI-HOP REASONING: The answer correctly synthesizes information across two filing years and identifies the evolution in framing strategy. The comparison is logically sound and addresses the question's focus on how disclosure evolved. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'stand-alone competition risk to a risk contextualized within wider economic and market dynamics' is semantically equivalent to the ground truth's 'shift toward framing competitive pressures as part of a larger set of external risks.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 544,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "In the 2023 Form 10‑K Target listed port‑security as one of many supply‑chain risks and singled out “California ports” as a key gateway for imported merchandise, warning that closures or congestion there could disrupt inventory, raise costs and hurt earnings【page_13】. The 2024 filing still flags port‑security but expands the geographic focus to “major U.S. ports,” indicating a broader exposure, while the operational impact remains the same – potential supply interruptions, higher costs and adverse effects on results of operations【page_15】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Target's port security risk exposure between 2023 and 2024. STRENGTHS: (1) Correctly identifies the geographic shift from 'California ports' (2023) to 'major U.S. ports' (2024), which is the core factual distinction in the ground truth. (2) Accurately captures the operational impacts mentioned: supply interruptions, higher costs, and adverse effects on results of operations. (3) Properly synthesizes the multi-hop information comparing two fiscal years. (4) Correctly attributes statements to the appropriate 10-K filings (2023 and 2024). (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention that in 2023 Target 'had made alternative arrangements due to past disruptions,' which is a specific detail in the ground truth about how the company had already responded to prior issues. (2) The 2024 shift in emphasis from 'past disruptions' to 'potential future impacts' and the mention of 'ongoing global conflicts and labor disputes' as contributing factors is not fully captured in the LLM response. The LLM notes the shift to 'potential future impacts' implicitly but doesn't explicitly reference the global conflicts and labor disputes context. (3) The phrase 'operational impact remains the same' in the LLM answer could be slightly misleading - while the types of impacts are similar, the ground truth suggests a shift in emphasis from past to future impacts. These are relatively minor omissions that don't fundamentally undermine the core answer but represent incomplete synthesis of all contextual details provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 460,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "In 2023 Emerson booked $258 million of intangibles amortization that was directly tied to the Heritage AspenTech acquisition and incurred $72 million of restructuring costs. By 2024 the Heritage‑AspenTech amortization was no longer shown as a separate line (the $1,077 million total intangibles amortization was driven mainly by a $560 million NI‑related charge) while restructuring expenses jumped to $228 million, indicating a shift from acquisition‑related amortization to higher restructuring activity【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $258 million in Heritage AspenTech-related intangibles amortization in 2023, $72 million restructuring costs in 2023, and $228 million restructuring costs in 2024. The answer correctly identifies that the Heritage AspenTech amortization was no longer separately reported in 2024. The multi-hop reasoning is sound, properly synthesizing the evolution of Emerson's financial relationship with Heritage AspenTech across the two years. The LLM provides additional context by noting that the $1,077 million total intangibles amortization in 2024 was driven mainly by a $560 million NI-related charge, which adds helpful detail without contradicting the ground truth. The semantic meaning aligns perfectly with the original answer - both convey that acquisition-related amortization shifted away while restructuring costs increased significantly. The answer appropriately addresses all parts of the question regarding the evolution of the financial relationship. Minor note: The LLM includes a citation reference (【page_55】) which adds credibility but is not part of the ground truth evaluation. The wording differs slightly from the original answer but conveys equivalent information with equal clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 364,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "In the 2022 Form 10‑K AIG noted that Expected‑Loss‑Ratio (ELR) techniques are used for D&O, E&O, EPLI and professional‑liability lines and are “given more weight in the more recent accident years” while older, mature years rely more on loss‑development methods【page_270】. By the 2024 filing the company made the ELR weighting explicit – it may be given “significant weight in the most recent five accident years” (especially for business written in excess of a deductible) and the ELR is now adjusted for rate changes, loss‑trend inflation and market conditions, reflecting a broader, more systematic reliance on ELR for newer accident years across multiple lines【page_149】. This evolution shows AIG moving from a general preference for ELR in recent years to a formal, line‑wide policy that emphasizes ELR in the newest accident years and for excess‑of‑deductible business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AIG's ELR method evolution between 2022 and 2024, with mostly accurate information and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the lines of business where ELR is applied (D&O, E&O, EPLI, professional liability) in both years; (2) Accurately captures the key evolution: from general preference for ELR in recent years to more formal, explicit weighting policies; (3) Correctly notes the shift from 'more weight in recent accident years' (2022) to 'significant weight in most recent five accident years' (2024); (4) Properly identifies the additional adjustments in 2024 (rate changes, loss-trend inflation, market conditions); (5) Provides specific page references that add credibility. WEAKNESSES: (1) The ground truth mentions U.S. Workers' Compensation as a new line of business where ELR was expanded to by 2024, but the LLM answer does not explicitly mention this expansion to a long-tail line of business - this is a notable omission; (2) The ground truth emphasizes the 'broader application of the method across different risk profiles' and 'more integrated approach to reserving in complex portfolios,' but the LLM answer focuses more narrowly on the formalization of weighting policies rather than the expansion to different risk profiles; (3) The ground truth mentions ELR used 'in conjunction with IBNR factor methods' in 2022, which the LLM answer does not capture. QUANTITATIVE ACCURACY: The specific detail about 'most recent five accident years' appears accurate and represents a concrete quantification of the evolution. No mathematical errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across two different years and identifies the evolution pattern, though it misses the dimension of expansion to new lines of business (Workers' Compensation). The reasoning about formalization of policies is sound but incomplete relative to the ground truth's emphasis on broader application across different risk profiles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 547,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Amazon still monetizes its produced and licensed video and music as a single “film‑group” unit, but the underlying asset base and cost structure have shifted.  The capitalized video‑and‑music library grew modestly from $16.7 billion at 12/31/2022 to $17.4 billion at 12/31/2023, while the related expense rose more sharply from $16.6 billion in 2022 to $18.9 billion in 2023【page_49】.  The larger expense increase relative to the modest asset rise suggests Amazon is spending more on licensing/production and accelerating amortization, reflecting a more aggressive content‑investment approach within the same film‑group monetization model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more nuanced analysis than the ground truth. (1) QUANTITATIVE VERIFICATION: All numbers are correct - capitalized costs of $16.7B (2022) and $17.4B (2023), expenses of $16.6B (2022) and $18.9B (2023). The calculations are accurate: asset growth of $0.7B (4.2%) vs. expense growth of $2.3B (13.9%), correctly characterized as 'modest asset rise' vs. 'sharper expense increase.' (2) COMPLETENESS: The answer fully addresses the question about monetization strategy evolution, covering both capitalized costs and expenses across both years. (3) ENTITY ACCURACY: All entities are correct - Amazon, film groups, video and music content, correct fiscal years (12/31/2022 and 12/31/2023). (4) REASONING QUALITY: The multi-hop synthesis is sound and actually superior to the ground truth. The LLM correctly identifies that the disproportionate expense increase relative to asset growth suggests accelerated amortization and more aggressive content investment. This provides deeper insight into the monetization strategy evolution than the ground truth's simpler statement that increases 'indicate a more aggressive investment.' (5) SEMANTIC EQUIVALENCE: The LLM answer conveys all information from the ground truth while adding valuable context about the expense-to-asset ratio disparity and its implications. Minor deduction (1 point) only because the LLM adds interpretive analysis beyond what was explicitly stated in the ground truth, though this analysis is logical and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 424,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "In the 2022 Form 10‑K PMI still held its equity investment in Rothmans, Benson & Hedges Inc. as a de‑consolidated Canadian subsidiary – the filing notes the de‑consolidation of RBH but records no impairment on that stake【page_32】. By the 2024 filing PMI concluded that the fair‑value of the RBH investment was below its carrying amount and booked a non‑cash impairment of $2.316 billion (a $1.49‑per‑share EPS hit)【page_30】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the impairment charge amount of $2.316 billion (matching the ground truth's $2,316 million - same value, different format). (2) The LLM correctly notes that in 2022 there was no impairment recorded, while in 2024 an impairment was booked. (3) The EPS impact of $1.49 per share is provided as additional context. (4) The filing page references are included. WEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM states PMI 'still held its equity investment in Rothmans, Benson & Hedges Inc. as a de‑consolidated Canadian subsidiary' in 2022, but the ground truth indicates that in 2022, PMI maintained a TRADEMARK RELATIONSHIP with RBH, not an equity investment. The ground truth explicitly states the relationship shifted FROM a trademark/brand licensing relationship TO a direct equity investment by 2024. (2) The LLM fails to mention the $32.5 billion Canadian tobacco litigation settlement that was the underlying cause of the impairment. (3) The LLM does not adequately capture the nature of the relationship evolution - it mischaracterizes 2022 as already involving an equity investment when the ground truth indicates this was a trademark/licensing relationship. (4) The LLM does not explain WHY the impairment occurred (unresolved allocation of settlement proceeds among RBH, ITL, and JTIM). MULTI-HOP REASONING: The LLM partially synthesizes the evolution but fundamentally misunderstands the 2022 baseline, claiming an equity investment existed when it was actually a trademark relationship. This is a significant conceptual error that undermines the answer's accuracy regarding how the relationship 'evolved.' The answer captures the 2024 impairment correctly but fails on the 2022 characterization and the causal explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 482,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "In the 2023 filing, Eli Lilly said that a 5 % change in its consolidated sales‑return, rebate and discount liability would alter revenue by roughly **$615 million**. In the 2024 filing the same 5 % change would affect revenue by about **$600 million**. Thus, the sensitivity of net product revenue to those liability changes fell slightly – by roughly $15 million – from 2023 to 2024.【page_53】【page_54】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that in 2024, LLY 'did not provide an updated sensitivity figure' and that there was 'a lack of updated quantitative disclosure compared to 2023.' However, the LLM claims that the 2024 filing disclosed a $600 million sensitivity figure, representing a $15 million decrease from 2023's $615 million. This is fundamentally incorrect. The LLM fabricated a 2024 sensitivity number ($600 million) that does not exist in the actual filing. The 2023 figure of $615 million is correct, but the entire premise of the LLM's comparison is false. The LLM's reasoning that 'sensitivity fell slightly by roughly $15 million' is based on this non-existent 2024 data point. The citations to pages 53-54 appear to be fabricated or misinterpreted, as they do not support the claimed 2024 sensitivity figure. The LLM failed to recognize and accurately convey the key finding from the ground truth: that 2024 lacked the quantitative disclosure that was present in 2023. This represents a major failure in multi-hop synthesis and factual accuracy, as the model invented data rather than acknowledging the absence of updated disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 347,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Bulk shipments remain a core commodity group for Union Pacific. In the 2022 filing the company reported Bulk freight revenues of $6.656 billion, which was roughly 33 % of total freight revenues of $20.2 billion (see pages 35 & 34). By 2024 the 10‑K states that Bulk shipments generated 32 % of freight revenues (see page 6), showing the segment’s share has stayed near one‑third of total freight revenue, with only a modest decline in percentage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and percentages that differ significantly from the ground truth, creating substantial factual discrepancies. QUANTITATIVE ISSUES: (1) The LLM cites $6.656 billion in Bulk freight revenues for 2022 and calculates this as 33% of $20.2 billion total freight revenues. However, the ground truth references an average revenue per car of $3,305 in 2021 (from the 2022 filing), which is a fundamentally different metric - per-unit revenue rather than total segment revenue. The LLM conflates these different measurement approaches. (2) The LLM states 2024 Bulk shipments were 32% of freight revenues, which matches the ground truth's 32% figure for 2024, but the 2022 comparison is problematic since the ground truth doesn't provide a comparable 2022 percentage figure - it only references per-car metrics. (3) The LLM's claim of a 'modest decline' from 33% to 32% is mathematically trivial but may misrepresent the actual evolution if the ground truth's 2022 data point (per-car revenue) cannot be directly compared to 2024 percentage data. QUALITATIVE ISSUES: (1) The ground truth emphasizes a transformation from 'revenue-per-unit perspective to a more strategically embedded and revenue-significant component,' highlighting strategic evolution and operational details (grain, fertilizer, coal, Mexico connections, Canadian interline routes). The LLM answer focuses narrowly on percentage stability and misses this strategic narrative entirely. (2) The LLM provides specific page citations ($6.656B on pages 35 & 34, 32% on page 6) which adds credibility but cannot be verified against the ground truth. (3) The LLM fails to address the qualitative evolution described in the ground truth regarding market coverage and strategic importance. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 and 2024 data but does so by comparing incompatible metrics (per-car revenue vs. percentage of total), which represents a reasoning error. The ground truth's comparison is more nuanced, showing evolution in how the segment is measured and characterized. COMPLETENESS: The LLM addresses the 2022-to-2024 evolution but incompletely - it misses the strategic transformation and operational details that constitute the core of the ground truth answer. The answer is partially correct on the 2024 percentage (32%) but problematic on the 2022 comparison and entirely misses the qualitative evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 650,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "In the 2023 Form 10‑K IBM listed a 0.300 % and a 1.750 % note due 2028, and the 2024 Form 10‑K shows the same two coupons (0.300 % and 1.750 %) for its 2028 notes【page_1】. The unchanged rates indicate IBM has kept its existing low‑coupon, long‑dated debt unchanged, reflecting a strategy of preserving cheap, stable financing rather than refinancing or altering the terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a 0.300% note due 2028 that does not appear in the ground truth answer. The ground truth specifically identifies only the 1.750% Notes due 2028 (IBM 28A) as present in both 2023 and 2024. The LLM's claim about a 0.300% coupon for 2028 notes appears to be factually incorrect or confused with a different security. This is a critical error in financial data accuracy. (2) INCOMPLETENESS - The LLM fails to mention the new debt issuances in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033) that are central to understanding IBM's debt strategy evolution. The ground truth explicitly states these new issuances indicate a broader strategy to issue debt at higher rates for longer maturities. (3) REASONING QUALITY - While the LLM correctly identifies that the 1.750% rate remained unchanged, it misses the strategic context that IBM was simultaneously issuing new debt at significantly higher rates (2.900% and 3.150%), which is crucial to understanding the company's debt management strategy. The conclusion about 'preserving cheap, stable financing' is incomplete without acknowledging the new higher-rate issuances. (4) MULTI-HOP SYNTHESIS - The answer fails to synthesize the complete picture: the unchanged 1.750% notes PLUS the new higher-rate notes in 2024 together tell the story of IBM's strategy. The LLM only addresses half of this synthesis. (5) FACTUAL ERRORS - The introduction of the 0.300% coupon is a significant factual error that undermines credibility and suggests potential confusion or hallucination in the data retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 443,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "In 2023 AT&T eliminated its legacy Mobility II preferred securities – it repurchased all 320 million Series A cumulative perpetual preferred membership interests and removed them from the balance sheet (Note 16, p. 55; “All outstanding Mobility preferred interests were repurchased as of April 2023” p. 86). By 2024 the company had no Mobility preferred interests outstanding, but it broadened its preferred‑equity toolkit, issuing cumulative perpetual common‑stock preferred shares (Series A, B and C) and new subsidiary‑level preferred instruments—including Mobility II non‑controlling interests, a restructuring of Tower Holdings preferred interests, and a planned Telco Class A‑4 issuance (pages 86‑88). This marks a shift from retiring legacy preferred capital in 2023 to actively deploying new preferred instruments in 2024 to support its capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift - AT&T repurchased all Mobility Preferred Interests in 2023 and introduced new preferred instruments in 2024. The answer appropriately references specific page numbers and correctly notes the April 2023 timing of the repurchase. The qualitative narrative about pivoting from legacy to new preferred instruments is sound and well-reasoned. The answer correctly identifies that new instruments were introduced in 2024 including Tower Holdings restructuring and Telco LLC preferred interests.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include critical financial metrics from the ground truth: (1) The redemption value of Mobility Preferred Interests (~$5,340 million) is completely omitted, (2) The annual cash distributions ($373 million) are not mentioned, (3) The Telco LLC preferred interests total of $7,250 million is not specified in the LLM answer. These are material omissions for a question specifically asking about capital structure evolution. The mention of '320 million Series A cumulative perpetual preferred membership interests' appears to be a specific detail but lacks the dollar valuation context.\n\nWEAKNESSES - COMPLETENESS: While the LLM answer mentions new instruments were introduced, it lacks the specific quantification of the Telco LLC expansion to $7,250 million, which is a key metric in the ground truth answer. The answer mentions 'planned Telco Class A-4 issuance' but doesn't provide the total preferred interests value.\n\nMULTI-HOP REASONING: The synthesis across 2023-2024 is logically sound - the answer correctly traces the elimination of Mobility interests in 2023 and the introduction of new instruments in 2024. However, the reasoning would be stronger with the specific financial metrics that quantify the scale of this strategic shift.\n\nSEMANTIC EQUIVALENCE: The core narrative matches the ground truth (elimination then diversification), but the answer is incomplete on the quantitative dimension that is essential for evaluating capital structure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 560,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Amazon’s 2022 Form 10‑K listed the threat from online rivals only as a static item – “the introduction of competitive stores, **web sites**, products, services, price decreases, or improvements” (2022 p. 9). In the 2023 filing the wording was updated to “the introduction of competitive stores, **websites**, products, services, price decreases, or improvements” and was followed by a new clause about “**changes in usage or adoption rates of the Internet, e‑commerce, electronic devices, and web services, including outside the U.S.**” (2023 p. 9), indicating that Amazon now views competition as a dynamic, internet‑adoption‑driven force rather than just the presence of rival sites.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer identifies specific textual changes between 2022 and 2023 filings and attempts to characterize the evolution of Amazon's competitive threat language. However, there are significant issues with accuracy and interpretation: (1) FACTUAL ERRORS: The LLM claims the 2022 filing used 'web sites' (with space) while 2023 used 'websites' (no space), but this appears to be a minor formatting observation that doesn't substantively support the claimed shift in competitive characterization. The ground truth indicates the 2022 language was more general/static, but the LLM presents nearly identical language in both years for the core competitive threat description. (2) INCOMPLETE SYNTHESIS: The LLM introduces a new clause about 'changes in usage or adoption rates of the Internet, e-commerce, electronic devices, and web services' as evidence of the shift, but the ground truth doesn't mention this specific addition as the key differentiator. The ground truth emphasizes a shift from 'general awareness' to 'more direct and strategic competitive stance,' but the LLM's evidence (a hyphenation change and a new clause about internet adoption) doesn't clearly support this characterization. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information across two years but the reasoning connecting the textual changes to the claimed shift in competitive characterization is weak. The claim that adding language about internet adoption rates represents a shift from 'static' to 'dynamic' competition is somewhat speculative. (4) MISSING CONTEXT: The ground truth emphasizes an evolution from 'general operational risk to more strategic and dynamic competitive challenge,' but the LLM focuses on technical wording changes rather than substantive strategic shifts in how Amazon characterizes competitive threats. The answer partially addresses the question but with questionable evidence and incomplete alignment with the ground truth's characterization of the nature of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 537,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "In the 2022 filing PMI described its January 2020 global collaboration with KT&G as an exclusive three‑year agreement that gave PMI the right to commercialize KT&G’s heat‑not‑burn products (e.g., LIL Mini/Plus) outside South Korea and noted that it had begun launching those licensed products in select markets. By the 2024 filing, KT&G‑licensed heat‑not‑burn brands such as Fiit and Miix are listed as part of PMI’s HTU (heated‑tobacco unit) category and are included in the company’s smoke‑free net‑revenue and shipment‑volume totals, showing that PMI’s reliance on KT&G’s heat‑not‑burn offerings has become an integral, ongoing component of its smoke‑free portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2022 filing reference to the January 2020 global collaboration agreement with KT&G is accurate; (2) The three-year exclusive agreement structure is correct; (3) The mention of LIL Mini/Plus products is accurate; (4) The geographic scope (outside South Korea) is correct; (5) The 2024 integration of KT&G products into PMI's smoke-free portfolio is accurate; (6) The characterization of the evolution from distribution to integrated component is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Fiit' and 'Miix' as KT&G-licensed brands in the 2024 filing, but the ground truth specifically mentions 'LIL Mini and LIL Plus' as the products being integrated. The introduction of different product names (Fiit, Miix) without verification against the ground truth is a factual concern - these may or may not be accurate KT&G product names in PMI's portfolio, but they are not mentioned in the original answer; (2) The LLM uses the term 'HTU (heated-tobacco unit)' which is a reasonable categorization but adds terminology not explicitly in the ground truth; (3) The reference to 'smoke-free net-revenue and shipment-volume totals' adds specificity about financial metrics that, while plausible, goes beyond what the ground truth explicitly states about integration. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2022-2024 filings and identifies the shift from distribution partnership to integrated supplier role, matching the ground truth's core narrative. However, the introduction of unverified product names (Fiit, Miix) instead of the confirmed LIL products creates uncertainty about factual accuracy. The answer demonstrates good understanding of the relationship evolution but introduces details not confirmed in the ground truth, which is a significant concern for a financial/factual evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 518,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "IBM’s PWCC Acquisition Long‑Term Performance Plan was administered in both years by the Executive Compensation and Management Resources Committee of the Board (with authority that may be delegated to officers) 【page_28】, and the filing for 2024 repeats that same administration under the 2001 Plan description 【page_17】. In each filing the plan is described as being used **solely** to fund equity awards for employees who became IBM staff through the PwCC acquisition, with senior executives expressly excluded, and this scope has not changed from the 2022 filing 【page_28】to the 2024 filing 【page_18】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts about the PWCC Plan's administration and scope but fails to address the core evolution question that the ground truth emphasizes. Strengths: (1) Correctly identifies the plan's sole use for PwCC employees, (2) Accurately notes senior executives are excluded, (3) Properly cites that administration remained consistent across years, (4) Correctly references the 2001 Plan framework. Critical Weaknesses: (1) The LLM states 'this scope has not changed from the 2022 filing to the 2024 filing,' which directly contradicts the ground truth's key insight about the evolution in language and commitment tone. The ground truth explicitly notes a shift from 'would continue to be used' (2022) to 'has been and will continue to be used solely' (2024), representing a meaningful evolution in how IBM framed its commitment. (2) The LLM completely misses the nuanced distinction about the 'shift in language' and 'stronger commitment to maintaining the plan's current usage without expansion' that the ground truth identifies as the actual evolution. (3) The answer treats the evolution question as asking whether scope changed (it didn't), rather than how the framing and commitment language evolved (it did). The LLM's conclusion that 'scope has not changed' is technically correct but fundamentally misses what the question and ground truth are asking about—the evolution in how IBM described and committed to the plan's usage. This represents a failure in multi-hop reasoning to synthesize the temporal comparison of language and tone across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 437,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "In 2023 AT&T still carried a liability for its Mobility II Series A cumulative perpetual preferred interests – about $2.7 billion in current liabilities and $2.7 billion in non‑current liabilities (total ≈ $5.4 billion) that were re‑classified from equity and reflected in interest expense (see page 25 and page 87). By 2024 the company had fully repurchased all 320 million Mobility preferred interests (the April 2023 redemption of the remaining 213 million for $5.4 billion) and reported no outstanding Mobility preferred interests, removing the liability and any dividend‑repurchase constraints (see page 86). This transition signals AT&T’s broader effort to simplify its capital structure by retiring costly preferred equity and reducing non‑controlling interests, thereby increasing financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AT&T's Mobility Preferred Interests evolution. STRENGTHS: (1) Correctly identifies the $5.4 billion repurchase amount in 2023, matching the ground truth figure of $5,414 million (minor formatting difference acceptable). (2) Accurately states that all Mobility preferred interests were eliminated by 2024 with no outstanding balance. (3) Provides specific details (320 million shares, April 2023 redemption of 213 million) that add credibility and demonstrate source documentation. (4) Correctly synthesizes the multi-hop reasoning: 2023 liability status → 2024 complete elimination → strategic implications for capital structure. (5) Appropriately contextualizes the shift as part of broader capital management strategy. MINOR WEAKNESSES: (1) The LLM answer focuses heavily on the Mobility Preferred Interests details but provides less explicit comparison to other preferred interests (Tower Holdings, Telco LLC) that remained outstanding, which the ground truth mentions as a contrasting point. However, the LLM does mention 'retiring costly preferred equity' which implicitly acknowledges selective approach. (2) The breakdown of $2.7B current + $2.7B non-current liabilities is not explicitly mentioned in the ground truth, though it sums correctly to ~$5.4B. This additional detail is accurate but represents a slightly different analytical angle. QUANTITATIVE VERIFICATION: $5.4 billion figure is correct (matches $5,414M); 320 million shares and 213 million redemption figures appear accurate; timeline (April 2023 redemption, 2024 elimination) is correct. REASONING QUALITY: The multi-hop synthesis is sound - correctly connects 2023 liability status to 2024 elimination to strategic implications about capital structure flexibility. The conclusion about 'simplifying capital structure' and 'increasing financial flexibility' aligns well with ground truth's 'selective approach to managing capital structure.' Overall, this is a high-quality answer with accurate numbers, proper multi-hop reasoning, and appropriate contextual framing, with only minor gaps in comparative analysis versus other preferred interests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 596,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings note that IBM’s debt securities are subject to “governmental and stock‑exchange regulations” that can affect their value (2022 p. 22; 2024 p. 11). The wording is essentially identical, showing that IBM’s regulatory exposure to stock‑exchange rules for its debt securities has remained unchanged between 2022 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that IBM's language EVOLVED from 2022 to 2024, with a shift from describing stock exchange regulations as 'one of several factors' (more general mention) to stating the company is 'subject to' stock exchange regulations (more direct/binding exposure). This represents a meaningful change in regulatory acknowledgment. However, the LLM answer claims the wording is 'essentially identical' and that regulatory exposure 'remained unchanged,' which directly contradicts the ground truth. The LLM correctly identifies that both years mention 'governmental and stock-exchange regulations' affecting debt securities, and the page citations appear plausible, but it completely misses the critical distinction in how the language evolved - from passive/general mention to active/direct subjection. The question specifically asks about how the relationship 'evolved,' and the ground truth demonstrates a clear evolution, while the LLM denies any evolution occurred. This is a significant failure in multi-hop reasoning and semantic analysis. The LLM needed to recognize the nuanced difference between 'one of several factors influencing value' versus 'subject to' regulations, which represents a shift in regulatory posture and acknowledgment. The quantitative accuracy score is higher because the years (2022, 2024) and general topic are correct, but the qualitative accuracy is very low because the fundamental interpretation and synthesis of the regulatory evolution is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 431,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "In fiscal 2022 Disney’s 50 % joint‑venture stake in A+E generated roughly $1.1 billion of equity earnings (reported as “Equity in the income of investees, net”)【DIS_10k_2022.pdf p. 14】. By fiscal 2024 that contribution had fallen to $575 million, a drop of about $485 million, as Disney noted the decline was driven by lower income from A+E【DIS_10k_2024.pdf p. 34‑35】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Disney's 50% stake in A+E generated $1.1 billion in equity earnings in 2022 and $575 million in 2024, representing a $485 million decline. However, the ground truth states that Disney's total equity income from investees decreased by $207 million specifically due to lower income from A+E between 2022-2024. The LLM's figures are approximately 2-3x larger than what the ground truth indicates. The $485 million decline cited by the LLM does not match the $207 million decrease mentioned in the ground truth. (2) CALCULATION ERROR: Even if the LLM's individual numbers were correct, the calculation of $1.1B - $575M = $525M, not $485M as stated. This compounds the error. (3) ENTITY/METRIC CONFUSION: The LLM appears to have confused or inflated the actual equity income contribution figures. The ground truth emphasizes A&E as 'one of the most notable equity method investees' but does not support the $1.1B and $575M figures cited. (4) MULTI-HOP REASONING: While the LLM correctly identified the need to compare 2022 and 2024 figures and recognize the decline, the underlying numbers are fundamentally wrong, making the synthesis invalid. (5) MISSING CONTEXT: The LLM failed to mention CTV Specialty Television, which the ground truth identifies as another significant equity method investee alongside A&E. The answer addresses the right question structure but with materially incorrect data that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 439,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from $16.973 billion at year‑end 2022 (COF 2023 10‑K, page 211) to $18.043 billion at year‑end 2023 (COF 2023 10‑K, page 210), an increase of roughly $1.07 billion. This upward move shows Capital One is expanding its securitization program, using securitized debt more heavily as a long‑term funding source to diversify its wholesale funding mix and support ongoing growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific numbers with page citations and correctly identifies the year-end 2023 carrying value of securitized debt obligations at $18.043 billion, which matches the ground truth. The calculation of the increase ($1.07 billion) is mathematically accurate based on the stated 2022 and 2023 figures ($18.043B - $16.973B = $1.07B). However, there is a critical discrepancy in the baseline comparison: the ground truth references 2022 long-term funding at $42.3 billion as of December 31, 2021, which appears to be a different metric or time period than the LLM's 2022 securitized debt figure of $16.973 billion. The LLM correctly identifies the company as Capital One (COF) and provides proper source citations. The interpretation of the trend differs significantly: the ground truth characterizes the change as 'a strategic shift or reduction in reliance on securitized debt obligations,' while the LLM interprets the increase as 'expanding its securitization program.' This represents opposite conclusions about the company's strategy. The LLM's interpretation is logically sound given the upward trend in securitized debt from 2022 to 2023, but it contradicts the ground truth's characterization. The LLM answer is more specific and detailed with page references, but the fundamental disagreement about what the trend indicates about long-term funding strategy is a significant qualitative issue. The answer addresses both parts of the question (the change and what it indicates), but the strategic interpretation diverges from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 431,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "By 2022 Disney’s international general‑entertainment channels—Fox, National Geographic and Star—were the primary outlets for scripted series, but the company already warned that its expanding DTC focus would shift monetization away from linear licensing (2022 International Channels). By 2024 Disney still airs scripted content on those channels, yet it has accelerated the DTC pivot—producing series for Disney+ and Disney+ Hotstar, merging Star+ into Disney+ in Latin America, and planning an ESPN tile on Disney+—so scripted programming is increasingly being funneled through its streaming services rather than linear channels (2024 General Entertainment; 2024 Direct‑to‑Consumer).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic shift from linear to DTC platforms and correctly identifies the key brands (Fox, National Geographic, Star) and streaming services (Disney+, Disney+ Hotstar). However, there are significant gaps and inaccuracies: (1) MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifies Disney operated 'approximately 220 General Entertainment channels outside the U.S.' in 2022—this specific number is completely absent from the LLM answer, which is a material omission for a quantitative question. (2) INCOMPLETE VENU SPORTS REFERENCE: The ground truth mentions the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery as a significant strategic signal. The LLM answer does not mention Venu Sports at all, missing an important multi-hop connection showing Disney's strategic pivot. (3) MISSING ESPN DTC LAUNCH DETAIL: The ground truth specifically mentions Disney's plans to launch a new DTC offering in 'early fall 2025' with live linear streams of ESPN channels and ESPN+. The LLM answer mentions 'an ESPN tile on Disney+' but lacks the specificity about the 2025 timeline and the dedicated DTC platform for sports content. (4) REASONING QUALITY: The LLM correctly synthesizes the shift from linear to DTC and identifies the key strategic pivot, showing sound multi-hop reasoning. The mention of Star+ merging into Disney+ in Latin America is accurate contextual detail. (5) SEMANTIC ISSUES: The LLM's framing of 'scripted programming being funneled through streaming services' is accurate but somewhat misses the broader strategic emphasis on 'live and sports-driven DTC offerings' highlighted in the ground truth. The answer focuses more on scripted content repositioning than the sports/live content emphasis that appears central to the 2024 strategy. Overall, the answer demonstrates understanding of the directional shift but lacks the quantitative specificity and completeness expected for a comprehensive multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 540,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "In the 2022 filing Tesla’s energy‑storage challenges were framed mainly as a credit‑risk issue – the company’s accounts‑receivable balance (which includes sales of storage systems, financing receivables and regulatory‑credit payments) required an allowance for expected credit losses and could vary with payment timing and government‑rebate cycles, but it was not concentrated in any single counter‑party【page_64】. The 2023 filing, by contrast, shifts the emphasis to operational risk: scaling the production of its storage products now depends on securing enough battery‑cell capacity and raw‑material supply (lithium, nickel, cobalt, etc.) and on successfully ramping new factories; any shortfall could force curtailments or higher‑cost procurement【page_16】【page_17】【page_18】. Thus, the focus moved from managing receivable credit exposure in 2022 to managing supply‑chain and production‑scaling dependencies in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core shift in focus from 2022 to 2023 - from financial/credit risk exposure related to receivables to operational/production scaling risks. The qualitative characterization of the evolution is accurate: 2022 emphasized accounts receivable management and credit loss allowances, while 2023 emphasized supply chain constraints, battery cell capacity, and raw material dependencies. The multi-hop reasoning is sound in synthesizing this shift across the two years. The answer appropriately identifies specific operational challenges (bottlenecks, supplier constraints, facility ramp delays) and supply chain dependencies (lithium, nickel, cobalt). CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY FAILURE: The original answer provides a specific, verifiable number - $627 million in long-term government rebates receivable as of December 31, 2021 - which is a key factual anchor. The LLM answer completely omits this specific dollar amount and instead provides only vague references to 'accounts receivable balance' without quantifying it. This is a significant omission of concrete financial data that was explicitly in the ground truth. (2) TEMPORAL PRECISION: The original answer specifies 'December 31, 2021' as the date for the $627 million figure, providing precise temporal context. The LLM answer lacks this specificity. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the shift in focus, it doesn't explicitly connect the specific $627 million receivable figure to the 2022 disclosure, missing an important quantitative anchor point for the 2022-2023 comparison. (4) MISSING DETAIL: The original answer mentions 'extended collection periods of up to a year or more' which provides important context about the nature of these receivables - the LLM answer doesn't capture this temporal aspect of the receivables. ASSESSMENT: The LLM demonstrates good qualitative understanding of the strategic shift in Tesla's disclosures and reasoning about why the focus changed. However, the failure to include or reference the specific $627 million figure is a material omission that reduces the answer's factual completeness and quantitative rigor. The answer would have been stronger with explicit reference to this key number and the specific date it applies to.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 618,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "In the 2022 filing, syrups were treated as part of the concentrate business – sold to bottling partners and accounted for as “concentrates or syrups” with revenue recognized only when a consolidated bottler sold the finished product (or immediately when sold to an unconsolidated partner)【page_45】. By the 2023 filing, Coca‑Cola highlights a distinct fountain‑syrup operation, stating it now manufactures fountain syrups and sells them directly to fountain retailers (or through authorized wholesalers) while still supplying bottling partners, making syrups a separate channel for immediate‑consumption sales【page_37】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required across 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies the 2022 treatment of syrups as part of concentrate business with conditional revenue recognition (immediate for unconsolidated, deferred for consolidated bottlers); (2) Accurately captures the 2023 shift emphasizing fountain syrups as a distinct operation sold directly to fountain retailers or through authorized channels; (3) Properly synthesizes the evolution from volume-driven metrics to operationally embedded component; (4) Correctly identifies both bottling partners and fountain retailers as key stakeholders in the relationship evolution; (5) No quantitative errors or incorrect dates. MINOR WEAKNESSES: (1) The phrase 'immediate-consumption sales' is slightly imprecise terminology compared to ground truth's 'operationally embedded component' - though semantically similar, the ground truth emphasizes strategic integration rather than consumption type; (2) Could have been slightly more explicit about the shift from 'primarily volume-driven metric' to the new framework, though this is implied; (3) Page citations (page_45, page_37) cannot be verified against ground truth but appear reasonable for 10-K structure. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple business relationships (consolidated bottlers, unconsolidated bottlers, fountain retailers, wholesalers), demonstrating proper understanding of how the role evolved. The core insight about the shift from revenue recognition mechanics to operational integration is sound and matches the ground truth's characterization. No factual errors detected in the financial or operational descriptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 483,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney’s Other Mortgage‑ and Asset‑Backed Securities holdings rose from $84 million in FY 2022 (≈ 1% of the fair‑value hierarchy) to $120 million in FY 2023 and $166 million in FY 2024. Despite the dollar increase, the investment’s share of the total fair‑value assets stayed essentially unchanged at about 1% each year.【page_104】【page_107】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) FY 2022 value: LLM states $84 million, but ground truth shows $96 million - a $12 million discrepancy. (2) FY 2023 value: LLM introduces $120 million for FY 2023, but the ground truth only provides FY 2022 ($96M) and FY 2024 ($120M) data - FY 2023 is not mentioned in the original answer. (3) FY 2024 value: LLM states $166 million, but ground truth clearly shows $120 million - a $46 million error. The LLM appears to have fabricated or misread the FY 2024 figure entirely. (4) Percentage accuracy: While the LLM correctly identifies the 1% proportion for each year, this is overshadowed by the incorrect dollar amounts. (5) Multi-hop synthesis: The LLM failed to correctly synthesize the two-year comparison (FY 2022 to FY 2024) that was the core of the question. The answer does address the trend question and correctly notes the stable proportional representation, but the underlying numbers are fundamentally wrong. The inclusion of FY 2023 data (which wasn't in the ground truth) and the completely incorrect FY 2024 figure ($166M vs. $120M) represent critical factual failures. The page citations provided cannot verify the accuracy of these numbers based on the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 366,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings describe Skunk Works (the Advanced Development Programs) as concentrating on the same next‑generation capabilities – unmanned and manned aerial systems and “next‑generation” air‑dominance, hypersonics, intelligence‑surveillance‑reconnaissance, situational‑awareness and air‑mobility – while emphasizing rapid‑prototype design, technology insertion and network‑enabled integration. In other words, the focus areas did not shift between 2022 and 2023; they remained consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental question. The ground truth explicitly states that focus areas EVOLVED between 2022 and 2023, with a specific shift: 2022 included 'unmanned and manned aerial systems' while 2023 emphasized 'air dominance' as a core capability. The LLM incorrectly claims 'the focus areas did not shift between 2022 and 2023; they remained consistent.' This is factually wrong. The ground truth clearly identifies a refinement of priorities where 'air dominance' became emphasized in 2023 whereas the 2022 description focused on 'unmanned and manned aerial systems.' The LLM conflates the two years' descriptions and misses the key evolution. While the LLM correctly identifies some capabilities (hypersonics, ISR, situational awareness, air mobility) that appear in both years, it fails to recognize and articulate the actual shift in emphasis. The LLM also adds details about 'rapid-prototype design, technology insertion and network-enabled integration' that, while potentially accurate, are not part of the ground truth answer and don't address the core question about how focus areas evolved. The quantitative accuracy score is high because there are no specific numbers to verify, but the qualitative accuracy is very low because the LLM fundamentally misunderstood the nature of the change (evolution vs. consistency) and reached the opposite conclusion from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 405,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "In the 2022 filing Tesla said it was improving Powerwall availability and “emphasizing cross‑selling with our residential solar energy products” to capture growing customer interest while ramping production to meet that demand【page_34】. By the 2023 filing the company stresses that Solar Roof and Powerwall are “designed to integrate” and that a modular, vehicle‑technology‑derived battery architecture is being used to “optimize manufacturing capacity of our energy storage products,” reflecting a tighter product integration and a stronger focus on scalable production of Powerwall units【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the 2022 emphasis on cross-selling Powerwall with residential solar products and the 2023 shift toward designed integration. The specific quotes about 'emphasizing cross-selling' and 'designed to integrate' are accurate and well-sourced. (2) QUANTITATIVE ACCURACY: No numerical claims are made, so this dimension is not applicable, but the answer avoids any erroneous numbers or dates. The years 2022 and 2023 are correctly referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the evolution from a sales/availability focus (2022) to a technical/strategic integration focus (2023). The connection between Solar Roof, Powerwall, and battery architecture is properly established. (4) COMPLETENESS: The answer addresses both parts of the question - integration strategy AND production emphasis. The 2022 section covers availability and cross-selling; the 2023 section covers designed integration and manufacturing optimization. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insight as the ground truth: a shift from sales-driven cross-selling to engineered product integration. The phrase 'modular, vehicle-technology-derived battery architecture' adds technical specificity that enriches the answer while remaining consistent with the ground truth's characterization of 'deeper technical and strategic integration.' The inclusion of page references (page_34, page_7) demonstrates source attribution. Minor: The answer could have explicitly mentioned 'grid stability concerns' from 2022, but this is a minor omission that doesn't significantly detract from the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 494,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "In the 2022 filing, Gilead presented Biktarvy as a flagship, revenue‑generating HIV product—a once‑daily, single‑tablet regimen that sits at the center of its HIV portfolio (2022 10‑K, p. 5). By the 2024 filing, the company’s discussion of HIV now emphasizes the commercial vulnerability of its TAF‑based suite—including Biktarvy—citing risks such as competitive market‑share loss, generic entry and a possible shift away from nucleoside‑based regimens that could depress sales (2024 10‑K, Risk Factors, p. 18). This marks a shift from positioning Biktarvy as a core growth driver to acknowledging heightened competitive and paradigm‑change risks around the drug.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Biktarvy's 2022 positioning as a flagship, revenue-generating HIV product with accurate description of its formulation (once-daily, single-tablet regimen combining bictegravir, emtricitabine, and TAF). (2) Accurately captures the 2024 shift toward emphasizing commercial vulnerabilities and risks, including competitive market-share loss, generic entry, and paradigm shifts away from nucleoside-based therapies. (3) Properly synthesizes the multi-hop comparison across 2022 and 2024 filings, showing the evolution from growth-driver positioning to risk acknowledgment. (4) Correctly identifies the core issue: overreliance on TAF-based products creating vulnerability. (5) Appropriately cites specific filing locations (2022 10-K p. 5, 2024 10-K Risk Factors p. 18), adding credibility. (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: The LLM answer is slightly more specific in citing page numbers and risk categories (competitive loss, generic entry) compared to the ground truth's more general framing of 'shift in treatment paradigms.' However, this represents added specificity rather than error—the LLM correctly identifies the specific risks that constitute the paradigm shift concern. The semantic equivalence is strong: both answers convey that Biktarvy evolved from a core growth product to a vulnerable asset dependent on TAF-based therapies. The reasoning chain is sound and multi-hop synthesis is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 432,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "In the 2022 10‑K the U.S. Retrospective Responsibility Plan was described as consisting of the U.S. litigation escrow agreement, the conversion feature of the company’s class B common stock, the indemnification obligations of Visa U.S.A. members, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement 【page_71】. The 2023 10‑K keeps all of those components but adds “makewhole agreements relating to the class B‑1 common‑stock exchange offer” to the list of mechanisms 【page_72】. Thus, the plan’s composition expanded in 2023 to include makewhole agreements in addition to the original escrow‑related mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about changes to the U.S. Retrospective Responsibility Plan between 2022 and 2023. (1) CORRECTNESS: All factual information is correct. The 2022 components are accurately listed (U.S. litigation escrow agreement, conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, interchange-judgment-sharing agreement, loss-sharing agreement, and omnibus agreement). The 2023 addition of 'makewhole agreements relating to the class B-1 common-stock exchange offer' is correctly identified. (2) QUANTITATIVE ACCURACY: No numerical calculations are required for this question, but all entity names, years (2022, 2023), and specific mechanism names are precisely correct. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across two years of 10-K filings and identifies both continuity (retention of original mechanisms) and change (addition of new makewhole agreements). The conclusion that the plan 'expanded' is logically supported. (4) CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question's focus on composition changes and mechanisms referenced in relation to the U.S. Litigation Escrow Agreement. The citation references (page_71, page_72) add credibility. Minor deduction from perfect score (9 vs 10) only because the answer could have slightly emphasized that the U.S. Litigation Escrow Agreement itself was retained as a core mechanism, though this is clearly implied in the statement 'keeps all of those components.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 444,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "Biktarvy remains a cornerstone of Gilead’s HIV franchise – the 2022 filing shows its primary compound patents run through 2033 in both the United States and the EU (2022 10‑K, patent‑expiration table on page 11). By 2024 the company’s risk‑factor discussion still stresses that a “substantial portion of our revenue” comes from HIV products and warns that loss of market share or generic competition could force a scale‑back of R&D (2024 10‑K, HIV risk factors on page 18 and product‑commercialization risks on page 19). Thus, the long‑term patent protection keeps Biktarvy strategically vital, while the ongoing HIV‑dependency disclosures highlight both its revenue importance and the vulnerability if that protection erodes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY ON PATENT EXPIRATION: The LLM claims Biktarvy patents expire in 2033 in BOTH the United States AND the EU. However, the ground truth explicitly states that in 2022, Biktarvy had a U.S. patent expiration in 2033 but 'no expiration listed in the E.U.' This is a significant factual error that contradicts the original answer's key finding about differential patent protection across regions. The LLM's statement that patents run through 2033 'in both the United States and the EU' is incorrect and materially changes the strategic analysis.\n\nCORRECT ELEMENTS: The LLM correctly identifies (1) Biktarvy as a cornerstone of Gilead's HIV franchise, (2) the 2033 U.S. patent expiration date, (3) the 2024 risk factor disclosures about HIV product dependency, (4) the vulnerability to generic competition and market share loss, and (5) the overall strategic tension between long-term patent protection and market pressures.\n\nMULTI-HOP REASONING: The synthesis across 2022 and 2024 filings is logically sound and addresses the evolution question appropriately. The connection between patent protection and risk disclosures is well-articulated.\n\nSEMANTIC ISSUES: The LLM's framing that patent protection 'keeps Biktarvy strategically vital' while acknowledging vulnerability is reasonable, though the ground truth emphasizes that despite protection, the strategic position has 'become more vulnerable' - a subtle but important distinction about the direction of change.\n\nPAGE REFERENCES: The LLM provides specific page citations (page 11 for patent table, pages 18-19 for risk factors) which adds credibility, though these cannot be independently verified against the ground truth provided.\n\nOVERALL: The patent expiration error in the EU is a material factual mistake that significantly undermines the answer's accuracy, despite otherwise sound reasoning and mostly correct supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 518,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "The 2023 Form 10‑K includes a guarantee for Illinois Bell Telephone Company listed as Exhibit 4‑d (the same 2011‑dated guarantee that covers multiple Bell subsidiaries). The 2022 excerpts contain no guarantee reference for Illinois Bell, and the 2023 filing does not disclose any amendment or new structure—so the guarantee’s structure and the documentation it cites remain unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the guarantee structure remained unchanged between 2022 and 2023, and accurately references Exhibit 4-d and the 2011 Form 10-K filing date. However, there are significant issues with the reasoning and completeness: (1) The LLM states '2022 excerpts contain no guarantee reference for Illinois Bell' which contradicts the ground truth that explicitly states the guarantee WAS referenced in 2022 under Exhibit 4-d. This is a material factual error in the multi-hop reasoning. (2) The ground truth clearly establishes that BOTH 2022 and 2023 contained the same guarantee reference (Exhibit 4-d, Form 10-K ending December 31, 2011), but the LLM suggests the 2022 filing lacked this reference entirely. (3) While the LLM correctly concludes no modifications occurred, the reasoning path is flawed because it mischaracterizes the 2022 filing status. (4) The LLM does correctly identify that the guarantee covers 'multiple Bell subsidiaries' and that no amendments or new structures were disclosed. The quantitative accuracy is acceptable (dates and exhibit numbers are correct), but the qualitative accuracy suffers from the incorrect assertion about 2022 documentation. The answer reaches the right conclusion but through partially incorrect intermediate reasoning, which is problematic for multi-hop synthesis verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 379,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The conversion rate for Class C to Class A common stock remained at 4.0‑to‑1 in both 2022 and 2023 (Note 15‑Stockholders’ Equity, page 87). Because the rate did not change, the number of Class A shares that could be created from a Class C conversion – and thus any dilution of voting power for existing Class A shareholders in a merger or other significant transaction – stays at the same level, not increasing the voting‑power impact (see discussion of voting dilution on page 32).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: the Class C to Class A conversion rate remained at 4.0-to-1 in both 2022 and 2023. The numeric accuracy is strong - the conversion rate is stated correctly and the years are accurate. The answer appropriately cites the source (Note 15-Stockholders' Equity, page 87) and references relevant discussion on page 32.\n\nHowever, there are notable differences from the ground truth answer:\n\n1. OMISSION OF CONTEXT: The ground truth provides additional context about the as-converted Class A common stock value increasing from 38 million to 39 million shares, which adds nuance to the analysis. The LLM answer omits this detail entirely.\n\n2. REASONING DEPTH: The ground truth explicitly states that despite the value increase, the unchanged conversion rate indicates 'no structural change in how Class C stockholders could influence significant corporate decisions.' The LLM answer focuses more narrowly on the mechanics of dilution (\"the number of Class A shares that could be created from a Class C conversion... stays at the same level\") without fully exploring the implications for Class A stockholders' relative influence.\n\n3. SEMANTIC ALIGNMENT: The ground truth emphasizes that the stability of the conversion rate means 'relative voting power dilution for Class A common stockholders remained stable.' The LLM answer states dilution \"stays at the same level, not increasing the voting-power impact,\" which is similar but slightly different in emphasis - the LLM focuses on non-increase rather than stability of relative impact.\n\n4. COMPLETENESS: The ground truth directly addresses the question's core inquiry about \"potential impact on Class A common stockholders' voting power\" by explaining what the stable rate suggests about structural stability. The LLM answer addresses this but with less explicit connection to the broader implications.\n\nThe answer is fundamentally sound and factually accurate on the key metric (4.0-to-1 conversion rate in both years), but lacks the comprehensive context and deeper analytical synthesis present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 574,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "In 2022 Tesla presented the Solar Roof as a standard part of its energy‑generation portfolio—offered with financing options and produced at its dedicated Gigafactory New York site (2022 p. 9). By the 2023 filing the tone had shifted to risk‑focused language, emphasizing that the Solar Roof’s launch and production ramp could face delays and that its success now hinges on expanding manufacturing capacity and managing supplier and supply‑chain dependencies (2023 p. 15‑16). This marks a move from a product‑offering focus to a production‑ramp and strategic‑dependency focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the key evolution of Tesla's Solar Roof relationship from 2022 to 2023. It accurately captures that in 2022, Tesla directly produced the Solar Roof at Gigafactory New York as part of its standard energy portfolio, and by 2023, the narrative shifted to emphasize risks, delays, supply chain constraints, and manufacturing capacity challenges. (2) QUANTITATIVE ACCURACY: While the question itself contains no specific numerical values to verify, the LLM appropriately cites page references (2022 p. 9 and 2023 p. 15-16) which adds credibility and specificity. These page citations appear reasonable for 10-K filings and support the claims made. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two different strategic perspectives. It correctly identifies the transition from a 'product-offering focus' to a 'production-ramp and strategic-dependency focus,' which directly mirrors the ground truth's characterization of moving from 'production-centric view to a more cautionary outlook on strategic execution risks.' (4) ENTITY ACCURACY: Tesla is correctly identified, the Solar Roof product is properly named, Gigafactory New York is accurately referenced, and the 2022-2023 timeframe is correct. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('move from a product-offering focus to a production-ramp and strategic-dependency focus') is semantically equivalent to the ground truth's 'transition from a production-centric view to a more cautionary outlook on strategic execution risks.' Both convey the same fundamental shift in Tesla's positioning. The only minor consideration is that the LLM provides slightly more specific detail about financing options and page references, which enhances rather than detracts from the answer. No factual errors or calculation issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 533,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "In the 2022 filing Coca‑Cola described syrups as an intermediate product sold to its bottling partners, who mix the syrups (or concentrates) with still or sparkling water and sweeteners to create the finished beverages that are then packaged and sold to retailers, wholesalers or fountain‑retail outlets【page_6】.  The 2023 filing repeats that same bottler‑to‑finished‑beverage flow, but shows a modest shift in the business mix: the share of net operating revenue (and case volume) coming from concentrate operations—including syrups—rose from 56 % to 58 % (and from 82 % to 83 % of volume) between 2022 and 2023, indicating a slightly greater reliance on syrups while the distribution channels remain unchanged【page_37】【page_38】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses key elements of the ground truth. CRITICAL ISSUES: (1) The LLM claims concentrate operations (including syrups) revenue share rose from 56% to 58% and volume from 82% to 83% between 2022-2023, but provides no source verification for these specific percentages. The ground truth does not mention these quantitative metrics at all, suggesting the LLM may have fabricated or misattributed data. (2) The LLM fundamentally misses the core evolution described in the ground truth: the 2023 shift toward DIRECT management of fountain syrup sales by Coca-Cola (not just through bottling partners) and the specific inclusion of fountain syrup operations in the North America operating segment. This represents a strategic shift toward tighter control that the LLM completely overlooks. (3) The LLM states 'distribution channels remain unchanged,' which directly contradicts the ground truth's emphasis on a strategic shift toward more structured, regionally-focused distribution with direct Coca-Cola management. (4) The LLM correctly identifies syrups as intermediate products and mentions the bottler-to-finished-beverage flow, which aligns with 2022 description, but fails to capture the 2023 evolution regarding direct sales management and segment-specific organization. (5) The citation references (page_37, page_38) are provided but the specific percentages cited (56%, 58%, 82%, 83%) cannot be verified against the ground truth and appear to be unsupported claims. The answer addresses the basic question structure but misses the substantive strategic evolution that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 455,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The Africa/Eurasia market remains a distinct report‑able operating segment of the Oral, Personal & Home Care business in both filings – the 2022 10‑K lists the five geographic segments (North America, Latin America, Europe, Asia‑Pacific and Africa/Eurasia) and the 2024 10‑K repeats the same structure, noting only a broader skin‑health realignment that required a recasting of historic segment data【page_116】【page_114】.  Financially, Africa/Eurasia’s net sales rose modestly from $1.082 billion in 2022 to $1.095 billion in 2024 and operating profit grew from $228 million to $253 million, while capital expenditures fell sharply from $30 million to $12 million, indicating a slightly larger contribution but reduced investment focus【page_116】【page_115】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific financial numbers that directly contradict the ground truth: Operating profit is stated as $228M (2022) and $253M (2024), but the ground truth explicitly states $203M for 2022. This is a $25M discrepancy for 2022 alone - a material error. Net sales figures ($1.082B and $1.095B) are not verified in the ground truth but cannot be confirmed. Capital expenditure figures ($30M to $12M) are also unverified. (2) STRUCTURAL ACCURACY - The LLM correctly identifies that Africa/Eurasia remained a distinct reportable segment in both years and mentions the skin health realignment, which aligns with ground truth. However, the LLM states the segment structure includes 'five geographic segments' which is accurate but the ground truth doesn't explicitly confirm this count. (3) MULTI-HOP REASONING - The LLM attempts to synthesize geographic structure evolution and financial contribution, but the fundamental financial numbers are wrong, undermining the entire analysis. The ground truth indicates Africa/Eurasia was 'relatively minor' with $203M operating profit in 2022, but the LLM's $228M figure contradicts this characterization. (4) MISSING CONTEXT - The ground truth emphasizes that the 2024 structure represents a 'more nuanced operational focus' and 'strategic refinement,' which the LLM mentions but doesn't adequately emphasize as a key evolution point. The LLM's statement about 'modest' sales growth and 'slightly larger contribution' may be accurate directionally but is built on incorrect baseline numbers. The sharp capex reduction is noted but not contextualized against the ground truth's emphasis on strategic realignment. VERDICT: While the LLM demonstrates understanding of the structural question and attempts multi-hop synthesis, the material error in the 2022 operating profit figure ($228M vs. $203M ground truth) is a critical factual failure that significantly undermines credibility and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 539,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "In the 2023 Form 10‑K Johnson & Johnson reported Orthopaedics as a revenue line within MedTech, showing $8.9 billion of worldwide sales (U.S. $5.5 bn + International $3.4 bn) – a 4.1 % increase versus 2022 – and broke the business out into sub‑segments such as knees ($1.456 bn), trauma ($2.979 bn), spine ($2.947 bn) and others【page_90†L31-L38】【page_91†L1-L27】.  \nThe 2024 filing, however, presents Orthopaedics more as a strategic portfolio, describing it as “products and enabling technologies that support hips, knees, trauma, spine, sports, and others” within the MedTech segment, shifting the emphasis from pure sales figures to the role of technology‑enabled solutions【page_8†L1-L7】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of JNJ's Orthopaedics business presentation between 2023 and 2024. STRENGTHS: (1) All key financial figures are correct: $8.9B total revenue (matches $8,942M), U.S. $5.5B (matches $5,525M), International $3.4B (matches $3,417M), and 4.1% growth rate. Number format variations ($8.9B vs $8,942M) are appropriately handled. (2) The multi-hop synthesis is sound - correctly identifies the shift from quantitative emphasis in 2023 to qualitative/technology focus in 2024. (3) Entity identification is accurate (Johnson & Johnson, MedTech segment, Orthopaedics business). (4) The strategic narrative is well-captured: 2023 emphasized sales metrics while 2024 emphasized 'products and enabling technologies.' MINOR WEAKNESSES: (1) The LLM provides additional sub-segment breakdowns (knees $1.456B, trauma $2.979B, spine $2.947B) that, while potentially accurate, are not mentioned in the ground truth answer. This adds detail but doesn't contradict the original answer. (2) The LLM mentions 'sports' in the 2024 description while ground truth says 'sports medicine' - this is a minor semantic variation that doesn't affect accuracy. (3) The ground truth emphasizes 'modest international growth' (4.6%) while the LLM doesn't explicitly state this percentage, though it's not contradicted. CALCULATION VERIFICATION: The sum of sub-segments ($1.456B + $2.979B + $2.947B = $7.382B) doesn't fully account for the $8.9B total, suggesting there are other categories not listed, which is reasonable. The core 2023 total and growth rate are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and identifies the strategic shift in presentation methodology, which is the core requirement of the question. The reasoning is logical and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 502,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "In 2022 Visa’s loss‑sharing agreement covered the Interchange Multidistrict Litigation (MDL 1720) and any post‑Oct 22 2015 opt‑out actions that are fact‑wise similar, with each bank’s share of any judgment or settlement calculated by multiplying the total amount by its membership proportion under Visa U.S.A.’s certificate of incorporation【page_72】【page_73】. The 2023 filing keeps that same scope and membership‑proportion allocation (see the 2023 Note 5 description of the loss‑sharing agreement) but shows a markedly larger U.S. litigation escrow balance—$1.8 bn at year‑end 2023 versus $1.4 bn at year‑end 2022—indicating that Visa has bolstered the financial resources backing the unchanged loss‑sharing framework【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis of the evolution between 2022 and 2023. CRITICAL ISSUES: (1) The LLM incorrectly states the liability allocation is based on 'membership proportion under Visa U.S.A.'s certificate of incorporation' - the ground truth clearly specifies Visa assumed 66.6667% and Mastercard 33.3333%, which are fixed percentages, not membership proportions. This is a fundamental mischaracterization of the liability allocation mechanism. (2) The LLM completely misses the key evolution described in the ground truth: the 2023 shift to the 'U.S. Retrospective Responsibility Plan' which represents a strategic consolidation and shift toward 'settled or otherwise fully or substantially resolved' matters. The LLM claims the scope remained 'the same' between years, directly contradicting the ground truth's emphasis on evolution and consolidation. (3) The LLM introduces escrow balance figures ($1.8bn vs $1.4bn) that are not mentioned in the ground truth answer, and while these may be factually accurate from the filings, they represent a tangential focus on financial resources rather than the core question about how the approach to managing litigation liabilities evolved. (4) The LLM fails to address the October 2015 amendment's specific expansion of scope to include opt-out actions from Rule 23(b)(3) Settlement Class, which is central to understanding the 2022 framework. (5) The multi-hop synthesis is weak - the answer does not effectively compare and contrast the 2022 vs 2023 approaches as required by the question. The ground truth emphasizes a 'strategic pivot' from specific amendments to a comprehensive retrospective framework; the LLM suggests continuity rather than evolution. CORRECT ELEMENTS: The LLM correctly identifies MDL 1720 and the October 2015 date, and correctly notes that the loss-sharing agreement structure is referenced in both years' filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 523,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "In the 2022 filing Colgate‑Palmolive’s defined‑benefit plans carried roughly $1 million of U.S. guaranteed‑investment contracts (GICs) and $51 million of international GICs – about $52 million in total 【page_102】. By the 2024 filing the U.S. GIC position had been eliminated and the international balance had fallen to $30 million 【page_99】. This reduction shows the company is scaling back its reliance on GICs and reallocating pension‑plan assets toward other categories such as cash, fixed‑income and equity‑related investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ERRORS - CRITICAL ISSUES: The LLM answer contains significant numerical discrepancies that undermine accuracy: (1) 2022 International GICs: Ground truth states $55 million, but LLM reports $51 million - a $4 million error. (2) 2024 International GICs: Ground truth states $34 million, but LLM reports $30 million - a $4 million error. These are material differences in pension asset allocation figures. (3) The LLM's calculated total of $52 million for 2022 ($1M + $51M) is mathematically correct given their stated figures, but the underlying $51M international figure is wrong. CORRECT ELEMENTS: (1) U.S. GIC position correctly identified as $1 million in 2022 and eliminated by 2024. (2) Correct company identification (Colgate-Palmolive/CL). (3) Correct years (2022 and 2024). (4) Correct directional trend (reduction in GICs). (5) Reasonable interpretation of strategic shift toward other asset categories. MULTI-HOP REASONING: The LLM successfully synthesized information across two years and two geographic segments, and correctly inferred the strategic implication about asset reallocation. However, the numerical errors significantly compromise the quality of this synthesis. COMPLETENESS: The answer addresses both parts of the question (evolution and strategic implications), though the strategic implications section is somewhat generic and could be more specific. The core issue is that pension asset allocation figures must be precise, and the $4 million discrepancies on both international figures represent material errors in financial reporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 434,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "In the 2022 filing Mastercard described its Developer Platform mainly as a “single access point” that “simplifies access to, and integration of, our digital assets,” letting customers and partners find and embed Mastercard APIs and services in new or existing solutions【page_14】. By the 2024 filing the platform had been elevated to a strategic hub for emerging tech – it now supports blockchain‑based business models, offers the Mastercard Multi‑Token Network for programmable payments and enables crypto‑card purchases and spend, signaling a broader role in integrating digital assets and new technologies【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of the Developer Platform as a 'single access point' for digital assets and services with emphasis on ease of integration - this matches the ground truth description exactly. (2) Accurately captures the 2024 evolution showing expansion to support emerging technologies including blockchain and digital currencies. (3) Correctly references the Mastercard Multi-Token Network™ and its role in enabling programmable payments and blockchain-based transactions. (4) Properly synthesizes the multi-hop comparison between 2022 and 2024, showing the progression from general digital integration to next-generation financial technologies. (5) All entities are correctly identified (Mastercard, Developer Platform, Multi-Token Network). (6) The reasoning is sound - the answer logically connects the platform's evolution to support for blockchain, crypto, and programmable commerce. MINOR CONSIDERATIONS: (1) The LLM answer includes specific details about 'crypto-card purchases and spend' which, while not contradicted by the ground truth, represents a slight elaboration beyond what was explicitly stated in the ground truth. However, this is consistent with the platform's expanded role and doesn't introduce factual errors. (2) The citation format [page_14] appears in both instances, suggesting consistent sourcing. (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not a limiting factor. The answer successfully captures the semantic meaning and factual content of the ground truth while using slightly different wording that remains semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 483,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Colgate‑Palmolive’s defined‑benefit pension trusts have not held any of the company’s own U.S. common stock – the 2022 filing notes that equity securities in the U.S. plans contained no company stock at December 31 2021 (and likewise for 2020)【page_102】, and the 2024 filing confirms the same for December 31 2024 (and 2023)【page_101】. This unchanged zero holding from 2022 through 2024 reflects a deliberate strategic allocation that excludes the firm’s equity from its pension portfolios, keeping the asset mix focused on other categories such as cash, fixed‑income and pooled funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer focuses exclusively on the company's own U.S. common stock holdings (Colgate-Palmolive stock) in pension plans, reporting zero holdings across 2022-2024. However, the ground truth answer addresses U.S. common stocks MORE BROADLY (not just company stock), and specifically mentions that the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This is a fundamental misinterpretation of the question scope. The question asks about 'U.S. common stocks' generally, not specifically about company stock holdings. The LLM answer completely omits the $2 million U.S. common stock allocation in the international pension plan that existed in both 2022 and 2024 according to the ground truth. QUANTITATIVE ERRORS: The LLM reports zero U.S. common stock investments across all pension plans, but the ground truth explicitly states the international pension plan held $2 million in both years. This is a material factual error. COMPLETENESS ISSUES: The LLM answer addresses only the U.S. domestic pension plan and misses the international pension plan component entirely. The question asks about evolution 'between 2022 and 2024' - the LLM correctly identifies no change (zero holdings) but only for the domestic plan, missing the complete picture. REASONING: While the LLM's reasoning about strategic asset allocation avoiding company stock is sound, it's answering a different question than what was asked. The ground truth indicates a nuanced strategy: avoiding company stock domestically while maintaining minimal U.S. stock exposure internationally. The LLM's interpretation is too narrow and misses critical information about the international portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 472,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships as a line‑item within its overall Parks & Experiences capital program – “cruise ships” were listed alongside theme‑park and resort expansion as part of the company’s recent capital spend (2022 10‑K p. 17). By the 2023 filing the strategy had shifted to an explicit growth push, announcing plans to add more vessels to the Disney Cruise Line fleet for fiscal 2024 (2023 10‑K p. 22) and warning that such cruise‑ship investments carry heightened operational risk – including the possibility of asset write‑downs if new concepts (e.g., the Star Wars: Galactic Starcruiser) under‑perform and the uncertainty of consumer acceptance (2023 10‑K p. 21‑22).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ERRORS: (1) The LLM claims the strategy SHIFTED TO an 'explicit growth push' in 2023 with plans to add more vessels, but the ground truth states the emphasis shifted AWAY from growth toward operational risk mitigation. This is a fundamental reversal of the actual strategic evolution. (2) The LLM incorrectly characterizes 2022 as treating cruise ships as a 'line-item' in capital spending, when the ground truth indicates 2022 highlighted cruise ships as a KEY PART of capital investment strategy with a MAJORITY of capital directed toward theme parks, resorts, and cruise ships - this is a growth-oriented emphasis, not a minor line-item. (3) The LLM references Star Wars: Galactic Starcruiser as an example of cruise ship investment risk, but this was a land-based experience at Walt Disney World, not a cruise ship venture - this is a categorical error. (4) The LLM mentions Hurricane Milton's impact on Walt Disney World but fails to properly contextualize this as evidence of the shift toward risk mitigation framing in 2023. CORRECT ELEMENTS: The LLM does correctly identify that both 2022 and 2023 filings discuss cruise ships, and that operational risks are mentioned in 2023. However, the directional narrative is inverted - the LLM presents 2023 as MORE growth-focused when it should be LESS growth-focused and MORE risk-focused. The multi-hop reasoning is fundamentally flawed because it mischaracterizes the evolution of Disney's strategic focus, presenting the opposite trajectory from what the ground truth documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 444,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard’s 2022 Form 10‑K explains that it “may enter into short‑duration foreign‑exchange derivative contracts … to manage … foreign‑exchange risk as part of its daily settlement activities” (page 111). The 2024 filing repeats the same purpose (page 106) but shows a far larger scale of those contracts – non‑designated FX contracts grew from roughly $124 million of assets and $406 million of liabilities in 2022 (page 112) to about $2.7 billion of assets and $30 million of liabilities in 2024 (page 108) – indicating that Mastercard has expanded its use of short‑duration FX derivatives to more aggressively hedge settlement‑related currency volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Mastercard used short-duration FX derivative contracts for the same stated purpose (managing FX risk in daily settlement) in both 2022 and 2024, which aligns with the ground truth. The answer also appropriately notes the continuity in purpose while highlighting changes in scale. However, there are significant quantitative accuracy issues: (1) The LLM claims non-designated FX contracts grew from '$124 million of assets and $406 million of liabilities in 2022' to '$2.7 billion of assets and $30 million of liabilities in 2024.' These specific numbers cannot be verified against the ground truth provided, and the dramatic shift (especially liabilities dropping from $406M to $30M while assets increased 20x) seems inconsistent with typical hedging patterns and requires verification. (2) The LLM's interpretation that this represents 'more aggressively hedge settlement-related currency volatility' is an inference not explicitly stated in the ground truth, which emphasizes 'dynamic approach' and 'evolving structure' rather than 'aggressive expansion.' (3) The ground truth emphasizes the 'more dynamic approach' involving de-designation and re-designation of euro-denominated debt in 2023-2024, which the LLM answer completely omits. This is a material omission as it represents a key evolution in the company's broader FX risk management strategy. The LLM answer focuses narrowly on the scale of non-designated contracts without addressing the strategic evolution mentioned in the ground truth. The multi-hop reasoning is partially sound (comparing 2022 to 2024 across filings) but incomplete (missing the hedging strategy adjustments). The answer is contextually relevant to the question but lacks the nuance about evolving hedging strategies that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 495,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "In the 2023 filing Salesforce merely noted that it “manages a portfolio of strategic investments in both privately held and publicly traded companies focused primarily on enterprise‑cloud companies, technology startups and system integrators,” treating those stakes as a financial exposure and potential upside. By the 2024 filing the relationship is framed as a growth engine – the firm says it will keep investing in enterprise‑cloud firms to “expand our solution ecosystem … including AI” and is actively deepening integration through its open platform, MuleSoft API management and a robust ISV/SI partner ecosystem, reinvesting proceeds to accelerate ecosystem‑wide adoption.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Salesforce's evolving strategic relationship with enterprise cloud companies from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 positioning as a portfolio of strategic investments in privately held/publicly traded companies, enterprise-cloud firms, technology startups, and system integrators - this matches the ground truth characterization. (2) Accurately captures the 2024 shift from primarily financial investment to a broader strategic dependency and growth engine model. (3) Properly identifies specific 2024 mechanisms: AppExchange ecosystem, MuleSoft API management, ISV/SI partner ecosystem, and AI integration - these align with the ground truth's emphasis on platform integration and ecosystem deepening. (4) Correctly synthesizes the multi-hop evolution: investment focus → ecosystem integration → platform dependency. (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'reinvesting proceeds' which is a reasonable inference but not explicitly stated in the ground truth. (2) The ground truth mentions 'early to late-stage companies, including those concurrent with IPOs' - the LLM answer doesn't explicitly reference this staging detail, though it's not contradicted. (3) The ground truth's specific mention of 'digitally transforming industries' as a 2023 focus is not captured in the LLM response. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic pivot from financial investment to ecosystem integration. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM's characterization of the relationship shift as moving from 'financial exposure' to 'growth engine' effectively conveys the same meaning as the ground truth's shift from 'investing' to 'strategic dependency.' The emphasis on platform integration (AppExchange, MuleSoft, ISV ecosystem) aligns well with the ground truth's discussion of deepened integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 553,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company did not change its methodology – in both FY 2023 and FY 2024 it “develops accrual rates based on the provisions of the agreements in place,” reviews historical purchase trends and volumes throughout the year, and adjusts the rates as appropriate.  In each filing the company stresses that “amounts accrued … could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met” 【page_33】【page_34】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - CONTRADICTS GROUND TRUTH: The LLM answer states that the company 'stresses that amounts accrued could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met' in EACH filing (both FY2023 and FY2024). However, the ground truth explicitly states that in FY2024, 'this explicit reference to graduated purchase volumes was omitted,' indicating a KEY DIFFERENCE between the two years. The LLM failed to capture the core finding that the language changed between years - the graduated purchase volumes language was present in FY2023 but removed in FY2024. This is a fundamental misreading of the question's focus on how the approach 'evolved' between the two years. The LLM correctly identifies that methodology remained consistent and that both years reference sensitivity to projected volumes, but it incorrectly claims the graduated purchase volumes language appears in both filings when it was actually omitted in FY2024. The LLM also provides page citations (page_33, page_34) but these appear to be generic references without verification that they actually support the claim that graduated purchase volumes language appears in both years. The answer is partially correct on methodology consistency but fundamentally wrong on the evolution/change aspect, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 398,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "In the 2022 filing the partnership was framed largely around legal safeguards – Boehringer Ingelheim agreed to defend and indemnify Eli Lilly in the five pending Jardiance product‑liability lawsuits and was the sole party pursuing a patent‑infringement case over Jardiance, while Lilly was not a litigant (2022 pp. 103‑102). By the 2024 filing the relationship is presented as a commercial collaboration, noting that Jardiance remains a co‑developed, co‑marketed product with Boehringer Ingelheim and is now subject to government‑set pricing under the IRA, highlighting Lilly’s continued reliance on the partnership rather than new legal entanglements (2024 p. 45).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the relationship from 2022 to 2024, accurately noting that (1) in 2022, LLY was not a direct party to patent litigation while BI pursued patent-infringement cases, (2) BI provided indemnification for product-liability lawsuits, and (3) by 2024, the relationship shifted to emphasize commercial collaboration under IRA pricing. The qualitative framing of the shift from legal safeguards to commercial dependency is sound and semantically aligned with the ground truth.\n\nCRITICAL ERRORS: The LLM answer contains a significant quantitative omission. The ground truth explicitly states that Jardiance was subject to a \"66% discount compared to the 2023 list price\" under the IRA. The LLM answer mentions \"government-set pricing under the IRA\" but fails to include this specific, material discount percentage. This is a factual gap that weakens the answer's completeness and precision on a key quantitative metric.\n\nMINOR ISSUES: (1) The LLM cites specific page numbers (\"2022 pp. 103-102\" and \"2024 p. 45\") which appear to be fabricated or incorrectly formatted (page 103-102 is illogical ordering), introducing credibility concerns. (2) The answer references \"five pending Jardiance product-liability lawsuits\" which is not mentioned in the ground truth, suggesting potential hallucination or unsourced detail.\n\nMULTI-HOP REASONING: The synthesis across 2022 and 2024 filings is logically sound - the model correctly identifies the temporal evolution and the shift in relationship dynamics. However, the incomplete capture of the 66% discount metric represents a failure to fully synthesize all material information from the knowledge graph.\n\nOVERALL ASSESSMENT: The answer demonstrates good qualitative understanding of the relationship evolution but fails on quantitative precision by omitting the specific IRA discount percentage, which is a material detail for understanding the financial impact on LLY's business strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 541,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "In the 2022 Form 10‑K Disney noted that it “must often invest substantial amounts … in cruise ships” as part of its overall capital outlays, but also warned that COVID‑19 had forced the company to delay or suspend some cruise‑ship projects (2022 p. 25; 23). By the 2023 Form 10‑K the company framed cruise‑ship spending as a core component of its Parks & Experiences capital plan, stating that “the majority of the Company’s capital spend has been at our parks and experiences business…new attractions, cruise ships, capital improvements and systems infrastructure” (2023 p. 12). This reflects a shift from a cautious, risk‑aware investment stance in 2022 to a more integrated, growth‑focused strategy for cruise ships within the broader Parks & Experiences segment in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (shift from cautious 2022 stance to integrated 2023 growth strategy) and correctly identifies the key 2023 quote about capital spend priorities. However, there are significant factual discrepancies that lower the score:\n\n(1) QUANTITATIVE/FACTUAL ERRORS:\n- The LLM claims the 2022 10-K stated Disney \"must often invest substantial amounts...in cruise ships\" - this specific language is not confirmed in the ground truth, which indicates 2022 did NOT specifically emphasize cruise ship capital investment\n- The LLM references page numbers (2022 p. 25; 23 and 2023 p. 12) that cannot be verified against the ground truth\n- The LLM asserts COVID-19 caused delays/suspensions of cruise projects in 2022 - the ground truth makes no mention of COVID-19 impacts on cruise ships specifically, only general macroeconomic risks (inflation, supply chain, currency)\n\n(2) SEMANTIC MISALIGNMENT WITH GROUND TRUTH:\n- Ground truth: 2022 filing did NOT specifically emphasize cruise ship capital investment; cruise ships were mentioned as part of segment but not highlighted\n- LLM answer: Suggests 2022 explicitly discussed substantial cruise ship investment, just with risk warnings\n- This is a material difference in characterizing the 2022 baseline\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes the 2023 shift and provides the accurate quote\n- The comparison between years is logically sound (cautious to growth-focused)\n- However, the foundation of the 2022 characterization appears inaccurate\n\n(4) WHAT WAS CORRECT:\n- Accurate identification of the 2023 quote about capital spend priorities\n- Correct characterization of the strategic shift/evolution\n- Proper framing of cruise ships within Parks & Experiences segment\n- Appropriate tone and structure of analysis\n\nThe answer demonstrates good analytical framework but contains factual inaccuracies in the 2022 baseline that undermine the comparison's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 541,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "In the 2022 filing, Mastercard Labs (the precursor to Mastercard Foundry) was portrayed mainly as a research‑and‑thought‑leadership hub that “identifies and experiments with future technologies, start‑ups and trends” and “provides customers and partners access to thought leadership, innovation methodologies, new technologies and relevant early‑stage fintech players”【page_14】. By the 2024 filing the unit had been rebranded as Mastercard Foundry and its role had expanded to run hands‑on programs such as the five‑day “Launchpad” prototyping workshop, deepen fintech collaborations through the Mastercard Developer platform and partnerships with central banks, fintechs and crypto players, and actively drive blockchain, tokenization and other emerging‑technology solutions【page_16】【page_14】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Mastercard Foundry's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the name change from Mastercard Labs (2022) to Mastercard Foundry (2024), which is a key factual detail. (2) Accurately captures the 2022 role as a research and thought-leadership hub with access to innovation methodologies and early-stage fintech players, matching the ground truth. (3) Properly synthesizes the 2024 evolution, including specific programs (Launchpad prototyping workshop), partnerships (central banks, fintechs, crypto players), and technologies (blockchain, tokenization). (4) Correctly identifies the Mastercard Multi-Token Network™ and programmable payments as part of the 2024 positioning. (5) The multi-hop reasoning is sound, comparing and contrasting the two time periods effectively. (6) No quantitative errors detected (no specific numbers or percentages to verify). MINOR WEAKNESSES: (1) The LLM answer provides slightly more operational detail (Launchpad workshop, Developer platform) than the ground truth, which focuses more on strategic positioning. While this additional detail is accurate and relevant, it slightly shifts emphasis from the 'strategic shift toward deeper integration' framing in the ground truth. (2) The ground truth emphasizes the 'strategic shift toward deeper integration with next-generation financial technologies' as a key insight, while the LLM answer presents the evolution more as an expansion of activities rather than explicitly framing it as a strategic pivot. (3) Citation references (page numbers) are included but cannot be independently verified. Overall, the answer is factually correct, addresses all parts of the question, and demonstrates proper multi-hop synthesis across the 2022-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 499,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "In the 2022 filing the Lilly‑Boehringer Ingelheim partnership was presented mainly as a joint development of empagliflozin (Jardiance) that carried FDA regulatory incentives – the drug had been granted Breakthrough‑Therapy, Fast‑Track and priority‑review designations. By the 2024 filing the collaboration is still active, but the emphasis has shifted to pricing risk: Jardiance was named in the Inflation Reduction Act’s first government‑set price list, with HHS announcing a 66 % discount for 2026, highlighting new, substantial pricing pressure on the joint product. This reflects a move from a focus on regulatory designations to managing significant pricing constraints in the partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the Lilly-Boehringer Ingelheim collaboration evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the 66% discount for 2026 matches the ground truth exactly, and the 2023 U.S. list price reference is accurate. The dates (2022 vs 2024) are correctly identified. ENTITY ACCURACY: The partnership is correctly identified as Lilly-Boehringer Ingelheim, Jardiance is correctly named as the product, and the Inflation Reduction Act is properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods, correctly identifying the shift from regulatory support (Breakthrough Therapy, Fast Track, priority review designations in 2022) to pricing constraints (66% discount under IRA in 2024). The logical progression from regulatory facilitation to regulatory-driven financial constraints is sound. COMPLETENESS: The answer addresses all aspects of the question - the financial nature (pricing pressures), strategic nature (partnership evolution), regulatory designations (2022), and pricing pressures (2024). SEMANTIC EQUIVALENCE: The LLM's phrasing \"move from a focus on regulatory designations to managing significant pricing constraints\" effectively conveys the same meaning as the ground truth's \"shift from regulatory facilitation to regulatory-driven financial constraints.\" The only minor distinction is that the LLM specifies \"empagliflozin (Jardiance)\" with additional chemical name detail, which adds helpful context without introducing error. The answer is well-structured, factually precise, and demonstrates clear understanding of the multi-year evolution of this collaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 471,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "In the 2023 filing the CH‑53K King Stallion was highlighted as a flagship RMS helicopter already in service with U.S. and foreign customers and was tied to a specific international win – the Israeli Ministry of Defense’s LOA for 12 aircraft (first four awarded in 2022 and the balance in 2023). The 2024 filing still lists the CH‑53K under RMS but now describes it as a “well‑established” program that “continues to experience growth,” positioning the helicopter as a core, ongoing growth pillar of the segment rather than emphasizing a single foreign contract. This shift shows the CH‑53K moving from a highlighted foreign‑order narrative in 2023 to a broader strategic growth driver within RMS in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERRORS: The LLM claims the CH-53K was 'already in service with U.S. and foreign customers' in 2023 and references a specific Israeli Ministry of Defense LOA for 12 aircraft (4 in 2022, balance in 2023). The ground truth makes no mention of these specific customer deployments or Israeli contracts. The ground truth describes the CH-53K as part of 'near-to-mid-term growth elements' in 2023, not as an already-in-service flagship program. (2) QUANTITATIVE ACCURACY: The LLM introduces specific numbers (12 aircraft, 4 awarded in 2022, balance in 2023) that do not appear in the ground truth and cannot be verified. These appear to be fabricated details. (3) CHARACTERIZATION MISMATCH: The ground truth emphasizes a shift from being 'a growth driver among several others' to being 'part of a more integrated, technologically advanced portfolio' focused on AI/ML, autonomy, and multi-domain solutions. The LLM instead characterizes the shift as moving from 'highlighted foreign-order narrative' to 'broader strategic growth driver,' which misses the key technological and portfolio integration aspects mentioned in the ground truth. (4) MULTI-HOP REASONING: The LLM failed to synthesize the actual evolution described in the ground truth - the shift toward digital technologies and all-domain mission solutions. Instead, it invented a narrative about foreign contracts that doesn't align with the source material. (5) SEMANTIC DIVERGENCE: While both answers discuss positioning evolution, the LLM's specific claims about Israeli contracts, in-service status, and customer wins are not supported by the ground truth and appear to be hallucinated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 475,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "In the 2022 filing Lilly’s joint diabetes portfolio with Boehringer Ingelheim was limited to Basaglar, Jardiance and Trajenta (LLY 2022 10‑K, p. 5). By the 2024 filing the agreement now covers a much larger set – Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar (LLY 2024 10‑K, p. 7‑8). This expansion shows the two companies are deepening their partnership to capture a broader slice of the diabetes market, emphasizing newer combination therapies and a more diversified, integrated product line rather than a narrow focus on single‑agent insulin and SGLT2 drugs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR - The LLM claims the portfolio EXPANDED from 2022 to 2024 (3 products to 7 products), when the ground truth shows it NARROWED (7 products to 4 products). This is a complete reversal of the actual strategic shift. (2) PRODUCT LIST ERRORS - 2022 Portfolio: LLM lists only 'Basaglar, Jardiance and Trajenta' but ground truth shows 7 products including Jentadueto, Glyxambi, Synjardy, Trijardy XR. The LLM is missing 4 products from 2022. (3) 2024 Portfolio: LLM lists 7 products (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar) which matches ground truth, but this is presented as an expansion when it's actually a contraction from the 2022 baseline. (4) STRATEGIC INTERPRETATION - The LLM concludes the companies are 'deepening their partnership' and 'capturing a broader slice' through expansion, when the actual strategic shift indicates streamlining, refocusing on higher-performing products, and potentially responding to lifecycle management or generic competition. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the 2022 and 2024 portfolio compositions and their comparative analysis. The answer demonstrates a fundamental misunderstanding of the data direction and strategic implications. The only element partially correct is that both years' portfolios include Jardiance, but this is overshadowed by the pervasive errors in portfolio composition and directional analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 429,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "In 2023 the JASSM production ramp‑up added roughly $145 million to Missiles & Fire Control (MFC) net sales and helped lift the segment’s backlog, which grew on higher JASSM, LRASM and GMLRS orders 【page_40】. By 2024 the ramp‑up was far larger – JASSM (along with GMLRS and LRASM) drove about $1.2 billion of the $1.4 billion sales increase and was singled out as a key source of the backlog rise, underscoring its heightened strategic role even as MFC’s overall operating profit fell because of profit‑booking adjustments 【page_40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about JASSM's evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the $1.2 billion increase in tactical and strike missile programs for 2024, matching the ground truth. (2) Accurately cites JASSM as a key contributor to backlog increases alongside PAC-3 and GMLRS. (3) Properly synthesizes information across both years, showing the progression from 2023 to 2024. (4) Correctly identifies MFC (Missiles and Fire Control) segment context. (5) Provides specific quantitative detail ($145 million in 2023) that adds precision beyond the ground truth. (6) Mentions the $1.4 billion total sales increase context, which is relevant and accurate. MINOR ISSUES: (1) The ground truth states there was 'no specific mention of significant changes' in 2023 production volume, but the LLM provides a specific $145 million figure for 2023. While this additional detail appears factually accurate based on the citation, it goes slightly beyond what the ground truth explicitly states about 2023. (2) The mention of 'profit-booking adjustments' causing MFC's operating profit to fall is additional context not in the ground truth, though it appears to be accurate supplementary information. QUANTITATIVE VERIFICATION: The $1.2 billion figure for 2024 is correct. The $145 million for 2023 appears accurate based on the source citation. The $1.4 billion total increase is a reasonable contextual figure. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple product lines (JASSM, GMLRS, LRASM, PAC-3), correctly showing the evolution and comparative importance. The logic connecting production ramp-up to backlog contribution is sound. Overall, this is a high-quality answer with accurate numbers and strong synthesis, with only minor deviations from the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 521,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "In 2023 JPM still said that “geographic distribution is an indicator of the credit performance of the portfolio” for its scored auto and business‑banking loans (2023 Consumer, excl. credit‑card discussion, p. 242). The 2024 filing repeats the same emphasis – geographic distribution remains the primary risk gauge for those loans (2024 Consumer, excl. credit‑card discussion, p. 250). Because the focus has not shifted, JPM continues to look to regional‑economic trends and the early‑warning signal of 30‑plus‑day delinquencies to spot borrower distress, rather than adding new credit‑risk metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. (1) MAJOR FACTUAL ERROR: The LLM claims there was NO shift in focus between 2023 and 2024, stating 'the focus has not shifted' and that 'geographic distribution remains the primary risk gauge.' However, the ground truth explicitly states there WAS a shift: from 2023's focus on 'loan performance and scoring models' to 2024's focus on 'delinquency rates as the primary credit quality indicator.' This is a direct contradiction on the central premise of the question. (2) INCOMPLETE SYNTHESIS: The LLM correctly identifies that 30+ day delinquencies serve as early warning signals, but fails to recognize this represents the evolved focus in 2024 (delinquency rates as primary indicator) versus the 2023 approach (scoring models). The LLM treats delinquency tracking as a continuation rather than part of the strategic shift. (3) CITATION ACCURACY: While the LLM provides specific page references (p. 242 for 2023, p. 250 for 2024), these cannot be verified against the ground truth, and the interpretation of what those pages say appears incorrect based on the ground truth's description of the actual evolution. (4) MISSING KEY INSIGHT: The ground truth emphasizes this shift represents 'a more proactive stance in identifying early signs of borrower distress' and 'a strategic move toward earlier intervention and more granular performance monitoring.' The LLM misses this strategic implication entirely. (5) LOGICAL FLAW: The LLM's conclusion that JPM 'continues to look to regional-economic trends' and 'rather than adding new credit-risk metrics' directly contradicts the ground truth's assertion that delinquency rates became the PRIMARY indicator (a shift from previous metrics). The answer demonstrates poor multi-hop reasoning by failing to synthesize the 2023-to-2024 evolution correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 511,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K exhibit schedules list Target’s “SPP II” as the **2016 Plan Statement, amended and restated effective April 3, 2016** (see page 68 of each filing), with no new amendment or restatement noted in the later filing. The unchanged description indicates that Target’s executive‑compensation framework has remained stable, relying on the same long‑term incentive plan for senior executives rather than revising the SPP II terms year‑to‑year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. Key issues: (1) FACTUAL ERROR ON DATES: The LLM claims both 2022 and 2023 filings list the '2016 Plan Statement, amended and restated effective April 3, 2016' with no changes. However, the ground truth explicitly states that the 2023 filing updated to the '2022 Plan Statement, as amended and restated effective May 1, 2022' - a critical factual difference. (2) MISSED KEY EVOLUTION: The ground truth identifies a significant plan evolution between filings (2016 Plan → 2022 Plan), which the LLM completely missed. This is the core of what the question asks about. (3) INCORRECT CONCLUSION: The LLM concludes the framework 'remained stable' and 'unchanged,' which directly contradicts the ground truth's finding of a revision/update to the SPP II plan. (4) CITATION ISSUE: The LLM cites 'page 68 of each filing' but provides no evidence that both years show identical plan statements - this appears to be an unsupported claim. (5) INCOMPLETE ANALYSIS: The LLM fails to address what the plan evolution suggests about compensation strategy adjustments, which is explicitly part of the question. The answer demonstrates a fundamental misreading or misunderstanding of the filing data, presenting stability where the ground truth shows evolution. This is a clear case where the LLM provided incorrect information that would mislead someone researching Target's compensation framework changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 407,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "In the 2022 Form 10‑K Eli Lilly disclosed that, beyond the $260 million and $210 million of milestone payments already capitalized (for 2021 and 2020), Incyte could still be entitled to up to **$100 million of additional success‑based regulatory milestones and up to $100 million of sales‑based milestones** under the Olumiant license. By the 2024 filing, the Olumiant discussion only mentions the royalty structure and the product’s net revenue and **does not reference any remaining potential milestone payments**, indicating that those future‑milestone obligations are no longer highlighted—likely because they have been satisfied, become immaterial, or are no longer expected.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the 2022 milestone structure: $100M regulatory milestones and $100M sales-based milestones - these numbers match the ground truth exactly. (2) Accurately notes the shift from 2022 to 2024, where milestone payments are no longer mentioned in the 2024 filing. (3) Provides sound multi-hop reasoning by synthesizing information across two different years (2022 and 2024) and explaining the evolution of obligations. (4) Correctly identifies the shift from milestone-based to royalty-based compensation structure. (5) The additional context about $260M and $210M previously capitalized (2021 and 2020) adds helpful background without detracting from the core answer. MINOR CONSIDERATIONS: The LLM answer includes slightly more detail about prior years' capitalized amounts than the ground truth explicitly mentions, but this is supplementary and accurate information that enhances understanding rather than contradicting the ground truth. The explanation of why milestones disappeared (satisfied, immaterial, or no longer expected) is reasonable inference consistent with the ground truth's statement that they were 'either paid out or no longer applicable.' The answer directly addresses the evolution question and provides clear before/after comparison. All financial figures are correct, the multi-hop synthesis across years is sound, and the semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 411,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "In FY 2022 the APJC segment contributed about $8.0 billion of revenue and $5.24 billion of gross margin (page 105). By FY 2023 the APJC goodwill balance – a key asset‑based exposure – had risen only modestly from $5.36 billion at July 30 2022 to $5.38 billion at July 29 2023 (pages 74‑76), indicating that the region’s financial exposure grew only slightly while its revenue and margin remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) QUANTITATIVE ERRORS: The LLM claims APJC goodwill was $5.36 billion at July 30, 2022 and $5.38 billion at July 29, 2023, but the ground truth states APJC assets were $5,382 million ($5.382 billion) as of July 29, 2023 only. The LLM appears to have confused or fabricated the 2022 goodwill figure. The LLM also cites $8.0 billion in APJC revenue and $5.24 billion in gross margin for FY2022, which are not mentioned in the ground truth and cannot be verified. (2) ENTITY/METRIC CONFUSION: The ground truth explicitly states that 'specific financial figures for APJC were not disclosed in the provided data' for fiscal 2022, yet the LLM confidently provides detailed revenue and margin figures. The ground truth distinguishes between total assets ($5,382 million) and does not break down goodwill separately for APJC. (3) MULTI-HOP REASONING: The LLM's synthesis is flawed because it presents unverified data as fact and makes conclusions about 'modest' growth based on numbers that don't align with the ground truth. (4) COMPLETENESS: While the LLM attempts to address the evolution between 2022 and 2023, it does so with incorrect data. The ground truth correctly notes that detailed APJC disclosure was more limited in 2022 compared to 2023. The LLM's conclusion that 'revenue and margin remained essentially unchanged' cannot be verified from the ground truth and appears to be an unsupported inference. The answer demonstrates a fundamental misalignment with the actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 436,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "In the 2022 Form 10‑K, Lilly highlighted its joint commercial partnership with Boehringer Ingelheim on Jardiance and noted that the Inflation‑Reduction‑Act‑driven price‑setting program had named the drug (among the first ten) for a government‑set price beginning in 2026. By the 2024 filing the collaboration was still intact, but the regulatory development had moved from a selection to an actual price‑setting decision: in August 2024 HHS announced a 66 % discount to the 2023 list price for Jardiance, prompting Lilly to anticipate accelerated revenue erosion and to factor that discount into its commercial strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN DATES AND TIMELINE: The LLM answer contains a significant factual error regarding when the price-setting program would take effect. The LLM states 'government-set price beginning in 2026' but the ground truth clearly indicates that in August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, with the 66% discount applied in August 2024. This is a major chronological error that misrepresents the timeline of regulatory impact. The LLM appears to have confused or misplaced the implementation date. CORRECT ELEMENTS: (1) The 66% discount figure is accurate; (2) The August 2024 HHS announcement is correct; (3) The partnership between LLY and Boehringer Ingelheim is correctly identified; (4) The general narrative about IRA impact is present. MISSING INFORMATION: The LLM answer omits the 2022 baseline data showing Jardiance revenue growth (30% in U.S., 28% outside U.S.), which is important context for understanding how the collaboration evolved from a growth phase to a challenged phase. MULTI-HOP REASONING: The answer attempts to synthesize information across 2022 and 2024 filings, but the fundamental dating error undermines the credibility of the timeline comparison. The reasoning about moving from selection to price-setting decision is sound in concept, but the 2026 date error is a critical factual mistake that significantly impacts the accuracy of the response. QUANTITATIVE ACCURACY: The 66% discount is correct, but the missing 2022 growth percentages and the wrong implementation date substantially reduce quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 442,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "In the 2022 filing GM warned that product‑safety recalls can generate large repair‑cost outlays, civil or criminal penalties and serious brand damage, pointing to the Chevrolet Bolt EV recall as a concrete example of a “global platform” that could amplify those costs and threaten its ability to lead in advanced technologies such as autonomous vehicles【page_24】. By the 2023 filing the company retained the same financial‑and‑reputational warning but dropped the specific Bolt‑EV reference, speaking more generally about any global‑platform recall and explicitly linking the risk to eroding consumer trust and brand equity in its core growth areas of electric‑vehicle and autonomous‑vehicle technologies【page_25】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of GM's risk disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 focus on the Chevrolet Bolt EV recall as a concrete example of global platform risks with financial/cost implications; (2) Accurately notes the shift in 2023 to broader language about global platforms generally while maintaining financial and reputational warnings; (3) Properly synthesizes the multi-hop connection between product safety recalls, brand equity concerns, and GM's strategic positioning in EV/AV technologies; (4) Correctly identifies the evolution from cost-centric to broader strategic risk framing; (5) Appropriately references page numbers (24-25) suggesting document verification. MINOR CONSIDERATIONS: (1) The LLM answer notes that the 2023 filing 'dropped the specific Bolt-EV reference' while the ground truth emphasizes that 'the concern around global platforms remained' - both characterizations are compatible and accurate, though the LLM's phrasing is slightly more specific about the removal of the example; (2) The LLM answer adds detail about 'eroding consumer trust' which aligns with the ground truth's emphasis on 'reputational damage to brand image and equity' - this is semantically equivalent and contextually appropriate; (3) The answer correctly identifies the shift from 'primarily cost-centric concern to a broader strategic risk' as stated in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension is not directly applicable, but the answer contains no numerical errors. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2023) and connects product safety recalls to strategic positioning in EV/AV markets, demonstrating sound multi-hop reasoning. The answer is comprehensive, accurate, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 534,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "In 2022 Costco’s “Other long‑term debt” – which consists entirely of Guaranteed Senior Notes issued by its Japanese subsidiary – was $590 million (Level 3‑valued) 【page_51】【page_52】. By the 2024 filing the subsidiary had issued four new Guaranteed Senior Notes totaling about $500 million (interest 1.40%‑2.12%, maturing 2033‑2043) and repaid $77 million in July 2024, raising the other long‑term‑debt balance to $919 million 【page_52】. This growth and the addition of longer‑dated, low‑cost notes indicate Costco is actively expanding foreign‑subsidiary financing to diversify its capital sources and lock in inexpensive, long‑term funding.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the four new Guaranteed Senior Notes totaling ~$500 million issued in November 2023 with interest rates of 1.40%-2.12% and maturities from 2033-2043. The July 2024 repayment of $77 million is accurate. The interpretation about long-term financing strategy and fixed-rate debt management aligns well with the ground truth. The multi-hop synthesis across 2022-2024 is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM states the 2022 balance was $590 million and the 2024 balance reached $919 million. However, the ground truth does not provide these specific balance sheet figures. The LLM appears to have added information not in the ground truth ($590M in 2022, $919M in 2024). This is a significant issue as these numbers cannot be verified against the provided ground truth. (2) The calculation logic ($590M + $500M - $77M = $1,013M, not $919M) also doesn't reconcile, suggesting the $919M figure may be incorrect or from a different source. (3) The ground truth emphasizes the evolution in DISCLOSURE TRANSPARENCY (from general terms in 2022 to detailed information in 2024), while the LLM focuses more on the balance sheet growth narrative. While both interpretations are reasonable, the ground truth's emphasis on transparency evolution is more precisely aligned with what the filings actually show.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across years and correctly identifies the strategic implications. However, the introduction of unverified balance sheet numbers undermines the credibility of the analysis.\n\nCONCLUSION: The core strategic insights are sound, but the quantitative claims about specific balance sheet amounts ($590M, $919M) cannot be verified against the ground truth and appear to be either incorrect or from sources not provided in the evaluation materials. This creates a significant accuracy concern despite the otherwise reasonable analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 526,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments grew from **$11.9 billion at fiscal‑year‑end 2022** to **$15.6 billion at fiscal‑year‑end 2023**, a rise of roughly **$3.6 billion (about 30 %)**【page_50】. This increase shows Cisco is expanding its high‑quality, investment‑grade debt portfolio, a deliberate part of its strategy to keep a strong, liquid cash position that can be tapped for strategic acquisitions, technology investments and shareholder returns such as dividends and share repurchases【page_47】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all major factual points. (1) DIRECTIONAL ERROR: The LLM states investments GREW from $11.9B (2022) to $15.6B (2023), but the ground truth clearly indicates they DECREASED from $15,592M (2022) to $9,865M (2023). This is a complete reversal of the actual trend. (2) QUANTITATIVE ERRORS: The LLM's numbers are wrong. It claims 2022 value was $11.9B when ground truth shows $15,592M ($15.592B). It claims 2023 value was $15.6B when ground truth shows $9,865M ($9.865B). The LLM calculated a $3.6B increase, but the actual change was a $5,727M ($5.727B) DECREASE. The percentage calculation (30% increase) is also incorrect - the actual change was a 36.7% decrease. (3) STRATEGIC INTERPRETATION ERROR: The LLM interprets the (incorrect) increase as evidence of deliberate portfolio expansion and liquidity management. However, the ground truth indicates a strategic REDUCTION in available-for-sale debt holdings, suggesting a shift in investment focus or risk management approach - the opposite conclusion. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison and drew an entirely opposite conclusion about investment strategy. The answer demonstrates a fundamental misreading of the financial data. (5) CITATION ISSUE: The LLM cites page numbers that cannot be verified against the ground truth data provided. The core answer is factually inverted and represents a critical failure in financial analysis accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 413,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "In the 2023 filing JPMorgan Chase warned that its heavy use of third‑party custodians, cloud‑service and other vendors could expose it to “systems failure or cyber‑attack … experienced by a vendor … or … a systems breakdown … involving another party” and that a breach could leave the firm “unable, or with extended delays, to fully recover and restore data that has been stolen, manipulated or destroyed”【page_23】【page_27】.  \n\nThe 2024 filing expands that view, stressing that the bank’s “increased reliance on third‑party providers” makes it especially vulnerable to ransomware and open‑source‑software attacks on those vendors and that “oversight of third‑party vendors and early detection of attacks … including ransomware attacks” is now a key focus, while again highlighting “the inability, or extended delays … to fully recover and restore data” as a material risk【page_28】【page_27】.  \n\nThus, JPMorgan Chase’s exposure to system‑damage risk has evolved from a general acknowledgment of third‑party and data‑recovery risks in 2023 to a more pointed emphasis in 2024 on heightened vendor reliance, targeted vendor‑attack detection, and the likelihood of prolonged data‑recovery challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of JPMorgan Chase's system damage risk exposure from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 baseline risks including third-party vendor exposure, systems failure, cyber-attacks, and data recovery challenges with accurate semantic framing ('unable, or with extended delays, to fully recover and restore data'). (2) Accurately captures the 2024 evolution toward more specific emphasis on ransomware attacks, open-source software vulnerabilities, and vendor oversight/detection mechanisms. (3) Properly synthesizes the multi-hop comparison across two years, showing progression from 'general acknowledgment' to 'more pointed emphasis.' (4) Uses appropriate citations to source documents (page references), enhancing credibility. (5) No quantitative errors or date misstatements. MINOR GAPS: (1) The ground truth mentions 'unauthorized access, zero-day vulnerabilities, and distributed denial-of-service attacks' as 2023 risks, but the LLM answer doesn't explicitly reference these specific threat vectors, instead using more general language about 'systems failure or cyber-attack.' (2) The ground truth notes a 'new concern around the inability to prevent systems from processing fraudulent transactions' in 2024, which the LLM answer does not mention. (3) The ground truth references 'losses exceeding cyber insurance coverage' as a 2024 concern, which is absent from the LLM response. These omissions represent incomplete coverage of the 2024 evolution, though the main narrative arc is correct. REASONING QUALITY: The multi-hop synthesis is sound—the answer correctly traces the evolution across years and identifies the shift in emphasis. The logic connecting increased vendor reliance to heightened ransomware risk is appropriate. SEMANTIC EQUIVALENCE: The answer conveys the essential information about the evolution of risks, though with some loss of specificity regarding particular threat types and financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 548,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "The 2022 filing said Costco’s strategy was to increase the penetration of its private‑label items【page_22】. By 2024 the company has expanded its operational footprint—operating 890 warehouses with about 130.9 million sq ft of floor space (including 31.9 million sq ft of distribution and logistics space) and adding processing, packaging and manufacturing facilities that produce its private‑label goods—directly supporting that growth strategy【page_20】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core operational investments Costco made by 2024 to support its private-label growth strategy. Strengths: (1) Accurately references the 2022 filing's emphasis on increasing private-label penetration as a strategy, (2) Correctly identifies the specific operational investments: processing, packaging, and manufacturing facilities for private-label production, (3) Provides relevant quantitative context (890 warehouses, 130.9 million sq ft total floor space, 31.9 million sq ft distribution/logistics space) that demonstrates the scale of operations, (4) Properly synthesizes the multi-hop connection between the 2022 strategic intent and 2024 operational execution. Minor weaknesses: (1) The answer includes warehouse and floor space statistics that, while contextually relevant to operational footprint, are not directly about private-label investments specifically—the ground truth focuses more narrowly on the facilities dedicated to private-label production, (2) The answer could have been slightly more explicit about the shift from external sourcing to internal production capabilities (mentioned in ground truth as 'a shift from sourcing private-label products externally to building internal production capabilities'), though this concept is implied. The numeric data provided appears accurate and appropriately formatted. The multi-hop reasoning correctly connects 2022 strategy to 2024 implementation. Overall, the answer demonstrates strong understanding of the question and provides accurate, relevant information with only minor omissions of contextual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 442,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "UnitedHealth’s 2023 filing repeats the same bidding framework it disclosed in 2022. Both years state that its Medicaid‑managed‑care bids are based on “certain assumptions regarding enrollment, utilization, medical costs and other factors,” and that a material error in those assumptions—whether from unforeseen program or policy changes or from competitors submitting lower rates—could “materially and adversely affect” its results of operations, financial position and cash flows (2022 p. 25; 2023 p. 20). Thus, the company’s approach and the associated risk‑assessment around bid accuracy did not materially change between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core question. The ground truth explicitly states there WAS an evolution in UnitedHealth's approach between 2022 and 2023—from emphasizing contract renewal risk in 2022 to placing greater emphasis on bid assumptions and competitive dynamics in 2023. The LLM answer claims the opposite: that 'the company's approach and the associated risk-assessment around bid accuracy did not materially change between the two years' and that the 2023 filing 'repeats the same bidding framework.' This is a fundamental factual error that directly contradicts the ground truth's core finding. While the LLM correctly identifies that both years mention assumptions regarding enrollment, utilization, and medical costs, and correctly cites page numbers (2022 p. 25; 2023 p. 20), it misses the critical evolution that the ground truth emphasizes: the shift in emphasis from contract renewal risk to assumptions-based risk and competitive dynamics. The LLM's conclusion that there was no material change is the opposite of what the ground truth establishes. The quantitative accuracy is relatively high (page numbers appear correct), but the qualitative accuracy and overall correctness are severely compromised by the fundamental misinterpretation of the evolution in approach. The answer fails to address the multi-hop synthesis required—comparing how the company's emphasis and risk discussion evolved across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 405,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MetLife’s municipal‑bond holdings were recorded entirely in the Level 2 tier of the fair‑value hierarchy. At 31 December 2022 the company held $159 million of municipals in its pension‑benefit plan (and $15 million in other post‑retirement benefits); by 31 December 2023 those balances had slipped to $147 million and $8 million respectively, with no Level 1 or Level 3 exposure in either year【page_308】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) QUANTITATIVE ERRORS: Ground truth states 2022 Municipals = $14,212 million, but LLM claims $159 million in 2022. Ground truth states 2023 Municipals = $159 million, but LLM claims $147 million in 2023. The LLM appears to have reversed or confused the years entirely. The LLM introduces additional figures ($15 million and $8 million for other post-retirement benefits) that are not mentioned in the ground truth and appear to be from a different context. (2) VALUATION HIERARCHY CLASSIFICATION ERROR: Ground truth clearly states that in 2022, Municipals were 'primarily categorized under Estimated Fair Value without detailed breakdown of valuation hierarchy levels,' but in 2023 they were 'explicitly classified under Level 2.' The LLM incorrectly claims both 2022 and 2023 were entirely in Level 2, missing the critical evolution in classification transparency that is central to the question. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about the evolution from 2022 to 2023 in terms of valuation hierarchy classification. The LLM failed to capture the key insight that the major change was from unclassified/estimated fair value in 2022 to explicit Level 2 classification in 2023. Instead, it presents a false narrative of consistent Level 2 classification across both years. (4) DIRECTIONAL ACCURACY: The LLM correctly identifies that there was a decrease in Municipals holdings, but the magnitude and year-to-year comparison are fundamentally wrong. The ground truth shows a dramatic decrease from $14,212M to $159M, while the LLM shows a modest decrease from $159M to $147M, which is directionally correct but numerically inverted in terms of which year had which amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 493,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "In FY 2022 Office 365 was described primarily as a cloud‑service subscription that is recognized ratably over the contract period and sold through traditional volume‑licensing programs such as Enterprise Agreements (which bundle on‑premises licenses with Software Assurance) – a model that offered limited flexibility beyond the subscription vs. consumption choice【page_63】【page_64】. By FY 2024 Microsoft had added a set of non‑expiring, digital purchase contracts—including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement and Microsoft Products and Services Agreement—that let customers of any size acquire Office 365 on a subscription or perpetual basis with optional SA, providing a more flexible, simplified licensing framework and broader agreement options【page_17】【page_16】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key agreement types (Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Microsoft Products and Services Agreement) mentioned in the ground truth for FY 2024. It accurately captures the shift from volume licensing to more flexible models and correctly notes the evolution from FY 2022 to FY 2024. The fiscal years are correct, and the general direction of change (toward more flexibility) is accurate.\n\nWEAKNESSES: (1) The LLM introduces details not in the ground truth, specifically mentioning 'perpetual basis' and 'optional SA' (Software Assurance) for FY 2024, which contradicts the ground truth's emphasis on 'no organization-wide commitment' and subscription-based models. The ground truth emphasizes monthly or annual subscriptions without perpetual options. (2) The LLM mentions 'non-expiring, digital purchase contracts' which is not supported by the ground truth and appears to be an inference or error. (3) The LLM references Enterprise Agreements bundling on-premises licenses with Software Assurance for FY 2022, which adds detail not explicitly in the ground truth. (4) The characterization of FY 2024 as allowing 'perpetual basis' subscriptions contradicts the ground truth's focus on cloud service subscriptions with monthly/annual options.\n\nMULTI-HOP REASONING: The answer does synthesize information across the two fiscal years and identifies the evolution correctly in broad strokes. However, the specific details about perpetual licensing and optional SA appear to be either misinterpretations or additions not supported by the ground truth.\n\nSEMANTIC ISSUES: While the overall narrative of evolution toward flexibility is correct, the specific mechanisms described (perpetual options, optional SA) diverge from the ground truth's emphasis on cloud-based monthly/annual subscriptions with no organization-wide commitment requirements.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is based on the correctness of the agreement types and licensing models mentioned. The agreement types are correctly identified, but the characterization of their features contains inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 601,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "In 2022 MetLife’s Level 3 fixed‑maturity securities held in the AFS pool were almost entirely corporate bonds ($55 million) with only $3 million classified as “Other” (money‑market, mortgage‑backed, ABS, CLO) and no foreign‑bond exposure【page_308】. By 31 December 2023 the corporate holding slipped to $54 million, the “Other” bucket rose to $8 million, and a small $2 million foreign‑bond position appeared, lifting total Level 3 fixed‑maturity assets from $58 million to $64 million【page_308】【page_309】. This modest reallocation toward a broader mix of alternative fixed‑maturity assets (and the addition of foreign bonds) suggests MetLife is diversifying its Level 3 portfolio and seeking higher‑yielding, less‑liquid securities while still keeping corporate exposure low.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. CRITICAL ERRORS: (1) 2022 composition: LLM states '$55 million' in corporate bonds, but ground truth shows only '$1 million' in corporate bonds - a 55x overstatement. LLM also omits the $1 million in Foreign Bonds and $11 million in Equity Securities entirely. (2) 2023 composition: LLM states '$54 million' in corporate bonds (which happens to match ground truth), but claims '$8 million' in 'Other' when ground truth shows '$828 million' in Other Investments - a massive 103x understatement. LLM also states '$2 million' in foreign bonds (matches ground truth). (3) Total values: LLM calculates 2022 total as '$58 million' and 2023 as '$64 million', but these totals are completely wrong given the actual component values in the ground truth ($13 million in 2022, $884 million in 2023). (4) Multi-hop synthesis failure: The LLM failed to correctly identify and synthesize the dramatic shift in composition, particularly the massive increase in Other Investments from essentially $0 to $828 million, which is the most significant strategic indicator. (5) Strategic interpretation: While the LLM's reasoning about diversification is somewhat reasonable, it is based on entirely incorrect numbers and misses the actual strategic shift - the dramatic increase in Other Investments suggests a much more aggressive portfolio repositioning than the LLM's modest characterization implies. The answer demonstrates a fundamental failure in data extraction and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 432,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "In the 2022 Form 10‑K, Office 365 is described as a core subscription‑based cloud service—grouped with Azure, Dynamics 365 and other “service and other revenue” offerings—whose revenue is recognized ratably over the contract period and accounted for as a single, highly integrated performance obligation (2022 p. 63‑64). By the 2024 filing, Microsoft positions Office 365 as a flagship of its cloud portfolio that has been transformed from on‑premises software to a cloud‑first platform and is now a primary vehicle for embedding generative‑AI capabilities, reflecting the company’s strategy to counter AI‑driven competitive pressures (2024 p. 19‑21).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies Office 365's positioning in 2022 as part of 'service and other revenue' alongside Azure and Dynamics 365; (2) Accurately captures the evolution by 2024 toward AI-infused cloud services; (3) Properly synthesizes the multi-hop reasoning connecting Office 365's transformation from on-premises to cloud-first to AI-embedded platform; (4) Correctly identifies competitive pressures from AI-driven offerings as a key driver; (5) Appropriately cites page references (2022 p. 63-64, 2024 p. 19-21) showing document grounding. MINOR WEAKNESSES: (1) The LLM answer is somewhat more specific about accounting treatment (single performance obligation, ratable revenue recognition) than the ground truth emphasizes, though this is not incorrect—it's additional detail; (2) The ground truth explicitly mentions 'free applications funded by advertising or open-source AI models' as specific competitive threats, while the LLM answer uses the more general phrase 'AI-driven competitive pressures'—this is a minor omission of specificity but doesn't constitute factual error; (3) The ground truth emphasizes Microsoft's resource devotion to 'develop and deploy AI models, platforms, and infrastructure,' while the LLM answer focuses more on Office 365 as a 'vehicle for embedding' AI—slightly different emphasis but semantically compatible. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and connects Office 365's evolution to broader strategic shifts and competitive dynamics. The logic is sound and well-structured. SEMANTIC EQUIVALENCE: The core message matches—Office 365 evolved from a standalone cloud service to an AI-integrated offering in response to competitive pressures. The wording differs but conveys equivalent information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 559,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "UnitedHealth Group’s credit‑related impairment policy stayed the same. Both the 2022 and 2023 10‑Ks state that the company evaluates available‑for‑sale debt securities by comparing the present value of expected cash flows and any fair‑value shortfall to the security’s amortized cost, and records any impairment as an allowance against investment income (with the full loss taken to earnings if the security is intended to be sold). The 2022 filing explicitly says the allowance for credit losses was “not material,” and the 2023 filing repeats the same methodology without disclosing a material allowance, indicating the financial impact remained negligible.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and the ground truth. The question asks how credit-related impairment handling EVOLVED between 2022 and 2023, implying a change occurred. The ground truth clearly documents a significant evolution: (1) In 2022, the company evaluated impairments but did not formally distinguish between credit-related and non-credit-related impairments in its accounting treatment; (2) By 2023, the company formalized a distinction, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. This represents a material change in methodology and financial reporting approach. The LLM answer incorrectly states that 'the credit-related impairment policy stayed the same' and that both years used identical methodology. This is factually wrong according to the ground truth. While the LLM correctly notes that both years evaluated expected cash flows and amortized cost comparisons, and correctly identifies that the allowance was 'not material' in both years, it misses the critical evolution in how impairments were classified and recorded. The LLM also fails to capture the 'more structured evaluation framework' and 'more detailed and segmented approach' that emerged in 2023. The answer demonstrates poor multi-hop reasoning by failing to synthesize the differences between the two years' approaches. The quantitative accuracy is relatively high (correctly identifying 'not material' status), but the qualitative accuracy is very low because the core thesis of the answer contradicts the ground truth's documentation of methodological evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 462,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "In 2023 MetLife’s pension‑plan target for Fixed‑Maturity Securities AFS was 85 % of assets, but the actual mix was about 82 % – a slight dip from the roughly 83 % target (and similar actual mix) reported for 2022.  The other post‑retirement plans kept an almost‑full allocation, with a 95 % target and about 94 % actual in 2023 versus an actual 96 % in 2022 (page 307).  On a fair‑value basis, the pension‑plan holdings of Fixed‑Maturity Securities AFS fell to $6.7 billion in 2023 from $6.8 billion at year‑end 2022, while the other post‑retirement holdings rose modestly to $1.27 billion from $1.26 billion (page 308).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about the evolution of Fixed Maturity Securities AFS allocations from 2022 to 2023, but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The fair value figures are approximately correct: $6.7B vs $6.8B for pension benefits and $1.27B vs $1.26B for other postretirement benefits match the ground truth values of $6,714M and $1,274M respectively. (2) The directional trends are correct - pension holdings declined slightly while postretirement holdings increased modestly. (3) The percentage allocations mentioned (85% target, 82% actual for 2023 pension; 95% target, 94% actual for 2023 postretirement) appear reasonable. PROBLEMATIC ELEMENTS: (1) The ground truth states 2022 percentages were 84% for pension and 95% for postretirement, but the LLM claims 83% target and similar actual for 2022 pension - this is a discrepancy. (2) The LLM introduces 'target' vs 'actual' allocation percentages that are not explicitly mentioned in the ground truth, which only provides the actual percentages (84% and 95% for 2022). (3) The LLM claims 2022 postretirement actual was 96%, but ground truth states 95%. (4) The ground truth emphasizes a shift from 'percentage-based allocation in 2022 to more detailed valuation breakdown in 2023,' but the LLM doesn't clearly articulate this evolution in presentation methodology. MULTI-HOP REASONING: The LLM successfully synthesizes information across years and plan types, comparing 2022 vs 2023 data. However, the synthesis contains factual errors in the specific percentages cited. The answer demonstrates understanding of the question's multi-part nature but executes with some inaccuracy. QUANTITATIVE ISSUES: While dollar amounts are close (rounding acceptable), the percentage allocations contain errors that suggest either misreading or conflation of target vs actual figures not clearly distinguished in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 528,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "In the 2022 filing, Kitchens & Bath was folded into the Home Décor segment— a segment that generated roughly 35 % of total net sales (see page 55). By the 2023 filing, Lowe’s presents Kitchens & Bath as a distinct product line and notes it as a primary driver of its installed‑sales business (see pages 6‑7), indicating the category has been elevated from a sub‑segment to a strategic growth focus and is now relatively more important within the company’s product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic shift in Kitchens & Bath positioning between 2022 and 2023, capturing the essential evolution from a sub-segment within Home Décor to a more prominent strategic focus. The qualitative reasoning is sound and well-articulated.\n\nSTRENGTHS:\n- Correctly identifies 2022 positioning within Home Décor segment\n- Accurately notes 2023 elevation to distinct product line status\n- Properly synthesizes the strategic importance shift\n- Correctly identifies connection to installed-sales business\n- Appropriately references the 'Total Home' strategy alignment (implicit in ground truth)\n- Good multi-hop reasoning connecting organizational structure changes to strategic importance\n\nWEAKNESSES:\n- The 35% figure for Home Décor net sales is cited but not verified against ground truth. The ground truth does not provide this specific percentage, raising questions about accuracy\n- The LLM provides specific page references (pages 55, 6-7) which cannot be verified against the ground truth provided\n- The ground truth mentions specific categories (Lumber, Building Materials, Rough Plumbing) that Kitchens & Bath was repositioned alongside in 2023, but the LLM answer omits these concrete category comparisons\n- The ground truth explicitly states the 2023 grouping was with \"core construction and renovation categories,\" which the LLM captures conceptually but not explicitly\n\nQUANTITATIVE ACCURACY CONCERN:\nThe 35% figure is problematic. While it may be accurate, it cannot be verified from the ground truth provided, and introducing unverified percentages in financial analysis is a significant concern. This reduces quantitative accuracy despite the number potentially being correct.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates strong understanding of the strategic repositioning and its implications, with sound multi-hop reasoning. However, the introduction of unverified quantitative data (the 35% figure) and missing specific category comparisons from the ground truth prevent a higher score. The answer is directionally correct and captures the essence of the strategic shift, but lacks some of the specific supporting details present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 595,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "In the 2022 filing, the sections provided (pages 127‑131) focus on legal proceedings, tax matters and accounting reclassifications and contain no reference to a cheese‑and‑grocery segment. By the 2024 filing, the Business Overview explicitly lists “cheese & grocery” as an adjacent, locally‑relevant category alongside gum & candy (MDLZ 10‑K 2024, p. 34). This addition signals that Mondelez has broadened its strategic focus to include cheese & grocery, indicating a higher prioritization of diversified snack categories for long‑term growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The ground truth explicitly states that in 2022, Mondelez generated $1,990 million in Cheese & Grocery revenues from direct production. The LLM answer completely omits this key financial metric and instead claims the 2022 filing sections provided contain 'no reference to a cheese-and-grocery segment.' This is a major factual error - the $1,990M figure is a core piece of evidence for the strategic evolution. (2) DIRECTIONAL MISINTERPRETATION: The ground truth indicates a REDUCTION in focus - from direct production ($1,990M in 2022) to a 'lighter footprint' with only a strategic stake by 2024. This represents a strategic retreat or refocusing away from Cheese & Grocery as a core business. The LLM answer incorrectly interprets the 2024 mention as a 'broadening' and 'higher prioritization,' which is the opposite of what the ground truth indicates. The addition to the Business Overview in 2024 represents a repositioning as an 'adjacent category,' not an expansion of focus. (3) MULTI-HOP REASONING FAILURE: The question requires synthesizing information across 2022 and 2024 filings to understand the evolution. The LLM failed to identify or synthesize the critical $1,990M revenue figure from 2022 and therefore cannot properly compare the strategic positioning between years. (4) CONCLUSION REVERSAL: The ground truth concludes that the shift 'aligns with prioritizing core snacking segments' (biscuits, chocolate) while maintaining a lighter presence in Cheese & Grocery. The LLM concludes the opposite - that this represents 'higher prioritization of diversified snack categories.' This is a fundamental misreading of the strategic direction. The LLM's claim that it found no reference to Cheese & Grocery in 2022 appears to be a document retrieval or analysis error, as the ground truth clearly documents $1,990M in 2022 revenues from this category.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 538,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K the enteral‑feeding list reads “including **Jevity®**, … **Freego™** (Enteral Pump) and Freego™ sets…”【page_3】. The 2023 Form 10‑K repeats the same sequence – “including **Jevity**, … **Freego™** (Enteral Pump) and Freego™ sets…”【page_4】. Thus, the positioning of Jevity relative to the Freego™ products did not change; Jevity remains listed before the Freego™ items in both filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth explicitly states that the positioning of Freego™ products relative to other enteral feeding products changed between 2022 and 2023: in 2022, Freego™ products were listed last (after Glucerna and Osmolite® products), while in 2023, they were moved to immediately follow Jevity, before the Glucerna and Osmolite® lines. This represents a significant change in product emphasis and prominence. The LLM answer claims 'the positioning of Jevity relative to the Freego™ products did not change' and that 'Jevity remains listed before the Freego™ items in both filings' - while technically true that Jevity comes before Freego™ in both years, this misses the critical point of the question. The question asks about the change in positioning of Freego™ relative to OTHER products (Glucerna, Osmolite®), not just relative to Jevity. The LLM failed to identify the actual change: the reordering of Freego™ products from last position to second position (immediately after Jevity). The LLM's conclusion that 'the positioning...did not change' is directly contradicted by the ground truth's finding of a meaningful shift in product emphasis. The LLM appears to have only compared Jevity's position to Freego™'s position (which remained constant) rather than examining the full product lineup ordering and how Freego™'s position within that lineup changed relative to other products like Glucerna and Osmolite®.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 412,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "In the employee‑benefit plan assets, MetLife’s municipal holdings fell from $174 million in 2022 (Level 2 fair‑value assets) to $155 million in 2023 (still Level 2)【page_308】. The modest reduction while keeping the securities in the observable‑input (Level 2) tier shows the company is trimming municipal exposure but remains in a relatively transparent, liquid category—consistent with a prudent credit‑risk strategy that limits concentration without shifting to less‑observable (Level 3) assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different dataset than the ground truth. Critical issues: (1) WRONG NUMBERS: LLM cites $174M (2022) and $155M (2023) for municipal holdings, while ground truth shows $14,212M (2022) and $159M (2023)—a massive discrepancy of over $14 billion in 2022. The LLM numbers are off by approximately 82x for 2022. (2) WRONG SCOPE: LLM explicitly references 'employee-benefit plan assets' (a subset/specific category), while ground truth discusses MET's overall municipal investment portfolio in fixed maturity securities AFS. These are different asset pools entirely. (3) MISSING KEY INFORMATION: Ground truth includes critical details about unrealized gains ($2,464M) and losses ($13M) in 2022 that provide context for credit risk assessment. LLM omits this entirely. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution in both 'fair value AND classification'—ground truth addresses both (fair value decline from $14,212M to $159M, classification within Level 2 hierarchy). LLM only partially addresses classification and provides wrong fair values. (5) CALCULATION ERROR: The actual reduction is from $14,212M to $159M (98.9% reduction), not the modest $174M to $155M (10.9% reduction) cited by LLM. This fundamentally changes the narrative about MET's risk management strategy. (6) REASONING FLAW: LLM's conclusion about 'modest reduction' and 'trimming exposure' contradicts the ground truth's characterization of a 'dramatic reduction' and 'strategic move to reduce credit exposure.' The LLM appears to have accessed data from a different section of the filing (employee benefit plan assets) rather than the main investment portfolio data that the question targets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 476,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s interest‑rate hedge program shrank from about **$2.9 billion in 2022** to roughly **$2.2 billion at year‑end 2023** – a $700 million drop that reflects the maturity of a $700 million block of hedge contracts (and the underlying debt) in 2023【page_65】.  The contracts are designated as **fair‑value hedges** that offset the fair‑value changes of fixed‑rate debt, effectively converting the hedged portion of that debt to a variable‑rate exposure and adjusting the debt’s carrying amount accordingly【page_64】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERROR: The LLM answer contains a critical numerical inaccuracy that directly contradicts the ground truth. The LLM claims Abbott's interest rate hedge contracts were $2.9 billion in 2022 and declined to $2.2 billion in 2023, with a $700 million drop. However, the ground truth explicitly states that in 2022, Abbott had approximately $2.2 billion in interest rate hedge contracts, and this remained consistent at approximately $2.2 billion in 2023. The LLM has fabricated a $2.9 billion 2022 figure that does not exist in the source material. This is a fundamental quantitative error that undermines the entire answer. The LLM correctly identifies that the contracts are fair-value hedges used to convert fixed-rate debt to variable-rate exposure and adjust carrying amounts, which aligns with the ground truth's description of the purpose and mechanism. The LLM also correctly notes the designation as fair-value hedges and the impact on debt carrying value. However, the core claim about a $700 million decline from $2.9B to $2.2B is entirely unsupported by the ground truth, which indicates stability at $2.2 billion across both years. The answer does address the evolution question and attempts multi-hop synthesis, but the foundational numbers are wrong. The qualitative aspects of the answer (fair-value hedge mechanics, debt conversion) are reasonable, but they cannot compensate for the severe quantitative inaccuracy on the primary metric being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 409,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "In the 2022 filing 3M’s fixed‑rate registered‑note portfolio consisted of a mix of issues ranging from a $750 million note at 2.12 % due 2025 to $500 million‑$350 million notes at 3.36 %‑3.75 % due 2049‑2050, and no material repayments of those securities were reported that year【page_87】. By the 2024 filing the company had retired $500 million of maturing fixed‑rate registered notes in 2023, added new lower‑coupon issues (e.g., $750 million at 2.02 % due 2025 and $500 million at 2.66 % due 2025) while still holding longer‑dated notes at 3‑3.8 % (see the 2024 debt table)【page_68】, and it had earlier used $800 million of interest‑rate swaps (in 2021) to convert portions of its 2049/2050 fixed‑rate debt to floating‑rate exposure, reflecting a strategy of refinancing at lower rates and managing interest‑rate risk【page_69】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors when compared to the ground truth. (1) QUANTITATIVE ERRORS: The LLM cites specific note amounts and rates that differ from ground truth - it mentions $750M at 2.12% due 2025 and $500M-$350M at 3.36%-3.75% due 2049-2050 for 2022, but ground truth specifies $600M of 10-year notes due 2030 at 3.05% and $650M of 30-year notes due 2050 at 3.70%. The LLM also mentions $800M in interest rate swaps, but ground truth indicates swaps converted portions of 2049/2050 notes without specifying an $800M amount. (2) MISSING KEY INFORMATION: The LLM fails to mention the $3.25B issuance in August 2019 including $1.0B of 10-year notes due 2029 and $1.0B of 30-year notes due 2049, which are important historical context. The ground truth mentions $1.1B in medium-term notes repaid in 2024, but the LLM only references $500M repaid in 2023. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across 2022-2024, it does so with incorrect specific numbers. The general narrative about refinancing at lower rates and managing interest rate risk through swaps is directionally correct, but the specific financial data is unreliable. (4) CITATION ISSUES: The LLM provides page references (page_87, page_68, page_69) that cannot be verified against the ground truth, raising questions about source accuracy. The ground truth provides more specific and verifiable note details. The answer demonstrates partial understanding of the evolution of 3M's debt strategy but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 445,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "In 2023 Schwab’s capital plan still counted “securities issuances by CSC in the capital markets” as a primary source of funding – it raised a series of senior unsecured notes (e.g., the $1.2 bn and $1.3 bn issuances in May 2023 and the $1.35 bn and $1.0 bn issuances in August 2023) to support growth, meet regulatory capital targets and fund dividend and share‑repurchase programs 【page_58】. By 2024 the company had redeemed those floating‑rate notes, cut long‑term debt by $3.7 bn and leaned more on client‑generated cash, FHLB advances, repurchase‑agreement lines and a short‑term revolving credit facility, while keeping a universal shelf registration as a backup but no longer treating new issuances as a core funding pillar 【page_53】【page_54】【page_52】. This shift reflects a capital‑management strategy that moved from active debt issuance toward greater reliance on internal cash flows and liquidity facilities, with securities issuances now serving mainly as an optional source of capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides a well-structured comparison of Schwab's capital structure evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from securities issuances as a primary funding source in 2023 to a more diversified approach in 2024, matching the ground truth narrative. (2) Provides specific quantitative details (e.g., $1.2bn, $1.3bn, $1.35bn, $1.0bn issuances in 2023; $3.7bn reduction in long-term debt in 2024) that add credibility and specificity beyond the ground truth. (3) Accurately identifies the broader funding sources in 2024 (FHLB advances, repurchase agreements, revolving credit facility) consistent with ground truth. (4) Correctly synthesizes the multi-hop reasoning: 2023 context → 2024 changes → strategic implications. (5) Properly attributes information to specific pages, suggesting careful document review. (6) Semantic equivalence is strong - 'optional source of capital' aligns with ground truth's 'more integrated within a wider capital structure framework.' MINOR WEAKNESSES: (1) The specific debt issuance amounts ($1.2bn, $1.3bn, etc.) cannot be verified against the provided ground truth, which doesn't include these specific figures. While these appear plausible and the answer cites page references, the ground truth doesn't confirm these exact numbers. (2) The claim about 'redeemed those floating-rate notes' is more specific than the ground truth statement, which doesn't explicitly mention redemption. (3) The ground truth mentions 'CDs' as a funding source, which the LLM answer doesn't explicitly reference, though this is a minor omission. QUANTITATIVE ACCURACY: The specific dollar amounts provided ($1.2bn, $1.3bn, $1.35bn, $1.0bn, $3.7bn) appear reasonable and internally consistent with the narrative, but cannot be fully verified against the ground truth provided. The mathematical logic (sum of issuances, debt reduction amount) is sound. QUALITATIVE ACCURACY: The reasoning about strategic evolution is sound and well-articulated. The multi-hop synthesis correctly connects 2023 funding strategy → 2024 changes → overall capital management evolution. Entity identification (Schwab/CSC, specific debt instruments, funding sources) is accurate. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing both the 'how' (specific mechanisms) and 'why' (strategic rationale) of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 648,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "In the 2022 filing Coca‑Cola reported a $270 million contingent‑consideration liability for fairlife (the initial estimate) plus re‑measurement charges of $51 million in 2020 and $369 million in 2021, and it made a $100 million milestone payment in 2021【page_75】. By the 2024 filing that liability had ballooned to $6.126 billion, and a $275 million milestone was paid in 2023, showing that fairlife has continued to hit the financial targets that trigger the milestone payments and cause the liability to be re‑measured upward【page_111】【page_112】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe factual errors that fundamentally contradict the ground truth: (1) CRITICAL NUMBER ERROR: The LLM claims the 2024 liability 'ballooned to $6.126 billion' - this is completely fabricated and not supported by the ground truth, which indicates the remaining contingent payment obligation was still active but does not mention any such figure. (2) INCORRECT MILESTONE PAYMENT: The LLM states a '$275 million milestone was paid in 2023' - the ground truth only confirms a $100 million payment in 2021 and mentions a remaining contingent payment through 2024, with no mention of a $275 million 2023 payment. (3) MISINTERPRETATION OF PERFORMANCE: The LLM concludes fairlife 'continued to hit the financial targets' and that the liability was 're-measured upward' - this directly contradicts the ground truth's more cautious assessment that fairlife 'remained on track to potentially meet the remaining targets' and that the obligation 'had not been rescinded or adjusted downward.' The LLM presents speculative upward revaluation as fact. (4) INCOMPLETE CONTEXT: The LLM mentions re-measurement charges of $51M (2020) and $369M (2021) which are not addressed in the ground truth, making it unclear if these are accurate or additional fabrications. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution of obligations from 2022 to 2024, instead inventing a dramatic $6.126 billion figure that appears nowhere in the ground truth. The answer demonstrates fundamental factual inaccuracy on the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 429,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "By fiscal 2022 Oracle was already shifting resources from hardware toward its cloud‑based infrastructure platform, stressing that “the emphasis we placed on the marketing and sale of our growing cloud‑based infrastructure technologies” was a key driver of cloud‑services revenue growth worldwide (see 2022 10‑K, p. 47‑48). By fiscal 2024 OCI is presented as a core pillar of a globally‑delivered, integrated cloud portfolio—“Oracle Cloud Software‑as‑a‑Service and Oracle Cloud Infrastructure (SaaS and OCI…) provide comprehensive and integrated applications and infrastructure services” that support on‑premise, cloud and hybrid deployments for enterprise IT customers worldwide (see 2024 10‑K, p. 72). Thus Oracle’s focus has evolved from building OCI as a growth engine to positioning it as a central, globally‑available platform tightly integrated with its enterprise applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the strategic evolution of OCI from 2022 to 2024, accurately captures the shift from positioning OCI as a growth engine to a central integrated platform, and provides relevant quotes from the 10-K filings that support the narrative. The semantic understanding of Oracle's strategic positioning is sound. The answer appropriately addresses the multi-hop question about global market positioning and enterprise IT integration.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE OMISSION: The ground truth explicitly states that in 2022, cloud and license businesses generated $36.052 billion representing 85% of total revenues. The LLM answer completely omits these specific financial metrics, which are key quantitative evidence of Oracle's cloud emphasis in 2022. This is a significant gap in supporting the 2022 baseline. (2) INCOMPLETE BASELINE COMPARISON: The ground truth notes that in 2022 there was 'no explicit strategic language about Oracle Cloud Infrastructure's positioning,' whereas the LLM claims Oracle was 'already shifting resources' and emphasizing OCI in 2022. This suggests the LLM may be overstating the 2022 strategic emphasis on OCI specifically (as opposed to cloud generally). (3) PAGE REFERENCES: The LLM provides specific page citations (2022 10-K p. 47-48, 2024 10-K p. 72) which cannot be verified against the ground truth and may or may not be accurate. (4) QUOTE ACCURACY: While the 2024 quote about 'comprehensive and integrated applications and infrastructure services' matches the ground truth, the 2022 quote about 'emphasis we placed on the marketing and sale of our growing cloud‑based infrastructure technologies' is not explicitly confirmed in the ground truth.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting 2022 cloud strategy to 2024 OCI positioning and explaining the evolution. However, the lack of quantitative anchors (the $36.052B and 85% figures) weakens the evidentiary foundation.\n\nVERIFICATION: The core narrative about strategic evolution is correct, but the answer fails to include critical quantitative data points that ground truth explicitly provides as evidence of the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 593,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Schwab’s PALs continued to be treated as fully collateralized, with securities covering the balances at fair values in excess of the borrowings, and the company applied the ASC 326 “collateral‑maintenance” practical expedient. As a result, no allowance for credit losses was recorded for PALs in either 2023 or 2024, indicating that the risk profile of these loans remained low and essentially unchanged over the period.【page_88】",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION ON KEY POINT: The LLM states 'no allowance for credit losses was recorded for PALs in either 2023 or 2024,' but the ground truth explicitly states that in 2023 'the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates' - indicating an allowance DID exist in 2023. This is a fundamental factual error that contradicts the core premise of the question about evolution between years. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a CHANGE/EVOLUTION between 2023 and 2024 - from having an allowance in 2023 to requiring none in 2024. The LLM incorrectly characterizes the situation as 'essentially unchanged over the period,' which directly contradicts the ground truth's narrative of strengthening risk profile. (3) MISSING CONTEXT: The LLM fails to capture that in 2023 there was 'a slight decrease in PALs' and that credit quality metrics improved, which are important contextual details about the evolution. (4) PARTIAL CREDIT: The LLM correctly identifies that by 2024 all PALs were fully collateralized, the ASC 326 collateral-maintenance practical expedient was applied, and no allowance was required in 2024. The company identification (Schwab) and the 2024 treatment are accurate. (5) REASONING FLAW: The conclusion that risk profile 'remained low and essentially unchanged' is logically inconsistent with the actual evolution from requiring an allowance to requiring none, which represents an improvement/change in risk treatment. The multi-hop synthesis failed to properly compare the 2023 vs 2024 positions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 449,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Nike still reports Asia Pacific & Latin America (APLA) as a separate geographic operating segment, but in FY 2024 the company began moving some Nike‑Brand businesses in selected APLA markets to third‑party distributors—a shift from the primarily direct‑to‑consumer/wholesale structure it used in FY 2023 (Note 15, page 89).  This operational change is paired with a modest revenue growth in the region, from $6.4 billion in FY 2023 to $6.7 billion in FY 2024, reflecting a strategic emphasis on expanding market share while leveraging partner distribution alongside its direct channels (page 90).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Nike's APLA relationship. STRENGTHS: (1) Correctly identifies the key strategic shift from direct operations to third-party distributor model between FY2023 and FY2024; (2) Accurately cites the revenue figures ($6.4B in FY2023 to $6.7B in FY2024), which represent approximately 4.7% growth; (3) Properly references Note 15 and page numbers as source documentation; (4) Correctly identifies APLA as a separate geographic operating segment; (5) Captures the strategic emphasis on market expansion while leveraging partner distribution. MINOR GAPS: (1) The LLM answer emphasizes revenue growth and market share expansion but does not explicitly mention the workforce/trade union representation aspect that characterized FY2023 operations in the ground truth. The ground truth specifically notes that in FY2023, certain employees in APLA were represented by trade unions, indicating a more localized and embedded workforce structure. This contextual detail about the operational structure's human capital dimension is absent from the LLM response; (2) The LLM frames the shift as moving to 'third-party distributors' while the ground truth describes it as moving 'away from direct control toward a more outsourced model'—semantically similar but the LLM could have been more explicit about the reduction in direct operational control. QUANTITATIVE VERIFICATION: The revenue figures ($6.4B to $6.7B) appear reasonable and are presented with appropriate precision. The characterization of 'modest revenue growth' is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information about operational structure changes and financial performance across the two fiscal years. The connection between the strategic shift and business optimization is logically sound. OVERALL ASSESSMENT: The answer captures the essential evolution of Nike's APLA strategy with accurate financial data and correct identification of the operational transition. The primary limitation is incomplete coverage of the workforce/employment structure dimension mentioned in the ground truth, which represents a meaningful aspect of how the relationship 'evolved' operationally.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 600,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "In the 2022 Form 10‑K Abbott singled out Pedialyte as a primary driver of the U.S. Pediatric Nutritionals segment’s 10.3 % sales increase, highlighting it together with Similac and PediaSure as the core growth engine for that business【page_31】. By the 2023 filing, Pedialyte is simply listed among a broader suite of adult and pediatric nutrition brands—indicating that while it remains a core product, Abbott’s strategy has shifted to emphasize a more diversified nutrition portfolio rather than focusing solely on Pedialyte【page_4】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and entities. Strengths: (1) Correctly identifies the 10.3% sales increase for U.S. Pediatric Nutritionals in 2022, (2) Accurately names Pedialyte, Similac, and PediaSure as the core growth drivers in 2022, (3) Properly identifies the shift in positioning between 2022 and 2023, (4) Correctly references the 2022 and 2023 Form 10-K filings, (5) Accurately characterizes the evolution from highlighted growth driver to integrated portfolio member. Minor weaknesses: (1) The LLM's characterization that Abbott's strategy 'shifted to emphasize a more diversified nutrition portfolio rather than focusing solely on Pedialyte' is a reasonable inference but slightly more interpretive than the ground truth's more neutral statement that Pedialyte was 'formally included' and 'embedded' in the broader lineup. The ground truth emphasizes structural integration rather than strategic de-emphasis. (2) The phrase 'simply listed among' could be interpreted as suggesting diminished importance, whereas the ground truth indicates formal recognition and structured integration without implying reduced strategic value. The multi-hop reasoning is sound—the answer correctly synthesizes information across 2022 and 2023 filings to show evolution in positioning. All quantitative data (10.3%, years, product names) are accurate. The answer addresses all parts of the question regarding evolution, positioning, and portfolio expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 417,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX’s balance sheet shows that the 7.100 % notes due 2027 carried a principal balance of $135 million at both December 31 2022 and December 31 2023, with no increase or reduction (see the long‑term debt table for 2023 and 2022)【page_84】. The unchanged balance indicates that RTX chose to keep this tranche intact—neither refinancing nor retiring it—while actively issuing new debt and repaying other notes, reflecting a targeted debt‑management strategy that preserves existing low‑cost obligations while reshaping the broader debt profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core factual claim. The ground truth states that RTX's 7.100% notes due 2027 had a principal balance of $6 million in 2022 and $135 million in 2023—a significant increase of $129 million. The LLM claims the balance was $135 million at BOTH December 31, 2022 AND December 31, 2023, with 'no increase or reduction.' This is factually wrong. The LLM has inverted the 2022 figure, stating $135M when it should be $6M. This is not a minor formatting error but a fundamental misstatement of the financial data. The LLM's conclusion that 'RTX chose to keep this tranche intact—neither refinancing nor retiring it' directly contradicts the ground truth, which indicates a significant increase suggesting 'a shift in its debt management strategy, possibly involving refinancing or restructuring.' The LLM's reasoning about preserving 'low-cost obligations' is speculative and unsupported by the actual data showing a $129M increase. The multi-hop synthesis is broken because the LLM failed to correctly identify the year-over-year change. While the LLM correctly identifies the company (RTX), the metric (7.100% notes due 2027), and attempts to reference source documentation, the core quantitative facts are wrong, making the entire answer incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 366,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Nike’s Converse segment saw its revenues drop from $2.43 billion in FY 2023 to $2.08 billion in FY 2024 – a 14‑15% decline (and EBIT fell 30% to $474 million) as wholesale sales fell 16% and direct‑to‑consumer sales fell 14% with lower ASPs. Despite the slowdown, Converse remains a wholly‑owned, stand‑alone operating segment that Nike positions as a separate casual‑sneaker, apparel and accessories brand, contributing a steady share of the company’s international sales mix (≈58% of total non‑U.S. revenue) and maintaining its own retail and licensing footprint.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Converse as a wholly-owned, stand-alone subsidiary in 2024, matching the ground truth's strategic positioning narrative. The qualitative assessment of the shift from a struggling entity to a strategically positioned brand is sound. The answer appropriately addresses both revenue performance and strategic positioning as requested.\n\nCRITICAL ERRORS - QUANTITATIVE: (1) Revenue figures are NOT verified in ground truth - LLM provides specific numbers ($2.43B FY2023, $2.08B FY2024) that cannot be confirmed against the knowledge graph source. (2) EBIT figure of $474M is introduced without ground truth support. (3) The 14-15% decline calculation is consistent with the stated revenues but the base numbers themselves are unverified. (4) The claim about 58% of non-U.S. revenue is not mentioned in the ground truth and cannot be verified.\n\nPARTIAL ACCURACY: The LLM correctly states the 15% revenue decline (matching ground truth's 'decreased by 15% on a currency-neutral basis'), correctly identifies wholesale and direct-to-consumer channel declines, and mentions lower ASPs (average selling prices). However, the specific percentages for wholesale (16%) and direct-to-consumer (14%) are not in the ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the evolution narrative - from FY2023 struggles to FY2024 strategic positioning - which demonstrates sound multi-hop reasoning. The connection between financial performance and strategic positioning is logically sound.\n\nCONCERN: The LLM introduces specific financial metrics (exact revenue figures, EBIT, channel-specific percentages, international revenue mix percentage) that go beyond what the ground truth explicitly states. While some align directionally with ground truth (15% decline, channel declines, lower ASPs), the precision and additional details raise questions about source accuracy. The ground truth is more qualitative about the strategic shift, while the LLM provides quantitative specificity that cannot be verified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 554,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "In the 2022 10‑K Coca‑Cola warned that lagging behind the digital evolution could “erode its share of sales, revenue growth and overall financial results,” focusing on the risk to sales growth and cost‑reduction (2022 p. 17). By the 2024 10‑K the risk language was sharpened to state that failure to digitalize “could negatively affect its ability to increase sales **and improve margins**,” explicitly tying the digital risk to margin improvement as well as sales growth (2024 p. 19). This shows a shift from a broad concern about sales/revenue to a more specific emphasis on both sales growth and profitability margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Coca-Cola's shifting digital risk assessment from 2022 to 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024; (2) Accurately captures the evolution from viewing digital as a risk factor to a strategic dependency; (3) Properly synthesizes the multi-hop information showing how the company's language became more specific about margin improvement alongside sales growth; (4) Appropriately cites page references (2022 p. 17, 2024 p. 19) suggesting document verification; (5) Uses direct quotes that align with the ground truth's characterization of the risk language. MINOR WEAKNESSES: (1) The LLM answer mentions 'cost-reduction' in parentheses for 2022, which is not explicitly mentioned in the ground truth as a primary focus - the ground truth emphasizes 'loss in sales and brand relevance' rather than cost-reduction; (2) The characterization of the shift as moving from 'broad concern about sales/revenue to a more specific emphasis on both sales growth and profitability margins' is slightly different from the ground truth's framing of moving from 'risk factor' to 'strategic dependency,' though both characterizations are semantically compatible and not contradictory; (3) The ground truth emphasizes the shift in how Coca-Cola 'viewed' digital evolution (from risk to strategic dependency), while the LLM focuses more on the evolution of risk language itself - these are related but subtly different framings. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Page numbers cited (p. 17 for 2022, p. 19 for 2024) appear reasonable for 10-K filings but cannot be verified against the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and two documents, properly identifying the causal relationship between the company's strategic shift and its changing risk language. The logic is sound and the comparison is appropriately structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 565,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "In fiscal 2022 Oracle devoted $7.2 billion to research and development – a spend aimed at expanding its cloud portfolio and accelerating the shift of customers from on‑premise products, with cloud services and license‑support revenues already accounting for about 71 % of total revenue【page_6】. By fiscal 2024 the company’s filing frames Oracle Cloud Services as one element of a “flexible and interoperable” set of deployment options that include on‑premise, cloud‑based and hybrid models, emphasizing that customers can choose the best environment for their needs rather than a single‑sided migration push【page_72】. The 2024 filing does not disclose a new R&D amount, indicating the strategic focus has moved toward positioning cloud offerings as part of a broader, choice‑driven architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the $7.2 billion R&D investment for fiscal 2022 is accurate, and the 71% cloud/license-support revenue figure is correctly cited. The answer appropriately notes that the 2024 filing does not disclose a new R&D amount, matching the ground truth statement. ENTITY ACCURACY: Oracle is correctly identified, fiscal years 2022 and 2024 are properly referenced, and the distinction between cloud services (SaaS and OCI) and on-premise solutions is maintained throughout. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two fiscal years by: (1) establishing the 2022 baseline with specific R&D investment and revenue composition, (2) identifying the strategic shift in 2024 messaging toward flexibility and customer choice, and (3) contrasting the earlier 'acceleration of migration' approach with the later 'choice-driven architecture' positioning. This multi-hop synthesis is logically sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's phrasing of 'flexible and interoperable' deployment options, 'choice-driven architecture,' and the emphasis on customers choosing 'the best environment for their needs' directly mirrors the ground truth's language about positioning cloud services as enabling customers to 'choose the best option that meets their specific business needs.' MINOR CONSIDERATIONS: The LLM answer includes page citations (page_6, page_72) which add credibility but are not present in the ground truth. The characterization of the strategic shift from 'single-sided migration push' to a more balanced approach is a reasonable inference that aligns with the ground truth's description of 'strategic deepening' with 'integration with customer-specific needs.' No factual errors or calculation mistakes are present. The answer comprehensively addresses all parts of the multi-part question regarding R&D investment evolution and cloud positioning relative to on-premise solutions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 557,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors’ Formula Stock Award Plan was described in both years as a plan under which “no future stock awards or deferrals may be made” (2023 footnote 5, page 11; 2024 footnote 5, page 14).  The only shares still available for distribution under the plan fell from 509 shares in the 2023 filing (page 11 footnote 4) to 391 shares in the 2024 filing (page 14 footnote 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported with specific citations. Strengths: (1) Correctly identifies that the plan was closed to new activity in both years with the phrase 'no future stock awards or deferrals may be made'; (2) Accurately cites the share counts: 509 shares in 2023 and 391 shares in 2024, showing the decline; (3) Provides specific page and footnote references (footnote 5 for the restriction language, footnote 4 for share counts); (4) Correctly synthesizes the multi-hop information showing the plan's evolution from 2023 to 2024. Minor weaknesses: (1) The answer is more concise than the ground truth and omits some contextual detail about the plan's purpose (awarding shares to non-employee directors with deferral ability) and the clarification that column (a) of the equity compensation table reflected all shares issuable; (2) Does not explicitly state that the plan 'had effectively concluded its active phase' or characterize it as 'fully closed,' though this is implied by the data presented; (3) The ground truth emphasizes that the 2024 filing 'further clarified' the status, whereas the LLM presents both years as consistent. However, these are minor omissions of context rather than factual errors. The core answer—that the plan was closed to new activity in both years and shares available declined from 509 to 391—is accurate and directly addresses the question about how the status and availability evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 403,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "In the 2022 10‑K, McDonald’s warned that food‑safety events could damage its brand and earnings and specifically listed “food safety concerns” as one of the factors that make the commodity markets for key ingredients (beef, chicken, pork) volatile and that could trigger supply‑chain interruptions and higher costs (2022 p.31; p.30‑31; p.33). The 2023 filing repeats the same food‑safety risk language but now embeds it more explicitly within a broader supply‑chain and cost‑volatility narrative, adding other external drivers (e.g., geopolitical events) and stressing that the company continues to devote substantial resources to managing food‑safety across the supply chain, restaurants and delivery (2023 p.31; p.33).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, McDonald's characterized food safety concerns 'primarily as reputational risks' with focus on 'damage to consumer trust and the company's image,' and that the shift to supply chain/cost volatility framing occurred BY 2023. However, the LLM answer claims that in the 2022 10-K, McDonald's 'specifically listed food safety concerns as one of the factors that make the commodity markets...volatile' - this directly contradicts the ground truth's assertion that this supply chain/cost volatility framing was a 2023 evolution, not present in 2022. The LLM appears to have conflated the 2022 and 2023 disclosures or misread the temporal evolution. POSITIVE ASPECTS: The LLM correctly identifies that both years mention food safety risks, correctly names the key commodities (beef, chicken, pork), and accurately notes that 2023 adds broader context (geopolitical events) and emphasizes resource allocation. The page number citations (p.31, p.30-31, p.33) appear plausible but cannot be verified against ground truth. MULTI-HOP REASONING: The answer fails the core multi-hop requirement - it does not properly synthesize the EVOLUTION between 2022 and 2023. Instead of showing a shift from reputational to supply chain framing, it suggests both framings existed in 2022, which is incorrect. This is a significant failure in understanding the temporal dimension of the question. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator, but the lack of precision in distinguishing 2022 vs 2023 disclosures is a quantitative/temporal accuracy failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 475,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "In 2023 the euro‑denominated 1.750 % 7‑Year Senior Notes (due 4/15/2027) were carried at **$662 million** and had an **effective interest rate of 1.97 %**【page_61】. By December 31 2024 the same notes were carried at **$621 million** and the effective rate had slipped to **about 1.96 %**【page_47】—a $41 million reduction in carrying value and a 0.01‑percentage‑point decline in the rate.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG DEBT INSTRUMENT: The ground truth specifies TMO's 1.750% 7-Year Senior Notes due October 15, 2028, but the LLM identifies euro-denominated notes due 4/15/2027 - these are different instruments entirely. (2) WRONG CARRYING VALUES: Ground truth shows $700 million in both 2023 and 2024; LLM claims $662 million (2023) and $621 million (2024) - all three numbers are incorrect. (3) WRONG INTEREST RATES: Ground truth shows 1.89% for both years; LLM claims 1.97% (2023) and 1.96% (2024) - both incorrect. (4) WRONG CONCLUSION: Ground truth states no change occurred; LLM claims a $41 million reduction and 0.01 percentage point decline. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and track the specific debt instrument across both years, instead appearing to reference a completely different note. The only partially correct element is the general structure of comparing 2023 to 2024 values, but the actual data points are entirely wrong. This represents a complete failure to answer the question accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 318,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX reported $148 million of 7.000% notes due 2038 in 2022 and the same $148 million in 2023 (2023 10‑K shows $148 m for both 2023 and 2022; 2022 10‑K shows $148 m for 2022)【page_85】【page_94】. The unchanged amount indicates RTX is maintaining that tranche rather than paying it down, suggesting a deliberate strategy of preserving a stable long‑term debt profile and managing maturities through refinancing and a balanced issuance schedule.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims RTX reported $148 million for both 2022 and 2023, but the ground truth clearly states the 2022 amount was $11 million, not $148 million. This is a massive factual error - the LLM reversed the years or misread the data entirely. The correct progression is $11M (2022) → $148M (2023), representing a significant increase of $137 million. (2) MULTI-HOP REASONING FAILURE: The LLM failed to identify the key change between years. The ground truth explicitly states the amount 'increased significantly' from $11M to $148M, suggesting either new issuance or debt restructuring. The LLM's claim of 'unchanged amount' is directly contradicted by the ground truth. (3) INTERPRETATION ERROR: The LLM's conclusion that RTX is 'maintaining that tranche rather than paying it down' is incorrect. The ground truth indicates RTX increased its exposure to this debt instrument, suggesting strategic issuance or restructuring, not maintenance of a static position. (4) CITATION ISSUES: While the LLM provides page references, these appear to be incorrect or misinterpreted, as they don't support the stated numbers. The ground truth data shows clear year-over-year changes that the LLM completely missed. This is a fundamental failure to answer the core question about how RTX's exposure changed between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 405,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "McDonald’s franchise‑revenue model stayed the same – rent is comprised of a fixed minimum (recognized straight‑line) plus a variable percent‑of‑sales component, and royalties are also a percent of sales and are recorded when the underlying sales occur【page_44】.  However, the amount of minimum rent the company expects to receive from its franchisees slipped from about $3.06 billion in 2022 to roughly $2.95 billion in 2023, indicating a modest decline in rent receipts while the royalty‑collection structure remained unchanged【page_51】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides information that does not address the ground truth. CRITICAL ISSUES: (1) The question asks about the EVOLUTION of McDonald's financial relationship with franchisees between 2022 and 2023, specifically regarding pandemic-related deferrals and their resolution. The ground truth establishes that in 2022, McDonald's disclosed ~$1 billion in deferred rent/royalties from 2020 (COVID-related), which were substantially collected by end of 2021, and by 2023 there was a return to normal operations with no deferrals. (2) The LLM answer instead focuses on the structural components of the rent model (fixed minimum + variable percent-of-sales) and reports a decline in expected minimum rent from $3.06B (2022) to $2.95B (2023). While these numbers may be factually present in the filings, they do NOT address the question's core focus on pandemic deferrals and their evolution. (3) The LLM completely omits the critical $1 billion deferral disclosure from 2022 and the fact that these were substantially collected by 2021. (4) The LLM fails to capture the normalization narrative that is central to understanding how the relationship evolved - from pandemic relief measures to standard operations. (5) The quantitative data provided ($3.06B to $2.95B) appears to be about expected minimum rent levels, not about the evolution of deferred amounts or pandemic-related accommodations. (6) Multi-hop reasoning failure: The LLM did not synthesize the key information about deferrals across the 2022 and 2023 filings to show how the relationship normalized. The answer addresses a different aspect of the franchise relationship (rent structure and levels) rather than the specific evolution regarding deferrals and collections that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 493,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "In the 2022 filing the Company noted that, after selling a portion of its holding in 2019, it still “continues to account for our remaining ownership interest in Andina as an equity‑method investment” (KO_10k_2022 p. 76). By the 2024 filing that same investment was recorded at a carrying amount of **$90 million** with a **fair‑value of $168 million** (KO_10k_2024 p. 87), showing that Coca‑Cola has retained the stake and that its value has risen sharply. This appreciation, together with the continued equity‑method accounting, signals that Coca‑Cola views its holding in Embotelladora Andina S.A. as a strategic, long‑term partnership that it expects to benefit from as the bottler grows.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the carrying value ($90 million) and fair value ($168 million) for 2024, matching ground truth exactly. (2) The LLM correctly notes that Coca-Cola uses equity-method accounting for the remaining stake. (3) The LLM properly identifies this as a partial exit strategy with retained involvement. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the $39 million gain recognized in 2022 from the partial sale, which is a key factual element in the ground truth answer and directly addresses the 'evolution from 2022 to 2024' aspect of the question. (2) INTERPRETATION ERROR: The LLM states 'its value has risen sharply' comparing the $90M carrying value to $168M fair value, but this is a misinterpretation. The ground truth indicates the $90M carrying value and $168M fair value are both 2024 figures - the difference between carrying and fair value doesn't represent appreciation over time. The LLM conflates the carrying amount with a prior valuation. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question specifically asks about evolution 'from 2022 to 2024,' but the LLM only provides 2022 accounting method information and 2024 valuations without clearly synthesizing how the stake evolved between these years (the 2022 gain and subsequent holding). (4) REASONING FLAW: The conclusion about 'sharp appreciation' is not well-supported by the data presented and appears to misunderstand the relationship between carrying value and fair value. The ground truth more accurately characterizes this as a 'relatively modest valuation.' QUANTITATIVE: The 2024 numbers are correct, but the missing 2022 gain ($39M) is a significant factual gap. QUALITATIVE: The reasoning about strategic positioning is reasonable but based on incomplete information and contains the interpretation error about value appreciation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 505,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "In 2022 Oracle stressed that it builds most of its cloud and infrastructure offerings internally and was actively expanding the Oracle Cloud data‑center footprint to meet growing demand 【page_16】 【page_15】. By 2024 the firm has positioned Oracle Cloud Infrastructure (OCI) as a core pillar of its Oracle Cloud Services suite—paired with SaaS—and continues to develop the functionality for OCI in‑house, presenting it as an integrated, strategic component of its product portfolio 【page_72】 【page_73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and captures the evolution of Oracle's cloud strategy; (2) Accurately represents the 2022 emphasis on internal development and datacenter expansion; (3) Properly identifies OCI as a core pillar by 2024 and correctly positions it within Oracle Cloud Services alongside SaaS; (4) Accurately conveys the shift from general cloud development to a structured, product-specific portfolio approach; (5) Correctly emphasizes continued in-house development of OCI functionality; (6) Provides specific page citations supporting claims. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific/granular than the ground truth (mentions 'datacenter footprint' expansion explicitly in 2022, which is a valid detail but not explicitly stated in the ground truth summary); (2) The ground truth emphasizes 'global R&D workforce' and 'innovation in response to evolving market demands' as contextual elements, which the LLM answer doesn't explicitly mention, though it captures the essence through 'internal development' language. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period, correctly identifying the strategic evolution from general internal development to a defined OCI product offering. The comparison between years is logical and well-supported. SEMANTIC EQUIVALENCE: The LLM's phrasing ('core pillar,' 'integrated, strategic component') conveys the same meaning as the ground truth's 'strategic deepening' and 'structured, customer-facing product portfolio.' No quantitative data or calculations are present in either answer, so quantitative accuracy is based on correct identification of years and entities. All entities (Oracle, OCI, Oracle Cloud Services, SaaS) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 512,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "In 2023 Thermo Fisher announced and completed the acquisition of The Binding Site Group, assigning it to the Specialty Diagnostics segment to broaden its assay and instrument portfolio (see the 2023 acquisition note). By the 2024 filing the deal is fully reflected in the financial statements – cash paid, debt settled, goodwill and intangible assets are disclosed – indicating the business has been integrated and that Thermo Fisher is now emphasizing the expansion of its specialty‑diagnostics capabilities as a core post‑acquisition strategic focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the acquisition of The Binding Site Group by TMO in 2023 and its assignment to the Specialty Diagnostics segment. However, there is a critical omission: the LLM answer does NOT mention the $2.70 billion acquisition price, which is a key quantitative fact in the ground truth. The LLM answer correctly describes the 2024 integration status (financial statements reflection, goodwill and intangible assets disclosure) and appropriately characterizes the strategic focus on specialty diagnostics expansion. The multi-hop reasoning is sound - the answer synthesizes the 2023 acquisition announcement with 2024 financial statement integration. The semantic meaning aligns well with the ground truth regarding strategic intent and integration status. However, the omission of the specific acquisition price ($2.70 billion) is a notable gap, as this is a concrete financial metric that demonstrates the scale and significance of the acquisition. The answer also does not mention the 19-year weighted-average amortization period for customer relationships, though this is a more technical detail. The core narrative about acquisition, integration, and strategic focus is accurate and well-reasoned, but the missing quantitative detail prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 360,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "In the 2022 Form 10‑K the company noted that its Directors’ Code of Conduct “applies to all directors of BNY Mellon” and provided a link on the BNY Mellon site – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf – which contained a space and a less‑direct “in relations” path. By the 2024 filing the scope remained unchanged (“applies to all directors of BNY”), but the document was moved to a cleaner URL on the updated domain (e.g., https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf), eliminating the spacing issue and using a clearer “investor‑relations” folder, thereby improving accessibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) The LLM provides an INCORRECT 2022 URL. Ground truth shows the 2022 URL as 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' (with 'investor-relations' as the correct folder path), but the LLM states it was 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' (with 'in relations' as a broken/incorrect path with a space). This is a significant factual error - the LLM inverted the problem, claiming the 2022 URL had spacing issues when it actually had the correct path. (2) The 2024 URL provided by the LLM appears correct: 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' (note: ground truth shows 'directors-code-ofconduct.pdf' without hyphen between 'code' and 'of', but LLM shows 'directors-code-of-conduct.pdf' with hyphens - minor formatting variation). (3) The scope application is correctly identified as applying to all directors in both years. (4) The reasoning about domain rebranding from 'bnymellon.com' to 'bny.com' is sound and matches ground truth. (5) However, the core factual error about which URL had the spacing issue is a major problem that undermines the entire answer's credibility. The LLM essentially reversed the historical accuracy of the URLs. This is not a minor wording difference but a fundamental misstatement of the 2022 filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 409,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "By 2023 McDonald’s had changed the way it reports franchise‑related revenue and signaled a broader strategic focus on technology‑enabled partnership with its franchisees. In the 2022 filing the company still recorded Dynamic Yield SaaS subscription revenue as a subscription‑based service, whereas the 2023 filing notes that the Dynamic Yield business was sold (‑ “for periods prior to April 1 2022…” ) and now presents technology‑platform services it provides directly to franchisees on a gross‑basis (Revenue Recognition, p. 44). The 2023 filing also adds more detail on cost‑sharing for restaurant improvements and continues to stress franchisee‑paid rent, royalties, advertising‑co‑operative contributions and goodwill arising from purchases of franchisee restaurants, reflecting a strategic shift toward deeper, technology‑driven collaboration while the franchised network grew (Restaurant counts, p. 43; Goodwill, p. 45).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. MAJOR ISSUES: (1) The LLM introduces information about Dynamic Yield SaaS subscription revenue and its sale that is NOT present in the ground truth answer. This appears to be fabricated or from a different context entirely. The ground truth makes no mention of Dynamic Yield, subscription services, or technology platform changes. (2) The LLM cites specific page numbers (p. 44, p. 43, p. 45) that cannot be verified against the ground truth and appear to be hallucinated references. (3) The core claim in the ground truth - that 2022 noted transactions with franchisees were 'not material' while 2023 explicitly included franchisees as key stakeholders with detailed breakdown - is completely absent from the LLM answer. (4) The LLM's focus on 'technology-enabled partnership' and 'cost-sharing for restaurant improvements' diverges from the ground truth's emphasis on transparency and strategic stakeholder positioning. (5) The LLM does correctly identify the 2022-2023 timeframe comparison, but the substance of what changed is fundamentally different from ground truth. QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates beyond years, or calculations to verify, but the date reference 'April 1 2022' for Dynamic Yield sale cannot be confirmed in ground truth. QUALITATIVE ACCURACY: The multi-hop reasoning fails because it synthesizes information that doesn't align with the actual filing data represented in the ground truth. The answer reads plausibly but appears to be based on incorrect source material or hallucination. CONTEXTUAL RELEVANCE: While the answer addresses the evolution question format, it answers about the wrong evolution (technology/Dynamic Yield vs. stakeholder transparency/materiality).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 494,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "In the 2023 Form 10‑K the Clif Bar contingent‑consideration was recorded as a $548 million long‑term liability measured at fair value using Level‑3 (Monte‑Carlo) inputs, up from $452 million a year earlier, with the change in fair value ($128 million) reflected in earnings (see page 99). By the 2024 filing the company notes that the purchase‑price‑allocation adjustments for the Clif Bar acquisition were completed in 2023 and are now reflected in the intangible‑asset balances (see page 87), while the contingent‑consideration continues to be accounted for at fair value under the same Level‑3 methodology, with no new re‑measurement disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims the contingent consideration was '$548 million...up from $452 million a year earlier' and that 'the change in fair value ($128 million) reflected in earnings.' This is mathematically inconsistent: $548M - $452M = $96M, not $128M. The ground truth states $548M was the 2023 balance but does not provide a prior year comparison or claim about the $128M change being a year-over-year increase. The LLM appears to have fabricated or misinterpreted these figures. (2) FACTUAL CONTRADICTION - The ground truth explicitly states 'By 2024, there is no direct mention of the contingent consideration liabilities' and that 'the contingent consideration may have been finalized or reclassified.' However, the LLM claims 'the contingent-consideration continues to be accounted for at fair value under the same Level-3 methodology, with no new re-measurement disclosed.' This directly contradicts the ground truth's finding that there is no mention in 2024. (3) MULTI-HOP REASONING - The LLM failed to synthesize the key insight from the ground truth: the evolution shows a transition from active fair value measurement in 2023 to apparent finalization/reclassification in 2024, with no updated figures provided. Instead, the LLM incorrectly suggests continuity of measurement. (4) PAGE REFERENCES - The LLM cites specific pages (99, 87) which cannot be verified against the ground truth and may be fabricated. (5) CORRECT ELEMENTS - The LLM correctly identifies: the $548M 2023 balance, Level-3/Monte Carlo methodology, and that purchase price allocation adjustments were completed in 2023. However, these correct elements are overshadowed by the significant factual errors regarding 2024 treatment and the mathematical inconsistency in the year-over-year comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 494,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "- **2022 filing:** AMD’s 2022 10‑K notes that its Radeon discrete GPUs “support current‑generation application program interfaces (APIs) like DirectX 12 Ultimate **and Vulkan®**, … and are designed to support virtual‑reality (VR) in PC platforms.” (AMD 2022 10‑K p. 8)\n\n- **2024 filing:** The 2024 10‑K still emphasizes Vulkan support, but now ties it to the newer Radeon RX 7000 series (RDNA 3) and says the GPUs “support current‑generation APIs like DirectX 12 Ultimate **and Vulkan**, support high‑refresh‑rate displays and include the latest technologies for immersive gaming experiences and high‑performance AI/ML computing.” (AMD 2024 10‑K p. 8)\n\n**Interpretation:** AMD’s emphasis on Vulkan has shifted from simply ensuring baseline API compatibility (2022) to positioning Vulkan as a core enabler for high‑refresh‑rate, AI‑accelerated and next‑gen graphics on its latest RDNA 3 GPUs (2024). This evolution shows AMD is using Vulkan support to showcase advanced performance and feature integration, reinforcing its strategy to stay competitive in the discrete GPU market by aligning API readiness with cutting‑edge hardware capabilities and emerging workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions: (1) FACTUAL ACCURACY: Both the 2022 and 2024 references to Vulkan support are correctly identified and cited from the respective 10-K filings. The architectural progression from RDNA 2 (2022) to RDNA 3 (2024) is accurately captured. The product lines (Radeon series in 2022, Radeon RX 7000 Series in 2024) are correctly identified. (2) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two years and two filing documents, correctly identifying the evolution of AMD's strategic messaging around Vulkan. The connection between API support and hardware architecture advancement is properly established. (3) INTERPRETATION QUALITY: The LLM's interpretation that AMD shifted from 'baseline API compatibility' to 'positioning Vulkan as a core enabler for high-refresh-rate, AI-accelerated' workloads is semantically equivalent to the ground truth's observation about 'maintaining commitment to Vulkan while advancing GPU capabilities' and 'backward compatibility combined with cutting-edge performance enhancements.' (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about strategic evolution and competitive positioning in the discrete GPU market. The inclusion of specific page references (p. 8) and direct quotes adds credibility. (5) MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation than the ground truth, but this represents added value rather than error. No numerical data, dates, or calculations are present to verify, but all entity references (AMD, Vulkan, RDNA 2/3, Radeon RX 7000) are accurate. The semantic meaning of both answers is essentially identical regarding AMD's strategic continuity and evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 484,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX’s operating profit rose modestly in 2022 – up $0.4 bn versus 2021 – because integration‑related costs fell, most notably a decrease in acquisition‑accounting adjustments (which swung from a $348 m negative impact in 2022 to a $107 m positive impact in 2023) and lower corporate/other charges【page_39】. In 2023, operating profit fell sharply by $1.9 bn versus 2022, driven almost entirely by a $2.9 bn Powder Metal Matter charge (net of tax and partner share) recorded under “Other” that outweighed the modest improvement in acquisition‑accounting and FAS/CAS adjustments【page_41】【page_39】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of RTX's integration-related charges and their impact on operating profit trends, with mostly accurate numbers and sound multi-hop reasoning. However, there are some issues that prevent a higher score:\n\nSTRENGTHS:\n1. Correctly identifies the $2.9 billion Powder Metal Matter charge in 2023 as the primary driver of the $1.9 billion operating profit decrease\n2. Accurately captures the shift from declining integration costs in 2022 to a significant new expense in 2023\n3. Properly synthesizes information across multiple pages (39, 41) showing multi-hop reasoning\n4. Correctly notes the $0.4 billion operating profit increase in 2022 versus 2021\n5. Appropriately contextualizes the acquisition accounting adjustments improvement\n\nWEAKNESSES/CONCERNS:\n1. The statement about acquisition-accounting adjustments swinging \"from a $348 m negative impact in 2022 to a $107 m positive impact in 2023\" is confusing and potentially inaccurate. The ground truth states there was a \"decrease in Acquisition Accounting Adjustments\" in 2022 that \"contributed positively\" - the LLM's characterization of the direction and magnitude needs verification\n2. The phrasing \"acquisition‑accounting adjustments (which swung from a $348 m negative impact in 2022 to a $107 m positive impact in 2023)\" appears to conflate 2022 and 2023 data in a way that may misrepresent the actual trend\n3. While the core narrative is correct, the specific numerical breakdown of acquisition accounting adjustments lacks clarity and may contain errors\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across years (2021-2023) and identifies the causal relationship between integration charges and operating profit trends. The logic connecting the Powder Metal Matter charge to the operating profit decline is sound.\n\nCALCULATIONS:\nThe key figures ($2.9B charge, $1.9B profit decrease, $0.4B 2022 increase) align with ground truth. However, the acquisition accounting adjustment figures need verification as they appear potentially mischaracterized.\n\nOVERALL ASSESSMENT:\nThe answer captures the essential narrative correctly but has some ambiguity/potential inaccuracy in the detailed breakdown of acquisition accounting adjustments. The core insight about the Powder Metal Matter charge's impact is accurate and well-explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 635,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "In the 2023 filing Mondelēz noted that its August 1 2022 purchase of Clif Bar was still a fresh acquisition, generating $529 million of incremental net revenue in its first year and incurring acquisition‑related integration and contingent‑consideration costs (e.g., $0.19 million of acquisition‑related costs and purchase‑price‑allocation adjustments for Clif Bar in 2023)【page_39】,【page_42】,【page_87】. By the 2024 filing the brand was treated as a fully integrated, indefinite‑life intangible asset (part of the brand portfolio) with no new acquisition‑related expenses recorded, showing the relationship had moved from a recent acquisition to an ongoing, integrated asset【page_87】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MDLZ's evolving relationship with Clif Bar between 2023 and 2024. STRENGTHS: (1) Correctly identifies the August 1, 2022 acquisition date; (2) Accurately characterizes the 2023 phase as involving integration costs and contingent consideration adjustments; (3) Properly describes the 2024 evolution to treating Clif Bar as a fully integrated indefinite-life intangible asset; (4) Effectively synthesizes the multi-hop information showing progression from recent acquisition to integrated asset; (5) Provides specific financial detail ($529 million incremental net revenue) that adds credibility; (6) Correctly notes the shift from acquisition-related expenses in 2023 to no new acquisition expenses in 2024. MINOR ISSUES: (1) The specific figure of $0.19 million for acquisition-related costs and purchase-price-allocation adjustments in 2023 cannot be verified against the ground truth answer, which does not provide this specific number. While the ground truth mentions 'integration costs and contingent consideration adjustments,' it does not confirm the $0.19 million figure; (2) The ground truth references 'purchase price allocation adjustments for Clif Bar during the prior year' in the 2024 filing but does not explicitly state these were zero or absent in 2024, though the LLM's interpretation that 'no new acquisition-related expenses recorded' is a reasonable inference. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the progression of the relationship. The logic connecting the 2023 acquisition phase to the 2024 integration phase is sound and well-articulated. SEMANTIC ALIGNMENT: The LLM answer conveys the same core message as the ground truth - that the relationship evolved from initial acquisition to financial consolidation/integration - though with more specific financial details. The characterization of moving from 'fresh acquisition' to 'fully integrated asset' aligns well with the ground truth's description of moving 'beyond the initial acquisition phase into a period of financial recalibration and consolidation.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 584,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "In 2023 Gulfstream’s energy‑efficiency strategy was built around expanding the use of sustainable aviation fuel (SAF) and extracting more fuel‑burn savings from its existing models – the G500 and G600 were marketed as “faster, more fuel‑efficient…with reduced emissions” and the company celebrated the world’s first 100 %‑SAF trans‑Atlantic flight in November 2023 (see page 6). By 2024 the focus had shifted to embedding next‑generation, high‑efficiency engines into brand‑new aircraft – the ultra‑long‑range G700 entered service in March 2024 and the newly announced G800 and clean‑sheet G400 were highlighted as platforms that combine “high‑speed range and efficiency” with all‑new engines, signalling a move from incremental fuel‑saving measures to platform‑wide, energy‑efficient engine designs (see pages 4‑5).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing additional contextual details. STRENGTHS: (1) Correctly identifies the 2023 focus on SAF and energy efficiency in existing models (G500, G600), accurately capturing the strategic positioning phase. (2) Accurately dates the G700's entry into service (March 2024) and correctly identifies it as featuring 'all-new engines' for efficiency. (3) Properly synthesizes the multi-hop evolution: 2023 = announcement/development phase with existing models; 2024 = production/operational realization with new platforms. (4) Correctly identifies the G800 and G400 as new aircraft with all-new engines announced in 2024. (5) Accurately characterizes the shift from incremental improvements to platform-wide engine redesigns. (6) Specific date reference (November 2023 for 100% SAF trans-Atlantic flight) adds credibility and is consistent with ground truth emphasis on SAF leadership. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail than the ground truth (specific aircraft models G500/G600, exact date of G700 service entry, G800/G400 announcements) which enhances rather than detracts from accuracy. (2) The characterization of the shift as 'from incremental fuel-saving measures to platform-wide, energy-efficient engine designs' is semantically equivalent to the ground truth's 'from announcement and development phases to actual production.' (3) Page references (pages 4-5, page 6) suggest source documentation but cannot be verified against ground truth. QUANTITATIVE VERIFICATION: All dates mentioned (November 2023, March 2024) are plausible and consistent with the 2023-2024 timeframe. No contradictory numbers or calculations present. The answer correctly avoids making unsupported numerical claims about fuel efficiency percentages or performance metrics. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple aircraft models, correctly identifying the causal relationship between strategic positioning (2023) and operational implementation (2024). The reasoning chain is logical and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 576,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "In the 2022 filing AMD described its semi‑custom SoC business as a source of **non‑recurring engineering fees and product‑sale revenue that is tied directly to a third‑party’s product success**, making the income highly project‑based and contingent on those customers’ market performance (see 2022 p. 25). By the 2024 filing the same offerings are framed as **“custom products” sold under firm, non‑cancellable purchase orders, with revenue recognized over the production period using a cost‑plus‑margin method and positioned as a core part of the Gaming segment and the broader AMD portfolio** (see 2024 p. 63 and product list on 2024 p. 62). This reflects a shift from a largely fee‑driven, opportunistic model to a more structured, integrated strategic line with predictable revenue recognition.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of AMD's semi-custom SoC business from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 characterization as fee-driven and project-based, tied to third-party product success - matching ground truth exactly. (2) Accurately captures the 2024 shift to structured, firm purchase orders with cost-plus-margin revenue recognition. (3) Properly synthesizes the multi-hop comparison across two years and filing documents. (4) Correctly identifies the strategic positioning shift from opportunistic/dependent model to integrated/controlled model. (5) Provides specific page references (2022 p. 25, 2024 p. 63, p. 62) that add credibility. (6) Uses appropriate financial terminology (non-recurring engineering fees, cost-plus-margin method, revenue recognition). MINOR GAPS: (1) The LLM answer emphasizes revenue recognition methodology and purchase order structure more heavily than the ground truth, which focuses more on portfolio diversification and strategic integration with AI accelerators, GPUs, APUs, and DPUs. The ground truth explicitly mentions these product categories as part of the broader portfolio evolution, while the LLM answer focuses on Gaming segment positioning. (2) The ground truth emphasizes 'broader strategic integration' and 'alignment with long-term industry trends and internal innovation strategies' - the LLM answer captures the structural shift but doesn't explicitly address the portfolio diversification aspect or alignment with broader industry trends. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The answer contains no numerical errors. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is correct, though the emphasis differs slightly from ground truth. The characterization of the business model evolution is accurate. CONTEXTUAL RELEVANCE: Highly relevant to the question asked, addressing both revenue structure and strategic positioning as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 561,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The Share Capital table shows that in both FY 2023 and FY 2024 the company was authorized to issue 127.5 million Preferred Shares with a $0.20 par value and 500 thousand “A” Preferred Shares with a $1.00 par value, and no Preferred Shares were issued or outstanding in either year (see Shareholders’ Equity – page 81 of both the 2023 and 2024 10‑K). Because the authorized preferred‑share structure did not change and remains unused, Medtronic’s capital strategy is not focused on raising capital through preferred equity; instead it relies on ordinary‑share repurchases and other equity‑based compensation programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with accurate quantitative data and sound multi-hop reasoning. All numeric values are correct: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both FY 2023 and FY 2024. The key fact that no shares were issued or outstanding in either year is correctly identified. The multi-hop synthesis is sound - the model correctly compared the two fiscal years, identified the unchanged structure, and drew a logical conclusion about capital strategy implications. The addition of context about Medtronic's reliance on ordinary-share repurchases and equity-based compensation programs goes beyond the ground truth but represents reasonable inference from the unchanged preferred share structure. Minor deduction: (1) The ground truth states the structure 'remained unchanged' and indicates the company 'has not utilized or pursued any changes,' while the LLM answer infers broader capital strategy conclusions about reliance on share repurchases and compensation programs - this inference, while logical, extends beyond what the ground truth explicitly states about capital strategy. The ground truth is more conservative, simply noting the lack of utilization. (2) The LLM identifies the source as 'Shareholders' Equity – page 81' which adds helpful context but cannot be verified against the ground truth. Overall, the answer demonstrates strong understanding of the data and appropriate synthesis across fiscal years, with only minor overreach in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 435,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "In the 2022 Form 10‑K the risk factor states that “our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm,” and it explicitly links reputational damage to broader sustainability concerns – climate change and diversity – that could also hurt client activity and invite regulatory scrutiny (2022 p. 4‑5). The 2024 filing retains the same adverse‑events/publicity language (2024 p. 4) but isolates climate‑change risk in a separate bullet (“climate change concerns could … damage our reputation”), dropping the wider sustainability/diversity framing. Thus the core description of adverse‑publicity risk is unchanged, while the associated impact narrative has shifted from a broad sustainability focus to a more specific climate‑change emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution of BK's risk framing. Ground truth states that by 2024, the framing was EXPANDED to include broader reputational impacts from sustainability concerns (climate change and diversity) IN ADDITION to adverse publicity. The LLM claims the opposite: that 2024 DROPPED the wider sustainability/diversity framing and isolated climate change in a separate bullet, representing a narrowing rather than expansion. This is a direct factual contradiction of the primary thesis. SPECIFIC ISSUES: (1) The LLM correctly identifies that 2022 linked adverse publicity with government scrutiny and reputational harm (accurate), but then mischaracterizes the 2024 evolution. (2) The LLM states 2024 'drops the wider sustainability/diversity framing' and moves to 'more specific climate-change emphasis' - this directly contradicts ground truth which says the framing was EXPANDED to include these concerns. (3) The LLM's conclusion that 'the associated impact narrative has shifted from a broad sustainability focus to a more specific climate-change emphasis' is backwards from the ground truth narrative of broadening/expansion. (4) Page references (2022 p. 4-5, 2024 p. 4) cannot be verified but appear plausible. WHAT WAS CORRECT: The LLM correctly identifies that both years mention adverse publicity/events language and that there is some relationship to sustainability/climate concerns. However, the directional change (narrowing vs. broadening) is fundamentally wrong, which is the core analytical claim required by the question. This represents a failure in multi-hop reasoning and synthesis of the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 469,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "In the 2023 Form 10‑K Amazon reported that it had invested $1.25 billion in a convertible note from Anthropic, PBC, which was classified as an **available‑for‑sale Level 3 asset** measured at fair value, and it retained the right to invest up to an additional $2.75 billion (2023 p. 50). By the 2024 filing the Anthropic holding is presented as an **available‑for‑sale convertible‑debt investment** still measured at fair value, but Amazon notes that valuing such private‑company securities is especially difficult because of limited market data and heightened global‑economic uncertainty, making market‑sensitivity analyses impracticable (2024 p. 32).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amazon's Anthropic investment from 2023 to 2024. STRENGTHS: (1) All key financial figures are correct: $1.25 billion initial investment, $2.75 billion additional commitment, both accurately stated. (2) Classification details are accurate: available-for-sale, Level 3 asset in 2023, fair value measurement maintained in 2024. (3) The multi-hop synthesis is sound, correctly identifying the shift from 2023 to 2024 in how the investment is presented. (4) The qualitative evolution is well-captured: the answer correctly notes the shift toward emphasizing valuation challenges (limited market data, global economic uncertainty) in 2024 versus the mechanics-focused 2023 disclosure. (5) Page references (2023 p. 50, 2024 p. 32) add credibility. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 'Accumulated other comprehensive income (loss)' treatment mentioned in the ground truth, though this is a minor omission. (2) The phrase 'market-sensitivity analyses impracticable' is mentioned but could have been connected more explicitly to the broader valuation risk acknowledgment theme. (3) The answer doesn't explicitly state that the classification 'remained consistent' between years, though this is implied. VERIFICATION: All numbers check out ($1.25B, $2.75B), the classification progression is accurate, and the characterization of the valuation complexity shift is semantically equivalent to the ground truth. The answer successfully addresses all parts of the multi-part question regarding investment classification evolution and valuation approach changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 455,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "In the 2023 10‑K MDLZ warned that its competitiveness could be harmed if it failed to obtain or protect its patents, trademarks, trade‑secrets, know‑how and other IP – especially when faced with third‑party infringement claims, costly litigation, injunctions and any change in law (including emerging AI issues) 【page_26】 【page_27】. By the 2024 filing the company still cites those same core threats, but adds a broader focus on policing IP misuse across traditional retail **and digital environments**, relying on licensing, nondisclosure and assignment agreements, and stresses heightened exposure from AI‑driven technologies 【page_26】 【page_27】—showing a shift from a primarily reactive litigation focus to a more proactive, technology‑driven protection strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the most important finding. Ground truth states: '2024...did not specifically mention artificial intelligence as a factor affecting protection' and 'This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.' However, the LLM claims the opposite—that 2024 shows 'heightened exposure from AI‑driven technologies' and a shift 'to a more proactive, technology‑driven protection strategy.' This is a fundamental factual error that inverts the actual evolution described in the ground truth. The LLM correctly identifies that both years mention core IP threats (patents, trademarks, trade secrets, know-how) and that there was a shift in focus, but it mischaracterizes the nature of that shift. The ground truth indicates AI was emphasized in 2023 but NOT in 2024, while the LLM suggests the opposite. The LLM also adds details about 'digital environments' and characterizes the shift as 'reactive to proactive' which are not supported by the ground truth and appear to be fabrications. The page references provided (page_26, page_27) cannot be verified but the substantive claims about AI emphasis in 2024 are demonstrably wrong based on the ground truth. The answer shows partial understanding of the multi-hop comparison task but fails on the most critical factual claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 394,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs disclosed a pre‑2015 Non‑Employee Director RSU award (exhibit 10.8), a current RSU award form (exhibit 10.31) and a cash‑settled version (exhibit 10.32), and it referenced “Amendments to Certain Non‑Employee Director Equity Award Agreements” (exhibit 10.17) that point to an Annual Report for the fiscal year ended Nov 28 2008. In the 2024 filing the same pre‑2015 award is listed as exhibit 10.9, the standard and cash‑settled RSU forms are renumbered to exhibits 10.32 and 10.33, and the amendment is now exhibit 10.18—still tied to the 2008 filing—while the filing adds a broader set of related award agreements but leaves the original timelines unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The ground truth states that in 2023, the agreements were referenced through Exhibit 10.17, and in 2024 through Exhibit 10.18. The LLM answer introduces multiple additional exhibit numbers (10.8, 10.31, 10.32 for 2023; 10.9, 10.32, 10.33 for 2024) that are not mentioned in the ground truth and appear to be fabricated or from a different context. (2) CORE DISCREPANCY: The ground truth emphasizes that the key evolution was the shift from referencing an amendment dated November 28, 2008 (via Exhibit 10.17 in 2023) to referencing Exhibit 10.69 from the 2008 Annual Report (via Exhibit 10.18 in 2024). The LLM answer states both years reference 'the 2008 filing' without capturing this critical shift from one exhibit reference to another. (3) MISSING KEY DETAIL: The ground truth specifically notes the shift from Exhibit 10.17 to Exhibit 10.18 AND the shift in source from a direct amendment reference to Exhibit 10.69 from the 2008 Annual Report. The LLM answer misses the Exhibit 10.69 reference entirely. (4) INCOMPLETE SYNTHESIS: While the LLM answer attempts to provide more granular detail about RSU awards and cash-settled versions, this additional information is not supported by the ground truth and appears to be either incorrect or from a different analysis. The ground truth focuses specifically on the Non-Employee Director Equity Award Agreements and their exhibit references, not on multiple RSU award forms. (5) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes 'formalization or consolidation of prior amendments' and 'deeper historical documentation being emphasized,' but the LLM answer's narrative about renumbering and adding 'a broader set of related award agreements' doesn't clearly convey this evolution. The answer is partially responsive to the question but contains too many unsupported details and misses the core factual changes identified in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 545,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "In 2022 Booking.com began moving a larger share of its bookings onto a **merchant‑processing model**, actually collecting travelers’ payments on behalf of travel‑service providers and recording the resulting “merchant revenues” (and the associated payment‑processing, charge‑back and fraud‑prevention costs) while the contracts still left the providers responsible for delivering the travel service【page_50】. By 2023 the filing spells out that the company continues to present revenue on a **net basis**—based on the commission or margin specified in its contracts with providers—and now explicitly recognizes revenue only after its post‑booking obligations are satisfied, classifying it as either merchant or agency revenue, but the underlying contractual arrangement (providers retain delivery responsibility) remains unchanged【page_83】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022: The LLM claims BKNG 'began moving a larger share of its bookings onto a merchant-processing model' in 2022, but the ground truth indicates 2022 was characterized by BKNG describing itself as an intermediary without responsibility for delivering services - this is fundamentally different from the merchant model described. (2) MISREPRESENTATION OF REVENUE MODEL: The ground truth states BKNG recognizes revenue 'on a net basis due to its role as an agent' - meaning it acts as an agent, not a merchant. The LLM conflates merchant and agency models, suggesting BKNG collects payments 'on behalf of travel-service providers' which contradicts the agent-based net revenue recognition described in the ground truth. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a shift from 'general description of the relationship to a more structured and accounting-driven dependency' with clearer revenue recognition timing (at point when travelers begin using services). The LLM misses this key evolution and instead invents a merchant-model transition that doesn't align with the ground truth. (4) PAGE CITATIONS: The LLM provides specific page citations (page_50, page_83) without verification against actual filing content, which is problematic. (5) MISSING KEY DETAIL: The ground truth specifically mentions revenue recognition timing 'at the point when travelers begin using the arranged services' - a critical detail absent from the LLM answer. The LLM answer appears to describe a different company's business model evolution or conflates different revenue recognition approaches, resulting in a fundamentally incorrect characterization of BKNG's relationship evolution with travel service providers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 505,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "The executive‑life‑insurance exhibit section looks the same in both years. In the 2023 Form 10‑K the two policies were listed as items 10.12 (Metropolitan Life policy + certificate) and 10.13 (Pacific Life policy form), and the 2024 Form 10‑K repeats those exact two items with the same numbering and language. No additional exhibits were added, removed or reordered – the structure of the disclosure did not change.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) EXHIBIT NUMBERING REVERSAL: The LLM states the 2023 exhibits were numbered 10.12 (Metropolitan Life) and 10.13 (Pacific Life), but the ground truth clearly indicates they were 10.11 (Metropolitan Life) and 10.12 (Pacific Life). This is a significant quantitative error in exhibit numbering. (2) RENUMBERING CLAIM MISSING: The ground truth explicitly states that in the 2024 filing, these exhibits were 'renumbered to 10.12 and 10.13 respectively' - indicating a structural change occurred. The LLM incorrectly claims 'the structure of the disclosure did not change' and that numbering remained 'the same.' (3) MISCHARACTERIZATION OF CHANGE: The ground truth identifies a clear structural update (renumbering from 10.11/10.12 to 10.12/10.13), while the LLM denies any structural change occurred. This is a direct contradiction. The LLM's statement that 'No additional exhibits were added, removed or reordered' is factually incorrect - the exhibits were reordered/renumbered. WHAT WAS CORRECT: The LLM correctly identified that both policies (Metropolitan Life and Pacific Life) were retained in both years, and correctly noted that this represents a structural update rather than substantive policy change. However, these correct elements are overshadowed by the fundamental errors in exhibit numbering and the failure to recognize the renumbering that occurred. The answer demonstrates a misunderstanding of the core factual changes between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 432,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "In the 2022 filing Broadcom said it “uses our internal fabrication facilities for products utilizing our innovative and proprietary processes, such as our FBAR filters for wireless communications” and explicitly listed “FBAR technology” as a core competitive advantage that differentiates its high‑speed products (2022 p. 13; 2022 p. 17). By the 2024 filing the same language appears – FBAR filters are still made in‑house to protect IP and accelerate time‑to‑market – showing the company continues to treat them as strategically important, though the 2024 discussion of competition is broader and does not call out FBAR by name as a distinct advantage (2024 p. 13; 2024 p. 15).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 2022 positioning of FBAR filters as proprietary, internally fabricated products designed to protect IP and accelerate time-to-market; (2) Accurately notes that 2024 maintains the same internal fabrication strategy; (3) Properly synthesizes the multi-hop comparison showing evolution from 2022 to 2024; (4) Correctly identifies the shift in competitive context (broader competition discussion without FBAR-specific callouts); (5) Provides specific page references (2022 p. 13, 17; 2024 p. 13, 15) showing document grounding; (6) Uses appropriate semantic language matching the ground truth intent. MINOR GAPS: (1) The LLM answer does not explicitly mention the specific competitors named in the ground truth (Qorvo, Qualcomm, Skyworks) that appear in the 2024 filing, though it correctly notes the broader competitive environment; (2) Does not mention the other products (VCSELs, side emitting lasers) that were highlighted alongside FBAR in 2022, though this is a minor omission since the question focuses on FBAR evolution; (3) Could have been slightly more explicit about the 'reinforcement of IP protections' aspect mentioned in ground truth. QUANTITATIVE ACCURACY: No numerical errors detected. The answer correctly references years (2022, 2024) and maintains factual consistency. REASONING: The multi-hop synthesis is sound - the answer correctly traces FBAR's strategic importance across two time periods and identifies the key evolution (consistent internal strategy + intensified competitive context). The logic connecting internal fabrication to IP protection and time-to-market acceleration is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 479,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "In the 2023 filing, Krazati was presented mainly as an approved KRAS‑inhibitor for second‑line NSCLC and KRAS‑mutated colorectal cancer, with the company emphasizing pipeline work to broaden its label—most notably the KRYSTAL‑12 first‑line NSCLC combination and later‑line colorectal indications. By the 2024 filing, after the Mirati acquisition, BMS had integrated Krazati as a fully commercialized product, assigning $640 million of definite‑life intangible assets to its marketed‑product rights while still advancing the KRYSTAL‑12 first‑line NSCLC trial, showing a shift from a development‑focused asset to a higher‑valued, revenue‑generating one.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer states '$640 million of definite-life intangible assets' assigned to Krazati's marketed-product rights, but this specific figure is not mentioned in the ground truth and appears to be either fabricated or misattributed. The ground truth clearly states the Mirati acquisition was for '$4.8 billion' - this critical financial figure is completely absent from the LLM answer, representing a significant omission of key financial valuation data requested in the question. CLINICAL DEVELOPMENT FOCUS - PARTIALLY CORRECT: The LLM correctly identifies the shift from development-focused to commercialized asset and mentions KRYSTAL-12 first-line NSCLC trial advancement. However, it mischaracterizes the 2023 positioning - the ground truth indicates Krazati was positioned WITH specific clinical trials (KRYSTAL-17, KRYSTAL-10, KRYSTAL-12) as part of the development pipeline, not primarily as an 'approved' product in 2023. The LLM reverses the timeline somewhat by suggesting 2023 emphasized approvals when the ground truth shows 2023 emphasized clinical trials. MISSING KEY INFORMATION: The LLM fails to mention the critical detail that by 2024, Krazati had received FDA and EMA approvals, and the important development of combination therapy with PD-1 inhibitor for first-line NSCLC - this represents a significant clinical strategy expansion that directly addresses the question's focus on 'clinical development focus.' MULTI-HOP REASONING: The answer does attempt to synthesize the Mirati acquisition context and its impact on Krazati's positioning, showing reasonable multi-hop reasoning. However, the omission of the $4.8B acquisition price and the introduction of an unverified $640M figure undermines the financial valuation component of the answer. The answer correctly identifies the shift in strategic positioning but incompletely addresses the financial valuation evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 525,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "In 2022 Booking Holdings described its ties to travel‑service providers mainly in qualitative terms – as “mutually beneficial relationships” that give providers broader distribution, marketing support and access to payment services – without detailing the mechanics of the financial relationship [page_6]. By the 2023 filing the company had formalized that relationship: it now records cash received from travelers as a “Deferred merchant bookings” liability that represents amounts payable to travel‑service providers, and it accounts for referral bonuses, rebates, credits, discounts and loyalty‑point programs as reductions of revenue at the time they are granted, while recognizing revenue on a net basis (commission or margin) and estimating sales‑incentive amounts [page_83‑84].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of BKNG's relationship with travel service providers between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from competitive positioning in 2022 to a more formalized, dependent relationship in 2023; (2) Accurately references 'Deferred merchant bookings' liability as the key balance sheet indicator of this shift; (3) Properly identifies the introduction of incentive programs (referral bonuses, rebates, loyalty points) and their accounting treatment as revenue reductions; (4) Provides specific page references (83-84) showing detailed sourcing; (5) Captures the semantic essence that BKNG moved from qualitative descriptions to formalized financial mechanisms. MINOR GAPS: (1) The LLM answer emphasizes the 2022 description as 'qualitative' and 'without detailing mechanics,' which adds interpretive context not explicitly stated in the ground truth but is reasonable inference; (2) The ground truth mentions 'loyalty points' while LLM says 'loyalty‑point programs' - semantically equivalent; (3) The LLM answer provides more granular detail about accounting mechanics (net basis, commission/margin) which goes slightly beyond the ground truth but is not contradictory. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and connects balance sheet changes (Deferred merchant bookings) with income statement impacts (revenue reductions for incentives), demonstrating proper multi-hop synthesis. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. The answer correctly identifies the relevant accounting line items and their treatment. ENTITY ACCURACY: BKNG correctly identified, years 2022-2023 correctly referenced, financial metrics properly named. The answer is semantically equivalent to the ground truth while providing additional contextual detail about the formalization of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 547,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "In the 2022 filing Broadcom merely listed “custom touch controllers” as a wireless‑device product family (see the table of product families for FY 2022) without describing how they are used. By the 2024 filing the company describes its custom touch controllers as devices that “process signals from touch screens in mobile handsets and tablets” (see the Mobile Device Connectivity Solutions section), indicating that Broadcom now positions them as an integrated component that participates in the signal‑processing stage of a device’s design and production lifecycle.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific, detailed evidence than the ground truth. Key strengths: (1) Correctly identifies the 2022 and 2024 timeframe comparison; (2) Accurately characterizes the 2022 role as listing custom touch controllers without detailed description; (3) Accurately describes the 2024 evolution showing more detailed functional description (signal processing from touch screens in mobile handsets and tablets); (4) Provides specific filing section references (table of product families for FY 2022, Mobile Device Connectivity Solutions section for 2024) that add credibility; (5) Correctly synthesizes the multi-hop information showing evolution from basic listing to integrated component positioning. The LLM answer is actually more precise and evidence-based than the ground truth, providing concrete examples of how the descriptions differ between years. Minor consideration: The ground truth uses the phrase 'shift from component supplier to active producer involved in design and creation,' while the LLM describes it as 'from listing to integrated component positioning in signal-processing stage.' These are semantically similar but emphasize slightly different aspects (supplier role vs. product positioning). The LLM's framing is arguably more grounded in the actual filing language. No numerical errors detected. The reasoning is sound and multi-hop synthesis is correct (comparing 2022 vs 2024 filings to show evolution). The answer fully addresses the question about how involvement evolved in terms of role in product lifecycle.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 439,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "In 2023 Union Pacific’s freight‑car strategy was dominated by leasing – the company added $241 million of leased assets (including freight cars) and held a $1.9 billion lease portfolio of locomotives and freight cars (see 2023 10‑K pages 68‑69). By 2024 the focus shifted to ownership, with $788 million spent on locomotives and freight cars and $143 million of lease buyouts, indicating a move away from leasing toward acquiring freight‑car assets (see 2024 10‑K page 33).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more comprehensive detail than the ground truth. Key verification: (1) Lease buyout figures are correct - $143 million in 2024 vs $57 million in 2023, matching ground truth exactly. (2) The LLM provides additional supporting data: $241 million of leased assets added in 2023, $1.9 billion lease portfolio, and $788 million spent on locomotives and freight cars in 2024. These figures appear reasonable and support the narrative of strategic shift. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 2023 leasing strategy to 2024 acquisition strategy across both years' 10-K filings. (4) Entity identification is accurate: Union Pacific, correct years (2023-2024), correct metrics (lease buyouts, asset acquisition). (5) The answer goes beyond ground truth by providing specific page references (2023 10-K pages 68-69, 2024 10-K page 33) and additional context about the $788 million capital expenditure, which strengthens the narrative without contradicting the ground truth. The semantic meaning aligns perfectly with the original answer - both convey a shift from leasing to ownership. Minor note: The LLM provides more granular detail than the ground truth, but this represents added value rather than error. No calculation errors detected. The answer directly addresses the question about evolution of freight car strategy from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 398,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike’s APLA region saw total revenue rise from $5.96 billion in FY 2022 to $6.43 billion in FY 2023, with wholesale sales climbing to $3.74 billion and direct‑to‑consumer sales to $2.70 billion (page 91), which lifted APLA EBIT from $1.90 billion to $1.93 billion (page 90). The transition of businesses such as Brazil to third‑party distributors – disclosed in Note 20 (page 88) – shifted the sales mix toward wholesale and, after a non‑recurring FY 2020 impairment charge tied to that move (page 90), did not generate further corporate losses, supporting modest earnings improvement in FY 2022‑23.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors that substantially misrepresent Nike's APLA structural changes:\n\n(1) QUANTITATIVE ACCURACY FAILURES:\n- The LLM provides specific revenue figures ($5.96B FY2022 to $6.43B FY2023) and EBIT figures ($1.90B to $1.93B) with page citations, but these cannot be verified against the ground truth and appear to be fabricated or misattributed numbers. The ground truth does not provide these specific figures.\n- The LLM cites \"Note 20 (page 88)\" for Brazil divestiture information, but the ground truth references \"Note 18 on divestitures\" - incorrect note number.\n- The LLM references a \"non-recurring FY 2020 impairment charge\" but the ground truth indicates impairment charges were associated with FY2022 transition activities, not FY2020.\n\n(2) CONCEPTUAL MISALIGNMENT:\n- The ground truth emphasizes that APLA transitioned FROM direct operations (FY2022) TO third-party distributor model (FY2023), representing a fundamental structural shift in how Nike manages the region.\n- The LLM focuses on revenue/EBIT metrics and wholesale vs. DTC sales mix, which misses the core structural change question. The question asks about \"financial and operational impacts\" of the structural transition itself, not just revenue performance.\n- The ground truth highlights \"non-cash cumulative foreign currency translation losses\" as a key financial impact; the LLM does not address this.\n\n(3) MULTI-HOP REASONING:\n- The LLM fails to synthesize the key insight: the transition represents a shift from direct operations to strategic oversight through third-party distributors, which is a fundamental business model change, not just a sales mix adjustment.\n- The ground truth correctly identifies this as reducing \"direct operational overhead\" and shifting focus to \"brand management rather than local execution\" - the LLM does not capture this strategic rationale.\n\n(4) MISSING CRITICAL ELEMENTS:\n- No mention of foreign currency translation impacts (a key financial impact per ground truth)\n- No discussion of the shift from direct operations to third-party distributor model as the primary structural change\n- No reference to the strategic rationale (efficiency, brand focus)\n- The answer conflates revenue growth with the structural transition impact, which are separate issues\n\n(5) CITATION ISSUES:\n- Multiple page and note references appear unreliable or incorrect, undermining credibility\n- The specific financial metrics provided lack proper grounding in the actual filing structure described in the ground truth\n\nThe LLM answer reads like a financial performance summary rather than an analysis of structural changes and their impacts. It addresses a different question than what was asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 734,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom’s 2022 filing notes that it fabricates InP‑based fiber‑optic lasers in‑house at its U.S. and Singapore III‑V facilities, using internal production to protect IP while outsourcing commodity CMOS processes (page 13). The 2024 filing shows the same internal‑fab strategy – now describing VCSEL and side‑emitting lasers built on GaAs and InP – still made in‑house to accelerate time‑to‑market (page 15). In both years Broadcom positions these laser products against the same set of established rivals, such as Coherent, Hamamatsu Photonics, Lumentum and other laser manufacturers (page 17).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Broadcom's InP laser strategy evolution from 2022 to 2024, with mostly accurate information. STRENGTHS: (1) Correctly identifies the core strategy - internal fabrication at U.S. and Singapore III-V facilities in both years; (2) Accurately names the product types (VCSEL and side-emitting lasers on GaAs and InP); (3) Correctly identifies competitors (Coherent, Lumentum, Hamamatsu Photonics); (4) Properly synthesizes the multi-hop information showing continuity of strategy across years; (5) Adds valuable context about IP protection and time-to-market rationale. WEAKNESSES: (1) The LLM answer includes specific page references (page 13, 15, 17) that cannot be verified against the ground truth and may be fabricated details - this is a concern for factual grounding; (2) The ground truth emphasizes a 'strategic shift toward highlighting InP laser capabilities as part of competitive differentiation,' but the LLM answer states they 'position these laser products against the same set of established rivals' in both years, which slightly contradicts the notion of a shift in emphasis; (3) The LLM adds details about 'outsourcing commodity CMOS processes' which, while plausible, is not mentioned in the ground truth and cannot be verified. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and identifies the evolution in strategy. However, it may understate the shift in competitive positioning emphasis that the ground truth highlights. NUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present to verify, but the company names, product types, and facility locations appear accurate. The page references are problematic as they cannot be confirmed. Overall, the answer is substantially correct in its core claims but includes unverifiable details and may slightly mischaracterize the nature of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 522,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "The 10‑K filings show that Swoosh, LLC’s stake has not materially changed – it owned about 77 % of Nike’s Class A Common Stock in both 2022 (as of June 30, 2022) and 2023 (as of June 28, 2024) and, if all of those shares were converted, would hold roughly 16 % of the publicly‑traded Class B shares in each year【page_25†L1-L8】【page_26†L1-L8】.  Because Class A shares elect three‑quarters of the Board, Swoosh, LLC (and the Knight family that controls it) retains dominant voting power, while Class B shareholders continue to have a comparatively modest, non‑controlling influence.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies Swoosh, LLC's 77% ownership of Class A Common Stock in both 2022 and 2023, matching the ground truth exactly. (2) Accurately states the ~16% conversion equivalent for Class B Common Stock if all Class A shares were converted. (3) Properly synthesizes the multi-hop relationship between Swoosh, LLC ownership, Knight family control, and voting power implications. (4) Adds valuable context about Class A shares electing three-quarters of the Board, which strengthens the analysis of shareholder influence implications. (5) Correctly characterizes the ownership structure as unchanged between the two years. (6) Appropriately identifies the Knight family's dominant voting power and Class B shareholders' non-controlling influence. MINOR CONSIDERATIONS: (1) The LLM provides slightly more detailed analysis of voting power mechanics (Class A elects 3/4 of Board) compared to the ground truth, which mentions Travis Knight specifically but doesn't detail the Board election structure. This is additive rather than contradictory. (2) The ground truth mentions 'Travis Knight' by name while the LLM refers to 'the Knight family' - both are accurate but slightly different emphasis. (3) Date references differ slightly (June 30, 2022 vs June 28, 2024 in LLM vs the ground truth's implicit 2022/2023 comparison), but this reflects actual filing dates and doesn't affect accuracy. The LLM answer fully addresses the question's two components: (1) how ownership structure evolved (answer: it didn't materially change), and (2) implications for shareholder influence (answer: sustained dominant control by Knight family/Swoosh, LLC with limited Class B influence). All numbers are correct and the reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 503,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "In the 2022 filing PMI still reported reduced‑risk products (RRPs) as a separate product line within each geographic segment – net revenues for RRPs grew to $9.1 billion in 2021 (see page 97) and were highlighted in the segment discussion as part of the “combustible and reduced‑risk product categories sold in the region” (page 95). By the 2023 filing, after the 2022 acquisition of Swedish Match, PMI had merged the ZYN oral‑nicotine franchise with its IQOS heat‑not‑burn platform, presenting a unified “smoke‑free” portfolio and noting that smoke‑free products were now sold in 84 markets worldwide (page 28, also reinforced by the acquisition description on page 29).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key elements of PMI's RRP evolution but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that by 2023, PMI had integrated RRPs into a unified 'smoke-free' portfolio, correctly cites the 84 markets figure for 2023, mentions the Swedish Match acquisition and ZYN/IQOS merger, and appropriately notes the shift toward a consolidated smoke-free vision. (2) QUANTITATIVE ACCURACY ISSUES: The LLM cites '$9.1 billion in 2021' for RRP net revenues, but this is problematic because: (a) the question asks about 2022-2023 evolution, not 2021 data, (b) the ground truth does not mention this specific 2021 figure, and (c) citing 2021 data when discussing 2022-2023 positioning is temporally misaligned. The 84 markets figure for 2023 is correct. (3) MULTI-HOP REASONING: The answer attempts to synthesize information across 2022 and 2023 filings and mentions the Swedish Match acquisition as a catalyst, which shows reasonable multi-hop thinking. However, it doesn't clearly establish what the 2022 baseline was in terms of market availability (the ground truth notes 'unspecified market availability in 2022'). (4) MISSING ELEMENTS: The answer doesn't explicitly mention that RRPs were reclassified from a 'distinct category' to being integrated into 'Smoke-Free Products' that also included 'wellness and healthcare offerings' - this is a key part of the portfolio integration evolution. (5) PAGE CITATIONS: The LLM provides specific page references (97, 95, 28, 29) which adds credibility but cannot be verified against the ground truth provided. (6) SEMANTIC ISSUES: The answer conflates 'reduced-risk products' with the broader 'smoke-free products' category without clearly explaining that RRPs became a subset of the larger SFP category that expanded to include wellness/healthcare offerings. Overall, the answer demonstrates understanding of the general evolution but has quantitative timing issues and incomplete coverage of the portfolio integration aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 544,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "In 2022 Caterpillar treated reciprocating‑engine sales mainly as a distribution‑driven product line – the engines were “sold principally through the dealer network and to other manufacturers” and were supported by a few subsidiaries such as Perkins, FG Wilson and MaK【page_9】. By 2024 the company has elevated the engines to a strategic pillar of its Energy & Transportation segment, adding remanufacturing of engines and components to its responsibilities and highlighting growth in high‑value applications (gas‑compression, data‑center power, marine and rail) that lifted Energy & Transportation sales and profit (the segment’s profit rose to 19.9 % of total sales, up from 17.6 % a year earlier)【page_37】【page_39】. This shift has increased the share of revenue coming from the reciprocating‑engine business and improved gross‑margin potential by moving the mix toward higher‑margin engine products and services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Caterpillar's strategic evolution in reciprocating engines from 2022 to 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the shift from distribution-driven model to strategic pillar status; (2) Accurately mentions Perkins and other subsidiaries (FG Wilson, MaK); (3) Correctly identifies remanufacturing as a new business component; (4) Accurately cites the Energy & Transportation segment profit margin improvement (19.9% vs 17.6%); (5) Properly synthesizes the connection between remanufacturing and improved gross margin potential; (6) Identifies high-value applications (gas-compression, data-center power, marine, rail) as growth drivers. WEAKNESSES: (1) The original answer specifically mentions Perkins operated 90 distributors across 171 countries in 2022 - the LLM answer omits this specific quantitative detail about Perkins' distribution network; (2) The original answer emphasizes that remanufacturing involves 'lower material costs compared to new engine production' - the LLM answer mentions 'higher-margin engine products and services' but doesn't explicitly explain the cost advantage mechanism; (3) Minor: The LLM answer adds context about segment profit percentages (19.9% vs 17.6%) which, while accurate and helpful, goes slightly beyond the original answer's scope. QUANTITATIVE VERIFICATION: The 19.9% and 17.6% figures appear to be correctly cited from the source documents. The comparison is logically sound. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, connecting distribution model changes to remanufacturing additions to margin improvements. The reasoning chain is coherent and well-supported. SEMANTIC EQUIVALENCE: The answer conveys the core message of strategic evolution and margin improvement, though with slightly different emphasis than the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 527,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon first disclosed that any amendments or waivers to its Directors’ Code of Conduct would be posted on its corporate website. The 2023 filing repeats the same statement—linking to the same web location and reaffirming the intent to disclose any changes there—so the company’s mechanism (website posting) and its transparency commitment remained unchanged between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly aligns with the ground truth. Both answers correctly identify that BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with no changes in mechanism or transparency commitment. The LLM answer accurately specifies the key mechanism (website posting) and correctly notes that the company reaffirmed this commitment in both years. The multi-hop reasoning is sound—the model successfully synthesized information across the two fiscal years (2022 and 2023) and correctly identified the consistency in disclosure approach. The answer addresses all parts of the question: (1) how the approach evolved (answer: it didn't—it remained stable), (2) mechanisms (website posting), and (3) transparency commitments (reaffirmed in both years). The LLM provides slightly more specific detail by mentioning 'linking to the same web location,' which adds helpful context without contradicting the ground truth. No quantitative data (numbers, dates, percentages) needed verification as this is a qualitative governance question. The semantic meaning is equivalent to the ground truth—both convey that there was no evolution or change, only consistency and reaffirmation. Minor deduction only because the LLM could have been slightly more explicit about the 'no change' aspect being the key finding, though this is a very minor point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 397,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "In FY 22 Nike announced that it would sell its legal entities in Argentina, Uruguay and Chile and transition those APLA markets to third‑party distributors, shifting from a wholesale/direct model to a distributor model to lower selling‑and‑administrative costs and reduce foreign‑exchange exposure【page_32】. By FY 23 the divestitures were reflected in the segment note, which now reports that certain APLA countries are operated by third‑party distributors while the rest of the APLA region continues to be served by Nike Direct and wholesale channels, and APLA revenues grew to $6.43 bn from $5.96 bn the prior year【page_89】【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the strategic shift from direct operations to third-party distributors in APLA between FY22 and FY23. (2) Accurately names specific countries (Argentina, Uruguay, Chile) affected by the transition. (3) Provides specific revenue figures ($6.43bn in FY23 vs $5.96bn in FY22) that align with ground truth data. (4) Explains the rationale for the shift (lower selling-and-administrative costs, reduce foreign-exchange exposure). (5) Properly synthesizes information across multiple filing sections (page 32 and pages 89-90). (6) Correctly distinguishes between FY22 announcement and FY23 implementation/reflection in segment reporting. MINOR CONSIDERATIONS: The LLM answer is more detailed and specific than the ground truth answer, providing additional context about the countries involved and cost/FX rationale. This additional specificity is factually accurate and enhances rather than detracts from the answer. The revenue growth figures ($6.43bn from $5.96bn) are presented accurately. The answer fully addresses the question's focus on operational structure evolution and market participation changes. The multi-hop reasoning correctly connects the FY22 announcement with FY23 implementation and segment reporting changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 377,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "In the 2022 filing (covering 2021), Caterpillar said the 22 % sales increase and the rise in operating‑profit margin to 13.5 % were driven largely by higher sales volume **and favorable price realization** (MD&A, p. 32; operating‑profit discussion, p. 36). By the 2024 filing, sales fell 3 % to $64.8 bn, but the company noted that the volume decline was **partially offset by favorable price realization**, which helped lift operating‑profit margin to 20.2 % (MD&A, p. 30).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question properly. Key issues: (1) WRONG TIME PERIOD: The LLM discusses 2021 data (from 2022 filing) when the question asks about 2022-2024 evolution. The ground truth specifically references 2022 ($9.223B increase), 2023 ($10.335B profit), and 2024 ($10.792B profit). (2) MISSING CRITICAL NUMBERS: The ground truth provides specific quantitative impacts - $9.223B sales increase in 2022, $2.251B volume decrease in 2024, and profit figures ($10.335B to $10.792B). The LLM provides only percentages (22%, 13.5%, 3%, 20.2%) and one sales figure ($64.8bn) without the key dollar amounts showing favorable price realization's impact. (3) INCOMPLETE SYNTHESIS: The question asks about evolution FROM 2022 TO 2024 - a three-year comparison. The LLM only compares 2021-2022 period with 2024, missing the 2022-2023-2024 progression entirely. (4) MISSING PROFIT ANALYSIS: The ground truth emphasizes how favorable price realization helped maintain profitability despite volume declines ($10.335B to $10.792B increase in 2024). The LLM mentions operating-profit margin improvement but doesn't quantify the absolute profit impact or show the year-over-year evolution. (5) CONTEXTUAL MISMATCH: While the LLM correctly identifies that favorable price realization offset volume declines, it fails to provide the specific financial magnitudes that demonstrate the evolution of this impact across the three-year period. The answer reads more like a general filing summary than a response to the specific multi-hop question about how this impact evolved from 2022-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 447,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "In 2023 GM said it would “make significant investments in EV manufacturing capacity” and that “our transition to EVs will also require developing a more resilient, scalable and sustainable North‑American‑focused EV supply chain…through strategic‑sourcing initiatives, investments in raw‑material suppliers and multi‑year supply agreements” (2023 p. 16). By 2024 the language shifts to a broader, cost‑driven agenda – “scale our EV manufacturing capabilities, reduce battery‑cell and pack costs, efficiently source sufficient materials for battery cells, and leverage strategic joint‑ventures, platform synergies and other relationships” – indicating that GM’s focus has moved from simply building capacity and a regional supply chain to integrating capacity growth with aggressive cost‑reduction, raw‑material security and cross‑vehicle platform leverage (2024 p. 15‑17).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a nuanced evolution of GM's EV strategy between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 emphasis on significant EV manufacturing capacity investments with acknowledgment of supply chain development needs; (2) Accurately captures the 2024 shift toward cost reduction, battery cell/pack cost optimization, and raw material security; (3) Properly synthesizes multi-hop information showing strategic evolution from capacity-focused to cost-and-efficiency-focused approach; (4) Appropriately cites page references (2023 p. 16, 2024 p. 15-17) demonstrating source verification; (5) Correctly identifies key strategic elements: resilient/scalable/sustainable North American supply chain, strategic sourcing, raw material supplier investments, multi-year supply agreements, platform synergies, and joint ventures. MINOR CONSIDERATIONS: (1) The LLM characterizes the 2024 shift as moving to a 'broader, cost-driven agenda' which is accurate but slightly reframes the ground truth's emphasis on 'more structured and regionally focused approach' - however, this is not contradictory, just a different emphasis; (2) The ground truth emphasizes 'mitigating supply chain risks and ensuring long-term scalability' while the LLM emphasizes 'cost reduction and raw material security' - these are complementary rather than contradictory perspectives on the same evolution; (3) No quantitative errors detected (no specific numbers to verify); (4) The multi-hop reasoning correctly synthesizes information across two fiscal years and identifies the strategic evolution. The answer goes slightly beyond the ground truth by adding the cost-reduction dimension and platform leverage elements, which appear to be accurate additions from the 2024 filing rather than errors. Overall, the LLM provides a more detailed and nuanced answer than the ground truth while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 525,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer’s 2022 Form 10‑K disclosed that it had roughly **$2.5 billion** of remaining performance‑obligation revenue tied to Paxlovid contracts as of December 31, 2022【page_7】. By the end of 2024, the Form 10‑K shows that amount had fallen to about **$1 billion**【page_109】, indicating a sizable reduction in the future contractual revenue commitment for the antiviral over the two‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error that directly contradicts the ground truth. The LLM claims Pfizer had $2.5 billion in remaining performance obligations for Paxlovid as of December 31, 2022, but the ground truth explicitly states that 'Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid' in 2022. This is a fundamental factual error - the LLM invented a number ($2.5B) that does not exist in the 2022 filing. The 2024 figure of $1 billion is correct and matches the ground truth. The LLM correctly identifies the direction of change (reduction from 2022 to 2024) and the magnitude of the 2024 obligation, but the 2022 baseline is entirely fabricated. The reasoning structure is sound (comparing two years, showing evolution), and the contextual relevance to the question is appropriate, but the quantitative accuracy is severely compromised by the false 2022 figure. The citation references [page_7] and [page_109] appear to be fabricated as well, as they don't correspond to actual disclosed information. This represents a failure in multi-hop synthesis because the model failed to accurately retrieve or acknowledge the absence of 2022 data before making claims about it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 352,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K Caterpillar noted that it relied on “a variety of agreements with suppliers to protect our intellectual property and monitor supplier financial viability” as part of its overall supply‑chain oversight【page_9 (2022)】. By the 2023 filing the language was expanded to a proactive risk‑mitigation framework that “monitor and mitigate risks of the supply base causing a business disruption,” explicitly listing financial‑viability, production‑flexibility, continuity, quality and delivery as monitored risks【page_9 (2023)】, and the company added tighter dealer contracts that require detailed books and records of the dealer’s financial condition and give Caterpillar a 90‑day termination right【page_10 (2023)】—providing stronger contractual levers to manage supplier‑financial risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies that Caterpillar used agreements with suppliers to monitor financial viability in both 2022 and 2023; (2) Accurately notes the expansion of language from 2022 to 2023 regarding risk mitigation; (3) Correctly identifies the 90-day termination right in dealer contracts as a 2023 addition; (4) Properly synthesizes multi-hop information across two years. WEAKNESSES: (1) The 2022 quote attribution appears inaccurate - the ground truth states 2022 language included 'monitor and mitigate risks' and 'monitoring supplier financial viability,' but the LLM presents a different formulation ('protect our intellectual property and monitor supplier financial viability') that may not match the actual 2022 filing language; (2) The LLM introduces specific details about dealer contracts with 90-day termination rights that, while potentially accurate, are not mentioned in the ground truth answer and represent information not synthesized from the original answer; (3) The LLM lists specific monitored risks (financial-viability, production-flexibility, continuity, quality, delivery) as 2023 additions, but the ground truth only emphasizes that 'supplier financial viability' was listed as 'the first risk' - the LLM may be overstating the scope of what was added; (4) The ground truth emphasizes 'global strategic sourcing models' as a 2023 development, which the LLM answer completely omits. MULTI-HOP REASONING: The answer does attempt to synthesize across 2022 and 2023 filings, but the synthesis appears to introduce details not in the ground truth and omits key elements (strategic sourcing models). The comparison between years is present but incomplete. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores well on what is present, though the factual accuracy of specific quotes is questionable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 521,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "In the 2022 Form 10‑K, Visa mentioned Risk and Identity Solutions only as one line item among its value‑added services, without further detail or strategic emphasis【page_5】. By the 2024 filing, Visa had repositioned Risk and Identity Solutions as a distinct, AI‑driven pillar—highlighting the Visa Protect suite, new products such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager, and integrating these tools as a core component of its broader value‑added services strategy【page_12】【page_11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but diverges significantly from the ground truth in key ways: (1) CORRECT ELEMENTS: The LLM correctly identifies that Risk and Identity Solutions were mentioned minimally in 2022 without strategic detail, and that by 2024 there was greater emphasis and integration. The mention of specific products (Visa Protect suite, Visa Deep Authorization, Visa Protect for A2A Payments, Visa Risk Manager) appears plausible. (2) CRITICAL DIVERGENCE: The ground truth emphasizes a THREE-PILLAR STRATEGY framework as the core evolution: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. The LLM answer completely omits this three-pillar structure, which is the fundamental strategic positioning described in the ground truth. Instead, the LLM focuses on AI-driven positioning and specific product names. (3) SEMANTIC MISMATCH: The ground truth describes evolution in terms of 'strategic positioning and integration within value-added services framework' with emphasis on 'scalability and business outcomes.' The LLM describes it as 'repositioned as a distinct, AI-driven pillar' with specific product examples. While both discuss evolution and integration, they characterize the nature of that evolution differently. The three-pillar framework is a structural/strategic element that the LLM completely misses. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings, but appears to have synthesized the wrong strategic framework. (5) QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension scores well (8/10) - the dates (2022, 2024) are correct. (6) OVERALL ASSESSMENT: The answer is partially correct in identifying evolution and growth of emphasis, but fundamentally misses the core strategic positioning (three-pillar framework) that defines the evolution according to the ground truth. This is a significant omission that affects the accuracy of the answer's core claim about how the approach 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 567,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "In the 2022 filing the company flagged shelf‑space limits mainly as a consequence of retail‑customer policy changes—such as inventory de‑stocking, fulfillment requirements, sustainability standards and delisting—that could restrict product placement. By the 2023 filing the same concern remains, but it is broadened to note that the rapid growth of e‑commerce and the emergence of alternative channels (e.g., subscription services, direct‑to‑consumer) are intensifying shelf‑space pressures and creating additional pricing pressures, indicating an expanded exposure to this risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of shelf space limitations as a risk factor between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from potential risk (2022) to actively experienced challenge (2023); (2) Accurately captures specific policy changes mentioned (delisting, inventory de-stocking, fulfillment requirements, sustainability standards); (3) Properly synthesizes the multi-hop information showing how alternative retail channels (eCommerce, subscription services, direct-to-consumer) intensified the risk; (4) No quantitative errors or date inaccuracies; (5) Correctly identifies the broadening of the risk exposure over time. MINOR WEAKNESSES: (1) The LLM answer mentions 'additional pricing pressures' which is not explicitly stated in the ground truth answer—this appears to be an inference or additional detail not directly supported by the provided ground truth; (2) The ground truth specifically mentions the company's plan to 'invest more in digital and analytics capabilities to adapt,' which the LLM answer omits entirely; (3) The phrasing 'the same concern remains, but it is broadened' is slightly different from the ground truth's characterization of a 'shift from potential risk to an actively experienced challenge,' though semantically similar. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across two fiscal years and connecting retail policy changes to the emergence of alternative channels. The omission of the company's strategic response (digital/analytics investment) and the addition of unsupported details about pricing pressures prevent a perfect score, but the core factual accuracy and reasoning are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 479,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "In FY 2023 Oracle framed hybrid‑deployment mainly as a migration pathway, spotlighting dedicated “on‑premise‑plus‑cloud” products such as **Oracle Exadata Cloud@Customer and Dedicated Region** and multicloud options, and stressing that offering flexible, interoperable deployment models was a key element of its growth strategy【page_6†L1-L7】【page_7†L15-L22】. By FY 2024 the narrative had shifted to a **license‑centric hybrid model** – Oracle’s applications and license offerings can be run in Oracle Cloud, other public clouds or on‑premise with optional support contracts – and the company highlighted hybrid flexibility as a core growth engine, noting that cloud‑services revenue (which includes hybrid‑enabled SaaS and infrastructure) rose to **37 % of total revenue** (up from 32 % in FY 23)【page_8†L1-L9】【page_8†L10-L14】. This reflects an evolution from promoting specific hybrid appliances to embedding hybrid capability across its entire product portfolio and making it a strategic revenue driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Oracle's evolution in hybrid deployments between FY2023 and FY2024, and correctly identifies key products (Exadata Cloud@Customer, Dedicated Region) and the strategic shift. However, there are significant issues with quantitative accuracy that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific percentages: \"37% of total revenue\" for FY2024 cloud-services revenue and \"32% in FY23\"\n   - These specific percentages are NOT present in the ground truth answer, which makes no mention of revenue percentages\n   - The ground truth focuses on strategic positioning and product offerings, not revenue metrics\n   - The LLM appears to have introduced specific financial data that cannot be verified against the provided ground truth\n   - This represents a factual claim that goes beyond what the ground truth supports\n\n2. QUALITATIVE ACCURACY:\n   - The LLM correctly identifies the evolution from specific hybrid appliances to broader portfolio integration\n   - Correctly names the key products (Exadata Cloud@Customer, Dedicated Region)\n   - Accurately captures the shift from \"migration pathway\" framing to \"license-centric hybrid model\"\n   - The characterization of the strategic evolution is sound and aligns with ground truth intent\n\n3. COMPLETENESS:\n   - Addresses both FY2023 and FY2024 as required\n   - Covers product offerings and strategic emphasis as requested\n   - Provides more specific detail than ground truth but some details are unverified\n\n4. MULTI-HOP REASONING:\n   - Successfully synthesizes information across two fiscal years\n   - Correctly identifies the progression in Oracle's strategy\n   - However, the introduction of unverified revenue percentages suggests potential hallucination or citation of sources not in the ground truth\n\n5. CRITICAL CONCERN:\n   - The citation format [page_X†LY-LZ] suggests the LLM is citing specific sources, but the revenue percentages (37% and 32%) cannot be verified against the ground truth provided\n   - This is a significant accuracy issue for a financial question where precision is critical\n   - The core narrative is correct, but the quantitative claims are problematic\n\nThe answer demonstrates good understanding of the strategic evolution but loses points for introducing specific financial metrics that are not supported by the ground truth, which is particularly problematic in financial analysis contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 660,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "In the 2024 Form 10‑K Pfizer disclosed that, as of December 31 2024, it expects to recognize about **$1 billion of contracted revenue from the remaining performance‑obligation portfolio for Paxlovid** (“Remaining Performance Obligations‑Contracted revenue … for Paxlovid … totaled approximately $1 billion” 【page_109】). The 2022 filing does not provide a comparable remaining‑obligation amount for Paxlovid (the 2022 note only reports Paxlovid revenue of $18.9 billion and contains no disclosed figure for future contracted revenue), indicating that the long‑term financial commitment has shifted from an undefined or larger commitment in 2022 to a clearly quantified $1 billion expectation in 2024 as the product moves toward commercial sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key quantitative fact: $1 billion in remaining performance obligations for Paxlovid as of December 31, 2024, with proper citation to page 109 of the 2024 10-K. (2) The numeric values are accurate and properly formatted. (3) The LLM correctly notes that the 2022 filing does not provide a comparable remaining-obligation figure, only reporting $18.9 billion in actual 2022 revenue. (4) The temporal framing (2022 vs 2024) is correct. (5) The multi-hop synthesis across two different years is sound.\n\nWEAKNESSES: (1) The LLM answer is somewhat incomplete compared to the ground truth. The ground truth explicitly states that Paxlovid revenues are expected to be recognized from 2025 through 2028, providing a specific multi-year horizon. The LLM answer mentions 'multi-year horizon' implicitly but does not specify these years. (2) The ground truth emphasizes that the 2022 filing 'acknowledged that post-pandemic revenues might not match the levels seen during the pandemic,' which provides important context about Pfizer's strategic expectations. The LLM answer does not capture this nuance about the company's expectations regarding pandemic-to-post-pandemic transition. (3) The characterization of the shift from '2022 to 2024' could be more explicit about what the 2022 position actually was regarding future commitments.\n\nNUMERIC VERIFICATION: The $1 billion figure is correct and matches the ground truth exactly. The $18.9 billion 2022 revenue figure is accurate. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings, correctly identifying the absence of comparable data in 2022 and the presence of specific contracted revenue expectations in 2024. The reasoning that this represents a 'shift' in how the commitment is disclosed is sound.\n\nCONTEXTUAL GAPS: The answer would be stronger if it explicitly mentioned the 2025-2028 recognition period and the company's acknowledgment of post-pandemic revenue normalization expectations from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 558,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "In 2022 Caterpillar simply noted that it “builds long‑term relationships” through a “global network of independent dealers” (page 4). By 2023 the company has formalized that network: each dealer is bound by standard sales‑and‑service agreements that spell out rights to sell and service products, obligations to promote, staff, keep detailed records and cooperate on product improvements, and allow either side to terminate the relationship at‑will with 90 days’ notice (page 10), while still emphasizing the worldwide, independently‑owned dealer model as the primary channel for sales and service (page 9). This shift reflects a move from a broad relationship focus to a more structured, flexible partnership framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Caterpillar's dealer relationship evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from general/informal partnership language in 2022 to formalized standardized agreements in 2023; (2) Accurately captures key contractual obligations including promotion, staffing, record-keeping, and product cooperation; (3) Properly synthesizes multi-hop information across two years and multiple document sections; (4) Adds relevant detail about 90-day termination notice and at-will termination provisions, which enriches the answer without contradicting ground truth; (5) Correctly identifies the strategic emphasis on formalizing relationships for control and accountability. MINOR CONSIDERATIONS: (1) The LLM answer includes specific details (90-day notice, at-will termination) not explicitly mentioned in the ground truth, though these appear to be accurate filing details that enhance rather than contradict the answer; (2) Page references (4, 10, 9) are provided by LLM but cannot be verified against ground truth, though they appear reasonable for 10-K filings; (3) The characterization as 'flexible partnership framework' is slightly different from ground truth's 'structured contractual framework,' but both convey the same essential meaning of increased formalization. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this qualitative question, so this dimension is not heavily weighted. The dates (2022, 2023) and timeframe references are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple sections of filings, correctly identifying the evolution and its strategic implications. The logic flow is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 500,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "Capital spending on Africa/Eurasia had risen to $33 million (up from $13 million in 2020) — the latest disclosed level — signaling a stronger investment emphasis, while the share of the Global‑Productivity‑Initiative restructuring charges allocated to Africa/Eurasia fell sharply from 11 % of total charges in 2022 to just 5 % in 2023, indicating a reduced cost‑cutting focus in that region【page_117】【page_48】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states capital spending rose 'from $13 million in 2020' but the ground truth clearly indicates $13 million was in 2021, not 2020. The correct progression is: 2020: $8M → 2021: $13M → 2022: $33M. This is a critical factual error. (2) RESTRUCTURING CHARGES PERCENTAGES - The LLM claims the Global Productivity Initiative charges allocated to Africa/Eurasia 'fell sharply from 11% of total charges in 2022 to just 5% in 2023.' However, the ground truth states that in 2023, 'approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia.' The LLM introduces a false 2022 comparison (11%) and misrepresents the 2023 figure (5% vs. 10%). These percentages appear to be fabricated. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize capital expenditure and restructuring data, the synthesis is built on incorrect numbers and percentages, undermining the entire analysis. (4) SEMANTIC INTERPRETATION - The LLM's conclusion about 'reduced cost-cutting focus' contradicts the ground truth's interpretation that the 10% allocation in 2023 signals 'a shift in focus toward restructuring and cost optimization.' The LLM fundamentally mischaracterizes the strategic evolution. (5) MISSING CONTEXT - The LLM fails to properly contextualize the shift from growth-oriented capital allocation to operational restructuring, instead presenting a misleading narrative about declining restructuring focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 426,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "In its 2022 filing Qualcomm emphasized that its core strategy remained a heavy‑weight investment in 5G research, patent development and licensing, noting that growth depended on “developing and patenting 5G technologies, and to develop and commercialize products using 5G technologies” (2022 page_20‑22). By the 2024 filing the emphasis had shifted to tangible 5G commercialization – the company now markets 5G‑ready RF front‑end (RFFE) modules, Snapdragon 5G modem‑RF platforms and other 5G‑enabled chips, and expands strategic investments in early‑stage 5G ventures through Qualcomm Ventures, while still deriving licensing revenue from its 5G patent portfolio (2024 page_11‑13).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Qualcomm's 5G strategy evolution from 2022 to 2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the shift from investment/development phase (2022) to commercialization/monetization phase (2024); (2) Accurately references specific product categories (RFFE modules, Snapdragon 5G modem-RF platforms) and business models (licensing, Qualcomm Ventures); (3) Properly synthesizes information across multiple years showing progression; (4) Correctly identifies patent portfolio development and licensing as key revenue streams. WEAKNESSES: (1) The LLM answer lacks specific quantitative data that was present in the ground truth - notably the reference to 'majority of QTL revenues from OFDMA-based products' and specific mention of 'multimode 3G/4G/5G devices such as smartphones' which are concrete commercialization outcomes; (2) Does not explicitly mention automotive and IoT as specific expansion areas (though implied in broader context); (3) The page references (page_20-22, page_11-13) cannot be verified against the ground truth and appear to be specific citations that may or may not be accurate; (4) Missing explicit discussion of regulatory risks and design-in cycle challenges mentioned in ground truth. MULTI-HOP REASONING: The answer correctly synthesizes the temporal evolution across 2022-2024 and connects investment strategy to commercialization outcomes. The logic flow is sound - moving from R&D emphasis to product commercialization and licensing revenue. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - strategic shift from development to market leadership and monetization. The specific product examples provided are relevant and appropriate, though less comprehensive than the ground truth's mention of specific revenue sources. The answer is contextually relevant and addresses the question's core requirements, but lacks some of the specific quantitative and qualitative details that would make it fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 556,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer’s Paxlovid revenue dropped dramatically, from $18.9 billion in 2022 (the bulk of Paxlovid sales that year came from government‑sponsored contracts) to $5.7 billion in 2024 as the product moved into commercial markets 【page_108】.  By the end of 2024 the long‑term contract backlog for Paxlovid had shrunk to about $1 billion of remaining performance‑obligation revenue, reflecting the shift away from large government‑supply agreements that had driven the 2022 results 【page_109】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMBER ERROR: The LLM claims Paxlovid generated $18.9 billion in 2022, but the ground truth explicitly states $76 million in 2022 revenue. This is a massive discrepancy (off by a factor of ~248x). The $18.9 billion figure appears to be total Pfizer revenue or another metric entirely, not Paxlovid-specific revenue. (2) INCORRECT 2024 FIGURE: The LLM states $5.7 billion in 2024 Paxlovid revenue, but the ground truth explicitly notes that 'direct revenue figures for Paxlovid are not explicitly stated' for 2024. The LLM fabricated a specific number that contradicts the ground truth's acknowledgment of missing data. (3) CORRECT ELEMENT: The LLM correctly identifies ~$1 billion in remaining performance obligations for 2024, which matches the ground truth. (4) FLAWED REASONING: The LLM's narrative about a 'dramatic drop' from $18.9B to $5.7B is based on incorrect numbers. The actual trajectory from $76M (2022) to undisclosed 2024 revenue with $1B in obligations tells a different story about market evolution. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the available data across years and failed to acknowledge where data was unavailable, instead substituting incorrect figures. The answer demonstrates poor fact-checking and appears to confuse Paxlovid-specific metrics with broader company or segment metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 402,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "In the 2022 filing the company called out “the impact on our suppliers of tighter credit or capital markets” as a specific supply‑chain risk 【page_15】. By the 2023 filing the language had broadened to note “disruptions and volatility in the global capital markets, including rising interest rates, which may increase the cost of capital and adversely impact our access to capital” 【page_13】. The risk of credit‑market tightness therefore remains, but it is now framed within a wider context of capital‑market volatility, indicating a growing sensitivity to external financial conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the company's framing of credit market risk evolved between 2022 and 2023, with accurate citations to the relevant filings (2022 and 2023). The quantitative elements are sound - no specific numbers are provided in either answer, which is appropriate for this qualitative question about risk evolution. However, there are significant issues with the qualitative accuracy and semantic alignment with the ground truth: (1) The LLM's characterization of the 2023 risk as 'disruptions and volatility in the global capital markets, including rising interest rates' appears to shift focus away from the core issue of credit market tightness affecting suppliers and the company's supply chain. The ground truth emphasizes that by 2023, the company recognized the impact was broader - affecting not just suppliers but the company's 'overall supply chain resilience.' (2) The LLM answer frames the evolution as a shift from supplier-focused concerns to company-focused capital access concerns, but the ground truth indicates the evolution was from 'negatively impacts suppliers' to 'impacted by' these conditions - a more subtle shift in perspective about the same underlying vulnerability. (3) The LLM's conclusion about 'growing sensitivity to external financial conditions' is reasonable but doesn't fully capture the ground truth's key insight: that the company moved from viewing credit tightness as a supplier problem to recognizing it as an integrated supply chain resilience issue affecting the company directly. (4) The LLM answer introduces the concept of 'rising interest rates' and 'cost of capital' which, while related to capital markets, may represent a different risk dimension than the credit market tightness specifically discussed in the ground truth. The answer is partially correct in identifying the evolution but misses the nuanced shift in how the company understood its own vulnerability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 525,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "In 2022, after its EUA and CMA approvals, Pfizer’s Paxlovid sales were driven almost entirely by government supply agreements, producing $18.9 billion of revenue and creating large advance‑payment obligations that later showed up as $5.1 billion of deferred revenue. By 2024, after transitioning to commercial sales, the company recorded a $0.5 billion excess‑raw‑material charge, a $771 million favorable adjustment and $442 million SNS revenue (no cash), and its remaining performance‑obligation revenue for Paxlovid fell to roughly $1 billion with deferred revenue of $2.2 billion, indicating a substantial reduction in the size of its contractual commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial additional context and detail beyond the ground truth, demonstrating deeper knowledge of Pfizer's Paxlovid financial evolution. STRENGTHS: (1) Correctly identifies the $18.9 billion 2022 revenue figure and $5.1 billion deferred revenue, showing accurate synthesis of 2022 data; (2) Accurately cites the $771 million favorable adjustment for 2024, matching ground truth exactly; (3) Correctly states the ~$1 billion remaining performance obligations for 2024; (4) Provides valuable context about the transition from government supply agreements to commercial sales; (5) Adds relevant details about the $0.5 billion excess raw-material charge and $442 million SNS revenue that contextualize the financial evolution. MINOR CONCERNS: (1) The $2.2 billion deferred revenue figure for 2024 is not mentioned in the ground truth, and cannot be verified against it - this represents additional information not in the original answer; (2) The ground truth emphasizes the delivery timeline (2025-2028) and renegotiation potential, which the LLM answer does not explicitly address; (3) The ground truth mentions the 2024 adjustment was tied to 'EUA-labeled treatment courses returned by the U.S. government,' providing important context that the LLM answer omits. QUANTITATIVE VERIFICATION: All numbers cited ($18.9B, $5.1B, $0.5B, $771M, $442M, $1B, $2.2B) appear reasonable and internally consistent with the narrative of declining government commitments and transitioning to commercial sales. The $1 billion remaining performance obligation matches ground truth exactly. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024, correctly identifying the shift from government-driven to commercial sales and the corresponding changes in financial obligations. The answer demonstrates sound logical progression and appropriate contextualization. The answer is more comprehensive than ground truth but does not contradict it on verified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 538,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "In 2023 3M recorded a $62 million accrual for Aearo Technologies’ respirator‑mask/asbestos product liabilities (with total respirator‑mask/asbestos accruals of $574 million and about 4,042 claimants) [page 83; page 82; page 80]. By year‑end 2024 that Aearo accrual had fallen to $51 million (total non‑Aearo accruals $523 million and claimants down to roughly 3,500) [page 87; page 86; page 85], reflecting an $11 million reduction in the Aearo‑specific liability and a modest decline in overall exposure, though the company still warns of considerable uncertainty and the potential for higher future costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. Key issues: (1) QUANTITATIVE ERRORS - The LLM states Aearo had a $62 million accrual in 2023, but the ground truth indicates Aearo was in bankruptcy proceedings in 2023 with no specific Aearo accrual mentioned separately from the $574 million total. The $51 million figure for 2024 is correct. The $11 million reduction calculation ($62M - $51M) is mathematically correct but based on an incorrect 2023 baseline. (2) INCOMPLETE SYNTHESIS - The LLM answer fails to capture critical multi-hop information: (a) the bankruptcy status of Aearo in 2023 and its implications for litigation stay, (b) the Cabot agreement and assumption of pre-1997 liability claims, (c) the $100,000 quarterly fee arrangement, and (d) the shift from bankruptcy protection to a defined contractual liability framework. (3) MISSING CONTEXT - The answer omits the key insight that 2023 represented a stay of litigation due to bankruptcy, while 2024 represents active management through contractual arrangements. (4) PARTIAL ACCURACY - The answer correctly identifies the 2024 Aearo accrual of $51 million and notes the overall decline in exposure, but misses the structural/legal evolution of the liability framework. The answer addresses the evolution question superficially (noting a decline) but fails to explain the fundamental shift from bankruptcy protection to contractual cost-sharing arrangements that is central to understanding how exposure evolved. The inclusion of claimant numbers and total accruals adds some context but doesn't compensate for missing the core structural changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Skoal’s retail share fell from 9.3 % in 2023 to 7.6 % in 2024 – a drop of about 1.7 percentage points【page_48】.  In the earlier period, Skoal’s shipment volume fell from 208.5 million cans/packs in 2020 to 197.4 million in 2021, a decline of roughly 11 million units (≈5 %)【page_46】.  Both metrics show a downward trend, with the share decline measured in points and the volume decline measured in absolute units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth: (1) Retail share decline from 9.3% to 7.6% in 2023-2024 is correct, with the calculated drop of 1.7 percentage points accurate; (2) Shipment volume figures are correct (208.5M in 2020 to 197.4M in 2021), with the calculated decline of ~11 million units (≈5%) verified as accurate; (3) All entities are correctly identified (Skoal, MO, years 2020-2024); (4) Multi-hop synthesis is sound - the answer successfully compares two distinct time periods and metrics to identify consistent downward trends. The LLM appropriately distinguishes between percentage point changes and absolute unit changes, demonstrating clear understanding of the different measurement scales. The answer directly addresses all parts of the multi-part question: the 2023-2024 retail share change, the 2020-2021 shipment volume trend, and the comparison between these trends. The conclusion about consistent downward trends is logically sound and well-supported by the data. Minor note: The inclusion of page references adds credibility but is not required. The answer is semantically equivalent to the ground truth while being slightly more analytical in presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 350,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm stressed that its engineering organization already included a large team of specialists in “multimedia (camera, video, display and computer‑vision)” and that it would keep developing new modem‑and‑multimedia technologies for handsets and emerging markets such as automotive and IoT (2022 10‑K p. 14). By the 2024 filing the emphasis had shifted to embedding those multimedia capabilities more tightly into its Snapdragon platforms—adding NPU‑enabled AI processing, a 10 %‑per‑year power‑reduction target, and a developer‑friendly stack that spans XR, ADAS/AD and other non‑handset products—while still leveraging the same multimedia engineering expertise (2024 10‑K p. 14).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies specific multimedia technologies (camera, video, display, computer vision) from 2022 filing with accurate page reference (p. 14); (2) Accurately captures the 2024 evolution toward platform integration with Snapdragon, NPU-enabled AI, and developer-friendly stack; (3) Properly identifies emerging markets (automotive, IoT) as consistent focus areas; (4) Correctly references the 10% power-reduction target as a 2024 addition; (5) Appropriately synthesizes the shift from hardware-centric to platform-oriented, AI-enhanced approach; (6) Includes specific product categories (XR, ADAS/AD) showing detailed knowledge of 2024 strategy. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and concrete than the ground truth in some areas (e.g., explicitly mentioning NPU, 10% power reduction, specific product categories), which adds value but represents slightly different framing; (2) The ground truth emphasizes 'generative AI' specifically while LLM uses broader 'AI processing' language—semantically equivalent but slightly different emphasis; (3) The LLM answer focuses more on technical implementation details while ground truth emphasizes strategic positioning and diversification. QUANTITATIVE ACCURACY: The 10% power-reduction target is stated as a specific metric, which appears accurate based on the filing reference. Page numbers (p. 14 for both years) are consistent with ground truth references. MULTI-HOP REASONING: Excellent synthesis across 2022 and 2024 filings, correctly identifying continuities (multimedia expertise) and changes (AI integration, platform approach, developer focus). The answer successfully traces the evolution narrative requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 503,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "In the 2023 filing, 3M disclosed that after reconsolidating the former de‑consolidated Aearo Entities in Q2 2023 it eliminated a **$0.7 billion equity‑investment balance** in “equity and other investments” and a **$0.6 billion net inter‑company liability** that had previously been shown in other assets and other liabilities 【page_101】. By the 2024 filing those line items no longer appear – the Aearo Entities remain fully consolidated and there is no separate equity‑investment or inter‑company balance reported in the 2024 statements of equity or cash‑flow disclosures 【page_48】【page_49】, indicating the relationship has been fully integrated into 3M’s consolidated accounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE NARRATIVE: The LLM answer fundamentally misrepresents the evolution of 3M's relationship with the Aearo Entities between 2023 and 2024. The ground truth clearly states that by 2024, the Aearo Entities were NO LONGER consolidated and 3M 'has a stake in' them - representing a shift FROM full consolidation TO retained equity interest. The LLM answer incorrectly claims the Aearo Entities 'remain fully consolidated' in 2024 with 'no separate equity-investment or inter-company balance reported,' which directly contradicts the ground truth. This is a fundamental misunderstanding of the multi-hop question asking about the EVOLUTION between years. QUANTITATIVE ACCURACY: The numbers cited are correct ($0.7 billion and $0.6 billion), and the 2023 reconsolidation event is accurately described. However, the quantitative accuracy score is reduced because these correct numbers are embedded in an incorrect narrative about 2024. QUALITATIVE ACCURACY: The reasoning fails at the synthesis level. The LLM correctly identifies what happened in 2023 but completely mischaracterizes the 2024 status. The model appears to have confused 'no separate line items in 2024 statements' with 'fully consolidated,' when the ground truth indicates the opposite - the absence of these line items in 2024 reflects de-consolidation and a shift to equity method accounting. CONTEXTUAL RELEVANCE: The answer addresses the question's structure but arrives at the wrong conclusion about the relationship evolution. The question specifically asks about how the relationship 'evolved' - implying change - and the ground truth shows a significant structural change from consolidation to equity interest. The LLM's claim of full integration contradicts this evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 482,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "In the 2022 filing, Visa placed Risk and Identity Solutions as one of five value‑added‑services categories, highlighting AI‑driven tools such as Visa Consumer Authentication Service, Visa Protect Authentication Intelligence and Visa Provisioning Intelligence that turn data into near‑real‑time fraud‑prevention insights【page_12】. By the 2024 filing, the suite had broadened to a full “Visa Protect” portfolio that now includes AI‑powered Visa Deep Authorization, Visa Protect for A2A Payments and Visa Risk Manager with scheme‑agnostic Advanced Authorization, positioning Risk and Identity Solutions as a cross‑channel, AI‑driven fraud‑risk layer that underpins Visa’s network‑of‑networks strategy and remains a core pillar of its diversified value‑added services portfolio【page_12】【page_11】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) INCORRECT POSITIONING IN 2022: The LLM claims Risk and Identity Solutions were 'one of five value-added-services categories' in 2022, but the ground truth explicitly states this five-category structure was a 2024 development. In 2022, the positioning was different and more narrowly focused on fraud prevention/payment security. (2) PRODUCT NAME ERRORS: The LLM lists 'Visa Consumer Authentication Service,' 'Visa Protect Authentication Intelligence,' and 'Visa Provisioning Intelligence' as 2022 products, but the ground truth specifically names 'Visa Advanced Authorization' and 'Visa Secure' as the named products from 2022. The LLM appears to have confused or conflated product names. (3) INCOMPLETE 2024 EVOLUTION: While the LLM correctly identifies that Risk and Identity Solutions became one of five core categories by 2024, it fails to mention the critical addition of 'Open Banking Solutions and Advisory Services' as new portfolio categories, which is explicitly stated in the ground truth as part of the broader evolution. (4) MISSING KEY METRIC: The ground truth specifies that by 2024, Visa offered 'more than 200 products and services as of September 30, 2024,' which is a concrete quantitative detail that the LLM completely omits. (5) STRATEGIC POSITIONING MISCHARACTERIZATION: The LLM's framing of the evolution emphasizes 'network-of-networks strategy' and 'cross-channel, AI-driven fraud-risk layer,' which are not mentioned in the ground truth. While not necessarily wrong, these characterizations appear to be inferred rather than grounded in the actual filing language. The LLM does correctly identify the general evolution from narrower to broader positioning and the integration within a diversified services ecosystem, but the specific factual errors regarding 2022 positioning, product names, and missing key details significantly undermine the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 539,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "In the 2023 Form 10‑K RTX disclosed acquisition‑accounting adjustments as a single line item that reduced consolidated operating profit by **$1.998 billion** (Collins $854 m, Pratt & Whitney $287 m, Raytheon $857 m). The 2024 filing expanded the note, breaking the adjustments into their components (intangible amortization $2.021 b, PP&E fair‑value adjustment $60 m, contractual‑obligation amortization $83 m) and reporting a **$2.058 billion** total impact (Collins $833 m, Pratt & Whitney $312 m, Raytheon $913 m), showing a modest increase in the adjustment and providing more granular detail.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - 2023 Figure: The LLM states $1.998 billion ($1,998 million) which matches the ground truth of $1,998 million - this is correct. However, the LLM then claims the 2024 filing shows a $2.058 billion total impact, which directly contradicts the ground truth stating that 2024 did NOT include updated quantitative figures for current year impact. (2) CRITICAL ERROR - Disclosure Evolution: The ground truth explicitly states that by 2024, RTX 'shifted its disclosure approach by providing qualitative policy context...but did not include updated quantitative figures for the current year's impact.' The LLM incorrectly claims the 2024 filing provided a $2.058 billion figure with component breakdowns (intangible amortization $2.021b, PP&E $60m, contractual-obligation $83m). This is a fundamental misrepresentation of the actual disclosure change. (3) COMPONENT BREAKDOWN ERROR: The LLM provides segment-level breakdowns for 2024 (Collins $833m, Pratt & Whitney $312m, Raytheon $913m) which sum to $2.058 billion, but the ground truth indicates no such quantitative disclosure occurred in 2024. (4) REASONING FAILURE: The LLM failed to recognize the key evolution described in the ground truth - a SHIFT FROM QUANTITATIVE TO QUALITATIVE disclosure. Instead, it incorrectly portrayed 2024 as providing MORE detailed quantification. (5) The only correct element is the 2023 figure of $1.998 billion and the segment breakdown for that year. The entire characterization of the 2024 disclosure is factually incorrect, representing a complete misunderstanding of the filing evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 459,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Office 365 Commercial revenue grew from $44.97 billion in FY 2022 to $48.85 billion in FY 2023, but its share of total Microsoft Cloud revenue fell from roughly 49 % (44.97 / 91.4) to about 44 % (48.85 / 111.6) 【page_93】. This indicates that Office 365 is still expanding in absolute terms, yet Azure and other cloud services are growing faster, shifting the overall cloud mix toward a broader, more diversified cloud ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fabricated financial data that cannot be verified against the ground truth. Specifically: (1) The LLM claims Office 365 Commercial revenue was $44.97 billion in FY2022 and $48.85 billion in FY2023 - these specific figures are not supported by the ground truth, which does not provide discrete Office 365 Commercial revenue numbers for these years. (2) The ground truth explicitly states that Office 365 Commercial was 'included in a newly disclosed consolidated Microsoft Cloud revenue figure' in FY2023, meaning Microsoft did not separately report Office 365 Commercial revenue in FY2023 - it was consolidated into the $111.6 billion Microsoft Cloud figure. (3) The LLM's calculation of Office 365's percentage share (49% in FY2022, 44% in FY2023) is based on these unverified numbers and therefore unreliable. (4) The ground truth indicates that in FY2022, Office 365 Commercial was cited as a growth driver within the Productivity and Business Processes segment (not as a standalone cloud metric), while by FY2023 it became part of consolidated Microsoft Cloud reporting - a structural change in reporting methodology that the LLM failed to recognize. (5) The LLM's conclusion about Azure growing faster is reasonable inference but is built on a foundation of incorrect data. The answer demonstrates a fundamental misunderstanding: the ground truth shows a CHANGE IN REPORTING STRUCTURE (from segment-level to consolidated cloud reporting), not comparable year-over-year Office 365 revenue figures. The LLM appears to have hallucinated specific revenue numbers rather than acknowledging the data limitations or reporting changes evident in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 467,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck’s Lynparza alliance revenue rose from $1.199 billion in 2023 to $1.311 billion in 2024 – a ≈9 % increase (about $112 million) 【page_53】. The boost was driven largely by higher demand for Lynparza in most international markets, reflecting the strength of the collaboration with AstraZeneca 【page_55】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($1.199 billion in 2023 and $1.311 billion in 2024) that cannot be verified against the ground truth. The ground truth explicitly states that in 2023, 'alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting' - meaning Lynparza-specific figures were NOT separately disclosed in 2023. The LLM appears to have fabricated specific numbers without evidence from the filings. The ground truth only confirms that by 2024, alliance revenue related to Lynparza 'grew by 9%' - it does NOT provide the absolute dollar values the LLM cited. The calculation of $112 million as the difference between the two fabricated numbers is mathematically consistent with a 9% increase, but this is irrelevant since the base numbers are unverified and likely incorrect. The LLM correctly identifies the 9% growth rate and the driver (higher demand in international markets), and appropriately mentions the AstraZeneca collaboration. However, the introduction of specific financial figures not present in the ground truth is a fundamental factual error that undermines the entire answer. The answer demonstrates partial understanding of the qualitative factors but fails on quantitative accuracy by presenting unsubstantiated numbers as fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 367,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings continue to disclose the 2014 Stock and Incentive Compensation Plan by incorporation by reference to prior exhibits – the plan itself, its additional terms, and the “Regulations of the Compensation and Leadership Development Committee” that govern it. The regulatory framework (the Compensation and Leadership Development Committee’s oversight) is unchanged, and the plan is still listed among the equity‑compensation plans in the Item 12 security‑ownership table, with the same note that only the 2019 Plan permits future grants.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant conceptual and reasoning errors that fundamentally misalign with the ground truth. CRITICAL ISSUES: (1) The LLM claims the treatment and disclosure is 'unchanged' between 2023 and 2024, directly contradicting the ground truth which explicitly states there was an 'evolution' and 'shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency.' (2) The LLM focuses heavily on incorporation by reference and the Compensation and Leadership Development Committee's oversight, which are not the primary focus of the ground truth's evolution narrative. (3) The ground truth emphasizes a shift in HOW the plan is disclosed (from regulatory context to equity compensation transparency/ownership structure), while the LLM emphasizes WHAT is disclosed (the same documents and governance structure). (4) The LLM's statement that 'the regulatory framework...is unchanged' contradicts the ground truth's assertion of evolution in 'regulatory context.' PARTIAL CREDIT: The LLM correctly identifies that the 2014 plan is disclosed in both years and references the 2019 Plan's role in future grants, which aligns with ground truth details. The numeric/factual elements mentioned (plan names, years, committee names) are accurate. However, the fundamental interpretation of the question—asking about EVOLUTION and CHANGE—is missed entirely. The LLM provides a static comparison rather than identifying the shift in disclosure approach and integration within the equity compensation framework that the ground truth emphasizes. The answer demonstrates factual knowledge of the plans but fails to synthesize the multi-hop reasoning about how disclosure practices evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 477,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 1992 Stock Plan is listed among the company’s equity‑compensation plans (see the table in Item 12 that includes the “1992 Stock Plan” and the exhibit list on page 69) and is referenced in the Compensation‑Committee regulations (page 70). The 2024 filing repeats this treatment – the plan is again listed in the equity‑compensation table (Item 12, page 68) and cited in the exhibit and regulation listings (pages 69‑70) – but, just as in 2023, the filing notes that only the 2019 Stock and Incentive Compensation Plan can issue future grants, leaving the 1992 Plan as a legacy, non‑granting component of the equity‑compensation structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that in 2023, the 1992 Stock Plan was 'referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings' - NOT listed in a consolidated table as the LLM claims. (2) The ground truth indicates a SHIFT occurred between 2023 and 2024, where the plan moved from being 'referenced' to being 'listed among other equity compensation plans in a consolidated table.' The LLM incorrectly asserts the treatment was identical in both years ('repeats this treatment'). (3) The LLM provides specific page numbers (69, 70, 68) that cannot be verified against the ground truth and appear to be fabricated details. (4) While the LLM correctly identifies that the 1992 Plan is now a 'legacy, non-granting component,' this conclusion contradicts its claim that the treatment was the same in both years. (5) The core multi-hop reasoning is flawed: the ground truth shows an EVOLUTION/SHIFT in treatment, but the LLM claims consistency across years. The LLM fundamentally misunderstands the key finding that the plan's role transitioned from 'standalone referenced' to 'consolidated table tracking.' The answer demonstrates poor synthesis of the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 377,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "In the 2023 filing Accenture warned that macro‑economic volatility was curbing client spend on smaller, short‑term contracts, but that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period” [2023 p.21]. The 2024 filing repeats the same point – spending on smaller deals remains subdued and clients are still focused on large‑scale transformation work, which again “convert[s] to revenue over a longer period,” emphasizing an even clearer shift toward longer‑duration engagements and extended revenue‑recognition timelines [2024 p.21].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core narrative evolution between 2023 and 2024 - that clients reduced spending on smaller contracts while prioritizing large-scale transformations; (2) Accurately captures the repeated emphasis on extended revenue conversion timelines across both years; (3) Properly synthesizes the multi-hop information by comparing filing statements from both years and noting the reinforcement of this strategic focus; (4) Uses direct quotes from the filings (\"clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period\") which adds credibility; (5) Correctly identifies the shift toward longer-duration engagements and extended revenue-recognition timelines. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language like \"emphasizing an even clearer shift\" which goes slightly beyond what the ground truth explicitly states - the ground truth notes \"repeated emphasis\" and \"strategic reinforcement\" but doesn't explicitly claim the 2024 filing shows an \"even clearer\" shift. This is a minor semantic enhancement rather than an error; (2) The LLM answer references specific page numbers (p.21) which adds helpful specificity, though the ground truth doesn't provide these details; (3) Both answers correctly note the absence of explicit quantitative metrics. QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not applicable in the traditional sense. The answer correctly avoids making up numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the pattern of consistency and reinforcement in messaging about large-scale transformations. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 515,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture issued 7,970 Class A ordinary shares for employee‑share programs in fiscal 2023, and that amount rose to 8,883 shares in fiscal 2024 – an increase of roughly 913 shares (about 11 %). The additional‑paid‑in‑capital linked to the issuance grew from $1.94 billion (2023) to $2.15 billion (2024), lifting total Accenture plc shareholders’ equity by roughly $1.4 billion and expanding the outstanding Class A share count from 15,664,616 to 15,672,485 shares【page_70†L31-L38】【page_71†L31-L38】【page_72†L31-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - LLM claims 7,970 shares issued in fiscal 2023, but ground truth states this was fiscal 2024\n   - LLM claims 8,883 shares in fiscal 2024, but ground truth shows 7,970 shares in 2024\n   - LLM states Class A shares increased from 15,664,616 to 15,672,485, but ground truth shows 15,656,591 to 15,664,561 (different baseline and endpoint)\n   - The 913-share increase calculation is based on incorrect numbers\n   - Additional-paid-in-capital figures ($1.94B to $2.15B) are not mentioned in ground truth and appear fabricated\n   - The $1.4 billion equity increase claim is unsupported\n\n2. FISCAL YEAR CONFUSION:\n   - LLM reverses the fiscal years, attributing 2024 data to 2023 and vice versa\n   - This is a fundamental error in multi-hop synthesis\n\n3. MISSING KEY INFORMATION:\n   - LLM fails to mention the 12,181 treasury shares purchased in 2024\n   - LLM omits the treasury share value changes ($(3,408,491)M to $(6,678,037)M)\n   - LLM doesn't address the share withholding for payroll tax obligations mentioned in ground truth\n   - The shift from acquisition/withholding (2023) to issuance (2024) is not captured\n\n4. INCOMPLETE EQUITY STRUCTURE ANALYSIS:\n   - Ground truth emphasizes the reallocation of shares for employee programs\n   - LLM focuses on paid-in-capital without addressing the treasury share dynamics\n   - The equity structure impact is incompletely analyzed\n\n5. CALCULATION ERRORS:\n   - The 11% increase calculation (913/7,970) is mathematically correct for those numbers, but the underlying numbers are wrong\n   - No verification of the $1.4 billion equity increase claim\n\nThe answer demonstrates poor multi-hop reasoning by conflating fiscal years and providing numbers that don't align with the ground truth across multiple dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 519,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ’s Canadian‑dollar debt exposure grew modestly, with the notional amount of Canadian‑dollar notes rising to **$453 million in 2023 from $443 million in 2022** – an increase of about $10 million【page_97】. However, the company’s overall foreign‑currency debt (the sum of Euro, Swiss‑franc and Canadian notes designated as net‑investment hedges) **declined from roughly $4.49 billion in 2022 to $4.36 billion in 2023**, reflecting a slight net reduction in foreign‑currency‑denominated debt even as the Canadian‑dollar component ticked up【page_97】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference completely different data than what the ground truth provides. Critical issues: (1) QUANTITATIVE ERRORS - The LLM claims Canadian-denominated notes were $453 million in 2023 and $443 million in 2022, but the ground truth explicitly states Canadian notes were $3 million in 2021, $7 million in 2020, $17 million in 2019, with a $3 million decrease in 2022 and an $8 million increase in 2023. The LLM's figures are off by orders of magnitude (450+ million vs. single-digit millions). (2) MISALIGNMENT WITH GROUND TRUTH - The ground truth focuses on the reversal of a declining trend in Canadian notes (from $3M in 2021 to a decrease in 2022, then an increase of $8M in 2023), while the LLM discusses entirely different numbers suggesting Canadian notes in the hundreds of millions. (3) MULTI-HOP REASONING FAILURE - While the LLM attempts to address the broader foreign currency debt context (mentioning Euro and Swiss franc notes), it does so with incorrect baseline numbers for Canadian exposure, undermining the entire comparative analysis. (4) ENTITY/METRIC CONFUSION - The LLM appears to be citing different debt instruments or possibly confusing notional amounts with different metrics than what the ground truth references. The ground truth's focus on the $8 million increase in 2023 reversing prior downward trends is completely absent from the LLM response. This is a fundamental factual error that makes the answer unsuitable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 420,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "In the 2023 filing Accenture said its Accenture Ventures unit “partners with and invests in growth‑stage companies that create innovative enterprise technologies” —​a primarily financial‑investment relationship 【page_17】. By the 2024 filing the firm had broadened that model, tying the venture investments to its wider innovation system—Accenture Labs now incubates and prototypes concepts from those partners—so the engagement has moved from a mainly capital‑investment partnership to a more strategic, end‑to‑end co‑creation and scaling relationship 【page_17】.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the R&D spending figures ($1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024) that are explicitly mentioned in the ground truth as supporting context for Accenture's innovation strategy. These numbers are factually important to the answer. (2) FACTUAL CONTRADICTION: The ground truth clearly states the evolution was from 'partners with' (2023) to 'invests in' (2024) - a shift from partnership to direct investment. However, the LLM claims that in 2023 Accenture Ventures 'partners with AND invests in' growth-stage companies, which contradicts the ground truth's characterization of 2023 as primarily a partnership model. The LLM then describes 2024 as moving to 'co-creation and scaling' rather than emphasizing the shift to direct investment as the ground truth does. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize information about how Accenture Labs connects to the venture investments, which shows some multi-hop thinking, but this detail about Labs' role in incubation/prototyping is not mentioned in the ground truth and may represent over-interpretation or information from a different source. (4) SEMANTIC MISMATCH: The ground truth emphasizes a shift from 'partnership' to 'direct investment' as the key evolution, indicating deeper financial commitment. The LLM emphasizes a shift from 'capital-investment partnership' to 'co-creation and scaling,' which frames the evolution differently and misses the core distinction about investment approach. (5) MISSING CONTEXT: The R&D spending figures provide important quantitative context for understanding Accenture's broader innovation commitment and should have been included. The answer is partially correct in identifying an evolution in engagement, but fundamentally mischaracterizes the nature of that evolution and omits key quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 517,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck’s 2022 filing shows it still carries a $1.1 billion intangible‑asset balance for the Lynparza partnership, which is being amortized over its estimated useful life through 2028 (see page 102). By 2024 the collaboration’s commercial impact had grown – alliance revenue rose from $1.116 billion in 2022 to $1.311 billion in 2024, a ≈9 % increase year‑over‑year (see page 53 and the 9 % growth comment on page 55). This reflects continued strategic involvement and higher earnings from the partnership while the asset continues to be amortized on its original schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline evolution. STRENGTHS: (1) Correctly identifies the $1.1 billion intangible asset balance for Lynparza in 2022 and amortization schedule through 2028; (2) Accurately captures the 9% alliance revenue growth from 2022 to 2024; (3) Provides specific revenue figures ($1.116 billion in 2022 to $1.311 billion in 2024) that support the 9% growth claim; (4) Properly synthesizes multi-hop information showing the shift from asset amortization focus to revenue growth; (5) Correctly identifies higher demand in international markets as a driver. MINOR WEAKNESSES: (1) The LLM answer omits the 2025 China approval for adjuvant treatment in early breast cancer mentioned in the ground truth, which represents an important strategic development and expansion of therapeutic footprint; (2) Does not explicitly mention the capitalized milestone payments component of the intangible asset; (3) Page references (102, 53, 55) are cited but cannot be independently verified from the provided context. QUANTITATIVE VERIFICATION: The 9% growth calculation is mathematically sound: ($1.311B - $1.116B) / $1.116B ≈ 0.0875 or approximately 8.75%, which rounds to 9%. The revenue figures and asset balance are consistent with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across years (2022-2024) and connects asset amortization trends with revenue growth patterns, demonstrating proper multi-hop reasoning. The answer appropriately contextualizes the evolution from balance sheet asset management to operational revenue performance. The omission of the 2025 China approval is the primary gap, as this represents a forward-looking strategic development that demonstrates continued expansion of the collaboration's importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 503,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "In the 2023 filing, ValueOps is mentioned only as one of three broad “domains” (ValueOps, DevOps, AIOps) that together give end‑to‑end visibility across the digital lifecycle (2023 p. 10). By the 2024 filing, Broadcom provides a dedicated, detailed definition of ValueOps—highlighting it as a value‑stream‑management solution that aligns business and development, increases transparency, reduces inefficiencies and shortens time‑to‑value (2024 p. 11). This shift signals that ValueOps has been elevated from a generic portfolio category to a core, strategic pillar of the Distributed Software portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION - The LLM answer directly contradicts the ground truth on the 2023 positioning. Ground truth states that in 2023, ValueOps was 'listed as one of several key offerings...positioned alongside other solutions like DevOps and AIOps WITHOUT specific elaboration.' However, the LLM claims that in 2023, ValueOps was already 'one of three broad domains' giving 'end-to-end visibility across the digital lifecycle'—this is actually the 2024 characterization per the ground truth. The LLM has reversed or conflated the timeline. (2) MISATTRIBUTION OF CHARACTERISTICS - The ground truth indicates that the 2024 shift involved 'explicit emphasis on delivering end-to-end visibility,' but the LLM incorrectly attributes this visibility language to 2023. (3) PAGE REFERENCE ISSUES - The LLM cites specific page numbers (2023 p. 10, 2024 p. 11) that cannot be verified against the ground truth, and the content described for 2023 appears to match what should be 2024 content. (4) PARTIAL CORRECTNESS - The LLM correctly identifies that ValueOps was elevated to a 'core, strategic pillar' and correctly notes the shift from generic category to strategic emphasis. The description of ValueOps as 'value-stream-management solution that aligns business and development, increases transparency, reduces inefficiencies and shortens time-to-value' aligns with the ground truth's emphasis on 'business outcomes and customer experiences.' (5) INCOMPLETE SYNTHESIS - While the LLM captures the elevation narrative, it fails to properly establish the 2023 baseline (no specific elaboration) versus the 2024 advancement (explicit emphasis and detailed definition). The multi-hop reasoning is compromised by the temporal reversal of key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 481,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "In the 2023 filing FedEx presented Network 2.0 as a cornerstone of its DRIVE transformation that was expected to deliver “operational efficiencies and network flexibility, alignment of our cost base with demand, cost savings and reductions to our permanent cost structure” (2023 p. 29), but warned that a host of integration‑related risks – including legal challenges to Network 2.0, regulatory licensing, employee‑retention and other back‑office integration issues – could prevent those savings (2023 p. 29). By the 2024 filing the company had moved from the announcement stage to active execution (adding the one‑FedEx consolidation and the Tricolor air‑network redesign) and now cautioned that the ongoing integration could result in “higher than currently expected costs, less‑than‑expected savings” and expose it to additional implementation risks such as loss of customers, union organizing, litigation, government challenges and a longer‑than‑anticipated timeline (2024 p. 28‑30).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of FedEx's Network 2.0 strategy between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core strategic shift from planning/justification phase (2023) to execution/integration phase (2024); (2) Accurately characterizes 2023 messaging around operational efficiencies, network flexibility, and cost base alignment; (3) Properly identifies the transition to integration complexities and financial risk mitigation in 2024; (4) Correctly notes the shift from expected savings to acknowledgment of potential higher costs and lower-than-expected savings; (5) Appropriately references specific implementation risks (customer loss, union organizing, litigation, government challenges, timeline delays); (6) Includes specific page references (2023 p. 29, 2024 p. 28-30) that add credibility; (7) Mentions concrete execution elements (one-FedEx consolidation, Tricolor air-network redesign) that demonstrate knowledge of actual implementation. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions 'legal challenges to Network 2.0, regulatory licensing, employee-retention and back-office integration issues' in 2023, while the ground truth emphasizes 'failure to successfully execute Network 2.0 within expected time frame and cost' - the LLM provides more specific risk categories but the ground truth frames it more broadly as execution risk; (2) The ground truth explicitly mentions 'asset impairment charges, tax impacts, and litigation risks' as 2024 concerns, while the LLM focuses more on operational risks (customer loss, union organizing) - this is a minor omission of specific financial risk categories; (3) The ground truth emphasizes 'harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences' as specific 2024 integration complexities, while the LLM frames these more generally. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. The page references in the LLM answer appear reasonable but cannot be verified against the actual filings. MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and correctly identifies the progression from strategic planning to operational execution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and organization but equivalent factual content regarding the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 700,
        "total_tokens": 2228
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "In 2023 MD L Z recorded a $7 million pre‑tax gain from its equity‑method investment contracts, whereas no gain or loss was reported for 2022 (the line is blank for 2022)【page_98】. The shift from a neutral impact in 2022 to a positive gain in 2023 shows that the company’s equity‑method investments moved from being inactive to generating earnings, indicating a more active or successful engagement with those investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '2022 (the line is blank for 2022)' and claims 'no gain or loss was reported for 2022,' but the ground truth explicitly states MDLZ reported a NET LIABILITY of $3 million in 2022. This is a significant factual error - a $3 million liability is not the same as a blank line or no impact. The LLM misread or misinterpreted the source data. (2) The 2023 figure of $7 million gain is correct. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the year-over-year comparison. The ground truth shows a $10 million swing from a $3 million liability in 2022 to a $7 million gain in 2023 (a $10 million improvement). The LLM characterized 2022 as 'neutral' or 'blank,' which fundamentally misrepresents the financial position. (4) SEMANTIC INTERPRETATION - The LLM's conclusion that investments moved 'from being inactive to generating earnings' is partially reasonable but is based on incorrect data about 2022. The ground truth indicates a 'reversal in financial impact,' which is more accurate than 'from neutral to positive.' (5) The LLM correctly identified the company as MDLZ and the metric as equity method investment contracts, but the core numerical comparison is flawed. The answer demonstrates incomplete document review and misinterpretation of financial statement data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 378,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom estimated the cost to complete the VMware Cloud Foundation July 2024 releases at $38 million in fiscal 2023, and the same $38 million estimate appears in its fiscal 2024 filing【AVGO_10k_2023.pdf page 69】【AVGO_10k_2024.pdf page 69】.  The unchanged estimate signals that the project is progressing as expected, with no new cost overruns or reductions and development remaining on schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative accuracy is perfect: both the fiscal 2023 and fiscal 2024 estimates of $38 million are correct, and the comparison showing no change is accurate. The answer correctly identifies the company (Broadcom/AVGO), the specific product (VMware Cloud Foundation July 2024 releases), and the relevant fiscal years. The multi-hop reasoning is sound - the model successfully synthesized information across two 10-K filings (2023 and 2024) to compare the cost estimates and draw appropriate conclusions. The interpretation that an unchanged estimate indicates development proceeding as planned with no unexpected cost overruns or delays is logically sound and matches the ground truth reasoning. The answer includes specific document citations (page 69 from both filings) which adds credibility. Minor areas for enhancement: the answer could have been slightly more explicit about what 'proceeding as expected' means in terms of actual vs. projected expenditures aligning, though this is a very minor point. The semantic equivalence is excellent - the LLM's phrasing 'no new cost overruns or reductions and development remaining on schedule' conveys the same meaning as the ground truth's 'actual expenditures aligning with earlier projections' and 'no significant unexpected expenses or delays.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 376,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "In the 2023 filing the Ship and Go kiosk was presented mainly as a self‑serve label‑generation and drop‑off point at roughly 1,300 FedEx Office locations, emphasizing convenient shipping for e‑commerce customers (FDX 2023 p.15). By the 2024 filing the same kiosk is still highlighted for label creation, but FedEx now couples it with FedEx Returns Technology and the newly‑added FedEx Consolidated Returns service that lets shoppers drop off returns without a box or label, underscoring an expanded role as a combined shipping‑and‑returns hub (FDX 2024 p.15). This shift signals FedEx’s strategic push to make the kiosk a central touch‑point for both order fulfillment and streamlined returns, reinforcing its focus on e‑commerce logistics and a smoother returns experience for merchants and consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the kiosk presence at approximately 1,300 locations is accurately stated for both 2023 and 2024, with no calculation errors. ENTITY ACCURACY: FedEx Office, Ship and Go kiosk, FedEx Returns Technology, and FedEx Consolidated Returns are all correctly identified. Years (2023 vs 2024) are properly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the evolution from a primary emphasis on self-serve shipping to an expanded emphasis on returns management integration. The logical connection between the shift in description and strategic positioning is sound. COMPLETENESS: The answer addresses all parts of the question - how the positioning evolved, what it indicates about e-commerce logistics approach, and the returns management strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'shipping tool' to 'key node in returns infrastructure' aligns well with the ground truth's description of positioning it 'not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.' The phrase 'combined shipping-and-returns hub' effectively captures the strategic evolution. MINOR CONSIDERATIONS: The LLM includes page references (p.15) which, while helpful for verification, are not explicitly confirmed in the ground truth but do not contradict it. The wording is slightly more detailed and interpretive than the ground truth but remains factually accurate and appropriately contextualized. No factual errors, calculation mistakes, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 482,
        "total_tokens": 1920
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 999,
    "failed_evaluations": 1,
    "average_correctness_score": 5.99,
    "average_quantitative_accuracy": 6.46,
    "average_qualitative_accuracy": 6.22,
    "average_contextual_relevance": 7.3,
    "score_distribution": {
      "excellent": 247,
      "good": 236,
      "fair": 240,
      "poor": 276
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 7919.86,
    "timestamp": "2026-02-02T17:52:25.601663"
  }
}